ReferenceAllele,AlternateAllele,Chromosome,Start,Stop,GeneSymbol,ClinicalSignificance,PhenotypeList,Type,Assembly
na,na,7,4820844,4820847,AP5Z1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 48|Macular dystrophy with or without extraocular features|not provided,Indel,GRCh37
na,na,7,4781213,4781216,AP5Z1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 48|Macular dystrophy with or without extraocular features|not provided,Indel,GRCh38
na,na,7,4827361,4827374,AP5Z1,Pathogenic,Hereditary spastic paraplegia 48,Deletion,GRCh37
na,na,7,4787730,4787743,AP5Z1,Pathogenic,Hereditary spastic paraplegia 48,Deletion,GRCh38
na,na,15,85342440,85342440,ZNF592,Uncertain significance,Galloway-Mowat syndrome 1,single nucleotide variant,GRCh37
na,na,15,84799209,84799209,ZNF592,Uncertain significance,Galloway-Mowat syndrome 1,single nucleotide variant,GRCh38
na,na,11,126145284,126145284,FOXRED1,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 19|not provided|Leigh syndrome|FOXRED1-related disorder",single nucleotide variant,GRCh37
na,na,11,126275389,126275389,FOXRED1,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 19|not provided|Leigh syndrome|FOXRED1-related disorder",single nucleotide variant,GRCh38
na,na,11,126147412,126147412,FOXRED1,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 19",single nucleotide variant,GRCh37
na,na,11,126277517,126277517,FOXRED1,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 19",single nucleotide variant,GRCh38
na,na,14,32031331,32031331,NUBPL,Conflicting classifications of pathogenicity,"not provided|Inborn genetic diseases|not specified|Mitochondrial complex 1 deficiency, nuclear type 21",single nucleotide variant,GRCh37
na,na,14,31562125,31562125,NUBPL,Conflicting classifications of pathogenicity,"not provided|Inborn genetic diseases|not specified|Mitochondrial complex 1 deficiency, nuclear type 21",single nucleotide variant,GRCh38
na,na,6,26093141,26093141,HFE,"Pathogenic/Pathogenic, low penetrance; other; risk factor",Hemochromatosis type 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary hemochromatosis|Porphyrinuria;Cutaneous photosensitivity|Bronze diabetes|7 conditions|Cardiomyopathy|HFE-related disorder|Inborn genetic diseases|6 conditions|Juvenile hemochromatosis,single nucleotide variant,GRCh37
na,na,6,26092913,26092913,HFE,"Pathogenic/Pathogenic, low penetrance; other; risk factor",Hemochromatosis type 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary hemochromatosis|Porphyrinuria;Cutaneous photosensitivity|Bronze diabetes|7 conditions|Cardiomyopathy|HFE-related disorder|Inborn genetic diseases|6 conditions|Juvenile hemochromatosis,single nucleotide variant,GRCh38
na,na,6,26091179,26091179,HFE,Conflicting classifications of pathogenicity; other,Hemochromatosis type 1|not provided|Hereditary hemochromatosis|6 conditions|not specified|Bronze diabetes|Cystic fibrosis|Cardiomyopathy|Variegate porphyria|See cases,single nucleotide variant,GRCh37
na,na,6,26090951,26090951,HFE,Conflicting classifications of pathogenicity; other,Hemochromatosis type 1|not provided|Hereditary hemochromatosis|6 conditions|not specified|Bronze diabetes|Cystic fibrosis|Cardiomyopathy|Variegate porphyria|See cases,single nucleotide variant,GRCh38
na,na,6,26091185,26091185,HFE,Conflicting classifications of pathogenicity,Hemochromatosis type 1|Hereditary hemochromatosis|6 conditions|not provided|not specified|6 conditions|HFE-related disorder,single nucleotide variant,GRCh37
na,na,6,26090957,26090957,HFE,Conflicting classifications of pathogenicity,Hemochromatosis type 1|Hereditary hemochromatosis|6 conditions|not provided|not specified|6 conditions|HFE-related disorder,single nucleotide variant,GRCh38
na,na,6,26091306,26091306,HFE,Uncertain significance,Hemochromatosis type 1|Hereditary hemochromatosis,single nucleotide variant,GRCh37
na,na,6,26091078,26091078,HFE,Uncertain significance,Hemochromatosis type 1|Hereditary hemochromatosis,single nucleotide variant,GRCh38
na,na,6,26091269,26091269,HFE,Uncertain significance,Hemochromatosis type 1|not specified,single nucleotide variant,GRCh37
na,na,6,26091041,26091041,HFE,Uncertain significance,Hemochromatosis type 1|not specified,single nucleotide variant,GRCh38
na,na,6,26093236,26093236,HFE,Benign,HFE INTRONIC POLYMORPHISM|not provided,single nucleotide variant,GRCh37
na,na,6,26093008,26093008,HFE,Benign,HFE INTRONIC POLYMORPHISM|not provided,single nucleotide variant,GRCh38
na,na,6,26091149,26091149,HFE,Uncertain significance,HFE POLYMORPHISM|Hemochromatosis type 1|not provided,single nucleotide variant,GRCh37
na,na,6,26090921,26090921,HFE,Uncertain significance,HFE POLYMORPHISM|Hemochromatosis type 1|not provided,single nucleotide variant,GRCh38
na,na,6,26091167,26091167,HFE,Uncertain significance,HFE POLYMORPHISM|Hemochromatosis type 1|not specified,single nucleotide variant,GRCh37
na,na,6,26090939,26090939,HFE,Uncertain significance,HFE POLYMORPHISM|Hemochromatosis type 1|not specified,single nucleotide variant,GRCh38
na,na,6,26091582,26091582,HFE,Uncertain significance,Hemochromatosis type 1|not specified,single nucleotide variant,GRCh37
na,na,6,26091354,26091354,HFE,Uncertain significance,Hemochromatosis type 1|not specified,single nucleotide variant,GRCh38
na,na,6,26093443,26093443,HFE,Pathogenic,Hemochromatosis type 1,single nucleotide variant,GRCh37
na,na,6,26093215,26093215,HFE,Pathogenic,Hemochromatosis type 1,single nucleotide variant,GRCh38
na,na,6,26093144,26093144,HFE,Pathogenic/Likely pathogenic,Hemochromatosis type 1|Hereditary hemochromatosis|not provided|Incidental Discovery,single nucleotide variant,GRCh37
na,na,6,26092916,26092916,HFE,Pathogenic/Likely pathogenic,Hemochromatosis type 1|Hereditary hemochromatosis|not provided|Incidental Discovery,single nucleotide variant,GRCh38
na,na,2,20189045,20189045,WDR35,Pathogenic,Cranioectodermal dysplasia 2,single nucleotide variant,GRCh37
na,na,2,19989284,19989284,WDR35,Pathogenic,Cranioectodermal dysplasia 2,single nucleotide variant,GRCh38
na,na,2,20145548,20145548,WDR35,Pathogenic,Cranioectodermal dysplasia 2,single nucleotide variant,GRCh37
na,na,2,19945787,19945787,WDR35,Pathogenic,Cranioectodermal dysplasia 2,single nucleotide variant,GRCh38
na,na,2,20131136,20131136,WDR35,Pathogenic,Cranioectodermal dysplasia 2|Short-rib thoracic dysplasia 7 with or without polydactyly;Cranioectodermal dysplasia 2,Deletion,GRCh37
na,na,2,19931375,19931375,WDR35,Pathogenic,Cranioectodermal dysplasia 2|Short-rib thoracic dysplasia 7 with or without polydactyly;Cranioectodermal dysplasia 2,Deletion,GRCh38
na,na,2,20133230,20133230,WDR35,Likely pathogenic,Cranioectodermal dysplasia 2|not provided,single nucleotide variant,GRCh37
na,na,2,19933469,19933469,WDR35,Likely pathogenic,Cranioectodermal dysplasia 2|not provided,single nucleotide variant,GRCh38
na,na,20,25304045,25304046,ABHD12,Pathogenic,PHARC syndrome|not provided,Indel,GRCh37
na,na,20,25323409,25323410,ABHD12,Pathogenic,PHARC syndrome|not provided,Indel,GRCh38
na,GG,20,25364147,25378237,ABHD12,Pathogenic,PHARC syndrome,Indel,GRCh37
na,GG,20,25383511,25397601,ABHD12,Pathogenic,PHARC syndrome,Indel,GRCh38
na,na,20,25288616,25288617,ABHD12,Pathogenic,PHARC syndrome,Duplication,GRCh37
na,na,20,25307980,25307981,ABHD12,Pathogenic,PHARC syndrome,Duplication,GRCh38
na,na,20,25282958,25282958,ABHD12,Pathogenic,PHARC syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,25302322,25302322,ABHD12,Pathogenic,PHARC syndrome|not provided,single nucleotide variant,GRCh38
na,na,2,27601023,27601023,ZNF513,Conflicting classifications of pathogenicity,Retinitis pigmentosa 58|not provided,single nucleotide variant,GRCh37
na,na,2,27378156,27378156,ZNF513,Conflicting classifications of pathogenicity,Retinitis pigmentosa 58|not provided,single nucleotide variant,GRCh38
na,na,10,99371369,99371371,HOGA1,Pathogenic/Likely pathogenic,Primary hyperoxaluria type 3|not provided|HOGA1-related disorder,Microsatellite,GRCh37
na,na,10,97611612,97611614,HOGA1,Pathogenic/Likely pathogenic,Primary hyperoxaluria type 3|not provided|HOGA1-related disorder,Microsatellite,GRCh38
na,na,10,99371292,99371292,HOGA1,Pathogenic,Primary hyperoxaluria type 3|not provided,single nucleotide variant,GRCh37
na,na,10,97611535,97611535,HOGA1,Pathogenic,Primary hyperoxaluria type 3|not provided,single nucleotide variant,GRCh38
na,na,10,99358609,99358609,HOGA1,Pathogenic/Likely pathogenic,Primary hyperoxaluria type 3|not provided|HOGA1-related disorder,single nucleotide variant,GRCh37
na,na,10,97598852,97598852,HOGA1,Pathogenic/Likely pathogenic,Primary hyperoxaluria type 3|not provided|HOGA1-related disorder,single nucleotide variant,GRCh38
na,na,10,99359924,99359924,HOGA1,Pathogenic,Primary hyperoxaluria type 3,single nucleotide variant,GRCh37
na,na,10,97600167,97600167,HOGA1,Pathogenic,Primary hyperoxaluria type 3,single nucleotide variant,GRCh38
na,na,10,99344669,99344669,HOGA1,Pathogenic,Primary hyperoxaluria type 3|not provided,single nucleotide variant,GRCh37
na,na,10,97584912,97584912,HOGA1,Pathogenic,Primary hyperoxaluria type 3|not provided,single nucleotide variant,GRCh38
na,na,10,99361682,99361682,HOGA1,Pathogenic/Likely pathogenic,Primary hyperoxaluria type 3|not provided,single nucleotide variant,GRCh37
na,na,10,97601925,97601925,HOGA1,Pathogenic/Likely pathogenic,Primary hyperoxaluria type 3|not provided,single nucleotide variant,GRCh38
na,na,2,62067454,62067454,FAM161A,Pathogenic,Retinitis pigmentosa 28|Retinal dystrophy|Autosomal recessive retinitis pigmentosa|not provided,single nucleotide variant,GRCh37
na,na,2,61840319,61840319,FAM161A,Pathogenic,Retinitis pigmentosa 28|Retinal dystrophy|Autosomal recessive retinitis pigmentosa|not provided,single nucleotide variant,GRCh38
na,na,2,62066830,62066830,FAM161A,Pathogenic,Retinitis pigmentosa 28|not provided|Cone-rod dystrophy|Retinal dystrophy|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,2,61839695,61839695,FAM161A,Pathogenic,Retinitis pigmentosa 28|not provided|Cone-rod dystrophy|Retinal dystrophy|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,2,62066783,62066784,FAM161A,Pathogenic,Retinitis pigmentosa 28|not provided|Retinitis pigmentosa|Retinal dystrophy,Deletion,GRCh37
na,na,2,61839648,61839649,FAM161A,Pathogenic,Retinitis pigmentosa 28|not provided|Retinitis pigmentosa|Retinal dystrophy,Deletion,GRCh38
na,na,2,62066572,62066572,FAM161A,Pathogenic,Retinitis pigmentosa 28|Retinal dystrophy|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,2,61839437,61839437,FAM161A,Pathogenic,Retinitis pigmentosa 28|Retinal dystrophy|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,2,62063210,62063210,FAM161A,Pathogenic,Retinitis pigmentosa 28|not provided,single nucleotide variant,GRCh37
na,na,2,61836075,61836075,FAM161A,Pathogenic,Retinitis pigmentosa 28|not provided,single nucleotide variant,GRCh38
na,na,19,36595471,36595474,WDR62,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",Deletion,GRCh37
na,na,19,36104569,36104572,WDR62,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",Deletion,GRCh38
na,na,19,36575580,36575580,WDR62,Uncertain significance,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations|not provided|Autosomal recessive primary microcephaly|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,19,36084678,36084678,WDR62,Uncertain significance,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations|not provided|Autosomal recessive primary microcephaly|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,19,36558317,36558317,WDR62,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",single nucleotide variant,GRCh37
na,na,19,36067415,36067415,WDR62,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",single nucleotide variant,GRCh38
na,na,19,36574001,36574001,WDR62,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",single nucleotide variant,GRCh37
na,na,19,36083099,36083099,WDR62,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",single nucleotide variant,GRCh38
na,na,19,36594568,36594584,WDR62,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",Deletion,GRCh37
na,na,19,36103666,36103682,WDR62,Pathogenic,"Microcephaly 2, primary, autosomal recessive, with or without cortical malformations",Deletion,GRCh38
na,na,2,63720075,63720075,WDPCP,Pathogenic,Bardet-Biedl syndrome 15,single nucleotide variant,GRCh37
na,na,2,63492941,63492941,WDPCP,Pathogenic,Bardet-Biedl syndrome 15,single nucleotide variant,GRCh38
na,na,2,63664564,63664564,WDPCP,risk factor,"Bardet-Biedl syndrome 12, modifier of",single nucleotide variant,GRCh37
na,na,2,63437430,63437430,WDPCP,risk factor,"Bardet-Biedl syndrome 12, modifier of",single nucleotide variant,GRCh38
na,na,2,63714625,63714625,WDPCP,risk factor,"Meckel syndrome, type 6, modifier of",single nucleotide variant,GRCh37
na,na,2,63487491,63487491,WDPCP,risk factor,"Meckel syndrome, type 6, modifier of",single nucleotide variant,GRCh38
na,na,16,2546588,2546588,TBC1D24,Pathogenic,"Familial infantile myoclonic epilepsy|Developmental and epileptic encephalopathy, 1;Autosomal dominant nonsyndromic hearing loss 65;Caused by mutation in the TBC1 domain family, member 24",single nucleotide variant,GRCh37
na,na,16,2496587,2496587,TBC1D24,Pathogenic,"Familial infantile myoclonic epilepsy|Developmental and epileptic encephalopathy, 1;Autosomal dominant nonsyndromic hearing loss 65;Caused by mutation in the TBC1 domain family, member 24",single nucleotide variant,GRCh38
na,na,16,2550823,2550823,TBC1D24,Conflicting classifications of pathogenicity,"Familial infantile myoclonic epilepsy|Developmental and epileptic encephalopathy, 1;Autosomal dominant nonsyndromic hearing loss 65;Caused by mutation in the TBC1 domain family, member 24|not provided|DOORS syndrome|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,16,2500822,2500822,TBC1D24,Conflicting classifications of pathogenicity,"Familial infantile myoclonic epilepsy|Developmental and epileptic encephalopathy, 1;Autosomal dominant nonsyndromic hearing loss 65;Caused by mutation in the TBC1 domain family, member 24|not provided|DOORS syndrome|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,16,2546900,2546900,TBC1D24,Pathogenic,Familial infantile myoclonic epilepsy,single nucleotide variant,GRCh37
na,na,16,2496899,2496899,TBC1D24,Pathogenic,Familial infantile myoclonic epilepsy,single nucleotide variant,GRCh38
na,na,22,41320486,41320486,XPNPEP3,Pathogenic,Nephronophthisis-like nephropathy 1,single nucleotide variant,GRCh37
na,na,22,40924482,40924482,XPNPEP3,Pathogenic,Nephronophthisis-like nephropathy 1,single nucleotide variant,GRCh38
na,na,22,41305199,41305202,XPNPEP3,Pathogenic,Nephronophthisis-like nephropathy 1,Deletion,GRCh37
na,na,22,40909195,40909198,XPNPEP3,Pathogenic,Nephronophthisis-like nephropathy 1,Deletion,GRCh38
na,na,12,123738469,123738469,MTRFR,Pathogenic/Likely pathogenic,Combined oxidative phosphorylation defect type 7|Abnormal brain morphology|Hereditary spastic paraplegia 55|Epileptic encephalopathy,Deletion,GRCh37
na,na,12,123253922,123253922,MTRFR,Pathogenic/Likely pathogenic,Combined oxidative phosphorylation defect type 7|Abnormal brain morphology|Hereditary spastic paraplegia 55|Epileptic encephalopathy,Deletion,GRCh38
na,na,12,123738431,123738431,MTRFR,Pathogenic/Likely pathogenic,Combined oxidative phosphorylation defect type 7|not provided|Spastic paraplegia;Combined oxidative phosphorylation defect type 7,Deletion,GRCh37
na,na,12,123253884,123253884,MTRFR,Pathogenic/Likely pathogenic,Combined oxidative phosphorylation defect type 7|not provided|Spastic paraplegia;Combined oxidative phosphorylation defect type 7,Deletion,GRCh38
na,na,15,49085556,49085556,CEP152,Pathogenic/Likely pathogenic,"Microcephaly 9, primary, autosomal recessive|CEP152-related disorder|not provided|Microcephaly 9, primary, autosomal recessive;Seckel syndrome 5",single nucleotide variant,GRCh37
na,na,15,48793359,48793359,CEP152,Pathogenic/Likely pathogenic,"Microcephaly 9, primary, autosomal recessive|CEP152-related disorder|not provided|Microcephaly 9, primary, autosomal recessive;Seckel syndrome 5",single nucleotide variant,GRCh38
na,na,15,49048486,49048486,CEP152,Pathogenic/Likely pathogenic,"Microcephaly 9, primary, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,15,48756289,48756289,CEP152,Pathogenic/Likely pathogenic,"Microcephaly 9, primary, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,1,243507579,243507579,SDCCAG8,Pathogenic,Senior-Loken syndrome 7|Bardet-Biedl syndrome 16;Senior-Loken syndrome 7|not provided|Bardet-Biedl syndrome,Deletion,GRCh37
na,na,1,243344277,243344277,SDCCAG8,Pathogenic,Senior-Loken syndrome 7|Bardet-Biedl syndrome 16;Senior-Loken syndrome 7|not provided|Bardet-Biedl syndrome,Deletion,GRCh38
na,na,1,243504455,243504456,SDCCAG8,Pathogenic,Senior-Loken syndrome 7,Duplication,GRCh37
na,na,1,243341153,243341154,SDCCAG8,Pathogenic,Senior-Loken syndrome 7,Duplication,GRCh38
na,na,1,243589819,243589822,SDCCAG8,Pathogenic,Senior-Loken syndrome 7,Microsatellite,GRCh37
na,na,1,243426517,243426520,SDCCAG8,Pathogenic,Senior-Loken syndrome 7,Microsatellite,GRCh38
na,na,1,243468435,243468435,SDCCAG8,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 16|Senior-Loken syndrome 7|Bardet-Biedl syndrome|Bardet-Biedl syndrome 16;Senior-Loken syndrome 7|SDCCAG8-related disorder,single nucleotide variant,GRCh37
na,na,1,243305133,243305133,SDCCAG8,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 16|Senior-Loken syndrome 7|Bardet-Biedl syndrome|Bardet-Biedl syndrome 16;Senior-Loken syndrome 7|SDCCAG8-related disorder,single nucleotide variant,GRCh38
na,na,1,243468018,243468018,SDCCAG8,Pathogenic,Bardet-Biedl syndrome 16|Bardet-Biedl syndrome 16;Senior-Loken syndrome 7,single nucleotide variant,GRCh37
na,na,1,243304716,243304716,SDCCAG8,Pathogenic,Bardet-Biedl syndrome 16|Bardet-Biedl syndrome 16;Senior-Loken syndrome 7,single nucleotide variant,GRCh38
na,na,7,128415610,128415610,OPN1SW,Likely benign,Blue color blindness|not provided,single nucleotide variant,GRCh37
na,na,7,128775556,128775556,OPN1SW,Likely benign,Blue color blindness|not provided,single nucleotide variant,GRCh38
na,na,7,128414599,128414599,OPN1SW,Uncertain significance,Blue color blindness|not provided,single nucleotide variant,GRCh37
na,na,7,128774545,128774545,OPN1SW,Uncertain significance,Blue color blindness|not provided,single nucleotide variant,GRCh38
na,na,7,128413840,128413840,OPN1SW,Uncertain significance,Blue color blindness|not provided,single nucleotide variant,GRCh37
na,na,7,128773786,128773786,OPN1SW,Uncertain significance,Blue color blindness|not provided,single nucleotide variant,GRCh38
na,na,1,45480475,45480475,UROD,Pathogenic/Likely pathogenic,Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh37
na,na,1,45014803,45014803,UROD,Pathogenic/Likely pathogenic,Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh38
na,na,1,45480475,45480475,UROD,Pathogenic,Hepatoerythropoietic porphyria|Porphyria cutanea tarda|Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh37
na,na,1,45014803,45014803,UROD,Pathogenic,Hepatoerythropoietic porphyria|Porphyria cutanea tarda|Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh38
na,na,1,45479743,45479743,UROD,Pathogenic,Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh37
na,na,1,45014071,45014071,UROD,Pathogenic,Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh38
na,na,1,45479605,45479605,UROD,Uncertain significance,Hepatoerythropoietic porphyria|not provided,single nucleotide variant,GRCh37
na,na,1,45013933,45013933,UROD,Uncertain significance,Hepatoerythropoietic porphyria|not provided,single nucleotide variant,GRCh38
na,na,1,45480507,45480507,UROD,Pathogenic,Hepatoerythropoietic porphyria,single nucleotide variant,GRCh37
na,na,1,45014835,45014835,UROD,Pathogenic,Hepatoerythropoietic porphyria,single nucleotide variant,GRCh38
na,na,1,45478859,45478859,UROD,Pathogenic,Hepatoerythropoietic porphyria|not provided,single nucleotide variant,GRCh37
na,na,1,45013187,45013187,UROD,Pathogenic,Hepatoerythropoietic porphyria|not provided,single nucleotide variant,GRCh38
na,na,1,45480668,45480668,UROD,Conflicting classifications of pathogenicity,Hepatoerythropoietic porphyria|Sporadic porphyria cutanea tarda|not provided,single nucleotide variant,GRCh37
na,na,1,45014996,45014996,UROD,Conflicting classifications of pathogenicity,Hepatoerythropoietic porphyria|Sporadic porphyria cutanea tarda|not provided,single nucleotide variant,GRCh38
na,na,1,45480678,45480678,UROD,Likely pathogenic,Familial porphyria cutanea tarda|not provided|UROD-related disorder,single nucleotide variant,GRCh37
na,na,1,45015006,45015006,UROD,Likely pathogenic,Familial porphyria cutanea tarda|not provided|UROD-related disorder,single nucleotide variant,GRCh38
na,na,1,45479600,45479600,UROD,Pathogenic/Likely pathogenic,Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh37
na,na,1,45013928,45013928,UROD,Pathogenic/Likely pathogenic,Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh38
na,na,1,45479689,45479689,UROD,Pathogenic,Familial porphyria cutanea tarda,single nucleotide variant,GRCh37
na,na,1,45014017,45014017,UROD,Pathogenic,Familial porphyria cutanea tarda,single nucleotide variant,GRCh38
na,na,1,45480648,45480648,UROD,Pathogenic,Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh37
na,na,1,45014976,45014976,UROD,Pathogenic,Familial porphyria cutanea tarda|not provided,single nucleotide variant,GRCh38
na,na,1,45481061,45481061,UROD,Conflicting classifications of pathogenicity,Familial porphyria cutanea tarda,single nucleotide variant,GRCh37
na,na,1,45015389,45015389,UROD,Conflicting classifications of pathogenicity,Familial porphyria cutanea tarda,single nucleotide variant,GRCh38
na,na,10,90984925,90984925,LIPA,Pathogenic,Wolman disease|Lysosomal acid lipase deficiency|Cholesteryl ester storage disease,single nucleotide variant,GRCh37
na,na,10,89225168,89225168,LIPA,Pathogenic,Wolman disease|Lysosomal acid lipase deficiency|Cholesteryl ester storage disease,single nucleotide variant,GRCh38
na,na,10,90983467,90983467,LIPA,Pathogenic,Lysosomal acid lipase deficiency|Cholesteryl ester storage disease|not provided|Wolman disease|Cholesteryl ester storage disease;Wolman disease,single nucleotide variant,GRCh37
na,na,10,89223710,89223710,LIPA,Pathogenic,Lysosomal acid lipase deficiency|Cholesteryl ester storage disease|not provided|Wolman disease|Cholesteryl ester storage disease;Wolman disease,single nucleotide variant,GRCh38
na,na,10,90984929,90984930,LIPA,Pathogenic,Wolman disease|Lysosomal acid lipase deficiency|Cholesteryl ester storage disease|not provided|LIPA-related disorder,Duplication,GRCh37
na,na,10,89225172,89225173,LIPA,Pathogenic,Wolman disease|Lysosomal acid lipase deficiency|Cholesteryl ester storage disease|not provided|LIPA-related disorder,Duplication,GRCh38
na,na,10,90982267,90982267,LIPA,Pathogenic,Wolman disease,single nucleotide variant,GRCh37
na,na,10,89222510,89222510,LIPA,Pathogenic,Wolman disease,single nucleotide variant,GRCh38
na,na,10,91005533,91005533,LIPA,Pathogenic,Wolman disease,single nucleotide variant,GRCh37
na,na,10,89245776,89245776,LIPA,Pathogenic,Wolman disease,single nucleotide variant,GRCh38
na,na,10,100242490,100242490,HPSE2,Pathogenic/Likely pathogenic,Urofacial syndrome type 1|not provided,single nucleotide variant,GRCh37
na,na,10,98482733,98482733,HPSE2,Pathogenic/Likely pathogenic,Urofacial syndrome type 1|not provided,single nucleotide variant,GRCh38
na,na,10,100249808,100249809,HPSE2,Pathogenic/Likely pathogenic,Urofacial syndrome type 1|not provided,Deletion,GRCh37
na,na,10,98490051,98490052,HPSE2,Pathogenic/Likely pathogenic,Urofacial syndrome type 1|not provided,Deletion,GRCh38
na,na,10,100995318,100995319,HPSE2,Pathogenic,Urofacial syndrome type 1,Microsatellite,GRCh37
na,na,10,99235561,99235562,HPSE2,Pathogenic,Urofacial syndrome type 1,Microsatellite,GRCh38
na,na,na,-1,-1,HPSE2,Pathogenic,Urofacial syndrome type 1,Indel,na
na,na,na,-1,-1,HPSE2,Pathogenic,Urofacial syndrome type 1,Deletion,na
na,na,10,100249860,100249860,HPSE2,Pathogenic,Urofacial syndrome type 1|not provided,single nucleotide variant,GRCh37
na,na,10,98490103,98490103,HPSE2,Pathogenic,Urofacial syndrome type 1|not provided,single nucleotide variant,GRCh38
na,na,10,100904148,100904148,HPSE2,Pathogenic/Likely pathogenic,Urofacial syndrome type 1|Congenital anomaly of kidney and urinary tract|not provided,single nucleotide variant,GRCh37
na,na,10,99144391,99144391,HPSE2,Pathogenic/Likely pathogenic,Urofacial syndrome type 1|Congenital anomaly of kidney and urinary tract|not provided,single nucleotide variant,GRCh38
na,na,10,100995502,100995503,HPSE2,Pathogenic,Urofacial syndrome type 1|HPSE2-related disorder,Duplication,GRCh37
na,na,10,99235745,99235746,HPSE2,Pathogenic,Urofacial syndrome type 1|HPSE2-related disorder,Duplication,GRCh38
na,na,8,17919233,17919233,ASAH1,Pathogenic,Farber lipogranulomatosis,single nucleotide variant,GRCh37
na,na,8,18061724,18061724,ASAH1,Pathogenic,Farber lipogranulomatosis,single nucleotide variant,GRCh38
na,na,8,17922010,17922010,ASAH1,Likely pathogenic,Farber lipogranulomatosis|not provided,single nucleotide variant,GRCh37
na,na,8,18064501,18064501,ASAH1,Likely pathogenic,Farber lipogranulomatosis|not provided,single nucleotide variant,GRCh38
na,na,8,17933068,17933068,ASAH1,Pathogenic/Likely pathogenic,Farber lipogranulomatosis|not provided,single nucleotide variant,GRCh37
na,na,8,18075559,18075559,ASAH1,Pathogenic/Likely pathogenic,Farber lipogranulomatosis|not provided,single nucleotide variant,GRCh38
na,na,8,17916933,17916933,ASAH1,Pathogenic,Farber lipogranulomatosis,single nucleotide variant,GRCh37
na,na,8,18059424,18059424,ASAH1,Pathogenic,Farber lipogranulomatosis,single nucleotide variant,GRCh38
na,na,8,17919892,17919892,ASAH1,Pathogenic,Farber lipogranulomatosis,single nucleotide variant,GRCh37
na,na,8,18062383,18062383,ASAH1,Pathogenic,Farber lipogranulomatosis,single nucleotide variant,GRCh38
na,na,22,31011758,31011761,TCN2,Pathogenic,Transcobalamin II deficiency,Deletion,GRCh37
na,na,22,30615771,30615774,TCN2,Pathogenic,Transcobalamin II deficiency,Deletion,GRCh38
na,na,22,31011610,31011610,TCN2,Benign,TCN2 POLYMORPHISM|not specified|Transcobalamin II deficiency|not provided,single nucleotide variant,GRCh37
na,na,22,30615623,30615623,TCN2,Benign,TCN2 POLYMORPHISM|not specified|Transcobalamin II deficiency|not provided,single nucleotide variant,GRCh38
na,na,22,31009031,31009031,TCN2,Pathogenic,Transcobalamin II deficiency,single nucleotide variant,GRCh37
na,na,22,30613044,30613044,TCN2,Pathogenic,Transcobalamin II deficiency,single nucleotide variant,GRCh38
na,na,22,31012077,31014228,TCN2,Pathogenic,Transcobalamin II deficiency,Indel,GRCh37
na,na,22,30616090,30618241,TCN2,Pathogenic,Transcobalamin II deficiency,Indel,GRCh38
na,na,22,31011112,31011112,TCN2,Pathogenic,Transcobalamin II deficiency,single nucleotide variant,GRCh37
na,na,22,30615125,30615125,TCN2,Pathogenic,Transcobalamin II deficiency,single nucleotide variant,GRCh38
na,na,2,29296369,29296369,PCARE,Pathogenic,Retinitis pigmentosa 54,single nucleotide variant,GRCh37
na,na,2,29073503,29073503,PCARE,Pathogenic,Retinitis pigmentosa 54,single nucleotide variant,GRCh38
na,na,2,29296527,29296527,PCARE,Uncertain significance,Retinitis pigmentosa 54|not provided,single nucleotide variant,GRCh37
na,na,2,29073661,29073661,PCARE,Uncertain significance,Retinitis pigmentosa 54|not provided,single nucleotide variant,GRCh38
na,na,2,29296181,29296181,PCARE,Pathogenic,Retinitis pigmentosa 54|not provided|Stargardt disease,Deletion,GRCh37
na,na,2,29073315,29073315,PCARE,Pathogenic,Retinitis pigmentosa 54|not provided|Stargardt disease,Deletion,GRCh38
na,na,2,29296572,29296572,PCARE,Pathogenic,Retinitis pigmentosa 54|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,2,29073706,29073706,PCARE,Pathogenic,Retinitis pigmentosa 54|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,2,29294360,29294372,PCARE,Pathogenic,Retinitis pigmentosa 54|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|not provided|Retinal dystrophy,Deletion,GRCh37
na,na,2,29071494,29071506,PCARE,Pathogenic,Retinitis pigmentosa 54|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|not provided|Retinal dystrophy,Deletion,GRCh38
na,na,9,130548229,130548229,MIR2861,association,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15,single nucleotide variant,GRCh37
na,na,9,127785950,127785950,MIR2861,association,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15,single nucleotide variant,GRCh38
na,na,2,96919855,96919855,TMEM127,Pathogenic,"Pheochromocytoma, susceptibility to|Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma",single nucleotide variant,GRCh37
na,na,2,96254117,96254117,TMEM127,Pathogenic,"Pheochromocytoma, susceptibility to|Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma",single nucleotide variant,GRCh38
na,na,2,96919788,96919788,TMEM127,Pathogenic/Likely pathogenic,"Pheochromocytoma, susceptibility to|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma",single nucleotide variant,GRCh37
na,na,2,96254050,96254050,TMEM127,Pathogenic/Likely pathogenic,"Pheochromocytoma, susceptibility to|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma",single nucleotide variant,GRCh38
na,na,2,96920736,96920736,TMEM127,Pathogenic/Likely pathogenic,"Pheochromocytoma, susceptibility to|Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|not provided",single nucleotide variant,GRCh37
na,na,2,96254998,96254998,TMEM127,Pathogenic/Likely pathogenic,"Pheochromocytoma, susceptibility to|Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|not provided",single nucleotide variant,GRCh38
na,na,2,96930970,96930971,TMEM127,Likely pathogenic; risk factor,"Pheochromocytoma, susceptibility to|Pheochromocytoma",Duplication,GRCh37
na,na,2,96265232,96265233,TMEM127,Likely pathogenic; risk factor,"Pheochromocytoma, susceptibility to|Pheochromocytoma",Duplication,GRCh38
na,na,14,77910654,77910654,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",single nucleotide variant,GRCh37
na,na,14,77444311,77444311,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",single nucleotide variant,GRCh38
na,na,14,77907418,77907422,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",Deletion,GRCh37
na,na,14,77441075,77441079,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",Deletion,GRCh38
na,na,14,77908979,77908979,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",single nucleotide variant,GRCh37
na,na,14,77442636,77442636,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",single nucleotide variant,GRCh38
na,na,14,77902228,77902228,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",single nucleotide variant,GRCh37
na,na,14,77435885,77435885,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",single nucleotide variant,GRCh38
na,na,14,77920444,77920444,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",single nucleotide variant,GRCh37
na,na,14,77454101,77454101,VIPAS39,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 2",single nucleotide variant,GRCh38
na,na,13,29233226,29233226,POMP,Pathogenic,Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome|not provided,Deletion,GRCh37
na,na,13,28659089,28659089,POMP,Pathogenic,Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome|not provided,Deletion,GRCh38
na,na,21,44483098,44483098,CBS,Pathogenic,"Homocystinuria, pyridoxine-nonresponsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder",single nucleotide variant,GRCh37
na,na,21,43062988,43062988,CBS,Pathogenic,"Homocystinuria, pyridoxine-nonresponsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder",single nucleotide variant,GRCh38
na,na,21,44486370,44486370,CBS,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",single nucleotide variant,GRCh37
na,na,21,43066260,43066260,CBS,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",single nucleotide variant,GRCh38
na,na,21,44486463,44486463,CBS,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|not provided|Homocystinuria|Classic homocystinuria|CBS-related disorder|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh37
na,na,21,43066353,43066353,CBS,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|not provided|Homocystinuria|Classic homocystinuria|CBS-related disorder|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh38
na,na,21,44483184,44483184,CBS,Pathogenic,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|Homocystinuria|Intellectual disability|Connective tissue disorder|See cases|Familial thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm or dissection",single nucleotide variant,GRCh37
na,na,21,43063074,43063074,CBS,Pathogenic,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|Homocystinuria|Intellectual disability|Connective tissue disorder|See cases|Familial thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm or dissection",single nucleotide variant,GRCh38
na,na,21,44486389,44486389,CBS,Conflicting classifications of pathogenicity,"Homocystinuria, pyridoxine-responsive|not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",single nucleotide variant,GRCh37
na,na,21,43066279,43066279,CBS,Conflicting classifications of pathogenicity,"Homocystinuria, pyridoxine-responsive|not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",single nucleotide variant,GRCh38
na,na,21,44486374,44486374,CBS,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder",single nucleotide variant,GRCh37
na,na,21,43066264,43066264,CBS,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder",single nucleotide variant,GRCh38
na,na,21,44479409,44479409,CBS,Likely pathogenic,"Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",single nucleotide variant,GRCh37
na,na,21,43059299,43059299,CBS,Likely pathogenic,"Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",single nucleotide variant,GRCh38
na,na,21,44474030,44474030,CBS,Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",single nucleotide variant,GRCh37
na,na,21,43053920,43053920,CBS,Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED",single nucleotide variant,GRCh38
na,na,21,44484041,44484041,CBS,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh37
na,na,21,43063931,43063931,CBS,Pathogenic/Likely pathogenic,"Homocystinuria, pyridoxine-responsive|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh38
na,na,21,44478972,44478972,CBS,Pathogenic/Likely pathogenic,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder",single nucleotide variant,GRCh37
na,na,21,43058862,43058862,CBS,Pathogenic/Likely pathogenic,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder",single nucleotide variant,GRCh38
na,na,21,44485755,44485755,CBS,Conflicting classifications of pathogenicity,"Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Homocystinuria",single nucleotide variant,GRCh37
na,na,21,43065645,43065645,CBS,Conflicting classifications of pathogenicity,"Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Homocystinuria",single nucleotide variant,GRCh38
na,na,21,44479080,44479080,CBS,Pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh37
na,na,21,43058970,43058970,CBS,Pathogenic,"Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh38
na,na,21,44479037,44479037,CBS,Conflicting classifications of pathogenicity,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Familial thoracic aortic aneurysm and aortic dissection|Classic homocystinuria",single nucleotide variant,GRCh37
na,na,21,43058927,43058927,CBS,Conflicting classifications of pathogenicity,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Familial thoracic aortic aneurysm and aortic dissection|Classic homocystinuria",single nucleotide variant,GRCh38
na,na,21,44478325,44478325,CBS,Conflicting classifications of pathogenicity,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not specified",single nucleotide variant,GRCh37
na,na,21,43058215,43058215,CBS,Conflicting classifications of pathogenicity,"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not specified",single nucleotide variant,GRCh38
na,na,21,44480638,44480638,CBS,Pathogenic,"Homocystinuria, pyridoxine-nonresponsive|not provided|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh37
na,na,21,43060528,43060528,CBS,Pathogenic,"Homocystinuria, pyridoxine-nonresponsive|not provided|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh38
na,na,21,44485591,44485591,CBS,Pathogenic,"Homocystinuria, pyridoxine-nonresponsive|not provided|Homocystinuria|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh37
na,na,21,43065481,43065481,CBS,Pathogenic,"Homocystinuria, pyridoxine-nonresponsive|not provided|Homocystinuria|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh38
na,na,9,140093925,140093925,TPRN,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 79|Hearing loss, autosomal recessive",single nucleotide variant,GRCh37
na,na,9,137199473,137199473,TPRN,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 79|Hearing loss, autosomal recessive",single nucleotide variant,GRCh38
na,na,9,140093737,140093737,TPRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 79,Deletion,GRCh37
na,na,9,137199285,137199285,TPRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 79,Deletion,GRCh38
na,na,9,140094926,140094927,TPRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 79,Duplication,GRCh37
na,na,9,137200474,137200475,TPRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 79,Duplication,GRCh38
na,na,9,140094929,140094939,TPRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 79|not provided|TPRN-related disorder|Rare genetic deafness,Microsatellite,GRCh37
na,na,9,137200477,137200487,TPRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 79|not provided|TPRN-related disorder|Rare genetic deafness,Microsatellite,GRCh38
na,na,9,140093634,140093634,TPRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 79,Deletion,GRCh37
na,na,9,137199182,137199182,TPRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 79,Deletion,GRCh38
na,na,20,741754,741755,SLC52A3,Likely pathogenic,Brown-Vialetto-van Laere syndrome 1|not provided,Deletion,GRCh37
na,na,20,761110,761111,SLC52A3,Likely pathogenic,Brown-Vialetto-van Laere syndrome 1|not provided,Deletion,GRCh38
na,na,20,746208,746208,SLC52A3,Pathogenic,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,GRCh37
na,na,20,765564,765564,SLC52A3,Pathogenic,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,GRCh38
na,na,20,746025,746025,SLC52A3,Uncertain significance,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,GRCh37
na,na,20,765381,765381,SLC52A3,Uncertain significance,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,GRCh38
na,na,20,744545,744545,SLC52A3,Pathogenic,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,GRCh37
na,na,20,763901,763901,SLC52A3,Pathogenic,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,GRCh38
na,na,20,746313,746313,SLC52A3,Conflicting classifications of pathogenicity,Brown-Vialetto-van Laere syndrome 1|not provided|Progressive bulbar palsy of childhood,single nucleotide variant,GRCh37
na,na,20,765669,765669,SLC52A3,Conflicting classifications of pathogenicity,Brown-Vialetto-van Laere syndrome 1|not provided|Progressive bulbar palsy of childhood,single nucleotide variant,GRCh38
na,na,20,741842,741842,SLC52A3,Uncertain significance,Brown-Vialetto-van Laere syndrome 1|not specified,single nucleotide variant,GRCh37
na,na,20,761198,761198,SLC52A3,Uncertain significance,Brown-Vialetto-van Laere syndrome 1|not specified,single nucleotide variant,GRCh38
na,na,20,746337,746337,SLC52A3,Pathogenic,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,GRCh37
na,na,20,765693,765693,SLC52A3,Pathogenic,Brown-Vialetto-van Laere syndrome 1,single nucleotide variant,GRCh38
na,na,10,126100738,126100738,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124412169,124412169,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126100582,126100582,OAT,Pathogenic,Ornithine aminotransferase deficiency,Deletion,GRCh37
na,na,10,124412013,124412013,OAT,Pathogenic,Ornithine aminotransferase deficiency,Deletion,GRCh38
na,na,10,126094101,126094103,OAT,Pathogenic,Ornithine aminotransferase deficiency,Deletion,GRCh37
na,na,10,124405532,124405534,OAT,Pathogenic,Ornithine aminotransferase deficiency,Deletion,GRCh38
na,na,10,126086645,126086645,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,10,124398076,124398076,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,10,126100578,126100578,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124412009,124412009,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126097456,126097456,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124408887,124408887,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126097170,126097170,OAT,Conflicting classifications of pathogenicity,Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh37
na,na,10,124408601,124408601,OAT,Conflicting classifications of pathogenicity,Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh38
na,na,10,126094114,126094114,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124405545,124405545,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126091588,126091588,OAT,Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124403019,124403019,OAT,Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126091584,126091584,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124403015,124403015,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126086626,126086626,OAT,Pathogenic,Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh37
na,na,10,124398057,124398057,OAT,Pathogenic,Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh38
na,na,10,126086581,126086581,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124398012,124398012,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126086520,126086520,OAT,Benign,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124397951,124397951,OAT,Benign,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126089444,126089444,OAT,Conflicting classifications of pathogenicity,Ornithine aminotransferase deficiency|Retinal dystrophy|not specified,single nucleotide variant,GRCh37
na,na,10,124400875,124400875,OAT,Conflicting classifications of pathogenicity,Ornithine aminotransferase deficiency|Retinal dystrophy|not specified,single nucleotide variant,GRCh38
na,na,10,126092404,126092404,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124403835,124403835,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126089434,126089434,OAT,Benign,Ornithine aminotransferase deficiency|not provided|not specified,single nucleotide variant,GRCh37
na,na,10,124400865,124400865,OAT,Benign,Ornithine aminotransferase deficiency|not provided|not specified,single nucleotide variant,GRCh38
na,na,10,126090315,126090315,OAT,Pathogenic/Likely pathogenic,Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia|Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124401746,124401746,OAT,Pathogenic/Likely pathogenic,Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia|Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126100579,126100579,OAT,Conflicting classifications of pathogenicity,Ornithine aminotransferase deficiency|not specified,single nucleotide variant,GRCh37
na,na,10,124412010,124412010,OAT,Conflicting classifications of pathogenicity,Ornithine aminotransferase deficiency|not specified,single nucleotide variant,GRCh38
na,na,10,126090354,126090354,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124401785,124401785,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126097202,126097210,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,Deletion,GRCh37
na,na,10,124408633,124408641,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,Deletion,GRCh38
na,na,10,126094103,126094103,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124405534,124405534,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126092416,126092416,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh37
na,na,10,124403847,124403847,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh38
na,na,10,126092389,126092389,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124403820,124403820,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126089510,126089510,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,10,124400941,124400941,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,10,126086659,126086659,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124398090,124398090,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126086651,126086651,OAT,Uncertain significance,Ornithine aminotransferase deficiency|not specified,single nucleotide variant,GRCh37
na,na,10,124398082,124398082,OAT,Uncertain significance,Ornithine aminotransferase deficiency|not specified,single nucleotide variant,GRCh38
na,na,10,126086630,126086630,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124398061,124398061,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126093233,126094310,OAT,Pathogenic,Ornithine aminotransferase deficiency,Deletion,GRCh37
na,na,10,124404664,124405741,OAT,Pathogenic,Ornithine aminotransferase deficiency,Deletion,GRCh38
na,na,10,126094026,126094026,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124405457,124405457,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126091499,126091499,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,10,124402930,124402930,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,10,126086555,126086555,OAT,Pathogenic,Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh37
na,na,10,124397986,124397986,OAT,Pathogenic,Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh38
na,na,10,126100548,126100549,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,Microsatellite,GRCh37
na,na,10,124411979,124411980,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,Microsatellite,GRCh38
na,na,10,126094120,126094120,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124405551,124405551,OAT,Pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126091572,126091572,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124403003,124403003,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126092461,126092461,OAT,Pathogenic/Likely pathogenic,Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia|Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh37
na,na,10,124403892,124403892,OAT,Pathogenic/Likely pathogenic,Gyrate atrophy of choroid and retina with pyridoxine-responsive ornithinemia|Ornithine aminotransferase deficiency|Hyperornithinemia,single nucleotide variant,GRCh38
na,na,10,126097466,126097466,OAT,Uncertain significance,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124408897,124408897,OAT,Uncertain significance,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,10,126094057,126094057,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh37
na,na,10,124405488,124405488,OAT,Pathogenic/Likely pathogenic,Ornithine aminotransferase deficiency,single nucleotide variant,GRCh38
na,na,8,105440299,105440299,DPYS,Pathogenic,Dihydropyrimidinase deficiency|not provided,single nucleotide variant,GRCh37
na,na,8,104428071,104428071,DPYS,Pathogenic,Dihydropyrimidinase deficiency|not provided,single nucleotide variant,GRCh38
na,na,8,105405152,105405152,DPYS,Pathogenic,Dihydropyrimidinase deficiency,single nucleotide variant,GRCh37
na,na,8,104392924,104392924,DPYS,Pathogenic,Dihydropyrimidinase deficiency,single nucleotide variant,GRCh38
na,na,8,105440222,105440222,DPYS,Pathogenic/Likely pathogenic,Dihydropyrimidinase deficiency|not provided,single nucleotide variant,GRCh37
na,na,8,104427994,104427994,DPYS,Pathogenic/Likely pathogenic,Dihydropyrimidinase deficiency|not provided,single nucleotide variant,GRCh38
na,na,8,105436475,105436475,DPYS,Pathogenic,Dihydropyrimidinase deficiency,single nucleotide variant,GRCh37
na,na,8,104424247,104424247,DPYS,Pathogenic,Dihydropyrimidinase deficiency,single nucleotide variant,GRCh38
na,na,5,171849428,171849429,SH3PXD2B,Pathogenic,Frank-Ter Haar syndrome,Duplication,GRCh37
na,na,5,172422424,172422425,SH3PXD2B,Pathogenic,Frank-Ter Haar syndrome,Duplication,GRCh38
na,na,5,171777410,171777410,SH3PXD2B,Pathogenic,Frank-Ter Haar syndrome,Deletion,GRCh37
na,na,5,172350406,172350406,SH3PXD2B,Pathogenic,Frank-Ter Haar syndrome,Deletion,GRCh38
na,na,5,171849449,171849449,SH3PXD2B,Likely pathogenic,Frank-Ter Haar syndrome,single nucleotide variant,GRCh37
na,na,5,172422445,172422445,SH3PXD2B,Likely pathogenic,Frank-Ter Haar syndrome,single nucleotide variant,GRCh38
na,na,5,171849502,171849502,SH3PXD2B,Pathogenic,Frank-Ter Haar syndrome,single nucleotide variant,GRCh37
na,na,5,172422498,172422498,SH3PXD2B,Pathogenic,Frank-Ter Haar syndrome,single nucleotide variant,GRCh38
CTG,na,13,70713516,70713518,ATXN8;ATXN8OS;LOC109461478,Benign,Spinocerebellar ataxia type 8,Microsatellite,GRCh37
CTG,na,13,70139384,70139386,ATXN8;ATXN8OS;LOC109461478,Benign,Spinocerebellar ataxia type 8,Microsatellite,GRCh38
na,na,4,43022362,43022362,GRXCR1,Pathogenic,Autosomal recessive nonsyndromic hearing loss 25|not provided,single nucleotide variant,GRCh37
na,na,4,43020345,43020345,GRXCR1,Pathogenic,Autosomal recessive nonsyndromic hearing loss 25|not provided,single nucleotide variant,GRCh38
na,na,4,42965170,42965170,GRXCR1,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 25|not provided,single nucleotide variant,GRCh37
na,na,4,42963153,42963153,GRXCR1,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 25|not provided,single nucleotide variant,GRCh38
na,na,4,42895512,42895512,GRXCR1,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 25|Hearing loss, autosomal recessive",single nucleotide variant,GRCh37
na,na,4,42893495,42893495,GRXCR1,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 25|Hearing loss, autosomal recessive",single nucleotide variant,GRCh38
na,na,4,42964936,42964936,GRXCR1,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 25|not provided,single nucleotide variant,GRCh37
na,na,4,42962919,42962919,GRXCR1,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 25|not provided,single nucleotide variant,GRCh38
na,na,11,61161437,61161437,TMEM216,Pathogenic,"Joubert syndrome 2|Meckel syndrome, type 2|not provided|Joubert syndrome|Inborn genetic diseases|TMEM216-related disorder|Joubert syndrome 2;Meckel syndrome, type 2",single nucleotide variant,GRCh37
na,na,11,61393965,61393965,TMEM216,Pathogenic,"Joubert syndrome 2|Meckel syndrome, type 2|not provided|Joubert syndrome|Inborn genetic diseases|TMEM216-related disorder|Joubert syndrome 2;Meckel syndrome, type 2",single nucleotide variant,GRCh38
na,na,11,61161437,61161437,TMEM216,Pathogenic/Likely pathogenic,"Joubert syndrome 2|Meckel syndrome, type 2|Joubert syndrome|Joubert syndrome 2;Meckel syndrome, type 2",single nucleotide variant,GRCh37
na,na,11,61393965,61393965,TMEM216,Pathogenic/Likely pathogenic,"Joubert syndrome 2|Meckel syndrome, type 2|Joubert syndrome|Joubert syndrome 2;Meckel syndrome, type 2",single nucleotide variant,GRCh38
na,na,11,61165357,61165357,TMEM216,Pathogenic/Likely pathogenic,"Meckel syndrome, type 2",single nucleotide variant,GRCh37
na,na,11,61397885,61397885,TMEM216,Pathogenic/Likely pathogenic,"Meckel syndrome, type 2",single nucleotide variant,GRCh38
na,na,11,61165246,61165246,TMEM216,Pathogenic/Likely pathogenic,"Meckel syndrome, type 2",single nucleotide variant,GRCh37
na,na,11,61397774,61397774,TMEM216,Pathogenic/Likely pathogenic,"Meckel syndrome, type 2",single nucleotide variant,GRCh38
na,na,16,58051236,58051236,USB1,Pathogenic,Poikiloderma with neutropenia,single nucleotide variant,GRCh37
na,na,16,58017332,58017332,USB1,Pathogenic,Poikiloderma with neutropenia,single nucleotide variant,GRCh38
na,na,16,58052949,58052960,USB1,Pathogenic,Poikiloderma with neutropenia,Deletion,GRCh37
na,na,16,58019045,58019056,USB1,Pathogenic,Poikiloderma with neutropenia,Deletion,GRCh38
na,na,16,58048229,58048229,USB1,Pathogenic,Poikiloderma with neutropenia,single nucleotide variant,GRCh37
na,na,16,58014325,58014325,USB1,Pathogenic,Poikiloderma with neutropenia,single nucleotide variant,GRCh38
na,na,17,21703214,21703214,KCNJ18,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",Deletion,GRCh38
na,na,17,356212,356212,KCNJ18,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,17,21703847,21703847,KCNJ18,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,17,355765,355765,KCNJ18,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,17,21703400,21703400,KCNJ18,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,17,356248,356248,KCNJ18,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,17,21703883,21703883,KCNJ18,risk factor,"Thyrotoxic periodic paralysis, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,19,33892768,33892768,PEPD,Pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,19,33401862,33401862,PEPD,Pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,33878749,33879530,PEPD,Pathogenic,Prolidase deficiency,Deletion,GRCh37
na,na,19,33387843,33388624,PEPD,Pathogenic,Prolidase deficiency,Deletion,GRCh38
na,na,19,33954966,33954966,PEPD,Likely pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,19,33464060,33464060,PEPD,Likely pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,33892761,33892761,PEPD,Pathogenic/Likely pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,19,33401855,33401855,PEPD,Pathogenic/Likely pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,33878798,33878798,PEPD,Pathogenic/Likely pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,19,33387892,33387892,PEPD,Pathogenic/Likely pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,33878371,33878373,PEPD,Uncertain significance,Prolidase deficiency|not provided,Microsatellite,GRCh37
na,na,19,33387465,33387467,PEPD,Uncertain significance,Prolidase deficiency|not provided,Microsatellite,GRCh38
na,na,19,33902603,33902603,PEPD,Pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,19,33411697,33411697,PEPD,Pathogenic,Prolidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,33878906,33878906,PEPD,Pathogenic,Prolidase deficiency,single nucleotide variant,GRCh37
na,na,19,33388000,33388000,PEPD,Pathogenic,Prolidase deficiency,single nucleotide variant,GRCh38
na,na,19,33954893,33954894,PEPD,Pathogenic,Prolidase deficiency|not provided,Duplication,GRCh37
na,na,19,33463987,33463988,PEPD,Pathogenic,Prolidase deficiency|not provided,Duplication,GRCh38
na,na,19,33954912,33954912,PEPD,Pathogenic,Prolidase deficiency,single nucleotide variant,GRCh37
na,na,19,33464006,33464006,PEPD,Pathogenic,Prolidase deficiency,single nucleotide variant,GRCh38
na,na,4,178359918,178359918,AGA,Pathogenic,"Aspartylglucosaminuria, finnish type|Aspartylglucosaminuria",single nucleotide variant,GRCh37
na,na,4,177438764,177438764,AGA,Pathogenic,"Aspartylglucosaminuria, finnish type|Aspartylglucosaminuria",single nucleotide variant,GRCh38
na,na,4,178354404,178354404,AGA,Pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh37
na,na,4,177433250,177433250,AGA,Pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh38
na,na,4,178354392,178354392,AGA,Likely pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh37
na,na,4,177433238,177433238,AGA,Likely pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh38
na,na,4,178361529,178361529,AGA,Likely pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh37
na,na,4,177440375,177440375,AGA,Likely pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh38
na,na,4,178360822,178360822,AGA,Pathogenic/Likely pathogenic,Aspartylglucosaminuria|not provided|Autism,single nucleotide variant,GRCh37
na,na,4,177439668,177439668,AGA,Pathogenic/Likely pathogenic,Aspartylglucosaminuria|not provided|Autism,single nucleotide variant,GRCh38
na,na,4,178363422,178363428,AGA,Pathogenic/Likely pathogenic,Aspartylglucosaminuria,Deletion,GRCh37
na,na,4,177442268,177442274,AGA,Pathogenic/Likely pathogenic,Aspartylglucosaminuria,Deletion,GRCh38
na,na,4,178355541,178355542,AGA,Pathogenic,Aspartylglucosaminuria|Inborn genetic diseases|not provided,Duplication,GRCh37
na,na,4,177434387,177434388,AGA,Pathogenic,Aspartylglucosaminuria|Inborn genetic diseases|not provided,Duplication,GRCh38
na,na,4,178363402,178363403,AGA,Pathogenic/Likely pathogenic,Aspartylglucosaminuria,Insertion,GRCh37
na,na,4,177442248,177442249,AGA,Pathogenic/Likely pathogenic,Aspartylglucosaminuria,Insertion,GRCh38
na,na,4,178354367,178354367,AGA,Pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh37
na,na,4,177433213,177433213,AGA,Pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh38
na,na,4,178355542,178355542,AGA,Pathogenic,Aspartylglucosaminuria,Deletion,GRCh37
na,na,4,177434388,177434388,AGA,Pathogenic,Aspartylglucosaminuria,Deletion,GRCh38
na,na,4,178361494,178361494,AGA,Pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh37
na,na,4,177440340,177440340,AGA,Pathogenic,Aspartylglucosaminuria,single nucleotide variant,GRCh38
na,na,18,71930714,71930714,CYB5A,Pathogenic,Methemoglobinemia type 4,single nucleotide variant,GRCh37
na,na,18,74263479,74263479,CYB5A,Pathogenic,Methemoglobinemia type 4,single nucleotide variant,GRCh38
na,na,15,53908055,53908055,WDR72,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A3,single nucleotide variant,GRCh37
na,na,15,53615858,53615858,WDR72,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A3,single nucleotide variant,GRCh38
na,na,15,53901728,53901728,WDR72,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A3|not provided,single nucleotide variant,GRCh37
na,na,15,53609531,53609531,WDR72,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A3|not provided,single nucleotide variant,GRCh38
na,na,15,53905878,53905878,WDR72,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A3,Deletion,GRCh37
na,na,15,53613681,53613681,WDR72,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A3,Deletion,GRCh38
na,na,22,43024239,43024239,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh37
na,na,22,42628233,42628233,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh38
na,na,22,43027437,43027437,CYB5R3,Likely pathogenic,"METHEMOGLOBINEMIA, TYPE I|not provided|CYB5R3-related disorder",single nucleotide variant,GRCh37
na,na,22,42631431,42631431,CYB5R3,Likely pathogenic,"METHEMOGLOBINEMIA, TYPE I|not provided|CYB5R3-related disorder",single nucleotide variant,GRCh38
na,na,22,43024175,43024175,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE I",single nucleotide variant,GRCh37
na,na,22,42628169,42628169,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE I",single nucleotide variant,GRCh38
na,na,22,43026905,43026905,CYB5R3,Uncertain significance,"METHEMOGLOBINEMIA, TYPE I|not provided",single nucleotide variant,GRCh37
na,na,22,42630899,42630899,CYB5R3,Uncertain significance,"METHEMOGLOBINEMIA, TYPE I|not provided",single nucleotide variant,GRCh38
na,na,22,43015952,43015952,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh37
na,na,22,42619946,42619946,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh38
na,na,22,43024150,43024150,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh37
na,na,22,42628144,42628144,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh38
na,na,22,43019873,43019873,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh37
na,na,22,42623867,42623867,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh38
na,na,22,43023333,43023333,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh37
na,na,22,42627327,42627327,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",single nucleotide variant,GRCh38
na,na,22,43015866,43015868,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",Deletion,GRCh37
na,na,22,42619860,42619862,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",Deletion,GRCh38
na,na,22,43015788,43015790,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",Deletion,GRCh37
na,na,22,42619782,42619784,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II",Deletion,GRCh38
na,na,22,43024271,43024271,CYB5R3,Benign,CYB5R3 POLYMORPHISM|not provided|not specified,single nucleotide variant,GRCh37
na,na,22,42628265,42628265,CYB5R3,Benign,CYB5R3 POLYMORPHISM|not provided|not specified,single nucleotide variant,GRCh38
na,na,22,43023696,43023696,CYB5R3,Pathogenic/Likely pathogenic,"METHEMOGLOBINEMIA, TYPE II|Deficiency of cytochrome-b5 reductase|not provided",single nucleotide variant,GRCh37
na,na,22,42627690,42627690,CYB5R3,Pathogenic/Likely pathogenic,"METHEMOGLOBINEMIA, TYPE II|Deficiency of cytochrome-b5 reductase|not provided",single nucleotide variant,GRCh38
na,na,22,43027392,43027392,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE I",single nucleotide variant,GRCh37
na,na,22,42631386,42631386,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE I",single nucleotide variant,GRCh38
na,na,22,43026992,43026992,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II|not provided",single nucleotide variant,GRCh37
na,na,22,42630986,42630986,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II|not provided",single nucleotide variant,GRCh38
na,na,22,43023680,43023680,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II|not provided|Deficiency of cytochrome-b5 reductase",single nucleotide variant,GRCh37
na,na,22,42627674,42627674,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE II|not provided|Deficiency of cytochrome-b5 reductase",single nucleotide variant,GRCh38
na,na,22,43023332,43023332,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE I|Hereditary methemoglobinemia",single nucleotide variant,GRCh37
na,na,22,42627326,42627326,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE I|Hereditary methemoglobinemia",single nucleotide variant,GRCh38
na,na,22,43015810,43015810,CYB5R3,Pathogenic/Likely pathogenic,"METHEMOGLOBINEMIA, TYPE I|not provided|Deficiency of cytochrome-b5 reductase",single nucleotide variant,GRCh37
na,na,22,42619804,42619804,CYB5R3,Pathogenic/Likely pathogenic,"METHEMOGLOBINEMIA, TYPE I|not provided|Deficiency of cytochrome-b5 reductase",single nucleotide variant,GRCh38
na,na,22,43015917,43015919,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE I",Microsatellite,GRCh37
na,na,22,42619911,42619913,CYB5R3,Pathogenic,"METHEMOGLOBINEMIA, TYPE I",Microsatellite,GRCh38
na,na,22,43019809,43019809,CYB5R3,Conflicting classifications of pathogenicity,"METHEMOGLOBINEMIA, TYPE I|Deficiency of cytochrome-b5 reductase|not provided",single nucleotide variant,GRCh37
na,na,22,42623803,42623803,CYB5R3,Conflicting classifications of pathogenicity,"METHEMOGLOBINEMIA, TYPE I|Deficiency of cytochrome-b5 reductase|not provided",single nucleotide variant,GRCh38
na,na,3,14200382,14200382,XPC,Benign/Likely benign,"Xeroderma pigmentosum, group C|not specified|not provided|Xeroderma pigmentosum|XPC-related disorder",single nucleotide variant,GRCh37
na,na,3,14158882,14158882,XPC,Benign/Likely benign,"Xeroderma pigmentosum, group C|not specified|not provided|Xeroderma pigmentosum|XPC-related disorder",single nucleotide variant,GRCh38
na,na,na,-1,-1,XPC,Pathogenic,"Xeroderma pigmentosum, group C",Insertion,na
na,na,na,-1,-1,XPC,no classification for the single variant,-,Insertion,na
na,na,3,14200090,14200091,XPC,Pathogenic,"Xeroderma pigmentosum, group C",Deletion,GRCh37
na,na,3,14158590,14158591,XPC,Pathogenic,"Xeroderma pigmentosum, group C",Deletion,GRCh38
na,na,3,14197833,14197833,XPC,Pathogenic,"Xeroderma pigmentosum, group C",single nucleotide variant,GRCh37
na,na,3,14156333,14156333,XPC,Pathogenic,"Xeroderma pigmentosum, group C",single nucleotide variant,GRCh38
na,na,3,14208723,14208724,XPC,Pathogenic,"Xeroderma pigmentosum, group C|not provided|Xeroderma pigmentosum",Microsatellite,GRCh37
na,na,3,14167223,14167224,XPC,Pathogenic,"Xeroderma pigmentosum, group C|not provided|Xeroderma pigmentosum",Microsatellite,GRCh38
na,na,3,14199648,14199648,XPC,Pathogenic,"Xeroderma pigmentosum, group C|Xeroderma pigmentosum|not provided",single nucleotide variant,GRCh37
na,na,3,14158148,14158148,XPC,Pathogenic,"Xeroderma pigmentosum, group C|Xeroderma pigmentosum|not provided",single nucleotide variant,GRCh38
na,na,3,14209889,14209889,XPC,Pathogenic,"Xeroderma pigmentosum, group C",single nucleotide variant,GRCh37
na,na,3,14168389,14168389,XPC,Pathogenic,"Xeroderma pigmentosum, group C",single nucleotide variant,GRCh38
na,na,3,14209904,14209904,XPC,Pathogenic/Likely pathogenic,"Xeroderma pigmentosum, group C|not provided",single nucleotide variant,GRCh37
na,na,3,14168404,14168404,XPC,Pathogenic/Likely pathogenic,"Xeroderma pigmentosum, group C|not provided",single nucleotide variant,GRCh38
na,na,3,14199739,14199740,XPC,Pathogenic,"Xeroderma pigmentosum, group C|Xeroderma pigmentosum|not provided|See cases|XPC-related disorder",Microsatellite,GRCh37
na,na,3,14158239,14158240,XPC,Pathogenic,"Xeroderma pigmentosum, group C|Xeroderma pigmentosum|not provided|See cases|XPC-related disorder",Microsatellite,GRCh38
na,na,16,84203778,84203779,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Kartagener syndrome|Primary ciliary dyskinesia,Duplication,GRCh37
na,na,16,84170172,84170173,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Kartagener syndrome|Primary ciliary dyskinesia,Duplication,GRCh38
na,na,16,84193349,84193349,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Primary ciliary dyskinesia,single nucleotide variant,GRCh37
na,na,16,84159744,84159744,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Primary ciliary dyskinesia,single nucleotide variant,GRCh38
na,na,16,84193330,84193330,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Primary ciliary dyskinesia,single nucleotide variant,GRCh37
na,na,16,84159725,84159725,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Primary ciliary dyskinesia,single nucleotide variant,GRCh38
na,na,16,84188335,84188336,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Primary ciliary dyskinesia,Duplication,GRCh37
na,na,16,84154730,84154731,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Primary ciliary dyskinesia,Duplication,GRCh38
na,na,16,84188353,84188353,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Kartagener syndrome,single nucleotide variant,GRCh37
na,na,16,84154748,84154748,DNAAF1,Pathogenic,Primary ciliary dyskinesia 13|Kartagener syndrome,single nucleotide variant,GRCh38
na,na,10,112572068,112572068,RBM20,Pathogenic,Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Dilated cardiomyopathy 1S|Dilated cardiomyopathy 1A|RBM20-related disorder,single nucleotide variant,GRCh37
na,na,10,110812310,110812310,RBM20,Pathogenic,Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Dilated cardiomyopathy 1S|Dilated cardiomyopathy 1A|RBM20-related disorder,single nucleotide variant,GRCh38
na,na,10,112572056,112572056,RBM20,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1DD|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,10,110812298,110812298,RBM20,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1DD|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,10,112572061,112572061,RBM20,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1DD|Cardiovascular phenotype|Primary familial dilated cardiomyopathy|not provided|Primary dilated cardiomyopathy,single nucleotide variant,GRCh37
na,na,10,110812303,110812303,RBM20,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1DD|Cardiovascular phenotype|Primary familial dilated cardiomyopathy|not provided|Primary dilated cardiomyopathy,single nucleotide variant,GRCh38
na,na,10,112572062,112572062,RBM20,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy|not provided|Primary familial dilated cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype|RBM20-related disorder,single nucleotide variant,GRCh37
na,na,10,110812304,110812304,RBM20,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1DD|Primary dilated cardiomyopathy|not provided|Primary familial dilated cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype|RBM20-related disorder,single nucleotide variant,GRCh38
na,na,10,112572064,112572064,RBM20,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1DD|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,10,110812306,110812306,RBM20,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1DD|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,3,49209095,49209095,KLHDC8B,Likely benign,Classic Hodgkin lymphoma|not provided,single nucleotide variant,GRCh37
na,na,3,49171662,49171662,KLHDC8B,Likely benign,Classic Hodgkin lymphoma|not provided,single nucleotide variant,GRCh38
na,na,17,1657783,1657784,SERPINF2,Pathogenic,Alpha-2-plasmin inhibitor deficiency,Duplication,GRCh37
na,na,17,1754489,1754490,SERPINF2,Pathogenic,Alpha-2-plasmin inhibitor deficiency,Duplication,GRCh38
na,na,17,1650615,1650617,SERPINF2,Pathogenic,Alpha-2-plasmin inhibitor deficiency,Microsatellite,GRCh37
na,na,17,1747321,1747323,SERPINF2,Pathogenic,Alpha-2-plasmin inhibitor deficiency,Microsatellite,GRCh38
na,na,17,1657583,1657583,SERPINF2,Pathogenic,Alpha-2-plasmin inhibitor deficiency,single nucleotide variant,GRCh37
na,na,17,1754289,1754289,SERPINF2,Pathogenic,Alpha-2-plasmin inhibitor deficiency,single nucleotide variant,GRCh38
na,na,17,79009664,79009817,CANT1,Pathogenic,Desbuquois dysplasia 1,Deletion,GRCh38
na,na,17,76991201,76991201,CANT1,Pathogenic,Desbuquois dysplasia 1,Deletion,GRCh37
na,na,17,78995119,78995119,CANT1,Pathogenic,Desbuquois dysplasia 1,Deletion,GRCh38
na,na,17,76989940,76989940,CANT1,Pathogenic/Likely pathogenic,Desbuquois dysplasia 1|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,17,78993858,78993858,CANT1,Pathogenic/Likely pathogenic,Desbuquois dysplasia 1|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,17,76989939,76989939,CANT1,Likely pathogenic,Desbuquois dysplasia 1,single nucleotide variant,GRCh37
na,na,17,78993857,78993857,CANT1,Likely pathogenic,Desbuquois dysplasia 1,single nucleotide variant,GRCh38
na,na,17,76989928,76989929,CANT1,Pathogenic,Desbuquois dysplasia 1,Insertion,GRCh37
na,na,17,78993846,78993847,CANT1,Pathogenic,Desbuquois dysplasia 1,Insertion,GRCh38
na,na,17,76993331,76993331,CANT1,Conflicting classifications of pathogenicity,"Desbuquois dysplasia 1|Desbuquois dysplasia 1;Epiphyseal dysplasia, multiple, 7",single nucleotide variant,GRCh37
na,na,17,78997249,78997249,CANT1,Conflicting classifications of pathogenicity,"Desbuquois dysplasia 1|Desbuquois dysplasia 1;Epiphyseal dysplasia, multiple, 7",single nucleotide variant,GRCh38
na,na,17,76989942,76989942,CANT1,Likely pathogenic,Desbuquois dysplasia 1|CANT1-related disorder,single nucleotide variant,GRCh37
na,na,17,78993860,78993860,CANT1,Likely pathogenic,Desbuquois dysplasia 1|CANT1-related disorder,single nucleotide variant,GRCh38
na,na,12,6127701,6127701,VWF,Pathogenic,Von Willebrand disease type 2A|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|VWF-related disorder|von Willebrand disorder,single nucleotide variant,GRCh37
na,na,12,6018535,6018535,VWF,Pathogenic,Von Willebrand disease type 2A|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|VWF-related disorder|von Willebrand disorder,single nucleotide variant,GRCh38
na,na,12,6127795,6127795,VWF,Pathogenic,Von Willebrand disease type 2A|not provided|not specified|Hereditary von Willebrand disease|Inborn genetic diseases|von Willebrand disease type 2,single nucleotide variant,GRCh37
na,na,12,6018629,6018629,VWF,Pathogenic,Von Willebrand disease type 2A|not provided|not specified|Hereditary von Willebrand disease|Inborn genetic diseases|von Willebrand disease type 2,single nucleotide variant,GRCh38
na,na,12,6127764,6127764,VWF,Likely pathogenic,Von Willebrand disease type 2A|not provided|von Willebrand disease type 2,single nucleotide variant,GRCh37
na,na,12,6018598,6018598,VWF,Likely pathogenic,Von Willebrand disease type 2A|not provided|von Willebrand disease type 2,single nucleotide variant,GRCh38
na,na,12,6128645,6128645,VWF,Pathogenic,Von Willebrand disease type 2B|not provided,single nucleotide variant,GRCh37
na,na,12,6019479,6019479,VWF,Pathogenic,Von Willebrand disease type 2B|not provided,single nucleotide variant,GRCh38
na,na,12,6128668,6128668,VWF,Pathogenic,Von Willebrand disease type 2B|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|Abnormality of coagulation|von Willebrand disease type 2;von Willebrand disease type 1;von Willebrand disease type 3,single nucleotide variant,GRCh37
na,na,12,6019502,6019502,VWF,Pathogenic,Von Willebrand disease type 2B|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|Abnormality of coagulation|von Willebrand disease type 2;von Willebrand disease type 1;von Willebrand disease type 3,single nucleotide variant,GRCh38
na,na,12,6128662,6128662,VWF,Pathogenic,Von Willebrand disease type 2B|not provided|von Willebrand disease type 2|Hereditary von Willebrand disease,single nucleotide variant,GRCh37
na,na,12,6019496,6019496,VWF,Pathogenic,Von Willebrand disease type 2B|not provided|von Willebrand disease type 2|Hereditary von Willebrand disease,single nucleotide variant,GRCh38
na,na,12,6128638,6128638,VWF,Pathogenic,Von Willebrand disease type 2B|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|von Willebrand disease type 2;von Willebrand disease type 3;von Willebrand disease type 1,single nucleotide variant,GRCh37
na,na,12,6019472,6019472,VWF,Pathogenic,Von Willebrand disease type 2B|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|von Willebrand disease type 2;von Willebrand disease type 3;von Willebrand disease type 1,single nucleotide variant,GRCh38
na,na,12,6128562,6128562,VWF,Pathogenic,Von Willebrand disease type 2B|not provided|von Willebrand disease type 2|Hereditary von Willebrand disease|VWF-related disorder,single nucleotide variant,GRCh37
na,na,12,6019396,6019396,VWF,Pathogenic,Von Willebrand disease type 2B|not provided|von Willebrand disease type 2|Hereditary von Willebrand disease|VWF-related disorder,single nucleotide variant,GRCh38
na,na,12,6127747,6127747,VWF,Uncertain significance,Von Willebrand disease type 2A|not provided,single nucleotide variant,GRCh37
na,na,12,6018581,6018581,VWF,Uncertain significance,Von Willebrand disease type 2A|not provided,single nucleotide variant,GRCh38
na,na,12,6128388,6128388,VWF,Uncertain significance,not provided|Abnormality of coagulation|von Willebrand disease type 1|not specified|Hereditary von Willebrand disease|von Willebrand disease type 2|VWF-related disorder|von Willebrand disease type 3;von Willebrand disease type 1,single nucleotide variant,GRCh37
na,na,12,6019222,6019222,VWF,Uncertain significance,not provided|Abnormality of coagulation|von Willebrand disease type 1|not specified|Hereditary von Willebrand disease|von Willebrand disease type 2|VWF-related disorder|von Willebrand disease type 3;von Willebrand disease type 1,single nucleotide variant,GRCh38
na,na,12,6153527,6153527,VWF,Pathogenic,von Willebrand disease type 2N|not provided|Abnormal bleeding|Hereditary von Willebrand disease|von Willebrand disease type 2,single nucleotide variant,GRCh37
na,na,12,6044361,6044361,VWF,Pathogenic,von Willebrand disease type 2N|not provided|Abnormal bleeding|Hereditary von Willebrand disease|von Willebrand disease type 2,single nucleotide variant,GRCh38
na,na,12,6145654,6145654,VWF,Pathogenic,von Willebrand disease type 2N|not provided|Hereditary von Willebrand disease|von Willebrand disease type 1;von Willebrand disease type 3;von Willebrand disease type 2,single nucleotide variant,GRCh37
na,na,12,6036488,6036488,VWF,Pathogenic,von Willebrand disease type 2N|not provided|Hereditary von Willebrand disease|von Willebrand disease type 1;von Willebrand disease type 3;von Willebrand disease type 2,single nucleotide variant,GRCh38
na,na,12,6143978,6143978,VWF,Pathogenic,von Willebrand disease type 2N|von Willebrand disease type 1|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|von Willebrand disease type 2;von Willebrand disease type 3;von Willebrand disease type 1|Abnormality of coagulation|Abnormal bleeding;Thrombocytopenia|von Willebrand disease type 3|VWF-related disorder|von Willebrand disorder,single nucleotide variant,GRCh37
na,na,12,6034812,6034812,VWF,Pathogenic,von Willebrand disease type 2N|von Willebrand disease type 1|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|von Willebrand disease type 2;von Willebrand disease type 3;von Willebrand disease type 1|Abnormality of coagulation|Abnormal bleeding;Thrombocytopenia|von Willebrand disease type 3|VWF-related disorder|von Willebrand disorder,single nucleotide variant,GRCh38
na,na,12,6127609,6127609,VWF,Pathogenic,von Willebrand disease type 3|von Willebrand disease type 1|not provided|Hereditary von Willebrand disease|VWF-related disorder,single nucleotide variant,GRCh37
na,na,12,6018443,6018443,VWF,Pathogenic,von Willebrand disease type 3|von Willebrand disease type 1|not provided|Hereditary von Willebrand disease|VWF-related disorder,single nucleotide variant,GRCh38
na,na,12,6122710,6122710,VWF,Pathogenic,von Willebrand disease type 1|von Willebrand disease type 3|not provided|Abnormality of blood and blood-forming tissues|Hereditary von Willebrand disease|VWF-related disorder|von Willebrand disease type 2,single nucleotide variant,GRCh37
na,na,12,6013544,6013544,VWF,Pathogenic,von Willebrand disease type 1|von Willebrand disease type 3|not provided|Abnormality of blood and blood-forming tissues|Hereditary von Willebrand disease|VWF-related disorder|von Willebrand disease type 2,single nucleotide variant,GRCh38
na,na,12,6078503,6078503,VWF,Pathogenic,von Willebrand disease type 3|not provided|Hereditary von Willebrand disease|von Willebrand disease type 1|von Willebrand disorder,single nucleotide variant,GRCh37
na,na,12,5969337,5969337,VWF,Pathogenic,von Willebrand disease type 3|not provided|Hereditary von Willebrand disease|von Willebrand disease type 1|von Willebrand disorder,single nucleotide variant,GRCh38
na,na,12,6128614,6128614,VWF,Pathogenic,von Willebrand disease type 2M|not provided|von Willebrand disease type 2,single nucleotide variant,GRCh37
na,na,12,6019448,6019448,VWF,Pathogenic,von Willebrand disease type 2M|not provided|von Willebrand disease type 2,single nucleotide variant,GRCh38
na,na,12,6128770,6128770,VWF,Pathogenic,Von Willebrand disease type 2A|not provided|von Willebrand disease type 2,single nucleotide variant,GRCh37
na,na,12,6019604,6019604,VWF,Pathogenic,Von Willebrand disease type 2A|not provided|von Willebrand disease type 2,single nucleotide variant,GRCh38
na,na,12,6128644,6128644,VWF,Pathogenic,Von Willebrand disease type 2B|not provided,single nucleotide variant,GRCh37
na,na,12,6019478,6019478,VWF,Pathogenic,Von Willebrand disease type 2B|not provided,single nucleotide variant,GRCh38
na,na,12,6153464,6153464,VWF,Pathogenic,von Willebrand disease type 3|not provided|Abnormal bleeding|Hereditary von Willebrand disease|von Willebrand disease type 2;von Willebrand disease type 3;von Willebrand disease type 1|von Willebrand disease type 1|von Willebrand disease type 2,Deletion,GRCh37
na,na,12,6044298,6044298,VWF,Pathogenic,von Willebrand disease type 3|not provided|Abnormal bleeding|Hereditary von Willebrand disease|von Willebrand disease type 2;von Willebrand disease type 3;von Willebrand disease type 1|von Willebrand disease type 1|von Willebrand disease type 2,Deletion,GRCh38
na,na,12,6128043,6128043,VWF,Pathogenic,Von Willebrand disease type 2A|not provided,single nucleotide variant,GRCh37
na,na,12,6018877,6018877,VWF,Pathogenic,Von Willebrand disease type 2A|not provided,single nucleotide variant,GRCh38
na,na,12,6167096,6167096,VWF,Pathogenic,Von Willebrand disease type 2A|not provided,single nucleotide variant,GRCh37
na,na,12,6057930,6057930,VWF,Pathogenic,Von Willebrand disease type 2A|not provided,single nucleotide variant,GRCh38
na,na,12,6058306,6058306,VWF,Pathogenic,Von Willebrand disease type 2A|not provided,single nucleotide variant,GRCh37
na,na,12,5949140,5949140,VWF,Pathogenic,Von Willebrand disease type 2A|not provided,single nucleotide variant,GRCh38
na,na,12,6131126,6131126,VWF,Pathogenic,von Willebrand disease type 1|von Willebrand factor Vicenza|not provided|Reduced quantity of Von Willebrand factor;Reduced von Willebrand factor activity|Hereditary von Willebrand disease|VWF-related disorder,single nucleotide variant,GRCh37
na,na,12,6021960,6021960,VWF,Pathogenic,von Willebrand disease type 1|von Willebrand factor Vicenza|not provided|Reduced quantity of Von Willebrand factor;Reduced von Willebrand factor activity|Hereditary von Willebrand disease|VWF-related disorder,single nucleotide variant,GRCh38
na,na,12,6131999,6131999,VWF,Pathogenic,von Willebrand disease type 1|not provided|von Willebrand disease type 2|Von Willebrand disease type 2A,single nucleotide variant,GRCh37
na,na,12,6022833,6022833,VWF,Pathogenic,von Willebrand disease type 1|not provided|von Willebrand disease type 2|Von Willebrand disease type 2A,single nucleotide variant,GRCh38
na,na,12,6127833,6127833,VWF,Conflicting classifications of pathogenicity; risk factor,|not provided|Hereditary von Willebrand disease|Inborn genetic diseases|von Willebrand disease type 2|von Willebrand disease type 1|Thrombus|Thrombocytopenia|VWF-related disorder|von Willebrand disorder|von Willebrand disease type 3;von Willebrand disease type 2;von Willebrand disease type 1,single nucleotide variant,GRCh37
na,na,12,6018667,6018667,VWF,Conflicting classifications of pathogenicity; risk factor,|not provided|Hereditary von Willebrand disease|Inborn genetic diseases|von Willebrand disease type 2|von Willebrand disease type 1|Thrombus|Thrombocytopenia|VWF-related disorder|von Willebrand disorder|von Willebrand disease type 3;von Willebrand disease type 2;von Willebrand disease type 1,single nucleotide variant,GRCh38
na,na,12,6128730,6128730,VWF,Likely pathogenic,von Willebrand disease type 2M|not provided,single nucleotide variant,GRCh37
na,na,12,6019564,6019564,VWF,Likely pathogenic,von Willebrand disease type 2M|not provided,single nucleotide variant,GRCh38
na,na,12,6153515,6153515,VWF,Pathogenic,von Willebrand disease type 2N|not provided,single nucleotide variant,GRCh37
na,na,12,6044349,6044349,VWF,Pathogenic,von Willebrand disease type 2N|not provided,single nucleotide variant,GRCh38
na,na,12,6153488,6153488,VWF,Likely pathogenic,von Willebrand disease type 2N|not provided,single nucleotide variant,GRCh37
na,na,12,6044322,6044322,VWF,Likely pathogenic,von Willebrand disease type 2N|not provided,single nucleotide variant,GRCh38
na,na,12,6128787,6128787,VWF,Conflicting classifications of pathogenicity,Von Willebrand disease type 2B|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|von Willebrand disease type 1|Thrombocytopenia|VWF-related disorder|von Willebrand disease type 3;von Willebrand disease type 1,single nucleotide variant,GRCh37
na,na,12,6019621,6019621,VWF,Conflicting classifications of pathogenicity,Von Willebrand disease type 2B|not provided|Hereditary von Willebrand disease|von Willebrand disease type 2|von Willebrand disease type 1|Thrombocytopenia|VWF-related disorder|von Willebrand disease type 3;von Willebrand disease type 1,single nucleotide variant,GRCh38
na,na,12,6091154,6091154,VWF,Pathogenic,von Willebrand disease type 3|not provided,single nucleotide variant,GRCh37
na,na,12,5981988,5981988,VWF,Pathogenic,von Willebrand disease type 3|not provided,single nucleotide variant,GRCh38
na,na,12,6181535,6181535,VWF,Pathogenic,von Willebrand disease type 2N|not provided,single nucleotide variant,GRCh37
na,na,12,6072369,6072369,VWF,Pathogenic,von Willebrand disease type 2N|not provided,single nucleotide variant,GRCh38
na,na,12,6134790,6134790,VWF,Pathogenic,von Willebrand disease type 2N|not provided,single nucleotide variant,GRCh37
na,na,12,6025624,6025624,VWF,Pathogenic,von Willebrand disease type 2N|not provided,single nucleotide variant,GRCh38
na,na,12,6167161,6167161,VWF,Pathogenic,Von Willebrand disease type 2A|not provided|von Willebrand disease type 2,single nucleotide variant,GRCh37
na,na,12,6057995,6057995,VWF,Pathogenic,Von Willebrand disease type 2A|not provided|von Willebrand disease type 2,single nucleotide variant,GRCh38
na,na,7,120428855,120428855,TSPAN12,Pathogenic,Exudative vitreoretinopathy 5,single nucleotide variant,GRCh37
na,na,7,120788801,120788801,TSPAN12,Pathogenic,Exudative vitreoretinopathy 5,single nucleotide variant,GRCh38
na,na,7,120446653,120446653,TSPAN12,Uncertain significance,Exudative vitreoretinopathy 5|not provided,single nucleotide variant,GRCh37
na,na,7,120806599,120806599,TSPAN12,Uncertain significance,Exudative vitreoretinopathy 5|not provided,single nucleotide variant,GRCh38
na,na,7,120478897,120478898,TSPAN12,Pathogenic,Exudative vitreoretinopathy 5,Microsatellite,GRCh37
na,na,7,120838843,120838844,TSPAN12,Pathogenic,Exudative vitreoretinopathy 5,Microsatellite,GRCh38
na,na,7,120450566,120450566,TSPAN12,Pathogenic,Exudative vitreoretinopathy 5,single nucleotide variant,GRCh37
na,na,7,120810512,120810512,TSPAN12,Pathogenic,Exudative vitreoretinopathy 5,single nucleotide variant,GRCh38
na,na,7,120450625,120450629,TSPAN12,Pathogenic,Exudative vitreoretinopathy 5,Deletion,GRCh37
na,na,7,120810571,120810575,TSPAN12,Pathogenic,Exudative vitreoretinopathy 5,Deletion,GRCh38
na,na,7,120455841,120455841,TSPAN12,Uncertain significance,Exudative vitreoretinopathy 5|not provided,single nucleotide variant,GRCh37
na,na,7,120815787,120815787,TSPAN12,Uncertain significance,Exudative vitreoretinopathy 5|not provided,single nucleotide variant,GRCh38
na,na,1,78408441,78408441,NEXN,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1CC|not provided|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC|Cardiovascular phenotype|Dilated cardiomyopathy 1S|Cardiomyopathy|not specified|Hypertrophic cardiomyopathy 20,single nucleotide variant,GRCh37
na,na,1,77942756,77942756,NEXN,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1CC|not provided|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC|Cardiovascular phenotype|Dilated cardiomyopathy 1S|Cardiomyopathy|not specified|Hypertrophic cardiomyopathy 20,single nucleotide variant,GRCh38
na,na,1,78408317,78408317,NEXN,Uncertain significance,Dilated cardiomyopathy 1CC|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,1,77942632,77942632,NEXN,Uncertain significance,Dilated cardiomyopathy 1CC|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,5,16477845,16477845,RETREG1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2B|not provided|Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type 2",single nucleotide variant,GRCh37
na,na,5,16477736,16477736,RETREG1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2B|not provided|Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type 2",single nucleotide variant,GRCh38
na,na,5,16565897,16565897,RETREG1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2B|not provided|Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type 2",single nucleotide variant,GRCh37
na,na,5,16565788,16565788,RETREG1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2B|not provided|Charcot-Marie-Tooth disease|Hereditary sensory and autonomic neuropathy type 2",single nucleotide variant,GRCh38
na,na,na,-1,-1,NF1,Pathogenic,"Neurofibromatosis, type 1",Insertion,na
na,na,17,29653188,29653192,NF1,Pathogenic,"Neurofibromatosis, type 1",Deletion,GRCh37
na,na,17,31326170,31326174,NF1,Pathogenic,"Neurofibromatosis, type 1",Deletion,GRCh38
na,na,17,29661901,29661901,NF1,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 1|not provided|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,17,31334883,31334883,NF1,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 1|not provided|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,17,29661951,29661951,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh37
na,na,17,31334933,31334933,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh38
na,na,17,29585518,29585518,NF1,Pathogenic,"Neurofibromatosis, type 1|Cafe au lait spots, multiple;Neurofibroma;Optic nerve glioma;Axillary freckling|not provided|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|Pheochromocytoma|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia|Café-au-lait macules with pulmonary stenosis",single nucleotide variant,GRCh37
na,na,17,31258500,31258500,NF1,Pathogenic,"Neurofibromatosis, type 1|Cafe au lait spots, multiple;Neurofibroma;Optic nerve glioma;Axillary freckling|not provided|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|Pheochromocytoma|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia|Café-au-lait macules with pulmonary stenosis",single nucleotide variant,GRCh38
na,na,17,29654758,29654759,NF1,Pathogenic,"Neurofibromatosis, type 1",Duplication,GRCh37
na,na,17,31327740,31327741,NF1,Pathogenic,"Neurofibromatosis, type 1",Duplication,GRCh38
na,na,17,29654776,29654777,NF1,Pathogenic,"Neurofibromatosis, type 1",Insertion,GRCh37
na,na,17,31327758,31327759,NF1,Pathogenic,"Neurofibromatosis, type 1",Insertion,GRCh38
na,na,17,29664448,29664448,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh37
na,na,17,31337430,31337430,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh38
na,na,17,29664532,29664532,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh37
na,na,17,31337514,31337514,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh38
na,na,17,29440614,29440615,NF1,Pathogenic,Café-au-lait macules with pulmonary stenosis,Insertion,GRCh37
na,na,17,31113596,31113597,NF1,Pathogenic,Café-au-lait macules with pulmonary stenosis,Insertion,GRCh38
na,na,na,-1,-1,NF1,Pathogenic,Café-au-lait macules with pulmonary stenosis,Deletion,na
na,na,17,29661945,29661945,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|Neurofibromatosis, type 1;Tibial pseudarthrosis|Juvenile myelomonocytic leukemia|NF1-related disorder|Neurofibromatosis-Noonan syndrome|Neoplasm|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,17,31334927,31334927,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|Neurofibromatosis, type 1;Tibial pseudarthrosis|Juvenile myelomonocytic leukemia|NF1-related disorder|Neurofibromatosis-Noonan syndrome|Neoplasm|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,17,29576111,29576111,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal",single nucleotide variant,GRCh37
na,na,17,31249093,31249093,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal",single nucleotide variant,GRCh38
na,na,17,29557401,29557401,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided|Neurofibromatosis, type 1;Tibial pseudarthrosis|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome|NF1-related disorder",single nucleotide variant,GRCh37
na,na,17,31230383,31230383,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided|Neurofibromatosis, type 1;Tibial pseudarthrosis|Hereditary cancer-predisposing syndrome|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome|NF1-related disorder",single nucleotide variant,GRCh38
na,na,17,29546036,29546037,NF1,Pathogenic,"Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|not specified|Neurofibromatosis-Noonan syndrome|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|NF1-related disorder",Deletion,GRCh37
na,na,17,31219018,31219019,NF1,Pathogenic,"Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|not specified|Neurofibromatosis-Noonan syndrome|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|NF1-related disorder",Deletion,GRCh38
na,na,17,29557391,29557391,NF1,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh37
na,na,17,31230373,31230373,NF1,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh38
na,na,17,29585424,29585424,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,17,31258406,31258406,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,17,29685631,29685632,NF1,Pathogenic,"Neurofibromatosis, familial spinal",Duplication,GRCh37
na,na,17,31358613,31358614,NF1,Pathogenic,"Neurofibromatosis, familial spinal",Duplication,GRCh38
na,na,17,29588828,29588828,NF1,Pathogenic,"Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh37
na,na,17,31261810,31261810,NF1,Pathogenic,"Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh38
na,na,na,-1,-1,NF1,Pathogenic,Juvenile myelomonocytic leukemia,single nucleotide variant,na
na,na,17,29548860,29548860,NF1,Pathogenic,"Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1",single nucleotide variant,GRCh37
na,na,17,31221842,31221842,NF1,Pathogenic,"Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1",single nucleotide variant,GRCh38
na,na,17,29562747,29562747,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,17,31235729,31235729,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,17,29541542,29541542,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1;Tibial pseudarthrosis|Rhabdomyosarcoma|Abnormality of the skin|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|NF1-related disorder|Neurofibromatosis-Noonan syndrome",single nucleotide variant,GRCh37
na,na,17,31214524,31214524,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1;Tibial pseudarthrosis|Rhabdomyosarcoma|Abnormality of the skin|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|NF1-related disorder|Neurofibromatosis-Noonan syndrome",single nucleotide variant,GRCh38
na,na,17,29541599,29541599,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh37
na,na,17,31214581,31214581,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh38
na,na,17,29528504,29528504,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh37
na,na,17,31201486,31201486,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh38
na,na,17,29576048,29576048,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh37
na,na,17,31249030,31249030,NF1,Pathogenic,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh38
na,na,17,29663768,29663768,NF1,Uncertain significance,"Neurofibromatosis, familial spinal|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,17,31336750,31336750,NF1,Uncertain significance,"Neurofibromatosis, familial spinal|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,17,29663346,29663346,NF1,Pathogenic,"Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|not provided|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia",single nucleotide variant,GRCh37
na,na,17,31336328,31336328,NF1,Pathogenic,"Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|not provided|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia",single nucleotide variant,GRCh38
na,na,17,31094927,31377677,NF1,Pathogenic,"Neurofibromatosis, type 1",Deletion,GRCh38
na,na,17,29562641,29562641,NF1,Pathogenic,"Neurofibromatosis, type 1|Inborn genetic diseases|not provided|Juvenile myelomonocytic leukemia|NF1-related disorder|Neoplasm",single nucleotide variant,GRCh37
na,na,17,31235623,31235623,NF1,Pathogenic,"Neurofibromatosis, type 1|Inborn genetic diseases|not provided|Juvenile myelomonocytic leukemia|NF1-related disorder|Neoplasm",single nucleotide variant,GRCh38
na,na,17,29556972,29556974,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Gastric cancer",Deletion,GRCh37
na,na,17,31229954,31229956,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Gastric cancer",Deletion,GRCh38
na,na,17,29586087,29586089,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome|not provided|NF1-related disorder",Microsatellite,GRCh37
na,na,17,31259069,31259071,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome|not provided|NF1-related disorder",Microsatellite,GRCh38
na,na,17,29576122,29576123,NF1,Pathogenic,Neurofibromatosis-Noonan syndrome,Insertion,GRCh37
na,na,17,31249104,31249105,NF1,Pathogenic,Neurofibromatosis-Noonan syndrome,Insertion,GRCh38
na,na,17,29527496,29527497,NF1,Pathogenic,"Neurofibromatosis, type 1",Indel,GRCh37
na,na,17,31200478,31200479,NF1,Pathogenic,"Neurofibromatosis, type 1",Indel,GRCh38
na,na,17,29562701,29562701,NF1,Pathogenic,"Neurofibromatosis, type 1",Deletion,GRCh37
na,na,17,31235683,31235683,NF1,Pathogenic,"Neurofibromatosis, type 1",Deletion,GRCh38
na,na,17,29528062,29528062,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|not provided|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal",single nucleotide variant,GRCh37
na,na,17,31201044,31201044,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|not provided|Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis-Noonan syndrome;Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal",single nucleotide variant,GRCh38
na,na,17,29670156,29670156,NF1,Likely pathogenic,"Neurofibromatosis, familial spinal|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,17,31343138,31343138,NF1,Likely pathogenic,"Neurofibromatosis, familial spinal|Cardiovascular phenotype;Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,na,-1,-1,NF1,Pathogenic,"Neurofibromatosis, type 1",Deletion,na
na,na,17,29562648,29562648,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh37
na,na,17,31235630,31235630,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh38
na,na,17,29657477,29657477,NF1,Pathogenic,"Neurofibromatosis, type 1|Neoplasm",single nucleotide variant,GRCh37
na,na,17,31330459,31330459,NF1,Pathogenic,"Neurofibromatosis, type 1|Neoplasm",single nucleotide variant,GRCh38
na,na,17,29556164,29556164,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh37
na,na,17,31229146,31229146,NF1,Pathogenic,"Neurofibromatosis, type 1",single nucleotide variant,GRCh38
na,na,17,29588876,29588876,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh37
na,na,17,31261858,31261858,NF1,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 1|not provided",single nucleotide variant,GRCh38
na,na,20,44526707,44526707,CTSA,Likely pathogenic,"Galactosialidosis, late infantile|Combined deficiency of sialidase AND beta galactosidase|not provided",single nucleotide variant,GRCh37
na,na,20,45898068,45898068,CTSA,Likely pathogenic,"Galactosialidosis, late infantile|Combined deficiency of sialidase AND beta galactosidase|not provided",single nucleotide variant,GRCh38
na,na,20,44521953,44521953,CTSA,Pathogenic,"Galactosialidosis, adult|Combined deficiency of sialidase AND beta galactosidase",single nucleotide variant,GRCh37
na,na,20,45893314,45893314,CTSA,Pathogenic,"Galactosialidosis, adult|Combined deficiency of sialidase AND beta galactosidase",single nucleotide variant,GRCh38
na,na,20,44520353,44520353,CTSA,Pathogenic/Likely pathogenic,Combined deficiency of sialidase AND beta galactosidase,single nucleotide variant,GRCh37
na,na,20,45891714,45891714,CTSA,Pathogenic/Likely pathogenic,Combined deficiency of sialidase AND beta galactosidase,single nucleotide variant,GRCh38
na,na,20,44520400,44520400,CTSA,Pathogenic,Combined deficiency of sialidase AND beta galactosidase,single nucleotide variant,GRCh37
na,na,20,45891761,45891761,CTSA,Pathogenic,Combined deficiency of sialidase AND beta galactosidase,single nucleotide variant,GRCh38
na,na,20,44520629,44520629,CTSA,Likely pathogenic,Combined deficiency of sialidase AND beta galactosidase,single nucleotide variant,GRCh37
na,na,20,45891990,45891990,CTSA,Likely pathogenic,Combined deficiency of sialidase AND beta galactosidase,single nucleotide variant,GRCh38
na,na,20,44526375,44526375,CTSA,Likely pathogenic,Combined deficiency of sialidase AND beta galactosidase|not provided,single nucleotide variant,GRCh37
na,na,20,45897736,45897736,CTSA,Likely pathogenic,Combined deficiency of sialidase AND beta galactosidase|not provided,single nucleotide variant,GRCh38
na,na,20,44522679,44522679,CTSA,Pathogenic,"Combined deficiency of sialidase AND beta galactosidase|Galactosialidosis, late infantile",single nucleotide variant,GRCh37
na,na,20,45894040,45894040,CTSA,Pathogenic,"Combined deficiency of sialidase AND beta galactosidase|Galactosialidosis, late infantile",single nucleotide variant,GRCh38
na,na,20,44521073,44521073,CTSA,Uncertain significance,"Galactosialidosis, early infantile|Combined deficiency of sialidase AND beta galactosidase",single nucleotide variant,GRCh37
na,na,20,45892434,45892434,CTSA,Uncertain significance,"Galactosialidosis, early infantile|Combined deficiency of sialidase AND beta galactosidase",single nucleotide variant,GRCh38
na,na,20,44522641,44522641,CTSA,Pathogenic,"Galactosialidosis, early infantile",single nucleotide variant,GRCh37
na,na,20,45894002,45894002,CTSA,Pathogenic,"Galactosialidosis, early infantile",single nucleotide variant,GRCh38
na,na,20,44526704,44526704,CTSA,Conflicting classifications of pathogenicity,"Galactosialidosis, early infantile|Combined deficiency of sialidase AND beta galactosidase",single nucleotide variant,GRCh37
na,na,20,45898065,45898065,CTSA,Conflicting classifications of pathogenicity,"Galactosialidosis, early infantile|Combined deficiency of sialidase AND beta galactosidase",single nucleotide variant,GRCh38
na,na,20,44526408,44526408,CTSA,Pathogenic,"Galactosialidosis, late infantile",single nucleotide variant,GRCh37
na,na,20,45897769,45897769,CTSA,Pathogenic,"Galactosialidosis, late infantile",single nucleotide variant,GRCh38
na,na,20,44521434,44521435,CTSA,Pathogenic,"Galactosialidosis, late infantile|Combined deficiency of sialidase AND beta galactosidase",Deletion,GRCh37
na,na,20,45892795,45892796,CTSA,Pathogenic,"Galactosialidosis, late infantile|Combined deficiency of sialidase AND beta galactosidase",Deletion,GRCh38
na,na,20,44526746,44526746,CTSA,Pathogenic,"Galactosialidosis, late infantile",single nucleotide variant,GRCh37
na,na,20,45898107,45898107,CTSA,Pathogenic,"Galactosialidosis, late infantile",single nucleotide variant,GRCh38
na,na,20,44522720,44522720,CTSA,Pathogenic,"Galactosialidosis, late infantile",single nucleotide variant,GRCh37
na,na,20,45894081,45894081,CTSA,Pathogenic,"Galactosialidosis, late infantile",single nucleotide variant,GRCh38
na,na,5,150646460,150646460,GM2A,Pathogenic,"Tay-Sachs disease, variant AB",single nucleotide variant,GRCh37
na,na,5,151266899,151266899,GM2A,Pathogenic,"Tay-Sachs disease, variant AB",single nucleotide variant,GRCh38
na,na,5,150646936,150646936,GM2A,Pathogenic,"Tay-Sachs disease, variant AB",single nucleotide variant,GRCh37
na,na,5,151267375,151267375,GM2A,Pathogenic,"Tay-Sachs disease, variant AB",single nucleotide variant,GRCh38
na,na,5,150646458,150646458,GM2A,Pathogenic,"Tay-Sachs disease, variant AB",Deletion,GRCh37
na,na,5,151266897,151266897,GM2A,Pathogenic,"Tay-Sachs disease, variant AB",Deletion,GRCh38
na,na,5,150639394,150639394,GM2A,Pathogenic,"Tay-Sachs disease, variant AB",single nucleotide variant,GRCh37
na,na,5,151259833,151259833,GM2A,Pathogenic,"Tay-Sachs disease, variant AB",single nucleotide variant,GRCh38
na,na,18,44152088,44152088,LOXHD1,Pathogenic,Autosomal recessive nonsyndromic hearing loss 77|not provided|LOXHD1-related disorder,single nucleotide variant,GRCh37
na,na,18,46572125,46572125,LOXHD1,Pathogenic,Autosomal recessive nonsyndromic hearing loss 77|not provided|LOXHD1-related disorder,single nucleotide variant,GRCh38
na,na,9,139324183,139324183,INPP5E,Pathogenic,MORM syndrome|MORM syndrome;Joubert syndrome 1,single nucleotide variant,GRCh37
na,na,9,136429731,136429731,INPP5E,Pathogenic,MORM syndrome|MORM syndrome;Joubert syndrome 1,single nucleotide variant,GRCh38
na,na,9,139326282,139326282,INPP5E,Pathogenic/Likely pathogenic,Joubert syndrome 1|Joubert syndrome|Joubert syndrome 1;MORM syndrome,single nucleotide variant,GRCh37
na,na,9,136431830,136431830,INPP5E,Pathogenic/Likely pathogenic,Joubert syndrome 1|Joubert syndrome|Joubert syndrome 1;MORM syndrome,single nucleotide variant,GRCh38
na,na,9,139324843,139324843,INPP5E,Likely pathogenic,Joubert syndrome 1|Joubert syndrome and related disorders,single nucleotide variant,GRCh37
na,na,9,136430391,136430391,INPP5E,Likely pathogenic,Joubert syndrome 1|Joubert syndrome and related disorders,single nucleotide variant,GRCh38
na,na,9,139327014,139327014,INPP5E,Pathogenic/Likely pathogenic,Joubert syndrome 1|Joubert syndrome|Retinal dystrophy|not provided|INPP5E-related disorder|not specified|Joubert syndrome 1;MORM syndrome,single nucleotide variant,GRCh37
na,na,9,136432562,136432562,INPP5E,Pathogenic/Likely pathogenic,Joubert syndrome 1|Joubert syndrome|Retinal dystrophy|not provided|INPP5E-related disorder|not specified|Joubert syndrome 1;MORM syndrome,single nucleotide variant,GRCh38
na,na,9,139327634,139327634,INPP5E,Pathogenic/Likely pathogenic,Joubert syndrome 1|Inborn genetic diseases|Joubert syndrome and related disorders|Joubert syndrome|16 conditions|INPP5E-related disorder|not provided|MORM syndrome;Joubert syndrome 1,single nucleotide variant,GRCh37
na,na,9,136433182,136433182,INPP5E,Pathogenic/Likely pathogenic,Joubert syndrome 1|Inborn genetic diseases|Joubert syndrome and related disorders|Joubert syndrome|16 conditions|INPP5E-related disorder|not provided|MORM syndrome;Joubert syndrome 1,single nucleotide variant,GRCh38
na,na,11,61205292,61205292,SDHAF2,Pathogenic,Paragangliomas 2|Hereditary cancer-predisposing syndrome|not provided|Hereditary pheochromocytoma-paraganglioma,single nucleotide variant,GRCh37
na,na,11,61437820,61437820,SDHAF2,Pathogenic,Paragangliomas 2|Hereditary cancer-predisposing syndrome|not provided|Hereditary pheochromocytoma-paraganglioma,single nucleotide variant,GRCh38
na,na,16,71610150,71610150,TAT,Pathogenic,Tyrosinemia type II|not provided,single nucleotide variant,GRCh37
na,na,16,71576247,71576247,TAT,Pathogenic,Tyrosinemia type II|not provided,single nucleotide variant,GRCh38
na,na,16,71606127,71606127,TAT,Pathogenic,Tyrosinemia type II,single nucleotide variant,GRCh37
na,na,16,71572224,71572224,TAT,Pathogenic,Tyrosinemia type II,single nucleotide variant,GRCh38
na,na,16,71602163,71602163,TAT,Pathogenic,Tyrosinemia type II,single nucleotide variant,GRCh37
na,na,16,71568260,71568260,TAT,Pathogenic,Tyrosinemia type II,single nucleotide variant,GRCh38
na,na,16,71603797,71603797,TAT,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,16,71569894,71569894,TAT,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,16,71609934,71609934,TAT,Pathogenic,Tyrosinemia type II,single nucleotide variant,GRCh37
na,na,16,71576031,71576031,TAT,Pathogenic,Tyrosinemia type II,single nucleotide variant,GRCh38
na,na,3,126216984,126216984,UROC1,Pathogenic,Urocanate hydratase deficiency,single nucleotide variant,GRCh37
na,na,3,126498141,126498141,UROC1,Pathogenic,Urocanate hydratase deficiency,single nucleotide variant,GRCh38
na,na,3,126229555,126229555,UROC1,Pathogenic,Urocanate hydratase deficiency,single nucleotide variant,GRCh37
na,na,3,126510712,126510712,UROC1,Pathogenic,Urocanate hydratase deficiency,single nucleotide variant,GRCh38
na,na,4,3076604,3076660,HTT,Pathogenic,Huntington disease,Microsatellite,GRCh37
na,na,4,3074935,3074936,HTT,Pathogenic,Huntington disease,Microsatellite,GRCh38
na,na,11,85365183,85365183,TMEM126A,Pathogenic,"Autosomal recessive optic atrophy, OPA7 type|not provided|TMEM126A-related disorder",single nucleotide variant,GRCh37
na,na,11,85654139,85654139,TMEM126A,Pathogenic,"Autosomal recessive optic atrophy, OPA7 type|not provided|TMEM126A-related disorder",single nucleotide variant,GRCh38
na,na,17,61683755,61683756,TACO1,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial complex 4 deficiency, nuclear type 8",Duplication,GRCh37
na,na,17,63606395,63606396,TACO1,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial complex 4 deficiency, nuclear type 8",Duplication,GRCh38
na,na,6,167344549,167344549,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,single nucleotide variant,GRCh37
na,na,6,166931061,166931061,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,single nucleotide variant,GRCh38
na,na,6,167364795,167367377,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,Deletion,GRCh37
na,na,6,166951307,166953889,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,Deletion,GRCh38
na,na,6,167356579,167356579,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,single nucleotide variant,GRCh37
na,na,6,166943091,166943091,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,single nucleotide variant,GRCh38
na,na,6,167356506,167356506,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,Deletion,GRCh37
na,na,6,166943018,166943018,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,Deletion,GRCh38
na,na,6,167369607,167369621,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,Deletion,GRCh37
na,na,6,166956119,166956133,RNASET2,Pathogenic,Cystic leukoencephalopathy without megalencephaly,Deletion,GRCh38
na,na,6,167344532,167344532,RNASET2,Uncertain significance,Cystic leukoencephalopathy without megalencephaly,single nucleotide variant,GRCh37
na,na,6,166931044,166931044,RNASET2,Uncertain significance,Cystic leukoencephalopathy without megalencephaly,single nucleotide variant,GRCh38
na,na,7,44104896,44104896,PGAM2,Pathogenic/Likely pathogenic,Glycogen storage disease type X|not provided|PGAM2-related disorder,single nucleotide variant,GRCh37
na,na,7,44065297,44065297,PGAM2,Pathogenic/Likely pathogenic,Glycogen storage disease type X|not provided|PGAM2-related disorder,single nucleotide variant,GRCh38
na,na,7,44104863,44104863,PGAM2,Conflicting classifications of pathogenicity,Glycogen storage disease type X,single nucleotide variant,GRCh37
na,na,7,44065264,44065264,PGAM2,Conflicting classifications of pathogenicity,Glycogen storage disease type X,single nucleotide variant,GRCh38
na,na,7,44104861,44104861,PGAM2,Uncertain significance,Glycogen storage disease type X|not provided,single nucleotide variant,GRCh37
na,na,7,44065262,44065262,PGAM2,Uncertain significance,Glycogen storage disease type X|not provided,single nucleotide variant,GRCh38
na,na,7,44104839,44104839,PGAM2,Conflicting classifications of pathogenicity,Glycogen storage disease type X|not provided,single nucleotide variant,GRCh37
na,na,7,44065240,44065240,PGAM2,Conflicting classifications of pathogenicity,Glycogen storage disease type X|not provided,single nucleotide variant,GRCh38
na,na,3,49059930,49059930,NDUFAF3,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 18",single nucleotide variant,GRCh37
na,na,3,49022497,49022497,NDUFAF3,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 18",single nucleotide variant,GRCh38
na,na,3,49060336,49060336,NDUFAF3,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 18",single nucleotide variant,GRCh37
na,na,3,49022903,49022903,NDUFAF3,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 18",single nucleotide variant,GRCh38
na,na,3,49059579,49059579,NDUFAF3,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 18|not provided",single nucleotide variant,GRCh37
na,na,3,49022146,49022146,NDUFAF3,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 18|not provided",single nucleotide variant,GRCh38
na,na,20,57599434,57599434,TUBB1,Conflicting classifications of pathogenicity,"Macrothrombocytopenia, isolated, 1, autosomal dominant|Macrothrombocytopenia|not provided",single nucleotide variant,GRCh37
na,na,20,59024379,59024379,TUBB1,Conflicting classifications of pathogenicity,"Macrothrombocytopenia, isolated, 1, autosomal dominant|Macrothrombocytopenia|not provided",single nucleotide variant,GRCh38
na,na,6,3225809,3225809,TUBB2B,Pathogenic,Complex cortical dysplasia with other brain malformations 7,single nucleotide variant,GRCh37
na,na,6,3225575,3225575,TUBB2B,Pathogenic,Complex cortical dysplasia with other brain malformations 7,single nucleotide variant,GRCh38
na,na,6,3225640,3225640,TUBB2B,Pathogenic,Complex cortical dysplasia with other brain malformations 7,single nucleotide variant,GRCh37
na,na,6,3225406,3225406,TUBB2B,Pathogenic,Complex cortical dysplasia with other brain malformations 7,single nucleotide variant,GRCh38
na,na,6,3225530,3225530,TUBB2B,Pathogenic,Complex cortical dysplasia with other brain malformations 7,single nucleotide variant,GRCh37
na,na,6,3225296,3225296,TUBB2B,Pathogenic,Complex cortical dysplasia with other brain malformations 7,single nucleotide variant,GRCh38
na,na,19,36486345,36486345,SDHAF1,Pathogenic,"Mitochondrial complex 2 deficiency, nuclear type 2",single nucleotide variant,GRCh37
na,na,19,35995443,35995443,SDHAF1,Pathogenic,"Mitochondrial complex 2 deficiency, nuclear type 2",single nucleotide variant,GRCh38
na,na,19,36486340,36486340,SDHAF1,Pathogenic,"Mitochondrial complex 2 deficiency, nuclear type 2",single nucleotide variant,GRCh37
na,na,19,35995438,35995438,SDHAF1,Pathogenic,"Mitochondrial complex 2 deficiency, nuclear type 2",single nucleotide variant,GRCh38
na,na,16,57493495,57493495,COQ9,Pathogenic,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome|not provided,single nucleotide variant,GRCh37
na,na,16,57459583,57459583,COQ9,Pathogenic,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,97915614,97915614,DPYD,drug response,"Dihydropyrimidine dehydrogenase deficiency|Fluorouracil response|not provided|Hirschsprung disease, susceptibility to, 1|fluorouracil response - Toxicity|fluorouracil response - Other|capecitabine response - Toxicity|tegafur response - Toxicity|Inborn genetic diseases|DPYD-related disorder",single nucleotide variant,GRCh37
na,na,1,97450058,97450058,DPYD,drug response,"Dihydropyrimidine dehydrogenase deficiency|Fluorouracil response|not provided|Hirschsprung disease, susceptibility to, 1|fluorouracil response - Toxicity|fluorouracil response - Other|capecitabine response - Toxicity|tegafur response - Toxicity|Inborn genetic diseases|DPYD-related disorder",single nucleotide variant,GRCh38
na,na,1,97544689,97544689,DPYD,Pathogenic,Fluorouracil response,single nucleotide variant,GRCh37
na,na,1,97079133,97079133,DPYD,Pathogenic,Fluorouracil response,single nucleotide variant,GRCh38
na,na,1,98348885,98348885,DPYD,drug response,Dihydropyrimidine dehydrogenase deficiency|not provided|capecitabine response - Toxicity|fluorouracil response - Toxicity|not specified,single nucleotide variant,GRCh37
na,na,1,97883329,97883329,DPYD,drug response,Dihydropyrimidine dehydrogenase deficiency|not provided|capecitabine response - Toxicity|fluorouracil response - Toxicity|not specified,single nucleotide variant,GRCh38
na,na,1,97564154,97564154,DPYD,Uncertain significance,Dihydropyrimidine dehydrogenase deficiency|not specified,single nucleotide variant,GRCh37
na,na,1,97098598,97098598,DPYD,Uncertain significance,Dihydropyrimidine dehydrogenase deficiency|not specified,single nucleotide variant,GRCh38
na,na,19,45315445,45315445,BCAM,Benign,LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b)|not provided,single nucleotide variant,GRCh37
na,na,19,44812188,44812188,BCAM,Benign,LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b)|not provided,single nucleotide variant,GRCh38
na,na,19,45322744,45322744,BCAM,Benign,AUBERGER BLOOD GROUP POLYMORPHISM Au(a)/Au(b)|LuLu phenotype;BLOOD GROUP--LUTHERAN SYSTEM|BCAM-related disorder|not provided,single nucleotide variant,GRCh37
na,na,19,44819487,44819487,BCAM,Benign,AUBERGER BLOOD GROUP POLYMORPHISM Au(a)/Au(b)|LuLu phenotype;BLOOD GROUP--LUTHERAN SYSTEM|BCAM-related disorder|not provided,single nucleotide variant,GRCh38
na,na,19,45316784,45316784,BCAM,Pathogenic,BLOOD GROUP--LUTHERAN NULL,single nucleotide variant,GRCh37
na,na,19,44813527,44813527,BCAM,Pathogenic,BLOOD GROUP--LUTHERAN NULL,single nucleotide variant,GRCh38
na,na,na,-1,-1,BCAM,Pathogenic,BLOOD GROUP--LUTHERAN NULL,Deletion,na
na,na,19,45316804,45316804,BCAM,Pathogenic,BLOOD GROUP--LUTHERAN NULL,single nucleotide variant,GRCh37
na,na,19,44813547,44813547,BCAM,Pathogenic,BLOOD GROUP--LUTHERAN NULL,single nucleotide variant,GRCh38
na,na,19,45315576,45315576,BCAM,Pathogenic,BLOOD GROUP--LUTHERAN NULL,single nucleotide variant,GRCh37
na,na,19,44812319,44812319,BCAM,Pathogenic,BLOOD GROUP--LUTHERAN NULL,single nucleotide variant,GRCh38
na,na,15,45409472,45409472,DUOXA2,Pathogenic/Likely pathogenic,Thyroglobulin synthesis defect|Inborn genetic diseases|Familial thyroid dyshormonogenesis,single nucleotide variant,GRCh37
na,na,15,45117274,45117274,DUOXA2,Pathogenic/Likely pathogenic,Thyroglobulin synthesis defect|Inborn genetic diseases|Familial thyroid dyshormonogenesis,single nucleotide variant,GRCh38
na,na,18,57147460,57147460,CCBE1,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,18,59480228,59480228,CCBE1,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,18,57136800,57136800,CCBE1,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1,single nucleotide variant,GRCh37
na,na,18,59469568,59469568,CCBE1,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1,single nucleotide variant,GRCh38
na,na,18,57105351,57105351,CCBE1,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1,single nucleotide variant,GRCh37
na,na,18,59438119,59438119,CCBE1,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1,single nucleotide variant,GRCh38
na,na,18,57115306,57115307,CCBE1,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided,Insertion,GRCh37
na,na,18,59448074,59448075,CCBE1,Pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided,Insertion,GRCh38
na,na,18,57134052,57134052,CCBE1,Conflicting classifications of pathogenicity,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided|not specified|CCBE1-related disorder,single nucleotide variant,GRCh37
na,na,18,59466820,59466820,CCBE1,Conflicting classifications of pathogenicity,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided|not specified|CCBE1-related disorder,single nucleotide variant,GRCh38
na,na,18,57134004,57134004,CCBE1,Likely pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,18,59466772,59466772,CCBE1,Likely pathogenic,Hennekam lymphangiectasia-lymphedema syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,3,98304466,98304466,CPOX,Uncertain significance,Coproporphyria|Hereditary coproporphyria,single nucleotide variant,GRCh37
na,na,3,98585622,98585622,CPOX,Uncertain significance,Coproporphyria|Hereditary coproporphyria,single nucleotide variant,GRCh38
na,na,3,98300251,98300251,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh37
na,na,3,98581407,98581407,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh38
na,na,3,98300318,98300318,CPOX,Pathogenic/Likely pathogenic,Harderoporphyria|not provided|Harderoporphyria;Hereditary coproporphyria|CPOX-related hereditary coproporphyria,single nucleotide variant,GRCh37
na,na,3,98581474,98581474,CPOX,Pathogenic/Likely pathogenic,Harderoporphyria|not provided|Harderoporphyria;Hereditary coproporphyria|CPOX-related hereditary coproporphyria,single nucleotide variant,GRCh38
na,na,3,98312217,98312218,CPOX,Pathogenic,Coproporphyria|not provided|CPOX-related disorder,Microsatellite,GRCh37
na,na,3,98593373,98593374,CPOX,Pathogenic,Coproporphyria|not provided|CPOX-related disorder,Microsatellite,GRCh38
na,na,3,98311840,98311860,CPOX,Pathogenic,Coproporphyria,Deletion,GRCh37
na,na,3,98592996,98593016,CPOX,Pathogenic,Coproporphyria,Deletion,GRCh38
na,na,3,98307627,98307627,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh37
na,na,3,98588783,98588783,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh38
na,na,3,98300248,98300248,CPOX,Uncertain significance,Harderoporphyria|not provided,single nucleotide variant,GRCh37
na,na,3,98581404,98581404,CPOX,Uncertain significance,Harderoporphyria|not provided,single nucleotide variant,GRCh38
na,na,3,98312264,98312264,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh37
na,na,3,98593420,98593420,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh38
na,na,3,98299553,98299553,CPOX,Conflicting classifications of pathogenicity,Coproporphyria|Hereditary coproporphyria|not provided,single nucleotide variant,GRCh37
na,na,3,98580709,98580709,CPOX,Conflicting classifications of pathogenicity,Coproporphyria|Hereditary coproporphyria|not provided,single nucleotide variant,GRCh38
na,na,3,98309933,98309933,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh37
na,na,3,98591089,98591089,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh38
na,na,3,98304475,98304475,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh37
na,na,3,98585631,98585631,CPOX,Pathogenic,Coproporphyria,single nucleotide variant,GRCh38
na,na,3,98307653,98307654,CPOX,Pathogenic,Coproporphyria,Duplication,GRCh37
na,na,3,98588809,98588810,CPOX,Pathogenic,Coproporphyria,Duplication,GRCh38
na,na,3,98307675,98307675,CPOX,Pathogenic,"COPROPORPHYRIA, DIGENIC",single nucleotide variant,GRCh37
na,na,3,98588831,98588831,CPOX,Pathogenic,"COPROPORPHYRIA, DIGENIC",single nucleotide variant,GRCh38
na,na,9,104189856,104189856,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria|not provided|See cases|ALDOB-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,101427574,101427574,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria|not provided|See cases|ALDOB-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,104189780,104189780,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria|not provided|See cases|ALDOB-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,101427498,101427498,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria|not provided|See cases|ALDOB-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,104187257,104187259,ALDOB,Pathogenic,Hereditary fructosuria,Deletion,GRCh37
na,na,9,101424975,101424977,ALDOB,Pathogenic,Hereditary fructosuria,Deletion,GRCh38
na,na,9,104187814,104187814,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria,single nucleotide variant,GRCh37
na,na,9,101425532,101425532,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria,single nucleotide variant,GRCh38
na,na,9,104184181,104184181,ALDOB,Pathogenic,Hereditary fructosuria|not provided|ALDOB-related disorder,single nucleotide variant,GRCh37
na,na,9,101421899,101421899,ALDOB,Pathogenic,Hereditary fructosuria|not provided|ALDOB-related disorder,single nucleotide variant,GRCh38
na,na,9,104193160,104193160,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria,single nucleotide variant,GRCh37
na,na,9,101430878,101430878,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria,single nucleotide variant,GRCh38
na,na,9,104192183,104192183,ALDOB,Pathogenic,Hereditary fructosuria|not provided|See cases|ALDOB-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,101429901,101429901,ALDOB,Pathogenic,Hereditary fructosuria|not provided|See cases|ALDOB-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,104187910,104187910,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria,single nucleotide variant,GRCh37
na,na,9,101425628,101425628,ALDOB,Pathogenic/Likely pathogenic,Hereditary fructosuria,single nucleotide variant,GRCh38
na,na,9,104188908,104188913,ALDOB,Pathogenic,Hereditary fructosuria,Deletion,GRCh37
na,na,9,101426626,101426631,ALDOB,Pathogenic,Hereditary fructosuria,Deletion,GRCh38
na,na,9,104189862,104189862,ALDOB,Uncertain significance,Hereditary fructosuria|not specified,single nucleotide variant,GRCh37
na,na,9,101427580,101427580,ALDOB,Uncertain significance,Hereditary fructosuria|not specified,single nucleotide variant,GRCh38
na,na,11,112097240,112097240,PTS,Pathogenic/Likely pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,single nucleotide variant,GRCh37
na,na,11,112226517,112226517,PTS,Pathogenic/Likely pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,single nucleotide variant,GRCh38
na,na,11,112097212,112097212,PTS,Likely pathogenic,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency",single nucleotide variant,GRCh37
na,na,11,112226489,112226489,PTS,Likely pathogenic,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency",single nucleotide variant,GRCh38
na,na,11,112104201,112104214,PTS,Pathogenic,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency",Deletion,GRCh37
na,na,11,112233478,112233491,PTS,Pathogenic,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency",Deletion,GRCh38
na,na,11,112099388,112099388,PTS,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|not provided|PTS-related disorder,single nucleotide variant,GRCh37
na,na,11,112228665,112228665,PTS,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|not provided|PTS-related disorder,single nucleotide variant,GRCh38
na,na,11,112103901,112103901,PTS,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|Hyperphenylalaninemia due to tetrahydrobiopterin deficiency|not provided|GTP cyclohydrolase I deficiency with hyperphenylalaninemia,single nucleotide variant,GRCh37
na,na,11,112233178,112233178,PTS,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|Hyperphenylalaninemia due to tetrahydrobiopterin deficiency|not provided|GTP cyclohydrolase I deficiency with hyperphenylalaninemia,single nucleotide variant,GRCh38
na,na,11,112100933,112100933,PTS,Pathogenic/Likely pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,single nucleotide variant,GRCh37
na,na,11,112230210,112230210,PTS,Pathogenic/Likely pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,single nucleotide variant,GRCh38
na,na,11,112099372,112099372,PTS,Pathogenic,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency",single nucleotide variant,GRCh37
na,na,11,112228649,112228649,PTS,Pathogenic,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency",single nucleotide variant,GRCh38
na,na,11,112104187,112104187,PTS,Conflicting classifications of pathogenicity,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|not specified",single nucleotide variant,GRCh37
na,na,11,112233464,112233464,PTS,Conflicting classifications of pathogenicity,"Hyperphenylalaninemia, bh4-deficient, a, due to partial pts deficiency|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|not specified",single nucleotide variant,GRCh38
na,na,11,112103928,112103928,PTS,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,single nucleotide variant,GRCh37
na,na,11,112233205,112233205,PTS,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,single nucleotide variant,GRCh38
na,na,11,112100090,112100144,PTS,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,Deletion,GRCh37
na,na,11,112229367,112229421,PTS,Pathogenic,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency,Deletion,GRCh38
na,na,11,112098994,112098994,PTS,Uncertain significance,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|not provided,single nucleotide variant,GRCh37
na,na,11,112228271,112228271,PTS,Uncertain significance,6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|not provided,single nucleotide variant,GRCh38
na,na,3,196214430,196214431,RNF168,Pathogenic,RIDDLE syndrome,Duplication,GRCh37
na,na,3,196487559,196487560,RNF168,Pathogenic,RIDDLE syndrome,Duplication,GRCh38
na,na,3,196199080,196199083,RNF168,Likely pathogenic,RIDDLE syndrome|not provided,Deletion,GRCh37
na,na,3,196472209,196472212,RNF168,Likely pathogenic,RIDDLE syndrome|not provided,Deletion,GRCh38
na,na,4,17503409,17503410,QDPR,Pathogenic,Dihydropteridine reductase deficiency,Duplication,GRCh37
na,na,4,17501786,17501787,QDPR,Pathogenic,Dihydropteridine reductase deficiency,Duplication,GRCh38
na,na,4,17513610,17513610,QDPR,Pathogenic/Likely pathogenic,Dihydropteridine reductase deficiency|Hyperphenylalaninemia due to tetrahydrobiopterin deficiency,single nucleotide variant,GRCh37
na,na,4,17511987,17511987,QDPR,Pathogenic/Likely pathogenic,Dihydropteridine reductase deficiency|Hyperphenylalaninemia due to tetrahydrobiopterin deficiency,single nucleotide variant,GRCh38
na,na,4,17503456,17503456,QDPR,Pathogenic,Dihydropteridine reductase deficiency,single nucleotide variant,GRCh37
na,na,4,17501833,17501833,QDPR,Pathogenic,Dihydropteridine reductase deficiency,single nucleotide variant,GRCh38
na,na,4,17510986,17510986,QDPR,Pathogenic,Dihydropteridine reductase deficiency,single nucleotide variant,GRCh37
na,na,4,17509363,17509363,QDPR,Pathogenic,Dihydropteridine reductase deficiency,single nucleotide variant,GRCh38
na,na,4,17494392,17494392,QDPR,Pathogenic,Dihydropteridine reductase deficiency,single nucleotide variant,GRCh37
na,na,4,17492769,17492769,QDPR,Pathogenic,Dihydropteridine reductase deficiency,single nucleotide variant,GRCh38
na,na,4,17493951,17493951,QDPR,Pathogenic,Dihydropteridine reductase deficiency|not provided,single nucleotide variant,GRCh37
na,na,4,17492328,17492328,QDPR,Pathogenic,Dihydropteridine reductase deficiency|not provided,single nucleotide variant,GRCh38
na,na,4,17506027,17506027,QDPR,Pathogenic,Dihydropteridine reductase deficiency,single nucleotide variant,GRCh37
na,na,4,17504404,17504404,QDPR,Pathogenic,Dihydropteridine reductase deficiency,single nucleotide variant,GRCh38
na,na,6,117199117,117199117,RFX6,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,single nucleotide variant,GRCh37
na,na,6,116877954,116877954,RFX6,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,single nucleotide variant,GRCh38
na,na,6,117198947,117198947,RFX6,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome|Diabetes mellitus,single nucleotide variant,GRCh37
na,na,6,116877784,116877784,RFX6,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome|Diabetes mellitus,single nucleotide variant,GRCh38
na,na,6,117216372,117216372,RFX6,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,single nucleotide variant,GRCh37
na,na,6,116895209,116895209,RFX6,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,single nucleotide variant,GRCh38
na,na,6,117216347,117216347,RFX6,Likely pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,single nucleotide variant,GRCh37
na,na,6,116895184,116895184,RFX6,Likely pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,single nucleotide variant,GRCh38
na,na,6,117203567,117203567,RFX6,Likely pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome|RFX6-related disorder,single nucleotide variant,GRCh37
na,na,6,116882404,116882404,RFX6,Likely pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome|RFX6-related disorder,single nucleotide variant,GRCh38
na,na,6,117232201,117232214,RFX6,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,Deletion,GRCh37
na,na,6,116911038,116911051,RFX6,Pathogenic,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome,Deletion,GRCh38
na,na,6,116938246,116938246,RSPH4A,Pathogenic,Primary ciliary dyskinesia 11|Primary ciliary dyskinesia|Respiratory ciliopathies including non-CF bronchiectasis,single nucleotide variant,GRCh37
na,na,6,116617083,116617083,RSPH4A,Pathogenic,Primary ciliary dyskinesia 11|Primary ciliary dyskinesia|Respiratory ciliopathies including non-CF bronchiectasis,single nucleotide variant,GRCh38
na,na,6,116938111,116938111,RSPH4A,Pathogenic,Primary ciliary dyskinesia 11|Primary ciliary dyskinesia,single nucleotide variant,GRCh37
na,na,6,116616948,116616948,RSPH4A,Pathogenic,Primary ciliary dyskinesia 11|Primary ciliary dyskinesia,single nucleotide variant,GRCh38
na,na,6,116949338,116949338,RSPH4A,Pathogenic/Likely pathogenic,Primary ciliary dyskinesia 11|Primary ciliary dyskinesia,single nucleotide variant,GRCh37
na,na,6,116628175,116628175,RSPH4A,Pathogenic/Likely pathogenic,Primary ciliary dyskinesia 11|Primary ciliary dyskinesia,single nucleotide variant,GRCh38
na,na,8,41529963,41529963,ANK1,Pathogenic,Hereditary spherocytosis type 1,single nucleotide variant,GRCh37
na,na,8,41672445,41672445,ANK1,Pathogenic,Hereditary spherocytosis type 1,single nucleotide variant,GRCh38
na,na,8,41655164,41655164,ANK1,Conflicting classifications of pathogenicity,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE|Hereditary spherocytosis type 1|not specified|not provided",single nucleotide variant,GRCh37
na,na,8,41797646,41797646,ANK1,Conflicting classifications of pathogenicity,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE|Hereditary spherocytosis type 1|not specified|not provided",single nucleotide variant,GRCh38
na,na,8,41655128,41655129,ANK1,no classifications from unflagged records,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE",Deletion,GRCh37
na,na,8,41797610,41797611,ANK1,no classifications from unflagged records,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE",Deletion,GRCh38
na,na,8,41526016,41526016,ANK1,Pathogenic,Hereditary spherocytosis type 1|not provided,single nucleotide variant,GRCh37
na,na,8,41668498,41668498,ANK1,Pathogenic,Hereditary spherocytosis type 1|not provided,single nucleotide variant,GRCh38
na,na,8,41519441,41519441,ANK1,Pathogenic/Likely pathogenic,Hereditary spherocytosis type 1|not provided|ANK1-related disorder,single nucleotide variant,GRCh37
na,na,8,41661923,41661923,ANK1,Pathogenic/Likely pathogenic,Hereditary spherocytosis type 1|not provided|ANK1-related disorder,single nucleotide variant,GRCh38
na,na,8,41573252,41573253,ANK1,Pathogenic,Hereditary spherocytosis type 1|ANK1-related disorder,Duplication,GRCh37
na,na,8,41715734,41715735,ANK1,Pathogenic,Hereditary spherocytosis type 1|ANK1-related disorder,Duplication,GRCh38
na,na,8,41655209,41655209,ANK1,Conflicting classifications of pathogenicity,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE|not provided",single nucleotide variant,GRCh37
na,na,8,41797691,41797691,ANK1,Conflicting classifications of pathogenicity,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE|not provided",single nucleotide variant,GRCh38
na,na,8,41566510,41566510,ANK1,Pathogenic/Likely pathogenic,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE|Hereditary spherocytosis type 1|not provided",single nucleotide variant,GRCh37
na,na,8,41708992,41708992,ANK1,Pathogenic/Likely pathogenic,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE|Hereditary spherocytosis type 1|not provided",single nucleotide variant,GRCh38
na,na,8,41583352,41583371,ANK1,Pathogenic,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE",Deletion,GRCh37
na,na,8,41725834,41725853,ANK1,Pathogenic,"SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE",Deletion,GRCh38
na,na,6,70451727,70451728,LMBRD1,Pathogenic/Likely pathogenic,Methylmalonic aciduria and homocystinuria type cblF|Cobalamin C disease|not provided,Deletion,GRCh37
na,na,6,69741835,69741836,LMBRD1,Pathogenic/Likely pathogenic,Methylmalonic aciduria and homocystinuria type cblF|Cobalamin C disease|not provided,Deletion,GRCh38
na,na,6,70462152,70462152,LMBRD1,Pathogenic,Methylmalonic aciduria and homocystinuria type cblF,Deletion,GRCh37
na,na,6,69752260,69752260,LMBRD1,Pathogenic,Methylmalonic aciduria and homocystinuria type cblF,Deletion,GRCh38
na,na,5,127671236,127671236,FBN2,Likely pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh37
na,na,5,128335544,128335544,FBN2,Likely pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh38
na,na,5,127730875,127730875,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh37
na,na,5,128395182,128395182,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh38
na,na,5,127664515,127664515,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh37
na,na,5,128328823,128328823,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh38
na,na,5,127671284,127671284,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh37
na,na,5,128335592,128335592,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh38
na,na,5,127670562,127670562,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh37
na,na,5,128334870,128334870,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh38
na,na,5,127680077,127680077,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh37
na,na,5,128344385,128344385,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh38
na,na,5,127674672,127674672,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh37
na,na,5,128338980,128338980,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh38
na,na,5,127671235,127671235,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh37
na,na,5,128335543,128335543,FBN2,Pathogenic,Congenital contractural arachnodactyly,single nucleotide variant,GRCh38
na,na,14,50101845,50101845,DNAAF2,Pathogenic,Primary ciliary dyskinesia 10|Kartagener syndrome,single nucleotide variant,GRCh37
na,na,14,49635127,49635127,DNAAF2,Pathogenic,Primary ciliary dyskinesia 10|Kartagener syndrome,single nucleotide variant,GRCh38
na,na,2,172291137,172291137,DCAF17,Pathogenic,Woodhouse-Sakati syndrome,Deletion,GRCh37
na,na,2,171434627,171434627,DCAF17,Pathogenic,Woodhouse-Sakati syndrome,Deletion,GRCh38
na,na,2,172336708,172336708,DCAF17,Pathogenic,Woodhouse-Sakati syndrome,single nucleotide variant,GRCh37
na,na,2,171480198,171480198,DCAF17,Pathogenic,Woodhouse-Sakati syndrome,single nucleotide variant,GRCh38
na,na,2,172330491,172330491,DCAF17,Pathogenic,Woodhouse-Sakati syndrome,single nucleotide variant,GRCh37
na,na,2,171473981,171473981,DCAF17,Pathogenic,Woodhouse-Sakati syndrome,single nucleotide variant,GRCh38
na,na,6,65612309,65612325,EYS,Pathogenic,Retinitis pigmentosa 25,Deletion,GRCh37
na,na,6,64902416,64902432,EYS,Pathogenic,Retinitis pigmentosa 25,Deletion,GRCh38
na,na,6,65550600,65706998,EYS,Pathogenic,Retinitis pigmentosa 25,Deletion,GRCh37
na,na,6,64840707,64997105,EYS,Pathogenic,Retinitis pigmentosa 25,Deletion,GRCh38
na,na,6,65767621,66030608,EYS,Pathogenic,Retinitis pigmentosa 25,Deletion,GRCh37
na,na,6,65057728,65320715,EYS,Pathogenic,Retinitis pigmentosa 25,Deletion,GRCh38
na,na,6,65146137,65146137,EYS,Pathogenic,Retinitis pigmentosa 25|not provided,single nucleotide variant,GRCh37
na,na,6,64436244,64436244,EYS,Pathogenic,Retinitis pigmentosa 25|not provided,single nucleotide variant,GRCh38
na,na,6,64430522,64430522,EYS,Pathogenic/Likely pathogenic,Retinitis pigmentosa 25|not provided|Retinal dystrophy|Retinitis pigmentosa|EYS-related disorder,single nucleotide variant,GRCh37
na,na,6,63720626,63720626,EYS,Pathogenic/Likely pathogenic,Retinitis pigmentosa 25|not provided|Retinal dystrophy|Retinitis pigmentosa|EYS-related disorder,single nucleotide variant,GRCh38
na,na,8,74893388,74893388,TMEM70,Pathogenic/Likely pathogenic,Mitochondrial complex V (ATP synthase) deficiency nuclear type 2|not provided|See cases|TMEM70-related disorder|Neurodevelopmental disorder,single nucleotide variant,GRCh37
na,na,8,73981153,73981153,TMEM70,Pathogenic/Likely pathogenic,Mitochondrial complex V (ATP synthase) deficiency nuclear type 2|not provided|See cases|TMEM70-related disorder|Neurodevelopmental disorder,single nucleotide variant,GRCh38
na,na,11,71817140,71817140,LRTOMT,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63|Rare genetic deafness,single nucleotide variant,GRCh37
na,na,11,72106094,72106094,LRTOMT,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63|Rare genetic deafness,single nucleotide variant,GRCh38
na,na,11,71817211,71817211,LRTOMT,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63,single nucleotide variant,GRCh37
na,na,11,72106165,72106165,LRTOMT,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63,single nucleotide variant,GRCh38
na,na,11,71817226,71817226,LRTOMT,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63,single nucleotide variant,GRCh37
na,na,11,72106180,72106180,LRTOMT,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63,single nucleotide variant,GRCh38
na,na,11,71817231,71817231,LRTOMT,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63,single nucleotide variant,GRCh37
na,na,11,72106185,72106185,LRTOMT,Pathogenic,Autosomal recessive nonsyndromic hearing loss 63,single nucleotide variant,GRCh38
na,na,8,96044321,96044321,NDUFAF6,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 17",single nucleotide variant,GRCh37
na,na,8,95032093,95032093,NDUFAF6,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 17",single nucleotide variant,GRCh38
na,na,18,55247336,55247336,FECH,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|not specified|not provided",single nucleotide variant,GRCh37
na,na,18,57580104,57580104,FECH,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|not specified|not provided",single nucleotide variant,GRCh38
na,na,18,55226380,55226380,FECH,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|not provided",single nucleotide variant,GRCh37
na,na,18,57559148,57559148,FECH,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|not provided",single nucleotide variant,GRCh38
na,na,18,55247454,55247454,FECH,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|not provided|Jaundice;Erythema|not specified",single nucleotide variant,GRCh37
na,na,18,57580222,57580222,FECH,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|not provided|Jaundice;Erythema|not specified",single nucleotide variant,GRCh38
na,na,18,55217966,55217966,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh37
na,na,18,57550734,57550734,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh38
na,na,18,55221491,55221491,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh37
na,na,18,57554259,57554259,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh38
na,na,18,55218544,55218544,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",single nucleotide variant,GRCh37
na,na,18,57551312,57551312,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",single nucleotide variant,GRCh38
na,na,18,55218599,55218599,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh37
na,na,18,57551367,57551367,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh38
na,na,18,55240476,55240476,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",single nucleotide variant,GRCh37
na,na,18,57573244,57573244,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",single nucleotide variant,GRCh38
na,na,18,55240472,55240472,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh37
na,na,18,57573240,57573240,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh38
na,na,18,55218549,55218549,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",single nucleotide variant,GRCh37
na,na,18,57551317,57551317,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",single nucleotide variant,GRCh38
na,na,18,55218548,55218548,FECH,Pathogenic/Likely pathogenic,"Protoporphyria, erythropoietic, 1|not provided|FECH-related disorder",Deletion,GRCh37
na,na,18,57551316,57551316,FECH,Pathogenic/Likely pathogenic,"Protoporphyria, erythropoietic, 1|not provided|FECH-related disorder",Deletion,GRCh38
na,na,18,55247294,55247294,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh37
na,na,18,57580062,57580062,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1",single nucleotide variant,GRCh38
na,na,18,55233693,55233697,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",Deletion,GRCh37
na,na,18,57566461,57566465,FECH,Pathogenic,"Protoporphyria, erythropoietic, 1|not provided",Deletion,GRCh38
na,na,18,55217992,55217992,FECH,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,18,57550760,57550760,FECH,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,18,55238820,55238820,FECH,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|Erythema;Jaundice|Autosomal erythropoietic protoporphyria|not provided|not specified",single nucleotide variant,GRCh37
na,na,18,57571588,57571588,FECH,Conflicting classifications of pathogenicity,"Protoporphyria, erythropoietic, 1|Erythema;Jaundice|Autosomal erythropoietic protoporphyria|not provided|not specified",single nucleotide variant,GRCh38
na,na,10,73122216,73122216,SLC29A3,Pathogenic,H syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,71362459,71362459,SLC29A3,Pathogenic,H syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,73122267,73122267,SLC29A3,Pathogenic/Likely pathogenic,H syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,71362510,71362510,SLC29A3,Pathogenic/Likely pathogenic,H syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,73122246,73122246,SLC29A3,Pathogenic,H syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,71362489,71362489,SLC29A3,Pathogenic,H syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,73121978,73121978,SLC29A3,Pathogenic,H syndrome|not provided,Deletion,GRCh37
na,na,10,71362221,71362221,SLC29A3,Pathogenic,H syndrome|not provided,Deletion,GRCh38
na,na,10,73121877,73121877,SLC29A3,Pathogenic,H syndrome,Deletion,GRCh37
na,na,10,71362120,71362120,SLC29A3,Pathogenic,H syndrome,Deletion,GRCh38
na,na,10,73104012,73104012,SLC29A3,Likely pathogenic,H syndrome,single nucleotide variant,GRCh37
na,na,10,71344255,71344255,SLC29A3,Likely pathogenic,H syndrome,single nucleotide variant,GRCh38
na,na,10,73122283,73122283,SLC29A3,Pathogenic,H syndrome|SLC29A3-related disorder,single nucleotide variant,GRCh37
na,na,10,71362526,71362526,SLC29A3,Pathogenic,H syndrome|SLC29A3-related disorder,single nucleotide variant,GRCh38
na,na,20,13782298,13782298,NDUFAF5,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 16|not provided|Mitochondrial complex I deficiency",single nucleotide variant,GRCh37
na,na,20,13801652,13801652,NDUFAF5,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 16|not provided|Mitochondrial complex I deficiency",single nucleotide variant,GRCh38
na,na,20,13775585,13775585,NDUFAF5,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 16",single nucleotide variant,GRCh37
na,na,20,13794939,13794939,NDUFAF5,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 16",single nucleotide variant,GRCh38
na,na,3,186445047,186445047,KNG1,Pathogenic,"KININOGEN DEFICIENCY, TOTAL|High molecular weight kininogen deficiency",single nucleotide variant,GRCh37
na,na,3,186727258,186727258,KNG1,Pathogenic,"KININOGEN DEFICIENCY, TOTAL|High molecular weight kininogen deficiency",single nucleotide variant,GRCh38
na,na,3,186459677,186459677,KNG1,Affects,High molecular weight kininogen deficiency,Deletion,GRCh37
na,na,3,186741888,186741888,KNG1,Affects,High molecular weight kininogen deficiency,Deletion,GRCh38
na,na,3,186458773,186458799,KNG1,Affects,High molecular weight kininogen deficiency,Indel,GRCh37
na,na,3,186740984,186741010,KNG1,Affects,High molecular weight kininogen deficiency,Indel,GRCh38
na,na,3,186459397,186459398,KNG1,Affects,High molecular weight kininogen deficiency,Duplication,GRCh37
na,na,3,186741608,186741609,KNG1,Affects,High molecular weight kininogen deficiency,Duplication,GRCh38
na,na,12,103234177,103234177,PAH,Pathogenic,"Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder|Pituitary hormone deficiency, combined, 2",single nucleotide variant,GRCh37
na,na,12,102840399,102840399,PAH,Pathogenic,"Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder|Pituitary hormone deficiency, combined, 2",single nucleotide variant,GRCh38
na,na,12,103234271,103234271,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|Inborn genetic diseases|See cases,single nucleotide variant,GRCh37
na,na,12,102840493,102840493,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|Inborn genetic diseases|See cases,single nucleotide variant,GRCh38
na,na,12,103240710,103240710,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102846932,102846932,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103238202,103238202,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102844424,102844424,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103246597,103246597,PAH,Pathogenic,"Phenylketonuria|not provided|Inborn genetic diseases|Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis|PAH-related disorder",single nucleotide variant,GRCh37
na,na,12,102852819,102852819,PAH,Pathogenic,"Phenylketonuria|not provided|Inborn genetic diseases|Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis|PAH-related disorder",single nucleotide variant,GRCh38
na,na,12,103288534,103288534,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102894756,102894756,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103246653,103246653,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102852875,102852875,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103288604,103288604,PAH,Pathogenic/Likely pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102894826,102894826,PAH,Pathogenic/Likely pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103246681,103246681,PAH,Pathogenic,"Phenylketonuria|not provided|Pulmonary hypertension, primary, 1|See cases",single nucleotide variant,GRCh37
na,na,12,102852903,102852903,PAH,Pathogenic,"Phenylketonuria|not provided|Pulmonary hypertension, primary, 1|See cases",single nucleotide variant,GRCh38
na,na,12,103287046,103293645,PAH,Pathogenic,Phenylketonuria|not provided,Indel,GRCh37
na,na,12,102893268,102899867,PAH,Pathogenic,Phenylketonuria|not provided,Indel,GRCh38
na,na,12,103310908,103310908,PAH,Pathogenic,Phenylketonuria|Hyperphenylalaninemia|not provided,single nucleotide variant,GRCh37
na,na,12,102917130,102917130,PAH,Pathogenic,Phenylketonuria|Hyperphenylalaninemia|not provided,single nucleotide variant,GRCh38
na,na,12,103260410,103260410,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102866632,102866632,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103246708,103246708,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|Hyperphenylalaninemia|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102852930,102852930,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|Hyperphenylalaninemia|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103246593,103246593,PAH,Likely pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102852815,102852815,PAH,Likely pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103249009,103249009,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102855231,102855231,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103246707,103246707,PAH,Pathogenic/Likely pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102852929,102852929,PAH,Pathogenic/Likely pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103234255,103234255,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102840477,102840477,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103234252,103234252,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|PAH-related disorder|See cases,single nucleotide variant,GRCh37
na,na,12,102840474,102840474,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|PAH-related disorder|See cases,single nucleotide variant,GRCh38
na,na,12,103260442,103260442,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102866664,102866664,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103237555,103237555,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102843777,102843777,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103246621,103246621,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102852843,102852843,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103237529,103237531,PAH,Likely pathogenic,Phenylketonuria|not provided,Deletion,GRCh37
na,na,12,102843751,102843753,PAH,Likely pathogenic,Phenylketonuria|not provided,Deletion,GRCh38
na,na,12,103246617,103246617,PAH,Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102852839,102852839,PAH,Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103246592,103246592,PAH,Pathogenic,Phenylketonuria|not provided|Hyperphenylalaninemia,single nucleotide variant,GRCh37
na,na,12,102852814,102852814,PAH,Pathogenic,Phenylketonuria|not provided|Hyperphenylalaninemia,single nucleotide variant,GRCh38
na,na,12,103246671,103246671,PAH,Pathogenic/Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102852893,102852893,PAH,Pathogenic/Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103237426,103237426,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102843648,102843648,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103246659,103246659,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102852881,102852881,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103246606,103246606,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102852828,102852828,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103288579,103288581,PAH,Pathogenic,Phenylketonuria|not provided,Microsatellite,GRCh37
na,na,12,102894801,102894803,PAH,Pathogenic,Phenylketonuria|not provided,Microsatellite,GRCh38
na,na,12,103306620,103306620,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102912842,102912842,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103237568,103237568,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|Hyperphenylalaninemia,single nucleotide variant,GRCh37
na,na,12,102843790,102843790,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|Hyperphenylalaninemia,single nucleotide variant,GRCh38
na,na,12,103306594,103306594,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102912816,102912816,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103248958,103248958,PAH,Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102855180,102855180,PAH,Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103246654,103246654,PAH,Pathogenic,"Phenylketonuria|not provided|Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh37
na,na,12,102852876,102852876,PAH,Pathogenic,"Phenylketonuria|not provided|Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh38
na,na,12,103306572,103306572,PAH,Pathogenic,Phenylketonuria|not provided,Deletion,GRCh37
na,na,12,102912794,102912794,PAH,Pathogenic,Phenylketonuria|not provided,Deletion,GRCh38
na,na,12,103234270,103234270,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|Hyperphenylalaninemia,single nucleotide variant,GRCh37
na,na,12,102840492,102840492,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|Hyperphenylalaninemia,single nucleotide variant,GRCh38
na,na,12,103245481,103245481,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102851703,102851703,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103246591,103246591,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102852813,102852813,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103238134,103238134,PAH,Pathogenic/Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102844356,102844356,PAH,Pathogenic/Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103240677,103240677,PAH,Likely pathogenic,Mild non-PKU hyperphenylalanemia|not provided|Phenylketonuria|See cases,single nucleotide variant,GRCh37
na,na,12,102846899,102846899,PAH,Likely pathogenic,Mild non-PKU hyperphenylalanemia|not provided|Phenylketonuria|See cases,single nucleotide variant,GRCh38
na,na,12,103234250,103234250,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|PAH-related disorder,single nucleotide variant,GRCh37
na,na,12,102840472,102840472,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|PAH-related disorder,single nucleotide variant,GRCh38
na,na,12,103240726,103240726,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh37
na,na,12,102846948,102846948,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh38
na,na,12,103237461,103237461,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102843683,102843683,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103237517,103237531,PAH,Likely pathogenic,Phenylketonuria|not provided,Deletion,GRCh37
na,na,12,102843739,102843753,PAH,Likely pathogenic,Phenylketonuria|not provided,Deletion,GRCh38
na,na,12,103246704,103246704,PAH,Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102852926,102852926,PAH,Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103310906,103310906,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102917128,102917128,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103237560,103237560,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102843782,102843782,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103238182,103238182,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh37
na,na,12,102844404,102844404,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh38
na,na,12,103237454,103237454,PAH,Pathogenic,Hyperphenylalaninemia|Phenylketonuria|not provided|PAH-related disorder|Mild hyperphenylalaninemia,single nucleotide variant,GRCh37
na,na,12,102843676,102843676,PAH,Pathogenic,Hyperphenylalaninemia|Phenylketonuria|not provided|PAH-related disorder|Mild hyperphenylalaninemia,single nucleotide variant,GRCh38
na,na,12,103237547,103237547,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102843769,102843769,PAH,Pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103288572,103288572,PAH,Likely pathogenic,Mild non-PKU hyperphenylalanemia|not provided|Phenylketonuria|PAH-related disorder|not specified,single nucleotide variant,GRCh37
na,na,12,102894794,102894794,PAH,Likely pathogenic,Mild non-PKU hyperphenylalanemia|not provided|Phenylketonuria|PAH-related disorder|not specified,single nucleotide variant,GRCh38
na,na,12,103237484,103237484,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|Marfanoid habitus and intellectual disability|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|PAH-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,102843706,102843706,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|Marfanoid habitus and intellectual disability|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|PAH-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,103306601,103306601,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,102912823,102912823,PAH,Pathogenic,Phenylketonuria|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,103306597,103306597,PAH,Likely pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh37
na,na,12,102912819,102912819,PAH,Likely pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh38
na,na,12,103249093,103249093,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|Inborn genetic diseases|See cases,single nucleotide variant,GRCh37
na,na,12,102855315,102855315,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|6-Pyruvoyl-tetrahydrobiopterin synthase deficiency|Inborn genetic diseases|See cases,single nucleotide variant,GRCh38
na,na,12,103246701,103246701,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,102852923,102852923,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,103238111,103238111,PAH,Likely pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh37
na,na,12,102844333,102844333,PAH,Likely pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh38
na,na,12,103237494,103237494,PAH,Pathogenic,Phenylketonuria|not provided,Deletion,GRCh37
na,na,12,102843716,102843716,PAH,Pathogenic,Phenylketonuria|not provided,Deletion,GRCh38
na,na,12,103234273,103234273,PAH,Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh37
na,na,12,102840495,102840495,PAH,Likely pathogenic,Phenylketonuria|not provided,single nucleotide variant,GRCh38
na,na,12,103288671,103288671,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|See cases|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,102894893,102894893,PAH,Pathogenic,Phenylketonuria|not provided|PAH-related disorder|See cases|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,102840516,102851686,PAH,Pathogenic,Phenylketonuria,Deletion,GRCh38
na,na,12,103311316,103315074,PAH,Likely pathogenic,Hyperphenylalaninemia|Phenylketonuria,Deletion,GRCh37
na,na,12,102917538,102921296,PAH,Likely pathogenic,Hyperphenylalaninemia|Phenylketonuria,Deletion,GRCh38
na,na,12,103288638,103288638,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh37
na,na,12,102894860,102894860,PAH,Pathogenic,Hyperphenylalaninemia|not provided|Phenylketonuria,single nucleotide variant,GRCh38
na,na,6,52880897,52880897,CILK1,Pathogenic,Endocrine-cerebro-osteodysplasia syndrome,single nucleotide variant,GRCh37
na,na,6,53016099,53016099,CILK1,Pathogenic,Endocrine-cerebro-osteodysplasia syndrome,single nucleotide variant,GRCh38
na,na,2,207638988,207638988,FASTKD2,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Combined oxidative phosphorylation deficiency 44",single nucleotide variant,GRCh37
na,na,2,206774264,206774264,FASTKD2,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Combined oxidative phosphorylation deficiency 44",single nucleotide variant,GRCh38
na,na,1,169519049,169519049,F5,drug response,"Budd-Chiari syndrome, susceptibility to|Ischemic stroke|Pregnancy loss, recurrent, susceptibility to, 1|Factor V deficiency|Thrombophilia due to activated protein C resistance|not specified|Thrombophilia due to activated protein C resistance;Factor V deficiency|Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process|Inborn genetic diseases|not provided|hormonal contraceptives for systemic use response - Toxicity|Congenital factor V deficiency|Thrombophilia due to activated protein C resistance;Ischemic stroke;Congenital factor V deficiency;Pregnancy loss, recurrent, susceptibility to, 1;Budd-Chiari syndrome",single nucleotide variant,GRCh37
na,na,1,169549811,169549811,F5,drug response,"Budd-Chiari syndrome, susceptibility to|Ischemic stroke|Pregnancy loss, recurrent, susceptibility to, 1|Factor V deficiency|Thrombophilia due to activated protein C resistance|not specified|Thrombophilia due to activated protein C resistance;Factor V deficiency|Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process|Inborn genetic diseases|not provided|hormonal contraceptives for systemic use response - Toxicity|Congenital factor V deficiency|Thrombophilia due to activated protein C resistance;Ischemic stroke;Congenital factor V deficiency;Pregnancy loss, recurrent, susceptibility to, 1;Budd-Chiari syndrome",single nucleotide variant,GRCh38
na,na,1,169524538,169524538,F5,Conflicting classifications of pathogenicity,Factor V Hong Kong|not provided|Thrombophilia due to activated protein C resistance|Congenital factor V deficiency,single nucleotide variant,GRCh37
na,na,1,169555300,169555300,F5,Conflicting classifications of pathogenicity,Factor V Hong Kong|not provided|Thrombophilia due to activated protein C resistance|Congenital factor V deficiency,single nucleotide variant,GRCh38
na,na,1,169524537,169524537,F5,Conflicting classifications of pathogenicity,Thrombophilia due to activated protein C resistance|Congenital factor V deficiency,single nucleotide variant,GRCh37
na,na,1,169555299,169555299,F5,Conflicting classifications of pathogenicity,Thrombophilia due to activated protein C resistance|Congenital factor V deficiency,single nucleotide variant,GRCh38
na,na,1,169529939,169529939,F5,Pathogenic,Thrombophilia due to activated protein C resistance,single nucleotide variant,GRCh37
na,na,1,169560701,169560701,F5,Pathogenic,Thrombophilia due to activated protein C resistance,single nucleotide variant,GRCh38
na,na,1,169510401,169510404,F5,Pathogenic,Factor V deficiency,Microsatellite,GRCh37
na,na,1,169541163,169541166,F5,Pathogenic,Factor V deficiency,Microsatellite,GRCh38
na,na,1,169509625,169509626,F5,Pathogenic,Factor V deficiency,Duplication,GRCh37
na,na,1,169540387,169540388,F5,Pathogenic,Factor V deficiency,Duplication,GRCh38
na,na,1,169524489,169524496,F5,Pathogenic,Factor V deficiency,Deletion,GRCh37
na,na,1,169555251,169555258,F5,Pathogenic,Factor V deficiency,Deletion,GRCh38
na,na,1,169500043,169500043,F5,Pathogenic/Likely pathogenic,Factor V deficiency|Congenital factor V deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,169530805,169530805,F5,Pathogenic/Likely pathogenic,Factor V deficiency|Congenital factor V deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,169511927,169511927,F5,Pathogenic,Factor V deficiency,single nucleotide variant,GRCh37
na,na,1,169542689,169542689,F5,Pathogenic,Factor V deficiency,single nucleotide variant,GRCh38
na,na,1,169510847,169510847,F5,Pathogenic,Factor V deficiency,single nucleotide variant,GRCh37
na,na,1,169541609,169541609,F5,Pathogenic,Factor V deficiency,single nucleotide variant,GRCh38
na,na,1,169498861,169498862,F5,Pathogenic,Factor V deficiency,Insertion,GRCh37
na,na,1,169529623,169529624,F5,Pathogenic,Factor V deficiency,Insertion,GRCh38
na,na,1,169487691,169487691,F5,Likely pathogenic,Factor V deficiency,single nucleotide variant,GRCh37
na,na,1,169518453,169518453,F5,Likely pathogenic,Factor V deficiency,single nucleotide variant,GRCh38
na,na,1,169521931,169521931,F5,Pathogenic,Thrombophilia due to activated protein C resistance,single nucleotide variant,GRCh37
na,na,1,169552693,169552693,F5,Pathogenic,Thrombophilia due to activated protein C resistance,single nucleotide variant,GRCh38
na,na,2,128186178,128186178,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|not provided",single nucleotide variant,GRCh37
na,na,2,127428602,127428602,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|not provided",single nucleotide variant,GRCh38
na,na,2,128186468,128186468,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,127428892,127428892,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,na,-1,-1,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",Variation,na
na,na,2,128183756,128183756,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant|Reduced protein C activity|not provided",single nucleotide variant,GRCh37
na,na,2,127426180,127426180,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant|Reduced protein C activity|not provided",single nucleotide variant,GRCh38
na,na,2,128186038,128186038,PROC,Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,2,127428462,127428462,PROC,Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,2,128183754,128183754,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,127426178,127426178,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,128186061,128186061,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant|not provided|Hereditary thrombophilia due to congenital protein C deficiency",single nucleotide variant,GRCh37
na,na,2,127428485,127428485,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant|not provided|Hereditary thrombophilia due to congenital protein C deficiency",single nucleotide variant,GRCh38
na,na,2,128186163,128186163,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",single nucleotide variant,GRCh37
na,na,2,127428587,127428587,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,128178973,128178973,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|PROC-related disorder|not provided",single nucleotide variant,GRCh37
na,na,2,127421397,127421397,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|PROC-related disorder|not provided",single nucleotide variant,GRCh38
na,na,2,128179014,128179014,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Abnormal thrombosis|Cerebral palsy|PROC-related disorder",single nucleotide variant,GRCh37
na,na,2,127421438,127421438,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive|Abnormal thrombosis|Cerebral palsy|PROC-related disorder",single nucleotide variant,GRCh38
na,na,2,128186136,128186136,PROC,Conflicting classifications of pathogenicity,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant|not provided|PROC-related disorder",single nucleotide variant,GRCh37
na,na,2,127428560,127428560,PROC,Conflicting classifications of pathogenicity,"Thrombophilia due to protein C deficiency, autosomal recessive|Thrombophilia due to protein C deficiency, autosomal dominant|not provided|PROC-related disorder",single nucleotide variant,GRCh38
na,na,2,128186002,128186002,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",single nucleotide variant,GRCh37
na,na,2,127428426,127428426,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,128183783,128183783,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|PROC-related disorder",single nucleotide variant,GRCh37
na,na,2,127426207,127426207,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|PROC-related disorder",single nucleotide variant,GRCh38
na,na,2,128183784,128183784,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|Reduced protein C activity|Thrombophilia due to protein C deficiency, autosomal dominant;Thrombophilia due to protein C deficiency, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,2,127426208,127426208,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|Reduced protein C activity|Thrombophilia due to protein C deficiency, autosomal dominant;Thrombophilia due to protein C deficiency, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,2,128186401,128186401,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",Deletion,GRCh37
na,na,2,127428825,127428825,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",Deletion,GRCh38
na,na,2,128185950,128185950,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|Thromboembolism|not provided",single nucleotide variant,GRCh37
na,na,2,127428374,127428374,PROC,Pathogenic/Likely pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|Thromboembolism|not provided",single nucleotide variant,GRCh38
na,na,2,128183677,128183678,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",Insertion,GRCh37
na,na,2,127426101,127426102,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",Insertion,GRCh38
na,na,2,128183812,128183812,PROC,Uncertain significance,"Thrombophilia due to protein C deficiency, autosomal dominant|Reduced protein C activity",single nucleotide variant,GRCh37
na,na,2,127426236,127426236,PROC,Uncertain significance,"Thrombophilia due to protein C deficiency, autosomal dominant|Reduced protein C activity",single nucleotide variant,GRCh38
na,na,2,128183803,128183803,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,127426227,127426227,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,128184795,128184795,PROC,Conflicting classifications of pathogenicity,"Thrombophilia due to protein C deficiency, autosomal recessive|Deep venous thrombosis|Reduced protein C activity|Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,127427219,127427219,PROC,Conflicting classifications of pathogenicity,"Thrombophilia due to protein C deficiency, autosomal recessive|Deep venous thrombosis|Reduced protein C activity|Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,128186471,128186471,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",single nucleotide variant,GRCh37
na,na,2,127428895,127428895,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,128186151,128186151,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|Inborn genetic diseases|not provided",single nucleotide variant,GRCh37
na,na,2,127428575,127428575,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|Inborn genetic diseases|not provided",single nucleotide variant,GRCh38
na,na,2,128176001,128176001,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,127418425,127418425,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,128180895,128180895,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,127423319,127423319,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,128186071,128186071,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|not provided",single nucleotide variant,GRCh37
na,na,2,127428495,127428495,PROC,Pathogenic,"Thrombophilia due to protein C deficiency, autosomal dominant|not provided",single nucleotide variant,GRCh38
na,na,1,24172327,24172327,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh37
na,na,1,23845837,23845837,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh38
na,na,na,-1,-1,FUCA1,Pathogenic,Fucosidosis,Deletion,na
na,na,1,24175161,24175161,FUCA1,Pathogenic,Fucosidosis|not provided,single nucleotide variant,GRCh37
na,na,1,23848671,23848671,FUCA1,Pathogenic,Fucosidosis|not provided,single nucleotide variant,GRCh38
na,na,1,24180849,24180849,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh37
na,na,1,23854359,23854359,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh38
na,na,1,24194533,24194533,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh37
na,na,1,23868043,23868043,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh38
na,na,1,24175139,24175139,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh37
na,na,1,23848649,23848649,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh38
na,na,1,24189638,24189638,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh37
na,na,1,23863148,23863148,FUCA1,Pathogenic,Fucosidosis,single nucleotide variant,GRCh38
na,na,1,24192068,24192068,FUCA1,Pathogenic,Fucosidosis,Deletion,GRCh37
na,na,1,23865578,23865578,FUCA1,Pathogenic,Fucosidosis,Deletion,GRCh38
na,na,1,24189625,24189625,FUCA1,Pathogenic/Likely pathogenic,Fucosidosis,Deletion,GRCh37
na,na,1,23863135,23863135,FUCA1,Pathogenic/Likely pathogenic,Fucosidosis,Deletion,GRCh38
na,na,1,24180962,24180962,FUCA1,Benign,FU1/FU2 POLYMORPHISM|not provided|Fucosidosis,single nucleotide variant,GRCh37
na,na,1,23854472,23854472,FUCA1,Benign,FU1/FU2 POLYMORPHISM|not provided|Fucosidosis,single nucleotide variant,GRCh38
na,na,1,24172595,24172595,FUCA1,Likely pathogenic,Fucosidosis,single nucleotide variant,GRCh37
na,na,1,23846105,23846105,FUCA1,Likely pathogenic,Fucosidosis,single nucleotide variant,GRCh38
na,na,9,136405747,136405747,ADAMTSL2,Pathogenic,Geleophysic dysplasia 1,single nucleotide variant,GRCh37
na,na,9,133540625,133540625,ADAMTSL2,Pathogenic,Geleophysic dysplasia 1,single nucleotide variant,GRCh38
na,na,9,136404921,136404921,ADAMTSL2,Likely pathogenic,"Geleophysic dysplasia 1|Lethal short-limb skeletal dysplasia, Al Gazali type",single nucleotide variant,GRCh37
na,na,9,133539799,133539799,ADAMTSL2,Likely pathogenic,"Geleophysic dysplasia 1|Lethal short-limb skeletal dysplasia, Al Gazali type",single nucleotide variant,GRCh38
na,na,9,136404923,136404923,ADAMTSL2,Conflicting classifications of pathogenicity,Geleophysic dysplasia 1|not provided|Geleophysic dysplasia,single nucleotide variant,GRCh37
na,na,9,133539801,133539801,ADAMTSL2,Conflicting classifications of pathogenicity,Geleophysic dysplasia 1|not provided|Geleophysic dysplasia,single nucleotide variant,GRCh38
na,na,9,136435468,136435468,ADAMTSL2,Pathogenic,Geleophysic dysplasia 1,single nucleotide variant,GRCh37
na,na,9,133570346,133570346,ADAMTSL2,Pathogenic,Geleophysic dysplasia 1,single nucleotide variant,GRCh38
na,na,9,136435623,136435623,ADAMTSL2,Pathogenic,Geleophysic dysplasia 1,single nucleotide variant,GRCh37
na,na,9,133570501,133570501,ADAMTSL2,Pathogenic,Geleophysic dysplasia 1,single nucleotide variant,GRCh38
na,na,16,88902630,88902630,GALNS,Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh37
na,na,16,88836222,88836222,GALNS,Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh38
na,na,16,88907409,88907409,GALNS,Uncertain significance,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh37
na,na,16,88841001,88841001,GALNS,Uncertain significance,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh38
na,na,16,88891261,88891261,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided|Morquio syndrome",single nucleotide variant,GRCh37
na,na,16,88824853,88824853,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided|Morquio syndrome",single nucleotide variant,GRCh38
na,na,16,88884437,88884437,GALNS,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh37
na,na,16,88818029,88818029,GALNS,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh38
na,na,16,88907485,88907485,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome|not provided",single nucleotide variant,GRCh37
na,na,16,88841077,88841077,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome|not provided",single nucleotide variant,GRCh38
na,na,16,88884480,88884480,GALNS,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh37
na,na,16,88818072,88818072,GALNS,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh38
na,na,16,88908344,88908344,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",single nucleotide variant,GRCh37
na,na,16,88841936,88841936,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",single nucleotide variant,GRCh38
na,na,16,88901743,88901743,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided",single nucleotide variant,GRCh37
na,na,16,88835335,88835335,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided",single nucleotide variant,GRCh38
na,na,16,88901648,88901648,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",single nucleotide variant,GRCh37
na,na,16,88835240,88835240,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",single nucleotide variant,GRCh38
na,na,16,88898507,88898507,GALNS,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome|not provided",single nucleotide variant,GRCh37
na,na,16,88832099,88832099,GALNS,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome|not provided",single nucleotide variant,GRCh38
na,na,16,88904111,88904111,GALNS,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided",single nucleotide variant,GRCh37
na,na,16,88837703,88837703,GALNS,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A|not provided",single nucleotide variant,GRCh38
na,na,16,88909153,88909153,GALNS,Uncertain significance,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh37
na,na,16,88842745,88842745,GALNS,Uncertain significance,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh38
na,na,16,88902202,88902202,GALNS,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",single nucleotide variant,GRCh37
na,na,16,88835794,88835794,GALNS,Pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",single nucleotide variant,GRCh38
na,na,16,88898473,88898473,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",single nucleotide variant,GRCh37
na,na,16,88832065,88832065,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome",single nucleotide variant,GRCh38
na,na,16,88909180,88909180,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh37
na,na,16,88842772,88842772,GALNS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-A",single nucleotide variant,GRCh38
na,na,6,29641105,29641105,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",single nucleotide variant,GRCh37
na,na,6,29673328,29673328,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",single nucleotide variant,GRCh38
na,na,6,29643197,29643198,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",Microsatellite,GRCh37
na,na,6,29675420,29675421,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",Microsatellite,GRCh38
na,na,6,29640505,29640505,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",Deletion,GRCh37
na,na,6,29672728,29672728,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",Deletion,GRCh38
na,na,6,29640516,29640516,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",single nucleotide variant,GRCh37
na,na,6,29672739,29672739,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",single nucleotide variant,GRCh38
na,na,6,29641145,29641145,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",single nucleotide variant,GRCh37
na,na,6,29673368,29673368,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",single nucleotide variant,GRCh38
na,na,6,29641059,29641059,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",single nucleotide variant,GRCh37
na,na,6,29673282,29673282,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",single nucleotide variant,GRCh38
na,na,6,29640983,29640990,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",Deletion,GRCh37
na,na,6,29673206,29673213,ZFP57,Pathogenic,"Diabetes mellitus, transient neonatal, 1",Deletion,GRCh38
na,na,8,18258103,18258103,NAT2,Benign; drug response,Slow acetylator due to N-acetyltransferase enzyme variant|NAT2-related disorder,single nucleotide variant,GRCh37
na,na,8,18400593,18400593,NAT2,Benign; drug response,Slow acetylator due to N-acetyltransferase enzyme variant|NAT2-related disorder,single nucleotide variant,GRCh38
na,na,8,18257854,18257854,NAT2,Benign; drug response,Slow acetylator due to N-acetyltransferase enzyme variant|NAT2-related disorder,single nucleotide variant,GRCh37
na,na,8,18400344,18400344,NAT2,Benign; drug response,Slow acetylator due to N-acetyltransferase enzyme variant|NAT2-related disorder,single nucleotide variant,GRCh38
na,na,8,18258316,18258316,NAT2,drug response,Slow acetylator due to N-acetyltransferase enzyme variant,single nucleotide variant,GRCh37
na,na,8,18400806,18400806,NAT2,drug response,Slow acetylator due to N-acetyltransferase enzyme variant,single nucleotide variant,GRCh38
na,na,8,18258370,18258370,NAT2,drug response,Slow acetylator due to N-acetyltransferase enzyme variant,single nucleotide variant,GRCh37
na,na,8,18400860,18400860,NAT2,drug response,Slow acetylator due to N-acetyltransferase enzyme variant,single nucleotide variant,GRCh38
na,na,8,18257704,18257704,NAT2,Likely benign; drug response,Slow acetylator due to N-acetyltransferase enzyme variant|NAT2-related disorder,single nucleotide variant,GRCh37
na,na,8,18400194,18400194,NAT2,Likely benign; drug response,Slow acetylator due to N-acetyltransferase enzyme variant|NAT2-related disorder,single nucleotide variant,GRCh38
na,na,11,68846399,68846399,TPCN2,association,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10",single nucleotide variant,GRCh37
na,na,11,69078931,69078931,TPCN2,association,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10",single nucleotide variant,GRCh38
na,na,11,68855363,68855363,TPCN2,association,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10",single nucleotide variant,GRCh37
na,na,11,69087895,69087895,TPCN2,association,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10",single nucleotide variant,GRCh38
na,na,5,132202707,132202707,UQCRQ,Pathogenic,Mitochondrial complex III deficiency nuclear type 4|not provided,single nucleotide variant,GRCh37
na,na,5,132867015,132867015,UQCRQ,Pathogenic,Mitochondrial complex III deficiency nuclear type 4|not provided,single nucleotide variant,GRCh38
na,na,16,88499905,88499905,ZNF469,Pathogenic,Brittle cornea syndrome 1,Deletion,GRCh37
na,na,16,88433497,88433497,ZNF469,Pathogenic,Brittle cornea syndrome 1,Deletion,GRCh38
na,na,16,88503489,88503489,ZNF469,Pathogenic,Brittle cornea syndrome 1,Deletion,GRCh37
na,na,16,88437081,88437081,ZNF469,Pathogenic,Brittle cornea syndrome 1,Deletion,GRCh38
na,na,7,127970949,127970949,RBM28,Pathogenic,ANE syndrome,single nucleotide variant,GRCh37
na,na,7,128330896,128330896,RBM28,Pathogenic,ANE syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,BEAN1,Pathogenic,Spinocerebellar ataxia type 31,Insertion,na
na,na,3,14183165,14183165,TMEM43,Pathogenic,Arrhythmogenic right ventricular dysplasia 5|Arrhythmogenic right ventricular cardiomyopathy|not provided|Familial isolated arrhythmogenic right ventricular dysplasia|Cardiovascular phenotype|Cardiomyopathy|Hypertrophic cardiomyopathy|Primary dilated cardiomyopathy,single nucleotide variant,GRCh37
na,na,3,14141665,14141665,TMEM43,Pathogenic,Arrhythmogenic right ventricular dysplasia 5|Arrhythmogenic right ventricular cardiomyopathy|not provided|Familial isolated arrhythmogenic right ventricular dysplasia|Cardiovascular phenotype|Cardiomyopathy|Hypertrophic cardiomyopathy|Primary dilated cardiomyopathy,single nucleotide variant,GRCh38
na,na,4,1095281,1095281,RNF212,association,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,single nucleotide variant,GRCh37
na,na,4,1101493,1101493,RNF212,association,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,single nucleotide variant,GRCh38
na,na,4,1078187,1078187,RNF212,association,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,single nucleotide variant,GRCh37
na,na,4,1084399,1084399,RNF212,association,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,single nucleotide variant,GRCh38
na,na,6,150710610,150710610,IYD,Likely pathogenic,Iodotyrosine deiodination defect|IYD-related disorder,single nucleotide variant,GRCh37
na,na,6,150389474,150389474,IYD,Likely pathogenic,Iodotyrosine deiodination defect|IYD-related disorder,single nucleotide variant,GRCh38
na,na,6,150710623,150710625,IYD,Conflicting classifications of pathogenicity,Iodotyrosine deiodination defect|IYD-related disorder|not specified,Deletion,GRCh37
na,na,6,150389487,150389489,IYD,Conflicting classifications of pathogenicity,Iodotyrosine deiodination defect|IYD-related disorder|not specified,Deletion,GRCh38
na,na,6,150710656,150710656,IYD,Likely pathogenic,Iodotyrosine deiodination defect,single nucleotide variant,GRCh37
na,na,6,150389520,150389520,IYD,Likely pathogenic,Iodotyrosine deiodination defect,single nucleotide variant,GRCh38
na,na,6,150715362,150715362,IYD,Pathogenic/Likely pathogenic,Iodotyrosine deiodination defect,single nucleotide variant,GRCh37
na,na,6,150394226,150394226,IYD,Pathogenic/Likely pathogenic,Iodotyrosine deiodination defect,single nucleotide variant,GRCh38
na,na,4,15552604,15552604,CC2D2A,Pathogenic,Joubert syndrome 9,single nucleotide variant,GRCh37
na,na,4,15550981,15550981,CC2D2A,Pathogenic,Joubert syndrome 9,single nucleotide variant,GRCh38
na,na,4,15538697,15538697,CC2D2A,Pathogenic,"Meckel syndrome, type 6|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9|not provided",single nucleotide variant,GRCh37
na,na,4,15537074,15537074,CC2D2A,Pathogenic,"Meckel syndrome, type 6|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9|not provided",single nucleotide variant,GRCh38
na,na,4,15569375,15569375,CC2D2A,Conflicting classifications of pathogenicity,Joubert syndrome 9|not provided|COACH syndrome 1|Meckel-Gruber syndrome;Joubert syndrome,single nucleotide variant,GRCh37
na,na,4,15567752,15567752,CC2D2A,Conflicting classifications of pathogenicity,Joubert syndrome 9|not provided|COACH syndrome 1|Meckel-Gruber syndrome;Joubert syndrome,single nucleotide variant,GRCh38
na,na,4,15601237,15601237,CC2D2A,Pathogenic/Likely pathogenic,"Joubert syndrome 9|not provided|COACH syndrome 2|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 6|CC2D2A-related disorder|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9",single nucleotide variant,GRCh37
na,na,4,15599614,15599614,CC2D2A,Pathogenic/Likely pathogenic,"Joubert syndrome 9|not provided|COACH syndrome 2|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 6|CC2D2A-related disorder|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9",single nucleotide variant,GRCh38
na,na,4,15560806,15560806,CC2D2A,Pathogenic,"Joubert syndrome 9|not provided|Inborn genetic diseases|Meckel-Gruber syndrome;Joubert syndrome|CC2D2A-related disorder|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9",single nucleotide variant,GRCh37
na,na,4,15559183,15559183,CC2D2A,Pathogenic,"Joubert syndrome 9|not provided|Inborn genetic diseases|Meckel-Gruber syndrome;Joubert syndrome|CC2D2A-related disorder|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9",single nucleotide variant,GRCh38
na,na,4,15565108,15565108,CC2D2A,Pathogenic,"COACH syndrome 2|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome 9/15, digenic|not provided|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9|See cases|Inborn genetic diseases|Meckel syndrome, type 6;COACH syndrome 2;Joubert syndrome 9",single nucleotide variant,GRCh37
na,na,4,15563485,15563485,CC2D2A,Pathogenic,"COACH syndrome 2|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome 9/15, digenic|not provided|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9|See cases|Inborn genetic diseases|Meckel syndrome, type 6;COACH syndrome 2;Joubert syndrome 9",single nucleotide variant,GRCh38
na,na,4,15569358,15569358,CC2D2A,Conflicting classifications of pathogenicity,"COACH syndrome 2|not provided|Joubert syndrome 9|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9",single nucleotide variant,GRCh37
na,na,4,15567735,15567735,CC2D2A,Conflicting classifications of pathogenicity,"COACH syndrome 2|not provided|Joubert syndrome 9|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 6;Retinitis pigmentosa 93;COACH syndrome 2;Joubert syndrome 9",single nucleotide variant,GRCh38
na,na,14,68249557,68249557,ZFYVE26,Pathogenic,Hereditary spastic paraplegia 15|Spastic paraplegia|not provided,single nucleotide variant,GRCh37
na,na,14,67782840,67782840,ZFYVE26,Pathogenic,Hereditary spastic paraplegia 15|Spastic paraplegia|not provided,single nucleotide variant,GRCh38
na,na,14,68236448,68236448,ZFYVE26,Pathogenic,Hereditary spastic paraplegia 15,single nucleotide variant,GRCh37
na,na,14,67769731,67769731,ZFYVE26,Pathogenic,Hereditary spastic paraplegia 15,single nucleotide variant,GRCh38
na,na,14,68222680,68222749,ZFYVE26,Pathogenic,Hereditary spastic paraplegia 15,Deletion,GRCh37
na,na,14,67755963,67756032,ZFYVE26,Pathogenic,Hereditary spastic paraplegia 15,Deletion,GRCh38
na,na,14,68268958,68268958,ZFYVE26,Pathogenic,Hereditary spastic paraplegia 15,single nucleotide variant,GRCh37
na,na,14,67802241,67802241,ZFYVE26,Pathogenic,Hereditary spastic paraplegia 15,single nucleotide variant,GRCh38
na,na,2,233612450,233612450,GIGYF2,Uncertain significance,"Parkinson disease 11, autosomal dominant, susceptibility to|not specified|not provided|GIGYF2-related disorder",single nucleotide variant,GRCh37
na,na,2,232747740,232747740,GIGYF2,Uncertain significance,"Parkinson disease 11, autosomal dominant, susceptibility to|not specified|not provided|GIGYF2-related disorder",single nucleotide variant,GRCh38
na,na,2,233659545,233659545,GIGYF2,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",single nucleotide variant,GRCh37
na,na,2,232794835,232794835,GIGYF2,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",single nucleotide variant,GRCh38
na,na,2,233674441,233674441,GIGYF2,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",single nucleotide variant,GRCh37
na,na,2,232809731,232809731,GIGYF2,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",single nucleotide variant,GRCh38
na,na,2,233655527,233655527,GIGYF2,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",single nucleotide variant,GRCh37
na,na,2,232790817,232790817,GIGYF2,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",single nucleotide variant,GRCh38
na,na,2,233656136,233656136,GIGYF2,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",single nucleotide variant,GRCh37
na,na,2,232791426,232791426,GIGYF2,risk factor,"Parkinson disease 11, autosomal dominant, susceptibility to",single nucleotide variant,GRCh38
na,na,8,141407724,141407724,TRAPPC9,Pathogenic,"Intellectual disability, autosomal recessive 13|Abnormality of the nervous system|not provided",single nucleotide variant,GRCh37
na,na,8,140397625,140397625,TRAPPC9,Pathogenic,"Intellectual disability, autosomal recessive 13|Abnormality of the nervous system|not provided",single nucleotide variant,GRCh38
na,na,8,141370230,141370230,TRAPPC9,Pathogenic/Likely pathogenic,"Intellectual disability, autosomal recessive 13|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,8,140360131,140360131,TRAPPC9,Pathogenic/Likely pathogenic,"Intellectual disability, autosomal recessive 13|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,8,141294080,141294083,TRAPPC9,Pathogenic,"Intellectual disability, autosomal recessive 13|not provided",Deletion,GRCh37
na,na,8,140283981,140283984,TRAPPC9,Pathogenic,"Intellectual disability, autosomal recessive 13|not provided",Deletion,GRCh38
na,na,2,150426603,150426603,MMADHC,Pathogenic/Likely pathogenic,Homocystinuria-megaloblastic anemia cblD type|Methylmalonic aciduria and homocystinuria type cblD,single nucleotide variant,GRCh37
na,na,2,149570089,149570089,MMADHC,Pathogenic/Likely pathogenic,Homocystinuria-megaloblastic anemia cblD type|Methylmalonic aciduria and homocystinuria type cblD,single nucleotide variant,GRCh38
na,na,2,150432289,150432289,MMADHC,Pathogenic,Homocystinuria-megaloblastic anemia cblD type,single nucleotide variant,GRCh37
na,na,2,149575775,149575775,MMADHC,Pathogenic,Homocystinuria-megaloblastic anemia cblD type,single nucleotide variant,GRCh38
na,na,2,150426633,150426633,MMADHC,Pathogenic/Likely pathogenic,Homocystinuria-megaloblastic anemia cblD type|Cobalamin C disease|Methylmalonic aciduria and homocystinuria type cblD|See cases,single nucleotide variant,GRCh37
na,na,2,149570119,149570119,MMADHC,Pathogenic/Likely pathogenic,Homocystinuria-megaloblastic anemia cblD type|Cobalamin C disease|Methylmalonic aciduria and homocystinuria type cblD|See cases,single nucleotide variant,GRCh38
na,na,2,150438731,150438738,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD|Isolated methylmalonic aciduria cblD type,Deletion,GRCh37
na,na,2,149582217,149582224,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD|Isolated methylmalonic aciduria cblD type,Deletion,GRCh38
na,na,2,150436157,150436157,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD|Isolated methylmalonic aciduria cblD type,single nucleotide variant,GRCh37
na,na,2,149579643,149579643,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD|Isolated methylmalonic aciduria cblD type,single nucleotide variant,GRCh38
na,na,2,150435992,150435993,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD|Isolated methylmalonic aciduria cblD type,Duplication,GRCh37
na,na,2,149579478,149579479,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD|Isolated methylmalonic aciduria cblD type,Duplication,GRCh38
na,na,2,150426631,150426631,MMADHC,Pathogenic/Likely pathogenic,Methylmalonic aciduria and homocystinuria type cblD|not provided,single nucleotide variant,GRCh37
na,na,2,149570117,149570117,MMADHC,Pathogenic/Likely pathogenic,Methylmalonic aciduria and homocystinuria type cblD|not provided,single nucleotide variant,GRCh38
na,na,2,150433009,150433010,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD|not provided,Duplication,GRCh37
na,na,2,149576495,149576496,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD|not provided,Duplication,GRCh38
na,na,2,150427593,150427596,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD,Deletion,GRCh37
na,na,2,149571079,149571082,MMADHC,Pathogenic,Methylmalonic aciduria and homocystinuria type cblD,Deletion,GRCh38
na,na,8,144810658,144810658,FAM83H,Pathogenic,"Amelogenesis imperfecta, hypocalcification type|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143728488,143728488,FAM83H,Pathogenic,"Amelogenesis imperfecta, hypocalcification type|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,8,144810439,144810439,FAM83H,Pathogenic,"FAM83H-related disorder|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143728269,143728269,FAM83H,Pathogenic,"FAM83H-related disorder|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,8,144810388,144810388,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143728218,143728218,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,8,144810740,144810740,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143728570,143728570,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,8,144810251,144810251,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143728081,143728081,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,8,144809602,144809602,FAM83H,Pathogenic/Likely pathogenic,"Amelogenesis imperfecta, hypocalcification type|not provided|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143727432,143727432,FAM83H,Pathogenic/Likely pathogenic,"Amelogenesis imperfecta, hypocalcification type|not provided|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,8,144810223,144810223,FAM83H,Pathogenic,"Amelogenesis imperfecta, hypocalcification type|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143728053,143728053,FAM83H,Pathogenic,"Amelogenesis imperfecta, hypocalcification type|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,8,144810771,144810771,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143728601,143728601,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,8,144809551,144809551,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143727381,143727381,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,8,144809758,144809759,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",Deletion,GRCh37
na,na,8,143727588,143727589,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",Deletion,GRCh38
na,na,8,144810707,144810708,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",Microsatellite,GRCh37
na,na,8,143728537,143728538,FAM83H,Pathogenic,"Amelogenesis imperfecta, type 3A",Microsatellite,GRCh38
na,na,8,144810252,144810252,FAM83H,Pathogenic,"Amelogenesis imperfecta, hypocalcification type|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh37
na,na,8,143728082,143728082,FAM83H,Pathogenic,"Amelogenesis imperfecta, hypocalcification type|Amelogenesis imperfecta, type 3A",single nucleotide variant,GRCh38
na,na,12,108958089,108958089,ISCU,Likely pathogenic,Hereditary myopathy with lactic acidosis due to ISCU deficiency|not provided,single nucleotide variant,GRCh37
na,na,12,108564313,108564313,ISCU,Likely pathogenic,Hereditary myopathy with lactic acidosis due to ISCU deficiency|not provided,single nucleotide variant,GRCh38
na,na,10,91198656,91198656,SLC16A12,Pathogenic,Juvenile cataract-microcornea-renal glucosuria syndrome,single nucleotide variant,GRCh37
na,na,10,89438899,89438899,SLC16A12,Pathogenic,Juvenile cataract-microcornea-renal glucosuria syndrome,single nucleotide variant,GRCh38
na,na,3,53157807,53157807,RFT1,Pathogenic/Likely pathogenic,RFT1-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,3,53123791,53123791,RFT1,Pathogenic/Likely pathogenic,RFT1-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,3,32200588,32200588,GPD1L,Conflicting classifications of pathogenicity,Brugada syndrome 2|not provided|Death in infancy|Cardiovascular phenotype|not specified|Brugada syndrome|Brugada syndrome (shorter-than-normal QT interval)|Long QT syndrome|GPD1L-related disorder,single nucleotide variant,GRCh37
na,na,3,32159096,32159096,GPD1L,Conflicting classifications of pathogenicity,Brugada syndrome 2|not provided|Death in infancy|Cardiovascular phenotype|not specified|Brugada syndrome|Brugada syndrome (shorter-than-normal QT interval)|Long QT syndrome|GPD1L-related disorder,single nucleotide variant,GRCh38
na,na,3,32180100,32180100,GPD1L,Conflicting classifications of pathogenicity,Brugada syndrome 2|not provided|Cardiovascular phenotype|Brugada syndrome,single nucleotide variant,GRCh37
na,na,3,32138608,32138608,GPD1L,Conflicting classifications of pathogenicity,Brugada syndrome 2|not provided|Cardiovascular phenotype|Brugada syndrome,single nucleotide variant,GRCh38
na,na,3,32181723,32181723,GPD1L,Conflicting classifications of pathogenicity,Brugada syndrome 2|SUDDEN INFANT DEATH SYNDROME|Long QT syndrome;Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Brugada syndrome|GPD1L-related disorder,single nucleotide variant,GRCh37
na,na,3,32140231,32140231,GPD1L,Conflicting classifications of pathogenicity,Brugada syndrome 2|SUDDEN INFANT DEATH SYNDROME|Long QT syndrome;Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Brugada syndrome|GPD1L-related disorder,single nucleotide variant,GRCh38
na,na,3,32200566,32200566,GPD1L,Conflicting classifications of pathogenicity,Brugada syndrome 2|not provided|Cardiovascular phenotype|Brugada syndrome,single nucleotide variant,GRCh37
na,na,3,32159074,32159074,GPD1L,Conflicting classifications of pathogenicity,Brugada syndrome 2|not provided|Cardiovascular phenotype|Brugada syndrome,single nucleotide variant,GRCh38
na,na,6,97344666,97344666,NDUFAF4,Pathogenic,Mitochondrial complex I deficiency,single nucleotide variant,GRCh37
na,na,6,96896790,96896790,NDUFAF4,Pathogenic,Mitochondrial complex I deficiency,single nucleotide variant,GRCh38
na,na,8,23560419,23560419,NKX2-6,Likely pathogenic,Persistent truncus arteriosus|Conotruncal heart malformations,single nucleotide variant,GRCh37
na,na,8,23702906,23702906,NKX2-6,Likely pathogenic,Persistent truncus arteriosus|Conotruncal heart malformations,single nucleotide variant,GRCh38
na,na,16,919982,919982,LMF1,Pathogenic,"Lipase deficiency, combined|not provided",single nucleotide variant,GRCh37
na,na,16,869982,869982,LMF1,Pathogenic,"Lipase deficiency, combined|not provided",single nucleotide variant,GRCh38
na,na,5,112136974,112136975,APC,Pathogenic,Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome,Microsatellite,GRCh37
na,na,5,112801277,112801278,APC,Pathogenic,Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome,Microsatellite,GRCh38
na,na,5,112157647,112157647,APC,Pathogenic,Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,5,112821950,112821950,APC,Pathogenic,Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,5,112162896,112162896,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,5,112827199,112827199,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,5,112154969,112154969,APC,Benign,Gardner syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Familial adenomatous polyposis 1|APC-Associated Polyposis Disorders|Classic or attenuated familial adenomatous polyposis,single nucleotide variant,GRCh37
na,na,5,112819272,112819272,APC,Benign,Gardner syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Familial adenomatous polyposis 1|APC-Associated Polyposis Disorders|Classic or attenuated familial adenomatous polyposis,single nucleotide variant,GRCh38
na,na,5,112151261,112151261,APC,Pathogenic/Likely pathogenic,"Familial adenomatous polyposis 1|Gardner syndrome|Hereditary cancer-predisposing syndrome|not provided|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Neoplasm|Classic or attenuated familial adenomatous polyposis",single nucleotide variant,GRCh37
na,na,5,112815564,112815564,APC,Pathogenic/Likely pathogenic,"Familial adenomatous polyposis 1|Gardner syndrome|Hereditary cancer-predisposing syndrome|not provided|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Neoplasm|Classic or attenuated familial adenomatous polyposis",single nucleotide variant,GRCh38
na,na,5,112151196,112151196,APC,Pathogenic,Gardner syndrome|Familial multiple polyposis syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh37
na,na,5,112815499,112815499,APC,Pathogenic,Gardner syndrome|Familial multiple polyposis syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh38
na,na,5,112173429,112173429,APC,Pathogenic,Gardner syndrome|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh37
na,na,5,112837732,112837732,APC,Pathogenic,Gardner syndrome|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh38
na,na,5,112175303,112175303,APC,Pathogenic,Carcinoma of colon|Familial adenomatous polyposis 1,single nucleotide variant,GRCh37
na,na,5,112839606,112839606,APC,Pathogenic,Carcinoma of colon|Familial adenomatous polyposis 1,single nucleotide variant,GRCh38
na,na,5,112174650,112174650,APC,Uncertain significance,Gastric cancer|Classic or attenuated familial adenomatous polyposis|Familial adenomatous polyposis 1,single nucleotide variant,GRCh37
na,na,5,112838953,112838953,APC,Uncertain significance,Gastric cancer|Classic or attenuated familial adenomatous polyposis|Familial adenomatous polyposis 1,single nucleotide variant,GRCh38
na,na,5,112174490,112174490,APC,Pathogenic,Gastric cancer|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh37
na,na,5,112838793,112838793,APC,Pathogenic,Gastric cancer|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh38
na,na,5,112111408,112111411,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome,Microsatellite,GRCh37
na,na,5,112775711,112775714,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome,Microsatellite,GRCh38
na,na,5,112154797,112154798,APC,Pathogenic,Familial adenomatous polyposis 1,Duplication,GRCh37
na,na,5,112819100,112819101,APC,Pathogenic,Familial adenomatous polyposis 1,Duplication,GRCh38
na,na,5,112163698,112163698,APC,Pathogenic,Brain tumor-polyposis syndrome 2|Familial adenomatous polyposis 1|Carcinoma of colon|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,5,112828001,112828001,APC,Pathogenic,Brain tumor-polyposis syndrome 2|Familial adenomatous polyposis 1|Carcinoma of colon|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,5,112164586,112164586,APC,Pathogenic,"Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Hepatocellular carcinoma;Neoplasm of stomach;Familial adenomatous polyposis 1;Carcinoma of colon;Desmoid disease, hereditary|not provided|Gastric cancer",single nucleotide variant,GRCh37
na,na,5,112828889,112828889,APC,Pathogenic,"Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Hepatocellular carcinoma;Neoplasm of stomach;Familial adenomatous polyposis 1;Carcinoma of colon;Desmoid disease, hereditary|not provided|Gastric cancer",single nucleotide variant,GRCh38
na,na,5,112164616,112164616,APC,Pathogenic,Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided|Familial multiple polyposis syndrome|Neoplasm|Classic or attenuated familial adenomatous polyposis,single nucleotide variant,GRCh37
na,na,5,112828919,112828919,APC,Pathogenic,Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided|Familial multiple polyposis syndrome|Neoplasm|Classic or attenuated familial adenomatous polyposis,single nucleotide variant,GRCh38
na,na,5,112170789,112170790,APC,Pathogenic,Familial adenomatous polyposis 1,Insertion,GRCh37
na,na,5,112835092,112835093,APC,Pathogenic,Familial adenomatous polyposis 1,Insertion,GRCh38
na,na,5,112174096,112174096,APC,Pathogenic,"Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Neoplasm of stomach;Carcinoma of colon;Familial adenomatous polyposis 1;Hepatocellular carcinoma;Desmoid disease, hereditary",single nucleotide variant,GRCh37
na,na,5,112838399,112838399,APC,Pathogenic,"Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|not provided|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Neoplasm of stomach;Carcinoma of colon;Familial adenomatous polyposis 1;Hepatocellular carcinoma;Desmoid disease, hereditary",single nucleotide variant,GRCh38
na,na,5,112175676,112175677,APC,Pathogenic,"Gardner syndrome|Periampullary adenoma|not provided|Colorectal cancer, susceptibility to|Carcinoma of colon|Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome|Familial adenomatous polyposis 1",Microsatellite,GRCh37
na,na,5,112839979,112839980,APC,Pathogenic,"Gardner syndrome|Periampullary adenoma|not provided|Colorectal cancer, susceptibility to|Carcinoma of colon|Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome|Familial adenomatous polyposis 1",Microsatellite,GRCh38
na,na,5,112175676,112175679,APC,Pathogenic,Periampullary adenoma|Carcinoma of colon|Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis 1,Microsatellite,GRCh37
na,na,5,112839979,112839982,APC,Pathogenic,Periampullary adenoma|Carcinoma of colon|Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis 1,Microsatellite,GRCh38
na,na,5,112111373,112111373,APC,Pathogenic,Familial adenomatous polyposis 1,single nucleotide variant,GRCh37
na,na,5,112775676,112775676,APC,Pathogenic,Familial adenomatous polyposis 1,single nucleotide variant,GRCh38
na,na,5,112116598,112116598,APC,Pathogenic,Familial adenomatous polyposis 1|Brain tumor-polyposis syndrome 2|not provided|not specified|Hereditary cancer-predisposing syndrome|6 conditions,single nucleotide variant,GRCh37
na,na,5,112780901,112780901,APC,Pathogenic,Familial adenomatous polyposis 1|Brain tumor-polyposis syndrome 2|not provided|not specified|Hereditary cancer-predisposing syndrome|6 conditions,single nucleotide variant,GRCh38
na,na,5,112172610,112244011,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh37
na,na,5,112836913,112908314,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh38
na,na,5,112175212,112175216,APC,Pathogenic,Familial adenomatous polyposis 1|Gardner syndrome|Adenomatous polyposis coli with congenital cholesteatoma|Hereditary cancer-predisposing syndrome|not provided|Hyperplastic colonic polyposis;Duodenal polyposis;Adenomatous colonic polyposis;Intestinal polyp;Gastric polyposis|Colon adenocarcinoma|Colorectal cancer|APC-related disorder|Carcinoma of colon|Familial multiple polyposis syndrome|Classic or attenuated familial adenomatous polyposis|6 conditions|Neoplasm,Microsatellite,GRCh37
na,na,5,112839515,112839519,APC,Pathogenic,Familial adenomatous polyposis 1|Gardner syndrome|Adenomatous polyposis coli with congenital cholesteatoma|Hereditary cancer-predisposing syndrome|not provided|Hyperplastic colonic polyposis;Duodenal polyposis;Adenomatous colonic polyposis;Intestinal polyp;Gastric polyposis|Colon adenocarcinoma|Colorectal cancer|APC-related disorder|Carcinoma of colon|Familial multiple polyposis syndrome|Classic or attenuated familial adenomatous polyposis|6 conditions|Neoplasm,Microsatellite,GRCh38
na,na,5,112175474,112175474,APC,Pathogenic,Hepatoblastoma,single nucleotide variant,GRCh37
na,na,5,112839777,112839777,APC,Pathogenic,Hepatoblastoma,single nucleotide variant,GRCh38
na,na,na,-1,-1,APC,Pathogenic,"Desmoid disease, hereditary",Insertion,na
na,na,5,112177232,112177232,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh37
na,na,5,112841535,112841535,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh38
na,na,5,112176871,112176874,APC,Pathogenic,Familial adenomatous polyposis 1|Familial multiple polyposis syndrome,Deletion,GRCh37
na,na,5,112841174,112841177,APC,Pathogenic,Familial adenomatous polyposis 1|Familial multiple polyposis syndrome,Deletion,GRCh38
na,na,5,112175211,112175211,APC,Conflicting classifications of pathogenicity; association; risk factor,"|Breast cancer, susceptibility to|Familial adenomatous polyposis 1|not provided|not specified|Hereditary cancer-predisposing syndrome|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Carcinoma of colon|Colorectal cancer|Breast carcinoma|APC-Associated Polyposis Disorders|Familial colorectal cancer|Diffuse midline glioma, H3 K27-altered",single nucleotide variant,GRCh37
na,na,5,112839514,112839514,APC,Conflicting classifications of pathogenicity; association; risk factor,"|Breast cancer, susceptibility to|Familial adenomatous polyposis 1|not provided|not specified|Hereditary cancer-predisposing syndrome|Colorectal cancer, susceptibility to|Familial multiple polyposis syndrome|Carcinoma of colon|Colorectal cancer|Breast carcinoma|APC-Associated Polyposis Disorders|Familial colorectal cancer|Diffuse midline glioma, H3 K27-altered",single nucleotide variant,GRCh38
na,na,5,112175902,112175903,APC,Pathogenic,Gardner syndrome|not provided|Familial adenomatous polyposis 1|6 conditions|Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome,Deletion,GRCh37
na,na,5,112840205,112840206,APC,Pathogenic,Gardner syndrome|not provided|Familial adenomatous polyposis 1|6 conditions|Hereditary cancer-predisposing syndrome|Familial multiple polyposis syndrome,Deletion,GRCh38
na,na,5,112162891,112162891,APC,Pathogenic,Gardner syndrome|Familial adenomatous polyposis 1|Familial multiple polyposis syndrome|Hereditary cancer-predisposing syndrome|not provided|Carcinoma of colon|APC-Associated Polyposis Disorders,single nucleotide variant,GRCh37
na,na,5,112827194,112827194,APC,Pathogenic,Gardner syndrome|Familial adenomatous polyposis 1|Familial multiple polyposis syndrome|Hereditary cancer-predisposing syndrome|not provided|Carcinoma of colon|APC-Associated Polyposis Disorders,single nucleotide variant,GRCh38
na,na,5,112162854,112162854,APC,Pathogenic,Familial adenomatous polyposis 1,single nucleotide variant,GRCh37
na,na,5,112827157,112827157,APC,Pathogenic,Familial adenomatous polyposis 1,single nucleotide variant,GRCh38
na,na,5,112155040,112155042,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh37
na,na,5,112819343,112819345,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh38
na,na,5,112154921,112154922,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,5,112819224,112819225,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,5,112175240,112175240,APC,Benign/Likely benign,Familial adenomatous polyposis 1|not provided|not specified|APC-Associated Polyposis Disorders|Hereditary cancer-predisposing syndrome|Carcinoma of colon,single nucleotide variant,GRCh37
na,na,5,112839543,112839543,APC,Benign/Likely benign,Familial adenomatous polyposis 1|not provided|not specified|APC-Associated Polyposis Disorders|Hereditary cancer-predisposing syndrome|Carcinoma of colon,single nucleotide variant,GRCh38
na,na,5,112154666,112154667,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Familial multiple polyposis syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,5,112818969,112818970,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Familial multiple polyposis syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,5,112173384,112173384,APC,Pathogenic,Gardner syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh37
na,na,5,112837687,112837687,APC,Pathogenic,Gardner syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh38
na,na,5,112175866,112175867,APC,Pathogenic,"Desmoid disease, hereditary",Insertion,GRCh37
na,na,5,112840169,112840170,APC,Pathogenic,"Desmoid disease, hereditary",Insertion,GRCh38
na,na,5,112043201,112181937,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh37
na,na,5,112707504,112846240,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh38
na,na,5,112111325,112111325,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,5,112775628,112775628,APC,Pathogenic,Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,5,112154787,112154788,APC,Pathogenic,Familial adenomatous polyposis 1,Insertion,GRCh37
na,na,5,112819090,112819091,APC,Pathogenic,Familial adenomatous polyposis 1,Insertion,GRCh38
na,na,na,-1,-1,APC,Pathogenic,"Desmoid disease, hereditary",Deletion,na
na,na,na,-1,-1,APC,Pathogenic,Desmoid tumor caused by somatic mutation,Deletion,na
na,na,5,112116577,112116577,APC,Pathogenic,Gardner syndrome|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh37
na,na,5,112780880,112780880,APC,Pathogenic,Gardner syndrome|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1,single nucleotide variant,GRCh38
na,na,5,112164620,112164620,APC,Pathogenic,Hepatocellular carcinoma,Deletion,GRCh37
na,na,5,112828923,112828923,APC,Pathogenic,Hepatocellular carcinoma,Deletion,GRCh38
na,na,5,112173250,112181936,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh37
na,na,5,112837553,112846239,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,GRCh38
na,na,na,-1,-1,APC,Pathogenic,Familial adenomatous polyposis 1,Deletion,na
na,na,7,66098412,66098412,KCTD7,Pathogenic,Progressive myoclonic epilepsy type 3,single nucleotide variant,GRCh37
na,na,7,66633425,66633425,KCTD7,Pathogenic,Progressive myoclonic epilepsy type 3,single nucleotide variant,GRCh38
na,na,12,124239084,124239084,ATP6V0A2,Pathogenic,Cutis laxa with osteodystrophy|ALG9 congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,12,123754537,123754537,ATP6V0A2,Pathogenic,Cutis laxa with osteodystrophy|ALG9 congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,12,124203239,124203239,ATP6V0A2,Pathogenic,Cutis laxa with osteodystrophy|not provided|Cutis laxa|ALG9 congenital disorder of glycosylation|Wrinkly skin syndrome;Cutis laxa with osteodystrophy,single nucleotide variant,GRCh37
na,na,12,123718692,123718692,ATP6V0A2,Pathogenic,Cutis laxa with osteodystrophy|not provided|Cutis laxa|ALG9 congenital disorder of glycosylation|Wrinkly skin syndrome;Cutis laxa with osteodystrophy,single nucleotide variant,GRCh38
na,na,15,43069308,43069309,TTBK2,Pathogenic,Spinocerebellar ataxia type 11|not provided,Duplication,GRCh37
na,na,15,42777110,42777111,TTBK2,Pathogenic,Spinocerebellar ataxia type 11|not provided,Duplication,GRCh38
na,na,15,43069350,43069351,TTBK2,Pathogenic,Spinocerebellar ataxia type 11,Microsatellite,GRCh37
na,na,15,42777152,42777153,TTBK2,Pathogenic,Spinocerebellar ataxia type 11,Microsatellite,GRCh38
na,na,12,108924063,108924063,SART3,Uncertain significance,"Porokeratosis 3, disseminated superficial actinic type",single nucleotide variant,GRCh37
na,na,12,108530286,108530286,SART3,Uncertain significance,"Porokeratosis 3, disseminated superficial actinic type",single nucleotide variant,GRCh38
na,na,17,26729340,26729340,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided|Inborn genetic diseases|SLC46A1-related disorder,single nucleotide variant,GRCh37
na,na,17,28402322,28402322,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided|Inborn genetic diseases|SLC46A1-related disorder,single nucleotide variant,GRCh38
na,na,17,26732939,26732939,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,Deletion,GRCh37
na,na,17,28405921,28405921,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,Deletion,GRCh38
na,na,17,26732378,26732378,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,single nucleotide variant,GRCh37
na,na,17,28405360,28405360,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,single nucleotide variant,GRCh38
na,na,17,26731761,26731761,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,single nucleotide variant,GRCh37
na,na,17,28404743,28404743,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,single nucleotide variant,GRCh38
na,na,17,26729295,26729295,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,single nucleotide variant,GRCh37
na,na,17,28402277,28402277,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,single nucleotide variant,GRCh38
na,na,17,26732378,26732378,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,single nucleotide variant,GRCh37
na,na,17,28405360,28405360,SLC46A1,Pathogenic,Congenital defect of folate absorption|not provided,single nucleotide variant,GRCh38
na,na,1,11333893,11333893,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh37
na,na,1,11273836,11273836,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh38
na,na,1,11334117,11334117,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh37
na,na,1,11274060,11274060,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh38
na,na,1,11333943,11333943,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh37
na,na,1,11273886,11273886,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh38
na,na,1,11334112,11334112,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh37
na,na,1,11274055,11274055,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh38
na,na,1,11345866,11345866,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh37
na,na,1,11285809,11285809,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh38
na,na,1,11333923,11333923,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh37
na,na,1,11273866,11273866,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh38
na,na,1,11334099,11334099,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh37
na,na,1,11274042,11274042,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh38
na,na,1,11345727,11345727,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh37
na,na,1,11285670,11285670,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh38
na,na,1,11345879,11345879,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh37
na,na,1,11285822,11285822,UBIAD1,Pathogenic,Schnyder crystalline corneal dystrophy,single nucleotide variant,GRCh38
na,na,7,129414597,129414597,MIR96,Pathogenic,Autosomal dominant nonsyndromic hearing loss 50,single nucleotide variant,GRCh37
na,na,7,129774757,129774757,MIR96,Pathogenic,Autosomal dominant nonsyndromic hearing loss 50,single nucleotide variant,GRCh38
na,na,7,129414596,129414596,MIR96,Pathogenic,Autosomal dominant nonsyndromic hearing loss 50,single nucleotide variant,GRCh37
na,na,7,129774756,129774756,MIR96,Pathogenic,Autosomal dominant nonsyndromic hearing loss 50,single nucleotide variant,GRCh38
na,na,9,97365719,97365720,FBP1,Pathogenic/Likely pathogenic,Fructose-biphosphatase deficiency|Inborn genetic diseases|not provided,Insertion,GRCh37
na,na,9,94603437,94603438,FBP1,Pathogenic/Likely pathogenic,Fructose-biphosphatase deficiency|Inborn genetic diseases|not provided,Insertion,GRCh38
na,na,9,97372280,97372280,FBP1,Pathogenic/Likely pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh37
na,na,9,94609998,94609998,FBP1,Pathogenic/Likely pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh38
na,na,9,97372240,97372240,FBP1,Pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh37
na,na,9,94609958,94609958,FBP1,Pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh38
na,na,9,97401505,97401505,FBP1,Pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh37
na,na,9,94639223,94639223,FBP1,Pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh38
na,na,9,97369221,97369221,FBP1,Pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh37
na,na,9,94606939,94606939,FBP1,Pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh38
na,na,9,97365829,97365829,FBP1,Pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh37
na,na,9,94603547,94603547,FBP1,Pathogenic,Fructose-biphosphatase deficiency,single nucleotide variant,GRCh38
na,na,22,45691554,45691554,UPK3A,Uncertain significance,Congenital anomalies of kidney and urinary tract 1|Renal hypodysplasia/aplasia 1|UPK3A-related disorder|not provided,single nucleotide variant,GRCh37
na,na,22,45295673,45295673,UPK3A,Uncertain significance,Congenital anomalies of kidney and urinary tract 1|Renal hypodysplasia/aplasia 1|UPK3A-related disorder|not provided,single nucleotide variant,GRCh38
na,na,22,45691707,45691707,UPK3A,Uncertain significance,Renal hypodysplasia/aplasia 1|UPK3A-related disorder,single nucleotide variant,GRCh37
na,na,22,45295826,45295826,UPK3A,Uncertain significance,Renal hypodysplasia/aplasia 1|UPK3A-related disorder,single nucleotide variant,GRCh38
na,na,22,45689095,45689095,UPK3A,Uncertain significance,Congenital anomalies of kidney and urinary tract 1,single nucleotide variant,GRCh37
na,na,22,45293214,45293214,UPK3A,Uncertain significance,Congenital anomalies of kidney and urinary tract 1,single nucleotide variant,GRCh38
na,na,6,31560910,31560910,NCR3,Pathogenic; risk factor,"Malaria, mild, susceptibility to|Malaria, severe, susceptibility to",single nucleotide variant,GRCh37
na,na,6,31593133,31593133,NCR3,Pathogenic; risk factor,"Malaria, mild, susceptibility to|Malaria, severe, susceptibility to",single nucleotide variant,GRCh38
na,na,5,78264918,78264918,ARSB,Uncertain significance,"Mucopolysaccharidosis, type vi, intermediate|Mucopolysaccharidosis type 6",single nucleotide variant,GRCh37
na,na,5,78969095,78969095,ARSB,Uncertain significance,"Mucopolysaccharidosis, type vi, intermediate|Mucopolysaccharidosis type 6",single nucleotide variant,GRCh38
na,na,5,78264979,78264979,ARSB,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6",single nucleotide variant,GRCh37
na,na,5,78969156,78969156,ARSB,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6",single nucleotide variant,GRCh38
na,na,5,78251309,78251309,ARSB,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, type vi, mild|Mucopolysaccharidosis type 6",single nucleotide variant,GRCh37
na,na,5,78955486,78955486,ARSB,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, type vi, mild|Mucopolysaccharidosis type 6",single nucleotide variant,GRCh38
na,na,5,78077797,78077797,ARSB,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6|not provided|Metachromatic leukodystrophy",single nucleotide variant,GRCh37
na,na,5,78781974,78781974,ARSB,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6|not provided|Metachromatic leukodystrophy",single nucleotide variant,GRCh38
na,na,5,78280834,78280834,ARSB,Pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6",Deletion,GRCh37
na,na,5,78985011,78985011,ARSB,Pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6",Deletion,GRCh38
na,na,5,78251273,78251273,ARSB,Pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6",Deletion,GRCh37
na,na,5,78955450,78955450,ARSB,Pathogenic,"Mucopolysaccharidosis, type vi, severe|Mucopolysaccharidosis type 6",Deletion,GRCh38
na,na,5,78280857,78280857,ARSB,Conflicting classifications of pathogenicity,not provided|Mucopolysaccharidosis type 6|not specified,single nucleotide variant,GRCh37
na,na,5,78985034,78985034,ARSB,Conflicting classifications of pathogenicity,not provided|Mucopolysaccharidosis type 6|not specified,single nucleotide variant,GRCh38
na,na,5,78280788,78280788,ARSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 6|not provided,single nucleotide variant,GRCh37
na,na,5,78984965,78984965,ARSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 6|not provided,single nucleotide variant,GRCh38
na,na,5,78260300,78260300,ARSB,Pathogenic,Mucopolysaccharidosis type 6|not provided|Metachromatic leukodystrophy|ARSB-related disorder,single nucleotide variant,GRCh37
na,na,5,78964477,78964477,ARSB,Pathogenic,Mucopolysaccharidosis type 6|not provided|Metachromatic leukodystrophy|ARSB-related disorder,single nucleotide variant,GRCh38
na,na,5,78135214,78135214,ARSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 6|not provided,single nucleotide variant,GRCh37
na,na,5,78839391,78839391,ARSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 6|not provided,single nucleotide variant,GRCh38
na,na,5,78135250,78135250,ARSB,Pathogenic,Mucopolysaccharidosis type 6,single nucleotide variant,GRCh37
na,na,5,78839427,78839427,ARSB,Pathogenic,Mucopolysaccharidosis type 6,single nucleotide variant,GRCh38
na,na,5,78135257,78135257,ARSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 6,single nucleotide variant,GRCh37
na,na,5,78839434,78839434,ARSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 6,single nucleotide variant,GRCh38
na,na,1,63788091,63788091,FOXD3,risk factor,"Autoimmune disease, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,1,63322420,63322420,FOXD3,risk factor,"Autoimmune disease, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,12,7083589,7083589,EMG1,Pathogenic,Bowen-Conradi syndrome,single nucleotide variant,GRCh37
na,na,12,6974427,6974427,EMG1,Pathogenic,Bowen-Conradi syndrome,single nucleotide variant,GRCh38
na,na,6,88279230,88279230,RARS2,Pathogenic,Pontocerebellar hypoplasia type 6|not provided,single nucleotide variant,GRCh37
na,na,6,87569512,87569512,RARS2,Pathogenic,Pontocerebellar hypoplasia type 6|not provided,single nucleotide variant,GRCh38
na,na,4,103806378,103806378,CISD2,Pathogenic,Wolfram syndrome 2,single nucleotide variant,GRCh37
na,na,4,102885221,102885221,CISD2,Pathogenic,Wolfram syndrome 2,single nucleotide variant,GRCh38
na,na,7,65425984,65425984,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|not provided,single nucleotide variant,GRCh37
na,na,7,65960997,65960997,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|not provided,single nucleotide variant,GRCh38
na,na,7,65439613,65439613,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|Non-immune hydrops fetalis,single nucleotide variant,GRCh37
na,na,7,65974626,65974626,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|Non-immune hydrops fetalis,single nucleotide variant,GRCh38
na,na,7,65444464,65444464,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|not provided,single nucleotide variant,GRCh37
na,na,7,65979477,65979477,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|not provided,single nucleotide variant,GRCh38
na,na,7,65439910,65439910,GUSB,Conflicting classifications of pathogenicity,Mucopolysaccharidosis type 7|not provided,single nucleotide variant,GRCh37
na,na,7,65974923,65974923,GUSB,Conflicting classifications of pathogenicity,Mucopolysaccharidosis type 7|not provided,single nucleotide variant,GRCh38
na,na,7,65426009,65426009,GUSB,Conflicting classifications of pathogenicity,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh37
na,na,7,65961022,65961022,GUSB,Conflicting classifications of pathogenicity,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh38
na,na,7,65444853,65444853,GUSB,Pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh37
na,na,7,65979866,65979866,GUSB,Pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh38
na,na,7,65432887,65432887,GUSB,Uncertain significance,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh37
na,na,7,65967900,65967900,GUSB,Uncertain significance,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh38
na,na,7,65432850,65432850,GUSB,Pathogenic,Mucopolysaccharidosis type 7|not provided,single nucleotide variant,GRCh37
na,na,7,65967863,65967863,GUSB,Pathogenic,Mucopolysaccharidosis type 7|not provided,single nucleotide variant,GRCh38
na,na,7,65432754,65432754,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh37
na,na,7,65967767,65967767,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh38
na,na,7,65429369,65429369,GUSB,Likely pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh37
na,na,7,65964382,65964382,GUSB,Likely pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh38
na,na,7,65438663,65438664,GUSB,Pathogenic,Mucopolysaccharidosis type 7,Deletion,GRCh37
na,na,7,65973676,65973677,GUSB,Pathogenic,Mucopolysaccharidosis type 7,Deletion,GRCh38
na,na,7,65439335,65439335,GUSB,Pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh37
na,na,7,65974348,65974348,GUSB,Pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh38
na,na,7,65444769,65444769,GUSB,Pathogenic,Mucopolysaccharidosis type 7|Mucopolysaccharidosis type 6|not provided|GUSB-related disorder,single nucleotide variant,GRCh37
na,na,7,65979782,65979782,GUSB,Pathogenic,Mucopolysaccharidosis type 7|Mucopolysaccharidosis type 6|not provided|GUSB-related disorder,single nucleotide variant,GRCh38
na,na,7,65439921,65439921,GUSB,Pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh37
na,na,7,65974934,65974934,GUSB,Pathogenic,Mucopolysaccharidosis type 7,single nucleotide variant,GRCh38
na,na,7,65425959,65425959,GUSB,Likely pathogenic,Mucopolysaccharidosis type 7|not provided|GUSB-related disorder,single nucleotide variant,GRCh37
na,na,7,65960972,65960972,GUSB,Likely pathogenic,Mucopolysaccharidosis type 7|not provided|GUSB-related disorder,single nucleotide variant,GRCh38
na,na,7,65439688,65439688,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|Non-immune hydrops fetalis|not provided,single nucleotide variant,GRCh37
na,na,7,65974701,65974701,GUSB,Pathogenic/Likely pathogenic,Mucopolysaccharidosis type 7|Non-immune hydrops fetalis|not provided,single nucleotide variant,GRCh38
na,na,19,15659981,15659981,CYP4F22,Pathogenic,Autosomal recessive congenital ichthyosis 5|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,19,15549170,15549170,CYP4F22,Pathogenic,Autosomal recessive congenital ichthyosis 5|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,19,15659984,15659984,CYP4F22,Pathogenic,Autosomal recessive congenital ichthyosis 5,single nucleotide variant,GRCh37
na,na,19,15549173,15549173,CYP4F22,Pathogenic,Autosomal recessive congenital ichthyosis 5,single nucleotide variant,GRCh38
na,na,19,15651317,15651317,CYP4F22,Pathogenic,Autosomal recessive congenital ichthyosis 5|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,19,15540506,15540506,CYP4F22,Pathogenic,Autosomal recessive congenital ichthyosis 5|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,na,-1,-1,CYP4F22,Pathogenic,Autosomal recessive congenital ichthyosis 5,Deletion,na
na,na,8,86392989,86392989,CA2,Benign/Likely benign,CARBONIC ANHYDRASE II VARIANT|Osteopetrosis with renal tubular acidosis|not provided,single nucleotide variant,GRCh37
na,na,8,85480760,85480760,CA2,Benign/Likely benign,CARBONIC ANHYDRASE II VARIANT|Osteopetrosis with renal tubular acidosis|not provided,single nucleotide variant,GRCh38
na,na,8,86377518,86377518,CA2,Pathogenic,CARBONIC ANHYDRASE II VARIANT,single nucleotide variant,GRCh37
na,na,8,85465289,85465289,CA2,Pathogenic,CARBONIC ANHYDRASE II VARIANT,single nucleotide variant,GRCh38
na,na,8,86392942,86392942,CA2,Pathogenic,CARBONIC ANHYDRASE II VARIANT,single nucleotide variant,GRCh37
na,na,8,85480713,85480713,CA2,Pathogenic,CARBONIC ANHYDRASE II VARIANT,single nucleotide variant,GRCh38
na,na,8,86386008,86386008,CA2,Pathogenic,Osteopetrosis with renal tubular acidosis,single nucleotide variant,GRCh37
na,na,8,85473779,85473779,CA2,Pathogenic,Osteopetrosis with renal tubular acidosis,single nucleotide variant,GRCh38
na,na,8,86389348,86389348,CA2,Pathogenic,Osteopetrosis with renal tubular acidosis,single nucleotide variant,GRCh37
na,na,8,85477119,85477119,CA2,Pathogenic,Osteopetrosis with renal tubular acidosis,single nucleotide variant,GRCh38
na,na,8,86377586,86377586,CA2,Pathogenic,Osteopetrosis with renal tubular acidosis,single nucleotide variant,GRCh37
na,na,8,85465357,85465357,CA2,Pathogenic,Osteopetrosis with renal tubular acidosis,single nucleotide variant,GRCh38
na,na,8,86389461,86389461,CA2,Pathogenic,Osteopetrosis with renal tubular acidosis,Deletion,GRCh37
na,na,8,85477232,85477232,CA2,Pathogenic,Osteopetrosis with renal tubular acidosis,Deletion,GRCh38
na,na,na,-1,-1,MBD5,Pathogenic,"Intellectual disability, autosomal dominant 1",Deletion,na
na,na,17,43555265,43555265,PLEKHM1,Pathogenic,Autosomal recessive osteopetrosis 6,single nucleotide variant,GRCh37
na,na,17,45477899,45477899,PLEKHM1,Pathogenic,Autosomal recessive osteopetrosis 6,single nucleotide variant,GRCh38
na,na,3,33114136,33114136,GLB1,Conflicting classifications of pathogenicity,"Infantile GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh37
na,na,3,33072644,33072644,GLB1,Conflicting classifications of pathogenicity,"Infantile GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh38
na,na,3,33058311,33058311,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3;Infantile GM1 gangliosidosis;GM1 gangliosidosis type 2|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 2",single nucleotide variant,GRCh37
na,na,3,33016819,33016819,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3;Infantile GM1 gangliosidosis;GM1 gangliosidosis type 2|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 2",single nucleotide variant,GRCh38
na,na,3,33099713,33099713,GLB1,Pathogenic/Likely pathogenic,"GM1 gangliosidosis type 2|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GLB1-related disorder|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2",single nucleotide variant,GRCh37
na,na,3,33058221,33058221,GLB1,Pathogenic/Likely pathogenic,"GM1 gangliosidosis type 2|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GLB1-related disorder|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2",single nucleotide variant,GRCh38
na,na,3,33114129,33114129,GLB1,Pathogenic,"GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh37
na,na,3,33072637,33072637,GLB1,Pathogenic,"GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh38
na,na,na,-1,-1,GLB1,Pathogenic,Infantile GM1 gangliosidosis,Duplication,na
na,na,3,33110341,33110341,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|not provided|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh37
na,na,3,33068849,33068849,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|not provided|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh38
na,na,3,33093258,33093258,GLB1,Pathogenic/Likely pathogenic,"Infantile GM1 gangliosidosis|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh37
na,na,3,33051766,33051766,GLB1,Pathogenic/Likely pathogenic,"Infantile GM1 gangliosidosis|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh38
na,na,3,33058310,33058310,GLB1,Pathogenic/Likely pathogenic,"GM1 gangliosidosis type 3|GM1 gangliosidosis type 2;Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis",single nucleotide variant,GRCh37
na,na,3,33016818,33016818,GLB1,Pathogenic/Likely pathogenic,"GM1 gangliosidosis type 3|GM1 gangliosidosis type 2;Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis",single nucleotide variant,GRCh38
na,na,3,33093471,33093471,GLB1,Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis",single nucleotide variant,GRCh37
na,na,3,33051979,33051979,GLB1,Likely pathogenic,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis",single nucleotide variant,GRCh38
na,na,3,33058235,33058235,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2",single nucleotide variant,GRCh37
na,na,3,33016743,33016743,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2",single nucleotide variant,GRCh38
na,na,3,33055755,33055755,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh37
na,na,3,33014263,33014263,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh38
na,na,3,33110429,33110430,GLB1,Pathogenic,Infantile GM1 gangliosidosis,Duplication,GRCh37
na,na,3,33068937,33068938,GLB1,Pathogenic,Infantile GM1 gangliosidosis,Duplication,GRCh38
na,na,3,33114036,33114036,GLB1,Pathogenic/Likely pathogenic,"GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|not provided|Inborn genetic diseases|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis",single nucleotide variant,GRCh37
na,na,3,33072544,33072544,GLB1,Pathogenic/Likely pathogenic,"GM1 gangliosidosis type 3|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|not provided|Inborn genetic diseases|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis",single nucleotide variant,GRCh38
na,na,3,33138500,33138501,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Inborn genetic diseases",Duplication,GRCh37
na,na,3,33097008,33097009,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Inborn genetic diseases",Duplication,GRCh38
na,na,3,33110461,33110461,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh37
na,na,3,33068969,33068969,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh38
na,na,3,33058236,33058236,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh37
na,na,3,33016744,33016744,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh38
na,na,3,33099692,33099692,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,3,33058200,33058200,GLB1,Pathogenic,"Infantile GM1 gangliosidosis|GM1 gangliosidosis|not provided|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,3,33059974,33059974,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|not provided|Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3;Infantile GM1 gangliosidosis;GM1 gangliosidosis type 2|Spondyloepiphyseal dysplasia|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis",single nucleotide variant,GRCh37
na,na,3,33018482,33018482,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|not provided|Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3;Infantile GM1 gangliosidosis;GM1 gangliosidosis type 2|Spondyloepiphyseal dysplasia|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis",single nucleotide variant,GRCh38
na,na,3,33087629,33087629,GLB1,Pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|Spastic ataxia",single nucleotide variant,GRCh37
na,na,3,33046137,33046137,GLB1,Pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|Spastic ataxia",single nucleotide variant,GRCh38
na,na,3,33055784,33055784,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis type 3|GM1 gangliosidosis|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh37
na,na,3,33014292,33014292,GLB1,Pathogenic,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|not provided|GM1 gangliosidosis type 3|GM1 gangliosidosis|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh38
na,na,3,33063068,33063068,GLB1,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh37
na,na,3,33021576,33021576,GLB1,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B",single nucleotide variant,GRCh38
na,na,3,33114079,33114079,GLB1,Pathogenic,"GM1 gangliosidosis type 2|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided|GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2;Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3",single nucleotide variant,GRCh37
na,na,3,33072587,33072587,GLB1,Pathogenic,"GM1 gangliosidosis type 2|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided|GM1 gangliosidosis type 3;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 2;Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3",single nucleotide variant,GRCh38
na,na,3,33114105,33114105,GLB1,Pathogenic/Likely pathogenic,"Infantile GM1 gangliosidosis|GM1-gangliosidosis, type I, with cardiac involvement|not provided|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3;Infantile GM1 gangliosidosis;GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GLB1-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,3,33072613,33072613,GLB1,Pathogenic/Likely pathogenic,"Infantile GM1 gangliosidosis|GM1-gangliosidosis, type I, with cardiac involvement|not provided|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3;Infantile GM1 gangliosidosis;GM1 gangliosidosis type 2|GM1 gangliosidosis type 3|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GLB1-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,3,33055804,33055804,GLB1,Pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis|GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis|Infantile GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2",single nucleotide variant,GRCh37
na,na,3,33014312,33014312,GLB1,Pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis|GM1 gangliosidosis|not provided|Infantile GM1 gangliosidosis|Infantile GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2",single nucleotide variant,GRCh38
na,na,3,33038800,33038800,GLB1,Pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement",single nucleotide variant,GRCh37
na,na,3,32997308,32997308,GLB1,Pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement",single nucleotide variant,GRCh38
na,na,3,33038799,33038799,GLB1,Pathogenic/Likely pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2",single nucleotide variant,GRCh37
na,na,3,32997307,32997307,GLB1,Pathogenic/Likely pathogenic,"GM1-gangliosidosis, type I, with cardiac involvement|Infantile GM1 gangliosidosis;GM1 gangliosidosis type 3;GM1 gangliosidosis type 2;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis;Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2",single nucleotide variant,GRCh38
na,na,9,336714,336714,DOCK8,Pathogenic,Combined immunodeficiency due to DOCK8 deficiency|,single nucleotide variant,GRCh37
na,na,9,336714,336714,DOCK8,Pathogenic,Combined immunodeficiency due to DOCK8 deficiency|,single nucleotide variant,GRCh38
na,na,9,333830,394034,DOCK8,Pathogenic,Combined immunodeficiency due to DOCK8 deficiency,Deletion,GRCh37
na,na,9,333830,394034,DOCK8,Pathogenic,Combined immunodeficiency due to DOCK8 deficiency,Deletion,GRCh38
na,na,9,311734,398139,DOCK8,Pathogenic,Combined immunodeficiency due to DOCK8 deficiency,Deletion,GRCh37
na,na,9,311734,398139,DOCK8,Pathogenic,Combined immunodeficiency due to DOCK8 deficiency,Deletion,GRCh38
na,na,15,28263543,28263703,OCA2,Pathogenic,Brown oculocutaneous albinism|Tyrosinase-positive oculocutaneous albinism,Deletion,GRCh37
na,na,15,28018397,28018557,OCA2,Pathogenic,Brown oculocutaneous albinism|Tyrosinase-positive oculocutaneous albinism,Deletion,GRCh38
na,na,15,28200303,28200303,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism",single nucleotide variant,GRCh37
na,na,15,27955157,27955157,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism",single nucleotide variant,GRCh38
na,na,15,28228553,28228553,OCA2,Conflicting classifications of pathogenicity,Tyrosinase-positive oculocutaneous albinism|not specified|not provided|OCA2-related disorder,single nucleotide variant,GRCh37
na,na,15,27983407,27983407,OCA2,Conflicting classifications of pathogenicity,Tyrosinase-positive oculocutaneous albinism|not specified|not provided|OCA2-related disorder,single nucleotide variant,GRCh38
na,na,15,28230247,28230247,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|Inborn genetic diseases|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism|See cases|OCA2-related disorder|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Albinism or congenital nystagmus",single nucleotide variant,GRCh37
na,na,15,27985101,27985101,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|Inborn genetic diseases|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism|See cases|OCA2-related disorder|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Albinism or congenital nystagmus",single nucleotide variant,GRCh38
na,na,15,28116316,28116316,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|Tyrosinase-positive oculocutaneous albinism;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Nonsyndromic Oculocutaneous Albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism",single nucleotide variant,GRCh37
na,na,15,27871170,27871170,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|Tyrosinase-positive oculocutaneous albinism;SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Nonsyndromic Oculocutaneous Albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism",single nucleotide variant,GRCh38
na,na,15,28171392,28171392,OCA2,Pathogenic,Tyrosinase-positive oculocutaneous albinism,Deletion,GRCh37
na,na,15,27926246,27926246,OCA2,Pathogenic,Tyrosinase-positive oculocutaneous albinism,Deletion,GRCh38
na,na,15,28259965,28259965,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",single nucleotide variant,GRCh37
na,na,15,28014819,28014819,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",single nucleotide variant,GRCh38
na,na,15,28123663,28246288,OCA2,Pathogenic,Tyrosinase-positive oculocutaneous albinism,Deletion,GRCh37
na,na,15,27878517,28001142,OCA2,Pathogenic,Tyrosinase-positive oculocutaneous albinism,Deletion,GRCh38
na,na,15,28171315,28171315,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|not provided|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism",single nucleotide variant,GRCh37
na,na,15,27926169,27926169,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|not provided|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism",single nucleotide variant,GRCh38
na,na,15,28228529,28228529,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism|OCA2-related disorder|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism",single nucleotide variant,GRCh37
na,na,15,27983383,27983383,OCA2,Pathogenic/Likely pathogenic,"Tyrosinase-positive oculocutaneous albinism|not provided|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism|OCA2-related disorder|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|Oculocutaneous albinism",single nucleotide variant,GRCh38
na,na,15,28260053,28260053,OCA2,Benign,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|not specified|Tyrosinase-positive oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism|not provided",single nucleotide variant,GRCh37
na,na,15,28014907,28014907,OCA2,Benign,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|not specified|Tyrosinase-positive oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;Tyrosinase-positive oculocutaneous albinism|not provided",single nucleotide variant,GRCh38
na,na,15,28230318,28230318,OCA2,Benign,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|not specified|Tyrosinase-positive oculocutaneous albinism|not provided",single nucleotide variant,GRCh37
na,na,15,27985172,27985172,OCA2,Benign,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES|not specified|Tyrosinase-positive oculocutaneous albinism|not provided",single nucleotide variant,GRCh38
na,na,15,28335820,28335820,OCA2,no classification for the single variant,-,Variation,GRCh37
na,na,15,28090674,28090674,OCA2,no classification for the single variant,-,Variation,GRCh38
na,na,15,28234747,28234747,OCA2,Uncertain significance,Tyrosinase-positive oculocutaneous albinism,single nucleotide variant,GRCh37
na,na,15,27989601,27989601,OCA2,Uncertain significance,Tyrosinase-positive oculocutaneous albinism,single nucleotide variant,GRCh38
na,na,6,80198881,80198881,LCA5,Pathogenic,Leber congenital amaurosis 5|not provided|Leber congenital amaurosis|Retinal dystrophy,Deletion,GRCh37
na,na,6,79489164,79489164,LCA5,Pathogenic,Leber congenital amaurosis 5|not provided|Leber congenital amaurosis|Retinal dystrophy,Deletion,GRCh38
na,na,6,80197338,80197339,LCA5,Pathogenic,Leber congenital amaurosis 5,Duplication,GRCh37
na,na,6,79487621,79487622,LCA5,Pathogenic,Leber congenital amaurosis 5,Duplication,GRCh38
na,na,6,80203353,80203353,LCA5,Pathogenic,Leber congenital amaurosis 5|Inborn genetic diseases|not provided|Retinal dystrophy|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,6,79493636,79493636,LCA5,Pathogenic,Leber congenital amaurosis 5|Inborn genetic diseases|not provided|Retinal dystrophy|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,6,80246622,80248219,LCA5,Pathogenic,Leber congenital amaurosis 5,Deletion,GRCh37
na,na,6,79536905,79538502,LCA5,Pathogenic,Leber congenital amaurosis 5,Deletion,GRCh38
na,na,12,50898787,50898807,DIP2B,Pathogenic,"Intellectual disability, FRA12A type",Insertion,GRCh37
na,na,12,50505004,50506073,DIP2B,Pathogenic,"Intellectual disability, FRA12A type",Insertion,GRCh38
na,na,15,89858550,89858550,FANCI,Conflicting classifications of pathogenicity,Fanconi anemia complementation group I|Fanconi anemia,single nucleotide variant,GRCh37
na,na,15,89315319,89315319,FANCI,Conflicting classifications of pathogenicity,Fanconi anemia complementation group I|Fanconi anemia,single nucleotide variant,GRCh38
na,na,15,89858549,89858549,FANCI;POLG,Pathogenic,Fanconi anemia complementation group I|not provided|Fanconi anemia|FANCI-related disorder,single nucleotide variant,GRCh37
na,na,15,89315318,89315318,FANCI;POLG,Pathogenic,Fanconi anemia complementation group I|not provided|Fanconi anemia|FANCI-related disorder,single nucleotide variant,GRCh38
na,na,17,29324307,29324307,RNF135,Uncertain significance,"Macrocephaly, macrosomia, facial dysmorphism syndrome",single nucleotide variant,GRCh37
na,na,17,30997289,30997289,RNF135,Uncertain significance,"Macrocephaly, macrosomia, facial dysmorphism syndrome",single nucleotide variant,GRCh38
na,na,17,29324322,29324322,RNF135,Uncertain significance,"Macrocephaly, macrosomia, facial dysmorphism syndrome",Deletion,GRCh37
na,na,17,30997304,30997304,RNF135,Uncertain significance,"Macrocephaly, macrosomia, facial dysmorphism syndrome",Deletion,GRCh38
na,na,17,29325924,29325924,RNF135,Pathogenic,"Macrocephaly, macrosomia, facial dysmorphism syndrome|Autism spectrum disorder",Deletion,GRCh37
na,na,17,30998906,30998906,RNF135,Pathogenic,"Macrocephaly, macrosomia, facial dysmorphism syndrome|Autism spectrum disorder",Deletion,GRCh38
na,na,17,29325767,29325767,RNF135,Uncertain significance,"Macrocephaly, macrosomia, facial dysmorphism syndrome",single nucleotide variant,GRCh37
na,na,17,30998749,30998749,RNF135,Uncertain significance,"Macrocephaly, macrosomia, facial dysmorphism syndrome",single nucleotide variant,GRCh38
na,na,10,124214448,124214448,ARMS2,Benign,Age related macular degeneration 8|not provided|ARMS2-related disorder,single nucleotide variant,GRCh37
na,na,10,122454932,122454932,ARMS2,Benign,Age related macular degeneration 8|not provided|ARMS2-related disorder,single nucleotide variant,GRCh38
na,na,10,124216821,124217264,ARMS2,risk factor,Age related macular degeneration 8,Indel,GRCh37
na,na,10,122457305,122457748,ARMS2,risk factor,Age related macular degeneration 8,Indel,GRCh38
na,na,2,220022916,220022916,NHEJ1,Conflicting classifications of pathogenicity,Cernunnos-XLF deficiency|not provided,single nucleotide variant,GRCh37
na,na,2,219158194,219158194,NHEJ1,Conflicting classifications of pathogenicity,Cernunnos-XLF deficiency|not provided,single nucleotide variant,GRCh38
na,na,2,220022217,220022217,NHEJ1,Pathogenic,Cernunnos-XLF deficiency,single nucleotide variant,GRCh37
na,na,2,219157495,219157495,NHEJ1,Pathogenic,Cernunnos-XLF deficiency,single nucleotide variant,GRCh38
na,na,2,220011458,220011458,NHEJ1,Pathogenic,not provided|Cernunnos-XLF deficiency,single nucleotide variant,GRCh37
na,na,2,219146736,219146736,NHEJ1,Pathogenic,not provided|Cernunnos-XLF deficiency,single nucleotide variant,GRCh38
na,na,2,220022905,220022907,NHEJ1,Pathogenic,Cernunnos-XLF deficiency,Indel,GRCh37
na,na,2,219158183,219158185,NHEJ1,Pathogenic,Cernunnos-XLF deficiency,Indel,GRCh38
na,na,2,220023073,220023074,NHEJ1,Pathogenic,Cernunnos-XLF deficiency|Severe combined immunodeficiency disease,Duplication,GRCh37
na,na,2,219158351,219158352,NHEJ1,Pathogenic,Cernunnos-XLF deficiency|Severe combined immunodeficiency disease,Duplication,GRCh38
na,na,6,20661034,20661034,CDKAL1,Uncertain significance,Type 2 diabetes mellitus,single nucleotide variant,GRCh37
na,na,6,20660803,20660803,CDKAL1,Uncertain significance,Type 2 diabetes mellitus,single nucleotide variant,GRCh38
na,na,6,20679709,20679709,CDKAL1,Uncertain significance,Type 2 diabetes mellitus,single nucleotide variant,GRCh37
na,na,6,20679478,20679478,CDKAL1,Uncertain significance,Type 2 diabetes mellitus,single nucleotide variant,GRCh38
na,na,3,160095273,160095273,IFT80,Pathogenic,Asphyxiating thoracic dystrophy 2,single nucleotide variant,GRCh37
na,na,3,160377485,160377485,IFT80,Pathogenic,Asphyxiating thoracic dystrophy 2,single nucleotide variant,GRCh38
na,na,3,159986323,159986323,IFT80,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 2|Jeune thoracic dystrophy|not provided,single nucleotide variant,GRCh37
na,na,3,160268535,160268535,IFT80,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 2|Jeune thoracic dystrophy|not provided,single nucleotide variant,GRCh38
na,na,9,100451882,100451882,XPA,Likely pathogenic,Xeroderma pigmentosum group A|Xeroderma pigmentosum,single nucleotide variant,GRCh37
na,na,9,97689600,97689600,XPA,Likely pathogenic,Xeroderma pigmentosum group A|Xeroderma pigmentosum,single nucleotide variant,GRCh38
na,na,9,100451852,100451856,XPA,Pathogenic,Xeroderma pigmentosum group A|Xeroderma pigmentosum|not provided,Microsatellite,GRCh37
na,na,9,97689570,97689574,XPA,Pathogenic,Xeroderma pigmentosum group A|Xeroderma pigmentosum|not provided,Microsatellite,GRCh38
na,na,9,100437861,100437861,XPA,Pathogenic,Xeroderma pigmentosum group A|Xeroderma pigmentosum|not provided,single nucleotide variant,GRCh37
na,na,9,97675579,97675579,XPA,Pathogenic,Xeroderma pigmentosum group A|Xeroderma pigmentosum|not provided,single nucleotide variant,GRCh38
na,na,9,100447259,100447259,XPA,Pathogenic,Xeroderma pigmentosum group A|not provided|Xeroderma pigmentosum,single nucleotide variant,GRCh37
na,na,9,97684977,97684977,XPA,Pathogenic,Xeroderma pigmentosum group A|not provided|Xeroderma pigmentosum,single nucleotide variant,GRCh38
na,na,9,100451857,100451857,XPA,Pathogenic,Xeroderma pigmentosum group A,single nucleotide variant,GRCh37
na,na,9,97689575,97689575,XPA,Pathogenic,Xeroderma pigmentosum group A,single nucleotide variant,GRCh38
na,na,9,100459401,100459401,XPA,Pathogenic,Xeroderma pigmentosum group A,single nucleotide variant,GRCh37
na,na,9,97697119,97697119,XPA,Pathogenic,Xeroderma pigmentosum group A,single nucleotide variant,GRCh38
na,na,22,46191240,46191244,ATXN10,Benign,Spinocerebellar ataxia type 10,Microsatellite,GRCh37
na,na,22,45795360,45795364,ATXN10,Benign,Spinocerebellar ataxia type 10,Microsatellite,GRCh38
na,na,8,118184783,118184783,SLC30A8,Benign; risk factor,"Diabetes mellitus type 2, susceptibility to|SLC30A8-related disorder",single nucleotide variant,GRCh37
na,na,8,117172544,117172544,SLC30A8,Benign; risk factor,"Diabetes mellitus type 2, susceptibility to|SLC30A8-related disorder",single nucleotide variant,GRCh38
na,na,4,128851907,128851907,MFSD8,Likely pathogenic,Neuronal ceroid lipofuscinosis 7,single nucleotide variant,GRCh37
na,na,4,127930752,127930752,MFSD8,Likely pathogenic,Neuronal ceroid lipofuscinosis 7,single nucleotide variant,GRCh38
na,na,4,128842743,128842743,MFSD8,Pathogenic,Neuronal ceroid lipofuscinosis 7,single nucleotide variant,GRCh37
na,na,4,127921588,127921588,MFSD8,Pathogenic,Neuronal ceroid lipofuscinosis 7,single nucleotide variant,GRCh38
na,na,4,128851942,128851942,MFSD8,Pathogenic,Neuronal ceroid lipofuscinosis 7|not provided|Neuronal ceroid lipofuscinosis 7;Macular dystrophy with central cone involvement,single nucleotide variant,GRCh37
na,na,4,127930787,127930787,MFSD8,Pathogenic,Neuronal ceroid lipofuscinosis 7|not provided|Neuronal ceroid lipofuscinosis 7;Macular dystrophy with central cone involvement,single nucleotide variant,GRCh38
na,na,4,128864984,128864984,MFSD8,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 7|not provided|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh37
na,na,4,127943829,127943829,MFSD8,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 7|not provided|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh38
na,na,4,128842794,128842794,MFSD8,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 7|not provided|Inborn genetic diseases|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 7;Macular dystrophy with central cone involvement,single nucleotide variant,GRCh37
na,na,4,127921639,127921639,MFSD8,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 7|not provided|Inborn genetic diseases|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 7;Macular dystrophy with central cone involvement,single nucleotide variant,GRCh38
na,na,4,128851955,128851955,MFSD8,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 7|not provided|Late-infantile neuronal ceroid lipofuscinosis|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,4,127930800,127930800,MFSD8,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 7|not provided|Late-infantile neuronal ceroid lipofuscinosis|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,4,128863284,128863285,MFSD8,Pathogenic,Neuronal ceroid lipofuscinosis 7,Indel,GRCh37
na,na,4,127942129,127942130,MFSD8,Pathogenic,Neuronal ceroid lipofuscinosis 7,Indel,GRCh38
na,na,7,23180394,23180394,KLHL7,Pathogenic/Likely pathogenic,Retinitis pigmentosa 42|not provided,single nucleotide variant,GRCh37
na,na,7,23140775,23140775,KLHL7,Pathogenic/Likely pathogenic,Retinitis pigmentosa 42|not provided,single nucleotide variant,GRCh38
na,na,7,23180403,23180403,KLHL7,Pathogenic/Likely pathogenic,Retinitis pigmentosa 42|not provided|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,7,23140784,23140784,KLHL7,Pathogenic/Likely pathogenic,Retinitis pigmentosa 42|not provided|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,7,23180402,23180402,KLHL7,Pathogenic,Retinitis pigmentosa 42|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,7,23140783,23140783,KLHL7,Pathogenic,Retinitis pigmentosa 42|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,12,32751500,32751500,FGD4,Pathogenic,Charcot-Marie-Tooth disease type 4H|not provided|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh37
na,na,12,32598566,32598566,FGD4,Pathogenic,Charcot-Marie-Tooth disease type 4H|not provided|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh38
na,na,12,32777993,32777994,FGD4,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease,Microsatellite,GRCh37
na,na,12,32625059,32625060,FGD4,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease,Microsatellite,GRCh38
na,na,12,32778708,32778708,FGD4,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H,single nucleotide variant,GRCh37
na,na,12,32625774,32625774,FGD4,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H,single nucleotide variant,GRCh38
na,na,12,32755151,32755151,FGD4,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,12,32602217,32602217,FGD4,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,12,32754344,32754344,FGD4,Pathogenic,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh37
na,na,12,32601410,32601410,FGD4,Pathogenic,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh38
na,na,12,32786481,32786481,FGD4,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,12,32633547,32633547,FGD4,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,3,128598490,128598491,ACAD9,Conflicting classifications of pathogenicity,Acyl-CoA dehydrogenase 9 deficiency|not specified|not provided,Duplication,GRCh37
na,na,3,128879647,128879648,ACAD9,Conflicting classifications of pathogenicity,Acyl-CoA dehydrogenase 9 deficiency|not specified|not provided,Duplication,GRCh38
na,na,1,6529504,6529504,PLEKHG5,Conflicting classifications of pathogenicity,"Neuronopathy, distal hereditary motor, autosomal recessive 4|Hereditary motor neuron disease",single nucleotide variant,GRCh37
na,na,1,6469444,6469444,PLEKHG5,Conflicting classifications of pathogenicity,"Neuronopathy, distal hereditary motor, autosomal recessive 4|Hereditary motor neuron disease",single nucleotide variant,GRCh38
na,na,3,9726311,9726311,MTMR14,Uncertain significance,"MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF|not provided",single nucleotide variant,GRCh37
na,na,3,9684627,9684627,MTMR14,Uncertain significance,"MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF|not provided",single nucleotide variant,GRCh38
na,na,3,9730718,9730718,MTMR14,Uncertain significance,"MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF|not provided",single nucleotide variant,GRCh37
na,na,3,9689034,9689034,MTMR14,Uncertain significance,"MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF|not provided",single nucleotide variant,GRCh38
na,na,na,-1,-1,MIAT,no classification for the single variant,-,single nucleotide variant,na
na,na,7,295835,295835,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh37
na,na,7,255869,255869,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh38
na,na,7,295905,295905,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh37
na,na,7,255939,255939,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh38
na,na,7,299836,299836,FAM20C,Uncertain significance,Lethal osteosclerotic bone dysplasia|not provided,single nucleotide variant,GRCh37
na,na,7,259870,259870,FAM20C,Uncertain significance,Lethal osteosclerotic bone dysplasia|not provided,single nucleotide variant,GRCh38
na,na,7,288278,288278,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh37
na,na,7,248312,248312,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh38
na,na,7,295878,295878,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh37
na,na,7,255912,255912,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh38
na,na,7,296969,296969,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh37
na,na,7,257003,257003,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh38
na,na,7,286478,286478,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh37
na,na,7,246512,246512,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh38
na,na,7,298611,298611,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh37
na,na,7,258645,258645,FAM20C,Pathogenic,Lethal osteosclerotic bone dysplasia,single nucleotide variant,GRCh38
na,na,18,42531917,42531917,SETBP1,Pathogenic/Likely pathogenic,"Schinzel-Giedion syndrome|not provided|Intellectual disability, autosomal dominant 29|Fetal akinesia deformation sequence 1;Arthrogryposis multiplex congenita|SETBP1-related disorder",single nucleotide variant,GRCh37
na,na,18,44951952,44951952,SETBP1,Pathogenic/Likely pathogenic,"Schinzel-Giedion syndrome|not provided|Intellectual disability, autosomal dominant 29|Fetal akinesia deformation sequence 1;Arthrogryposis multiplex congenita|SETBP1-related disorder",single nucleotide variant,GRCh38
na,na,18,42531907,42531907,SETBP1,Pathogenic,"Schinzel-Giedion syndrome|Schinzel-Giedion syndrome;Intellectual disability, autosomal dominant 29|not provided|Intellectual disability, autosomal dominant 29|SETBP1-related disorder",single nucleotide variant,GRCh37
na,na,18,44951942,44951942,SETBP1,Pathogenic,"Schinzel-Giedion syndrome|Schinzel-Giedion syndrome;Intellectual disability, autosomal dominant 29|not provided|Intellectual disability, autosomal dominant 29|SETBP1-related disorder",single nucleotide variant,GRCh38
na,na,18,42531908,42531908,SETBP1,Pathogenic,Schinzel-Giedion syndrome,single nucleotide variant,GRCh37
na,na,18,44951943,44951943,SETBP1,Pathogenic,Schinzel-Giedion syndrome,single nucleotide variant,GRCh38
na,na,18,42531914,42531914,SETBP1,Pathogenic,Schinzel-Giedion syndrome,single nucleotide variant,GRCh37
na,na,18,44951949,44951949,SETBP1,Pathogenic,Schinzel-Giedion syndrome,single nucleotide variant,GRCh38
na,na,18,42531913,42531913,SETBP1,Pathogenic,Schinzel-Giedion syndrome|not provided|SETBP1-related disorder,single nucleotide variant,GRCh37
na,na,18,44951948,44951948,SETBP1,Pathogenic,Schinzel-Giedion syndrome|not provided|SETBP1-related disorder,single nucleotide variant,GRCh38
na,na,3,191107355,191107356,CCDC50,no classifications from unflagged records,Autosomal dominant nonsyndromic hearing loss 44,Duplication,GRCh37
na,na,3,191389566,191389567,CCDC50,no classifications from unflagged records,Autosomal dominant nonsyndromic hearing loss 44,Duplication,GRCh38
na,na,17,42153128,42153128,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency|not provided,single nucleotide variant,GRCh37
na,na,17,44075760,44075760,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency|not provided,single nucleotide variant,GRCh38
na,na,17,42152696,42152696,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,single nucleotide variant,GRCh37
na,na,17,44075328,44075328,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,single nucleotide variant,GRCh38
na,na,17,42148474,42148474,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,single nucleotide variant,GRCh37
na,na,17,44071106,44071106,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,single nucleotide variant,GRCh38
na,na,17,42153154,42153154,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,single nucleotide variant,GRCh37
na,na,17,44075786,44075786,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,single nucleotide variant,GRCh38
na,na,17,42152068,42152068,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,single nucleotide variant,GRCh37
na,na,17,44074700,44074700,G6PC3,Pathogenic,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency,single nucleotide variant,GRCh38
na,na,16,74752885,74752885,FA2H,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 35|not provided,single nucleotide variant,GRCh37
na,na,16,74718987,74718987,FA2H,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 35|not provided,single nucleotide variant,GRCh38
na,na,16,74808551,74808551,FA2H,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 35,single nucleotide variant,GRCh37
na,na,16,74774653,74774653,FA2H,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 35,single nucleotide variant,GRCh38
na,na,2,220432910,220432910,OBSL1,Pathogenic,3M syndrome 2|not provided,single nucleotide variant,GRCh37
na,na,2,219568188,219568188,OBSL1,Pathogenic,3M syndrome 2|not provided,single nucleotide variant,GRCh38
na,na,2,220432794,220432803,OBSL1,Pathogenic,3M syndrome 2,Deletion,GRCh37
na,na,2,219568072,219568081,OBSL1,Pathogenic,3M syndrome 2,Deletion,GRCh38
na,na,2,220432509,220432509,OBSL1,Pathogenic,3M syndrome 2,single nucleotide variant,GRCh37
na,na,2,219567787,219567787,OBSL1,Pathogenic,3M syndrome 2,single nucleotide variant,GRCh38
na,na,14,105169680,105169680,INF2,Pathogenic,Focal segmental glomerulosclerosis 5|INF2-related disorder,single nucleotide variant,GRCh37
na,na,14,104703343,104703343,INF2,Pathogenic,Focal segmental glomerulosclerosis 5|INF2-related disorder,single nucleotide variant,GRCh38
na,na,14,105169777,105169777,INF2,Pathogenic/Likely pathogenic,Focal segmental glomerulosclerosis 5|not provided|Inborn genetic diseases|Focal segmental glomerulosclerosis 5;Charcot-Marie-Tooth disease dominant intermediate E|Kidney disorder|Charcot-Marie-Tooth disease dominant intermediate E,single nucleotide variant,GRCh37
na,na,14,104703440,104703440,INF2,Pathogenic/Likely pathogenic,Focal segmental glomerulosclerosis 5|not provided|Inborn genetic diseases|Focal segmental glomerulosclerosis 5;Charcot-Marie-Tooth disease dominant intermediate E|Kidney disorder|Charcot-Marie-Tooth disease dominant intermediate E,single nucleotide variant,GRCh38
na,na,14,105169776,105169776,INF2,Pathogenic/Likely pathogenic,Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease dominant intermediate E;Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease dominant intermediate E,single nucleotide variant,GRCh37
na,na,14,104703439,104703439,INF2,Pathogenic/Likely pathogenic,Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease dominant intermediate E;Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease dominant intermediate E,single nucleotide variant,GRCh38
na,na,14,105169765,105169765,INF2,Pathogenic/Likely pathogenic,Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease dominant intermediate E;Focal segmental glomerulosclerosis 5|Kidney disorder,single nucleotide variant,GRCh37
na,na,14,104703428,104703428,INF2,Pathogenic/Likely pathogenic,Focal segmental glomerulosclerosis 5|Charcot-Marie-Tooth disease dominant intermediate E;Focal segmental glomerulosclerosis 5|Kidney disorder,single nucleotide variant,GRCh38
na,na,14,105167827,105167827,INF2,Pathogenic,Focal segmental glomerulosclerosis 5,single nucleotide variant,GRCh37
na,na,14,104701490,104701490,INF2,Pathogenic,Focal segmental glomerulosclerosis 5,single nucleotide variant,GRCh38
na,na,16,53907749,53907749,FTO,Pathogenic,"Lethal polymalformative syndrome, Boissel type",single nucleotide variant,GRCh37
na,na,16,53873837,53873837,FTO,Pathogenic,"Lethal polymalformative syndrome, Boissel type",single nucleotide variant,GRCh38
na,na,12,32908653,32908653,YARS2,Pathogenic/Likely pathogenic,"Myopathy, lactic acidosis, and sideroblastic anemia 2|not provided",single nucleotide variant,GRCh37
na,na,12,32755719,32755719,YARS2,Pathogenic/Likely pathogenic,"Myopathy, lactic acidosis, and sideroblastic anemia 2|not provided",single nucleotide variant,GRCh38
na,na,1,173797450,173797451,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|Gait ataxia;Gait imbalance;Dysmetria|10 conditions|not provided,Indel,GRCh37
na,na,1,173828312,173828313,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|Gait ataxia;Gait imbalance;Dysmetria|10 conditions|not provided,Indel,GRCh38
na,na,1,173826781,173826781,DARS2,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,single nucleotide variant,GRCh37
na,na,1,173857643,173857643,DARS2,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,single nucleotide variant,GRCh38
na,na,1,173807344,173807344,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,173838206,173838206,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,173807345,173807345,DARS2,Pathogenic/Likely pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,173838207,173838207,DARS2,Pathogenic/Likely pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,173800731,173800731,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided|See cases|DARS2-related disorder,single nucleotide variant,GRCh37
na,na,1,173831593,173831593,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided|See cases|DARS2-related disorder,single nucleotide variant,GRCh38
na,na,1,173800770,173800770,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided|Dysmetria;Gait ataxia;Gait imbalance|10 conditions|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,1,173831632,173831632,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided|Dysmetria;Gait ataxia;Gait imbalance|10 conditions|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,173795830,173795830,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,single nucleotide variant,GRCh37
na,na,1,173826692,173826692,DARS2,Pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,single nucleotide variant,GRCh38
na,na,1,173802557,173802557,DARS2,Pathogenic/Likely pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,173833419,173833419,DARS2,Pathogenic/Likely pathogenic,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,173819546,173819546,DARS2,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,173850408,173850408,DARS2,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,173826742,173826742,DARS2,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,single nucleotide variant,GRCh37
na,na,1,173857604,173857604,DARS2,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,single nucleotide variant,GRCh38
na,na,1,173826782,173826782,DARS2,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,single nucleotide variant,GRCh37
na,na,1,173857644,173857644,DARS2,Uncertain significance,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,single nucleotide variant,GRCh38
na,na,16,53720424,53720424,RPGRIP1L,Pathogenic,Joubert syndrome 7|RPGRIP1L-related disorder|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome|not provided,single nucleotide variant,GRCh37
na,na,16,53686512,53686512,RPGRIP1L,Pathogenic,Joubert syndrome 7|RPGRIP1L-related disorder|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome|not provided,single nucleotide variant,GRCh38
na,na,16,53686756,53686756,RPGRIP1L,Pathogenic,"Joubert syndrome 7|Joubert syndrome;Meckel-Gruber syndrome|not provided|Joubert syndrome|Joubert syndrome 7;COACH syndrome 3;Meckel syndrome, type 5|RPGRIP1L-related disorder|Joubert syndrome and related disorders",single nucleotide variant,GRCh37
na,na,16,53652844,53652844,RPGRIP1L,Pathogenic,"Joubert syndrome 7|Joubert syndrome;Meckel-Gruber syndrome|not provided|Joubert syndrome|Joubert syndrome 7;COACH syndrome 3;Meckel syndrome, type 5|RPGRIP1L-related disorder|Joubert syndrome and related disorders",single nucleotide variant,GRCh38
na,na,16,53720364,53720364,RPGRIP1L,Pathogenic,"Joubert syndrome 7|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome|Joubert syndrome and related disorders|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3",single nucleotide variant,GRCh37
na,na,16,53686452,53686452,RPGRIP1L,Pathogenic,"Joubert syndrome 7|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome|Joubert syndrome and related disorders|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3",single nucleotide variant,GRCh38
na,na,16,53686516,53686516,RPGRIP1L,Pathogenic/Likely pathogenic,Joubert syndrome 7|Joubert syndrome,single nucleotide variant,GRCh37
na,na,16,53652604,53652604,RPGRIP1L,Pathogenic/Likely pathogenic,Joubert syndrome 7|Joubert syndrome,single nucleotide variant,GRCh38
na,na,16,53726113,53726113,RPGRIP1L,Pathogenic,"Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome",single nucleotide variant,GRCh37
na,na,16,53692201,53692201,RPGRIP1L,Pathogenic,"Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome",single nucleotide variant,GRCh38
na,na,16,53705492,53705492,RPGRIP1L,Pathogenic,"Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome",single nucleotide variant,GRCh37
na,na,16,53671580,53671580,RPGRIP1L,Pathogenic,"Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome",single nucleotide variant,GRCh38
na,na,16,53679606,53679606,RPGRIP1L,Pathogenic/Likely pathogenic,"Meckel syndrome, type 5|not provided|Meckel-Gruber syndrome;Joubert syndrome|COACH syndrome 1;Joubert syndrome 7;Meckel syndrome, type 5|RPGRIP1L-related disorder|Joubert syndrome|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3|Meckel-Gruber syndrome",single nucleotide variant,GRCh37
na,na,16,53645694,53645694,RPGRIP1L,Pathogenic/Likely pathogenic,"Meckel syndrome, type 5|not provided|Meckel-Gruber syndrome;Joubert syndrome|COACH syndrome 1;Joubert syndrome 7;Meckel syndrome, type 5|RPGRIP1L-related disorder|Joubert syndrome|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3|Meckel-Gruber syndrome",single nucleotide variant,GRCh38
na,na,16,53686549,53686549,RPGRIP1L,Pathogenic/Likely pathogenic,"Joubert syndrome 7|Joubert syndrome 7;COACH syndrome 1;Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome|not provided|Joubert syndrome|Abnormality of prenatal development or birth|COACH syndrome 3;Joubert syndrome 7;Meckel syndrome, type 5",single nucleotide variant,GRCh37
na,na,16,53652637,53652637,RPGRIP1L,Pathogenic/Likely pathogenic,"Joubert syndrome 7|Joubert syndrome 7;COACH syndrome 1;Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome|not provided|Joubert syndrome|Abnormality of prenatal development or birth|COACH syndrome 3;Joubert syndrome 7;Meckel syndrome, type 5",single nucleotide variant,GRCh38
na,na,16,53682911,53682911,RPGRIP1L,Pathogenic,Joubert syndrome 7,Deletion,GRCh37
na,na,16,53648999,53648999,RPGRIP1L,Pathogenic,Joubert syndrome 7,Deletion,GRCh38
na,na,16,53720436,53720436,RPGRIP1L,Benign,"Retinitis pigmentosa in ciliopathies, modifier of|Joubert syndrome|not specified|Nephronophthisis|Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome 7|Nephronophthisis 8|not provided|Focal segmental glomerulosclerosis|Meckel syndrome, type 5;Joubert syndrome 7;COACH syndrome 3",single nucleotide variant,GRCh37
na,na,16,53686524,53686524,RPGRIP1L,Benign,"Retinitis pigmentosa in ciliopathies, modifier of|Joubert syndrome|not specified|Nephronophthisis|Meckel syndrome, type 5|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome 7|Nephronophthisis 8|not provided|Focal segmental glomerulosclerosis|Meckel syndrome, type 5;Joubert syndrome 7;COACH syndrome 3",single nucleotide variant,GRCh38
na,na,16,53679807,53679807,RPGRIP1L,Pathogenic,"COACH syndrome 3|Joubert syndrome 7|not provided|Joubert syndrome|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3",single nucleotide variant,GRCh37
na,na,16,53645895,53645895,RPGRIP1L,Pathogenic,"COACH syndrome 3|Joubert syndrome 7|not provided|Joubert syndrome|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome 7;Meckel syndrome, type 5;COACH syndrome 3",single nucleotide variant,GRCh38
na,na,16,53686624,53686624,RPGRIP1L,Pathogenic,COACH syndrome 3|Joubert syndrome 7,single nucleotide variant,GRCh37
na,na,16,53652712,53652712,RPGRIP1L,Pathogenic,COACH syndrome 3|Joubert syndrome 7,single nucleotide variant,GRCh38
na,na,9,80915563,80915563,PSAT1,Pathogenic,PSAT deficiency|not provided|Neu-Laxova syndrome 2,Deletion,GRCh37
na,na,9,78300647,78300647,PSAT1,Pathogenic,PSAT deficiency|not provided|Neu-Laxova syndrome 2,Deletion,GRCh38
na,na,9,80919758,80919758,PSAT1,Pathogenic,PSAT deficiency|not provided|Neu-Laxova syndrome 2,single nucleotide variant,GRCh37
na,na,9,78304842,78304842,PSAT1,Pathogenic,PSAT deficiency|not provided|Neu-Laxova syndrome 2,single nucleotide variant,GRCh38
na,na,7,144096940,144096940,NOBOX,Conflicting classifications of pathogenicity,Premature ovarian failure 5|Genetic non-acquired premature ovarian failure|not provided,single nucleotide variant,GRCh37
na,na,7,144399847,144399847,NOBOX,Conflicting classifications of pathogenicity,Premature ovarian failure 5|Genetic non-acquired premature ovarian failure|not provided,single nucleotide variant,GRCh38
na,na,8,135610207,135610207,ZFAT,risk factor,"Autoimmune thyroid disease, susceptibility to, 3",single nucleotide variant,GRCh37
na,na,8,134597964,134597964,ZFAT,risk factor,"Autoimmune thyroid disease, susceptibility to, 3",single nucleotide variant,GRCh38
na,na,20,32438775,32438775,CHMP4B,Pathogenic,Cataract 31 multiple types,single nucleotide variant,GRCh37
na,na,20,33850969,33850969,CHMP4B,Pathogenic,Cataract 31 multiple types,single nucleotide variant,GRCh38
na,na,20,32438870,32438870,CHMP4B,Pathogenic,Cataract 31 multiple types,single nucleotide variant,GRCh37
na,na,20,33851064,33851064,CHMP4B,Pathogenic,Cataract 31 multiple types,single nucleotide variant,GRCh38
na,na,14,76107351,76107351,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh37
na,na,14,75641008,75641008,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh38
na,na,14,76045644,76045649,FLVCR2,Pathogenic,Fowler syndrome,Deletion,GRCh37
na,na,14,75579301,75579306,FLVCR2,Pathogenic,Fowler syndrome,Deletion,GRCh38
na,na,14,76105762,76105762,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh37
na,na,14,75639419,75639419,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh38
na,na,14,76045788,76045788,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh37
na,na,14,75579445,75579445,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh38
na,na,14,76090982,76090982,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh37
na,na,14,75624639,75624639,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh38
na,na,14,76099996,76099996,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh37
na,na,14,75633653,75633653,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh38
na,na,14,76107405,76107405,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh37
na,na,14,75641062,75641062,FLVCR2,Pathogenic,Fowler syndrome,single nucleotide variant,GRCh38
na,na,1,100387136,100387137,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIa|Inborn genetic diseases|Glycogen storage disease type III,Duplication,GRCh37
na,na,1,99921580,99921581,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIa|Inborn genetic diseases|Glycogen storage disease type III,Duplication,GRCh38
na,na,1,100316614,100316614,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIb|Glycogen storage disease type III|not provided,single nucleotide variant,GRCh37
na,na,1,99851058,99851058,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIb|Glycogen storage disease type III|not provided,single nucleotide variant,GRCh38
na,na,1,100346885,100346885,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIb|Glycogen storage disease type III|not provided|Glycogen storage disease IIIa,single nucleotide variant,GRCh37
na,na,1,99881329,99881329,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIb|Glycogen storage disease type III|not provided|Glycogen storage disease IIIa,single nucleotide variant,GRCh38
na,na,1,100382260,100382260,AGL,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided|AGL-related disorder,Deletion,GRCh37
na,na,1,99916704,99916704,AGL,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided|AGL-related disorder,Deletion,GRCh38
na,na,1,100381954,100381954,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIa|Glycogen storage disease IIIb|Glycogen storage disease type III|not provided|AGL-related disorder,single nucleotide variant,GRCh37
na,na,1,99916398,99916398,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIa|Glycogen storage disease IIIb|Glycogen storage disease type III|not provided|AGL-related disorder,single nucleotide variant,GRCh38
na,na,1,100345603,100345603,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III,single nucleotide variant,GRCh37
na,na,1,99880047,99880047,AGL,Pathogenic/Likely pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III,single nucleotide variant,GRCh38
na,na,na,-1,-1,AGL,Pathogenic,Glycogen storage disease IIIa,Variation,na
na,na,1,100382048,100382048,AGL,Pathogenic,Glycogen storage disease IIIa,single nucleotide variant,GRCh37
na,na,1,99916492,99916492,AGL,Pathogenic,Glycogen storage disease IIIa,single nucleotide variant,GRCh38
na,na,1,100379098,100379098,AGL,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided,Deletion,GRCh37
na,na,1,99913542,99913542,AGL,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided,Deletion,GRCh38
na,na,1,100346731,100346731,AGL,Pathogenic,Glycogen storage disease IIIb,Deletion,GRCh37
na,na,1,99881175,99881175,AGL,Pathogenic,Glycogen storage disease IIIb,Deletion,GRCh38
na,na,1,100381047,100381047,AGL,Conflicting classifications of pathogenicity,Glycogen storage disease IIIb|Glycogen storage disease type III|not provided,single nucleotide variant,GRCh37
na,na,1,99915491,99915491,AGL,Conflicting classifications of pathogenicity,Glycogen storage disease IIIb|Glycogen storage disease type III|not provided,single nucleotide variant,GRCh38
na,na,1,100340950,100340950,AGL,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided,single nucleotide variant,GRCh37
na,na,1,99875394,99875394,AGL,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided,single nucleotide variant,GRCh38
na,na,1,100366268,100366268,AGL,Pathogenic,Glycogen storage disease IIIc,single nucleotide variant,GRCh37
na,na,1,99900712,99900712,AGL,Pathogenic,Glycogen storage disease IIIc,single nucleotide variant,GRCh38
na,na,1,100379113,100379113,AGL,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided,single nucleotide variant,GRCh37
na,na,1,99913557,99913557,AGL,Pathogenic,Glycogen storage disease IIIa|Glycogen storage disease type III|not provided,single nucleotide variant,GRCh38
na,na,15,44865850,44865850,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Charcot-Marie-Tooth disease axonal type 2X;Hereditary spastic paraplegia 11|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2X;Hereditary spastic paraplegia 11;Amyotrophic lateral sclerosis type 5,single nucleotide variant,GRCh37
na,na,15,44573652,44573652,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Charcot-Marie-Tooth disease axonal type 2X;Hereditary spastic paraplegia 11|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2X;Hereditary spastic paraplegia 11;Amyotrophic lateral sclerosis type 5,single nucleotide variant,GRCh38
na,na,15,44951411,44951415,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|not provided,Microsatellite,GRCh37
na,na,15,44659213,44659217,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|not provided,Microsatellite,GRCh38
na,na,15,44955728,44955728,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5|not provided,single nucleotide variant,GRCh37
na,na,15,44663530,44663530,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X|Amyotrophic lateral sclerosis type 5|not provided,single nucleotide variant,GRCh38
na,na,15,44949428,44949429,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Amyotrophic lateral sclerosis type 5|Hereditary spastic paraplegia|Amyotrophic lateral sclerosis type 5;Hereditary spastic paraplegia 11|not provided|Charcot-Marie-Tooth disease axonal type 2X|Inborn genetic diseases|Amyotrophic lateral sclerosis type 5;Charcot-Marie-Tooth disease axonal type 2X;Hereditary spastic paraplegia 11,Deletion,GRCh37
na,na,15,44657230,44657231,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Amyotrophic lateral sclerosis type 5|Hereditary spastic paraplegia|Amyotrophic lateral sclerosis type 5;Hereditary spastic paraplegia 11|not provided|Charcot-Marie-Tooth disease axonal type 2X|Inborn genetic diseases|Amyotrophic lateral sclerosis type 5;Charcot-Marie-Tooth disease axonal type 2X;Hereditary spastic paraplegia 11,Deletion,GRCh38
na,na,15,44914104,44914105,SPG11,Pathogenic,Hereditary spastic paraplegia 11,Insertion,GRCh37
na,na,15,44621906,44621907,SPG11,Pathogenic,Hereditary spastic paraplegia 11,Insertion,GRCh38
na,na,15,44952629,44952629,SPG11,Pathogenic,Hereditary spastic paraplegia 11|not provided|Hereditary spastic paraplegia,single nucleotide variant,GRCh37
na,na,15,44660431,44660431,SPG11,Pathogenic,Hereditary spastic paraplegia 11|not provided|Hereditary spastic paraplegia,single nucleotide variant,GRCh38
na,na,15,44855500,44855500,SPG11,Pathogenic,Hereditary spastic paraplegia 11,single nucleotide variant,GRCh37
na,na,15,44563302,44563302,SPG11,Pathogenic,Hereditary spastic paraplegia 11,single nucleotide variant,GRCh38
na,na,15,44876255,44876255,SPG11,Pathogenic,Hereditary spastic paraplegia 11|not provided|Inborn genetic diseases|Hereditary spastic paraplegia 11;Charcot-Marie-Tooth disease axonal type 2X;Amyotrophic lateral sclerosis type 5,single nucleotide variant,GRCh37
na,na,15,44584057,44584057,SPG11,Pathogenic,Hereditary spastic paraplegia 11|not provided|Inborn genetic diseases|Hereditary spastic paraplegia 11;Charcot-Marie-Tooth disease axonal type 2X;Amyotrophic lateral sclerosis type 5,single nucleotide variant,GRCh38
na,na,15,44905697,44905698,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Amyotrophic lateral sclerosis type 5|not provided|Hereditary spastic paraplegia 11;Charcot-Marie-Tooth disease axonal type 2X;Amyotrophic lateral sclerosis type 5|SPG11-related disorder,Duplication,GRCh37
na,na,15,44613499,44613500,SPG11,Pathogenic,Hereditary spastic paraplegia 11|Amyotrophic lateral sclerosis type 5|not provided|Hereditary spastic paraplegia 11;Charcot-Marie-Tooth disease axonal type 2X;Amyotrophic lateral sclerosis type 5|SPG11-related disorder,Duplication,GRCh38
na,na,3,39433004,39433004,SLC25A38,Pathogenic,Sideroblastic anemia 2|not provided,single nucleotide variant,GRCh37
na,na,3,39391513,39391513,SLC25A38,Pathogenic,Sideroblastic anemia 2|not provided,single nucleotide variant,GRCh38
na,na,3,39432975,39432976,SLC25A38,Pathogenic/Likely pathogenic,Sideroblastic anemia 2|SLC25A38-related disorder|not provided,Microsatellite,GRCh37
na,na,3,39391484,39391485,SLC25A38,Pathogenic/Likely pathogenic,Sideroblastic anemia 2|SLC25A38-related disorder|not provided,Microsatellite,GRCh38
na,na,3,39433447,39433447,SLC25A38,Conflicting classifications of pathogenicity,Sideroblastic anemia 2|not provided,single nucleotide variant,GRCh37
na,na,3,39391956,39391956,SLC25A38,Conflicting classifications of pathogenicity,Sideroblastic anemia 2|not provided,single nucleotide variant,GRCh38
na,na,3,39432931,39432931,SLC25A38,Pathogenic,Sideroblastic anemia 2,single nucleotide variant,GRCh37
na,na,3,39391440,39391440,SLC25A38,Pathogenic,Sideroblastic anemia 2,single nucleotide variant,GRCh38
na,na,3,39436065,39436065,SLC25A38,Pathogenic,Sideroblastic anemia 2,single nucleotide variant,GRCh37
na,na,3,39394574,39394574,SLC25A38,Pathogenic,Sideroblastic anemia 2,single nucleotide variant,GRCh38
na,na,1,67519572,67519572,SLC35D1,Pathogenic,Schneckenbecken dysplasia,Deletion,GRCh37
na,na,1,67053889,67053889,SLC35D1,Pathogenic,Schneckenbecken dysplasia,Deletion,GRCh38
na,na,1,67474795,67474795,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh37
na,na,1,67009112,67009112,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh38
na,na,1,67512947,67512947,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh37
na,na,1,67047264,67047264,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh38
na,na,1,67518459,67518459,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh37
na,na,1,67052776,67052776,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh38
na,na,1,67517692,67517692,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh37
na,na,1,67052009,67052009,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh38
na,na,1,67509777,67514735,SLC35D1,Pathogenic,Schneckenbecken dysplasia,Deletion,GRCh37
na,na,1,67044094,67049052,SLC35D1,Pathogenic,Schneckenbecken dysplasia,Deletion,GRCh38
na,na,1,67519504,67519504,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh37
na,na,1,67053821,67053821,SLC35D1,Pathogenic,Schneckenbecken dysplasia,single nucleotide variant,GRCh38
na,na,2,234183368,234183368,ATG16L1,Benign,"Inflammatory bowel disease 10, susceptibility to|not specified|not provided|ATG16L1-related disorder",single nucleotide variant,GRCh37
na,na,2,233274722,233274722,ATG16L1,Benign,"Inflammatory bowel disease 10, susceptibility to|not specified|not provided|ATG16L1-related disorder",single nucleotide variant,GRCh38
na,na,9,131709288,131709288,DOLK,Pathogenic,DK1-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,9,128947009,128947009,DOLK,Pathogenic,DK1-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,9,131708261,131708261,DOLK,Pathogenic,DK1-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,9,128945982,128945982,DOLK,Pathogenic,DK1-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,15,74483230,74483230,STRA6,Likely pathogenic,Matthew-Wood syndrome|not provided,single nucleotide variant,GRCh37
na,na,15,74190889,74190889,STRA6,Likely pathogenic,Matthew-Wood syndrome|not provided,single nucleotide variant,GRCh38
na,na,15,74490126,74490126,STRA6,Pathogenic,Matthew-Wood syndrome,Deletion,GRCh37
na,na,15,74197785,74197785,STRA6,Pathogenic,Matthew-Wood syndrome,Deletion,GRCh38
na,na,15,74472462,74472462,STRA6,Uncertain significance,Matthew-Wood syndrome|not provided,single nucleotide variant,GRCh37
na,na,15,74180121,74180121,STRA6,Uncertain significance,Matthew-Wood syndrome|not provided,single nucleotide variant,GRCh38
na,na,15,74472494,74472494,STRA6,Pathogenic,Matthew-Wood syndrome,single nucleotide variant,GRCh37
na,na,15,74180153,74180153,STRA6,Pathogenic,Matthew-Wood syndrome,single nucleotide variant,GRCh38
na,na,15,74488486,74488486,STRA6,Pathogenic,Matthew-Wood syndrome,single nucleotide variant,GRCh37
na,na,15,74196145,74196145,STRA6,Pathogenic,Matthew-Wood syndrome,single nucleotide variant,GRCh38
na,na,15,74481585,74481585,STRA6,Uncertain significance,Matthew-Wood syndrome|STRA6-related disorder,single nucleotide variant,GRCh37
na,na,15,74189244,74189244,STRA6,Uncertain significance,Matthew-Wood syndrome|STRA6-related disorder,single nucleotide variant,GRCh38
na,na,15,74494557,74494559,STRA6,Pathogenic,Matthew-Wood syndrome,Indel,GRCh37
na,na,15,74202216,74202218,STRA6,Pathogenic,Matthew-Wood syndrome,Indel,GRCh38
na,na,15,74487712,74487713,STRA6,Likely pathogenic,Matthew-Wood syndrome|not provided,Duplication,GRCh37
na,na,15,74195371,74195372,STRA6,Likely pathogenic,Matthew-Wood syndrome|not provided,Duplication,GRCh38
na,na,15,74494572,74494573,STRA6,Pathogenic,Matthew-Wood syndrome,Duplication,GRCh37
na,na,15,74202231,74202232,STRA6,Pathogenic,Matthew-Wood syndrome,Duplication,GRCh38
na,na,15,74494540,74494540,STRA6,Pathogenic,Matthew-Wood syndrome,single nucleotide variant,GRCh37
na,na,15,74202199,74202199,STRA6,Pathogenic,Matthew-Wood syndrome,single nucleotide variant,GRCh38
na,na,11,125769895,125769895,HYLS1;PUS3,Pathogenic,Hydrolethalus syndrome|Hydrolethalus syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,11,125900000,125900000,HYLS1;PUS3,Pathogenic,Hydrolethalus syndrome|Hydrolethalus syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,2,191159365,191159365,HIBCH,Pathogenic,3-hydroxyisobutyryl-CoA hydrolase deficiency,single nucleotide variant,GRCh37
na,na,2,190294639,190294639,HIBCH,Pathogenic,3-hydroxyisobutyryl-CoA hydrolase deficiency,single nucleotide variant,GRCh38
na,na,2,191155151,191155151,HIBCH,Conflicting classifications of pathogenicity,3-hydroxyisobutyryl-CoA hydrolase deficiency|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,2,190290425,190290425,HIBCH,Conflicting classifications of pathogenicity,3-hydroxyisobutyryl-CoA hydrolase deficiency|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,2,191161682,191161682,HIBCH,Pathogenic,3-hydroxyisobutyryl-CoA hydrolase deficiency,single nucleotide variant,GRCh37
na,na,2,190296956,190296956,HIBCH,Pathogenic,3-hydroxyisobutyryl-CoA hydrolase deficiency,single nucleotide variant,GRCh38
na,na,4,123664110,123664110,BBS12,Pathogenic,"Bardet-Biedl syndrome 12|Bardet-Biedl syndrome|Abnormal cardiovascular system morphology;Visual impairment;Polydactyly, postaxial, type A1;Inability to walk|not provided|Bardet-Biedl syndrome 1",single nucleotide variant,GRCh37
na,na,4,122742955,122742955,BBS12,Pathogenic,"Bardet-Biedl syndrome 12|Bardet-Biedl syndrome|Abnormal cardiovascular system morphology;Visual impairment;Polydactyly, postaxial, type A1;Inability to walk|not provided|Bardet-Biedl syndrome 1",single nucleotide variant,GRCh38
na,na,4,123663382,123663384,BBS12,Pathogenic,Bardet-Biedl syndrome 12,Deletion,GRCh37
na,na,4,122742227,122742229,BBS12,Pathogenic,Bardet-Biedl syndrome 12,Deletion,GRCh38
na,na,4,123664529,123664530,BBS12,Pathogenic,Bardet-Biedl syndrome 12,Deletion,GRCh37
na,na,4,122743374,122743375,BBS12,Pathogenic,Bardet-Biedl syndrome 12,Deletion,GRCh38
na,na,4,123663912,123663912,BBS12,Likely pathogenic,Bardet-Biedl syndrome 12|Retinal dystrophy|Bardet-Biedl syndrome|not provided,single nucleotide variant,GRCh37
na,na,4,122742757,122742757,BBS12,Likely pathogenic,Bardet-Biedl syndrome 12|Retinal dystrophy|Bardet-Biedl syndrome|not provided,single nucleotide variant,GRCh38
na,na,4,123664161,123664162,BBS12,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 12|not provided|Bardet-Biedl syndrome|Retinal dystrophy|BBS12-related disorder,Deletion,GRCh37
na,na,4,122743006,122743007,BBS12,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 12|not provided|Bardet-Biedl syndrome|Retinal dystrophy|BBS12-related disorder,Deletion,GRCh38
na,na,12,48534655,48534655,PFKM,Pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh37
na,na,12,48140872,48140872,PFKM,Pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh38
na,na,12,48527096,48527096,PFKM,Pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh37
na,na,12,48133313,48133313,PFKM,Pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh38
na,na,12,48524176,48524176,PFKM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh37
na,na,12,48130393,48130393,PFKM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh38
na,na,12,48535824,48535824,PFKM,Uncertain significance,"Glycogen storage disease, type VII",single nucleotide variant,GRCh37
na,na,12,48142041,48142041,PFKM,Uncertain significance,"Glycogen storage disease, type VII",single nucleotide variant,GRCh38
na,na,12,48524176,48524176,PFKM,Pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh37
na,na,12,48130393,48130393,PFKM,Pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh38
na,na,12,48526696,48526696,PFKM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh37
na,na,12,48132913,48132913,PFKM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh38
na,na,12,48538879,48538879,PFKM,Pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh37
na,na,12,48145096,48145096,PFKM,Pathogenic,"Glycogen storage disease, type VII",single nucleotide variant,GRCh38
na,na,8,126069059,126069059,WASHC5,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 8|Hereditary spastic paraplegia|Hereditary spastic paraplegia 8;Ritscher-Schinzel syndrome|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,8,125056817,125056817,WASHC5,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 8|Hereditary spastic paraplegia|Hereditary spastic paraplegia 8;Ritscher-Schinzel syndrome|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,8,126069816,126069816,WASHC5,Pathogenic,Hereditary spastic paraplegia 8|Ritscher-Schinzel syndrome;Hereditary spastic paraplegia 8,single nucleotide variant,GRCh37
na,na,8,125057574,125057574,WASHC5,Pathogenic,Hereditary spastic paraplegia 8|Ritscher-Schinzel syndrome;Hereditary spastic paraplegia 8,single nucleotide variant,GRCh38
na,na,8,126073434,126073434,WASHC5,Pathogenic,Hereditary spastic paraplegia 8,single nucleotide variant,GRCh37
na,na,8,125061192,125061192,WASHC5,Pathogenic,Hereditary spastic paraplegia 8,single nucleotide variant,GRCh38
na,na,5,176829373,176829373,F12,Pathogenic,FACTOR XII (WASHINGTON D.C.),single nucleotide variant,GRCh37
na,na,5,177402372,177402372,F12,Pathogenic,FACTOR XII (WASHINGTON D.C.),single nucleotide variant,GRCh38
na,na,5,176830995,176830995,F12,Pathogenic,FACTOR XII (LOCARNO),single nucleotide variant,GRCh37
na,na,5,177403994,177403994,F12,Pathogenic,FACTOR XII (LOCARNO),single nucleotide variant,GRCh38
na,na,5,176829461,176829461,F12,Conflicting classifications of pathogenicity,Factor XII deficiency disease|F12-related disorder|not provided|Hereditary angioedema type 3,single nucleotide variant,GRCh37
na,na,5,177402460,177402460,F12,Conflicting classifications of pathogenicity,Factor XII deficiency disease|F12-related disorder|not provided|Hereditary angioedema type 3,single nucleotide variant,GRCh38
na,na,5,176836532,176836532,F12,Benign,F12 POLYMORPHISM|Hereditary angioedema type 3|not specified|Factor XII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,5,177409531,177409531,F12,Benign,F12 POLYMORPHISM|Hereditary angioedema type 3|not specified|Factor XII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,5,176833020,176833020,F12,Uncertain significance,Hereditary angioedema type 3|Factor XII deficiency disease,single nucleotide variant,GRCh37
na,na,5,177406019,177406019,F12,Uncertain significance,Hereditary angioedema type 3|Factor XII deficiency disease,single nucleotide variant,GRCh38
na,na,5,176831232,176831232,F12,Pathogenic,Hereditary angioedema type 3|not provided|Hereditary angioneurotic edema|Hereditary angioedema type 3;Factor XII deficiency disease,single nucleotide variant,GRCh37
na,na,5,177404231,177404231,F12,Pathogenic,Hereditary angioedema type 3|not provided|Hereditary angioneurotic edema|Hereditary angioedema type 3;Factor XII deficiency disease,single nucleotide variant,GRCh38
na,na,5,176831232,176831232,F12,Pathogenic,Hereditary angioedema type 3|Angioedema;Hyperbilirubinemia;Urticaria;Hypertensive disorder|Factor XII deficiency disease,single nucleotide variant,GRCh37
na,na,5,177404231,177404231,F12,Pathogenic,Hereditary angioedema type 3|Angioedema;Hyperbilirubinemia;Urticaria;Hypertensive disorder|Factor XII deficiency disease,single nucleotide variant,GRCh38
na,na,8,143956428,143956428,CYP11B1,Pathogenic/Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|Glucocorticoid-remediable aldosteronism;Deficiency of steroid 11-beta-monooxygenase|not provided|CYP11B1-related disorder,single nucleotide variant,GRCh37
na,na,8,142875012,142875012,CYP11B1,Pathogenic/Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|Glucocorticoid-remediable aldosteronism;Deficiency of steroid 11-beta-monooxygenase|not provided|CYP11B1-related disorder,single nucleotide variant,GRCh38
na,na,8,142876886,142915045,CYP11B1,Pathogenic,Glucocorticoid-remediable aldosteronism,Duplication,GRCh38
na,na,8,143957658,143957658,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism|not provided,single nucleotide variant,GRCh37
na,na,8,142876242,142876242,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism|not provided,single nucleotide variant,GRCh38
na,na,8,143957128,143957128,CYP11B1,Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|not provided,single nucleotide variant,GRCh37
na,na,8,142875712,142875712,CYP11B1,Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|not provided,single nucleotide variant,GRCh38
na,na,8,143960496,143960496,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,single nucleotide variant,GRCh37
na,na,8,142879080,142879080,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,single nucleotide variant,GRCh38
na,na,8,143958637,143958637,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,single nucleotide variant,GRCh37
na,na,8,142877221,142877221,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,single nucleotide variant,GRCh38
na,na,8,143957293,143957293,CYP11B1,Pathogenic/Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|not provided|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism,single nucleotide variant,GRCh37
na,na,8,142875877,142875877,CYP11B1,Pathogenic/Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism|not provided|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism,single nucleotide variant,GRCh38
na,na,8,143961106,143961106,CYP11B1,Pathogenic/Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Congenital adrenal hyperplasia|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism|not provided,single nucleotide variant,GRCh37
na,na,8,142879690,142879690,CYP11B1,Pathogenic/Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Congenital adrenal hyperplasia|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism|not provided,single nucleotide variant,GRCh38
na,na,8,143956369,143956369,CYP11B1,Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism,single nucleotide variant,GRCh37
na,na,8,142874953,142874953,CYP11B1,Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism,single nucleotide variant,GRCh38
na,na,8,142876396,142914704,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,Deletion,GRCh38
na,na,8,143958423,143958423,CYP11B1,Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism;Deficiency of steroid 11-beta-monooxygenase|Congenital adrenal hyperplasia,single nucleotide variant,GRCh37
na,na,8,142877007,142877007,CYP11B1,Likely pathogenic,Deficiency of steroid 11-beta-monooxygenase|Glucocorticoid-remediable aldosteronism;Deficiency of steroid 11-beta-monooxygenase|Congenital adrenal hyperplasia,single nucleotide variant,GRCh38
na,na,na,-1,-1,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,Deletion,na
na,na,8,143956502,143956502,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase|not provided|CYP11B1-related disorder|Glucocorticoid-remediable aldosteronism;Deficiency of steroid 11-beta-monooxygenase,single nucleotide variant,GRCh37
na,na,8,142875086,142875086,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase|not provided|CYP11B1-related disorder|Glucocorticoid-remediable aldosteronism;Deficiency of steroid 11-beta-monooxygenase,single nucleotide variant,GRCh38
na,na,8,143960562,143960562,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase|not provided|Congenital adrenal hyperplasia|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism,single nucleotide variant,GRCh37
na,na,8,142879146,142879146,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase|not provided|Congenital adrenal hyperplasia|Deficiency of steroid 11-beta-monooxygenase;Glucocorticoid-remediable aldosteronism,single nucleotide variant,GRCh38
na,na,8,143957146,143957146,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,single nucleotide variant,GRCh37
na,na,8,142875730,142875730,CYP11B1,Pathogenic,Deficiency of steroid 11-beta-monooxygenase,single nucleotide variant,GRCh38
na,na,17,74536228,74536228,PRCD,Uncertain significance,Retinitis pigmentosa 36|not provided,single nucleotide variant,GRCh37
na,na,17,76540146,76540146,PRCD,Uncertain significance,Retinitis pigmentosa 36|not provided,single nucleotide variant,GRCh38
na,na,12,57870155,57870155,ARHGAP9,Uncertain significance,"Coronary artery spasm 3, susceptibility to",single nucleotide variant,GRCh37
na,na,12,57476372,57476372,ARHGAP9,Uncertain significance,"Coronary artery spasm 3, susceptibility to",single nucleotide variant,GRCh38
na,na,20,948667,948667,RSPO4,Pathogenic,Anonychia,single nucleotide variant,GRCh37
na,na,20,968024,968024,RSPO4,Pathogenic,Anonychia,single nucleotide variant,GRCh38
na,na,20,947907,947907,RSPO4,Pathogenic,Anonychia,single nucleotide variant,GRCh37
na,na,20,967264,967264,RSPO4,Pathogenic,Anonychia,single nucleotide variant,GRCh38
na,na,20,947873,947873,RSPO4,Pathogenic,Anonychia,single nucleotide variant,GRCh37
na,na,20,967230,967230,RSPO4,Pathogenic,Anonychia,single nucleotide variant,GRCh38
na,na,20,948643,948643,RSPO4,Pathogenic,Anonychia,single nucleotide variant,GRCh37
na,na,20,968000,968000,RSPO4,Pathogenic,Anonychia,single nucleotide variant,GRCh38
na,na,20,948762,948763,RSPO4,Uncertain significance,Anonychia,Duplication,GRCh37
na,na,20,968119,968120,RSPO4,Uncertain significance,Anonychia,Duplication,GRCh38
na,na,5,68728353,68728353,MARVELD2,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 49,single nucleotide variant,GRCh37
na,na,5,69432526,69432526,MARVELD2,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 49,single nucleotide variant,GRCh38
na,na,5,68728503,68728506,MARVELD2,Pathogenic,Autosomal recessive nonsyndromic hearing loss 49,Deletion,GRCh37
na,na,5,69432676,69432679,MARVELD2,Pathogenic,Autosomal recessive nonsyndromic hearing loss 49,Deletion,GRCh38
na,na,5,68728915,68728915,MARVELD2,Pathogenic/Likely pathogenic,Rare genetic deafness|not provided|Ear malformation|Autosomal recessive nonsyndromic hearing loss 49,single nucleotide variant,GRCh37
na,na,5,69433088,69433088,MARVELD2,Pathogenic/Likely pathogenic,Rare genetic deafness|not provided|Ear malformation|Autosomal recessive nonsyndromic hearing loss 49,single nucleotide variant,GRCh38
na,na,6,107531687,107531687,PDSS2,Pathogenic,"Coenzyme Q10 deficiency, primary, 3",single nucleotide variant,GRCh37
na,na,6,107210483,107210483,PDSS2,Pathogenic,"Coenzyme Q10 deficiency, primary, 3",single nucleotide variant,GRCh38
na,na,6,107475878,107475878,PDSS2,Conflicting classifications of pathogenicity,"Coenzyme Q10 deficiency, primary, 3|Nephrotic syndrome|not provided|not specified",single nucleotide variant,GRCh37
na,na,6,107154674,107154674,PDSS2,Conflicting classifications of pathogenicity,"Coenzyme Q10 deficiency, primary, 3|Nephrotic syndrome|not provided|not specified",single nucleotide variant,GRCh38
na,na,10,82034395,82034395,MAT1A,Likely pathogenic,Hepatic methionine adenosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,10,80274639,80274639,MAT1A,Likely pathogenic,Hepatic methionine adenosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,10,82045273,82045273,MAT1A,Uncertain significance,Hepatic methionine adenosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,10,80285517,80285517,MAT1A,Uncertain significance,Hepatic methionine adenosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,10,82034291,82034291,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,10,80274535,80274535,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,10,82034810,82034810,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,10,80275054,80275054,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,10,82034897,82034898,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency,Duplication,GRCh37
na,na,10,80275141,80275142,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency,Duplication,GRCh38
na,na,10,82034317,82034318,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency,Microsatellite,GRCh37
na,na,10,80274561,80274562,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency,Microsatellite,GRCh38
na,na,10,82034933,82034933,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,10,80275177,80275177,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,10,82034934,82034934,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency|MAT1A-related disorder,single nucleotide variant,GRCh37
na,na,10,80275178,80275178,MAT1A,Pathogenic,Hepatic methionine adenosyltransferase deficiency|MAT1A-related disorder,single nucleotide variant,GRCh38
na,na,10,82034355,82034355,MAT1A,Conflicting classifications of pathogenicity,Hepatic methionine adenosyltransferase deficiency|not specified|not provided,single nucleotide variant,GRCh37
na,na,10,80274599,80274599,MAT1A,Conflicting classifications of pathogenicity,Hepatic methionine adenosyltransferase deficiency|not specified|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,GNAS;GNAS-AS1,Pathogenic,Pseudohypoparathyroidism type 1B,Deletion,na
na,na,5,167845791,167845791,WWC1,association,Memory quantitative trait locus,single nucleotide variant,GRCh37
na,na,5,168418786,168418786,WWC1,association,Memory quantitative trait locus,single nucleotide variant,GRCh38
na,na,7,23030679,23030679,HYCC1,Pathogenic,Hypomyelination and Congenital Cataract,single nucleotide variant,GRCh37
na,na,7,22991060,22991060,HYCC1,Pathogenic,Hypomyelination and Congenital Cataract,single nucleotide variant,GRCh38
na,na,7,23016959,23016959,HYCC1,Likely pathogenic,Hypomyelination and Congenital Cataract,single nucleotide variant,GRCh37
na,na,7,22977340,22977340,HYCC1,Likely pathogenic,Hypomyelination and Congenital Cataract,single nucleotide variant,GRCh38
na,na,7,23018063,23018063,HYCC1,Pathogenic,Hypomyelination and Congenital Cataract,single nucleotide variant,GRCh37
na,na,7,22978444,22978444,HYCC1,Pathogenic,Hypomyelination and Congenital Cataract,single nucleotide variant,GRCh38
na,na,1,17322876,17322876,ATP13A2,Pathogenic/Likely pathogenic,Kufor-Rakeb syndrome|Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78|not provided,single nucleotide variant,GRCh37
na,na,1,16996381,16996381,ATP13A2,Pathogenic/Likely pathogenic,Kufor-Rakeb syndrome|Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78|not provided,single nucleotide variant,GRCh38
na,na,1,17320218,17320219,ATP13A2,Pathogenic,Kufor-Rakeb syndrome,Duplication,GRCh37
na,na,1,16993723,16993724,ATP13A2,Pathogenic,Kufor-Rakeb syndrome,Duplication,GRCh38
na,na,1,17322503,17322503,ATP13A2,Pathogenic/Likely pathogenic,Kufor-Rakeb syndrome|Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78|See cases|Neurodegeneration with brain iron accumulation,single nucleotide variant,GRCh37
na,na,1,16996008,16996008,ATP13A2,Pathogenic/Likely pathogenic,Kufor-Rakeb syndrome|Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78|See cases|Neurodegeneration with brain iron accumulation,single nucleotide variant,GRCh38
na,na,20,18496339,18496339,SEC23B,Pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Congenital dyserythropoietic anemia, type II;Cowden syndrome 7|SEC23B-related disorder|See cases",single nucleotide variant,GRCh37
na,na,20,18515695,18515695,SEC23B,Pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Congenital dyserythropoietic anemia, type II;Cowden syndrome 7|SEC23B-related disorder|See cases",single nucleotide variant,GRCh38
na,na,20,18491519,18491519,SEC23B,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Congenital dyserythropoietic anemia, type II;Cowden syndrome 7|SEC23B-related disorder",single nucleotide variant,GRCh37
na,na,20,18510875,18510875,SEC23B,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Congenital dyserythropoietic anemia, type II;Cowden syndrome 7|SEC23B-related disorder",single nucleotide variant,GRCh38
na,na,20,18523739,18523739,SEC23B,Conflicting classifications of pathogenicity,"Congenital dyserythropoietic anemia, type II|not provided|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II",single nucleotide variant,GRCh37
na,na,20,18543095,18543095,SEC23B,Conflicting classifications of pathogenicity,"Congenital dyserythropoietic anemia, type II|not provided|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II",single nucleotide variant,GRCh38
na,na,20,18506532,18506532,SEC23B,Pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Congenital dyserythropoietic anemia, type II;Cowden syndrome 7",single nucleotide variant,GRCh37
na,na,20,18525888,18525888,SEC23B,Pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Congenital dyserythropoietic anemia, type II;Cowden syndrome 7",single nucleotide variant,GRCh38
na,na,20,18507152,18507152,SEC23B,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type II|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II|not provided",single nucleotide variant,GRCh37
na,na,20,18526508,18526508,SEC23B,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type II|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II|not provided",single nucleotide variant,GRCh38
na,na,20,18505624,18505624,SEC23B,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II",single nucleotide variant,GRCh37
na,na,20,18524980,18524980,SEC23B,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type II|not provided|Cowden syndrome 7;Congenital dyserythropoietic anemia, type II",single nucleotide variant,GRCh38
na,na,14,39536460,39536460,SEC23A,Pathogenic,Craniolenticulosutural dysplasia,single nucleotide variant,GRCh37
na,na,14,39067256,39067256,SEC23A,Pathogenic,Craniolenticulosutural dysplasia,single nucleotide variant,GRCh38
na,na,7,92730928,92730928,SAMD9,Pathogenic,Normophosphatemic familial tumoral calcinosis|not provided,single nucleotide variant,GRCh37
na,na,7,93101615,93101615,SAMD9,Pathogenic,Normophosphatemic familial tumoral calcinosis|not provided,single nucleotide variant,GRCh38
na,na,8,43014188,43014188,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-C;Retinitis pigmentosa 73|Inborn genetic diseases|not provided",single nucleotide variant,GRCh37
na,na,8,43159045,43159045,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-C;Retinitis pigmentosa 73|Inborn genetic diseases|not provided",single nucleotide variant,GRCh38
na,na,8,43047540,43047541,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C",Duplication,GRCh37
na,na,8,43192397,43192398,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C",Duplication,GRCh38
na,na,8,43028883,43028883,HGSNAT,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-C|not provided|Retinal dystrophy|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome|Retinitis pigmentosa 73",single nucleotide variant,GRCh37
na,na,8,43173740,43173740,HGSNAT,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-C|not provided|Retinal dystrophy|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome|Retinitis pigmentosa 73",single nucleotide variant,GRCh38
na,na,8,43033327,43033327,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C",single nucleotide variant,GRCh37
na,na,8,43178184,43178184,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C",single nucleotide variant,GRCh38
na,na,8,43048967,43048967,HGSNAT,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,8,43193824,43193824,HGSNAT,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,8,43016611,43016612,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|not provided|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C",Duplication,GRCh37
na,na,8,43161468,43161469,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|not provided|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C",Duplication,GRCh38
na,na,8,43014064,43014064,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis, MPS-III-C;Retinitis pigmentosa 73|Sanfilippo syndrome|not provided",single nucleotide variant,GRCh37
na,na,8,43158921,43158921,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis, MPS-III-C;Retinitis pigmentosa 73|Sanfilippo syndrome|not provided",single nucleotide variant,GRCh38
na,na,8,43037305,43037305,HGSNAT,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis|Sanfilippo syndrome|not provided|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,8,43182162,43182162,HGSNAT,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis|Sanfilippo syndrome|not provided|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,8,43052825,43052825,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|not provided|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C",single nucleotide variant,GRCh37
na,na,8,43197682,43197682,HGSNAT,Pathogenic,"Mucopolysaccharidosis, MPS-III-C|not provided|Retinitis pigmentosa 73;Mucopolysaccharidosis, MPS-III-C",single nucleotide variant,GRCh38
na,na,1,156028185,156028185,LAMTOR2,Uncertain significance,Primary immunodeficiency syndrome due to p14 deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,156058394,156058394,LAMTOR2,Uncertain significance,Primary immunodeficiency syndrome due to p14 deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,3770914,3770914,RAX2,Uncertain significance,Age related macular degeneration 6|not provided,single nucleotide variant,GRCh37
na,na,19,3770916,3770916,RAX2,Uncertain significance,Age related macular degeneration 6|not provided,single nucleotide variant,GRCh38
na,na,19,3770765,3770765,RAX2,Pathogenic,Cone-rod dystrophy 11,single nucleotide variant,GRCh37
na,na,19,3770767,3770767,RAX2,Pathogenic,Cone-rod dystrophy 11,single nucleotide variant,GRCh38
na,na,19,3770751,3770752,RAX2,Conflicting classifications of pathogenicity,Cone-rod dystrophy 11|not provided,Microsatellite,GRCh37
na,na,19,3770753,3770754,RAX2,Conflicting classifications of pathogenicity,Cone-rod dystrophy 11|not provided,Microsatellite,GRCh38
na,na,16,23646214,23646214,PALB2,Pathogenic/Likely pathogenic,"Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5",single nucleotide variant,GRCh37
na,na,16,23634893,23634893,PALB2,Pathogenic/Likely pathogenic,"Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 5",single nucleotide variant,GRCh38
na,na,16,23614792,23614792,PALB2,Pathogenic/Likely pathogenic,"Fanconi anemia complementation group N|not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Inherited breast cancer and ovarian cancer|PALB2-related disorder",single nucleotide variant,GRCh37
na,na,16,23603471,23603471,PALB2,Pathogenic/Likely pathogenic,"Fanconi anemia complementation group N|not provided|Pancreatic cancer, susceptibility to, 3|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 5|Inherited breast cancer and ovarian cancer|PALB2-related disorder",single nucleotide variant,GRCh38
na,na,16,23634324,23634324,PALB2,Pathogenic,"Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5",single nucleotide variant,GRCh37
na,na,16,23623003,23623003,PALB2,Pathogenic,"Fanconi anemia complementation group N|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Breast-ovarian cancer, familial, susceptibility to, 5",single nucleotide variant,GRCh38
na,na,1,43223453,43223453,P3H1,Pathogenic,Osteogenesis imperfecta type 8|not provided|Osteogenesis imperfecta|P3H1-related disorder,single nucleotide variant,GRCh37
na,na,1,42757782,42757782,P3H1,Pathogenic,Osteogenesis imperfecta type 8|not provided|Osteogenesis imperfecta|P3H1-related disorder,single nucleotide variant,GRCh38
na,na,1,43218207,43218207,P3H1,Pathogenic,Osteogenesis imperfecta type 8,single nucleotide variant,GRCh37
na,na,1,42752536,42752536,P3H1,Pathogenic,Osteogenesis imperfecta type 8,single nucleotide variant,GRCh38
na,na,1,43224933,43224933,P3H1,Pathogenic,Osteogenesis imperfecta type 8,Deletion,GRCh37
na,na,1,42759262,42759262,P3H1,Pathogenic,Osteogenesis imperfecta type 8,Deletion,GRCh38
na,na,1,43215921,43215921,P3H1,Pathogenic,Osteogenesis imperfecta type 8,single nucleotide variant,GRCh37
na,na,1,42750250,42750250,P3H1,Pathogenic,Osteogenesis imperfecta type 8,single nucleotide variant,GRCh38
na,na,1,43218315,43218316,P3H1,Pathogenic,Osteogenesis imperfecta type 8,Indel,GRCh37
na,na,1,42752644,42752645,P3H1,Pathogenic,Osteogenesis imperfecta type 8,Indel,GRCh38
na,na,1,43221287,43221287,P3H1,Pathogenic,Osteogenesis imperfecta type 8|not provided,single nucleotide variant,GRCh37
na,na,1,42755616,42755616,P3H1,Pathogenic,Osteogenesis imperfecta type 8|not provided,single nucleotide variant,GRCh38
na,na,1,43212925,43212925,P3H1,Pathogenic/Likely pathogenic,Osteogenesis imperfecta type 8|not provided,single nucleotide variant,GRCh37
na,na,1,42747254,42747254,P3H1,Pathogenic/Likely pathogenic,Osteogenesis imperfecta type 8|not provided,single nucleotide variant,GRCh38
na,na,11,65487856,65487856,RNASEH2C,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 3|not provided|Abnormality of the nervous system|Aicardi Goutieres syndrome,single nucleotide variant,GRCh37
na,na,11,65720385,65720385,RNASEH2C,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 3|not provided|Abnormality of the nervous system|Aicardi Goutieres syndrome,single nucleotide variant,GRCh38
na,na,11,65487556,65487556,RNASEH2C,Uncertain significance,Aicardi-Goutieres syndrome 3|not provided|not specified,single nucleotide variant,GRCh37
na,na,11,65720085,65720085,RNASEH2C,Uncertain significance,Aicardi-Goutieres syndrome 3|not provided|not specified,single nucleotide variant,GRCh38
na,na,13,51519581,51519581,RNASEH2B,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 2|Aicardi Goutieres syndrome|not provided|Cerebral palsy|Abnormality of the nervous system|Autism spectrum disorder|RNASEH2B-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,13,50945445,50945445,RNASEH2B,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 2|Aicardi Goutieres syndrome|not provided|Cerebral palsy|Abnormality of the nervous system|Autism spectrum disorder|RNASEH2B-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,13,51519606,51519606,RNASEH2B,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 2|not provided,single nucleotide variant,GRCh37
na,na,13,50945470,50945470,RNASEH2B,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 2|not provided,single nucleotide variant,GRCh38
na,na,13,31843415,31843415,B3GLCT,Pathogenic,Peters plus syndrome|not provided|B3GLCT-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,13,31269278,31269278,B3GLCT,Pathogenic,Peters plus syndrome|not provided|B3GLCT-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,13,31821241,31821241,B3GLCT,Pathogenic,Peters plus syndrome,single nucleotide variant,GRCh37
na,na,13,31247104,31247104,B3GLCT,Pathogenic,Peters plus syndrome,single nucleotide variant,GRCh38
na,na,13,31803389,31803390,B3GLCT,Pathogenic,Peters plus syndrome,Duplication,GRCh37
na,na,13,31229252,31229253,B3GLCT,Pathogenic,Peters plus syndrome,Duplication,GRCh38
na,na,13,31891816,31891816,B3GLCT,Pathogenic,Peters plus syndrome,single nucleotide variant,GRCh37
na,na,13,31317679,31317679,B3GLCT,Pathogenic,Peters plus syndrome,single nucleotide variant,GRCh38
na,na,4,102751076,102751076,BANK1,Uncertain significance,Variant of unknown significance,single nucleotide variant,GRCh37
na,na,4,101829919,101829919,BANK1,Uncertain significance,Variant of unknown significance,single nucleotide variant,GRCh38
na,na,9,101569983,101569983,GALNT12,Uncertain significance,"Colorectal cancer, susceptibility to, 1|not provided|not specified",single nucleotide variant,GRCh37
na,na,9,98807701,98807701,GALNT12,Uncertain significance,"Colorectal cancer, susceptibility to, 1|not provided|not specified",single nucleotide variant,GRCh38
na,na,9,101608272,101608272,GALNT12,Uncertain significance,"Colorectal cancer, susceptibility to, 1|not specified|not provided",single nucleotide variant,GRCh37
na,na,9,98845990,98845990,GALNT12,Uncertain significance,"Colorectal cancer, susceptibility to, 1|not specified|not provided",single nucleotide variant,GRCh38
na,na,9,101599403,101599403,GALNT12,Uncertain significance,"Colorectal cancer, susceptibility to, 1|not provided|not specified",single nucleotide variant,GRCh37
na,na,9,98837121,98837121,GALNT12,Uncertain significance,"Colorectal cancer, susceptibility to, 1|not provided|not specified",single nucleotide variant,GRCh38
na,na,4,3494833,3494834,DOK7,Pathogenic,Congenital myasthenic syndrome 10|not provided|Congenital myasthenic syndrome|Inborn genetic diseases|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 3|See cases|Fetal akinesia deformation sequence 3|DOK7-related disorder,Duplication,GRCh37
na,na,4,3493106,3493107,DOK7,Pathogenic,Congenital myasthenic syndrome 10|not provided|Congenital myasthenic syndrome|Inborn genetic diseases|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 3|See cases|Fetal akinesia deformation sequence 3|DOK7-related disorder,Duplication,GRCh38
na,na,4,3494969,3494970,DOK7,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 10|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome|not provided|Rett syndrome|Fetal akinesia deformation sequence 3;Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 3|DOK7-related disorder,Duplication,GRCh37
na,na,4,3493242,3493243,DOK7,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 10|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome|not provided|Rett syndrome|Fetal akinesia deformation sequence 3;Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 3|DOK7-related disorder,Duplication,GRCh38
na,na,4,3487279,3487282,DOK7,Pathogenic,Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 10,Deletion,GRCh37
na,na,4,3485552,3485555,DOK7,Pathogenic,Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 10,Deletion,GRCh38
na,na,4,3495043,3495044,DOK7,Pathogenic,Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 10|not provided|Fetal akinesia deformation sequence 3|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 3,Microsatellite,GRCh37
na,na,4,3493316,3493317,DOK7,Pathogenic,Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 10|not provided|Fetal akinesia deformation sequence 3|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 3,Microsatellite,GRCh38
na,na,4,3494851,3494852,DOK7,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 10|not provided|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 3|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 3,Duplication,GRCh37
na,na,4,3493124,3493125,DOK7,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 10|not provided|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 3|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 3,Duplication,GRCh38
na,na,4,3487272,3487272,DOK7,Likely pathogenic,Congenital myasthenic syndrome 10|not provided,single nucleotide variant,GRCh37
na,na,4,3485545,3485545,DOK7,Likely pathogenic,Congenital myasthenic syndrome 10|not provided,single nucleotide variant,GRCh38
na,na,4,3487334,3487334,DOK7,Pathogenic,Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 10|not provided|Fetal akinesia deformation sequence 3|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 3,single nucleotide variant,GRCh37
na,na,4,3485607,3485607,DOK7,Pathogenic,Congenital myasthenic syndrome 10|Fetal akinesia deformation sequence 1;Congenital myasthenic syndrome 10|not provided|Fetal akinesia deformation sequence 3|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 3,single nucleotide variant,GRCh38
na,na,4,3465232,3465232,DOK7,Pathogenic,Congenital myasthenic syndrome 10,single nucleotide variant,GRCh37
na,na,4,3463505,3463505,DOK7,Pathogenic,Congenital myasthenic syndrome 10,single nucleotide variant,GRCh38
na,na,4,3495085,3495086,DOK7,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 10|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 1|not provided|Fetal akinesia deformation sequence 3|See cases|Congenital myasthenic syndrome,Duplication,GRCh37
na,na,4,3493358,3493359,DOK7,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 10|Congenital myasthenic syndrome 10;Fetal akinesia deformation sequence 1|not provided|Fetal akinesia deformation sequence 3|See cases|Congenital myasthenic syndrome,Duplication,GRCh38
na,na,12,122064924,122064924,ORAI1,Pathogenic,Combined immunodeficiency due to ORAI1 deficiency,single nucleotide variant,GRCh37
na,na,12,121627018,121627018,ORAI1,Pathogenic,Combined immunodeficiency due to ORAI1 deficiency,single nucleotide variant,GRCh38
na,na,1,27121547,27121547,PIGV,Pathogenic/Likely pathogenic,Hyperphosphatasia with intellectual disability syndrome 1|Inborn genetic diseases|not provided|Hyperphosphatasia-intellectual disability syndrome|PIGV-related disorder,single nucleotide variant,GRCh37
na,na,1,26795056,26795056,PIGV,Pathogenic/Likely pathogenic,Hyperphosphatasia with intellectual disability syndrome 1|Inborn genetic diseases|not provided|Hyperphosphatasia-intellectual disability syndrome|PIGV-related disorder,single nucleotide variant,GRCh38
na,na,1,27121679,27121679,PIGV,Pathogenic,Hyperphosphatasia with intellectual disability syndrome 1,single nucleotide variant,GRCh37
na,na,1,26795188,26795188,PIGV,Pathogenic,Hyperphosphatasia with intellectual disability syndrome 1,single nucleotide variant,GRCh38
na,na,1,27121291,27121291,PIGV,Pathogenic,Hyperphosphatasia with intellectual disability syndrome 1,single nucleotide variant,GRCh37
na,na,1,26794800,26794800,PIGV,Pathogenic,Hyperphosphatasia with intellectual disability syndrome 1,single nucleotide variant,GRCh38
na,na,1,27121547,27121547,PIGV,Pathogenic,Hyperphosphatasia with intellectual disability syndrome 1,single nucleotide variant,GRCh37
na,na,1,26795056,26795056,PIGV,Pathogenic,Hyperphosphatasia with intellectual disability syndrome 1,single nucleotide variant,GRCh38
na,na,1,160001799,160001799,PIGM,Pathogenic,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,single nucleotide variant,GRCh37
na,na,1,160032009,160032009,PIGM,Pathogenic,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,single nucleotide variant,GRCh38
na,na,10,99509251,99509251,ZFYVE27,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 33|not specified|Spastic tetraparesis|Spastic paraplegia|not provided,single nucleotide variant,GRCh37
na,na,10,97749494,97749494,ZFYVE27,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 33|not specified|Spastic tetraparesis|Spastic paraplegia|not provided,single nucleotide variant,GRCh38
na,na,22,46731689,46731689,TRMU,Benign/Likely benign,"Deafness, mitochondrial, modifier of|not specified|not provided|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins;Aminoglycoside-induced deafness",single nucleotide variant,GRCh37
na,na,22,46335792,46335792,TRMU,Benign/Likely benign,"Deafness, mitochondrial, modifier of|not specified|not provided|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins;Aminoglycoside-induced deafness",single nucleotide variant,GRCh38
na,na,22,46733822,46733822,TRMU,Pathogenic,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins|not provided|TRMU-related disorder|Aminoglycoside-induced deafness|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins;Aminoglycoside-induced deafness,single nucleotide variant,GRCh37
na,na,22,46337925,46337925,TRMU,Pathogenic,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins|not provided|TRMU-related disorder|Aminoglycoside-induced deafness|Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins;Aminoglycoside-induced deafness,single nucleotide variant,GRCh38
na,na,22,46749706,46749706,TRMU,Pathogenic,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,single nucleotide variant,GRCh37
na,na,22,46353809,46353809,TRMU,Pathogenic,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,single nucleotide variant,GRCh38
na,na,22,46731663,46731663,TRMU,Pathogenic,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,single nucleotide variant,GRCh37
na,na,22,46335766,46335766,TRMU,Pathogenic,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,single nucleotide variant,GRCh38
na,na,17,80790274,80790275,ZNF750,Pathogenic,Seborrhea-like dermatitis with psoriasiform elements,Duplication,GRCh37
na,na,17,82832398,82832399,ZNF750,Pathogenic,Seborrhea-like dermatitis with psoriasiform elements,Duplication,GRCh38
na,na,20,19956394,19956394,RIN2,Pathogenic,RIN2 syndrome,Deletion,GRCh37
na,na,20,19975750,19975750,RIN2,Pathogenic,RIN2 syndrome,Deletion,GRCh38
na,na,2,179320876,179320876,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59|not provided|Ear malformation,single nucleotide variant,GRCh37
na,na,2,178456149,178456149,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59|not provided|Ear malformation,single nucleotide variant,GRCh38
na,na,2,179318297,179318297,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,single nucleotide variant,GRCh37
na,na,2,178453570,178453570,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,single nucleotide variant,GRCh38
na,na,2,179318248,179318249,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,Duplication,GRCh37
na,na,2,178453521,178453522,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,Duplication,GRCh38
na,na,2,179320828,179320828,PJVK,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 59|Rare genetic deafness|not provided,single nucleotide variant,GRCh37
na,na,2,178456101,178456101,PJVK,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 59|Rare genetic deafness|not provided,single nucleotide variant,GRCh38
na,na,2,179325131,179325131,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,Deletion,GRCh37
na,na,2,178460404,178460404,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,Deletion,GRCh38
na,na,2,179325930,179325930,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,Deletion,GRCh37
na,na,2,178461203,178461203,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,Deletion,GRCh38
na,na,2,179318257,179318257,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,Deletion,GRCh37
na,na,2,178453530,178453530,PJVK,Pathogenic,Autosomal recessive nonsyndromic hearing loss 59,Deletion,GRCh38
na,na,20,3209330,3209330,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea|not provided,single nucleotide variant,GRCh37
na,na,20,3228684,3228684,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea|not provided,single nucleotide variant,GRCh38
na,na,20,3210904,3210904,SLC4A11,Pathogenic/Likely pathogenic,Congenital hereditary endothelial dystrophy of cornea|not provided|Corneal dystrophy-perceptive deafness syndrome,single nucleotide variant,GRCh37
na,na,20,3230258,3230258,SLC4A11,Pathogenic/Likely pathogenic,Congenital hereditary endothelial dystrophy of cornea|not provided|Corneal dystrophy-perceptive deafness syndrome,single nucleotide variant,GRCh38
na,na,20,3211233,3211233,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea,single nucleotide variant,GRCh37
na,na,20,3230587,3230587,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea,single nucleotide variant,GRCh38
na,na,20,3210076,3210076,SLC4A11,Pathogenic,"Congenital hereditary endothelial dystrophy of cornea|not provided|Corneal dystrophy-perceptive deafness syndrome|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh37
na,na,20,3229430,3229430,SLC4A11,Pathogenic,"Congenital hereditary endothelial dystrophy of cornea|not provided|Corneal dystrophy-perceptive deafness syndrome|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh38
na,na,20,3214944,3214947,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea,Deletion,GRCh37
na,na,20,3234298,3234301,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea,Deletion,GRCh38
na,na,20,3208906,3208906,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea|not provided,single nucleotide variant,GRCh37
na,na,20,3228260,3228260,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea|not provided,single nucleotide variant,GRCh38
na,na,20,3209663,3209673,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea,Indel,GRCh37
na,na,20,3229017,3229027,SLC4A11,Pathogenic,Congenital hereditary endothelial dystrophy of cornea,Indel,GRCh38
na,na,20,3208905,3208905,SLC4A11,Pathogenic/Likely pathogenic,"Congenital hereditary endothelial dystrophy of cornea|not provided|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh37
na,na,20,3228259,3228259,SLC4A11,Pathogenic/Likely pathogenic,"Congenital hereditary endothelial dystrophy of cornea|not provided|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh38
na,na,20,3214820,3214827,SLC4A11,Pathogenic,Corneal dystrophy-perceptive deafness syndrome|not provided|Congenital hereditary endothelial dystrophy of cornea,Microsatellite,GRCh37
na,na,20,3234174,3234181,SLC4A11,Pathogenic,Corneal dystrophy-perceptive deafness syndrome|not provided|Congenital hereditary endothelial dystrophy of cornea,Microsatellite,GRCh38
na,na,20,3211243,3211246,SLC4A11,Pathogenic,Corneal dystrophy-perceptive deafness syndrome,Indel,GRCh37
na,na,20,3230597,3230600,SLC4A11,Pathogenic,Corneal dystrophy-perceptive deafness syndrome,Indel,GRCh38
na,na,20,3211161,3211161,SLC4A11,Pathogenic,Corneal dystrophy-perceptive deafness syndrome,single nucleotide variant,GRCh37
na,na,20,3230515,3230515,SLC4A11,Pathogenic,Corneal dystrophy-perceptive deafness syndrome,single nucleotide variant,GRCh38
na,na,20,3208945,3208945,SLC4A11,Likely pathogenic,"Corneal dystrophy-perceptive deafness syndrome|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh37
na,na,20,3228299,3228299,SLC4A11,Likely pathogenic,"Corneal dystrophy-perceptive deafness syndrome|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh38
na,na,20,3208983,3208983,SLC4A11,Pathogenic/Likely pathogenic,"Corneal dystrophy-perceptive deafness syndrome|not provided|Congenital hereditary endothelial dystrophy of cornea;Corneal dystrophy, Fuchs endothelial, 4;Corneal dystrophy-perceptive deafness syndrome|Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh37
na,na,20,3228337,3228337,SLC4A11,Pathogenic/Likely pathogenic,"Corneal dystrophy-perceptive deafness syndrome|not provided|Congenital hereditary endothelial dystrophy of cornea;Corneal dystrophy, Fuchs endothelial, 4;Corneal dystrophy-perceptive deafness syndrome|Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh38
na,na,na,-1,-1,SLC4A11,Pathogenic,Corneal dystrophy-perceptive deafness syndrome,Deletion,na
na,na,20,3214583,3214583,SLC4A11,Pathogenic,Corneal dystrophy-perceptive deafness syndrome,single nucleotide variant,GRCh37
na,na,20,3233937,3233937,SLC4A11,Pathogenic,Corneal dystrophy-perceptive deafness syndrome,single nucleotide variant,GRCh38
na,na,20,3209598,3209598,SLC4A11,Pathogenic,"Corneal dystrophy, Fuchs endothelial, 4",single nucleotide variant,GRCh37
na,na,20,3228952,3228952,SLC4A11,Pathogenic,"Corneal dystrophy, Fuchs endothelial, 4",single nucleotide variant,GRCh38
na,na,20,3209333,3209333,SLC4A11,Conflicting classifications of pathogenicity,"Corneal dystrophy, Fuchs endothelial, 4|not specified|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh37
na,na,20,3228687,3228687,SLC4A11,Conflicting classifications of pathogenicity,"Corneal dystrophy, Fuchs endothelial, 4|not specified|Corneal dystrophy-perceptive deafness syndrome;Corneal dystrophy, Fuchs endothelial, 4;Congenital hereditary endothelial dystrophy of cornea",single nucleotide variant,GRCh38
na,na,20,3218226,3218227,SLC4A11,Pathogenic,"Corneal dystrophy, Fuchs endothelial, 4|not provided",Microsatellite,GRCh37
na,na,20,3237580,3237581,SLC4A11,Pathogenic,"Corneal dystrophy, Fuchs endothelial, 4|not provided",Microsatellite,GRCh38
na,na,20,3211600,3211600,SLC4A11,Uncertain significance,"Corneal dystrophy, Fuchs endothelial, 4|not specified|not provided",single nucleotide variant,GRCh37
na,na,20,3230954,3230954,SLC4A11,Uncertain significance,"Corneal dystrophy, Fuchs endothelial, 4|not specified|not provided",single nucleotide variant,GRCh38
na,na,19,50334047,50334047,MED25,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2B2|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2|Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome|not specified|Tip-toe gait|MED25-related disorder,single nucleotide variant,GRCh37
na,na,19,49830790,49830790,MED25,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2B2|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2|Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome|not specified|Tip-toe gait|MED25-related disorder,single nucleotide variant,GRCh38
na,na,9,3856143,3856144,GLIS3,Pathogenic,Neonatal diabetes mellitus with congenital hypothyroidism,Duplication,GRCh37
na,na,9,3856143,3856144,GLIS3,Pathogenic,Neonatal diabetes mellitus with congenital hypothyroidism,Duplication,GRCh38
na,na,1,32669645,32669645,CCDC28B,Uncertain significance,"Bardet-Biedl syndrome 1, modifier of|Bardet-Biedl syndrome|CCDC28B-related disorder",single nucleotide variant,GRCh37
na,na,1,32204044,32204044,CCDC28B,Uncertain significance,"Bardet-Biedl syndrome 1, modifier of|Bardet-Biedl syndrome|CCDC28B-related disorder",single nucleotide variant,GRCh38
na,na,5,10256175,10256175,CCT5,Uncertain significance,Hereditary sensory and autonomic neuropathy with spastic paraplegia|not provided|CCT5-related disorder,single nucleotide variant,GRCh37
na,na,5,10256063,10256063,CCT5,Uncertain significance,Hereditary sensory and autonomic neuropathy with spastic paraplegia|not provided|CCT5-related disorder,single nucleotide variant,GRCh38
na,na,12,76741493,76741494,BBS10,Pathogenic,"Bardet-Biedl syndrome 10|Bardet-Biedl syndrome|Bardet-biedl syndrome 6/10, digenic|not provided|Retinitis pigmentosa|Inborn genetic diseases|Bardet-Biedl syndrome 1|Retinal dystrophy|BBS10-related disorder",Duplication,GRCh37
na,na,12,76347713,76347714,BBS10,Pathogenic,"Bardet-Biedl syndrome 10|Bardet-Biedl syndrome|Bardet-biedl syndrome 6/10, digenic|not provided|Retinitis pigmentosa|Inborn genetic diseases|Bardet-Biedl syndrome 1|Retinal dystrophy|BBS10-related disorder",Duplication,GRCh38
na,na,12,76742038,76742038,BBS10,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 10,single nucleotide variant,GRCh37
na,na,12,76348258,76348258,BBS10,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 10,single nucleotide variant,GRCh38
na,na,12,76740834,76740834,BBS10,Pathogenic,Bardet-Biedl syndrome 10|not provided|Bardet-Biedl syndrome|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,12,76347054,76347054,BBS10,Pathogenic,Bardet-Biedl syndrome 10|not provided|Bardet-Biedl syndrome|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,12,76742107,76742107,BBS10,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 10,single nucleotide variant,GRCh37
na,na,12,76348327,76348327,BBS10,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 10,single nucleotide variant,GRCh38
na,na,12,88471040,88471040,CEP290,Pathogenic/Likely pathogenic,"Joubert syndrome 5|not provided|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Meckel-Gruber syndrome|Retinal dystrophy|Retinitis pigmentosa|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5|Meckel syndrome, type 6|Leber congenital amaurosis|Meckel syndrome, type 4|Senior-Loken syndrome 6;Joubert syndrome 5|COG7 congenital disorder of glycosylation|Abnormality of the nervous system|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Joubert syndrome 5|Leber congenital amaurosis 10|CEP290-related disorder",single nucleotide variant,GRCh37
na,na,12,88077263,88077263,CEP290,Pathogenic/Likely pathogenic,"Joubert syndrome 5|not provided|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Meckel-Gruber syndrome|Retinal dystrophy|Retinitis pigmentosa|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5|Meckel syndrome, type 6|Leber congenital amaurosis|Meckel syndrome, type 4|Senior-Loken syndrome 6;Joubert syndrome 5|COG7 congenital disorder of glycosylation|Abnormality of the nervous system|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Joubert syndrome 5|Leber congenital amaurosis 10|CEP290-related disorder",single nucleotide variant,GRCh38
na,na,12,88535064,88535064,CEP290,Pathogenic,Joubert syndrome 5|not provided|Leber congenital amaurosis|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Nephronophthisis,single nucleotide variant,GRCh37
na,na,12,88141287,88141287,CEP290,Pathogenic,Joubert syndrome 5|not provided|Leber congenital amaurosis|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Nephronophthisis,single nucleotide variant,GRCh38
na,na,12,88505124,88505128,CEP290,Pathogenic,Senior-Loken syndrome 6,Deletion,GRCh37
na,na,12,88111347,88111351,CEP290,Pathogenic,Senior-Loken syndrome 6,Deletion,GRCh38
na,na,12,88494960,88494960,CEP290,Pathogenic/Likely pathogenic,"Leber congenital amaurosis 10|not provided|Retinitis pigmentosa|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 4;Leber congenital amaurosis 10;Joubert syndrome 5;Bardet-Biedl syndrome 14;Senior-Loken syndrome 6|Joubert syndrome 1|Retinal dystrophy|Intellectual disability|Joubert syndrome 5|CEP290-related disorder|Leber congenital amaurosis|Bardet-Biedl syndrome 14",single nucleotide variant,GRCh37
na,na,12,88101183,88101183,CEP290,Pathogenic/Likely pathogenic,"Leber congenital amaurosis 10|not provided|Retinitis pigmentosa|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 4;Leber congenital amaurosis 10;Joubert syndrome 5;Bardet-Biedl syndrome 14;Senior-Loken syndrome 6|Joubert syndrome 1|Retinal dystrophy|Intellectual disability|Joubert syndrome 5|CEP290-related disorder|Leber congenital amaurosis|Bardet-Biedl syndrome 14",single nucleotide variant,GRCh38
na,na,12,88505097,88505097,CEP290,Pathogenic,Leber congenital amaurosis 10|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Bardet-Biedl syndrome 14,single nucleotide variant,GRCh37
na,na,12,88111320,88111320,CEP290,Pathogenic,Leber congenital amaurosis 10|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Bardet-Biedl syndrome 14,single nucleotide variant,GRCh38
na,na,12,88477713,88477713,CEP290,Pathogenic,"Joubert syndrome 5|Leber congenital amaurosis 10|not provided|not specified|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5|Retinal dystrophy|Blindness|Nystagmus;Central hypotonia;Molar tooth sign on MRI|Senior-Loken syndrome 6|Leber congenital amaurosis|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|CEP290-related ciliopathy|Bardet-Biedl syndrome 14|CEP290-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,12,88083936,88083936,CEP290,Pathogenic,"Joubert syndrome 5|Leber congenital amaurosis 10|not provided|not specified|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5|Retinal dystrophy|Blindness|Nystagmus;Central hypotonia;Molar tooth sign on MRI|Senior-Loken syndrome 6|Leber congenital amaurosis|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|CEP290-related ciliopathy|Bardet-Biedl syndrome 14|CEP290-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,12,88524101,88524101,CEP290,Pathogenic,"Meckel syndrome, type 4|Polycystic kidney disease;Severe hydrocephalus;Encephalocele|Leber congenital amaurosis|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Leber congenital amaurosis 10|not provided|Retinal dystrophy|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5|Bardet-Biedl syndrome 14|CEP290-related disorder",single nucleotide variant,GRCh37
na,na,12,88130324,88130324,CEP290,Pathogenic,"Meckel syndrome, type 4|Polycystic kidney disease;Severe hydrocephalus;Encephalocele|Leber congenital amaurosis|Nephronophthisis;Meckel-Gruber syndrome;Joubert syndrome|Leber congenital amaurosis 10|not provided|Retinal dystrophy|Bardet-Biedl syndrome 14;Meckel syndrome, type 4;Senior-Loken syndrome 6;Leber congenital amaurosis 10;Joubert syndrome 5|Bardet-Biedl syndrome 14|CEP290-related disorder",single nucleotide variant,GRCh38
na,na,12,88514869,88514873,CEP290,Pathogenic,Leber congenital amaurosis 10,Deletion,GRCh37
na,na,12,88121092,88121096,CEP290,Pathogenic,Leber congenital amaurosis 10,Deletion,GRCh38
na,na,12,88471004,88471004,CEP290,Pathogenic/Likely pathogenic,"Bardet-Biedl syndrome 14|Joubert syndrome 5|Meckel syndrome, type 6|Leber congenital amaurosis 10",single nucleotide variant,GRCh37
na,na,12,88077227,88077227,CEP290,Pathogenic/Likely pathogenic,"Bardet-Biedl syndrome 14|Joubert syndrome 5|Meckel syndrome, type 6|Leber congenital amaurosis 10",single nucleotide variant,GRCh38
na,na,1,116206792,116206792,VANGL1,Uncertain significance,Caudal regression sequence|not provided,single nucleotide variant,GRCh37
na,na,1,115664171,115664171,VANGL1,Uncertain significance,Caudal regression sequence|not provided,single nucleotide variant,GRCh38
na,na,1,116224993,116224993,VANGL1,Likely pathogenic,"Neural tube defects, susceptibility to|not provided",single nucleotide variant,GRCh37
na,na,1,115682372,115682372,VANGL1,Likely pathogenic,"Neural tube defects, susceptibility to|not provided",single nucleotide variant,GRCh38
na,na,1,116226601,116226601,VANGL1,risk factor,"Neural tube defects, susceptibility to",single nucleotide variant,GRCh37
na,na,1,115683980,115683980,VANGL1,risk factor,"Neural tube defects, susceptibility to",single nucleotide variant,GRCh38
na,na,1,150529450,150529450,ADAMTSL4,Pathogenic,"Ectopia lentis 2, isolated, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,1,150556974,150556974,ADAMTSL4,Pathogenic,"Ectopia lentis 2, isolated, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,11,124517292,124517292,SIAE,Uncertain significance,"Autoimmune disease, susceptibility to, 6|not provided",single nucleotide variant,GRCh37
na,na,11,124647396,124647396,SIAE,Uncertain significance,"Autoimmune disease, susceptibility to, 6|not provided",single nucleotide variant,GRCh38
na,na,11,124519650,124519650,SIAE,Uncertain significance,"Autoimmune disease, susceptibility to, 6|not provided|SIAE-related disorder|not specified",single nucleotide variant,GRCh37
na,na,11,124649754,124649754,SIAE,Uncertain significance,"Autoimmune disease, susceptibility to, 6|not provided|SIAE-related disorder|not specified",single nucleotide variant,GRCh38
na,na,11,124530664,124530664,SIAE,Benign,"Autoimmune disease, susceptibility to, 6|not provided",single nucleotide variant,GRCh37
na,na,11,124660768,124660768,SIAE,Benign,"Autoimmune disease, susceptibility to, 6|not provided",single nucleotide variant,GRCh38
na,na,11,124508547,124508547,SIAE,Uncertain significance,"Autoimmune disease, susceptibility to, 6|not provided|not specified",single nucleotide variant,GRCh37
na,na,11,124638651,124638651,SIAE,Uncertain significance,"Autoimmune disease, susceptibility to, 6|not provided|not specified",single nucleotide variant,GRCh38
na,na,19,14030327,14033916,CC2D1A,Pathogenic,"Intellectual disability, autosomal recessive 3",Deletion,GRCh37
na,na,19,13919514,13923103,CC2D1A,Pathogenic,"Intellectual disability, autosomal recessive 3",Deletion,GRCh38
na,na,6,24528395,24528395,ALDH5A1,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,6,24528167,24528167,ALDH5A1,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,6,24512097,24512097,ALDH5A1,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,6,24511869,24511869,ALDH5A1,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,6,24505099,24505099,ALDH5A1,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,6,24504871,24504871,ALDH5A1,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,6,24528285,24528285,ALDH5A1,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,6,24528057,24528057,ALDH5A1,Pathogenic,Succinate-semialdehyde dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,6,24528277,24528277,ALDH5A1,Pathogenic/Likely pathogenic,Succinate-semialdehyde dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,6,24528049,24528049,ALDH5A1,Pathogenic/Likely pathogenic,Succinate-semialdehyde dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,6,24521492,24523946,ALDH5A1,Likely pathogenic,Succinate-semialdehyde dehydrogenase deficiency,Deletion,GRCh37
na,na,6,24521264,24523718,ALDH5A1,Likely pathogenic,Succinate-semialdehyde dehydrogenase deficiency,Deletion,GRCh38
na,na,1,43205676,43205676,CLDN19,Pathogenic/Likely pathogenic,Renal hypomagnesemia 5 with ocular involvement|not provided|CLDN19-related disorder,single nucleotide variant,GRCh37
na,na,1,42740005,42740005,CLDN19,Pathogenic/Likely pathogenic,Renal hypomagnesemia 5 with ocular involvement|not provided|CLDN19-related disorder,single nucleotide variant,GRCh38
na,na,1,43205566,43205566,CLDN19,Pathogenic,Renal hypomagnesemia 5 with ocular involvement,single nucleotide variant,GRCh37
na,na,1,42739895,42739895,CLDN19,Pathogenic,Renal hypomagnesemia 5 with ocular involvement,single nucleotide variant,GRCh38
na,na,1,43204211,43204211,CLDN19,Pathogenic,Renal hypomagnesemia 5 with ocular involvement,single nucleotide variant,GRCh37
na,na,1,42738540,42738540,CLDN19,Pathogenic,Renal hypomagnesemia 5 with ocular involvement,single nucleotide variant,GRCh38
na,na,2,63131731,63131731,EHBP1,Uncertain significance,"Prostate cancer, hereditary, 12|EHBP1-related disorder",single nucleotide variant,GRCh37
na,na,2,62904596,62904596,EHBP1,Uncertain significance,"Prostate cancer, hereditary, 12|EHBP1-related disorder",single nucleotide variant,GRCh38
na,na,8,94770780,94770781,TMEM67,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",Deletion,GRCh37
na,na,8,93758552,93758553,TMEM67,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",Deletion,GRCh38
na,na,8,94777870,94777870,TMEM67,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",Deletion,GRCh37
na,na,8,93765642,93765642,TMEM67,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",Deletion,GRCh38
na,na,8,94793100,94793100,TMEM67,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",single nucleotide variant,GRCh37
na,na,8,93780872,93780872,TMEM67,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",single nucleotide variant,GRCh38
na,na,8,94815905,94815916,TMEM67,Pathogenic,Joubert syndrome 6,Indel,GRCh37
na,na,8,93803677,93803688,TMEM67,Pathogenic,Joubert syndrome 6,Indel,GRCh38
na,na,8,94794684,94794684,TMEM67,Pathogenic,"Meckel syndrome, type 3",single nucleotide variant,GRCh37
na,na,8,93782456,93782456,TMEM67,Pathogenic,"Meckel syndrome, type 3",single nucleotide variant,GRCh38
na,na,8,94803548,94803548,TMEM67,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",single nucleotide variant,GRCh37
na,na,8,93791320,93791320,TMEM67,Pathogenic/Likely pathogenic,"Meckel syndrome, type 3",single nucleotide variant,GRCh38
na,na,8,94803510,94803510,TMEM67,Pathogenic/Likely pathogenic,Joubert syndrome 6|COACH syndrome 1|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome and related disorders|6 conditions,single nucleotide variant,GRCh37
na,na,8,93791282,93791282,TMEM67,Pathogenic/Likely pathogenic,Joubert syndrome 6|COACH syndrome 1|Meckel-Gruber syndrome;Joubert syndrome|Joubert syndrome and related disorders|6 conditions,single nucleotide variant,GRCh38
na,na,8,94817111,94817111,TMEM67,Pathogenic,Joubert syndrome 6|Meckel-Gruber syndrome;Joubert syndrome,single nucleotide variant,GRCh37
na,na,8,93804883,93804883,TMEM67,Pathogenic,Joubert syndrome 6|Meckel-Gruber syndrome;Joubert syndrome,single nucleotide variant,GRCh38
na,na,8,94777876,94777876,TMEM67,Conflicting classifications of pathogenicity,"Joubert syndrome 6|Meckel syndrome, type 3|not provided|Meckel-Gruber syndrome;Joubert syndrome|TMEM67-related disorder|Joubert syndrome and related disorders",single nucleotide variant,GRCh37
na,na,8,93765648,93765648,TMEM67,Conflicting classifications of pathogenicity,"Joubert syndrome 6|Meckel syndrome, type 3|not provided|Meckel-Gruber syndrome;Joubert syndrome|TMEM67-related disorder|Joubert syndrome and related disorders",single nucleotide variant,GRCh38
na,na,8,94805484,94805484,TMEM67,Pathogenic/Likely pathogenic,Meckel-Gruber syndrome;Joubert syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,93793256,93793256,TMEM67,Pathogenic/Likely pathogenic,Meckel-Gruber syndrome;Joubert syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,94809557,94809557,TMEM67,Pathogenic,COACH syndrome 1|Joubert syndrome 6,single nucleotide variant,GRCh37
na,na,8,93797329,93797329,TMEM67,Pathogenic,COACH syndrome 1|Joubert syndrome 6,single nucleotide variant,GRCh38
na,na,8,94777845,94777845,TMEM67,Pathogenic,"Joubert syndrome 6|Meckel syndrome, type 3|Meckel-Gruber syndrome;Joubert syndrome|TMEM67-related disorder|not provided|RHYNS syndrome|Joubert syndrome and related disorders|6 conditions|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,8,93765617,93765617,TMEM67,Pathogenic,"Joubert syndrome 6|Meckel syndrome, type 3|Meckel-Gruber syndrome;Joubert syndrome|TMEM67-related disorder|not provided|RHYNS syndrome|Joubert syndrome and related disorders|6 conditions|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,8,94793190,94793190,TMEM67,Conflicting classifications of pathogenicity,"Bardet-Biedl syndrome 14, modifier of|Nephronophthisis|Meckel-Gruber syndrome;Joubert syndrome|not provided|COACH syndrome 1|Joubert syndrome 6|RHYNS syndrome|Meckel syndrome, type 3|Nephronophthisis 11|TMEM67-related disorder|not specified|6 conditions",single nucleotide variant,GRCh37
na,na,8,93780962,93780962,TMEM67,Conflicting classifications of pathogenicity,"Bardet-Biedl syndrome 14, modifier of|Nephronophthisis|Meckel-Gruber syndrome;Joubert syndrome|not provided|COACH syndrome 1|Joubert syndrome 6|RHYNS syndrome|Meckel syndrome, type 3|Nephronophthisis 11|TMEM67-related disorder|not specified|6 conditions",single nucleotide variant,GRCh38
na,na,8,94821126,94821126,TMEM67,Pathogenic/Likely pathogenic,"COACH syndrome 1|Joubert syndrome 6|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 3|not provided|Joubert syndrome and related disorders|6 conditions|TMEM67-related disorder|Nephronophthisis 11;Joubert syndrome 6;RHYNS syndrome;COACH syndrome 1",single nucleotide variant,GRCh37
na,na,8,93808898,93808898,TMEM67,Pathogenic/Likely pathogenic,"COACH syndrome 1|Joubert syndrome 6|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 3|not provided|Joubert syndrome and related disorders|6 conditions|TMEM67-related disorder|Nephronophthisis 11;Joubert syndrome 6;RHYNS syndrome;COACH syndrome 1",single nucleotide variant,GRCh38
na,na,8,94821185,94821185,TMEM67,Pathogenic,COACH syndrome 1|Joubert syndrome 6,single nucleotide variant,GRCh37
na,na,8,93808957,93808957,TMEM67,Pathogenic,COACH syndrome 1|Joubert syndrome 6,single nucleotide variant,GRCh38
na,na,8,94768099,94768099,TMEM67,Pathogenic,COACH syndrome 1|Meckel-Gruber syndrome;Joubert syndrome|6 conditions,single nucleotide variant,GRCh37
na,na,8,93755871,93755871,TMEM67,Pathogenic,COACH syndrome 1|Meckel-Gruber syndrome;Joubert syndrome|6 conditions,single nucleotide variant,GRCh38
na,na,8,94807731,94807731,TMEM67,Pathogenic/Likely pathogenic,COACH syndrome 1|Joubert syndrome 6|not provided|Meckel-Gruber syndrome;Joubert syndrome|6 conditions,single nucleotide variant,GRCh37
na,na,8,93795503,93795503,TMEM67,Pathogenic/Likely pathogenic,COACH syndrome 1|Joubert syndrome 6|not provided|Meckel-Gruber syndrome;Joubert syndrome|6 conditions,single nucleotide variant,GRCh38
na,na,8,94821089,94821089,TMEM67,Pathogenic,Nephronophthisis 11|Joubert syndrome 6,single nucleotide variant,GRCh37
na,na,8,93808861,93808861,TMEM67,Pathogenic,Nephronophthisis 11|Joubert syndrome 6,single nucleotide variant,GRCh38
na,na,8,94808198,94808198,TMEM67,Pathogenic/Likely pathogenic,"Joubert syndrome 6|Nephronophthisis 11|TMEM67-related disorder|not provided|Nephronophthisis|Oligohydramnios;Joubert syndrome;Renal cyst|Meckel-Gruber syndrome;Joubert syndrome|Inborn genetic diseases|14 conditions|COACH syndrome 1;Joubert syndrome 6;Bardet-Biedl syndrome 14;Nephronophthisis 11;Meckel syndrome, type 3|RHYNS syndrome|COACH syndrome 1;Joubert syndrome 6;RHYNS syndrome;Nephronophthisis 11|6 conditions",single nucleotide variant,GRCh37
na,na,8,93795970,93795970,TMEM67,Pathogenic/Likely pathogenic,"Joubert syndrome 6|Nephronophthisis 11|TMEM67-related disorder|not provided|Nephronophthisis|Oligohydramnios;Joubert syndrome;Renal cyst|Meckel-Gruber syndrome;Joubert syndrome|Inborn genetic diseases|14 conditions|COACH syndrome 1;Joubert syndrome 6;Bardet-Biedl syndrome 14;Nephronophthisis 11;Meckel syndrome, type 3|RHYNS syndrome|COACH syndrome 1;Joubert syndrome 6;RHYNS syndrome;Nephronophthisis 11|6 conditions",single nucleotide variant,GRCh38
na,na,8,94792975,94792975,TMEM67,Pathogenic,Nephronophthisis 11,single nucleotide variant,GRCh37
na,na,8,93780747,93780747,TMEM67,Pathogenic,Nephronophthisis 11,single nucleotide variant,GRCh38
na,na,8,94821089,94821089,TMEM67,Pathogenic,Joubert syndrome 6|Nephronophthisis 11,single nucleotide variant,GRCh37
na,na,8,93808861,93808861,TMEM67,Pathogenic,Joubert syndrome 6|Nephronophthisis 11,single nucleotide variant,GRCh38
na,na,8,94767272,94767272,TMEM67,Pathogenic,Joubert syndrome 6|Meckel-Gruber syndrome;Joubert syndrome,single nucleotide variant,GRCh37
na,na,8,93755044,93755044,TMEM67,Pathogenic,Joubert syndrome 6|Meckel-Gruber syndrome;Joubert syndrome,single nucleotide variant,GRCh38
na,na,8,94792861,94792861,TMEM67,Pathogenic/Likely pathogenic,Joubert syndrome 6|Nephronophthisis|not provided|Meckel-Gruber syndrome;Joubert syndrome|6 conditions|TMEM67-related disorder|Joubert syndrome and related disorders,single nucleotide variant,GRCh37
na,na,8,93780633,93780633,TMEM67,Pathogenic/Likely pathogenic,Joubert syndrome 6|Nephronophthisis|not provided|Meckel-Gruber syndrome;Joubert syndrome|6 conditions|TMEM67-related disorder|Joubert syndrome and related disorders,single nucleotide variant,GRCh38
na,na,17,56296537,56296538,MKS1,Pathogenic,"Meckel syndrome, type 1",Duplication,GRCh37
na,na,17,58219176,58219177,MKS1,Pathogenic,"Meckel syndrome, type 1",Duplication,GRCh38
na,na,17,56296510,56296510,MKS1,Pathogenic/Likely pathogenic,"Meckel syndrome, type 1|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28",single nucleotide variant,GRCh37
na,na,17,58219149,58219149,MKS1,Pathogenic/Likely pathogenic,"Meckel syndrome, type 1|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28",single nucleotide variant,GRCh38
na,na,17,56288019,56288019,MKS1,Pathogenic/Likely pathogenic,"Meckel syndrome, type 1|Meckel-Gruber syndrome;Joubert syndrome|Bardet-Biedl syndrome 13|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28|not provided|MKS1-related disorder",single nucleotide variant,GRCh37
na,na,17,58210658,58210658,MKS1,Pathogenic/Likely pathogenic,"Meckel syndrome, type 1|Meckel-Gruber syndrome;Joubert syndrome|Bardet-Biedl syndrome 13|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28|not provided|MKS1-related disorder",single nucleotide variant,GRCh38
na,na,17,56293449,56293449,MKS1,Conflicting classifications of pathogenicity,"Meckel syndrome, type 1|Joubert syndrome|Meckel-Gruber syndrome|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28|Inborn genetic diseases|not provided|Meckel-Gruber syndrome;Joubert syndrome|Bardet-Biedl syndrome 13|MKS1-related disorder",single nucleotide variant,GRCh37
na,na,17,58216088,58216088,MKS1,Conflicting classifications of pathogenicity,"Meckel syndrome, type 1|Joubert syndrome|Meckel-Gruber syndrome|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28|Inborn genetic diseases|not provided|Meckel-Gruber syndrome;Joubert syndrome|Bardet-Biedl syndrome 13|MKS1-related disorder",single nucleotide variant,GRCh38
na,na,17,56283840,56283840,MKS1,Conflicting classifications of pathogenicity,"Bardet-Biedl syndrome 13|Hypotonia;Nystagmus;Polydactyly|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28|not provided|Joubert syndrome 28|MKS1-related disorder|Meckel syndrome, type 1|Bardet-Biedl syndrome",single nucleotide variant,GRCh37
na,na,17,58206479,58206479,MKS1,Conflicting classifications of pathogenicity,"Bardet-Biedl syndrome 13|Hypotonia;Nystagmus;Polydactyly|Meckel-Gruber syndrome;Joubert syndrome|Meckel syndrome, type 1;Bardet-Biedl syndrome 13;Joubert syndrome 28|not provided|Joubert syndrome 28|MKS1-related disorder|Meckel syndrome, type 1|Bardet-Biedl syndrome",single nucleotide variant,GRCh38
na,na,17,56285517,56285519,MKS1,Pathogenic,Bardet-Biedl syndrome 13,Deletion,GRCh37
na,na,17,58208156,58208158,MKS1,Pathogenic,Bardet-Biedl syndrome 13,Deletion,GRCh38
na,na,14,88883138,88883138,SPATA7,Pathogenic/Likely pathogenic,Leber congenital amaurosis 3|SPATA7-related disorder|not provided|Leber congenital amaurosis|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,14,88416794,88416794,SPATA7,Pathogenic/Likely pathogenic,Leber congenital amaurosis 3|SPATA7-related disorder|not provided|Leber congenital amaurosis|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,14,88895738,88895739,SPATA7,Pathogenic,Leber congenital amaurosis 3,Duplication,GRCh37
na,na,14,88429394,88429395,SPATA7,Pathogenic,Leber congenital amaurosis 3,Duplication,GRCh38
na,na,14,88903909,88903909,SPATA7,Pathogenic/Likely pathogenic,"Leber congenital amaurosis 3|not provided|Retinitis pigmentosa 94, variable age at onset|Leber congenital amaurosis|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,14,88437565,88437565,SPATA7,Pathogenic/Likely pathogenic,"Leber congenital amaurosis 3|not provided|Retinitis pigmentosa 94, variable age at onset|Leber congenital amaurosis|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,14,88904360,88904360,SPATA7,Pathogenic,"Leber congenital amaurosis 3|Retinitis pigmentosa 94, variable age at onset",Deletion,GRCh37
na,na,14,88438016,88438016,SPATA7,Pathogenic,"Leber congenital amaurosis 3|Retinitis pigmentosa 94, variable age at onset",Deletion,GRCh38
na,na,22,37465347,37465348,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,Duplication,GRCh37
na,na,22,37069307,37069308,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,Duplication,GRCh38
na,na,22,37466579,37466579,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,Deletion,GRCh37
na,na,22,37070539,37070539,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,Deletion,GRCh38
na,na,22,37469571,37469571,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,single nucleotide variant,GRCh37
na,na,22,37073531,37073531,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,single nucleotide variant,GRCh38
na,na,22,37465112,37465112,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,single nucleotide variant,GRCh37
na,na,22,37069072,37069072,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,single nucleotide variant,GRCh38
na,na,22,37471220,37471220,TMPRSS6,Pathogenic/Likely pathogenic,Iron-refractory iron deficiency anemia|not provided,single nucleotide variant,GRCh37
na,na,22,37075180,37075180,TMPRSS6,Pathogenic/Likely pathogenic,Iron-refractory iron deficiency anemia|not provided,single nucleotide variant,GRCh38
na,na,22,37469593,37469593,TMPRSS6,Likely pathogenic,Microcytic anemia|Iron-refractory iron deficiency anemia|TMPRSS6-related disorder,single nucleotide variant,GRCh37
na,na,22,37073553,37073553,TMPRSS6,Likely pathogenic,Microcytic anemia|Iron-refractory iron deficiency anemia|TMPRSS6-related disorder,single nucleotide variant,GRCh38
na,na,22,37480815,37480815,TMPRSS6,Likely pathogenic,Iron-refractory iron deficiency anemia|not provided|TMPRSS6-related disorder,single nucleotide variant,GRCh37
na,na,22,37084775,37084775,TMPRSS6,Likely pathogenic,Iron-refractory iron deficiency anemia|not provided|TMPRSS6-related disorder,single nucleotide variant,GRCh38
na,na,22,37470736,37470736,TMPRSS6,Likely pathogenic,Iron-refractory iron deficiency anemia,Deletion,GRCh37
na,na,22,37074696,37074696,TMPRSS6,Likely pathogenic,Iron-refractory iron deficiency anemia,Deletion,GRCh38
na,na,22,37480379,37480379,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,single nucleotide variant,GRCh37
na,na,22,37084339,37084339,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,single nucleotide variant,GRCh38
na,na,22,37466597,37466597,TMPRSS6,Pathogenic/Likely pathogenic,Microcytic anemia|Iron-refractory iron deficiency anemia|not provided,single nucleotide variant,GRCh37
na,na,22,37070557,37070557,TMPRSS6,Pathogenic/Likely pathogenic,Microcytic anemia|Iron-refractory iron deficiency anemia|not provided,single nucleotide variant,GRCh38
na,na,22,37465194,37465195,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,Duplication,GRCh37
na,na,22,37069154,37069155,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,Duplication,GRCh38
na,na,22,37494466,37494466,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,single nucleotide variant,GRCh37
na,na,22,37098426,37098426,TMPRSS6,Pathogenic,Iron-refractory iron deficiency anemia,single nucleotide variant,GRCh38
na,na,3,172737276,172737276,SPATA16,Likely benign,Globozoospermia|not provided,single nucleotide variant,GRCh37
na,na,3,173019486,173019486,SPATA16,Likely benign,Globozoospermia|not provided,single nucleotide variant,GRCh38
na,na,3,164737520,164737520,SI,Uncertain significance,Sucrase-isomaltase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,165019732,165019732,SI,Uncertain significance,Sucrase-isomaltase deficiency|not provided,single nucleotide variant,GRCh38
na,na,3,164777814,164777814,SI,Pathogenic,Sucrase-isomaltase deficiency,single nucleotide variant,GRCh37
na,na,3,165060026,165060026,SI,Pathogenic,Sucrase-isomaltase deficiency,single nucleotide variant,GRCh38
na,na,3,164786889,164786889,SI,Pathogenic,Sucrase-isomaltase deficiency,single nucleotide variant,GRCh37
na,na,3,165069101,165069101,SI,Pathogenic,Sucrase-isomaltase deficiency,single nucleotide variant,GRCh38
na,na,3,164764657,164764657,SI,Pathogenic,Sucrase-isomaltase deficiency,single nucleotide variant,GRCh37
na,na,3,165046869,165046869,SI,Pathogenic,Sucrase-isomaltase deficiency,single nucleotide variant,GRCh38
na,na,3,164735409,164735409,SI,Pathogenic,Sucrase-isomaltase deficiency,single nucleotide variant,GRCh37
na,na,3,165017621,165017621,SI,Pathogenic,Sucrase-isomaltase deficiency,single nucleotide variant,GRCh38
na,na,3,164700803,164700803,SI,Conflicting classifications of pathogenicity,Sucrase-isomaltase deficiency|not provided|SI-related disorder,single nucleotide variant,GRCh37
na,na,3,164983015,164983015,SI,Conflicting classifications of pathogenicity,Sucrase-isomaltase deficiency|not provided|SI-related disorder,single nucleotide variant,GRCh38
na,na,3,164764786,164764786,SI,Conflicting classifications of pathogenicity,Sucrase-isomaltase deficiency|not provided|SI-related disorder,single nucleotide variant,GRCh37
na,na,3,165046998,165046998,SI,Conflicting classifications of pathogenicity,Sucrase-isomaltase deficiency|not provided|SI-related disorder,single nucleotide variant,GRCh38
na,na,3,164739053,164739053,SI,Conflicting classifications of pathogenicity,Sucrase-isomaltase deficiency|Inborn genetic diseases|not provided|SI-related disorder,single nucleotide variant,GRCh37
na,na,3,165021265,165021265,SI,Conflicting classifications of pathogenicity,Sucrase-isomaltase deficiency|Inborn genetic diseases|not provided|SI-related disorder,single nucleotide variant,GRCh38
na,na,14,92773663,92773663,SLC24A4,association,"SKIN/HAIR/EYE PIGMENTATION 6, BLOND/BROWN HAIR",single nucleotide variant,GRCh37
na,na,14,92307319,92307319,SLC24A4,association,"SKIN/HAIR/EYE PIGMENTATION 6, BLOND/BROWN HAIR",single nucleotide variant,GRCh38
na,na,1,45973216,45973217,MMACHC,Pathogenic,"Cobalamin C disease|not provided|Disorders of Intracellular Cobalamin Metabolism|not specified|METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC|Atypical hemolytic-uremic syndrome|Methylmalonic acidemia with homocystinuria cblC|MMACHC-related disorder|See cases|Inborn genetic diseases|Methylmalonic aciduria and homocystinuria",Duplication,GRCh37
na,na,1,45507544,45507545,MMACHC,Pathogenic,"Cobalamin C disease|not provided|Disorders of Intracellular Cobalamin Metabolism|not specified|METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC|Atypical hemolytic-uremic syndrome|Methylmalonic acidemia with homocystinuria cblC|MMACHC-related disorder|See cases|Inborn genetic diseases|Methylmalonic aciduria and homocystinuria",Duplication,GRCh38
na,na,1,45973954,45973954,MMACHC,Pathogenic/Likely pathogenic,Cobalamin C disease|Disorders of Intracellular Cobalamin Metabolism,single nucleotide variant,GRCh37
na,na,1,45508282,45508282,MMACHC,Pathogenic/Likely pathogenic,Cobalamin C disease|Disorders of Intracellular Cobalamin Metabolism,single nucleotide variant,GRCh38
na,na,1,45974001,45974001,MMACHC,Pathogenic,Cobalamin C disease|not provided|Methylmalonic acidemia with homocystinuria cblC|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Abnormality of metabolism/homeostasis|cblC type of combined methylmalonic aciduria and homocystinuria|Disorders of Intracellular Cobalamin Metabolism|Methylmalonic aciduria and homocystinuria type cblD,single nucleotide variant,GRCh37
na,na,1,45508329,45508329,MMACHC,Pathogenic,Cobalamin C disease|not provided|Methylmalonic acidemia with homocystinuria cblC|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Abnormality of metabolism/homeostasis|cblC type of combined methylmalonic aciduria and homocystinuria|Disorders of Intracellular Cobalamin Metabolism|Methylmalonic aciduria and homocystinuria type cblD,single nucleotide variant,GRCh38
na,na,1,45973938,45973938,MMACHC,Pathogenic,Cobalamin C disease|not provided|Methylmalonic acidemia with homocystinuria cblC|Disorders of Intracellular Cobalamin Metabolism|MMACHC-related disorder,single nucleotide variant,GRCh37
na,na,1,45508266,45508266,MMACHC,Pathogenic,Cobalamin C disease|not provided|Methylmalonic acidemia with homocystinuria cblC|Disorders of Intracellular Cobalamin Metabolism|MMACHC-related disorder,single nucleotide variant,GRCh38
na,na,1,45974520,45974520,MMACHC,Pathogenic,Cobalamin C disease|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Inborn genetic diseases|Methylmalonic acidemia with homocystinuria cblC|Disorders of Intracellular Cobalamin Metabolism|MMACHC-related disorder,single nucleotide variant,GRCh37
na,na,1,45508848,45508848,MMACHC,Pathogenic,Cobalamin C disease|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Inborn genetic diseases|Methylmalonic acidemia with homocystinuria cblC|Disorders of Intracellular Cobalamin Metabolism|MMACHC-related disorder,single nucleotide variant,GRCh38
na,na,9,140128373,140128373,SLC34A3,Pathogenic,Autosomal recessive hypophosphatemic bone disease,Deletion,GRCh37
na,na,9,137233921,137233921,SLC34A3,Pathogenic,Autosomal recessive hypophosphatemic bone disease,Deletion,GRCh38
na,na,9,140128693,140128693,SLC34A3,Conflicting classifications of pathogenicity,Autosomal recessive hypophosphatemic bone disease|not provided,single nucleotide variant,GRCh37
na,na,9,137234241,137234241,SLC34A3,Conflicting classifications of pathogenicity,Autosomal recessive hypophosphatemic bone disease|not provided,single nucleotide variant,GRCh38
na,na,9,140129086,140129086,SLC34A3,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease,single nucleotide variant,GRCh37
na,na,9,137234634,137234634,SLC34A3,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease,single nucleotide variant,GRCh38
na,na,9,140128174,140128174,SLC34A3,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided,single nucleotide variant,GRCh37
na,na,9,137233722,137233722,SLC34A3,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided,single nucleotide variant,GRCh38
na,na,9,140127078,140127078,SLC34A3,Pathogenic,Autosomal recessive hypophosphatemic bone disease,Deletion,GRCh37
na,na,9,137232626,137232626,SLC34A3,Pathogenic,Autosomal recessive hypophosphatemic bone disease,Deletion,GRCh38
na,na,9,140127686,140127686,SLC34A3,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided,single nucleotide variant,GRCh37
na,na,9,137233234,137233234,SLC34A3,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided,single nucleotide variant,GRCh38
na,na,9,140130470,140130470,SLC34A3,Pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided|SLC34A3-related disorder,single nucleotide variant,GRCh37
na,na,9,137236018,137236018,SLC34A3,Pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided|SLC34A3-related disorder,single nucleotide variant,GRCh38
na,na,9,140128413,140128513,SLC34A3,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided,Deletion,GRCh37
na,na,9,137233910,137234010,SLC34A3,Pathogenic/Likely pathogenic,Autosomal recessive hypophosphatemic bone disease|not provided,Deletion,GRCh38
na,na,9,140127856,140127856,SLC34A3,Conflicting classifications of pathogenicity,Autosomal recessive hypophosphatemic bone disease|not provided|SLC34A3-related disorder|not specified,single nucleotide variant,GRCh37
na,na,9,137233404,137233404,SLC34A3,Conflicting classifications of pathogenicity,Autosomal recessive hypophosphatemic bone disease|not provided|SLC34A3-related disorder|not specified,single nucleotide variant,GRCh38
na,na,9,140128753,140128837,SLC34A3,Pathogenic,Autosomal recessive hypophosphatemic bone disease,Deletion,GRCh37
na,na,9,137234301,137234385,SLC34A3,Pathogenic,Autosomal recessive hypophosphatemic bone disease,Deletion,GRCh38
na,na,4,84191035,84191035,COQ2,Likely pathogenic,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|not provided",single nucleotide variant,GRCh37
na,na,4,83269882,83269882,COQ2,Likely pathogenic,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|not provided",single nucleotide variant,GRCh38
na,na,4,84194751,84194751,COQ2,Pathogenic/Likely pathogenic,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|not provided|Coenzyme Q10 deficiency, primary, 1;Multiple system atrophy 1, susceptibility to",single nucleotide variant,GRCh37
na,na,4,83273598,83273598,COQ2,Pathogenic/Likely pathogenic,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|not provided|Coenzyme Q10 deficiency, primary, 1;Multiple system atrophy 1, susceptibility to",single nucleotide variant,GRCh38
na,na,4,84194658,84194658,COQ2,Conflicting classifications of pathogenicity,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|not provided|Inborn genetic diseases|Nephrotic syndrome",single nucleotide variant,GRCh37
na,na,4,83273505,83273505,COQ2,Conflicting classifications of pathogenicity,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|not provided|Inborn genetic diseases|Nephrotic syndrome",single nucleotide variant,GRCh38
na,na,4,84200234,84200234,COQ2,Pathogenic,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|Coenzyme Q10 deficiency, primary, 1;Multiple system atrophy 1, susceptibility to",single nucleotide variant,GRCh37
na,na,4,83279081,83279081,COQ2,Pathogenic,"Coenzyme Q10 deficiency, primary, 1|Coenzyme Q10 deficiency|Coenzyme Q10 deficiency, primary, 1;Multiple system atrophy 1, susceptibility to",single nucleotide variant,GRCh38
na,na,11,118955777,118955777,HMBS,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant|not provided",single nucleotide variant,GRCh37
na,na,11,119085067,119085067,HMBS,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant|not provided",single nucleotide variant,GRCh38
na,na,11,118959008,118959008,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119088298,119088298,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118955777,118955777,HMBS,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant|not provided",single nucleotide variant,GRCh37
na,na,11,119085067,119085067,HMBS,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant|not provided",single nucleotide variant,GRCh38
na,na,11,118960701,118960701,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119089991,119089991,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118962124,118962124,HMBS,Pathogenic/Likely pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related|Leukoencephalopathy, porphyria-related",single nucleotide variant,GRCh37
na,na,11,119091414,119091414,HMBS,Pathogenic/Likely pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related|Leukoencephalopathy, porphyria-related",single nucleotide variant,GRCh38
na,na,11,118962142,118962142,HMBS,Pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",single nucleotide variant,GRCh37
na,na,11,119091432,119091432,HMBS,Pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",single nucleotide variant,GRCh38
na,na,11,118960940,118960940,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119090230,119090230,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118960923,118960923,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119090213,119090213,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118963196,118963196,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119092486,119092486,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118963719,118963719,HMBS,Pathogenic,Acute intermittent porphyria,Deletion,GRCh37
na,na,11,119093009,119093009,HMBS,Pathogenic,Acute intermittent porphyria,Deletion,GRCh38
na,na,11,118962217,118962217,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119091507,119091507,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118959348,118959348,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119088638,119088638,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118959357,118959357,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119088647,119088647,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118962123,118962123,HMBS,Pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",single nucleotide variant,GRCh37
na,na,11,119091413,119091413,HMBS,Pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",single nucleotide variant,GRCh38
na,na,11,118962124,118962124,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119091414,119091414,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118959794,118959794,HMBS,Uncertain significance,Acute intermittent porphyria|not provided|not specified,single nucleotide variant,GRCh37
na,na,11,119089084,119089084,HMBS,Uncertain significance,Acute intermittent porphyria|not provided|not specified,single nucleotide variant,GRCh38
na,na,11,118959804,118959804,HMBS,Pathogenic,Acute intermittent porphyria,Deletion,GRCh37
na,na,11,119089094,119089094,HMBS,Pathogenic,Acute intermittent porphyria,Deletion,GRCh38
na,na,11,118959808,118959809,HMBS,Pathogenic,Acute intermittent porphyria,Duplication,GRCh37
na,na,11,119089098,119089099,HMBS,Pathogenic,Acute intermittent porphyria,Duplication,GRCh38
na,na,11,118959926,118959926,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119089216,119089216,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118962225,118962225,HMBS,Pathogenic/Likely pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",single nucleotide variant,GRCh37
na,na,11,119091515,119091515,HMBS,Pathogenic/Likely pathogenic,"Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",single nucleotide variant,GRCh38
na,na,11,118960457,118960457,HMBS,Pathogenic/Likely pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119089747,119089747,HMBS,Pathogenic/Likely pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118962122,118962122,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119091412,119091412,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118962154,118962154,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119091444,119091444,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118963129,118963129,HMBS,Conflicting classifications of pathogenicity,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119092419,119092419,HMBS,Conflicting classifications of pathogenicity,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118963190,118963191,HMBS,Pathogenic,Acute intermittent porphyria|not provided,Microsatellite,GRCh37
na,na,11,119092480,119092481,HMBS,Pathogenic,Acute intermittent porphyria|not provided,Microsatellite,GRCh38
na,na,11,118963201,118963201,HMBS,Likely pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119092491,119092491,HMBS,Likely pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118963191,118963192,HMBS,Pathogenic,Acute intermittent porphyria,Duplication,GRCh37
na,na,11,119092481,119092482,HMBS,Pathogenic,Acute intermittent porphyria,Duplication,GRCh38
na,na,11,118963210,118963210,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119092500,119092500,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118963216,118963216,HMBS,Uncertain significance,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119092506,119092506,HMBS,Uncertain significance,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118963217,118963217,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119092507,119092507,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118963228,118963228,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119092518,119092518,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118963234,118963234,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119092524,119092524,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118963819,118963819,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119093109,119093109,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118959983,118959983,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh37
na,na,11,119089273,119089273,HMBS,Pathogenic,Acute intermittent porphyria,single nucleotide variant,GRCh38
na,na,11,118962869,118962869,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119092159,119092159,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118963666,118963667,HMBS,Pathogenic,Acute intermittent porphyria,Deletion,GRCh37
na,na,11,119092956,119092957,HMBS,Pathogenic,Acute intermittent porphyria,Deletion,GRCh38
na,na,na,-1,-1,HMBS,Pathogenic,Acute intermittent porphyria,Insertion,na
na,na,11,118955589,118955589,HMBS,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant",Deletion,GRCh37
na,na,11,119084879,119084879,HMBS,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant",Deletion,GRCh38
na,na,11,118958969,118958969,HMBS,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant",Deletion,GRCh37
na,na,11,119088259,119088259,HMBS,Pathogenic,"Porphyria, acute intermittent, nonerythroid variant",Deletion,GRCh38
na,na,11,118963668,118963668,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh37
na,na,11,119092958,119092958,HMBS,Pathogenic,Acute intermittent porphyria|not provided,single nucleotide variant,GRCh38
na,na,11,118955744,118955744,HMBS,Uncertain significance,"Porphyria, acute intermittent, nonerythroid variant|not provided",single nucleotide variant,GRCh37
na,na,11,119085034,119085034,HMBS,Uncertain significance,"Porphyria, acute intermittent, nonerythroid variant|not provided",single nucleotide variant,GRCh38
na,na,11,118959958,118959958,HMBS,Pathogenic,"Encephalopathy, porphyria-related",single nucleotide variant,GRCh37
na,na,11,119089248,119089248,HMBS,Pathogenic,"Encephalopathy, porphyria-related",single nucleotide variant,GRCh38
na,na,11,118960922,118960922,HMBS,Pathogenic,Acute intermittent porphyria|not provided|HMBS-related disorder,single nucleotide variant,GRCh37
na,na,11,119090212,119090212,HMBS,Pathogenic,Acute intermittent porphyria|not provided|HMBS-related disorder,single nucleotide variant,GRCh38
na,na,15,48426484,48426484,SLC24A5,association,"Skin/hair/eye pigmentation, variation in, 4",single nucleotide variant,GRCh37
na,na,15,48134287,48134287,SLC24A5,association,"Skin/hair/eye pigmentation, variation in, 4",single nucleotide variant,GRCh38
na,na,17,27065739,27065739,NEK8,Pathogenic,Nephronophthisis 9,single nucleotide variant,GRCh37
na,na,17,28738721,28738721,NEK8,Pathogenic,Nephronophthisis 9,single nucleotide variant,GRCh38
na,na,19,45683000,45683000,BLOC1S3,Pathogenic,Hermansky-Pudlak syndrome 8,Deletion,GRCh37
na,na,19,45179742,45179742,BLOC1S3,Pathogenic,Hermansky-Pudlak syndrome 8,Deletion,GRCh38
na,na,22,38119602,38119602,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|not provided,single nucleotide variant,GRCh37
na,na,22,37723595,37723595,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|not provided,single nucleotide variant,GRCh38
na,na,22,38120304,38120304,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh37
na,na,22,37724297,37724297,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh38
na,na,22,38119452,38119452,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28,single nucleotide variant,GRCh37
na,na,22,37723445,37723445,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28,single nucleotide variant,GRCh38
na,na,22,38120925,38120925,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|not provided,single nucleotide variant,GRCh37
na,na,22,37724918,37724918,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|not provided,single nucleotide variant,GRCh38
na,na,22,38121765,38121765,TRIOBP,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 28,single nucleotide variant,GRCh37
na,na,22,37725758,37725758,TRIOBP,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 28,single nucleotide variant,GRCh38
na,na,22,38121912,38121912,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|not provided,single nucleotide variant,GRCh37
na,na,22,37725905,37725905,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28|not provided,single nucleotide variant,GRCh38
na,na,22,38121765,38121766,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28,Deletion,GRCh37
na,na,22,37725758,37725759,TRIOBP,Pathogenic,Autosomal recessive nonsyndromic hearing loss 28,Deletion,GRCh38
na,na,na,-1,-1,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,Deletion,na
na,na,17,73949644,73949644,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,single nucleotide variant,GRCh37
na,na,17,75953563,75953563,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,single nucleotide variant,GRCh38
na,na,17,73953546,73953546,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,single nucleotide variant,GRCh37
na,na,17,75957465,75957465,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,single nucleotide variant,GRCh38
na,na,17,73949550,73949550,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,single nucleotide variant,GRCh37
na,na,17,75953469,75953469,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,single nucleotide variant,GRCh38
na,na,17,73953636,73953636,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency|not provided|Acyl-CoA oxidase deficiency;Mitchell syndrome,single nucleotide variant,GRCh37
na,na,17,75957555,75957555,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency|not provided|Acyl-CoA oxidase deficiency;Mitchell syndrome,single nucleotide variant,GRCh38
na,na,17,73956337,73956354,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,Deletion,GRCh37
na,na,17,75960256,75960273,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,Deletion,GRCh38
na,na,na,-1,-1,ACOX1,Pathogenic,Acyl-CoA oxidase deficiency,Deletion,na
na,na,na,-1,-1,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells,Deletion,na
na,na,1,155265248,155265248,PKLR,Uncertain significance,Pyruvate kinase deficiency of red cells|not provided,single nucleotide variant,GRCh37
na,na,1,155295457,155295457,PKLR,Uncertain significance,Pyruvate kinase deficiency of red cells|not provided,single nucleotide variant,GRCh38
na,na,1,155263347,155263347,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells|not provided,single nucleotide variant,GRCh37
na,na,1,155293556,155293556,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells|not provided,single nucleotide variant,GRCh38
na,na,1,155263237,155263237,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells,single nucleotide variant,GRCh37
na,na,1,155293446,155293446,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells,single nucleotide variant,GRCh38
na,na,1,155262968,155262968,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells|not provided,single nucleotide variant,GRCh37
na,na,1,155293177,155293177,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells|not provided,single nucleotide variant,GRCh38
na,na,1,155261636,155261636,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells|not provided|PKLR-related disorder,single nucleotide variant,GRCh37
na,na,1,155291845,155291845,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells|not provided|PKLR-related disorder,single nucleotide variant,GRCh38
na,na,1,155270062,155270062,PKLR,Affects,Pyruvate kinase hyperactivity,single nucleotide variant,GRCh37
na,na,1,155300271,155300271,PKLR,Affects,Pyruvate kinase hyperactivity,single nucleotide variant,GRCh38
na,na,1,155261709,155261709,PKLR,Pathogenic/Likely pathogenic,Pyruvate kinase deficiency of red cells|not provided|Pyruvate kinase hyperactivity|Pyruvate kinase deficiency of red cells;Pyruvate kinase hyperactivity|See cases|PKLR-related disorder,single nucleotide variant,GRCh37
na,na,1,155291918,155291918,PKLR,Pathogenic/Likely pathogenic,Pyruvate kinase deficiency of red cells|not provided|Pyruvate kinase hyperactivity|Pyruvate kinase deficiency of red cells;Pyruvate kinase hyperactivity|See cases|PKLR-related disorder,single nucleotide variant,GRCh38
na,na,1,155265346,155265346,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells,single nucleotide variant,GRCh37
na,na,1,155295555,155295555,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells,single nucleotide variant,GRCh38
na,na,1,155271269,155271269,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells,single nucleotide variant,GRCh37
na,na,1,155301478,155301478,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells,single nucleotide variant,GRCh38
na,na,1,155263086,155263086,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells|not provided,single nucleotide variant,GRCh37
na,na,1,155293295,155293295,PKLR,Pathogenic,Pyruvate kinase deficiency of red cells|not provided,single nucleotide variant,GRCh38
na,na,1,155263229,155263229,PKLR,Pathogenic/Likely pathogenic,Pyruvate kinase deficiency of red cells|Pyruvate kinase deficiency of red cells;Pyruvate kinase hyperactivity|not provided,single nucleotide variant,GRCh37
na,na,1,155293438,155293438,PKLR,Pathogenic/Likely pathogenic,Pyruvate kinase deficiency of red cells|Pyruvate kinase deficiency of red cells;Pyruvate kinase hyperactivity|not provided,single nucleotide variant,GRCh38
na,na,8,19811696,19811696,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19954185,19954185,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,na,-1,-1,LPL,Pathogenic,"Hyperlipoproteinemia, type I",Insertion,na
na,na,8,19813473,19813474,LPL,Pathogenic,"Hyperlipoproteinemia, type I",Duplication,GRCh37
na,na,8,19955962,19955963,LPL,Pathogenic,"Hyperlipoproteinemia, type I",Duplication,GRCh38
na,na,8,19811733,19811733,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype|LPL-related disorder",single nucleotide variant,GRCh37
na,na,8,19954222,19954222,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype|LPL-related disorder",single nucleotide variant,GRCh38
na,na,na,-1,-1,LPL,Pathogenic,"Hyperlipoproteinemia, type I",Deletion,na
na,na,8,19809427,19809427,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided",single nucleotide variant,GRCh37
na,na,8,19951916,19951916,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided",single nucleotide variant,GRCh38
na,na,8,19813387,19813387,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19955876,19955876,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19809279,19809279,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19951768,19951768,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19811790,19811790,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|LPL-related disorder",single nucleotide variant,GRCh37
na,na,8,19954279,19954279,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|LPL-related disorder",single nucleotide variant,GRCh38
na,na,8,19811782,19811782,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19954271,19954271,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19811751,19811751,LPL,Conflicting classifications of pathogenicity,"Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,8,19954240,19954240,LPL,Conflicting classifications of pathogenicity,"Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,8,19813385,19813385,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,8,19955874,19955874,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,8,19809330,19809330,LPL,Pathogenic,"Hyperlipoproteinemia, type I|not provided",single nucleotide variant,GRCh37
na,na,8,19951819,19951819,LPL,Pathogenic,"Hyperlipoproteinemia, type I|not provided",single nucleotide variant,GRCh38
na,na,8,19810897,19810897,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19953386,19953386,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19811637,19811637,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19954126,19954126,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19819724,19819724,LPL,Benign,"Hyperlipoproteinemia, type I|Cardiovascular phenotype|not provided|not specified|LPL-related disorder|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh37
na,na,8,19962213,19962213,LPL,Benign,"Hyperlipoproteinemia, type I|Cardiovascular phenotype|not provided|not specified|LPL-related disorder|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh38
na,na,8,19805852,19805852,LPL,Pathogenic,"Hyperlipoproteinemia, type I|not provided|Cardiovascular phenotype|Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh37
na,na,8,19948341,19948341,LPL,Pathogenic,"Hyperlipoproteinemia, type I|not provided|Cardiovascular phenotype|Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh38
na,na,8,19809294,19809294,LPL,Pathogenic,"Hyperlipoproteinemia, type I|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,8,19951783,19951783,LPL,Pathogenic,"Hyperlipoproteinemia, type I|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,8,19818499,19818499,LPL,Pathogenic,"Hyperlipoproteinemia, type I|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh37
na,na,8,19960988,19960988,LPL,Pathogenic,"Hyperlipoproteinemia, type I|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh38
na,na,8,19811831,19811831,LPL,Pathogenic,"|Hyperlipoproteinemia, type I",Deletion,GRCh37
na,na,8,19954320,19954320,LPL,Pathogenic,"|Hyperlipoproteinemia, type I",Deletion,GRCh38
na,na,8,19813405,19813405,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh37
na,na,8,19955894,19955894,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh38
na,na,8,19809367,19809367,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related|not provided|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh37
na,na,8,19951856,19951856,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related|not provided|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh38
na,na,8,19809302,19809302,LPL,Pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,8,19951791,19951791,LPL,Pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipidemia, familial combined, LPL related|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,8,19797040,19797040,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19939529,19939529,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19816833,19816833,LPL,Pathogenic,"Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh37
na,na,8,19959322,19959322,LPL,Pathogenic,"Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh38
na,na,8,19811685,19811685,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19954174,19954174,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19809336,19809336,LPL,Pathogenic,"Hyperlipoproteinemia, type I|not provided",single nucleotide variant,GRCh37
na,na,8,19951825,19951825,LPL,Pathogenic,"Hyperlipoproteinemia, type I|not provided",single nucleotide variant,GRCh38
na,na,8,19811754,19811754,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19954243,19954243,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19811710,19811710,LPL,Likely pathogenic,"Hyperlipoproteinemia, type I|not provided",single nucleotide variant,GRCh37
na,na,8,19954199,19954199,LPL,Likely pathogenic,"Hyperlipoproteinemia, type I|not provided",single nucleotide variant,GRCh38
na,na,8,19813384,19813384,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|LPL-related disorder|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh37
na,na,8,19955873,19955873,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|LPL-related disorder|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh38
na,na,8,19796725,19796725,LPL,Uncertain significance,"Hyperlipidemia, familial combined, susceptibility to|not specified",single nucleotide variant,GRCh37
na,na,8,19939214,19939214,LPL,Uncertain significance,"Hyperlipidemia, familial combined, susceptibility to|not specified",single nucleotide variant,GRCh38
na,na,8,19813529,19813529,LPL,Conflicting classifications of pathogenicity,"Hyperlipidemia, familial combined, LPL related|Hyperlipidemia, familial combined, susceptibility to|Hyperlipoproteinemia, type I|not specified|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,8,19956018,19956018,LPL,Conflicting classifications of pathogenicity,"Hyperlipidemia, familial combined, LPL related|Hyperlipidemia, familial combined, susceptibility to|Hyperlipoproteinemia, type I|not specified|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,8,19818446,19818446,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19960935,19960935,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19805708,19805708,LPL,Benign/Likely benign; other,"Hyperlipidemia, familial combined, susceptibility to|Coronary heart disease|not specified|Hyperlipoproteinemia, type I|not provided|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|LPL-related disorder",single nucleotide variant,GRCh37
na,na,8,19948197,19948197,LPL,Benign/Likely benign; other,"Hyperlipidemia, familial combined, susceptibility to|Coronary heart disease|not specified|Hyperlipoproteinemia, type I|not provided|Cardiovascular phenotype|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related|LPL-related disorder",single nucleotide variant,GRCh38
na,na,8,19819637,19819637,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19962126,19962126,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19811844,19811844,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh37
na,na,8,19954333,19954333,LPL,Pathogenic/Likely pathogenic,"Hyperlipoproteinemia, type I|not provided|Hyperlipoproteinemia, type I;Hyperlipidemia, familial combined, LPL related",single nucleotide variant,GRCh38
na,na,8,19813563,19813563,LPL,Pathogenic,"LIPOPROTEIN LIPASE (OLBIA)|Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19956052,19956052,LPL,Pathogenic,"LIPOPROTEIN LIPASE (OLBIA)|Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,8,19813374,19813374,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh37
na,na,8,19955863,19955863,LPL,Pathogenic,"Hyperlipoproteinemia, type I",single nucleotide variant,GRCh38
na,na,na,-1,-1,LPL,Pathogenic,"Hyperlipoproteinemia, type I",Deletion,na
na,na,8,19819439,19819439,LPL,Benign,High density lipoprotein cholesterol level quantitative trait locus 11|not provided,single nucleotide variant,GRCh37
na,na,8,19961928,19961928,LPL,Benign,High density lipoprotein cholesterol level quantitative trait locus 11|not provided,single nucleotide variant,GRCh38
na,na,17,40696045,40696045,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|not provided|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",single nucleotide variant,GRCh37
na,na,17,42544027,42544027,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|not provided|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",single nucleotide variant,GRCh38
na,na,17,40695900,40695900,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V|not provided",single nucleotide variant,GRCh37
na,na,17,42543882,42543882,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V|not provided",single nucleotide variant,GRCh38
na,na,17,40693092,40693092,NAGLU,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|not provided|Mucopolysaccharidosis|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",single nucleotide variant,GRCh37
na,na,17,42541074,42541074,NAGLU,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|not provided|Mucopolysaccharidosis|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",single nucleotide variant,GRCh38
na,na,17,40695952,40695952,NAGLU,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",single nucleotide variant,GRCh37
na,na,17,42543934,42543934,NAGLU,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",single nucleotide variant,GRCh38
na,na,17,40689535,40689544,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|8 conditions|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V|not provided",Deletion,GRCh37
na,na,17,42537517,42537526,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|8 conditions|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V|not provided",Deletion,GRCh38
na,na,17,40695951,40695951,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",single nucleotide variant,GRCh37
na,na,17,42543933,42543933,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",single nucleotide variant,GRCh38
na,na,17,40695586,40695586,NAGLU,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V|not provided|Mucopolysaccharidosis",single nucleotide variant,GRCh37
na,na,17,42543568,42543568,NAGLU,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V|not provided|Mucopolysaccharidosis",single nucleotide variant,GRCh38
na,na,17,40695717,40695717,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B|not provided",single nucleotide variant,GRCh37
na,na,17,42543699,42543699,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B|not provided",single nucleotide variant,GRCh38
na,na,17,40695718,40695718,NAGLU,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",single nucleotide variant,GRCh37
na,na,17,42543700,42543700,NAGLU,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",single nucleotide variant,GRCh38
na,na,17,40688432,40688432,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",single nucleotide variant,GRCh37
na,na,17,42536414,42536414,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",single nucleotide variant,GRCh38
na,na,17,40693145,40693145,NAGLU,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B|NAGLU-related disorder",single nucleotide variant,GRCh37
na,na,17,42541127,42541127,NAGLU,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B|NAGLU-related disorder",single nucleotide variant,GRCh38
na,na,17,40695468,40695468,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",single nucleotide variant,GRCh37
na,na,17,42543450,42543450,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B;Charcot-Marie-Tooth disease axonal type 2V",single nucleotide variant,GRCh38
na,na,17,40690709,40690709,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",single nucleotide variant,GRCh37
na,na,17,42538691,42538691,NAGLU,Pathogenic,"Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease axonal type 2V;Mucopolysaccharidosis, MPS-III-B",single nucleotide variant,GRCh38
na,na,12,122287632,122287632,HPD,Likely pathogenic,Tyrosinemia type III|Hawkinsinuria;Tyrosinemia type III,single nucleotide variant,GRCh37
na,na,12,121849726,121849726,HPD,Likely pathogenic,Tyrosinemia type III|Hawkinsinuria;Tyrosinemia type III,single nucleotide variant,GRCh38
na,na,12,122284825,122284825,HPD,Pathogenic,Tyrosinemia type III,single nucleotide variant,GRCh37
na,na,12,121846919,121846919,HPD,Pathogenic,Tyrosinemia type III,single nucleotide variant,GRCh38
na,na,12,122285117,122285117,HPD,Pathogenic,Tyrosinemia type III,single nucleotide variant,GRCh37
na,na,12,121847211,121847211,HPD,Pathogenic,Tyrosinemia type III,single nucleotide variant,GRCh38
na,na,12,122277904,122277904,HPD,Conflicting classifications of pathogenicity,Tyrosinemia type III|Hawkinsinuria|Tyrosinemia type III;Hawkinsinuria|not provided|HPD-related disorder|not specified,single nucleotide variant,GRCh37
na,na,12,121839998,121839998,HPD,Conflicting classifications of pathogenicity,Tyrosinemia type III|Hawkinsinuria|Tyrosinemia type III;Hawkinsinuria|not provided|HPD-related disorder|not specified,single nucleotide variant,GRCh38
na,na,12,122295335,122295335,HPD,Benign,Hawkinsinuria|Tyrosinemia type III;Hawkinsinuria,single nucleotide variant,GRCh37
na,na,12,121857429,121857429,HPD,Benign,Hawkinsinuria|Tyrosinemia type III;Hawkinsinuria,single nucleotide variant,GRCh38
na,na,13,84454379,84454379,SLITRK1,Pathogenic,Tourette syndrome|Trichotillomania,Deletion,GRCh37
na,na,13,83880244,83880244,SLITRK1,Pathogenic,Tourette syndrome|Trichotillomania,Deletion,GRCh38
na,na,13,84452863,84452863,SLITRK1,Pathogenic,Tourette syndrome,single nucleotide variant,GRCh37
na,na,13,83878728,83878728,SLITRK1,Pathogenic,Tourette syndrome,single nucleotide variant,GRCh38
na,na,5,110454719,110454719,WDR36,Benign/Likely benign,"Glaucoma 1, open angle, G|not specified|not provided",single nucleotide variant,GRCh37
na,na,5,111119021,111119021,WDR36,Benign/Likely benign,"Glaucoma 1, open angle, G|not specified|not provided",single nucleotide variant,GRCh38
na,na,5,110440041,110440041,WDR36,Conflicting classifications of pathogenicity,"Glaucoma 1, open angle, G|not provided",single nucleotide variant,GRCh37
na,na,5,111104342,111104342,WDR36,Conflicting classifications of pathogenicity,"Glaucoma 1, open angle, G|not provided",single nucleotide variant,GRCh38
na,na,5,110441839,110441839,WDR36,Benign/Likely benign,"Glaucoma 1, open angle, G|not provided|Usher syndrome type 2C|WDR36-related disorder",single nucleotide variant,GRCh37
na,na,5,111106140,111106140,WDR36,Benign/Likely benign,"Glaucoma 1, open angle, G|not provided|Usher syndrome type 2C|WDR36-related disorder",single nucleotide variant,GRCh38
na,na,5,110445979,110445979,WDR36,Uncertain significance,"Glaucoma 1, open angle, G|not specified|not provided",single nucleotide variant,GRCh37
na,na,5,111110280,111110280,WDR36,Uncertain significance,"Glaucoma 1, open angle, G|not specified|not provided",single nucleotide variant,GRCh38
na,na,19,55452298,55452298,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh37
na,na,19,54940930,54940930,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh38
na,na,19,55445856,55445856,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh37
na,na,19,54934488,54934488,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh38
na,na,19,55449464,55449464,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh37
na,na,19,54938096,54938096,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh38
na,na,19,55449463,55449463,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh37
na,na,19,54938095,54938095,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh38
na,na,19,55441939,55441939,NLRP7,Likely pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh37
na,na,19,54930571,54930571,NLRP7,Likely pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh38
na,na,19,55450893,55450893,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh37
na,na,19,54939525,54939525,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh38
na,na,19,55449463,55449463,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh37
na,na,19,54938095,54938095,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh38
na,na,19,55450994,55450994,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh37
na,na,19,54939626,54939626,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh38
na,na,19,55449590,55449590,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh37
na,na,19,54938222,54938222,NLRP7,Pathogenic,"Hydatidiform mole, recurrent, 1",single nucleotide variant,GRCh38
na,na,5,60368963,60368963,NDUFAF2,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 10|Inborn genetic diseases|Leigh syndrome|not specified|Mitochondrial complex I deficiency, nuclear type 1|not provided",single nucleotide variant,GRCh37
na,na,5,61073136,61073136,NDUFAF2,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 10|Inborn genetic diseases|Leigh syndrome|not specified|Mitochondrial complex I deficiency, nuclear type 1|not provided",single nucleotide variant,GRCh38
na,na,5,60241185,60241185,NDUFAF2,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 10",Deletion,GRCh37
na,na,5,60945358,60945358,NDUFAF2,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 10",Deletion,GRCh38
na,na,19,54314063,54314063,NLRP12,Conflicting classifications of pathogenicity,Familial cold autoinflammatory syndrome 2|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh37
na,na,19,53810809,53810809,NLRP12,Conflicting classifications of pathogenicity,Familial cold autoinflammatory syndrome 2|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh38
na,na,19,54312838,54312839,NLRP12,Conflicting classifications of pathogenicity,Familial cold autoinflammatory syndrome 2|not provided|Autoinflammatory syndrome,Duplication,GRCh37
na,na,19,53809584,53809585,NLRP12,Conflicting classifications of pathogenicity,Familial cold autoinflammatory syndrome 2|not provided|Autoinflammatory syndrome,Duplication,GRCh38
na,na,14,45642268,45642268,FANCM,Uncertain significance,"Fanconi anemia, complementation group M",single nucleotide variant,GRCh37
na,na,14,45173065,45173065,FANCM,Uncertain significance,"Fanconi anemia, complementation group M",single nucleotide variant,GRCh38
na,na,14,45648157,45650710,FANCM,Uncertain significance,"Fanconi anemia, complementation group M",Deletion,GRCh37
na,na,14,45178954,45181507,FANCM,Uncertain significance,"Fanconi anemia, complementation group M",Deletion,GRCh38
na,na,1,161046145,161046145,NECTIN4,Pathogenic,Ectodermal dysplasia-syndactyly syndrome 1,single nucleotide variant,GRCh37
na,na,1,161076355,161076355,NECTIN4,Pathogenic,Ectodermal dysplasia-syndactyly syndrome 1,single nucleotide variant,GRCh38
na,na,1,161047419,161047419,NECTIN4,Pathogenic,Ectodermal dysplasia-syndactyly syndrome 1,single nucleotide variant,GRCh37
na,na,1,161077629,161077629,NECTIN4,Pathogenic,Ectodermal dysplasia-syndactyly syndrome 1,single nucleotide variant,GRCh38
na,na,1,161044495,161044495,NECTIN4,Pathogenic,Ectodermal dysplasia-syndactyly syndrome 1,Deletion,GRCh37
na,na,1,161074705,161074705,NECTIN4,Pathogenic,Ectodermal dysplasia-syndactyly syndrome 1,Deletion,GRCh38
na,na,1,38082333,38082334,RSPO1,Pathogenic,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,Duplication,GRCh37
na,na,1,37616661,37616662,RSPO1,Pathogenic,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,Duplication,GRCh38
na,na,1,38093283,38096034,RSPO1,Pathogenic,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,Deletion,GRCh37
na,na,1,37627611,37630362,RSPO1,Pathogenic,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,Deletion,GRCh38
na,na,1,38082155,38082155,RSPO1,Pathogenic,Palmoplantar hyperkeratosis and true hermaphroditism,single nucleotide variant,GRCh37
na,na,1,37616483,37616483,RSPO1,Pathogenic,Palmoplantar hyperkeratosis and true hermaphroditism,single nucleotide variant,GRCh38
na,na,14,96001720,96001720,GLRX5,Pathogenic,Sideroblastic anemia 3,single nucleotide variant,GRCh37
na,na,14,95535383,95535383,GLRX5,Pathogenic,Sideroblastic anemia 3,single nucleotide variant,GRCh38
na,na,14,50735882,50735882,L2HGDH,Pathogenic/Likely pathogenic,L-2-hydroxyglutaric aciduria|not provided,single nucleotide variant,GRCh37
na,na,14,50269164,50269164,L2HGDH,Pathogenic/Likely pathogenic,L-2-hydroxyglutaric aciduria|not provided,single nucleotide variant,GRCh38
na,na,14,50732157,50732157,L2HGDH,Pathogenic,L-2-hydroxyglutaric aciduria,Deletion,GRCh37
na,na,14,50265439,50265439,L2HGDH,Pathogenic,L-2-hydroxyglutaric aciduria,Deletion,GRCh38
na,na,14,50735880,50735880,L2HGDH,Pathogenic,L-2-hydroxyglutaric aciduria,single nucleotide variant,GRCh37
na,na,14,50269162,50269162,L2HGDH,Pathogenic,L-2-hydroxyglutaric aciduria,single nucleotide variant,GRCh38
na,na,14,50769712,50769712,L2HGDH,Pathogenic/Likely pathogenic,L-2-hydroxyglutaric aciduria|L2HGDH-related disorder,single nucleotide variant,GRCh37
na,na,14,50302994,50302994,L2HGDH,Pathogenic/Likely pathogenic,L-2-hydroxyglutaric aciduria|L2HGDH-related disorder,single nucleotide variant,GRCh38
na,na,14,50000000,50247254,L2HGDH,Pathogenic,L-2-hydroxyglutaric aciduria,Deletion,GRCh38
na,na,14,50768850,50768850,L2HGDH,Pathogenic/Likely pathogenic,L-2-hydroxyglutaric aciduria|not provided,single nucleotide variant,GRCh37
na,na,14,50302132,50302132,L2HGDH,Pathogenic/Likely pathogenic,L-2-hydroxyglutaric aciduria|not provided,single nucleotide variant,GRCh38
na,na,6,43006687,43006687,CUL7,Pathogenic,3M syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,6,43038949,43038949,CUL7,Pathogenic,3M syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,6,43006629,43006629,CUL7,Pathogenic/Likely pathogenic,3M syndrome 1|3-M syndrome|not provided,single nucleotide variant,GRCh37
na,na,6,43038891,43038891,CUL7,Pathogenic/Likely pathogenic,3M syndrome 1|3-M syndrome|not provided,single nucleotide variant,GRCh38
na,na,6,43006419,43006420,CUL7,Pathogenic,3M syndrome 1|CUL7-related disorder,Microsatellite,GRCh37
na,na,6,43038681,43038682,CUL7,Pathogenic,3M syndrome 1|CUL7-related disorder,Microsatellite,GRCh38
na,na,6,43006196,43006197,CUL7,Pathogenic,Yakut short stature syndrome,Duplication,GRCh37
na,na,6,43038458,43038459,CUL7,Pathogenic,Yakut short stature syndrome,Duplication,GRCh38
na,na,6,43010894,43010895,CUL7,Pathogenic,3M syndrome 1|not provided,Deletion,GRCh37
na,na,6,43043156,43043157,CUL7,Pathogenic,3M syndrome 1|not provided,Deletion,GRCh38
na,na,6,43017403,43017403,CUL7,Pathogenic,3M syndrome 1,single nucleotide variant,GRCh37
na,na,6,43049665,43049665,CUL7,Pathogenic,3M syndrome 1,single nucleotide variant,GRCh38
na,na,2,211060050,211060050,ACADL,Benign,not provided,single nucleotide variant,GRCh37
na,na,2,210195326,210195326,ACADL,Benign,not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,ACADVL,Pathogenic,Very long chain acyl-CoA dehydrogenase deficiency,Deletion,na
na,na,17,7126557,7126557,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,17,7223238,7223238,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,17,7128285,7128285,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,17,7224966,7224966,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,17,7124242,7124242,ACADVL,Pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|Inborn genetic diseases,Deletion,GRCh37
na,na,17,7220923,7220923,ACADVL,Pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|Inborn genetic diseases,Deletion,GRCh38
na,na,17,7124284,7124286,ACADVL,Pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|ACADVL-related disorder,Microsatellite,GRCh37
na,na,17,7220965,7220967,ACADVL,Pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|ACADVL-related disorder,Microsatellite,GRCh38
na,na,17,7126518,7126518,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,17,7223199,7223199,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,17,7123838,7123838,ACADVL,Benign,Very long chain acyl-CoA dehydrogenase deficiency|not specified|not provided,single nucleotide variant,GRCh37
na,na,17,7220519,7220519,ACADVL,Benign,Very long chain acyl-CoA dehydrogenase deficiency|not specified|not provided,single nucleotide variant,GRCh38
na,na,17,7127326,7127326,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|ACADVL-related disorder,single nucleotide variant,GRCh37
na,na,17,7224007,7224007,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|ACADVL-related disorder,single nucleotide variant,GRCh38
na,na,17,7127026,7127026,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,17,7223707,7223707,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,17,7127303,7127303,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|Rhabdomyolysis;Abnormal circulating enzyme concentration,single nucleotide variant,GRCh37
na,na,17,7223984,7223984,ACADVL,Likely pathogenic,Very long chain acyl-CoA dehydrogenase deficiency|not provided|Rhabdomyolysis;Abnormal circulating enzyme concentration,single nucleotide variant,GRCh38
na,na,16,67313932,67313932,PLEKHG4,Uncertain significance,Spinocerebellar ataxia type 31,single nucleotide variant,GRCh37
na,na,16,67280029,67280029,PLEKHG4,Uncertain significance,Spinocerebellar ataxia type 31,single nucleotide variant,GRCh38
na,na,17,19559728,19559728,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome,Deletion,GRCh37
na,na,17,19656415,19656415,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome,Deletion,GRCh38
na,na,17,19564449,19564449,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome,Deletion,GRCh37
na,na,17,19661136,19661136,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome,Deletion,GRCh38
na,na,17,19566646,19566648,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome|Cerebral palsy|Inborn genetic diseases,Indel,GRCh37
na,na,17,19663333,19663335,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome|Cerebral palsy|Inborn genetic diseases,Indel,GRCh38
na,na,17,19559848,19559848,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome,single nucleotide variant,GRCh37
na,na,17,19656535,19656535,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome,single nucleotide variant,GRCh38
na,na,17,19566648,19566648,ALDH3A2,Pathogenic/Likely pathogenic,Sjögren-Larsson syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,19663335,19663335,ALDH3A2,Pathogenic/Likely pathogenic,Sjögren-Larsson syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,19575118,19575119,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome|not provided,Microsatellite,GRCh37
na,na,17,19671805,19671806,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome|not provided,Microsatellite,GRCh38
na,na,17,19575131,19575132,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome|not provided,Duplication,GRCh37
na,na,17,19671818,19671819,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome|not provided,Duplication,GRCh38
na,na,17,19561175,19561175,ALDH3A2,Pathogenic/Likely pathogenic,Sjögren-Larsson syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,19657862,19657862,ALDH3A2,Pathogenic/Likely pathogenic,Sjögren-Larsson syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,19568310,19568310,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,19664997,19664997,ALDH3A2,Pathogenic,Sjögren-Larsson syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,42694355,42694355,THAP1,Uncertain significance,Torsion dystonia 6,single nucleotide variant,GRCh37
na,na,8,42839212,42839212,THAP1,Uncertain significance,Torsion dystonia 6,single nucleotide variant,GRCh38
na,na,8,42693287,42693287,THAP1,Pathogenic,Torsion dystonia 6,Deletion,GRCh37
na,na,8,42838144,42838144,THAP1,Pathogenic,Torsion dystonia 6,Deletion,GRCh38
na,na,8,42694330,42694330,THAP1,Uncertain significance,Torsion dystonia 6|not provided,single nucleotide variant,GRCh37
na,na,8,42839187,42839187,THAP1,Uncertain significance,Torsion dystonia 6|not provided,single nucleotide variant,GRCh38
na,na,8,42693358,42693359,THAP1,Pathogenic,Torsion dystonia 6,Microsatellite,GRCh37
na,na,8,42838215,42838216,THAP1,Pathogenic,Torsion dystonia 6,Microsatellite,GRCh38
na,na,8,42693273,42693273,THAP1,Pathogenic,Torsion dystonia 6,Deletion,GRCh37
na,na,8,42838130,42838130,THAP1,Pathogenic,Torsion dystonia 6,Deletion,GRCh38
na,na,8,42698213,42698213,THAP1,Pathogenic,Torsion dystonia 6,single nucleotide variant,GRCh37
na,na,8,42843070,42843070,THAP1,Pathogenic,Torsion dystonia 6,single nucleotide variant,GRCh38
na,na,3,87302571,87302571,CHMP2B,Uncertain significance,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided,single nucleotide variant,GRCh37
na,na,3,87253421,87253421,CHMP2B,Uncertain significance,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided,single nucleotide variant,GRCh38
na,na,3,87302948,87302948,CHMP2B,Pathogenic,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided,single nucleotide variant,GRCh37
na,na,3,87253798,87253798,CHMP2B,Pathogenic,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided,single nucleotide variant,GRCh38
na,na,3,87302622,87302622,CHMP2B,Pathogenic,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided,single nucleotide variant,GRCh37
na,na,3,87253472,87253472,CHMP2B,Pathogenic,Frontotemporal dementia and/or amyotrophic lateral sclerosis 7|not provided,single nucleotide variant,GRCh38
na,na,9,32542048,32542049,TOPORS,Pathogenic,Retinitis pigmentosa 31|not provided|TOPORS-related disorder,Duplication,GRCh37
na,na,9,32542050,32542051,TOPORS,Pathogenic,Retinitis pigmentosa 31|not provided|TOPORS-related disorder,Duplication,GRCh38
na,na,12,58159856,58159856,CYP27B1,Likely pathogenic,"Vitamin D-dependent rickets, type 1|Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh37
na,na,12,57766073,57766073,CYP27B1,Likely pathogenic,"Vitamin D-dependent rickets, type 1|Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh38
na,na,12,58159802,58159802,CYP27B1,Likely pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh37
na,na,12,57766019,57766019,CYP27B1,Likely pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh38
na,na,12,58158293,58158293,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh37
na,na,12,57764510,57764510,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh38
na,na,12,58157952,58157952,CYP27B1,Uncertain significance,"Vitamin D-dependent rickets, type 1A|not provided",single nucleotide variant,GRCh37
na,na,12,57764169,57764169,CYP27B1,Uncertain significance,"Vitamin D-dependent rickets, type 1A|not provided",single nucleotide variant,GRCh38
na,na,12,58158953,58158953,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",Deletion,GRCh37
na,na,12,57765170,57765170,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",Deletion,GRCh38
na,na,12,58158891,58158891,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",Deletion,GRCh37
na,na,12,57765108,57765108,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",Deletion,GRCh38
na,na,12,58159914,58159914,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A|not provided|CYP27B1-related disorder",Deletion,GRCh37
na,na,12,57766131,57766131,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A|not provided|CYP27B1-related disorder",Deletion,GRCh38
na,na,12,58158538,58158538,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh37
na,na,12,57764755,57764755,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh38
na,na,12,58159079,58159079,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh37
na,na,12,57765296,57765296,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh38
na,na,12,58157581,58157581,CYP27B1,Pathogenic/Likely pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",single nucleotide variant,GRCh37
na,na,12,57763798,57763798,CYP27B1,Pathogenic/Likely pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",single nucleotide variant,GRCh38
na,na,12,58157930,58157930,CYP27B1,Pathogenic/Likely pathogenic,"Vitamin D-dependent rickets, type 1|not provided|Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh37
na,na,12,57764147,57764147,CYP27B1,Pathogenic/Likely pathogenic,"Vitamin D-dependent rickets, type 1|not provided|Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh38
na,na,12,58159972,58159975,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",Indel,GRCh37
na,na,12,57766189,57766192,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",Indel,GRCh38
na,na,12,58159789,58159789,CYP27B1,Likely pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",single nucleotide variant,GRCh37
na,na,12,57766006,57766006,CYP27B1,Likely pathogenic,"Vitamin D-dependent rickets, type 1A|not provided",single nucleotide variant,GRCh38
na,na,12,58157931,58157931,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh37
na,na,12,57764148,57764148,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh38
na,na,12,58158270,58158270,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh37
na,na,12,57764487,57764487,CYP27B1,Pathogenic,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh38
na,na,12,58159103,58159103,CYP27B1,Uncertain significance,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh37
na,na,12,57765320,57765320,CYP27B1,Uncertain significance,"Vitamin D-dependent rickets, type 1A",single nucleotide variant,GRCh38
na,na,4,103610730,103610730,MANBA,Pathogenic/Likely pathogenic,Beta-D-mannosidosis|not provided,single nucleotide variant,GRCh37
na,na,4,102689573,102689573,MANBA,Pathogenic/Likely pathogenic,Beta-D-mannosidosis|not provided,single nucleotide variant,GRCh38
na,na,4,103635695,103635696,MANBA,Pathogenic,Beta-D-mannosidosis,Duplication,GRCh37
na,na,4,102714538,102714539,MANBA,Pathogenic,Beta-D-mannosidosis,Duplication,GRCh38
na,na,4,103571859,103571859,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh37
na,na,4,102650702,102650702,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh38
na,na,4,103579030,103579030,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh37
na,na,4,102657873,102657873,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh38
na,na,4,103645022,103645022,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh37
na,na,4,102723865,102723865,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh38
na,na,4,103647771,103647771,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh37
na,na,4,102726614,102726614,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh38
na,na,4,103590161,103590161,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh37
na,na,4,102669004,102669004,MANBA,Pathogenic,Beta-D-mannosidosis,single nucleotide variant,GRCh38
na,na,4,103585872,103585873,MANBA,Pathogenic,Beta-D-mannosidosis,Deletion,GRCh37
na,na,4,102664715,102664716,MANBA,Pathogenic,Beta-D-mannosidosis,Deletion,GRCh38
na,na,19,12776564,12776564,MAN2B1,Pathogenic/Likely pathogenic,Deficiency of alpha-mannosidase,single nucleotide variant,GRCh37
na,na,19,12665750,12665750,MAN2B1,Pathogenic/Likely pathogenic,Deficiency of alpha-mannosidase,single nucleotide variant,GRCh38
na,na,19,12760232,12760232,MAN2B1,Pathogenic,Deficiency of alpha-mannosidase,single nucleotide variant,GRCh37
na,na,19,12649418,12649418,MAN2B1,Pathogenic,Deficiency of alpha-mannosidase,single nucleotide variant,GRCh38
na,na,19,12763190,12763190,MAN2B1,Likely pathogenic,Deficiency of alpha-mannosidase,single nucleotide variant,GRCh37
na,na,19,12652376,12652376,MAN2B1,Likely pathogenic,Deficiency of alpha-mannosidase,single nucleotide variant,GRCh38
na,na,19,12760746,12760746,MAN2B1,Pathogenic/Likely pathogenic,Deficiency of alpha-mannosidase|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,19,12649932,12649932,MAN2B1,Pathogenic/Likely pathogenic,Deficiency of alpha-mannosidase|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,19,12769284,12769284,MAN2B1,Uncertain significance,Deficiency of alpha-mannosidase,single nucleotide variant,GRCh37
na,na,19,12658470,12658470,MAN2B1,Uncertain significance,Deficiency of alpha-mannosidase,single nucleotide variant,GRCh38
na,na,12,96386556,96386556,HAL,Affects,Histidinemia,single nucleotide variant,GRCh37
na,na,12,95992778,95992778,HAL,Affects,Histidinemia,single nucleotide variant,GRCh38
na,na,12,96386550,96386550,HAL,Affects,Histidinemia,single nucleotide variant,GRCh37
na,na,12,95992772,95992772,HAL,Affects,Histidinemia,single nucleotide variant,GRCh38
na,na,12,96384250,96384250,HAL,Affects,Histidinemia,single nucleotide variant,GRCh37
na,na,12,95990472,95990472,HAL,Affects,Histidinemia,single nucleotide variant,GRCh38
na,na,12,96380931,96380931,HAL,Affects,Histidinemia,single nucleotide variant,GRCh37
na,na,12,95987153,95987153,HAL,Affects,Histidinemia,single nucleotide variant,GRCh38
na,na,19,19627062,19627062,NDUFA13,Pathogenic,Hurthle cell carcinoma of thyroid,single nucleotide variant,GRCh37
na,na,19,19516253,19516253,NDUFA13,Pathogenic,Hurthle cell carcinoma of thyroid,single nucleotide variant,GRCh38
na,na,6,35773693,35773693,LHFPL5,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 67|Hearing loss, autosomal recessive",Deletion,GRCh37
na,na,6,35805916,35805916,LHFPL5,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 67|Hearing loss, autosomal recessive",Deletion,GRCh38
na,na,6,35773827,35773827,LHFPL5,Pathogenic,Autosomal recessive nonsyndromic hearing loss 67,single nucleotide variant,GRCh37
na,na,6,35806050,35806050,LHFPL5,Pathogenic,Autosomal recessive nonsyndromic hearing loss 67,single nucleotide variant,GRCh38
na,na,6,35782559,35782559,LHFPL5,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 67|Ear malformation,Deletion,GRCh37
na,na,6,35814782,35814782,LHFPL5,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 67|Ear malformation,Deletion,GRCh38
na,na,6,35782404,35782404,LHFPL5,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 67|not provided|LHFPL5-related disorder,single nucleotide variant,GRCh37
na,na,6,35814627,35814627,LHFPL5,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 67|not provided|LHFPL5-related disorder,single nucleotide variant,GRCh38
na,na,2,209190843,209190843,PIKFYVE,Pathogenic,Fleck corneal dystrophy,single nucleotide variant,GRCh37
na,na,2,208326119,208326119,PIKFYVE,Pathogenic,Fleck corneal dystrophy,single nucleotide variant,GRCh38
na,na,2,209190497,209190497,PIKFYVE,Pathogenic,Fleck corneal dystrophy,single nucleotide variant,GRCh37
na,na,2,208325773,208325773,PIKFYVE,Pathogenic,Fleck corneal dystrophy,single nucleotide variant,GRCh38
na,na,10,50708719,50708719,ERCC6,Pathogenic,Cockayne syndrome type 2|not provided,single nucleotide variant,GRCh37
na,na,10,49500673,49500673,ERCC6,Pathogenic,Cockayne syndrome type 2|not provided,single nucleotide variant,GRCh38
na,na,10,50686483,50686483,ERCC6,Pathogenic,DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome type 2|ERCC6-related disorder|not provided|Cerebrooculofacioskeletal syndrome 1|7 conditions,single nucleotide variant,GRCh37
na,na,10,49478437,49478437,ERCC6,Pathogenic,DE SANCTIS-CACCHIONE SYNDROME|Cockayne syndrome type 2|ERCC6-related disorder|not provided|Cerebrooculofacioskeletal syndrome 1|7 conditions,single nucleotide variant,GRCh38
na,na,10,50732119,50732119,ERCC6,Pathogenic,Cockayne syndrome type 2|Cockayne syndrome type 2;DE SANCTIS-CACCHIONE SYNDROME;Cerebrooculofacioskeletal syndrome 1|7 conditions|not provided|7 conditions,single nucleotide variant,GRCh37
na,na,10,49524073,49524073,ERCC6,Pathogenic,Cockayne syndrome type 2|Cockayne syndrome type 2;DE SANCTIS-CACCHIONE SYNDROME;Cerebrooculofacioskeletal syndrome 1|7 conditions|not provided|7 conditions,single nucleotide variant,GRCh38
na,na,10,50732503,50732504,ERCC6,Pathogenic,Cockayne syndrome type 2,Duplication,GRCh37
na,na,10,49524457,49524458,ERCC6,Pathogenic,Cockayne syndrome type 2,Duplication,GRCh38
na,na,10,50691409,50691410,ERCC6,Pathogenic,Cockayne syndrome type 2|7 conditions|not provided,Duplication,GRCh37
na,na,10,49483363,49483364,ERCC6,Pathogenic,Cockayne syndrome type 2|7 conditions|not provided,Duplication,GRCh38
na,na,10,50678290,50678291,ERCC6,Pathogenic,Cerebrooculofacioskeletal syndrome 1|ERCC6-related disorder|not provided,Deletion,GRCh37
na,na,10,49470244,49470245,ERCC6,Pathogenic,Cerebrooculofacioskeletal syndrome 1|ERCC6-related disorder|not provided,Deletion,GRCh38
na,na,10,50678722,50678722,ERCC6,Conflicting classifications of pathogenicity,Cockayne syndrome type 2|not specified|Cerebrooculofacioskeletal syndrome 1|not provided|Age related macular degeneration 5|DE SANCTIS-CACCHIONE SYNDROME,single nucleotide variant,GRCh37
na,na,10,49470676,49470676,ERCC6,Conflicting classifications of pathogenicity,Cockayne syndrome type 2|not specified|Cerebrooculofacioskeletal syndrome 1|not provided|Age related macular degeneration 5|DE SANCTIS-CACCHIONE SYNDROME,single nucleotide variant,GRCh38
na,na,10,50740782,50740782,ERCC6,Pathogenic,UV-sensitive syndrome 1|Cockayne syndrome type 2|not provided|Cockayne syndrome,single nucleotide variant,GRCh37
na,na,10,49532736,49532736,ERCC6,Pathogenic,UV-sensitive syndrome 1|Cockayne syndrome type 2|not provided|Cockayne syndrome,single nucleotide variant,GRCh38
na,na,10,50747539,50747539,ERCC6,Benign,"LUNG CANCER, SUSCEPTIBILITY TO|Age related macular degeneration 5|not provided",single nucleotide variant,GRCh37
na,na,10,49539493,49539493,ERCC6,Benign,"LUNG CANCER, SUSCEPTIBILITY TO|Age related macular degeneration 5|not provided",single nucleotide variant,GRCh38
na,na,10,50732441,50732442,ERCC6,Pathogenic,Cockayne syndrome type 2|not provided,Insertion,GRCh37
na,na,10,49524395,49524396,ERCC6,Pathogenic,Cockayne syndrome type 2|not provided,Insertion,GRCh38
na,na,10,50690855,50690855,ERCC6,Pathogenic/Likely pathogenic,Cerebrooculofacioskeletal syndrome 1|not provided|ERCC6-related disorder|DE SANCTIS-CACCHIONE SYNDROME|7 conditions|Cockayne syndrome type 2,single nucleotide variant,GRCh37
na,na,10,49482809,49482809,ERCC6,Pathogenic/Likely pathogenic,Cerebrooculofacioskeletal syndrome 1|not provided|ERCC6-related disorder|DE SANCTIS-CACCHIONE SYNDROME|7 conditions|Cockayne syndrome type 2,single nucleotide variant,GRCh38
na,na,10,50679131,50679131,ERCC6,Uncertain significance,Cerebrooculofacioskeletal syndrome 1|not specified,single nucleotide variant,GRCh37
na,na,10,49471085,49471085,ERCC6,Uncertain significance,Cerebrooculofacioskeletal syndrome 1|not specified,single nucleotide variant,GRCh38
na,na,10,50686432,50686432,ERCC6,Pathogenic,Cerebrooculofacioskeletal syndrome 1,single nucleotide variant,GRCh37
na,na,10,49478386,49478386,ERCC6,Pathogenic,Cerebrooculofacioskeletal syndrome 1,single nucleotide variant,GRCh38
na,na,na,-1,-1,ERCC8,Pathogenic,Cockayne syndrome type 1,Deletion,na
na,na,5,60186791,60186791,ERCC8,Pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome,single nucleotide variant,GRCh37
na,na,5,60890964,60890964,ERCC8,Pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome,single nucleotide variant,GRCh38
na,na,5,60240799,60240799,NDUFAF2;ERCC8,Pathogenic/Likely pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome|Cockayne syndrome type 1;UV-sensitive syndrome 2,single nucleotide variant,GRCh37
na,na,5,60944972,60944972,NDUFAF2;ERCC8,Pathogenic/Likely pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome|Cockayne syndrome type 1;UV-sensitive syndrome 2,single nucleotide variant,GRCh38
na,na,5,60200621,60200621,ERCC8,Pathogenic/Likely pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome,single nucleotide variant,GRCh37
na,na,5,60904794,60904794,ERCC8,Pathogenic/Likely pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome,single nucleotide variant,GRCh38
na,na,5,60198273,60198273,ERCC8,Pathogenic/Likely pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome type 1;UV-sensitive syndrome 2,single nucleotide variant,GRCh37
na,na,5,60902446,60902446,ERCC8,Pathogenic/Likely pathogenic,Cockayne syndrome type 1|not provided|Cockayne syndrome type 1;UV-sensitive syndrome 2,single nucleotide variant,GRCh38
na,na,10,70641860,70641860,STOX1,risk factor,Preeclampsia/eclampsia 4,single nucleotide variant,GRCh37
na,na,10,68882104,68882104,STOX1,risk factor,Preeclampsia/eclampsia 4,single nucleotide variant,GRCh38
na,na,10,70645376,70645376,STOX1,Benign,Preeclampsia/eclampsia 4|not specified|not provided,single nucleotide variant,GRCh37
na,na,10,68885620,68885620,STOX1,Benign,Preeclampsia/eclampsia 4|not specified|not provided,single nucleotide variant,GRCh38
na,na,6,110036336,110036336,FIG4,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 4J|Charcot-Marie-Tooth disease type 4|not provided|Amyotrophic lateral sclerosis|Amyotrophic lateral sclerosis type 11|Yunis-Varon syndrome|Bilateral parasagittal parieto-occipital polymicrogyria|Yunis-Varon syndrome;Charcot-Marie-Tooth disease type 4J|Inborn genetic diseases|FIG4-related disorder|Bilateral parasagittal parieto-occipital polymicrogyria;Yunis-Varon syndrome;Amyotrophic lateral sclerosis type 11;Charcot-Marie-Tooth disease type 4J,single nucleotide variant,GRCh37
na,na,6,109715133,109715133,FIG4,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 4J|Charcot-Marie-Tooth disease type 4|not provided|Amyotrophic lateral sclerosis|Amyotrophic lateral sclerosis type 11|Yunis-Varon syndrome|Bilateral parasagittal parieto-occipital polymicrogyria|Yunis-Varon syndrome;Charcot-Marie-Tooth disease type 4J|Inborn genetic diseases|FIG4-related disorder|Bilateral parasagittal parieto-occipital polymicrogyria;Yunis-Varon syndrome;Amyotrophic lateral sclerosis type 11;Charcot-Marie-Tooth disease type 4J,single nucleotide variant,GRCh38
na,na,6,110048313,110048313,FIG4,Pathogenic,Charcot-Marie-Tooth disease type 4J|Yunis-Varon syndrome|Charcot-Marie-Tooth disease,Deletion,GRCh37
na,na,6,109727110,109727110,FIG4,Pathogenic,Charcot-Marie-Tooth disease type 4J|Yunis-Varon syndrome|Charcot-Marie-Tooth disease,Deletion,GRCh38
na,na,6,110056402,110056402,FIG4,Pathogenic/Likely pathogenic,Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease type 4J|not provided|Amyotrophic lateral sclerosis|Charcot-Marie-Tooth disease type 4|FIG4-related disorder,single nucleotide variant,GRCh37
na,na,6,109735199,109735199,FIG4,Pathogenic/Likely pathogenic,Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease type 4J|not provided|Amyotrophic lateral sclerosis|Charcot-Marie-Tooth disease type 4|FIG4-related disorder,single nucleotide variant,GRCh38
na,na,6,110064881,110064888,FIG4,Pathogenic,Charcot-Marie-Tooth disease type 4J|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4,Deletion,GRCh37
na,na,6,109743678,109743685,FIG4,Pathogenic,Charcot-Marie-Tooth disease type 4J|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4,Deletion,GRCh38
na,na,6,110036371,110036371,FIG4,Uncertain significance,Amyotrophic lateral sclerosis type 11|Amyotrophic lateral sclerosis,single nucleotide variant,GRCh37
na,na,6,109715168,109715168,FIG4,Uncertain significance,Amyotrophic lateral sclerosis type 11|Amyotrophic lateral sclerosis,single nucleotide variant,GRCh38
na,na,5,156890311,156890311,NIPAL4,Pathogenic,Autosomal recessive congenital ichthyosis 6|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,5,157463303,157463303,NIPAL4,Pathogenic,Autosomal recessive congenital ichthyosis 6|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,na,-1,-1,NIPAL4,Pathogenic,Autosomal recessive congenital ichthyosis 6,single nucleotide variant,na
na,na,5,156895736,156895736,NIPAL4,Pathogenic,Autosomal recessive congenital ichthyosis 6|not provided|Autosomal recessive congenital ichthyosis|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,5,157468728,157468728,NIPAL4,Pathogenic,Autosomal recessive congenital ichthyosis 6|not provided|Autosomal recessive congenital ichthyosis|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,5,156898826,156898826,NIPAL4,Pathogenic,Autosomal recessive congenital ichthyosis 6,single nucleotide variant,GRCh37
na,na,5,157471818,157471818,NIPAL4,Pathogenic,Autosomal recessive congenital ichthyosis 6,single nucleotide variant,GRCh38
na,na,10,70748856,70748856,KIFBP,Pathogenic,Goldberg-Shprintzen syndrome,single nucleotide variant,GRCh37
na,na,10,68989100,68989100,KIFBP,Pathogenic,Goldberg-Shprintzen syndrome,single nucleotide variant,GRCh38
na,na,10,70748838,70748838,KIFBP,Pathogenic,Goldberg-Shprintzen syndrome,single nucleotide variant,GRCh37
na,na,10,68989082,68989082,KIFBP,Pathogenic,Goldberg-Shprintzen syndrome,single nucleotide variant,GRCh38
na,na,8,27657175,27657175,ESCO2,Likely pathogenic,Roberts-SC phocomelia syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,27799658,27799658,ESCO2,Likely pathogenic,Roberts-SC phocomelia syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,27634330,27634330,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided|Roberts syndrome|Roberts-SC phocomelia syndrome;Juberg-Hayward syndrome,single nucleotide variant,GRCh37
na,na,8,27776813,27776813,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided|Roberts syndrome|Roberts-SC phocomelia syndrome;Juberg-Hayward syndrome,single nucleotide variant,GRCh38
na,na,8,27634575,27634576,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided,Duplication,GRCh37
na,na,8,27777058,27777059,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided,Duplication,GRCh38
na,na,8,27634576,27634577,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided|Roberts-SC phocomelia syndrome;Juberg-Hayward syndrome|ESCO2-related disorder,Duplication,GRCh37
na,na,8,27777059,27777060,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided|Roberts-SC phocomelia syndrome;Juberg-Hayward syndrome|ESCO2-related disorder,Duplication,GRCh38
na,na,8,27649485,27649485,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,27791968,27791968,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,27634429,27634429,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,27776912,27776912,ESCO2,Pathogenic,Roberts-SC phocomelia syndrome|not provided,single nucleotide variant,GRCh38
na,na,11,59612859,59612859,CBLIF,Benign,"Intrinsic factor deficiency, congenital, susceptibility to|Hereditary intrinsic factor deficiency|not provided",single nucleotide variant,GRCh37
na,na,11,59845386,59845386,CBLIF,Benign,"Intrinsic factor deficiency, congenital, susceptibility to|Hereditary intrinsic factor deficiency|not provided",single nucleotide variant,GRCh38
na,na,11,59611529,59611529,CBLIF,Pathogenic,Hereditary intrinsic factor deficiency,single nucleotide variant,GRCh37
na,na,11,59844056,59844056,CBLIF,Pathogenic,Hereditary intrinsic factor deficiency,single nucleotide variant,GRCh38
na,na,11,59611471,59611471,CBLIF,Likely pathogenic,Hereditary intrinsic factor deficiency,single nucleotide variant,GRCh37
na,na,11,59843998,59843998,CBLIF,Likely pathogenic,Hereditary intrinsic factor deficiency,single nucleotide variant,GRCh38
na,na,11,59611447,59611447,CBLIF,Pathogenic,Hereditary intrinsic factor deficiency,Deletion,GRCh37
na,na,11,59843974,59843974,CBLIF,Pathogenic,Hereditary intrinsic factor deficiency,Deletion,GRCh38
na,na,11,59599167,59599168,CBLIF,Pathogenic,Hereditary intrinsic factor deficiency,Duplication,GRCh37
na,na,11,59831694,59831695,CBLIF,Pathogenic,Hereditary intrinsic factor deficiency,Duplication,GRCh38
na,na,9,136500515,136500515,DBH,association,Dopamine beta-hydroxylase polymorphism,single nucleotide variant,GRCh37
na,na,9,133635393,133635393,DBH,association,Dopamine beta-hydroxylase polymorphism,single nucleotide variant,GRCh38
na,na,9,136501834,136501834,DBH,Pathogenic,Orthostatic hypotension 1|not provided,single nucleotide variant,GRCh37
na,na,9,133636712,133636712,DBH,Pathogenic,Orthostatic hypotension 1|not provided,single nucleotide variant,GRCh38
na,na,9,136504970,136504970,DBH,Uncertain significance,Orthostatic hypotension 1,single nucleotide variant,GRCh37
na,na,9,133639848,133639848,DBH,Uncertain significance,Orthostatic hypotension 1,single nucleotide variant,GRCh38
na,na,9,136501794,136501794,DBH,Uncertain significance,Orthostatic hypotension 1,single nucleotide variant,GRCh37
na,na,9,133636672,133636672,DBH,Uncertain significance,Orthostatic hypotension 1,single nucleotide variant,GRCh38
na,na,2,47702269,47702269,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided,single nucleotide variant,GRCh37
na,na,2,47475130,47475130,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,MSH2,Pathogenic,Lynch syndrome 1,Deletion,na
na,na,2,47657020,47657020,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|not provided|Carcinoma of colon|Lynch syndrome 1;Muir-Torré syndrome;Mismatch repair cancer syndrome 1|Gastric cancer,single nucleotide variant,GRCh37
na,na,2,47429881,47429881,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|not provided|Carcinoma of colon|Lynch syndrome 1;Muir-Torré syndrome;Mismatch repair cancer syndrome 1|Gastric cancer,single nucleotide variant,GRCh38
na,na,2,47702319,47702319,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary nonpolyposis colon cancer,single nucleotide variant,GRCh37
na,na,2,47475180,47475180,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary nonpolyposis colon cancer,single nucleotide variant,GRCh38
na,na,2,47702190,47702192,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms|Carcinoma of colon|MSH2-related disorder,Deletion,GRCh37
na,na,2,47475051,47475053,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms|Carcinoma of colon|MSH2-related disorder,Deletion,GRCh38
na,na,2,47702205,47702205,MSH2,Pathogenic,Muir-Torré syndrome|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch syndrome 1,single nucleotide variant,GRCh37
na,na,2,47475066,47475066,MSH2,Pathogenic,Muir-Torré syndrome|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch syndrome 1,single nucleotide variant,GRCh38
na,na,2,47693857,47693857,MSH2,Likely pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Hereditary nonpolyposis colon cancer,single nucleotide variant,GRCh37
na,na,2,47466718,47466718,MSH2,Likely pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Hereditary nonpolyposis colon cancer,single nucleotide variant,GRCh38
na,na,2,47703613,47703613,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer|Hereditary nonpolyposis colorectal neoplasms,Deletion,GRCh37
na,na,2,47476474,47476474,MSH2,Pathogenic,Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colon cancer|Hereditary nonpolyposis colorectal neoplasms,Deletion,GRCh38
na,na,2,47635595,47635596,MSH2,Pathogenic,Muir-Torré syndrome|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms,Duplication,GRCh37
na,na,2,47408456,47408457,MSH2,Pathogenic,Muir-Torré syndrome|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms,Duplication,GRCh38
na,na,2,47643457,47643457,MSH2,Benign,MSH2 POLYMORPHISM|not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome 1|not specified|Breast carcinoma|Hereditary nonpolyposis colorectal neoplasms|Carcinoma of colon,single nucleotide variant,GRCh37
na,na,2,47416318,47416318,MSH2,Benign,MSH2 POLYMORPHISM|not provided|Lynch syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome 1|not specified|Breast carcinoma|Hereditary nonpolyposis colorectal neoplasms|Carcinoma of colon,single nucleotide variant,GRCh38
na,na,2,47702310,47702310,MSH2,Pathogenic,Lynch syndrome|Lynch syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Mismatch repair cancer syndrome 1;Muir-Torré syndrome;Lynch syndrome 1|Hereditary nonpolyposis colorectal neoplasms|Carcinoma of colon,single nucleotide variant,GRCh37
na,na,2,47475171,47475171,MSH2,Pathogenic,Lynch syndrome|Lynch syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Mismatch repair cancer syndrome 1;Muir-Torré syndrome;Lynch syndrome 1|Hereditary nonpolyposis colorectal neoplasms|Carcinoma of colon,single nucleotide variant,GRCh38
na,na,na,-1,-1,MSH2,Pathogenic,Lynch syndrome 1,Insertion,na
na,na,2,47637317,47637317,MSH2,Pathogenic,Mismatch repair cancer syndrome 2|Lynch syndrome,Deletion,GRCh37
na,na,2,47410178,47410178,MSH2,Pathogenic,Mismatch repair cancer syndrome 2|Lynch syndrome,Deletion,GRCh38
na,na,2,47618487,47650860,MSH2,Pathogenic,Muir-Torré syndrome|Lynch syndrome 1,Deletion,GRCh37
na,na,11,792429,792429,SLC25A22,Pathogenic/Likely pathogenic,"Early myoclonic encephalopathy|Developmental and epileptic encephalopathy|Developmental and epileptic encephalopathy, 3",single nucleotide variant,GRCh37
na,na,11,792429,792429,SLC25A22,Pathogenic/Likely pathogenic,"Early myoclonic encephalopathy|Developmental and epileptic encephalopathy|Developmental and epileptic encephalopathy, 3",single nucleotide variant,GRCh38
na,na,11,792340,792340,SLC25A22,Pathogenic,"Developmental and epileptic encephalopathy, 3",single nucleotide variant,GRCh37
na,na,11,792340,792340,SLC25A22,Pathogenic,"Developmental and epileptic encephalopathy, 3",single nucleotide variant,GRCh38
na,na,10,104590547,104590548,CYP17A1,Pathogenic/Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",Duplication,GRCh37
na,na,10,102830790,102830791,CYP17A1,Pathogenic/Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",Duplication,GRCh38
na,na,10,104596957,104596959,CYP17A1,Pathogenic/Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|Deficiency of steroid 17-alpha-monooxygenase|not provided",Microsatellite,GRCh37
na,na,10,102837200,102837202,CYP17A1,Pathogenic/Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|Deficiency of steroid 17-alpha-monooxygenase|not provided",Microsatellite,GRCh38
na,na,10,104595087,104595088,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",Duplication,GRCh37
na,na,10,102835330,102835331,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",Duplication,GRCh38
na,na,10,104595131,104595131,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|CYP17A1-related disorder",single nucleotide variant,GRCh37
na,na,10,102835374,102835374,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|CYP17A1-related disorder",single nucleotide variant,GRCh38
na,na,na,-1,-1,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",Indel,na
na,na,10,104593831,104593831,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|Breast cancer, susceptibility to|not provided|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh37
na,na,10,102834074,102834074,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|Breast cancer, susceptibility to|not provided|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh38
na,na,10,104592383,104592383,CYP17A1,Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|not provided",single nucleotide variant,GRCh37
na,na,10,102832626,102832626,CYP17A1,Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|not provided",single nucleotide variant,GRCh38
na,na,10,104590673,104590673,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",Deletion,GRCh37
na,na,10,102830916,102830916,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",Deletion,GRCh38
na,na,10,104596833,104596833,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",single nucleotide variant,GRCh37
na,na,10,102837076,102837076,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",single nucleotide variant,GRCh38
na,na,10,104591260,104591260,CYP17A1,Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh37
na,na,10,102831503,102831503,CYP17A1,Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh38
na,na,10,104592367,104592367,CYP17A1,Pathogenic,"17,20-lyase deficiency, isolated|Deficiency of steroid 17-alpha-monooxygenase|not provided",single nucleotide variant,GRCh37
na,na,10,102832610,102832610,CYP17A1,Pathogenic,"17,20-lyase deficiency, isolated|Deficiency of steroid 17-alpha-monooxygenase|not provided",single nucleotide variant,GRCh38
na,na,10,104592334,104592334,CYP17A1,Pathogenic/Likely pathogenic,"17,20-lyase deficiency, isolated|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",single nucleotide variant,GRCh37
na,na,10,102832577,102832577,CYP17A1,Pathogenic/Likely pathogenic,"17,20-lyase deficiency, isolated|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",single nucleotide variant,GRCh38
na,na,10,104597068,104597068,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided",single nucleotide variant,GRCh37
na,na,10,102837311,102837311,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided",single nucleotide variant,GRCh38
na,na,10,104595006,104595006,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh37
na,na,10,102835249,102835249,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh38
na,na,10,104596841,104596841,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh37
na,na,10,102837084,102837084,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh38
na,na,10,104595107,104595107,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh37
na,na,10,102835350,102835350,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh38
na,na,10,104595100,104595100,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",single nucleotide variant,GRCh37
na,na,10,102835343,102835343,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",single nucleotide variant,GRCh38
na,na,10,104592368,104592368,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|Congenital adrenal hyperplasia|Deficiency of steroid 17-alpha-monooxygenase|not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",single nucleotide variant,GRCh37
na,na,10,102832611,102832611,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|Congenital adrenal hyperplasia|Deficiency of steroid 17-alpha-monooxygenase|not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",single nucleotide variant,GRCh38
na,na,10,104596889,104596913,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|not provided",Deletion,GRCh37
na,na,10,102837132,102837156,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|not provided",Deletion,GRCh38
na,na,10,104592323,104592323,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia|CYP17A1-related disorder",single nucleotide variant,GRCh37
na,na,10,102832566,102832566,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia|CYP17A1-related disorder",single nucleotide variant,GRCh38
na,na,10,104591292,104591292,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh37
na,na,10,102831535,102831535,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh38
na,na,10,104592422,104592422,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh37
na,na,10,102832665,102832665,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh38
na,na,10,104590703,104590703,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh37
na,na,10,102830946,102830946,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh38
na,na,10,104594607,104594607,CYP17A1,Uncertain significance,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|not specified|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh37
na,na,10,102834850,102834850,CYP17A1,Uncertain significance,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial|not specified|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh38
na,na,10,104597038,104597038,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh37
na,na,10,102837281,102837281,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete",single nucleotide variant,GRCh38
na,na,10,104596832,104596832,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",single nucleotide variant,GRCh37
na,na,10,102837075,102837075,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase|Congenital adrenal hyperplasia",single nucleotide variant,GRCh38
na,na,10,104595073,104595073,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh37
na,na,10,102835316,102835316,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh38
na,na,10,104590739,104590739,CYP17A1,Pathogenic/Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|CYP17A1-related disorder|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh37
na,na,10,102830982,102830982,CYP17A1,Pathogenic/Likely pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined complete|not provided|CYP17A1-related disorder|Deficiency of steroid 17-alpha-monooxygenase",single nucleotide variant,GRCh38
na,na,10,104590628,104590628,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",single nucleotide variant,GRCh37
na,na,10,102830871,102830871,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",single nucleotide variant,GRCh38
na,na,10,104594773,104594773,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",single nucleotide variant,GRCh37
na,na,10,102835016,102835016,CYP17A1,Pathogenic,"17-alpha-hydroxylase/17,20-lyase deficiency, combined partial",single nucleotide variant,GRCh38
na,na,15,38614583,38614583,SPRED1,Pathogenic,Legius syndrome|not provided|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|Neurodevelopmental delay,single nucleotide variant,GRCh37
na,na,15,38322382,38322382,SPRED1,Pathogenic,Legius syndrome|not provided|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|Neurodevelopmental delay,single nucleotide variant,GRCh38
na,na,15,38591611,38591611,SPRED1,Pathogenic,Legius syndrome|not provided,single nucleotide variant,GRCh37
na,na,15,38299410,38299410,SPRED1,Pathogenic,Legius syndrome|not provided,single nucleotide variant,GRCh38
na,na,15,38617011,38617011,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh37
na,na,15,38324810,38324810,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh38
na,na,15,38641683,38641683,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh37
na,na,15,38349482,38349482,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh38
na,na,15,38591731,38591731,SPRED1,Pathogenic,Legius syndrome|not provided,single nucleotide variant,GRCh37
na,na,15,38299530,38299530,SPRED1,Pathogenic,Legius syndrome|not provided,single nucleotide variant,GRCh38
na,na,15,38641677,38641677,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh37
na,na,15,38349476,38349476,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh38
na,na,15,38643314,38643314,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh37
na,na,15,38351113,38351113,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh38
na,na,15,38591672,38591672,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh37
na,na,15,38299471,38299471,SPRED1,Pathogenic,Legius syndrome,single nucleotide variant,GRCh38
na,na,13,25487146,25487146,CPAP,Pathogenic,"Microcephaly 6, primary, autosomal recessive|Microcephaly 1, primary, autosomal recessive|not provided",Deletion,GRCh37
na,na,13,24913008,24913008,CPAP,Pathogenic,"Microcephaly 6, primary, autosomal recessive|Microcephaly 1, primary, autosomal recessive|not provided",Deletion,GRCh38
na,na,13,25458221,25458221,CPAP,Pathogenic,"Microcephaly 6, primary, autosomal recessive",single nucleotide variant,GRCh37
na,na,13,24884083,24884083,CPAP,Pathogenic,"Microcephaly 6, primary, autosomal recessive",single nucleotide variant,GRCh38
na,na,13,25463509,25463512,CPAP,Pathogenic/Likely pathogenic,"Microcephaly 6, primary, autosomal recessive|not provided|Microcephaly;Lissencephaly",Deletion,GRCh37
na,na,13,24889371,24889374,CPAP,Pathogenic/Likely pathogenic,"Microcephaly 6, primary, autosomal recessive|not provided|Microcephaly;Lissencephaly",Deletion,GRCh38
na,na,1,220338075,220338075,RAB3GAP2,Pathogenic,Martsolf syndrome|Martsolf syndrome 1,single nucleotide variant,GRCh37
na,na,1,220164733,220164733,RAB3GAP2,Pathogenic,Martsolf syndrome|Martsolf syndrome 1,single nucleotide variant,GRCh38
na,na,3,3192623,3192623,CRBN,Conflicting classifications of pathogenicity,"Intellectual disability, autosomal recessive 2|not provided",single nucleotide variant,GRCh37
na,na,3,3150939,3150939,CRBN,Conflicting classifications of pathogenicity,"Intellectual disability, autosomal recessive 2|not provided",single nucleotide variant,GRCh38
na,na,21,15561623,15561623,LIPI,Benign,Hypertriglyceridemia 1|not provided,single nucleotide variant,GRCh37
na,na,21,14189302,14189302,LIPI,Benign,Hypertriglyceridemia 1|not provided,single nucleotide variant,GRCh38
na,na,1,109440214,109440214,GPSM2,Pathogenic,"Chudley-McCullough syndrome|Hearing loss, autosomal recessive|Breast-ovarian cancer, familial, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,1,108897592,108897592,GPSM2,Pathogenic,"Chudley-McCullough syndrome|Hearing loss, autosomal recessive|Breast-ovarian cancer, familial, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,13,48986097,48986097,LPAR6,Likely pathogenic,Hypotrichosis 8,single nucleotide variant,GRCh37
na,na,13,48411961,48411961,LPAR6,Likely pathogenic,Hypotrichosis 8,single nucleotide variant,GRCh38
na,na,13,48985998,48985998,LPAR6,Pathogenic/Likely pathogenic,"Wooly hair, autosomal recessive 1, with or without hypotrichosis|Hypotrichosis 8",single nucleotide variant,GRCh37
na,na,13,48411862,48411862,LPAR6,Pathogenic/Likely pathogenic,"Wooly hair, autosomal recessive 1, with or without hypotrichosis|Hypotrichosis 8",single nucleotide variant,GRCh38
na,na,13,48986124,48986124,LPAR6,Likely pathogenic,Hypotrichosis 8,single nucleotide variant,GRCh37
na,na,13,48411988,48411988,LPAR6,Likely pathogenic,Hypotrichosis 8,single nucleotide variant,GRCh38
na,na,13,48985995,48985995,LPAR6,Pathogenic/Likely pathogenic,Hypotrichosis 8,single nucleotide variant,GRCh37
na,na,13,48411859,48411859,LPAR6,Pathogenic/Likely pathogenic,Hypotrichosis 8,single nucleotide variant,GRCh38
na,na,3,121500619,121500619,IQCB1,Pathogenic,Senior-Loken syndrome 5|Nephronophthisis|Retinal dystrophy|not provided|Renal dysplasia and retinal aplasia|IQCB1-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,3,121781772,121781772,IQCB1,Pathogenic,Senior-Loken syndrome 5|Nephronophthisis|Retinal dystrophy|not provided|Renal dysplasia and retinal aplasia|IQCB1-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,3,121527825,121527826,IQCB1,Pathogenic,Senior-Loken syndrome 5|Leber congenital amaurosis|Nephronophthisis|Retinal dystrophy|not provided,Deletion,GRCh37
na,na,3,121808978,121808979,IQCB1,Pathogenic,Senior-Loken syndrome 5|Leber congenital amaurosis|Nephronophthisis|Retinal dystrophy|not provided,Deletion,GRCh38
na,na,3,121527802,121527805,IQCB1,Pathogenic,Senior-Loken syndrome 5,Microsatellite,GRCh37
na,na,3,121808955,121808958,IQCB1,Pathogenic,Senior-Loken syndrome 5,Microsatellite,GRCh38
na,na,3,121516013,121516016,IQCB1,Pathogenic,Senior-Loken syndrome 5|Nephronophthisis|IQCB1-related disorder,Deletion,GRCh37
na,na,3,121797166,121797169,IQCB1,Pathogenic,Senior-Loken syndrome 5|Nephronophthisis|IQCB1-related disorder,Deletion,GRCh38
na,na,3,121508980,121508980,IQCB1,Pathogenic,Senior-Loken syndrome 5,single nucleotide variant,GRCh37
na,na,3,121790133,121790133,IQCB1,Pathogenic,Senior-Loken syndrome 5,single nucleotide variant,GRCh38
na,na,10,75010693,75010693,MRPS16,Uncertain significance,Combined oxidative phosphorylation defect type 2|not provided,single nucleotide variant,GRCh37
na,na,10,73250935,73250935,MRPS16,Uncertain significance,Combined oxidative phosphorylation defect type 2|not provided,single nucleotide variant,GRCh38
na,na,21,33671389,33671389,MRAP,Pathogenic,Glucocorticoid deficiency 2,single nucleotide variant,GRCh37
na,na,21,32299078,32299078,MRAP,Pathogenic,Glucocorticoid deficiency 2,single nucleotide variant,GRCh38
na,na,21,33671389,33671389,MRAP,Pathogenic,Glucocorticoid deficiency 2,single nucleotide variant,GRCh37
na,na,21,32299078,32299078,MRAP,Pathogenic,Glucocorticoid deficiency 2,single nucleotide variant,GRCh38
na,na,21,33671389,33671389,MRAP,Pathogenic,Glucocorticoid deficiency 2,single nucleotide variant,GRCh37
na,na,21,32299078,32299078,MRAP,Pathogenic,Glucocorticoid deficiency 2,single nucleotide variant,GRCh38
na,na,21,33671391,33671392,MRAP,Pathogenic,Glucocorticoid deficiency 2,Insertion,GRCh37
na,na,21,32299080,32299081,MRAP,Pathogenic,Glucocorticoid deficiency 2,Insertion,GRCh38
na,na,21,33671285,33671285,MRAP,Pathogenic,Glucocorticoid deficiency 2|Glucocorticoid deficiency 1,single nucleotide variant,GRCh37
na,na,21,32298974,32298974,MRAP,Pathogenic,Glucocorticoid deficiency 2|Glucocorticoid deficiency 1,single nucleotide variant,GRCh38
na,na,21,33678972,33678972,MRAP,Uncertain significance,Glucocorticoid deficiency 2|not provided,Deletion,GRCh37
na,na,21,32306661,32306661,MRAP,Uncertain significance,Glucocorticoid deficiency 2|not provided,Deletion,GRCh38
na,na,21,33671299,33671305,MRAP,Pathogenic,Glucocorticoid deficiency 2,Deletion,GRCh37
na,na,21,32298988,32298994,MRAP,Pathogenic,Glucocorticoid deficiency 2,Deletion,GRCh38
na,na,7,40172768,40172768,MPLKIP,Pathogenic/Likely pathogenic,"Trichothiodystrophy 4, nonphotosensitive|not provided",single nucleotide variant,GRCh37
na,na,7,40133169,40133169,MPLKIP,Pathogenic/Likely pathogenic,"Trichothiodystrophy 4, nonphotosensitive|not provided",single nucleotide variant,GRCh38
na,na,7,40174029,40174030,MPLKIP,Pathogenic,"Trichothiodystrophy 4, nonphotosensitive",Deletion,GRCh37
na,na,7,40134430,40134431,MPLKIP,Pathogenic,"Trichothiodystrophy 4, nonphotosensitive",Deletion,GRCh38
na,na,7,40116368,40134601,MPLKIP,Pathogenic,"Trichothiodystrophy 4, nonphotosensitive",Deletion,GRCh38
na,na,7,40173890,40173890,MPLKIP,Pathogenic,"Trichothiodystrophy 4, nonphotosensitive|not provided",Deletion,GRCh37
na,na,7,40134291,40134291,MPLKIP,Pathogenic,"Trichothiodystrophy 4, nonphotosensitive|not provided",Deletion,GRCh38
na,na,7,40174015,40174019,MPLKIP,Pathogenic,"Trichothiodystrophy 4, nonphotosensitive",Deletion,GRCh37
na,na,7,40134416,40134420,MPLKIP,Pathogenic,"Trichothiodystrophy 4, nonphotosensitive",Deletion,GRCh38
na,na,7,40498796,40498796,SUGCT,Conflicting classifications of pathogenicity,Glutaryl-CoA oxidase deficiency|not provided|SUGCT-related disorder,single nucleotide variant,GRCh37
na,na,7,40459197,40459197,SUGCT,Conflicting classifications of pathogenicity,Glutaryl-CoA oxidase deficiency|not provided|SUGCT-related disorder,single nucleotide variant,GRCh38
na,na,7,40277263,40277263,SUGCT,Pathogenic,Glutaryl-CoA oxidase deficiency,single nucleotide variant,GRCh37
na,na,7,40237664,40237664,SUGCT,Pathogenic,Glutaryl-CoA oxidase deficiency,single nucleotide variant,GRCh38
na,na,7,40228168,40228168,SUGCT,Conflicting classifications of pathogenicity,Glutaryl-CoA oxidase deficiency,single nucleotide variant,GRCh37
na,na,7,40188569,40188569,SUGCT,Conflicting classifications of pathogenicity,Glutaryl-CoA oxidase deficiency,single nucleotide variant,GRCh38
na,na,2,242707149,242707149,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh37
na,na,2,241767734,241767734,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh38
na,na,2,242681939,242681939,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh37
na,na,2,241742524,241742524,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh38
na,na,2,242680425,242680425,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh37
na,na,2,241741010,241741010,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh38
na,na,2,242684122,242684122,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh37
na,na,2,241744707,241744707,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh38
na,na,2,242707133,242707133,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh37
na,na,2,241767718,241767718,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh38
na,na,2,242680479,242680480,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,Duplication,GRCh37
na,na,2,241741064,241741065,D2HGDH,Pathogenic,D-2-hydroxyglutaric aciduria 1,Duplication,GRCh38
na,na,2,242690786,242690786,D2HGDH,Uncertain significance,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh37
na,na,2,241751371,241751371,D2HGDH,Uncertain significance,D-2-hydroxyglutaric aciduria 1,single nucleotide variant,GRCh38
na,na,2,86459831,86459831,REEP1,Pathogenic,Hereditary spastic paraplegia 31|Hereditary spastic paraplegia,Deletion,GRCh37
na,na,2,86232708,86232708,REEP1,Pathogenic,Hereditary spastic paraplegia 31|Hereditary spastic paraplegia,Deletion,GRCh38
na,na,2,86481939,86481939,REEP1,Pathogenic,Hereditary spastic paraplegia 31,single nucleotide variant,GRCh37
na,na,2,86254816,86254816,REEP1,Pathogenic,Hereditary spastic paraplegia 31,single nucleotide variant,GRCh38
na,na,2,86444180,86444180,REEP1,Conflicting classifications of pathogenicity,"Hereditary spastic paraplegia 31|Neuronopathy, distal hereditary motor, type 5B|not provided|Hereditary spastic paraplegia|Inborn genetic diseases|REEP1-related disorder|not specified",single nucleotide variant,GRCh37
na,na,2,86217057,86217057,REEP1,Conflicting classifications of pathogenicity,"Hereditary spastic paraplegia 31|Neuronopathy, distal hereditary motor, type 5B|not provided|Hereditary spastic paraplegia|Inborn genetic diseases|REEP1-related disorder|not specified",single nucleotide variant,GRCh38
na,na,2,86509339,86509339,REEP1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 31|Spastic paraplegia|not provided|Hereditary spastic paraplegia|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,2,86282216,86282216,REEP1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 31|Spastic paraplegia|not provided|Hereditary spastic paraplegia|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,2,86479160,86479160,REEP1,Pathogenic,Hereditary spastic paraplegia 31|Hereditary spastic paraplegia|not provided,single nucleotide variant,GRCh37
na,na,2,86252037,86252037,REEP1,Pathogenic,Hereditary spastic paraplegia 31|Hereditary spastic paraplegia|not provided,single nucleotide variant,GRCh38
na,na,3,167413394,167413394,PDCD10,Pathogenic,Cerebral cavernous malformation 3,single nucleotide variant,GRCh37
na,na,3,167695606,167695606,PDCD10,Pathogenic,Cerebral cavernous malformation 3,single nucleotide variant,GRCh38
na,na,na,-1,-1,PDCD10,Pathogenic,Cerebral cavernous malformation 3,Deletion,na
na,na,3,167405105,167405105,PDCD10,Pathogenic,Cerebral cavernous malformation 3,single nucleotide variant,GRCh37
na,na,3,167687317,167687317,PDCD10,Pathogenic,Cerebral cavernous malformation 3,single nucleotide variant,GRCh38
na,na,na,-1,-1,PDCD10,Pathogenic,Cerebral cavernous malformation 3,Deletion,na
na,na,7,39379302,39379302,POU6F2,Pathogenic,Wilms tumor 5,single nucleotide variant,GRCh37
na,na,7,39339703,39339703,POU6F2,Pathogenic,Wilms tumor 5,single nucleotide variant,GRCh38
na,na,7,39017615,39017615,POU6F2,Pathogenic,Wilms tumor 5,single nucleotide variant,GRCh37
na,na,7,38978015,38978015,POU6F2,Pathogenic,Wilms tumor 5,single nucleotide variant,GRCh38
na,na,11,823740,823740,PNPLA2,Pathogenic,Neutral lipid storage myopathy,Deletion,GRCh37
na,na,11,823740,823740,PNPLA2,Pathogenic,Neutral lipid storage myopathy,Deletion,GRCh38
na,na,11,822494,822494,PNPLA2,Pathogenic,Neutral lipid storage myopathy,single nucleotide variant,GRCh37
na,na,11,822494,822494,PNPLA2,Pathogenic,Neutral lipid storage myopathy,single nucleotide variant,GRCh38
na,na,11,823781,823781,PNPLA2,Pathogenic,Neutral lipid storage myopathy,Deletion,GRCh37
na,na,11,823781,823781,PNPLA2,Pathogenic,Neutral lipid storage myopathy,Deletion,GRCh38
na,na,11,823801,823801,PNPLA2,Pathogenic,Neutral lipid storage myopathy,single nucleotide variant,GRCh37
na,na,11,823801,823801,PNPLA2,Pathogenic,Neutral lipid storage myopathy,single nucleotide variant,GRCh38
na,na,6,49427128,49427128,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|not provided",single nucleotide variant,GRCh37
na,na,6,49459415,49459415,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|not provided",single nucleotide variant,GRCh38
na,na,6,49426867,49426867,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia",single nucleotide variant,GRCh37
na,na,6,49459154,49459154,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia",single nucleotide variant,GRCh38
na,na,6,49419381,49419381,MMUT,Likely pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency",single nucleotide variant,GRCh37
na,na,6,49451668,49451668,MMUT,Likely pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency",single nucleotide variant,GRCh38
na,na,6,49426902,49426902,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|not provided|MMUT-related disorder",single nucleotide variant,GRCh37
na,na,6,49459189,49459189,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|not provided|MMUT-related disorder",single nucleotide variant,GRCh38
na,na,6,49399544,49399544,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(-) TYPE|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency",single nucleotide variant,GRCh37
na,na,6,49431831,49431831,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(-) TYPE|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency",single nucleotide variant,GRCh38
na,na,6,49426831,49426831,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(-) TYPE|not provided|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency",single nucleotide variant,GRCh37
na,na,6,49459118,49459118,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(-) TYPE|not provided|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency",single nucleotide variant,GRCh38
na,na,6,49425467,49425468,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(-) TYPE",Deletion,GRCh37
na,na,6,49457754,49457755,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(-) TYPE",Deletion,GRCh38
na,na,6,49408008,49408008,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|MMUT-related disorder",single nucleotide variant,GRCh37
na,na,6,49440295,49440295,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|MMUT-related disorder",single nucleotide variant,GRCh38
na,na,6,49403186,49403186,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided",single nucleotide variant,GRCh37
na,na,6,49435473,49435473,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided",single nucleotide variant,GRCh38
na,na,6,49425502,49425502,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency",single nucleotide variant,GRCh37
na,na,6,49457789,49457789,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency",single nucleotide variant,GRCh38
na,na,6,49426858,49426858,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|not provided|MMUT-related disorder|not specified",single nucleotide variant,GRCh37
na,na,6,49459145,49459145,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency|Methylmalonic acidemia|not provided|MMUT-related disorder|not specified",single nucleotide variant,GRCh38
na,na,6,49425514,49425514,MMUT,Pathogenic/Likely pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided|Methylmalonic acidemia",single nucleotide variant,GRCh37
na,na,6,49457801,49457801,MMUT,Pathogenic/Likely pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|not provided|Methylmalonic acidemia",single nucleotide variant,GRCh38
na,na,6,49404228,49404228,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE",single nucleotide variant,GRCh37
na,na,6,49436515,49436515,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE",single nucleotide variant,GRCh38
na,na,6,49409553,49409553,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided",single nucleotide variant,GRCh37
na,na,6,49441840,49441840,MMUT,Pathogenic,"METHYLMALONIC ACIDURIA, mut(0) TYPE|not provided",single nucleotide variant,GRCh38
na,na,12,52827608,52827608,KRT75,Benign; risk factor,not provided|Pseudofolliculitis barbae|KRT75-related disorder,single nucleotide variant,GRCh37
na,na,12,52433824,52433824,KRT75,Benign; risk factor,not provided|Pseudofolliculitis barbae|KRT75-related disorder,single nucleotide variant,GRCh38
na,na,2,219135284,219135284,PNKD,Pathogenic/Likely pathogenic,Paroxysmal nonkinesigenic dyskinesia 1|Paroxysmal dyskinesia;Episodic hemiplegia;Paroxysmal dystonia|not provided|Paroxysmal nonkinesigenic dyskinesia,single nucleotide variant,GRCh37
na,na,2,218270561,218270561,PNKD,Pathogenic/Likely pathogenic,Paroxysmal nonkinesigenic dyskinesia 1|Paroxysmal dyskinesia;Episodic hemiplegia;Paroxysmal dystonia|not provided|Paroxysmal nonkinesigenic dyskinesia,single nucleotide variant,GRCh38
na,na,2,219135278,219135278,PNKD,Pathogenic/Likely pathogenic,Paroxysmal nonkinesigenic dyskinesia 1|Paroxysmal nonkinesigenic dyskinesia,single nucleotide variant,GRCh37
na,na,2,218270555,218270555,PNKD,Pathogenic/Likely pathogenic,Paroxysmal nonkinesigenic dyskinesia 1|Paroxysmal nonkinesigenic dyskinesia,single nucleotide variant,GRCh38
na,na,2,219136133,219136133,PNKD,Conflicting classifications of pathogenicity,Paroxysmal nonkinesigenic dyskinesia 1|Paroxysmal nonkinesigenic dyskinesia|not provided,single nucleotide variant,GRCh37
na,na,2,218271410,218271410,PNKD,Conflicting classifications of pathogenicity,Paroxysmal nonkinesigenic dyskinesia 1|Paroxysmal nonkinesigenic dyskinesia|not provided,single nucleotide variant,GRCh38
na,na,3,15676984,15676990,BTD,Pathogenic,Biotinidase deficiency|not provided,Indel,GRCh37
na,na,3,15635477,15635483,BTD,Pathogenic,Biotinidase deficiency|not provided,Indel,GRCh38
na,na,3,15686958,15686958,BTD,Pathogenic/Likely pathogenic,Biotinidase deficiency|not provided|Inborn genetic diseases|BTD-related disorder,single nucleotide variant,GRCh37
na,na,3,15645451,15645451,BTD,Pathogenic/Likely pathogenic,Biotinidase deficiency|not provided|Inborn genetic diseases|BTD-related disorder,single nucleotide variant,GRCh38
na,na,3,15686975,15686975,BTD,Pathogenic,Biotinidase deficiency|not provided|BTD-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,3,15645468,15645468,BTD,Pathogenic,Biotinidase deficiency|not provided|BTD-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,3,15676986,15676986,BTD,Pathogenic/Likely pathogenic,Biotinidase deficiency|BTD-related disorder,single nucleotide variant,GRCh37
na,na,3,15635479,15635479,BTD,Pathogenic/Likely pathogenic,Biotinidase deficiency|BTD-related disorder,single nucleotide variant,GRCh38
na,na,3,15686693,15686693,BTD,Conflicting classifications of pathogenicity,Biotinidase deficiency|not provided|Inborn genetic diseases|BTD-related disorder,single nucleotide variant,GRCh37
na,na,3,15645186,15645186,BTD,Conflicting classifications of pathogenicity,Biotinidase deficiency|not provided|Inborn genetic diseases|BTD-related disorder,single nucleotide variant,GRCh38
na,na,3,15686118,15686118,BTD,Pathogenic,Biotinidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,15644611,15644611,BTD,Pathogenic,Biotinidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,3,15686731,15686731,BTD,Pathogenic/Likely pathogenic,Biotinidase deficiency|not provided|Intellectual disability|Inborn genetic diseases|BTD-related disorder,single nucleotide variant,GRCh37
na,na,3,15645224,15645224,BTD,Pathogenic/Likely pathogenic,Biotinidase deficiency|not provided|Intellectual disability|Inborn genetic diseases|BTD-related disorder,single nucleotide variant,GRCh38
na,na,3,15686829,15686829,BTD,Conflicting classifications of pathogenicity,Biotinidase deficiency|not specified|not provided,single nucleotide variant,GRCh37
na,na,3,15645322,15645322,BTD,Conflicting classifications of pathogenicity,Biotinidase deficiency|not specified|not provided,single nucleotide variant,GRCh38
na,na,3,15686570,15686570,BTD,Conflicting classifications of pathogenicity; other,Biotinidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,15645063,15645063,BTD,Conflicting classifications of pathogenicity; other,Biotinidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,3,15677121,15677121,BTD,Pathogenic/Likely pathogenic,Biotinidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,15635614,15635614,BTD,Pathogenic/Likely pathogenic,Biotinidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,21,38309035,38309035,HLCS,Pathogenic,Holocarboxylase synthetase deficiency,single nucleotide variant,GRCh37
na,na,21,36936735,36936735,HLCS,Pathogenic,Holocarboxylase synthetase deficiency,single nucleotide variant,GRCh38
na,na,21,38132112,38132112,HLCS,Pathogenic/Likely pathogenic,Holocarboxylase synthetase deficiency|not provided,single nucleotide variant,GRCh37
na,na,21,36759811,36759811,HLCS,Pathogenic/Likely pathogenic,Holocarboxylase synthetase deficiency|not provided,single nucleotide variant,GRCh38
na,na,21,38137471,38137471,HLCS,Pathogenic,Holocarboxylase synthetase deficiency,single nucleotide variant,GRCh37
na,na,21,36765170,36765170,HLCS,Pathogenic,Holocarboxylase synthetase deficiency,single nucleotide variant,GRCh38
na,na,21,38132082,38132082,HLCS,Pathogenic/Likely pathogenic,Holocarboxylase synthetase deficiency,single nucleotide variant,GRCh37
na,na,21,36759781,36759781,HLCS,Pathogenic/Likely pathogenic,Holocarboxylase synthetase deficiency,single nucleotide variant,GRCh38
na,na,21,38137345,38137345,HLCS,Pathogenic/Likely pathogenic,Holocarboxylase synthetase deficiency|not provided,single nucleotide variant,GRCh37
na,na,21,36765044,36765044,HLCS,Pathogenic/Likely pathogenic,Holocarboxylase synthetase deficiency|not provided,single nucleotide variant,GRCh38
na,na,21,38139514,38139514,HLCS,Pathogenic,Holocarboxylase synthetase deficiency|not provided,single nucleotide variant,GRCh37
na,na,21,36767213,36767213,HLCS,Pathogenic,Holocarboxylase synthetase deficiency|not provided,single nucleotide variant,GRCh38
na,na,21,38309089,38309090,HLCS,Pathogenic,Holocarboxylase synthetase deficiency,Duplication,GRCh37
na,na,21,36936789,36936790,HLCS,Pathogenic,Holocarboxylase synthetase deficiency,Duplication,GRCh38
na,na,21,38309098,38309098,HLCS,Pathogenic,Holocarboxylase synthetase deficiency,single nucleotide variant,GRCh37
na,na,21,36936798,36936798,HLCS,Pathogenic,Holocarboxylase synthetase deficiency,single nucleotide variant,GRCh38
na,na,1,43296656,43296657,ERMAP,Pathogenic,"SCIANNA BLOOD GROUP SYSTEM, SC:-1,-2",Microsatellite,GRCh37
na,na,1,42830985,42830986,ERMAP,Pathogenic,"SCIANNA BLOOD GROUP SYSTEM, SC:-1,-2",Microsatellite,GRCh38
na,na,1,43296522,43296522,ERMAP,Likely benign,"SCIANNA BLOOD GROUP SYSTEM, SC:-1,2|not specified",single nucleotide variant,GRCh37
na,na,1,42830851,42830851,ERMAP,Likely benign,"SCIANNA BLOOD GROUP SYSTEM, SC:-1,2|not specified",single nucleotide variant,GRCh38
na,na,1,43296531,43296531,ERMAP,Affects,RADIN BLOOD GROUP ANTIGEN,single nucleotide variant,GRCh37
na,na,1,42830860,42830860,ERMAP,Affects,RADIN BLOOD GROUP ANTIGEN,single nucleotide variant,GRCh38
na,na,1,43296492,43296492,ERMAP,Affects,Antigen in Scianna blood group system,single nucleotide variant,GRCh37
na,na,1,42830821,42830821,ERMAP,Affects,Antigen in Scianna blood group system,single nucleotide variant,GRCh38
na,na,5,70900186,70900187,MCCC2,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided,Duplication,GRCh37
na,na,5,71604359,71604360,MCCC2,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided,Duplication,GRCh38
na,na,5,70895499,70895499,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency,single nucleotide variant,GRCh37
na,na,5,71599672,71599672,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency,single nucleotide variant,GRCh38
na,na,5,70898413,70898413,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,single nucleotide variant,GRCh37
na,na,5,71602586,71602586,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,single nucleotide variant,GRCh38
na,na,5,70931003,70931003,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|Autism spectrum disorder|Methylcrotonyl-CoA carboxylase deficiency,single nucleotide variant,GRCh37
na,na,5,71635176,71635176,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|Autism spectrum disorder|Methylcrotonyl-CoA carboxylase deficiency,single nucleotide variant,GRCh38
na,na,5,70898448,70898448,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|Methylcrotonyl-CoA carboxylase deficiency,single nucleotide variant,GRCh37
na,na,5,71602621,71602621,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|Methylcrotonyl-CoA carboxylase deficiency,single nucleotide variant,GRCh38
na,na,5,70928012,70928012,MCCC2,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided,single nucleotide variant,GRCh37
na,na,5,71632185,71632185,MCCC2,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided,single nucleotide variant,GRCh38
na,na,5,70945016,70945016,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency,single nucleotide variant,GRCh37
na,na,5,71649189,71649189,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency,single nucleotide variant,GRCh38
na,na,5,70900240,70900240,MCCC2,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,single nucleotide variant,GRCh37
na,na,5,71604413,71604413,MCCC2,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,single nucleotide variant,GRCh38
na,na,5,70930804,70930804,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,single nucleotide variant,GRCh37
na,na,5,71634977,71634977,MCCC2,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,single nucleotide variant,GRCh38
na,na,5,70948582,70948582,MCCC2,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,single nucleotide variant,GRCh37
na,na,5,71652755,71652755,MCCC2,Pathogenic,3-methylcrotonyl-CoA carboxylase 2 deficiency,single nucleotide variant,GRCh38
na,na,3,182763310,182763310,MCCC1,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,3,183045522,183045522,MCCC1,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,3,182759467,182759467,MCCC1,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,3,183041679,183041679,MCCC1,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,3,182755006,182755006,MCCC1,Pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,single nucleotide variant,GRCh37
na,na,3,183037218,183037218,MCCC1,Pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,single nucleotide variant,GRCh38
na,na,3,182756881,182756881,MCCC1,Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,single nucleotide variant,GRCh37
na,na,3,183039093,183039093,MCCC1,Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,single nucleotide variant,GRCh38
na,na,3,182751856,182751856,MCCC1,Pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,single nucleotide variant,GRCh37
na,na,3,183034068,183034068,MCCC1,Pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,single nucleotide variant,GRCh38
na,na,3,182733325,182733325,MCCC1,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency|MCCC1-related disorder,Deletion,GRCh37
na,na,3,183015537,183015537,MCCC1,Pathogenic/Likely pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency|not provided|Methylcrotonyl-CoA carboxylase deficiency|MCCC1-related disorder,Deletion,GRCh38
na,na,3,182755220,182755220,MCCC1,Pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,single nucleotide variant,GRCh37
na,na,3,183037432,183037432,MCCC1,Pathogenic,3-methylcrotonyl-CoA carboxylase 1 deficiency,single nucleotide variant,GRCh38
na,na,12,40704236,40704236,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8|not provided,single nucleotide variant,GRCh37
na,na,12,40310434,40310434,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8|not provided,single nucleotide variant,GRCh38
na,na,12,40714916,40714916,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8,single nucleotide variant,GRCh37
na,na,12,40321114,40321114,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8,single nucleotide variant,GRCh38
na,na,12,40704236,40704236,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8|not provided,single nucleotide variant,GRCh37
na,na,12,40310434,40310434,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8|not provided,single nucleotide variant,GRCh38
na,na,12,40692927,40692927,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8,single nucleotide variant,GRCh37
na,na,12,40299125,40299125,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8,single nucleotide variant,GRCh38
na,na,12,40734202,40734202,LRRK2,Pathogenic/Likely pathogenic; risk factor,"Autosomal dominant Parkinson disease 8|Inborn genetic diseases|Young-onset Parkinson disease|not provided|Parkinson disease, late-onset|LRRK2-related disorder|Parkinson disease",single nucleotide variant,GRCh37
na,na,12,40340400,40340400,LRRK2,Pathogenic/Likely pathogenic; risk factor,"Autosomal dominant Parkinson disease 8|Inborn genetic diseases|Young-onset Parkinson disease|not provided|Parkinson disease, late-onset|LRRK2-related disorder|Parkinson disease",single nucleotide variant,GRCh38
na,na,12,40734206,40734206,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8|not provided,single nucleotide variant,GRCh37
na,na,12,40340404,40340404,LRRK2,Pathogenic,Autosomal dominant Parkinson disease 8|not provided,single nucleotide variant,GRCh38
na,na,12,40704237,40704237,LRRK2,Pathogenic/Likely pathogenic,Autosomal dominant Parkinson disease 8,single nucleotide variant,GRCh37
na,na,12,40310435,40310435,LRRK2,Pathogenic/Likely pathogenic,Autosomal dominant Parkinson disease 8,single nucleotide variant,GRCh38
na,na,12,40757328,40757328,LRRK2,Conflicting classifications of pathogenicity; risk factor,Autosomal dominant Parkinson disease 8|Parkinson disease|not provided,single nucleotide variant,GRCh37
na,na,12,40363526,40363526,LRRK2,Conflicting classifications of pathogenicity; risk factor,Autosomal dominant Parkinson disease 8|Parkinson disease|not provided,single nucleotide variant,GRCh38
na,na,19,8665913,8665913,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,19,8601029,8601029,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,19,8661190,8661190,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1,single nucleotide variant,GRCh37
na,na,19,8596306,8596306,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1,single nucleotide variant,GRCh38
na,na,19,8665811,8665811,ADAMTS10,Likely pathogenic,Weill-Marchesani syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,19,8600927,8600927,ADAMTS10,Likely pathogenic,Weill-Marchesani syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,19,8670523,8670523,ADAMTS10,Uncertain significance,Weill-Marchesani syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,19,8605638,8605638,ADAMTS10,Uncertain significance,Weill-Marchesani syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,19,8661959,8661959,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1,single nucleotide variant,GRCh37
na,na,19,8597075,8597075,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1,single nucleotide variant,GRCh38
na,na,19,8657681,8657681,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1,single nucleotide variant,GRCh37
na,na,19,8592797,8592797,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1,single nucleotide variant,GRCh38
na,na,19,8654186,8654186,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1,single nucleotide variant,GRCh37
na,na,19,8589302,8589302,ADAMTS10,Pathogenic,Weill-Marchesani syndrome 1,single nucleotide variant,GRCh38
na,na,3,180704811,180704811,DNAJC19,Pathogenic,3-methylglutaconic aciduria type 5|DNAJC19-related disorder,single nucleotide variant,GRCh37
na,na,3,180987023,180987023,DNAJC19,Pathogenic,3-methylglutaconic aciduria type 5|DNAJC19-related disorder,single nucleotide variant,GRCh38
na,na,11,67226100,67226101,CABP4,Pathogenic/Likely pathogenic,"Cone-rod synaptic disorder, congenital nonprogressive|not provided",Microsatellite,GRCh37
na,na,11,67458629,67458630,CABP4,Pathogenic/Likely pathogenic,"Cone-rod synaptic disorder, congenital nonprogressive|not provided",Microsatellite,GRCh38
na,na,11,67223662,67223662,CABP4,Conflicting classifications of pathogenicity,"Cone-rod synaptic disorder, congenital nonprogressive|not provided",single nucleotide variant,GRCh37
na,na,11,67456191,67456191,CABP4,Conflicting classifications of pathogenicity,"Cone-rod synaptic disorder, congenital nonprogressive|not provided",single nucleotide variant,GRCh38
na,na,20,43255220,43255220,ADA,Benign,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified|not provided",single nucleotide variant,GRCh37
na,na,20,44626579,44626579,ADA,Benign,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified|not provided",single nucleotide variant,GRCh38
na,na,20,43255158,43255158,ADA,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh37
na,na,20,44626517,44626517,ADA,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh38
na,na,20,43255157,43255157,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",single nucleotide variant,GRCh37
na,na,20,44626516,44626516,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",single nucleotide variant,GRCh38
na,na,20,43251694,43251694,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided",single nucleotide variant,GRCh37
na,na,20,44623053,44623053,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided",single nucleotide variant,GRCh38
na,na,20,43249723,43249723,ADA,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|ADA-related disorder|not provided",single nucleotide variant,GRCh37
na,na,20,44621082,44621082,ADA,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|ADA-related disorder|not provided",single nucleotide variant,GRCh38
na,na,20,43249032,43249032,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|ADA-related disorder",single nucleotide variant,GRCh37
na,na,20,44620391,44620391,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|ADA-related disorder",single nucleotide variant,GRCh38
na,na,20,43278576,43281831,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",Deletion,GRCh37
na,na,20,44649935,44653190,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",Deletion,GRCh38
na,na,20,43249744,43249744,ADA,Conflicting classifications of pathogenicity,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|ADA-related disorder|Severe combined immunodeficiency disease",single nucleotide variant,GRCh37
na,na,20,44621103,44621103,ADA,Conflicting classifications of pathogenicity,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|ADA-related disorder|Severe combined immunodeficiency disease",single nucleotide variant,GRCh38
na,na,20,43255233,43255233,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided",single nucleotide variant,GRCh37
na,na,20,44626592,44626592,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided",single nucleotide variant,GRCh38
na,na,20,43254242,43254242,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified",single nucleotide variant,GRCh37
na,na,20,44625601,44625601,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified",single nucleotide variant,GRCh38
na,na,20,43251253,43251253,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh37
na,na,20,44622612,44622612,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh38
na,na,20,43255139,43255139,ADA,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",single nucleotide variant,GRCh37
na,na,20,44626498,44626498,ADA,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",single nucleotide variant,GRCh38
na,na,20,43251695,43251695,ADA;PKIG,Likely pathogenic,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|Severe combined immunodeficiency disease",single nucleotide variant,GRCh37
na,na,20,44623054,44623054,ADA;PKIG,Likely pathogenic,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|Severe combined immunodeficiency disease",single nucleotide variant,GRCh38
na,na,20,43251683,43251683,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified",single nucleotide variant,GRCh37
na,na,20,44623042,44623042,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified",single nucleotide variant,GRCh38
na,na,20,43251680,43251680,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|ADA-related disorder",single nucleotide variant,GRCh37
na,na,20,44623039,44623039,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|ADA-related disorder",single nucleotide variant,GRCh38
na,na,20,43255242,43255242,ADA,Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh37
na,na,20,44626601,44626601,ADA,Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh38
na,na,20,43254222,43254222,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|Severe combined immunodeficiency disease|not provided",single nucleotide variant,GRCh37
na,na,20,44625581,44625581,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|Severe combined immunodeficiency disease|not provided",single nucleotide variant,GRCh38
na,na,20,43249762,43249762,ADA,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",single nucleotide variant,GRCh37
na,na,20,44621121,44621121,ADA,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",single nucleotide variant,GRCh38
na,na,20,43249076,43249076,ADA,Likely pathogenic,"SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh37
na,na,20,44620435,44620435,ADA,Likely pathogenic,"SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh38
na,na,20,43280227,43280227,ADA,Benign,"Adenosine deaminase 2 allozyme|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified|not provided",single nucleotide variant,GRCh37
na,na,20,44651586,44651586,ADA,Benign,"Adenosine deaminase 2 allozyme|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not specified|not provided",single nucleotide variant,GRCh38
na,na,20,43251293,43251296,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",Indel,GRCh37
na,na,20,44622652,44622655,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",Indel,GRCh38
na,na,20,43280215,43280215,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh37
na,na,20,44651574,44651574,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh38
na,na,20,43255238,43255238,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh37
na,na,20,44626597,44626597,ADA,Pathogenic,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh38
na,na,20,43254234,43254234,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",single nucleotide variant,GRCh37
na,na,20,44625593,44625593,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|not provided|Severe combined immunodeficiency disease",single nucleotide variant,GRCh38
na,na,20,43251552,43251552,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh37
na,na,20,44622911,44622911,ADA,Uncertain significance,"Partial adenosine deaminase deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh38
na,na,20,43255169,43255169,ADA,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,20,44626528,44626528,ADA,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,20,43248503,43248503,ADA,Uncertain significance,"SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh37
na,na,20,44619862,44619862,ADA,Uncertain significance,"SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency",single nucleotide variant,GRCh38
na,na,20,43248492,43248502,ADA,no classification for the single variant,-,Deletion,GRCh37
na,na,20,44619851,44619861,ADA,no classification for the single variant,-,Deletion,GRCh38
na,na,20,43254221,43254221,ADA,Pathogenic/Likely pathogenic,"SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|Severe combined immunodeficiency disease",single nucleotide variant,GRCh37
na,na,20,44625580,44625580,ADA,Pathogenic/Likely pathogenic,"SCID due to ADA deficiency, delayed onset|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency|Severe combined immunodeficiency disease",single nucleotide variant,GRCh38
na,na,13,39433728,39433728,FREM2,Pathogenic,Fraser syndrome 2,single nucleotide variant,GRCh37
na,na,13,38859591,38859591,FREM2,Pathogenic,Fraser syndrome 2,single nucleotide variant,GRCh38
na,na,13,39358840,39358840,FREM2,Uncertain significance,Fraser syndrome 2|Fraser syndrome 2;Isolated cryptophthalmia,single nucleotide variant,GRCh37
na,na,13,38784703,38784703,FREM2,Uncertain significance,Fraser syndrome 2|Fraser syndrome 2;Isolated cryptophthalmia,single nucleotide variant,GRCh38
na,na,9,14812981,14812981,FREM1,Pathogenic,BNAR syndrome|Oculotrichoanal syndrome,Deletion,GRCh37
na,na,9,14812983,14812983,FREM1,Pathogenic,BNAR syndrome|Oculotrichoanal syndrome,Deletion,GRCh38
na,na,9,14824927,14824927,FREM1,Uncertain significance,BNAR syndrome|not provided|Trigonocephaly 2;Oculotrichoanal syndrome;BNAR syndrome|Oculotrichoanal syndrome,single nucleotide variant,GRCh37
na,na,9,14824929,14824929,FREM1,Uncertain significance,BNAR syndrome|not provided|Trigonocephaly 2;Oculotrichoanal syndrome;BNAR syndrome|Oculotrichoanal syndrome,single nucleotide variant,GRCh38
na,na,9,14784492,14784492,FREM1,Uncertain significance,BNAR syndrome|not provided|Oculotrichoanal syndrome|Trigonocephaly 2;Oculotrichoanal syndrome;BNAR syndrome,single nucleotide variant,GRCh37
na,na,9,14784494,14784494,FREM1,Uncertain significance,BNAR syndrome|not provided|Oculotrichoanal syndrome|Trigonocephaly 2;Oculotrichoanal syndrome;BNAR syndrome,single nucleotide variant,GRCh38
na,na,3,93722608,93722608,ARL13B,Pathogenic,Joubert syndrome 8,single nucleotide variant,GRCh37
na,na,3,94003764,94003764,ARL13B,Pathogenic,Joubert syndrome 8,single nucleotide variant,GRCh38
na,na,3,93722618,93722618,ARL13B,Pathogenic,Joubert syndrome 8,single nucleotide variant,GRCh37
na,na,3,94003774,94003774,ARL13B,Pathogenic,Joubert syndrome 8,single nucleotide variant,GRCh38
na,na,3,93755507,93755507,ARL13B,Pathogenic/Likely pathogenic,Joubert syndrome 8|Joubert syndrome and related disorders,single nucleotide variant,GRCh37
na,na,3,94036663,94036663,ARL13B,Pathogenic/Likely pathogenic,Joubert syndrome 8|Joubert syndrome and related disorders,single nucleotide variant,GRCh38
na,na,17,6371557,6371557,PITPNM3,Conflicting classifications of pathogenicity,Cone-rod dystrophy 5|not specified|not provided|Retinitis pigmentosa|PITPNM3-related disorder|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,17,6468237,6468237,PITPNM3,Conflicting classifications of pathogenicity,Cone-rod dystrophy 5|not specified|not provided|Retinitis pigmentosa|PITPNM3-related disorder|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,17,17931590,17931590,ATPAF2,Pathogenic,"Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1",single nucleotide variant,GRCh37
na,na,17,18028276,18028276,ATPAF2,Pathogenic,"Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1",single nucleotide variant,GRCh38
na,na,17,73831499,73831510,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3,Deletion,GRCh37
na,na,17,75835418,75835429,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3,Deletion,GRCh38
na,na,17,73839285,73839285,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3,Deletion,GRCh37
na,na,17,75843204,75843204,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3,Deletion,GRCh38
na,na,17,73831583,73831584,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3,Duplication,GRCh37
na,na,17,75835502,75835503,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3,Duplication,GRCh38
na,na,17,73832419,73832419,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh37
na,na,17,75836338,75836338,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh38
na,na,17,73836398,73836398,UNC13D,Pathogenic/Likely pathogenic,Familial hemophagocytic lymphohistiocytosis 3|not provided|Autoinflammatory syndrome|UNC13D-related disorder,single nucleotide variant,GRCh37
na,na,17,75840317,75840317,UNC13D,Pathogenic/Likely pathogenic,Familial hemophagocytic lymphohistiocytosis 3|not provided|Autoinflammatory syndrome|UNC13D-related disorder,single nucleotide variant,GRCh38
na,na,17,73836587,73836587,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3|not provided,single nucleotide variant,GRCh37
na,na,17,75840506,75840506,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3|not provided,single nucleotide variant,GRCh38
na,na,17,73832743,73832743,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3|Familial hemophagocytic lymphohistiocytosis,single nucleotide variant,GRCh37
na,na,17,75836662,75836662,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3|Familial hemophagocytic lymphohistiocytosis,single nucleotide variant,GRCh38
na,na,17,73827234,73827234,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3,single nucleotide variant,GRCh37
na,na,17,75831153,75831153,UNC13D,Pathogenic,Familial hemophagocytic lymphohistiocytosis 3,single nucleotide variant,GRCh38
na,na,13,23898605,23898606,SGCG,Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|not provided,Deletion,GRCh37
na,na,13,23324466,23324467,SGCG,Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|not provided,Deletion,GRCh38
na,na,13,23898652,23898652,SGCG,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|not provided,single nucleotide variant,GRCh37
na,na,13,23324513,23324513,SGCG,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|not provided,single nucleotide variant,GRCh38
na,na,13,23777919,23777920,SGCG,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|Autosomal recessive limb-girdle muscular dystrophy,Duplication,GRCh37
na,na,13,23203780,23203781,SGCG,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|Autosomal recessive limb-girdle muscular dystrophy,Duplication,GRCh38
na,na,13,23898591,23898591,SGCG,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|not provided|Autosomal recessive limb-girdle muscular dystrophy|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,13,23324452,23324452,SGCG,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2C|not provided|Autosomal recessive limb-girdle muscular dystrophy|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,6,135778732,135778732,AHI1,Pathogenic,Joubert syndrome 3|Joubert syndrome,single nucleotide variant,GRCh37
na,na,6,135457594,135457594,AHI1,Pathogenic,Joubert syndrome 3|Joubert syndrome,single nucleotide variant,GRCh38
na,na,6,135776913,135776913,AHI1,Pathogenic,Joubert syndrome 3|Joubert syndrome,single nucleotide variant,GRCh37
na,na,6,135455775,135455775,AHI1,Pathogenic,Joubert syndrome 3|Joubert syndrome,single nucleotide variant,GRCh38
na,na,6,135776888,135776888,AHI1,Pathogenic/Likely pathogenic,Joubert syndrome 3|Global developmental delay;Typical Joubert syndrome MRI findings,single nucleotide variant,GRCh37
na,na,6,135455750,135455750,AHI1,Pathogenic/Likely pathogenic,Joubert syndrome 3|Global developmental delay;Typical Joubert syndrome MRI findings,single nucleotide variant,GRCh38
na,na,6,135644364,135644365,AHI1,Uncertain significance,Joubert syndrome 3,Deletion,GRCh37
na,na,6,135323226,135323227,AHI1,Uncertain significance,Joubert syndrome 3,Deletion,GRCh38
na,na,6,135768160,135768160,AHI1,Pathogenic,Joubert syndrome 3|not provided|Rod-cone dystrophy|Joubert syndrome,single nucleotide variant,GRCh37
na,na,6,135447022,135447022,AHI1,Pathogenic,Joubert syndrome 3|not provided|Rod-cone dystrophy|Joubert syndrome,single nucleotide variant,GRCh38
na,na,6,135754263,135754263,AHI1,Conflicting classifications of pathogenicity,Joubert syndrome 3|Joubert syndrome|Joubert syndrome with ocular defect|not provided|AHI1-related disorder,single nucleotide variant,GRCh37
na,na,6,135433125,135433125,AHI1,Conflicting classifications of pathogenicity,Joubert syndrome 3|Joubert syndrome|Joubert syndrome with ocular defect|not provided|AHI1-related disorder,single nucleotide variant,GRCh38
na,na,6,135752350,135752351,AHI1,Pathogenic,Joubert syndrome 3,Insertion,GRCh37
na,na,6,135431212,135431213,AHI1,Pathogenic,Joubert syndrome 3,Insertion,GRCh38
na,na,5,1214175,1214176,SLC6A19,Pathogenic,Neutral 1 amino acid transport defect,Microsatellite,GRCh37
na,na,5,1214060,1214061,SLC6A19,Pathogenic,Neutral 1 amino acid transport defect,Microsatellite,GRCh38
na,na,5,1212453,1212453,SLC6A19,Pathogenic/Likely pathogenic,Neutral 1 amino acid transport defect|not provided|Hyperglycinuria;Iminoglycinuria;Neutral 1 amino acid transport defect|not specified|SLC6A19-related disorder,single nucleotide variant,GRCh37
na,na,5,1212338,1212338,SLC6A19,Pathogenic/Likely pathogenic,Neutral 1 amino acid transport defect|not provided|Hyperglycinuria;Iminoglycinuria;Neutral 1 amino acid transport defect|not specified|SLC6A19-related disorder,single nucleotide variant,GRCh38
na,na,5,1213632,1213632,SLC6A19,Pathogenic,Neutral 1 amino acid transport defect|Hyperglycinuria;Iminoglycinuria;Neutral 1 amino acid transport defect|not provided,single nucleotide variant,GRCh37
na,na,5,1213517,1213517,SLC6A19,Pathogenic,Neutral 1 amino acid transport defect|Hyperglycinuria;Iminoglycinuria;Neutral 1 amino acid transport defect|not provided,single nucleotide variant,GRCh38
na,na,5,1216900,1216900,SLC6A19,Benign,"Iminoglycinuria, digenic|Hyperglycinuria|not specified|Neutral 1 amino acid transport defect|not provided",single nucleotide variant,GRCh37
na,na,5,1216785,1216785,SLC6A19,Benign,"Iminoglycinuria, digenic|Hyperglycinuria|not specified|Neutral 1 amino acid transport defect|not provided",single nucleotide variant,GRCh38
na,na,8,61735186,61735186,CHD7,Pathogenic/Likely pathogenic,CHARGE syndrome|not provided|CHARGE syndrome;Hypogonadotropic hypogonadism 5 with or without anosmia|See cases,single nucleotide variant,GRCh37
na,na,8,60822627,60822627,CHD7,Pathogenic/Likely pathogenic,CHARGE syndrome|not provided|CHARGE syndrome;Hypogonadotropic hypogonadism 5 with or without anosmia|See cases,single nucleotide variant,GRCh38
na,na,8,61743128,61743128,CHD7,Pathogenic,CHARGE syndrome,single nucleotide variant,GRCh37
na,na,8,60830569,60830569,CHD7,Pathogenic,CHARGE syndrome,single nucleotide variant,GRCh38
na,na,8,61763065,61763065,CHD7,Pathogenic,CHARGE syndrome,single nucleotide variant,GRCh37
na,na,8,60850506,60850506,CHD7,Pathogenic,CHARGE syndrome,single nucleotide variant,GRCh38
na,na,8,61768552,61768552,CHD7,Pathogenic,CHARGE syndrome,single nucleotide variant,GRCh37
na,na,8,60855993,60855993,CHD7,Pathogenic,CHARGE syndrome,single nucleotide variant,GRCh38
na,na,8,61748664,61748664,CHD7,Pathogenic,CHARGE syndrome,single nucleotide variant,GRCh37
na,na,8,60836105,60836105,CHD7,Pathogenic,CHARGE syndrome,single nucleotide variant,GRCh38
na,na,8,61764663,61764664,CHD7,Pathogenic,CHARGE syndrome,Duplication,GRCh37
na,na,8,60852104,60852105,CHD7,Pathogenic,CHARGE syndrome,Duplication,GRCh38
na,na,8,61690321,61690321,CHD7,Uncertain significance,"Scoliosis, isolated, susceptibility to, 3",single nucleotide variant,GRCh37
na,na,8,60777762,60777762,CHD7,Uncertain significance,"Scoliosis, isolated, susceptibility to, 3",single nucleotide variant,GRCh38
na,na,na,-1,-1,CHD7,Pathogenic,CHARGE syndrome,Deletion,na
na,na,8,61765606,61765606,CHD7,Pathogenic/Likely pathogenic,CHARGE syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,60853047,60853047,CHD7,Pathogenic/Likely pathogenic,CHARGE syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,61728948,61728948,CHD7,Pathogenic,CHARGE syndrome|HYPOGONADOTROPIC HYPOGONADISM 5 WITHOUT ANOSMIA,single nucleotide variant,GRCh37
na,na,8,60816389,60816389,CHD7,Pathogenic,CHARGE syndrome|HYPOGONADOTROPIC HYPOGONADISM 5 WITHOUT ANOSMIA,single nucleotide variant,GRCh38
na,na,8,61714157,61714157,CHD7,Pathogenic,Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE syndrome,single nucleotide variant,GRCh37
na,na,8,60801598,60801598,CHD7,Pathogenic,Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE syndrome,single nucleotide variant,GRCh38
na,na,8,61729065,61729065,CHD7,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 5 with or without anosmia|not provided|Childhood onset hearing loss|CHARGE syndrome|CHARGE syndrome;Hypogonadotropic hypogonadism 5 with or without anosmia|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,8,60816506,60816506,CHD7,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 5 with or without anosmia|not provided|Childhood onset hearing loss|CHARGE syndrome|CHARGE syndrome;Hypogonadotropic hypogonadism 5 with or without anosmia|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,8,61654155,61654155,CHD7,Benign,Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE syndrome,single nucleotide variant,GRCh37
na,na,8,60741596,60741596,CHD7,Benign,Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE syndrome,single nucleotide variant,GRCh38
na,na,8,61778180,61778181,CHD7,Pathogenic,CHARGE syndrome,Insertion,GRCh37
na,na,8,60865621,60865622,CHD7,Pathogenic,CHARGE syndrome,Insertion,GRCh38
na,na,8,61754556,61754556,CHD7,Pathogenic,CHARGE syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,60841997,60841997,CHD7,Pathogenic,CHARGE syndrome|not provided,single nucleotide variant,GRCh38
na,na,5,149212243,149212243,PPARGC1B,Benign,PPARGC1B polymorphism|not provided,single nucleotide variant,GRCh37
na,na,5,149832680,149832680,PPARGC1B,Benign,PPARGC1B polymorphism|not provided,single nucleotide variant,GRCh38
na,na,3,97506848,97506848,ARL6,Pathogenic,Bardet-Biedl syndrome 3|Bardet-Biedl syndrome|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,97788004,97788004,ARL6,Pathogenic,Bardet-Biedl syndrome 3|Bardet-Biedl syndrome|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,97510641,97510641,ARL6,Pathogenic/Likely pathogenic,"Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 1, modifier of|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55;Bardet-Biedl syndrome 1",single nucleotide variant,GRCh37
na,na,3,97791797,97791797,ARL6,Pathogenic/Likely pathogenic,"Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 1, modifier of|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55;Bardet-Biedl syndrome 1",single nucleotide variant,GRCh38
na,na,3,97487043,97487043,ARL6,Pathogenic,Bardet-Biedl syndrome 3|Retinitis pigmentosa|Retinitis pigmentosa 55;Bardet-Biedl syndrome 3|not provided|Bardet-Biedl syndrome 1;Retinitis pigmentosa 55;Bardet-Biedl syndrome 3,single nucleotide variant,GRCh37
na,na,3,97768199,97768199,ARL6,Pathogenic,Bardet-Biedl syndrome 3|Retinitis pigmentosa|Retinitis pigmentosa 55;Bardet-Biedl syndrome 3|not provided|Bardet-Biedl syndrome 1;Retinitis pigmentosa 55;Bardet-Biedl syndrome 3,single nucleotide variant,GRCh38
na,na,3,97510644,97510644,ARL6,Pathogenic,Bardet-Biedl syndrome 3,single nucleotide variant,GRCh37
na,na,3,97791800,97791800,ARL6,Pathogenic,Bardet-Biedl syndrome 3,single nucleotide variant,GRCh38
na,na,3,97487043,97487043,ARL6,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55;Bardet-Biedl syndrome 1|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,97768199,97768199,ARL6,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55|Bardet-Biedl syndrome 3;Retinitis pigmentosa 55;Bardet-Biedl syndrome 1|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,97503810,97503810,ARL6,Likely pathogenic,Retinitis pigmentosa 55|Autosomal recessive retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,3,97784966,97784966,ARL6,Likely pathogenic,Retinitis pigmentosa 55|Autosomal recessive retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,14,68195926,68195926,RDH12,Pathogenic/Likely pathogenic,Leber congenital amaurosis 13|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,14,67729209,67729209,RDH12,Pathogenic/Likely pathogenic,Leber congenital amaurosis 13|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,14,68196054,68196058,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinal dystrophy|Abnormality of the eye|RDH12-related disorder|Retinitis pigmentosa|not provided|Leber congenital amaurosis,Deletion,GRCh37
na,na,14,67729337,67729341,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinal dystrophy|Abnormality of the eye|RDH12-related disorder|Retinitis pigmentosa|not provided|Leber congenital amaurosis,Deletion,GRCh38
na,na,14,68193814,68193814,RDH12,Pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh37
na,na,14,67727097,67727097,RDH12,Pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh38
na,na,14,68191267,68191267,RDH12,Pathogenic,Leber congenital amaurosis 13|not provided|Leber congenital amaurosis|Cone-rod dystrophy|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,14,67724550,67724550,RDH12,Pathogenic,Leber congenital amaurosis 13|not provided|Leber congenital amaurosis|Cone-rod dystrophy|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,14,68191305,68191305,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinal dystrophy|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,14,67724588,67724588,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinal dystrophy|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,14,68192803,68192803,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,14,67726086,67726086,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,14,68193700,68193700,RDH12,Pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh37
na,na,14,67726983,67726983,RDH12,Pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh38
na,na,14,68195937,68195937,RDH12,Pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh37
na,na,14,67729220,67729220,RDH12,Pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh38
na,na,14,68193700,68193700,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,14,67726983,67726983,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,14,68191923,68191923,RDH12,Pathogenic/Likely pathogenic,Leber congenital amaurosis 13|not provided|Retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,14,67725206,67725206,RDH12,Pathogenic/Likely pathogenic,Leber congenital amaurosis 13|not provided|Retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,14,68193772,68193772,RDH12,Pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh37
na,na,14,67727055,67727055,RDH12,Pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh38
na,na,14,68191273,68191273,RDH12,Likely pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh37
na,na,14,67724556,67724556,RDH12,Likely pathogenic,Leber congenital amaurosis 13,single nucleotide variant,GRCh38
na,na,14,68193908,68193908,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,14,67727191,67727191,RDH12,Pathogenic,Leber congenital amaurosis 13|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,14,68193713,68193713,RDH12,Pathogenic/Likely pathogenic,Leber congenital amaurosis 13|not provided|Leber congenital amaurosis|Cone-rod dystrophy|See cases|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,14,67726996,67726996,RDH12,Pathogenic/Likely pathogenic,Leber congenital amaurosis 13|not provided|Leber congenital amaurosis|Cone-rod dystrophy|See cases|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,14,68192801,68192801,RDH12,Pathogenic/Likely pathogenic,Retinitis pigmentosa 53|Retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis 13|not provided|Leber congenital amaurosis|RDH12-related disorder,single nucleotide variant,GRCh37
na,na,14,67726084,67726084,RDH12,Pathogenic/Likely pathogenic,Retinitis pigmentosa 53|Retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis 13|not provided|Leber congenital amaurosis|RDH12-related disorder,single nucleotide variant,GRCh38
na,na,6,149721690,149721690,SUMO4;TAB2,Benign,Type 1 diabetes mellitus 5|not specified|not provided,single nucleotide variant,GRCh37
na,na,6,149400554,149400554,SUMO4;TAB2,Benign,Type 1 diabetes mellitus 5|not specified|not provided,single nucleotide variant,GRCh38
na,na,6,52303361,52303361,EFHC1,Benign,"Myoclonic epilepsy, juvenile, susceptibility to, 1|not specified|Juvenile myoclonic epilepsy|not provided|Absence seizure;Myoclonic epilepsy, juvenile, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,6,52438563,52438563,EFHC1,Benign,"Myoclonic epilepsy, juvenile, susceptibility to, 1|not specified|Juvenile myoclonic epilepsy|not provided|Absence seizure;Myoclonic epilepsy, juvenile, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,6,52317597,52317597,EFHC1,Conflicting classifications of pathogenicity,"Myoclonic epilepsy, juvenile, susceptibility to, 1|not specified|not provided|Absence seizure|Myoclonic epilepsy, juvenile, susceptibility to, 1;Absence seizure",single nucleotide variant,GRCh37
na,na,6,52452799,52452799,EFHC1,Conflicting classifications of pathogenicity,"Myoclonic epilepsy, juvenile, susceptibility to, 1|not specified|not provided|Absence seizure|Myoclonic epilepsy, juvenile, susceptibility to, 1;Absence seizure",single nucleotide variant,GRCh38
na,na,6,52317540,52317540,EFHC1,Uncertain significance,"Myoclonic epilepsy, juvenile, susceptibility to, 1|Myoclonic epilepsy, juvenile, susceptibility to, 1;Absence seizure",single nucleotide variant,GRCh37
na,na,6,52452742,52452742,EFHC1,Uncertain significance,"Myoclonic epilepsy, juvenile, susceptibility to, 1|Myoclonic epilepsy, juvenile, susceptibility to, 1;Absence seizure",single nucleotide variant,GRCh38
na,na,6,52318926,52318926,EFHC1,risk factor,"Myoclonic epilepsy, juvenile, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,6,52454128,52454128,EFHC1,risk factor,"Myoclonic epilepsy, juvenile, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,6,52288909,52288909,EFHC1,Benign/Likely benign,"not specified|not provided|Absence seizure;Myoclonic epilepsy, juvenile, susceptibility to, 1|EFHC1-related disorder",single nucleotide variant,GRCh37
na,na,6,52424111,52424111,EFHC1,Benign/Likely benign,"not specified|not provided|Absence seizure;Myoclonic epilepsy, juvenile, susceptibility to, 1|EFHC1-related disorder",single nucleotide variant,GRCh38
na,na,6,52303336,52303336,EFHC1,risk factor,Absence seizure,single nucleotide variant,GRCh37
na,na,6,52438538,52438538,EFHC1,risk factor,Absence seizure,single nucleotide variant,GRCh38
na,na,6,52318945,52318945,EFHC1,risk factor,Absence seizure,single nucleotide variant,GRCh37
na,na,6,52454147,52454147,EFHC1,risk factor,Absence seizure,single nucleotide variant,GRCh38
na,na,6,52319052,52319052,EFHC1,risk factor,"Myoclonic epilepsy, juvenile, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,6,52454254,52454254,EFHC1,risk factor,"Myoclonic epilepsy, juvenile, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,1,228346316,228346316,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2|See cases,single nucleotide variant,GRCh37
na,na,1,228158615,228158615,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2|See cases,single nucleotide variant,GRCh38
na,na,1,228345727,228345727,GJC2,Likely pathogenic,Hypomyelinating leukodystrophy 2,single nucleotide variant,GRCh37
na,na,1,228158026,228158026,GJC2,Likely pathogenic,Hypomyelinating leukodystrophy 2,single nucleotide variant,GRCh38
na,na,1,228346446,228346446,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2,Deletion,GRCh37
na,na,1,228158745,228158745,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2,Deletion,GRCh38
na,na,1,228346177,228346177,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2|not provided,single nucleotide variant,GRCh37
na,na,1,228158476,228158476,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2|not provided,single nucleotide variant,GRCh38
na,na,1,228346273,228346273,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2,single nucleotide variant,GRCh37
na,na,1,228158572,228158572,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2,single nucleotide variant,GRCh38
na,na,1,228346360,228346393,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2|not provided,Deletion,GRCh37
na,na,1,228158659,228158692,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2|not provided,Deletion,GRCh38
na,na,1,228346154,228346155,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2,Insertion,GRCh37
na,na,1,228158453,228158454,GJC2,Pathogenic,Hypomyelinating leukodystrophy 2,Insertion,GRCh38
na,na,1,228345567,228345567,GJC2,Pathogenic,Hereditary spastic paraplegia 44,single nucleotide variant,GRCh37
na,na,1,228157866,228157866,GJC2,Pathogenic,Hereditary spastic paraplegia 44,single nucleotide variant,GRCh38
na,na,1,228345602,228345602,GJC2,Pathogenic,Lymphatic malformation 3,single nucleotide variant,GRCh37
na,na,1,228157901,228157901,GJC2,Pathogenic,Lymphatic malformation 3,single nucleotide variant,GRCh38
na,na,1,228346237,228346237,GJC2,Pathogenic,Lymphatic malformation 3,single nucleotide variant,GRCh37
na,na,1,228158536,228158536,GJC2,Pathogenic,Lymphatic malformation 3,single nucleotide variant,GRCh38
na,na,19,13007754,13007754,GCDH,Pathogenic/Likely pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh37
na,na,19,12896940,12896940,GCDH,Pathogenic/Likely pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh38
na,na,19,13010300,13010300,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh37
na,na,19,12899486,12899486,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh38
na,na,19,13007748,13007748,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh37
na,na,19,12896934,12896934,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh38
na,na,19,13010285,13010285,GCDH,Likely pathogenic,"Glutaric aciduria, type 1",single nucleotide variant,GRCh37
na,na,19,12899471,12899471,GCDH,Likely pathogenic,"Glutaric aciduria, type 1",single nucleotide variant,GRCh38
na,na,19,13008638,13008638,GCDH,Pathogenic/Likely pathogenic,"Glutaric aciduria, type 1|not provided|Abnormality of metabolism/homeostasis|Primary ciliary dyskinesia 29|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,19,12897824,12897824,GCDH,Pathogenic/Likely pathogenic,"Glutaric aciduria, type 1|not provided|Abnormality of metabolism/homeostasis|Primary ciliary dyskinesia 29|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,19,13008527,13008527,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh37
na,na,19,12897713,12897713,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh38
na,na,19,13002214,13002214,GCDH;KLF1;LOC117125594,Pathogenic,"Glutaric aciduria, type 1|BLOOD GROUP--LUTHERAN INHIBITOR;FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6;Congenital dyserythropoietic anemia type 4",single nucleotide variant,GRCh37
na,na,19,12891400,12891400,GCDH;KLF1;LOC117125594,Pathogenic,"Glutaric aciduria, type 1|BLOOD GROUP--LUTHERAN INHIBITOR;FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6;Congenital dyserythropoietic anemia type 4",single nucleotide variant,GRCh38
na,na,19,13008632,13008632,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided|GCDH-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,19,12897818,12897818,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided|GCDH-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,19,13007063,13007063,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh37
na,na,19,12896249,12896249,GCDH,Pathogenic,"Glutaric aciduria, type 1|not provided",single nucleotide variant,GRCh38
na,na,na,-1,-1,GSDME,Pathogenic,Autosomal dominant nonsyndromic hearing loss 5,Complex,na
na,na,7,24746001,24746001,GSDME,Pathogenic,Autosomal dominant nonsyndromic hearing loss 5,single nucleotide variant,GRCh37
na,na,7,24706382,24706382,GSDME,Pathogenic,Autosomal dominant nonsyndromic hearing loss 5,single nucleotide variant,GRCh38
na,na,7,24745799,24745799,GSDME,Pathogenic,Autosomal dominant nonsyndromic hearing loss 5,single nucleotide variant,GRCh37
na,na,7,24706180,24706180,GSDME,Pathogenic,Autosomal dominant nonsyndromic hearing loss 5,single nucleotide variant,GRCh38
na,na,11,66619415,66619415,PC,Pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh37
na,na,11,66851944,66851944,PC,Pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh38
na,na,11,66618389,66618389,PC,Pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh37
na,na,11,66850918,66850918,PC,Pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh38
na,na,11,66638839,66638839,PC,Pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh37
na,na,11,66871368,66871368,PC,Pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh38
na,na,11,66631262,66631262,PC,Likely pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh37
na,na,11,66863791,66863791,PC,Likely pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh38
na,na,11,66619905,66619908,PC,Pathogenic,Pyruvate carboxylase deficiency,Deletion,GRCh37
na,na,11,66852434,66852437,PC,Pathogenic,Pyruvate carboxylase deficiency,Deletion,GRCh38
na,na,11,66638806,66638806,PC,Conflicting classifications of pathogenicity,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh37
na,na,11,66871335,66871335,PC,Conflicting classifications of pathogenicity,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh38
na,na,11,66619987,66619987,PC,Pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh37
na,na,11,66852516,66852516,PC,Pathogenic,Pyruvate carboxylase deficiency,single nucleotide variant,GRCh38
na,na,11,66617429,66617430,PC,Pathogenic,Pyruvate carboxylase deficiency,Duplication,GRCh37
na,na,11,66849958,66849959,PC,Pathogenic,Pyruvate carboxylase deficiency,Duplication,GRCh38
na,na,6,158613139,158613139,GTF2H5,Pathogenic/Likely pathogenic,"Trichothiodystrophy 3, photosensitive|not provided",single nucleotide variant,GRCh37
na,na,6,158192107,158192107,GTF2H5,Pathogenic/Likely pathogenic,"Trichothiodystrophy 3, photosensitive|not provided",single nucleotide variant,GRCh38
na,na,6,158613035,158613035,GTF2H5,Pathogenic,"Trichothiodystrophy 3, photosensitive",single nucleotide variant,GRCh37
na,na,6,158192003,158192003,GTF2H5,Pathogenic,"Trichothiodystrophy 3, photosensitive",single nucleotide variant,GRCh38
na,na,11,113270828,113270828,ANKK1,Benign,Taq1A POLYMORPHISM|not specified|ANKK1-related disorder|Schizophrenia|not provided,single nucleotide variant,GRCh37
na,na,11,113400106,113400106,ANKK1,Benign,Taq1A POLYMORPHISM|not specified|ANKK1-related disorder|Schizophrenia|not provided,single nucleotide variant,GRCh38
na,na,12,116457651,116457651,MED13L,Uncertain significance,"Transposition of the great arteries, dextro-looped|Impaired intellectual development and distinctive facial features with cardiac defects|Cardiac anomalies - developmental delay - facial dysmorphism syndrome",single nucleotide variant,GRCh37
na,na,12,116019846,116019846,MED13L,Uncertain significance,"Transposition of the great arteries, dextro-looped|Impaired intellectual development and distinctive facial features with cardiac defects|Cardiac anomalies - developmental delay - facial dysmorphism syndrome",single nucleotide variant,GRCh38
na,na,12,116413092,116413092,MED13L,Uncertain significance,"Transposition of the great arteries, dextro-looped",single nucleotide variant,GRCh37
na,na,12,115975287,115975287,MED13L,Uncertain significance,"Transposition of the great arteries, dextro-looped",single nucleotide variant,GRCh38
na,na,12,116406902,116406902,MED13L,Uncertain significance,"Transposition of the great arteries, dextro-looped",single nucleotide variant,GRCh37
na,na,12,115969097,115969097,MED13L,Uncertain significance,"Transposition of the great arteries, dextro-looped",single nucleotide variant,GRCh38
na,na,11,111897003,111897005,DLAT,Pathogenic,Pyruvate dehydrogenase E2 deficiency,Deletion,GRCh37
na,na,11,112026279,112026281,DLAT,Pathogenic,Pyruvate dehydrogenase E2 deficiency,Deletion,GRCh38
na,na,11,111931812,111931812,DLAT,Conflicting classifications of pathogenicity,Pyruvate dehydrogenase E2 deficiency,single nucleotide variant,GRCh37
na,na,11,112061088,112061088,DLAT,Conflicting classifications of pathogenicity,Pyruvate dehydrogenase E2 deficiency,single nucleotide variant,GRCh38
na,na,11,34938280,34952952,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh37
na,na,11,34916733,34931405,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh38
na,na,11,34999671,34999729,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh37
na,na,11,34978124,34978182,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh38
na,na,11,34938289,34938292,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh37
na,na,11,34916742,34916745,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh38
na,na,11,34982066,34982066,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,single nucleotide variant,GRCh37
na,na,11,34960519,34960519,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,single nucleotide variant,GRCh38
na,na,11,35006116,35006116,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,single nucleotide variant,GRCh37
na,na,11,34984569,34984569,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,single nucleotide variant,GRCh38
na,na,11,34982042,34982042,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh37
na,na,11,34960495,34960495,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh38
na,na,na,-1,-1,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,na
na,na,11,34988287,34988287,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,single nucleotide variant,GRCh37
na,na,11,34966740,34966740,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,single nucleotide variant,GRCh38
na,na,11,35010771,35014683,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh37
na,na,11,34989224,34993136,PDHX,Pathogenic,Pyruvate dehydrogenase E3-binding protein deficiency,Deletion,GRCh38
na,na,17,73518081,73518081,TSEN54,Pathogenic,Pontocerebellar hypoplasia type 2A|Olivopontocerebellar hypoplasia|Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5|Microcephaly;Global developmental delay|not provided|Congenital cerebellar hypoplasia|Amblyopia;Hypertonia;Global developmental delay|Pontocerebellar hypoplasia type 2A;Pontocerebellar hypoplasia type 4|Inborn genetic diseases|Intellectual disability|Pontoneocerebellar hypoplasia|Pontocerebellar hypoplasia type 2;Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 2A;Pontocerebellar hypoplasia type 5;Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5;Pontocerebellar hypoplasia type 4;Methylmalonic aciduria and homocystinuria type cblD|TSEN54-related disorder|TSEN54 Pontocerebellar Hypoplasia,single nucleotide variant,GRCh37
na,na,17,75522000,75522000,TSEN54,Pathogenic,Pontocerebellar hypoplasia type 2A|Olivopontocerebellar hypoplasia|Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5|Microcephaly;Global developmental delay|not provided|Congenital cerebellar hypoplasia|Amblyopia;Hypertonia;Global developmental delay|Pontocerebellar hypoplasia type 2A;Pontocerebellar hypoplasia type 4|Inborn genetic diseases|Intellectual disability|Pontoneocerebellar hypoplasia|Pontocerebellar hypoplasia type 2;Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 2A;Pontocerebellar hypoplasia type 5;Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5;Pontocerebellar hypoplasia type 4;Methylmalonic aciduria and homocystinuria type cblD|TSEN54-related disorder|TSEN54 Pontocerebellar Hypoplasia,single nucleotide variant,GRCh38
na,na,17,73517898,73517898,TSEN54,Pathogenic/Likely pathogenic,Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5|not provided,single nucleotide variant,GRCh37
na,na,17,75521817,75521817,TSEN54,Pathogenic/Likely pathogenic,Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 5|not provided,single nucleotide variant,GRCh38
na,na,17,73518189,73518189,TSEN54,Pathogenic,Pontocerebellar hypoplasia type 4,single nucleotide variant,GRCh37
na,na,17,75522108,75522108,TSEN54,Pathogenic,Pontocerebellar hypoplasia type 4,single nucleotide variant,GRCh38
na,na,19,54695387,54695387,TSEN34,Pathogenic,Pontocerebellar hypoplasia type 2C,single nucleotide variant,GRCh37
na,na,19,54191536,54191536,TSEN34,Pathogenic,Pontocerebellar hypoplasia type 2C,single nucleotide variant,GRCh38
na,na,3,12558126,12558126,TSEN2,Conflicting classifications of pathogenicity,Pontocerebellar hypoplasia type 2B|Pontoneocerebellar hypoplasia|not provided,single nucleotide variant,GRCh37
na,na,3,12516627,12516627,TSEN2,Conflicting classifications of pathogenicity,Pontocerebellar hypoplasia type 2B|Pontoneocerebellar hypoplasia|not provided,single nucleotide variant,GRCh38
na,na,11,119210284,119210284,C1QTNF5,Pathogenic/Likely pathogenic,Late-onset retinal degeneration|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,119339574,119339574,C1QTNF5,Pathogenic/Likely pathogenic,Late-onset retinal degeneration|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,183963347,183963347,ALG3,Pathogenic,ALG3-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,3,184245559,184245559,ALG3,Pathogenic,ALG3-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,3,183966564,183966564,ALG3,Pathogenic/Likely pathogenic,ALG3-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,3,184248776,184248776,ALG3,Pathogenic/Likely pathogenic,ALG3-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,3,183963079,183963079,ALG3,Pathogenic/Likely pathogenic,ALG3-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,3,184245291,184245291,ALG3,Pathogenic/Likely pathogenic,ALG3-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,3,183963586,183963586,ALG3,Uncertain significance,ALG3-congenital disorder of glycosylation|not specified,single nucleotide variant,GRCh37
na,na,3,184245798,184245798,ALG3,Uncertain significance,ALG3-congenital disorder of glycosylation|not specified,single nucleotide variant,GRCh38
na,na,3,183963121,183963121,ALG3,Pathogenic,ALG3-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,3,184245333,184245333,ALG3,Pathogenic,ALG3-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,11,47433963,47433971,SLC39A13,Pathogenic,"Ehlers-Danlos syndrome, spondylocheirodysplastic type",Deletion,GRCh37
na,na,11,47412412,47412420,SLC39A13,Pathogenic,"Ehlers-Danlos syndrome, spondylocheirodysplastic type",Deletion,GRCh38
na,na,11,47431866,47431866,SLC39A13,Conflicting classifications of pathogenicity,"Ehlers-Danlos syndrome, spondylocheirodysplastic type|not provided",single nucleotide variant,GRCh37
na,na,11,47410315,47410315,SLC39A13,Conflicting classifications of pathogenicity,"Ehlers-Danlos syndrome, spondylocheirodysplastic type|not provided",single nucleotide variant,GRCh38
na,na,11,14907393,14907393,CYP2R1,Pathogenic/Likely pathogenic,"Vitamin D hydroxylation-deficient rickets, type 1B|not provided|Vitamin D-dependent rickets, type 1|CYP2R1-related disorder",single nucleotide variant,GRCh37
na,na,11,14885847,14885847,CYP2R1,Pathogenic/Likely pathogenic,"Vitamin D hydroxylation-deficient rickets, type 1B|not provided|Vitamin D-dependent rickets, type 1|CYP2R1-related disorder",single nucleotide variant,GRCh38
na,na,15,55790530,55790530,DNAAF4,Benign,"Dyslexia, susceptibility to, 1|not specified|not provided",single nucleotide variant,GRCh37
na,na,15,55498332,55498332,DNAAF4,Benign,"Dyslexia, susceptibility to, 1|not specified|not provided",single nucleotide variant,GRCh38
na,na,15,55722882,55722882,DNAAF4,Benign,"Dyslexia, susceptibility to, 1|not specified|not provided|Primary ciliary dyskinesia 25",single nucleotide variant,GRCh37
na,na,15,55430684,55430684,DNAAF4,Benign,"Dyslexia, susceptibility to, 1|not specified|not provided|Primary ciliary dyskinesia 25",single nucleotide variant,GRCh38
na,na,2,71017735,71017756,FIGLA,Pathogenic,Premature ovarian failure 6,Deletion,GRCh37
na,na,2,70790603,70790624,FIGLA,Pathogenic,Premature ovarian failure 6,Deletion,GRCh38
na,na,2,71012735,71012737,FIGLA,Pathogenic,Premature ovarian failure 6,Microsatellite,GRCh37
na,na,2,70785603,70785605,FIGLA,Pathogenic,Premature ovarian failure 6,Microsatellite,GRCh38
na,na,5,36953800,36953800,NIPBL,Pathogenic/Likely pathogenic,Cornelia de Lange syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,5,36953698,36953698,NIPBL,Pathogenic/Likely pathogenic,Cornelia de Lange syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,5,37057313,37057313,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh37
na,na,5,37057211,37057211,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh38
na,na,5,36955659,36955659,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Deletion,GRCh37
na,na,5,36955557,36955557,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Deletion,GRCh38
na,na,5,37057329,37057330,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Duplication,GRCh37
na,na,5,37057227,37057228,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Duplication,GRCh38
na,na,5,36984824,36984825,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Duplication,GRCh37
na,na,5,36984722,36984723,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Duplication,GRCh38
na,na,5,37001131,37001133,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Deletion,GRCh37
na,na,5,37001029,37001031,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Deletion,GRCh38
na,na,5,37020717,37020717,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh37
na,na,5,37020615,37020615,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh38
na,na,5,37002836,37002836,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh37
na,na,5,37002734,37002734,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh38
na,na,5,37063891,37063891,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh37
na,na,5,37063789,37063789,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh38
na,na,na,-1,-1,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,na
na,na,5,37014830,37014830,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh37
na,na,5,37014728,37014728,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,single nucleotide variant,GRCh38
na,na,5,36877039,36877040,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Indel,GRCh37
na,na,5,36876937,36876938,NIPBL,Pathogenic,Cornelia de Lange syndrome 1,Indel,GRCh38
na,na,22,18562701,18562701,PEX26,Pathogenic,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder|not provided|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|PEX26-related disorder,single nucleotide variant,GRCh37
na,na,22,18079935,18079935,PEX26,Pathogenic,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder|not provided|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|PEX26-related disorder,single nucleotide variant,GRCh38
na,na,22,18562674,18562674,PEX26,Pathogenic/Likely pathogenic,Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B,single nucleotide variant,GRCh37
na,na,22,18079908,18079908,PEX26,Pathogenic/Likely pathogenic,Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B,single nucleotide variant,GRCh38
na,na,22,18561170,18561171,PEX26,Pathogenic,Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder|not provided,Duplication,GRCh37
na,na,22,18078404,18078405,PEX26,Pathogenic,Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder|not provided,Duplication,GRCh38
na,na,na,-1,-1,PEX26,no classification for the single variant,-,Deletion,na
na,na,22,18561144,18561144,PEX26,Pathogenic/Likely pathogenic,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|not provided|Peroxisome biogenesis disorder 7B;Peroxisome biogenesis disorder 7A (Zellweger),single nucleotide variant,GRCh37
na,na,22,18078378,18078378,PEX26,Pathogenic/Likely pathogenic,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|not provided|Peroxisome biogenesis disorder 7B;Peroxisome biogenesis disorder 7A (Zellweger),single nucleotide variant,GRCh38
na,na,22,18561276,18561276,PEX26,Conflicting classifications of pathogenicity,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder,single nucleotide variant,GRCh37
na,na,22,18078510,18078510,PEX26,Conflicting classifications of pathogenicity,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder,single nucleotide variant,GRCh38
na,na,22,18562662,18562663,PEX26,Pathogenic,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7B;Peroxisome biogenesis disorder 7A (Zellweger),Duplication,GRCh37
na,na,22,18079896,18079897,PEX26,Pathogenic,Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7B;Peroxisome biogenesis disorder 7A (Zellweger),Duplication,GRCh38
na,na,22,18561373,18561373,PEX26,Pathogenic,Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder,single nucleotide variant,GRCh37
na,na,22,18078607,18078607,PEX26,Pathogenic,Peroxisome biogenesis disorder 7A (Zellweger)|Peroxisome biogenesis disorder 7A (Zellweger);Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder,single nucleotide variant,GRCh38
na,na,11,22272339,22272339,ANO5,Pathogenic,Gnathodiaphyseal dysplasia|not provided,single nucleotide variant,GRCh37
na,na,11,22250793,22250793,ANO5,Pathogenic,Gnathodiaphyseal dysplasia|not provided,single nucleotide variant,GRCh38
na,na,11,22272339,22272339,ANO5,Pathogenic,Gnathodiaphyseal dysplasia|not provided,single nucleotide variant,GRCh37
na,na,11,22250793,22250793,ANO5,Pathogenic,Gnathodiaphyseal dysplasia|not provided,single nucleotide variant,GRCh38
na,na,11,22277031,22277031,ANO5,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia;Miyoshi muscular dystrophy 3|Autosomal recessive limb-girdle muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia|ANO5-related disorder,single nucleotide variant,GRCh37
na,na,11,22255485,22255485,ANO5,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia;Miyoshi muscular dystrophy 3|Autosomal recessive limb-girdle muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia|ANO5-related disorder,single nucleotide variant,GRCh38
na,na,11,22242646,22242647,ANO5,Pathogenic,Miyoshi muscular dystrophy 3|Autosomal recessive limb-girdle muscular dystrophy type 2L|Polycystic kidney disease;Lower limb amyotrophy;Achilles tendon contracture;Elevated circulating creatine kinase concentration;Lower limb muscle weakness|Myopathy|Miyoshi muscular dystrophy 3;Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L|ANO5-related disorder|Intellectual disability|Autosomal recessive limb-girdle muscular dystrophy|Gnathodiaphyseal dysplasia|ANO5-related muscular dystrophy,Duplication,GRCh37
na,na,11,22221100,22221101,ANO5,Pathogenic,Miyoshi muscular dystrophy 3|Autosomal recessive limb-girdle muscular dystrophy type 2L|Polycystic kidney disease;Lower limb amyotrophy;Achilles tendon contracture;Elevated circulating creatine kinase concentration;Lower limb muscle weakness|Myopathy|Miyoshi muscular dystrophy 3;Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L|ANO5-related disorder|Intellectual disability|Autosomal recessive limb-girdle muscular dystrophy|Gnathodiaphyseal dysplasia|ANO5-related muscular dystrophy,Duplication,GRCh38
na,na,11,22257752,22257752,ANO5,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L|ANO5-related disorder|Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L;Miyoshi muscular dystrophy 3|Hereditary fructosuria|Autosomal recessive limb-girdle muscular dystrophy|Miyoshi muscular dystrophy 3,single nucleotide variant,GRCh37
na,na,11,22236206,22236206,ANO5,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L|ANO5-related disorder|Gnathodiaphyseal dysplasia;Autosomal recessive limb-girdle muscular dystrophy type 2L;Miyoshi muscular dystrophy 3|Hereditary fructosuria|Autosomal recessive limb-girdle muscular dystrophy|Miyoshi muscular dystrophy 3,single nucleotide variant,GRCh38
na,na,11,22296151,22296151,ANO5,Pathogenic,Miyoshi muscular dystrophy 3|Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia|ANO5 Muscle Disease|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,11,22274605,22274605,ANO5,Pathogenic,Miyoshi muscular dystrophy 3|Autosomal recessive limb-girdle muscular dystrophy type 2L|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2L;Gnathodiaphyseal dysplasia|ANO5 Muscle Disease|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,6,108250670,108250670,SEC63,Pathogenic,Polycystic liver disease 2,single nucleotide variant,GRCh37
na,na,6,107929466,107929466,SEC63,Pathogenic,Polycystic liver disease 2,single nucleotide variant,GRCh38
na,na,6,108243010,108243011,SEC63,Pathogenic,Polycystic liver disease 2,Insertion,GRCh37
na,na,6,107921806,107921807,SEC63,Pathogenic,Polycystic liver disease 2,Insertion,GRCh38
na,na,6,108230130,108230130,SEC63,Pathogenic,Polycystic liver disease 2|not provided,single nucleotide variant,GRCh37
na,na,6,107908926,107908926,SEC63,Pathogenic,Polycystic liver disease 2|not provided,single nucleotide variant,GRCh38
na,na,11,104763117,104763117,CASP12,Likely benign,not specified|CASP12-related disorder|not provided,single nucleotide variant,GRCh37
na,na,11,104892390,104892390,CASP12,Likely benign,not specified|CASP12-related disorder|not provided,single nucleotide variant,GRCh38
na,na,11,124740958,124740958,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124871062,124871062,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,11,124748483,124748484,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",Duplication,GRCh37
na,na,11,124878587,124878588,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",Duplication,GRCh38
na,na,11,124745041,124745041,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124875145,124875145,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,11,124745046,124745046,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124875150,124875150,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,11,124742815,124742815,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124872919,124872919,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,11,124740546,124740546,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124870650,124870650,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,11,124745469,124745470,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",Duplication,GRCh37
na,na,11,124875573,124875574,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",Duplication,GRCh38
na,na,11,124735487,124735487,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124865591,124865591,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,11,124738733,124738733,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124868837,124868837,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,11,124744806,124744806,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124874910,124874910,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,11,124744018,124744019,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",Microsatellite,GRCh37
na,na,11,124874122,124874123,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",Microsatellite,GRCh38
na,na,11,124744067,124744068,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",Deletion,GRCh37
na,na,11,124874171,124874172,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",Deletion,GRCh38
na,na,11,124739931,124739931,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124870035,124870035,ROBO3,Likely pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,11,124745477,124745477,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh37
na,na,11,124875581,124875581,ROBO3,Pathogenic,"Gaze palsy, familial horizontal, with progressive scoliosis 1",single nucleotide variant,GRCh38
na,na,17,61779448,61786751,STRADA,Pathogenic,"Polyhydramnios, megalencephaly, and symptomatic epilepsy",Deletion,GRCh37
na,na,17,63702088,63709391,STRADA,Pathogenic,"Polyhydramnios, megalencephaly, and symptomatic epilepsy",Deletion,GRCh38
na,na,4,187113107,187113107,CYP4V2,Uncertain significance,Bietti crystalline corneoretinal dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,4,186191953,186191953,CYP4V2,Uncertain significance,Bietti crystalline corneoretinal dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,4,187117161,187117161,CYP4V2,Pathogenic,Bietti crystalline corneoretinal dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,4,186196007,186196007,CYP4V2,Pathogenic,Bietti crystalline corneoretinal dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,4,187131740,187131740,CYP4V2,Conflicting classifications of pathogenicity,Bietti crystalline corneoretinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,4,186210586,186210586,CYP4V2,Conflicting classifications of pathogenicity,Bietti crystalline corneoretinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,4,187113158,187113158,CYP4V2,Pathogenic,Bietti crystalline corneoretinal dystrophy,single nucleotide variant,GRCh37
na,na,4,186192004,186192004,CYP4V2,Pathogenic,Bietti crystalline corneoretinal dystrophy,single nucleotide variant,GRCh38
na,na,4,187130017,187130017,CYP4V2,Pathogenic/Likely pathogenic,Bietti crystalline corneoretinal dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,4,186208863,186208863,CYP4V2,Pathogenic/Likely pathogenic,Bietti crystalline corneoretinal dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,7,34818113,34818113,NPSR1,Benign,"Asthma-related traits, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,7,34778501,34778501,NPSR1,Benign,"Asthma-related traits, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,8,10480579,10480579,RP1L1,Pathogenic/Likely pathogenic,Occult macular dystrophy|not provided|Retinal dystrophy|Retinitis pigmentosa 88|Optic atrophy,single nucleotide variant,GRCh37
na,na,8,10623069,10623069,RP1L1,Pathogenic/Likely pathogenic,Occult macular dystrophy|not provided|Retinal dystrophy|Retinitis pigmentosa 88|Optic atrophy,single nucleotide variant,GRCh38
na,na,8,10468730,10468730,RP1L1,Uncertain significance,Occult macular dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,8,10611220,10611220,RP1L1,Uncertain significance,Occult macular dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,8,102656449,102656450,GRHL2,Pathogenic,Autosomal dominant nonsyndromic hearing loss 28,Duplication,GRCh37
na,na,8,101644221,101644222,GRHL2,Pathogenic,Autosomal dominant nonsyndromic hearing loss 28,Duplication,GRCh38
na,na,19,50713642,50713642,MYH14,Pathogenic,Autosomal dominant nonsyndromic hearing loss 4A,single nucleotide variant,GRCh37
na,na,19,50210385,50210385,MYH14,Pathogenic,Autosomal dominant nonsyndromic hearing loss 4A,single nucleotide variant,GRCh38
na,na,19,50774681,50774681,MYH14,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 4A|not provided,single nucleotide variant,GRCh37
na,na,19,50271424,50271424,MYH14,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 4A|not provided,single nucleotide variant,GRCh38
na,na,19,50762467,50762467,MYH14,Pathogenic,Autosomal dominant nonsyndromic hearing loss 4A,single nucleotide variant,GRCh37
na,na,19,50259210,50259210,MYH14,Pathogenic,Autosomal dominant nonsyndromic hearing loss 4A,single nucleotide variant,GRCh38
na,na,19,50747534,50747534,MYH14,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 4A|not specified|not provided|Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome,single nucleotide variant,GRCh37
na,na,19,50244277,50244277,MYH14,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 4A|not specified|not provided|Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome,single nucleotide variant,GRCh38
na,na,19,50713981,50713981,MYH14,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 4A|not provided|MYH14-related disorder,single nucleotide variant,GRCh37
na,na,19,50210724,50210724,MYH14,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 4A|not provided|MYH14-related disorder,single nucleotide variant,GRCh38
na,na,15,91543193,91543193,VPS33B,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1|not provided",single nucleotide variant,GRCh37
na,na,15,90999963,90999963,VPS33B,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1|not provided",single nucleotide variant,GRCh38
na,na,15,91545373,91545373,VPS33B,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1|not provided|VPS33B-related disorder|Arthrogryposis, renal dysfunction, and cholestasis 1;Keratoderma-ichthyosis-deafness syndrome, autosomal recessive;Cholestasis, progressive familial intrahepatic, 12",single nucleotide variant,GRCh37
na,na,15,91002143,91002143,VPS33B,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1|not provided|VPS33B-related disorder|Arthrogryposis, renal dysfunction, and cholestasis 1;Keratoderma-ichthyosis-deafness syndrome, autosomal recessive;Cholestasis, progressive familial intrahepatic, 12",single nucleotide variant,GRCh38
na,na,15,91565391,91565391,VPS33B,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1",single nucleotide variant,GRCh37
na,na,15,91022161,91022161,VPS33B,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1",single nucleotide variant,GRCh38
na,na,15,91550179,91550179,VPS33B,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1",single nucleotide variant,GRCh37
na,na,15,91006949,91006949,VPS33B,Pathogenic,"Arthrogryposis, renal dysfunction, and cholestasis 1",single nucleotide variant,GRCh38
na,na,1,186147638,186147638,HMCN1,Conflicting classifications of pathogenicity,"MACULAR DEGENERATION, AGE-RELATED, 1, SUSCEPTIBILITY TO|Age related macular degeneration 1|not provided",single nucleotide variant,GRCh37
na,na,1,186178506,186178506,HMCN1,Conflicting classifications of pathogenicity,"MACULAR DEGENERATION, AGE-RELATED, 1, SUSCEPTIBILITY TO|Age related macular degeneration 1|not provided",single nucleotide variant,GRCh38
na,na,16,31102655,31102655,VKORC1,Likely pathogenic,"Vitamin K-dependent clotting factors, combined deficiency of, type 2|Hereditary combined deficiency of vitamin K-dependent clotting factors",single nucleotide variant,GRCh37
na,na,16,31091334,31091334,VKORC1,Likely pathogenic,"Vitamin K-dependent clotting factors, combined deficiency of, type 2|Hereditary combined deficiency of vitamin K-dependent clotting factors",single nucleotide variant,GRCh38
na,na,16,31105966,31105966,VKORC1,Pathogenic,Warfarin response,single nucleotide variant,GRCh37
na,na,16,31094645,31094645,VKORC1,Pathogenic,Warfarin response,single nucleotide variant,GRCh38
na,na,16,31105917,31105917,VKORC1,Pathogenic,Warfarin response,single nucleotide variant,GRCh37
na,na,16,31094596,31094596,VKORC1,Pathogenic,Warfarin response,single nucleotide variant,GRCh38
na,na,16,31105879,31105879,VKORC1,Pathogenic,Warfarin response,single nucleotide variant,GRCh37
na,na,16,31094558,31094558,VKORC1,Pathogenic,Warfarin response,single nucleotide variant,GRCh38
na,na,16,31102564,31102564,VKORC1,drug response,Warfarin response,single nucleotide variant,GRCh37
na,na,16,31091243,31091243,VKORC1,drug response,Warfarin response,single nucleotide variant,GRCh38
na,na,16,31107689,31107689,VKORC1,drug response,Warfarin response|not provided|not specified|phenprocoumon response - Dosage|warfarin response - Toxicity|phenprocoumon response - Toxicity|warfarin response - Dosage|VKORC1-related disorder|Venous thromboembolism|acenocoumarol response - Dosage|warfarin response - Efficacy|See cases|Thrombus,single nucleotide variant,GRCh37
na,na,16,31096368,31096368,VKORC1,drug response,Warfarin response|not provided|not specified|phenprocoumon response - Dosage|warfarin response - Toxicity|phenprocoumon response - Toxicity|warfarin response - Dosage|VKORC1-related disorder|Venous thromboembolism|acenocoumarol response - Dosage|warfarin response - Efficacy|See cases|Thrombus,single nucleotide variant,GRCh38
na,na,16,31105945,31105945,VKORC1,drug response,"Warfarin response|not provided|Vitamin K-dependent clotting factors, combined deficiency of, type 2|not specified|Thrombus|VKORC1-related disorder|warfarin response - Dosage",single nucleotide variant,GRCh37
na,na,16,31094624,31094624,VKORC1,drug response,"Warfarin response|not provided|Vitamin K-dependent clotting factors, combined deficiency of, type 2|not specified|Thrombus|VKORC1-related disorder|warfarin response - Dosage",single nucleotide variant,GRCh38
na,na,3,10183752,10183754,VHL,Pathogenic,Von Hippel-Lindau syndrome,Deletion,GRCh37
na,na,3,10142068,10142070,VHL,Pathogenic,Von Hippel-Lindau syndrome,Deletion,GRCh38
na,na,3,10191555,10191555,VHL,Pathogenic,Papillary renal cell carcinoma type 1|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,3,10149871,10149871,VHL,Pathogenic,Papillary renal cell carcinoma type 1|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,3,10191507,10191507,VHL,Pathogenic,Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Pheochromocytoma|Chuvash polycythemia,single nucleotide variant,GRCh37
na,na,3,10149823,10149823,VHL,Pathogenic,Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Pheochromocytoma|Chuvash polycythemia,single nucleotide variant,GRCh38
na,na,3,10191488,10191488,VHL,Pathogenic,Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Familial infantile myasthenia|Von Hippel-Lindau syndrome;Chuvash polycythemia,single nucleotide variant,GRCh37
na,na,3,10149804,10149804,VHL,Pathogenic,Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome|Familial infantile myasthenia|Von Hippel-Lindau syndrome;Chuvash polycythemia,single nucleotide variant,GRCh38
na,na,3,10191506,10191506,VHL,Pathogenic/Likely pathogenic,Pheochromocytoma|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Von Hippel-Lindau syndrome;Nonpapillary renal cell carcinoma;Chuvash polycythemia;Pheochromocytoma|Chuvash polycythemia,single nucleotide variant,GRCh37
na,na,3,10149822,10149822,VHL,Pathogenic/Likely pathogenic,Pheochromocytoma|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Von Hippel-Lindau syndrome;Nonpapillary renal cell carcinoma;Chuvash polycythemia;Pheochromocytoma|Chuvash polycythemia,single nucleotide variant,GRCh38
na,na,3,10191506,10191506,VHL,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,3,10149822,10149822,VHL,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,3,10183794,10183794,VHL,Pathogenic,Von Hippel-Lindau syndrome,single nucleotide variant,GRCh37
na,na,3,10142110,10142110,VHL,Pathogenic,Von Hippel-Lindau syndrome,single nucleotide variant,GRCh38
na,na,3,10188262,10188262,VHL,Pathogenic,Von Hippel-Lindau syndrome,single nucleotide variant,GRCh37
na,na,3,10146578,10146578,VHL,Pathogenic,Von Hippel-Lindau syndrome,single nucleotide variant,GRCh38
na,na,3,10183865,10183865,VHL,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|VHL-related disorder|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,3,10142181,10142181,VHL,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|VHL-related disorder|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,3,10183823,10183823,VHL,Pathogenic,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided|VHL-related disorder,single nucleotide variant,GRCh37
na,na,3,10142139,10142139,VHL,Pathogenic,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided|VHL-related disorder,single nucleotide variant,GRCh38
na,na,3,10191503,10191503,VHL,Pathogenic,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,single nucleotide variant,GRCh37
na,na,3,10149819,10149819,VHL,Pathogenic,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,single nucleotide variant,GRCh38
na,na,3,10191569,10191569,VHL,Uncertain significance,Chuvash polycythemia|Von Hippel-Lindau syndrome|Pheochromocytoma|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not provided|VHL-related disorder|Au-Kline syndrome,single nucleotide variant,GRCh37
na,na,3,10149885,10149885,VHL,Uncertain significance,Chuvash polycythemia|Von Hippel-Lindau syndrome|Pheochromocytoma|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not provided|VHL-related disorder|Au-Kline syndrome,single nucleotide variant,GRCh38
na,na,3,10183722,10183722,VHL,Pathogenic,Pheochromocytoma|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,single nucleotide variant,GRCh37
na,na,3,10142038,10142038,VHL,Pathogenic,Pheochromocytoma|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,single nucleotide variant,GRCh38
na,na,3,10183719,10183719,VHL,Uncertain significance,Pheochromocytoma|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,single nucleotide variant,GRCh37
na,na,3,10142035,10142035,VHL,Uncertain significance,Pheochromocytoma|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,single nucleotide variant,GRCh38
na,na,3,10183865,10183865,VHL,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia,single nucleotide variant,GRCh37
na,na,3,10142181,10142181,VHL,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia,single nucleotide variant,GRCh38
na,na,3,10188245,10188245,VHL,Pathogenic,Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Chuvash polycythemia;Von Hippel-Lindau syndrome,single nucleotide variant,GRCh37
na,na,3,10146561,10146561,VHL,Pathogenic,Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Chuvash polycythemia;Von Hippel-Lindau syndrome,single nucleotide variant,GRCh38
na,na,3,10188233,10188233,VHL,Likely pathogenic,Chuvash polycythemia|Von Hippel-Lindau syndrome;Chuvash polycythemia,single nucleotide variant,GRCh37
na,na,3,10146549,10146549,VHL,Likely pathogenic,Chuvash polycythemia|Von Hippel-Lindau syndrome;Chuvash polycythemia,single nucleotide variant,GRCh38
na,na,3,10191495,10191495,VHL,Likely pathogenic,RENAL CELL CARCINOMA WITH PARANEOPLASTIC ERYTHROCYTOSIS|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome,single nucleotide variant,GRCh37
na,na,3,10149811,10149811,VHL,Likely pathogenic,RENAL CELL CARCINOMA WITH PARANEOPLASTIC ERYTHROCYTOSIS|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome,single nucleotide variant,GRCh38
na,na,3,10191605,10191605,VHL,Conflicting classifications of pathogenicity,Chuvash polycythemia|not specified|Von Hippel-Lindau syndrome|not provided|Acute leukemia of ambiguous lineage|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|VHL-related disorder|Nonpapillary renal cell carcinoma|Von Hippel-Lindau syndrome;Pheochromocytoma;Chuvash polycythemia;Nonpapillary renal cell carcinoma,single nucleotide variant,GRCh37
na,na,3,10149921,10149921,VHL,Conflicting classifications of pathogenicity,Chuvash polycythemia|not specified|Von Hippel-Lindau syndrome|not provided|Acute leukemia of ambiguous lineage|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|VHL-related disorder|Nonpapillary renal cell carcinoma|Von Hippel-Lindau syndrome;Pheochromocytoma;Chuvash polycythemia;Nonpapillary renal cell carcinoma,single nucleotide variant,GRCh38
na,na,3,10183772,10183772,VHL,Benign,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hepatoblastoma|Enchondromatosis|Chuvash polycythemia,single nucleotide variant,GRCh37
na,na,3,10142088,10142088,VHL,Benign,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hepatoblastoma|Enchondromatosis|Chuvash polycythemia,single nucleotide variant,GRCh38
na,na,3,10191581,10191581,VHL,Conflicting classifications of pathogenicity,Chuvash polycythemia|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Von Hippel-Lindau syndrome;Nonpapillary renal cell carcinoma;Chuvash polycythemia;Pheochromocytoma|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome,single nucleotide variant,GRCh37
na,na,3,10149897,10149897,VHL,Conflicting classifications of pathogenicity,Chuvash polycythemia|not provided|Von Hippel-Lindau syndrome;Chuvash polycythemia|Von Hippel-Lindau syndrome;Nonpapillary renal cell carcinoma;Chuvash polycythemia;Pheochromocytoma|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome,single nucleotide variant,GRCh38
na,na,3,10191578,10191578,VHL,Likely pathogenic,Chuvash polycythemia|Von Hippel-Lindau syndrome;Chuvash polycythemia,single nucleotide variant,GRCh37
na,na,3,10149894,10149894,VHL,Likely pathogenic,Chuvash polycythemia|Von Hippel-Lindau syndrome;Chuvash polycythemia,single nucleotide variant,GRCh38
na,na,3,10183781,10183781,VHL,Pathogenic,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,single nucleotide variant,GRCh37
na,na,3,10142097,10142097,VHL,Pathogenic,Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided,single nucleotide variant,GRCh38
na,na,3,10183808,10183808,VHL,Pathogenic,Pheochromocytoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not provided|Chuvash polycythemia,single nucleotide variant,GRCh37
na,na,3,10142124,10142124,VHL,Pathogenic,Pheochromocytoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not provided|Chuvash polycythemia,single nucleotide variant,GRCh38
na,na,3,10191498,10191498,VHL,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,3,10149814,10149814,VHL,Pathogenic,Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,1,183543722,183543723,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",Duplication,GRCh37
na,na,1,183574587,183574588,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",Duplication,GRCh38
na,na,1,183543644,183543644,NCF2,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,1,183574509,183574509,NCF2,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,1,183546796,183546796,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",single nucleotide variant,GRCh37
na,na,1,183577661,183577661,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",single nucleotide variant,GRCh38
na,na,1,183532572,183532576,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided",Deletion,GRCh37
na,na,1,183563437,183563441,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided",Deletion,GRCh38
na,na,1,183546733,183546733,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided",single nucleotide variant,GRCh37
na,na,1,183577598,183577598,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided",single nucleotide variant,GRCh38
na,na,1,183546802,183546802,NCF2,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",single nucleotide variant,GRCh37
na,na,1,183577667,183577667,NCF2,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",single nucleotide variant,GRCh38
na,na,1,183559402,183559410,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided",Deletion,GRCh37
na,na,1,183590267,183590275,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided",Deletion,GRCh38
na,na,1,183543740,183543740,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",single nucleotide variant,GRCh37
na,na,1,183574605,183574605,NCF2,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",single nucleotide variant,GRCh38
na,na,1,183556057,183556057,NCF2,Uncertain significance,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified",single nucleotide variant,GRCh37
na,na,1,183586922,183586922,NCF2,Uncertain significance,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified",single nucleotide variant,GRCh38
na,na,1,183532437,183532437,NCF2,Benign/Likely benign,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified|not provided",single nucleotide variant,GRCh37
na,na,1,183563302,183563302,NCF2,Benign/Likely benign,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified|not provided",single nucleotide variant,GRCh38
na,na,7,74191613,74191614,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1|not provided|Granulomatous disease, chronic, X-linked",Microsatellite,GRCh37
na,na,7,74777267,74777268,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1|not provided|Granulomatous disease, chronic, X-linked",Microsatellite,GRCh38
na,na,7,74197332,74197332,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",Deletion,GRCh37
na,na,7,74782989,74782989,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",Deletion,GRCh38
na,na,7,74191665,74191665,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1|not provided",single nucleotide variant,GRCh37
na,na,7,74777319,74777319,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1|not provided",single nucleotide variant,GRCh38
na,na,7,74202338,74202338,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",Deletion,GRCh37
na,na,7,74787994,74787994,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",Deletion,GRCh38
na,na,7,74193644,74193644,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",single nucleotide variant,GRCh37
na,na,7,74779298,74779298,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",single nucleotide variant,GRCh38
na,na,7,74193706,74193706,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",single nucleotide variant,GRCh37
na,na,7,74779360,74779360,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",single nucleotide variant,GRCh38
na,na,7,74197404,74197404,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",single nucleotide variant,GRCh37
na,na,7,74783061,74783061,NCF1,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",single nucleotide variant,GRCh38
na,na,na,-1,-1,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",Deletion,na
na,na,16,88713181,88713181,CYBA,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",single nucleotide variant,GRCh37
na,na,16,88646773,88646773,CYBA,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",single nucleotide variant,GRCh38
na,na,16,88712539,88712539,CYBA,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided|Chronic granulomatous disease",single nucleotide variant,GRCh37
na,na,16,88646131,88646131,CYBA,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided|Chronic granulomatous disease",single nucleotide variant,GRCh38
na,na,16,88709882,88709882,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease",single nucleotide variant,GRCh37
na,na,16,88643474,88643474,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease",single nucleotide variant,GRCh38
na,na,16,88713169,88713169,CYBA,Uncertain significance,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not specified",single nucleotide variant,GRCh37
na,na,16,88646761,88646761,CYBA,Uncertain significance,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not specified",single nucleotide variant,GRCh38
na,na,16,88713162,88713162,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",single nucleotide variant,GRCh37
na,na,16,88646754,88646754,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",single nucleotide variant,GRCh38
na,na,16,88713236,88713236,CYBA,Benign,"CYBA POLYMORPHISM|not specified|Very early onset inflammatory bowel disease|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease|not provided",single nucleotide variant,GRCh37
na,na,16,88646828,88646828,CYBA,Benign,"CYBA POLYMORPHISM|not specified|Very early onset inflammatory bowel disease|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease|not provided",single nucleotide variant,GRCh38
na,na,16,88717415,88717415,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease",single nucleotide variant,GRCh37
na,na,16,88651007,88651007,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease",single nucleotide variant,GRCh38
na,na,16,88714511,88714511,CYBA,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided|Chronic granulomatous disease",single nucleotide variant,GRCh37
na,na,16,88648103,88648103,CYBA,Pathogenic/Likely pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided|Chronic granulomatous disease",single nucleotide variant,GRCh38
na,na,16,88712583,88712618,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",Deletion,GRCh37
na,na,16,88646175,88646210,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",Deletion,GRCh38
na,na,16,88709976,88709976,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",single nucleotide variant,GRCh37
na,na,16,88643568,88643568,CYBA,Pathogenic,"Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative",single nucleotide variant,GRCh38
na,na,1,12052717,12052717,MFN2,Pathogenic,"Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|Neuropathy, hereditary motor and sensory, type 6A|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,1,11992660,11992660,MFN2,Pathogenic,"Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|Neuropathy, hereditary motor and sensory, type 6A|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,1,12071567,12071567,MFN2,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2|not provided|Charcot-Marie-Tooth disease type 2A2;Hereditary motor and sensory neuropathy with optic atrophy;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|not specified|Charcot-Marie-Tooth disease|Inborn genetic diseases|MFN2-related disorder",single nucleotide variant,GRCh37
na,na,1,12011510,12011510,MFN2,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2|not provided|Charcot-Marie-Tooth disease type 2A2;Hereditary motor and sensory neuropathy with optic atrophy;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|not specified|Charcot-Marie-Tooth disease|Inborn genetic diseases|MFN2-related disorder",single nucleotide variant,GRCh38
na,na,1,12052663,12052663,MFN2,Pathogenic,Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2,single nucleotide variant,GRCh37
na,na,1,11992606,11992606,MFN2,Pathogenic,Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2,single nucleotide variant,GRCh38
na,na,1,12061480,12061480,MFN2,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Neuropathy, hereditary motor and sensory, type 6A|Neuropathy, hereditary motor and sensory, type 6A;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;Charcot-Marie-Tooth disease type 2A2",single nucleotide variant,GRCh37
na,na,1,12001423,12001423,MFN2,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Neuropathy, hereditary motor and sensory, type 6A|Neuropathy, hereditary motor and sensory, type 6A;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;Charcot-Marie-Tooth disease type 2A2",single nucleotide variant,GRCh38
na,na,1,12059087,12059087,MFN2,Pathogenic,Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,1,11999030,11999030,MFN2,Pathogenic,Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,1,12052641,12052641,MFN2,Pathogenic,Charcot-Marie-Tooth disease type 2A2,single nucleotide variant,GRCh37
na,na,1,11992584,11992584,MFN2,Pathogenic,Charcot-Marie-Tooth disease type 2A2,single nucleotide variant,GRCh38
na,na,1,12062071,12062071,MFN2,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2|not provided,single nucleotide variant,GRCh37
na,na,1,12002014,12002014,MFN2,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2|not provided,single nucleotide variant,GRCh38
na,na,1,12057372,12057372,MFN2,Pathogenic,Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2,single nucleotide variant,GRCh37
na,na,1,11997315,11997315,MFN2,Pathogenic,Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2,single nucleotide variant,GRCh38
na,na,1,12052716,12052716,MFN2,Pathogenic,"Charcot-Marie-Tooth disease type 2A2|Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2|Inborn genetic diseases|14 conditions|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|Neuropathy, hereditary motor and sensory, type 6A",single nucleotide variant,GRCh37
na,na,1,11992659,11992659,MFN2,Pathogenic,"Charcot-Marie-Tooth disease type 2A2|Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2|Inborn genetic diseases|14 conditions|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|Neuropathy, hereditary motor and sensory, type 6A",single nucleotide variant,GRCh38
na,na,1,12061468,12061468,MFN2,Conflicting classifications of pathogenicity,Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease type 2A2|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,1,12001411,12001411,MFN2,Conflicting classifications of pathogenicity,Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease type 2A2|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,12062090,12062090,MFN2,Pathogenic,Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh37
na,na,1,12002033,12002033,MFN2,Pathogenic,Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease type 2A2|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh38
na,na,1,12058844,12058844,MFN2,Pathogenic,Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,1,11998787,11998787,MFN2,Pathogenic,Hereditary motor and sensory neuropathy with optic atrophy|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,1,12069698,12069698,MFN2,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|not provided|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2|Inborn genetic diseases|MFN2-related disorder|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;Charcot-Marie-Tooth disease type 2A2|Peripheral axonal neuropathy|Charcot-Marie-Tooth disease, type 2A;Hereditary motor and sensory neuropathy with optic atrophy|Multiple symmetric lipomatosis|Neuropathy, hereditary motor and sensory, type 6A;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;Charcot-Marie-Tooth disease type 2A2|Neuropathy, hereditary motor and sensory, type 6A|Tip-toe gait",single nucleotide variant,GRCh37
na,na,1,12009641,12009641,MFN2,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;|not provided|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2|Inborn genetic diseases|MFN2-related disorder|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;Charcot-Marie-Tooth disease type 2A2|Peripheral axonal neuropathy|Charcot-Marie-Tooth disease, type 2A;Hereditary motor and sensory neuropathy with optic atrophy|Multiple symmetric lipomatosis|Neuropathy, hereditary motor and sensory, type 6A;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;Charcot-Marie-Tooth disease type 2A2|Neuropathy, hereditary motor and sensory, type 6A|Tip-toe gait",single nucleotide variant,GRCh38
na,na,1,12052746,12052746,MFN2,Pathogenic,"Charcot-Marie-Tooth disease type 2A2|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2|not provided|Hereditary motor and sensory neuropathy with optic atrophy;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;Charcot-Marie-Tooth disease type 2A2|Inborn genetic diseases|Neuropathy, hereditary motor and sensory, type 6A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;",single nucleotide variant,GRCh37
na,na,1,11992689,11992689,MFN2,Pathogenic,"Charcot-Marie-Tooth disease type 2A2|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 2|not provided|Hereditary motor and sensory neuropathy with optic atrophy;Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;;Charcot-Marie-Tooth disease type 2A2|Inborn genetic diseases|Neuropathy, hereditary motor and sensory, type 6A|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;",single nucleotide variant,GRCh38
na,na,1,12064892,12064892,MFN2,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2A2|Hereditary motor and sensory neuropathy with optic atrophy|not specified|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Tip-toe gait|Inborn genetic diseases|Retinal dystrophy|Optic atrophy,single nucleotide variant,GRCh37
na,na,1,12004835,12004835,MFN2,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2A2|Hereditary motor and sensory neuropathy with optic atrophy|not specified|not provided|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|Tip-toe gait|Inborn genetic diseases|Retinal dystrophy|Optic atrophy,single nucleotide variant,GRCh38
na,na,12,42863325,42863325,PRICKLE1,Pathogenic/Likely pathogenic,"Epilepsy, progressive myoclonic, 1B|not provided",single nucleotide variant,GRCh37
na,na,12,42469523,42469523,PRICKLE1,Pathogenic/Likely pathogenic,"Epilepsy, progressive myoclonic, 1B|not provided",single nucleotide variant,GRCh38
na,na,9,135202898,135202898,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Inborn genetic diseases|not provided|SETX-related disorder",single nucleotide variant,GRCh37
na,na,9,132327511,132327511,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Inborn genetic diseases|not provided|SETX-related disorder",single nucleotide variant,GRCh38
na,na,9,135204383,135204383,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh37
na,na,9,132328996,132328996,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh38
na,na,9,135156870,135156870,SETX,Uncertain significance,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh37
na,na,9,132281483,132281483,SETX,Uncertain significance,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh38
na,na,9,135204014,135204018,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",Deletion,GRCh37
na,na,9,132328627,132328631,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",Deletion,GRCh38
na,na,9,135206680,135206680,SETX,Pathogenic/Likely pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not provided|SETX-related disorder",single nucleotide variant,GRCh37
na,na,9,132331293,132331293,SETX,Pathogenic/Likely pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not provided|SETX-related disorder",single nucleotide variant,GRCh38
na,na,9,135205819,135205819,SETX,Pathogenic,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;Amyotrophic lateral sclerosis type 4|not provided|Distal spinal muscular atrophy|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh37
na,na,9,132330432,132330432,SETX,Pathogenic,"Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;Amyotrophic lateral sclerosis type 4|not provided|Distal spinal muscular atrophy|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh38
na,na,9,135224808,135224808,SETX,Likely pathogenic,Amyotrophic lateral sclerosis type 4|not provided|Distal spinal muscular atrophy,single nucleotide variant,GRCh37
na,na,9,132349421,132349421,SETX,Likely pathogenic,Amyotrophic lateral sclerosis type 4|not provided|Distal spinal muscular atrophy,single nucleotide variant,GRCh38
na,na,9,135158790,135158790,SETX,Likely pathogenic,Amyotrophic lateral sclerosis type 4|Distal spinal muscular atrophy|not provided,single nucleotide variant,GRCh37
na,na,9,132283403,132283403,SETX,Likely pathogenic,Amyotrophic lateral sclerosis type 4|Distal spinal muscular atrophy|not provided,single nucleotide variant,GRCh38
na,na,9,135172296,135172296,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not provided",single nucleotide variant,GRCh37
na,na,9,132296909,132296909,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not provided",single nucleotide variant,GRCh38
na,na,9,135205178,135205178,SETX,Benign/Likely benign,"Hereditary spastic paraplegia|Amyotrophic lateral sclerosis type 4|not provided|Amyotrophic lateral sclerosis type 4;Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh37
na,na,9,132329791,132329791,SETX,Benign/Likely benign,"Hereditary spastic paraplegia|Amyotrophic lateral sclerosis type 4|not provided|Amyotrophic lateral sclerosis type 4;Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh38
na,na,9,135210011,135210011,SETX,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,9,132334624,132334624,SETX,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,9,135172294,135172294,SETX,Conflicting classifications of pathogenicity,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not provided|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;Amyotrophic lateral sclerosis type 4",single nucleotide variant,GRCh37
na,na,9,132296907,132296907,SETX,Conflicting classifications of pathogenicity,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not provided|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2;Amyotrophic lateral sclerosis type 4",single nucleotide variant,GRCh38
na,na,9,135206510,135206510,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh37
na,na,9,132331123,132331123,SETX,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2",single nucleotide variant,GRCh38
na,na,9,135221691,135221693,SETX,Likely pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Inborn genetic diseases",Microsatellite,GRCh37
na,na,9,132346304,132346306,SETX,Likely pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Inborn genetic diseases",Microsatellite,GRCh38
na,na,11,64527223,64527223,PYGM,Pathogenic,"Glycogen storage disease, type V|not provided|Inborn genetic diseases|See cases|Tip-toe gait",single nucleotide variant,GRCh37
na,na,11,64759751,64759751,PYGM,Pathogenic,"Glycogen storage disease, type V|not provided|Inborn genetic diseases|See cases|Tip-toe gait",single nucleotide variant,GRCh38
na,na,11,64525298,64525298,PYGM,Pathogenic,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh37
na,na,11,64757826,64757826,PYGM,Pathogenic,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh38
na,na,11,64519536,64519536,PYGM,Pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh37
na,na,11,64752064,64752064,PYGM,Pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh38
na,na,11,64518803,64518803,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh37
na,na,11,64751331,64751331,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh38
na,na,11,64518029,64518029,PYGM,Conflicting classifications of pathogenicity,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh37
na,na,11,64750557,64750557,PYGM,Conflicting classifications of pathogenicity,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh38
na,na,11,64521403,64521403,PYGM,Pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh37
na,na,11,64753931,64753931,PYGM,Pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh38
na,na,11,64517969,64517969,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V|not provided|PYGM-related disorder|Tip-toe gait",single nucleotide variant,GRCh37
na,na,11,64750497,64750497,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V|not provided|PYGM-related disorder|Tip-toe gait",single nucleotide variant,GRCh38
na,na,11,64519438,64519438,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh37
na,na,11,64751966,64751966,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh38
na,na,11,64519439,64519439,PYGM,Pathogenic,"Glycogen storage disease, type V",Deletion,GRCh37
na,na,11,64751967,64751967,PYGM,Pathogenic,"Glycogen storage disease, type V",Deletion,GRCh38
na,na,11,64527370,64527370,PYGM,Pathogenic,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh37
na,na,11,64759898,64759898,PYGM,Pathogenic,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh38
na,na,11,64519543,64519543,PYGM,Pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh37
na,na,11,64752071,64752071,PYGM,Pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh38
na,na,11,64514268,64514268,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh37
na,na,11,64746796,64746796,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh38
na,na,11,64519069,64519069,PYGM,Pathogenic,"Glycogen storage disease, type V|See cases",single nucleotide variant,GRCh37
na,na,11,64751597,64751597,PYGM,Pathogenic,"Glycogen storage disease, type V|See cases",single nucleotide variant,GRCh38
na,na,11,64519442,64519442,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh37
na,na,11,64751970,64751970,PYGM,Pathogenic/Likely pathogenic,"Glycogen storage disease, type V",single nucleotide variant,GRCh38
na,na,11,64523631,64523631,PYGM,Pathogenic/Likely pathogenic,"McArdle disease, mild|Glycogen storage disease, type V",single nucleotide variant,GRCh37
na,na,11,64756159,64756159,PYGM,Pathogenic/Likely pathogenic,"McArdle disease, mild|Glycogen storage disease, type V",single nucleotide variant,GRCh38
na,na,11,64525847,64525847,PYGM,Pathogenic/Likely pathogenic,"McArdle disease, mild|Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh37
na,na,11,64758375,64758375,PYGM,Pathogenic/Likely pathogenic,"McArdle disease, mild|Glycogen storage disease, type V|not provided",single nucleotide variant,GRCh38
na,na,19,44015607,44015607,ETHE1,Pathogenic,Ethylmalonic encephalopathy|not provided,single nucleotide variant,GRCh37
na,na,19,43511455,43511455,ETHE1,Pathogenic,Ethylmalonic encephalopathy|not provided,single nucleotide variant,GRCh38
na,na,19,44031327,44031327,ETHE1,Pathogenic,Ethylmalonic encephalopathy|not provided,single nucleotide variant,GRCh37
na,na,19,43527175,43527175,ETHE1,Pathogenic,Ethylmalonic encephalopathy|not provided,single nucleotide variant,GRCh38
na,na,14,64676751,64676751,SYNE2,Benign/Likely benign,"Emery-Dreifuss muscular dystrophy 5, autosomal dominant|not specified|not provided|SYNE2-related disorder",single nucleotide variant,GRCh37
na,na,14,64210033,64210033,SYNE2,Benign/Likely benign,"Emery-Dreifuss muscular dystrophy 5, autosomal dominant|not specified|not provided|SYNE2-related disorder",single nucleotide variant,GRCh38
na,na,6,152643033,152643033,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type|not provided|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|SYNE1-related disorder|Arthrogryposis multiplex congenita 3, myogenic type;Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh37
na,na,6,152321898,152321898,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type|not provided|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|SYNE1-related disorder|Arthrogryposis multiplex congenita 3, myogenic type;Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh38
na,na,6,152702455,152702455,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not provided|Arthrogryposis multiplex congenita 3, myogenic type;Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh37
na,na,6,152381320,152381320,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not provided|Arthrogryposis multiplex congenita 3, myogenic type;Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh38
na,na,6,152522973,152522973,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type|not provided",single nucleotide variant,GRCh37
na,na,6,152201838,152201838,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type|not provided",single nucleotide variant,GRCh38
na,na,6,152534872,152534872,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type",single nucleotide variant,GRCh37
na,na,6,152213737,152213737,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type",single nucleotide variant,GRCh38
na,na,6,152668362,152668363,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type",Deletion,GRCh37
na,na,6,152347227,152347228,SYNE1,Pathogenic,"Autosomal recessive ataxia, Beauce type",Deletion,GRCh38
na,na,6,152473122,152473122,SYNE1,Uncertain significance,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh37
na,na,6,152151987,152151987,SYNE1,Uncertain significance,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh38
na,na,6,152462425,152462425,SYNE1,Uncertain significance,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh37
na,na,6,152141290,152141290,SYNE1,Uncertain significance,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh38
na,na,6,152461162,152461162,SYNE1,Conflicting classifications of pathogenicity,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not provided|not specified|Autosomal recessive ataxia, Beauce type|Intellectual disability|Autosomal recessive ataxia, Beauce type;Arthrogryposis multiplex congenita 3, myogenic type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh37
na,na,6,152140027,152140027,SYNE1,Conflicting classifications of pathogenicity,"Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Autosomal recessive ataxia, Beauce type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant|not provided|not specified|Autosomal recessive ataxia, Beauce type|Intellectual disability|Autosomal recessive ataxia, Beauce type;Arthrogryposis multiplex congenita 3, myogenic type;Emery-Dreifuss muscular dystrophy 4, autosomal dominant",single nucleotide variant,GRCh38
na,na,6,152472827,152472827,SYNE1,Pathogenic,"Arthrogryposis multiplex congenita 3, myogenic type",single nucleotide variant,GRCh37
na,na,6,152151692,152151692,SYNE1,Pathogenic,"Arthrogryposis multiplex congenita 3, myogenic type",single nucleotide variant,GRCh38
na,na,15,40763556,40763556,CHST14,Conflicting classifications of pathogenicity,"Ehlers-Danlos syndrome, musculocontractural type|Ehlers-Danlos syndrome, musculocontractural type 1|not provided",Deletion,GRCh37
na,na,15,40471357,40471357,CHST14,Conflicting classifications of pathogenicity,"Ehlers-Danlos syndrome, musculocontractural type|Ehlers-Danlos syndrome, musculocontractural type 1|not provided",Deletion,GRCh38
na,na,15,40764050,40764050,CHST14,Likely pathogenic,"Ehlers-Danlos syndrome, musculocontractural type|Ehlers-Danlos syndrome, musculocontractural type 1",single nucleotide variant,GRCh37
na,na,15,40471851,40471851,CHST14,Likely pathogenic,"Ehlers-Danlos syndrome, musculocontractural type|Ehlers-Danlos syndrome, musculocontractural type 1",single nucleotide variant,GRCh38
na,na,15,40764290,40764290,CHST14,Pathogenic/Likely pathogenic,"Ehlers-Danlos syndrome, musculocontractural type|not provided|Ehlers-Danlos syndrome, musculocontractural type 1|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,15,40472091,40472091,CHST14,Pathogenic/Likely pathogenic,"Ehlers-Danlos syndrome, musculocontractural type|not provided|Ehlers-Danlos syndrome, musculocontractural type 1|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,15,40764254,40764254,CHST14,Pathogenic,"Ehlers-Danlos syndrome, musculocontractural type|Ehlers-Danlos syndrome, musculocontractural type 1",single nucleotide variant,GRCh37
na,na,15,40472055,40472055,CHST14,Pathogenic,"Ehlers-Danlos syndrome, musculocontractural type|Ehlers-Danlos syndrome, musculocontractural type 1",single nucleotide variant,GRCh38
na,na,15,40763617,40763617,CHST14,Pathogenic,"Ehlers-Danlos syndrome, musculocontractural type 1",single nucleotide variant,GRCh37
na,na,15,40471418,40471418,CHST14,Pathogenic,"Ehlers-Danlos syndrome, musculocontractural type 1",single nucleotide variant,GRCh38
na,na,15,40764278,40764278,CHST14,Pathogenic,"Ehlers-Danlos syndrome, musculocontractural type 1",single nucleotide variant,GRCh37
na,na,15,40472079,40472079,CHST14,Pathogenic,"Ehlers-Danlos syndrome, musculocontractural type 1",single nucleotide variant,GRCh38
na,na,2,71351575,71351575,MCEE,Pathogenic,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency|not provided|Inborn genetic diseases|Methylmalonic acidemia|MCEE-related disorder,single nucleotide variant,GRCh37
na,na,2,71124445,71124445,MCEE,Pathogenic,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency|not provided|Inborn genetic diseases|Methylmalonic acidemia|MCEE-related disorder,single nucleotide variant,GRCh38
na,na,10,95791949,95791949,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",Deletion,GRCh37
na,na,10,94032192,94032192,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",Deletion,GRCh38
na,na,10,95892201,95892201,PLCE1,Pathogenic,"Nephrotic syndrome, type 3|not provided",single nucleotide variant,GRCh37
na,na,10,94132444,94132444,PLCE1,Pathogenic,"Nephrotic syndrome, type 3|not provided",single nucleotide variant,GRCh38
na,na,10,96014013,96014013,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",single nucleotide variant,GRCh37
na,na,10,94254256,94254256,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",single nucleotide variant,GRCh38
na,na,10,96022279,96022279,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",Deletion,GRCh37
na,na,10,94262522,94262522,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",Deletion,GRCh38
na,na,10,96043597,96043597,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",single nucleotide variant,GRCh37
na,na,10,94283840,94283840,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",single nucleotide variant,GRCh38
na,na,10,96064340,96064340,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",single nucleotide variant,GRCh37
na,na,10,94304583,94304583,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",single nucleotide variant,GRCh38
na,na,10,96030304,96030304,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",single nucleotide variant,GRCh37
na,na,10,94270547,94270547,PLCE1,Pathogenic,"Nephrotic syndrome, type 3",single nucleotide variant,GRCh38
na,na,1,216420437,216420437,USH2A,Pathogenic,Usher syndrome type 2A|Retinitis pigmentosa|Retinitis pigmentosa 39|Retinal dystrophy|not provided|Usher syndrome|Inborn genetic diseases|not specified|Cone-rod dystrophy|Congenital stationary night blindness|Rare genetic deafness;Usher syndrome|Macular dystrophy|USH2A-related disorder|Retinitis pigmentosa 39;Usher syndrome type 2A|Usher syndrome type 2,Deletion,GRCh37
na,na,1,216247095,216247095,USH2A,Pathogenic,Usher syndrome type 2A|Retinitis pigmentosa|Retinitis pigmentosa 39|Retinal dystrophy|not provided|Usher syndrome|Inborn genetic diseases|not specified|Cone-rod dystrophy|Congenital stationary night blindness|Rare genetic deafness;Usher syndrome|Macular dystrophy|USH2A-related disorder|Retinitis pigmentosa 39;Usher syndrome type 2A|Usher syndrome type 2,Deletion,GRCh38
na,na,1,216405390,216405390,USH2A,Pathogenic,Usher syndrome type 2A|not provided|Retinitis pigmentosa 39;Usher syndrome type 2A|Rare genetic deafness|Retinitis pigmentosa 39,Deletion,GRCh37
na,na,1,216232048,216232048,USH2A,Pathogenic,Usher syndrome type 2A|not provided|Retinitis pigmentosa 39;Usher syndrome type 2A|Rare genetic deafness|Retinitis pigmentosa 39,Deletion,GRCh38
na,na,1,216363622,216363623,USH2A,Pathogenic,Usher syndrome type 2A|USH2A-related disorder|not provided|Retinal dystrophy|Usher syndrome|Retinitis pigmentosa 39|Usher syndrome type 2A;Retinitis pigmentosa 39,Microsatellite,GRCh37
na,na,1,216190280,216190281,USH2A,Pathogenic,Usher syndrome type 2A|USH2A-related disorder|not provided|Retinal dystrophy|Usher syndrome|Retinitis pigmentosa 39|Usher syndrome type 2A;Retinitis pigmentosa 39,Microsatellite,GRCh38
na,na,1,216538300,216538300,USH2A,Pathogenic,Usher syndrome type 2A,single nucleotide variant,GRCh37
na,na,1,216364958,216364958,USH2A,Pathogenic,Usher syndrome type 2A,single nucleotide variant,GRCh38
na,na,1,216498834,216498834,USH2A,Pathogenic,Usher syndrome type 2A|not provided|Usher syndrome|Retinal dystrophy|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome type 2A;Retinitis pigmentosa 39,single nucleotide variant,GRCh37
na,na,1,216325492,216325492,USH2A,Pathogenic,Usher syndrome type 2A|not provided|Usher syndrome|Retinal dystrophy|Rare genetic deafness|Retinitis pigmentosa 39|Usher syndrome type 2A;Retinitis pigmentosa 39,single nucleotide variant,GRCh38
na,na,1,216420460,216420460,USH2A,Pathogenic,Retinitis pigmentosa 39|Retinitis pigmentosa|Usher syndrome type 2A|not provided|Retinal dystrophy|Usher syndrome|USH2A-related disorder|Inborn genetic diseases|Autosomal recessive retinitis pigmentosa|Retinitis pigmentosa 39;Usher syndrome type 2A|Ear malformation|See cases,single nucleotide variant,GRCh37
na,na,1,216247118,216247118,USH2A,Pathogenic,Retinitis pigmentosa 39|Retinitis pigmentosa|Usher syndrome type 2A|not provided|Retinal dystrophy|Usher syndrome|USH2A-related disorder|Inborn genetic diseases|Autosomal recessive retinitis pigmentosa|Retinitis pigmentosa 39;Usher syndrome type 2A|Ear malformation|See cases,single nucleotide variant,GRCh38
na,na,1,215901574,215901574,USH2A,Pathogenic,Usher syndrome type 2A|Retinitis pigmentosa 39|Congenital sensorineural hearing impairment|Hearing impairment|not provided|Retinitis pigmentosa|Rare genetic deafness;Usher syndrome|Usher syndrome type 2|Retinal dystrophy|USH2A-related disorder|Retinitis pigmentosa 39;Usher syndrome type 2A|Usher syndrome type 3A|Usher syndrome|See cases,single nucleotide variant,GRCh37
na,na,1,215728232,215728232,USH2A,Pathogenic,Usher syndrome type 2A|Retinitis pigmentosa 39|Congenital sensorineural hearing impairment|Hearing impairment|not provided|Retinitis pigmentosa|Rare genetic deafness;Usher syndrome|Usher syndrome type 2|Retinal dystrophy|USH2A-related disorder|Retinitis pigmentosa 39;Usher syndrome type 2A|Usher syndrome type 3A|Usher syndrome|See cases,single nucleotide variant,GRCh38
na,na,1,216498841,216498841,USH2A,Pathogenic,Usher syndrome type 2A|not provided|Pigmentary retinopathy;Abnormal macular morphology;Retinal pigment epithelial atrophy;Rod-cone dystrophy;Blindness|Retinitis pigmentosa 39;Usher syndrome type 2A|Retinitis pigmentosa 39|Rare genetic deafness|Retinal dystrophy|Usher syndrome type 2,single nucleotide variant,GRCh37
na,na,1,216325499,216325499,USH2A,Pathogenic,Usher syndrome type 2A|not provided|Pigmentary retinopathy;Abnormal macular morphology;Retinal pigment epithelial atrophy;Rod-cone dystrophy;Blindness|Retinitis pigmentosa 39;Usher syndrome type 2A|Retinitis pigmentosa 39|Rare genetic deafness|Retinal dystrophy|Usher syndrome type 2,single nucleotide variant,GRCh38
na,na,1,216497582,216497582,USH2A,Pathogenic,Usher syndrome type 2A|not provided|Usher syndrome|USH2A-related disorder|Rare genetic deafness|Retinitis pigmentosa 39|Retinal dystrophy|Retinitis pigmentosa 39;Usher syndrome type 2A,single nucleotide variant,GRCh37
na,na,1,216324240,216324240,USH2A,Pathogenic,Usher syndrome type 2A|not provided|Usher syndrome|USH2A-related disorder|Rare genetic deafness|Retinitis pigmentosa 39|Retinal dystrophy|Retinitis pigmentosa 39;Usher syndrome type 2A,single nucleotide variant,GRCh38
na,na,1,216595438,216595439,USH2A,Pathogenic,Retinitis pigmentosa 39|Usher syndrome type 2A,Insertion,GRCh37
na,na,1,216422096,216422097,USH2A,Pathogenic,Retinitis pigmentosa 39|Usher syndrome type 2A,Insertion,GRCh38
na,na,1,216420527,216420527,USH2A,Pathogenic,Usher syndrome type 2A|Retinitis pigmentosa 39|not provided|Usher syndrome type 2|Rare genetic deafness,single nucleotide variant,GRCh37
na,na,1,216247185,216247185,USH2A,Pathogenic,Usher syndrome type 2A|Retinitis pigmentosa 39|not provided|Usher syndrome type 2|Rare genetic deafness,single nucleotide variant,GRCh38
na,na,1,215844427,215844427,USH2A,Likely pathogenic,Retinitis pigmentosa 39|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh37
na,na,1,215671085,215671085,USH2A,Likely pathogenic,Retinitis pigmentosa 39|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh38
na,na,3,143212543,143212543,SLC9A9,risk factor,"Autism, susceptibility to, 16",single nucleotide variant,GRCh37
na,na,3,143493701,143493701,SLC9A9,risk factor,"Autism, susceptibility to, 16",single nucleotide variant,GRCh38
na,na,2,182423344,182423344,CERKL,Pathogenic/Likely pathogenic,Retinitis pigmentosa 26|Retinitis pigmentosa|Retinal dystrophy|Cone dystrophy;Retinal pigment epithelial atrophy|not provided|Cone-rod dystrophy|See cases|CERKL-related disorder|CERKL-related retinopathy,single nucleotide variant,GRCh37
na,na,2,181558617,181558617,CERKL,Pathogenic/Likely pathogenic,Retinitis pigmentosa 26|Retinitis pigmentosa|Retinal dystrophy|Cone dystrophy;Retinal pigment epithelial atrophy|not provided|Cone-rod dystrophy|See cases|CERKL-related disorder|CERKL-related retinopathy,single nucleotide variant,GRCh38
na,na,1,145416614,145416614,HJV,Pathogenic,Hemochromatosis type 2A|Hemochromatosis type 1|not provided|Juvenile hemochromatosis,single nucleotide variant,GRCh37
na,na,1,146018399,146018399,HJV,Pathogenic,Hemochromatosis type 2A|Hemochromatosis type 1|not provided|Juvenile hemochromatosis,single nucleotide variant,GRCh38
na,na,1,145416631,145416631,HJV,Pathogenic/Likely pathogenic,Hemochromatosis type 2A|not provided,single nucleotide variant,GRCh37
na,na,1,146018382,146018382,HJV,Pathogenic/Likely pathogenic,Hemochromatosis type 2A|not provided,single nucleotide variant,GRCh38
na,na,1,145416320,145416320,HJV,Conflicting classifications of pathogenicity,Hemochromatosis type 2A|not provided|not specified,single nucleotide variant,GRCh37
na,na,1,146018693,146018693,HJV,Conflicting classifications of pathogenicity,Hemochromatosis type 2A|not provided|not specified,single nucleotide variant,GRCh38
na,na,1,145416497,145416497,HJV,Pathogenic,Hemochromatosis type 2A|not provided,single nucleotide variant,GRCh37
na,na,1,146018516,146018516,HJV,Pathogenic,Hemochromatosis type 2A|not provided,single nucleotide variant,GRCh38
na,na,1,145415419,145415419,HJV,Pathogenic,Hemochromatosis type 2A|not provided,single nucleotide variant,GRCh37
na,na,1,146019594,146019594,HJV,Pathogenic,Hemochromatosis type 2A|not provided,single nucleotide variant,GRCh38
na,na,1,145415483,145415483,HJV,Pathogenic,Hemochromatosis type 2A|not provided|HJV-related disorder,single nucleotide variant,GRCh37
na,na,1,146019530,146019530,HJV,Pathogenic,Hemochromatosis type 2A|not provided|HJV-related disorder,single nucleotide variant,GRCh38
na,na,1,145416618,145416618,HJV,Pathogenic,Hemochromatosis type 2A|Hemochromatosis type 1,single nucleotide variant,GRCh37
na,na,1,146018395,146018395,HJV,Pathogenic,Hemochromatosis type 2A|Hemochromatosis type 1,single nucleotide variant,GRCh38
na,na,1,145416634,145416637,HJV,Pathogenic,Hemochromatosis type 2A,Microsatellite,GRCh37
na,na,1,146018373,146018376,HJV,Pathogenic,Hemochromatosis type 2A,Microsatellite,GRCh38
na,na,1,145415341,145415341,HJV,Pathogenic,Hemochromatosis type 2A|not provided,single nucleotide variant,GRCh37
na,na,1,146019672,146019672,HJV,Pathogenic,Hemochromatosis type 2A|not provided,single nucleotide variant,GRCh38
na,na,9,12891379,12891380,-,Pathogenic,"Agammaglobulinemia 5, autosomal dominant",Translocation,GRCh38
na,na,20,4720489,4720490,-,Pathogenic,"Agammaglobulinemia 5, autosomal dominant",Translocation,GRCh38
na,na,19,41930487,41930487,BCKDHA,Pathogenic/Likely pathogenic,Maple syrup urine disease type 1A|not provided|Maple syrup urine disease|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,41424582,41424582,BCKDHA,Pathogenic/Likely pathogenic,Maple syrup urine disease type 1A|not provided|Maple syrup urine disease|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,41928548,41928548,BCKDHA,Pathogenic/Likely pathogenic,Maple syrup urine disease|not provided|Maple syrup urine disease type 1A,single nucleotide variant,GRCh37
na,na,19,41422643,41422643,BCKDHA,Pathogenic/Likely pathogenic,Maple syrup urine disease|not provided|Maple syrup urine disease type 1A,single nucleotide variant,GRCh38
na,na,19,41930401,41930401,BCKDHA,Pathogenic/Likely pathogenic,Maple syrup urine disease,single nucleotide variant,GRCh37
na,na,19,41424496,41424496,BCKDHA,Pathogenic/Likely pathogenic,Maple syrup urine disease,single nucleotide variant,GRCh38
na,na,19,41928215,41928215,BCKDHA,Conflicting classifications of pathogenicity,not provided|Maple syrup urine disease|Maple syrup urine disease type 1A,single nucleotide variant,GRCh37
na,na,19,41422310,41422310,BCKDHA,Conflicting classifications of pathogenicity,not provided|Maple syrup urine disease|Maple syrup urine disease type 1A,single nucleotide variant,GRCh38
na,na,19,41928167,41928167,BCKDHA,Likely pathogenic,Maple syrup urine disease|not provided|Maple syrup urine disease type 1A,single nucleotide variant,GRCh37
na,na,19,41422262,41422262,BCKDHA,Likely pathogenic,Maple syrup urine disease|not provided|Maple syrup urine disease type 1A,single nucleotide variant,GRCh38
na,na,19,41928609,41928609,BCKDHA,Pathogenic/Likely pathogenic,not provided|Maple syrup urine disease|Maple syrup urine disease type 1A,single nucleotide variant,GRCh37
na,na,19,41422704,41422704,BCKDHA,Pathogenic/Likely pathogenic,not provided|Maple syrup urine disease|Maple syrup urine disease type 1A,single nucleotide variant,GRCh38
na,na,19,41928214,41928214,BCKDHA,Conflicting classifications of pathogenicity,Maple syrup urine disease|Maple syrup urine disease type 1A,single nucleotide variant,GRCh37
na,na,19,41422309,41422309,BCKDHA,Conflicting classifications of pathogenicity,Maple syrup urine disease|Maple syrup urine disease type 1A,single nucleotide variant,GRCh38
na,na,5,150723155,150723155,SLC36A2,Conflicting classifications of pathogenicity,Hyperglycinuria|not provided|Iminoglycinuria|not specified,single nucleotide variant,GRCh37
na,na,5,151343594,151343594,SLC36A2,Conflicting classifications of pathogenicity,Hyperglycinuria|not provided|Iminoglycinuria|not specified,single nucleotide variant,GRCh38
na,na,5,150726857,150726857,SLC36A2,Uncertain significance,Hyperglycinuria|Iminoglycinuria,single nucleotide variant,GRCh37
na,na,5,151347296,151347296,SLC36A2,Uncertain significance,Hyperglycinuria|Iminoglycinuria,single nucleotide variant,GRCh38
na,na,6,131900382,131900385,ARG1,Pathogenic,Arginase deficiency,Deletion,GRCh37
na,na,6,131579242,131579245,ARG1,Pathogenic,Arginase deficiency,Deletion,GRCh38
na,na,6,131897822,131897822,ARG1,Pathogenic,Arginase deficiency,Deletion,GRCh37
na,na,6,131576682,131576682,ARG1,Pathogenic,Arginase deficiency,Deletion,GRCh38
na,na,6,131904950,131904950,ARG1,Pathogenic,Arginase deficiency,single nucleotide variant,GRCh37
na,na,6,131583810,131583810,ARG1,Pathogenic,Arginase deficiency,single nucleotide variant,GRCh38
na,na,6,131904948,131904948,ARG1,Pathogenic,Arginase deficiency,single nucleotide variant,GRCh37
na,na,6,131583808,131583808,ARG1,Pathogenic,Arginase deficiency,single nucleotide variant,GRCh38
na,na,6,131902418,131902418,ARG1,Pathogenic,Arginase deficiency|not provided,single nucleotide variant,GRCh37
na,na,6,131581278,131581278,ARG1,Pathogenic,Arginase deficiency|not provided,single nucleotide variant,GRCh38
na,na,6,131904532,131904532,ARG1,Pathogenic,Arginase deficiency,single nucleotide variant,GRCh37
na,na,6,131583392,131583392,ARG1,Pathogenic,Arginase deficiency,single nucleotide variant,GRCh38
na,na,6,131904921,131904921,ARG1,Pathogenic,Arginase deficiency,Deletion,GRCh37
na,na,6,131583781,131583781,ARG1,Pathogenic,Arginase deficiency,Deletion,GRCh38
na,na,6,131894454,131894454,ARG1,Pathogenic/Likely pathogenic,Arginase deficiency,single nucleotide variant,GRCh37
na,na,6,131573314,131573314,ARG1,Pathogenic/Likely pathogenic,Arginase deficiency,single nucleotide variant,GRCh38
na,na,6,131902466,131902466,ARG1,Uncertain significance,Arginase deficiency,single nucleotide variant,GRCh37
na,na,6,131581326,131581326,ARG1,Uncertain significance,Arginase deficiency,single nucleotide variant,GRCh38
na,na,6,131894480,131894480,ARG1,Pathogenic/Likely pathogenic,Arginase deficiency,single nucleotide variant,GRCh37
na,na,6,131573340,131573340,ARG1,Pathogenic/Likely pathogenic,Arginase deficiency,single nucleotide variant,GRCh38
na,na,6,131897806,131897806,ARG1,Pathogenic,Arginase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,6,131576666,131576666,ARG1,Pathogenic,Arginase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,7,65547430,65547430,ASL,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency,single nucleotide variant,GRCh37
na,na,7,66082443,66082443,ASL,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency,single nucleotide variant,GRCh38
na,na,7,65554101,65554101,ASL,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency|not provided,single nucleotide variant,GRCh37
na,na,7,66089114,66089114,ASL,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency|not provided,single nucleotide variant,GRCh38
na,na,7,65557553,65557553,ASL,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency,single nucleotide variant,GRCh37
na,na,7,66092566,66092566,ASL,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency,single nucleotide variant,GRCh38
na,na,7,65551738,65551738,ASL,Pathogenic,Argininosuccinate lyase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,7,66086751,66086751,ASL,Pathogenic,Argininosuccinate lyase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,7,65557065,65557065,ASL,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency|not provided|ASL-related disorder,single nucleotide variant,GRCh37
na,na,7,66092078,66092078,ASL,Pathogenic/Likely pathogenic,Argininosuccinate lyase deficiency|not provided|ASL-related disorder,single nucleotide variant,GRCh38
na,na,1,20971132,20971132,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh37
na,na,1,20644639,20644639,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh38
na,na,1,20971019,20971019,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh37
na,na,1,20644526,20644526,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh38
na,na,1,20975547,20975547,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh37
na,na,1,20649054,20649054,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh38
na,na,1,20966445,20966445,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh37
na,na,1,20639952,20639952,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh38
na,na,1,20972133,20972133,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6|not provided,single nucleotide variant,GRCh37
na,na,1,20645640,20645640,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6|not provided,single nucleotide variant,GRCh38
na,na,1,20977005,20977006,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,Duplication,GRCh37
na,na,1,20650512,20650513,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,Duplication,GRCh38
na,na,1,20977034,20977035,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,Microsatellite,GRCh37
na,na,1,20650541,20650542,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,Microsatellite,GRCh38
na,na,1,20971042,20971042,PINK1,Uncertain significance,Autosomal recessive early-onset Parkinson disease 6|not provided,single nucleotide variant,GRCh37
na,na,1,20644549,20644549,PINK1,Uncertain significance,Autosomal recessive early-onset Parkinson disease 6|not provided,single nucleotide variant,GRCh38
na,na,1,20973463,20978065,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,Deletion,GRCh37
na,na,1,20646970,20651572,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,Deletion,GRCh38
na,na,1,20971144,20971144,PINK1,Pathogenic/Likely pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh37
na,na,1,20644651,20644651,PINK1,Pathogenic/Likely pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh38
na,na,1,20964597,20964597,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh37
na,na,1,20638104,20638104,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6,single nucleotide variant,GRCh38
na,na,1,20975602,20975602,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6|not provided|PINK1-related disorder,single nucleotide variant,GRCh37
na,na,1,20649109,20649109,PINK1,Pathogenic,Autosomal recessive early-onset Parkinson disease 6|not provided|PINK1-related disorder,single nucleotide variant,GRCh38
na,na,1,20975527,20975527,PINK1,risk factor,Parkinson disease 6,single nucleotide variant,GRCh37
na,na,1,20649034,20649034,PINK1,risk factor,Parkinson disease 6,single nucleotide variant,GRCh38
na,na,1,20975070,20975070,PINK1,Pathogenic,"Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1",single nucleotide variant,GRCh37
na,na,1,20648577,20648577,PINK1,Pathogenic,"Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1",single nucleotide variant,GRCh38
na,na,2,211454958,211454958,CPS1,Likely pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",single nucleotide variant,GRCh37
na,na,2,210590234,210590234,CPS1,Likely pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",single nucleotide variant,GRCh38
na,na,2,211465360,211465360,CPS1,Pathogenic/Likely pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",single nucleotide variant,GRCh37
na,na,2,210600636,210600636,CPS1,Pathogenic/Likely pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",single nucleotide variant,GRCh38
na,na,2,211438025,211438025,CPS1,Pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",single nucleotide variant,GRCh37
na,na,2,210573301,210573301,CPS1,Pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",single nucleotide variant,GRCh38
na,na,2,211456617,211456617,CPS1,Pathogenic,"Congenital hyperammonemia, type I",single nucleotide variant,GRCh37
na,na,2,210591893,210591893,CPS1,Pathogenic,"Congenital hyperammonemia, type I",single nucleotide variant,GRCh38
na,na,na,-1,-1,CPS1,Pathogenic,"Congenital hyperammonemia, type I",Deletion,na
na,na,2,211504769,211504769,CPS1,Likely pathogenic,"Congenital hyperammonemia, type I",single nucleotide variant,GRCh37
na,na,2,210640045,210640045,CPS1,Likely pathogenic,"Congenital hyperammonemia, type I",single nucleotide variant,GRCh38
na,na,2,211473251,211473251,CPS1,Pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",single nucleotide variant,GRCh37
na,na,2,210608527,210608527,CPS1,Pathogenic,"Congenital hyperammonemia, type I|Pulmonary hypertension, neonatal, susceptibility to",single nucleotide variant,GRCh38
na,na,17,42084006,42084006,NAGS,Pathogenic,"Hyperammonemia, type III|Inborn genetic diseases",Deletion,GRCh37
na,na,17,44006638,44006638,NAGS,Pathogenic,"Hyperammonemia, type III|Inborn genetic diseases",Deletion,GRCh38
na,na,17,42083952,42083952,NAGS,Pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh37
na,na,17,44006584,44006584,NAGS,Pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh38
na,na,17,42083895,42083895,NAGS,Pathogenic/Likely pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh37
na,na,17,44006527,44006527,NAGS,Pathogenic/Likely pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh38
na,na,17,42084996,42084997,NAGS,Pathogenic,"Hyperammonemia, type III",Duplication,GRCh37
na,na,17,44007628,44007629,NAGS,Pathogenic,"Hyperammonemia, type III",Duplication,GRCh38
na,na,17,42083525,42083525,NAGS,Pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh37
na,na,17,44006157,44006157,NAGS,Pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh38
na,na,17,42084979,42084979,NAGS,Likely pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh37
na,na,17,44007611,44007611,NAGS,Likely pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh38
na,na,17,42085140,42085140,NAGS,Pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh37
na,na,17,44007772,44007772,NAGS,Pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh38
na,na,17,42084989,42084989,NAGS,Pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh37
na,na,17,44007621,44007621,NAGS,Pathogenic,"Hyperammonemia, type III",single nucleotide variant,GRCh38
na,na,3,185511687,185511687,IGF2BP2,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh37
na,na,3,185793899,185793899,IGF2BP2,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh38
na,na,12,39726207,39726207,KIF21A,Pathogenic,"Congenital fibrosis of extraocular muscles type 1|Fibrosis of extraocular muscles, congenital, 3b|not provided|KIF21A-related disorder",single nucleotide variant,GRCh37
na,na,12,39332405,39332405,KIF21A,Pathogenic,"Congenital fibrosis of extraocular muscles type 1|Fibrosis of extraocular muscles, congenital, 3b|not provided|KIF21A-related disorder",single nucleotide variant,GRCh38
na,na,12,39726206,39726206,KIF21A,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3b|Congenital fibrosis of extraocular muscles type 1|not provided|Abnormality of eye movement",single nucleotide variant,GRCh37
na,na,12,39332404,39332404,KIF21A,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3b|Congenital fibrosis of extraocular muscles type 1|not provided|Abnormality of eye movement",single nucleotide variant,GRCh38
na,na,12,39726038,39726038,KIF21A,Pathogenic,Congenital fibrosis of extraocular muscles type 1,single nucleotide variant,GRCh37
na,na,12,39332236,39332236,KIF21A,Pathogenic,Congenital fibrosis of extraocular muscles type 1,single nucleotide variant,GRCh38
na,na,12,39752128,39752128,KIF21A,Pathogenic,Congenital fibrosis of extraocular muscles type 1,single nucleotide variant,GRCh37
na,na,12,39358326,39358326,KIF21A,Pathogenic,Congenital fibrosis of extraocular muscles type 1,single nucleotide variant,GRCh38
na,na,12,39726410,39726410,KIF21A,Pathogenic,Congenital fibrosis of extraocular muscles type 1,single nucleotide variant,GRCh37
na,na,12,39332608,39332608,KIF21A,Pathogenic,Congenital fibrosis of extraocular muscles type 1,single nucleotide variant,GRCh38
na,na,12,39726409,39726409,KIF21A,Pathogenic,Congenital fibrosis of extraocular muscles type 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,39332607,39332607,KIF21A,Pathogenic,Congenital fibrosis of extraocular muscles type 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,39726408,39726408,KIF21A,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3b",single nucleotide variant,GRCh37
na,na,12,39332606,39332606,KIF21A,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3b",single nucleotide variant,GRCh38
na,na,6,31827615,31827615,NEU1,Pathogenic,Sialidosis type 1,single nucleotide variant,GRCh37
na,na,6,31859838,31859838,NEU1,Pathogenic,Sialidosis type 1,single nucleotide variant,GRCh38
na,na,6,31829856,31829856,NEU1,Pathogenic,Sialidosis type 2,single nucleotide variant,GRCh37
na,na,6,31862079,31862079,NEU1,Pathogenic,Sialidosis type 2,single nucleotide variant,GRCh38
na,na,6,31827536,31827536,NEU1,Pathogenic,Sialidosis type 2,Deletion,GRCh37
na,na,6,31859759,31859759,NEU1,Pathogenic,Sialidosis type 2,Deletion,GRCh38
na,na,6,31828235,31828235,NEU1,Pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh37
na,na,6,31860458,31860458,NEU1,Pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh38
na,na,6,31827656,31827656,NEU1,Likely pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh37
na,na,6,31859879,31859879,NEU1,Likely pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh38
na,na,6,31828389,31828389,NEU1,Pathogenic,Sialidosis type 2|not provided,Deletion,GRCh37
na,na,6,31860612,31860612,NEU1,Pathogenic,Sialidosis type 2|not provided,Deletion,GRCh38
na,na,6,31828365,31828365,NEU1,Pathogenic/Likely pathogenic,Sialidosis type 1|not provided|Sialidosis|NEU1-related disorder,single nucleotide variant,GRCh37
na,na,6,31860588,31860588,NEU1,Pathogenic/Likely pathogenic,Sialidosis type 1|not provided|Sialidosis|NEU1-related disorder,single nucleotide variant,GRCh38
na,na,6,31828287,31828287,NEU1,Pathogenic/Likely pathogenic,Sialidosis type 1|not provided,single nucleotide variant,GRCh37
na,na,6,31860510,31860510,NEU1,Pathogenic/Likely pathogenic,Sialidosis type 1|not provided,single nucleotide variant,GRCh38
na,na,6,31830467,31830467,NEU1,Pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh37
na,na,6,31862690,31862690,NEU1,Pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh38
na,na,6,31829889,31829889,NEU1,Pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh37
na,na,6,31862112,31862112,NEU1,Pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh38
na,na,6,31828296,31828296,NEU1,Pathogenic,Sialidosis type 2,single nucleotide variant,GRCh37
na,na,6,31860519,31860519,NEU1,Pathogenic,Sialidosis type 2,single nucleotide variant,GRCh38
na,na,6,31827894,31827894,NEU1,Pathogenic,Sialidosis type 1,single nucleotide variant,GRCh37
na,na,6,31860117,31860117,NEU1,Pathogenic,Sialidosis type 1,single nucleotide variant,GRCh38
na,na,6,31827818,31827818,NEU1,Pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh37
na,na,6,31860041,31860041,NEU1,Pathogenic,Sialidosis type 2|not provided,single nucleotide variant,GRCh38
na,na,6,31828340,31828340,NEU1,Pathogenic,Sialidosis type 2,single nucleotide variant,GRCh37
na,na,6,31860563,31860563,NEU1,Pathogenic,Sialidosis type 2,single nucleotide variant,GRCh38
na,na,6,31827947,31827947,NEU1,Likely pathogenic,Sialidosis type 2|not provided|Sialidosis,single nucleotide variant,GRCh37
na,na,6,31860170,31860170,NEU1,Likely pathogenic,Sialidosis type 2|not provided|Sialidosis,single nucleotide variant,GRCh38
na,na,6,31830485,31830485,NEU1,Pathogenic,Sialidosis type 2|not provided|NEU1-related disorder,single nucleotide variant,GRCh37
na,na,6,31862708,31862708,NEU1,Pathogenic,Sialidosis type 2|not provided|NEU1-related disorder,single nucleotide variant,GRCh38
na,na,11,118011980,118011980,SCN4B,Pathogenic,Long QT syndrome 10,single nucleotide variant,GRCh37
na,na,11,118141265,118141265,SCN4B,Pathogenic,Long QT syndrome 10,single nucleotide variant,GRCh38
na,na,12,52967118,52967118,KRT74,Pathogenic,Autosomal dominant wooly hair|not provided,single nucleotide variant,GRCh37
na,na,12,52573334,52573334,KRT74,Pathogenic,Autosomal dominant wooly hair|not provided,single nucleotide variant,GRCh38
na,na,22,40761004,40761004,ADSL,Pathogenic,Adenylosuccinate lyase deficiency,single nucleotide variant,GRCh37
na,na,22,40365000,40365000,ADSL,Pathogenic,Adenylosuccinate lyase deficiency,single nucleotide variant,GRCh38
na,na,22,40760969,40760969,ADSL,Pathogenic,Adenylosuccinate lyase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,22,40364965,40364965,ADSL,Pathogenic,Adenylosuccinate lyase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,22,40745980,40745980,ADSL,Pathogenic,Adenylosuccinate lyase deficiency,single nucleotide variant,GRCh37
na,na,22,40349976,40349976,ADSL,Pathogenic,Adenylosuccinate lyase deficiency,single nucleotide variant,GRCh38
na,na,22,40760956,40760956,ADSL,Pathogenic,Adenylosuccinate lyase deficiency,single nucleotide variant,GRCh37
na,na,22,40364952,40364952,ADSL,Pathogenic,Adenylosuccinate lyase deficiency,single nucleotide variant,GRCh38
na,na,22,40754954,40754954,ADSL,Pathogenic/Likely pathogenic,Adenylosuccinate lyase deficiency|not provided,single nucleotide variant,GRCh37
na,na,22,40358950,40358950,ADSL,Pathogenic/Likely pathogenic,Adenylosuccinate lyase deficiency|not provided,single nucleotide variant,GRCh38
na,na,22,40756440,40756440,ADSL,Pathogenic/Likely pathogenic,Adenylosuccinate lyase deficiency|not provided|ADSL-related disorder,single nucleotide variant,GRCh37
na,na,22,40360436,40360436,ADSL,Pathogenic/Likely pathogenic,Adenylosuccinate lyase deficiency|not provided|ADSL-related disorder,single nucleotide variant,GRCh38
na,na,22,40755283,40755283,ADSL,Pathogenic,Adenylosuccinate lyase deficiency,single nucleotide variant,GRCh37
na,na,22,40359279,40359279,ADSL,Pathogenic,Adenylosuccinate lyase deficiency,single nucleotide variant,GRCh38
na,na,10,27450059,27450059,MASTL,Uncertain significance,Thrombocytopenia 2,single nucleotide variant,GRCh37
na,na,10,27161130,27161130,MASTL,Uncertain significance,Thrombocytopenia 2,single nucleotide variant,GRCh38
na,na,11,123524481,123524481,SCN3B,Conflicting classifications of pathogenicity,"Brugada syndrome 7|Atrial fibrillation, familial, 16|not provided|Brugada syndrome|not specified|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,11,123653773,123653773,SCN3B,Conflicting classifications of pathogenicity,"Brugada syndrome 7|Atrial fibrillation, familial, 16|not provided|Brugada syndrome|not specified|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,11,44129712,44129715,EXT2,Pathogenic,"Exostoses, multiple, type 2|EXT2-related disorder",Microsatellite,GRCh37
na,na,11,44108162,44108165,EXT2,Pathogenic,"Exostoses, multiple, type 2|EXT2-related disorder",Microsatellite,GRCh38
na,na,11,44129776,44129776,EXT2,Pathogenic,"Exostoses, multiple, type 2|not provided|Seizures-scoliosis-macrocephaly syndrome;Exostoses, multiple, type 2|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,11,44108226,44108226,EXT2,Pathogenic,"Exostoses, multiple, type 2|not provided|Seizures-scoliosis-macrocephaly syndrome;Exostoses, multiple, type 2|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,11,44193293,44193293,EXT2,Pathogenic,"Exostoses, multiple, type 2",single nucleotide variant,GRCh37
na,na,11,44171743,44171743,EXT2,Pathogenic,"Exostoses, multiple, type 2",single nucleotide variant,GRCh38
na,na,11,44135787,44135787,EXT2,Pathogenic,"Exostoses, multiple, type 2|Seizures-scoliosis-macrocephaly syndrome|not provided|Exostoses, multiple, type 2;Seizures-scoliosis-macrocephaly syndrome",single nucleotide variant,GRCh37
na,na,11,44114237,44114237,EXT2,Pathogenic,"Exostoses, multiple, type 2|Seizures-scoliosis-macrocephaly syndrome|not provided|Exostoses, multiple, type 2;Seizures-scoliosis-macrocephaly syndrome",single nucleotide variant,GRCh38
na,na,11,44135774,44135774,EXT2,Pathogenic,"Exostoses, multiple, type 2|EXT2-related disorder|Seizures-scoliosis-macrocephaly syndrome;Exostoses, multiple, type 2|not provided",single nucleotide variant,GRCh37
na,na,11,44114224,44114224,EXT2,Pathogenic,"Exostoses, multiple, type 2|EXT2-related disorder|Seizures-scoliosis-macrocephaly syndrome;Exostoses, multiple, type 2|not provided",single nucleotide variant,GRCh38
na,na,11,44146367,44146367,EXT2,Pathogenic,"Exostoses, multiple, type 2",single nucleotide variant,GRCh37
na,na,11,44124817,44124817,EXT2,Pathogenic,"Exostoses, multiple, type 2",single nucleotide variant,GRCh38
na,na,11,44146337,44146337,EXT2,Pathogenic,"Exostoses, multiple, type 2|EXT2-related disorder",single nucleotide variant,GRCh37
na,na,11,44124787,44124787,EXT2,Pathogenic,"Exostoses, multiple, type 2|EXT2-related disorder",single nucleotide variant,GRCh38
na,na,5,148407709,148407709,SH3TC2,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4C|not provided|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh37
na,na,5,149028146,149028146,SH3TC2,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4C|not provided|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh38
na,na,5,148407547,148407548,SH3TC2,Pathogenic,Charcot-Marie-Tooth disease type 4C,Microsatellite,GRCh37
na,na,5,149027984,149027985,SH3TC2,Pathogenic,Charcot-Marie-Tooth disease type 4C,Microsatellite,GRCh38
na,na,5,148421182,148421182,SH3TC2,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4C|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,5,149041619,149041619,SH3TC2,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4C|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,5,148406466,148406466,SH3TC2,Pathogenic,Charcot-Marie-Tooth disease type 4C|Charcot-Marie-Tooth disease type 4|not provided,single nucleotide variant,GRCh37
na,na,5,149026903,149026903,SH3TC2,Pathogenic,Charcot-Marie-Tooth disease type 4C|Charcot-Marie-Tooth disease type 4|not provided,single nucleotide variant,GRCh38
na,na,5,148406435,148406435,SH3TC2,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 4C|Susceptibility to mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|not provided|SH3TC2-related disorder|Inborn genetic diseases|Susceptibility to mononeuropathy of the median nerve, mild;Charcot-Marie-Tooth disease type 4C|Tip-toe gait",single nucleotide variant,GRCh37
na,na,5,149026872,149026872,SH3TC2,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 4C|Susceptibility to mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|not provided|SH3TC2-related disorder|Inborn genetic diseases|Susceptibility to mononeuropathy of the median nerve, mild;Charcot-Marie-Tooth disease type 4C|Tip-toe gait",single nucleotide variant,GRCh38
na,na,5,148389835,148389835,SH3TC2,Pathogenic,"Charcot-Marie-Tooth disease type 4C|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|Susceptibility to mononeuropathy of the median nerve, mild;Charcot-Marie-Tooth disease type 4C",single nucleotide variant,GRCh37
na,na,5,149010272,149010272,SH3TC2,Pathogenic,"Charcot-Marie-Tooth disease type 4C|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|Susceptibility to mononeuropathy of the median nerve, mild;Charcot-Marie-Tooth disease type 4C",single nucleotide variant,GRCh38
na,na,5,148422281,148422281,SH3TC2,Conflicting classifications of pathogenicity,"Susceptibility to mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4C|7 conditions|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not specified|Tip-toe gait|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,5,149042718,149042718,SH3TC2,Conflicting classifications of pathogenicity,"Susceptibility to mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4C|7 conditions|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not specified|Tip-toe gait|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,11,67765829,67765829,UNC93B1,risk factor,"Herpes simplex encephalitis, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,11,67998359,67998359,UNC93B1,risk factor,"Herpes simplex encephalitis, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,9,123313130,123313130,CDK5RAP2,Pathogenic,"Microcephaly 3, primary, autosomal recessive",single nucleotide variant,GRCh37
na,na,9,120550852,120550852,CDK5RAP2,Pathogenic,"Microcephaly 3, primary, autosomal recessive",single nucleotide variant,GRCh38
na,na,9,123182253,123182253,CDK5RAP2,Pathogenic,"Microcephaly 3, primary, autosomal recessive",single nucleotide variant,GRCh37
na,na,9,120419975,120419975,CDK5RAP2,Pathogenic,"Microcephaly 3, primary, autosomal recessive",single nucleotide variant,GRCh38
na,na,15,65261659,65261660,SPG21,Pathogenic,Mast syndrome|Hereditary spastic paraplegia,Duplication,GRCh37
na,na,15,64969322,64969323,SPG21,Pathogenic,Mast syndrome|Hereditary spastic paraplegia,Duplication,GRCh38
na,na,8,119122866,119122867,EXT1,Pathogenic,"Exostoses, multiple, type 1",Duplication,GRCh37
na,na,8,118110627,118110628,EXT1,Pathogenic,"Exostoses, multiple, type 1",Duplication,GRCh38
na,na,8,118849384,118849384,EXT1,Pathogenic,"Multiple congenital exostosis|Exostoses, multiple, type 1|Exostoses, multiple, type 1;Chondrosarcoma",single nucleotide variant,GRCh37
na,na,8,117837145,117837145,EXT1,Pathogenic,"Multiple congenital exostosis|Exostoses, multiple, type 1|Exostoses, multiple, type 1;Chondrosarcoma",single nucleotide variant,GRCh38
na,na,8,119122751,119122758,EXT1,Pathogenic,Chondrosarcoma,Deletion,GRCh37
na,na,8,118110512,118110519,EXT1,Pathogenic,Chondrosarcoma,Deletion,GRCh38
na,na,8,118849387,118849387,EXT1,Pathogenic,"Multiple congenital exostosis|Exostoses, multiple, type 1|not provided",single nucleotide variant,GRCh37
na,na,8,117837148,117837148,EXT1,Pathogenic,"Multiple congenital exostosis|Exostoses, multiple, type 1|not provided",single nucleotide variant,GRCh38
na,na,8,119122929,119122929,EXT1,Pathogenic/Likely pathogenic,"Exostoses, multiple, type 1|not provided",single nucleotide variant,GRCh37
na,na,8,118110690,118110690,EXT1,Pathogenic/Likely pathogenic,"Exostoses, multiple, type 1|not provided",single nucleotide variant,GRCh38
na,na,8,118849385,118849385,EXT1,Pathogenic/Likely pathogenic,"Multiple congenital exostosis|not provided|Exostoses, multiple, type 1|Inborn genetic diseases|EXT1-related disorder|Exostoses, multiple, type 1;Chondrosarcoma",single nucleotide variant,GRCh37
na,na,8,117837146,117837146,EXT1,Pathogenic/Likely pathogenic,"Multiple congenital exostosis|not provided|Exostoses, multiple, type 1|Inborn genetic diseases|EXT1-related disorder|Exostoses, multiple, type 1;Chondrosarcoma",single nucleotide variant,GRCh38
na,na,8,119122323,119122323,EXT1,Pathogenic,"Exostoses, multiple, type 1|Multiple congenital exostosis",single nucleotide variant,GRCh37
na,na,8,118110084,118110084,EXT1,Pathogenic,"Exostoses, multiple, type 1|Multiple congenital exostosis",single nucleotide variant,GRCh38
na,na,8,118825168,118825169,EXT1,Pathogenic,"Exostoses, multiple, type 1",Duplication,GRCh37
na,na,8,117812929,117812930,EXT1,Pathogenic,"Exostoses, multiple, type 1",Duplication,GRCh38
na,na,8,119122318,119122321,EXT1,Pathogenic/Likely pathogenic,"Exostoses, multiple, type 1|Chondrosarcoma|Multiple congenital exostosis",Microsatellite,GRCh37
na,na,8,118110079,118110082,EXT1,Pathogenic/Likely pathogenic,"Exostoses, multiple, type 1|Chondrosarcoma|Multiple congenital exostosis",Microsatellite,GRCh38
na,na,12,1953632,1953632,CACNA2D4,Conflicting classifications of pathogenicity,Retinal cone dystrophy 4|not provided|not specified|CACNA2D4-related disorder,single nucleotide variant,GRCh37
na,na,12,1844466,1844466,CACNA2D4,Conflicting classifications of pathogenicity,Retinal cone dystrophy 4|not provided|not specified|CACNA2D4-related disorder,single nucleotide variant,GRCh38
na,na,7,82997122,82997122,SEMA3E,Conflicting classifications of pathogenicity,CHARGE syndrome|not specified|Hypogonadotropic hypogonadism 5 with or without anosmia,single nucleotide variant,GRCh37
na,na,7,83367806,83367806,SEMA3E,Conflicting classifications of pathogenicity,CHARGE syndrome|not specified|Hypogonadotropic hypogonadism 5 with or without anosmia,single nucleotide variant,GRCh38
na,na,17,70119011,70119011,SOX9,Pathogenic,Camptomelic dysplasia,single nucleotide variant,GRCh37
na,na,17,72122870,72122870,SOX9,Pathogenic,Camptomelic dysplasia,single nucleotide variant,GRCh38
na,na,17,70119780,70119781,SOX9,Pathogenic/Likely pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia|not provided,Duplication,GRCh37
na,na,17,72123639,72123640,SOX9,Pathogenic/Likely pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia|not provided,Duplication,GRCh38
na,na,17,70119852,70119853,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL,Duplication,GRCh37
na,na,17,72123711,72123712,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL,Duplication,GRCh38
na,na,17,70119733,70119734,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia,Duplication,GRCh37
na,na,17,72123592,72123593,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia,Duplication,GRCh38
na,na,17,70120318,70120318,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia|not provided|Connective tissue disorder,single nucleotide variant,GRCh37
na,na,17,72124177,72124177,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia|not provided|Connective tissue disorder,single nucleotide variant,GRCh38
na,na,17,70118945,70118945,SOX9,Pathogenic,ACAMPOMELIC CAMPOMELIC DYSPLASIA|Camptomelic dysplasia,single nucleotide variant,GRCh37
na,na,17,72122804,72122804,SOX9,Pathogenic,ACAMPOMELIC CAMPOMELIC DYSPLASIA|Camptomelic dysplasia,single nucleotide variant,GRCh38
na,na,17,70117828,70117828,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL,Deletion,GRCh37
na,na,17,72121687,72121687,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL,Deletion,GRCh38
na,na,17,70118921,70118921,SOX9,Pathogenic,ACAMPOMELIC CAMPOMELIC DYSPLASIA,single nucleotide variant,GRCh37
na,na,17,72122780,72122780,SOX9,Pathogenic,ACAMPOMELIC CAMPOMELIC DYSPLASIA,single nucleotide variant,GRCh38
na,na,17,70117759,70117759,SOX9,Pathogenic,ACAMPOMELIC CAMPOMELIC DYSPLASIA|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,17,72121618,72121618,SOX9,Pathogenic,ACAMPOMELIC CAMPOMELIC DYSPLASIA|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,17,70117723,70117752,SOX9,Pathogenic,Camptomelic dysplasia,Deletion,GRCh37
na,na,17,72121582,72121611,SOX9,Pathogenic,Camptomelic dysplasia,Deletion,GRCh38
na,na,17,70118890,70118890,SOX9,Pathogenic,Camptomelic dysplasia,single nucleotide variant,GRCh37
na,na,17,72122749,72122749,SOX9,Pathogenic,Camptomelic dysplasia,single nucleotide variant,GRCh38
na,na,17,70118900,70118900,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia,single nucleotide variant,GRCh37
na,na,17,72122759,72122759,SOX9,Pathogenic,CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL|Camptomelic dysplasia,single nucleotide variant,GRCh38
na,na,17,70120100,70120101,SOX9,Pathogenic,Camptomelic dysplasia|CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL,Duplication,GRCh37
na,na,17,72123959,72123960,SOX9,Pathogenic,Camptomelic dysplasia|CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL,Duplication,GRCh38
na,na,2,200213882,200213882,SATB2,Pathogenic,Chromosome 2q32-q33 deletion syndrome|not provided|Intellectual disability|Cleft palate|SATB2-related disorder,single nucleotide variant,GRCh37
na,na,2,199349159,199349159,SATB2,Pathogenic,Chromosome 2q32-q33 deletion syndrome|not provided|Intellectual disability|Cleft palate|SATB2-related disorder,single nucleotide variant,GRCh38
na,na,15,23086278,23086278,NIPA1,Pathogenic,Hereditary spastic paraplegia 6|not provided,single nucleotide variant,GRCh37
na,na,15,22786790,22786790,NIPA1,Pathogenic,Hereditary spastic paraplegia 6|not provided,single nucleotide variant,GRCh38
na,na,15,23060816,23060816,NIPA1,Pathogenic,Hereditary spastic paraplegia 6,single nucleotide variant,GRCh37
na,na,15,22812252,22812252,NIPA1,Pathogenic,Hereditary spastic paraplegia 6,single nucleotide variant,GRCh38
na,na,15,23060816,23060816,NIPA1,Pathogenic,Hereditary spastic paraplegia 6|Hereditary spastic paraplegia|not provided|Spastic paraplegia,single nucleotide variant,GRCh37
na,na,15,22812252,22812252,NIPA1,Pathogenic,Hereditary spastic paraplegia 6|Hereditary spastic paraplegia|not provided|Spastic paraplegia,single nucleotide variant,GRCh38
na,na,9,140344108,140344108,NSMF,risk factor,Hypogonadotropic hypogonadism 9 with or without anosmia,single nucleotide variant,GRCh37
na,na,9,137449656,137449656,NSMF,risk factor,Hypogonadotropic hypogonadism 9 with or without anosmia,single nucleotide variant,GRCh38
na,na,9,140347053,140347061,NSMF,risk factor,Hypogonadotropic hypogonadism 9 with or without anosmia,Deletion,GRCh37
na,na,9,137452601,137452609,NSMF,risk factor,Hypogonadotropic hypogonadism 9 with or without anosmia,Deletion,GRCh38
na,na,8,1830835,1830835,ARHGEF10,no classifications from unflagged records,Autosomal dominant slowed nerve conduction velocity,single nucleotide variant,GRCh37
na,na,8,1882669,1882669,ARHGEF10,no classifications from unflagged records,Autosomal dominant slowed nerve conduction velocity,single nucleotide variant,GRCh38
na,na,9,95237024,95237025,ASPN;CENPP,Benign,"Osteoarthritis susceptibility 3|Lumbar disk degeneration, susceptibility to|not specified|CENPP-related disorder",Microsatellite,GRCh37
na,na,9,92474742,92474743,ASPN;CENPP,Benign,"Osteoarthritis susceptibility 3|Lumbar disk degeneration, susceptibility to|not specified|CENPP-related disorder",Microsatellite,GRCh38
na,na,14,89310158,89310163,TTC8,Pathogenic,Bardet-Biedl syndrome 8,Deletion,GRCh37
na,na,14,88843814,88843819,TTC8,Pathogenic,Bardet-Biedl syndrome 8,Deletion,GRCh38
na,na,14,89336544,89336546,TTC8,Pathogenic,Bardet-Biedl syndrome 8|Bardet-Biedl syndrome,Deletion,GRCh37
na,na,14,88870200,88870202,TTC8,Pathogenic,Bardet-Biedl syndrome 8|Bardet-Biedl syndrome,Deletion,GRCh38
na,na,14,89307540,89307540,TTC8,Pathogenic/Likely pathogenic,"Bardet-Biedl syndrome 8|Bardet-Biedl syndrome|Retinitis pigmentosa 51|Truncal obesity;Postaxial foot polydactyly;Intellectual disability, moderate|Retinal dystrophy|TTC8-related disorder|Retinitis pigmentosa 51;Bardet-Biedl syndrome 8|not provided",single nucleotide variant,GRCh37
na,na,14,88841196,88841196,TTC8,Pathogenic/Likely pathogenic,"Bardet-Biedl syndrome 8|Bardet-Biedl syndrome|Retinitis pigmentosa 51|Truncal obesity;Postaxial foot polydactyly;Intellectual disability, moderate|Retinal dystrophy|TTC8-related disorder|Retinitis pigmentosa 51;Bardet-Biedl syndrome 8|not provided",single nucleotide variant,GRCh38
na,na,14,89310195,89310195,TTC8,Pathogenic,Bardet-Biedl syndrome 8|not provided,single nucleotide variant,GRCh37
na,na,14,88843851,88843851,TTC8,Pathogenic,Bardet-Biedl syndrome 8|not provided,single nucleotide variant,GRCh38
na,na,14,89300035,89300035,TTC8,Likely pathogenic,Retinitis pigmentosa 51|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,14,88833691,88833691,TTC8,Likely pathogenic,Retinitis pigmentosa 51|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,17,48437456,48437456,XYLT2,Benign,"PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF|Spondylo-ocular syndrome|not provided|Osteogenesis imperfecta",single nucleotide variant,GRCh37
na,na,17,50360095,50360095,XYLT2,Benign,"PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF|Spondylo-ocular syndrome|not provided|Osteogenesis imperfecta",single nucleotide variant,GRCh38
na,na,16,17564311,17564311,XYLT1,Benign,"PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF|Desbuquois dysplasia 1|Desbuquois dysplasia 2|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Desbuquois dysplasia 2",single nucleotide variant,GRCh37
na,na,16,17470454,17470454,XYLT1,Benign,"PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF|Desbuquois dysplasia 1|Desbuquois dysplasia 2|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Desbuquois dysplasia 2",single nucleotide variant,GRCh38
na,na,2,58390091,58390097,FANCL,Pathogenic,Fanconi anemia complementation group L,Indel,GRCh37
na,na,2,58162956,58162962,FANCL,Pathogenic,Fanconi anemia complementation group L,Indel,GRCh38
na,na,12,132416846,132416846,PUS1,Pathogenic/Likely pathogenic,"Myopathy, lactic acidosis, and sideroblastic anemia 1|not provided",single nucleotide variant,GRCh37
na,na,12,131932301,131932301,PUS1,Pathogenic/Likely pathogenic,"Myopathy, lactic acidosis, and sideroblastic anemia 1|not provided",single nucleotide variant,GRCh38
na,na,12,132425950,132425950,PUS1,Pathogenic,"Myopathy, lactic acidosis, and sideroblastic anemia 1",single nucleotide variant,GRCh37
na,na,12,131941405,131941405,PUS1,Pathogenic,"Myopathy, lactic acidosis, and sideroblastic anemia 1",single nucleotide variant,GRCh38
na,na,16,3293407,3293407,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder|Inborn genetic diseases|Recurrent fever",single nucleotide variant,GRCh37
na,na,16,3243407,3243407,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder|Inborn genetic diseases|Recurrent fever",single nucleotide variant,GRCh38
na,na,16,3293405,3293405,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant",single nucleotide variant,GRCh37
na,na,16,3243405,3243405,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant",single nucleotide variant,GRCh38
na,na,16,3293310,3293310,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Inborn genetic diseases|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder",single nucleotide variant,GRCh37
na,na,16,3243310,3243310,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Inborn genetic diseases|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder",single nucleotide variant,GRCh38
na,na,16,3304626,3304626,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not specified|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|See cases|Autoinflammatory syndrome|Inborn genetic diseases|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder|Systemic lupus erythematosus",single nucleotide variant,GRCh37
na,na,16,3254626,3254626,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not specified|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|See cases|Autoinflammatory syndrome|Inborn genetic diseases|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder|Systemic lupus erythematosus",single nucleotide variant,GRCh38
na,na,16,3304567,3304567,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|Autoinflammatory syndrome|Familial Mediterranean fever, autosomal dominant|not specified|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever",single nucleotide variant,GRCh37
na,na,16,3254567,3254567,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|Autoinflammatory syndrome|Familial Mediterranean fever, autosomal dominant|not specified|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever",single nucleotide variant,GRCh38
na,na,16,3304268,3304268,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not specified|not provided|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever",single nucleotide variant,GRCh37
na,na,16,3254268,3254268,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not specified|not provided|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|MEFV-related disorder|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever",single nucleotide variant,GRCh38
na,na,16,3297166,3297166,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|Autoinflammatory syndrome|Familial Mediterranean fever, autosomal dominant|not specified|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever|Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever",single nucleotide variant,GRCh37
na,na,16,3247166,3247166,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|Autoinflammatory syndrome|Familial Mediterranean fever, autosomal dominant|not specified|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever|Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever",single nucleotide variant,GRCh38
na,na,16,3293403,3293403,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|6 conditions|not specified|Inborn genetic diseases|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Abnormal cardiovascular system morphology;Renal insufficiency;Heart, malformation of|Autoinflammatory syndrome|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|MEFV-related disorder",single nucleotide variant,GRCh37
na,na,16,3243403,3243403,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|6 conditions|not specified|Inborn genetic diseases|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Abnormal cardiovascular system morphology;Renal insufficiency;Heart, malformation of|Autoinflammatory syndrome|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|MEFV-related disorder",single nucleotide variant,GRCh38
na,na,16,3293257,3293257,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|not specified|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|Inborn genetic diseases|MEFV-related disorder",single nucleotide variant,GRCh37
na,na,16,3243257,3243257,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not provided|not specified|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|Inborn genetic diseases|MEFV-related disorder",single nucleotide variant,GRCh38
na,na,16,3293205,3293205,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|Inborn genetic diseases|Familial Mediterranean fever, autosomal dominant|MEFV-related disorder",single nucleotide variant,GRCh37
na,na,16,3243205,3243205,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|Inborn genetic diseases|Familial Mediterranean fever, autosomal dominant|MEFV-related disorder",single nucleotide variant,GRCh38
na,na,16,3293447,3293447,MEFV,Pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder",single nucleotide variant,GRCh37
na,na,16,3243447,3243447,MEFV,Pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever, autosomal dominant|Autoinflammatory syndrome|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant|MEFV-related disorder",single nucleotide variant,GRCh38
na,na,16,3299586,3299586,MEFV,Conflicting classifications of pathogenicity,Familial Mediterranean fever|not specified|not provided|Autoinflammatory syndrome|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,3249586,3249586,MEFV,Conflicting classifications of pathogenicity,Familial Mediterranean fever|not specified|not provided|Autoinflammatory syndrome|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,16,3299468,3299468,MEFV,Conflicting classifications of pathogenicity,Familial Mediterranean fever|not specified|not provided|Autoinflammatory syndrome|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,3249468,3249468,MEFV,Conflicting classifications of pathogenicity,Familial Mediterranean fever|not specified|not provided|Autoinflammatory syndrome|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,16,3293529,3293529,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant",single nucleotide variant,GRCh37
na,na,16,3243529,3243529,MEFV,Pathogenic/Likely pathogenic,"Familial Mediterranean fever|not provided|Familial Mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant",single nucleotide variant,GRCh38
na,na,16,3304625,3304625,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not specified|not provided|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever|Acute febrile neutrophilic dermatosis|Autoinflammatory syndrome|Familial Mediterranean fever, autosomal dominant",single nucleotide variant,GRCh37
na,na,16,3254625,3254625,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever|not specified|not provided|Acute febrile neutrophilic dermatosis;Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever|Acute febrile neutrophilic dermatosis|Autoinflammatory syndrome|Familial Mediterranean fever, autosomal dominant",single nucleotide variant,GRCh38
na,na,16,3293404,3293406,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever|not provided",Microsatellite,GRCh37
na,na,16,3243404,3243406,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever|not provided",Microsatellite,GRCh38
na,na,16,3297171,3297171,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever|not provided|Acute febrile neutrophilic dermatosis",single nucleotide variant,GRCh37
na,na,16,3247171,3247171,MEFV,Conflicting classifications of pathogenicity,"Familial Mediterranean fever, autosomal dominant|Familial Mediterranean fever|not provided|Acute febrile neutrophilic dermatosis",single nucleotide variant,GRCh38
na,na,11,77832176,77832176,ALG8,Pathogenic,ALG8 congenital disorder of glycosylation,Deletion,GRCh37
na,na,11,78121130,78121130,ALG8,Pathogenic,ALG8 congenital disorder of glycosylation,Deletion,GRCh38
na,na,11,77832192,77832193,ALG8,Conflicting classifications of pathogenicity,ALG8 congenital disorder of glycosylation|not provided,Duplication,GRCh37
na,na,11,78121146,78121147,ALG8,Conflicting classifications of pathogenicity,ALG8 congenital disorder of glycosylation|not provided,Duplication,GRCh38
na,na,11,77838484,77838484,ALG8,Pathogenic,ALG8 congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,11,78127438,78127438,ALG8,Pathogenic,ALG8 congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,11,77838439,77838439,ALG8,Pathogenic,ALG8 congenital disorder of glycosylation|ALG8 congenital disorder of glycosylation;Polycystic liver disease 3 with or without kidney cysts,single nucleotide variant,GRCh37
na,na,11,78127393,78127393,ALG8,Pathogenic,ALG8 congenital disorder of glycosylation|ALG8 congenital disorder of glycosylation;Polycystic liver disease 3 with or without kidney cysts,single nucleotide variant,GRCh38
na,na,11,77825308,77825308,ALG8,Likely pathogenic,ALG8 congenital disorder of glycosylation|ALG8 congenital disorder of glycosylation;Polycystic liver disease 3 with or without kidney cysts,single nucleotide variant,GRCh37
na,na,11,78114262,78114262,ALG8,Likely pathogenic,ALG8 congenital disorder of glycosylation|ALG8 congenital disorder of glycosylation;Polycystic liver disease 3 with or without kidney cysts,single nucleotide variant,GRCh38
na,na,11,77823770,77823770,ALG8,Likely pathogenic,ALG8 congenital disorder of glycosylation|ALG8 congenital disorder of glycosylation;Polycystic liver disease 3 with or without kidney cysts,single nucleotide variant,GRCh37
na,na,11,78112724,78112724,ALG8,Likely pathogenic,ALG8 congenital disorder of glycosylation|ALG8 congenital disorder of glycosylation;Polycystic liver disease 3 with or without kidney cysts,single nucleotide variant,GRCh38
na,na,13,77575053,77575054,CLN5,Pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis|not provided,Microsatellite,GRCh37
na,na,13,77000918,77000919,CLN5,Pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis|not provided,Microsatellite,GRCh38
na,na,13,77566311,77566311,CLN5,Pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh37
na,na,13,76992176,76992176,CLN5,Pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh38
na,na,13,77574715,77574715,CLN5,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis|not specified,single nucleotide variant,GRCh37
na,na,13,77000580,77000580,CLN5,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis|not specified,single nucleotide variant,GRCh38
na,na,13,77569212,77569212,CLN5,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis|not provided,single nucleotide variant,GRCh37
na,na,13,76995077,76995077,CLN5,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis|not provided,single nucleotide variant,GRCh38
na,na,13,77574934,77574934,CLN5,Pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh37
na,na,13,77000799,77000799,CLN5,Pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh38
na,na,13,77569254,77569254,CLN5,Likely pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh37
na,na,13,76995119,76995119,CLN5,Likely pathogenic,Neuronal ceroid lipofuscinosis 5|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh38
na,na,13,77575001,77575001,CLN5,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 5|not provided|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh37
na,na,13,77000866,77000866,CLN5,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 5|not provided|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh38
na,na,13,77574551,77575150,CLN5,Pathogenic,Neuronal ceroid lipofuscinosis 5,Deletion,GRCh37
na,na,13,77000416,77001015,CLN5,Pathogenic,Neuronal ceroid lipofuscinosis 5,Deletion,GRCh38
na,na,4,169799457,169799457,PALLD,Conflicting classifications of pathogenicity,"Pancreatic cancer, susceptibility to, 1|Pancreatic adenocarcinoma|not specified|PALLD-related disorder",single nucleotide variant,GRCh37
na,na,4,168878306,168878306,PALLD,Conflicting classifications of pathogenicity,"Pancreatic cancer, susceptibility to, 1|Pancreatic adenocarcinoma|not specified|PALLD-related disorder",single nucleotide variant,GRCh38
na,na,19,45452429,45452429,APOC4-APOC2;APOC2,Benign/Likely benign,APOLIPOPROTEIN C-II (AFRICAN)|not provided|Familial apolipoprotein C-II deficiency|Cardiovascular phenotype|not specified,single nucleotide variant,GRCh37
na,na,19,44949172,44949172,APOC4-APOC2;APOC2,Benign/Likely benign,APOLIPOPROTEIN C-II (AFRICAN)|not provided|Familial apolipoprotein C-II deficiency|Cardiovascular phenotype|not specified,single nucleotide variant,GRCh38
na,na,19,45452079,45452079,APOC2,Likely pathogenic,APOLIPOPROTEIN C-II (PADOVA)|Familial apolipoprotein C-II deficiency|not provided,single nucleotide variant,GRCh37
na,na,19,44948822,44948822,APOC2,Likely pathogenic,APOLIPOPROTEIN C-II (PADOVA)|Familial apolipoprotein C-II deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,45452472,45452473,APOC2,Likely pathogenic,APOLIPOPROTEIN C-II (ST. MICHAEL)|Familial apolipoprotein C-II deficiency,Duplication,GRCh37
na,na,19,44949215,44949216,APOC2,Likely pathogenic,APOLIPOPROTEIN C-II (ST. MICHAEL)|Familial apolipoprotein C-II deficiency,Duplication,GRCh38
na,na,19,45452470,45452470,APOC2,Pathogenic,APOLIPOPROTEIN C-II (TORONTO)|Familial apolipoprotein C-II deficiency,Deletion,GRCh37
na,na,19,44949213,44949213,APOC2,Pathogenic,APOLIPOPROTEIN C-II (TORONTO)|Familial apolipoprotein C-II deficiency,Deletion,GRCh38
na,na,19,45451791,45451791,APOC2,Pathogenic,APOLIPOPROTEIN C-II (HAMBURG)|Familial apolipoprotein C-II deficiency,single nucleotide variant,GRCh37
na,na,19,44948534,44948534,APOC2,Pathogenic,APOLIPOPROTEIN C-II (HAMBURG)|Familial apolipoprotein C-II deficiency,single nucleotide variant,GRCh38
na,na,19,45451736,45451736,APOC2,Pathogenic,APOLIPOPROTEIN C-II (PARIS)|Familial apolipoprotein C-II deficiency,single nucleotide variant,GRCh37
na,na,19,44948479,44948479,APOC2,Pathogenic,APOLIPOPROTEIN C-II (PARIS)|Familial apolipoprotein C-II deficiency,single nucleotide variant,GRCh38
na,na,19,45452079,45452079,APOC2,Pathogenic,APOLIPOPROTEIN C-II (BARI)|Familial apolipoprotein C-II deficiency,single nucleotide variant,GRCh37
na,na,19,44948822,44948822,APOC2,Pathogenic,APOLIPOPROTEIN C-II (BARI)|Familial apolipoprotein C-II deficiency,single nucleotide variant,GRCh38
na,na,19,45452024,45452024,APOC2,Conflicting classifications of pathogenicity,Apolipoprotein c-ii variant|Familial apolipoprotein C-II deficiency|Cardiovascular phenotype|not provided|APOC2-related disorder|not specified,single nucleotide variant,GRCh37
na,na,19,44948767,44948767,APOC2,Conflicting classifications of pathogenicity,Apolipoprotein c-ii variant|Familial apolipoprotein C-II deficiency|Cardiovascular phenotype|not provided|APOC2-related disorder|not specified,single nucleotide variant,GRCh38
na,na,19,45452080,45452080,APOC2,Benign/Likely benign,APOLIPOPROTEIN C-II (SAN FRANCISCO)|Familial apolipoprotein C-II deficiency|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,19,44948823,44948823,APOC2,Benign/Likely benign,APOLIPOPROTEIN C-II (SAN FRANCISCO)|Familial apolipoprotein C-II deficiency|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,19,45452044,45452044,APOC2,Pathogenic,Familial apolipoprotein C-II deficiency|APOLIPOPROTEIN C-II (WAKAYAMA),single nucleotide variant,GRCh37
na,na,19,44948787,44948787,APOC2,Pathogenic,Familial apolipoprotein C-II deficiency|APOLIPOPROTEIN C-II (WAKAYAMA),single nucleotide variant,GRCh38
na,na,19,45452455,45452455,APOC2,Pathogenic,APOLIPOPROTEIN C-II (AUCKLAND)|Familial apolipoprotein C-II deficiency,single nucleotide variant,GRCh37
na,na,19,44949198,44949198,APOC2,Pathogenic,APOLIPOPROTEIN C-II (AUCKLAND)|Familial apolipoprotein C-II deficiency,single nucleotide variant,GRCh38
na,na,6,18122762,18122762,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2|Lafora disease|not provided,single nucleotide variant,GRCh37
na,na,6,18122531,18122531,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2|Lafora disease|not provided,single nucleotide variant,GRCh38
na,na,6,18122633,18122633,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2|not provided|Lafora disease|NHLRC1-related disorder,single nucleotide variant,GRCh37
na,na,6,18122402,18122402,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2|not provided|Lafora disease|NHLRC1-related disorder,single nucleotide variant,GRCh38
na,na,6,18122369,18122370,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2|not provided|Lafora disease|Inborn genetic diseases,Deletion,GRCh37
na,na,6,18122138,18122139,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2|not provided|Lafora disease|Inborn genetic diseases,Deletion,GRCh38
na,na,6,18121846,18121846,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2,Deletion,GRCh37
na,na,6,18121615,18121615,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2,Deletion,GRCh38
na,na,6,18122045,18122045,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2,single nucleotide variant,GRCh37
na,na,6,18121814,18121814,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2,single nucleotide variant,GRCh38
na,na,6,18122245,18122245,NHLRC1,Likely pathogenic,Myoclonic epilepsy of Lafora 2|Lafora disease|not provided,single nucleotide variant,GRCh37
na,na,6,18122014,18122014,NHLRC1,Likely pathogenic,Myoclonic epilepsy of Lafora 2|Lafora disease|not provided,single nucleotide variant,GRCh38
na,na,6,18121915,18121915,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2,single nucleotide variant,GRCh37
na,na,6,18121684,18121684,NHLRC1,Pathogenic,Myoclonic epilepsy of Lafora 2,single nucleotide variant,GRCh38
na,na,15,76578804,76578804,ETFA,Pathogenic/Likely pathogenic,Glutaric acidemia IIa|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,15,76286463,76286463,ETFA,Pathogenic/Likely pathogenic,Glutaric acidemia IIa|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,15,76566772,76566772,ETFA,Pathogenic,Glutaric acidemia IIa|not provided|Multiple acyl-CoA dehydrogenase deficiency|ETFA-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,15,76274431,76274431,ETFA,Pathogenic,Glutaric acidemia IIa|not provided|Multiple acyl-CoA dehydrogenase deficiency|ETFA-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,15,76584777,76584777,ETFA,Likely pathogenic,Glutaric acidemia IIa|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,15,76292436,76292436,ETFA,Likely pathogenic,Glutaric acidemia IIa|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,15,76518189,76518189,ETFA,Conflicting classifications of pathogenicity,Glutaric acidemia IIa|Multiple acyl-CoA dehydrogenase deficiency|not specified,Deletion,GRCh37
na,na,15,76225848,76225848,ETFA,Conflicting classifications of pathogenicity,Glutaric acidemia IIa|Multiple acyl-CoA dehydrogenase deficiency|not specified,Deletion,GRCh38
na,na,4,80905032,80905032,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh37
na,na,4,79983878,79983878,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh38
na,na,4,80905069,80905069,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh37
na,na,4,79983915,79983915,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh38
na,na,4,80977150,80977150,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh37
na,na,4,80055996,80055996,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh38
na,na,4,80929730,80929730,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh37
na,na,4,80008576,80008576,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh38
na,na,4,80957165,80957165,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh37
na,na,4,80036011,80036011,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh38
na,na,4,80975496,80975496,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh37
na,na,4,80054342,80054342,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome,single nucleotide variant,GRCh38
na,na,4,80905985,80905986,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome|not provided,Duplication,GRCh37
na,na,4,79984831,79984832,ANTXR2,Pathogenic,Hyaline fibromatosis syndrome|not provided,Duplication,GRCh38
na,na,17,3402294,3402294,ASPA,Pathogenic/Likely pathogenic,"Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,17,3499000,3499000,ASPA,Pathogenic/Likely pathogenic,"Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,17,3386814,3386814,ASPA,Pathogenic/Likely pathogenic,"Spongy degeneration of central nervous system|Canavan Disease, Familial Form",single nucleotide variant,GRCh37
na,na,17,3483520,3483520,ASPA,Pathogenic/Likely pathogenic,"Spongy degeneration of central nervous system|Canavan Disease, Familial Form",single nucleotide variant,GRCh38
na,na,17,3402354,3402354,ASPA,Pathogenic,"Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,17,3499060,3499060,ASPA,Pathogenic,"Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,17,3397663,3397663,ASPA,Pathogenic,"Spongy degeneration of central nervous system|Canavan Disease, Familial Form",single nucleotide variant,GRCh37
na,na,17,3494369,3494369,ASPA,Pathogenic,"Spongy degeneration of central nervous system|Canavan Disease, Familial Form",single nucleotide variant,GRCh38
na,na,17,3397702,3397702,ASPA,Pathogenic,"Spongy degeneration of central nervous system|Canavan Disease, Familial Form|not provided|Inborn genetic diseases|ASPA-related disorder",single nucleotide variant,GRCh37
na,na,17,3494408,3494408,ASPA,Pathogenic,"Spongy degeneration of central nervous system|Canavan Disease, Familial Form|not provided|Inborn genetic diseases|ASPA-related disorder",single nucleotide variant,GRCh38
na,na,17,3397701,3397701,ASPA,Pathogenic,Spongy degeneration of central nervous system,single nucleotide variant,GRCh37
na,na,17,3494407,3494407,ASPA,Pathogenic,Spongy degeneration of central nervous system,single nucleotide variant,GRCh38
na,na,17,3392527,3392634,ASPA,Pathogenic,Spongy degeneration of central nervous system,Deletion,GRCh37
na,na,17,3489233,3489340,ASPA,Pathogenic,Spongy degeneration of central nervous system,Deletion,GRCh38
na,na,17,3379524,3379524,ASPA,Likely pathogenic,Spongy degeneration of central nervous system,single nucleotide variant,GRCh37
na,na,17,3476230,3476230,ASPA,Likely pathogenic,Spongy degeneration of central nervous system,single nucleotide variant,GRCh38
na,na,17,3402186,3402186,ASPA,Pathogenic/Likely pathogenic,Spongy degeneration of central nervous system,single nucleotide variant,GRCh37
na,na,17,3498892,3498892,ASPA,Pathogenic/Likely pathogenic,Spongy degeneration of central nervous system,single nucleotide variant,GRCh38
na,na,17,3379665,3379665,ASPA,Pathogenic/Likely pathogenic,"Mild Canavan disease|Spongy degeneration of central nervous system|not provided|Inborn genetic diseases|Canavan Disease, Familial Form",single nucleotide variant,GRCh37
na,na,17,3476371,3476371,ASPA,Pathogenic/Likely pathogenic,"Mild Canavan disease|Spongy degeneration of central nervous system|not provided|Inborn genetic diseases|Canavan Disease, Familial Form",single nucleotide variant,GRCh38
na,na,12,119624885,119624885,HSPB8,Pathogenic,"Neuronopathy, distal hereditary motor, type 2A",single nucleotide variant,GRCh37
na,na,12,119187080,119187080,HSPB8,Pathogenic,"Neuronopathy, distal hereditary motor, type 2A",single nucleotide variant,GRCh38
na,na,12,119624883,119624883,HSPB8,Pathogenic,"Neuronopathy, distal hereditary motor, type 2A|Charcot-Marie-Tooth disease axonal type 2L|not provided",single nucleotide variant,GRCh37
na,na,12,119187078,119187078,HSPB8,Pathogenic,"Neuronopathy, distal hereditary motor, type 2A|Charcot-Marie-Tooth disease axonal type 2L|not provided",single nucleotide variant,GRCh38
na,na,12,119624885,119624885,HSPB8,Pathogenic,Charcot-Marie-Tooth disease axonal type 2L|Charcot-Marie-Tooth disease|not provided,single nucleotide variant,GRCh37
na,na,12,119187080,119187080,HSPB8,Pathogenic,Charcot-Marie-Tooth disease axonal type 2L|Charcot-Marie-Tooth disease|not provided,single nucleotide variant,GRCh38
na,na,7,44579833,44579833,NPC1L1,drug response,Ezetimibe response,single nucleotide variant,GRCh37
na,na,7,44540234,44540234,NPC1L1,drug response,Ezetimibe response,single nucleotide variant,GRCh38
na,na,7,44555699,44555699,NPC1L1,Likely benign,Ezetimibe response|not specified|not provided,single nucleotide variant,GRCh37
na,na,7,44516100,44516100,NPC1L1,Likely benign,Ezetimibe response|not specified|not provided,single nucleotide variant,GRCh38
na,na,5,138362625,138362626,SIL1,Pathogenic,Marinesco-Sjögren syndrome,Microsatellite,GRCh37
na,na,5,139026936,139026937,SIL1,Pathogenic,Marinesco-Sjögren syndrome,Microsatellite,GRCh38
na,na,5,138362489,138362489,SIL1,Pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh37
na,na,5,139026800,139026800,SIL1,Pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh38
na,na,5,138362488,138362488,SIL1,Likely pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh37
na,na,5,139026799,139026799,SIL1,Likely pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh38
na,na,5,138386649,138386649,SIL1,Pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh37
na,na,5,139050960,139050960,SIL1,Pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh38
na,na,5,138286859,138286859,SIL1,Pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh37
na,na,5,138951170,138951170,SIL1,Pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh38
na,na,5,138282880,138282880,SIL1,Pathogenic,Marinesco-Sjögren syndrome|not provided,single nucleotide variant,GRCh37
na,na,5,138947191,138947191,SIL1,Pathogenic,Marinesco-Sjögren syndrome|not provided,single nucleotide variant,GRCh38
na,na,5,138282822,138282822,SIL1,Pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh37
na,na,5,138947133,138947133,SIL1,Pathogenic,Marinesco-Sjögren syndrome,single nucleotide variant,GRCh38
na,na,5,138286952,138286953,SIL1,Pathogenic,Marinesco-Sjögren syndrome,Duplication,GRCh37
na,na,5,138951263,138951264,SIL1,Pathogenic,Marinesco-Sjögren syndrome,Duplication,GRCh38
na,na,5,138362528,138362532,SIL1,Pathogenic,Marinesco-Sjögren syndrome,Microsatellite,GRCh37
na,na,5,139026839,139026843,SIL1,Pathogenic,Marinesco-Sjögren syndrome,Microsatellite,GRCh38
na,na,5,138311134,138369402,SIL1,Pathogenic,Marinesco-Sjögren syndrome,Deletion,GRCh37
na,na,5,138975444,139033712,SIL1,Pathogenic,Marinesco-Sjögren syndrome,Deletion,GRCh38
na,na,3,132400921,132400923,NPHP3,Pathogenic/Likely pathogenic,Nephronophthisis 3|Nephronophthisis|Nephronophthisis 3;Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome,Microsatellite,GRCh37
na,na,3,132682077,132682079,NPHP3,Pathogenic/Likely pathogenic,Nephronophthisis 3|Nephronophthisis|Nephronophthisis 3;Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome,Microsatellite,GRCh38
na,na,3,132432009,132432009,NPHP3,Pathogenic,Nephronophthisis 3,single nucleotide variant,GRCh37
na,na,3,132713165,132713165,NPHP3,Pathogenic,Nephronophthisis 3,single nucleotide variant,GRCh38
na,na,3,132423185,132423185,NPHP3,Pathogenic,Nephronophthisis 3|not provided|NPHP3-related Meckel-like syndrome|Nephronophthisis|Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome;Nephronophthisis 3,single nucleotide variant,GRCh37
na,na,3,132704341,132704341,NPHP3,Pathogenic,Nephronophthisis 3|not provided|NPHP3-related Meckel-like syndrome|Nephronophthisis|Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome;Nephronophthisis 3,single nucleotide variant,GRCh38
na,na,3,132419192,132419192,NPHP3,Pathogenic,NPHP3-related Meckel-like syndrome|not provided|Nephronophthisis|NPHP3-related disorder,single nucleotide variant,GRCh37
na,na,3,132700348,132700348,NPHP3,Pathogenic,NPHP3-related Meckel-like syndrome|not provided|Nephronophthisis|NPHP3-related disorder,single nucleotide variant,GRCh38
na,na,3,132407701,132407701,NPHP3,Conflicting classifications of pathogenicity,Renal-hepatic-pancreatic dysplasia 1|NPHP3-related Meckel-like syndrome;Renal-hepatic-pancreatic dysplasia 1;Nephronophthisis 3|not specified,single nucleotide variant,GRCh37
na,na,3,132688857,132688857,NPHP3,Conflicting classifications of pathogenicity,Renal-hepatic-pancreatic dysplasia 1|NPHP3-related Meckel-like syndrome;Renal-hepatic-pancreatic dysplasia 1;Nephronophthisis 3|not specified,single nucleotide variant,GRCh38
na,na,3,132403628,132403628,NPHP3,Pathogenic,Renal-hepatic-pancreatic dysplasia 1|Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome;Nephronophthisis 3,single nucleotide variant,GRCh37
na,na,3,132684784,132684784,NPHP3,Pathogenic,Renal-hepatic-pancreatic dysplasia 1|Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome;Nephronophthisis 3,single nucleotide variant,GRCh38
na,na,3,132418192,132418192,NPHP3,Conflicting classifications of pathogenicity,Renal-hepatic-pancreatic dysplasia 1|Nephronophthisis|not provided|Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome;Nephronophthisis 3,single nucleotide variant,GRCh37
na,na,3,132699348,132699348,NPHP3,Conflicting classifications of pathogenicity,Renal-hepatic-pancreatic dysplasia 1|Nephronophthisis|not provided|Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome;Nephronophthisis 3,single nucleotide variant,GRCh38
na,na,3,132415642,132415642,NPHP3,Pathogenic,Nephronophthisis 3|Nephronophthisis|NPHP3-related Meckel-like syndrome|not provided|Nephronophthisis 3;Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome|Joubert syndrome and related disorders|NPHP3-related disorder,single nucleotide variant,GRCh37
na,na,3,132696798,132696798,NPHP3,Pathogenic,Nephronophthisis 3|Nephronophthisis|NPHP3-related Meckel-like syndrome|not provided|Nephronophthisis 3;Renal-hepatic-pancreatic dysplasia 1;NPHP3-related Meckel-like syndrome|Joubert syndrome and related disorders|NPHP3-related disorder,single nucleotide variant,GRCh38
na,na,11,6637288,6637288,TPP1,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Neuronal ceroid lipofuscinosis|TPP1-related disorder,single nucleotide variant,GRCh37
na,na,11,6616057,6616057,TPP1,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Neuronal ceroid lipofuscinosis|TPP1-related disorder,single nucleotide variant,GRCh38
na,na,11,6637287,6637287,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Neuronal ceroid lipofuscinosis|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2|TPP1-related disorder,single nucleotide variant,GRCh37
na,na,11,6616056,6616056,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Neuronal ceroid lipofuscinosis|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2|TPP1-related disorder,single nucleotide variant,GRCh38
na,na,11,6638271,6638271,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|Neuronal ceroid lipofuscinosis|Inborn genetic diseases|not provided|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2|Abnormality of the nervous system|TPP1-related disorder,single nucleotide variant,GRCh37
na,na,11,6617040,6617040,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|Neuronal ceroid lipofuscinosis|Inborn genetic diseases|not provided|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2|Abnormality of the nervous system|TPP1-related disorder,single nucleotide variant,GRCh38
na,na,11,6638385,6638385,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|Autosomal recessive spinocerebellar ataxia 7|not provided|Inborn genetic diseases|Neuronal ceroid lipofuscinosis|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2|TPP1-related disorder,single nucleotide variant,GRCh37
na,na,11,6617154,6617154,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|Autosomal recessive spinocerebellar ataxia 7|not provided|Inborn genetic diseases|Neuronal ceroid lipofuscinosis|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2|TPP1-related disorder,single nucleotide variant,GRCh38
na,na,11,6636487,6636487,TPP1,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2,single nucleotide variant,GRCh37
na,na,11,6615256,6615256,TPP1,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2,single nucleotide variant,GRCh38
na,na,11,6638277,6638277,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided,single nucleotide variant,GRCh37
na,na,11,6617046,6617046,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided,single nucleotide variant,GRCh38
na,na,11,6637927,6637927,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2,single nucleotide variant,GRCh37
na,na,11,6616696,6616696,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided|Autosomal recessive spinocerebellar ataxia 7;Neuronal ceroid lipofuscinosis 2,single nucleotide variant,GRCh38
na,na,11,6637921,6637921,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided,single nucleotide variant,GRCh37
na,na,11,6616690,6616690,TPP1,Pathogenic,Neuronal ceroid lipofuscinosis 2|not provided,single nucleotide variant,GRCh38
na,na,11,6637744,6637744,TPP1,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 2|not provided|Neuronal ceroid lipofuscinosis 2;Autosomal recessive spinocerebellar ataxia 7,single nucleotide variant,GRCh37
na,na,11,6616513,6616513,TPP1,Conflicting classifications of pathogenicity,Neuronal ceroid lipofuscinosis 2|not provided|Neuronal ceroid lipofuscinosis 2;Autosomal recessive spinocerebellar ataxia 7,single nucleotide variant,GRCh38
na,na,1,170508656,170508656,GORAB,Pathogenic,Geroderma osteodysplastica|not provided|GORAB-related disorder,single nucleotide variant,GRCh37
na,na,1,170539515,170539515,GORAB,Pathogenic,Geroderma osteodysplastica|not provided|GORAB-related disorder,single nucleotide variant,GRCh38
na,na,1,170521277,170521277,GORAB,Pathogenic/Likely pathogenic,Geroderma osteodysplastica|not provided,single nucleotide variant,GRCh37
na,na,1,170552136,170552136,GORAB,Pathogenic/Likely pathogenic,Geroderma osteodysplastica|not provided,single nucleotide variant,GRCh38
na,na,1,170513991,170513991,GORAB,Pathogenic,Geroderma osteodysplastica,single nucleotide variant,GRCh37
na,na,1,170544850,170544850,GORAB,Pathogenic,Geroderma osteodysplastica,single nucleotide variant,GRCh38
na,na,na,-1,-1,GORAB,Pathogenic,Geroderma osteodysplastica,Deletion,na
na,na,20,30232603,30232603,COX4I2,Uncertain significance,Pancreatic insufficiency-anemia-hyperostosis syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,31644800,31644800,COX4I2,Uncertain significance,Pancreatic insufficiency-anemia-hyperostosis syndrome|not provided,single nucleotide variant,GRCh38
na,na,7,33407475,33407475,BBS9,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 9|not provided|Bardet-Biedl syndrome|BBS9-related disorder,single nucleotide variant,GRCh37
na,na,7,33367863,33367863,BBS9,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 9|not provided|Bardet-Biedl syndrome|BBS9-related disorder,single nucleotide variant,GRCh38
na,na,7,33423280,33423280,BBS9,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 9|Bardet-Biedl syndrome|Nephronophthisis 4,single nucleotide variant,GRCh37
na,na,7,33383668,33383668,BBS9,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 9|Bardet-Biedl syndrome|Nephronophthisis 4,single nucleotide variant,GRCh38
na,na,7,33427685,33427686,BBS9,Pathogenic,Bardet-Biedl syndrome 9,Duplication,GRCh37
na,na,7,33388073,33388074,BBS9,Pathogenic,Bardet-Biedl syndrome 9,Duplication,GRCh38
na,na,7,33217182,33217182,BBS9,Likely pathogenic,Bardet-Biedl syndrome|Bardet-Biedl syndrome 9,single nucleotide variant,GRCh37
na,na,7,33177570,33177570,BBS9,Likely pathogenic,Bardet-Biedl syndrome|Bardet-Biedl syndrome 9,single nucleotide variant,GRCh38
na,na,7,33376099,33376099,BBS9,Pathogenic,Bardet-Biedl syndrome|Bardet-Biedl syndrome 9|not provided|BBS9-related disorder,single nucleotide variant,GRCh37
na,na,7,33336487,33336487,BBS9,Pathogenic,Bardet-Biedl syndrome|Bardet-Biedl syndrome 9|not provided|BBS9-related disorder,single nucleotide variant,GRCh38
na,na,7,33217204,33217204,BBS9,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 9|Bardet-Biedl syndrome,single nucleotide variant,GRCh37
na,na,7,33177592,33177592,BBS9,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 9|Bardet-Biedl syndrome,single nucleotide variant,GRCh38
na,na,7,33423364,33423367,BBS9,Pathogenic,Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 1|not provided|Bardet-Biedl syndrome|BBS9-related disorder|Retinal dystrophy,Deletion,GRCh37
na,na,7,33383752,33383755,BBS9,Pathogenic,Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 1|not provided|Bardet-Biedl syndrome|BBS9-related disorder|Retinal dystrophy,Deletion,GRCh38
na,na,3,4490942,4490945,SUMF1,Pathogenic,Multiple sulfatase deficiency,Microsatellite,GRCh37
na,na,3,4449258,4449261,SUMF1,Pathogenic,Multiple sulfatase deficiency,Microsatellite,GRCh38
na,na,3,4403877,4403877,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh37
na,na,3,4362193,4362193,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh38
na,na,3,4418049,4418049,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh37
na,na,3,4376365,4376365,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh38
na,na,3,4403908,4403908,SUMF1,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,4362224,4362224,SUMF1,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency|not provided,single nucleotide variant,GRCh38
na,na,3,4403907,4403907,SUMF1,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,4362223,4362223,SUMF1,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency|not provided,single nucleotide variant,GRCh38
na,na,3,4418022,4418022,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh37
na,na,3,4376338,4376338,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh38
na,na,3,4458816,4458816,SUMF1,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,4417132,4417132,SUMF1,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency|not provided,single nucleotide variant,GRCh38
na,na,3,4508687,4508687,SUMF1,Pathogenic,Multiple sulfatase deficiency,Deletion,GRCh37
na,na,3,4467003,4467003,SUMF1,Pathogenic,Multiple sulfatase deficiency,Deletion,GRCh38
na,na,3,4459758,4459758,SUMF1,Pathogenic,Multiple sulfatase deficiency,Deletion,GRCh37
na,na,3,4418074,4418074,SUMF1,Pathogenic,Multiple sulfatase deficiency,Deletion,GRCh38
na,na,3,4491006,4491006,SUMF1,Pathogenic,Multiple sulfatase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,4449322,4449322,SUMF1,Pathogenic,Multiple sulfatase deficiency|not provided,single nucleotide variant,GRCh38
na,na,3,4508928,4508928,SUMF1,Likely pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh37
na,na,3,4467244,4467244,SUMF1,Likely pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh38
na,na,3,4403920,4403920,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh37
na,na,3,4362236,4362236,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh38
na,na,3,4403911,4403911,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh37
na,na,3,4362227,4362227,SUMF1,Pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh38
na,na,3,4459766,4459766,SUMF1,Likely pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh37
na,na,3,4418082,4418082,SUMF1,Likely pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh38
na,na,7,56144525,56144525,SUMF2,Pathogenic,Multiple sulfatase deficiency,Deletion,GRCh37
na,na,7,56076832,56076832,SUMF2,Pathogenic,Multiple sulfatase deficiency,Deletion,GRCh38
na,na,3,4508929,4508929,SUMF1,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh37
na,na,3,4467245,4467245,SUMF1,Pathogenic/Likely pathogenic,Multiple sulfatase deficiency,single nucleotide variant,GRCh38
na,na,7,45039953,45039953,CCM2,Pathogenic,Cerebral cavernous malformation 2,Deletion,GRCh37
na,na,7,45000354,45000354,CCM2,Pathogenic,Cerebral cavernous malformation 2,Deletion,GRCh38
na,na,7,45104092,45104092,CCM2,Pathogenic,Cerebral cavernous malformation 2|not provided,single nucleotide variant,GRCh37
na,na,7,45064493,45064493,CCM2,Pathogenic,Cerebral cavernous malformation 2|not provided,single nucleotide variant,GRCh38
na,na,7,45039933,45039933,CCM2,Pathogenic,Cerebral cavernous malformation 2|not provided,single nucleotide variant,GRCh37
na,na,7,45000334,45000334,CCM2,Pathogenic,Cerebral cavernous malformation 2|not provided,single nucleotide variant,GRCh38
na,na,7,45103601,45103601,CCM2,Pathogenic,Cerebral cavernous malformation 2,single nucleotide variant,GRCh37
na,na,7,45064002,45064002,CCM2,Pathogenic,Cerebral cavernous malformation 2,single nucleotide variant,GRCh38
na,na,7,45108162,45108162,CCM2,Pathogenic,Cerebral cavernous malformation 2,single nucleotide variant,GRCh37
na,na,7,45068563,45068563,CCM2,Pathogenic,Cerebral cavernous malformation 2,single nucleotide variant,GRCh38
na,na,na,-1,-1,CCM2,Pathogenic,Cerebral cavernous malformation 2,Deletion,na
na,na,9,117166262,117166262,WHRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 31|not provided|Usher syndrome|Usher syndrome type 2D;Autosomal recessive nonsyndromic hearing loss 31,single nucleotide variant,GRCh37
na,na,9,114403982,114403982,WHRN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 31|not provided|Usher syndrome|Usher syndrome type 2D;Autosomal recessive nonsyndromic hearing loss 31,single nucleotide variant,GRCh38
na,na,9,117266775,117266775,WHRN,Pathogenic,Usher syndrome type 2D,single nucleotide variant,GRCh37
na,na,9,114504495,114504495,WHRN,Pathogenic,Usher syndrome type 2D,single nucleotide variant,GRCh38
na,na,9,117240832,117240832,WHRN,Pathogenic,Usher syndrome type 2D,single nucleotide variant,GRCh37
na,na,9,114478552,114478552,WHRN,Pathogenic,Usher syndrome type 2D,single nucleotide variant,GRCh38
na,na,22,43089410,43089410,A4GALT,Affects,p phenotype,single nucleotide variant,GRCh37
na,na,22,42693404,42693404,A4GALT,Affects,p phenotype,single nucleotide variant,GRCh38
na,na,22,43089206,43089206,A4GALT,Uncertain significance,p phenotype|not provided,single nucleotide variant,GRCh37
na,na,22,42693200,42693200,A4GALT,Uncertain significance,p phenotype|not provided,single nucleotide variant,GRCh38
na,na,22,43089175,43089175,A4GALT,Affects,p phenotype,single nucleotide variant,GRCh37
na,na,22,42693169,42693169,A4GALT,Affects,p phenotype,single nucleotide variant,GRCh38
na,na,22,43089398,43089398,A4GALT,Affects,p phenotype,single nucleotide variant,GRCh37
na,na,22,42693392,42693392,A4GALT,Affects,p phenotype,single nucleotide variant,GRCh38
na,na,22,43089715,43089717,A4GALT,Affects,p phenotype,Microsatellite,GRCh37
na,na,22,42693709,42693711,A4GALT,Affects,p phenotype,Microsatellite,GRCh38
na,na,22,43088928,43088929,A4GALT,Affects,p phenotype,Duplication,GRCh37
na,na,22,42692922,42692923,A4GALT,Affects,p phenotype,Duplication,GRCh38
na,na,9,101980427,101980427,ALG2,Pathogenic/Likely pathogenic,ALG2-congenital disorder of glycosylation;Congenital myasthenic syndrome 14|not provided|ALG2-congenital disorder of glycosylation,Deletion,GRCh37
na,na,9,99218145,99218145,ALG2,Pathogenic/Likely pathogenic,ALG2-congenital disorder of glycosylation;Congenital myasthenic syndrome 14|not provided|ALG2-congenital disorder of glycosylation,Deletion,GRCh38
na,na,9,101981074,101981074,ALG2,Pathogenic,ALG2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,9,99218792,99218792,ALG2,Pathogenic,ALG2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,1245503,1245503,CACNA1H,risk factor,"Epilepsy, childhood absence, susceptibility to, 6",single nucleotide variant,GRCh37
na,na,16,1195503,1195503,CACNA1H,risk factor,"Epilepsy, childhood absence, susceptibility to, 6",single nucleotide variant,GRCh38
na,na,16,1250296,1250296,CACNA1H,Uncertain significance,"Epilepsy, childhood absence, susceptibility to, 6|Epilepsy, childhood absence, susceptibility to, 6;Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV",single nucleotide variant,GRCh37
na,na,16,1200296,1200296,CACNA1H,Uncertain significance,"Epilepsy, childhood absence, susceptibility to, 6|Epilepsy, childhood absence, susceptibility to, 6;Hyperaldosteronism, familial, type IV|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV",single nucleotide variant,GRCh38
na,na,16,1255153,1255153,CACNA1H,Uncertain significance,"Epilepsy, childhood absence, susceptibility to, 6|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV",single nucleotide variant,GRCh37
na,na,16,1205153,1205153,CACNA1H,Uncertain significance,"Epilepsy, childhood absence, susceptibility to, 6|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV",single nucleotide variant,GRCh38
na,na,16,1254325,1254325,CACNA1H,Likely benign,"Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV|Hyperaldosteronism, familial, type IV;Epilepsy, childhood absence, susceptibility to, 6",single nucleotide variant,GRCh37
na,na,16,1204325,1204325,CACNA1H,Likely benign,"Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV|Hyperaldosteronism, familial, type IV;Epilepsy, childhood absence, susceptibility to, 6",single nucleotide variant,GRCh38
na,na,16,1252303,1252303,CACNA1H,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 6|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV|not provided",single nucleotide variant,GRCh37
na,na,16,1202303,1202303,CACNA1H,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 6|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV|not provided",single nucleotide variant,GRCh38
na,na,16,1256126,1256126,CACNA1H,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 6|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV|Epilepsy, childhood absence, susceptibility to, 6|not provided|not specified|CACNA1H-related disorder",single nucleotide variant,GRCh37
na,na,16,1206126,1206126,CACNA1H,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 6|Idiopathic generalized epilepsy;Hyperaldosteronism, familial, type IV|Epilepsy, childhood absence, susceptibility to, 6|not provided|not specified|CACNA1H-related disorder",single nucleotide variant,GRCh38
na,na,11,63990518,63990518,FERMT3,Pathogenic,Leukocyte adhesion deficiency 3,single nucleotide variant,GRCh37
na,na,11,64223046,64223046,FERMT3,Pathogenic,Leukocyte adhesion deficiency 3,single nucleotide variant,GRCh38
na,na,11,63974884,63974884,FERMT3,Pathogenic,Leukocyte adhesion deficiency 3|Leukocyte adhesion deficiency,single nucleotide variant,GRCh37
na,na,11,64207412,64207412,FERMT3,Pathogenic,Leukocyte adhesion deficiency 3|Leukocyte adhesion deficiency,single nucleotide variant,GRCh38
na,na,11,63990566,63990566,FERMT3,Pathogenic/Likely pathogenic,Leukocyte adhesion deficiency 3,single nucleotide variant,GRCh37
na,na,11,64223094,64223094,FERMT3,Pathogenic/Likely pathogenic,Leukocyte adhesion deficiency 3,single nucleotide variant,GRCh38
na,na,11,63979120,63979120,FERMT3,Pathogenic,Leukocyte adhesion deficiency 3,single nucleotide variant,GRCh37
na,na,11,64211648,64211648,FERMT3,Pathogenic,Leukocyte adhesion deficiency 3,single nucleotide variant,GRCh38
na,na,11,63988121,63988121,FERMT3,Pathogenic,Leukocyte adhesion deficiency 3,single nucleotide variant,GRCh37
na,na,11,64220649,64220649,FERMT3,Pathogenic,Leukocyte adhesion deficiency 3,single nucleotide variant,GRCh38
na,na,20,6096456,6096456,FERMT1,Pathogenic,Kindler syndrome,single nucleotide variant,GRCh37
na,na,20,6115809,6115809,FERMT1,Pathogenic,Kindler syndrome,single nucleotide variant,GRCh38
na,na,20,6088241,6088241,FERMT1,Pathogenic,Kindler syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,6107594,6107594,FERMT1,Pathogenic,Kindler syndrome|not provided,single nucleotide variant,GRCh38
na,na,20,6064690,6064691,FERMT1,Pathogenic,Kindler syndrome,Insertion,GRCh37
na,na,20,6084043,6084044,FERMT1,Pathogenic,Kindler syndrome,Insertion,GRCh38
na,na,20,6093192,6093192,FERMT1,Pathogenic,Kindler syndrome,Deletion,GRCh37
na,na,20,6112545,6112545,FERMT1,Pathogenic,Kindler syndrome,Deletion,GRCh38
na,na,20,6088217,6088217,FERMT1,Pathogenic,Kindler syndrome|not provided|FERMT1-related disorder,single nucleotide variant,GRCh37
na,na,20,6107570,6107570,FERMT1,Pathogenic,Kindler syndrome|not provided|FERMT1-related disorder,single nucleotide variant,GRCh38
na,na,20,6078266,6078266,FERMT1,Pathogenic,Kindler syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,6097619,6097619,FERMT1,Pathogenic,Kindler syndrome|not provided,single nucleotide variant,GRCh38
na,na,18,28968802,28972592,DSG4,Pathogenic,Hypotrichosis 6,Deletion,GRCh37
na,na,18,31388839,31392629,DSG4,Pathogenic,Hypotrichosis 6,Deletion,GRCh38
na,na,18,28966653,28966653,DSG4,Likely pathogenic,Hypotrichosis 6,Deletion,GRCh37
na,na,18,31386690,31386690,DSG4,Likely pathogenic,Hypotrichosis 6,Deletion,GRCh38
na,na,18,28970675,28970675,DSG4,Pathogenic,Hypotrichosis 6,single nucleotide variant,GRCh37
na,na,18,31390712,31390712,DSG4,Pathogenic,Hypotrichosis 6,single nucleotide variant,GRCh38
na,na,18,28989518,28989519,DSG4,Pathogenic,Hypotrichosis 6,Duplication,GRCh37
na,na,18,31409555,31409556,DSG4,Pathogenic,Hypotrichosis 6,Duplication,GRCh38
na,na,18,28966783,28966783,DSG4,Pathogenic,Hypotrichosis 6,single nucleotide variant,GRCh37
na,na,18,31386820,31386820,DSG4,Pathogenic,Hypotrichosis 6,single nucleotide variant,GRCh38
na,na,18,28971156,28971156,DSG4,Pathogenic,Hypotrichosis 6,single nucleotide variant,GRCh37
na,na,18,31391193,31391193,DSG4,Pathogenic,Hypotrichosis 6,single nucleotide variant,GRCh38
na,na,18,28971119,28971119,DSG4,Pathogenic,Hypotrichosis 6,Deletion,GRCh37
na,na,18,31391156,31391156,DSG4,Pathogenic,Hypotrichosis 6,Deletion,GRCh38
na,na,18,28972163,28972163,DSG4,Likely pathogenic,Hypotrichosis 6,single nucleotide variant,GRCh37
na,na,18,31392200,31392200,DSG4,Likely pathogenic,Hypotrichosis 6,single nucleotide variant,GRCh38
na,na,11,61723221,61723221,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided,single nucleotide variant,GRCh37
na,na,11,61955749,61955749,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided,single nucleotide variant,GRCh38
na,na,11,61723195,61723195,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,61955723,61955723,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,61726998,61726998,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,61959526,61959526,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,61719365,61719365,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided,single nucleotide variant,GRCh37
na,na,11,61951893,61951893,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided,single nucleotide variant,GRCh38
na,na,11,61724901,61724901,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,61957429,61957429,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,61719294,61719294,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided,single nucleotide variant,GRCh37
na,na,11,61951822,61951822,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided,single nucleotide variant,GRCh38
na,na,11,61726983,61726985,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,Microsatellite,GRCh37
na,na,11,61959511,61959513,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,Microsatellite,GRCh38
na,na,11,61719303,61719303,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,61951831,61951831,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,61723297,61723297,BEST1,Conflicting classifications of pathogenicity,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,61955825,61955825,BEST1,Conflicting classifications of pathogenicity,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,61723378,61723379,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided,Indel,GRCh37
na,na,11,61955906,61955907,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided,Indel,GRCh38
na,na,11,61725631,61725631,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy|Autosomal dominant vitreoretinochoroidopathy|Vitelliform macular dystrophy 1,single nucleotide variant,GRCh37
na,na,11,61958159,61958159,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy|Autosomal dominant vitreoretinochoroidopathy|Vitelliform macular dystrophy 1,single nucleotide variant,GRCh38
na,na,11,61719418,61719418,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy|Vitelliform macular dystrophy 2;Autosomal dominant vitreoretinochoroidopathy;Retinitis pigmentosa 50;Autosomal recessive bestrophinopathy,single nucleotide variant,GRCh37
na,na,11,61951946,61951946,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy|Vitelliform macular dystrophy 2;Autosomal dominant vitreoretinochoroidopathy;Retinitis pigmentosa 50;Autosomal recessive bestrophinopathy,single nucleotide variant,GRCh38
na,na,11,61730094,61730095,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy|Autosomal recessive bestrophinopathy|BEST1-related disorder,Microsatellite,GRCh37
na,na,11,61962622,61962623,BEST1,Pathogenic,Vitelliform macular dystrophy 2|not provided|Retinal dystrophy|Autosomal recessive bestrophinopathy|BEST1-related disorder,Microsatellite,GRCh38
na,na,11,61723364,61723364,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|Autosomal recessive bestrophinopathy|not provided|Stargardt disease|Retinal dystrophy|BEST1-related disorder|BEST1-related dominant retinopathy,single nucleotide variant,GRCh37
na,na,11,61955892,61955892,BEST1,Pathogenic/Likely pathogenic,Vitelliform macular dystrophy 2|Autosomal recessive bestrophinopathy|not provided|Stargardt disease|Retinal dystrophy|BEST1-related disorder|BEST1-related dominant retinopathy,single nucleotide variant,GRCh38
na,na,11,61724432,61724432,BEST1,Pathogenic,Autosomal recessive bestrophinopathy|not provided|Vitelliform macular dystrophy 2;Autosomal dominant vitreoretinochoroidopathy;Retinitis pigmentosa 50;Autosomal recessive bestrophinopathy|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,61956960,61956960,BEST1,Pathogenic,Autosomal recessive bestrophinopathy|not provided|Vitelliform macular dystrophy 2;Autosomal dominant vitreoretinochoroidopathy;Retinitis pigmentosa 50;Autosomal recessive bestrophinopathy|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,61727364,61727364,BEST1,Pathogenic,Autosomal recessive bestrophinopathy,single nucleotide variant,GRCh37
na,na,11,61959892,61959892,BEST1,Pathogenic,Autosomal recessive bestrophinopathy,single nucleotide variant,GRCh38
na,na,11,61719400,61719400,BEST1,Pathogenic/Likely pathogenic,Autosomal recessive bestrophinopathy|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,61951928,61951928,BEST1,Pathogenic/Likely pathogenic,Autosomal recessive bestrophinopathy|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,61723198,61723198,BEST1,Pathogenic,Autosomal dominant vitreoretinochoroidopathy|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,11,61955726,61955726,BEST1,Pathogenic,Autosomal dominant vitreoretinochoroidopathy|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,11,61725618,61725618,BEST1,Likely pathogenic,"Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2|not provided",single nucleotide variant,GRCh37
na,na,11,61958146,61958146,BEST1,Likely pathogenic,"Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2|not provided",single nucleotide variant,GRCh38
na,na,11,61724929,61724929,BEST1,Uncertain significance,Autosomal dominant vitreoretinochoroidopathy|not provided,single nucleotide variant,GRCh37
na,na,11,61957457,61957457,BEST1,Uncertain significance,Autosomal dominant vitreoretinochoroidopathy|not provided,single nucleotide variant,GRCh38
na,na,11,61724448,61724448,BEST1,Pathogenic,Retinitis pigmentosa 50|not provided,single nucleotide variant,GRCh37
na,na,11,61956976,61956976,BEST1,Pathogenic,Retinitis pigmentosa 50|not provided,single nucleotide variant,GRCh38
na,na,11,61724904,61724904,BEST1,Conflicting classifications of pathogenicity,Retinitis pigmentosa 50|not provided|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,61957432,61957432,BEST1,Conflicting classifications of pathogenicity,Retinitis pigmentosa 50|not provided|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,61724902,61724902,BEST1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 50|Vitelliform macular dystrophy 2|not provided,single nucleotide variant,GRCh37
na,na,11,61957430,61957430,BEST1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 50|Vitelliform macular dystrophy 2|not provided,single nucleotide variant,GRCh38
na,na,11,61723360,61723360,BEST1,Conflicting classifications of pathogenicity,Retinitis pigmentosa 50|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,11,61955888,61955888,BEST1,Conflicting classifications of pathogenicity,Retinitis pigmentosa 50|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,11,61724926,61724926,BEST1,Pathogenic,Autosomal dominant vitreoretinochoroidopathy,single nucleotide variant,GRCh37
na,na,11,61957454,61957454,BEST1,Pathogenic,Autosomal dominant vitreoretinochoroidopathy,single nucleotide variant,GRCh38
na,na,12,65563833,65563833,LEMD3,Pathogenic,Osteopoikilosis,single nucleotide variant,GRCh37
na,na,12,65170053,65170053,LEMD3,Pathogenic,Osteopoikilosis,single nucleotide variant,GRCh38
na,na,12,65564409,65564411,LEMD3,Pathogenic,Dermatofibrosis lenticularis disseminata,Indel,GRCh37
na,na,12,65170629,65170631,LEMD3,Pathogenic,Dermatofibrosis lenticularis disseminata,Indel,GRCh38
na,na,12,65564408,65564409,LEMD3,Pathogenic,Dermatofibrosis lenticularis disseminata,Duplication,GRCh37
na,na,12,65170628,65170629,LEMD3,Pathogenic,Dermatofibrosis lenticularis disseminata,Duplication,GRCh38
na,na,12,65609805,65609805,LEMD3,Pathogenic,Melorheostosis with osteopoikilosis|not provided,single nucleotide variant,GRCh37
na,na,12,65216025,65216025,LEMD3,Pathogenic,Melorheostosis with osteopoikilosis|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,LEMD3,Pathogenic,Osteopoikilosis,Deletion,na
na,na,12,65634715,65634716,LEMD3,Pathogenic,Dermatofibrosis lenticularis disseminata|Osteopoikilosis,Duplication,GRCh37
na,na,12,65240935,65240936,LEMD3,Pathogenic,Dermatofibrosis lenticularis disseminata|Osteopoikilosis,Duplication,GRCh38
na,na,12,65639711,65639711,LEMD3,Pathogenic,Dermatofibrosis lenticularis disseminata,single nucleotide variant,GRCh37
na,na,12,65245931,65245931,LEMD3,Pathogenic,Dermatofibrosis lenticularis disseminata,single nucleotide variant,GRCh38
na,na,12,65633750,65633750,LEMD3,Pathogenic,"Melorheostosis with osteopoikilosis|Dermatofibrosis lenticularis disseminata, isolated|not provided",single nucleotide variant,GRCh37
na,na,12,65239970,65239970,LEMD3,Pathogenic,"Melorheostosis with osteopoikilosis|Dermatofibrosis lenticularis disseminata, isolated|not provided",single nucleotide variant,GRCh38
na,na,12,65564899,65564899,LEMD3,Pathogenic,"Dermatofibrosis lenticularis disseminata, isolated",single nucleotide variant,GRCh37
na,na,12,65171119,65171119,LEMD3,Pathogenic,"Dermatofibrosis lenticularis disseminata, isolated",single nucleotide variant,GRCh38
na,na,12,102173930,102173930,GNPTAB,Likely pathogenic,"Mucolipidosis III alpha/beta, atypical|Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Mucolipidosis type II|Mucolipidosis",single nucleotide variant,GRCh37
na,na,12,101780152,101780152,GNPTAB,Likely pathogenic,"Mucolipidosis III alpha/beta, atypical|Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Mucolipidosis type II|Mucolipidosis",single nucleotide variant,GRCh38
na,na,12,102163863,102163863,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy,single nucleotide variant,GRCh37
na,na,12,101770085,101770085,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy,single nucleotide variant,GRCh38
na,na,12,102183729,102183729,GNPTAB,Pathogenic,Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy,single nucleotide variant,GRCh37
na,na,12,101789951,101789951,GNPTAB,Pathogenic,Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy,single nucleotide variant,GRCh38
na,na,12,102147187,102147187,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy|not provided|Mucolipidosis|GNPTAB-related disorder,single nucleotide variant,GRCh37
na,na,12,101753409,101753409,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy|not provided|Mucolipidosis|GNPTAB-related disorder,single nucleotide variant,GRCh38
na,na,12,102153884,102153884,GNPTAB,Pathogenic,Mucolipidosis type II,single nucleotide variant,GRCh37
na,na,12,101760106,101760106,GNPTAB,Pathogenic,Mucolipidosis type II,single nucleotide variant,GRCh38
na,na,12,102147277,102147278,GNPTAB,Pathogenic,Mucolipidosis type II,Deletion,GRCh37
na,na,12,101753499,101753500,GNPTAB,Pathogenic,Mucolipidosis type II,Deletion,GRCh38
na,na,12,102158014,102158014,GNPTAB,Pathogenic,Mucolipidosis type II|Pseudo-Hurler polydystrophy;Mucolipidosis type II,single nucleotide variant,GRCh37
na,na,12,101764236,101764236,GNPTAB,Pathogenic,Mucolipidosis type II|Pseudo-Hurler polydystrophy;Mucolipidosis type II,single nucleotide variant,GRCh38
na,na,12,102157979,102157979,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Mucolipidosis|Mucolipidosis type II|not provided|GNPTAB-related disorder,single nucleotide variant,GRCh37
na,na,12,101764201,101764201,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Mucolipidosis|Mucolipidosis type II|not provided|GNPTAB-related disorder,single nucleotide variant,GRCh38
na,na,12,102158120,102158121,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy,Microsatellite,GRCh37
na,na,12,101764342,101764343,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy,Microsatellite,GRCh38
na,na,12,102159069,102159070,GNPTAB,Pathogenic,Mucolipidosis type II,Insertion,GRCh37
na,na,12,101765291,101765292,GNPTAB,Pathogenic,Mucolipidosis type II,Insertion,GRCh38
na,na,12,102147248,102147249,GNPTAB,Pathogenic,Mucolipidosis type II|Pseudo-Hurler polydystrophy|not provided|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Inborn genetic diseases|GNPTAB-related disorder,Microsatellite,GRCh37
na,na,12,101753470,101753471,GNPTAB,Pathogenic,Mucolipidosis type II|Pseudo-Hurler polydystrophy|not provided|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Inborn genetic diseases|GNPTAB-related disorder,Microsatellite,GRCh38
na,na,12,102151349,102151349,GNPTAB,Pathogenic,Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy|not provided|Mucolipidosis|Pseudo-Hurler polydystrophy,single nucleotide variant,GRCh37
na,na,12,101757571,101757571,GNPTAB,Pathogenic,Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy|not provided|Mucolipidosis|Pseudo-Hurler polydystrophy,single nucleotide variant,GRCh38
na,na,12,102151344,102151344,GNPTAB,Pathogenic,"Pseudo-Hurler polydystrophy|Mucopolysaccharidosis, MPS-III-A|Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy|not provided",single nucleotide variant,GRCh37
na,na,12,101757566,101757566,GNPTAB,Pathogenic,"Pseudo-Hurler polydystrophy|Mucopolysaccharidosis, MPS-III-A|Mucolipidosis type II|Mucolipidosis type II;Pseudo-Hurler polydystrophy|not provided",single nucleotide variant,GRCh38
na,na,12,102224444,102224444,GNPTAB,Pathogenic,"Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Mucopolysaccharidosis, MPS-III-A",single nucleotide variant,GRCh37
na,na,12,101830666,101830666,GNPTAB,Pathogenic,"Pseudo-Hurler polydystrophy|Mucolipidosis type II;Pseudo-Hurler polydystrophy|Mucopolysaccharidosis, MPS-III-A",single nucleotide variant,GRCh38
na,na,12,102163963,102163963,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II,single nucleotide variant,GRCh37
na,na,12,101770185,101770185,GNPTAB,Pathogenic,Pseudo-Hurler polydystrophy|Mucolipidosis type II,single nucleotide variant,GRCh38
na,na,3,81692142,81692142,GBE1,Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh37
na,na,3,81642991,81642991,GBE1,Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh38
na,na,3,81691938,81691938,GBE1,Pathogenic,"Glycogen storage disease IV, nonprogressive hepatic|Glycogen storage disease, type IV|GBE1-related disorder|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Adult polyglucosan body neuropathy|Adult polyglucosan body disease;Glycogen storage disease, type IV|not provided|Adult polyglucosan body disease|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,3,81642787,81642787,GBE1,Pathogenic,"Glycogen storage disease IV, nonprogressive hepatic|Glycogen storage disease, type IV|GBE1-related disorder|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Adult polyglucosan body neuropathy|Adult polyglucosan body disease;Glycogen storage disease, type IV|not provided|Adult polyglucosan body disease|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,3,81698027,81698027,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, nonprogressive hepatic|Adult polyglucosan body neuropathy|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV;Adult polyglucosan body disease",single nucleotide variant,GRCh37
na,na,3,81648876,81648876,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, nonprogressive hepatic|Adult polyglucosan body neuropathy|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV;Adult polyglucosan body disease",single nucleotide variant,GRCh38
na,na,3,81627151,81627151,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|Inborn genetic diseases|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh37
na,na,3,81578000,81578000,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|Inborn genetic diseases|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh38
na,na,3,81695554,81695554,GBE1,Conflicting classifications of pathogenicity,"Glycogen storage disease IV, classic hepatic|not provided|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV;Adult polyglucosan body disease|not specified",single nucleotide variant,GRCh37
na,na,3,81646403,81646403,GBE1,Conflicting classifications of pathogenicity,"Glycogen storage disease IV, classic hepatic|not provided|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV;Adult polyglucosan body disease|not specified",single nucleotide variant,GRCh38
na,na,3,81627124,81627124,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, classic hepatic|Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form|Glycogen storage disease, type IV|not provided|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Adult polyglucosan body disease;Glycogen storage disease, type IV",single nucleotide variant,GRCh37
na,na,3,81577973,81577973,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, classic hepatic|Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form|Glycogen storage disease, type IV|not provided|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Adult polyglucosan body disease;Glycogen storage disease, type IV",single nucleotide variant,GRCh38
na,na,3,81627123,81627123,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, combined hepatic and myopathic|Glycogen storage disease, type IV|Adult polyglucosan body neuropathy|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh37
na,na,3,81577972,81577972,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease IV, combined hepatic and myopathic|Glycogen storage disease, type IV|Adult polyglucosan body neuropathy|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh38
na,na,3,81586246,81691932,GBE1,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV",Deletion,GRCh37
na,na,3,81537095,81642781,GBE1,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV",Deletion,GRCh38
na,na,3,81810525,81810525,GBE1,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh37
na,na,3,81761374,81761374,GBE1,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh38
na,na,3,81586231,81586231,GBE1,Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh37
na,na,3,81537080,81537080,GBE1,Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic",single nucleotide variant,GRCh38
na,na,3,81586091,81586091,GBE1,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV",single nucleotide variant,GRCh37
na,na,3,81536940,81536940,GBE1,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV",single nucleotide variant,GRCh38
na,na,na,-1,-1,GBE1,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form",Deletion,na
na,na,3,81584397,81584397,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form|Glycogen storage disease, type IV|not provided|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Adult polyglucosan body disease;Glycogen storage disease, type IV",single nucleotide variant,GRCh37
na,na,3,81535246,81535246,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form|Glycogen storage disease, type IV|not provided|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Adult polyglucosan body disease;Glycogen storage disease, type IV",single nucleotide variant,GRCh38
na,na,3,81810630,81810631,GBE1,Pathogenic,"Glycogen storage disease IV, combined hepatic and myopathic",Duplication,GRCh37
na,na,3,81761479,81761480,GBE1,Pathogenic,"Glycogen storage disease IV, combined hepatic and myopathic",Duplication,GRCh38
na,na,3,81695617,81695617,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|not provided|Adult polyglucosan body disease;Glycogen storage disease, type IV|GBE1-related disorder",single nucleotide variant,GRCh37
na,na,3,81646466,81646466,GBE1,Pathogenic/Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease, type IV;Glycogen storage disease IV, classic hepatic|not provided|Adult polyglucosan body disease;Glycogen storage disease, type IV|GBE1-related disorder",single nucleotide variant,GRCh38
na,na,3,81692140,81692140,GBE1,Conflicting classifications of pathogenicity,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Adult polyglucosan body disease|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Glycogen storage disease, type IV",single nucleotide variant,GRCh37
na,na,3,81642989,81642989,GBE1,Conflicting classifications of pathogenicity,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Adult polyglucosan body disease|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV|Glycogen storage disease, type IV",single nucleotide variant,GRCh38
na,na,3,81698002,81698002,GBE1,Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV",single nucleotide variant,GRCh37
na,na,3,81648851,81648851,GBE1,Likely pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic;Glycogen storage disease, type IV",single nucleotide variant,GRCh38
na,na,3,81586222,81586222,GBE1,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV",single nucleotide variant,GRCh37
na,na,3,81537071,81537071,GBE1,Pathogenic,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form|Glycogen storage disease, type IV",single nucleotide variant,GRCh38
na,na,16,1412611,1412611,GNPTG,Pathogenic,GNPTG-mucolipidosis,Deletion,GRCh37
na,na,16,1362610,1362610,GNPTG,Pathogenic,GNPTG-mucolipidosis,Deletion,GRCh38
na,na,16,1412642,1412669,GNPTG,Pathogenic,GNPTG-mucolipidosis,Deletion,GRCh37
na,na,16,1362641,1362668,GNPTG,Pathogenic,GNPTG-mucolipidosis,Deletion,GRCh38
na,na,16,1412054,1412054,GNPTG,Pathogenic,GNPTG-mucolipidosis|not provided,single nucleotide variant,GRCh37
na,na,16,1362053,1362053,GNPTG,Pathogenic,GNPTG-mucolipidosis|not provided,single nucleotide variant,GRCh38
na,na,16,1411955,1411955,GNPTG,Pathogenic/Likely pathogenic,GNPTG-mucolipidosis|not provided,single nucleotide variant,GRCh37
na,na,16,1361954,1361954,GNPTG,Pathogenic/Likely pathogenic,GNPTG-mucolipidosis|not provided,single nucleotide variant,GRCh38
na,na,8,1719290,1719290,CLN8,Pathogenic,Neuronal ceroid lipofuscinosis 8 northern epilepsy variant|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 8|Neuronal ceroid lipofuscinosis 8 northern epilepsy variant;Neuronal ceroid lipofuscinosis 8,single nucleotide variant,GRCh37
na,na,8,1771124,1771124,CLN8,Pathogenic,Neuronal ceroid lipofuscinosis 8 northern epilepsy variant|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 8|Neuronal ceroid lipofuscinosis 8 northern epilepsy variant;Neuronal ceroid lipofuscinosis 8,single nucleotide variant,GRCh38
na,na,8,1728661,1728661,CLN8,Pathogenic,Neuronal ceroid lipofuscinosis 8|not provided|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh37
na,na,8,1780495,1780495,CLN8,Pathogenic,Neuronal ceroid lipofuscinosis 8|not provided|Neuronal ceroid lipofuscinosis,single nucleotide variant,GRCh38
na,na,8,1728482,1728482,CLN8,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 8|Neuronal ceroid lipofuscinosis|not provided|Neuronal ceroid lipofuscinosis 8;Neuronal ceroid lipofuscinosis 8 northern epilepsy variant|CLN8-related disorder,single nucleotide variant,GRCh37
na,na,8,1780316,1780316,CLN8,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 8|Neuronal ceroid lipofuscinosis|not provided|Neuronal ceroid lipofuscinosis 8;Neuronal ceroid lipofuscinosis 8 northern epilepsy variant|CLN8-related disorder,single nucleotide variant,GRCh38
na,na,8,1719308,1719308,CLN8,Pathogenic,Neuronal ceroid lipofuscinosis 8,single nucleotide variant,GRCh37
na,na,8,1771142,1771142,CLN8,Pathogenic,Neuronal ceroid lipofuscinosis 8,single nucleotide variant,GRCh38
na,na,4,79403116,79403116,FRAS1,Pathogenic,Fraser syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,4,78481962,78481962,FRAS1,Pathogenic,Fraser syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,4,79418013,79418013,FRAS1,Pathogenic,Fraser syndrome 1,single nucleotide variant,GRCh37
na,na,4,78496859,78496859,FRAS1,Pathogenic,Fraser syndrome 1,single nucleotide variant,GRCh38
na,na,4,79308679,79308679,FRAS1,Pathogenic,Fraser syndrome 1,single nucleotide variant,GRCh37
na,na,4,78387525,78387525,FRAS1,Pathogenic,Fraser syndrome 1,single nucleotide variant,GRCh38
na,na,4,79328958,79328958,FRAS1,Pathogenic,Fraser syndrome 1,single nucleotide variant,GRCh37
na,na,4,78407804,78407804,FRAS1,Pathogenic,Fraser syndrome 1,single nucleotide variant,GRCh38
na,na,4,79360107,79360112,FRAS1,Pathogenic,Fraser syndrome 1,Deletion,GRCh37
na,na,4,78438953,78438958,FRAS1,Pathogenic,Fraser syndrome 1,Deletion,GRCh38
na,na,4,79385669,79385670,FRAS1,Pathogenic/Likely pathogenic,Fraser syndrome 1|not provided,Duplication,GRCh37
na,na,4,78464515,78464516,FRAS1,Pathogenic/Likely pathogenic,Fraser syndrome 1|not provided,Duplication,GRCh38
na,na,4,79393485,79393485,FRAS1,Pathogenic,Fraser syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,4,78472331,78472331,FRAS1,Pathogenic,Fraser syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,10,64415184,64415184,ZNF365,Benign,"Nephrolithiasis, uric acid, susceptibility to|not provided",single nucleotide variant,GRCh37
na,na,10,62655424,62655424,ZNF365,Benign,"Nephrolithiasis, uric acid, susceptibility to|not provided",single nucleotide variant,GRCh38
na,na,8,100454764,100454765,VPS13B,Pathogenic,Cohen syndrome|not provided,Microsatellite,GRCh37
na,na,8,99442536,99442537,VPS13B,Pathogenic,Cohen syndrome|not provided,Microsatellite,GRCh38
na,na,8,100729447,100729447,VPS13B,Pathogenic,Cohen syndrome,single nucleotide variant,GRCh37
na,na,8,99717219,99717219,VPS13B,Pathogenic,Cohen syndrome,single nucleotide variant,GRCh38
na,na,8,100733201,100733201,VPS13B,Pathogenic,Cohen syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,99720973,99720973,VPS13B,Pathogenic,Cohen syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,100832259,100832259,VPS13B,Conflicting classifications of pathogenicity,Cohen syndrome|not specified|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,8,99820031,99820031,VPS13B,Conflicting classifications of pathogenicity,Cohen syndrome|not specified|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,8,100523503,100523503,VPS13B,Pathogenic,Cohen syndrome,single nucleotide variant,GRCh37
na,na,8,99511275,99511275,VPS13B,Pathogenic,Cohen syndrome,single nucleotide variant,GRCh38
na,na,8,100396522,100396522,VPS13B,Pathogenic,Cohen syndrome|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,8,99384294,99384294,VPS13B,Pathogenic,Cohen syndrome|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,8,100796622,100796622,VPS13B,Pathogenic/Likely pathogenic,Cohen syndrome,single nucleotide variant,GRCh37
na,na,8,99784394,99784394,VPS13B,Pathogenic/Likely pathogenic,Cohen syndrome,single nucleotide variant,GRCh38
na,na,8,100866430,100866430,VPS13B,Pathogenic/Likely pathogenic,Cohen syndrome,single nucleotide variant,GRCh37
na,na,8,99854202,99854202,VPS13B,Pathogenic/Likely pathogenic,Cohen syndrome,single nucleotide variant,GRCh38
na,na,8,100836059,100836060,VPS13B,Pathogenic,Cohen syndrome|not provided|Inborn genetic diseases|VPS13B-related disorder,Duplication,GRCh37
na,na,8,99823831,99823832,VPS13B,Pathogenic,Cohen syndrome|not provided|Inborn genetic diseases|VPS13B-related disorder,Duplication,GRCh38
na,na,8,100830701,100830701,VPS13B,Uncertain significance,Cohen syndrome|Inborn genetic diseases|VPS13B-related disorder|not provided,single nucleotide variant,GRCh37
na,na,8,99818473,99818473,VPS13B,Uncertain significance,Cohen syndrome|Inborn genetic diseases|VPS13B-related disorder|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,VPS13B,Pathogenic,Cohen syndrome,Deletion,na
na,na,na,-1,-1,VPS13B,Pathogenic,Cohen syndrome,Deletion,na
na,na,19,33167360,33167361,RGS9BP,Pathogenic,Bradyopsia,Duplication,GRCh37
na,na,19,32676454,32676455,RGS9BP,Pathogenic,Bradyopsia,Duplication,GRCh38
na,na,11,108017061,108017061,ACAT1,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh37
na,na,11,108146334,108146334,ACAT1,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh38
na,na,11,108009736,108009736,ACAT1,Pathogenic/Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh37
na,na,11,108139009,108139009,ACAT1,Pathogenic/Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh38
na,na,11,108016927,108016927,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase|not provided,single nucleotide variant,GRCh37
na,na,11,108146200,108146200,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase|not provided,single nucleotide variant,GRCh38
na,na,11,108017088,108017088,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh37
na,na,11,108146361,108146361,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh38
na,na,11,107992335,107992335,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh37
na,na,11,108121608,108121608,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh38
na,na,11,108017059,108017059,ACAT1,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh37
na,na,11,108146332,108146332,ACAT1,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh38
na,na,11,108012415,108012415,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase|not provided,single nucleotide variant,GRCh37
na,na,11,108141688,108141688,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase|not provided,single nucleotide variant,GRCh38
na,na,11,108016954,108016956,ACAT1,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,Microsatellite,GRCh37
na,na,11,108146227,108146229,ACAT1,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,Microsatellite,GRCh38
na,na,11,108017005,108017006,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase,Duplication,GRCh37
na,na,11,108146278,108146279,ACAT1,Pathogenic,Deficiency of acetyl-CoA acetyltransferase,Duplication,GRCh38
na,na,11,108004987,108004987,ACAT1,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh37
na,na,11,108134260,108134260,ACAT1,Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh38
na,na,11,108013272,108013272,ACAT1,Pathogenic/Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh37
na,na,11,108142545,108142545,ACAT1,Pathogenic/Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh38
na,na,11,108014766,108014766,ACAT1,Pathogenic/Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh37
na,na,11,108144039,108144039,ACAT1,Pathogenic/Likely pathogenic,Deficiency of acetyl-CoA acetyltransferase,single nucleotide variant,GRCh38
na,na,11,108005967,108005967,ACAT1,Conflicting classifications of pathogenicity,Deficiency of acetyl-CoA acetyltransferase|not specified,single nucleotide variant,GRCh37
na,na,11,108135240,108135240,ACAT1,Conflicting classifications of pathogenicity,Deficiency of acetyl-CoA acetyltransferase|not specified,single nucleotide variant,GRCh38
na,na,2,97428042,97428043,CNNM4,Likely pathogenic,Jalili syndrome|Retinal dystrophy,Duplication,GRCh37
na,na,2,96762305,96762306,CNNM4,Likely pathogenic,Jalili syndrome|Retinal dystrophy,Duplication,GRCh38
na,na,2,97427443,97427443,CNNM4,Pathogenic/Likely pathogenic,Jalili syndrome,single nucleotide variant,GRCh37
na,na,2,96761706,96761706,CNNM4,Pathogenic/Likely pathogenic,Jalili syndrome,single nucleotide variant,GRCh38
na,na,2,97427707,97427707,CNNM4,Pathogenic,Jalili syndrome,single nucleotide variant,GRCh37
na,na,2,96761970,96761970,CNNM4,Pathogenic,Jalili syndrome,single nucleotide variant,GRCh38
na,na,2,97464802,97464802,CNNM4,Pathogenic,Jalili syndrome|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,96799065,96799065,CNNM4,Pathogenic,Jalili syndrome|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,2,97427335,97427335,CNNM4,Pathogenic,Jalili syndrome,single nucleotide variant,GRCh37
na,na,2,96761598,96761598,CNNM4,Pathogenic,Jalili syndrome,single nucleotide variant,GRCh38
na,na,2,97475075,97475075,CNNM4,Pathogenic/Likely pathogenic,Jalili syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,96809338,96809338,CNNM4,Pathogenic/Likely pathogenic,Jalili syndrome|not provided,single nucleotide variant,GRCh38
na,na,2,97426798,97426881,CNNM4,Pathogenic,Jalili syndrome,Deletion,GRCh37
na,na,2,96761061,96761144,CNNM4,Pathogenic,Jalili syndrome,Deletion,GRCh38
na,na,2,215851287,215851287,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4A,single nucleotide variant,GRCh37
na,na,2,214986563,214986563,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4A,single nucleotide variant,GRCh38
na,na,2,215851290,215851290,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4A|not provided|Autosomal recessive congenital ichthyosis 4A;Autosomal recessive congenital ichthyosis 4B,single nucleotide variant,GRCh37
na,na,2,214986566,214986566,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4A|not provided|Autosomal recessive congenital ichthyosis 4A;Autosomal recessive congenital ichthyosis 4B,single nucleotide variant,GRCh38
na,na,2,215843554,215843554,ABCA12,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 4A|Autosomal recessive congenital ichthyosis 4B|not provided,single nucleotide variant,GRCh37
na,na,2,214978830,214978830,ABCA12,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 4A|Autosomal recessive congenital ichthyosis 4B|not provided,single nucleotide variant,GRCh38
na,na,2,215846949,215846949,ABCA12,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 4A|ABCA12-related disorder|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,2,214982225,214982225,ABCA12,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 4A|ABCA12-related disorder|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,2,215845332,215845332,ABCA12,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 4A|not provided|Autosomal recessive congenital ichthyosis 4A;Autosomal recessive congenital ichthyosis 4B,single nucleotide variant,GRCh37
na,na,2,214980608,214980608,ABCA12,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 4A|not provided|Autosomal recessive congenital ichthyosis 4A;Autosomal recessive congenital ichthyosis 4B,single nucleotide variant,GRCh38
na,na,2,215809745,215809745,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4B|not provided|Autosomal recessive congenital ichthyosis 4B;Autosomal recessive congenital ichthyosis 4A,Deletion,GRCh37
na,na,2,214945021,214945021,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4B|not provided|Autosomal recessive congenital ichthyosis 4B;Autosomal recessive congenital ichthyosis 4A,Deletion,GRCh38
na,na,2,215843156,215843156,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4B,Deletion,GRCh37
na,na,2,214978432,214978432,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4B,Deletion,GRCh38
na,na,2,215813331,215813331,ABCA12,Benign/Likely benign,Autosomal recessive congenital ichthyosis 4B|Congenital ichthyosis of skin|not specified|not provided|Autosomal recessive congenital ichthyosis 4B;Autosomal recessive congenital ichthyosis 4A,single nucleotide variant,GRCh37
na,na,2,214948607,214948607,ABCA12,Benign/Likely benign,Autosomal recessive congenital ichthyosis 4B|Congenital ichthyosis of skin|not specified|not provided|Autosomal recessive congenital ichthyosis 4B;Autosomal recessive congenital ichthyosis 4A,single nucleotide variant,GRCh38
na,na,2,215818615,215818615,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4B|Autosomal recessive congenital ichthyosis 4A|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,2,214953891,214953891,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4B|Autosomal recessive congenital ichthyosis 4A|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,2,215855515,215855515,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4B,single nucleotide variant,GRCh37
na,na,2,214990791,214990791,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4B,single nucleotide variant,GRCh38
na,na,2,215896621,215910560,ABCA12,Pathogenic,Autosomal recessive congenital ichthyosis 4B,Deletion,GRCh37
na,na,2,47136157,47136157,MCFD2,Likely pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2|Factor V and factor VIII, combined deficiency of, type 1|MCFD2-related disorder",single nucleotide variant,GRCh37
na,na,2,46909018,46909018,MCFD2,Likely pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2|Factor V and factor VIII, combined deficiency of, type 1|MCFD2-related disorder",single nucleotide variant,GRCh38
na,na,2,47134948,47134948,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",single nucleotide variant,GRCh37
na,na,2,46907809,46907809,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",single nucleotide variant,GRCh38
na,na,2,47136208,47136208,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",Deletion,GRCh37
na,na,2,46909069,46909069,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",Deletion,GRCh38
na,na,2,47135009,47135009,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2|not provided",Deletion,GRCh37
na,na,2,46907870,46907870,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2|not provided",Deletion,GRCh38
na,na,2,47134986,47134993,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",Deletion,GRCh37
na,na,2,46907847,46907854,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",Deletion,GRCh38
na,na,2,47132656,47132656,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",single nucleotide variant,GRCh37
na,na,2,46905517,46905517,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",single nucleotide variant,GRCh38
na,na,2,47132636,47132636,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",single nucleotide variant,GRCh37
na,na,2,46905497,46905497,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",single nucleotide variant,GRCh38
na,na,2,47135017,47135017,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",single nucleotide variant,GRCh37
na,na,2,46907878,46907878,MCFD2,Pathogenic,"Factor 5 and Factor VIII, combined deficiency of, 2",single nucleotide variant,GRCh38
na,na,1,55509689,55509689,PCSK9,Pathogenic/Likely pathogenic,"Hypercholesterolemia, autosomal dominant, 3|Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,1,55044016,55044016,PCSK9,Pathogenic/Likely pathogenic,"Hypercholesterolemia, autosomal dominant, 3|Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,1,55518073,55518073,PCSK9,Pathogenic,"Hypercholesterolemia, autosomal dominant, 3",single nucleotide variant,GRCh37
na,na,1,55052400,55052400,PCSK9,Pathogenic,"Hypercholesterolemia, autosomal dominant, 3",single nucleotide variant,GRCh38
na,na,1,55523127,55523127,PCSK9,Pathogenic/Likely pathogenic,"Hypercholesterolemia, autosomal dominant, 3|Hypercholesterolemia, familial, 1|Cardiovascular phenotype|Homozygous familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,1,55057454,55057454,PCSK9,Pathogenic/Likely pathogenic,"Hypercholesterolemia, autosomal dominant, 3|Hypercholesterolemia, familial, 1|Cardiovascular phenotype|Homozygous familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,1,55512222,55512222,PCSK9,Conflicting classifications of pathogenicity,"Low density lipoprotein cholesterol level quantitative trait locus 1|not provided|Familial hypercholesterolemia|Hypercholesterolemia, autosomal dominant, 3|not specified|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,1,55046549,55046549,PCSK9,Conflicting classifications of pathogenicity,"Low density lipoprotein cholesterol level quantitative trait locus 1|not provided|Familial hypercholesterolemia|Hypercholesterolemia, autosomal dominant, 3|not specified|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,1,55529215,55529215,PCSK9,Conflicting classifications of pathogenicity,"Low density lipoprotein cholesterol level quantitative trait locus 1|Hypocholesterolemia|Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia|not provided|not specified|Cardiovascular phenotype|PCSK9-related disorder",single nucleotide variant,GRCh37
na,na,1,55063542,55063542,PCSK9,Conflicting classifications of pathogenicity,"Low density lipoprotein cholesterol level quantitative trait locus 1|Hypocholesterolemia|Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia|not provided|not specified|Cardiovascular phenotype|PCSK9-related disorder",single nucleotide variant,GRCh38
na,na,1,55505647,55505647,PCSK9,Benign/Likely benign,"Low density lipoprotein cholesterol level quantitative trait locus 1|Hypercholesterolemia, autosomal dominant, 3|Hypercholesterolemia, familial, 1|Hypocholesterolemia|not specified|not provided|Hypobetalipoproteinemia|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,1,55039974,55039974,PCSK9,Benign/Likely benign,"Low density lipoprotein cholesterol level quantitative trait locus 1|Hypercholesterolemia, autosomal dominant, 3|Hypercholesterolemia, familial, 1|Hypocholesterolemia|not specified|not provided|Hypobetalipoproteinemia|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,1,55509593,55509595,PCSK9,Likely benign,"Low density lipoprotein cholesterol level quantitative trait locus 1|Hypercholesterolemia, autosomal dominant, 3",Microsatellite,GRCh37
na,na,1,55043920,55043922,PCSK9,Likely benign,"Low density lipoprotein cholesterol level quantitative trait locus 1|Hypercholesterolemia, autosomal dominant, 3",Microsatellite,GRCh38
na,na,16,30999433,30999434,HSD3B7,Pathogenic,Congenital bile acid synthesis defect 1,Deletion,GRCh37
na,na,16,30988112,30988113,HSD3B7,Pathogenic,Congenital bile acid synthesis defect 1,Deletion,GRCh38
na,na,16,30997494,30997495,HSD3B7,Pathogenic,Congenital bile acid synthesis defect 1|not provided,Duplication,GRCh37
na,na,16,30986173,30986174,HSD3B7,Pathogenic,Congenital bile acid synthesis defect 1|not provided,Duplication,GRCh38
na,na,16,30997526,30997526,HSD3B7,Likely pathogenic,Congenital bile acid synthesis defect 1,single nucleotide variant,GRCh37
na,na,16,30986205,30986205,HSD3B7,Likely pathogenic,Congenital bile acid synthesis defect 1,single nucleotide variant,GRCh38
na,na,16,30997933,30997933,HSD3B7,Pathogenic,Congenital bile acid synthesis defect 1|not provided,single nucleotide variant,GRCh37
na,na,16,30986612,30986612,HSD3B7,Pathogenic,Congenital bile acid synthesis defect 1|not provided,single nucleotide variant,GRCh38
na,na,16,30997024,30997025,HSD3B7,Pathogenic,Congenital bile acid synthesis defect 1|not provided|Congenital bile acid synthesis defect|HSD3B7-related disorder,Deletion,GRCh37
na,na,16,30985703,30985704,HSD3B7,Pathogenic,Congenital bile acid synthesis defect 1|not provided|Congenital bile acid synthesis defect|HSD3B7-related disorder,Deletion,GRCh38
na,na,11,126432745,126432745,KIRREL3,Uncertain significance,"Intellectual disability, autosomal dominant 4",single nucleotide variant,GRCh37
na,na,11,126562850,126562850,KIRREL3,Uncertain significance,"Intellectual disability, autosomal dominant 4",single nucleotide variant,GRCh38
na,na,11,126316772,126316772,KIRREL3,Likely benign,"Intellectual disability, autosomal dominant 4|not provided|KIRREL3-related disorder",single nucleotide variant,GRCh37
na,na,11,126446877,126446877,KIRREL3,Likely benign,"Intellectual disability, autosomal dominant 4|not provided|KIRREL3-related disorder",single nucleotide variant,GRCh38
na,na,11,126294621,126294621,KIRREL3,Uncertain significance,"Intellectual disability, autosomal dominant 4|not provided",single nucleotide variant,GRCh37
na,na,11,126424726,126424726,KIRREL3,Uncertain significance,"Intellectual disability, autosomal dominant 4|not provided",single nucleotide variant,GRCh38
na,na,17,42463074,42463086,ITGA2B,Pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,Deletion,GRCh37
na,na,17,44385706,44385718,ITGA2B,Pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,Deletion,GRCh38
na,na,17,42461576,42466170,ITGA2B,Pathogenic,Glanzmann thrombasthenia 1,Indel,GRCh37
na,na,17,44384208,44388802,ITGA2B,Pathogenic,Glanzmann thrombasthenia 1,Indel,GRCh38
na,na,17,42453065,42453065,ITGA2B,Benign,BAK PLATELET-SPECIFIC ANTIGEN|not specified|Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not provided,single nucleotide variant,GRCh37
na,na,17,44375697,44375697,ITGA2B,Benign,BAK PLATELET-SPECIFIC ANTIGEN|not specified|Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not provided,single nucleotide variant,GRCh38
na,na,17,42457372,42457372,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|Glanzmann thrombasthenia 1;Platelet-type bleeding disorder 16,single nucleotide variant,GRCh37
na,na,17,44380004,44380004,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|Glanzmann thrombasthenia 1;Platelet-type bleeding disorder 16,single nucleotide variant,GRCh38
na,na,17,42453087,42453087,ITGA2B,Likely pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,single nucleotide variant,GRCh37
na,na,17,44375719,44375719,ITGA2B,Likely pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,single nucleotide variant,GRCh38
na,na,17,42461935,42461935,ITGA2B,Likely pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,single nucleotide variant,GRCh37
na,na,17,44384567,44384567,ITGA2B,Likely pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,single nucleotide variant,GRCh38
na,na,17,42457753,42457753,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,single nucleotide variant,GRCh37
na,na,17,44380385,44380385,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,single nucleotide variant,GRCh38
na,na,17,42460998,42460998,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,single nucleotide variant,GRCh37
na,na,17,44383630,44383630,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,single nucleotide variant,GRCh38
na,na,17,42458269,42458274,ITGA2B,Likely pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,Deletion,GRCh37
na,na,17,44380901,44380906,ITGA2B,Likely pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,Deletion,GRCh38
na,na,17,42461008,42461008,ITGA2B,Pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,single nucleotide variant,GRCh37
na,na,17,44383640,44383640,ITGA2B,Pathogenic,Glanzmann thrombasthenia 1|Glanzmann thrombasthenia,single nucleotide variant,GRCh38
na,na,17,42457148,42457148,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not provided|ITGA2B-related disorder,single nucleotide variant,GRCh37
na,na,17,44379780,44379780,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not provided|ITGA2B-related disorder,single nucleotide variant,GRCh38
na,na,17,42462561,42462561,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|Glanzmann thrombasthenia 1;Platelet-type bleeding disorder 16|not provided,single nucleotide variant,GRCh37
na,na,17,44385193,44385193,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|Glanzmann thrombasthenia 1;Platelet-type bleeding disorder 16|not provided,single nucleotide variant,GRCh38
na,na,17,42452100,42452100,ITGA2B,Uncertain significance,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not specified,single nucleotide variant,GRCh37
na,na,17,44374732,44374732,ITGA2B,Uncertain significance,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not specified,single nucleotide variant,GRCh38
na,na,17,42457057,42457057,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,single nucleotide variant,GRCh37
na,na,17,44379689,44379689,ITGA2B,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 1,single nucleotide variant,GRCh38
na,na,7,141673345,141673345,TAS2R38,drug response,Phenylthiocarbamide tasting,single nucleotide variant,GRCh37
na,na,7,141973545,141973545,TAS2R38,drug response,Phenylthiocarbamide tasting,single nucleotide variant,GRCh38
na,na,7,141672705,141672705,TAS2R38,Benign,Phenylthiocarbamide tasting|not provided,single nucleotide variant,GRCh37
na,na,7,141972905,141972905,TAS2R38,Benign,Phenylthiocarbamide tasting|not provided,single nucleotide variant,GRCh38
na,na,7,141672604,141672604,TAS2R38,drug response,Phenylthiocarbamide tasting,single nucleotide variant,GRCh37
na,na,7,141972804,141972804,TAS2R38,drug response,Phenylthiocarbamide tasting,single nucleotide variant,GRCh38
na,na,9,71831283,71831283,TJP2,Pathogenic/Likely pathogenic,"Hypercholanemia, familial 1|Cholestasis, progressive familial intrahepatic, 4|not provided",single nucleotide variant,GRCh37
na,na,9,69216367,69216367,TJP2,Pathogenic/Likely pathogenic,"Hypercholanemia, familial 1|Cholestasis, progressive familial intrahepatic, 4|not provided",single nucleotide variant,GRCh38
na,na,9,606181,831563,KANK1,Pathogenic,"Cerebral palsy, spastic quadriplegic, 2",Deletion,GRCh38
na,na,11,10013316,10014616,SBF2,Pathogenic,Charcot-Marie-Tooth disease type 4B2,Deletion,GRCh37
na,na,11,9991769,9993069,SBF2,Pathogenic,Charcot-Marie-Tooth disease type 4B2,Deletion,GRCh38
na,na,11,9868562,9868562,SBF2,Pathogenic,Charcot-Marie-Tooth disease type 4B2,single nucleotide variant,GRCh37
na,na,11,9847015,9847015,SBF2,Pathogenic,Charcot-Marie-Tooth disease type 4B2,single nucleotide variant,GRCh38
na,na,11,9853837,9853837,SBF2,Pathogenic,Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4B2,single nucleotide variant,GRCh37
na,na,11,9832290,9832290,SBF2,Pathogenic,Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4B2,single nucleotide variant,GRCh38
na,na,11,9990029,9990029,SBF2,Pathogenic,Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4B2|not provided,single nucleotide variant,GRCh37
na,na,11,9968482,9968482,SBF2,Pathogenic,Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4B2|not provided,single nucleotide variant,GRCh38
na,na,17,72919026,72919026,USH1G,Pathogenic,Usher syndrome type 1G,single nucleotide variant,GRCh37
na,na,17,74922931,74922931,USH1G,Pathogenic,Usher syndrome type 1G,single nucleotide variant,GRCh38
na,na,17,72916744,72916745,USH1G,Pathogenic,Usher syndrome type 1G,Deletion,GRCh37
na,na,17,74920649,74920650,USH1G,Pathogenic,Usher syndrome type 1G,Deletion,GRCh38
na,na,17,72916080,72916099,USH1G,Pathogenic,Usher syndrome type 1G|Usher syndrome type 1,Deletion,GRCh37
na,na,17,74919985,74920004,USH1G,Pathogenic,Usher syndrome type 1G|Usher syndrome type 1,Deletion,GRCh38
na,na,17,72916536,72916537,USH1G,Pathogenic,Usher syndrome type 1G|Usher syndrome type 1,Duplication,GRCh37
na,na,17,74920441,74920442,USH1G,Pathogenic,Usher syndrome type 1G|Usher syndrome type 1,Duplication,GRCh38
na,na,17,72919056,72919056,USH1G,Pathogenic,Usher syndrome type 1G|not provided,single nucleotide variant,GRCh37
na,na,17,74922961,74922961,USH1G,Pathogenic,Usher syndrome type 1G|not provided,single nucleotide variant,GRCh38
na,na,9,91963010,91963010,SECISBP2,Conflicting classifications of pathogenicity,"Thyroid hormone metabolism, abnormal 1|SECISBP2-related disorder",single nucleotide variant,GRCh37
na,na,9,89348095,89348095,SECISBP2,Conflicting classifications of pathogenicity,"Thyroid hormone metabolism, abnormal 1|SECISBP2-related disorder",single nucleotide variant,GRCh38
na,na,9,91956271,91956271,SECISBP2,Pathogenic,"Thyroid hormone metabolism, abnormal 1",single nucleotide variant,GRCh37
na,na,9,89341356,89341356,SECISBP2,Pathogenic,"Thyroid hormone metabolism, abnormal 1",single nucleotide variant,GRCh38
na,na,9,91953524,91953524,SECISBP2,Pathogenic,"Thyroid hormone metabolism, abnormal 1",single nucleotide variant,GRCh37
na,na,9,89338609,89338609,SECISBP2,Pathogenic,"Thyroid hormone metabolism, abnormal 1",single nucleotide variant,GRCh38
na,na,5,133956692,133956692,SAR1B,Pathogenic,Chylomicron retention disease,single nucleotide variant,GRCh37
na,na,5,134621002,134621002,SAR1B,Pathogenic,Chylomicron retention disease,single nucleotide variant,GRCh38
na,na,5,133944133,133944133,SAR1B,Pathogenic/Likely pathogenic,Chylomicron retention disease|not provided,single nucleotide variant,GRCh37
na,na,5,134608443,134608443,SAR1B,Pathogenic/Likely pathogenic,Chylomicron retention disease|not provided,single nucleotide variant,GRCh38
na,na,5,133956725,133956726,SAR1B,Pathogenic,Chylomicron retention disease,Deletion,GRCh37
na,na,5,134621035,134621036,SAR1B,Pathogenic,Chylomicron retention disease,Deletion,GRCh38
na,na,5,133942700,133942700,SAR1B,Likely pathogenic,Chylomicron retention disease|SAR1B-related disorder,single nucleotide variant,GRCh37
na,na,5,134607010,134607010,SAR1B,Likely pathogenic,Chylomicron retention disease|SAR1B-related disorder,single nucleotide variant,GRCh38
na,na,5,133942678,133942679,SAR1B,Pathogenic,Chylomicron retention disease,Duplication,GRCh37
na,na,5,134606988,134606989,SAR1B,Pathogenic,Chylomicron retention disease,Duplication,GRCh38
na,na,5,133944194,133944194,SAR1B,Pathogenic,Chylomicron retention disease,single nucleotide variant,GRCh37
na,na,5,134608504,134608504,SAR1B,Pathogenic,Chylomicron retention disease,single nucleotide variant,GRCh38
na,na,5,133944178,133944178,SAR1B,Pathogenic,Chylomicron retention disease,single nucleotide variant,GRCh37
na,na,5,134608488,134608488,SAR1B,Pathogenic,Chylomicron retention disease,single nucleotide variant,GRCh38
na,na,5,133942683,133942683,SAR1B,Pathogenic,Chylomicron retention disease,single nucleotide variant,GRCh37
na,na,5,134606993,134606993,SAR1B,Pathogenic,Chylomicron retention disease,single nucleotide variant,GRCh38
na,na,11,67132964,67132964,CLCF1,Pathogenic,Cold-induced sweating syndrome 2,single nucleotide variant,GRCh37
na,na,11,67365493,67365493,CLCF1,Pathogenic,Cold-induced sweating syndrome 2,single nucleotide variant,GRCh38
na,na,11,67132695,67132695,CLCF1,Pathogenic,Cold-induced sweating syndrome 2,single nucleotide variant,GRCh37
na,na,11,67365224,67365224,CLCF1,Pathogenic,Cold-induced sweating syndrome 2,single nucleotide variant,GRCh38
na,na,12,65130819,65130819,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D|not provided",single nucleotide variant,GRCh37
na,na,12,64737039,64737039,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D|not provided",single nucleotide variant,GRCh38
na,na,12,65122767,65122767,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D",Deletion,GRCh37
na,na,12,64728987,64728987,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D",Deletion,GRCh38
na,na,12,65122768,65122768,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D",single nucleotide variant,GRCh37
na,na,12,64728988,64728988,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D",single nucleotide variant,GRCh38
na,na,12,65122797,65122798,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D",Insertion,GRCh37
na,na,12,64729017,64729018,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D",Insertion,GRCh38
na,na,12,65116867,65116868,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D",Duplication,GRCh37
na,na,12,64723087,64723088,GNS,Pathogenic,"Mucopolysaccharidosis, MPS-III-D",Duplication,GRCh38
na,na,1,70897823,70897824,CTH,Pathogenic,Cystathioninuria,Microsatellite,GRCh37
na,na,1,70432140,70432141,CTH,Pathogenic,Cystathioninuria,Microsatellite,GRCh38
na,na,1,70881670,70881670,CTH,Conflicting classifications of pathogenicity,Cystathioninuria|not provided|CTH-related disorder,single nucleotide variant,GRCh37
na,na,1,70415987,70415987,CTH,Conflicting classifications of pathogenicity,Cystathioninuria|not provided|CTH-related disorder,single nucleotide variant,GRCh38
na,na,1,70896071,70896071,CTH,Pathogenic,Cystathioninuria,single nucleotide variant,GRCh37
na,na,1,70430388,70430388,CTH,Pathogenic,Cystathioninuria,single nucleotide variant,GRCh38
na,na,1,70904800,70904800,CTH,Benign,Homocysteine level elevated|Cystathioninuria|not provided|CTH-related disorder,single nucleotide variant,GRCh37
na,na,1,70439117,70439117,CTH,Benign,Homocysteine level elevated|Cystathioninuria|not provided|CTH-related disorder,single nucleotide variant,GRCh38
na,na,6,108370452,108370452,OSTM1,Pathogenic,Autosomal recessive osteopetrosis 5,single nucleotide variant,GRCh37
na,na,6,108049248,108049248,OSTM1,Pathogenic,Autosomal recessive osteopetrosis 5,single nucleotide variant,GRCh38
na,na,6,108395820,108395820,OSTM1,Pathogenic,Autosomal recessive osteopetrosis 5,single nucleotide variant,GRCh37
na,na,6,108074616,108074616,OSTM1,Pathogenic,Autosomal recessive osteopetrosis 5,single nucleotide variant,GRCh38
na,na,17,79495629,79495629,FSCN2,Conflicting classifications of pathogenicity,Retinitis pigmentosa 30|not provided|Leber congenital amaurosis|Macular degeneration|Retinal dystrophy,Deletion,GRCh37
na,na,17,81528603,81528603,FSCN2,Conflicting classifications of pathogenicity,Retinitis pigmentosa 30|not provided|Leber congenital amaurosis|Macular degeneration|Retinal dystrophy,Deletion,GRCh38
na,na,17,17701522,17701522,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh37
na,na,17,17798208,17798208,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh38
na,na,17,17697708,17697708,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh37
na,na,17,17794394,17794394,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh38
na,na,17,17699034,17699062,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh37
na,na,17,17795720,17795748,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh38
na,na,17,17701685,17701685,RAI1,Benign,Smith-Magenis syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,17798371,17798371,RAI1,Benign,Smith-Magenis syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,17700947,17700947,RAI1,Pathogenic,Smith-Magenis syndrome,single nucleotide variant,GRCh37
na,na,17,17797633,17797633,RAI1,Pathogenic,Smith-Magenis syndrome,single nucleotide variant,GRCh38
na,na,17,17700059,17700059,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh37
na,na,17,17796745,17796745,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh38
na,na,17,17696505,17696523,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh37
na,na,17,17793191,17793209,RAI1,Pathogenic,Smith-Magenis syndrome,Deletion,GRCh38
na,na,3,63898362,63898364,ATXN7,Benign,Spinocerebellar ataxia 7,Microsatellite,GRCh37
na,na,3,63912686,63912688,ATXN7,Benign,Spinocerebellar ataxia 7,Microsatellite,GRCh38
na,na,2,31609391,31609391,XDH,Pathogenic/Likely pathogenic,Hereditary xanthinuria type 1|Xanthinuria type II,single nucleotide variant,GRCh37
na,na,2,31386525,31386525,XDH,Pathogenic/Likely pathogenic,Hereditary xanthinuria type 1|Xanthinuria type II,single nucleotide variant,GRCh38
na,na,2,31587088,31587088,XDH,Pathogenic,Hereditary xanthinuria type 1,Deletion,GRCh37
na,na,2,31364222,31364222,XDH,Pathogenic,Hereditary xanthinuria type 1,Deletion,GRCh38
na,na,2,31620584,31620584,XDH,Pathogenic/Likely pathogenic,Hereditary xanthinuria type 1,single nucleotide variant,GRCh37
na,na,2,31397718,31397718,XDH,Pathogenic/Likely pathogenic,Hereditary xanthinuria type 1,single nucleotide variant,GRCh38
na,na,18,21119787,21119787,NPC1,Pathogenic,"Niemann-Pick disease, type C1",single nucleotide variant,GRCh37
na,na,18,23539823,23539823,NPC1,Pathogenic,"Niemann-Pick disease, type C1",single nucleotide variant,GRCh38
na,na,18,21116775,21116775,NPC1,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,18,23536811,23536811,NPC1,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,18,21115443,21115443,NPC1,Pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C|not provided",single nucleotide variant,GRCh37
na,na,18,23535479,23535479,NPC1,Pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C|not provided",single nucleotide variant,GRCh38
na,na,18,21118573,21118573,NPC1,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type D|Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,18,23538609,23538609,NPC1,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type D|Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,18,21119905,21119905,NPC1,Pathogenic,"Niemann-Pick disease, type C1, adult form",single nucleotide variant,GRCh37
na,na,18,23539941,23539941,NPC1,Pathogenic,"Niemann-Pick disease, type C1, adult form",single nucleotide variant,GRCh38
na,na,18,21116842,21116842,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1, adult form|Niemann-Pick disease, type C1",Deletion,GRCh37
na,na,18,23536878,23536878,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1, adult form|Niemann-Pick disease, type C1",Deletion,GRCh38
na,na,18,21115647,21115647,NPC1,Pathogenic,"Niemann-Pick disease, type C1, juvenile form|Niemann-Pick disease, type C1",single nucleotide variant,GRCh37
na,na,18,23535683,23535683,NPC1,Pathogenic,"Niemann-Pick disease, type C1, juvenile form|Niemann-Pick disease, type C1",single nucleotide variant,GRCh38
na,na,18,21113434,21113434,NPC1,Pathogenic,"Niemann-Pick disease, type C1, juvenile form",single nucleotide variant,GRCh37
na,na,18,23533470,23533470,NPC1,Pathogenic,"Niemann-Pick disease, type C1, juvenile form",single nucleotide variant,GRCh38
na,na,18,21118528,21118528,NPC1,Pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C|6 conditions|Inborn genetic diseases|NPC1-related disorder",single nucleotide variant,GRCh37
na,na,18,23538564,23538564,NPC1,Pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C|6 conditions|Inborn genetic diseases|NPC1-related disorder",single nucleotide variant,GRCh38
na,na,18,21116700,21116700,NPC1,Pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C|Inborn genetic diseases|Sphingomyelin/cholesterol lipidosis|NPC1-related disorder",single nucleotide variant,GRCh37
na,na,18,23536736,23536736,NPC1,Pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C|Inborn genetic diseases|Sphingomyelin/cholesterol lipidosis|NPC1-related disorder",single nucleotide variant,GRCh38
na,na,18,21119357,21119357,NPC1,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type C1",single nucleotide variant,GRCh37
na,na,18,23539393,23539393,NPC1,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type C1",single nucleotide variant,GRCh38
na,na,18,21118573,21118573,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,18,23538609,23538609,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,18,21136400,21136400,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,18,23556436,23556436,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,18,21119382,21119382,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|NPC1-related disorder",single nucleotide variant,GRCh37
na,na,18,23539418,23539418,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|NPC1-related disorder",single nucleotide variant,GRCh38
na,na,18,21116778,21116778,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided",single nucleotide variant,GRCh37
na,na,18,23536814,23536814,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided",single nucleotide variant,GRCh38
na,na,18,21114409,21114409,NPC1,Pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,18,23534445,23534445,NPC1,Pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,18,21141425,21141425,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,18,23561461,23561461,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,na,-1,-1,NPC1,Pathogenic,"Niemann-Pick disease, type C1",single nucleotide variant,na
na,na,18,21118615,21118615,NPC1,Pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,18,23538651,23538651,NPC1,Pathogenic,"Niemann-Pick disease, type C1|not provided|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,18,21113411,21113411,NPC1,Pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C",Deletion,GRCh37
na,na,18,23533447,23533447,NPC1,Pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C",Deletion,GRCh38
na,na,18,21148913,21148913,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,18,23568949,23568949,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,18,21113459,21113462,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|NPC1-related disorder|Niemann-Pick disease, type C",Deletion,GRCh37
na,na,18,23533495,23533498,NPC1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C1|NPC1-related disorder|Niemann-Pick disease, type C",Deletion,GRCh38
na,na,11,6415434,6415434,APBB1;SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A;Niemann-Pick disease, type B|not provided|Niemann-Pick disease, type B|Inborn genetic diseases|SMPD1-related disorder",single nucleotide variant,GRCh37
na,na,11,6394204,6394204,APBB1;SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A;Niemann-Pick disease, type B|not provided|Niemann-Pick disease, type B|Inborn genetic diseases|SMPD1-related disorder",single nucleotide variant,GRCh38
na,na,11,6415676,6415676,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B;Niemann-Pick disease, type A",single nucleotide variant,GRCh37
na,na,11,6394446,6394446,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B;Niemann-Pick disease, type A",single nucleotide variant,GRCh38
na,na,11,6414897,6414897,SMPD1,Pathogenic,"Niemann-Pick disease, type B",single nucleotide variant,GRCh37
na,na,11,6393667,6393667,SMPD1,Pathogenic,"Niemann-Pick disease, type B",single nucleotide variant,GRCh38
na,na,11,6413083,6413083,SMPD1,Pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B;Niemann-Pick disease, type A",single nucleotide variant,GRCh37
na,na,11,6391853,6391853,SMPD1,Pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B;Niemann-Pick disease, type A",single nucleotide variant,GRCh38
na,na,11,6414506,6414506,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|not provided|Sphingomyelin/cholesterol lipidosis",single nucleotide variant,GRCh37
na,na,11,6393276,6393276,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|not provided|Sphingomyelin/cholesterol lipidosis",single nucleotide variant,GRCh38
na,na,11,6413025,6413025,SMPD1,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type B|not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A;Niemann-Pick disease, type B|not specified|Niemann-Pick disease, type A",single nucleotide variant,GRCh37
na,na,11,6391795,6391795,SMPD1,Conflicting classifications of pathogenicity,"Niemann-Pick disease, type B|not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A;Niemann-Pick disease, type B|not specified|Niemann-Pick disease, type A",single nucleotide variant,GRCh38
na,na,11,6414508,6414508,SMPD1,Likely pathogenic,"Niemann-Pick disease, type B|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A;Niemann-Pick disease, type B",single nucleotide variant,GRCh37
na,na,11,6393278,6393278,SMPD1,Likely pathogenic,"Niemann-Pick disease, type B|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A;Niemann-Pick disease, type B",single nucleotide variant,GRCh38
na,na,11,6413206,6413206,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B|Niemann-Pick disease, type A;Niemann-Pick disease, type B",single nucleotide variant,GRCh37
na,na,11,6391976,6391976,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B|Niemann-Pick disease, type A;Niemann-Pick disease, type B",single nucleotide variant,GRCh38
na,na,11,6413286,6413286,SMPD1,Pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|not provided|Niemann-Pick disease, type A;Niemann-Pick disease, type B|Niemann-Pick disease, type B|Acid sphingomyelinase deficiency",Deletion,GRCh37
na,na,11,6392056,6392056,SMPD1,Pathogenic,"Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|not provided|Niemann-Pick disease, type A;Niemann-Pick disease, type B|Niemann-Pick disease, type B|Acid sphingomyelinase deficiency",Deletion,GRCh38
na,na,11,6414531,6414531,SMPD1,Pathogenic,"Niemann-pick disease, intermediate, protracted neurovisceral|Niemann-Pick disease, type A|Niemann-Pick disease, type B;Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|not provided",single nucleotide variant,GRCh37
na,na,11,6393301,6393301,SMPD1,Pathogenic,"Niemann-pick disease, intermediate, protracted neurovisceral|Niemann-Pick disease, type A|Niemann-Pick disease, type B;Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|not provided",single nucleotide variant,GRCh38
na,na,11,6414850,6414850,SMPD1,Pathogenic,"Niemann-Pick disease, type B|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A|Niemann-Pick disease, type A;Niemann-Pick disease, type B|not provided",single nucleotide variant,GRCh37
na,na,11,6393620,6393620,SMPD1,Pathogenic,"Niemann-Pick disease, type B|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A|Niemann-Pick disease, type A;Niemann-Pick disease, type B|not provided",single nucleotide variant,GRCh38
na,na,11,6414910,6414910,SMPD1,Pathogenic,"Niemann-Pick disease, type B|Niemann-Pick disease, type A;Niemann-Pick disease, type B|Niemann-Pick disease, type A|not provided|not specified|Sphingomyelin/cholesterol lipidosis",single nucleotide variant,GRCh37
na,na,11,6393680,6393680,SMPD1,Pathogenic,"Niemann-Pick disease, type B|Niemann-Pick disease, type A;Niemann-Pick disease, type B|Niemann-Pick disease, type A|not provided|not specified|Sphingomyelin/cholesterol lipidosis",single nucleotide variant,GRCh38
na,na,11,6413175,6413175,SMPD1,Pathogenic,"Niemann-Pick disease, type B|Niemann-pick disease, intermediate, protracted neurovisceral|Niemann-Pick disease, type A|not specified|Niemann-Pick disease, type B;Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Inborn genetic diseases|not provided",single nucleotide variant,GRCh37
na,na,11,6391945,6391945,SMPD1,Pathogenic,"Niemann-Pick disease, type B|Niemann-pick disease, intermediate, protracted neurovisceral|Niemann-Pick disease, type A|not specified|Niemann-Pick disease, type B;Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Inborn genetic diseases|not provided",single nucleotide variant,GRCh38
na,na,11,6415236,6415236,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|not specified|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B|Niemann-Pick disease, type B;Niemann-Pick disease, type A",single nucleotide variant,GRCh37
na,na,11,6394006,6394006,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type A|not specified|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type B|Niemann-Pick disease, type B;Niemann-Pick disease, type A",single nucleotide variant,GRCh38
na,na,11,6415191,6415191,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type B;Niemann-Pick disease, type A|Niemann-Pick disease, type A",single nucleotide variant,GRCh37
na,na,11,6393961,6393961,SMPD1,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type B;Niemann-Pick disease, type A|Niemann-Pick disease, type A",single nucleotide variant,GRCh38
na,na,17,39727758,39727758,KRT9,Pathogenic/Likely pathogenic,"Palmoplantar keratoderma, epidermolytic|not provided|Palmoplantar keratoderma|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571506,41571506,KRT9,Pathogenic/Likely pathogenic,"Palmoplantar keratoderma, epidermolytic|not provided|Palmoplantar keratoderma|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727730,39727730,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571478,41571478,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727764,39727764,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571512,41571512,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727762,39727762,KRT9,Likely pathogenic,"Palmoplantar keratoderma, epidermolytic|not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571510,41571510,KRT9,Likely pathogenic,"Palmoplantar keratoderma, epidermolytic|not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727757,39727757,KRT9,Pathogenic/Likely pathogenic,"Palmoplantar keratoderma, epidermolytic|not provided|Inborn genetic diseases|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571505,41571505,KRT9,Pathogenic/Likely pathogenic,"Palmoplantar keratoderma, epidermolytic|not provided|Inborn genetic diseases|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727776,39727776,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571524,41571524,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727763,39727763,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571511,41571511,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727742,39727742,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571490,41571490,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727767,39727767,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571515,41571515,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727775,39727775,KRT9,Uncertain significance,"Palmoplantar keratoderma, epidermolytic|not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571523,41571523,KRT9,Uncertain significance,"Palmoplantar keratoderma, epidermolytic|not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727734,39727734,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571482,41571482,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727767,39727767,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571515,41571515,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,17,39727763,39727763,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh37
na,na,17,41571511,41571511,KRT9,Pathogenic,"not provided|Epidermolytic palmoplantar keratoderma, 1",single nucleotide variant,GRCh38
na,na,9,2718166,2718166,KCNV2,Pathogenic/Likely pathogenic,Cone dystrophy with supernormal rod response|not provided|KCNV2-related disorder,single nucleotide variant,GRCh37
na,na,9,2718166,2718166,KCNV2,Pathogenic/Likely pathogenic,Cone dystrophy with supernormal rod response|not provided|KCNV2-related disorder,single nucleotide variant,GRCh38
na,na,9,2718655,2718655,KCNV2,Pathogenic,Cone dystrophy with supernormal rod response,single nucleotide variant,GRCh37
na,na,9,2718655,2718655,KCNV2,Pathogenic,Cone dystrophy with supernormal rod response,single nucleotide variant,GRCh38
na,na,9,2729465,2729465,KCNV2,Pathogenic,Cone dystrophy with supernormal rod response,single nucleotide variant,GRCh37
na,na,9,2729465,2729465,KCNV2,Pathogenic,Cone dystrophy with supernormal rod response,single nucleotide variant,GRCh38
na,na,9,2718746,2718754,KCNV2,Uncertain significance,Cone dystrophy with supernormal rod response|not provided,Microsatellite,GRCh37
na,na,9,2718746,2718754,KCNV2,Uncertain significance,Cone dystrophy with supernormal rod response|not provided,Microsatellite,GRCh38
na,na,9,2718506,2718506,KCNV2,Pathogenic,Cone dystrophy with supernormal rod response,single nucleotide variant,GRCh37
na,na,9,2718506,2718506,KCNV2,Pathogenic,Cone dystrophy with supernormal rod response,single nucleotide variant,GRCh38
na,na,4,122768628,122768628,BBS7,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 7|Bardet-Biedl syndrome|not provided|BBS7-related disorder|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,4,121847473,121847473,BBS7,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 7|Bardet-Biedl syndrome|not provided|BBS7-related disorder|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,4,122775945,122775945,BBS7,Pathogenic,"Bardet-Biedl syndrome 1/7, digenic|Bardet-Biedl syndrome|Bardet-Biedl syndrome 7|BBS7-related disorder",single nucleotide variant,GRCh37
na,na,4,121854790,121854790,BBS7,Pathogenic,"Bardet-Biedl syndrome 1/7, digenic|Bardet-Biedl syndrome|Bardet-Biedl syndrome 7|BBS7-related disorder",single nucleotide variant,GRCh38
na,na,4,122775865,122775868,BBS7,Pathogenic,Bardet-Biedl syndrome 7,Deletion,GRCh37
na,na,4,121854710,121854713,BBS7,Pathogenic,Bardet-Biedl syndrome 7,Deletion,GRCh38
na,na,11,108216624,108216626,ATM,Pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast,Microsatellite,GRCh37
na,na,11,108345897,108345899,ATM,Pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast,Microsatellite,GRCh38
na,na,11,108202612,108202620,ATM,Pathogenic/Likely pathogenic,T-cell prolymphocytic leukemia|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Breast neoplasm|Familial cancer of breast|Malignant tumor of breast|Breast and/or ovarian cancer|ATM-related disorder,Deletion,GRCh37
na,na,11,108331885,108331893,ATM,Pathogenic/Likely pathogenic,T-cell prolymphocytic leukemia|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Breast neoplasm|Familial cancer of breast|Malignant tumor of breast|Breast and/or ovarian cancer|ATM-related disorder,Deletion,GRCh38
na,na,11,108199937,108199942,ATM,Pathogenic,Ataxia-telangiectasia syndrome,Deletion,GRCh37
na,na,11,108329210,108329215,ATM,Pathogenic,Ataxia-telangiectasia syndrome,Deletion,GRCh38
na,na,11,108179837,108179837,ATM,Pathogenic,Ataxia - telangiectasia variant|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Ataxia-telangiectasia syndrome;Familial cancer of breast|Familial cancer of breast|Breast and/or ovarian cancer|ATM-related cancer predisposition|Familial colorectal cancer type X|ATM-related disorder,single nucleotide variant,GRCh37
na,na,11,108309110,108309110,ATM,Pathogenic,Ataxia - telangiectasia variant|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Ataxia-telangiectasia syndrome;Familial cancer of breast|Familial cancer of breast|Breast and/or ovarian cancer|ATM-related cancer predisposition|Familial colorectal cancer type X|ATM-related disorder,single nucleotide variant,GRCh38
na,na,11,108216531,108216531,ATM,Likely pathogenic,Ataxia - telangiectasia variant|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Familial cancer of breast|ATM-related cancer predisposition,single nucleotide variant,GRCh37
na,na,11,108345804,108345804,ATM,Likely pathogenic,Ataxia - telangiectasia variant|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Familial cancer of breast|ATM-related cancer predisposition,single nucleotide variant,GRCh38
na,na,11,108199929,108199929,ATM,Pathogenic,"T-cell prolymphocytic leukemia|Breast cancer, susceptibility to|Ataxia - telangiectasia variant|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|Ataxia-telangiectasia syndrome;Familial cancer of breast|not provided|Breast neoplasm|Familial cancer of breast|Breast and/or ovarian cancer|ATM-related disorder|Inherited breast cancer and ovarian cancer|NICE approved PARP inhibitor treatment",single nucleotide variant,GRCh37
na,na,11,108329202,108329202,ATM,Pathogenic,"T-cell prolymphocytic leukemia|Breast cancer, susceptibility to|Ataxia - telangiectasia variant|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|Ataxia-telangiectasia syndrome;Familial cancer of breast|not provided|Breast neoplasm|Familial cancer of breast|Breast and/or ovarian cancer|ATM-related disorder|Inherited breast cancer and ovarian cancer|NICE approved PARP inhibitor treatment",single nucleotide variant,GRCh38
na,na,11,108098533,108098533,ATM,Pathogenic/Likely pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast;Ataxia-telangiectasia syndrome|Familial cancer of breast|See cases|ATM-related disorder,single nucleotide variant,GRCh37
na,na,11,108227806,108227806,ATM,Pathogenic/Likely pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast;Ataxia-telangiectasia syndrome|Familial cancer of breast|See cases|ATM-related disorder,single nucleotide variant,GRCh38
na,na,11,108170479,108170479,ATM,Uncertain significance,T-cell prolymphocytic leukemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,11,108299752,108299752,ATM,Uncertain significance,T-cell prolymphocytic leukemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,11,108143299,108143299,ATM,Benign,B-cell non-Hodgkin lymphoma|not specified|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Familial cancer of breast,single nucleotide variant,GRCh37
na,na,11,108272572,108272572,ATM,Benign,B-cell non-Hodgkin lymphoma|not specified|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Familial cancer of breast,single nucleotide variant,GRCh38
na,na,11,108204652,108204652,ATM,Likely pathogenic,Ataxia-telangiectasia without immunodeficiency|not provided,single nucleotide variant,GRCh37
na,na,11,108333925,108333925,ATM,Likely pathogenic,Ataxia-telangiectasia without immunodeficiency|not provided,single nucleotide variant,GRCh38
na,na,11,108236203,108236203,ATM,Pathogenic,Ataxia-telangiectasia without immunodeficiency|Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Ataxia-telangiectasia syndrome;Familial cancer of breast|Malignant tumor of urinary bladder|ATM-related cancer predisposition,single nucleotide variant,GRCh37
na,na,11,108365476,108365476,ATM,Pathogenic,Ataxia-telangiectasia without immunodeficiency|Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Ataxia-telangiectasia syndrome;Familial cancer of breast|Malignant tumor of urinary bladder|ATM-related cancer predisposition,single nucleotide variant,GRCh38
na,na,11,108203575,108203576,ATM,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Familial cancer of breast,Indel,GRCh37
na,na,11,108332848,108332849,ATM,Pathogenic/Likely pathogenic,Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided|Familial cancer of breast,Indel,GRCh38
na,na,11,108143540,108143542,ATM,Pathogenic,"Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast;Ataxia-telangiectasia syndrome|Familial cancer of breast|Breast cancer, susceptibility to;Ataxia-telangiectasia syndrome|ATM-related disorder",Indel,GRCh37
na,na,11,108272813,108272815,ATM,Pathogenic,"Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast;Ataxia-telangiectasia syndrome|Familial cancer of breast|Breast cancer, susceptibility to;Ataxia-telangiectasia syndrome|ATM-related disorder",Indel,GRCh38
na,na,11,108204673,108204676,ATM,Pathogenic,Ataxia-telangiectasia syndrome,Deletion,GRCh37
na,na,11,108333946,108333949,ATM,Pathogenic,Ataxia-telangiectasia syndrome,Deletion,GRCh38
na,na,11,108151895,108151895,ATM,Pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Familial cancer of breast|Malignant tumor of pancreas|ATM-related cancer predisposition|Familial cancer of breast;Ataxia-telangiectasia syndrome,single nucleotide variant,GRCh37
na,na,11,108281168,108281168,ATM,Pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Familial cancer of breast|Malignant tumor of pancreas|ATM-related cancer predisposition|Familial cancer of breast;Ataxia-telangiectasia syndrome,single nucleotide variant,GRCh38
na,na,11,108200960,108200960,ATM,Pathogenic,Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Carcinoma of pancreas|Familial cancer of breast|Tip-toe gait|See cases|Hereditary breast ovarian cancer syndrome|Neoplasm|ATM-related cancer predisposition,single nucleotide variant,GRCh37
na,na,11,108330233,108330233,ATM,Pathogenic,Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Carcinoma of pancreas|Familial cancer of breast|Tip-toe gait|See cases|Hereditary breast ovarian cancer syndrome|Neoplasm|ATM-related cancer predisposition,single nucleotide variant,GRCh38
na,na,11,108218094,108218095,ATM,Pathogenic,Familial cancer of breast|Papillary renal cell carcinoma type 1,Insertion,GRCh37
na,na,11,108347367,108347368,ATM,Pathogenic,Familial cancer of breast|Papillary renal cell carcinoma type 1,Insertion,GRCh38
na,na,11,108119654,108119654,ATM,Benign,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast|Familial cancer of breast;Ataxia-telangiectasia syndrome,single nucleotide variant,GRCh37
na,na,11,108248927,108248927,ATM,Benign,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast|Familial cancer of breast;Ataxia-telangiectasia syndrome,single nucleotide variant,GRCh38
na,na,11,108199926,108199926,ATM,Uncertain significance,Mantle cell lymphoma|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,11,108329199,108329199,ATM,Uncertain significance,Mantle cell lymphoma|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,11,108199908,108199909,ATM,Pathogenic,Mantle cell lymphoma,Duplication,GRCh37
na,na,11,108329181,108329182,ATM,Pathogenic,Mantle cell lymphoma,Duplication,GRCh38
na,na,11,108158414,108158414,ATM,Pathogenic,Mantle cell lymphoma|Ataxia-telangiectasia syndrome|Familial cancer of breast,single nucleotide variant,GRCh37
na,na,11,108287687,108287687,ATM,Pathogenic,Mantle cell lymphoma|Ataxia-telangiectasia syndrome|Familial cancer of breast,single nucleotide variant,GRCh38
na,na,11,108172506,108172506,ATM,Pathogenic,T-cell prolymphocytic leukemia|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast,single nucleotide variant,GRCh37
na,na,11,108301779,108301779,ATM,Pathogenic,T-cell prolymphocytic leukemia|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast,single nucleotide variant,GRCh38
na,na,11,108141210,108141213,ATM,Pathogenic/Likely pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|ATM-related cancer predisposition,Deletion,GRCh37
na,na,11,108270483,108270486,ATM,Pathogenic/Likely pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|ATM-related cancer predisposition,Deletion,GRCh38
na,na,11,108127067,108127067,ATM,Pathogenic/Likely pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast;Ataxia-telangiectasia syndrome|Malignant tumor of breast|Familial cancer of breast,single nucleotide variant,GRCh37
na,na,11,108256340,108256340,ATM,Pathogenic/Likely pathogenic,Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast;Ataxia-telangiectasia syndrome|Malignant tumor of breast|Familial cancer of breast,single nucleotide variant,GRCh38
na,na,11,108205715,108205715,ATM,Likely pathogenic,Ataxia - telangiectasia variant|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast,single nucleotide variant,GRCh37
na,na,11,108334988,108334988,ATM,Likely pathogenic,Ataxia - telangiectasia variant|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast,single nucleotide variant,GRCh38
na,na,11,108106566,108106566,ATM,Pathogenic/Likely pathogenic,Ataxia - telangiectasia variant|not provided|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast,single nucleotide variant,GRCh37
na,na,11,108235839,108235839,ATM,Pathogenic/Likely pathogenic,Ataxia - telangiectasia variant|not provided|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast,single nucleotide variant,GRCh38
na,na,11,108098576,108098576,ATM,Benign,"Breast cancer, susceptibility to|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Tip-toe gait|Malignant tumor of breast|Hereditary breast ovarian cancer syndrome",single nucleotide variant,GRCh37
na,na,11,108227849,108227849,ATM,Benign,"Breast cancer, susceptibility to|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Tip-toe gait|Malignant tumor of breast|Hereditary breast ovarian cancer syndrome",single nucleotide variant,GRCh38
na,na,22,51063477,51063477,ARSA,Benign; other,ARYLSULFATASE A PSEUDODEFICIENCY|Metachromatic leukodystrophy|not provided|not specified,single nucleotide variant,GRCh37
na,na,22,50625049,50625049,ARSA,Benign; other,ARYLSULFATASE A PSEUDODEFICIENCY|Metachromatic leukodystrophy|not provided|not specified,single nucleotide variant,GRCh38
na,na,22,51064416,51064416,ARSA,Benign/Likely benign; other,"Metachromatic leukodystrophy|not provided|not specified|Metachromatic leukodystrophy, juvenile type",single nucleotide variant,GRCh37
na,na,22,50625988,50625988,ARSA,Benign/Likely benign; other,"Metachromatic leukodystrophy|not provided|not specified|Metachromatic leukodystrophy, juvenile type",single nucleotide variant,GRCh38
na,na,22,51065593,51065593,ARSA,Pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy|not provided|Intellectual disability|Inborn genetic diseases|See cases|Neurodevelopmental disorder|ARSA-related disorder",single nucleotide variant,GRCh37
na,na,22,50627165,50627165,ARSA,Pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy|not provided|Intellectual disability|Inborn genetic diseases|See cases|Neurodevelopmental disorder|ARSA-related disorder",single nucleotide variant,GRCh38
na,na,22,51063820,51063820,ARSA,Pathogenic,"Metachromatic leukodystrophy, juvenile type||Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|not provided|Intellectual disability|See cases|ARSA-related disorder",single nucleotide variant,GRCh37
na,na,22,50625392,50625392,ARSA,Pathogenic,"Metachromatic leukodystrophy, juvenile type||Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|not provided|Intellectual disability|See cases|ARSA-related disorder",single nucleotide variant,GRCh38
na,na,22,51065757,51065757,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh37
na,na,22,50627329,50627329,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh38
na,na,22,51065766,51065766,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, late infantile form|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh37
na,na,22,50627338,50627338,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, late infantile form|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh38
na,na,22,51065404,51065404,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,22,50626976,50626976,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,22,51064006,51064006,ARSA,Pathogenic,"Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh37
na,na,22,50625578,50625578,ARSA,Pathogenic,"Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh38
na,na,22,51064630,51064630,ARSA,Conflicting classifications of pathogenicity,"Metachromatic leukodystrophy, late infantile form|PSEUDOARYLSULFATASE A DEFICIENCY|Metachromatic leukodystrophy|Abnormality of the nervous system|not provided",single nucleotide variant,GRCh37
na,na,22,50626202,50626202,ARSA,Conflicting classifications of pathogenicity,"Metachromatic leukodystrophy, late infantile form|PSEUDOARYLSULFATASE A DEFICIENCY|Metachromatic leukodystrophy|Abnormality of the nervous system|not provided",single nucleotide variant,GRCh38
na,na,22,51065796,51065796,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy",single nucleotide variant,GRCh37
na,na,22,50627368,50627368,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy",single nucleotide variant,GRCh38
na,na,22,51065766,51065767,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|not provided",Indel,GRCh37
na,na,22,50627338,50627339,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|not provided",Indel,GRCh38
na,na,22,51065689,51065689,ARSA,Conflicting classifications of pathogenicity,Metachromatic leukodystrophy|not provided|Inborn genetic diseases|ARSA-related disorder,single nucleotide variant,GRCh37
na,na,22,50627261,50627261,ARSA,Conflicting classifications of pathogenicity,Metachromatic leukodystrophy|not provided|Inborn genetic diseases|ARSA-related disorder,single nucleotide variant,GRCh38
na,na,22,51065646,51065646,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy",single nucleotide variant,GRCh37
na,na,22,50627218,50627218,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy",single nucleotide variant,GRCh38
na,na,na,-1,-1,ARSA,Pathogenic,Metachromatic leukodystrophy,Deletion,na
na,na,22,51065479,51065479,ARSA,Likely pathogenic,Metachromatic leukodystrophy,single nucleotide variant,GRCh37
na,na,22,50627051,50627051,ARSA,Likely pathogenic,Metachromatic leukodystrophy,single nucleotide variant,GRCh38
na,na,22,51065476,51065476,ARSA,Pathogenic,ARYLSULFATASE A PSEUDODEFICIENCY,single nucleotide variant,GRCh37
na,na,22,50627048,50627048,ARSA,Pathogenic,ARYLSULFATASE A PSEUDODEFICIENCY,single nucleotide variant,GRCh38
na,na,22,51065440,51065440,ARSA,Uncertain significance,Metachromatic leukodystrophy,single nucleotide variant,GRCh37
na,na,22,50627012,50627012,ARSA,Uncertain significance,Metachromatic leukodystrophy,single nucleotide variant,GRCh38
na,na,22,51065435,51065435,ARSA,Conflicting classifications of pathogenicity,ARYLSULFATASE A PSEUDODEFICIENCY|not specified|not provided|Metachromatic leukodystrophy|Intellectual disability,single nucleotide variant,GRCh37
na,na,22,50627007,50627007,ARSA,Conflicting classifications of pathogenicity,ARYLSULFATASE A PSEUDODEFICIENCY|not specified|not provided|Metachromatic leukodystrophy|Intellectual disability,single nucleotide variant,GRCh38
na,na,22,51065305,51065305,ARSA,Pathogenic,Metachromatic leukodystrophy|not provided,single nucleotide variant,GRCh37
na,na,22,50626877,50626877,ARSA,Pathogenic,Metachromatic leukodystrophy|not provided,single nucleotide variant,GRCh38
na,na,22,51065269,51065269,ARSA,Conflicting classifications of pathogenicity,Metachromatic leukodystrophy|not provided,single nucleotide variant,GRCh37
na,na,22,50626841,50626841,ARSA,Conflicting classifications of pathogenicity,Metachromatic leukodystrophy|not provided,single nucleotide variant,GRCh38
na,na,22,51065176,51065176,ARSA,Uncertain significance,Metachromatic leukodystrophy|not specified,single nucleotide variant,GRCh37
na,na,22,50626748,50626748,ARSA,Uncertain significance,Metachromatic leukodystrophy|not specified,single nucleotide variant,GRCh38
na,na,22,51065137,51065137,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy|Metachromatic leukodystrophy, juvenile type",single nucleotide variant,GRCh37
na,na,22,50626709,50626709,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy|Metachromatic leukodystrophy, juvenile type",single nucleotide variant,GRCh38
na,na,22,51065134,51065134,ARSA,Pathogenic/Likely pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh37
na,na,22,50626706,50626706,ARSA,Pathogenic/Likely pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh38
na,na,22,51065046,51065046,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided|ARSA-related disorder",single nucleotide variant,GRCh37
na,na,22,50626618,50626618,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided|ARSA-related disorder",single nucleotide variant,GRCh38
na,na,22,51064693,51064693,ARSA,Pathogenic,Metachromatic leukodystrophy|Spastic ataxia|not provided,single nucleotide variant,GRCh37
na,na,22,50626265,50626265,ARSA,Pathogenic,Metachromatic leukodystrophy|Spastic ataxia|not provided,single nucleotide variant,GRCh38
na,na,22,51064671,51064671,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy",single nucleotide variant,GRCh37
na,na,22,50626243,50626243,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy",single nucleotide variant,GRCh38
na,na,22,51064582,51064582,ARSA,Pathogenic,ARYLSULFATASE A PSEUDODEFICIENCY,single nucleotide variant,GRCh37
na,na,22,50626154,50626154,ARSA,Pathogenic,ARYLSULFATASE A PSEUDODEFICIENCY,single nucleotide variant,GRCh38
na,na,22,51064461,51064461,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided|Leukodystrophy",single nucleotide variant,GRCh37
na,na,22,50626033,50626033,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided|Leukodystrophy",single nucleotide variant,GRCh38
na,na,22,51064103,51064103,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh37
na,na,22,50625675,50625675,ARSA,Pathogenic,"METACHROMATIC LEUKODYSTROPHY, SEVERE|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh38
na,na,22,51064102,51064102,ARSA,Pathogenic/Likely pathogenic,"METACHROMATIC LEUKODYSTROPHY, MILD|Metachromatic leukodystrophy",single nucleotide variant,GRCh37
na,na,22,50625674,50625674,ARSA,Pathogenic/Likely pathogenic,"METACHROMATIC LEUKODYSTROPHY, MILD|Metachromatic leukodystrophy",single nucleotide variant,GRCh38
na,na,22,51064081,51064081,ARSA,Pathogenic,"ARYLSULFATASE A PSEUDODEFICIENCY, SEVERE|not provided|Metachromatic leukodystrophy",single nucleotide variant,GRCh37
na,na,22,50625653,50625653,ARSA,Pathogenic,"ARYLSULFATASE A PSEUDODEFICIENCY, SEVERE|not provided|Metachromatic leukodystrophy",single nucleotide variant,GRCh38
na,na,22,51064067,51064067,ARSA,Pathogenic/Likely pathogenic,"ARYLSULFATASE A PSEUDODEFICIENCY, INTERMEDIATE|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh37
na,na,22,50625639,50625639,ARSA,Pathogenic/Likely pathogenic,"ARYLSULFATASE A PSEUDODEFICIENCY, INTERMEDIATE|Metachromatic leukodystrophy|not provided",single nucleotide variant,GRCh38
na,na,22,51064043,51064043,ARSA,Conflicting classifications of pathogenicity,Metachromatic leukodystrophy|not provided,single nucleotide variant,GRCh37
na,na,22,50625615,50625615,ARSA,Conflicting classifications of pathogenicity,Metachromatic leukodystrophy|not provided,single nucleotide variant,GRCh38
na,na,22,51064014,51064016,ARSA,Pathogenic,Metachromatic leukodystrophy,Microsatellite,GRCh37
na,na,22,50625586,50625588,ARSA,Pathogenic,Metachromatic leukodystrophy,Microsatellite,GRCh38
na,na,22,51063871,51063871,ARSA,Pathogenic/Likely pathogenic,"METACHROMATIC LEUKODYSTROPHY, MILD|Metachromatic leukodystrophy",single nucleotide variant,GRCh37
na,na,22,50625443,50625443,ARSA,Pathogenic/Likely pathogenic,"METACHROMATIC LEUKODYSTROPHY, MILD|Metachromatic leukodystrophy",single nucleotide variant,GRCh38
na,na,22,51063641,51063641,ARSA,Pathogenic,ARYLSULFATASE A PSEUDODEFICIENCY,single nucleotide variant,GRCh37
na,na,22,50625213,50625213,ARSA,Pathogenic,ARYLSULFATASE A PSEUDODEFICIENCY,single nucleotide variant,GRCh38
na,na,22,51065649,51065649,ARSA,Pathogenic,"Metachromatic leukodystrophy, adult type",single nucleotide variant,GRCh37
na,na,22,50627221,50627221,ARSA,Pathogenic,"Metachromatic leukodystrophy, adult type",single nucleotide variant,GRCh38
na,na,22,51064699,51064699,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|ARSA-related disorder",single nucleotide variant,GRCh37
na,na,22,50626271,50626271,ARSA,Pathogenic/Likely pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy|ARSA-related disorder",single nucleotide variant,GRCh38
na,na,22,51065110,51065110,ARSA,Pathogenic,"Metachromatic leukodystrophy, late infantile form|not provided|Metachromatic leukodystrophy",single nucleotide variant,GRCh37
na,na,22,50626682,50626682,ARSA,Pathogenic,"Metachromatic leukodystrophy, late infantile form|not provided|Metachromatic leukodystrophy",single nucleotide variant,GRCh38
na,na,22,51063874,51063874,ARSA,Likely pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy",single nucleotide variant,GRCh37
na,na,22,50625446,50625446,ARSA,Likely pathogenic,"Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy",single nucleotide variant,GRCh38
na,na,22,51064656,51064656,ARSA,Pathogenic,"Metachromatic leukodystrophy, late infantile form|not provided",single nucleotide variant,GRCh37
na,na,22,50626228,50626228,ARSA,Pathogenic,"Metachromatic leukodystrophy, late infantile form|not provided",single nucleotide variant,GRCh38
na,na,22,51063824,51063824,ARSA,Pathogenic,"Metachromatic leukodystrophy, juvenile type",single nucleotide variant,GRCh37
na,na,22,50625396,50625396,ARSA,Pathogenic,"Metachromatic leukodystrophy, juvenile type",single nucleotide variant,GRCh38
na,na,12,109998873,109998873,MMAB,Pathogenic/Likely pathogenic,"Methylmalonic aciduria, cblB type|not provided|Methylmalonic acidemia|Inborn genetic diseases|MMAB-related disorder",single nucleotide variant,GRCh37
na,na,12,109561068,109561068,MMAB,Pathogenic/Likely pathogenic,"Methylmalonic aciduria, cblB type|not provided|Methylmalonic acidemia|Inborn genetic diseases|MMAB-related disorder",single nucleotide variant,GRCh38
na,na,12,109998852,109998856,MMAB,Pathogenic,"Methylmalonic aciduria, cblB type",Deletion,GRCh37
na,na,12,109561047,109561051,MMAB,Pathogenic,"Methylmalonic aciduria, cblB type",Deletion,GRCh38
na,na,6,145948827,145948827,EPM2A,Pathogenic,Lafora disease|not provided|Progressive myoclonic epilepsy|Inborn genetic diseases|EPM2A-related disorder|Myoclonic epilepsy of Lafora 1,single nucleotide variant,GRCh37
na,na,6,145627691,145627691,EPM2A,Pathogenic,Lafora disease|not provided|Progressive myoclonic epilepsy|Inborn genetic diseases|EPM2A-related disorder|Myoclonic epilepsy of Lafora 1,single nucleotide variant,GRCh38
na,na,6,145948713,145948713,EPM2A,Pathogenic/Likely pathogenic,not provided|Myoclonic epilepsy of Lafora 1|Progressive myoclonic epilepsy|Lafora disease,single nucleotide variant,GRCh37
na,na,6,145627577,145627577,EPM2A,Pathogenic/Likely pathogenic,not provided|Myoclonic epilepsy of Lafora 1|Progressive myoclonic epilepsy|Lafora disease,single nucleotide variant,GRCh38
na,na,6,146007412,146007412,EPM2A,Pathogenic/Likely pathogenic,Progressive myoclonic epilepsy|Lafora disease|Myoclonic epilepsy of Lafora 1,single nucleotide variant,GRCh37
na,na,6,145686276,145686276,EPM2A,Pathogenic/Likely pathogenic,Progressive myoclonic epilepsy|Lafora disease|Myoclonic epilepsy of Lafora 1,single nucleotide variant,GRCh38
na,na,6,146007398,146007399,EPM2A,Pathogenic,Myoclonic epilepsy of Lafora 1|Lafora disease,Duplication,GRCh37
na,na,6,145686262,145686263,EPM2A,Pathogenic,Myoclonic epilepsy of Lafora 1|Lafora disease,Duplication,GRCh38
na,na,6,145956587,145956587,EPM2A,Likely pathogenic,Lafora disease|Progressive myoclonic epilepsy|not provided|Myoclonic epilepsy of Lafora 1,single nucleotide variant,GRCh37
na,na,6,145635451,145635451,EPM2A,Likely pathogenic,Lafora disease|Progressive myoclonic epilepsy|not provided|Myoclonic epilepsy of Lafora 1,single nucleotide variant,GRCh38
na,na,6,145948594,145948595,EPM2A,Likely pathogenic,Myoclonic epilepsy of Lafora 1|Lafora disease,Duplication,GRCh37
na,na,6,145627458,145627459,EPM2A,Likely pathogenic,Myoclonic epilepsy of Lafora 1|Lafora disease,Duplication,GRCh38
na,na,6,146056541,146056541,EPM2A,Pathogenic/Likely pathogenic,not provided|Myoclonic epilepsy of Lafora 1|Progressive myoclonic epilepsy|Lafora disease,single nucleotide variant,GRCh37
na,na,6,145735405,145735405,EPM2A,Pathogenic/Likely pathogenic,not provided|Myoclonic epilepsy of Lafora 1|Progressive myoclonic epilepsy|Lafora disease,single nucleotide variant,GRCh38
na,na,1,67705958,67705958,IL23R,Benign,"Inflammatory bowel disease 17, protection against|Psoriasis, protection against|not provided",single nucleotide variant,GRCh37
na,na,1,67240275,67240275,IL23R,Benign,"Inflammatory bowel disease 17, protection against|Psoriasis, protection against|not provided",single nucleotide variant,GRCh38
na,na,12,100790151,100790151,SLC17A8,Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 25|not provided,single nucleotide variant,GRCh37
na,na,12,100396373,100396373,SLC17A8,Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 25|not provided,single nucleotide variant,GRCh38
na,na,2,44201383,44201383,LRPPRC,Pathogenic,"Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type|not provided|LRPPRC-related disorder",single nucleotide variant,GRCh37
na,na,2,43974244,43974244,LRPPRC,Pathogenic,"Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type|not provided|LRPPRC-related disorder",single nucleotide variant,GRCh38
na,na,na,-1,-1,LRPPRC,Pathogenic,"Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type",Deletion,na
na,na,11,2591912,2591912,KCNQ1,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome,single nucleotide variant,GRCh37
na,na,11,2570682,2570682,KCNQ1,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome,single nucleotide variant,GRCh38
na,na,11,2591945,2591945,KCNQ1,Uncertain significance,Long QT syndrome 1|not provided|Congenital long QT syndrome|Long QT syndrome,single nucleotide variant,GRCh37
na,na,11,2570715,2570715,KCNQ1,Uncertain significance,Long QT syndrome 1|not provided|Congenital long QT syndrome|Long QT syndrome,single nucleotide variant,GRCh38
na,na,11,2594211,2594211,KCNQ1,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,11,2572981,2572981,KCNQ1,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,11,2604678,2604678,KCNQ1,Pathogenic/Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiac arrhythmia|Cardiovascular phenotype|Long QT syndrome,single nucleotide variant,GRCh37
na,na,11,2583448,2583448,KCNQ1,Pathogenic/Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiac arrhythmia|Cardiovascular phenotype|Long QT syndrome,single nucleotide variant,GRCh38
na,na,11,2591949,2591949,KCNQ1,Pathogenic/Likely pathogenic,Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Cardiac arrhythmia,single nucleotide variant,GRCh37
na,na,11,2570719,2570719,KCNQ1,Pathogenic/Likely pathogenic,Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Cardiac arrhythmia,single nucleotide variant,GRCh38
na,na,11,2593319,2593319,KCNQ1,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,11,2572089,2572089,KCNQ1,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,11,2594112,2594112,KCNQ1,Likely pathogenic,Long QT syndrome 1|not provided|Cardiovascular phenotype|Congenital long QT syndrome|Long QT syndrome,single nucleotide variant,GRCh37
na,na,11,2572882,2572882,KCNQ1,Likely pathogenic,Long QT syndrome 1|not provided|Cardiovascular phenotype|Congenital long QT syndrome|Long QT syndrome,single nucleotide variant,GRCh38
na,na,11,2604765,2604765,KCNQ1,Pathogenic,"Long QT syndrome 1/2, digenic|Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype|Cardiac arrhythmia",single nucleotide variant,GRCh37
na,na,11,2583535,2583535,KCNQ1,Pathogenic,"Long QT syndrome 1/2, digenic|Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype|Cardiac arrhythmia",single nucleotide variant,GRCh38
na,na,11,2604765,2604765,KCNQ1,Pathogenic,Long QT syndrome 1|not provided|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,11,2583535,2583535,KCNQ1,Pathogenic,Long QT syndrome 1|not provided|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,11,2606443,2606443,KCNQ1,Pathogenic/Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiac arrhythmia,single nucleotide variant,GRCh37
na,na,11,2585213,2585213,KCNQ1,Pathogenic/Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiac arrhythmia,single nucleotide variant,GRCh38
na,na,11,2604683,2604683,KCNQ1,Pathogenic,Long QT syndrome 1|not provided|Congenital long QT syndrome|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,11,2583453,2583453,KCNQ1,Pathogenic,Long QT syndrome 1|not provided|Congenital long QT syndrome|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,11,2797262,2797262,KCNQ1,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome|Cardiac arrhythmia,single nucleotide variant,GRCh37
na,na,11,2776032,2776032,KCNQ1,Pathogenic,Long QT syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome|Cardiac arrhythmia,single nucleotide variant,GRCh38
na,na,11,2594209,2594209,KCNQ1,Pathogenic,Jervell and Lange-Nielsen syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome,single nucleotide variant,GRCh37
na,na,11,2572979,2572979,KCNQ1,Pathogenic,Jervell and Lange-Nielsen syndrome 1|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome,single nucleotide variant,GRCh38
na,na,11,2594193,2594193,KCNQ1,Conflicting classifications of pathogenicity,"Long QT syndrome 1|not provided|not specified|Long QT syndrome|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 1|Atrial fibrillation, familial, 3|Cardiac arrhythmia",single nucleotide variant,GRCh37
na,na,11,2572963,2572963,KCNQ1,Conflicting classifications of pathogenicity,"Long QT syndrome 1|not provided|not specified|Long QT syndrome|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 1|Atrial fibrillation, familial, 3|Cardiac arrhythmia",single nucleotide variant,GRCh38
na,na,11,2466530,2466538,KCNQ1,Uncertain significance,"Long QT syndrome 1|Long QT syndrome|not provided|Long QT syndrome 1;Short QT syndrome type 2;Jervell and Lange-Nielsen syndrome 1;Atrial fibrillation, familial, 3;Beckwith-Wiedemann syndrome|Cardiovascular phenotype",Microsatellite,GRCh37
na,na,11,2445300,2445308,KCNQ1,Uncertain significance,"Long QT syndrome 1|Long QT syndrome|not provided|Long QT syndrome 1;Short QT syndrome type 2;Jervell and Lange-Nielsen syndrome 1;Atrial fibrillation, familial, 3;Beckwith-Wiedemann syndrome|Cardiovascular phenotype",Microsatellite,GRCh38
na,na,11,2790111,2790111,KCNQ1,Likely pathogenic,"Long QT syndrome 1, recessive|Long QT syndrome|not provided|Long QT syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1;Short QT syndrome type 2;Jervell and Lange-Nielsen syndrome 1|Congenital long QT syndrome|KCNQ1-related disorder|not specified",single nucleotide variant,GRCh37
na,na,11,2768881,2768881,KCNQ1,Likely pathogenic,"Long QT syndrome 1, recessive|Long QT syndrome|not provided|Long QT syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1;Short QT syndrome type 2;Jervell and Lange-Nielsen syndrome 1|Congenital long QT syndrome|KCNQ1-related disorder|not specified",single nucleotide variant,GRCh38
na,na,11,2790132,2790132,KCNQ1,Pathogenic/Likely pathogenic,"Long QT syndrome 1, recessive|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome",single nucleotide variant,GRCh37
na,na,11,2768902,2768902,KCNQ1,Pathogenic/Likely pathogenic,"Long QT syndrome 1, recessive|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome",single nucleotide variant,GRCh38
na,na,11,2604664,2604664,KCNQ1,Pathogenic,Long QT syndrome 1|Long QT syndrome,single nucleotide variant,GRCh37
na,na,11,2583434,2583434,KCNQ1,Pathogenic,Long QT syndrome 1|Long QT syndrome,single nucleotide variant,GRCh38
na,na,11,2604775,2604775,KCNQ1,Pathogenic,Long QT syndrome 1|Long QT syndrome|Long QT syndrome 2|not provided|Cardiovascular phenotype|Beckwith-Wiedemann syndrome|Congenital long QT syndrome,single nucleotide variant,GRCh37
na,na,11,2583545,2583545,KCNQ1,Pathogenic,Long QT syndrome 1|Long QT syndrome|Long QT syndrome 2|not provided|Cardiovascular phenotype|Beckwith-Wiedemann syndrome|Congenital long QT syndrome,single nucleotide variant,GRCh38
na,na,11,2799233,2799233,KCNQ1,Pathogenic,Jervell and Lange-Nielsen syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome 1|KCNQ1-related disorder,single nucleotide variant,GRCh37
na,na,11,2778003,2778003,KCNQ1,Pathogenic,Jervell and Lange-Nielsen syndrome 1|Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome 1|KCNQ1-related disorder,single nucleotide variant,GRCh38
na,na,na,-1,-1,KCNQ1,Pathogenic,Jervell and Lange-Nielsen syndrome 1,Variation,na
na,na,11,2799239,2799239,KCNQ1,Pathogenic,Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1|not provided|Congenital long QT syndrome|Cardiovascular phenotype|Long QT syndrome|Cardiac arrhythmia|Long QT syndrome 1;Jervell and Lange-Nielsen syndrome 1,single nucleotide variant,GRCh37
na,na,11,2778009,2778009,KCNQ1,Pathogenic,Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1|not provided|Congenital long QT syndrome|Cardiovascular phenotype|Long QT syndrome|Cardiac arrhythmia|Long QT syndrome 1;Jervell and Lange-Nielsen syndrome 1,single nucleotide variant,GRCh38
na,na,11,2466678,2466678,KCNQ1,Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome,single nucleotide variant,GRCh37
na,na,11,2445448,2445448,KCNQ1,Likely pathogenic,Long QT syndrome 1|Congenital long QT syndrome|Long QT syndrome,single nucleotide variant,GRCh38
na,na,11,2799220,2799220,KCNQ1,Conflicting classifications of pathogenicity,"Acquired susceptibility to long QT syndrome 1|Long QT syndrome 1|Congenital long QT syndrome|not provided|Long QT syndrome 1;Beckwith-Wiedemann syndrome;Short QT syndrome type 2;Atrial fibrillation, familial, 3;Jervell and Lange-Nielsen syndrome 1|KCNQ1-related disorder|Long QT syndrome|Cardiovascular phenotype|Cardiac arrhythmia|Long QT syndrome 1;Short QT syndrome type 2;Atrial fibrillation, familial, 3;Jervell and Lange-Nielsen syndrome 1",single nucleotide variant,GRCh37
na,na,11,2777990,2777990,KCNQ1,Conflicting classifications of pathogenicity,"Acquired susceptibility to long QT syndrome 1|Long QT syndrome 1|Congenital long QT syndrome|not provided|Long QT syndrome 1;Beckwith-Wiedemann syndrome;Short QT syndrome type 2;Atrial fibrillation, familial, 3;Jervell and Lange-Nielsen syndrome 1|KCNQ1-related disorder|Long QT syndrome|Cardiovascular phenotype|Cardiac arrhythmia|Long QT syndrome 1;Short QT syndrome type 2;Atrial fibrillation, familial, 3;Jervell and Lange-Nielsen syndrome 1",single nucleotide variant,GRCh38
na,na,11,2549189,2549189,KCNQ1,Pathogenic,"Atrial fibrillation, familial, 3|Atrial fibrillation",single nucleotide variant,GRCh37
na,na,11,2527959,2527959,KCNQ1,Pathogenic,"Atrial fibrillation, familial, 3|Atrial fibrillation",single nucleotide variant,GRCh38
na,na,11,2594100,2594100,KCNQ1,Pathogenic,"Long QT syndrome 1|Congenital long QT syndrome|not provided|Long QT syndrome|not specified|Short QT syndrome type 2;Long QT syndrome 1;Atrial fibrillation, familial, 3;Beckwith-Wiedemann syndrome;Jervell and Lange-Nielsen syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia",single nucleotide variant,GRCh37
na,na,11,2572870,2572870,KCNQ1,Pathogenic,"Long QT syndrome 1|Congenital long QT syndrome|not provided|Long QT syndrome|not specified|Short QT syndrome type 2;Long QT syndrome 1;Atrial fibrillation, familial, 3;Beckwith-Wiedemann syndrome;Jervell and Lange-Nielsen syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia",single nucleotide variant,GRCh38
na,na,11,2594101,2594101,KCNQ1,Pathogenic/Likely pathogenic,Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome|not provided|Cardiovascular phenotype|KCNQ1-related disorder,single nucleotide variant,GRCh37
na,na,11,2572871,2572871,KCNQ1,Pathogenic/Likely pathogenic,Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome|not provided|Cardiovascular phenotype|KCNQ1-related disorder,single nucleotide variant,GRCh38
na,na,11,2594214,2594214,KCNQ1,Uncertain significance,Short QT syndrome type 2|Short QT syndrome|Long QT syndrome,single nucleotide variant,GRCh37
na,na,11,2572984,2572984,KCNQ1,Uncertain significance,Short QT syndrome type 2|Short QT syndrome|Long QT syndrome,single nucleotide variant,GRCh38
na,na,11,2593287,2593287,KCNQ1,Pathogenic,"Long QT syndrome 1/2, digenic|Congenital long QT syndrome",single nucleotide variant,GRCh37
na,na,11,2572057,2572057,KCNQ1,Pathogenic,"Long QT syndrome 1/2, digenic|Congenital long QT syndrome",single nucleotide variant,GRCh38
na,na,10,103826942,103826945,HPS6,Pathogenic,Hermansky-Pudlak syndrome 6,Deletion,GRCh37
na,na,10,102067185,102067188,HPS6,Pathogenic,Hermansky-Pudlak syndrome 6,Deletion,GRCh38
na,na,11,18313400,18313403,HPS5,Pathogenic,Hermansky-Pudlak syndrome 5,Deletion,GRCh37
na,na,11,18291853,18291856,HPS5,Pathogenic,Hermansky-Pudlak syndrome 5,Deletion,GRCh38
na,na,15,100589194,100589195,ADAMTS17,Pathogenic,"Weill-Marchesani 4 syndrome, recessive",Duplication,GRCh37
na,na,15,100048989,100048990,ADAMTS17,Pathogenic,"Weill-Marchesani 4 syndrome, recessive",Duplication,GRCh38
na,na,15,100821463,100821463,ADAMTS17,Pathogenic,"Weill-Marchesani 4 syndrome, recessive",single nucleotide variant,GRCh37
na,na,15,100281258,100281258,ADAMTS17,Pathogenic,"Weill-Marchesani 4 syndrome, recessive",single nucleotide variant,GRCh38
na,na,15,100672211,100672211,ADAMTS17,Pathogenic/Likely pathogenic,"Weill-Marchesani 4 syndrome, recessive|not provided",single nucleotide variant,GRCh37
na,na,15,100132006,100132006,ADAMTS17,Pathogenic/Likely pathogenic,"Weill-Marchesani 4 syndrome, recessive|not provided",single nucleotide variant,GRCh38
na,na,4,146560551,146560552,MMAA,Pathogenic,"Methylmalonic aciduria, cblA type",Insertion,GRCh37
na,na,4,145639399,145639400,MMAA,Pathogenic,"Methylmalonic aciduria, cblA type",Insertion,GRCh38
na,na,4,146560574,146560574,MMAA,Pathogenic,"Methylmalonic aciduria, cblA type|Methylmalonic acidemia",single nucleotide variant,GRCh37
na,na,4,145639422,145639422,MMAA,Pathogenic,"Methylmalonic aciduria, cblA type|Methylmalonic acidemia",single nucleotide variant,GRCh38
na,na,4,146567195,146567195,MMAA,Pathogenic,"Methylmalonic aciduria, cblA type",single nucleotide variant,GRCh37
na,na,4,145646043,145646043,MMAA,Pathogenic,"Methylmalonic aciduria, cblA type",single nucleotide variant,GRCh38
na,na,4,146560724,146560724,MMAA,Pathogenic/Likely pathogenic,"Methylmalonic aciduria, cblA type|not provided|Methylmalonic acidemia|See cases|MMAA-related disorder",single nucleotide variant,GRCh37
na,na,4,145639572,145639572,MMAA,Pathogenic/Likely pathogenic,"Methylmalonic aciduria, cblA type|not provided|Methylmalonic acidemia|See cases|MMAA-related disorder",single nucleotide variant,GRCh38
na,na,18,10455004,10455004,APCDD1,Pathogenic,Hypotrichosis 1,single nucleotide variant,GRCh37
na,na,18,10455007,10455007,APCDD1,Pathogenic,Hypotrichosis 1,single nucleotide variant,GRCh38
na,na,12,72425324,72425324,TPH2,risk factor,"Unipolar depression, susceptibility to",single nucleotide variant,GRCh37
na,na,12,72031544,72031544,TPH2,risk factor,"Unipolar depression, susceptibility to",single nucleotide variant,GRCh38
na,na,12,72372833,72372833,TPH2,risk factor,"Attention deficit-hyperactivity disorder, susceptibility to, 7",single nucleotide variant,GRCh37
na,na,12,71979053,71979053,TPH2,risk factor,"Attention deficit-hyperactivity disorder, susceptibility to, 7",single nucleotide variant,GRCh38
na,na,12,72366306,72366306,TPH2,Uncertain significance,"Bipolar affective disorder, susceptibility to|Tryptophan 5-monooxygenase deficiency|Attention deficit-hyperactivity disorder, susceptibility to, 7;Major depressive disorder",single nucleotide variant,GRCh37
na,na,12,71972526,71972526,TPH2,Uncertain significance,"Bipolar affective disorder, susceptibility to|Tryptophan 5-monooxygenase deficiency|Attention deficit-hyperactivity disorder, susceptibility to, 7;Major depressive disorder",single nucleotide variant,GRCh38
na,na,3,120363252,120363252,HGD,Pathogenic,Alkaptonuria,single nucleotide variant,GRCh37
na,na,3,120644405,120644405,HGD,Pathogenic,Alkaptonuria,single nucleotide variant,GRCh38
na,na,3,120357409,120357409,HGD,Pathogenic,Alkaptonuria,single nucleotide variant,GRCh37
na,na,3,120638562,120638562,HGD,Pathogenic,Alkaptonuria,single nucleotide variant,GRCh38
na,na,3,120357318,120357318,HGD,Uncertain significance,Alkaptonuria,single nucleotide variant,GRCh37
na,na,3,120638471,120638471,HGD,Uncertain significance,Alkaptonuria,single nucleotide variant,GRCh38
na,na,3,120365888,120365888,HGD,Pathogenic,Alkaptonuria|not provided,single nucleotide variant,GRCh37
na,na,3,120647041,120647041,HGD,Pathogenic,Alkaptonuria|not provided,single nucleotide variant,GRCh38
na,na,3,120366735,120366736,HGD,Pathogenic,Alkaptonuria,Duplication,GRCh37
na,na,3,120647888,120647889,HGD,Pathogenic,Alkaptonuria,Duplication,GRCh38
na,na,3,120394711,120394711,HGD,Pathogenic,Alkaptonuria|not provided|HGD-related disorder,single nucleotide variant,GRCh37
na,na,3,120675864,120675864,HGD,Pathogenic,Alkaptonuria|not provided|HGD-related disorder,single nucleotide variant,GRCh38
na,na,3,120393749,120393749,HGD,Pathogenic,Alkaptonuria|not provided,Deletion,GRCh37
na,na,3,120674902,120674902,HGD,Pathogenic,Alkaptonuria|not provided,Deletion,GRCh38
na,na,3,120352070,120352070,HGD,Likely pathogenic,Alkaptonuria,single nucleotide variant,GRCh37
na,na,3,120633223,120633223,HGD,Likely pathogenic,Alkaptonuria,single nucleotide variant,GRCh38
na,na,3,120352080,120352080,HGD,Pathogenic,Alkaptonuria|not provided|See cases,single nucleotide variant,GRCh37
na,na,3,120633233,120633233,HGD,Pathogenic,Alkaptonuria|not provided|See cases,single nucleotide variant,GRCh38
na,na,3,120360507,120360507,HGD,Pathogenic/Likely pathogenic,Alkaptonuria,single nucleotide variant,GRCh37
na,na,3,120641660,120641660,HGD,Pathogenic/Likely pathogenic,Alkaptonuria,single nucleotide variant,GRCh38
na,na,15,43018588,43018588,CDAN1,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a",single nucleotide variant,GRCh37
na,na,15,42726390,42726390,CDAN1,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a",single nucleotide variant,GRCh38
na,na,15,43017748,43017748,CDAN1,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a",single nucleotide variant,GRCh37
na,na,15,42725550,42725550,CDAN1,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a",single nucleotide variant,GRCh38
na,na,15,43023473,43023473,CDAN1,Likely pathogenic,"Congenital dyserythropoietic anemia, type I|Anemia, congenital dyserythropoietic, type 1a",single nucleotide variant,GRCh37
na,na,15,42731275,42731275,CDAN1,Likely pathogenic,"Congenital dyserythropoietic anemia, type I|Anemia, congenital dyserythropoietic, type 1a",single nucleotide variant,GRCh38
na,na,15,43022955,43022955,CDAN1,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a",single nucleotide variant,GRCh37
na,na,15,42730757,42730757,CDAN1,Pathogenic/Likely pathogenic,"Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a",single nucleotide variant,GRCh38
na,na,15,43021264,43021264,CDAN1,Pathogenic,"Congenital dyserythropoietic anemia, type I",single nucleotide variant,GRCh37
na,na,15,42729066,42729066,CDAN1,Pathogenic,"Congenital dyserythropoietic anemia, type I",single nucleotide variant,GRCh38
na,na,15,43023404,43023404,CDAN1,Uncertain significance,"Congenital dyserythropoietic anemia, type I|Anemia, congenital dyserythropoietic, type 1a|not provided|not specified",single nucleotide variant,GRCh37
na,na,15,42731206,42731206,CDAN1,Uncertain significance,"Congenital dyserythropoietic anemia, type I|Anemia, congenital dyserythropoietic, type 1a|not provided|not specified",single nucleotide variant,GRCh38
na,na,15,43027315,43027317,CDAN1,Pathogenic,"Congenital dyserythropoietic anemia, type I",Deletion,GRCh37
na,na,15,42735117,42735119,CDAN1,Pathogenic,"Congenital dyserythropoietic anemia, type I",Deletion,GRCh38
na,na,18,46956717,46956717,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome|not provided,single nucleotide variant,GRCh37
na,na,18,49430347,49430347,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome|not provided,single nucleotide variant,GRCh38
na,na,18,46858234,46858234,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome,Deletion,GRCh37
na,na,18,49331864,49331864,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome,Deletion,GRCh38
na,na,18,46904962,46904962,DYM,Pathogenic/Likely pathogenic,Dyggve-Melchior-Clausen syndrome|Dyggve-Melchior-Clausen syndrome;Smith-McCort dysplasia 1|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,18,49378592,49378592,DYM,Pathogenic/Likely pathogenic,Dyggve-Melchior-Clausen syndrome|Dyggve-Melchior-Clausen syndrome;Smith-McCort dysplasia 1|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,18,46783435,46783435,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome,single nucleotide variant,GRCh37
na,na,18,49257065,49257065,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome,single nucleotide variant,GRCh38
na,na,18,46906063,46906063,DYM,Pathogenic,Smith-McCort dysplasia 1|not provided|DYM-related disorder,single nucleotide variant,GRCh37
na,na,18,49379693,49379693,DYM,Pathogenic,Smith-McCort dysplasia 1|not provided|DYM-related disorder,single nucleotide variant,GRCh38
na,na,18,46784864,46784864,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome|not provided,single nucleotide variant,GRCh37
na,na,18,49258494,49258494,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome|not provided,single nucleotide variant,GRCh38
na,na,18,46570557,46570557,DYM,Pathogenic/Likely pathogenic,Dyggve-Melchior-Clausen syndrome|not provided,Deletion,GRCh37
na,na,18,49044187,49044187,DYM,Pathogenic/Likely pathogenic,Dyggve-Melchior-Clausen syndrome|not provided,Deletion,GRCh38
na,na,18,46889605,46889605,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome,single nucleotide variant,GRCh37
na,na,18,49363235,49363235,DYM,Pathogenic,Dyggve-Melchior-Clausen syndrome,single nucleotide variant,GRCh38
na,na,18,46645236,46645236,DYM,Pathogenic,Smith-McCort dysplasia 1,single nucleotide variant,GRCh37
na,na,18,49118866,49118866,DYM,Pathogenic,Smith-McCort dysplasia 1,single nucleotide variant,GRCh38
na,na,16,69199289,69199289,UTP4,Conflicting classifications of pathogenicity,Hereditary North American Indian childhood cirrhosis|not provided|UTP4-related disorder,single nucleotide variant,GRCh37
na,na,16,69165386,69165386,UTP4,Conflicting classifications of pathogenicity,Hereditary North American Indian childhood cirrhosis|not provided|UTP4-related disorder,single nucleotide variant,GRCh38
na,na,7,66459273,66459274,SBDS,Pathogenic,Shwachman-Diamond syndrome 1|not provided|Inborn genetic diseases|Aplastic anemia;Shwachman-Diamond syndrome 1|Aplastic anemia|Shwachman syndrome|SBDS-related disorder,Indel,GRCh37
na,na,7,66994286,66994287,SBDS,Pathogenic,Shwachman-Diamond syndrome 1|not provided|Inborn genetic diseases|Aplastic anemia;Shwachman-Diamond syndrome 1|Aplastic anemia|Shwachman syndrome|SBDS-related disorder,Indel,GRCh38
na,na,7,66459197,66459197,SBDS,Pathogenic/Likely pathogenic,"Shwachman-Diamond syndrome 1|Aplastic anemia, susceptibility to|not provided|Aplastic anemia;Shwachman-Diamond syndrome 1|not specified|Inborn genetic diseases|Microcephaly;Agenesis of permanent teeth;Deeply set eye;Splenomegaly;Short stature|Shwachman syndrome|Aplastic anemia|SBDS-related disorder",single nucleotide variant,GRCh37
na,na,7,66994210,66994210,SBDS,Pathogenic/Likely pathogenic,"Shwachman-Diamond syndrome 1|Aplastic anemia, susceptibility to|not provided|Aplastic anemia;Shwachman-Diamond syndrome 1|not specified|Inborn genetic diseases|Microcephaly;Agenesis of permanent teeth;Deeply set eye;Splenomegaly;Short stature|Shwachman syndrome|Aplastic anemia|SBDS-related disorder",single nucleotide variant,GRCh38
na,na,7,66460381,66460381,SBDS,Uncertain significance,Shwachman-Diamond syndrome 1,single nucleotide variant,GRCh37
na,na,7,66995394,66995394,SBDS,Uncertain significance,Shwachman-Diamond syndrome 1,single nucleotide variant,GRCh38
na,na,7,66460303,66460304,SBDS,Pathogenic,Shwachman-Diamond syndrome 1,Duplication,GRCh37
na,na,7,66995316,66995317,SBDS,Pathogenic,Shwachman-Diamond syndrome 1,Duplication,GRCh38
na,na,na,-1,-1,FKTN,Pathogenic,"Dilated cardiomyopathy 1X|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4",Insertion,na
na,na,9,108358912,108358912,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1X",single nucleotide variant,GRCh37
na,na,9,105596631,105596631,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1X",single nucleotide variant,GRCh38
na,na,9,108363446,108363447,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy",Deletion,GRCh37
na,na,9,105601165,105601166,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy",Deletion,GRCh38
na,na,na,-1,-1,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4",Insertion,na
na,na,9,108382330,108382331,FKTN,Pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|not provided|FKTN-related disorder|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Dilated cardiomyopathy 1X|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Cardiovascular phenotype|Dilated cardiomyopathy 1X",Duplication,GRCh37
na,na,9,105620049,105620050,FKTN,Pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|not provided|FKTN-related disorder|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Dilated cardiomyopathy 1X|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Cardiovascular phenotype|Dilated cardiomyopathy 1X",Duplication,GRCh38
na,na,9,108366653,108366653,FKTN,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4",single nucleotide variant,GRCh37
na,na,9,105604372,105604372,FKTN,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4",single nucleotide variant,GRCh38
na,na,9,108366579,108366580,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|Dilated cardiomyopathy 1X",Duplication,GRCh37
na,na,9,105604298,105604299,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|Dilated cardiomyopathy 1X",Duplication,GRCh38
na,na,9,108363606,108363606,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|Dilated cardiomyopathy 1X|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,9,105601325,105601325,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|Dilated cardiomyopathy 1X|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,9,108397520,108397520,FKTN,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2M,Deletion,GRCh37
na,na,9,105635239,105635239,FKTN,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2M,Deletion,GRCh38
na,na,9,108380249,108380249,FKTN,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4|not provided|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Dilated cardiomyopathy 1X;Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Autosomal recessive limb-girdle muscular dystrophy type 2M|Dilated cardiomyopathy 1X|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,9,105617968,105617968,FKTN,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4|not provided|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Dilated cardiomyopathy 1X;Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Autosomal recessive limb-girdle muscular dystrophy type 2M|Dilated cardiomyopathy 1X|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,9,108382243,108382243,FKTN,Pathogenic,Dilated cardiomyopathy 1X,single nucleotide variant,GRCh37
na,na,9,105619962,105619962,FKTN,Pathogenic,Dilated cardiomyopathy 1X,single nucleotide variant,GRCh38
na,na,9,108366662,108366662,FKTN,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1X|not provided|Walker-Warburg congenital muscular dystrophy,single nucleotide variant,GRCh37
na,na,9,105604381,105604381,FKTN,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1X|not provided|Walker-Warburg congenital muscular dystrophy,single nucleotide variant,GRCh38
na,na,9,108366499,108366499,FKTN,Benign/Likely benign,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|not specified|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh37
na,na,9,105604218,105604218,FKTN,Benign/Likely benign,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|not specified|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh38
na,na,9,108402913,108403385,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4",Deletion,GRCh37
na,na,9,105640632,105641104,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4",Deletion,GRCh38
na,na,9,108363600,108363600,FKTN,Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy",single nucleotide variant,GRCh37
na,na,9,105601319,105601319,FKTN,Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2M|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy",single nucleotide variant,GRCh38
na,na,9,108366635,108366635,FKTN,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Dilated cardiomyopathy 1X|Walker-Warburg congenital muscular dystrophy",single nucleotide variant,GRCh37
na,na,9,105604354,105604354,FKTN,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Dilated cardiomyopathy 1X|Walker-Warburg congenital muscular dystrophy",single nucleotide variant,GRCh38
na,na,9,108382282,108382282,FKTN,Conflicting classifications of pathogenicity,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Dilated cardiomyopathy 1X|Cardiovascular phenotype|Dilated cardiomyopathy 1X|Autosomal recessive limb-girdle muscular dystrophy type 2M",single nucleotide variant,GRCh37
na,na,9,105620001,105620001,FKTN,Conflicting classifications of pathogenicity,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|Walker-Warburg congenital muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Dilated cardiomyopathy 1X|Cardiovascular phenotype|Dilated cardiomyopathy 1X|Autosomal recessive limb-girdle muscular dystrophy type 2M",single nucleotide variant,GRCh38
na,na,9,108380248,108380248,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|not provided|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|Dilated cardiomyopathy 1X|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Dilated cardiomyopathy 1X",single nucleotide variant,GRCh37
na,na,9,105617967,105617967,FKTN,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4|not provided|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|Dilated cardiomyopathy 1X|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4|Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4;Autosomal recessive limb-girdle muscular dystrophy type 2M;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4;Dilated cardiomyopathy 1X",single nucleotide variant,GRCh38
na,na,14,77745192,77745192,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh37
na,na,14,77278849,77278849,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh38
na,na,14,77765031,77765031,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh37
na,na,14,77298688,77298688,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh38
na,na,14,77753158,77753158,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2",Deletion,GRCh37
na,na,14,77286815,77286815,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2",Deletion,GRCh38
na,na,14,77745107,77745107,POMT2,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|POMT2-related disorder",single nucleotide variant,GRCh37
na,na,14,77278764,77278764,POMT2,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|POMT2-related disorder",single nucleotide variant,GRCh38
na,na,14,77743795,77743795,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh37
na,na,14,77277452,77277452,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh38
na,na,14,77745163,77745163,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",single nucleotide variant,GRCh37
na,na,14,77278820,77278820,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",single nucleotide variant,GRCh38
na,na,14,77743730,77743730,POMT2,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh37
na,na,14,77277387,77277387,POMT2,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh38
na,na,14,77755120,77755120,POMT2,Conflicting classifications of pathogenicity,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",single nucleotide variant,GRCh37
na,na,14,77288777,77288777,POMT2,Conflicting classifications of pathogenicity,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",single nucleotide variant,GRCh38
na,na,14,77757723,77757723,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2",single nucleotide variant,GRCh37
na,na,14,77291380,77291380,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2",single nucleotide variant,GRCh38
na,na,14,77769241,77769241,POMT2,Uncertain significance,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh37
na,na,14,77302898,77302898,POMT2,Uncertain significance,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh38
na,na,14,77767512,77767512,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",single nucleotide variant,GRCh37
na,na,14,77301169,77301169,POMT2,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",single nucleotide variant,GRCh38
na,na,14,77769283,77769283,POMT2,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2N|not provided|Intellectual disability|Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Autosomal recessive limb-girdle muscular dystrophy",single nucleotide variant,GRCh37
na,na,14,77302940,77302940,POMT2,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2N|not provided|Intellectual disability|Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Autosomal recessive limb-girdle muscular dystrophy",single nucleotide variant,GRCh38
na,na,14,77743729,77743729,POMT2,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2N,single nucleotide variant,GRCh37
na,na,14,77277386,77277386,POMT2,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2N,single nucleotide variant,GRCh38
na,na,14,77762566,77762566,POMT2,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|not provided|POMT2-related disorder",single nucleotide variant,GRCh37
na,na,14,77296223,77296223,POMT2,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|not provided|POMT2-related disorder",single nucleotide variant,GRCh38
na,na,14,77786772,77786772,POMT2,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh37
na,na,14,77320429,77320429,POMT2,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh38
na,na,14,77751989,77751989,POMT2,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",single nucleotide variant,GRCh37
na,na,14,77285646,77285646,POMT2,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2",single nucleotide variant,GRCh38
na,na,14,77751863,77751863,POMT2,Uncertain significance,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh37
na,na,14,77285520,77285520,POMT2,Uncertain significance,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N",single nucleotide variant,GRCh38
na,na,10,27024406,27024406,PDSS1,Pathogenic,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,single nucleotide variant,GRCh37
na,na,10,26735477,26735477,PDSS1,Pathogenic,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,single nucleotide variant,GRCh38
na,na,9,134381604,134381604,POMT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|not provided|Autosomal recessive limb-girdle muscular dystrophy",single nucleotide variant,GRCh37
na,na,9,131506217,131506217,POMT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|not provided|Autosomal recessive limb-girdle muscular dystrophy",single nucleotide variant,GRCh38
na,na,9,134385788,134385788,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Abnormality of the musculature|not provided|Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K",single nucleotide variant,GRCh37
na,na,9,131510401,131510401,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Abnormality of the musculature|not provided|Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K",single nucleotide variant,GRCh38
na,na,9,134398357,134398358,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",Duplication,GRCh37
na,na,9,131522970,131522971,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",Duplication,GRCh38
na,na,9,134390831,134390833,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",Deletion,GRCh37
na,na,9,131515444,131515446,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",Deletion,GRCh38
na,na,9,134395562,134395562,POMT1,Uncertain significance,"Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1",single nucleotide variant,GRCh37
na,na,9,131520175,131520175,POMT1,Uncertain significance,"Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1",single nucleotide variant,GRCh38
na,na,9,134385188,134385188,POMT1,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2K|not provided|Abnormality of the nervous system|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh37
na,na,9,131509801,131509801,POMT1,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2K|not provided|Abnormality of the nervous system|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh38
na,na,9,134381571,134381571,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh37
na,na,9,131506184,131506184,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh38
na,na,9,134394332,134394332,POMT1,Pathogenic,"not provided|Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh37
na,na,9,131518945,131518945,POMT1,Pathogenic,"not provided|Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh38
na,na,9,134396738,134396738,POMT1,Conflicting classifications of pathogenicity,"not provided|not specified|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Walker-Warburg congenital muscular dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1",single nucleotide variant,GRCh37
na,na,9,131521351,131521351,POMT1,Conflicting classifications of pathogenicity,"not provided|not specified|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Walker-Warburg congenital muscular dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1",single nucleotide variant,GRCh38
na,na,9,134397547,134397547,POMT1,Pathogenic/Likely pathogenic,"not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh37
na,na,9,131522160,131522160,POMT1,Pathogenic/Likely pathogenic,"not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh38
na,na,9,134388719,134388719,POMT1,Pathogenic,"Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh37
na,na,9,131513332,131513332,POMT1,Pathogenic,"Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",single nucleotide variant,GRCh38
na,na,9,134398425,134398426,POMT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",Microsatellite,GRCh37
na,na,9,131523038,131523039,POMT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",Microsatellite,GRCh38
na,na,9,134382890,134382892,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",Deletion,GRCh37
na,na,9,131507503,131507505,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1",Deletion,GRCh38
na,na,9,134398412,134398413,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|POMT1-related disorder|Ventriculomegaly;Abnormal brainstem morphology|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Autosomal recessive limb-girdle muscular dystrophy|Inborn genetic diseases|Muscular dystrophy-dystroglycanopathy, type C",Duplication,GRCh37
na,na,9,131523025,131523026,POMT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|POMT1-related disorder|Ventriculomegaly;Abnormal brainstem morphology|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Autosomal recessive limb-girdle muscular dystrophy|Inborn genetic diseases|Muscular dystrophy-dystroglycanopathy, type C",Duplication,GRCh38
na,na,7,37927908,37927908,NME8,Uncertain significance,Primary ciliary dyskinesia 6|NME8-related disorder|Primary ciliary dyskinesia,single nucleotide variant,GRCh37
na,na,7,37888306,37888306,NME8,Uncertain significance,Primary ciliary dyskinesia 6|NME8-related disorder|Primary ciliary dyskinesia,single nucleotide variant,GRCh38
na,na,7,37901603,37901603,NME8,Benign/Likely benign,Primary ciliary dyskinesia 6|not specified|Primary ciliary dyskinesia|not provided,single nucleotide variant,GRCh37
na,na,7,37862001,37862001,NME8,Benign/Likely benign,Primary ciliary dyskinesia 6|not specified|Primary ciliary dyskinesia|not provided,single nucleotide variant,GRCh38
na,na,18,13885297,13885297,MC2R,Pathogenic,Glucocorticoid deficiency 1|Glucocorticoid Deficiency|not provided,single nucleotide variant,GRCh37
na,na,18,13885298,13885298,MC2R,Pathogenic,Glucocorticoid deficiency 1|Glucocorticoid Deficiency|not provided,single nucleotide variant,GRCh38
na,na,18,13884917,13884917,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh37
na,na,18,13884918,13884918,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh38
na,na,18,13885158,13885158,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh37
na,na,18,13885159,13885159,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh38
na,na,18,13885136,13885136,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh37
na,na,18,13885137,13885137,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh38
na,na,18,13885199,13885199,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh37
na,na,18,13885200,13885200,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh38
na,na,18,13884865,13884866,MC2R,Pathogenic,Glucocorticoid deficiency 1,Insertion,GRCh37
na,na,18,13884866,13884867,MC2R,Pathogenic,Glucocorticoid deficiency 1,Insertion,GRCh38
na,na,18,13884766,13884766,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh37
na,na,18,13884767,13884767,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh38
na,na,18,13885109,13885109,MC2R,Pathogenic/Likely pathogenic,Glucocorticoid deficiency 1|Glucocorticoid Deficiency|not provided,single nucleotide variant,GRCh37
na,na,18,13885110,13885110,MC2R,Pathogenic/Likely pathogenic,Glucocorticoid deficiency 1|Glucocorticoid Deficiency|not provided,single nucleotide variant,GRCh38
na,na,18,13884757,13884757,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh37
na,na,18,13884758,13884758,MC2R,Pathogenic,Glucocorticoid deficiency 1,single nucleotide variant,GRCh38
na,na,1,193091333,193091333,CDC73,Pathogenic,Hyperparathyroidism 2 with jaw tumors,single nucleotide variant,GRCh37
na,na,1,193122203,193122203,CDC73,Pathogenic,Hyperparathyroidism 2 with jaw tumors,single nucleotide variant,GRCh38
na,na,1,193091355,193091355,CDC73,Pathogenic,Hyperparathyroidism 2 with jaw tumors|Hereditary cancer-predisposing syndrome|Parathyroid carcinoma,single nucleotide variant,GRCh37
na,na,1,193122225,193122225,CDC73,Pathogenic,Hyperparathyroidism 2 with jaw tumors|Hereditary cancer-predisposing syndrome|Parathyroid carcinoma,single nucleotide variant,GRCh38
na,na,na,-1,-1,CDC73,Pathogenic,Hyperparathyroidism 2 with jaw tumors,Duplication,na
na,na,1,193111146,193111147,CDC73,Pathogenic,Hyperparathyroidism 2 with jaw tumors|Parathyroid carcinoma|Hyperparathyroidism 1,Insertion,GRCh37
na,na,1,193142016,193142017,CDC73,Pathogenic,Hyperparathyroidism 2 with jaw tumors|Parathyroid carcinoma|Hyperparathyroidism 1,Insertion,GRCh38
na,na,1,193091458,193091458,CDC73,Pathogenic,Parathyroid carcinoma,single nucleotide variant,GRCh37
na,na,1,193122328,193122328,CDC73,Pathogenic,Parathyroid carcinoma,single nucleotide variant,GRCh38
na,na,1,193094301,193094301,CDC73,Likely pathogenic,Hyperparathyroidism 1|Parathyroid carcinoma,single nucleotide variant,GRCh37
na,na,1,193125171,193125171,CDC73,Likely pathogenic,Hyperparathyroidism 1|Parathyroid carcinoma,single nucleotide variant,GRCh38
na,na,1,193091383,193091383,CDC73,Pathogenic,Cystic parathyroid adenoma,Deletion,GRCh37
na,na,1,193122253,193122253,CDC73,Pathogenic,Cystic parathyroid adenoma,Deletion,GRCh38
na,na,1,193094272,193094272,CDC73,Pathogenic,Parathyroid carcinoma,single nucleotide variant,GRCh37
na,na,1,193125142,193125142,CDC73,Pathogenic,Parathyroid carcinoma,single nucleotide variant,GRCh38
na,na,1,193104668,193104669,CDC73,Pathogenic,Parathyroid carcinoma,Duplication,GRCh37
na,na,1,193135538,193135539,CDC73,Pathogenic,Parathyroid carcinoma,Duplication,GRCh38
na,na,1,193091462,193091462,CDC73,Pathogenic/Likely pathogenic,"Hyperparathyroidism 1|Parathyroid adenoma, somatic|Parathyroid carcinoma|not provided|Hereditary cancer-predisposing syndrome|Parathyroid carcinoma;Hyperparathyroidism 2 with jaw tumors;Hyperparathyroidism 1",single nucleotide variant,GRCh37
na,na,1,193122332,193122332,CDC73,Pathogenic/Likely pathogenic,"Hyperparathyroidism 1|Parathyroid adenoma, somatic|Parathyroid carcinoma|not provided|Hereditary cancer-predisposing syndrome|Parathyroid carcinoma;Hyperparathyroidism 2 with jaw tumors;Hyperparathyroidism 1",single nucleotide variant,GRCh38
na,na,1,193111146,193111149,CDC73,Pathogenic,Parathyroid gland adenoma|Parathyroid carcinoma,Microsatellite,GRCh37
na,na,1,193142016,193142019,CDC73,Pathogenic,Parathyroid gland adenoma|Parathyroid carcinoma,Microsatellite,GRCh38
na,na,1,193099303,193099303,CDC73,Pathogenic,Hyperparathyroidism 2 with jaw tumors,single nucleotide variant,GRCh37
na,na,1,193130173,193130173,CDC73,Pathogenic,Hyperparathyroidism 2 with jaw tumors,single nucleotide variant,GRCh38
na,na,1,193091412,193091412,CDC73,Pathogenic,Parathyroid carcinoma,Deletion,GRCh37
na,na,1,193122282,193122282,CDC73,Pathogenic,Parathyroid carcinoma,Deletion,GRCh38
na,na,1,193091342,193091359,CDC73,Pathogenic,Parathyroid carcinoma,Deletion,GRCh37
na,na,1,193122212,193122229,CDC73,Pathogenic,Parathyroid carcinoma,Deletion,GRCh38
na,na,22,30067894,30067894,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh37
na,na,22,29671905,29671905,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh38
na,na,22,30032866,30032866,NF2,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 2|Acoustic neuroma|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,22,29636877,29636877,NF2,Pathogenic/Likely pathogenic,"Neurofibromatosis, type 2|Acoustic neuroma|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,22,30064429,30064429,NF2,Pathogenic,Meningioma,Deletion,GRCh37
na,na,22,29668440,29668440,NF2,Pathogenic,Meningioma,Deletion,GRCh38
na,na,22,30032794,30032794,NF2,Pathogenic,"Meningioma|not provided|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,22,29636805,29636805,NF2,Pathogenic,"Meningioma|not provided|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,22,30077457,30077457,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh37
na,na,22,29681468,29681468,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh38
na,na,22,30077466,30077466,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh37
na,na,22,29681477,29681477,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh38
na,na,22,30035123,30035125,NF2,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 2|SMARCB1-related schwannomatosis|Hereditary cancer-predisposing syndrome",Microsatellite,GRCh37
na,na,22,29639134,29639136,NF2,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 2|SMARCB1-related schwannomatosis|Hereditary cancer-predisposing syndrome",Microsatellite,GRCh38
na,na,22,30051610,30051610,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh37
na,na,22,29655621,29655621,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh38
na,na,22,30057302,30057302,NF2,Pathogenic,"Neurofibromatosis, type 2|not provided",single nucleotide variant,GRCh37
na,na,22,29661313,29661313,NF2,Pathogenic,"Neurofibromatosis, type 2|not provided",single nucleotide variant,GRCh38
na,na,22,30064394,30064394,NF2,Pathogenic,"Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,22,29668405,29668405,NF2,Pathogenic,"Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,22,30067836,30067836,NF2,Pathogenic,"Neurofibromatosis, type 2|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,22,29671847,29671847,NF2,Pathogenic,"Neurofibromatosis, type 2|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,22,30069354,30069354,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh37
na,na,22,29673365,29673365,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh38
na,na,22,30070871,30070871,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh37
na,na,22,29674882,29674882,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh38
na,na,22,30070880,30070880,NF2,Pathogenic,"Neurofibromatosis, type 2|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,22,29674891,29674891,NF2,Pathogenic,"Neurofibromatosis, type 2|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,22,30077432,30077432,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh37
na,na,22,29681443,29681443,NF2,Pathogenic,"Neurofibromatosis, type 2",single nucleotide variant,GRCh38
na,na,22,30032810,30032810,NF2,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 2|Acoustic neuroma",single nucleotide variant,GRCh37
na,na,22,29636821,29636821,NF2,Conflicting classifications of pathogenicity,"Neurofibromatosis, type 2|Acoustic neuroma",single nucleotide variant,GRCh38
na,na,22,29668447,29681601,NF2,Pathogenic,SMARCB1-related schwannomatosis,Deletion,GRCh38
na,na,22,30032750,30032751,NF2,Pathogenic,SMARCB1-related schwannomatosis,Insertion,GRCh37
na,na,22,29636761,29636762,NF2,Pathogenic,SMARCB1-related schwannomatosis,Insertion,GRCh38
na,na,22,30032830,30032836,NF2,Pathogenic,SMARCB1-related schwannomatosis,Deletion,GRCh37
na,na,22,29636841,29636847,NF2,Pathogenic,SMARCB1-related schwannomatosis,Deletion,GRCh38
na,na,na,-1,-1,LIPH,Pathogenic,Hypotrichosis 7,Deletion,na
na,na,3,185252620,185252624,LIPH,Pathogenic,Hypotrichosis 7,Deletion,GRCh37
na,na,3,185534832,185534836,LIPH,Pathogenic,Hypotrichosis 7,Deletion,GRCh38
na,na,3,185241917,185241918,LIPH,Pathogenic,"Hypotrichosis 7|Woolly hair, autosomal recessive 2, with or without hypotrichosis|not provided|LIPH-related disorder",Deletion,GRCh37
na,na,3,185524129,185524130,LIPH,Pathogenic,"Hypotrichosis 7|Woolly hair, autosomal recessive 2, with or without hypotrichosis|not provided|LIPH-related disorder",Deletion,GRCh38
na,na,3,185231236,185236525,LIPH,Pathogenic,"Woolly hair, autosomal recessive 2, with or without hypotrichosis|Hypotrichosis 7",Deletion,GRCh37
na,na,3,185513448,185518737,LIPH,Pathogenic,"Woolly hair, autosomal recessive 2, with or without hypotrichosis|Hypotrichosis 7",Deletion,GRCh38
na,na,3,185252648,185252648,LIPH,Pathogenic,"Woolly hair, autosomal recessive 2, with or without hypotrichosis",single nucleotide variant,GRCh37
na,na,3,185534860,185534860,LIPH,Pathogenic,"Woolly hair, autosomal recessive 2, with or without hypotrichosis",single nucleotide variant,GRCh38
na,na,3,185252600,185252601,LIPH,Pathogenic,"Woolly hair, autosomal recessive 2, with or without hypotrichosis|not provided",Duplication,GRCh37
na,na,3,185534812,185534813,LIPH,Pathogenic,"Woolly hair, autosomal recessive 2, with or without hypotrichosis|not provided",Duplication,GRCh38
na,na,21,45709656,45709656,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1|not provided|AIRE-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,21,44289773,44289773,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1|not provided|AIRE-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,21,45706554,45706554,AIRE,Likely pathogenic,"Polyglandular autoimmune syndrome, type 1",single nucleotide variant,GRCh37
na,na,21,44286671,44286671,AIRE,Likely pathogenic,"Polyglandular autoimmune syndrome, type 1",single nucleotide variant,GRCh38
na,na,21,45711063,45711075,AIRE,Pathogenic/Likely pathogenic,"Autoimmune polyglandular syndrome type 1, with reversible metaphyseal dysplasia|Polyglandular autoimmune syndrome, type 1|not provided|AIRE-related disorder",Deletion,GRCh37
na,na,21,44291180,44291192,AIRE,Pathogenic/Likely pathogenic,"Autoimmune polyglandular syndrome type 1, with reversible metaphyseal dysplasia|Polyglandular autoimmune syndrome, type 1|not provided|AIRE-related disorder",Deletion,GRCh38
na,na,21,45706968,45706968,AIRE,Pathogenic,"not provided|Polyglandular autoimmune syndrome, type 1",single nucleotide variant,GRCh37
na,na,21,44287085,44287085,AIRE,Pathogenic,"not provided|Polyglandular autoimmune syndrome, type 1",single nucleotide variant,GRCh38
na,na,21,45712877,45712878,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1",Duplication,GRCh37
na,na,21,44292994,44292995,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1",Duplication,GRCh38
na,na,21,45716275,45716275,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1",Deletion,GRCh37
na,na,21,44296392,44296392,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1",Deletion,GRCh38
na,na,21,45709569,45709569,AIRE,not provided,"Autoimmune polyglandular syndrome type 1, autosomal dominant",single nucleotide variant,GRCh37
na,na,21,44289686,44289686,AIRE,not provided,"Autoimmune polyglandular syndrome type 1, autosomal dominant",single nucleotide variant,GRCh38
na,na,21,45705890,45705890,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1|not provided",single nucleotide variant,GRCh37
na,na,21,44286007,44286007,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1|not provided",single nucleotide variant,GRCh38
na,na,21,45709676,45709676,AIRE,Pathogenic,"Autoimmune polyglandular syndrome type 1, with reversible metaphyseal dysplasia|Polyglandular autoimmune syndrome, type 1",Deletion,GRCh37
na,na,21,44289793,44289793,AIRE,Pathogenic,"Autoimmune polyglandular syndrome type 1, with reversible metaphyseal dysplasia|Polyglandular autoimmune syndrome, type 1",Deletion,GRCh38
na,na,21,45706546,45706546,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1",single nucleotide variant,GRCh37
na,na,21,44286663,44286663,AIRE,Pathogenic,"Polyglandular autoimmune syndrome, type 1",single nucleotide variant,GRCh38
na,na,20,50407068,50407068,SALL4,Pathogenic,Duane-radial ray syndrome,single nucleotide variant,GRCh37
na,na,20,51790529,51790529,SALL4,Pathogenic,Duane-radial ray syndrome,single nucleotide variant,GRCh38
na,na,20,50407968,50407968,SALL4,Pathogenic,Duane-radial ray syndrome,Deletion,GRCh37
na,na,20,51791429,51791429,SALL4,Pathogenic,Duane-radial ray syndrome,Deletion,GRCh38
na,na,20,50408080,50408081,SALL4,Pathogenic,Duane-radial ray syndrome,Duplication,GRCh37
na,na,20,51791541,51791542,SALL4,Pathogenic,Duane-radial ray syndrome,Duplication,GRCh38
na,na,20,50407118,50407118,SALL4,Pathogenic,Duane-radial ray syndrome,Deletion,GRCh37
na,na,20,51790579,51790579,SALL4,Pathogenic,Duane-radial ray syndrome,Deletion,GRCh38
na,na,20,50405549,50405549,SALL4,Pathogenic/Likely pathogenic,Duane-radial ray syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,51789010,51789010,SALL4,Pathogenic/Likely pathogenic,Duane-radial ray syndrome|not provided,single nucleotide variant,GRCh38
na,na,20,50406597,50406597,SALL4,Pathogenic,Duane-radial ray syndrome,Deletion,GRCh37
na,na,20,51790058,51790058,SALL4,Pathogenic,Duane-radial ray syndrome,Deletion,GRCh38
na,na,20,50408696,50408696,SALL4,Pathogenic,Duane-radial ray syndrome,Deletion,GRCh37
na,na,20,51792157,51792157,SALL4,Pathogenic,Duane-radial ray syndrome,Deletion,GRCh38
na,na,20,50408499,50408499,SALL4,Pathogenic,Duane-radial ray syndrome,single nucleotide variant,GRCh37
na,na,20,51791960,51791960,SALL4,Pathogenic,Duane-radial ray syndrome,single nucleotide variant,GRCh38
na,na,20,50407173,50407173,SALL4,Pathogenic,Duane-radial ray syndrome,single nucleotide variant,GRCh37
na,na,20,51790634,51790634,SALL4,Pathogenic,Duane-radial ray syndrome,single nucleotide variant,GRCh38
na,na,20,51758515,51894383,SALL4,Pathogenic,Duane-radial ray syndrome,Deletion,GRCh38
na,na,20,50405429,50405429,SALL4,Likely pathogenic,Duane-radial ray syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,51788890,51788890,SALL4,Likely pathogenic,Duane-radial ray syndrome|not provided,single nucleotide variant,GRCh38
na,na,20,50405479,50405479,SALL4,Pathogenic,Duane-radial ray syndrome,single nucleotide variant,GRCh37
na,na,20,51788940,51788940,SALL4,Pathogenic,Duane-radial ray syndrome,single nucleotide variant,GRCh38
na,na,20,50405535,50405535,SALL4,Pathogenic,Oculootoradial syndrome,Deletion,GRCh37
na,na,20,51788996,51788996,SALL4,Pathogenic,Oculootoradial syndrome,Deletion,GRCh38
na,na,9,101340316,101340316,GABBR2,Benign,Epileptic encephalopathy|not provided,single nucleotide variant,GRCh37
na,na,9,98578034,98578034,GABBR2,Benign,Epileptic encephalopathy|not provided,single nucleotide variant,GRCh38
na,na,7,33136162,33136162,RP9,Uncertain significance,Retinitis pigmentosa 9|not provided,single nucleotide variant,GRCh37
na,na,7,33096550,33096550,RP9,Uncertain significance,Retinitis pigmentosa 9|not provided,single nucleotide variant,GRCh38
na,na,7,33135003,33135003,RP9,Uncertain significance,Retinitis pigmentosa 9|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,7,33095391,33095391,RP9,Uncertain significance,Retinitis pigmentosa 9|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,2,31524586,31580971,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,Deletion,GRCh38
na,na,2,31751295,31751295,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,2,31526225,31526225,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,2,31756518,31756520,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,Deletion,GRCh37
na,na,2,31531448,31531450,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,Deletion,GRCh38
na,na,2,31805807,31805807,SRD5A2,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided|Abnormality of the genitourinary system,single nucleotide variant,GRCh37
na,na,2,31580737,31580737,SRD5A2,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided|Abnormality of the genitourinary system,single nucleotide variant,GRCh38
na,na,2,31758774,31758774,SRD5A2,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,2,31533704,31533704,SRD5A2,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,2,31756441,31756441,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|SRD5A2-related disorder|not provided,single nucleotide variant,GRCh37
na,na,2,31531371,31531371,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|SRD5A2-related disorder|not provided,single nucleotide variant,GRCh38
na,na,2,31754396,31754396,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,2,31529326,31529326,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,2,31751278,31751278,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,Deletion,GRCh37
na,na,2,31526208,31526208,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,Deletion,GRCh38
na,na,2,31754393,31754393,SRD5A2,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,2,31529323,31529323,SRD5A2,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,2,31754489,31754489,SRD5A2,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided|SRD5A2-related disorder,single nucleotide variant,GRCh37
na,na,2,31529419,31529419,SRD5A2,Pathogenic/Likely pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided|SRD5A2-related disorder,single nucleotide variant,GRCh38
na,na,2,31754383,31754383,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,2,31529313,31529313,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,2,31805826,31805826,SRD5A2,Benign,SRD5A2 POLYMORPHISM|not provided|3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|SRD5A2-related disorder,single nucleotide variant,GRCh37
na,na,2,31580756,31580756,SRD5A2,Benign,SRD5A2 POLYMORPHISM|not provided|3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|SRD5A2-related disorder,single nucleotide variant,GRCh38
na,na,2,31754440,31754440,SRD5A2,Conflicting classifications of pathogenicity,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not specified,single nucleotide variant,GRCh37
na,na,2,31529370,31529370,SRD5A2,Conflicting classifications of pathogenicity,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not specified,single nucleotide variant,GRCh38
na,na,2,31754484,31754484,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,2,31529414,31529414,SRD5A2,Pathogenic,3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,2,31805892,31805892,SRD5A2,Pathogenic,Micropenis,single nucleotide variant,GRCh37
na,na,2,31580823,31580823,SRD5A2,Pathogenic,Micropenis,single nucleotide variant,GRCh38
na,na,2,31754395,31754395,SRD5A2,Pathogenic/Likely pathogenic,Micropenis|not provided|3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|SRD5A2-related disorder|Autism spectrum disorder,single nucleotide variant,GRCh37
na,na,2,31529325,31529325,SRD5A2,Pathogenic/Likely pathogenic,Micropenis|not provided|3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|SRD5A2-related disorder|Autism spectrum disorder,single nucleotide variant,GRCh38
na,na,1,150316692,150316692,PRPF3,Pathogenic,Retinitis pigmentosa 18|not provided|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,1,150344216,150344216,PRPF3,Pathogenic,Retinitis pigmentosa 18|not provided|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,1,150316688,150316688,PRPF3,Pathogenic,Retinitis pigmentosa 18|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,1,150344212,150344212,PRPF3,Pathogenic,Retinitis pigmentosa 18|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,1,150316677,150316677,PRPF3,Pathogenic,Retinitis pigmentosa 18,single nucleotide variant,GRCh37
na,na,1,150344201,150344201,PRPF3,Pathogenic,Retinitis pigmentosa 18,single nucleotide variant,GRCh38
na,na,17,1554178,1554178,PRPF8,Pathogenic,Retinitis pigmentosa 13|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,17,1650884,1650884,PRPF8,Pathogenic,Retinitis pigmentosa 13|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,17,1554178,1554178,PRPF8,Pathogenic/Likely pathogenic,Retinitis pigmentosa 13|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,17,1650884,1650884,PRPF8,Pathogenic/Likely pathogenic,Retinitis pigmentosa 13|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,17,1554175,1554175,PRPF8,Pathogenic,Retinitis pigmentosa 13|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,17,1650881,1650881,PRPF8,Pathogenic,Retinitis pigmentosa 13|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,17,1554203,1554203,PRPF8,Likely pathogenic,Retinitis pigmentosa 13|not provided,single nucleotide variant,GRCh37
na,na,17,1650909,1650909,PRPF8,Likely pathogenic,Retinitis pigmentosa 13|not provided,single nucleotide variant,GRCh38
na,na,17,1554192,1554192,PRPF8,Pathogenic/Likely pathogenic,Retinitis pigmentosa 13|not provided,single nucleotide variant,GRCh37
na,na,17,1650898,1650898,PRPF8,Pathogenic/Likely pathogenic,Retinitis pigmentosa 13|not provided,single nucleotide variant,GRCh38
na,na,1,156132784,156132784,SEMA4A,Uncertain significance,Cone-rod dystrophy 10|Retinitis pigmentosa 35|not provided,single nucleotide variant,GRCh37
na,na,1,156162993,156162993,SEMA4A,Uncertain significance,Cone-rod dystrophy 10|Retinitis pigmentosa 35|not provided,single nucleotide variant,GRCh38
na,na,1,156132800,156132800,SEMA4A,Pathogenic,Cone-rod dystrophy 10|Retinitis pigmentosa 35,single nucleotide variant,GRCh37
na,na,1,156163009,156163009,SEMA4A,Pathogenic,Cone-rod dystrophy 10|Retinitis pigmentosa 35,single nucleotide variant,GRCh38
na,na,1,156146640,156146640,SEMA4A,Benign/Likely benign,"Retinitis pigmentosa 35|not specified|Cone-rod dystrophy 10|Retinitis Pigmentosa, Recessive|Retinitis pigmentosa|not provided|Retinal dystrophy|Retinitis pigmentosa 35;Cone-rod dystrophy 10",single nucleotide variant,GRCh37
na,na,1,156176849,156176849,SEMA4A,Benign/Likely benign,"Retinitis pigmentosa 35|not specified|Cone-rod dystrophy 10|Retinitis Pigmentosa, Recessive|Retinitis pigmentosa|not provided|Retinal dystrophy|Retinitis pigmentosa 35;Cone-rod dystrophy 10",single nucleotide variant,GRCh38
na,na,17,17119708,17119709,FLCN,Pathogenic,Birt-Hogg-Dube syndrome|Familial spontaneous pneumothorax|not provided|Hereditary cancer-predisposing syndrome|FLCN-related disorder|Colorectal cancer;Nonpapillary renal cell carcinoma;17p11.2 microduplication syndrome;Familial spontaneous pneumothorax;Birt-Hogg-Dube syndrome|Birt-Hogg-Dube syndrome 1|Colorectal cancer;Nonpapillary renal cell carcinoma;Familial spontaneous pneumothorax;Birt-Hogg-Dube syndrome 1,Duplication,GRCh37
na,na,17,17216394,17216395,FLCN,Pathogenic,Birt-Hogg-Dube syndrome|Familial spontaneous pneumothorax|not provided|Hereditary cancer-predisposing syndrome|FLCN-related disorder|Colorectal cancer;Nonpapillary renal cell carcinoma;17p11.2 microduplication syndrome;Familial spontaneous pneumothorax;Birt-Hogg-Dube syndrome|Birt-Hogg-Dube syndrome 1|Colorectal cancer;Nonpapillary renal cell carcinoma;Familial spontaneous pneumothorax;Birt-Hogg-Dube syndrome 1,Duplication,GRCh38
na,na,17,17119709,17119709,FLCN,Pathogenic,Birt-Hogg-Dube syndrome|not provided|Hereditary cancer-predisposing syndrome|FLCN-related disorder|Birt-Hogg-Dube syndrome 1;Familial spontaneous pneumothorax;Colorectal cancer;Nonpapillary renal cell carcinoma|Birt-Hogg-Dube syndrome 1,Deletion,GRCh37
na,na,17,17216395,17216395,FLCN,Pathogenic,Birt-Hogg-Dube syndrome|not provided|Hereditary cancer-predisposing syndrome|FLCN-related disorder|Birt-Hogg-Dube syndrome 1;Familial spontaneous pneumothorax;Colorectal cancer;Nonpapillary renal cell carcinoma|Birt-Hogg-Dube syndrome 1,Deletion,GRCh38
na,na,17,17118542,17118542,FLCN,Pathogenic,Birt-Hogg-Dube syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial spontaneous pneumothorax|FLCN-related disorder|Birt-Hogg-Dube syndrome 1,single nucleotide variant,GRCh37
na,na,17,17215228,17215228,FLCN,Pathogenic,Birt-Hogg-Dube syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial spontaneous pneumothorax|FLCN-related disorder|Birt-Hogg-Dube syndrome 1,single nucleotide variant,GRCh38
na,na,17,17119716,17119717,FLCN,Pathogenic,Chromophobe renal cell carcinoma,Indel,GRCh37
na,na,17,17216402,17216403,FLCN,Pathogenic,Chromophobe renal cell carcinoma,Indel,GRCh38
na,na,17,17131216,17131216,FLCN,Uncertain significance,Carcinoma of colon|Birt-Hogg-Dube syndrome,single nucleotide variant,GRCh37
na,na,17,17227902,17227902,FLCN,Uncertain significance,Carcinoma of colon|Birt-Hogg-Dube syndrome,single nucleotide variant,GRCh38
na,na,17,17118598,17118598,FLCN,Conflicting classifications of pathogenicity,Carcinoma of colon|not provided|not specified|Hereditary cancer-predisposing syndrome|Birt-Hogg-Dube syndrome|Familial spontaneous pneumothorax|Birt-Hogg-Dube syndrome 1;Colorectal cancer;Nonpapillary renal cell carcinoma;17p11.2 microduplication syndrome;Familial spontaneous pneumothorax,single nucleotide variant,GRCh37
na,na,17,17215284,17215284,FLCN,Conflicting classifications of pathogenicity,Carcinoma of colon|not provided|not specified|Hereditary cancer-predisposing syndrome|Birt-Hogg-Dube syndrome|Familial spontaneous pneumothorax|Birt-Hogg-Dube syndrome 1;Colorectal cancer;Nonpapillary renal cell carcinoma;17p11.2 microduplication syndrome;Familial spontaneous pneumothorax,single nucleotide variant,GRCh38
na,na,17,17131214,17131217,FLCN,Pathogenic,Familial spontaneous pneumothorax|not provided|Hereditary cancer-predisposing syndrome|Birt-Hogg-Dube syndrome|Birt-Hogg-Dube syndrome 1,Deletion,GRCh37
na,na,17,17227900,17227903,FLCN,Pathogenic,Familial spontaneous pneumothorax|not provided|Hereditary cancer-predisposing syndrome|Birt-Hogg-Dube syndrome|Birt-Hogg-Dube syndrome 1,Deletion,GRCh38
na,na,17,17118301,17118304,FLCN,Pathogenic,Familial spontaneous pneumothorax|Birt-Hogg-Dube syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,17,17214987,17214990,FLCN,Pathogenic,Familial spontaneous pneumothorax|Birt-Hogg-Dube syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,17,17127450,17127450,FLCN,Pathogenic,Familial spontaneous pneumothorax|Birt-Hogg-Dube syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,17,17224136,17224136,FLCN,Pathogenic,Familial spontaneous pneumothorax|Birt-Hogg-Dube syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,17,17120384,17120403,FLCN,Pathogenic,Familial spontaneous pneumothorax,Deletion,GRCh37
na,na,17,17217070,17217089,FLCN,Pathogenic,Familial spontaneous pneumothorax,Deletion,GRCh38
na,na,17,17118627,17118637,FLCN,Likely pathogenic,Birt-Hogg-Dube syndrome 1|Birt-Hogg-Dube syndrome,Deletion,GRCh37
na,na,17,17215313,17215323,FLCN,Likely pathogenic,Birt-Hogg-Dube syndrome 1|Birt-Hogg-Dube syndrome,Deletion,GRCh38
na,na,17,17213654,17221536,FLCN,Pathogenic,Familial spontaneous pneumothorax,Deletion,GRCh38
na,na,4,5624708,5624709,EVC2,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome,Duplication,GRCh37
na,na,4,5622981,5622982,EVC2,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome,Duplication,GRCh38
na,na,4,5642516,5642516,EVC2,Pathogenic,Ellis-van Creveld syndrome|Short-rib thoracic dysplasia 6 with or without polydactyly|not provided|Ellis-van Creveld syndrome;Curry-Hall syndrome,single nucleotide variant,GRCh37
na,na,4,5640789,5640789,EVC2,Pathogenic,Ellis-van Creveld syndrome|Short-rib thoracic dysplasia 6 with or without polydactyly|not provided|Ellis-van Creveld syndrome;Curry-Hall syndrome,single nucleotide variant,GRCh38
na,na,4,5630317,5630317,EVC2,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|not provided,single nucleotide variant,GRCh37
na,na,4,5628590,5628590,EVC2,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|not provided,single nucleotide variant,GRCh38
na,na,4,5683009,5683009,EVC2,Pathogenic,Ellis-van Creveld syndrome,single nucleotide variant,GRCh37
na,na,4,5681282,5681282,EVC2,Pathogenic,Ellis-van Creveld syndrome,single nucleotide variant,GRCh38
na,na,4,5577974,5577974,EVC2,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,4,5576247,5576247,EVC2,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,4,5586559,5586559,EVC2,Uncertain significance,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|not provided,single nucleotide variant,GRCh37
na,na,4,5584832,5584832,EVC2,Uncertain significance,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome|not provided,single nucleotide variant,GRCh38
na,na,4,5564709,5564709,EVC2,Pathogenic,Curry-Hall syndrome,Deletion,GRCh37
na,na,4,5562982,5562982,EVC2,Pathogenic,Curry-Hall syndrome,Deletion,GRCh38
na,na,3,46747307,46747310,TMIE,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,Deletion,GRCh37
na,na,3,46705817,46705820,TMIE,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,Deletion,GRCh38
na,na,3,46750645,46750645,TMIE,Conflicting classifications of pathogenicity,"Autosomal recessive nonsyndromic hearing loss 6|Hearing loss, autosomal recessive|not provided|Sensorineural hearing loss disorder",single nucleotide variant,GRCh37
na,na,3,46709155,46709155,TMIE,Conflicting classifications of pathogenicity,"Autosomal recessive nonsyndromic hearing loss 6|Hearing loss, autosomal recessive|not provided|Sensorineural hearing loss disorder",single nucleotide variant,GRCh38
na,na,3,46750654,46750654,TMIE,Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 6|not provided|Sensorineural hearing loss disorder|Hearing impairment|Hearing loss, autosomal recessive",single nucleotide variant,GRCh37
na,na,3,46709164,46709164,TMIE,Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 6|not provided|Sensorineural hearing loss disorder|Hearing impairment|Hearing loss, autosomal recessive",single nucleotide variant,GRCh38
na,na,3,46750678,46750678,TMIE,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,single nucleotide variant,GRCh37
na,na,3,46709188,46709188,TMIE,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,single nucleotide variant,GRCh38
na,na,3,46747278,46747284,TMIE,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,Indel,GRCh37
na,na,3,46705788,46705794,TMIE,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,Indel,GRCh38
na,na,3,46747356,46747356,TMIE,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,single nucleotide variant,GRCh37
na,na,3,46705866,46705866,TMIE,Pathogenic,Autosomal recessive nonsyndromic hearing loss 6,single nucleotide variant,GRCh38
na,na,7,128577914,128577915,IRF5,risk factor,"Inflammatory bowel disease 14, susceptibility to|Systemic lupus erythematosus, susceptibility to, 10",Microsatellite,GRCh37
na,na,7,128937860,128937861,IRF5,risk factor,"Inflammatory bowel disease 14, susceptibility to|Systemic lupus erythematosus, susceptibility to, 10",Microsatellite,GRCh38
na,na,7,128578301,128578301,IRF5,Uncertain significance,"Systemic lupus erythematosus, susceptibility to, 10|Rheumatoid arthritis|Systemic lupus erythematosus",single nucleotide variant,GRCh37
na,na,7,128938247,128938247,IRF5,Uncertain significance,"Systemic lupus erythematosus, susceptibility to, 10|Rheumatoid arthritis|Systemic lupus erythematosus",single nucleotide variant,GRCh38
na,na,7,128589427,128589427,IRF5,risk factor,"Systemic lupus erythematosus, susceptibility to, 10",single nucleotide variant,GRCh37
na,na,7,128949373,128949373,IRF5,risk factor,"Systemic lupus erythematosus, susceptibility to, 10",single nucleotide variant,GRCh38
na,na,7,128589000,128589000,IRF5,risk factor,"Systemic lupus erythematosus, association with susceptibility to, 10",single nucleotide variant,GRCh37
na,na,7,128948946,128948946,IRF5,risk factor,"Systemic lupus erythematosus, association with susceptibility to, 10",single nucleotide variant,GRCh38
na,na,1,5947463,5947463,NPHP4,Pathogenic,Nephronophthisis 4|Nephronophthisis,single nucleotide variant,GRCh37
na,na,1,5887403,5887403,NPHP4,Pathogenic,Nephronophthisis 4|Nephronophthisis,single nucleotide variant,GRCh38
na,na,1,5947454,5947454,NPHP4,Pathogenic,Nephronophthisis 4|Nephronophthisis,single nucleotide variant,GRCh37
na,na,1,5887394,5887394,NPHP4,Pathogenic,Nephronophthisis 4|Nephronophthisis,single nucleotide variant,GRCh38
na,na,1,5964776,5964776,NPHP4,Pathogenic,"Nephronophthisis 4|Infertility disorder;Cerebello-oculo-renal syndrome (nephronophthisis, oculomotor apraxia and cerebellar abnormalities)|Nephronophthisis",single nucleotide variant,GRCh37
na,na,1,5904716,5904716,NPHP4,Pathogenic,"Nephronophthisis 4|Infertility disorder;Cerebello-oculo-renal syndrome (nephronophthisis, oculomotor apraxia and cerebellar abnormalities)|Nephronophthisis",single nucleotide variant,GRCh38
na,na,1,5935006,5935006,NPHP4,Pathogenic,Nephronophthisis 4,single nucleotide variant,GRCh37
na,na,1,5874946,5874946,NPHP4,Pathogenic,Nephronophthisis 4,single nucleotide variant,GRCh38
na,na,1,5933355,5933355,NPHP4,Pathogenic,Nephronophthisis 4|Nephronophthisis 4;Senior-Loken syndrome 4|not provided|Nephronophthisis|NPHP4-related disorder,Deletion,GRCh37
na,na,1,5873295,5873295,NPHP4,Pathogenic,Nephronophthisis 4|Nephronophthisis 4;Senior-Loken syndrome 4|not provided|Nephronophthisis|NPHP4-related disorder,Deletion,GRCh38
na,na,1,5947496,5947496,NPHP4,Pathogenic,Senior-Loken syndrome 4|Nephronophthisis,single nucleotide variant,GRCh37
na,na,1,5887436,5887436,NPHP4,Pathogenic,Senior-Loken syndrome 4|Nephronophthisis,single nucleotide variant,GRCh38
na,na,1,5964848,5964848,NPHP4,Pathogenic,Senior-Loken syndrome 4|Nephronophthisis|Nephronophthisis 4,single nucleotide variant,GRCh37
na,na,1,5904788,5904788,NPHP4,Pathogenic,Senior-Loken syndrome 4|Nephronophthisis|Nephronophthisis 4,single nucleotide variant,GRCh38
na,na,9,139264814,139264814,CARD9,Pathogenic,Predisposition to invasive fungal disease due to CARD9 deficiency,single nucleotide variant,GRCh37
na,na,9,136370362,136370362,CARD9,Pathogenic,Predisposition to invasive fungal disease due to CARD9 deficiency,single nucleotide variant,GRCh38
na,na,17,8012556,8012556,ALOXE3,Pathogenic,Autosomal recessive congenital ichthyosis 3,single nucleotide variant,GRCh37
na,na,17,8109238,8109238,ALOXE3,Pathogenic,Autosomal recessive congenital ichthyosis 3,single nucleotide variant,GRCh38
na,na,17,8015495,8015495,ALOXE3,Pathogenic,Autosomal recessive congenital ichthyosis 3|not provided|ALOXE3-related disorder|Autosomal recessive congenital ichthyosis 2;Autosomal recessive congenital ichthyosis 3,single nucleotide variant,GRCh37
na,na,17,8112177,8112177,ALOXE3,Pathogenic,Autosomal recessive congenital ichthyosis 3|not provided|ALOXE3-related disorder|Autosomal recessive congenital ichthyosis 2;Autosomal recessive congenital ichthyosis 3,single nucleotide variant,GRCh38
na,na,17,8013529,8013529,ALOXE3,Pathogenic,Autosomal recessive congenital ichthyosis 3,single nucleotide variant,GRCh37
na,na,17,8110211,8110211,ALOXE3,Pathogenic,Autosomal recessive congenital ichthyosis 3,single nucleotide variant,GRCh38
na,na,17,8015486,8015486,ALOXE3,Benign/Likely benign,Autosomal recessive congenital ichthyosis 3|not provided|not specified,single nucleotide variant,GRCh37
na,na,17,8112168,8112168,ALOXE3,Benign/Likely benign,Autosomal recessive congenital ichthyosis 3|not provided|not specified,single nucleotide variant,GRCh38
na,na,1,209969798,209969798,IRF6,Pathogenic,"Van der Woude syndrome 1|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to",single nucleotide variant,GRCh37
na,na,1,209796453,209796453,IRF6,Pathogenic,"Van der Woude syndrome 1|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to",single nucleotide variant,GRCh38
na,na,1,209964012,209964030,IRF6,Pathogenic,Van der Woude syndrome 1,Indel,GRCh37
na,na,1,209790667,209790685,IRF6,Pathogenic,Van der Woude syndrome 1,Indel,GRCh38
na,na,1,209963014,209963014,IRF6,Likely pathogenic,Popliteal pterygium syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,209789669,209789669,IRF6,Likely pathogenic,Popliteal pterygium syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,209969822,209969822,IRF6,Pathogenic,"Popliteal pterygium syndrome|not provided|Autosomal dominant popliteal pterygium syndrome|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to|IRF6-related condition",single nucleotide variant,GRCh37
na,na,1,209796477,209796477,IRF6,Pathogenic,"Popliteal pterygium syndrome|not provided|Autosomal dominant popliteal pterygium syndrome|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to|IRF6-related condition",single nucleotide variant,GRCh38
na,na,1,209969821,209969821,IRF6,Pathogenic,"Popliteal pterygium syndrome|not provided|Autosomal dominant popliteal pterygium syndrome|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to|Van der Woude syndrome 1",single nucleotide variant,GRCh37
na,na,1,209796476,209796476,IRF6,Pathogenic,"Popliteal pterygium syndrome|not provided|Autosomal dominant popliteal pterygium syndrome|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to|Van der Woude syndrome 1",single nucleotide variant,GRCh38
na,na,1,209974754,209974754,IRF6,Pathogenic,Van der Woude syndrome 1,single nucleotide variant,GRCh37
na,na,1,209801409,209801409,IRF6,Pathogenic,Van der Woude syndrome 1,single nucleotide variant,GRCh38
na,na,1,209974743,209974743,IRF6,Pathogenic/Likely pathogenic,"Van der Woude syndrome 1|Cleft palate|not provided|Orofacial cleft 6, susceptibility to;Popliteal pterygium syndrome;Van der Woude syndrome 1|IRF6-related condition",single nucleotide variant,GRCh37
na,na,1,209801398,209801398,IRF6,Pathogenic/Likely pathogenic,"Van der Woude syndrome 1|Cleft palate|not provided|Orofacial cleft 6, susceptibility to;Popliteal pterygium syndrome;Van der Woude syndrome 1|IRF6-related condition",single nucleotide variant,GRCh38
na,na,1,209963054,209963054,IRF6,Pathogenic,Van der Woude syndrome 1,single nucleotide variant,GRCh37
na,na,1,209789709,209789709,IRF6,Pathogenic,Van der Woude syndrome 1,single nucleotide variant,GRCh38
na,na,1,209961971,209961971,IRF6,Pathogenic,"Van der Woude syndrome 1|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to",single nucleotide variant,GRCh37
na,na,1,209788626,209788626,IRF6,Pathogenic,"Van der Woude syndrome 1|Van der Woude syndrome;Popliteal pterygium syndrome;Orofacial cleft 6, susceptibility to",single nucleotide variant,GRCh38
na,na,1,209955818,209972979,IRF6,Pathogenic,Van der Woude syndrome 1,Deletion,GRCh37
na,na,1,209782473,209799634,IRF6,Pathogenic,Van der Woude syndrome 1,Deletion,GRCh38
na,na,1,209974625,209974625,IRF6,Conflicting classifications of pathogenicity,"Van der Woude syndrome 1|not provided|Popliteal pterygium syndrome;Van der Woude syndrome;Orofacial cleft 6, susceptibility to|Van der Woude syndrome",single nucleotide variant,GRCh37
na,na,1,209801280,209801280,IRF6,Conflicting classifications of pathogenicity,"Van der Woude syndrome 1|not provided|Popliteal pterygium syndrome;Van der Woude syndrome;Orofacial cleft 6, susceptibility to|Van der Woude syndrome",single nucleotide variant,GRCh38
na,na,1,209961983,209961983,IRF6,Pathogenic,Van der Woude syndrome 1,single nucleotide variant,GRCh37
na,na,1,209788638,209788638,IRF6,Pathogenic,Van der Woude syndrome 1,single nucleotide variant,GRCh38
na,na,1,209963884,209963884,IRF6,Pathogenic,Van der Woude syndrome 1|Popliteal pterygium syndrome,single nucleotide variant,GRCh37
na,na,1,209790539,209790539,IRF6,Pathogenic,Van der Woude syndrome 1|Popliteal pterygium syndrome,single nucleotide variant,GRCh38
na,na,14,90459764,90459764,TDP1,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1|not provided",single nucleotide variant,GRCh37
na,na,14,89993420,89993420,TDP1,Pathogenic,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1|not provided",single nucleotide variant,GRCh38
na,na,10,23482734,23482734,PTF1A,Pathogenic,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,single nucleotide variant,GRCh37
na,na,10,23193805,23193805,PTF1A,Pathogenic,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,single nucleotide variant,GRCh38
na,na,10,23482158,23482159,PTF1A,Pathogenic,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,Duplication,GRCh37
na,na,10,23193229,23193230,PTF1A,Pathogenic,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,Duplication,GRCh38
na,na,3,9985136,9985136,CRELD1,Likely benign,"Atrioventricular septal defect, susceptibility to, 2|not provided",single nucleotide variant,GRCh37
na,na,3,9943452,9943452,CRELD1,Likely benign,"Atrioventricular septal defect, susceptibility to, 2|not provided",single nucleotide variant,GRCh38
na,na,3,9985083,9985083,CRELD1,Likely benign,"Atrioventricular septal defect, susceptibility to, 2|not provided",single nucleotide variant,GRCh37
na,na,3,9943399,9943399,CRELD1,Likely benign,"Atrioventricular septal defect, susceptibility to, 2|not provided",single nucleotide variant,GRCh38
na,na,3,9979308,9979308,CRELD1,Conflicting classifications of pathogenicity,"Atrioventricular septal defect, partial, with heterotaxy syndrome|not provided|Atrioventricular septal defect, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,3,9937624,9937624,CRELD1,Conflicting classifications of pathogenicity,"Atrioventricular septal defect, partial, with heterotaxy syndrome|not provided|Atrioventricular septal defect, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,3,9982557,9982557,CRELD1,risk factor,"Atrioventricular septal defect, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,3,9940873,9940873,CRELD1,risk factor,"Atrioventricular septal defect, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,3,9986240,9986240,CRELD1,risk factor,"Atrioventricular septal defect, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,3,9944556,9944556,CRELD1,risk factor,"Atrioventricular septal defect, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,6,15627622,15627622,DTNBP1,Pathogenic,Hermansky-Pudlak syndrome 7|not provided,single nucleotide variant,GRCh37
na,na,6,15627391,15627391,DTNBP1,Pathogenic,Hermansky-Pudlak syndrome 7|not provided,single nucleotide variant,GRCh38
na,na,22,50304127,50304127,ALG12,Likely pathogenic,ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,22,49910479,49910479,ALG12,Likely pathogenic,ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,22,50307128,50307128,ALG12,Conflicting classifications of pathogenicity,ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,22,49913480,49913480,ALG12,Conflicting classifications of pathogenicity,ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,22,50304114,50304114,ALG12,Pathogenic/Likely pathogenic,ALG12-congenital disorder of glycosylation|ALG12-related disorder|not provided,single nucleotide variant,GRCh37
na,na,22,49910466,49910466,ALG12,Pathogenic/Likely pathogenic,ALG12-congenital disorder of glycosylation|ALG12-related disorder|not provided,single nucleotide variant,GRCh38
na,na,22,50304250,50304250,ALG12,Likely pathogenic,ALG12-congenital disorder of glycosylation|not provided|ALG12-related disorder,single nucleotide variant,GRCh37
na,na,22,49910602,49910602,ALG12,Likely pathogenic,ALG12-congenital disorder of glycosylation|not provided|ALG12-related disorder,single nucleotide variant,GRCh38
na,na,22,50303733,50303733,ALG12,Pathogenic,ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,22,49910085,49910085,ALG12,Pathogenic,ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,22,50297711,50297711,ALG12,Pathogenic,ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,22,49904063,49904063,ALG12,Pathogenic,ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,na,-1,-1,FANCA,Pathogenic,Fanconi anemia complementation group A,Deletion,na
na,na,16,89858442,89858445,FANCA,Pathogenic,Fanconi anemia complementation group A|Fanconi anemia|not provided|FANCA-related disorder,Microsatellite,GRCh37
na,na,16,89792034,89792037,FANCA,Pathogenic,Fanconi anemia complementation group A|Fanconi anemia|not provided|FANCA-related disorder,Microsatellite,GRCh38
na,na,na,-1,-1,FANCA,Pathogenic,Fanconi anemia complementation group A,Deletion,na
na,na,na,-1,-1,FANCA,Pathogenic,Fanconi anemia complementation group A,Deletion,na
na,na,16,89849278,89849278,FANCA,Pathogenic,Fanconi anemia complementation group A|Fanconi anemia|not provided,Deletion,GRCh37
na,na,16,89782870,89782870,FANCA,Pathogenic,Fanconi anemia complementation group A|Fanconi anemia|not provided,Deletion,GRCh38
na,na,16,89811434,89811435,FANCA,Pathogenic,Fanconi anemia complementation group A|Fanconi anemia|not provided|FANCA-related disorder|Hereditary cancer-predisposing syndrome,Duplication,GRCh37
na,na,16,89745026,89745027,FANCA,Pathogenic,Fanconi anemia complementation group A|Fanconi anemia|not provided|FANCA-related disorder|Hereditary cancer-predisposing syndrome,Duplication,GRCh38
na,na,16,89817632,89861789,FANCA,Pathogenic,Fanconi anemia complementation group A,Deletion,GRCh37
na,na,16,89751224,89795381,FANCA,Pathogenic,Fanconi anemia complementation group A,Deletion,GRCh38
na,na,16,89849287,89849287,FANCA,Pathogenic,Fanconi anemia complementation group A,Deletion,GRCh37
na,na,16,89782879,89782879,FANCA,Pathogenic,Fanconi anemia complementation group A,Deletion,GRCh38
na,na,16,89877124,89877124,FANCA,Pathogenic,Fanconi anemia complementation group A,single nucleotide variant,GRCh37
na,na,16,89810716,89810716,FANCA,Pathogenic,Fanconi anemia complementation group A,single nucleotide variant,GRCh38
na,na,16,89809249,89809253,FANCA,Pathogenic,Fanconi anemia complementation group A|Fanconi anemia,Deletion,GRCh37
na,na,16,89742841,89742845,FANCA,Pathogenic,Fanconi anemia complementation group A|Fanconi anemia,Deletion,GRCh38
na,na,20,5283323,5283323,PROKR2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 3 with or without anosmia|not specified|not provided|Infertility disorder|Hypogonadotropic hypogonadism,single nucleotide variant,GRCh37
na,na,20,5302677,5302677,PROKR2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 3 with or without anosmia|not specified|not provided|Infertility disorder|Hypogonadotropic hypogonadism,single nucleotide variant,GRCh38
na,na,20,5283212,5283212,PROKR2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 3 with or without anosmia|not specified,single nucleotide variant,GRCh37
na,na,20,5302566,5302566,PROKR2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 3 with or without anosmia|not specified,single nucleotide variant,GRCh38
na,na,20,5294762,5294762,PROKR2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 3 with or without anosmia|not provided|Amenorrhea|Hypogonadism with anosmia|PROKR2-related disorder|not specified|Male infertility with azoospermia or oligozoospermia due to single gene mutation,single nucleotide variant,GRCh37
na,na,20,5314116,5314116,PROKR2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 3 with or without anosmia|not provided|Amenorrhea|Hypogonadism with anosmia|PROKR2-related disorder|not specified|Male infertility with azoospermia or oligozoospermia due to single gene mutation,single nucleotide variant,GRCh38
na,na,20,5294958,5294958,PROKR2,Pathogenic/Likely pathogenic,Hypogonadotropic hypogonadism 3 with or without anosmia|not provided|Inborn genetic diseases|not specified|Hypogonadotropic hypogonadism 2 with or without anosmia|PROKR2-related disorder,Deletion,GRCh37
na,na,20,5314312,5314312,PROKR2,Pathogenic/Likely pathogenic,Hypogonadotropic hypogonadism 3 with or without anosmia|not provided|Inborn genetic diseases|not specified|Hypogonadotropic hypogonadism 2 with or without anosmia|PROKR2-related disorder,Deletion,GRCh38
na,na,20,5282872,5282872,PROKR2,Pathogenic,Hypogonadotropic hypogonadism 3 with or without anosmia,single nucleotide variant,GRCh37
na,na,20,5302226,5302226,PROKR2,Pathogenic,Hypogonadotropic hypogonadism 3 with or without anosmia,single nucleotide variant,GRCh38
na,na,8,6266851,6266851,MCPH1,Pathogenic,"Microcephaly 1, primary, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,8,6409330,6409330,MCPH1,Pathogenic,"Microcephaly 1, primary, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,8,6293668,6293669,MCPH1,Pathogenic/Likely pathogenic,"Microcephaly 1, primary, autosomal recessive|Abnormal brain morphology",Duplication,GRCh37
na,na,8,6436147,6436148,MCPH1,Pathogenic/Likely pathogenic,"Microcephaly 1, primary, autosomal recessive|Abnormal brain morphology",Duplication,GRCh38
na,na,8,6264113,6299587,MCPH1,Pathogenic,"Microcephaly 1, primary, autosomal recessive",Deletion,GRCh37
na,na,8,6406592,6442066,MCPH1,Pathogenic,"Microcephaly 1, primary, autosomal recessive",Deletion,GRCh38
na,na,13,36903553,36903553,SPART,Pathogenic,Troyer syndrome|not provided|SPART-related disorder,Deletion,GRCh37
na,na,13,36329416,36329416,SPART,Pathogenic,Troyer syndrome|not provided|SPART-related disorder,Deletion,GRCh38
na,na,13,36909603,36909604,SPART,Pathogenic,Troyer syndrome|Inborn genetic diseases|not provided|Neurodevelopmental delay,Deletion,GRCh37
na,na,13,36335466,36335467,SPART,Pathogenic,Troyer syndrome|Inborn genetic diseases|not provided|Neurodevelopmental delay,Deletion,GRCh38
na,na,11,31815267,31815268,PAX6,Pathogenic,Aniridia 1,Duplication,GRCh37
na,na,11,31793719,31793720,PAX6,Pathogenic,Aniridia 1,Duplication,GRCh38
na,na,11,31815668,31815668,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh37
na,na,11,31794120,31794120,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh38
na,na,11,31822356,31822356,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh37
na,na,11,31800808,31800808,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh38
na,na,11,31812383,31812383,PAX6,Pathogenic,"Cataracts, congenital, with late-onset corneal dystrophy|Aniridia 1",single nucleotide variant,GRCh37
na,na,11,31790835,31790835,PAX6,Pathogenic,"Cataracts, congenital, with late-onset corneal dystrophy|Aniridia 1",single nucleotide variant,GRCh38
na,na,11,31824317,31824317,PAX6,Pathogenic/Likely pathogenic,"Aniridia 1|ANTERIOR SEGMENT DYSGENESIS 5, PETERS ANOMALY SUBTYPE|Coloboma, ocular, autosomal dominant",single nucleotide variant,GRCh37
na,na,11,31802769,31802769,PAX6,Pathogenic/Likely pathogenic,"Aniridia 1|ANTERIOR SEGMENT DYSGENESIS 5, PETERS ANOMALY SUBTYPE|Coloboma, ocular, autosomal dominant",single nucleotide variant,GRCh38
na,na,11,31823159,31823159,PAX6,Pathogenic,Aniridia 1|not provided|Irido-corneo-trabecular dysgenesis;Aniridia 1,single nucleotide variant,GRCh37
na,na,11,31801611,31801611,PAX6,Pathogenic,Aniridia 1|not provided|Irido-corneo-trabecular dysgenesis;Aniridia 1,single nucleotide variant,GRCh38
na,na,11,31812258,31812258,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh37
na,na,11,31790710,31790710,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh38
na,na,11,31816253,31816253,PAX6,Pathogenic,Aniridia 1;Irido-corneo-trabecular dysgenesis|Aniridia 1|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,11,31794705,31794705,PAX6,Pathogenic,Aniridia 1;Irido-corneo-trabecular dysgenesis|Aniridia 1|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,11,31815627,31815627,PAX6,Pathogenic,Aniridia 1|not provided|Aniridia 1;Irido-corneo-trabecular dysgenesis|Irido-corneo-trabecular dysgenesis,single nucleotide variant,GRCh37
na,na,11,31794079,31794079,PAX6,Pathogenic,Aniridia 1|not provided|Aniridia 1;Irido-corneo-trabecular dysgenesis|Irido-corneo-trabecular dysgenesis,single nucleotide variant,GRCh38
na,na,11,31812410,31812410,PAX6,Pathogenic,Aniridia 1|not provided|Aniridia 1;Irido-corneo-trabecular dysgenesis,single nucleotide variant,GRCh37
na,na,11,31790862,31790862,PAX6,Pathogenic,Aniridia 1|not provided|Aniridia 1;Irido-corneo-trabecular dysgenesis,single nucleotide variant,GRCh38
na,na,11,31815103,31815103,PAX6,Pathogenic,Autosomal dominant keratitis,single nucleotide variant,GRCh37
na,na,11,31793555,31793555,PAX6,Pathogenic,Autosomal dominant keratitis,single nucleotide variant,GRCh38
na,na,11,31822380,31822380,PAX6,Pathogenic/Likely pathogenic,Foveal hypoplasia 1|Aniridia 1|Aniridia 1;Irido-corneo-trabecular dysgenesis,single nucleotide variant,GRCh37
na,na,11,31800832,31800832,PAX6,Pathogenic/Likely pathogenic,Foveal hypoplasia 1|Aniridia 1|Aniridia 1;Irido-corneo-trabecular dysgenesis,single nucleotide variant,GRCh38
na,na,11,31822385,31822385,PAX6,Likely pathogenic,"Aniridia, atypical|Irido-corneo-trabecular dysgenesis;Aniridia 1|PAX6-related ocular dysgenesis",single nucleotide variant,GRCh37
na,na,11,31800837,31800837,PAX6,Likely pathogenic,"Aniridia, atypical|Irido-corneo-trabecular dysgenesis;Aniridia 1|PAX6-related ocular dysgenesis",single nucleotide variant,GRCh38
na,na,11,31823275,31823275,PAX6,Pathogenic,Foveal hypoplasia 1 with cataract|Aniridia 1,single nucleotide variant,GRCh37
na,na,11,31801727,31801727,PAX6,Pathogenic,Foveal hypoplasia 1 with cataract|Aniridia 1,single nucleotide variant,GRCh38
na,na,11,31823441,31823441,PAX6,Pathogenic,"ANTERIOR SEGMENT DYSGENESIS 5, MULTIPLE SUBTYPES|Foveal hypoplasia 1 with or without anterior segment anomalies",single nucleotide variant,GRCh37
na,na,11,31801893,31801893,PAX6,Pathogenic,"ANTERIOR SEGMENT DYSGENESIS 5, MULTIPLE SUBTYPES|Foveal hypoplasia 1 with or without anterior segment anomalies",single nucleotide variant,GRCh38
na,na,11,31811483,31811483,PAX6,Pathogenic/Likely pathogenic,Aniridia 1|not provided|Nystagmus;Visual impairment;Hypertelorism|8 conditions|Irido-corneo-trabecular dysgenesis;Aniridia 1|Foveal hypoplasia 1,single nucleotide variant,GRCh37
na,na,11,31789935,31789935,PAX6,Pathogenic/Likely pathogenic,Aniridia 1|not provided|Nystagmus;Visual impairment;Hypertelorism|8 conditions|Irido-corneo-trabecular dysgenesis;Aniridia 1|Foveal hypoplasia 1,single nucleotide variant,GRCh38
na,na,11,31823264,31823264,PAX6,Pathogenic,Coloboma of optic nerve,single nucleotide variant,GRCh37
na,na,11,31801716,31801716,PAX6,Pathogenic,Coloboma of optic nerve,single nucleotide variant,GRCh38
na,na,11,31816247,31816247,PAX6,Pathogenic,Isolated optic nerve hypoplasia|not provided|Irido-corneo-trabecular dysgenesis;Aniridia 1,single nucleotide variant,GRCh37
na,na,11,31794699,31794699,PAX6,Pathogenic,Isolated optic nerve hypoplasia|not provided|Irido-corneo-trabecular dysgenesis;Aniridia 1,single nucleotide variant,GRCh38
na,na,11,31815343,31815343,PAX6,Pathogenic,"Coloboma, ocular, autosomal dominant",single nucleotide variant,GRCh37
na,na,11,31793795,31793795,PAX6,Pathogenic,"Coloboma, ocular, autosomal dominant",single nucleotide variant,GRCh38
na,na,11,31812270,31812270,PAX6,Pathogenic,"Optic nerve aplasia, bilateral",single nucleotide variant,GRCh37
na,na,11,31790722,31790722,PAX6,Pathogenic,"Optic nerve aplasia, bilateral",single nucleotide variant,GRCh38
na,na,11,31827945,31827945,PAX6,Likely pathogenic,Foveal hypoplasia 1,single nucleotide variant,GRCh37
na,na,11,31806397,31806397,PAX6,Likely pathogenic,Foveal hypoplasia 1,single nucleotide variant,GRCh38
na,na,11,31815620,31815620,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh37
na,na,11,31794072,31794072,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh38
na,na,11,31823109,31823109,PAX6,Pathogenic/Likely pathogenic,Aniridia 1|not provided,single nucleotide variant,GRCh37
na,na,11,31801561,31801561,PAX6,Pathogenic/Likely pathogenic,Aniridia 1|not provided,single nucleotide variant,GRCh38
na,na,11,31832374,31832374,PAX6,Pathogenic,Aniridia 1;Irido-corneo-trabecular dysgenesis|Aniridia 1,single nucleotide variant,GRCh37
na,na,11,31810826,31810826,PAX6,Pathogenic,Aniridia 1;Irido-corneo-trabecular dysgenesis|Aniridia 1,single nucleotide variant,GRCh38
na,na,11,31815345,31815345,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh37
na,na,11,31793797,31793797,PAX6,Pathogenic,Aniridia 1,single nucleotide variant,GRCh38
na,na,11,32439179,32439195,WT1,Pathogenic,Wilms tumor 1,Deletion,GRCh37
na,na,11,32417633,32417649,WT1,Pathogenic,Wilms tumor 1,Deletion,GRCh38
na,na,11,32421513,32421513,WT1,Pathogenic,Wilms tumor 1,Deletion,GRCh37
na,na,11,32399967,32399967,WT1,Pathogenic,Wilms tumor 1,Deletion,GRCh38
na,na,11,32413512,32413512,WT1,Pathogenic,Frasier syndrome,single nucleotide variant,GRCh37
na,na,11,32391966,32391966,WT1,Pathogenic,Frasier syndrome,single nucleotide variant,GRCh38
na,na,11,32413566,32413566,WT1,Pathogenic/Likely pathogenic,"Drash syndrome|Meacham syndrome|Nephrotic syndrome, type 4|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|not provided|Steroid-resistant nephrotic syndrome;Nephrotic range proteinuria|Kidney disorder|Wilms tumor 1|WT1-related disorder|6 conditions",single nucleotide variant,GRCh37
na,na,11,32392020,32392020,WT1,Pathogenic/Likely pathogenic,"Drash syndrome|Meacham syndrome|Nephrotic syndrome, type 4|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|not provided|Steroid-resistant nephrotic syndrome;Nephrotic range proteinuria|Kidney disorder|Wilms tumor 1|WT1-related disorder|6 conditions",single nucleotide variant,GRCh38
na,na,11,32414250,32414250,WT1,Pathogenic,"Drash syndrome|not provided|Wilms tumor 1;Drash syndrome;Frasier syndrome;Nephrotic syndrome, type 4|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Nephrotic syndrome, type 4|Wilms tumor 1|8 conditions",single nucleotide variant,GRCh37
na,na,11,32392704,32392704,WT1,Pathogenic,"Drash syndrome|not provided|Wilms tumor 1;Drash syndrome;Frasier syndrome;Nephrotic syndrome, type 4|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Nephrotic syndrome, type 4|Wilms tumor 1|8 conditions",single nucleotide variant,GRCh38
na,na,11,32413559,32413559,WT1,Likely pathogenic,Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome,single nucleotide variant,GRCh37
na,na,11,32392013,32392013,WT1,Likely pathogenic,Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome,single nucleotide variant,GRCh38
na,na,11,32413560,32413560,WT1,Pathogenic,"Drash syndrome|Nephrotic syndrome, type 4|not provided",single nucleotide variant,GRCh37
na,na,11,32392014,32392014,WT1,Pathogenic,"Drash syndrome|Nephrotic syndrome, type 4|not provided",single nucleotide variant,GRCh38
na,na,11,32413565,32413565,WT1,Pathogenic,Drash syndrome|WT1-related disorder,single nucleotide variant,GRCh37
na,na,11,32392019,32392019,WT1,Pathogenic,Drash syndrome|WT1-related disorder,single nucleotide variant,GRCh38
na,na,11,32417859,32417859,WT1,Pathogenic,Drash syndrome,single nucleotide variant,GRCh37
na,na,11,32396313,32396313,WT1,Pathogenic,Drash syndrome,single nucleotide variant,GRCh38
na,na,11,32413513,32413513,WT1,Pathogenic,"Drash syndrome|Frasier syndrome|Familial idiopathic steroid-resistant nephrotic syndrome|Nephrotic syndrome, type 4|Drash syndrome;Wilms tumor 1;11p partial monosomy syndrome;Frasier syndrome|Wilms tumor 1|not provided|WT1-related disorder|6 conditions|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,11,32391967,32391967,WT1,Pathogenic,"Drash syndrome|Frasier syndrome|Familial idiopathic steroid-resistant nephrotic syndrome|Nephrotic syndrome, type 4|Drash syndrome;Wilms tumor 1;11p partial monosomy syndrome;Frasier syndrome|Wilms tumor 1|not provided|WT1-related disorder|6 conditions|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,11,32413578,32413578,WT1,Pathogenic,Wilms tumor 1|Frasier syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|not provided|Focal segmental glomerulosclerosis|6 conditions,single nucleotide variant,GRCh37
na,na,11,32392032,32392032,WT1,Pathogenic,Wilms tumor 1|Frasier syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|not provided|Focal segmental glomerulosclerosis|6 conditions,single nucleotide variant,GRCh38
na,na,11,32414218,32414218,WT1,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 4|Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome",single nucleotide variant,GRCh37
na,na,11,32392672,32392672,WT1,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 4|Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome",single nucleotide variant,GRCh38
na,na,11,32414269,32414269,WT1,Likely pathogenic,Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome,single nucleotide variant,GRCh37
na,na,11,32392723,32392723,WT1,Likely pathogenic,Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome,single nucleotide variant,GRCh38
na,na,11,32414263,32414263,WT1,Pathogenic,Drash syndrome|Wilms tumor 1|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|8 conditions|not provided|6 conditions,single nucleotide variant,GRCh37
na,na,11,32392717,32392717,WT1,Pathogenic,Drash syndrome|Wilms tumor 1|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|8 conditions|not provided|6 conditions,single nucleotide variant,GRCh38
na,na,11,32414228,32414228,WT1,Pathogenic,Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome,single nucleotide variant,GRCh37
na,na,11,32392682,32392682,WT1,Pathogenic,Drash syndrome|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome,single nucleotide variant,GRCh38
na,na,11,32421571,32421571,WT1,Pathogenic,Mesothelioma,single nucleotide variant,GRCh37
na,na,11,32400025,32400025,WT1,Pathogenic,Mesothelioma,single nucleotide variant,GRCh38
na,na,11,32413514,32413514,WT1,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 4|Frasier syndrome|Familial idiopathic steroid-resistant nephrotic syndrome|not provided|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Nephrotic range proteinuria|Wilms tumor 1|WT1-related disorder|6 conditions",single nucleotide variant,GRCh37
na,na,11,32391968,32391968,WT1,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 4|Frasier syndrome|Familial idiopathic steroid-resistant nephrotic syndrome|not provided|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Nephrotic range proteinuria|Wilms tumor 1|WT1-related disorder|6 conditions",single nucleotide variant,GRCh38
na,na,11,32413599,32413599,WT1,Pathogenic,"Nephrotic syndrome, type 4",single nucleotide variant,GRCh37
na,na,11,32392053,32392053,WT1,Pathogenic,"Nephrotic syndrome, type 4",single nucleotide variant,GRCh38
na,na,11,32413572,32413572,WT1,Pathogenic,Frasier syndrome,single nucleotide variant,GRCh37
na,na,11,32392026,32392026,WT1,Pathogenic,Frasier syndrome,single nucleotide variant,GRCh38
na,na,11,32414251,32414251,WT1,Pathogenic,"Meacham syndrome|not provided|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Nephrotic syndrome, type 4",single nucleotide variant,GRCh37
na,na,11,32392705,32392705,WT1,Pathogenic,"Meacham syndrome|not provided|Wilms tumor 1;Drash syndrome;11p partial monosomy syndrome;Frasier syndrome|Nephrotic syndrome, type 4",single nucleotide variant,GRCh38
na,na,11,32456361,32456361,WT1,Pathogenic,Wilms tumor 1,single nucleotide variant,GRCh37
na,na,11,32434815,32434815,WT1,Pathogenic,Wilms tumor 1,single nucleotide variant,GRCh38
na,na,2,110886762,110886762,NPHP1,Pathogenic/Likely pathogenic,Nephronophthisis 1|Nephronophthisis|Joubert syndrome with renal defect|Joubert syndrome with renal defect;Nephronophthisis 1;Senior-Loken syndrome 1,single nucleotide variant,GRCh37
na,na,2,110129185,110129185,NPHP1,Pathogenic/Likely pathogenic,Nephronophthisis 1|Nephronophthisis|Joubert syndrome with renal defect|Joubert syndrome with renal defect;Nephronophthisis 1;Senior-Loken syndrome 1,single nucleotide variant,GRCh38
na,na,2,110959061,110959061,NPHP1,Pathogenic,Nephronophthisis 1|Nephronophthisis,single nucleotide variant,GRCh37
na,na,2,110201484,110201484,NPHP1,Pathogenic,Nephronophthisis 1|Nephronophthisis,single nucleotide variant,GRCh38
na,na,2,110920625,110920625,NPHP1,Pathogenic,Nephronophthisis 1|not provided|Nephronophthisis|NPHP1-related disorder|Joubert syndrome with renal defect|Inborn genetic diseases|Joubert syndrome with renal defect;Nephronophthisis 1;Senior-Loken syndrome 1|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,110163048,110163048,NPHP1,Pathogenic,Nephronophthisis 1|not provided|Nephronophthisis|NPHP1-related disorder|Joubert syndrome with renal defect|Inborn genetic diseases|Joubert syndrome with renal defect;Nephronophthisis 1;Senior-Loken syndrome 1|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,64361219,64361219,SLC22A12,Pathogenic,Dalmatian hypouricemia|not provided|SLC22A12-related disorder,single nucleotide variant,GRCh37
na,na,11,64593747,64593747,SLC22A12,Pathogenic,Dalmatian hypouricemia|not provided|SLC22A12-related disorder,single nucleotide variant,GRCh38
na,na,11,64361020,64361020,SLC22A12,Likely pathogenic,Dalmatian hypouricemia|not provided,single nucleotide variant,GRCh37
na,na,11,64593548,64593548,SLC22A12,Likely pathogenic,Dalmatian hypouricemia|not provided,single nucleotide variant,GRCh38
na,na,11,64366051,64366051,SLC22A12,Pathogenic,Dalmatian hypouricemia,single nucleotide variant,GRCh37
na,na,11,64598579,64598579,SLC22A12,Pathogenic,Dalmatian hypouricemia,single nucleotide variant,GRCh38
na,na,11,64367330,64367330,SLC22A12,Pathogenic,Dalmatian hypouricemia,single nucleotide variant,GRCh37
na,na,11,64599858,64599858,SLC22A12,Pathogenic,Dalmatian hypouricemia,single nucleotide variant,GRCh38
na,na,11,64359297,64359297,SLC22A12,Pathogenic,Dalmatian hypouricemia|Familial renal hypouricemia|not provided,single nucleotide variant,GRCh37
na,na,11,64591825,64591825,SLC22A12,Pathogenic,Dalmatian hypouricemia|Familial renal hypouricemia|not provided,single nucleotide variant,GRCh38
na,na,11,64367159,64367159,SLC22A12,Pathogenic,Dalmatian hypouricemia,single nucleotide variant,GRCh37
na,na,11,64599687,64599687,SLC22A12,Pathogenic,Dalmatian hypouricemia,single nucleotide variant,GRCh38
na,na,1,11860308,11860308,MTHFR,Pathogenic,Abnormality of metabolism/homeostasis|Homocystinuria due to methylene tetrahydrofolate reductase deficiency,single nucleotide variant,GRCh37
na,na,1,11800251,11800251,MTHFR,Pathogenic,Abnormality of metabolism/homeostasis|Homocystinuria due to methylene tetrahydrofolate reductase deficiency,single nucleotide variant,GRCh38
na,na,1,11861223,11861223,MTHFR,Pathogenic/Likely pathogenic,"Homocystinuria due to methylene tetrahydrofolate reductase deficiency|Neural tube defects, folate-sensitive;Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Schizophrenia;Thrombophilia due to thrombin defect|Neural tube defects, folate-sensitive|not provided",single nucleotide variant,GRCh37
na,na,1,11801166,11801166,MTHFR,Pathogenic/Likely pathogenic,"Homocystinuria due to methylene tetrahydrofolate reductase deficiency|Neural tube defects, folate-sensitive;Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Schizophrenia;Thrombophilia due to thrombin defect|Neural tube defects, folate-sensitive|not provided",single nucleotide variant,GRCh38
na,na,1,11856378,11856378,MTHFR,drug response,"MTHFR THERMOLABILE POLYMORPHISM|not provided|Gastrointestinal stromal tumor|Neural tube defects, folate-sensitive|not specified|Homocystinuria due to methylene tetrahydrofolate reductase deficiency|methotrexate response - Toxicity|See cases|Thrombophilia due to thrombin defect",single nucleotide variant,GRCh37
na,na,1,11796321,11796321,MTHFR,drug response,"MTHFR THERMOLABILE POLYMORPHISM|not provided|Gastrointestinal stromal tumor|Neural tube defects, folate-sensitive|not specified|Homocystinuria due to methylene tetrahydrofolate reductase deficiency|methotrexate response - Toxicity|See cases|Thrombophilia due to thrombin defect",single nucleotide variant,GRCh38
na,na,1,11854476,11854476,MTHFR,Benign/Likely benign; other,"Schizophrenia, susceptibility to|MTHFR THERMOLABILE POLYMORPHISM|not provided|Gastrointestinal stromal tumor|Neural tube defects, folate-sensitive|not specified|Homocystinuria due to methylene tetrahydrofolate reductase deficiency|MTHFR-related disorder|Schizophrenia;Thrombophilia due to thrombin defect;Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Neural tube defects, folate-sensitive",single nucleotide variant,GRCh37
na,na,1,11794419,11794419,MTHFR,Benign/Likely benign; other,"Schizophrenia, susceptibility to|MTHFR THERMOLABILE POLYMORPHISM|not provided|Gastrointestinal stromal tumor|Neural tube defects, folate-sensitive|not specified|Homocystinuria due to methylene tetrahydrofolate reductase deficiency|MTHFR-related disorder|Schizophrenia;Thrombophilia due to thrombin defect;Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Neural tube defects, folate-sensitive",single nucleotide variant,GRCh38
na,na,1,11855215,11855215,MTHFR,Likely pathogenic,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,single nucleotide variant,GRCh37
na,na,1,11795158,11795158,MTHFR,Likely pathogenic,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,single nucleotide variant,GRCh38
na,na,1,11855171,11855171,MTHFR,Pathogenic,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,single nucleotide variant,GRCh37
na,na,1,11795114,11795114,MTHFR,Pathogenic,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,MTHFR,Pathogenic,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,single nucleotide variant,na
na,na,1,11851273,11851273,MTHFR,Uncertain significance,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,single nucleotide variant,GRCh37
na,na,1,11791216,11791216,MTHFR,Uncertain significance,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,single nucleotide variant,GRCh38
na,na,1,11854823,11854823,MTHFR,Conflicting classifications of pathogenicity,"Homocystinuria due to methylene tetrahydrofolate reductase deficiency|not provided|Neural tube defects, folate-sensitive",single nucleotide variant,GRCh37
na,na,1,11794766,11794766,MTHFR,Conflicting classifications of pathogenicity,"Homocystinuria due to methylene tetrahydrofolate reductase deficiency|not provided|Neural tube defects, folate-sensitive",single nucleotide variant,GRCh38
na,na,1,11855218,11855218,MTHFR,Pathogenic/Likely pathogenic,"Homocystinuria due to methylene tetrahydrofolate reductase deficiency|Neural tube defects, folate-sensitive|Neural tube defects, folate-sensitive;Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Schizophrenia;Thrombophilia due to thrombin defect",single nucleotide variant,GRCh37
na,na,1,11795161,11795161,MTHFR,Pathogenic/Likely pathogenic,"Homocystinuria due to methylene tetrahydrofolate reductase deficiency|Neural tube defects, folate-sensitive|Neural tube defects, folate-sensitive;Homocystinuria due to methylene tetrahydrofolate reductase deficiency;Schizophrenia;Thrombophilia due to thrombin defect",single nucleotide variant,GRCh38
na,na,3,50339586,50339586,HYAL1,Uncertain significance,Deficiency of hyaluronoglucosaminidase,single nucleotide variant,GRCh37
na,na,3,50302155,50302155,HYAL1,Uncertain significance,Deficiency of hyaluronoglucosaminidase,single nucleotide variant,GRCh38
na,na,3,50339601,50339637,HYAL1,Pathogenic,Deficiency of hyaluronoglucosaminidase,Indel,GRCh37
na,na,3,50302170,50302206,HYAL1,Pathogenic,Deficiency of hyaluronoglucosaminidase,Indel,GRCh38
na,na,17,39973378,39973410,FKBP10,Pathogenic,Osteogenesis imperfecta type 12|not provided,Deletion,GRCh37
na,na,17,41817126,41817158,FKBP10,Pathogenic,Osteogenesis imperfecta type 12|not provided,Deletion,GRCh38
na,na,8,145639401,145639405,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,Deletion,GRCh37
na,na,8,144414017,144414021,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,Deletion,GRCh38
na,na,8,145640112,145640115,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,Deletion,GRCh37
na,na,8,144414728,144414731,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,Deletion,GRCh38
na,na,8,145640822,145640822,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh37
na,na,8,144415438,144415438,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh38
na,na,8,145640679,145640679,SLC39A4,Pathogenic/Likely pathogenic,Hereditary acrodermatitis enteropathica|not provided|SLC39A4-related disorder,single nucleotide variant,GRCh37
na,na,8,144415295,144415295,SLC39A4,Pathogenic/Likely pathogenic,Hereditary acrodermatitis enteropathica|not provided|SLC39A4-related disorder,single nucleotide variant,GRCh38
na,na,8,145638672,145638672,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh37
na,na,8,144413288,144413288,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh38
na,na,8,145639675,145639675,SLC39A4,Likely pathogenic,Hereditary acrodermatitis enteropathica|not provided,single nucleotide variant,GRCh37
na,na,8,144414291,144414291,SLC39A4,Likely pathogenic,Hereditary acrodermatitis enteropathica|not provided,single nucleotide variant,GRCh38
na,na,8,145641350,145641350,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh37
na,na,8,144415966,144415966,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh38
na,na,na,-1,-1,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,Deletion,na
na,na,8,145639806,145639806,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh37
na,na,8,144414422,144414422,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh38
na,na,8,145639724,145639725,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,Duplication,GRCh37
na,na,8,144414340,144414341,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,Duplication,GRCh38
na,na,8,145641385,145641385,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica|not provided,single nucleotide variant,GRCh37
na,na,8,144416001,144416001,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica|not provided,single nucleotide variant,GRCh38
na,na,8,145640176,145640176,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh37
na,na,8,144414792,144414792,SLC39A4,Pathogenic,Hereditary acrodermatitis enteropathica,single nucleotide variant,GRCh38
na,na,3,100994538,100994538,IMPG2,Pathogenic,Retinitis pigmentosa 56|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,3,101275694,101275694,IMPG2,Pathogenic,Retinitis pigmentosa 56|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,3,100986081,100987929,IMPG2,Likely pathogenic,Retinitis pigmentosa 56|Retinal dystrophy,Deletion,GRCh37
na,na,3,101267237,101269085,IMPG2,Likely pathogenic,Retinitis pigmentosa 56|Retinal dystrophy,Deletion,GRCh38
na,na,3,100962459,100962459,IMPG2,Pathogenic,Retinitis pigmentosa 56|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,101243615,101243615,IMPG2,Pathogenic,Retinitis pigmentosa 56|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,100961664,100961664,IMPG2,Pathogenic,Retinitis pigmentosa 56|Macular dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,101242820,101242820,IMPG2,Pathogenic,Retinitis pigmentosa 56|Macular dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,101023121,101023121,IMPG2,Conflicting classifications of pathogenicity,Vitelliform macular dystrophy 5|not provided|Retinitis pigmentosa|Retinitis pigmentosa 56|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,101304277,101304277,IMPG2,Conflicting classifications of pathogenicity,Vitelliform macular dystrophy 5|not provided|Retinitis pigmentosa|Retinitis pigmentosa 56|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,14,92537355,92537357,ATXN3,Pathogenic; risk factor,"Azorean disease|Parkinson disease, late-onset",Microsatellite,GRCh37
na,na,14,92071011,92071013,ATXN3,Pathogenic; risk factor,"Azorean disease|Parkinson disease, late-onset",Microsatellite,GRCh38
na,na,16,28497286,28498251,CLN3,Pathogenic,Neuronal ceroid lipofuscinosis 3|not provided|Retinitis pigmentosa,Deletion,GRCh37
na,na,16,28485965,28486930,CLN3,Pathogenic,Neuronal ceroid lipofuscinosis 3|not provided|Retinitis pigmentosa,Deletion,GRCh38
na,na,na,-1,-1,CLN3,Pathogenic,Neuronal ceroid lipofuscinosis 3,Deletion,na
na,na,na,-1,-1,CLN3,Pathogenic,Neuronal ceroid lipofuscinosis 3,Deletion,na
na,na,16,28493821,28493821,CLN3,Pathogenic,"Ceroid lipofuscinosis, neuronal, 3, protracted|Neuronal ceroid lipofuscinosis 3|Retinal dystrophy|Neuronal ceroid lipofuscinosis|early onset and severe retinal dystrophy|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,16,28482500,28482500,CLN3,Pathogenic,"Ceroid lipofuscinosis, neuronal, 3, protracted|Neuronal ceroid lipofuscinosis 3|Retinal dystrophy|Neuronal ceroid lipofuscinosis|early onset and severe retinal dystrophy|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,16,28497748,28497748,CLN3,Pathogenic,"Ceroid lipofuscinosis, neuronal, 3, protracted|Neuronal ceroid lipofuscinosis 3|not provided|Neuronal ceroid lipofuscinosis",single nucleotide variant,GRCh37
na,na,16,28486427,28486427,CLN3,Pathogenic,"Ceroid lipofuscinosis, neuronal, 3, protracted|Neuronal ceroid lipofuscinosis 3|not provided|Neuronal ceroid lipofuscinosis",single nucleotide variant,GRCh38
na,na,16,48258198,48258198,ABCC11,Benign,"APOCRINE GLAND SECRETION, VARIATION IN|Axillary odor|Colostrum secretion|not provided",single nucleotide variant,GRCh37
na,na,16,48224287,48224287,ABCC11,Benign,"APOCRINE GLAND SECRETION, VARIATION IN|Axillary odor|Colostrum secretion|not provided",single nucleotide variant,GRCh38
na,na,16,48201498,48201524,ABCC11,Affects,"APOCRINE GLAND SECRETION, VARIATION IN",Deletion,GRCh37
na,na,16,48167587,48167613,ABCC11,Affects,"APOCRINE GLAND SECRETION, VARIATION IN",Deletion,GRCh38
na,na,16,21721426,21721426,OTOA,Pathogenic,Autosomal recessive nonsyndromic hearing loss 22|not provided,single nucleotide variant,GRCh37
na,na,16,21710105,21710105,OTOA,Pathogenic,Autosomal recessive nonsyndromic hearing loss 22|not provided,single nucleotide variant,GRCh38
na,na,16,21419562,21746863,OTOA,Pathogenic,Autosomal recessive nonsyndromic hearing loss 22,Deletion,NCBI36
na,na,15,40698153,40698153,IVD,Pathogenic,"Isovaleric acidemia, type I",single nucleotide variant,GRCh37
na,na,15,40405952,40405952,IVD,Pathogenic,"Isovaleric acidemia, type I",single nucleotide variant,GRCh38
na,na,15,40703799,40703799,IVD,Pathogenic/Likely pathogenic,"Isovaleric acidemia, type I|not provided|Isovaleryl-CoA dehydrogenase deficiency",single nucleotide variant,GRCh37
na,na,15,40411600,40411600,IVD,Pathogenic/Likely pathogenic,"Isovaleric acidemia, type I|not provided|Isovaleryl-CoA dehydrogenase deficiency",single nucleotide variant,GRCh38
na,na,na,-1,-1,IVD,Pathogenic,"Isovaleric acidemia, type II",Deletion,na
na,na,15,40699840,40699840,IVD,Pathogenic/Likely pathogenic,Isovaleryl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,15,40407639,40407639,IVD,Pathogenic/Likely pathogenic,Isovaleryl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,15,40707653,40707653,IVD,Pathogenic,Isovaleryl-CoA dehydrogenase deficiency|not provided|IVD-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,15,40415454,40415454,IVD,Pathogenic,Isovaleryl-CoA dehydrogenase deficiency|not provided|IVD-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,10,104263953,104263953,SUFU,Uncertain significance,Medulloblastoma|not provided,single nucleotide variant,GRCh37
na,na,10,102504196,102504196,SUFU,Uncertain significance,Medulloblastoma|not provided,single nucleotide variant,GRCh38
na,na,10,104264051,104264052,SUFU,Pathogenic,Medulloblastoma,Duplication,GRCh37
na,na,10,102504294,102504295,SUFU,Pathogenic,Medulloblastoma,Duplication,GRCh38
na,na,10,104359302,104359302,SUFU,Pathogenic,not provided|Basal cell nevus syndrome 2|SUFU-related disorder|Gorlin syndrome;Medulloblastoma|Medulloblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,10,102599545,102599545,SUFU,Pathogenic,not provided|Basal cell nevus syndrome 2|SUFU-related disorder|Gorlin syndrome;Medulloblastoma|Medulloblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,10,102444036,104726221,SUFU,Pathogenic,Desmoplastic/nodular medulloblastoma,Deletion,GRCh38
na,na,10,104263974,104263974,SUFU,Pathogenic,Medulloblastoma;Gorlin syndrome|not provided|Hereditary cancer-predisposing syndrome|Medulloblastoma|Basal cell nevus syndrome 2,Deletion,GRCh37
na,na,10,102504217,102504217,SUFU,Pathogenic,Medulloblastoma;Gorlin syndrome|not provided|Hereditary cancer-predisposing syndrome|Medulloblastoma|Basal cell nevus syndrome 2,Deletion,GRCh38
na,na,10,104263973,104263974,SUFU,Pathogenic,Medulloblastoma;Gorlin syndrome|Medulloblastoma|Hereditary cancer-predisposing syndrome,Duplication,GRCh37
na,na,10,102504216,102504217,SUFU,Pathogenic,Medulloblastoma;Gorlin syndrome|Medulloblastoma|Hereditary cancer-predisposing syndrome,Duplication,GRCh38
na,na,9,77417054,77417054,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh37
na,na,9,74802138,74802138,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh38
na,na,9,77431613,77431613,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,Deletion,GRCh37
na,na,9,74816697,74816697,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,Deletion,GRCh38
na,na,9,77377796,77377808,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,Deletion,GRCh37
na,na,9,74762880,74762892,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,Deletion,GRCh38
na,na,9,77415200,77415200,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,Deletion,GRCh37
na,na,9,74800284,74800284,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,Deletion,GRCh38
na,na,9,77416813,77416813,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh37
na,na,9,74801897,74801897,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh38
na,na,9,77427238,77427238,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh37
na,na,9,74812322,74812322,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh38
na,na,9,77457246,77457246,TRPM6,Pathogenic/Likely pathogenic,Intestinal hypomagnesemia 1|not provided,single nucleotide variant,GRCh37
na,na,9,74842330,74842330,TRPM6,Pathogenic/Likely pathogenic,Intestinal hypomagnesemia 1|not provided,single nucleotide variant,GRCh38
na,na,9,77436580,77436580,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh37
na,na,9,74821664,74821664,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh38
na,na,na,-1,-1,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,na
na,na,9,77455062,77455062,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh37
na,na,9,74840146,74840146,TRPM6,Pathogenic,Intestinal hypomagnesemia 1,single nucleotide variant,GRCh38
na,na,1,76226846,76226846,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|Epileptic spasm|See cases|Inborn genetic diseases|ACADM-related disorder,single nucleotide variant,GRCh37
na,na,1,75761161,75761161,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|Epileptic spasm|See cases|Inborn genetic diseases|ACADM-related disorder,single nucleotide variant,GRCh38
na,na,1,76226858,76226859,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder,Duplication,GRCh37
na,na,1,75761173,75761174,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder,Duplication,GRCh38
na,na,1,76215194,76215194,ACADM,Pathogenic/Likely pathogenic,not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency|ACADM-related disorder,single nucleotide variant,GRCh37
na,na,1,75749509,75749509,ACADM,Pathogenic/Likely pathogenic,not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency|ACADM-related disorder,single nucleotide variant,GRCh38
na,na,1,76226985,76226985,ACADM,Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,1,75761300,75761300,ACADM,Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,1,76215125,76215125,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,1,75749440,75749440,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,1,76200535,76200535,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder,single nucleotide variant,GRCh37
na,na,1,75734850,75734850,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder,single nucleotide variant,GRCh38
na,na,1,76226961,76226964,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder|Inborn genetic diseases,Deletion,GRCh37
na,na,1,75761276,75761279,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder|Inborn genetic diseases,Deletion,GRCh38
na,na,1,76199268,76199273,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,Deletion,GRCh37
na,na,1,75733583,75733588,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,Deletion,GRCh38
na,na,1,76205779,76205779,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,75740094,75740094,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,76205773,76205773,ACADM,Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,1,75740088,75740088,ACADM,Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,1,76215237,76215237,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,1,75749552,75749552,ACADM,Pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,1,76198409,76198409,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,1,75732724,75732724,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,76215129,76215129,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,75749444,75749444,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,76199288,76199288,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder,single nucleotide variant,GRCh37
na,na,1,75733603,75733603,ACADM,Pathogenic/Likely pathogenic,Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided|ACADM-related disorder,single nucleotide variant,GRCh38
na,na,3,71834110,71834110,PROK2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 4 with or without anosmia|PROK2-related disorder,single nucleotide variant,GRCh37
na,na,3,71784959,71784959,PROK2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 4 with or without anosmia|PROK2-related disorder,single nucleotide variant,GRCh38
na,na,3,71830677,71830677,PROK2,Pathogenic,Hypogonadotropic hypogonadism 4 with or without anosmia|not provided|Male infertility with azoospermia or oligozoospermia due to single gene mutation|PROK2-related disorder|Inborn genetic diseases,Deletion,GRCh37
na,na,3,71781526,71781526,PROK2,Pathogenic,Hypogonadotropic hypogonadism 4 with or without anosmia|not provided|Male infertility with azoospermia or oligozoospermia due to single gene mutation|PROK2-related disorder|Inborn genetic diseases,Deletion,GRCh38
na,na,3,71830623,71830623,PROK2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 4 with or without anosmia|not provided|PROK2-related disorder,single nucleotide variant,GRCh37
na,na,3,71781472,71781472,PROK2,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 4 with or without anosmia|not provided|PROK2-related disorder,single nucleotide variant,GRCh38
na,na,9,140712552,140712552,EHMT1,Pathogenic/Likely pathogenic,Kleefstra syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,9,137818100,137818100,EHMT1,Pathogenic/Likely pathogenic,Kleefstra syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,9,140652371,140652383,EHMT1,Pathogenic,Kleefstra syndrome 1,Deletion,GRCh37
na,na,9,137757919,137757931,EHMT1,Pathogenic,Kleefstra syndrome 1,Deletion,GRCh38
na,na,9,140708920,140708920,EHMT1,Pathogenic,Kleefstra syndrome 1,single nucleotide variant,GRCh37
na,na,9,137814468,137814468,EHMT1,Pathogenic,Kleefstra syndrome 1,single nucleotide variant,GRCh38
na,na,9,140637870,140637870,EHMT1,Pathogenic,Kleefstra syndrome 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,137743418,137743418,EHMT1,Pathogenic,Kleefstra syndrome 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,34647876,34647876,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|GALT-related disorder,single nucleotide variant,GRCh37
na,na,9,34647879,34647879,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|GALT-related disorder,single nucleotide variant,GRCh38
na,na,9,34649499,34649499,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia,single nucleotide variant,GRCh37
na,na,9,34649502,34649502,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia,single nucleotide variant,GRCh38
na,na,9,34647133,34647133,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,single nucleotide variant,GRCh37
na,na,9,34647136,34647136,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,single nucleotide variant,GRCh38
na,na,9,34647187,34647187,GALT,Benign,GALT POLYMORPHISM,single nucleotide variant,GRCh37
na,na,9,34647190,34647190,GALT,Benign,GALT POLYMORPHISM,single nucleotide variant,GRCh38
na,na,9,34649442,34649442,GALT,Conflicting classifications of pathogenicity; other,"GALT POLYMORPHISM (DUARTE, D2)|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|GALT-related disorder",single nucleotide variant,GRCh37
na,na,9,34649445,34649445,GALT,Conflicting classifications of pathogenicity; other,"GALT POLYMORPHISM (DUARTE, D2)|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|GALT-related disorder",single nucleotide variant,GRCh38
na,na,9,34648167,34648167,GALT,Conflicting classifications of pathogenicity,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|GALT-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,34648170,34648170,GALT,Conflicting classifications of pathogenicity,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|GALT-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,34647224,34647224,GALT,Conflicting classifications of pathogenicity,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia,single nucleotide variant,GRCh37
na,na,9,34647227,34647227,GALT,Conflicting classifications of pathogenicity,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia,single nucleotide variant,GRCh38
na,na,9,34648116,34648116,GALT,Pathogenic/Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,34648119,34648119,GALT,Pathogenic/Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,34649459,34649459,GALT,Pathogenic/Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,single nucleotide variant,GRCh37
na,na,9,34649462,34649462,GALT,Pathogenic/Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided,single nucleotide variant,GRCh38
na,na,9,34647855,34647855,GALT,Pathogenic/Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Inborn genetic diseases|Galactosemia|See cases|GALT-related disorder,single nucleotide variant,GRCh37
na,na,9,34647858,34647858,GALT,Pathogenic/Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Inborn genetic diseases|Galactosemia|See cases|GALT-related disorder,single nucleotide variant,GRCh38
na,na,9,34648151,34648151,GALT,Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,single nucleotide variant,GRCh37
na,na,9,34648154,34648154,GALT,Likely pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,single nucleotide variant,GRCh38
na,na,9,34648418,34648418,GALT,Benign; other,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|not specified|Galactosemia,single nucleotide variant,GRCh37
na,na,9,34648421,34648421,GALT,Benign; other,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|not specified|Galactosemia,single nucleotide variant,GRCh38
na,na,9,34649029,34649029,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,34649032,34649032,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided|Galactosemia|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,34648373,34648373,GALT,Conflicting classifications of pathogenicity,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia|not provided,single nucleotide variant,GRCh37
na,na,9,34648376,34648376,GALT,Conflicting classifications of pathogenicity,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia|not provided,single nucleotide variant,GRCh38
na,na,9,34649499,34649499,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia,single nucleotide variant,GRCh37
na,na,9,34649502,34649502,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia,single nucleotide variant,GRCh38
na,na,9,34648346,34648346,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,single nucleotide variant,GRCh37
na,na,9,34648349,34648349,GALT,Pathogenic,Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase,single nucleotide variant,GRCh38
na,na,17,56350196,56350196,MPO,Pathogenic/Likely pathogenic,Myeloperoxidase deficiency|not provided|Alzheimer disease type 1;Myeloperoxidase deficiency|MPO-related disorder,single nucleotide variant,GRCh37
na,na,17,58272835,58272835,MPO,Pathogenic/Likely pathogenic,Myeloperoxidase deficiency|not provided|Alzheimer disease type 1;Myeloperoxidase deficiency|MPO-related disorder,single nucleotide variant,GRCh38
na,na,17,56356914,56356914,MPO,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided|Alzheimer disease type 1;Myeloperoxidase deficiency,single nucleotide variant,GRCh37
na,na,17,58279553,58279553,MPO,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided|Alzheimer disease type 1;Myeloperoxidase deficiency,single nucleotide variant,GRCh38
na,na,17,56356502,56356502,LPO;MPO,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided|MPO-related disorder,single nucleotide variant,GRCh37
na,na,17,58279141,58279141,LPO;MPO,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided|MPO-related disorder,single nucleotide variant,GRCh38
na,na,17,56350828,56350841,MPO,Pathogenic/Likely pathogenic,Myeloperoxidase deficiency|not provided|MPO-related disorder,Deletion,GRCh37
na,na,17,58273467,58273480,MPO,Pathogenic/Likely pathogenic,Myeloperoxidase deficiency|not provided|MPO-related disorder,Deletion,GRCh38
na,na,17,56355397,56355397,MPO,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,17,58278036,58278036,MPO,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,17,56350186,56350186,MPO,Pathogenic,Myeloperoxidase deficiency,single nucleotide variant,GRCh37
na,na,17,58272825,58272825,MPO,Pathogenic,Myeloperoxidase deficiency,single nucleotide variant,GRCh38
na,na,17,56348226,56348226,LPO;MPO,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided|MPO-related disorder|Alzheimer disease type 1;Myeloperoxidase deficiency|not specified,single nucleotide variant,GRCh37
na,na,17,58270865,58270865,LPO;MPO,Conflicting classifications of pathogenicity,Myeloperoxidase deficiency|not provided|MPO-related disorder|Alzheimer disease type 1;Myeloperoxidase deficiency|not specified,single nucleotide variant,GRCh38
na,na,17,56358762,56358762,MPO,protective; risk factor,"Lung cancer, protection against, in smokers|",single nucleotide variant,GRCh37
na,na,17,58281401,58281401,MPO,protective; risk factor,"Lung cancer, protection against, in smokers|",single nucleotide variant,GRCh38
na,na,17,56350895,56350895,MPO,Pathogenic,Myeloperoxidase deficiency,single nucleotide variant,GRCh37
na,na,17,58273534,58273534,MPO,Pathogenic,Myeloperoxidase deficiency,single nucleotide variant,GRCh38
na,na,17,56350901,56350901,MPO,Pathogenic/Likely pathogenic,Myeloperoxidase deficiency|MPO-related disorder,single nucleotide variant,GRCh37
na,na,17,58273540,58273540,MPO,Pathogenic/Likely pathogenic,Myeloperoxidase deficiency|MPO-related disorder,single nucleotide variant,GRCh38
na,na,1,227173033,227173033,COQ8A,Conflicting classifications of pathogenicity,Autosomal recessive ataxia due to ubiquinone deficiency|See cases|Abnormality of the nervous system|not provided,single nucleotide variant,GRCh37
na,na,1,226985332,226985332,COQ8A,Conflicting classifications of pathogenicity,Autosomal recessive ataxia due to ubiquinone deficiency|See cases|Abnormality of the nervous system|not provided,single nucleotide variant,GRCh38
na,na,1,227153420,227153420,COQ8A,Pathogenic/Likely pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,226965719,226965719,COQ8A,Pathogenic/Likely pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,227169812,227169812,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,226982111,226982111,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,227169812,227169812,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency,single nucleotide variant,GRCh37
na,na,1,226982111,226982111,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency,single nucleotide variant,GRCh38
na,na,1,227174305,227174306,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency,Duplication,GRCh37
na,na,1,226986604,226986605,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency,Duplication,GRCh38
na,na,1,227171938,227171938,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,226984237,226984237,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,227153023,227153044,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,Indel,GRCh37
na,na,1,226965322,226965343,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,Indel,GRCh38
na,na,1,227172611,227172611,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency,single nucleotide variant,GRCh37
na,na,1,226984910,226984910,COQ8A,Pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency,single nucleotide variant,GRCh38
na,na,1,227174240,227174242,COQ8A,Pathogenic/Likely pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,Microsatellite,GRCh37
na,na,1,226986539,226986541,COQ8A,Pathogenic/Likely pathogenic,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,Microsatellite,GRCh38
na,na,1,227170648,227170648,COQ8A,Benign/Likely benign,Autosomal recessive ataxia due to ubiquinone deficiency|not specified|not provided|Joubert syndrome 17|Coenzyme Q10 deficiency,single nucleotide variant,GRCh37
na,na,1,226982947,226982947,COQ8A,Benign/Likely benign,Autosomal recessive ataxia due to ubiquinone deficiency|not specified|not provided|Joubert syndrome 17|Coenzyme Q10 deficiency,single nucleotide variant,GRCh38
na,na,1,227173027,227173027,COQ8A,Uncertain significance,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,226985326,226985326,COQ8A,Uncertain significance,Autosomal recessive ataxia due to ubiquinone deficiency|not provided,single nucleotide variant,GRCh38
na,na,16,69364970,69364970,COG8,Pathogenic,COG8-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,69331067,69331067,COG8,Pathogenic,COG8-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,69368423,69368423,COG8,Pathogenic,COG8-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,69334520,69334520,COG8,Pathogenic,COG8-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,69364893,69364894,COG8,Likely pathogenic,COG8-congenital disorder of glycosylation|COG8-related disorder,Deletion,GRCh37
na,na,16,69330990,69330991,COG8,Likely pathogenic,COG8-congenital disorder of glycosylation|COG8-related disorder,Deletion,GRCh38
na,na,16,23464143,23464143,COG7,Pathogenic,COG7 congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,23452822,23452822,COG7,Pathogenic,COG7 congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,23457289,23457289,COG7,Likely pathogenic,COG7 congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,16,23445968,23445968,COG7,Likely pathogenic,COG7 congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,16,70515300,70515300,COG4,Pathogenic/Likely pathogenic,COG4-congenital disorder of glycosylation|See cases|not provided,single nucleotide variant,GRCh37
na,na,16,70481397,70481397,COG4,Pathogenic/Likely pathogenic,COG4-congenital disorder of glycosylation|See cases|not provided,single nucleotide variant,GRCh38
na,na,16,70426035,70519648,COG4,Pathogenic,COG4-congenital disorder of glycosylation,Deletion,GRCh38
na,na,17,71196165,71196165,COG1,Pathogenic,COG1 congenital disorder of glycosylation|Nephrotic syndrome,single nucleotide variant,GRCh37
na,na,17,73200026,73200026,COG1,Pathogenic,COG1 congenital disorder of glycosylation|Nephrotic syndrome,single nucleotide variant,GRCh38
na,na,16,67976589,67976589,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh37
na,na,16,67942686,67942686,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh38
na,na,16,67974179,67974179,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh37
na,na,16,67940276,67940276,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh38
na,na,16,67976603,67976604,LCAT,Pathogenic,LCAT deficiency,Duplication,GRCh37
na,na,16,67942700,67942701,LCAT,Pathogenic,LCAT deficiency,Duplication,GRCh38
na,na,16,67974374,67974374,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh37
na,na,16,67940471,67940471,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh38
na,na,16,67976657,67976657,LCAT,Pathogenic,Fish-eye disease|not provided|LCAT-related disorder|Fish-eye disease;Norum disease,single nucleotide variant,GRCh37
na,na,16,67942754,67942754,LCAT,Pathogenic,Fish-eye disease|not provided|LCAT-related disorder|Fish-eye disease;Norum disease,single nucleotide variant,GRCh38
na,na,16,67977903,67977904,LCAT,Pathogenic,LCAT deficiency|Cardiovascular phenotype|not provided,Duplication,GRCh37
na,na,16,67944000,67944001,LCAT,Pathogenic,LCAT deficiency|Cardiovascular phenotype|not provided,Duplication,GRCh38
na,na,16,67977904,67977904,LCAT,Pathogenic,Fish-eye disease|Fish-eye disease;Norum disease|not provided,single nucleotide variant,GRCh37
na,na,16,67944001,67944001,LCAT,Pathogenic,Fish-eye disease|Fish-eye disease;Norum disease|not provided,single nucleotide variant,GRCh38
na,na,16,67974018,67974018,LCAT,Uncertain significance,Fish-eye disease|Fish-eye disease;Norum disease,single nucleotide variant,GRCh37
na,na,16,67940115,67940115,LCAT,Uncertain significance,Fish-eye disease|Fish-eye disease;Norum disease,single nucleotide variant,GRCh38
na,na,16,67974303,67974303,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh37
na,na,16,67940400,67940400,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh38
na,na,16,67976316,67976316,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh37
na,na,16,67942413,67942413,LCAT,Pathogenic,LCAT deficiency,single nucleotide variant,GRCh38
na,na,16,67976842,67976842,LCAT,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,16,67942939,67942939,LCAT,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,16,67976622,67976622,LCAT,Likely pathogenic,LCAT deficiency|not provided,single nucleotide variant,GRCh37
na,na,16,67942719,67942719,LCAT,Likely pathogenic,LCAT deficiency|not provided,single nucleotide variant,GRCh38
na,na,16,67973932,67973933,LCAT,Pathogenic,LCAT deficiency,Duplication,GRCh37
na,na,16,67940029,67940030,LCAT,Pathogenic,LCAT deficiency,Duplication,GRCh38
na,na,16,67974096,67974096,LCAT,Likely pathogenic,LCAT deficiency|Fish-eye disease;Norum disease|not provided,single nucleotide variant,GRCh37
na,na,16,67940193,67940193,LCAT,Likely pathogenic,LCAT deficiency|Fish-eye disease;Norum disease|not provided,single nucleotide variant,GRCh38
na,na,16,67976870,67976870,LCAT,Pathogenic/Likely pathogenic,LCAT deficiency|Fish-eye disease;Norum disease|not provided,single nucleotide variant,GRCh37
na,na,16,67942967,67942967,LCAT,Pathogenic/Likely pathogenic,LCAT deficiency|Fish-eye disease;Norum disease|not provided,single nucleotide variant,GRCh38
na,na,16,67974156,67974158,LCAT,Pathogenic,Fish-eye disease,Microsatellite,GRCh37
na,na,16,67940253,67940255,LCAT,Pathogenic,Fish-eye disease,Microsatellite,GRCh38
na,na,16,67976634,67976634,LCAT,Pathogenic,Fish-eye disease,single nucleotide variant,GRCh37
na,na,16,67942731,67942731,LCAT,Pathogenic,Fish-eye disease,single nucleotide variant,GRCh38
na,na,16,67976512,67976512,LCAT,Pathogenic,Fish-eye disease,single nucleotide variant,GRCh37
na,na,16,67942609,67942609,LCAT,Pathogenic,Fish-eye disease,single nucleotide variant,GRCh38
na,na,1,24123618,24123618,GALE,Likely pathogenic,"UDPglucose-4-epimerase deficiency|UDPglucose-4-epimerase deficiency;Thrombocytopenia 13, syndromic",single nucleotide variant,GRCh37
na,na,1,23797128,23797128,GALE,Likely pathogenic,"UDPglucose-4-epimerase deficiency|UDPglucose-4-epimerase deficiency;Thrombocytopenia 13, syndromic",single nucleotide variant,GRCh38
na,na,1,24125397,24125397,GALE,Conflicting classifications of pathogenicity,"UDPglucose-4-epimerase deficiency|not provided|not specified|Thrombocytopenia 13, syndromic;UDPglucose-4-epimerase deficiency",single nucleotide variant,GRCh37
na,na,1,23798907,23798907,GALE,Conflicting classifications of pathogenicity,"UDPglucose-4-epimerase deficiency|not provided|not specified|Thrombocytopenia 13, syndromic;UDPglucose-4-epimerase deficiency",single nucleotide variant,GRCh38
na,na,1,24124689,24124689,GALE,Pathogenic,UDPglucose-4-epimerase deficiency,single nucleotide variant,GRCh37
na,na,1,23798199,23798199,GALE,Pathogenic,UDPglucose-4-epimerase deficiency,single nucleotide variant,GRCh38
na,na,1,24124650,24124650,GALE,Uncertain significance,UDPglucose-4-epimerase deficiency,single nucleotide variant,GRCh37
na,na,1,23798160,23798160,GALE,Uncertain significance,UDPglucose-4-epimerase deficiency,single nucleotide variant,GRCh38
na,na,1,24123212,24123212,GALE,Conflicting classifications of pathogenicity; other,UDPglucose-4-epimerase deficiency|not specified|not provided|GALE-related disorder,single nucleotide variant,GRCh37
na,na,1,23796722,23796722,GALE,Conflicting classifications of pathogenicity; other,UDPglucose-4-epimerase deficiency|not specified|not provided|GALE-related disorder,single nucleotide variant,GRCh38
na,na,1,24122692,24122692,GALE,Pathogenic,UDPglucose-4-epimerase deficiency,single nucleotide variant,GRCh37
na,na,1,23796202,23796202,GALE,Pathogenic,UDPglucose-4-epimerase deficiency,single nucleotide variant,GRCh38
na,na,1,24122673,24122673,GALE,Conflicting classifications of pathogenicity; other,UDPglucose-4-epimerase deficiency|not provided|GALE-related disorder,single nucleotide variant,GRCh37
na,na,1,23796183,23796183,GALE,Conflicting classifications of pathogenicity; other,UDPglucose-4-epimerase deficiency|not provided|GALE-related disorder,single nucleotide variant,GRCh38
na,na,1,24124678,24124678,GALE,Pathogenic/Likely pathogenic,"UDPglucose-4-epimerase deficiency|Galactosemia III, severe|not provided|Thrombocytopenia 13, syndromic;UDPglucose-4-epimerase deficiency|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,1,23798188,23798188,GALE,Pathogenic/Likely pathogenic,"UDPglucose-4-epimerase deficiency|Galactosemia III, severe|not provided|Thrombocytopenia 13, syndromic;UDPglucose-4-epimerase deficiency|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,19,11210928,11210928,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,11100252,11100252,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,11213408,11213408,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11102732,11102732,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11216112,11216112,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,11105436,11105436,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,11226877,11226877,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11116201,11116201,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11231058,11231058,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11120382,11120382,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11216263,11216263,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11105587,11105587,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11216264,11216264,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11105588,11105588,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11218160,11218160,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder",single nucleotide variant,GRCh37
na,na,19,11107484,11107484,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder",single nucleotide variant,GRCh38
na,na,19,11224052,11224052,LDLR;MIR6886,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia|LDLR-related disorder",single nucleotide variant,GRCh37
na,na,19,11113376,11113376,LDLR;MIR6886,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia|LDLR-related disorder",single nucleotide variant,GRCh38
na,na,19,11224058,11224058,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11113382,11113382,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11224419,11224419,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,11113743,11113743,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,11226820,11226820,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,19,11116144,11116144,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,19,11226829,11226829,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11116153,11116153,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11231101,11231101,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|See cases|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11120425,11120425,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|See cases|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11218191,11223953,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|FH LEIDEN 1",Deletion,GRCh37
na,na,19,11107515,11113277,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|FH LEIDEN 1",Deletion,GRCh38
na,na,19,11231112,11231112,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11120436,11120436,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11240238,11240238,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided",single nucleotide variant,GRCh37
na,na,19,11129562,11129562,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided",single nucleotide variant,GRCh38
na,na,19,11240282,11240282,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Cardiovascular phenotype|Familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,19,11129606,11129606,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Cardiovascular phenotype|Familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,19,11240246,11240249,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided",Duplication,GRCh37
na,na,19,11129568,11129569,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided",Duplication,GRCh38
na,na,19,11216252,11216252,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Cardiovascular phenotype|Familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,19,11105576,11105576,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Cardiovascular phenotype|Familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,19,11077742,11093630,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh38
na,na,19,11200292,11215895,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh37
na,na,19,11089616,11105219,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh38
na,na,19,11234266,11242800,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh37
na,na,19,11123590,11132124,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh38
na,na,19,11200292,11221327,LDLR,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1",Deletion,GRCh37
na,na,19,11089616,11110651,LDLR,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1",Deletion,GRCh38
na,na,19,11211022,11223953,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh37
na,na,19,11100346,11113277,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh38
na,na,na,-1,-1,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,na
na,na,19,11221006,11232481,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh37
na,na,19,11110330,11121805,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh38
na,na,na,-1,-1,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,na
na,na,na,-1,-1,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1",Deletion,na
na,na,19,11230812,11235081,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh37
na,na,19,11120136,11124405,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1",Deletion,GRCh38
na,na,19,11216105,11216105,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,11105429,11105429,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,11216146,11216146,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,19,11105470,11105470,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|Homozygous familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,19,11218175,11218181,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided",Deletion,GRCh37
na,na,19,11107498,11107504,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided",Deletion,GRCh38
na,na,19,11216275,11216275,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,11105599,11105599,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,11216262,11216263,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|Familial hypercholesterolemia",Deletion,GRCh37
na,na,19,11105586,11105587,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|not provided|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|Familial hypercholesterolemia",Deletion,GRCh38
na,na,19,11224064,11224064,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,19,11113388,11113388,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,19,11216246,11216263,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided",Duplication,GRCh37
na,na,19,11105566,11105567,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided",Duplication,GRCh38
na,na,19,11240330,11240330,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,19,11129654,11129654,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,19,11223969,11223969,LDLR,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh37
na,na,19,11113293,11113293,LDLR,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh38
na,na,19,11213463,11213463,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder|See cases",single nucleotide variant,GRCh37
na,na,19,11102787,11102787,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|LDLR-related disorder|See cases",single nucleotide variant,GRCh38
na,na,19,11226873,11226873,LDLR,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not specified|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,11116197,11116197,LDLR,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not specified|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,11216278,11216278,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh37
na,na,19,11105602,11105602,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|Dyslipidemia",single nucleotide variant,GRCh38
na,na,19,11216133,11216133,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|not provided|Homozygous familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,19,11105457,11105457,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype|not provided|Homozygous familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,19,11217328,11217328,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh37
na,na,19,11106652,11106652,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Hypercholesterolemia|Homozygous familial hypercholesterolemia|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh38
na,na,19,11210962,11210962,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,11100286,11100286,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,11210968,11210968,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1",single nucleotide variant,GRCh37
na,na,19,11100292,11100292,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1",single nucleotide variant,GRCh38
na,na,19,11215908,11215908,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1",single nucleotide variant,GRCh37
na,na,19,11105232,11105232,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1",single nucleotide variant,GRCh38
na,na,19,11231199,11231199,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|LDLR-related disorder|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh37
na,na,19,11120523,11120523,LDLR,Pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|LDLR-related disorder|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh38
na,na,19,11200087,11200087,LDLR,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",Deletion,GRCh37
na,na,19,11089411,11089411,LDLR,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia",Deletion,GRCh38
na,na,19,11223983,11223983,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,11113307,11113307,LDLR,Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,11216203,11216203,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,11105527,11105527,LDLR,Pathogenic/Likely pathogenic,"Hypercholesterolemia, familial, 1|Familial hypercholesterolemia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,11,111706902,111706902,ALG9,Uncertain significance,ALG9 congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,11,111836179,111836179,ALG9,Uncertain significance,ALG9 congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,11,111724138,111724138,ALG9,Likely pathogenic,ALG9 congenital disorder of glycosylation|ALG9-related disorder|Gillessen-Kaesbach-Nishimura syndrome;ALG9 congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,11,111853415,111853415,ALG9,Likely pathogenic,ALG9 congenital disorder of glycosylation|ALG9-related disorder|Gillessen-Kaesbach-Nishimura syndrome;ALG9 congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,10,127503630,127503630,UROS,Pathogenic,Cutaneous porphyria|not provided|UROS-related disorder,single nucleotide variant,GRCh37
na,na,10,125815061,125815061,UROS,Pathogenic,Cutaneous porphyria|not provided|UROS-related disorder,single nucleotide variant,GRCh38
na,na,10,127503689,127503689,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh37
na,na,10,125815120,125815120,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh38
na,na,10,127503650,127503650,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh37
na,na,10,125815081,125815081,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh38
na,na,10,127503663,127503663,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh37
na,na,10,125815094,125815094,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh38
na,na,10,127477552,127477552,UROS,Conflicting classifications of pathogenicity,Cutaneous porphyria|not provided|UROS-related disorder,single nucleotide variant,GRCh37
na,na,10,125788983,125788983,UROS,Conflicting classifications of pathogenicity,Cutaneous porphyria|not provided|UROS-related disorder,single nucleotide variant,GRCh38
na,na,10,127505059,127505059,UROS,Pathogenic,Cutaneous porphyria|not provided|UROS-related disorder,single nucleotide variant,GRCh37
na,na,10,125816490,125816490,UROS,Pathogenic,Cutaneous porphyria|not provided|UROS-related disorder,single nucleotide variant,GRCh38
na,na,na,-1,-1,UROS,Pathogenic,Cutaneous porphyria,Deletion,na
na,na,na,-1,-1,UROS,Pathogenic,Cutaneous porphyria,Insertion,na
na,na,10,127503603,127503603,UROS,Uncertain significance,Cutaneous porphyria|not provided,single nucleotide variant,GRCh37
na,na,10,125815034,125815034,UROS,Uncertain significance,Cutaneous porphyria|not provided,single nucleotide variant,GRCh38
na,na,10,127483547,127483547,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh37
na,na,10,125794978,125794978,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh38
na,na,10,127503604,127503604,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh37
na,na,10,125815035,125815035,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh38
na,na,10,127483547,127483547,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh37
na,na,10,125794978,125794978,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh38
na,na,10,127511774,127511774,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh37
na,na,10,125823205,125823205,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh38
na,na,10,127505277,127505277,UROS,Pathogenic,Cutaneous porphyria|not provided,single nucleotide variant,GRCh37
na,na,10,125816708,125816708,UROS,Pathogenic,Cutaneous porphyria|not provided,single nucleotide variant,GRCh38
na,na,10,127505287,127505287,UROS,Pathogenic,Cutaneous porphyria|not provided,single nucleotide variant,GRCh37
na,na,10,125816718,125816718,UROS,Pathogenic,Cutaneous porphyria|not provided,single nucleotide variant,GRCh38
na,na,10,127505291,127505291,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh37
na,na,10,125816722,125816722,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh38
na,na,10,127477562,127477562,UROS,Pathogenic,Cutaneous porphyria|not provided,single nucleotide variant,GRCh37
na,na,10,125788993,125788993,UROS,Pathogenic,Cutaneous porphyria|not provided,single nucleotide variant,GRCh38
na,na,10,127505005,127505005,UROS,Pathogenic/Likely pathogenic,Cutaneous porphyria|not provided|UROS-related disorder,single nucleotide variant,GRCh37
na,na,10,125816436,125816436,UROS,Pathogenic/Likely pathogenic,Cutaneous porphyria|not provided|UROS-related disorder,single nucleotide variant,GRCh38
na,na,10,127486711,127486712,UROS,Pathogenic,Cutaneous porphyria,Duplication,GRCh37
na,na,10,125798142,125798143,UROS,Pathogenic,Cutaneous porphyria,Duplication,GRCh38
na,na,10,127477492,127477492,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh37
na,na,10,125788923,125788923,UROS,Pathogenic,Cutaneous porphyria,single nucleotide variant,GRCh38
na,na,19,49661142,49661142,TRPM4,Likely pathogenic,Progressive familial heart block type IB|TRPM4-related disorder,single nucleotide variant,GRCh37
na,na,19,49157885,49157885,TRPM4,Likely pathogenic,Progressive familial heart block type IB|TRPM4-related disorder,single nucleotide variant,GRCh38
na,na,11,88924475,88924476,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Inborn genetic diseases|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder",Duplication,GRCh37
na,na,11,89191307,89191308,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Inborn genetic diseases|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder",Duplication,GRCh38
na,na,11,88911363,88911363,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Albinism|Oculocutaneous albinism|Inborn genetic diseases|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder|Oculocutaneous albinism type 1",single nucleotide variant,GRCh37
na,na,11,89178195,89178195,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Albinism|Oculocutaneous albinism|Inborn genetic diseases|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder|Oculocutaneous albinism type 1",single nucleotide variant,GRCh38
na,na,11,88924373,88924373,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1B|not provided|Oculocutaneous albinism type 1A|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|TYR-related disorder|Albinism or congenital nystagmus",single nucleotide variant,GRCh37
na,na,11,89191205,89191205,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1B|not provided|Oculocutaneous albinism type 1A|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|TYR-related disorder|Albinism or congenital nystagmus",single nucleotide variant,GRCh38
na,na,11,88961072,88961072,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1B|TYR-related disorder|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh37
na,na,11,89227904,89227904,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1B|TYR-related disorder|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh38
na,na,11,88961101,88961101,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;Ocular albinism with congenital sensorineural hearing loss|Nonsyndromic Oculocutaneous Albinism|Inborn genetic diseases|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh37
na,na,11,89227933,89227933,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;Ocular albinism with congenital sensorineural hearing loss|Nonsyndromic Oculocutaneous Albinism|Inborn genetic diseases|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh38
na,na,11,88911351,88911351,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|See cases|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism|Albinism or congenital nystagmus",single nucleotide variant,GRCh37
na,na,11,89178183,89178183,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|See cases|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism|Albinism or congenital nystagmus",single nucleotide variant,GRCh38
na,na,11,89017973,89017973,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1B|not provided|Oculocutaneous albinism|Inborn genetic diseases|Oculocutaneous albinism type 1A|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Ocular albinism with congenital sensorineural hearing loss;Oculocutaneous albinism type 1B|Abnormality of the skin|Hearing impairment|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Albinism or congenital nystagmus|TYR-related disorder",single nucleotide variant,GRCh37
na,na,11,89284805,89284805,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1B|not provided|Oculocutaneous albinism|Inborn genetic diseases|Oculocutaneous albinism type 1A|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Ocular albinism with congenital sensorineural hearing loss;Oculocutaneous albinism type 1B|Abnormality of the skin|Hearing impairment|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Albinism or congenital nystagmus|TYR-related disorder",single nucleotide variant,GRCh38
na,na,11,88911696,88911696,TYR,Conflicting classifications of pathogenicity,"SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1A|not specified|not provided|Oculocutaneous albinism|Albinism or congenital nystagmus|Oculocutaneous albinism type 1B",single nucleotide variant,GRCh37
na,na,11,89178528,89178528,TYR,Conflicting classifications of pathogenicity,"SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1A|not specified|not provided|Oculocutaneous albinism|Albinism or congenital nystagmus|Oculocutaneous albinism type 1B",single nucleotide variant,GRCh38
na,na,11,89017961,89017961,TYR,Conflicting classifications of pathogenicity; other,"Oculocutaneous albinism type 1B|Temperature-sensitive oculocutaneous albinism type 1|Melanoma, cutaneous malignant, susceptibility to, 8|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Skin/hair/eye pigmentation 3, blue/green eyes|not provided|Oculocutaneous albinism type 1A|Autosomal recessive ocular albinism|not specified|Malignant tumor of breast|6 conditions|Oculocutaneous albinism type 1|Albinism or congenital nystagmus",single nucleotide variant,GRCh37
na,na,11,89284793,89284793,TYR,Conflicting classifications of pathogenicity; other,"Oculocutaneous albinism type 1B|Temperature-sensitive oculocutaneous albinism type 1|Melanoma, cutaneous malignant, susceptibility to, 8|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Skin/hair/eye pigmentation 3, blue/green eyes|not provided|Oculocutaneous albinism type 1A|Autosomal recessive ocular albinism|not specified|Malignant tumor of breast|6 conditions|Oculocutaneous albinism type 1|Albinism or congenital nystagmus",single nucleotide variant,GRCh38
na,na,11,88911386,88911386,TYR,Pathogenic,Oculocutaneous albinism type 1A|not provided|8 conditions,single nucleotide variant,GRCh37
na,na,11,89178218,89178218,TYR,Pathogenic,Oculocutaneous albinism type 1A|not provided|8 conditions,single nucleotide variant,GRCh38
na,na,11,89018021,89018021,TYR,Pathogenic,"Temperature-sensitive oculocutaneous albinism type 1|not provided|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1A|TYR-related disorder|Oculocutaneous albinism type 1B;Oculocutaneous albinism type 1A",single nucleotide variant,GRCh37
na,na,11,89284853,89284853,TYR,Pathogenic,"Temperature-sensitive oculocutaneous albinism type 1|not provided|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1A|TYR-related disorder|Oculocutaneous albinism type 1B;Oculocutaneous albinism type 1A",single nucleotide variant,GRCh38
na,na,11,88910923,88910923,TYR,Benign,Oculocutaneous albinism type 1A|not provided,single nucleotide variant,GRCh37
na,na,11,89177755,89177755,TYR,Benign,Oculocutaneous albinism type 1A|not provided,single nucleotide variant,GRCh38
na,na,11,88911654,88911654,TYR,Pathogenic,Oculocutaneous albinism type 1A|not provided,single nucleotide variant,GRCh37
na,na,11,89178486,89178486,TYR,Pathogenic,Oculocutaneous albinism type 1A|not provided,single nucleotide variant,GRCh38
na,na,11,88961100,88961100,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh37
na,na,11,89227932,89227932,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh38
na,na,11,88911850,88911851,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",Microsatellite,GRCh37
na,na,11,89178682,89178683,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|TYR-related disorder|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",Microsatellite,GRCh38
na,na,11,88911406,88911407,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Abnormality of the skin|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",Duplication,GRCh37
na,na,11,89178238,89178239,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Abnormality of the skin|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",Duplication,GRCh38
na,na,11,88911246,88911246,TYR,Likely pathogenic,Oculocutaneous albinism type 1A|not provided,single nucleotide variant,GRCh37
na,na,11,89178078,89178078,TYR,Likely pathogenic,Oculocutaneous albinism type 1A|not provided,single nucleotide variant,GRCh38
na,na,11,88911285,88911285,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;Ocular albinism with congenital sensorineural hearing loss|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",single nucleotide variant,GRCh37
na,na,11,89178117,89178117,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;Ocular albinism with congenital sensorineural hearing loss|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",single nucleotide variant,GRCh38
na,na,11,88911737,88911737,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",single nucleotide variant,GRCh37
na,na,11,89178569,89178569,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",single nucleotide variant,GRCh38
na,na,11,89018011,89018011,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Nonsyndromic Oculocutaneous Albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Albinism or congenital nystagmus",single nucleotide variant,GRCh37
na,na,11,89284843,89284843,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Nonsyndromic Oculocutaneous Albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|Oculocutaneous albinism type 1|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Albinism or congenital nystagmus",single nucleotide variant,GRCh38
na,na,11,88911182,88911182,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh37
na,na,11,89178014,89178014,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh38
na,na,11,88911261,88911261,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|Oculocutaneous albinism type 1B|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;Ocular albinism with congenital sensorineural hearing loss|Inborn genetic diseases|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh37
na,na,11,89178093,89178093,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|Oculocutaneous albinism type 1B|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B;Ocular albinism with congenital sensorineural hearing loss|Inborn genetic diseases|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh38
na,na,11,88911770,88911770,TYR,Conflicting classifications of pathogenicity,"Oculocutaneous albinism type 1A|not provided|Nonsyndromic Oculocutaneous Albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Ocular albinism with congenital sensorineural hearing loss;Oculocutaneous albinism type 1B;Oculocutaneous albinism type 1A|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1B;Oculocutaneous albinism type 1A|Oculocutaneous albinism|Oculocutaneous albinism type 1B;Oculocutaneous albinism type 1A",single nucleotide variant,GRCh37
na,na,11,89178602,89178602,TYR,Conflicting classifications of pathogenicity,"Oculocutaneous albinism type 1A|not provided|Nonsyndromic Oculocutaneous Albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Ocular albinism with congenital sensorineural hearing loss;Oculocutaneous albinism type 1B;Oculocutaneous albinism type 1A|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1B;Oculocutaneous albinism type 1A|Oculocutaneous albinism|Oculocutaneous albinism type 1B;Oculocutaneous albinism type 1A",single nucleotide variant,GRCh38
na,na,11,88924446,88924446,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Nonsyndromic Oculocutaneous Albinism|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|See cases|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh37
na,na,11,89191278,89191278,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Nonsyndromic Oculocutaneous Albinism|Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|See cases|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh38
na,na,11,88961066,88961066,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh37
na,na,11,89227898,89227898,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|TYR-related disorder|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh38
na,na,11,88961117,88961117,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",Deletion,GRCh37
na,na,11,89227949,89227949,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",Deletion,GRCh38
na,na,11,89017965,89017965,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh37
na,na,11,89284797,89284797,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B",single nucleotide variant,GRCh38
na,na,11,89018092,89018092,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|TYR-related disorder|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",single nucleotide variant,GRCh37
na,na,11,89284924,89284924,TYR,Pathogenic,"Oculocutaneous albinism type 1A|not provided|Oculocutaneous albinism|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|TYR-related disorder|Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",single nucleotide variant,GRCh38
na,na,11,89018098,89018098,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",single nucleotide variant,GRCh37
na,na,11,89284930,89284930,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN",single nucleotide variant,GRCh38
na,na,11,89028410,89028411,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1B|TYR-related disorder|Oculocutaneous albinism",Duplication,GRCh37
na,na,11,89295242,89295243,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1A|not provided|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Oculocutaneous albinism type 1A;Oculocutaneous albinism type 1B|SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN|Oculocutaneous albinism type 1B|TYR-related disorder|Oculocutaneous albinism",Duplication,GRCh38
na,na,11,89028444,89028445,TYR,Likely pathogenic,Oculocutaneous albinism type 1A|not provided,Duplication,GRCh37
na,na,11,89295276,89295277,TYR,Likely pathogenic,Oculocutaneous albinism type 1A|not provided,Duplication,GRCh38
na,na,11,88911828,88911828,TYR,Likely pathogenic,Oculocutaneous albinism type 1A|not provided,single nucleotide variant,GRCh37
na,na,11,89178660,89178660,TYR,Likely pathogenic,Oculocutaneous albinism type 1A|not provided,single nucleotide variant,GRCh38
na,na,11,88911767,88911767,TYR,Uncertain significance,Oculocutaneous albinism type 1A|not provided|not specified,single nucleotide variant,GRCh37
na,na,11,89178599,89178599,TYR,Uncertain significance,Oculocutaneous albinism type 1A|not provided|not specified,single nucleotide variant,GRCh38
na,na,11,88911122,88911122,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1B|not provided|Hypopigmentation of the skin;Iris transillumination defect;Hypopigmentation of hair;Horizontal nystagmus|Myopia;Albinism;Nystagmus|Oculocutaneous albinism type 1A|6 conditions|Abnormality of the skin|Oculocutaneous albinism type 1B;SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Ocular albinism with congenital sensorineural hearing loss;Oculocutaneous albinism type 1A|TYR-related disorder|Oculocutaneous albinism",single nucleotide variant,GRCh37
na,na,11,89177954,89177954,TYR,Pathogenic/Likely pathogenic,"Oculocutaneous albinism type 1B|not provided|Hypopigmentation of the skin;Iris transillumination defect;Hypopigmentation of hair;Horizontal nystagmus|Myopia;Albinism;Nystagmus|Oculocutaneous albinism type 1A|6 conditions|Abnormality of the skin|Oculocutaneous albinism type 1B;SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;Ocular albinism with congenital sensorineural hearing loss;Oculocutaneous albinism type 1A|TYR-related disorder|Oculocutaneous albinism",single nucleotide variant,GRCh38
na,na,1,235972651,235972651,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",Deletion,GRCh37
na,na,1,235809351,235809351,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",Deletion,GRCh38
na,na,1,235969126,235969126,LYST,Pathogenic/Likely pathogenic,"CHEDIAK-HIGASHI SYNDROME, ADULT TYPE|Chédiak-Higashi syndrome|not provided",single nucleotide variant,GRCh37
na,na,1,235805826,235805826,LYST,Pathogenic/Likely pathogenic,"CHEDIAK-HIGASHI SYNDROME, ADULT TYPE|Chédiak-Higashi syndrome|not provided",single nucleotide variant,GRCh38
na,na,1,235993599,235993600,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",Duplication,GRCh37
na,na,1,235830299,235830300,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",Duplication,GRCh38
na,na,1,235972215,235972216,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",Duplication,GRCh37
na,na,1,235808915,235808916,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",Duplication,GRCh38
na,na,1,235880049,235880049,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",Deletion,GRCh37
na,na,1,235716749,235716749,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",Deletion,GRCh38
na,na,1,235993570,235993570,LYST,Likely pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",single nucleotide variant,GRCh37
na,na,1,235830270,235830270,LYST,Likely pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome",single nucleotide variant,GRCh38
na,na,1,235969351,235969351,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome|not provided",single nucleotide variant,GRCh37
na,na,1,235806051,235806051,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE|Chédiak-Higashi syndrome|not provided",single nucleotide variant,GRCh38
na,na,1,235969813,235969813,LYST,Pathogenic,"Chédiak-Higashi syndrome|CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE",Deletion,GRCh37
na,na,1,235806513,235806513,LYST,Pathogenic,"Chédiak-Higashi syndrome|CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE",Deletion,GRCh38
na,na,1,235952001,235952001,LYST,Uncertain significance,"CHEDIAK-HIGASHI SYNDROME, ADULT TYPE|Chédiak-Higashi syndrome",single nucleotide variant,GRCh37
na,na,1,235788701,235788701,LYST,Uncertain significance,"CHEDIAK-HIGASHI SYNDROME, ADULT TYPE|Chédiak-Higashi syndrome",single nucleotide variant,GRCh38
na,na,1,235929504,235929504,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, ADULT TYPE|Chédiak-Higashi syndrome",single nucleotide variant,GRCh37
na,na,1,235766204,235766204,LYST,Pathogenic,"CHEDIAK-HIGASHI SYNDROME, ADULT TYPE|Chédiak-Higashi syndrome",single nucleotide variant,GRCh38
na,na,14,88429736,88429736,GALC,Pathogenic,Galactosylceramide beta-galactosidase deficiency,single nucleotide variant,GRCh37
na,na,14,87963392,87963392,GALC,Pathogenic,Galactosylceramide beta-galactosidase deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,GALC,Pathogenic,Galactosylceramide beta-galactosidase deficiency,Deletion,na
na,na,12,56397823,56397823,SUOX,Pathogenic/Likely pathogenic,Sulfite oxidase deficiency,single nucleotide variant,GRCh37
na,na,12,56004039,56004039,SUOX,Pathogenic/Likely pathogenic,Sulfite oxidase deficiency,single nucleotide variant,GRCh38
na,na,12,56397967,56397967,SUOX,Uncertain significance,Sulfite oxidase deficiency,single nucleotide variant,GRCh37
na,na,12,56004183,56004183,SUOX,Uncertain significance,Sulfite oxidase deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,SUOX,Pathogenic,Sulfite oxidase deficiency,single nucleotide variant,na
na,na,12,56398762,56398762,SUOX,Likely pathogenic,Sulfite oxidase deficiency|Sulfocysteinuria,single nucleotide variant,GRCh37
na,na,12,56004978,56004978,SUOX,Likely pathogenic,Sulfite oxidase deficiency|Sulfocysteinuria,single nucleotide variant,GRCh38
na,na,12,121164918,121164918,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided|Inborn genetic diseases|ACADS-related disorder,single nucleotide variant,GRCh37
na,na,12,120727115,120727115,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided|Inborn genetic diseases|ACADS-related disorder,single nucleotide variant,GRCh38
na,na,12,121174897,121174897,ACADS,Pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,120737094,120737094,ACADS,Pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,121174852,121174852,ACADS,Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase,single nucleotide variant,GRCh37
na,na,12,120737049,120737049,ACADS,Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase,single nucleotide variant,GRCh38
na,na,12,121175696,121175696,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided|ACADS-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,120737893,120737893,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided|ACADS-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,121177159,121177159,ACADS,Pathogenic/Likely pathogenic,not provided|Deficiency of butyryl-CoA dehydrogenase,single nucleotide variant,GRCh37
na,na,12,120739356,120739356,ACADS,Pathogenic/Likely pathogenic,not provided|Deficiency of butyryl-CoA dehydrogenase,single nucleotide variant,GRCh38
na,na,12,121175678,121175678,ACADS,Benign/Likely benign,Deficiency of butyryl-CoA dehydrogenase|not provided|not specified,single nucleotide variant,GRCh37
na,na,12,120737875,120737875,ACADS,Benign/Likely benign,Deficiency of butyryl-CoA dehydrogenase|not provided|not specified,single nucleotide variant,GRCh38
na,na,12,121176083,121176083,ACADS,Benign/Likely benign,Deficiency of butyryl-CoA dehydrogenase|not specified|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,120738280,120738280,ACADS,Benign/Likely benign,Deficiency of butyryl-CoA dehydrogenase|not specified|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,121174846,121174846,ACADS,Uncertain significance,Deficiency of butyryl-CoA dehydrogenase,single nucleotide variant,GRCh37
na,na,12,120737043,120737043,ACADS,Uncertain significance,Deficiency of butyryl-CoA dehydrogenase,single nucleotide variant,GRCh38
na,na,12,121174884,121174886,ACADS,Pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,Microsatellite,GRCh37
na,na,12,120737081,120737083,ACADS,Pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,Microsatellite,GRCh38
na,na,12,121175742,121175742,ACADS,Conflicting classifications of pathogenicity,Deficiency of butyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh37
na,na,12,120737939,120737939,ACADS,Conflicting classifications of pathogenicity,Deficiency of butyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh38
na,na,12,121176662,121176662,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh37
na,na,12,120738859,120738859,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh38
na,na,12,121176971,121176971,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh37
na,na,12,120739168,120739168,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh38
na,na,12,121177150,121177150,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh37
na,na,12,120739347,120739347,ACADS,Pathogenic/Likely pathogenic,Deficiency of butyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh38
na,na,12,44171537,44171537,IRAK4,Pathogenic,Immunodeficiency 67,Deletion,GRCh37
na,na,12,43777734,43777734,IRAK4,Pathogenic,Immunodeficiency 67,Deletion,GRCh38
na,na,12,44172041,44172041,IRAK4,Pathogenic,Immunodeficiency 67|not provided|IRAK4-related disorder,single nucleotide variant,GRCh37
na,na,12,43778238,43778238,IRAK4,Pathogenic,Immunodeficiency 67|not provided|IRAK4-related disorder,single nucleotide variant,GRCh38
na,na,12,44166844,44166845,IRAK4,Pathogenic,Immunodeficiency 67,Microsatellite,GRCh37
na,na,12,43773041,43773042,IRAK4,Pathogenic,Immunodeficiency 67,Microsatellite,GRCh38
na,na,12,44180201,44180201,IRAK4,Pathogenic,Immunodeficiency 67,single nucleotide variant,GRCh37
na,na,12,43786398,43786398,IRAK4,Pathogenic,Immunodeficiency 67,single nucleotide variant,GRCh38
na,na,12,44178047,44178047,IRAK4,Likely pathogenic,"Immunodeficiency 67|Invasive pneumococcal disease, recurrent isolated",single nucleotide variant,GRCh37
na,na,12,43784244,43784244,IRAK4,Likely pathogenic,"Immunodeficiency 67|Invasive pneumococcal disease, recurrent isolated",single nucleotide variant,GRCh38
na,na,13,52518281,52518281,ATP7B,Pathogenic,Wilson disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,13,51944145,51944145,ATP7B,Pathogenic,Wilson disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,13,52511719,52511719,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh37
na,na,13,51937583,51937583,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh38
na,na,13,52539170,52539170,ATP7B,Pathogenic,Wilson disease|not provided|Developmental and epileptic encephalopathy 93,single nucleotide variant,GRCh37
na,na,13,51965034,51965034,ATP7B,Pathogenic,Wilson disease|not provided|Developmental and epileptic encephalopathy 93,single nucleotide variant,GRCh38
na,na,13,52524252,52524252,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh37
na,na,13,51950116,51950116,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh38
na,na,13,52532469,52532469,ATP7B,Pathogenic,Wilson disease|not provided|Inborn genetic diseases|ATP7B-related disorder,single nucleotide variant,GRCh37
na,na,13,51958333,51958333,ATP7B,Pathogenic,Wilson disease|not provided|Inborn genetic diseases|ATP7B-related disorder,single nucleotide variant,GRCh38
na,na,13,52511621,52511623,ATP7B,Pathogenic,Wilson disease,Microsatellite,GRCh37
na,na,13,51937485,51937487,ATP7B,Pathogenic,Wilson disease,Microsatellite,GRCh38
na,na,13,52532509,52532509,ATP7B,Pathogenic/Likely pathogenic,Wilson disease,single nucleotide variant,GRCh37
na,na,13,51958373,51958373,ATP7B,Pathogenic/Likely pathogenic,Wilson disease,single nucleotide variant,GRCh38
na,na,13,52523836,52523836,ATP7B,Pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh37
na,na,13,51949700,51949700,ATP7B,Pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh38
na,na,13,52523908,52523908,ATP7B,Pathogenic,Wilson disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,13,51949772,51949772,ATP7B,Pathogenic,Wilson disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,13,52511706,52511706,ATP7B,Pathogenic,Wilson disease|not provided|Inborn genetic diseases|ATP7B-related disorder,single nucleotide variant,GRCh37
na,na,13,51937570,51937570,ATP7B,Pathogenic,Wilson disease|not provided|Inborn genetic diseases|ATP7B-related disorder,single nucleotide variant,GRCh38
na,na,13,52520574,52520574,ATP7B,Pathogenic,Wilson disease|not provided|ATP7B-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,13,51946438,51946438,ATP7B,Pathogenic,Wilson disease|not provided|ATP7B-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,13,52532505,52532505,ATP7B,Pathogenic/Likely pathogenic,Wilson disease,single nucleotide variant,GRCh37
na,na,13,51958369,51958369,ATP7B,Pathogenic/Likely pathogenic,Wilson disease,single nucleotide variant,GRCh38
na,na,13,52535985,52535985,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided|Inborn genetic diseases|ATP7B-related disorder,single nucleotide variant,GRCh37
na,na,13,51961849,51961849,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided|Inborn genetic diseases|ATP7B-related disorder,single nucleotide variant,GRCh38
na,na,13,52515330,52515330,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,13,51941194,51941194,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,13,52548491,52548491,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh37
na,na,13,51974355,51974355,ATP7B,Pathogenic/Likely pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh38
na,na,13,52532679,52532679,ATP7B,Pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh37
na,na,13,51958543,51958543,ATP7B,Pathogenic,Wilson disease|not provided,single nucleotide variant,GRCh38
na,na,13,52534334,52534334,ATP7B,Pathogenic/Likely pathogenic,Wilson disease,single nucleotide variant,GRCh37
na,na,13,51960198,51960198,ATP7B,Pathogenic/Likely pathogenic,Wilson disease,single nucleotide variant,GRCh38
na,na,1,120286529,120286529,PHGDH,Pathogenic/Likely pathogenic,PHGDH deficiency|Neu-Laxova syndrome 1;PHGDH deficiency|See cases|PHGDH-related disorder|Neu-Laxova syndrome 1,single nucleotide variant,GRCh37
na,na,1,119743906,119743906,PHGDH,Pathogenic/Likely pathogenic,PHGDH deficiency|Neu-Laxova syndrome 1;PHGDH deficiency|See cases|PHGDH-related disorder|Neu-Laxova syndrome 1,single nucleotide variant,GRCh38
na,na,1,120285493,120285493,PHGDH,Conflicting classifications of pathogenicity,PHGDH deficiency|Neu-Laxova syndrome 1,single nucleotide variant,GRCh37
na,na,1,119742870,119742870,PHGDH,Conflicting classifications of pathogenicity,PHGDH deficiency|Neu-Laxova syndrome 1,single nucleotide variant,GRCh38
na,na,1,120277986,120277986,PHGDH,Pathogenic,PHGDH deficiency,Deletion,GRCh37
na,na,1,119735363,119735363,PHGDH,Pathogenic,PHGDH deficiency,Deletion,GRCh38
na,na,1,120269520,120269520,PHGDH,Pathogenic/Likely pathogenic,PHGDH deficiency|PHGDH deficiency;Neu-Laxova syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,1,119726897,119726897,PHGDH,Pathogenic/Likely pathogenic,PHGDH deficiency|PHGDH deficiency;Neu-Laxova syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,1,120284440,120284440,PHGDH,Pathogenic/Likely pathogenic,PHGDH deficiency|Neu-Laxova syndrome 1;PHGDH deficiency|not provided|Neu-Laxova syndrome 1,single nucleotide variant,GRCh37
na,na,1,119741817,119741817,PHGDH,Pathogenic/Likely pathogenic,PHGDH deficiency|Neu-Laxova syndrome 1;PHGDH deficiency|not provided|Neu-Laxova syndrome 1,single nucleotide variant,GRCh38
na,na,1,120278055,120278055,PHGDH,Conflicting classifications of pathogenicity,PHGDH deficiency|Neu-Laxova syndrome 1|not provided|not specified,single nucleotide variant,GRCh37
na,na,1,119735432,119735432,PHGDH,Conflicting classifications of pathogenicity,PHGDH deficiency|Neu-Laxova syndrome 1|not provided|not specified,single nucleotide variant,GRCh38
na,na,na,-1,-1,HEXB,Pathogenic,Sandhoff disease,Deletion,na
na,na,5,73985215,73985215,HEXB,Benign,HEXB POLYMORPHISM|not specified|Sandhoff disease|not provided,single nucleotide variant,GRCh37
na,na,5,74689390,74689390,HEXB,Benign,HEXB POLYMORPHISM|not specified|Sandhoff disease|not provided,single nucleotide variant,GRCh38
na,na,5,74014746,74014746,HEXB,Uncertain significance,"Sandhoff disease, juvenile form|Sandhoff disease|not specified|not provided",single nucleotide variant,GRCh37
na,na,5,74718921,74718921,HEXB,Uncertain significance,"Sandhoff disease, juvenile form|Sandhoff disease|not specified|not provided",single nucleotide variant,GRCh38
na,na,5,74014629,74014629,HEXB,Pathogenic/Likely pathogenic,"Sandhoff disease, juvenile form|Sandhoff disease, adult form|not provided|Sandhoff disease|See cases|HEXB-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,5,74718804,74718804,HEXB,Pathogenic/Likely pathogenic,"Sandhoff disease, juvenile form|Sandhoff disease, adult form|not provided|Sandhoff disease|See cases|HEXB-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,5,74016473,74016473,HEXB,Pathogenic,"Sandhoff disease, adult form|Sandhoff disease",single nucleotide variant,GRCh37
na,na,5,74720648,74720648,HEXB,Pathogenic,"Sandhoff disease, adult form|Sandhoff disease",single nucleotide variant,GRCh38
na,na,5,74016956,74016956,HEXB,Likely benign; other,"HEXOSAMINIDASE B, HEAT-LABILE POLYMORPHISM|not provided|Sandhoff disease",single nucleotide variant,GRCh37
na,na,5,74721131,74721131,HEXB,Likely benign; other,"HEXOSAMINIDASE B, HEAT-LABILE POLYMORPHISM|not provided|Sandhoff disease",single nucleotide variant,GRCh38
na,na,5,73981270,73981270,HEXB,Benign,"Sandhoff disease, infantile form|Sandhoff disease",single nucleotide variant,GRCh37
na,na,5,74685445,74685445,HEXB,Benign,"Sandhoff disease, infantile form|Sandhoff disease",single nucleotide variant,GRCh38
na,na,5,74640023,74713505,HEXB,Pathogenic,"Sandhoff disease, infantile form",Deletion,GRCh38
na,na,5,74016469,74016469,HEXB,Pathogenic/Likely pathogenic,"Sandhoff disease, chronic|Sandhoff disease|not provided",single nucleotide variant,GRCh37
na,na,5,74720644,74720644,HEXB,Pathogenic/Likely pathogenic,"Sandhoff disease, chronic|Sandhoff disease|not provided",single nucleotide variant,GRCh38
na,na,5,74011520,74011520,HEXB,Pathogenic,"Sandhoff disease, infantile form",single nucleotide variant,GRCh37
na,na,5,74715695,74715695,HEXB,Pathogenic,"Sandhoff disease, infantile form",single nucleotide variant,GRCh38
na,na,5,73981161,73981161,HEXB,Pathogenic,"Sandhoff disease, infantile form|Sandhoff disease",Deletion,GRCh37
na,na,5,74685336,74685336,HEXB,Pathogenic,"Sandhoff disease, infantile form|Sandhoff disease",Deletion,GRCh38
na,na,5,74009409,74009409,HEXB,Pathogenic,"Sandhoff disease, infantile form|Sandhoff disease|not provided",single nucleotide variant,GRCh37
na,na,5,74713584,74713584,HEXB,Pathogenic,"Sandhoff disease, infantile form|Sandhoff disease|not provided",single nucleotide variant,GRCh38
na,na,15,72638921,72638924,HEXA,Pathogenic,"Tay-Sachs disease|not provided|Inborn genetic diseases|Tay-Sachs disease, variant AB;Tay-Sachs disease|Intellectual disability|HEXA-related disorder",Duplication,GRCh37
na,na,15,72346579,72346580,HEXA,Pathogenic,"Tay-Sachs disease|not provided|Inborn genetic diseases|Tay-Sachs disease, variant AB;Tay-Sachs disease|Intellectual disability|HEXA-related disorder",Duplication,GRCh38
na,na,15,72638575,72638575,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh37
na,na,15,72346234,72346234,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh38
na,na,15,72662933,72670877,HEXA,Pathogenic,Tay-Sachs disease,Indel,GRCh37
na,na,15,72370592,72378536,HEXA,Pathogenic,Tay-Sachs disease,Indel,GRCh38
na,na,15,72637869,72637869,HEXA,Pathogenic/Likely pathogenic,Tay-Sachs disease|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,15,72345528,72345528,HEXA,Pathogenic/Likely pathogenic,Tay-Sachs disease|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,15,72648865,72648865,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72356524,72356524,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72637803,72637803,HEXA,Pathogenic,Tay-Sachs disease,Deletion,GRCh37
na,na,15,72345462,72345462,HEXA,Pathogenic,Tay-Sachs disease,Deletion,GRCh38
na,na,15,72637802,72637802,HEXA,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, juvenile|Tay-Sachs disease|not provided",single nucleotide variant,GRCh37
na,na,15,72345461,72345461,HEXA,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, juvenile|Tay-Sachs disease|not provided",single nucleotide variant,GRCh38
na,na,15,72645446,72645446,HEXA,Pathogenic/Likely pathogenic,"Hexa, dn allele|Tay-Sachs disease, B1 variant|not provided|Tay-Sachs disease|Global developmental delay|Inborn genetic diseases|HEXA-related disorder",single nucleotide variant,GRCh37
na,na,15,72353105,72353105,HEXA,Pathogenic/Likely pathogenic,"Hexa, dn allele|Tay-Sachs disease, B1 variant|not provided|Tay-Sachs disease|Global developmental delay|Inborn genetic diseases|HEXA-related disorder",single nucleotide variant,GRCh38
na,na,15,72645447,72645447,HEXA,Pathogenic,"Tay-Sachs disease, B1 variant|Tay-Sachs disease",single nucleotide variant,GRCh37
na,na,15,72353106,72353106,HEXA,Pathogenic,"Tay-Sachs disease, B1 variant|Tay-Sachs disease",single nucleotide variant,GRCh38
na,na,15,72642859,72642859,HEXA,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, adult|Tay-Sachs disease|not provided|Gm2-gangliosidosis, late onset|Inborn genetic diseases|HEXA-related disorder",single nucleotide variant,GRCh37
na,na,15,72350518,72350518,HEXA,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, adult|Tay-Sachs disease|not provided|Gm2-gangliosidosis, late onset|Inborn genetic diseases|HEXA-related disorder",single nucleotide variant,GRCh38
na,na,15,72637817,72637817,HEXA,Pathogenic,"Gm2-gangliosidosis, juvenile|Inborn genetic diseases|Tay-Sachs disease|not provided",single nucleotide variant,GRCh37
na,na,15,72345476,72345476,HEXA,Pathogenic,"Gm2-gangliosidosis, juvenile|Inborn genetic diseases|Tay-Sachs disease|not provided",single nucleotide variant,GRCh38
na,na,15,72645470,72645470,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh37
na,na,15,72353129,72353129,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh38
na,na,15,72638938,72638938,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh37
na,na,15,72346597,72346597,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh38
na,na,15,72642915,72642915,HEXA,Pathogenic/Likely pathogenic,"Tay-sachs disease, juvenile|Tay-Sachs disease",single nucleotide variant,GRCh37
na,na,15,72350574,72350574,HEXA,Pathogenic/Likely pathogenic,"Tay-sachs disease, juvenile|Tay-Sachs disease",single nucleotide variant,GRCh38
na,na,15,72647903,72647903,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh37
na,na,15,72355562,72355562,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh38
na,na,15,72639021,72639021,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh37
na,na,15,72346680,72346680,HEXA,Pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh38
na,na,15,72637803,72637803,HEXA,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, chronic|not provided|Tay-Sachs disease|not specified",single nucleotide variant,GRCh37
na,na,15,72345462,72345462,HEXA,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, chronic|not provided|Tay-Sachs disease|not specified",single nucleotide variant,GRCh38
na,na,15,72643517,72643517,HEXA,Pathogenic/Likely pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72351176,72351176,HEXA,Pathogenic/Likely pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72645501,72645502,HEXA,Pathogenic,Tay-Sachs disease,Deletion,GRCh37
na,na,15,72353160,72353161,HEXA,Pathogenic,Tay-Sachs disease,Deletion,GRCh38
na,na,15,72668236,72668236,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72375895,72375895,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72645446,72645446,HEXA,Likely pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh37
na,na,15,72353105,72353105,HEXA,Likely pathogenic,Tay-Sachs disease|not provided,single nucleotide variant,GRCh38
na,na,15,72668313,72668313,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72375972,72375972,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72637818,72637818,HEXA,Pathogenic,"GM2-gangliosidosis, adult-onset|Tay-Sachs disease|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,15,72345477,72345477,HEXA,Pathogenic,"GM2-gangliosidosis, adult-onset|Tay-Sachs disease|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,15,72640475,72640475,HEXA,Likely pathogenic,"Gm2-gangliosidosis, variant b1|Tay-Sachs disease",single nucleotide variant,GRCh37
na,na,15,72348134,72348134,HEXA,Likely pathogenic,"Gm2-gangliosidosis, variant b1|Tay-Sachs disease",single nucleotide variant,GRCh38
na,na,15,72637860,72637860,HEXA,Uncertain significance,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72345519,72345519,HEXA,Uncertain significance,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72645432,72645433,HEXA,Pathogenic,Tay-Sachs disease,Duplication,GRCh37
na,na,15,72353091,72353092,HEXA,Pathogenic,Tay-Sachs disease,Duplication,GRCh38
na,na,15,72645439,72645439,HEXA,Affects,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72353098,72353098,HEXA,Affects,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72640388,72640388,HEXA,Pathogenic/Likely pathogenic,Tay-Sachs disease|not provided|Inborn genetic diseases|HEXA-related disorder,single nucleotide variant,GRCh37
na,na,15,72348047,72348047,HEXA,Pathogenic/Likely pathogenic,Tay-Sachs disease|not provided|Inborn genetic diseases|HEXA-related disorder,single nucleotide variant,GRCh38
na,na,15,72641442,72641444,HEXA,Pathogenic,"Tay-Sachs disease, B1 variant",Microsatellite,GRCh37
na,na,15,72349101,72349103,HEXA,Pathogenic,"Tay-Sachs disease, B1 variant",Microsatellite,GRCh38
na,na,15,72642925,72642925,HEXA,Benign/Likely benign; other,"Beta-hexosaminidase a, pseudodeficiency of|not specified|not provided|Tay-Sachs disease",single nucleotide variant,GRCh37
na,na,15,72350584,72350584,HEXA,Benign/Likely benign; other,"Beta-hexosaminidase a, pseudodeficiency of|not specified|not provided|Tay-Sachs disease",single nucleotide variant,GRCh38
na,na,15,72643572,72643572,HEXA,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,15,72351231,72351231,HEXA,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,15,72642892,72642892,HEXA,Pathogenic/Likely pathogenic,"Tay-Sachs disease, B1 variant|not provided|Tay-Sachs disease",single nucleotide variant,GRCh37
na,na,15,72350551,72350551,HEXA,Pathogenic/Likely pathogenic,"Tay-Sachs disease, B1 variant|not provided|Tay-Sachs disease",single nucleotide variant,GRCh38
na,na,15,72645471,72645471,HEXA,Pathogenic/Likely pathogenic,Tay-Sachs disease|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,15,72353130,72353130,HEXA,Pathogenic/Likely pathogenic,Tay-Sachs disease|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,15,72643556,72643556,HEXA,Conflicting classifications of pathogenicity,"Gm2-gangliosidosis, late onset|Tay-Sachs disease|not provided|not specified",single nucleotide variant,GRCh37
na,na,15,72351215,72351215,HEXA,Conflicting classifications of pathogenicity,"Gm2-gangliosidosis, late onset|Tay-Sachs disease|not provided|not specified",single nucleotide variant,GRCh38
na,na,15,72643473,72643473,HEXA,Pathogenic,"Tay-sachs disease, juvenile/adult|Tay-Sachs disease|not provided",single nucleotide variant,GRCh37
na,na,15,72351132,72351132,HEXA,Pathogenic,"Tay-sachs disease, juvenile/adult|Tay-Sachs disease|not provided",single nucleotide variant,GRCh38
na,na,15,72643514,72643514,HEXA,Affects,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72351173,72351173,HEXA,Affects,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72647932,72647932,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72355591,72355591,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72643535,72643535,HEXA,Conflicting classifications of pathogenicity,Tay-Sachs disease|not specified|not provided,single nucleotide variant,GRCh37
na,na,15,72351194,72351194,HEXA,Conflicting classifications of pathogenicity,Tay-Sachs disease|not specified|not provided,single nucleotide variant,GRCh38
na,na,15,72646065,72646066,HEXA,Pathogenic,Tay-Sachs disease,Deletion,GRCh37
na,na,15,72353724,72353725,HEXA,Pathogenic,Tay-Sachs disease,Deletion,GRCh38
na,na,15,72641504,72641504,HEXA,Conflicting classifications of pathogenicity,"Tay-Sachs disease|Tay-Sachs disease, variant AB;Tay-Sachs disease",single nucleotide variant,GRCh37
na,na,15,72349163,72349163,HEXA,Conflicting classifications of pathogenicity,"Tay-Sachs disease|Tay-Sachs disease, variant AB;Tay-Sachs disease",single nucleotide variant,GRCh38
na,na,15,72638637,72638637,HEXA,Likely pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72346296,72346296,HEXA,Likely pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72668198,72668198,HEXA,Affects,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72375857,72375857,HEXA,Affects,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72639022,72639022,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72346681,72346681,HEXA,Pathogenic,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72642858,72642858,HEXA,Pathogenic,Tay-Sachs disease|HEXA-related disorder,single nucleotide variant,GRCh37
na,na,15,72350517,72350517,HEXA,Pathogenic,Tay-Sachs disease|HEXA-related disorder,single nucleotide variant,GRCh38
na,na,15,72645441,72645441,HEXA,Likely pathogenic,"Gm2-gangliosidosis, late onset|Tay-Sachs disease",single nucleotide variant,GRCh37
na,na,15,72353100,72353100,HEXA,Likely pathogenic,"Gm2-gangliosidosis, late onset|Tay-Sachs disease",single nucleotide variant,GRCh38
na,na,15,72637891,72637891,HEXA,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, subacute|Tay-Sachs disease",single nucleotide variant,GRCh37
na,na,15,72345550,72345550,HEXA,Pathogenic/Likely pathogenic,"Gm2-gangliosidosis, subacute|Tay-Sachs disease",single nucleotide variant,GRCh38
na,na,15,72638646,72638646,HEXA,Uncertain significance; Affects,Tay-Sachs disease,single nucleotide variant,GRCh37
na,na,15,72346305,72346305,HEXA,Uncertain significance; Affects,Tay-Sachs disease,single nucleotide variant,GRCh38
na,na,15,72641434,72641434,HEXA,Conflicting classifications of pathogenicity,"Gm2-gangliosidosis, subacute|Tay-Sachs disease|not provided",single nucleotide variant,GRCh37
na,na,15,72349093,72349093,HEXA,Conflicting classifications of pathogenicity,"Gm2-gangliosidosis, subacute|Tay-Sachs disease|not provided",single nucleotide variant,GRCh38
na,na,na,-1,-1,SERPING1,Pathogenic,Hereditary angioedema type 1,Deletion,na
na,na,11,57381923,57381923,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor,single nucleotide variant,GRCh37
na,na,11,57614450,57614450,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor,single nucleotide variant,GRCh38
na,na,11,57381948,57381948,SERPING1,Conflicting classifications of pathogenicity,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|Hereditary angioedema type 1|not provided|Hereditary angioedema type 1;C1 inhibitor deficiency|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,11,57614475,57614475,SERPING1,Conflicting classifications of pathogenicity,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|Hereditary angioedema type 1|not provided|Hereditary angioedema type 1;C1 inhibitor deficiency|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,11,57381947,57381947,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|not provided|Hereditary angioedema type 1,single nucleotide variant,GRCh37
na,na,11,57614474,57614474,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|not provided|Hereditary angioedema type 1,single nucleotide variant,GRCh38
na,na,11,57381947,57381947,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|not provided,single nucleotide variant,GRCh37
na,na,11,57614474,57614474,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor|not provided,single nucleotide variant,GRCh38
na,na,11,57381818,57381819,SERPING1,Pathogenic,Hereditary angioedema type 1,Duplication,GRCh37
na,na,11,57614345,57614346,SERPING1,Pathogenic,Hereditary angioedema type 1,Duplication,GRCh38
na,na,11,57381811,57381811,SERPING1,Pathogenic,Hereditary angioedema type 1,Deletion,GRCh37
na,na,11,57614338,57614338,SERPING1,Pathogenic,Hereditary angioedema type 1,Deletion,GRCh38
na,na,11,57379410,57379410,SERPING1,Pathogenic,Hereditary angioedema type 1,single nucleotide variant,GRCh37
na,na,11,57611937,57611937,SERPING1,Pathogenic,Hereditary angioedema type 1,single nucleotide variant,GRCh38
na,na,11,57381857,57381857,SERPING1,Pathogenic,Hereditary angioedema type 1,Deletion,GRCh37
na,na,11,57614384,57614384,SERPING1,Pathogenic,Hereditary angioedema type 1,Deletion,GRCh38
na,na,11,57381912,57381912,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor,single nucleotide variant,GRCh37
na,na,11,57614439,57614439,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor,single nucleotide variant,GRCh38
na,na,11,57381908,57381909,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor,Insertion,GRCh37
na,na,11,57614435,57614436,SERPING1,Pathogenic,Hereditary C1 esterase inhibitor deficiency - dysfunctional factor,Insertion,GRCh38
na,na,11,57381945,57381945,SERPING1,Uncertain significance,"Complement component 4, partial deficiency of, due to dysfunctional c1 inhibitor|not provided",single nucleotide variant,GRCh37
na,na,11,57614472,57614472,SERPING1,Uncertain significance,"Complement component 4, partial deficiency of, due to dysfunctional c1 inhibitor|not provided",single nucleotide variant,GRCh38
na,na,11,57365055,57365055,SERPING1,Pathogenic,Hereditary angioedema type 1,single nucleotide variant,GRCh37
na,na,11,57597582,57597582,SERPING1,Pathogenic,Hereditary angioedema type 1,single nucleotide variant,GRCh38
na,na,11,57369554,57369554,SERPING1,Pathogenic,Hereditary angioedema type 1,single nucleotide variant,GRCh37
na,na,11,57602081,57602081,SERPING1,Pathogenic,Hereditary angioedema type 1,single nucleotide variant,GRCh38
na,na,6,53371799,53371799,GCLC,Pathogenic,Gamma-glutamylcysteine synthetase deficiency,single nucleotide variant,GRCh37
na,na,6,53507001,53507001,GCLC,Pathogenic,Gamma-glutamylcysteine synthetase deficiency,single nucleotide variant,GRCh38
na,na,5,149753851,149753851,TCOF1,Pathogenic,Treacher Collins syndrome 1,single nucleotide variant,GRCh37
na,na,5,150374288,150374288,TCOF1,Pathogenic,Treacher Collins syndrome 1,single nucleotide variant,GRCh38
na,na,5,149748321,149748322,TCOF1,Pathogenic,Treacher Collins syndrome 1,Duplication,GRCh37
na,na,5,150368758,150368759,TCOF1,Pathogenic,Treacher Collins syndrome 1,Duplication,GRCh38
na,na,5,149748397,149748400,TCOF1,Pathogenic,Treacher Collins syndrome 1,Deletion,GRCh37
na,na,5,150368834,150368837,TCOF1,Pathogenic,Treacher Collins syndrome 1,Deletion,GRCh38
na,na,5,149777936,149777940,TCOF1,Pathogenic,Treacher Collins syndrome 1|not provided|Treacher Collins syndrome|Inborn genetic diseases,Microsatellite,GRCh37
na,na,5,150398373,150398377,TCOF1,Pathogenic,Treacher Collins syndrome 1|not provided|Treacher Collins syndrome|Inborn genetic diseases,Microsatellite,GRCh38
na,na,5,149740759,149740759,TCOF1,Likely pathogenic,Treacher Collins syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,5,150361196,150361196,TCOF1,Likely pathogenic,Treacher Collins syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,5,149755048,149755049,TCOF1,Pathogenic,Treacher Collins syndrome 1|TCOF1-related disorder,Microsatellite,GRCh37
na,na,5,150375485,150375486,TCOF1,Pathogenic,Treacher Collins syndrome 1|TCOF1-related disorder,Microsatellite,GRCh38
na,na,5,149767567,149767567,TCOF1,Pathogenic,Treacher Collins syndrome 1,single nucleotide variant,GRCh37
na,na,5,150388004,150388004,TCOF1,Pathogenic,Treacher Collins syndrome 1,single nucleotide variant,GRCh38
na,na,5,149747475,149747492,TCOF1,Pathogenic,Treacher Collins syndrome 1,Deletion,GRCh37
na,na,5,150367912,150367929,TCOF1,Pathogenic,Treacher Collins syndrome 1,Deletion,GRCh38
na,na,5,149777932,149777932,TCOF1,Pathogenic,Treacher Collins syndrome 1,Deletion,GRCh37
na,na,5,150398369,150398369,TCOF1,Pathogenic,Treacher Collins syndrome 1,Deletion,GRCh38
na,na,2,73799533,73799534,ALMS1,Pathogenic,Alstrom syndrome,Insertion,GRCh37
na,na,2,73572406,73572407,ALMS1,Pathogenic,Alstrom syndrome,Insertion,GRCh38
na,na,2,73717466,73717466,ALMS1,Pathogenic,Alstrom syndrome,single nucleotide variant,GRCh37
na,na,2,73490339,73490339,ALMS1,Pathogenic,Alstrom syndrome,single nucleotide variant,GRCh38
na,na,2,73799776,73799776,ALMS1,Pathogenic,Alstrom syndrome|not provided|Retinal dystrophy|Cardiovascular phenotype,Deletion,GRCh37
na,na,2,73572649,73572649,ALMS1,Pathogenic,Alstrom syndrome|not provided|Retinal dystrophy|Cardiovascular phenotype,Deletion,GRCh38
na,na,2,73675788,73675789,ALMS1,Pathogenic,Alstrom syndrome|not provided,Microsatellite,GRCh37
na,na,2,73448661,73448662,ALMS1,Pathogenic,Alstrom syndrome|not provided,Microsatellite,GRCh38
na,na,2,73799993,73799993,ALMS1,Pathogenic,Alstrom syndrome,single nucleotide variant,GRCh37
na,na,2,73572866,73572866,ALMS1,Pathogenic,Alstrom syndrome,single nucleotide variant,GRCh38
na,na,2,73717247,73717247,ALMS1,Pathogenic,Alstrom syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,73490120,73490120,ALMS1,Pathogenic,Alstrom syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,53536328,53598019,RB1CC1,Pathogenic,Breast adenocarcinoma,Deletion,GRCh37
na,na,8,52623768,52685459,RB1CC1,Pathogenic,Breast adenocarcinoma,Deletion,GRCh38
na,na,8,53537321,53574220,RB1CC1,Pathogenic,Breast adenocarcinoma,Deletion,GRCh37
na,na,8,52624761,52661660,RB1CC1,Pathogenic,Breast adenocarcinoma,Deletion,GRCh38
na,na,9,71668109,71668109,FXN,Pathogenic,Friedreich ataxia,single nucleotide variant,GRCh37
na,na,9,69053193,69053193,FXN,Pathogenic,Friedreich ataxia,single nucleotide variant,GRCh38
na,na,9,71679852,71679852,FXN,Pathogenic,Friedreich ataxia,single nucleotide variant,GRCh37
na,na,9,69064936,69064936,FXN,Pathogenic,Friedreich ataxia,single nucleotide variant,GRCh38
na,na,9,71679929,71679929,FXN,Pathogenic,Friedreich ataxia|Friedreich ataxia 1,single nucleotide variant,GRCh37
na,na,9,69065013,69065013,FXN,Pathogenic,Friedreich ataxia|Friedreich ataxia 1,single nucleotide variant,GRCh38
na,na,9,71679858,71679858,FXN,Conflicting classifications of pathogenicity,Friedreich ataxia|not provided,single nucleotide variant,GRCh37
na,na,9,69064942,69064942,FXN,Conflicting classifications of pathogenicity,Friedreich ataxia|not provided,single nucleotide variant,GRCh38
na,na,9,71650701,71650701,FXN,Pathogenic,Friedreich ataxia|not provided|Friedreich ataxia 1,single nucleotide variant,GRCh37
na,na,9,69035785,69035785,FXN,Pathogenic,Friedreich ataxia|not provided|Friedreich ataxia 1,single nucleotide variant,GRCh38
na,na,9,71687562,71687562,FXN,Likely pathogenic,Friedreich ataxia,single nucleotide variant,GRCh37
na,na,9,69072646,69072646,FXN,Likely pathogenic,Friedreich ataxia,single nucleotide variant,GRCh38
na,na,9,71650852,71650852,FXN,Pathogenic,Friedreich ataxia|not provided,Deletion,GRCh37
na,na,9,69035936,69035936,FXN,Pathogenic,Friedreich ataxia|not provided,Deletion,GRCh38
na,na,1,46657979,46657979,POMGNT1,Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh37
na,na,1,46192307,46192307,POMGNT1,Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh38
na,na,1,46656145,46656145,POMGNT1,Pathogenic/Likely pathogenic,"Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy",single nucleotide variant,GRCh37
na,na,1,46190473,46190473,POMGNT1,Pathogenic/Likely pathogenic,"Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy",single nucleotide variant,GRCh38
na,na,1,46655592,46655592,POMGNT1,Pathogenic/Likely pathogenic,"Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",Deletion,GRCh37
na,na,1,46189920,46189920,POMGNT1,Pathogenic/Likely pathogenic,"Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",Deletion,GRCh38
na,na,1,46657831,46657831,POMGNT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh37
na,na,1,46192159,46192159,POMGNT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh38
na,na,1,46658069,46658069,POMGNT1,Pathogenic/Likely pathogenic,"not provided|Autosomal recessive limb-girdle muscular dystrophy type 2O|Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Retinitis pigmentosa 76|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Muscular dystrophy-dystroglycanopathy|Autosomal recessive limb-girdle muscular dystrophy|Retinal dystrophy|Retinitis pigmentosa 76;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3",single nucleotide variant,GRCh37
na,na,1,46192397,46192397,POMGNT1,Pathogenic/Likely pathogenic,"not provided|Autosomal recessive limb-girdle muscular dystrophy type 2O|Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Retinitis pigmentosa 76|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Muscular dystrophy-dystroglycanopathy|Autosomal recessive limb-girdle muscular dystrophy|Retinal dystrophy|Retinitis pigmentosa 76;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3",single nucleotide variant,GRCh38
na,na,1,46659545,46659545,POMGNT1,Pathogenic/Likely pathogenic,"Muscle eye brain disease|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy",single nucleotide variant,GRCh37
na,na,1,46193873,46193873,POMGNT1,Pathogenic/Likely pathogenic,"Muscle eye brain disease|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy",single nucleotide variant,GRCh38
na,na,1,46662690,46662690,POMGNT1,Pathogenic,"Retinitis pigmentosa 76|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Retinitis pigmentosa 76;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Autosomal recessive limb-girdle muscular dystrophy type 2O",single nucleotide variant,GRCh37
na,na,1,46197018,46197018,POMGNT1,Pathogenic,"Retinitis pigmentosa 76|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Retinitis pigmentosa 76;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Autosomal recessive limb-girdle muscular dystrophy type 2O",single nucleotide variant,GRCh38
na,na,1,46655193,46655193,POMGNT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",Deletion,GRCh37
na,na,1,46189521,46189521,POMGNT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",Deletion,GRCh38
na,na,1,46657884,46657884,POMGNT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh37
na,na,1,46192212,46192212,POMGNT1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh38
na,na,1,46655645,46655645,POMGNT1,Conflicting classifications of pathogenicity,"Autosomal recessive limb-girdle muscular dystrophy type 2O|not specified|Muscle eye brain disease|not provided|Congenital Muscular Dystrophy, alpha-dystroglycan related|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Retinitis pigmentosa 76|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Structural eye disease",single nucleotide variant,GRCh37
na,na,1,46189973,46189973,POMGNT1,Conflicting classifications of pathogenicity,"Autosomal recessive limb-girdle muscular dystrophy type 2O|not specified|Muscle eye brain disease|not provided|Congenital Muscular Dystrophy, alpha-dystroglycan related|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Retinitis pigmentosa 76|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Structural eye disease",single nucleotide variant,GRCh38
na,na,1,46655211,46655211,POMGNT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscle eye brain disease|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|not provided|Muscular dystrophy-dystroglycanopathy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh37
na,na,1,46189539,46189539,POMGNT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscle eye brain disease|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|not provided|Muscular dystrophy-dystroglycanopathy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh38
na,na,1,46660515,46660515,POMGNT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Muscular dystrophy-dystroglycanopathy",single nucleotide variant,GRCh37
na,na,1,46194843,46194843,POMGNT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscle eye brain disease|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3|Muscular dystrophy-dystroglycanopathy",single nucleotide variant,GRCh38
na,na,1,46657840,46657840,POMGNT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscle eye brain disease|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|not provided|Muscular dystrophy-dystroglycanopathy|Retinitis pigmentosa 76;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|POMGNT1-related disorder|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh37
na,na,1,46192168,46192168,POMGNT1,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|Muscle eye brain disease|Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|not provided|Muscular dystrophy-dystroglycanopathy|Retinitis pigmentosa 76;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;Autosomal recessive limb-girdle muscular dystrophy type 2O;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3|POMGNT1-related disorder|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3",single nucleotide variant,GRCh38
na,na,7,106898843,106898843,COG5,Pathogenic,COG5-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,7,107258398,107258398,COG5,Pathogenic,COG5-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,1,19200975,19200976,ALDH4A1,Pathogenic/Likely pathogenic,Hyperprolinemia type 2|not provided,Duplication,GRCh37
na,na,1,18874481,18874482,ALDH4A1,Pathogenic/Likely pathogenic,Hyperprolinemia type 2|not provided,Duplication,GRCh38
na,na,1,19203992,19203992,ALDH4A1,Conflicting classifications of pathogenicity,Hyperprolinemia type 2,single nucleotide variant,GRCh37
na,na,1,18877498,18877498,ALDH4A1,Conflicting classifications of pathogenicity,Hyperprolinemia type 2,single nucleotide variant,GRCh38
na,na,1,19228997,19228997,ALDH4A1,Likely pathogenic,Hyperprolinemia type 2|not provided,Deletion,GRCh37
na,na,1,18902503,18902503,ALDH4A1,Likely pathogenic,Hyperprolinemia type 2|not provided,Deletion,GRCh38
na,na,22,18893735,18924066,PRODH,Pathogenic; risk factor,Proline dehydrogenase deficiency|Schizophrenia 4,Deletion,GRCh37
na,na,22,18906222,18936553,PRODH,Pathogenic; risk factor,Proline dehydrogenase deficiency|Schizophrenia 4,Deletion,GRCh38
na,na,22,18905899,18905899,PRODH,Conflicting classifications of pathogenicity,Proline dehydrogenase deficiency|Schizophrenia 4|not specified|Schizophrenia 4;Proline dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,22,18918386,18918386,PRODH,Conflicting classifications of pathogenicity,Proline dehydrogenase deficiency|Schizophrenia 4|not specified|Schizophrenia 4;Proline dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,22,18909902,18909902,PRODH,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|not specified|Proline dehydrogenase deficiency;Schizophrenia 4,single nucleotide variant,GRCh37
na,na,22,18922389,18922389,PRODH,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|not specified|Proline dehydrogenase deficiency;Schizophrenia 4,single nucleotide variant,GRCh38
na,na,22,18905934,18905934,PRODH,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|Inborn genetic diseases|not specified|Schizophrenia 4;Proline dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,22,18918421,18918421,PRODH,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|Inborn genetic diseases|not specified|Schizophrenia 4;Proline dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,22,18905893,18905893,PRODH,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|Inborn genetic diseases|Schizophrenia 4;Proline dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,22,18918380,18918380,PRODH,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|Inborn genetic diseases|Schizophrenia 4;Proline dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,22,18901004,18901004,PRODH,Benign,Proline dehydrogenase deficiency|Schizophrenia 4|not provided,single nucleotide variant,GRCh37
na,na,22,18913491,18913491,PRODH,Benign,Proline dehydrogenase deficiency|Schizophrenia 4|not provided,single nucleotide variant,GRCh38
na,na,22,18905964,18905964,PRODH,Conflicting classifications of pathogenicity,Proline dehydrogenase deficiency|Schizophrenia 4|Proline dehydrogenase deficiency;Schizophrenia 4|not specified,single nucleotide variant,GRCh37
na,na,22,18918451,18918451,PRODH,Conflicting classifications of pathogenicity,Proline dehydrogenase deficiency|Schizophrenia 4|Proline dehydrogenase deficiency;Schizophrenia 4|not specified,single nucleotide variant,GRCh38
na,na,22,18901005,18901005,PRODH,Pathogenic,Proline dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,22,18913492,18913492,PRODH,Pathogenic,Proline dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,22,18905859,18905859,PRODH,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|Schizophrenia 4;Proline dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,22,18918346,18918346,PRODH,Conflicting classifications of pathogenicity,Schizophrenia 4|Proline dehydrogenase deficiency|not provided|Schizophrenia 4;Proline dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,10,26457658,26457658,MYO3A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 30,single nucleotide variant,GRCh37
na,na,10,26168729,26168729,MYO3A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 30,single nucleotide variant,GRCh38
na,na,10,26409593,26409593,MYO3A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 30,single nucleotide variant,GRCh37
na,na,10,26120664,26120664,MYO3A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 30,single nucleotide variant,GRCh38
na,na,10,26312949,26312949,MYO3A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 30,single nucleotide variant,GRCh37
na,na,10,26024020,26024020,MYO3A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 30,single nucleotide variant,GRCh38
na,na,21,47571859,47571859,FTCD,Uncertain significance,Glutamate formiminotransferase deficiency,single nucleotide variant,GRCh37
na,na,21,46151945,46151945,FTCD,Uncertain significance,Glutamate formiminotransferase deficiency,single nucleotide variant,GRCh38
na,na,21,47570043,47570043,FTCD,Uncertain significance,Glutamate formiminotransferase deficiency,single nucleotide variant,GRCh37
na,na,21,46150129,46150129,FTCD,Uncertain significance,Glutamate formiminotransferase deficiency,single nucleotide variant,GRCh38
na,na,21,47565839,47565840,FTCD,Pathogenic/Likely pathogenic,Glutamate formiminotransferase deficiency|not provided|FTCD-related disorder|Inborn genetic diseases,Duplication,GRCh37
na,na,21,46145925,46145926,FTCD,Pathogenic/Likely pathogenic,Glutamate formiminotransferase deficiency|not provided|FTCD-related disorder|Inborn genetic diseases,Duplication,GRCh38
na,na,17,78078656,78078656,GAA,Benign/Likely benign; other,"Acid alpha-glucosidase, allele 2|not provided|not specified|Glycogen storage disease, type II|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,17,80104857,80104857,GAA,Benign/Likely benign; other,"Acid alpha-glucosidase, allele 2|not provided|not specified|Glycogen storage disease, type II|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,17,78081693,78081693,GAA,Pathogenic,"Glycogen storage disease type II, infantile|not provided|Glycogen storage disease, type II",single nucleotide variant,GRCh37
na,na,17,80107894,80107894,GAA,Pathogenic,"Glycogen storage disease type II, infantile|not provided|Glycogen storage disease, type II",single nucleotide variant,GRCh38
na,na,17,78084749,78084749,GAA,Pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II|not provided",single nucleotide variant,GRCh37
na,na,17,80110950,80110950,GAA,Pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II|not provided",single nucleotide variant,GRCh38
na,na,17,78086713,78086713,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|not provided",single nucleotide variant,GRCh37
na,na,17,80112914,80112914,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|not provided",single nucleotide variant,GRCh38
na,na,17,78087149,78087149,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|not provided",single nucleotide variant,GRCh37
na,na,17,80113350,80113350,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|not provided",single nucleotide variant,GRCh38
na,na,17,78081636,78081636,GAA,Likely pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II",single nucleotide variant,GRCh37
na,na,17,80107837,80107837,GAA,Likely pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II",single nucleotide variant,GRCh38
na,na,17,78084773,78084774,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM",Indel,GRCh37
na,na,17,80110974,80110975,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM",Indel,GRCh38
na,na,17,78078341,78078341,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|not provided|Glycogen storage disease, type II|Myopathy|Cardiovascular phenotype|Glycogen storage disease due to acid maltase deficiency, late-onset|See cases|Glycogen storage disease, type IV|GAA-related disorder",single nucleotide variant,GRCh37
na,na,17,80104542,80104542,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|not provided|Glycogen storage disease, type II|Myopathy|Cardiovascular phenotype|Glycogen storage disease due to acid maltase deficiency, late-onset|See cases|Glycogen storage disease, type IV|GAA-related disorder",single nucleotide variant,GRCh38
na,na,17,78092510,78092512,GAA,Pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II",Deletion,GRCh37
na,na,17,80118711,80118713,GAA,Pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II",Deletion,GRCh38
na,na,17,78086721,78086721,GAA,Pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II|not provided|Cardiovascular phenotype|GAA-related disorder",single nucleotide variant,GRCh37
na,na,17,80112922,80112922,GAA,Pathogenic,"Glycogen storage disease type II, infantile|Glycogen storage disease, type II|not provided|Cardiovascular phenotype|GAA-related disorder",single nucleotide variant,GRCh38
na,na,17,78087041,78087041,GAA,Benign; other,"Acid alpha-glucosidase, allele 4|not specified|Glycogen storage disease, type II|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,17,80113242,80113242,GAA,Benign; other,"Acid alpha-glucosidase, allele 4|not specified|Glycogen storage disease, type II|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,17,78091992,78092156,GAA,Pathogenic,"Glycogen storage disease, type II",Deletion,GRCh37
na,na,17,80118193,80118357,GAA,Pathogenic,"Glycogen storage disease, type II",Deletion,GRCh38
na,na,17,78084822,78084822,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|not provided|Glycogen storage disease, type II",single nucleotide variant,GRCh37
na,na,17,80111023,80111023,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|not provided|Glycogen storage disease, type II",single nucleotide variant,GRCh38
na,na,17,78078910,78078910,GAA,Pathogenic,"Glycogen storage disease, type II|not provided|See cases",Deletion,GRCh37
na,na,17,80105111,80105111,GAA,Pathogenic,"Glycogen storage disease, type II|not provided|See cases",Deletion,GRCh38
na,na,17,78092070,78092070,GAA,Pathogenic,"Glycogen storage disease, type II|not provided|GAA-related disorder|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,17,80118271,80118271,GAA,Pathogenic,"Glycogen storage disease, type II|not provided|GAA-related disorder|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,17,78081373,78081373,GAA,Uncertain significance,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|GAA-related disorder|not specified|not provided",single nucleotide variant,GRCh37
na,na,17,80107574,80107574,GAA,Uncertain significance,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|GAA-related disorder|not specified|not provided",single nucleotide variant,GRCh38
na,na,17,78081617,78081617,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|not provided",single nucleotide variant,GRCh37
na,na,17,80107818,80107818,GAA,Pathogenic,"GLYCOGEN STORAGE DISEASE II, ADULT FORM|Glycogen storage disease, type II|not provided",single nucleotide variant,GRCh38
na,na,11,130079629,130079629,ST14,Pathogenic,Autosomal recessive congenital ichthyosis 11,single nucleotide variant,GRCh37
na,na,11,130209734,130209734,ST14,Pathogenic,Autosomal recessive congenital ichthyosis 11,single nucleotide variant,GRCh38
na,na,11,130029877,130029877,ST14,Pathogenic,Autosomal recessive congenital ichthyosis 11,single nucleotide variant,GRCh37
na,na,11,130159982,130159982,ST14,Pathogenic,Autosomal recessive congenital ichthyosis 11,single nucleotide variant,GRCh38
na,na,2,1491613,1491613,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh37
na,na,2,1487841,1487841,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh38
na,na,2,1488368,1488368,TPO,Pathogenic,Deficiency of iodide peroxidase,single nucleotide variant,GRCh37
na,na,2,1484596,1484596,TPO,Pathogenic,Deficiency of iodide peroxidase,single nucleotide variant,GRCh38
na,na,2,1488386,1488386,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh37
na,na,2,1484614,1484614,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh38
na,na,2,1491763,1491763,TPO,Pathogenic,Deficiency of iodide peroxidase,single nucleotide variant,GRCh37
na,na,2,1487991,1487991,TPO,Pathogenic,Deficiency of iodide peroxidase,single nucleotide variant,GRCh38
na,na,2,1507728,1507728,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh37
na,na,2,1503956,1503956,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh38
na,na,2,1507747,1507748,TPO,Pathogenic/Likely pathogenic,Deficiency of iodide peroxidase|not provided,Duplication,GRCh37
na,na,2,1503975,1503976,TPO,Pathogenic/Likely pathogenic,Deficiency of iodide peroxidase|not provided,Duplication,GRCh38
na,na,2,1497748,1497748,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh37
na,na,2,1493976,1493976,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh38
na,na,2,1507845,1507845,TPO,Pathogenic,Deficiency of iodide peroxidase,Deletion,GRCh37
na,na,2,1504073,1504073,TPO,Pathogenic,Deficiency of iodide peroxidase,Deletion,GRCh38
na,na,2,1500418,1500419,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,Duplication,GRCh37
na,na,2,1496646,1496647,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,Duplication,GRCh38
na,na,2,1499831,1499831,TPO,Uncertain significance,Deficiency of iodide peroxidase|not specified,single nucleotide variant,GRCh37
na,na,2,1496059,1496059,TPO,Uncertain significance,Deficiency of iodide peroxidase|not specified,single nucleotide variant,GRCh38
na,na,2,1488523,1488523,TPO,Pathogenic,Deficiency of iodide peroxidase,Deletion,GRCh37
na,na,2,1484751,1484751,TPO,Pathogenic,Deficiency of iodide peroxidase,Deletion,GRCh38
na,na,2,1497783,1497783,TPO,Pathogenic/Likely pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh37
na,na,2,1494011,1494011,TPO,Pathogenic/Likely pathogenic,Deficiency of iodide peroxidase|not provided,single nucleotide variant,GRCh38
na,na,2,1497759,1497760,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,Duplication,GRCh37
na,na,2,1493987,1493988,TPO,Pathogenic,Deficiency of iodide peroxidase|not provided,Duplication,GRCh38
na,na,16,83940623,83940623,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase|not provided,single nucleotide variant,GRCh37
na,na,16,83907018,83907018,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase|not provided,single nucleotide variant,GRCh38
na,na,16,83948547,83948547,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,single nucleotide variant,GRCh37
na,na,16,83914942,83914942,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,single nucleotide variant,GRCh38
na,na,16,83940700,83940703,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,Deletion,GRCh37
na,na,16,83907095,83907098,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,Deletion,GRCh38
na,na,16,83948675,83948676,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,Deletion,GRCh37
na,na,16,83915070,83915071,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,Deletion,GRCh38
na,na,16,83932757,83932757,MLYCD,Conflicting classifications of pathogenicity,Deficiency of malonyl-CoA decarboxylase|not provided,single nucleotide variant,GRCh37
na,na,16,83899152,83899152,MLYCD,Conflicting classifications of pathogenicity,Deficiency of malonyl-CoA decarboxylase|not provided,single nucleotide variant,GRCh38
na,na,16,83932868,83932868,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,single nucleotide variant,GRCh37
na,na,16,83899263,83899263,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,single nucleotide variant,GRCh38
na,na,16,83932833,83932857,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,Deletion,GRCh37
na,na,16,83899228,83899252,MLYCD,Pathogenic,Deficiency of malonyl-CoA decarboxylase,Deletion,GRCh38
na,na,15,45401085,45401085,DUOX2,Pathogenic,Thyroid dyshormonogenesis 6|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,15,45108887,45108887,DUOX2,Pathogenic,Thyroid dyshormonogenesis 6|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,15,45398415,45398415,DUOX2,Pathogenic,Thyroid dyshormonogenesis 6|not provided|Familial thyroid dyshormonogenesis;Genetic transient congenital hypothyroidism,single nucleotide variant,GRCh37
na,na,15,45106217,45106217,DUOX2,Pathogenic,Thyroid dyshormonogenesis 6|not provided|Familial thyroid dyshormonogenesis;Genetic transient congenital hypothyroidism,single nucleotide variant,GRCh38
na,na,15,45396374,45396374,DUOX2,Pathogenic/Likely pathogenic,Thyroid dyshormonogenesis 6|not provided|Genetic transient congenital hypothyroidism;Familial thyroid dyshormonogenesis,single nucleotide variant,GRCh37
na,na,15,45104176,45104176,DUOX2,Pathogenic/Likely pathogenic,Thyroid dyshormonogenesis 6|not provided|Genetic transient congenital hypothyroidism;Familial thyroid dyshormonogenesis,single nucleotide variant,GRCh38
na,na,15,45402093,45402093,DUOX2,Pathogenic/Likely pathogenic,Thyroid dyshormonogenesis 6|not provided|DUOX2-related disorder|Familial thyroid dyshormonogenesis;Genetic transient congenital hypothyroidism,single nucleotide variant,GRCh37
na,na,15,45109895,45109895,DUOX2,Pathogenic/Likely pathogenic,Thyroid dyshormonogenesis 6|not provided|DUOX2-related disorder|Familial thyroid dyshormonogenesis;Genetic transient congenital hypothyroidism,single nucleotide variant,GRCh38
na,na,20,35559163,35559163,SAMHD1,Likely pathogenic,Aicardi-Goutieres syndrome 5,single nucleotide variant,GRCh37
na,na,20,36930760,36930760,SAMHD1,Likely pathogenic,Aicardi-Goutieres syndrome 5,single nucleotide variant,GRCh38
na,na,20,35563508,35563508,SAMHD1,Pathogenic,Aicardi-Goutieres syndrome 5|Aicardi Goutieres syndrome|Aicardi-Goutieres syndrome 5;Chilblain lupus 2|not provided,single nucleotide variant,GRCh37
na,na,20,36935105,36935105,SAMHD1,Pathogenic,Aicardi-Goutieres syndrome 5|Aicardi Goutieres syndrome|Aicardi-Goutieres syndrome 5;Chilblain lupus 2|not provided,single nucleotide variant,GRCh38
na,na,20,35563451,35563451,SAMHD1,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 5|Aicardi Goutieres syndrome|Chilblain lupus 2;Aicardi-Goutieres syndrome 5,single nucleotide variant,GRCh37
na,na,20,36935048,36935048,SAMHD1,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 5|Aicardi Goutieres syndrome|Chilblain lupus 2;Aicardi-Goutieres syndrome 5,single nucleotide variant,GRCh38
na,na,20,35563496,35563496,SAMHD1,Pathogenic,Aicardi-Goutieres syndrome 5,single nucleotide variant,GRCh37
na,na,20,36935093,36935093,SAMHD1,Pathogenic,Aicardi-Goutieres syndrome 5,single nucleotide variant,GRCh38
na,na,20,35526329,35526329,SAMHD1,Pathogenic,Aicardi-Goutieres syndrome 5|Aicardi-Goutieres syndrome 5;Chilblain lupus 2|not provided,single nucleotide variant,GRCh37
na,na,20,36897926,36897926,SAMHD1,Pathogenic,Aicardi-Goutieres syndrome 5|Aicardi-Goutieres syndrome 5;Chilblain lupus 2|not provided,single nucleotide variant,GRCh38
na,na,20,35563573,35563573,SAMHD1,Pathogenic,Aicardi-Goutieres syndrome 5,single nucleotide variant,GRCh37
na,na,20,36935170,36935170,SAMHD1,Pathogenic,Aicardi-Goutieres syndrome 5,single nucleotide variant,GRCh38
na,na,20,35547859,35547859,SAMHD1,Uncertain significance,Aicardi-Goutieres syndrome 5|not specified,single nucleotide variant,GRCh37
na,na,20,36919456,36919456,SAMHD1,Uncertain significance,Aicardi-Goutieres syndrome 5|not specified,single nucleotide variant,GRCh38
na,na,4,166916242,166916242,TLL1,Pathogenic,Atrial septal defect 6,single nucleotide variant,GRCh37
na,na,4,165995090,165995090,TLL1,Pathogenic,Atrial septal defect 6,single nucleotide variant,GRCh38
na,na,4,166924623,166924623,TLL1,Uncertain significance,Atrial septal defect 6|not provided,single nucleotide variant,GRCh37
na,na,4,166003471,166003471,TLL1,Uncertain significance,Atrial septal defect 6|not provided,single nucleotide variant,GRCh38
na,na,4,166981218,166981218,TLL1,Pathogenic,Atrial septal defect 6,single nucleotide variant,GRCh37
na,na,4,166060066,166060066,TLL1,Pathogenic,Atrial septal defect 6,single nucleotide variant,GRCh38
na,na,15,68506711,68506711,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)",single nucleotide variant,GRCh37
na,na,15,68214373,68214373,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)",single nucleotide variant,GRCh38
na,na,15,68503627,68503629,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A",Microsatellite,GRCh37
na,na,15,68211289,68211291,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A",Microsatellite,GRCh38
na,na,15,68504131,68504131,CLN6,Conflicting classifications of pathogenicity,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)|not provided",single nucleotide variant,GRCh37
na,na,15,68211793,68211793,CLN6,Conflicting classifications of pathogenicity,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)|not provided",single nucleotide variant,GRCh38
na,na,15,68521916,68521916,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A",Deletion,GRCh37
na,na,15,68229578,68229578,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A",Deletion,GRCh38
na,na,15,68504182,68504183,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis|not provided|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)",Duplication,GRCh37
na,na,15,68211844,68211845,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis|not provided|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)",Duplication,GRCh38
na,na,15,68504103,68504104,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|not provided|Neuronal ceroid lipofuscinosis|See cases|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)|Ceroid lipofuscinosis, neuronal, 6B (Kufs type)",Microsatellite,GRCh37
na,na,15,68211765,68211766,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|not provided|Neuronal ceroid lipofuscinosis|See cases|Ceroid lipofuscinosis, neuronal, 6A;Ceroid lipofuscinosis, neuronal, 6B (Kufs type)|Ceroid lipofuscinosis, neuronal, 6B (Kufs type)",Microsatellite,GRCh38
na,na,15,68504036,68504038,CLN6,Pathogenic/Likely pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis|not provided|See cases|Ceroid lipofuscinosis, neuronal, 6B (Kufs type);Ceroid lipofuscinosis, neuronal, 6A",Microsatellite,GRCh37
na,na,15,68211698,68211700,CLN6,Pathogenic/Likely pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis|not provided|See cases|Ceroid lipofuscinosis, neuronal, 6B (Kufs type);Ceroid lipofuscinosis, neuronal, 6A",Microsatellite,GRCh38
na,na,15,68501977,68501977,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A",single nucleotide variant,GRCh37
na,na,15,68209639,68209639,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A",single nucleotide variant,GRCh38
na,na,15,68503596,68503596,CLN6,Uncertain significance,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis",single nucleotide variant,GRCh37
na,na,15,68211258,68211258,CLN6,Uncertain significance,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis",single nucleotide variant,GRCh38
na,na,15,68506653,68506654,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis",Duplication,GRCh37
na,na,15,68214315,68214316,CLN6,Pathogenic,"Ceroid lipofuscinosis, neuronal, 6A|Neuronal ceroid lipofuscinosis",Duplication,GRCh38
na,na,5,149360879,149360879,SLC26A2,Pathogenic,"Atelosteogenesis type II|Diastrophic dysplasia|Achondrogenesis, type IB|Sulfate transporter-related osteochondrodysplasia|Connective tissue disorder|Multiple epiphyseal dysplasia type 4;Achondrogenesis, type IB;Atelosteogenesis type II;Diastrophic dysplasia|Multiple epiphyseal dysplasia type 4",Deletion,GRCh37
na,na,5,149981316,149981316,SLC26A2,Pathogenic,"Atelosteogenesis type II|Diastrophic dysplasia|Achondrogenesis, type IB|Sulfate transporter-related osteochondrodysplasia|Connective tissue disorder|Multiple epiphyseal dysplasia type 4;Achondrogenesis, type IB;Atelosteogenesis type II;Diastrophic dysplasia|Multiple epiphyseal dysplasia type 4",Deletion,GRCh38
na,na,5,149357604,149357604,SLC26A2,Pathogenic,"Atelosteogenesis type II|Diastrophic dysplasia|Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB|Multiple epiphyseal dysplasia type 4|Achondrogenesis, type IB",Deletion,GRCh37
na,na,5,149978041,149978041,SLC26A2,Pathogenic,"Atelosteogenesis type II|Diastrophic dysplasia|Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB|Multiple epiphyseal dysplasia type 4|Achondrogenesis, type IB",Deletion,GRCh38
na,na,5,149359991,149359991,SLC26A2,Pathogenic/Likely pathogenic,"Atelosteogenesis type II|Diastrophic dysplasia|Multiple epiphyseal dysplasia type 4|not provided|SLC26A2-related disorder|Sulfate transporter-related osteochondrodysplasia|Inborn genetic diseases|Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia|Achondrogenesis, type IB|3MC syndrome 2|Connective tissue disorder",single nucleotide variant,GRCh37
na,na,5,149980428,149980428,SLC26A2,Pathogenic/Likely pathogenic,"Atelosteogenesis type II|Diastrophic dysplasia|Multiple epiphyseal dysplasia type 4|not provided|SLC26A2-related disorder|Sulfate transporter-related osteochondrodysplasia|Inborn genetic diseases|Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia|Achondrogenesis, type IB|3MC syndrome 2|Connective tissue disorder",single nucleotide variant,GRCh38
na,na,5,149359920,149359920,SLC26A2,Conflicting classifications of pathogenicity,"Atelosteogenesis type II|Multiple epiphyseal dysplasia type 4|Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB|Osteochondrodysplasia",single nucleotide variant,GRCh37
na,na,5,149980357,149980357,SLC26A2,Conflicting classifications of pathogenicity,"Atelosteogenesis type II|Multiple epiphyseal dysplasia type 4|Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB|Osteochondrodysplasia",single nucleotide variant,GRCh38
na,na,5,149361300,149361300,SLC26A2,Pathogenic/Likely pathogenic,"Atelosteogenesis type II|Multiple epiphyseal dysplasia type 4|Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB|Achondrogenesis, type IB",single nucleotide variant,GRCh37
na,na,5,149981737,149981737,SLC26A2,Pathogenic/Likely pathogenic,"Atelosteogenesis type II|Multiple epiphyseal dysplasia type 4|Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB|Achondrogenesis, type IB",single nucleotide variant,GRCh38
na,na,5,149357747,149357747,SLC26A2,Pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB|Multiple epiphyseal dysplasia type 4|not provided|Diastrophic dysplasia;Atelosteogenesis type II;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4|Atelosteogenesis type II|Sulfate transporter-related osteochondrodysplasia|SLC26A2-related disorder|3MC syndrome 2",single nucleotide variant,GRCh37
na,na,5,149978184,149978184,SLC26A2,Pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB|Multiple epiphyseal dysplasia type 4|not provided|Diastrophic dysplasia;Atelosteogenesis type II;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4|Atelosteogenesis type II|Sulfate transporter-related osteochondrodysplasia|SLC26A2-related disorder|3MC syndrome 2",single nucleotide variant,GRCh38
na,na,5,149360429,149360429,SLC26A2,Pathogenic/Likely pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB|Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4",single nucleotide variant,GRCh37
na,na,5,149980866,149980866,SLC26A2,Pathogenic/Likely pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB|Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4",single nucleotide variant,GRCh38
na,na,5,149361189,149361189,SLC26A2,Likely pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB|Multiple epiphyseal dysplasia type 4|Osteochondrodysplasia",single nucleotide variant,GRCh37
na,na,5,149981626,149981626,SLC26A2,Likely pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB|Multiple epiphyseal dysplasia type 4|Osteochondrodysplasia",single nucleotide variant,GRCh38
na,na,5,149360517,149360517,SLC26A2,Pathogenic,"Diastrophic dysplasia, broad bone-platyspondylic variant|Diastrophic dysplasia",single nucleotide variant,GRCh37
na,na,5,149980954,149980954,SLC26A2,Pathogenic,"Diastrophic dysplasia, broad bone-platyspondylic variant|Diastrophic dysplasia",single nucleotide variant,GRCh38
na,na,5,149340544,149340544,SLC26A2,Pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia|Multiple epiphyseal dysplasia type 4|not provided|Sulfate transporter-related osteochondrodysplasia|SLC26A2-related disorder|3MC syndrome 2|Atelosteogenesis type II|Achondrogenesis, type IB",single nucleotide variant,GRCh37
na,na,5,149960981,149960981,SLC26A2,Pathogenic,"Diastrophic dysplasia|Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia|Multiple epiphyseal dysplasia type 4|not provided|Sulfate transporter-related osteochondrodysplasia|SLC26A2-related disorder|3MC syndrome 2|Atelosteogenesis type II|Achondrogenesis, type IB",single nucleotide variant,GRCh38
na,na,5,149361113,149361113,SLC26A2,Pathogenic/Likely pathogenic,"Multiple epiphyseal dysplasia type 4|Diastrophic dysplasia|Achondrogenesis, type IB|not provided|Atelosteogenesis type II|Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia|Sulfate transporter-related osteochondrodysplasia|3MC syndrome 2|SLC26A2-related disorder|Connective tissue disorder",single nucleotide variant,GRCh37
na,na,5,149981550,149981550,SLC26A2,Pathogenic/Likely pathogenic,"Multiple epiphyseal dysplasia type 4|Diastrophic dysplasia|Achondrogenesis, type IB|not provided|Atelosteogenesis type II|Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4;Atelosteogenesis type II;Diastrophic dysplasia|Sulfate transporter-related osteochondrodysplasia|3MC syndrome 2|SLC26A2-related disorder|Connective tissue disorder",single nucleotide variant,GRCh38
na,na,5,149360691,149360691,SLC26A2,Pathogenic,"De la Chapelle dysplasia|Diastrophic dysplasia|Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4|Osteochondrodysplasia",single nucleotide variant,GRCh37
na,na,5,149981128,149981128,SLC26A2,Pathogenic,"De la Chapelle dysplasia|Diastrophic dysplasia|Atelosteogenesis type II;Diastrophic dysplasia;Achondrogenesis, type IB;Multiple epiphyseal dysplasia type 4|Osteochondrodysplasia",single nucleotide variant,GRCh38
na,na,5,149357613,149357613,SLC26A2,Uncertain significance,Diastrophic dysplasia|not specified,single nucleotide variant,GRCh37
na,na,5,149978050,149978050,SLC26A2,Uncertain significance,Diastrophic dysplasia|not specified,single nucleotide variant,GRCh38
na,na,4,119234487,119234490,PRSS12,no classifications from unflagged records,"Intellectual disability, autosomal recessive 1",Deletion,GRCh37
na,na,4,118313332,118313335,PRSS12,no classifications from unflagged records,"Intellectual disability, autosomal recessive 1",Deletion,GRCh38
na,na,9,75431077,75431077,TMC1,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 36|Rare genetic deafness|not provided,single nucleotide variant,GRCh37
na,na,9,72816161,72816161,TMC1,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 36|Rare genetic deafness|not provided,single nucleotide variant,GRCh38
na,na,9,75309494,75309494,TMC1,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 7|Rare genetic deafness|Hearing loss, autosomal recessive|not provided|Autosomal dominant nonsyndromic hearing loss 36|Autosomal dominant nonsyndromic hearing loss 36;Autosomal recessive nonsyndromic hearing loss 7",single nucleotide variant,GRCh37
na,na,9,72694578,72694578,TMC1,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 7|Rare genetic deafness|Hearing loss, autosomal recessive|not provided|Autosomal dominant nonsyndromic hearing loss 36|Autosomal dominant nonsyndromic hearing loss 36;Autosomal recessive nonsyndromic hearing loss 7",single nucleotide variant,GRCh38
na,na,9,75435954,75435954,TMC1,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 7|not provided|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh37
na,na,9,72821038,72821038,TMC1,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 7|not provided|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh38
na,na,9,75431077,75431077,TMC1,Pathogenic,Autosomal dominant nonsyndromic hearing loss 36,single nucleotide variant,GRCh37
na,na,9,72816161,72816161,TMC1,Pathogenic,Autosomal dominant nonsyndromic hearing loss 36,single nucleotide variant,GRCh38
na,na,9,75263581,75263581,TMC1,Pathogenic,Autosomal recessive nonsyndromic hearing loss 7,single nucleotide variant,GRCh37
na,na,9,72648665,72648665,TMC1,Pathogenic,Autosomal recessive nonsyndromic hearing loss 7,single nucleotide variant,GRCh38
na,na,9,75407245,75407245,TMC1,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 7|Hearing loss, autosomal recessive",single nucleotide variant,GRCh37
na,na,9,72792329,72792329,TMC1,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 7|Hearing loss, autosomal recessive",single nucleotide variant,GRCh38
na,na,6,51947999,51947999,PKHD1,Pathogenic/Likely pathogenic,"Autosomal recessive polycystic kidney disease|Colorectal cancer, protection against|not provided|Periportal fibrosis;Oligohydramnios;Polycystic kidney disease|Polycystic kidney disease|Autosomal dominant polycystic liver disease|Polycystic kidney disease 4|PKHD1-related disorder|Inborn genetic diseases|See cases",single nucleotide variant,GRCh37
na,na,6,52083201,52083201,PKHD1,Pathogenic/Likely pathogenic,"Autosomal recessive polycystic kidney disease|Colorectal cancer, protection against|not provided|Periportal fibrosis;Oligohydramnios;Polycystic kidney disease|Polycystic kidney disease|Autosomal dominant polycystic liver disease|Polycystic kidney disease 4|PKHD1-related disorder|Inborn genetic diseases|See cases",single nucleotide variant,GRCh38
na,na,6,51889617,51889617,PKHD1,Pathogenic,Autosomal recessive polycystic kidney disease,single nucleotide variant,GRCh37
na,na,6,52024819,52024819,PKHD1,Pathogenic,Autosomal recessive polycystic kidney disease,single nucleotide variant,GRCh38
na,na,6,51613361,51613361,PKHD1,Uncertain significance,Autosomal recessive polycystic kidney disease|not provided|not specified,single nucleotide variant,GRCh37
na,na,6,51748563,51748563,PKHD1,Uncertain significance,Autosomal recessive polycystic kidney disease|not provided|not specified,single nucleotide variant,GRCh38
na,na,6,51889387,51889387,PKHD1,Conflicting classifications of pathogenicity,Autosomal recessive polycystic kidney disease|not provided|Polycystic kidney disease 4|See cases|PKHD1-related disorder,single nucleotide variant,GRCh37
na,na,6,52024589,52024589,PKHD1,Conflicting classifications of pathogenicity,Autosomal recessive polycystic kidney disease|not provided|Polycystic kidney disease 4|See cases|PKHD1-related disorder,single nucleotide variant,GRCh38
na,na,6,51712669,51712669,PKHD1,Pathogenic,Autosomal recessive polycystic kidney disease|Polycystic kidney disease 4|not provided|PKHD1-related disorder,single nucleotide variant,GRCh37
na,na,6,51847871,51847871,PKHD1,Pathogenic,Autosomal recessive polycystic kidney disease|Polycystic kidney disease 4|not provided|PKHD1-related disorder,single nucleotide variant,GRCh38
na,na,6,51524266,51524266,PKHD1,Pathogenic/Likely pathogenic,Autosomal recessive polycystic kidney disease|Inborn genetic diseases|Polycystic kidney disease 4|PKHD1-related disorder,single nucleotide variant,GRCh37
na,na,6,51659468,51659468,PKHD1,Pathogenic/Likely pathogenic,Autosomal recessive polycystic kidney disease|Inborn genetic diseases|Polycystic kidney disease 4|PKHD1-related disorder,single nucleotide variant,GRCh38
na,na,6,51923147,51923147,PKHD1,Pathogenic,Autosomal recessive polycystic kidney disease|not provided|Autosomal dominant polycystic liver disease|Polycystic kidney disease 4,single nucleotide variant,GRCh37
na,na,6,52058349,52058349,PKHD1,Pathogenic,Autosomal recessive polycystic kidney disease|not provided|Autosomal dominant polycystic liver disease|Polycystic kidney disease 4,single nucleotide variant,GRCh38
na,na,6,51524512,51524512,PKHD1,Pathogenic/Likely pathogenic,Autosomal recessive polycystic kidney disease|not provided|Polycystic kidney disease 4,single nucleotide variant,GRCh37
na,na,6,51659714,51659714,PKHD1,Pathogenic/Likely pathogenic,Autosomal recessive polycystic kidney disease|not provided|Polycystic kidney disease 4,single nucleotide variant,GRCh38
na,na,2,27589747,27589747,EIF2B4,Likely pathogenic,Leukoencephalopathy with vanishing white matter 4|Vanishing white matter disease,single nucleotide variant,GRCh37
na,na,2,27366880,27366880,EIF2B4,Likely pathogenic,Leukoencephalopathy with vanishing white matter 4|Vanishing white matter disease,single nucleotide variant,GRCh38
na,na,2,27589697,27589697,EIF2B4,Conflicting classifications of pathogenicity,Leukoencephalopathy with vanishing white matter 4|not provided,single nucleotide variant,GRCh37
na,na,2,27366830,27366830,EIF2B4,Conflicting classifications of pathogenicity,Leukoencephalopathy with vanishing white matter 4|not provided,single nucleotide variant,GRCh38
na,na,2,27589625,27589625,EIF2B4,Pathogenic,Leukoencephalopathy with vanishing white matter 4,single nucleotide variant,GRCh37
na,na,2,27366758,27366758,EIF2B4,Pathogenic,Leukoencephalopathy with vanishing white matter 4,single nucleotide variant,GRCh38
na,na,2,27590914,27590914,EIF2B4,Pathogenic,Leukoencephalopathy with vanishing white matter 4,single nucleotide variant,GRCh37
na,na,2,27368047,27368047,EIF2B4,Pathogenic,Leukoencephalopathy with vanishing white matter 4,single nucleotide variant,GRCh38
na,na,2,27587446,27587446,EIF2B4,Pathogenic,Leukoencephalopathy with vanishing white matter 4,single nucleotide variant,GRCh37
na,na,2,27364579,27364579,EIF2B4,Pathogenic,Leukoencephalopathy with vanishing white matter 4,single nucleotide variant,GRCh38
na,na,2,27587374,27587374,EIF2B4,Pathogenic/Likely pathogenic,Leukoencephalopathy with vanishing white matter 4|Vanishing white matter disease,single nucleotide variant,GRCh37
na,na,2,27364507,27364507,EIF2B4,Pathogenic/Likely pathogenic,Leukoencephalopathy with vanishing white matter 4|Vanishing white matter disease,single nucleotide variant,GRCh38
na,na,12,124114943,124114943,EIF2B1,Conflicting classifications of pathogenicity,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 1,single nucleotide variant,GRCh37
na,na,12,123630396,123630396,EIF2B1,Conflicting classifications of pathogenicity,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 1,single nucleotide variant,GRCh38
na,na,12,124109339,124109339,EIF2B1,Uncertain significance,Vanishing white matter disease|not provided,single nucleotide variant,GRCh37
na,na,12,123624792,123624792,EIF2B1,Uncertain significance,Vanishing white matter disease|not provided,single nucleotide variant,GRCh38
na,na,22,26853889,26853889,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4|not provided,single nucleotide variant,GRCh37
na,na,22,26457923,26457923,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4|not provided,single nucleotide variant,GRCh38
na,na,22,26849232,26849233,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,Microsatellite,GRCh37
na,na,22,26453266,26453267,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,Microsatellite,GRCh38
na,na,22,26875306,26875306,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,Deletion,GRCh37
na,na,22,26479340,26479340,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,Deletion,GRCh38
na,na,22,26866740,26866740,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,single nucleotide variant,GRCh37
na,na,22,26470774,26470774,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,single nucleotide variant,GRCh38
na,na,22,26860623,26860624,HPS4,Uncertain significance,Hermansky-Pudlak syndrome 4|not provided|not specified,Duplication,GRCh37
na,na,22,26464657,26464658,HPS4,Uncertain significance,Hermansky-Pudlak syndrome 4|not provided|not specified,Duplication,GRCh38
na,na,22,26864537,26864537,HPS4,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 4|not provided|Hermansky-Pudlak syndrome|See cases,single nucleotide variant,GRCh37
na,na,22,26468571,26468571,HPS4,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 4|not provided|Hermansky-Pudlak syndrome|See cases,single nucleotide variant,GRCh38
na,na,22,26868357,26868357,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,single nucleotide variant,GRCh37
na,na,22,26472391,26472391,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,single nucleotide variant,GRCh38
na,na,22,26864522,26864522,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,single nucleotide variant,GRCh37
na,na,22,26468556,26468556,HPS4,Pathogenic,Hermansky-Pudlak syndrome 4,single nucleotide variant,GRCh38
na,na,na,-1,-1,NSD1,Pathogenic,Sotos syndrome,Deletion,na
na,na,5,176636710,176636710,NSD1,Pathogenic,Sotos syndrome|not provided,single nucleotide variant,GRCh37
na,na,5,177209709,177209709,NSD1,Pathogenic,Sotos syndrome|not provided,single nucleotide variant,GRCh38
na,na,5,176638936,176638936,NSD1,Pathogenic,Sotos syndrome,Deletion,GRCh37
na,na,5,177211935,177211935,NSD1,Pathogenic,Sotos syndrome,Deletion,GRCh38
na,na,5,176709570,176709571,NSD1,Pathogenic,Sotos syndrome,Insertion,GRCh37
na,na,5,177282569,177282570,NSD1,Pathogenic,Sotos syndrome,Insertion,GRCh38
na,na,5,176710930,176710930,NSD1,Pathogenic,not provided|Sotos syndrome,single nucleotide variant,GRCh37
na,na,5,177283929,177283929,NSD1,Pathogenic,not provided|Sotos syndrome,single nucleotide variant,GRCh38
na,na,5,176719125,176719125,NSD1,Pathogenic,Sotos syndrome,single nucleotide variant,GRCh37
na,na,5,177292124,177292124,NSD1,Pathogenic,Sotos syndrome,single nucleotide variant,GRCh38
na,na,5,176720917,176720917,NSD1,Pathogenic,Sotos syndrome,single nucleotide variant,GRCh37
na,na,5,177293916,177293916,NSD1,Pathogenic,Sotos syndrome,single nucleotide variant,GRCh38
na,na,5,176719144,176719145,NSD1,Pathogenic,Sotos syndrome,Duplication,GRCh37
na,na,5,177292143,177292144,NSD1,Pathogenic,Sotos syndrome,Duplication,GRCh38
na,na,5,176563000,176563000,NSD1,Pathogenic,Sotos syndrome,Deletion,GRCh37
na,na,5,177135999,177135999,NSD1,Pathogenic,Sotos syndrome,Deletion,GRCh38
na,na,5,176665274,176665274,NSD1,Pathogenic,not provided|Sotos syndrome,single nucleotide variant,GRCh37
na,na,5,177238273,177238273,NSD1,Pathogenic,not provided|Sotos syndrome,single nucleotide variant,GRCh38
na,na,5,176686999,176687000,NSD1,Pathogenic,Sotos syndrome,Duplication,GRCh37
na,na,5,177259998,177259999,NSD1,Pathogenic,Sotos syndrome,Duplication,GRCh38
na,na,5,176722334,176722337,NSD1,Pathogenic,Sotos syndrome,Deletion,GRCh37
na,na,5,177295333,177295336,NSD1,Pathogenic,Sotos syndrome,Deletion,GRCh38
na,na,5,176720974,176720974,NSD1,Pathogenic/Likely pathogenic,not provided|Sotos syndrome,single nucleotide variant,GRCh37
na,na,5,177293973,177293973,NSD1,Pathogenic/Likely pathogenic,not provided|Sotos syndrome,single nucleotide variant,GRCh38
na,na,22,24896073,24896073,UPB1,Pathogenic/Likely pathogenic,Deficiency of beta-ureidopropionase|not provided|UPB1-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,22,24500105,24500105,UPB1,Pathogenic/Likely pathogenic,Deficiency of beta-ureidopropionase|not provided|UPB1-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,22,24896224,24896224,UPB1,Conflicting classifications of pathogenicity,Deficiency of beta-ureidopropionase|not provided|not specified,single nucleotide variant,GRCh37
na,na,22,24500256,24500256,UPB1,Conflicting classifications of pathogenicity,Deficiency of beta-ureidopropionase|not provided|not specified,single nucleotide variant,GRCh38
na,na,22,24896179,24896179,UPB1,Uncertain significance,Deficiency of beta-ureidopropionase,single nucleotide variant,GRCh37
na,na,22,24500211,24500211,UPB1,Uncertain significance,Deficiency of beta-ureidopropionase,single nucleotide variant,GRCh38
na,na,17,4836976,4836976,GP1BA,Pathogenic,"Bernard-Soulier syndrome, type A1",single nucleotide variant,GRCh37
na,na,17,4933681,4933681,GP1BA,Pathogenic,"Bernard-Soulier syndrome, type A1",single nucleotide variant,GRCh38
na,na,17,4837132,4837133,GP1BA,Benign; risk factor,"PLATELET GLYCOPROTEIN Ib POLYMORPHISM|Nonarteritic anterior ischemic optic neuropathy, susceptibility to",Microsatellite,GRCh37
na,na,17,4933837,4933838,GP1BA,Benign; risk factor,"PLATELET GLYCOPROTEIN Ib POLYMORPHISM|Nonarteritic anterior ischemic optic neuropathy, susceptibility to",Microsatellite,GRCh38
na,na,17,4836645,4836645,GP1BA,Pathogenic/Likely pathogenic,Pseudo von Willebrand disease,single nucleotide variant,GRCh37
na,na,17,4933350,4933350,GP1BA,Pathogenic/Likely pathogenic,Pseudo von Willebrand disease,single nucleotide variant,GRCh38
na,na,17,4836116,4836116,GP1BA,Likely pathogenic,"Bernard-Soulier syndrome, type A2, autosomal dominant|Macrothrombocytopenia",single nucleotide variant,GRCh37
na,na,17,4932821,4932821,GP1BA,Likely pathogenic,"Bernard-Soulier syndrome, type A2, autosomal dominant|Macrothrombocytopenia",single nucleotide variant,GRCh38
na,na,17,4836662,4836662,GP1BA,Pathogenic/Likely pathogenic,Pseudo von Willebrand disease|Thrombocytopenia|Impaired ristocetin-induced platelet aggregation|not provided,single nucleotide variant,GRCh37
na,na,17,4933367,4933367,GP1BA,Pathogenic/Likely pathogenic,Pseudo von Willebrand disease|Thrombocytopenia|Impaired ristocetin-induced platelet aggregation|not provided,single nucleotide variant,GRCh38
na,na,17,4836414,4836414,GP1BA,Pathogenic,"Bernard-Soulier syndrome, type A1|Bernard-Soulier syndrome, type A2, autosomal dominant|not provided|Pseudo von Willebrand disease;Bernard Soulier syndrome;Bernard-Soulier syndrome, type A2, autosomal dominant;Nonarteritic anterior ischemic optic neuropathy, susceptibility to",single nucleotide variant,GRCh37
na,na,17,4933119,4933119,GP1BA,Pathogenic,"Bernard-Soulier syndrome, type A1|Bernard-Soulier syndrome, type A2, autosomal dominant|not provided|Pseudo von Willebrand disease;Bernard Soulier syndrome;Bernard-Soulier syndrome, type A2, autosomal dominant;Nonarteritic anterior ischemic optic neuropathy, susceptibility to",single nucleotide variant,GRCh38
na,na,17,4837519,4837519,GP1BA,Pathogenic/Likely pathogenic,"Bernard-Soulier syndrome, type A1|not provided|Pseudo von Willebrand disease;Bernard Soulier syndrome;Bernard-Soulier syndrome, type A2, autosomal dominant;Nonarteritic anterior ischemic optic neuropathy, susceptibility to",single nucleotide variant,GRCh37
na,na,17,4934224,4934224,GP1BA,Pathogenic/Likely pathogenic,"Bernard-Soulier syndrome, type A1|not provided|Pseudo von Willebrand disease;Bernard Soulier syndrome;Bernard-Soulier syndrome, type A2, autosomal dominant;Nonarteritic anterior ischemic optic neuropathy, susceptibility to",single nucleotide variant,GRCh38
na,na,13,32351535,32351535,RXFP2,Conflicting classifications of pathogenicity,Cryptorchidism|not provided,single nucleotide variant,GRCh37
na,na,13,31777398,31777398,RXFP2,Conflicting classifications of pathogenicity,Cryptorchidism|not provided,single nucleotide variant,GRCh38
na,na,3,158364685,158364685,GFM1,Likely pathogenic,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1|not provided,single nucleotide variant,GRCh37
na,na,3,158646896,158646896,GFM1,Likely pathogenic,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1|not provided,single nucleotide variant,GRCh38
na,na,3,158363475,158363475,GFM1,Pathogenic,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1|not provided,single nucleotide variant,GRCh37
na,na,3,158645686,158645686,GFM1,Pathogenic,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1|not provided,single nucleotide variant,GRCh38
na,na,3,158383232,158383232,GFM1,Pathogenic,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,single nucleotide variant,GRCh37
na,na,3,158665443,158665443,GFM1,Pathogenic,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,single nucleotide variant,GRCh38
na,na,17,5485367,5485367,NLRP1,Benign,"Vitiligo-associated multiple autoimmune disease susceptibility 1|Respiratory papillomatosis, juvenile recurrent, congenital|not provided|Autoinflammation with arthritis and dyskeratosis|Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome|not specified",single nucleotide variant,GRCh37
na,na,17,5582047,5582047,NLRP1,Benign,"Vitiligo-associated multiple autoimmune disease susceptibility 1|Respiratory papillomatosis, juvenile recurrent, congenital|not provided|Autoinflammation with arthritis and dyskeratosis|Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome|not specified",single nucleotide variant,GRCh38
na,na,21,19685292,19685292,TMPRSS15,Pathogenic,Enterokinase deficiency|not provided,single nucleotide variant,GRCh37
na,na,21,18312975,18312975,TMPRSS15,Pathogenic,Enterokinase deficiency|not provided,single nucleotide variant,GRCh38
na,na,21,19653456,19653456,TMPRSS15,Pathogenic,Enterokinase deficiency|not provided,single nucleotide variant,GRCh37
na,na,21,18281139,18281139,TMPRSS15,Pathogenic,Enterokinase deficiency|not provided,single nucleotide variant,GRCh38
na,na,21,19732173,19732173,TMPRSS15,Pathogenic,Enterokinase deficiency,single nucleotide variant,GRCh37
na,na,21,18359856,18359856,TMPRSS15,Pathogenic,Enterokinase deficiency,single nucleotide variant,GRCh38
na,na,21,19651337,19651338,TMPRSS15,Pathogenic,Enterokinase deficiency|not provided,Deletion,GRCh37
na,na,21,18279020,18279021,TMPRSS15,Pathogenic,Enterokinase deficiency|not provided,Deletion,GRCh38
na,na,6,72960710,72960710,RIMS1,Conflicting classifications of pathogenicity,Cone-rod dystrophy 7|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,6,72251007,72251007,RIMS1,Conflicting classifications of pathogenicity,Cone-rod dystrophy 7|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,6,42928654,42928654,GNMT,Pathogenic,Glycine N-methyltransferase deficiency,single nucleotide variant,GRCh37
na,na,6,42960916,42960916,GNMT,Pathogenic,Glycine N-methyltransferase deficiency,single nucleotide variant,GRCh38
na,na,6,42930887,42930887,GNMT,Uncertain significance,Glycine N-methyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,6,42963149,42963149,GNMT,Uncertain significance,Glycine N-methyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,2,217342939,217342939,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia|9 conditions|Nephrotic syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,216478216,216478216,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia|9 conditions|Nephrotic syndrome|not provided,single nucleotide variant,GRCh38
na,na,2,217279476,217279476,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh37
na,na,2,216414753,216414753,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh38
na,na,2,217279527,217279527,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh37
na,na,2,216414804,216414804,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh38
na,na,2,217300218,217300218,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh37
na,na,2,216435495,216435495,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh38
na,na,2,217315650,217315650,SMARCAL1,Pathogenic/Likely pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh37
na,na,2,216450927,216450927,SMARCAL1,Pathogenic/Likely pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh38
na,na,2,217311786,217311786,SMARCAL1,Conflicting classifications of pathogenicity,Schimke immuno-osseous dysplasia|Nephrotic syndrome,single nucleotide variant,GRCh37
na,na,2,216447063,216447063,SMARCAL1,Conflicting classifications of pathogenicity,Schimke immuno-osseous dysplasia|Nephrotic syndrome,single nucleotide variant,GRCh38
na,na,2,217340038,217340038,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh37
na,na,2,216475315,216475315,SMARCAL1,Pathogenic,Schimke immuno-osseous dysplasia,single nucleotide variant,GRCh38
na,na,3,48508395,48508395,TREX1,Pathogenic/Likely pathogenic,"Aicardi-Goutieres syndrome 1|Systemic lupus erythematosus, susceptibility to|not provided|Chilblain lupus 1;Aicardi-Goutieres syndrome 1;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations|Inborn genetic diseases|Chilblain lupus 1;Aicardi-Goutieres syndrome 1;Inborn genetic diseases|TREX1-related disorder|Chilblain lupus 1;Aicardi-Goutieres syndrome 1;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Systemic lupus erythematosus",single nucleotide variant,GRCh37
na,na,3,48466996,48466996,TREX1,Pathogenic/Likely pathogenic,"Aicardi-Goutieres syndrome 1|Systemic lupus erythematosus, susceptibility to|not provided|Chilblain lupus 1;Aicardi-Goutieres syndrome 1;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations|Inborn genetic diseases|Chilblain lupus 1;Aicardi-Goutieres syndrome 1;Inborn genetic diseases|TREX1-related disorder|Chilblain lupus 1;Aicardi-Goutieres syndrome 1;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Systemic lupus erythematosus",single nucleotide variant,GRCh38
na,na,3,48508544,48508544,TREX1,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 1|not provided|TREX1-related disorder|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1,single nucleotide variant,GRCh37
na,na,3,48467145,48467145,TREX1,Pathogenic/Likely pathogenic,Aicardi-Goutieres syndrome 1|not provided|TREX1-related disorder|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1,single nucleotide variant,GRCh38
na,na,3,48508650,48508651,TREX1,Likely pathogenic,Aicardi-Goutieres syndrome 1|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1|not provided|Systemic lupus erythematosus;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1,Duplication,GRCh37
na,na,3,48467251,48467252,TREX1,Likely pathogenic,Aicardi-Goutieres syndrome 1|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1|not provided|Systemic lupus erythematosus;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1,Duplication,GRCh38
na,na,3,48508656,48508656,TREX1,Pathogenic,Aicardi-Goutieres syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,3,48467257,48467257,TREX1,Pathogenic,Aicardi-Goutieres syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,3,48508428,48508429,TREX1,Likely pathogenic,Chilblain lupus|Systemic lupus erythematosus;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1|not provided,Duplication,GRCh37
na,na,3,48467029,48467030,TREX1,Likely pathogenic,Chilblain lupus|Systemic lupus erythematosus;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1|not provided,Duplication,GRCh38
na,na,3,48508652,48508652,TREX1,Pathogenic,"Aicardi-Goutieres syndrome 1, autosomal dominant|Aicardi-Goutieres syndrome 1|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1",single nucleotide variant,GRCh37
na,na,3,48467253,48467253,TREX1,Pathogenic,"Aicardi-Goutieres syndrome 1, autosomal dominant|Aicardi-Goutieres syndrome 1|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1",single nucleotide variant,GRCh38
na,na,3,48508106,48508106,TREX1,Pathogenic,"Aicardi-Goutieres syndrome 1, autosomal dominant|Aicardi-Goutieres syndrome 1|not provided|Chilblain lupus|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1",single nucleotide variant,GRCh37
na,na,3,48466707,48466707,TREX1,Pathogenic,"Aicardi-Goutieres syndrome 1, autosomal dominant|Aicardi-Goutieres syndrome 1|not provided|Chilblain lupus|Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Aicardi-Goutieres syndrome 1;Chilblain lupus 1",single nucleotide variant,GRCh38
na,na,3,48508756,48508757,TREX1,Pathogenic,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations,Duplication,GRCh37
na,na,3,48467357,48467358,TREX1,Pathogenic,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations,Duplication,GRCh38
na,na,1,236645755,236645755,EDARADD,Likely pathogenic,"Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant",single nucleotide variant,GRCh37
na,na,1,236482455,236482455,EDARADD,Likely pathogenic,"Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant",single nucleotide variant,GRCh38
na,na,1,236645666,236645666,EDARADD,Pathogenic,"Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh37
na,na,1,236482366,236482366,EDARADD,Pathogenic,"Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh38
na,na,8,75262788,75262788,GDAP1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4A,single nucleotide variant,GRCh37
na,na,8,74350553,74350553,GDAP1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4A,single nucleotide variant,GRCh38
na,na,8,75275175,75275175,GDAP1,Pathogenic,"Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|not provided|Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive",single nucleotide variant,GRCh37
na,na,8,74362940,74362940,GDAP1,Pathogenic,"Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|not provided|Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive",single nucleotide variant,GRCh38
na,na,8,75272543,75272543,GDAP1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 4A|not provided,single nucleotide variant,GRCh37
na,na,8,74360308,74360308,GDAP1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 4A|not provided,single nucleotide variant,GRCh38
na,na,8,75274121,75274121,GDAP1,Pathogenic,"Neuropathy, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease type 4A|not provided|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2K",single nucleotide variant,GRCh37
na,na,8,74361886,74361886,GDAP1,Pathogenic,"Neuropathy, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease type 4A|not provided|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease axonal type 2K",single nucleotide variant,GRCh38
na,na,8,75276382,75276383,GDAP1,Pathogenic,"Neuropathy, axonal, with vocal cord paresis, autosomal recessive",Duplication,GRCh37
na,na,8,74364147,74364148,GDAP1,Pathogenic,"Neuropathy, axonal, with vocal cord paresis, autosomal recessive",Duplication,GRCh38
na,na,8,75276369,75276369,GDAP1,Pathogenic,"Charcot-Marie-Tooth disease recessive intermediate A|not provided|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive",single nucleotide variant,GRCh37
na,na,8,74364134,74364134,GDAP1,Pathogenic,"Charcot-Marie-Tooth disease recessive intermediate A|not provided|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive",single nucleotide variant,GRCh38
na,na,8,75272419,75272419,GDAP1,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2K|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease axonal type 2K|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,8,74360184,74360184,GDAP1,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2K|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease type 4A;Charcot-Marie-Tooth disease axonal type 2K|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,8,75272530,75272530,GDAP1,Pathogenic,Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,8,74360295,74360295,GDAP1,Pathogenic,Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,8,75276240,75276240,GDAP1,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease recessive intermediate A|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease axonal type 2K|Elevated circulating alkaline phosphatase concentration;Elevated circulating creatine kinase concentration;Polyneuropathy;Sensory neuropathy;Peripheral axonal neuropathy|not provided|GDAP1-related disorder|Charcot-Marie-Tooth disease|Inborn genetic diseases|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A",single nucleotide variant,GRCh37
na,na,8,74364005,74364005,GDAP1,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease recessive intermediate A|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease axonal type 2K|Elevated circulating alkaline phosphatase concentration;Elevated circulating creatine kinase concentration;Polyneuropathy;Sensory neuropathy;Peripheral axonal neuropathy|not provided|GDAP1-related disorder|Charcot-Marie-Tooth disease|Inborn genetic diseases|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A",single nucleotide variant,GRCh38
na,na,8,75275246,75275246,GDAP1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease type 4A,single nucleotide variant,GRCh37
na,na,8,74363011,74363011,GDAP1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease type 4A,single nucleotide variant,GRCh38
na,na,8,75275286,75275286,GDAP1,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease axonal type 2K|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A",single nucleotide variant,GRCh37
na,na,8,74363051,74363051,GDAP1,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease axonal type 2K|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases|Charcot-Marie-Tooth disease type 4A|Charcot-Marie-Tooth disease recessive intermediate A;Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive;Charcot-Marie-Tooth disease axonal type 2K;Charcot-Marie-Tooth disease type 4A",single nucleotide variant,GRCh38
na,na,8,75276244,75276244,GDAP1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease axonal type 2K|Autosomal dominant Charcot-Marie-Tooth disease type 2K,single nucleotide variant,GRCh37
na,na,8,74364009,74364009,GDAP1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease axonal type 2K|Autosomal dominant Charcot-Marie-Tooth disease type 2K,single nucleotide variant,GRCh38
na,na,8,75275272,75275272,GDAP1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease axonal type 2K|Autosomal dominant Charcot-Marie-Tooth disease type 2K,single nucleotide variant,GRCh37
na,na,8,74363037,74363037,GDAP1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease axonal type 2K|Autosomal dominant Charcot-Marie-Tooth disease type 2K,single nucleotide variant,GRCh38
na,na,2,223161816,223161833,PAX3,Pathogenic,Waardenburg syndrome type 1,Deletion,GRCh37
na,na,2,222297097,222297114,PAX3,Pathogenic,Waardenburg syndrome type 1,Deletion,GRCh38
na,na,2,223161869,223161869,PAX3,Pathogenic,Waardenburg syndrome type 1,single nucleotide variant,GRCh37
na,na,2,222297150,222297150,PAX3,Pathogenic,Waardenburg syndrome type 1,single nucleotide variant,GRCh38
na,na,2,223161737,223161750,PAX3,Pathogenic,Waardenburg syndrome type 1,Deletion,GRCh37
na,na,2,222297018,222297031,PAX3,Pathogenic,Waardenburg syndrome type 1,Deletion,GRCh38
na,na,2,223161730,223161730,PAX3,Pathogenic,Waardenburg syndrome type 1,Deletion,GRCh37
na,na,2,222297011,222297011,PAX3,Pathogenic,Waardenburg syndrome type 1,Deletion,GRCh38
na,na,2,223158913,223158914,PAX3,Pathogenic,Waardenburg syndrome type 1|not provided,Microsatellite,GRCh37
na,na,2,222294194,222294195,PAX3,Pathogenic,Waardenburg syndrome type 1|not provided,Microsatellite,GRCh38
na,na,2,223161776,223161776,PAX3,Pathogenic/Likely pathogenic,Waardenburg syndrome type 1|not provided,single nucleotide variant,GRCh37
na,na,2,222297057,222297057,PAX3,Pathogenic/Likely pathogenic,Waardenburg syndrome type 1|not provided,single nucleotide variant,GRCh38
na,na,2,223160329,223160333,PAX3,Pathogenic,Waardenburg syndrome type 1,Deletion,GRCh37
na,na,2,222295610,222295614,PAX3,Pathogenic,Waardenburg syndrome type 1,Deletion,GRCh38
na,na,2,223161767,223161767,PAX3,Pathogenic,Waardenburg syndrome type 3|Waardenburg syndrome type 1|not provided,single nucleotide variant,GRCh37
na,na,2,222297048,222297048,PAX3,Pathogenic,Waardenburg syndrome type 3|Waardenburg syndrome type 1|not provided,single nucleotide variant,GRCh38
na,na,2,223161877,223161877,PAX3,Likely pathogenic,Craniofacial-deafness-hand syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,222297158,222297158,PAX3,Likely pathogenic,Craniofacial-deafness-hand syndrome|not provided,single nucleotide variant,GRCh38
na,na,2,223161879,223161879,PAX3,Pathogenic,Waardenburg syndrome type 3,single nucleotide variant,GRCh37
na,na,2,222297160,222297160,PAX3,Pathogenic,Waardenburg syndrome type 3,single nucleotide variant,GRCh38
na,na,2,223160300,223160312,PAX3,Pathogenic,Waardenburg syndrome type 3,Deletion,GRCh37
na,na,2,222295581,222295593,PAX3,Pathogenic,Waardenburg syndrome type 3,Deletion,GRCh38
na,na,2,223161750,223161750,PAX3,Pathogenic,Waardenburg syndrome type 3,single nucleotide variant,GRCh37
na,na,2,222297031,222297031,PAX3,Pathogenic,Waardenburg syndrome type 3,single nucleotide variant,GRCh38
na,na,2,223161851,223161851,PAX3,Pathogenic/Likely pathogenic,Waardenburg syndrome type 1|Waardenburg syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,222297132,222297132,PAX3,Pathogenic/Likely pathogenic,Waardenburg syndrome type 1|Waardenburg syndrome|not provided,single nucleotide variant,GRCh38
na,na,19,47259633,47259633,FKRP,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Walker-Warburg congenital muscular dystrophy|not provided",single nucleotide variant,GRCh37
na,na,19,46756376,46756376,FKRP,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Walker-Warburg congenital muscular dystrophy|not provided",single nucleotide variant,GRCh38
na,na,19,47259861,47259861,FKRP,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|not provided|Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Autosomal recessive limb-girdle muscular dystrophy type 2I",single nucleotide variant,GRCh37
na,na,19,46756604,46756604,FKRP,Pathogenic/Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|not provided|Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Autosomal recessive limb-girdle muscular dystrophy type 2I",single nucleotide variant,GRCh38
na,na,19,47260050,47260050,FKRP,Pathogenic/Likely pathogenic,"not provided|Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Walker-Warburg congenital muscular dystrophy",single nucleotide variant,GRCh37
na,na,19,46756793,46756793,FKRP,Pathogenic/Likely pathogenic,"not provided|Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Walker-Warburg congenital muscular dystrophy",single nucleotide variant,GRCh38
na,na,19,47259533,47259533,FKRP,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2I|not provided|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy|Limb-girdle muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|8 conditions|Myopathy|Muscular dystrophy-dystroglycanopathy type B5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Autosomal recessive limb-girdle muscular dystrophy|Cardiovascular phenotype|Nizon-Isidor syndrome|FKRP-related disorder|FKRP-related muscular dystrophy-dystroglycanopathy|Myopathy caused by variation in FKRP|Neuronopathy, distal hereditary motor, type 2B|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh37
na,na,19,46756276,46756276,FKRP,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2I|not provided|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy|Limb-girdle muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|8 conditions|Myopathy|Muscular dystrophy-dystroglycanopathy type B5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Autosomal recessive limb-girdle muscular dystrophy|Cardiovascular phenotype|Nizon-Isidor syndrome|FKRP-related disorder|FKRP-related muscular dystrophy-dystroglycanopathy|Myopathy caused by variation in FKRP|Neuronopathy, distal hereditary motor, type 2B|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh38
na,na,19,47259092,47259093,FKRP,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I,Duplication,GRCh37
na,na,19,46755835,46755836,FKRP,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I,Duplication,GRCh38
na,na,19,47260193,47260193,FKRP,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy|not provided|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,19,46756936,46756936,FKRP,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy|not provided|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,19,47259653,47259653,FKRP,Pathogenic/Likely pathogenic,Muscular dystrophy-dystroglycanopathy type B5|Autosomal recessive limb-girdle muscular dystrophy type 2I|not provided|Walker-Warburg congenital muscular dystrophy,single nucleotide variant,GRCh37
na,na,19,46756396,46756396,FKRP,Pathogenic/Likely pathogenic,Muscular dystrophy-dystroglycanopathy type B5|Autosomal recessive limb-girdle muscular dystrophy type 2I|not provided|Walker-Warburg congenital muscular dystrophy,single nucleotide variant,GRCh38
na,na,19,47259370,47259370,FKRP,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy type B5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh37
na,na,19,46756113,46756113,FKRP,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy type B5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh38
na,na,19,47260071,47260071,FKRP,Pathogenic,"Muscular dystrophy-dystroglycanopathy type B5|Walker-Warburg congenital muscular dystrophy|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh37
na,na,19,46756814,46756814,FKRP,Pathogenic,"Muscular dystrophy-dystroglycanopathy type B5|Walker-Warburg congenital muscular dystrophy|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh38
na,na,19,47259920,47259920,FKRP,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy type B5|Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh37
na,na,19,46756663,46756663,FKRP,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy type B5|Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh38
na,na,19,47258867,47258867,FKRP,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,19,46755610,46755610,FKRP,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,19,47258942,47258942,FKRP,Conflicting classifications of pathogenicity,Autosomal recessive limb-girdle muscular dystrophy type 2I|not specified|not provided|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,19,46755685,46755685,FKRP,Conflicting classifications of pathogenicity,Autosomal recessive limb-girdle muscular dystrophy type 2I|not specified|not provided|Walker-Warburg congenital muscular dystrophy|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,19,47259471,47259471,FKRP,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I,single nucleotide variant,GRCh37
na,na,19,46756214,46756214,FKRP,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2I,single nucleotide variant,GRCh38
na,na,19,47259107,47259107,FKRP,Uncertain significance,Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy,single nucleotide variant,GRCh37
na,na,19,46755850,46755850,FKRP,Uncertain significance,Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy,single nucleotide variant,GRCh38
na,na,19,47259606,47259606,FKRP,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy|not provided|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Autosomal recessive limb-girdle muscular dystrophy type 2I",single nucleotide variant,GRCh37
na,na,19,46756349,46756349,FKRP,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2I|Walker-Warburg congenital muscular dystrophy|not provided|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;Autosomal recessive limb-girdle muscular dystrophy type 2I",single nucleotide variant,GRCh38
na,na,19,47259626,47259626,FKRP,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|not provided|Walker-Warburg congenital muscular dystrophy|FKRP-related disorder|Autosomal recessive limb-girdle muscular dystrophy",single nucleotide variant,GRCh37
na,na,19,46756369,46756369,FKRP,Pathogenic/Likely pathogenic,"Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|not provided|Walker-Warburg congenital muscular dystrophy|FKRP-related disorder|Autosomal recessive limb-girdle muscular dystrophy",single nucleotide variant,GRCh38
na,na,19,47259660,47259660,FKRP,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh37
na,na,19,46756403,46756403,FKRP,Likely pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh38
na,na,19,47260094,47260094,FKRP,Pathogenic/Likely pathogenic,"not provided|Muscular dystrophy|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy type B5|Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh37
na,na,19,46756837,46756837,FKRP,Pathogenic/Likely pathogenic,"not provided|Muscular dystrophy|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy type B5|Autosomal recessive limb-girdle muscular dystrophy type 2I|Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Autosomal recessive limb-girdle muscular dystrophy type 2I;Muscular dystrophy-dystroglycanopathy type B5;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5|Cardiovascular phenotype|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5",single nucleotide variant,GRCh38
na,na,4,71501612,71501612,ENAM,Pathogenic,Amelogenesis imperfecta - hypoplastic autosomal dominant - local,single nucleotide variant,GRCh37
na,na,4,70635895,70635895,ENAM,Pathogenic,Amelogenesis imperfecta - hypoplastic autosomal dominant - local,single nucleotide variant,GRCh38
na,na,4,71497599,71497599,ENAM,Pathogenic,Amelogenesis imperfecta - hypoplastic autosomal dominant - local,single nucleotide variant,GRCh37
na,na,4,70631882,70631882,ENAM,Pathogenic,Amelogenesis imperfecta - hypoplastic autosomal dominant - local,single nucleotide variant,GRCh38
na,na,4,71508402,71508403,ENAM,Pathogenic/Likely pathogenic,Amelogenesis imperfecta type 1C|Amelogenesis imperfecta - hypoplastic autosomal dominant - local|not provided|ENAM-related disorder|Amelogenesis imperfecta - hypoplastic autosomal dominant - local;Amelogenesis imperfecta type 1C,Insertion,GRCh37
na,na,4,70642685,70642686,ENAM,Pathogenic/Likely pathogenic,Amelogenesis imperfecta type 1C|Amelogenesis imperfecta - hypoplastic autosomal dominant - local|not provided|ENAM-related disorder|Amelogenesis imperfecta - hypoplastic autosomal dominant - local;Amelogenesis imperfecta type 1C,Insertion,GRCh38
na,na,19,46057170,46057170,OPA3,Pathogenic,3-Methylglutaconic aciduria type 3|not provided|3-Methylglutaconic aciduria type 3;Optic atrophy 3,single nucleotide variant,GRCh37
na,na,19,45553912,45553912,OPA3,Pathogenic,3-Methylglutaconic aciduria type 3|not provided|3-Methylglutaconic aciduria type 3;Optic atrophy 3,single nucleotide variant,GRCh38
na,na,19,46057035,46057035,OPA3,Pathogenic,Optic atrophy 3,single nucleotide variant,GRCh37
na,na,19,45553777,45553777,OPA3,Pathogenic,Optic atrophy 3,single nucleotide variant,GRCh38
na,na,19,46056999,46056999,OPA3,Pathogenic,Optic atrophy 3|3-Methylglutaconic aciduria type 3;Optic atrophy 3|not provided,single nucleotide variant,GRCh37
na,na,19,45553741,45553741,OPA3,Pathogenic,Optic atrophy 3|3-Methylglutaconic aciduria type 3;Optic atrophy 3|not provided,single nucleotide variant,GRCh38
na,na,19,46056973,46056990,OPA3,Pathogenic,3-Methylglutaconic aciduria type 3,Deletion,GRCh37
na,na,19,45553715,45553732,OPA3,Pathogenic,3-Methylglutaconic aciduria type 3,Deletion,GRCh38
na,na,20,30408136,30408136,MYLK2,Conflicting classifications of pathogenicity,"Cardiomyopathy, hypertrophic, midventricular, digenic|Hypertrophic cardiomyopathy 1|not provided|not specified",single nucleotide variant,GRCh37
na,na,20,31820333,31820333,MYLK2,Conflicting classifications of pathogenicity,"Cardiomyopathy, hypertrophic, midventricular, digenic|Hypertrophic cardiomyopathy 1|not provided|not specified",single nucleotide variant,GRCh38
na,na,20,30408160,30408160,MYLK2,Benign/Likely benign,"Cardiomyopathy, hypertrophic, midventricular, digenic|not specified|Hypertrophic cardiomyopathy 1|Cardiomyopathy|not provided|MYLK2-related disorder",single nucleotide variant,GRCh37
na,na,20,31820357,31820357,MYLK2,Benign/Likely benign,"Cardiomyopathy, hypertrophic, midventricular, digenic|not specified|Hypertrophic cardiomyopathy 1|Cardiomyopathy|not provided|MYLK2-related disorder",single nucleotide variant,GRCh38
na,na,8,20112608,20112608,LZTS1,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh37
na,na,8,20255097,20255097,LZTS1,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh38
na,na,8,20111087,20111087,LZTS1,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh37
na,na,8,20253576,20253576,LZTS1,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh38
na,na,18,47489359,47489360,MYO5B,Pathogenic,Congenital microvillous atrophy,Insertion,GRCh37
na,na,18,49962989,49962990,MYO5B,Pathogenic,Congenital microvillous atrophy,Insertion,GRCh38
na,na,18,47489402,47489402,MYO5B,Uncertain significance,Congenital microvillous atrophy|not specified,single nucleotide variant,GRCh37
na,na,18,49963032,49963032,MYO5B,Uncertain significance,Congenital microvillous atrophy|not specified,single nucleotide variant,GRCh38
na,na,18,47563352,47563352,MYO5B,Pathogenic,Congenital microvillous atrophy,single nucleotide variant,GRCh37
na,na,18,50036982,50036982,MYO5B,Pathogenic,Congenital microvillous atrophy,single nucleotide variant,GRCh38
na,na,18,47500917,47500917,MYO5B,Pathogenic,Congenital microvillous atrophy|not provided,single nucleotide variant,GRCh37
na,na,18,49974547,49974547,MYO5B,Pathogenic,Congenital microvillous atrophy|not provided,single nucleotide variant,GRCh38
na,na,18,47462659,47462659,MYO5B,Conflicting classifications of pathogenicity,Congenital microvillous atrophy|not provided,single nucleotide variant,GRCh37
na,na,18,49936289,49936289,MYO5B,Conflicting classifications of pathogenicity,Congenital microvillous atrophy|not provided,single nucleotide variant,GRCh38
na,na,18,47462646,47462646,MYO5B,Pathogenic,Congenital microvillous atrophy|not provided,single nucleotide variant,GRCh37
na,na,18,49936276,49936276,MYO5B,Pathogenic,Congenital microvillous atrophy|not provided,single nucleotide variant,GRCh38
na,na,5,147258162,147258162,SCGB3A2,risk factor,Inherited susceptibility to asthma,single nucleotide variant,GRCh37
na,na,5,147878599,147878599,SCGB3A2,risk factor,Inherited susceptibility to asthma,single nucleotide variant,GRCh38
na,na,2,219679439,219679439,CYP27A1,Pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,single nucleotide variant,GRCh37
na,na,2,218814716,218814716,CYP27A1,Pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,single nucleotide variant,GRCh38
na,na,2,219678909,219678909,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|Intellectual disability|Cardiovascular phenotype|CYP27A1-related disorder,single nucleotide variant,GRCh37
na,na,2,218814186,218814186,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|Intellectual disability|Cardiovascular phenotype|CYP27A1-related disorder,single nucleotide variant,GRCh38
na,na,2,219677646,219677646,CYP27A1,Pathogenic,Cholestanol storage disease|not provided,single nucleotide variant,GRCh37
na,na,2,218812923,218812923,CYP27A1,Pathogenic,Cholestanol storage disease|not provided,single nucleotide variant,GRCh38
na,na,2,219677473,219677473,CYP27A1,Pathogenic,Cholestanol storage disease|not provided,single nucleotide variant,GRCh37
na,na,2,218812750,218812750,CYP27A1,Pathogenic,Cholestanol storage disease|not provided,single nucleotide variant,GRCh38
na,na,2,219679425,219679425,CYP27A1,Pathogenic,Cholestanol storage disease|CYP27A1-related disorder|not provided,single nucleotide variant,GRCh37
na,na,2,218814702,218814702,CYP27A1,Pathogenic,Cholestanol storage disease|CYP27A1-related disorder|not provided,single nucleotide variant,GRCh38
na,na,2,219679424,219679424,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,single nucleotide variant,GRCh37
na,na,2,218814701,218814701,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,single nucleotide variant,GRCh38
na,na,2,219679132,219679132,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|Intellectual disability,single nucleotide variant,GRCh37
na,na,2,218814409,218814409,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|Intellectual disability,single nucleotide variant,GRCh38
na,na,2,219678909,219678909,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease,single nucleotide variant,GRCh37
na,na,2,218814186,218814186,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease,single nucleotide variant,GRCh38
na,na,2,219679182,219679182,CYP27A1,Pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,single nucleotide variant,GRCh37
na,na,2,218814459,218814459,CYP27A1,Pathogenic,Cholestanol storage disease|not provided|CYP27A1-related disorder,single nucleotide variant,GRCh38
na,na,2,219674478,219674478,CYP27A1,Pathogenic,Cholestanol storage disease,single nucleotide variant,GRCh37
na,na,2,218809755,218809755,CYP27A1,Pathogenic,Cholestanol storage disease,single nucleotide variant,GRCh38
na,na,2,219677745,219677749,CYP27A1,Pathogenic,Cholestanol storage disease|not provided|Cardiovascular phenotype|CYP27A1-related disorder,Deletion,GRCh37
na,na,2,218813022,218813026,CYP27A1,Pathogenic,Cholestanol storage disease|not provided|Cardiovascular phenotype|CYP27A1-related disorder,Deletion,GRCh38
na,na,2,219677818,219677818,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|Cardiovascular phenotype|CYP27A1-related disorder,single nucleotide variant,GRCh37
na,na,2,218813095,218813095,CYP27A1,Pathogenic/Likely pathogenic,Cholestanol storage disease|not provided|Cardiovascular phenotype|CYP27A1-related disorder,single nucleotide variant,GRCh38
na,na,2,219679439,219679439,CYP27A1,Conflicting classifications of pathogenicity,Cholestanol storage disease|not provided,single nucleotide variant,GRCh37
na,na,2,218814716,218814716,CYP27A1,Conflicting classifications of pathogenicity,Cholestanol storage disease|not provided,single nucleotide variant,GRCh38
na,na,2,238402172,238402172,MLPH,Likely pathogenic,Griscelli syndrome type 3,single nucleotide variant,GRCh37
na,na,2,237493529,237493529,MLPH,Likely pathogenic,Griscelli syndrome type 3,single nucleotide variant,GRCh38
na,na,17,73274346,73274346,SLC25A19,Pathogenic,Amish lethal microcephaly,single nucleotide variant,GRCh37
na,na,17,75278265,75278265,SLC25A19,Pathogenic,Amish lethal microcephaly,single nucleotide variant,GRCh38
na,na,na,-1,-1,HAVCR1,Affects,"IgE responsiveness, atopic",Insertion,na
na,na,1,40756542,40756543,ZMPSTE24,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|Lethal tight skin contracture syndrome|not provided|ZMPSTE24-related disorder|Mandibuloacral dysplasia with type B lipodystrophy;Lethal tight skin contracture syndrome|Restrictive dermopathy 1,Duplication,GRCh37
na,na,1,40290870,40290871,ZMPSTE24,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|Lethal tight skin contracture syndrome|not provided|ZMPSTE24-related disorder|Mandibuloacral dysplasia with type B lipodystrophy;Lethal tight skin contracture syndrome|Restrictive dermopathy 1,Duplication,GRCh38
na,na,1,40751660,40751660,ZMPSTE24,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|not provided,single nucleotide variant,GRCh37
na,na,1,40285988,40285988,ZMPSTE24,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|not provided,single nucleotide variant,GRCh38
na,na,1,40724064,40724064,ZMPSTE24,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|not provided,single nucleotide variant,GRCh37
na,na,1,40258392,40258392,ZMPSTE24,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|not provided,single nucleotide variant,GRCh38
na,na,1,40737681,40737681,ZMPSTE24,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|not provided,single nucleotide variant,GRCh37
na,na,1,40272009,40272009,ZMPSTE24,Pathogenic,Mandibuloacral dysplasia with type B lipodystrophy|not provided,single nucleotide variant,GRCh38
na,na,1,40737653,40737653,ZMPSTE24,Pathogenic,Lethal tight skin contracture syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,40271981,40271981,ZMPSTE24,Pathogenic,Lethal tight skin contracture syndrome|not provided,single nucleotide variant,GRCh38
na,na,19,41224204,41224204,ITPKC,Conflicting classifications of pathogenicity,ITPKC-related disorder|Reclassified - variant of unknown significance,single nucleotide variant,GRCh37
na,na,19,40718299,40718299,ITPKC,Conflicting classifications of pathogenicity,ITPKC-related disorder|Reclassified - variant of unknown significance,single nucleotide variant,GRCh38
na,na,15,34634264,34634264,NOP10,Pathogenic,"Dyskeratosis congenita, autosomal recessive 1",single nucleotide variant,GRCh37
na,na,15,34342063,34342063,NOP10,Pathogenic,"Dyskeratosis congenita, autosomal recessive 1",single nucleotide variant,GRCh38
na,na,5,177576761,177576761,NHP2,Pathogenic,"Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita, autosomal recessive 1",single nucleotide variant,GRCh37
na,na,5,178149760,178149760,NHP2,Pathogenic,"Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita, autosomal recessive 1",single nucleotide variant,GRCh38
na,na,5,177576800,177576800,NHP2,Pathogenic,"Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita, autosomal recessive 1",single nucleotide variant,GRCh37
na,na,5,178149799,178149799,NHP2,Pathogenic,"Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita, autosomal recessive 1",single nucleotide variant,GRCh38
na,na,5,177576716,177576716,NHP2,Pathogenic,"Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita, autosomal recessive 1|not provided",single nucleotide variant,GRCh37
na,na,5,178149715,178149715,NHP2,Pathogenic,"Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita, autosomal recessive 1|not provided",single nucleotide variant,GRCh38
na,na,19,35775694,35775694,HAMP,Pathogenic,Hemochromatosis type 2B,Deletion,GRCh37
na,na,19,35284791,35284791,HAMP,Pathogenic,Hemochromatosis type 2B,Deletion,GRCh38
na,na,19,35775856,35775856,HAMP,Pathogenic,Hemochromatosis type 2B,single nucleotide variant,GRCh37
na,na,19,35284953,35284953,HAMP,Pathogenic,Hemochromatosis type 2B,single nucleotide variant,GRCh38
na,na,19,35775746,35775749,HAMP,Pathogenic,"Hemochromatosis, juvenile, digenic",Deletion,GRCh37
na,na,19,35284843,35284846,HAMP,Pathogenic,"Hemochromatosis, juvenile, digenic",Deletion,GRCh38
na,na,19,35775902,35775902,HAMP,Benign/Likely benign,"Hemochromatosis, type 2a, modifier of|not specified|Hemochromatosis type 1|Hereditary hemochromatosis|Hemochromatosis type 2B|HAMP-related disorder|not provided",single nucleotide variant,GRCh37
na,na,19,35284999,35284999,HAMP,Benign/Likely benign,"Hemochromatosis, type 2a, modifier of|not specified|Hemochromatosis type 1|Hereditary hemochromatosis|Hemochromatosis type 2B|HAMP-related disorder|not provided",single nucleotide variant,GRCh38
na,na,19,35773456,35773456,HAMP,Pathogenic/Likely pathogenic,Hemochromatosis type 2B|Hereditary hemochromatosis,single nucleotide variant,GRCh37
na,na,19,35282553,35282553,HAMP,Pathogenic/Likely pathogenic,Hemochromatosis type 2B|Hereditary hemochromatosis,single nucleotide variant,GRCh38
na,na,1,155205043,155205043,GBA1,Pathogenic; risk factor,"Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type II|Gaucher disease type I|Dementia, Lewy body, susceptibility to|Gaucher disease|not provided|Movement disorder;Hypomimic face;Resting tremor;Parkinsonian disorder;Thoracolumbar scoliosis|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Gaucher disease perinatal lethal|7 conditions|GBA1-related disorder|Lewy body dementia|not specified|Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome",single nucleotide variant,GRCh37
na,na,1,155235252,155235252,GBA1,Pathogenic; risk factor,"Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type II|Gaucher disease type I|Dementia, Lewy body, susceptibility to|Gaucher disease|not provided|Movement disorder;Hypomimic face;Resting tremor;Parkinsonian disorder;Thoracolumbar scoliosis|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Gaucher disease perinatal lethal|7 conditions|GBA1-related disorder|Lewy body dementia|not specified|Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome",single nucleotide variant,GRCh38
na,na,1,155205499,155205499,GBA1,Pathogenic,Gaucher disease type II,single nucleotide variant,GRCh37
na,na,1,155235708,155235708,GBA1,Pathogenic,Gaucher disease type II,single nucleotide variant,GRCh38
na,na,1,155205634,155205634,GBA1,Pathogenic/Likely pathogenic; risk factor,"Dementia, Lewy body, susceptibility to|Gaucher disease type I|Parkinson disease, late-onset|not provided|Akinesia;Rigidity|Gaucher disease|7 conditions|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Thrombocytopenia;Abnormal bleeding|Gaucher disease perinatal lethal|Parkinson disease|Lewy body dementia|GBA1-related disorder|not specified|Parkinson disease, late-onset;Lewy body dementia",single nucleotide variant,GRCh37
na,na,1,155235843,155235843,GBA1,Pathogenic/Likely pathogenic; risk factor,"Dementia, Lewy body, susceptibility to|Gaucher disease type I|Parkinson disease, late-onset|not provided|Akinesia;Rigidity|Gaucher disease|7 conditions|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Thrombocytopenia;Abnormal bleeding|Gaucher disease perinatal lethal|Parkinson disease|Lewy body dementia|GBA1-related disorder|not specified|Parkinson disease, late-onset;Lewy body dementia",single nucleotide variant,GRCh38
na,na,1,155208420,155208420,GBA1,Pathogenic/Likely pathogenic,Gaucher disease perinatal lethal|Gaucher disease type I|Gaucher disease|not provided|Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,single nucleotide variant,GRCh37
na,na,1,155238629,155238629,GBA1,Pathogenic/Likely pathogenic,Gaucher disease perinatal lethal|Gaucher disease type I|Gaucher disease|not provided|Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,single nucleotide variant,GRCh38
na,na,1,155205563,155205563,GBA1,Pathogenic/Likely pathogenic,"Gaucher disease type I|Gaucher disease type III|Gaucher disease|7 conditions|Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|not provided|Parkinson disease, late-onset",single nucleotide variant,GRCh37
na,na,1,155235772,155235772,GBA1,Pathogenic/Likely pathogenic,"Gaucher disease type I|Gaucher disease type III|Gaucher disease|7 conditions|Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|not provided|Parkinson disease, late-onset",single nucleotide variant,GRCh38
na,na,1,155205518,155205518,GBA1,Pathogenic/Likely pathogenic,"Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease perinatal lethal|not provided|Gaucher disease|7 conditions|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Parkinson disease, late-onset|not specified",single nucleotide variant,GRCh37
na,na,1,155235727,155235727,GBA1,Pathogenic/Likely pathogenic,"Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease perinatal lethal|not provided|Gaucher disease|7 conditions|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Parkinson disease, late-onset|not specified",single nucleotide variant,GRCh38
na,na,1,155205517,155205517,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type III|Gaucher disease|Gaucher disease type I,single nucleotide variant,GRCh37
na,na,1,155235726,155235726,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type III|Gaucher disease|Gaucher disease type I,single nucleotide variant,GRCh38
na,na,1,155204987,155204987,GBA1,Pathogenic,"Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease|not provided|7 conditions|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|not specified|GBA1-related disorder",single nucleotide variant,GRCh37
na,na,1,155235196,155235196,GBA1,Pathogenic,"Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease|not provided|7 conditions|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|not specified|GBA1-related disorder",single nucleotide variant,GRCh38
na,na,1,155209730,155209730,GBA1,Pathogenic,Gaucher disease type I|Gaucher disease|not provided,single nucleotide variant,GRCh37
na,na,1,155239939,155239939,GBA1,Pathogenic,Gaucher disease type I|Gaucher disease|not provided,single nucleotide variant,GRCh38
na,na,1,155207367,155207367,GBA1,Pathogenic/Likely pathogenic,"Gaucher disease type I|not provided|Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I;Gaucher disease type II;Gaucher disease type III|Gaucher disease|Parkinson disease, late-onset|7 conditions",single nucleotide variant,GRCh37
na,na,1,155237576,155237576,GBA1,Pathogenic/Likely pathogenic,"Gaucher disease type I|not provided|Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I;Gaucher disease type II;Gaucher disease type III|Gaucher disease|Parkinson disease, late-onset|7 conditions",single nucleotide variant,GRCh38
na,na,1,155208361,155208361,GBA1,Uncertain significance,not provided|Gaucher disease|not specified|Gaucher disease perinatal lethal,single nucleotide variant,GRCh37
na,na,1,155238570,155238570,GBA1,Uncertain significance,not provided|Gaucher disease|not specified|Gaucher disease perinatal lethal,single nucleotide variant,GRCh38
na,na,1,155208310,155208310,GBA1,Conflicting classifications of pathogenicity,Gaucher disease type I|not provided,single nucleotide variant,GRCh37
na,na,1,155238519,155238519,GBA1,Conflicting classifications of pathogenicity,Gaucher disease type I|not provided,single nucleotide variant,GRCh38
na,na,1,155207932,155207932,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type III|Gaucher disease type II|Gaucher disease type I|Gaucher disease|not provided|7 conditions|not specified|Lewy body dementia,single nucleotide variant,GRCh37
na,na,1,155238141,155238141,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type III|Gaucher disease type II|Gaucher disease type I|Gaucher disease|not provided|7 conditions|not specified|Lewy body dementia,single nucleotide variant,GRCh38
na,na,1,155210451,155210452,GBA1,Pathogenic,Gaucher disease type I|Gaucher disease|not provided|Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I;Gaucher disease type II;Gaucher disease type III|7 conditions|GBA1-related disorder,Duplication,GRCh37
na,na,1,155240660,155240661,GBA1,Pathogenic,Gaucher disease type I|Gaucher disease|not provided|Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;Gaucher disease type I;Gaucher disease type II;Gaucher disease type III|7 conditions|GBA1-related disorder,Duplication,GRCh38
na,na,1,155205551,155205551,GBA1,Pathogenic,Gaucher disease perinatal lethal,single nucleotide variant,GRCh37
na,na,1,155235760,155235760,GBA1,Pathogenic,Gaucher disease perinatal lethal,single nucleotide variant,GRCh38
na,na,1,155207148,155207148,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh37
na,na,1,155237357,155237357,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh38
na,na,1,155206175,155206175,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type I|Gaucher disease type II|not provided|Gaucher disease|7 conditions,single nucleotide variant,GRCh37
na,na,1,155236384,155236384,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type I|Gaucher disease type II|not provided|Gaucher disease|7 conditions,single nucleotide variant,GRCh38
na,na,1,155210463,155210463,GBA1,Pathogenic,Gaucher disease type I,Deletion,GRCh37
na,na,1,155240672,155240672,GBA1,Pathogenic,Gaucher disease type I,Deletion,GRCh38
na,na,1,155208415,155208415,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh37
na,na,1,155238624,155238624,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh38
na,na,1,155207935,155207935,GBA1,Uncertain significance,Gaucher disease type I|Gaucher disease|not provided,single nucleotide variant,GRCh37
na,na,1,155238144,155238144,GBA1,Uncertain significance,Gaucher disease type I|Gaucher disease|not provided,single nucleotide variant,GRCh38
na,na,1,155204848,155204848,GBA1,Conflicting classifications of pathogenicity,Gaucher disease type I|not provided|not specified,single nucleotide variant,GRCh37
na,na,1,155235057,155235057,GBA1,Conflicting classifications of pathogenicity,Gaucher disease type I|not provided|not specified,single nucleotide variant,GRCh38
na,na,1,155204793,155204793,GBA1,Pathogenic/Likely pathogenic,"Gaucher disease type I|Gaucher disease|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|7 conditions|not provided|Parkinson disease, late-onset|not specified",single nucleotide variant,GRCh37
na,na,1,155235002,155235002,GBA1,Pathogenic/Likely pathogenic,"Gaucher disease type I|Gaucher disease|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|7 conditions|not provided|Parkinson disease, late-onset|not specified",single nucleotide variant,GRCh38
na,na,1,155209824,155209824,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh37
na,na,1,155240033,155240033,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh38
na,na,1,155208006,155208006,GBA1,Pathogenic,Gaucher disease type I|Gaucher disease type III|Gaucher disease|not provided|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|7 conditions|Gaucher disease type II,single nucleotide variant,GRCh37
na,na,1,155238215,155238215,GBA1,Pathogenic,Gaucher disease type I|Gaucher disease type III|Gaucher disease|not provided|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|7 conditions|Gaucher disease type II,single nucleotide variant,GRCh38
na,na,1,155207368,155207368,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh37
na,na,1,155237577,155237577,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh38
na,na,1,155206217,155206217,GBA1,Uncertain significance,Gaucher disease type I|not specified,single nucleotide variant,GRCh37
na,na,1,155236426,155236426,GBA1,Uncertain significance,Gaucher disease type I|not specified,single nucleotide variant,GRCh38
na,na,1,155206207,155206207,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh37
na,na,1,155236416,155236416,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh38
na,na,1,155206170,155206170,GBA1,Likely pathogenic,Gaucher disease type II|not provided|Gaucher disease perinatal lethal|Gaucher disease|7 conditions,single nucleotide variant,GRCh37
na,na,1,155236379,155236379,GBA1,Likely pathogenic,Gaucher disease type II|not provided|Gaucher disease perinatal lethal|Gaucher disease|7 conditions,single nucleotide variant,GRCh38
na,na,1,155206119,155206119,GBA1,Pathogenic,Gaucher disease type II,single nucleotide variant,GRCh37
na,na,1,155236328,155236328,GBA1,Pathogenic,Gaucher disease type II,single nucleotide variant,GRCh38
na,na,1,155206052,155206052,GBA1,Likely pathogenic,Gaucher disease type I|not provided,single nucleotide variant,GRCh37
na,na,1,155236261,155236261,GBA1,Likely pathogenic,Gaucher disease type I|not provided,single nucleotide variant,GRCh38
na,na,1,155209725,155209725,GBA1,Pathogenic,"Gaucher disease type I|Gaucher disease|not provided|7 conditions|See cases|Parkinson disease, late-onset|Lewy body dementia",single nucleotide variant,GRCh37
na,na,1,155239934,155239934,GBA1,Pathogenic,"Gaucher disease type I|Gaucher disease|not provided|7 conditions|See cases|Parkinson disease, late-onset|Lewy body dementia",single nucleotide variant,GRCh38
na,na,1,155208363,155208363,GBA1,Likely pathogenic,Gaucher disease perinatal lethal|Gaucher disease type I,Deletion,GRCh37
na,na,1,155238572,155238572,GBA1,Likely pathogenic,Gaucher disease perinatal lethal|Gaucher disease type I,Deletion,GRCh38
na,na,1,155206086,155206086,GBA1,Pathogenic,Gaucher disease type III,single nucleotide variant,GRCh37
na,na,1,155236295,155236295,GBA1,Pathogenic,Gaucher disease type III,single nucleotide variant,GRCh38
na,na,1,155205541,155205541,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh37
na,na,1,155235750,155235750,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh38
na,na,1,155206211,155206211,GBA1,Pathogenic/Likely pathogenic,Gaucher disease perinatal lethal|not provided,single nucleotide variant,GRCh37
na,na,1,155236420,155236420,GBA1,Pathogenic/Likely pathogenic,Gaucher disease perinatal lethal|not provided,single nucleotide variant,GRCh38
na,na,1,155206068,155206068,GBA1,Pathogenic,Gaucher disease perinatal lethal|Gaucher disease|not provided|Gaucher disease type I|7 conditions,single nucleotide variant,GRCh37
na,na,1,155236277,155236277,GBA1,Pathogenic,Gaucher disease perinatal lethal|Gaucher disease|not provided|Gaucher disease type I|7 conditions,single nucleotide variant,GRCh38
na,na,1,155205614,155205614,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type I|Gaucher disease type III|Gaucher disease|Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Abnormal bleeding;Thrombocytopenia|7 conditions|not provided,single nucleotide variant,GRCh37
na,na,1,155235823,155235823,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type I|Gaucher disease type III|Gaucher disease|Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Abnormal bleeding;Thrombocytopenia|7 conditions|not provided,single nucleotide variant,GRCh38
na,na,1,155207244,155207244,GBA1,Pathogenic,"Gaucher disease perinatal lethal|Gaucher disease|not provided|7 conditions|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Parkinson disease, late-onset|Gaucher disease type I|GBA1-related disorder",single nucleotide variant,GRCh37
na,na,1,155237453,155237453,GBA1,Pathogenic,"Gaucher disease perinatal lethal|Gaucher disease|not provided|7 conditions|Gaucher disease type II;Gaucher disease type III;Gaucher disease type I;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Parkinson disease, late-onset|Gaucher disease type I|GBA1-related disorder",single nucleotide variant,GRCh38
na,na,1,155208387,155208387,GBA1,Likely pathogenic,Gaucher disease perinatal lethal|Gaucher disease,single nucleotide variant,GRCh37
na,na,1,155238596,155238596,GBA1,Likely pathogenic,Gaucher disease perinatal lethal|Gaucher disease,single nucleotide variant,GRCh38
na,na,1,155209507,155209507,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type I|Gaucher disease type III|not provided|Gaucher disease,single nucleotide variant,GRCh37
na,na,1,155239716,155239716,GBA1,Pathogenic/Likely pathogenic,Gaucher disease type I|Gaucher disease type III|not provided|Gaucher disease,single nucleotide variant,GRCh38
na,na,1,155207261,155207261,GBA1,Pathogenic,Gaucher disease perinatal lethal,single nucleotide variant,GRCh37
na,na,1,155237470,155237470,GBA1,Pathogenic,Gaucher disease perinatal lethal,single nucleotide variant,GRCh38
na,na,1,155205632,155205632,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh37
na,na,1,155235841,155235841,GBA1,Pathogenic,Gaucher disease type I,single nucleotide variant,GRCh38
na,na,1,155204892,155204892,GBA1,Pathogenic,Gaucher disease perinatal lethal,single nucleotide variant,GRCh37
na,na,1,155235101,155235101,GBA1,Pathogenic,Gaucher disease perinatal lethal,single nucleotide variant,GRCh38
na,na,1,155207249,155207249,GBA1,Conflicting classifications of pathogenicity; other,Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Gaucher disease type I|not provided|Gaucher disease|Gaucher disease perinatal lethal|not specified|GBA1-related disorder,single nucleotide variant,GRCh37
na,na,1,155237458,155237458,GBA1,Conflicting classifications of pathogenicity; other,Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome|Gaucher disease type I|not provided|Gaucher disease|Gaucher disease perinatal lethal|not specified|GBA1-related disorder,single nucleotide variant,GRCh38
na,na,1,155205047,155205047,GBA1,Conflicting classifications of pathogenicity,"Parkinson disease, late-onset|not specified|not provided|Gaucher disease|7 conditions",single nucleotide variant,GRCh37
na,na,1,155235256,155235256,GBA1,Conflicting classifications of pathogenicity,"Parkinson disease, late-onset|not specified|not provided|Gaucher disease|7 conditions",single nucleotide variant,GRCh38
na,na,14,75472609,75472609,EIF2B2,Pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 2|See cases|Leukoencephalopathy with vanishing white matter 1|EIF2B2-related disorder,single nucleotide variant,GRCh37
na,na,14,75005906,75005906,EIF2B2,Pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 2|See cases|Leukoencephalopathy with vanishing white matter 1|EIF2B2-related disorder,single nucleotide variant,GRCh38
na,na,14,75475782,75475782,EIF2B2,Pathogenic/Likely pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 2,single nucleotide variant,GRCh37
na,na,14,75009079,75009079,EIF2B2,Pathogenic/Likely pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 2,single nucleotide variant,GRCh38
na,na,14,75471553,75471553,EIF2B2,Pathogenic/Likely pathogenic,Leukoencephalopathy with vanishing white matter 2|not provided,single nucleotide variant,GRCh37
na,na,14,75004850,75004850,EIF2B2,Pathogenic/Likely pathogenic,Leukoencephalopathy with vanishing white matter 2|not provided,single nucleotide variant,GRCh38
na,na,14,75471518,75471518,EIF2B2,Likely pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 2,single nucleotide variant,GRCh37
na,na,14,75004815,75004815,EIF2B2,Likely pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 2,single nucleotide variant,GRCh38
na,na,14,75472578,75472583,EIF2B2,Pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 2,Indel,GRCh37
na,na,14,75005875,75005880,EIF2B2,Pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 2,Indel,GRCh38
na,na,2,74759825,74759825,LOXL3;HTRA2,Benign/Likely benign,"Parkinson disease 13, autosomal dominant, susceptibility to|not provided",single nucleotide variant,GRCh37
na,na,2,74532698,74532698,LOXL3;HTRA2,Benign/Likely benign,"Parkinson disease 13, autosomal dominant, susceptibility to|not provided",single nucleotide variant,GRCh38
na,na,2,74757554,74757554,HTRA2,Benign,"Parkinson disease 13, autosomal dominant, susceptibility to|not provided|Parkinson disease 13, autosomal dominant, susceptibility to;3-methylglutaconic aciduria type 8",single nucleotide variant,GRCh37
na,na,2,74530427,74530427,HTRA2,Benign,"Parkinson disease 13, autosomal dominant, susceptibility to|not provided|Parkinson disease 13, autosomal dominant, susceptibility to;3-methylglutaconic aciduria type 8",single nucleotide variant,GRCh38
na,na,15,43903495,43903496,STRC,Pathogenic,Autosomal recessive nonsyndromic hearing loss 16,Duplication,GRCh37
na,na,15,43611297,43611298,STRC,Pathogenic,Autosomal recessive nonsyndromic hearing loss 16,Duplication,GRCh38
na,na,15,43906634,43906637,STRC,Pathogenic,Autosomal recessive nonsyndromic hearing loss 16|not provided,Deletion,GRCh37
na,na,15,43614436,43614439,STRC,Pathogenic,Autosomal recessive nonsyndromic hearing loss 16|not provided,Deletion,GRCh38
na,na,15,43599438,43613711,STRC,Pathogenic,Autosomal recessive nonsyndromic hearing loss 16,Deletion,GRCh38
na,na,14,51080061,51080061,ATL1,Pathogenic/Likely pathogenic,"Hereditary spastic paraplegia 3A|not provided|Hereditary spastic paraplegia 3A;Neuropathy, hereditary sensory, type 1D|Spastic paraplegia|Hereditary spastic paraplegia",single nucleotide variant,GRCh37
na,na,14,50613343,50613343,ATL1,Pathogenic/Likely pathogenic,"Hereditary spastic paraplegia 3A|not provided|Hereditary spastic paraplegia 3A;Neuropathy, hereditary sensory, type 1D|Spastic paraplegia|Hereditary spastic paraplegia",single nucleotide variant,GRCh38
na,na,14,51081143,51081143,ATL1,Pathogenic,Hereditary spastic paraplegia 3A,single nucleotide variant,GRCh37
na,na,14,50614425,50614425,ATL1,Pathogenic,Hereditary spastic paraplegia 3A,single nucleotide variant,GRCh38
na,na,14,51081140,51081140,ATL1,Pathogenic,Hereditary spastic paraplegia 3A,single nucleotide variant,GRCh37
na,na,14,50614422,50614422,ATL1,Pathogenic,Hereditary spastic paraplegia 3A,single nucleotide variant,GRCh38
na,na,14,51079996,51079996,ATL1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 3A|not provided,single nucleotide variant,GRCh37
na,na,14,50613278,50613278,ATL1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 3A|not provided,single nucleotide variant,GRCh38
na,na,14,51094851,51094851,ATL1,Pathogenic,Hereditary spastic paraplegia 3A,single nucleotide variant,GRCh37
na,na,14,50628133,50628133,ATL1,Pathogenic,Hereditary spastic paraplegia 3A,single nucleotide variant,GRCh38
na,na,14,51094872,51094872,ATL1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 3A|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,14,50628154,50628154,ATL1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 3A|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,14,51058305,51058305,ATL1,Pathogenic,Hereditary spastic paraplegia 3A,single nucleotide variant,GRCh37
na,na,14,50591587,50591587,ATL1,Pathogenic,Hereditary spastic paraplegia 3A,single nucleotide variant,GRCh38
na,na,14,51094935,51094937,ATL1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 3A|Hereditary spastic paraplegia,Deletion,GRCh37
na,na,14,50628217,50628219,ATL1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 3A|Hereditary spastic paraplegia,Deletion,GRCh38
na,na,1,231509787,231509787,EGLN1,Conflicting classifications of pathogenicity,"Erythrocytosis, familial, 3|not specified",single nucleotide variant,GRCh37
na,na,1,231374041,231374041,EGLN1,Conflicting classifications of pathogenicity,"Erythrocytosis, familial, 3|not specified",single nucleotide variant,GRCh38
na,na,1,231506344,231506344,EGLN1,Pathogenic,"Erythrocytosis, familial, 3",single nucleotide variant,GRCh37
na,na,1,231370598,231370598,EGLN1,Pathogenic,"Erythrocytosis, familial, 3",single nucleotide variant,GRCh38
na,na,1,231506335,231506335,EGLN1,Pathogenic,"Erythrocytosis, familial, 3",single nucleotide variant,GRCh37
na,na,1,231370589,231370589,EGLN1,Pathogenic,"Erythrocytosis, familial, 3",single nucleotide variant,GRCh38
na,na,19,54631719,54631729,PRPF31,Pathogenic,Retinitis pigmentosa 11,Deletion,GRCh37
na,na,19,54128344,54128354,PRPF31,Pathogenic,Retinitis pigmentosa 11,Deletion,GRCh38
na,na,19,54627246,54627246,PRPF31,Pathogenic,Retinitis pigmentosa 11,single nucleotide variant,GRCh37
na,na,19,54123867,54123867,PRPF31,Pathogenic,Retinitis pigmentosa 11,single nucleotide variant,GRCh38
na,na,19,54626942,54626942,PRPF31,Pathogenic/Likely pathogenic,Retinitis pigmentosa 11|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,19,54123563,54123563,PRPF31,Pathogenic/Likely pathogenic,Retinitis pigmentosa 11|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,19,54627181,54627181,PRPF31,Pathogenic,Retinitis pigmentosa 11,single nucleotide variant,GRCh37
na,na,19,54123802,54123802,PRPF31,Pathogenic,Retinitis pigmentosa 11,single nucleotide variant,GRCh38
na,na,19,54627145,54627146,PRPF31,Uncertain significance,Retinitis pigmentosa 11|not provided,Duplication,GRCh37
na,na,19,54123766,54123767,PRPF31,Uncertain significance,Retinitis pigmentosa 11|not provided,Duplication,GRCh38
na,na,19,54627948,54627949,PRPF31,Pathogenic,Retinitis pigmentosa 11,Duplication,GRCh37
na,na,19,54124569,54124570,PRPF31,Pathogenic,Retinitis pigmentosa 11,Duplication,GRCh38
na,na,19,54625879,54625890,PRPF31,Pathogenic,Retinitis pigmentosa 11,Deletion,GRCh37
na,na,19,54122500,54122511,PRPF31,Pathogenic,Retinitis pigmentosa 11,Deletion,GRCh38
na,na,19,54633399,54633399,PRPF31,Pathogenic,Retinitis pigmentosa 11|not provided,single nucleotide variant,GRCh37
na,na,19,54130024,54130024,PRPF31,Pathogenic,Retinitis pigmentosa 11|not provided,single nucleotide variant,GRCh38
na,na,1,55318045,55318045,DHCR24,Likely pathogenic,Desmosterolosis,single nucleotide variant,GRCh37
na,na,1,54852372,54852372,DHCR24,Likely pathogenic,Desmosterolosis,single nucleotide variant,GRCh38
na,na,1,55331115,55331115,DHCR24,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,1,54865442,54865442,DHCR24,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,1,55340807,55340807,DHCR24,Likely pathogenic,Desmosterolosis,single nucleotide variant,GRCh37
na,na,1,54875134,54875134,DHCR24,Likely pathogenic,Desmosterolosis,single nucleotide variant,GRCh38
na,na,1,247588067,247588067,NLRP3,Pathogenic/Likely pathogenic,"Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome|Autoinflammatory syndrome|Familial cold autoinflammatory syndrome 1;Hearing loss, autosomal dominant 34, with or without inflammation;Keratitis fugax hereditaria;Familial amyloid nephropathy with urticaria AND deafness;Chronic infantile neurological, cutaneous and articular syndrome",single nucleotide variant,GRCh37
na,na,1,247424765,247424765,NLRP3,Pathogenic/Likely pathogenic,"Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome|Autoinflammatory syndrome|Familial cold autoinflammatory syndrome 1;Hearing loss, autosomal dominant 34, with or without inflammation;Keratitis fugax hereditaria;Familial amyloid nephropathy with urticaria AND deafness;Chronic infantile neurological, cutaneous and articular syndrome",single nucleotide variant,GRCh38
na,na,1,247587343,247587343,NLRP3,Conflicting classifications of pathogenicity,"Familial cold autoinflammatory syndrome 1|not provided|not specified|Familial cold autoinflammatory syndrome|Familial cold autoinflammatory syndrome 1;Familial amyloid nephropathy with urticaria AND deafness;Chronic infantile neurological, cutaneous and articular syndrome|Hearing loss, autosomal dominant 34, with or without inflammation|Cryopyrin associated periodic syndrome|Kidney disorder|Autoinflammatory syndrome|NLRP3-related disorder|Familial cold autoinflammatory syndrome 1;Hearing loss, autosomal dominant 34, with or without inflammation;Keratitis fugax hereditaria;Familial amyloid nephropathy with urticaria AND deafness;Chronic infantile neurological, cutaneous and articular syndrome|Chronic infantile neurological, cutaneous and articular syndrome",single nucleotide variant,GRCh37
na,na,1,247424041,247424041,NLRP3,Conflicting classifications of pathogenicity,"Familial cold autoinflammatory syndrome 1|not provided|not specified|Familial cold autoinflammatory syndrome|Familial cold autoinflammatory syndrome 1;Familial amyloid nephropathy with urticaria AND deafness;Chronic infantile neurological, cutaneous and articular syndrome|Hearing loss, autosomal dominant 34, with or without inflammation|Cryopyrin associated periodic syndrome|Kidney disorder|Autoinflammatory syndrome|NLRP3-related disorder|Familial cold autoinflammatory syndrome 1;Hearing loss, autosomal dominant 34, with or without inflammation;Keratitis fugax hereditaria;Familial amyloid nephropathy with urticaria AND deafness;Chronic infantile neurological, cutaneous and articular syndrome|Chronic infantile neurological, cutaneous and articular syndrome",single nucleotide variant,GRCh38
na,na,1,247588631,247588631,NLRP3,Likely pathogenic,Familial cold autoinflammatory syndrome 1|Autoinflammatory syndrome,single nucleotide variant,GRCh37
na,na,1,247425329,247425329,NLRP3,Likely pathogenic,Familial cold autoinflammatory syndrome 1|Autoinflammatory syndrome,single nucleotide variant,GRCh38
na,na,1,247587806,247587806,NLRP3,Pathogenic/Likely pathogenic,Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome,single nucleotide variant,GRCh37
na,na,1,247424504,247424504,NLRP3,Pathogenic/Likely pathogenic,Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome,single nucleotide variant,GRCh38
na,na,1,247587529,247587529,NLRP3,Pathogenic,Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided|Autoinflammatory syndrome|Cryopyrin associated periodic syndrome,single nucleotide variant,GRCh37
na,na,1,247424227,247424227,NLRP3,Pathogenic,Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided|Autoinflammatory syndrome|Cryopyrin associated periodic syndrome,single nucleotide variant,GRCh38
na,na,1,247588456,247588456,NLRP3,Pathogenic,Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1,single nucleotide variant,GRCh37
na,na,1,247425154,247425154,NLRP3,Pathogenic,Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1,single nucleotide variant,GRCh38
na,na,1,247588469,247588469,NLRP3,Pathogenic,"Chronic infantile neurological, cutaneous and articular syndrome|Familial cold autoinflammatory syndrome 1",single nucleotide variant,GRCh37
na,na,1,247425167,247425167,NLRP3,Pathogenic,"Chronic infantile neurological, cutaneous and articular syndrome|Familial cold autoinflammatory syndrome 1",single nucleotide variant,GRCh38
na,na,1,247587658,247587658,NLRP3,Pathogenic,"Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome",single nucleotide variant,GRCh37
na,na,1,247424356,247424356,NLRP3,Pathogenic,"Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold autoinflammatory syndrome 1|not provided|Cryopyrin associated periodic syndrome",single nucleotide variant,GRCh38
na,na,1,247587677,247587677,NLRP3,Pathogenic,"Chronic infantile neurological, cutaneous and articular syndrome|Familial cold autoinflammatory syndrome 1",single nucleotide variant,GRCh37
na,na,1,247424375,247424375,NLRP3,Pathogenic,"Chronic infantile neurological, cutaneous and articular syndrome|Familial cold autoinflammatory syndrome 1",single nucleotide variant,GRCh38
na,na,1,247587809,247587809,NLRP3,Pathogenic,"Familial cold autoinflammatory syndrome 1|not provided|not specified|Cryopyrin associated periodic syndrome|Hearing loss, autosomal dominant 34, with or without inflammation;Keratitis fugax hereditaria;Chronic infantile neurological, cutaneous and articular syndrome;Familial cold autoinflammatory syndrome 1;Familial amyloid nephropathy with urticaria AND deafness|NLRP3-related disorder",single nucleotide variant,GRCh37
na,na,1,247424507,247424507,NLRP3,Pathogenic,"Familial cold autoinflammatory syndrome 1|not provided|not specified|Cryopyrin associated periodic syndrome|Hearing loss, autosomal dominant 34, with or without inflammation;Keratitis fugax hereditaria;Chronic infantile neurological, cutaneous and articular syndrome;Familial cold autoinflammatory syndrome 1;Familial amyloid nephropathy with urticaria AND deafness|NLRP3-related disorder",single nucleotide variant,GRCh38
na,na,1,55464860,55464860,BSND,Pathogenic,Bartter disease type 4A|not provided,single nucleotide variant,GRCh37
na,na,1,54999187,54999187,BSND,Pathogenic,Bartter disease type 4A|not provided,single nucleotide variant,GRCh38
na,na,1,55464881,55464881,BSND,Pathogenic/Likely pathogenic,Bartter disease type 4A|Bartter syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,54999208,54999208,BSND,Pathogenic/Likely pathogenic,Bartter disease type 4A|Bartter syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,55465016,55465056,BSND,Pathogenic/Likely pathogenic,Bartter disease type 4A|not provided,Deletion,GRCh37
na,na,1,54999343,54999383,BSND,Pathogenic/Likely pathogenic,Bartter disease type 4A|not provided,Deletion,GRCh38
na,na,1,55471779,55474873,BSND,Pathogenic,Bartter disease type 4A,Deletion,GRCh37
na,na,1,55006106,55009200,BSND,Pathogenic,Bartter disease type 4A,Deletion,GRCh38
na,na,1,55464862,55464862,BSND,Pathogenic/Likely pathogenic,Bartter disease type 4A|not provided|Bartter syndrome,single nucleotide variant,GRCh37
na,na,1,54999189,54999189,BSND,Pathogenic/Likely pathogenic,Bartter disease type 4A|not provided|Bartter syndrome,single nucleotide variant,GRCh38
na,na,1,55464887,55464887,BSND,Pathogenic/Likely pathogenic,Bartter disease type 4A|Bartter syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,54999214,54999214,BSND,Pathogenic/Likely pathogenic,Bartter disease type 4A|Bartter syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,55464882,55464882,BSND,Pathogenic,Bartter disease type 4A,single nucleotide variant,GRCh37
na,na,1,54999209,54999209,BSND,Pathogenic,Bartter disease type 4A,single nucleotide variant,GRCh38
na,na,1,55464998,55464998,BSND,Pathogenic/Likely pathogenic,"Bartter disease type 4A|not provided|Bartter syndrome|BSND-related disorder|Bartter syndrome type 4|Hearing loss, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,54999325,54999325,BSND,Pathogenic/Likely pathogenic,"Bartter disease type 4A|not provided|Bartter syndrome|BSND-related disorder|Bartter syndrome type 4|Hearing loss, autosomal recessive",single nucleotide variant,GRCh38
na,na,1,55464894,55464894,BSND,Pathogenic,"Sensorineural deafness with mild renal dysfunction|Bartter disease type 4A|Hearing loss, autosomal recessive|not provided|Bartter syndrome",single nucleotide variant,GRCh37
na,na,1,54999221,54999221,BSND,Pathogenic,"Sensorineural deafness with mild renal dysfunction|Bartter disease type 4A|Hearing loss, autosomal recessive|not provided|Bartter syndrome",single nucleotide variant,GRCh38
na,na,1,55464869,55464869,BSND,Pathogenic,Sensorineural deafness with mild renal dysfunction|Hearing impairment|not provided|Bartter disease type 4A,single nucleotide variant,GRCh37
na,na,1,54999196,54999196,BSND,Pathogenic,Sensorineural deafness with mild renal dysfunction|Hearing impairment|not provided|Bartter disease type 4A,single nucleotide variant,GRCh38
na,na,2,69379325,69379325,ANTXR1,risk factor,Capillary infantile hemangioma,single nucleotide variant,GRCh37
na,na,2,69152193,69152193,ANTXR1,risk factor,Capillary infantile hemangioma,single nucleotide variant,GRCh38
na,na,20,33001602,33001603,ITCH,Pathogenic,Syndromic multisystem autoimmune disease due to ITCH deficiency|not provided,Duplication,GRCh37
na,na,20,34413796,34413797,ITCH,Pathogenic,Syndromic multisystem autoimmune disease due to ITCH deficiency|not provided,Duplication,GRCh38
na,na,3,150645894,150645894,CLRN1,Pathogenic/Likely pathogenic,Usher syndrome type 3|not provided|Hearing impairment|Retinitis pigmentosa|Retinitis pigmentosa 61|Retinitis pigmentosa 61;Usher syndrome type 3A;Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,3,150928107,150928107,CLRN1,Pathogenic/Likely pathogenic,Usher syndrome type 3|not provided|Hearing impairment|Retinitis pigmentosa|Retinitis pigmentosa 61|Retinitis pigmentosa 61;Usher syndrome type 3A;Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,3,150659443,150659443,CLRN1,Likely pathogenic,Usher syndrome type 3|not provided,single nucleotide variant,GRCh37
na,na,3,150941656,150941656,CLRN1,Likely pathogenic,Usher syndrome type 3|not provided,single nucleotide variant,GRCh38
na,na,3,150645961,150645963,CLRN1,Likely pathogenic,Usher syndrome type 3|Retinitis pigmentosa 61,Deletion,GRCh37
na,na,3,150928174,150928176,CLRN1,Likely pathogenic,Usher syndrome type 3|Retinitis pigmentosa 61,Deletion,GRCh38
na,na,3,150690352,150690352,CLRN1;CLRN1-AS1,Pathogenic/Likely pathogenic,Usher syndrome type 3|Retinitis pigmentosa|not provided|Usher syndrome type 3A|not specified|Retinal dystrophy|Retinitis pigmentosa;Usher syndrome type 3A|Retinitis pigmentosa 61;Usher syndrome type 3A|Retinitis pigmentosa 61,single nucleotide variant,GRCh37
na,na,3,150972565,150972565,CLRN1;CLRN1-AS1,Pathogenic/Likely pathogenic,Usher syndrome type 3|Retinitis pigmentosa|not provided|Usher syndrome type 3A|not specified|Retinal dystrophy|Retinitis pigmentosa;Usher syndrome type 3A|Retinitis pigmentosa 61;Usher syndrome type 3A|Retinitis pigmentosa 61,single nucleotide variant,GRCh38
na,na,3,150645973,150645973,CLRN1,Likely pathogenic,Usher syndrome type 3|Retinitis pigmentosa 61,single nucleotide variant,GRCh37
na,na,3,150928186,150928186,CLRN1,Likely pathogenic,Usher syndrome type 3|Retinitis pigmentosa 61,single nucleotide variant,GRCh38
na,na,3,150690307,150690307,CLRN1,Pathogenic,Usher syndrome type 3|Retinitis pigmentosa|Rare genetic deafness|CLRN1-related disorder|Usher syndrome type 3A|not provided|Retinitis pigmentosa 61|Retinitis pigmentosa 61;Usher syndrome type 3A,single nucleotide variant,GRCh37
na,na,3,150972520,150972520,CLRN1,Pathogenic,Usher syndrome type 3|Retinitis pigmentosa|Rare genetic deafness|CLRN1-related disorder|Usher syndrome type 3A|not provided|Retinitis pigmentosa 61|Retinitis pigmentosa 61;Usher syndrome type 3A,single nucleotide variant,GRCh38
na,na,3,150690286,150690308,CLRN1,Pathogenic,Usher syndrome type 3,Deletion,GRCh37
na,na,3,150972499,150972521,CLRN1,Pathogenic,Usher syndrome type 3,Deletion,GRCh38
na,na,3,150690378,150690378,CLRN1,Conflicting classifications of pathogenicity,Usher syndrome type 3|not provided|Usher syndrome type 3A|Usher syndrome|CLRN1-related disorder|Retinal dystrophy|Retinitis pigmentosa 61|Retinitis pigmentosa 61;Usher syndrome type 3A,single nucleotide variant,GRCh37
na,na,3,150972591,150972591,CLRN1,Conflicting classifications of pathogenicity,Usher syndrome type 3|not provided|Usher syndrome type 3A|Usher syndrome|CLRN1-related disorder|Retinal dystrophy|Retinitis pigmentosa 61|Retinitis pigmentosa 61;Usher syndrome type 3A,single nucleotide variant,GRCh38
na,na,11,65793311,65793312,CATSPER1,Pathogenic,Spermatogenic failure 7,Duplication,GRCh37
na,na,11,66025840,66025841,CATSPER1,Pathogenic,Spermatogenic failure 7,Duplication,GRCh38
na,na,11,65792902,65792903,CATSPER1,Pathogenic,Spermatogenic failure 7,Duplication,GRCh37
na,na,11,66025431,66025432,CATSPER1,Pathogenic,Spermatogenic failure 7,Duplication,GRCh38
na,na,11,116661392,116661392,APOA5,Conflicting classifications of pathogenicity,Hypertriglyceridemia 1|Cardiovascular phenotype|not provided|not specified,single nucleotide variant,GRCh37
na,na,11,116790676,116790676,APOA5,Conflicting classifications of pathogenicity,Hypertriglyceridemia 1|Cardiovascular phenotype|not provided|not specified,single nucleotide variant,GRCh38
na,na,11,116662407,116662407,APOA5,Benign/Likely benign,Hypertriglyceridemia 1|Cardiovascular phenotype|Familial type 5 hyperlipoproteinemia;Hypertriglyceridemia 1|not provided|not specified,single nucleotide variant,GRCh37
na,na,11,116791691,116791691,APOA5,Benign/Likely benign,Hypertriglyceridemia 1|Cardiovascular phenotype|Familial type 5 hyperlipoproteinemia;Hypertriglyceridemia 1|not provided|not specified,single nucleotide variant,GRCh38
na,na,11,116661530,116661530,APOA5,Pathogenic,Familial type 5 hyperlipoproteinemia,single nucleotide variant,GRCh37
na,na,11,116790814,116790814,APOA5,Pathogenic,Familial type 5 hyperlipoproteinemia,single nucleotide variant,GRCh38
na,na,2,202631989,202631989,ALS2,Pathogenic,"Amyotrophic lateral sclerosis type 2, juvenile",Deletion,GRCh37
na,na,2,201767266,201767266,ALS2,Pathogenic,"Amyotrophic lateral sclerosis type 2, juvenile",Deletion,GRCh38
na,na,2,202611419,202611420,ALS2,Pathogenic,Juvenile primary lateral sclerosis|Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh37
na,na,2,201746696,201746697,ALS2,Pathogenic,Juvenile primary lateral sclerosis|Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh38
na,na,2,202622168,202622169,ALS2,Pathogenic,Juvenile primary lateral sclerosis|not provided,Microsatellite,GRCh37
na,na,2,201757445,201757446,ALS2,Pathogenic,Juvenile primary lateral sclerosis|not provided,Microsatellite,GRCh38
na,na,2,202588058,202588058,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh37
na,na,2,201723335,201723335,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh38
na,na,2,202619395,202619395,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,GRCh37
na,na,2,201754672,201754672,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,GRCh38
na,na,2,202598041,202598042,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh37
na,na,2,201733318,201733319,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh38
na,na,2,202625709,202625710,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh37
na,na,2,201760986,201760987,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh38
na,na,2,202569294,202569294,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh37
na,na,2,201704571,201704571,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,Deletion,GRCh38
na,na,2,202591577,202591577,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,GRCh37
na,na,2,201726854,201726854,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,GRCh38
na,na,2,202626164,202626164,ALS2,Pathogenic,"Amyotrophic lateral sclerosis type 2, juvenile|Juvenile primary lateral sclerosis",Deletion,GRCh37
na,na,2,201761441,201761441,ALS2,Pathogenic,"Amyotrophic lateral sclerosis type 2, juvenile|Juvenile primary lateral sclerosis",Deletion,GRCh38
na,na,2,202626247,202626247,ALS2,Likely pathogenic,Infantile-onset ascending hereditary spastic paralysis|not provided,single nucleotide variant,GRCh37
na,na,2,201761524,201761524,ALS2,Likely pathogenic,Infantile-onset ascending hereditary spastic paralysis|not provided,single nucleotide variant,GRCh38
na,na,2,202591591,202591591,ALS2,Pathogenic,Juvenile primary lateral sclerosis,single nucleotide variant,GRCh37
na,na,2,201726868,201726868,ALS2,Pathogenic,Juvenile primary lateral sclerosis,single nucleotide variant,GRCh38
na,na,2,202609008,202609008,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,GRCh37
na,na,2,201744285,201744285,ALS2,Pathogenic,Infantile-onset ascending hereditary spastic paralysis,single nucleotide variant,GRCh38
na,na,1,6520108,6520111,ESPN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 36,Deletion,GRCh37
na,na,1,6460048,6460051,ESPN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 36,Deletion,GRCh38
na,na,1,6511735,6511738,ESPN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 36,Deletion,GRCh37
na,na,1,6451675,6451678,ESPN,Pathogenic,Autosomal recessive nonsyndromic hearing loss 36,Deletion,GRCh38
na,na,1,6511986,6511986,ESPN,Pathogenic,"Deafness, without vestibular involvement, autosomal dominant",single nucleotide variant,GRCh37
na,na,1,6451926,6451926,ESPN,Pathogenic,"Deafness, without vestibular involvement, autosomal dominant",single nucleotide variant,GRCh38
na,na,1,6512061,6512061,ESPN,Uncertain significance,"Deafness, without vestibular involvement, autosomal dominant|not provided|Autosomal recessive nonsyndromic hearing loss 36;Usher syndrome, type 1M",single nucleotide variant,GRCh37
na,na,1,6452001,6452001,ESPN,Uncertain significance,"Deafness, without vestibular involvement, autosomal dominant|not provided|Autosomal recessive nonsyndromic hearing loss 36;Usher syndrome, type 1M",single nucleotide variant,GRCh38
na,na,1,6512152,6512152,ESPN,Pathogenic,"Deafness, without vestibular involvement, autosomal dominant",single nucleotide variant,GRCh37
na,na,1,6452092,6452092,ESPN,Pathogenic,"Deafness, without vestibular involvement, autosomal dominant",single nucleotide variant,GRCh38
na,na,1,6520179,6520181,ESPN,Likely pathogenic,"Deafness, without vestibular involvement, autosomal dominant|Autosomal recessive nonsyndromic hearing loss 36",Microsatellite,GRCh37
na,na,1,6460119,6460121,ESPN,Likely pathogenic,"Deafness, without vestibular involvement, autosomal dominant|Autosomal recessive nonsyndromic hearing loss 36",Microsatellite,GRCh38
na,na,1,6508991,6508992,ESPN,Pathogenic,"Deafness, autosomal recessive 36, without vestibular involvement",Duplication,GRCh37
na,na,1,6448931,6448932,ESPN,Pathogenic,"Deafness, autosomal recessive 36, without vestibular involvement",Duplication,GRCh38
na,na,9,32984709,32984710,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia|Inborn genetic diseases",Duplication,GRCh37
na,na,9,32984711,32984712,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia|Inborn genetic diseases",Duplication,GRCh38
na,na,9,32984782,32984782,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh37
na,na,9,32984784,32984784,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh38
na,na,9,32974489,32974489,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",Deletion,GRCh37
na,na,9,32974491,32974491,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",Deletion,GRCh38
na,na,9,32974542,32974542,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh37
na,na,9,32974544,32974544,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh38
na,na,9,32984797,32984797,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh37
na,na,9,32984799,32984799,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh38
na,na,9,32973651,32973651,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh37
na,na,9,32973653,32973653,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh38
na,na,9,32974493,32974493,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia|not provided|Inborn genetic diseases|APTX-related disorder",single nucleotide variant,GRCh37
na,na,9,32974495,32974495,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia|not provided|Inborn genetic diseases|APTX-related disorder",single nucleotide variant,GRCh38
na,na,9,32973498,33001604,APTX,Pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",Deletion,GRCh38
na,na,9,32984731,32984731,APTX,Likely pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh37
na,na,9,32984733,32984733,APTX,Likely pathogenic,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia",single nucleotide variant,GRCh38
na,na,15,77324645,77324645,PSTPIP1,Pathogenic,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome,single nucleotide variant,GRCh37
na,na,15,77032304,77032304,PSTPIP1,Pathogenic,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome,single nucleotide variant,GRCh38
na,na,15,77323566,77323566,PSTPIP1,Pathogenic,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome|not provided|PSTPIP1-related disorder,single nucleotide variant,GRCh37
na,na,15,77031225,77031225,PSTPIP1,Pathogenic,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome|not provided|PSTPIP1-related disorder,single nucleotide variant,GRCh38
na,na,14,60976609,60976609,SIX6,Uncertain significance,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome,single nucleotide variant,GRCh37
na,na,14,60509891,60509891,SIX6,Uncertain significance,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome,single nucleotide variant,GRCh38
na,na,1,45347394,45347394,EIF2B3,Pathogenic/Likely pathogenic,not provided|Leukoencephalopathy with vanishing white matter 3,single nucleotide variant,GRCh37
na,na,1,44881722,44881722,EIF2B3,Pathogenic/Likely pathogenic,not provided|Leukoencephalopathy with vanishing white matter 3,single nucleotide variant,GRCh38
na,na,1,45340358,45340359,EIF2B3,Pathogenic,Leukoencephalopathy with vanishing white matter 3,Microsatellite,GRCh37
na,na,1,44874686,44874687,EIF2B3,Pathogenic,Leukoencephalopathy with vanishing white matter 3,Microsatellite,GRCh38
na,na,1,45444021,45444021,EIF2B3,Pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 3|EIF2B3-related disorder,single nucleotide variant,GRCh37
na,na,1,44978349,44978349,EIF2B3,Pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 3|EIF2B3-related disorder,single nucleotide variant,GRCh38
na,na,1,45341306,45341306,EIF2B3,Pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 3|not provided,single nucleotide variant,GRCh37
na,na,1,44875634,44875634,EIF2B3,Pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 3|not provided,single nucleotide variant,GRCh38
na,na,17,3558349,3558349,CTNS,Pathogenic,Nephropathic cystinosis,single nucleotide variant,GRCh37
na,na,17,3655055,3655055,CTNS,Pathogenic,Nephropathic cystinosis,single nucleotide variant,GRCh38
na,na,17,3543558,3543559,CTNS,Pathogenic,Nephropathic cystinosis,Microsatellite,GRCh37
na,na,17,3640264,3640265,CTNS,Pathogenic,Nephropathic cystinosis,Microsatellite,GRCh38
na,na,17,3558599,3558599,CTNS,Pathogenic,Nephropathic cystinosis|not provided|Inborn genetic diseases;Ocular cystinosis;Juvenile nephropathic cystinosis|CTNS-related disorder|Nephropathic cystinosis;Ocular cystinosis;Juvenile nephropathic cystinosis|Cystinosis,single nucleotide variant,GRCh37
na,na,17,3655305,3655305,CTNS,Pathogenic,Nephropathic cystinosis|not provided|Inborn genetic diseases;Ocular cystinosis;Juvenile nephropathic cystinosis|CTNS-related disorder|Nephropathic cystinosis;Ocular cystinosis;Juvenile nephropathic cystinosis|Cystinosis,single nucleotide variant,GRCh38
na,na,17,3504228,3561459,CTNS,Pathogenic,Nephropathic cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis,Deletion,GRCh37
na,na,17,3600934,3658165,CTNS,Pathogenic,Nephropathic cystinosis|Juvenile nephropathic cystinosis|Ocular cystinosis,Deletion,GRCh38
na,na,17,3559825,3559825,CTNS,Likely pathogenic,Nephropathic cystinosis|Ocular cystinosis;Juvenile nephropathic cystinosis;Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,17,3656531,3656531,CTNS,Likely pathogenic,Nephropathic cystinosis|Ocular cystinosis;Juvenile nephropathic cystinosis;Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,17,3550800,3550800,CTNS,Benign/Likely benign,"Cystinosis, atypical nephropathic|Ocular cystinosis|Nephropathic cystinosis|not provided|not specified|Inborn genetic diseases;Ocular cystinosis;Juvenile nephropathic cystinosis|CTNS-related disorder|Cystinosis",single nucleotide variant,GRCh37
na,na,17,3647506,3647506,CTNS,Benign/Likely benign,"Cystinosis, atypical nephropathic|Ocular cystinosis|Nephropathic cystinosis|not provided|not specified|Inborn genetic diseases;Ocular cystinosis;Juvenile nephropathic cystinosis|CTNS-related disorder|Cystinosis",single nucleotide variant,GRCh38
na,na,17,3563149,3563149,CTNS,Pathogenic,Ocular cystinosis,single nucleotide variant,GRCh37
na,na,17,3659855,3659855,CTNS,Pathogenic,Ocular cystinosis,single nucleotide variant,GRCh38
na,na,17,3559997,3559997,CTNS,Pathogenic/Likely pathogenic,Ocular cystinosis|Nephropathic cystinosis|not provided|Inborn genetic diseases;Juvenile nephropathic cystinosis;Ocular cystinosis|Nephropathic cystinosis;Juvenile nephropathic cystinosis;Ocular cystinosis|Cystinosis,single nucleotide variant,GRCh37
na,na,17,3656703,3656703,CTNS,Pathogenic/Likely pathogenic,Ocular cystinosis|Nephropathic cystinosis|not provided|Inborn genetic diseases;Juvenile nephropathic cystinosis;Ocular cystinosis|Nephropathic cystinosis;Juvenile nephropathic cystinosis;Ocular cystinosis|Cystinosis,single nucleotide variant,GRCh38
na,na,17,3539712,3539712,CTNS,Pathogenic,Ocular cystinosis,single nucleotide variant,GRCh37
na,na,17,3636418,3636418,CTNS,Pathogenic,Ocular cystinosis,single nucleotide variant,GRCh38
na,na,17,3539712,3539713,CTNS,Pathogenic,Ocular cystinosis,Insertion,GRCh37
na,na,17,3636418,3636419,CTNS,Pathogenic,Ocular cystinosis,Insertion,GRCh38
na,na,17,3563574,3563574,CTNS,Pathogenic,Nephropathic cystinosis|not provided|Ocular cystinosis;Juvenile nephropathic cystinosis;Nephropathic cystinosis|Ocular cystinosis;Juvenile nephropathic cystinosis;Inborn genetic diseases|CTNS-related disorder|Cystinosis,single nucleotide variant,GRCh37
na,na,17,3660280,3660280,CTNS,Pathogenic,Nephropathic cystinosis|not provided|Ocular cystinosis;Juvenile nephropathic cystinosis;Nephropathic cystinosis|Ocular cystinosis;Juvenile nephropathic cystinosis;Inborn genetic diseases|CTNS-related disorder|Cystinosis,single nucleotide variant,GRCh38
na,na,17,3563268,3563268,CTNS,Pathogenic,Juvenile nephropathic cystinosis|Ocular cystinosis;Juvenile nephropathic cystinosis;Inborn genetic diseases|Nephropathic cystinosis,single nucleotide variant,GRCh37
na,na,17,3659974,3659974,CTNS,Pathogenic,Juvenile nephropathic cystinosis|Ocular cystinosis;Juvenile nephropathic cystinosis;Inborn genetic diseases|Nephropathic cystinosis,single nucleotide variant,GRCh38
na,na,17,3558395,3558395,CTNS,Pathogenic,"Cystinosis, atypical nephropathic",single nucleotide variant,GRCh37
na,na,17,3655101,3655101,CTNS,Pathogenic,"Cystinosis, atypical nephropathic",single nucleotide variant,GRCh38
na,na,17,3558601,3558601,CTNS,Pathogenic/Likely pathogenic,"Cystinosis, atypical nephropathic|Juvenile nephropathic cystinosis|Nephropathic cystinosis|Inborn genetic diseases;Ocular cystinosis;Juvenile nephropathic cystinosis|Nephropathic cystinosis;Ocular cystinosis;Juvenile nephropathic cystinosis|Cystinosis|not provided",single nucleotide variant,GRCh37
na,na,17,3655307,3655307,CTNS,Pathogenic/Likely pathogenic,"Cystinosis, atypical nephropathic|Juvenile nephropathic cystinosis|Nephropathic cystinosis|Inborn genetic diseases;Ocular cystinosis;Juvenile nephropathic cystinosis|Nephropathic cystinosis;Ocular cystinosis;Juvenile nephropathic cystinosis|Cystinosis|not provided",single nucleotide variant,GRCh38
na,na,22,42322184,42322207,TNFRSF13C,Pathogenic,"Immunodeficiency, common variable, 4",Deletion,GRCh37
na,na,22,41926180,41926203,TNFRSF13C,Pathogenic,"Immunodeficiency, common variable, 4",Deletion,GRCh38
na,na,2,219755026,219755026,WNT10A,Pathogenic,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia",single nucleotide variant,GRCh37
na,na,2,218890304,218890304,WNT10A,Pathogenic,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia",single nucleotide variant,GRCh38
na,na,2,219747090,219747090,WNT10A,Pathogenic,"Odonto-onycho-dermal dysplasia|SchC6pf-Schulz-Passarge syndrome|Tooth agenesis, selective, 4|not provided|Inborn genetic diseases|Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome;Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia|WNT10A-related disorder|Ectodermal dysplasia|not specified",single nucleotide variant,GRCh37
na,na,2,218882368,218882368,WNT10A,Pathogenic,"Odonto-onycho-dermal dysplasia|SchC6pf-Schulz-Passarge syndrome|Tooth agenesis, selective, 4|not provided|Inborn genetic diseases|Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome;Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia|WNT10A-related disorder|Ectodermal dysplasia|not specified",single nucleotide variant,GRCh38
na,na,2,219755011,219755011,WNT10A,Conflicting classifications of pathogenicity,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4|not provided|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia|Inborn genetic diseases|Tooth agenesis|Hypohidrotic ectodermal dysplasia|Ectodermal dysplasia|Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome;Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome|WNT10A-related disorder|See cases|Ectodermal dysplasia WNT10A related",single nucleotide variant,GRCh37
na,na,2,218890289,218890289,WNT10A,Conflicting classifications of pathogenicity,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4|not provided|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia|Inborn genetic diseases|Tooth agenesis|Hypohidrotic ectodermal dysplasia|Ectodermal dysplasia|Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome;Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;SchC6pf-Schulz-Passarge syndrome|WNT10A-related disorder|See cases|Ectodermal dysplasia WNT10A related",single nucleotide variant,GRCh38
na,na,2,219754712,219754712,WNT10A,Pathogenic/Likely pathogenic,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4|not provided|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia|SchC6pf-Schulz-Passarge syndrome;Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia",single nucleotide variant,GRCh37
na,na,2,218889990,218889990,WNT10A,Pathogenic/Likely pathogenic,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4|not provided|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia|SchC6pf-Schulz-Passarge syndrome;Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia",single nucleotide variant,GRCh38
na,na,2,219757867,219757867,WNT10A,Pathogenic,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia",single nucleotide variant,GRCh37
na,na,2,218893145,218893145,WNT10A,Pathogenic,"Odonto-onycho-dermal dysplasia|Tooth agenesis, selective, 4;Odonto-onycho-dermal dysplasia",single nucleotide variant,GRCh38
na,na,2,219745744,219745744,WNT10A,Pathogenic,Odonto-onycho-dermal dysplasia,single nucleotide variant,GRCh37
na,na,2,218881022,218881022,WNT10A,Pathogenic,Odonto-onycho-dermal dysplasia,single nucleotide variant,GRCh38
na,na,12,10271087,10271087,CLEC7A,Benign/Likely benign,"Familial chronic mucocutaneous candidiasis|Aspergillosis, susceptibility to|not specified|Aspergillosis, susceptibility to;Familial chronic mucocutaneous candidiasis|CLEC7A-related disorder|not provided",single nucleotide variant,GRCh37
na,na,12,10118488,10118488,CLEC7A,Benign/Likely benign,"Familial chronic mucocutaneous candidiasis|Aspergillosis, susceptibility to|not specified|Aspergillosis, susceptibility to;Familial chronic mucocutaneous candidiasis|CLEC7A-related disorder|not provided",single nucleotide variant,GRCh38
na,na,11,126162843,126162843,TIRAP,Benign,"Invasive pneumococcal disease, protection against|Malaria, resistance to|Mycobacterium tuberculosis, protection against|Bacteremia, susceptibility|not provided|not specified|Malaria, susceptibility to;Mycobacterium tuberculosis, susceptibility to;Bacteremia, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,11,126292948,126292948,TIRAP,Benign,"Invasive pneumococcal disease, protection against|Malaria, resistance to|Mycobacterium tuberculosis, protection against|Bacteremia, susceptibility|not provided|not specified|Malaria, susceptibility to;Mycobacterium tuberculosis, susceptibility to;Bacteremia, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,14,95562509,95562509,DICER1,Likely pathogenic,Pleuropulmonary blastoma|DICER1-related tumor predisposition,single nucleotide variant,GRCh37
na,na,14,95096172,95096172,DICER1,Likely pathogenic,Pleuropulmonary blastoma|DICER1-related tumor predisposition,single nucleotide variant,GRCh38
na,na,14,95583961,95583961,DICER1,Pathogenic,Pleuropulmonary blastoma|Hereditary cancer-predisposing syndrome|DICER1-related tumor predisposition|not provided,single nucleotide variant,GRCh37
na,na,14,95117624,95117624,DICER1,Pathogenic,Pleuropulmonary blastoma|Hereditary cancer-predisposing syndrome|DICER1-related tumor predisposition|not provided,single nucleotide variant,GRCh38
na,na,14,95572535,95572535,DICER1,Pathogenic,Pleuropulmonary blastoma|DICER1-related tumor predisposition|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,14,95106198,95106198,DICER1,Pathogenic,Pleuropulmonary blastoma|DICER1-related tumor predisposition|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,14,95582912,95582912,DICER1,Pathogenic,Pleuropulmonary blastoma|DICER1-related tumor predisposition|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,14,95116575,95116575,DICER1,Pathogenic,Pleuropulmonary blastoma|DICER1-related tumor predisposition|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,11,119213687,119213688,MFRP,Pathogenic,Nanophthalmos 2|Isolated microphthalmia 5|Retinal dystrophy,Duplication,GRCh37
na,na,11,119342977,119342978,MFRP,Pathogenic,Nanophthalmos 2|Isolated microphthalmia 5|Retinal dystrophy,Duplication,GRCh38
na,na,11,119216248,119216248,MFRP,Pathogenic,Nanophthalmos 2|not provided|Isolated microphthalmia 5,single nucleotide variant,GRCh37
na,na,11,119345538,119345538,MFRP,Pathogenic,Nanophthalmos 2|not provided|Isolated microphthalmia 5,single nucleotide variant,GRCh38
na,na,11,119216273,119216273,MFRP,Pathogenic,Nanophthalmos 2|Isolated microphthalmia 5|not provided|MFRP-related disorder|Retinal dystrophy|Isolated microphthalmia 5;Nanophthalmos 2,Deletion,GRCh37
na,na,11,119345563,119345563,MFRP,Pathogenic,Nanophthalmos 2|Isolated microphthalmia 5|not provided|MFRP-related disorder|Retinal dystrophy|Isolated microphthalmia 5;Nanophthalmos 2,Deletion,GRCh38
na,na,11,119216226,119216226,MFRP,Pathogenic,Nanophthalmos 2,single nucleotide variant,GRCh37
na,na,11,119345516,119345516,MFRP,Pathogenic,Nanophthalmos 2,single nucleotide variant,GRCh38
na,na,11,119216272,119216273,MFRP,Pathogenic,Isolated microphthalmia 5|not provided|Retinal dystrophy,Duplication,GRCh37
na,na,11,119345562,119345563,MFRP,Pathogenic,Isolated microphthalmia 5|not provided|Retinal dystrophy,Duplication,GRCh38
na,na,7,33060929,33060929,NT5C3A,Pathogenic/Likely pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,7,33021317,33021317,NT5C3A,Pathogenic/Likely pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,7,33057113,33057113,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh37
na,na,7,33017501,33017501,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh38
na,na,7,33055483,33055483,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh37
na,na,7,33015871,33015871,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh38
na,na,7,33055330,33055331,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency|not provided,Duplication,GRCh37
na,na,7,33015718,33015719,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency|not provided,Duplication,GRCh38
na,na,7,33057099,33057099,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh37
na,na,7,33017487,33017487,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh38
na,na,7,33059290,33059291,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,Duplication,GRCh37
na,na,7,33019678,33019679,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,Duplication,GRCh38
na,na,7,33055483,33055483,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh37
na,na,7,33015871,33015871,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh38
na,na,7,33057073,33057073,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh37
na,na,7,33017461,33017461,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh38
na,na,7,33057065,33057065,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,Deletion,GRCh37
na,na,7,33017453,33017453,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,Deletion,GRCh38
na,na,7,33055353,33055353,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh37
na,na,7,33015741,33015741,NT5C3A,Pathogenic,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,single nucleotide variant,GRCh38
na,na,1,26135587,26135587,SELENON,Pathogenic,Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh37
na,na,1,25809096,25809096,SELENON,Pathogenic,Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh38
na,na,1,26139281,26139281,SELENON,Pathogenic,Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh37
na,na,1,25812790,25812790,SELENON,Pathogenic,Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh38
na,na,1,26126722,26126722,SELENON,Pathogenic/Likely pathogenic,Eichsfeld type congenital muscular dystrophy|not provided|Congenital myopathy with fiber type disproportion|Congenital myopathy with fiber type disproportion;Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh37
na,na,1,25800231,25800231,SELENON,Pathogenic/Likely pathogenic,Eichsfeld type congenital muscular dystrophy|not provided|Congenital myopathy with fiber type disproportion|Congenital myopathy with fiber type disproportion;Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh38
na,na,1,26140381,26140381,SELENON,Pathogenic/Likely pathogenic,Eichsfeld type congenital muscular dystrophy|not provided|SEPN1-related disorder|Muscular dystrophy,single nucleotide variant,GRCh37
na,na,1,25813890,25813890,SELENON,Pathogenic/Likely pathogenic,Eichsfeld type congenital muscular dystrophy|not provided|SEPN1-related disorder|Muscular dystrophy,single nucleotide variant,GRCh38
na,na,1,26139254,26139254,SELENON,Likely pathogenic,Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh37
na,na,1,25812763,25812763,SELENON,Likely pathogenic,Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh38
na,na,1,26135244,26135245,SELENON,Pathogenic,Eichsfeld type congenital muscular dystrophy|not provided|Eichsfeld type congenital muscular dystrophy;Congenital myopathy with fiber type disproportion|SELENON-related disorder,Duplication,GRCh37
na,na,1,25808753,25808754,SELENON,Pathogenic,Eichsfeld type congenital muscular dystrophy|not provided|Eichsfeld type congenital muscular dystrophy;Congenital myopathy with fiber type disproportion|SELENON-related disorder,Duplication,GRCh38
na,na,1,26139280,26139280,SELENON,Pathogenic,Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh37
na,na,1,25812789,25812789,SELENON,Pathogenic,Eichsfeld type congenital muscular dystrophy,single nucleotide variant,GRCh38
na,na,1,26136244,26136244,SELENON,Pathogenic/Likely pathogenic,"Eichsfeld type congenital muscular dystrophy|Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy with fiber type disproportion;Eichsfeld type congenital muscular dystrophy|SEPN1-related disorder|Congenital myopathy 4A, autosomal dominant;Eichsfeld type congenital muscular dystrophy|SELENON-related myopathy",single nucleotide variant,GRCh37
na,na,1,25809753,25809753,SELENON,Pathogenic/Likely pathogenic,"Eichsfeld type congenital muscular dystrophy|Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy with fiber type disproportion;Eichsfeld type congenital muscular dystrophy|SEPN1-related disorder|Congenital myopathy 4A, autosomal dominant;Eichsfeld type congenital muscular dystrophy|SELENON-related myopathy",single nucleotide variant,GRCh38
na,na,5,33964122,33964122,SLC45A2,Pathogenic,Oculocutaneous albinism type 4,single nucleotide variant,GRCh37
na,na,5,33964017,33964017,SLC45A2,Pathogenic,Oculocutaneous albinism type 4,single nucleotide variant,GRCh38
na,na,5,33951733,33951733,SLC45A2,Conflicting classifications of pathogenicity,"Oculocutaneous albinism type 4|not provided|SLC45A2-related disorder|SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR;Oculocutaneous albinism type 4",single nucleotide variant,GRCh37
na,na,5,33951628,33951628,SLC45A2,Conflicting classifications of pathogenicity,"Oculocutaneous albinism type 4|not provided|SLC45A2-related disorder|SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR;Oculocutaneous albinism type 4",single nucleotide variant,GRCh38
na,na,5,33954512,33954512,SLC45A2,Pathogenic,"Oculocutaneous albinism type 4|not provided|SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR",Deletion,GRCh37
na,na,5,33954407,33954407,SLC45A2,Pathogenic,"Oculocutaneous albinism type 4|not provided|SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR",Deletion,GRCh38
na,na,5,33964020,33964022,SLC45A2,Likely pathogenic,Oculocutaneous albinism type 4|not provided,Microsatellite,GRCh37
na,na,5,33963915,33963917,SLC45A2,Likely pathogenic,Oculocutaneous albinism type 4|not provided,Microsatellite,GRCh38
na,na,5,33944889,33944889,SLC45A2,Conflicting classifications of pathogenicity,Oculocutaneous albinism type 4|not provided|not specified,single nucleotide variant,GRCh37
na,na,5,33944784,33944784,SLC45A2,Conflicting classifications of pathogenicity,Oculocutaneous albinism type 4|not provided|not specified,single nucleotide variant,GRCh38
na,na,5,33982434,33982434,SLC45A2,Pathogenic,Oculocutaneous albinism type 4|not provided,single nucleotide variant,GRCh37
na,na,5,33982329,33982329,SLC45A2,Pathogenic,Oculocutaneous albinism type 4|not provided,single nucleotide variant,GRCh38
na,na,5,33963870,33963870,SLC45A2,Benign/Likely benign,"SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR|not provided|Oculocutaneous albinism type 4|SLC45A2-related disorder",single nucleotide variant,GRCh37
na,na,5,33963765,33963765,SLC45A2,Benign/Likely benign,"SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR|not provided|Oculocutaneous albinism type 4|SLC45A2-related disorder",single nucleotide variant,GRCh38
na,na,5,33951693,33951693,SLC45A2,Benign,"SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR|Malignant melanoma of skin|not provided",single nucleotide variant,GRCh37
na,na,5,33951588,33951588,SLC45A2,Benign,"SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR|Malignant melanoma of skin|not provided",single nucleotide variant,GRCh38
na,na,5,33951694,33951694,SLC45A2,Pathogenic,Oculocutaneous albinism type 4|not provided,Deletion,GRCh37
na,na,5,33951589,33951589,SLC45A2,Pathogenic,Oculocutaneous albinism type 4|not provided,Deletion,GRCh38
na,na,4,6303693,6303693,WFS1,Conflicting classifications of pathogenicity,Wolfram syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,4,6301966,6301966,WFS1,Conflicting classifications of pathogenicity,Wolfram syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,4,6303606,6303606,WFS1,Pathogenic/Likely pathogenic,Wolfram syndrome 1|not provided|Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Autosomal dominant nonsyndromic hearing loss 6;Type 2 diabetes mellitus,single nucleotide variant,GRCh37
na,na,4,6301879,6301879,WFS1,Pathogenic/Likely pathogenic,Wolfram syndrome 1|not provided|Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Autosomal dominant nonsyndromic hearing loss 6;Type 2 diabetes mellitus,single nucleotide variant,GRCh38
na,na,4,6303466,6303466,WFS1,Pathogenic,Wolfram syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,4,6301739,6301739,WFS1,Pathogenic,Wolfram syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,4,6303033,6303033,WFS1,Pathogenic/Likely pathogenic,Wolfram syndrome 1|Wolfram syndrome 1;Wolfram-like syndrome|not provided|Autosomal dominant nonsyndromic hearing loss 6;Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Type 2 diabetes mellitus|WFS1-related disorder,single nucleotide variant,GRCh37
na,na,4,6301306,6301306,WFS1,Pathogenic/Likely pathogenic,Wolfram syndrome 1|Wolfram syndrome 1;Wolfram-like syndrome|not provided|Autosomal dominant nonsyndromic hearing loss 6;Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Type 2 diabetes mellitus|WFS1-related disorder,single nucleotide variant,GRCh38
na,na,4,6302902,6302910,WFS1,Likely pathogenic,Wolfram syndrome 1,Deletion,GRCh37
na,na,4,6301175,6301183,WFS1,Likely pathogenic,Wolfram syndrome 1,Deletion,GRCh38
na,na,4,6290859,6290859,WFS1,Pathogenic,Wolfram syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,4,6289132,6289132,WFS1,Pathogenic,Wolfram syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,4,6293688,6293688,WFS1,Pathogenic,Wolfram syndrome 1,single nucleotide variant,GRCh37
na,na,4,6291961,6291961,WFS1,Pathogenic,Wolfram syndrome 1,single nucleotide variant,GRCh38
na,na,4,6303977,6303977,WFS1,Pathogenic,Wolfram syndrome 1,single nucleotide variant,GRCh37
na,na,4,6302250,6302250,WFS1,Pathogenic,Wolfram syndrome 1,single nucleotide variant,GRCh38
na,na,4,6290805,6290806,WFS1,Pathogenic/Likely pathogenic,Wolfram syndrome 1|Wolfram syndrome|WFS1-Related Spectrum Disorders|Type 2 diabetes mellitus|Retinal dystrophy|not provided|Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Autosomal dominant nonsyndromic hearing loss 6;Type 2 diabetes mellitus,Duplication,GRCh37
na,na,4,6289078,6289079,WFS1,Pathogenic/Likely pathogenic,Wolfram syndrome 1|Wolfram syndrome|WFS1-Related Spectrum Disorders|Type 2 diabetes mellitus|Retinal dystrophy|not provided|Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Autosomal dominant nonsyndromic hearing loss 6;Type 2 diabetes mellitus,Duplication,GRCh38
na,na,4,6303668,6303668,WFS1,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 6|not provided|Rare genetic deafness,single nucleotide variant,GRCh37
na,na,4,6301941,6301941,WFS1,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 6|not provided|Rare genetic deafness,single nucleotide variant,GRCh38
na,na,4,6304008,6304008,WFS1,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 6|not provided|Inborn genetic diseases|Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Autosomal dominant nonsyndromic hearing loss 6;Type 2 diabetes mellitus|Wolfram syndrome 1,single nucleotide variant,GRCh37
na,na,4,6302281,6302281,WFS1,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 6|not provided|Inborn genetic diseases|Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Autosomal dominant nonsyndromic hearing loss 6;Type 2 diabetes mellitus|Wolfram syndrome 1,single nucleotide variant,GRCh38
na,na,4,6303618,6303618,WFS1,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 6|not specified|not provided,single nucleotide variant,GRCh37
na,na,4,6301891,6301891,WFS1,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 6|not specified|not provided,single nucleotide variant,GRCh38
na,na,4,6304014,6304014,WFS1,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 6|not provided,single nucleotide variant,GRCh37
na,na,4,6302287,6302287,WFS1,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 6|not provided,single nucleotide variant,GRCh38
na,na,4,6303423,6303423,WFS1,Pathogenic,Autosomal dominant nonsyndromic hearing loss 6,single nucleotide variant,GRCh37
na,na,4,6301696,6301696,WFS1,Pathogenic,Autosomal dominant nonsyndromic hearing loss 6,single nucleotide variant,GRCh38
na,na,4,6304112,6304112,WFS1,Pathogenic/Likely pathogenic,Wolfram-like syndrome|Autosomal dominant nonsyndromic hearing loss 6|not provided|Rare genetic deafness|Wolfram syndrome 1|Nonsyndromic genetic hearing loss|Autosomal dominant nonsyndromic hearing loss|See cases|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,4,6302385,6302385,WFS1,Pathogenic/Likely pathogenic,Wolfram-like syndrome|Autosomal dominant nonsyndromic hearing loss 6|not provided|Rare genetic deafness|Wolfram syndrome 1|Nonsyndromic genetic hearing loss|Autosomal dominant nonsyndromic hearing loss|See cases|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,4,6292915,6292915,WFS1,Benign,Type 2 diabetes mellitus|WFS1-Related Spectrum Disorders|not specified|Autosomal dominant nonsyndromic hearing loss 6|not provided|Wolfram syndrome 1|Wolfram syndrome,single nucleotide variant,GRCh37
na,na,4,6291188,6291188,WFS1,Benign,Type 2 diabetes mellitus|WFS1-Related Spectrum Disorders|not specified|Autosomal dominant nonsyndromic hearing loss 6|not provided|Wolfram syndrome 1|Wolfram syndrome,single nucleotide variant,GRCh38
na,na,4,6295693,6295693,WFS1,Benign,"Diabetes mellitus, noninsulin-dependent, association with|not provided|Wolfram syndrome|Wolfram syndrome 1|Type 2 diabetes mellitus|not specified",single nucleotide variant,GRCh37
na,na,4,6293966,6293966,WFS1,Benign,"Diabetes mellitus, noninsulin-dependent, association with|not provided|Wolfram syndrome|Wolfram syndrome 1|Type 2 diabetes mellitus|not specified",single nucleotide variant,GRCh38
na,na,4,6304098,6304098,WFS1,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 6|not provided|Autosomal dominant nonsyndromic hearing loss 6;Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Type 2 diabetes mellitus|Optic atrophy|WFS1-related disorder,single nucleotide variant,GRCh37
na,na,4,6302371,6302371,WFS1,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 6|not provided|Autosomal dominant nonsyndromic hearing loss 6;Wolfram syndrome 1;Cataract 41;Wolfram-like syndrome;Type 2 diabetes mellitus|Optic atrophy|WFS1-related disorder,single nucleotide variant,GRCh38
na,na,12,26275297,26275297,BHLHE41,Affects,"Short sleep, familial natural, 1",single nucleotide variant,GRCh37
na,na,12,26122364,26122364,BHLHE41,Affects,"Short sleep, familial natural, 1",single nucleotide variant,GRCh38
na,na,11,62472792,62472793,BSCL2,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,Indel,GRCh37
na,na,11,62705320,62705321,BSCL2,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,Indel,GRCh38
na,na,11,62462176,62462177,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,Insertion,GRCh37
na,na,11,62694704,62694705,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,Insertion,GRCh38
na,na,11,62462162,62462163,BSCL2,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,Deletion,GRCh37
na,na,11,62694690,62694691,BSCL2,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,Deletion,GRCh38
na,na,na,-1,-1,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2,Indel,na
na,na,11,62462157,62462161,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Severe neurodegenerative syndrome with lipodystrophy|not provided|Berardinelli-Seip congenital lipodystrophy|Charcot-Marie-Tooth disease type 2,Deletion,GRCh37
na,na,11,62694685,62694689,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Severe neurodegenerative syndrome with lipodystrophy|not provided|Berardinelli-Seip congenital lipodystrophy|Charcot-Marie-Tooth disease type 2,Deletion,GRCh38
na,na,11,62462152,62462153,BSCL2,Pathogenic,"Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy|Neuronopathy, distal hereditary motor, type 5C;Severe neurodegenerative syndrome with lipodystrophy;Hereditary spastic paraplegia 17;Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2",Duplication,GRCh37
na,na,11,62694680,62694681,BSCL2,Pathogenic,"Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy|Neuronopathy, distal hereditary motor, type 5C;Severe neurodegenerative syndrome with lipodystrophy;Hereditary spastic paraplegia 17;Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2",Duplication,GRCh38
na,na,11,62462066,62462066,BSCL2,Pathogenic,"Congenital generalized lipodystrophy type 2|Neuronopathy, distal hereditary motor, type 5C|Inborn genetic diseases|Berardinelli-Seip congenital lipodystrophy",single nucleotide variant,GRCh37
na,na,11,62694594,62694594,BSCL2,Pathogenic,"Congenital generalized lipodystrophy type 2|Neuronopathy, distal hereditary motor, type 5C|Inborn genetic diseases|Berardinelli-Seip congenital lipodystrophy",single nucleotide variant,GRCh38
na,na,11,62462039,62462039,BSCL2,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,single nucleotide variant,GRCh37
na,na,11,62694567,62694567,BSCL2,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,single nucleotide variant,GRCh38
na,na,11,62459885,62459885,BSCL2,Pathogenic,"Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy|Charcot-Marie-Tooth disease type 2|Congenital generalized lipodystrophy type 2;Neuronopathy, distal hereditary motor, type 5C;Severe neurodegenerative syndrome with lipodystrophy;Hereditary spastic paraplegia 17",single nucleotide variant,GRCh37
na,na,11,62692413,62692413,BSCL2,Pathogenic,"Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy|Charcot-Marie-Tooth disease type 2|Congenital generalized lipodystrophy type 2;Neuronopathy, distal hereditary motor, type 5C;Severe neurodegenerative syndrome with lipodystrophy;Hereditary spastic paraplegia 17",single nucleotide variant,GRCh38
na,na,11,62459883,62459883,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2|Berardinelli-Seip congenital lipodystrophy,Deletion,GRCh37
na,na,11,62692411,62692411,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2|Berardinelli-Seip congenital lipodystrophy,Deletion,GRCh38
na,na,11,62459843,62459843,BSCL2,Uncertain significance,"Congenital generalized lipodystrophy type 2|Hereditary spastic paraplegia|Berardinelli-Seip congenital lipodystrophy|Hereditary spastic paraplegia 17;Severe neurodegenerative syndrome with lipodystrophy;Congenital generalized lipodystrophy type 2;Neuronopathy, distal hereditary motor, type 5C",single nucleotide variant,GRCh37
na,na,11,62692371,62692371,BSCL2,Uncertain significance,"Congenital generalized lipodystrophy type 2|Hereditary spastic paraplegia|Berardinelli-Seip congenital lipodystrophy|Hereditary spastic paraplegia 17;Severe neurodegenerative syndrome with lipodystrophy;Congenital generalized lipodystrophy type 2;Neuronopathy, distal hereditary motor, type 5C",single nucleotide variant,GRCh38
na,na,11,62458896,62458896,BSCL2,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,single nucleotide variant,GRCh37
na,na,11,62691424,62691424,BSCL2,Conflicting classifications of pathogenicity,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,single nucleotide variant,GRCh38
na,na,11,62469971,62469971,BSCL2;HNRNPUL2-BSCL2,Pathogenic,"Hereditary spastic paraplegia 17|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease type 2|not specified|not provided|Neuronopathy, distal hereditary motor, type 5C|Inborn genetic diseases|Hereditary spastic paraplegia|Peripheral neuropathy|Berardinelli-Seip congenital lipodystrophy|Neuronopathy, distal hereditary motor, type 5C;Hereditary spastic paraplegia 17",single nucleotide variant,GRCh37
na,na,11,62702499,62702499,BSCL2;HNRNPUL2-BSCL2,Pathogenic,"Hereditary spastic paraplegia 17|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease type 2|not specified|not provided|Neuronopathy, distal hereditary motor, type 5C|Inborn genetic diseases|Hereditary spastic paraplegia|Peripheral neuropathy|Berardinelli-Seip congenital lipodystrophy|Neuronopathy, distal hereditary motor, type 5C;Hereditary spastic paraplegia 17",single nucleotide variant,GRCh38
na,na,11,62469965,62469965,BSCL2,Pathogenic/Likely pathogenic,"Hereditary spastic paraplegia 17|Hereditary spastic paraplegia 17;Neuronopathy, distal hereditary motor, type 5A|not provided|Charcot-Marie-Tooth disease type 2|Abnormal central motor function|Berardinelli-Seip congenital lipodystrophy|Neuronopathy, distal hereditary motor, type 5C|BSCL2-related disorder",single nucleotide variant,GRCh37
na,na,11,62702493,62702493,BSCL2,Pathogenic/Likely pathogenic,"Hereditary spastic paraplegia 17|Hereditary spastic paraplegia 17;Neuronopathy, distal hereditary motor, type 5A|not provided|Charcot-Marie-Tooth disease type 2|Abnormal central motor function|Berardinelli-Seip congenital lipodystrophy|Neuronopathy, distal hereditary motor, type 5C|BSCL2-related disorder",single nucleotide variant,GRCh38
na,na,11,62458604,62458604,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,single nucleotide variant,GRCh37
na,na,11,62691132,62691132,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Berardinelli-Seip congenital lipodystrophy,single nucleotide variant,GRCh38
na,na,11,62460143,62460143,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2|Berardinelli-Seip congenital lipodystrophy,single nucleotide variant,GRCh37
na,na,11,62692671,62692671,BSCL2,Pathogenic,Congenital generalized lipodystrophy type 2|Charcot-Marie-Tooth disease type 2|Berardinelli-Seip congenital lipodystrophy,single nucleotide variant,GRCh38
na,na,20,3888871,3888877,PANK2,Pathogenic,Pigmentary pallidal degeneration,Deletion,GRCh37
na,na,20,3908224,3908230,PANK2,Pathogenic,Pigmentary pallidal degeneration,Deletion,GRCh38
na,na,20,3899342,3899342,PANK2,Pathogenic,"Pigmentary pallidal degeneration|Inborn genetic diseases|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|not provided|Retinitis pigmentosa|Pigmentary pallidal degeneration;Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|Rubinstein-Taybi syndrome due to EP300 haploinsufficiency",single nucleotide variant,GRCh37
na,na,20,3918695,3918695,PANK2,Pathogenic,"Pigmentary pallidal degeneration|Inborn genetic diseases|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|not provided|Retinitis pigmentosa|Pigmentary pallidal degeneration;Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|Rubinstein-Taybi syndrome due to EP300 haploinsufficiency",single nucleotide variant,GRCh38
na,na,20,3870317,3870317,PANK2,Pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh37
na,na,20,3889670,3889670,PANK2,Pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh38
na,na,20,3888734,3888734,PANK2,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration|not provided,single nucleotide variant,GRCh37
na,na,20,3908087,3908087,PANK2,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration|not provided,single nucleotide variant,GRCh38
na,na,20,3888800,3888800,PANK2,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh37
na,na,20,3908153,3908153,PANK2,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh38
na,na,20,3893281,3893281,PANK2,Likely pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh37
na,na,20,3912634,3912634,PANK2,Likely pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh38
na,na,20,3891293,3891293,PANK2,Pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh37
na,na,20,3910646,3910646,PANK2,Pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh38
na,na,20,3888644,3888644,PANK2,Conflicting classifications of pathogenicity,Pigmentary pallidal degeneration|not specified,single nucleotide variant,GRCh37
na,na,20,3907997,3907997,PANK2,Conflicting classifications of pathogenicity,Pigmentary pallidal degeneration|not specified,single nucleotide variant,GRCh38
na,na,20,3888776,3888776,PANK2,Uncertain significance,not provided|Pigmentary pallidal degeneration|not specified,single nucleotide variant,GRCh37
na,na,20,3908129,3908129,PANK2,Uncertain significance,not provided|Pigmentary pallidal degeneration|not specified,single nucleotide variant,GRCh38
na,na,20,3899364,3899364,MIR103A2;MIR103B2;PANK2,Pathogenic,"Pigmentary pallidal degeneration|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|not provided|Inborn genetic diseases|PANK2-related disorder",single nucleotide variant,GRCh37
na,na,20,3918717,3918717,MIR103A2;MIR103B2;PANK2,Pathogenic,"Pigmentary pallidal degeneration|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|not provided|Inborn genetic diseases|PANK2-related disorder",single nucleotide variant,GRCh38
na,na,20,3897602,3897602,PANK2,Pathogenic,Pigmentary pallidal degeneration|Dystonic disorder,single nucleotide variant,GRCh37
na,na,20,3916955,3916955,PANK2,Pathogenic,Pigmentary pallidal degeneration|Dystonic disorder,single nucleotide variant,GRCh38
na,na,20,3893179,3893179,PANK2,Pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh37
na,na,20,3912532,3912532,PANK2,Pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh38
na,na,20,3897573,3897573,PANK2,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,20,3916926,3916926,PANK2,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,20,3897603,3897605,PANK2,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration|not provided,Deletion,GRCh37
na,na,20,3916956,3916958,PANK2,Pathogenic/Likely pathogenic,Pigmentary pallidal degeneration|not provided,Deletion,GRCh38
na,na,20,3870280,3870280,PANK2,Pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh37
na,na,20,3889633,3889633,PANK2,Pathogenic,Pigmentary pallidal degeneration,single nucleotide variant,GRCh38
na,na,2,228566967,228566967,SLC19A3,Pathogenic/Likely pathogenic,Biotin-responsive basal ganglia disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,2,227702251,227702251,SLC19A3,Pathogenic/Likely pathogenic,Biotin-responsive basal ganglia disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,2,228552932,228552932,SLC19A3,Pathogenic,Biotin-responsive basal ganglia disease|not provided|Inborn genetic diseases|Thiamine metabolism dysfunction syndrome 2 (biotin/thiamine-responsive basal ganglia disease type),single nucleotide variant,GRCh37
na,na,2,227688216,227688216,SLC19A3,Pathogenic,Biotin-responsive basal ganglia disease|not provided|Inborn genetic diseases|Thiamine metabolism dysfunction syndrome 2 (biotin/thiamine-responsive basal ganglia disease type),single nucleotide variant,GRCh38
na,na,2,228566905,228566905,SLC19A3,Pathogenic,Biotin-responsive basal ganglia disease,single nucleotide variant,GRCh37
na,na,2,227702189,227702189,SLC19A3,Pathogenic,Biotin-responsive basal ganglia disease,single nucleotide variant,GRCh38
na,na,2,228563473,228563473,SLC19A3,Pathogenic,Biotin-responsive basal ganglia disease,single nucleotide variant,GRCh37
na,na,2,227698757,227698757,SLC19A3,Pathogenic,Biotin-responsive basal ganglia disease,single nucleotide variant,GRCh38
na,na,16,56536585,56536585,BBS2,Pathogenic,Bardet-Biedl syndrome 2,Deletion,GRCh37
na,na,16,56502673,56502673,BBS2,Pathogenic,Bardet-Biedl syndrome 2,Deletion,GRCh38
na,na,16,56548486,56548486,BBS2,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2,single nucleotide variant,GRCh37
na,na,16,56514574,56514574,BBS2,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2,single nucleotide variant,GRCh38
na,na,16,56553703,56553703,BBS2,Pathogenic/Likely pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Retinal dystrophy|Retinitis pigmentosa|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|BBS2-related disorder",single nucleotide variant,GRCh37
na,na,16,56519791,56519791,BBS2,Pathogenic/Likely pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Retinal dystrophy|Retinitis pigmentosa|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|BBS2-related disorder",single nucleotide variant,GRCh38
na,na,16,56548535,56548535,BBS2,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|not provided,single nucleotide variant,GRCh37
na,na,16,56514623,56514623,BBS2,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|not provided,single nucleotide variant,GRCh38
na,na,16,56536702,56536702,BBS2,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|not provided|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Retinal dystrophy|Retinitis pigmentosa 74|BBS2-related disorder,single nucleotide variant,GRCh37
na,na,16,56502790,56502790,BBS2,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|not provided|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Retinal dystrophy|Retinitis pigmentosa 74|BBS2-related disorder,single nucleotide variant,GRCh38
na,na,16,56536366,56536366,BBS2,Pathogenic/Likely pathogenic,"Bardet-biedl syndrome 2/4, digenic|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|Retinal dystrophy|Autosomal recessive retinitis pigmentosa",single nucleotide variant,GRCh37
na,na,16,56502454,56502454,BBS2,Pathogenic/Likely pathogenic,"Bardet-biedl syndrome 2/4, digenic|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|Retinal dystrophy|Autosomal recessive retinitis pigmentosa",single nucleotide variant,GRCh38
na,na,na,-1,-1,BBS2,Pathogenic,"Bardet-biedl syndrome 1/2, digenic",Variation,na
na,na,na,-1,-1,BBS2,Pathogenic,Bardet-Biedl syndrome 2,Variation,na
na,na,16,56548501,56548501,BBS2,Benign,"BARDET-BIEDL SYNDROME 2/6, DIGENIC|Bardet-Biedl syndrome",single nucleotide variant,GRCh37
na,na,16,56514589,56514589,BBS2,Benign,"BARDET-BIEDL SYNDROME 2/6, DIGENIC|Bardet-Biedl syndrome",single nucleotide variant,GRCh38
na,na,16,56548399,56548399,BBS2,Pathogenic,"Bardet-biedl syndrome 1/2, digenic|Bardet-Biedl syndrome|Retinitis pigmentosa 74|Retinitis pigmentosa|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|BBS2-related disorder|not provided",single nucleotide variant,GRCh37
na,na,16,56514487,56514487,BBS2,Pathogenic,"Bardet-biedl syndrome 1/2, digenic|Bardet-Biedl syndrome|Retinitis pigmentosa 74|Retinitis pigmentosa|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|BBS2-related disorder|not provided",single nucleotide variant,GRCh38
na,na,16,56530894,56530894,BBS2,Pathogenic,Bardet-Biedl syndrome 2|BBS2-related disorder|Retinitis pigmentosa 74|Retinitis pigmentosa|Retinal dystrophy|Bardet-Biedl syndrome|not provided|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,56496982,56496982,BBS2,Pathogenic,Bardet-Biedl syndrome 2|BBS2-related disorder|Retinitis pigmentosa 74|Retinitis pigmentosa|Retinal dystrophy|Bardet-Biedl syndrome|not provided|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,16,56548593,56548593,BBS2,Pathogenic,Bardet-Biedl syndrome 2,single nucleotide variant,GRCh37
na,na,16,56514681,56514681,BBS2,Pathogenic,Bardet-Biedl syndrome 2,single nucleotide variant,GRCh38
na,na,16,56544833,56544833,BBS2,Pathogenic/Likely pathogenic,"Bardet-biedl syndrome 1/2, digenic|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74",Deletion,GRCh37
na,na,16,56510921,56510921,BBS2,Pathogenic/Likely pathogenic,"Bardet-biedl syndrome 1/2, digenic|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74",Deletion,GRCh38
na,na,na,-1,-1,BBS2,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC",Variation,na
na,na,na,-1,-1,BBS2,Pathogenic,"Bardet-biedl syndrome 2/4, digenic",Variation,na
na,na,16,56540103,56540103,BBS2,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC|Retinal dystrophy|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74",single nucleotide variant,GRCh37
na,na,16,56506191,56506191,BBS2,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC|Retinal dystrophy|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74",single nucleotide variant,GRCh38
na,na,16,56545126,56545126,BBS2,Pathogenic,Bardet-Biedl syndrome 2,single nucleotide variant,GRCh37
na,na,16,56511214,56511214,BBS2,Pathogenic,Bardet-Biedl syndrome 2,single nucleotide variant,GRCh38
na,na,20,45354185,45354185,SLC2A10,Pathogenic,Arterial tortuosity syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,46725546,46725546,SLC2A10,Pathogenic,Arterial tortuosity syndrome|not provided,single nucleotide variant,GRCh38
na,na,20,45354636,45354636,SLC2A10,Pathogenic,Arterial tortuosity syndrome,Deletion,GRCh37
na,na,20,46725997,46725997,SLC2A10,Pathogenic,Arterial tortuosity syndrome,Deletion,GRCh38
na,na,20,45355547,45355547,SLC2A10,Pathogenic,Arterial tortuosity syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection|SLC2A10-related disorder,Deletion,GRCh37
na,na,20,46726908,46726908,SLC2A10,Pathogenic,Arterial tortuosity syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection|SLC2A10-related disorder,Deletion,GRCh38
na,na,20,45353918,45353918,SLC2A10,Pathogenic/Likely pathogenic,Arterial tortuosity syndrome|not provided|SLC2A10-related disorder,single nucleotide variant,GRCh37
na,na,20,46725279,46725279,SLC2A10,Pathogenic/Likely pathogenic,Arterial tortuosity syndrome|not provided|SLC2A10-related disorder,single nucleotide variant,GRCh38
na,na,20,45354951,45354951,SLC2A10,Pathogenic/Likely pathogenic,Arterial tortuosity syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh37
na,na,20,46726312,46726312,SLC2A10,Pathogenic/Likely pathogenic,Arterial tortuosity syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh38
na,na,20,45354069,45354069,SLC2A10,Pathogenic/Likely pathogenic,Arterial tortuosity syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided,single nucleotide variant,GRCh37
na,na,20,46725430,46725430,SLC2A10,Pathogenic/Likely pathogenic,Arterial tortuosity syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided,single nucleotide variant,GRCh38
na,na,6,57059615,57059615,RAB23,Pathogenic,RAB23-related Carpenter syndrome|not provided|Carpenter syndrome|Inborn genetic diseases|RAB23-related disorder,single nucleotide variant,GRCh37
na,na,6,57194817,57194817,RAB23,Pathogenic,RAB23-related Carpenter syndrome|not provided|Carpenter syndrome|Inborn genetic diseases|RAB23-related disorder,single nucleotide variant,GRCh38
na,na,6,57059640,57059641,RAB23,Pathogenic,RAB23-related Carpenter syndrome|Carpenter syndrome|RAB23-related disorder|not provided,Duplication,GRCh37
na,na,6,57194842,57194843,RAB23,Pathogenic,RAB23-related Carpenter syndrome|Carpenter syndrome|RAB23-related disorder|not provided,Duplication,GRCh38
na,na,4,9966380,9966380,SLC2A9,association,"Uric acid concentration, serum, quantitative trait locus 2",single nucleotide variant,GRCh37
na,na,4,9964756,9964756,SLC2A9,association,"Uric acid concentration, serum, quantitative trait locus 2",single nucleotide variant,GRCh38
na,na,4,9994215,9994215,SLC2A9,association,"Uric acid concentration, serum, quantitative trait locus 2",single nucleotide variant,GRCh37
na,na,4,9992591,9992591,SLC2A9,association,"Uric acid concentration, serum, quantitative trait locus 2",single nucleotide variant,GRCh38
na,na,4,9934744,9934744,SLC2A9,association,"Uric acid concentration, serum, quantitative trait locus 2",single nucleotide variant,GRCh37
na,na,4,9933120,9933120,SLC2A9,association,"Uric acid concentration, serum, quantitative trait locus 2",single nucleotide variant,GRCh38
na,na,4,9892311,9892311,SLC2A9,Conflicting classifications of pathogenicity,"Hypouricemia, renal, 2|not provided",single nucleotide variant,GRCh37
na,na,4,9890687,9890687,SLC2A9,Conflicting classifications of pathogenicity,"Hypouricemia, renal, 2|not provided",single nucleotide variant,GRCh38
na,na,4,9982305,9982305,SLC2A9,Conflicting classifications of pathogenicity,"Hypouricemia, renal, 2|not provided",single nucleotide variant,GRCh37
na,na,4,9980681,9980681,SLC2A9,Conflicting classifications of pathogenicity,"Hypouricemia, renal, 2|not provided",single nucleotide variant,GRCh38
na,na,4,9889247,9889247,SLC2A9,Pathogenic,"Hypouricemia, renal, 2",single nucleotide variant,GRCh37
na,na,4,9887623,9887623,SLC2A9,Pathogenic,"Hypouricemia, renal, 2",single nucleotide variant,GRCh38
na,na,8,143823317,143823317,SLURP1,Pathogenic,Acroerythrokeratoderma|not provided,Deletion,GRCh37
na,na,8,142741899,142741899,SLURP1,Pathogenic,Acroerythrokeratoderma|not provided,Deletion,GRCh38
na,na,8,143823220,143823220,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh37
na,na,8,142741802,142741802,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh38
na,na,8,143822587,143822587,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh37
na,na,8,142741169,142741169,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh38
na,na,8,143822617,143822617,SLURP1,Pathogenic,Acroerythrokeratoderma|not provided,single nucleotide variant,GRCh37
na,na,8,142741199,142741199,SLURP1,Pathogenic,Acroerythrokeratoderma|not provided,single nucleotide variant,GRCh38
na,na,8,143822617,143822617,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh37
na,na,8,142741199,142741199,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh38
na,na,8,143823803,143823803,SLURP1,Likely pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh37
na,na,8,142742385,142742385,SLURP1,Likely pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh38
na,na,8,143823761,143823761,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh37
na,na,8,142742343,142742343,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh38
na,na,8,143822644,143822644,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh37
na,na,8,142741226,142741226,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh38
na,na,8,143822577,143822577,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh37
na,na,8,142741159,142741159,SLURP1,Pathogenic,Acroerythrokeratoderma,single nucleotide variant,GRCh38
na,na,3,148844501,148848419,HPS3,Pathogenic,Hermansky-Pudlak syndrome 3,Deletion,GRCh37
na,na,3,149126714,149130632,HPS3,Pathogenic,Hermansky-Pudlak syndrome 3,Deletion,GRCh38
na,na,3,148863334,148863334,HPS3,Pathogenic,Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome|HPS3-related disorder,single nucleotide variant,GRCh37
na,na,3,149145547,149145547,HPS3,Pathogenic,Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome|HPS3-related disorder,single nucleotide variant,GRCh38
na,na,3,148875320,148875320,HPS3,Pathogenic,Hermansky-Pudlak syndrome 3,single nucleotide variant,GRCh37
na,na,3,149157533,149157533,HPS3,Pathogenic,Hermansky-Pudlak syndrome 3,single nucleotide variant,GRCh38
na,na,3,148881627,148881627,HPS3,Pathogenic,Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome,single nucleotide variant,GRCh37
na,na,3,149163840,149163840,HPS3,Pathogenic,Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome,single nucleotide variant,GRCh38
na,na,3,148881737,148881737,HPS3,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 3|not provided,single nucleotide variant,GRCh37
na,na,3,149163950,149163950,HPS3,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 3|not provided,single nucleotide variant,GRCh38
na,na,3,148868411,148868411,HPS3,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome,single nucleotide variant,GRCh37
na,na,3,149150624,149150624,HPS3,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 3|not provided|Hermansky-Pudlak syndrome,single nucleotide variant,GRCh38
na,na,19,3653452,3653452,PIP5K1C,Pathogenic,Lethal congenital contracture syndrome 3,single nucleotide variant,GRCh37
na,na,19,3653454,3653454,PIP5K1C,Pathogenic,Lethal congenital contracture syndrome 3,single nucleotide variant,GRCh38
na,na,10,102749020,102749021,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",Duplication,GRCh37
na,na,10,100989263,100989264,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",Duplication,GRCh38
na,na,10,102749580,102749580,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh37
na,na,10,100989823,100989823,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh38
na,na,10,102749042,102749042,TWNK,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Mitochondrial disease|not provided",single nucleotide variant,GRCh37
na,na,10,100989285,100989285,TWNK,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Mitochondrial disease|not provided",single nucleotide variant,GRCh38
na,na,10,102749579,102749579,TWNK,Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3;Infantile onset spinocerebellar ataxia;Perrault syndrome 5;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",single nucleotide variant,GRCh37
na,na,10,100989822,100989822,TWNK,Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3;Infantile onset spinocerebellar ataxia;Perrault syndrome 5;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",single nucleotide variant,GRCh38
na,na,10,102748911,102748911,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh37
na,na,10,100989154,100989154,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh38
na,na,10,102749028,102749028,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh37
na,na,10,100989271,100989271,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh38
na,na,10,102749109,102749109,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,10,100989352,100989352,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,10,102748968,102748968,TWNK,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Mitochondrial disease|Infantile onset spinocerebellar ataxia|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh37
na,na,10,100989211,100989211,TWNK,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Mitochondrial disease|Infantile onset spinocerebellar ataxia|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh38
na,na,10,102749073,102749073,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh37
na,na,10,100989316,100989316,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3",single nucleotide variant,GRCh38
na,na,10,102748922,102748922,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",single nucleotide variant,GRCh37
na,na,10,100989165,100989165,TWNK,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",single nucleotide variant,GRCh38
na,na,10,102749527,102749527,TWNK,Pathogenic,Infantile onset spinocerebellar ataxia,single nucleotide variant,GRCh37
na,na,10,100989770,100989770,TWNK,Pathogenic,Infantile onset spinocerebellar ataxia,single nucleotide variant,GRCh38
na,na,10,102750231,102750231,TWNK,Pathogenic/Likely pathogenic,Infantile onset spinocerebellar ataxia|not provided,single nucleotide variant,GRCh37
na,na,10,100990474,100990474,TWNK,Pathogenic/Likely pathogenic,Infantile onset spinocerebellar ataxia|not provided,single nucleotide variant,GRCh38
na,na,10,102748875,102748875,TWNK,Conflicting classifications of pathogenicity,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided",single nucleotide variant,GRCh37
na,na,10,100989118,100989118,TWNK,Conflicting classifications of pathogenicity,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided",single nucleotide variant,GRCh38
na,na,10,102749087,102749087,TWNK,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided",single nucleotide variant,GRCh37
na,na,10,100989330,100989330,TWNK,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3|not provided",single nucleotide variant,GRCh38
na,na,10,102748919,102748919,TWNK,Pathogenic,Infantile onset spinocerebellar ataxia|See cases,single nucleotide variant,GRCh37
na,na,10,100989162,100989162,TWNK,Pathogenic,Infantile onset spinocerebellar ataxia|See cases,single nucleotide variant,GRCh38
na,na,10,112349701,112349703,SMC3,Pathogenic,Cornelia de Lange syndrome 3,Microsatellite,GRCh37
na,na,10,110589943,110589945,SMC3,Pathogenic,Cornelia de Lange syndrome 3,Microsatellite,GRCh38
na,na,7,35288378,35288378,TBX20,Uncertain significance,Atrial septal defect 4|Cardiovascular phenotype|not provided,single nucleotide variant,GRCh37
na,na,7,35248766,35248766,TBX20,Uncertain significance,Atrial septal defect 4|Cardiovascular phenotype|not provided,single nucleotide variant,GRCh38
na,na,7,35284632,35284632,TBX20,Pathogenic,Atrial septal defect 4,single nucleotide variant,GRCh37
na,na,7,35245020,35245020,TBX20,Pathogenic,Atrial septal defect 4,single nucleotide variant,GRCh38
na,na,7,35289580,35289580,TBX20,Pathogenic,Atrial septal defect 4,single nucleotide variant,GRCh37
na,na,7,35249968,35249968,TBX20,Pathogenic,Atrial septal defect 4,single nucleotide variant,GRCh38
na,na,3,129200389,129200389,IFT122,Pathogenic,Cranioectodermal dysplasia 1,single nucleotide variant,GRCh37
na,na,3,129481546,129481546,IFT122,Pathogenic,Cranioectodermal dysplasia 1,single nucleotide variant,GRCh38
na,na,3,129195306,129195306,IFT122,Likely pathogenic,Cranioectodermal dysplasia 1,single nucleotide variant,GRCh37
na,na,3,129476463,129476463,IFT122,Likely pathogenic,Cranioectodermal dysplasia 1,single nucleotide variant,GRCh38
na,na,3,129180152,129180152,IFT122,Uncertain significance,Cranioectodermal dysplasia 1,single nucleotide variant,GRCh37
na,na,3,129461309,129461309,IFT122,Uncertain significance,Cranioectodermal dysplasia 1,single nucleotide variant,GRCh38
na,na,3,129159194,129159194,IFT122,Pathogenic,Cranioectodermal dysplasia 1,single nucleotide variant,GRCh37
na,na,3,129440351,129440351,IFT122,Pathogenic,Cranioectodermal dysplasia 1,single nucleotide variant,GRCh38
na,na,na,-1,-1,CD96,Pathogenic,C syndrome,Translocation,na
na,na,3,111304209,111304209,CD96,Pathogenic,C syndrome,single nucleotide variant,GRCh37
na,na,3,111585362,111585362,CD96,Pathogenic,C syndrome,single nucleotide variant,GRCh38
na,na,19,12917596,12917596,RNASEH2A,Pathogenic,Aicardi-Goutieres syndrome 4,single nucleotide variant,GRCh37
na,na,19,12806782,12806782,RNASEH2A,Pathogenic,Aicardi-Goutieres syndrome 4,single nucleotide variant,GRCh38
na,na,1,110604187,110604187,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh37
na,na,1,110061565,110061565,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh38
na,na,1,110604172,110604172,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh37
na,na,1,110061550,110061550,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh38
na,na,1,110607301,110607301,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh37
na,na,1,110064679,110064679,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh38
na,na,1,110607256,110607256,ALX3,Uncertain significance,Frontorhiny|not provided,single nucleotide variant,GRCh37
na,na,1,110064634,110064634,ALX3,Uncertain significance,Frontorhiny|not provided,single nucleotide variant,GRCh38
na,na,1,110607260,110607260,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh37
na,na,1,110064638,110064638,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh38
na,na,1,110607222,110607225,ALX3,Pathogenic,Frontorhiny,Microsatellite,GRCh37
na,na,1,110064600,110064603,ALX3,Pathogenic,Frontorhiny,Microsatellite,GRCh38
na,na,1,110607217,110607217,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh37
na,na,1,110064595,110064595,ALX3,Pathogenic,Frontorhiny,single nucleotide variant,GRCh38
na,na,6,32363816,32363816,BTNL2,risk factor,"Sarcoidosis, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,6,32396039,32396039,BTNL2,risk factor,"Sarcoidosis, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,1,154247641,154247641,HAX1,Pathogenic,Kostmann syndrome,single nucleotide variant,GRCh37
na,na,1,154275165,154275165,HAX1,Pathogenic,Kostmann syndrome,single nucleotide variant,GRCh38
na,na,1,154245888,154245889,HAX1,Pathogenic,Kostmann syndrome|not provided,Insertion,GRCh37
na,na,1,154273412,154273413,HAX1,Pathogenic,Kostmann syndrome|not provided,Insertion,GRCh38
na,na,1,154245925,154245926,HAX1,Pathogenic,Kostmann syndrome,Duplication,GRCh37
na,na,1,154273449,154273450,HAX1,Pathogenic,Kostmann syndrome,Duplication,GRCh38
na,na,1,154246014,154246014,HAX1,Pathogenic,Kostmann syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,154273538,154273538,HAX1,Pathogenic,Kostmann syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,154246306,154246364,HAX1,Pathogenic,Kostmann syndrome,Deletion,GRCh37
na,na,1,154273830,154273888,HAX1,Pathogenic,Kostmann syndrome,Deletion,GRCh38
na,na,1,154245878,154245879,HAX1,Pathogenic,Kostmann syndrome|not provided,Duplication,GRCh37
na,na,1,154273402,154273403,HAX1,Pathogenic,Kostmann syndrome|not provided,Duplication,GRCh38
na,na,1,10318660,10318660,KIF1B,Pathogenic,Charcot-Marie-Tooth disease type 2A1,single nucleotide variant,GRCh37
na,na,1,10258602,10258602,KIF1B,Pathogenic,Charcot-Marie-Tooth disease type 2A1,single nucleotide variant,GRCh38
na,na,1,10357264,10357264,KIF1B,risk factor,"Neuroblastoma, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,1,10297206,10297206,KIF1B,risk factor,"Neuroblastoma, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,1,10384896,10384896,KIF1B,Conflicting classifications of pathogenicity,"Neuroblastoma, susceptibility to, 1|Charcot-Marie-Tooth disease type 2|Malignant tumor of breast|Neuroblastoma|Charcot-Marie-Tooth disease|not provided|not specified|KIF1B-related disorder|Neuroblastoma, susceptibility to, 1;Charcot-Marie-Tooth disease type 2A1",single nucleotide variant,GRCh37
na,na,1,10324838,10324838,KIF1B,Conflicting classifications of pathogenicity,"Neuroblastoma, susceptibility to, 1|Charcot-Marie-Tooth disease type 2|Malignant tumor of breast|Neuroblastoma|Charcot-Marie-Tooth disease|not provided|not specified|KIF1B-related disorder|Neuroblastoma, susceptibility to, 1;Charcot-Marie-Tooth disease type 2A1",single nucleotide variant,GRCh38
na,na,1,10406001,10406001,KIF1B,Conflicting classifications of pathogenicity,"Neuroblastoma, susceptibility to, 1|Neuroblastoma|Charcot-Marie-Tooth disease type 2|not specified",single nucleotide variant,GRCh37
na,na,1,10345943,10345943,KIF1B,Conflicting classifications of pathogenicity,"Neuroblastoma, susceptibility to, 1|Neuroblastoma|Charcot-Marie-Tooth disease type 2|not specified",single nucleotide variant,GRCh38
na,na,1,10425534,10425534,KIF1B,Uncertain significance,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 1, INCLUDED|Charcot-Marie-Tooth disease type 2|not specified",single nucleotide variant,GRCh37
na,na,1,10365476,10365476,KIF1B,Uncertain significance,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 1, INCLUDED|Charcot-Marie-Tooth disease type 2|not specified",single nucleotide variant,GRCh38
na,na,8,94935137,94935139,PDP1,Pathogenic,Pyruvate dehydrogenase phosphatase deficiency,Deletion,GRCh37
na,na,8,93922909,93922911,PDP1,Pathogenic,Pyruvate dehydrogenase phosphatase deficiency,Deletion,GRCh38
na,na,8,94934564,94934564,PDP1,Pathogenic,Pyruvate dehydrogenase phosphatase deficiency,single nucleotide variant,GRCh37
na,na,8,93922336,93922336,PDP1,Pathogenic,Pyruvate dehydrogenase phosphatase deficiency,single nucleotide variant,GRCh38
na,na,10,14987109,14987109,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency|not provided|Histiocytic medullary reticulosis|Histiocytic medullary reticulosis;Severe combined immunodeficiency due to DCLRE1C deficiency|Severe combined immunodeficiency disease|DCLRE1C-related disorder,single nucleotide variant,GRCh37
na,na,10,14945110,14945110,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency|not provided|Histiocytic medullary reticulosis|Histiocytic medullary reticulosis;Severe combined immunodeficiency due to DCLRE1C deficiency|Severe combined immunodeficiency disease|DCLRE1C-related disorder,single nucleotide variant,GRCh38
na,na,na,-1,-1,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,Deletion,na
na,na,10,14934776,14939809,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,Deletion,GRCh38
na,na,10,14968841,14968841,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,single nucleotide variant,GRCh37
na,na,10,14926842,14926842,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,single nucleotide variant,GRCh38
na,na,10,14970014,14970014,DCLRE1C,Likely pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,single nucleotide variant,GRCh37
na,na,10,14928015,14928015,DCLRE1C,Likely pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,single nucleotide variant,GRCh38
na,na,10,14978536,14978536,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency|Histiocytic medullary reticulosis,single nucleotide variant,GRCh37
na,na,10,14936537,14936537,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency|Histiocytic medullary reticulosis,single nucleotide variant,GRCh38
na,na,10,14974852,14974852,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,Deletion,GRCh37
na,na,10,14932853,14932853,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,Deletion,GRCh38
na,na,na,-1,-1,DCLRE1C,Pathogenic,Severe combined immunodeficiency due to DCLRE1C deficiency,Deletion,na
na,na,10,14976460,14976460,DCLRE1C,Pathogenic,Athabaskan severe combined immunodeficiency|Severe combined immunodeficiency due to DCLRE1C deficiency|not provided|Histiocytic medullary reticulosis,single nucleotide variant,GRCh37
na,na,10,14934461,14934461,DCLRE1C,Pathogenic,Athabaskan severe combined immunodeficiency|Severe combined immunodeficiency due to DCLRE1C deficiency|not provided|Histiocytic medullary reticulosis,single nucleotide variant,GRCh38
na,na,10,14995907,14995907,DCLRE1C,Pathogenic,Histiocytic medullary reticulosis|Severe combined immunodeficiency due to DCLRE1C deficiency|Histiocytic medullary reticulosis;Severe combined immunodeficiency due to DCLRE1C deficiency,single nucleotide variant,GRCh37
na,na,10,14953908,14953908,DCLRE1C,Pathogenic,Histiocytic medullary reticulosis|Severe combined immunodeficiency due to DCLRE1C deficiency|Histiocytic medullary reticulosis;Severe combined immunodeficiency due to DCLRE1C deficiency,single nucleotide variant,GRCh38
na,na,10,14951130,14951136,DCLRE1C,Pathogenic,"Severe combined immunodeficiency, partial|Athabaskan severe combined immunodeficiency|Severe combined immunodeficiency due to DCLRE1C deficiency|Histiocytic medullary reticulosis",Deletion,GRCh37
na,na,10,14909131,14909137,DCLRE1C,Pathogenic,"Severe combined immunodeficiency, partial|Athabaskan severe combined immunodeficiency|Severe combined immunodeficiency due to DCLRE1C deficiency|Histiocytic medullary reticulosis",Deletion,GRCh38
na,na,na,-1,-1,DCLRE1C,Pathogenic,"Severe combined immunodeficiency, partial",Deletion,na
na,na,10,14996008,14996008,DCLRE1C,Uncertain significance,Histiocytic medullary reticulosis|Severe combined immunodeficiency due to DCLRE1C deficiency,single nucleotide variant,GRCh37
na,na,10,14954009,14954009,DCLRE1C,Uncertain significance,Histiocytic medullary reticulosis|Severe combined immunodeficiency due to DCLRE1C deficiency,single nucleotide variant,GRCh38
na,na,15,43374846,43374846,UBR1,Pathogenic,Johanson-Blizzard syndrome,single nucleotide variant,GRCh37
na,na,15,43082648,43082648,UBR1,Pathogenic,Johanson-Blizzard syndrome,single nucleotide variant,GRCh38
na,na,15,43324764,43324764,UBR1,Pathogenic,Johanson-Blizzard syndrome,single nucleotide variant,GRCh37
na,na,15,43032566,43032566,UBR1,Pathogenic,Johanson-Blizzard syndrome,single nucleotide variant,GRCh38
na,na,15,43340592,43340592,UBR1,Pathogenic,Johanson-Blizzard syndrome,single nucleotide variant,GRCh37
na,na,15,43048394,43048394,UBR1,Pathogenic,Johanson-Blizzard syndrome,single nucleotide variant,GRCh38
na,na,15,43314895,43314895,UBR1,Pathogenic,Johanson-Blizzard syndrome,single nucleotide variant,GRCh37
na,na,15,43022697,43022697,UBR1,Pathogenic,Johanson-Blizzard syndrome,single nucleotide variant,GRCh38
na,na,9,79820310,79820310,VPS13A,Pathogenic,Chorea-acanthocytosis,single nucleotide variant,GRCh37
na,na,9,77205394,77205394,VPS13A,Pathogenic,Chorea-acanthocytosis,single nucleotide variant,GRCh38
na,na,9,79954456,79954457,VPS13A,Pathogenic/Likely pathogenic,Chorea-acanthocytosis|not provided,Duplication,GRCh37
na,na,9,77339540,77339541,VPS13A,Pathogenic/Likely pathogenic,Chorea-acanthocytosis|not provided,Duplication,GRCh38
na,na,na,-1,-1,VPS13A,Pathogenic,Chorea-acanthocytosis,Deletion,na
na,na,9,79828156,79828156,VPS13A,Pathogenic,Chorea-acanthocytosis|not provided,single nucleotide variant,GRCh37
na,na,9,77213240,77213240,VPS13A,Pathogenic,Chorea-acanthocytosis|not provided,single nucleotide variant,GRCh38
na,na,9,79973354,79973354,VPS13A,Pathogenic,Chorea-acanthocytosis,single nucleotide variant,GRCh37
na,na,9,77358438,77358438,VPS13A,Pathogenic,Chorea-acanthocytosis,single nucleotide variant,GRCh38
na,na,na,-1,-1,VPS13A,Pathogenic,Chorea-acanthocytosis,Deletion,na
na,na,9,77390734,77428010,VPS13A,Pathogenic,Chorea-acanthocytosis,Deletion,GRCh38
na,na,16,50763778,50763779,NOD2,Conflicting classifications of pathogenicity; association,Crohn disease|Blau syndrome|Yao syndrome|not provided|not specified|Autoinflammatory syndrome|Inflammatory bowel disease 1|Crohn’s Disease|Regional enteritis;Blau syndrome|Inflammatory bowel disease 1;Yao syndrome;Blau syndrome|Crohn disease;Blau syndrome,Duplication,GRCh37
na,na,16,50729867,50729868,NOD2,Conflicting classifications of pathogenicity; association,Crohn disease|Blau syndrome|Yao syndrome|not provided|not specified|Autoinflammatory syndrome|Inflammatory bowel disease 1|Crohn’s Disease|Regional enteritis;Blau syndrome|Inflammatory bowel disease 1;Yao syndrome;Blau syndrome|Crohn disease;Blau syndrome,Duplication,GRCh38
na,na,16,50756540,50756540,NOD2,Conflicting classifications of pathogenicity; association,"not specified|Blau syndrome|Yao syndrome|not provided|Inflammatory bowel disease 1|Inflammatory bowel disease 1;Psoriatic arthritis, susceptibility to;Yao syndrome;Blau syndrome|Regional enteritis;Blau syndrome|Autoinflammatory syndrome|Inflammatory bowel disease 1;Yao syndrome;Blau syndrome",single nucleotide variant,GRCh37
na,na,16,50722629,50722629,NOD2,Conflicting classifications of pathogenicity; association,"not specified|Blau syndrome|Yao syndrome|not provided|Inflammatory bowel disease 1|Inflammatory bowel disease 1;Psoriatic arthritis, susceptibility to;Yao syndrome;Blau syndrome|Regional enteritis;Blau syndrome|Autoinflammatory syndrome|Inflammatory bowel disease 1;Yao syndrome;Blau syndrome",single nucleotide variant,GRCh38
na,na,16,50745926,50745926,NOD2,Conflicting classifications of pathogenicity; association,Blau syndrome|not specified|Yao syndrome|Crohn disease|not provided|Blau syndrome;Regional enteritis|Inflammatory bowel disease 1|Inflammatory bowel disease 1;Yao syndrome;Blau syndrome|Autoinflammatory syndrome,single nucleotide variant,GRCh37
na,na,16,50712015,50712015,NOD2,Conflicting classifications of pathogenicity; association,Blau syndrome|not specified|Yao syndrome|Crohn disease|not provided|Blau syndrome;Regional enteritis|Inflammatory bowel disease 1|Inflammatory bowel disease 1;Yao syndrome;Blau syndrome|Autoinflammatory syndrome,single nucleotide variant,GRCh38
na,na,16,50744823,50744823,NOD2,Pathogenic,Blau syndrome|not provided|Regional enteritis;Blau syndrome,single nucleotide variant,GRCh37
na,na,16,50710912,50710912,NOD2,Pathogenic,Blau syndrome|not provided|Regional enteritis;Blau syndrome,single nucleotide variant,GRCh38
na,na,16,50745227,50745227,NOD2,Pathogenic,Blau syndrome,single nucleotide variant,GRCh37
na,na,16,50711316,50711316,NOD2,Pathogenic,Blau syndrome,single nucleotide variant,GRCh38
na,na,16,50744822,50744822,NOD2,Pathogenic,Blau syndrome|not provided|Regional enteritis;Blau syndrome,single nucleotide variant,GRCh37
na,na,16,50710911,50710911,NOD2,Pathogenic,Blau syndrome|not provided|Regional enteritis;Blau syndrome,single nucleotide variant,GRCh38
na,na,16,50756774,50756774,NOD2,Conflicting classifications of pathogenicity,Blau syndrome|Yao syndrome|not provided|Autoinflammatory syndrome|Inflammatory bowel disease 1|Regional enteritis;Blau syndrome,single nucleotide variant,GRCh37
na,na,16,50722863,50722863,NOD2,Conflicting classifications of pathogenicity,Blau syndrome|Yao syndrome|not provided|Autoinflammatory syndrome|Inflammatory bowel disease 1|Regional enteritis;Blau syndrome,single nucleotide variant,GRCh38
na,na,16,50745309,50745309,NOD2,Pathogenic,Blau syndrome,single nucleotide variant,GRCh37
na,na,16,50711398,50711398,NOD2,Pathogenic,Blau syndrome,single nucleotide variant,GRCh38
na,na,16,50744968,50744968,NOD2,Pathogenic,Blau syndrome|Blau syndrome;Regional enteritis,single nucleotide variant,GRCh37
na,na,16,50711057,50711057,NOD2,Pathogenic,Blau syndrome|Blau syndrome;Regional enteritis,single nucleotide variant,GRCh38
na,na,16,50745656,50745656,NOD2,Conflicting classifications of pathogenicity,"Blau syndrome|Inflammatory bowel disease 1|Inflammatory bowel disease 1;Psoriatic arthritis, susceptibility to;Yao syndrome;Blau syndrome|Regional enteritis;Blau syndrome|not provided",single nucleotide variant,GRCh37
na,na,16,50711745,50711745,NOD2,Conflicting classifications of pathogenicity,"Blau syndrome|Inflammatory bowel disease 1|Inflammatory bowel disease 1;Psoriatic arthritis, susceptibility to;Yao syndrome;Blau syndrome|Regional enteritis;Blau syndrome|not provided",single nucleotide variant,GRCh38
na,na,16,50744969,50744969,NOD2,Pathogenic,Blau syndrome|Blau syndrome;Regional enteritis,single nucleotide variant,GRCh37
na,na,16,50711058,50711058,NOD2,Pathogenic,Blau syndrome|Blau syndrome;Regional enteritis,single nucleotide variant,GRCh38
na,na,1,155112463,155112463,DPM3,Pathogenic,DPM3-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,1,155139987,155139987,DPM3,Pathogenic,DPM3-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,21,47766060,47766060,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,single nucleotide variant,GRCh37
na,na,21,46346146,46346146,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,single nucleotide variant,GRCh38
na,na,21,47775492,47775492,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,Deletion,GRCh37
na,na,21,46355577,46355577,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,Deletion,GRCh38
na,na,21,47808759,47808760,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,Duplication,GRCh37
na,na,21,46388844,46388845,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,Duplication,GRCh38
na,na,21,47831754,47831754,PCNT,Pathogenic/Likely pathogenic,Microcephalic osteodysplastic primordial dwarfism type II|not provided,single nucleotide variant,GRCh37
na,na,21,46411840,46411840,PCNT,Pathogenic/Likely pathogenic,Microcephalic osteodysplastic primordial dwarfism type II|not provided,single nucleotide variant,GRCh38
na,na,21,47766777,47766778,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,Duplication,GRCh37
na,na,21,46346863,46346864,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,Duplication,GRCh38
na,na,21,47786998,47786998,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II|not provided,single nucleotide variant,GRCh37
na,na,21,46367083,46367083,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II,Deletion,na
na,na,21,47855817,47855817,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II|not provided,single nucleotide variant,GRCh37
na,na,21,46435904,46435904,PCNT,Pathogenic,Microcephalic osteodysplastic primordial dwarfism type II|not provided,single nucleotide variant,GRCh38
na,na,11,4045212,4045213,STIM1,Pathogenic,Combined immunodeficiency due to STIM1 deficiency,Duplication,GRCh37
na,na,11,4023982,4023983,STIM1,Pathogenic,Combined immunodeficiency due to STIM1 deficiency,Duplication,GRCh38
na,na,19,8429323,8429323,ANGPTL4,association,Plasma triglyceride level quantitative trait locus,single nucleotide variant,GRCh37
na,na,19,8364439,8364439,ANGPTL4,association,Plasma triglyceride level quantitative trait locus,single nucleotide variant,GRCh38
na,na,22,50506917,50506917,MLC1,Conflicting classifications of pathogenicity,Megalencephalic leukoencephalopathy with subcortical cysts 1,single nucleotide variant,GRCh37
na,na,22,50068488,50068488,MLC1,Conflicting classifications of pathogenicity,Megalencephalic leukoencephalopathy with subcortical cysts 1,single nucleotide variant,GRCh38
na,na,22,50518816,50518816,MLC1,Pathogenic/Likely pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,single nucleotide variant,GRCh37
na,na,22,50080387,50080387,MLC1,Pathogenic/Likely pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,single nucleotide variant,GRCh38
na,na,22,50502629,50502629,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1,single nucleotide variant,GRCh37
na,na,22,50064200,50064200,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1,single nucleotide variant,GRCh38
na,na,22,50518347,50518347,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1,single nucleotide variant,GRCh37
na,na,22,50079918,50079918,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1,single nucleotide variant,GRCh38
na,na,22,50518348,50518348,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1,single nucleotide variant,GRCh37
na,na,22,50079919,50079919,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1,single nucleotide variant,GRCh38
na,na,22,50518820,50518820,MLC1,Pathogenic/Likely pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|Megalencephalic leukoencephalopathy with subcortical cysts|not provided,single nucleotide variant,GRCh37
na,na,22,50080391,50080391,MLC1,Pathogenic/Likely pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|Megalencephalic leukoencephalopathy with subcortical cysts|not provided,single nucleotide variant,GRCh38
na,na,22,50515270,50515273,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,Deletion,GRCh37
na,na,22,50076841,50076844,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,Deletion,GRCh38
na,na,22,50523156,50523156,MLC1,Pathogenic/Likely pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,single nucleotide variant,GRCh37
na,na,22,50084727,50084727,MLC1,Pathogenic/Likely pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,single nucleotide variant,GRCh38
na,na,22,50523196,50523197,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,Duplication,GRCh37
na,na,22,50084767,50084768,MLC1,Pathogenic,Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided|Megalencephalic leukoencephalopathy with subcortical cysts,Duplication,GRCh38
na,na,16,5128790,5128790,ALG1,Pathogenic/Likely pathogenic,ALG1-congenital disorder of glycosylation|not provided|Inborn genetic diseases|Congenital disorder of glycosylation|Finnish congenital nephrotic syndrome|Encephalopathy|ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,5078789,5078789,ALG1,Pathogenic/Likely pathogenic,ALG1-congenital disorder of glycosylation|not provided|Inborn genetic diseases|Congenital disorder of glycosylation|Finnish congenital nephrotic syndrome|Encephalopathy|ALG12-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,5131010,5131010,ALG1,Pathogenic/Likely pathogenic,ALG1-congenital disorder of glycosylation|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,5081009,5081009,ALG1,Pathogenic/Likely pathogenic,ALG1-congenital disorder of glycosylation|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,16,5125448,5125448,ALG1,Pathogenic,ALG1-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,5075447,5075447,ALG1,Pathogenic,ALG1-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,10,88446920,88446920,LDB3,Pathogenic/Likely pathogenic,Myofibrillar myopathy 4|not provided|Cardiomyopathy|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,single nucleotide variant,GRCh37
na,na,10,86687163,86687163,LDB3,Pathogenic/Likely pathogenic,Myofibrillar myopathy 4|not provided|Cardiomyopathy|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,single nucleotide variant,GRCh38
na,na,10,88446975,88446975,LDB3,Pathogenic/Likely pathogenic,Myofibrillar myopathy 4|Neuromuscular disease|Myofibrillar myopathy|Cardiomyopathy|not provided|LDB3-related disorder|Cardiovascular phenotype|Dilated cardiomyopathy 1C,single nucleotide variant,GRCh37
na,na,10,86687218,86687218,LDB3,Pathogenic/Likely pathogenic,Myofibrillar myopathy 4|Neuromuscular disease|Myofibrillar myopathy|Cardiomyopathy|not provided|LDB3-related disorder|Cardiovascular phenotype|Dilated cardiomyopathy 1C,single nucleotide variant,GRCh38
na,na,10,88459081,88459081,LDB3,Uncertain significance,Myofibrillar myopathy 4|not specified|Dilated cardiomyopathy 1C|Primary familial dilated cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,single nucleotide variant,GRCh37
na,na,10,86699324,86699324,LDB3,Uncertain significance,Myofibrillar myopathy 4|not specified|Dilated cardiomyopathy 1C|Primary familial dilated cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,single nucleotide variant,GRCh38
na,na,10,88466426,88466426,LDB3,Uncertain significance,Dilated cardiomyopathy 1C|not provided|Myofibrillar myopathy 4,single nucleotide variant,GRCh37
na,na,10,86706669,86706669,LDB3,Uncertain significance,Dilated cardiomyopathy 1C|not provided|Myofibrillar myopathy 4,single nucleotide variant,GRCh38
na,na,10,88441437,88441437,LDB3,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1C|not specified|not provided|Familial hypertrophic cardiomyopathy 24|Myofibrillar myopathy 4|Cardiovascular phenotype|Dilated cardiomyopathy 1A|Cardiomyopathy|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,single nucleotide variant,GRCh37
na,na,10,86681680,86681680,LDB3,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1C|not specified|not provided|Familial hypertrophic cardiomyopathy 24|Myofibrillar myopathy 4|Cardiovascular phenotype|Dilated cardiomyopathy 1A|Cardiomyopathy|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,single nucleotide variant,GRCh38
na,na,10,88441488,88441488,LDB3,Uncertain significance,Dilated cardiomyopathy 1C|Cardiovascular phenotype|Myofibrillar myopathy 4,single nucleotide variant,GRCh37
na,na,10,86681731,86681731,LDB3,Uncertain significance,Dilated cardiomyopathy 1C|Cardiovascular phenotype|Myofibrillar myopathy 4,single nucleotide variant,GRCh38
na,na,10,88446830,88446830,LDB3,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1C|not specified|Primary dilated cardiomyopathy|Myofibrillar myopathy 4|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,10,86687073,86687073,LDB3,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1C|not specified|Primary dilated cardiomyopathy|Myofibrillar myopathy 4|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,10,88446864,88446864,LDB3,Uncertain significance,Dilated cardiomyopathy 1C|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,10,86687107,86687107,LDB3,Uncertain significance,Dilated cardiomyopathy 1C|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,10,88485932,88485932,LDB3,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1C|Left ventricular noncompaction 3|not provided|Myofibrillar myopathy 4|Cardiovascular phenotype|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,single nucleotide variant,GRCh37
na,na,10,86726175,86726175,LDB3,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1C|Left ventricular noncompaction 3|not provided|Myofibrillar myopathy 4|Cardiovascular phenotype|Myofibrillar myopathy 4;Dilated cardiomyopathy 1C,single nucleotide variant,GRCh38
na,na,17,59937223,59937223,BRIP1,Conflicting classifications of pathogenicity,"Breast cancer, early-onset|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast;Fanconi anemia complementation group J|Fanconi anemia complementation group J|not provided|BRIP1-related disorder|Familial cancer of breast|Malignant tumor of breast|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Ovarian cancer",single nucleotide variant,GRCh37
na,na,17,61859862,61859862,BRIP1,Conflicting classifications of pathogenicity,"Breast cancer, early-onset|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast;Fanconi anemia complementation group J|Fanconi anemia complementation group J|not provided|BRIP1-related disorder|Familial cancer of breast|Malignant tumor of breast|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Ovarian cancer",single nucleotide variant,GRCh38
na,na,17,59885849,59885849,BRIP1,Uncertain significance,"Breast cancer, early-onset|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J;Familial cancer of breast|not specified",single nucleotide variant,GRCh37
na,na,17,61808488,61808488,BRIP1,Uncertain significance,"Breast cancer, early-onset|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J;Familial cancer of breast|not specified",single nucleotide variant,GRCh38
na,na,17,59793412,59793412,BRIP1,Pathogenic,"Fanconi anemia complementation group J|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast;Fanconi anemia complementation group J|Fanconi anemia|Esophageal atresia/tracheoesophageal fistula;Familial cancer of breast;Fanconi anemia complementation group J|Breast cancer, early-onset|BRIP1-related disorder|Familial cancer of breast|BRIP1-related disorder;Fanconi anemia complementation group J|Malignant tumor of breast|Breast and/or ovarian cancer|Ovarian cancer|Gastric cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Inherited ovarian cancer (without breast cancer)",single nucleotide variant,GRCh37
na,na,17,61716051,61716051,BRIP1,Pathogenic,"Fanconi anemia complementation group J|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast;Fanconi anemia complementation group J|Fanconi anemia|Esophageal atresia/tracheoesophageal fistula;Familial cancer of breast;Fanconi anemia complementation group J|Breast cancer, early-onset|BRIP1-related disorder|Familial cancer of breast|BRIP1-related disorder;Fanconi anemia complementation group J|Malignant tumor of breast|Breast and/or ovarian cancer|Ovarian cancer|Gastric cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Inherited ovarian cancer (without breast cancer)",single nucleotide variant,GRCh38
na,na,11,45827791,45827791,SLC35C1,Likely pathogenic,Leukocyte adhesion deficiency type II,single nucleotide variant,GRCh37
na,na,11,45806240,45806240,SLC35C1,Likely pathogenic,Leukocyte adhesion deficiency type II,single nucleotide variant,GRCh38
na,na,11,45832714,45832714,SLC35C1,Pathogenic,Leukocyte adhesion deficiency type II,single nucleotide variant,GRCh37
na,na,11,45811163,45811163,SLC35C1,Pathogenic,Leukocyte adhesion deficiency type II,single nucleotide variant,GRCh38
na,na,8,140630920,140630920,KCNK9,Pathogenic,Birk-Barel syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,139618677,139618677,KCNK9,Pathogenic,Birk-Barel syndrome|not provided,single nucleotide variant,GRCh38
na,na,5,78351682,78351682,DMGDH,Likely pathogenic,Dimethylglycine dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,5,79055859,79055859,DMGDH,Likely pathogenic,Dimethylglycine dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,15,28530182,28530182,HERC2,association,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",single nucleotide variant,GRCh37
na,na,15,28285036,28285036,HERC2,association,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",single nucleotide variant,GRCh38
na,na,15,28513364,28513364,HERC2,Affects,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",single nucleotide variant,GRCh37
na,na,15,28268218,28268218,HERC2,Affects,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",single nucleotide variant,GRCh38
na,na,15,28365618,28365618,HERC2,association,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",single nucleotide variant,GRCh37
na,na,15,28120472,28120472,HERC2,association,"SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES",single nucleotide variant,GRCh38
na,na,17,76130019,76130019,TMC8,risk factor,"Epidermodysplasia verruciformis, susceptibility to, 2",Deletion,GRCh37
na,na,17,78133938,78133938,TMC8,risk factor,"Epidermodysplasia verruciformis, susceptibility to, 2",Deletion,GRCh38
na,na,17,76131047,76131047,TMC8,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 2|Epidermodysplasia verruciformis",single nucleotide variant,GRCh37
na,na,17,78134966,78134966,TMC8,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 2|Epidermodysplasia verruciformis",single nucleotide variant,GRCh38
na,na,17,76121957,76121957,TMC6,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis|not provided",single nucleotide variant,GRCh37
na,na,17,78125876,78125876,TMC6,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis|not provided",single nucleotide variant,GRCh38
na,na,17,76115463,76115463,TMC6,risk factor,"Epidermodysplasia verruciformis, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,17,78119382,78119382,TMC6,risk factor,"Epidermodysplasia verruciformis, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,17,76120752,76120752,TMC6,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis",single nucleotide variant,GRCh37
na,na,17,78124671,78124671,TMC6,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis",single nucleotide variant,GRCh38
na,na,17,76120262,76120262,TMC6,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis",single nucleotide variant,GRCh37
na,na,17,78124181,78124181,TMC6,Pathogenic,"Epidermodysplasia verruciformis, susceptibility to, 1|Epidermodysplasia verruciformis",single nucleotide variant,GRCh38
na,na,19,50411893,50411893,NUP62,Pathogenic,Infantile bilateral striatal necrosis,single nucleotide variant,GRCh37
na,na,19,49908636,49908636,NUP62,Pathogenic,Infantile bilateral striatal necrosis,single nucleotide variant,GRCh38
na,na,3,139069025,139069025,MRPS22,Pathogenic/Likely pathogenic,Hypotonia with lactic acidemia and hyperammonemia|not provided|Ovarian dysgenesis 7;Hypotonia with lactic acidemia and hyperammonemia,single nucleotide variant,GRCh37
na,na,3,139350183,139350183,MRPS22,Pathogenic/Likely pathogenic,Hypotonia with lactic acidemia and hyperammonemia|not provided|Ovarian dysgenesis 7;Hypotonia with lactic acidemia and hyperammonemia,single nucleotide variant,GRCh38
na,na,2,145157109,145157109,ZEB2,Pathogenic,Mowat-Wilson syndrome,single nucleotide variant,GRCh37
na,na,2,144399542,144399542,ZEB2,Pathogenic,Mowat-Wilson syndrome,single nucleotide variant,GRCh38
na,na,2,145156671,145156671,ZEB2,Pathogenic,Mowat-Wilson syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,144399104,144399104,ZEB2,Pathogenic,Mowat-Wilson syndrome|not provided,single nucleotide variant,GRCh38
na,na,2,145157578,145157581,ZEB2,Pathogenic,Mowat-Wilson syndrome,Deletion,GRCh37
na,na,2,144400011,144400014,ZEB2,Pathogenic,Mowat-Wilson syndrome,Deletion,GRCh38
na,na,2,145157327,145157328,ZEB2,Pathogenic,Mowat-Wilson syndrome|not provided|Inborn genetic diseases,Duplication,GRCh37
na,na,2,144399760,144399761,ZEB2,Pathogenic,Mowat-Wilson syndrome|not provided|Inborn genetic diseases,Duplication,GRCh38
na,na,2,145161528,145161529,ZEB2,Pathogenic,Mowat-Wilson syndrome,Duplication,GRCh37
na,na,2,144403961,144403962,ZEB2,Pathogenic,Mowat-Wilson syndrome,Duplication,GRCh38
na,na,2,145156300,145156301,ZEB2,Pathogenic,Mowat-Wilson syndrome,Duplication,GRCh37
na,na,2,144398733,144398734,ZEB2,Pathogenic,Mowat-Wilson syndrome,Duplication,GRCh38
na,na,2,145156862,145156862,ZEB2,Pathogenic,Mowat-Wilson syndrome,Deletion,GRCh37
na,na,2,144399295,144399295,ZEB2,Pathogenic,Mowat-Wilson syndrome,Deletion,GRCh38
na,na,2,145162441,145162442,ZEB2,Pathogenic,Mowat-Wilson syndrome,Insertion,GRCh37
na,na,2,144404874,144404875,ZEB2,Pathogenic,Mowat-Wilson syndrome,Insertion,GRCh38
na,na,2,145156199,145156199,ZEB2,Pathogenic,Mowat-Wilson syndrome,single nucleotide variant,GRCh37
na,na,2,144398632,144398632,ZEB2,Pathogenic,Mowat-Wilson syndrome,single nucleotide variant,GRCh38
na,na,2,145147095,145147096,ZEB2,Pathogenic,Mowat-Wilson syndrome,Duplication,GRCh37
na,na,2,144389528,144389529,ZEB2,Pathogenic,Mowat-Wilson syndrome,Duplication,GRCh38
na,na,2,145187367,145187369,ZEB2,Uncertain significance,"Hirschsprung disease-intellectual disability syndrome, late infantile|Mowat-Wilson syndrome",Microsatellite,GRCh37
na,na,2,144429800,144429802,ZEB2,Uncertain significance,"Hirschsprung disease-intellectual disability syndrome, late infantile|Mowat-Wilson syndrome",Microsatellite,GRCh38
na,na,2,144114719,144681958,ZEB2,Pathogenic,Mowat-Wilson syndrome,Deletion,GRCh38
na,na,2,145156892,145156892,ZEB2,Pathogenic,Mowat-Wilson syndrome,Deletion,GRCh37
na,na,2,144399325,144399325,ZEB2,Pathogenic,Mowat-Wilson syndrome,Deletion,GRCh38
na,na,2,145274987,145274987,ZEB2,Uncertain significance,Mowat-Wilson syndrome,single nucleotide variant,GRCh37
na,na,2,144517420,144517420,ZEB2,Uncertain significance,Mowat-Wilson syndrome,single nucleotide variant,GRCh38
na,na,2,145147307,145147307,ZEB2,Pathogenic,Mowat-Wilson syndrome,single nucleotide variant,GRCh37
na,na,2,144389740,144389740,ZEB2,Pathogenic,Mowat-Wilson syndrome,single nucleotide variant,GRCh38
na,na,14,103390126,103390126,AMN,Likely pathogenic,Imerslund-Grasbeck syndrome type 2|Imerslund-Grasbeck syndrome,single nucleotide variant,GRCh37
na,na,14,102923789,102923789,AMN,Likely pathogenic,Imerslund-Grasbeck syndrome type 2|Imerslund-Grasbeck syndrome,single nucleotide variant,GRCh38
na,na,16,81298282,81298282,BCO1,Uncertain significance,Hereditary hypercarotenemia and vitamin A deficiency|not specified|BCO1-related disorder,single nucleotide variant,GRCh37
na,na,16,81264677,81264677,BCO1,Uncertain significance,Hereditary hypercarotenemia and vitamin A deficiency|not specified|BCO1-related disorder,single nucleotide variant,GRCh38
na,na,1,25870254,25870254,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4",single nucleotide variant,GRCh37
na,na,1,25543763,25543763,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4",single nucleotide variant,GRCh38
na,na,1,25883731,25883732,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4",Insertion,GRCh37
na,na,1,25557240,25557241,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4",Insertion,GRCh38
na,na,1,25883705,25883705,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4|Cardiovascular phenotype|Familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,1,25557214,25557214,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4|Cardiovascular phenotype|Familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,1,25889633,25889633,LDLRAP1,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 4|Familial hypercholesterolemia|not specified",single nucleotide variant,GRCh37
na,na,1,25563142,25563142,LDLRAP1,Conflicting classifications of pathogenicity,"Hypercholesterolemia, familial, 4|Familial hypercholesterolemia|not specified",single nucleotide variant,GRCh38
na,na,1,25870261,25870262,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4",Duplication,GRCh37
na,na,1,25543770,25543771,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4",Duplication,GRCh38
na,na,1,25880412,25880412,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4|Familial hypercholesterolemia",single nucleotide variant,GRCh37
na,na,1,25553921,25553921,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4|Familial hypercholesterolemia",single nucleotide variant,GRCh38
na,na,1,25883760,25883760,LDLRAP1,Likely pathogenic,"Hypercholesterolemia, familial, 4|not provided",single nucleotide variant,GRCh37
na,na,1,25557269,25557269,LDLRAP1,Likely pathogenic,"Hypercholesterolemia, familial, 4|not provided",single nucleotide variant,GRCh38
na,na,1,25889626,25889627,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4|Familial hypercholesterolemia|not provided",Duplication,GRCh37
na,na,1,25563135,25563136,LDLRAP1,Pathogenic,"Hypercholesterolemia, familial, 4|Familial hypercholesterolemia|not provided",Duplication,GRCh38
na,na,22,18604222,18604235,TUBA8,Uncertain significance,Polymicrogyria with optic nerve hypoplasia,Deletion,GRCh37
na,na,22,18121455,18121468,TUBA8,Uncertain significance,Polymicrogyria with optic nerve hypoplasia,Deletion,GRCh38
na,na,17,41836040,41836040,SOST,Pathogenic,Sclerosteosis 1|not provided,single nucleotide variant,GRCh37
na,na,17,43758672,43758672,SOST,Pathogenic,Sclerosteosis 1|not provided,single nucleotide variant,GRCh38
na,na,17,41835887,41835887,SOST,not provided,Sclerosteosis 1,single nucleotide variant,GRCh37
na,na,17,43758519,43758519,SOST,not provided,Sclerosteosis 1,single nucleotide variant,GRCh38
na,na,17,41832980,41832980,SOST,Pathogenic,Sclerosteosis 1,single nucleotide variant,GRCh37
na,na,17,43755612,43755612,SOST,Pathogenic,Sclerosteosis 1,single nucleotide variant,GRCh38
na,na,17,41832976,41832976,SOST,Pathogenic,Sclerosteosis 1,single nucleotide variant,GRCh37
na,na,17,43755608,43755608,SOST,Pathogenic,Sclerosteosis 1,single nucleotide variant,GRCh38
na,na,19,40901402,40901402,PRX,Pathogenic,Autosomal recessive Dejerine-Sottas syndrome|not provided|Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|PRX-related disorder,single nucleotide variant,GRCh37
na,na,19,40395495,40395495,PRX,Pathogenic,Autosomal recessive Dejerine-Sottas syndrome|not provided|Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|PRX-related disorder,single nucleotide variant,GRCh38
na,na,19,40903157,40903157,PRX,Pathogenic/Likely pathogenic,Autosomal recessive Dejerine-Sottas syndrome|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4F|Peripheral neuropathy|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,40397250,40397250,PRX,Pathogenic/Likely pathogenic,Autosomal recessive Dejerine-Sottas syndrome|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4F|Peripheral neuropathy|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,40903673,40903673,PRX,Pathogenic,Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided,single nucleotide variant,GRCh37
na,na,19,40397766,40397766,PRX,Pathogenic,Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided,single nucleotide variant,GRCh38
na,na,19,40902114,40902114,PRX,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,40396207,40396207,PRX,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,40901051,40901051,PRX,Pathogenic/Likely pathogenic,Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh37
na,na,19,40395144,40395144,PRX,Pathogenic/Likely pathogenic,Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 4F|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh38
na,na,14,78021674,78021674,SPTLC2,Pathogenic/Likely pathogenic,"Neuropathy, hereditary sensory and autonomic, type 1C|not provided",single nucleotide variant,GRCh37
na,na,14,77555331,77555331,SPTLC2,Pathogenic/Likely pathogenic,"Neuropathy, hereditary sensory and autonomic, type 1C|not provided",single nucleotide variant,GRCh38
na,na,14,78021744,78021744,SPTLC2,Conflicting classifications of pathogenicity,"Neuropathy, hereditary sensory and autonomic, type 1C",single nucleotide variant,GRCh37
na,na,14,77555401,77555401,SPTLC2,Conflicting classifications of pathogenicity,"Neuropathy, hereditary sensory and autonomic, type 1C",single nucleotide variant,GRCh38
na,na,14,77984440,77984440,SPTLC2,Pathogenic,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC, SEVERE",single nucleotide variant,GRCh37
na,na,14,77518097,77518097,SPTLC2,Pathogenic,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC, SEVERE",single nucleotide variant,GRCh38
na,na,9,94842327,94842327,SPTLC1,Pathogenic,"Hereditary sensory and autonomic neuropathy type 1|Neuropathy, hereditary sensory and autonomic, type 1A|Charcot-Marie-Tooth disease|Inborn genetic diseases|not provided",single nucleotide variant,GRCh37
na,na,9,92080045,92080045,SPTLC1,Pathogenic,"Hereditary sensory and autonomic neuropathy type 1|Neuropathy, hereditary sensory and autonomic, type 1A|Charcot-Marie-Tooth disease|Inborn genetic diseases|not provided",single nucleotide variant,GRCh38
na,na,9,94830377,94830377,SPTLC1,Pathogenic/Likely pathogenic,"Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|not provided|SPTLC1-related disorder|Neuropathy, hereditary sensory and autonomic, type 1A|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,9,92068095,92068095,SPTLC1,Pathogenic/Likely pathogenic,"Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|not provided|SPTLC1-related disorder|Neuropathy, hereditary sensory and autonomic, type 1A|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,9,94800624,94800624,SPTLC1,Benign/Likely benign,"Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|Neuropathy, hereditary sensory and autonomic, type 1A|Inborn genetic diseases|not provided|not specified",single nucleotide variant,GRCh37
na,na,9,92038342,92038342,SPTLC1,Benign/Likely benign,"Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|Neuropathy, hereditary sensory and autonomic, type 1A|Inborn genetic diseases|not provided|not specified",single nucleotide variant,GRCh38
na,na,9,94842326,94842326,SPTLC1,Pathogenic,"Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|Sensorimotor neuropathy|Neuropathy, hereditary sensory and autonomic, type 1A|not provided",single nucleotide variant,GRCh37
na,na,9,92080044,92080044,SPTLC1,Pathogenic,"Hereditary sensory and autonomic neuropathy type 1|Charcot-Marie-Tooth disease|Sensorimotor neuropathy|Neuropathy, hereditary sensory and autonomic, type 1A|not provided",single nucleotide variant,GRCh38
na,na,9,94809543,94809543,SPTLC1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type IA, severe|Neuropathy, hereditary sensory and autonomic, type 1A",single nucleotide variant,GRCh37
na,na,9,92047261,92047261,SPTLC1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type IA, severe|Neuropathy, hereditary sensory and autonomic, type 1A",single nucleotide variant,GRCh38
na,na,9,94809480,94809480,SPTLC1,Uncertain significance,"Neuropathy, hereditary sensory and autonomic, type 1A|Hereditary sensory and autonomic neuropathy type 1",single nucleotide variant,GRCh37
na,na,9,92047198,92047198,SPTLC1,Uncertain significance,"Neuropathy, hereditary sensory and autonomic, type 1A|Hereditary sensory and autonomic neuropathy type 1",single nucleotide variant,GRCh38
na,na,20,56993374,56993374,VAPB,Pathogenic,"Amyotrophic lateral sclerosis type 8|not provided|Amyotrophic lateral sclerosis type 8;Adult-onset proximal spinal muscular atrophy, autosomal dominant|Adult-onset proximal spinal muscular atrophy, autosomal dominant",single nucleotide variant,GRCh37
na,na,20,58418318,58418318,VAPB,Pathogenic,"Amyotrophic lateral sclerosis type 8|not provided|Amyotrophic lateral sclerosis type 8;Adult-onset proximal spinal muscular atrophy, autosomal dominant|Adult-onset proximal spinal muscular atrophy, autosomal dominant",single nucleotide variant,GRCh38
na,na,15,50878630,50878630,TRPM7,Conflicting classifications of pathogenicity,"Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to|Juvenile amyotrophic lateral sclerosis|not provided|TRPM7-related disorder",single nucleotide variant,GRCh37
na,na,15,50586433,50586433,TRPM7,Conflicting classifications of pathogenicity,"Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to|Juvenile amyotrophic lateral sclerosis|not provided|TRPM7-related disorder",single nucleotide variant,GRCh38
na,na,22,32889256,32889256,FBXO7,Pathogenic,Parkinsonian-pyramidal syndrome,single nucleotide variant,GRCh37
na,na,22,32493269,32493269,FBXO7,Pathogenic,Parkinsonian-pyramidal syndrome,single nucleotide variant,GRCh38
na,na,22,32894440,32894440,FBXO7,Pathogenic,Parkinsonian-pyramidal syndrome|not provided,single nucleotide variant,GRCh37
na,na,22,32498453,32498453,FBXO7,Pathogenic,Parkinsonian-pyramidal syndrome|not provided,single nucleotide variant,GRCh38
na,na,22,32889269,32889269,FBXO7,Pathogenic,Parkinsonian-pyramidal syndrome,single nucleotide variant,GRCh37
na,na,22,32493282,32493282,FBXO7,Pathogenic,Parkinsonian-pyramidal syndrome,single nucleotide variant,GRCh38
na,na,22,32871054,32871054,FBXO7,Pathogenic/Likely pathogenic,Parkinsonian-pyramidal syndrome,single nucleotide variant,GRCh37
na,na,22,32475067,32475067,FBXO7,Pathogenic/Likely pathogenic,Parkinsonian-pyramidal syndrome,single nucleotide variant,GRCh38
na,na,7,107342468,107342468,SLC26A4,Pathogenic,Pendred syndrome,single nucleotide variant,GRCh37
na,na,7,107702023,107702023,SLC26A4,Pathogenic,Pendred syndrome,single nucleotide variant,GRCh38
na,na,7,107323798,107323798,SLC26A4,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4,Deletion,GRCh37
na,na,7,107683353,107683353,SLC26A4,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4,Deletion,GRCh38
na,na,7,107336429,107336429,SLC26A4,Pathogenic,Rare genetic deafness|Pendred syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 4|Hearing impairment|Deafness,single nucleotide variant,GRCh37
na,na,7,107695984,107695984,SLC26A4,Pathogenic,Rare genetic deafness|Pendred syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 4|Hearing impairment|Deafness,single nucleotide variant,GRCh38
na,na,7,107315496,107315496,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided|Rare genetic deafness|Hearing impairment|Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,7,107675051,107675051,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided|Rare genetic deafness|Hearing impairment|Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,7,107330665,107330665,SLC26A4,Pathogenic,Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided|Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|SLC26A4-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,7,107690220,107690220,SLC26A4,Pathogenic,Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided|Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|SLC26A4-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,7,107323983,107323983,SLC26A4,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided|Rare genetic deafness|SLC26A4-related disorder,single nucleotide variant,GRCh37
na,na,7,107683538,107683538,SLC26A4,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided|Rare genetic deafness|SLC26A4-related disorder,single nucleotide variant,GRCh38
na,na,7,107330570,107330570,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder,single nucleotide variant,GRCh37
na,na,7,107690125,107690125,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder,single nucleotide variant,GRCh38
na,na,7,107315415,107315415,SLC26A4,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|not provided|Rare genetic deafness|SLC26A4-related disorder,single nucleotide variant,GRCh37
na,na,7,107674970,107674970,SLC26A4,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|not provided|Rare genetic deafness|SLC26A4-related disorder,single nucleotide variant,GRCh38
na,na,7,107329601,107329601,SLC26A4,Pathogenic; Affects,Autosomal recessive nonsyndromic hearing loss 4,single nucleotide variant,GRCh37
na,na,7,107689156,107689156,SLC26A4,Pathogenic; Affects,Autosomal recessive nonsyndromic hearing loss 4,single nucleotide variant,GRCh38
na,na,7,107329611,107329611,SLC26A4,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome,single nucleotide variant,GRCh37
na,na,7,107689166,107689166,SLC26A4,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome,single nucleotide variant,GRCh38
na,na,7,107350577,107350577,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|SLC26A4-related disorder,single nucleotide variant,GRCh37
na,na,7,107710132,107710132,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|SLC26A4-related disorder,single nucleotide variant,GRCh38
na,na,7,107350571,107350571,SLC26A4,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|Rare genetic deafness|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh37
na,na,7,107710126,107710126,SLC26A4,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|Rare genetic deafness|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh38
na,na,7,107312700,107312700,SLC26A4,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh37
na,na,7,107672255,107672255,SLC26A4,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh38
na,na,7,107334918,107334918,SLC26A4,Pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome,single nucleotide variant,GRCh37
na,na,7,107694473,107694473,SLC26A4,Pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome,single nucleotide variant,GRCh38
na,na,7,107314771,107314771,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh37
na,na,7,107674326,107674326,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh38
na,na,7,107350591,107350592,SLC26A4,Pathogenic,Pendred syndrome,Insertion,GRCh37
na,na,7,107710146,107710147,SLC26A4,Pathogenic,Pendred syndrome,Insertion,GRCh38
na,na,7,107329494,107329494,SLC26A4,Likely pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4,single nucleotide variant,GRCh37
na,na,7,107689049,107689049,SLC26A4,Likely pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4,single nucleotide variant,GRCh38
na,na,7,107312675,107312675,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh37
na,na,7,107672230,107672230,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh38
na,na,7,107312690,107312690,SLC26A4,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|not provided|Rare genetic deafness|Hearing impairment|Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder,single nucleotide variant,GRCh37
na,na,7,107672245,107672245,SLC26A4,Pathogenic,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|not provided|Rare genetic deafness|Hearing impairment|Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder,single nucleotide variant,GRCh38
na,na,7,107338530,107338530,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4,single nucleotide variant,GRCh37
na,na,7,107698085,107698085,SLC26A4,Pathogenic/Likely pathogenic,Pendred syndrome|Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4,single nucleotide variant,GRCh38
na,na,7,107301201,107301201,SLC26A4,Uncertain significance,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not specified|not provided|Hearing impairment,single nucleotide variant,GRCh37
na,na,7,107660756,107660756,SLC26A4,Uncertain significance,Pendred syndrome|Autosomal recessive nonsyndromic hearing loss 4|not specified|not provided|Hearing impairment,single nucleotide variant,GRCh38
na,na,7,107302171,107302171,SLC26A4,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|Pendred syndrome|Wolff-Parkinson-White pattern|not provided|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder,single nucleotide variant,GRCh37
na,na,7,107661726,107661726,SLC26A4,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|Pendred syndrome|Wolff-Parkinson-White pattern|not provided|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|SLC26A4-related disorder,single nucleotide variant,GRCh38
na,na,7,107323898,107323898,SLC26A4,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|not provided|Rare genetic deafness|Hearing loss, autosomal recessive|SLC26A4-related disorder",single nucleotide variant,GRCh37
na,na,7,107683453,107683453,SLC26A4,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|not provided|Rare genetic deafness|Hearing loss, autosomal recessive|SLC26A4-related disorder",single nucleotide variant,GRCh38
na,na,7,107336480,107336480,SLC26A4,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh37
na,na,7,107696035,107696035,SLC26A4,Pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|not provided,single nucleotide variant,GRCh38
na,na,7,107329499,107329499,SLC26A4,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|Pendred syndrome|not provided|SLC26A4-related disorder,single nucleotide variant,GRCh37
na,na,7,107689054,107689054,SLC26A4,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome;Autosomal recessive nonsyndromic hearing loss 4|Rare genetic deafness|Pendred syndrome|not provided|SLC26A4-related disorder,single nucleotide variant,GRCh38
na,na,6,88218600,88218601,SLC35A1,Benign,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf, MODIFIER OF|not provided",Insertion,GRCh37
na,na,6,87508882,87508883,SLC35A1,Benign,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf, MODIFIER OF|not provided",Insertion,GRCh38
na,na,3,45814094,45814094,SLC6A20,Benign,Hyperglycinuria|not provided|SLC6A20-related disorder,single nucleotide variant,GRCh37
na,na,3,45772602,45772602,SLC6A20,Benign,Hyperglycinuria|not provided|SLC6A20-related disorder,single nucleotide variant,GRCh38
na,na,19,50365681,50365681,PNKP,Pathogenic,"Microcephaly, seizures, and developmental delay|not provided|Developmental and epileptic encephalopathy, 12|Abnormality of the nervous system",single nucleotide variant,GRCh37
na,na,19,49862424,49862424,PNKP,Pathogenic,"Microcephaly, seizures, and developmental delay|not provided|Developmental and epileptic encephalopathy, 12|Abnormality of the nervous system",single nucleotide variant,GRCh38
na,na,19,50365057,50365058,PNKP,Pathogenic,"Microcephaly, seizures, and developmental delay|Ataxia - oculomotor apraxia type 4|not provided|Developmental and epileptic encephalopathy, 12|Intellectual disability|Abnormality of the nervous system|Inborn genetic diseases|Seizure",Duplication,GRCh37
na,na,19,49861800,49861801,PNKP,Pathogenic,"Microcephaly, seizures, and developmental delay|Ataxia - oculomotor apraxia type 4|not provided|Developmental and epileptic encephalopathy, 12|Intellectual disability|Abnormality of the nervous system|Inborn genetic diseases|Seizure",Duplication,GRCh38
na,na,19,50367633,50367633,PNKP,Pathogenic,"Microcephaly, seizures, and developmental delay",single nucleotide variant,GRCh37
na,na,19,49864376,49864376,PNKP,Pathogenic,"Microcephaly, seizures, and developmental delay",single nucleotide variant,GRCh38
na,na,21,37833596,37833596,CLDN14,Pathogenic,Autosomal recessive nonsyndromic hearing loss 29,Deletion,GRCh37
na,na,21,36461298,36461298,CLDN14,Pathogenic,Autosomal recessive nonsyndromic hearing loss 29,Deletion,GRCh38
na,na,21,37833740,37833740,CLDN14,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 29|Hearing impairment|Hearing loss, autosomal recessive",single nucleotide variant,GRCh37
na,na,21,36461442,36461442,CLDN14,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 29|Hearing impairment|Hearing loss, autosomal recessive",single nucleotide variant,GRCh38
na,na,21,37833693,37833693,CLDN14,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 29|not provided,single nucleotide variant,GRCh37
na,na,21,36461395,36461395,CLDN14,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 29|not provided,single nucleotide variant,GRCh38
na,na,3,138664910,138664910,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome|not provided|Premature ovarian failure 3;Blepharophimosis, ptosis, and epicanthus inversus syndrome",single nucleotide variant,GRCh37
na,na,3,138946068,138946068,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome|not provided|Premature ovarian failure 3;Blepharophimosis, ptosis, and epicanthus inversus syndrome",single nucleotide variant,GRCh38
na,na,3,138664863,138664864,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|Blepharophimosis, ptosis, and epicanthus inversus, type II with Duane retraction syndrome|Blepharophimosis, ptosis, and epicanthus inversus syndrome|not provided|Inborn genetic diseases",Duplication,GRCh37
na,na,3,138946021,138946022,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|Blepharophimosis, ptosis, and epicanthus inversus, type II with Duane retraction syndrome|Blepharophimosis, ptosis, and epicanthus inversus syndrome|not provided|Inborn genetic diseases",Duplication,GRCh38
na,na,3,138665511,138665512,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I",Deletion,GRCh37
na,na,3,138946669,138946670,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I",Deletion,GRCh38
na,na,3,138664645,138664646,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I",Duplication,GRCh37
na,na,3,138945803,138945804,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I",Duplication,GRCh38
na,na,3,138665372,138665373,FOXL2,Pathogenic/Likely pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|Blepharophimosis, ptosis, and epicanthus inversus syndrome",Duplication,GRCh37
na,na,3,138946530,138946531,FOXL2,Pathogenic/Likely pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|Blepharophimosis, ptosis, and epicanthus inversus syndrome",Duplication,GRCh38
na,na,3,138664760,138664761,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome|not provided|Inborn genetic diseases|Blepharophimosis, ptosis, and epicanthus inversus syndrome;Premature ovarian failure 3",Duplication,GRCh37
na,na,3,138945918,138945919,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome|not provided|Inborn genetic diseases|Blepharophimosis, ptosis, and epicanthus inversus syndrome;Premature ovarian failure 3",Duplication,GRCh38
na,na,3,138664694,138664710,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|Blepharophimosis, ptosis, and epicanthus inversus syndrome",Deletion,GRCh37
na,na,3,138945852,138945868,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|Blepharophimosis, ptosis, and epicanthus inversus syndrome",Deletion,GRCh38
na,na,3,138665408,138665408,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|not provided",single nucleotide variant,GRCh37
na,na,3,138946566,138946566,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|not provided",single nucleotide variant,GRCh38
na,na,3,138664743,138664743,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome;Premature ovarian failure 3",single nucleotide variant,GRCh37
na,na,3,138945901,138945901,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome;Premature ovarian failure 3",single nucleotide variant,GRCh38
na,na,3,138664867,138664867,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|Blepharophimosis, ptosis, and epicanthus inversus syndrome;Premature ovarian failure 3",Microsatellite,GRCh37
na,na,3,138946024,138946025,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II|Blepharophimosis, ptosis, and epicanthus inversus syndrome;Premature ovarian failure 3",Microsatellite,GRCh38
na,na,3,138665314,138665314,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|FOXL2-related disorder",single nucleotide variant,GRCh37
na,na,3,138946472,138946472,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|FOXL2-related disorder",single nucleotide variant,GRCh38
na,na,3,138665270,138665270,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|not provided",single nucleotide variant,GRCh37
na,na,3,138946428,138946428,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|not provided",single nucleotide variant,GRCh38
na,na,3,138664979,138664979,FOXL2,Pathogenic,"Blepharophimosis, ptosis, and epicanthus inversus syndrome",single nucleotide variant,GRCh37
na,na,3,138946137,138946137,FOXL2,Pathogenic,"Blepharophimosis, ptosis, and epicanthus inversus syndrome",single nucleotide variant,GRCh38
na,na,3,138664693,138664694,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome|not provided",Duplication,GRCh37
na,na,3,138945851,138945852,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I|Blepharophimosis, ptosis, and epicanthus inversus syndrome|not provided",Duplication,GRCh38
na,na,3,138664605,138664606,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I",Duplication,GRCh37
na,na,3,138945763,138945764,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I",Duplication,GRCh38
na,na,3,138664873,138664902,FOXL2,Likely pathogenic,Premature ovarian failure 3|not provided,Deletion,GRCh37
na,na,3,138946031,138946060,FOXL2,Likely pathogenic,Premature ovarian failure 3|not provided,Deletion,GRCh38
na,na,3,138664793,138664793,FOXL2,Conflicting classifications of pathogenicity,"Premature ovarian failure 3|not provided|Blepharophimosis, ptosis, and epicanthus inversus syndrome",single nucleotide variant,GRCh37
na,na,3,138945951,138945951,FOXL2,Conflicting classifications of pathogenicity,"Premature ovarian failure 3|not provided|Blepharophimosis, ptosis, and epicanthus inversus syndrome",single nucleotide variant,GRCh38
na,na,3,138664866,138664867,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I",Duplication,GRCh37
na,na,3,138946024,138946025,FOXL2,Pathogenic,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I",Duplication,GRCh38
na,na,3,138665005,138665005,FOXL2,Conflicting classifications of pathogenicity,"Premature ovarian failure 3|Blepharophimosis, ptosis, and epicanthus inversus syndrome|See cases|not provided",single nucleotide variant,GRCh37
na,na,3,138946163,138946163,FOXL2,Conflicting classifications of pathogenicity,"Premature ovarian failure 3|Blepharophimosis, ptosis, and epicanthus inversus syndrome|See cases|not provided",single nucleotide variant,GRCh38
na,na,9,99003167,99003167,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,9,96240885,96240885,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,9,99003159,99003159,HSD17B3,Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,9,96240877,96240877,HSD17B3,Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,9,99017188,99017188,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided|Pseudohermaphroditism,single nucleotide variant,GRCh37
na,na,9,96254906,96254906,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided|Pseudohermaphroditism,single nucleotide variant,GRCh38
na,na,9,99006675,99006675,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|Inborn genetic diseases|Pseudohermaphroditism|not provided,single nucleotide variant,GRCh37
na,na,9,96244393,96244393,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|Inborn genetic diseases|Pseudohermaphroditism|not provided,single nucleotide variant,GRCh38
na,na,9,99017189,99017189,HSD17B3,Pathogenic/Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency|Pseudohermaphroditism|not provided,single nucleotide variant,GRCh37
na,na,9,96254907,96254907,HSD17B3,Pathogenic/Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency|Pseudohermaphroditism|not provided,single nucleotide variant,GRCh38
na,na,9,99006677,99006677,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,9,96244395,96244395,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,9,99060733,99060733,HSD17B3,Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,9,96298451,96298451,HSD17B3,Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,9,99013764,99013764,HSD17B3,Pathogenic/Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,9,96251482,96251482,HSD17B3,Pathogenic/Likely pathogenic,Testosterone 17-beta-dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,9,99003059,99003059,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,9,96240777,96240777,HSD17B3,Pathogenic,Testosterone 17-beta-dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,22,20230301,20230301,RTN4R,risk factor,"Schizophrenia, susceptibility to",single nucleotide variant,GRCh37
na,na,22,20242778,20242778,RTN4R,risk factor,"Schizophrenia, susceptibility to",single nucleotide variant,GRCh38
na,na,22,20230069,20230069,RTN4R,risk factor,"Schizophrenia, susceptibility to",single nucleotide variant,GRCh37
na,na,22,20242546,20242546,RTN4R,risk factor,"Schizophrenia, susceptibility to",single nucleotide variant,GRCh38
na,na,19,7735297,7735297,RETN,risk factor,"Diabetes mellitus type 2, susceptibility to|HYPERTENSION, INSULIN RESISTANCE-RELATED, SUSCEPTIBILITY TO",single nucleotide variant,GRCh37
na,na,19,7670411,7670411,RETN,risk factor,"Diabetes mellitus type 2, susceptibility to|HYPERTENSION, INSULIN RESISTANCE-RELATED, SUSCEPTIBILITY TO",single nucleotide variant,GRCh38
na,na,8,16850399,16850399,FGF20,Benign,"Parkinson disease, late-onset|not provided",single nucleotide variant,GRCh37
na,na,8,16992890,16992890,FGF20,Benign,"Parkinson disease, late-onset|not provided",single nucleotide variant,GRCh38
na,na,11,67250669,67250669,AIP,Pathogenic,Pituitary adenoma predisposition|Somatotroph adenoma|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,11,67483198,67483198,AIP,Pathogenic,Pituitary adenoma predisposition|Somatotroph adenoma|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,11,67257508,67257508,AIP,Uncertain significance,Somatotroph adenoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,11,67490037,67490037,AIP,Uncertain significance,Somatotroph adenoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,11,67258381,67258381,AIP,Pathogenic,Somatotroph adenoma|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,11,67490910,67490910,AIP,Pathogenic,Somatotroph adenoma|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,11,67250695,67250700,AIP,Pathogenic,Somatotroph adenoma,Deletion,GRCh37
na,na,11,67483224,67483229,AIP,Pathogenic,Somatotroph adenoma,Deletion,GRCh38
na,na,11,67258294,67258295,AIP,Pathogenic,Somatotroph adenoma,Duplication,GRCh37
na,na,11,67490823,67490824,AIP,Pathogenic,Somatotroph adenoma,Duplication,GRCh38
na,na,11,67257582,67257582,AIP,Pathogenic,Somatotroph adenoma,Deletion,GRCh37
na,na,11,67490111,67490111,AIP,Pathogenic,Somatotroph adenoma,Deletion,GRCh38
na,na,11,67258275,67258275,AIP,Pathogenic,Pituitary adenoma predisposition|Somatotroph adenoma|not provided,single nucleotide variant,GRCh37
na,na,11,67490804,67490804,AIP,Pathogenic,Pituitary adenoma predisposition|Somatotroph adenoma|not provided,single nucleotide variant,GRCh38
na,na,11,67258382,67258382,AIP,Conflicting classifications of pathogenicity,Pituitary dependent hypercortisolism|not specified|Somatotroph adenoma|not provided|Hereditary cancer-predisposing syndrome|Dopamine agonists response|AIP-related disorder,single nucleotide variant,GRCh37
na,na,11,67490911,67490911,AIP,Conflicting classifications of pathogenicity,Pituitary dependent hypercortisolism|not specified|Somatotroph adenoma|not provided|Hereditary cancer-predisposing syndrome|Dopamine agonists response|AIP-related disorder,single nucleotide variant,GRCh38
na,na,11,67250693,67250693,AIP,Pathogenic,Somatotroph adenoma,single nucleotide variant,GRCh37
na,na,11,67483222,67483222,AIP,Pathogenic,Somatotroph adenoma,single nucleotide variant,GRCh38
na,na,1,160807715,160807715,CD244,risk factor,Rheumatoid arthritis,single nucleotide variant,GRCh37
na,na,1,160837925,160837925,CD244,risk factor,Rheumatoid arthritis,single nucleotide variant,GRCh38
na,na,7,156615803,156621903,LMBR1,Pathogenic,Acheiropodia,Deletion,GRCh37
na,na,7,156823109,156829209,LMBR1,Pathogenic,Acheiropodia,Deletion,GRCh38
na,na,7,156584465,156584465,LMBR1;ZRS,Pathogenic,Polydactyly of a triphalangeal thumb,single nucleotide variant,GRCh37
na,na,7,156791771,156791771,LMBR1;ZRS,Pathogenic,Polydactyly of a triphalangeal thumb,single nucleotide variant,GRCh38
na,na,7,156584166,156584166,ZRS;LMBR1,Pathogenic,"Tibia, hypoplasia or aplasia of, with polydactyly",single nucleotide variant,GRCh37
na,na,7,156791472,156791472,ZRS;LMBR1,Pathogenic,"Tibia, hypoplasia or aplasia of, with polydactyly",single nucleotide variant,GRCh38
na,na,7,156584265,156584265,LMBR1;ZRS,Pathogenic,Polydactyly of a triphalangeal thumb,single nucleotide variant,GRCh37
na,na,7,156791571,156791571,LMBR1;ZRS,Pathogenic,Polydactyly of a triphalangeal thumb,single nucleotide variant,GRCh38
na,na,7,156584241,156584241,LMBR1;ZRS,Pathogenic,Polydactyly of a triphalangeal thumb|Triphalangeal thumb,single nucleotide variant,GRCh37
na,na,7,156791547,156791547,LMBR1;ZRS,Pathogenic,Polydactyly of a triphalangeal thumb|Triphalangeal thumb,single nucleotide variant,GRCh38
na,na,7,156539605,156619298,LMBR1,Pathogenic,Triphalangeal thumb-polysyndactyly syndrome,Duplication,GRCh37
na,na,7,156746911,156826604,LMBR1,Pathogenic,Triphalangeal thumb-polysyndactyly syndrome,Duplication,GRCh38
na,na,7,156583831,156583831,LMBR1;ZRS,Pathogenic,Triphalangeal thumb|Polydactyly of a triphalangeal thumb|not provided,single nucleotide variant,GRCh37
na,na,7,156791137,156791137,LMBR1;ZRS,Pathogenic,Triphalangeal thumb|Polydactyly of a triphalangeal thumb|not provided,single nucleotide variant,GRCh38
na,na,7,156583949,156583949,LMBR1;ZRS,Pathogenic,Polydactyly of a triphalangeal thumb|Triphalangeal thumb,single nucleotide variant,GRCh37
na,na,7,156791255,156791255,LMBR1;ZRS,Pathogenic,Polydactyly of a triphalangeal thumb|Triphalangeal thumb,single nucleotide variant,GRCh38
na,na,7,156350691,156939511,LMBR1,Pathogenic,Triphalangeal thumb-polysyndactyly syndrome,Duplication,GRCh38
na,na,na,-1,-1,LMBR1,Pathogenic,Syndactyly type 4,Duplication,na
na,na,7,156584275,156584275,LMBR1;ZRS,Pathogenic,Triphalangeal thumb|Polydactyly of a triphalangeal thumb|not provided,single nucleotide variant,GRCh37
na,na,7,156791581,156791581,LMBR1;ZRS,Pathogenic,Triphalangeal thumb|Polydactyly of a triphalangeal thumb|not provided,single nucleotide variant,GRCh38
na,na,7,156584174,156584174,LMBR1;ZRS,Uncertain significance,Polydactyly of a triphalangeal thumb|not provided,single nucleotide variant,GRCh37
na,na,7,156791480,156791480,LMBR1;ZRS,Uncertain significance,Polydactyly of a triphalangeal thumb|not provided,single nucleotide variant,GRCh38
na,na,18,2922171,2922171,LPIN2,Pathogenic/Likely pathogenic,Majeed syndrome|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh37
na,na,18,2922173,2922173,LPIN2,Pathogenic/Likely pathogenic,Majeed syndrome|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh38
na,na,18,2951102,2951103,LPIN2,Pathogenic,Majeed syndrome,Deletion,GRCh37
na,na,18,2951104,2951105,LPIN2,Pathogenic,Majeed syndrome,Deletion,GRCh38
na,na,2,11913792,11913792,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive",single nucleotide variant,GRCh37
na,na,2,11773666,11773666,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,11923960,11923960,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,2,11783834,11783834,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,2,11959716,11959716,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,2,11819590,11819590,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,2,11955367,11964757,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive",Deletion,GRCh37
na,na,2,11815241,11824631,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive",Deletion,GRCh38
na,na,2,11925204,11925204,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive",single nucleotide variant,GRCh37
na,na,2,11785078,11785078,LPIN1,Pathogenic,"Myoglobinuria, acute recurrent, autosomal recessive",single nucleotide variant,GRCh38
na,na,10,73499529,73499529,CDH23,Pathogenic,"Usher syndrome type 1D|not provided|Usher syndrome type 1|Pituitary adenoma 5, multiple types",single nucleotide variant,GRCh37
na,na,10,71739772,71739772,CDH23,Pathogenic,"Usher syndrome type 1D|not provided|Usher syndrome type 1|Pituitary adenoma 5, multiple types",single nucleotide variant,GRCh38
na,na,10,73539073,73539073,CDH23,Pathogenic,"Usher syndrome type 1D|not provided|Autosomal recessive nonsyndromic hearing loss 12;Pituitary adenoma 5, multiple types;Usher syndrome type 1D|Retinal dystrophy|Rare genetic deafness|Usher syndrome type 1|Childhood onset hearing loss|Usher syndrome|Autosomal recessive nonsyndromic hearing loss 12|Inborn genetic diseases|Pituitary adenoma 5, multiple types|CDH23-related disorder",single nucleotide variant,GRCh37
na,na,10,71779316,71779316,CDH23,Pathogenic,"Usher syndrome type 1D|not provided|Autosomal recessive nonsyndromic hearing loss 12;Pituitary adenoma 5, multiple types;Usher syndrome type 1D|Retinal dystrophy|Rare genetic deafness|Usher syndrome type 1|Childhood onset hearing loss|Usher syndrome|Autosomal recessive nonsyndromic hearing loss 12|Inborn genetic diseases|Pituitary adenoma 5, multiple types|CDH23-related disorder",single nucleotide variant,GRCh38
na,na,10,73491866,73491868,CDH23,Conflicting classifications of pathogenicity,Usher syndrome type 1D|not provided,Microsatellite,GRCh37
na,na,10,71732109,71732111,CDH23,Conflicting classifications of pathogenicity,Usher syndrome type 1D|not provided,Microsatellite,GRCh38
na,na,10,73559391,73559391,CDH23,Pathogenic,"Usher syndrome type 1D|Rare genetic deafness|not provided|Pituitary adenoma 5, multiple types",single nucleotide variant,GRCh37
na,na,10,71799634,71799634,CDH23,Pathogenic,"Usher syndrome type 1D|Rare genetic deafness|not provided|Pituitary adenoma 5, multiple types",single nucleotide variant,GRCh38
na,na,10,73550972,73550972,CDH23,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|Hearing loss, autosomal recessive|Pituitary adenoma 5, multiple types",single nucleotide variant,GRCh37
na,na,10,71791215,71791215,CDH23,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|Hearing loss, autosomal recessive|Pituitary adenoma 5, multiple types",single nucleotide variant,GRCh38
na,na,10,73553289,73553289,CDH23,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|not provided|Pituitary adenoma 5, multiple types|Hearing loss, autosomal recessive|Pituitary adenoma 5, multiple types;Usher syndrome type 1D;Autosomal recessive nonsyndromic hearing loss 12|Usher syndrome type 1|Usher syndrome",single nucleotide variant,GRCh37
na,na,10,71793532,71793532,CDH23,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|not provided|Pituitary adenoma 5, multiple types|Hearing loss, autosomal recessive|Pituitary adenoma 5, multiple types;Usher syndrome type 1D;Autosomal recessive nonsyndromic hearing loss 12|Usher syndrome type 1|Usher syndrome",single nucleotide variant,GRCh38
na,na,10,73491908,73491908,CDH23,Pathogenic,"Usher syndrome type 1D|not provided|Hearing loss, autosomal recessive",single nucleotide variant,GRCh37
na,na,10,71732151,71732151,CDH23,Pathogenic,"Usher syndrome type 1D|not provided|Hearing loss, autosomal recessive",single nucleotide variant,GRCh38
na,na,10,73553127,73553127,CDH23,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|Rare genetic deafness|Usher syndrome type 2A;Autosomal recessive nonsyndromic hearing loss 12|not provided|Usher syndrome type 1|Usher syndrome|Pituitary adenoma 5, multiple types|CDH23-related disorder|Retinal dystrophy|Usher syndrome type 1D|Usher syndrome type 1D;Pituitary adenoma 5, multiple types;Autosomal recessive nonsyndromic hearing loss 12",single nucleotide variant,GRCh37
na,na,10,71793370,71793370,CDH23,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|Rare genetic deafness|Usher syndrome type 2A;Autosomal recessive nonsyndromic hearing loss 12|not provided|Usher syndrome type 1|Usher syndrome|Pituitary adenoma 5, multiple types|CDH23-related disorder|Retinal dystrophy|Usher syndrome type 1D|Usher syndrome type 1D;Pituitary adenoma 5, multiple types;Autosomal recessive nonsyndromic hearing loss 12",single nucleotide variant,GRCh38
na,na,10,73492049,73492049,CDH23,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|not provided|Usher syndrome type 1|Pituitary adenoma 5, multiple types|Usher syndrome|Usher syndrome type 1D",single nucleotide variant,GRCh37
na,na,10,71732292,71732292,CDH23,Pathogenic/Likely pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|not provided|Usher syndrome type 1|Pituitary adenoma 5, multiple types|Usher syndrome|Usher syndrome type 1D",single nucleotide variant,GRCh38
na,na,10,73544808,73544808,CDH23,Pathogenic,Autosomal recessive nonsyndromic hearing loss 12|not provided|Usher syndrome,single nucleotide variant,GRCh37
na,na,10,71785051,71785051,CDH23,Pathogenic,Autosomal recessive nonsyndromic hearing loss 12|not provided|Usher syndrome,single nucleotide variant,GRCh38
na,na,10,73269882,73269882,CDH23,Pathogenic,"Usher syndrome type 1D|USHER SYNDROME, TYPE ID/F, DIGENIC|not provided|Usher syndrome type 1|Pituitary adenoma 5, multiple types;Usher syndrome type 1D;Autosomal recessive nonsyndromic hearing loss 12",Deletion,GRCh37
na,na,10,71510125,71510125,CDH23,Pathogenic,"Usher syndrome type 1D|USHER SYNDROME, TYPE ID/F, DIGENIC|not provided|Usher syndrome type 1|Pituitary adenoma 5, multiple types;Usher syndrome type 1D;Autosomal recessive nonsyndromic hearing loss 12",Deletion,GRCh38
na,na,10,73572579,73572579,CDH23,Uncertain significance,"USHER SYNDROME, TYPE ID/F, DIGENIC|not specified|Usher syndrome type 1|Usher syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 12;Pituitary adenoma 5, multiple types;Usher syndrome type 1D",single nucleotide variant,GRCh37
na,na,10,71812822,71812822,CDH23,Uncertain significance,"USHER SYNDROME, TYPE ID/F, DIGENIC|not specified|Usher syndrome type 1|Usher syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 12;Pituitary adenoma 5, multiple types;Usher syndrome type 1D",single nucleotide variant,GRCh38
na,na,10,73490271,73490271,CDH23,Benign,"Usher syndrome type 1D|not specified|not provided|Usher syndrome type 1|Autosomal recessive nonsyndromic hearing loss 12|Usher syndrome|Autosomal recessive nonsyndromic hearing loss 12;Pituitary adenoma 5, multiple types;Usher syndrome type 1D",single nucleotide variant,GRCh37
na,na,10,71730514,71730514,CDH23,Benign,"Usher syndrome type 1D|not specified|not provided|Usher syndrome type 1|Autosomal recessive nonsyndromic hearing loss 12|Usher syndrome|Autosomal recessive nonsyndromic hearing loss 12;Pituitary adenoma 5, multiple types;Usher syndrome type 1D",single nucleotide variant,GRCh38
na,na,10,73330641,73330641,CDH23,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|Usher syndrome type 1D|not provided|Usher syndrome type 1|Nonsyndromic genetic hearing loss|Pituitary adenoma 5, multiple types;Usher syndrome type 1D;Autosomal recessive nonsyndromic hearing loss 12|Pituitary adenoma 5, multiple types",single nucleotide variant,GRCh37
na,na,10,71570884,71570884,CDH23,Pathogenic,"Autosomal recessive nonsyndromic hearing loss 12|Usher syndrome type 1D|not provided|Usher syndrome type 1|Nonsyndromic genetic hearing loss|Pituitary adenoma 5, multiple types;Usher syndrome type 1D;Autosomal recessive nonsyndromic hearing loss 12|Pituitary adenoma 5, multiple types",single nucleotide variant,GRCh38
na,na,10,73375330,73375330,CDH23,Uncertain significance,"Autosomal recessive nonsyndromic hearing loss 12|not provided|Nonsyndromic genetic hearing loss|Pituitary adenoma 5, multiple types|Usher syndrome",single nucleotide variant,GRCh37
na,na,10,71615573,71615573,CDH23,Uncertain significance,"Autosomal recessive nonsyndromic hearing loss 12|not provided|Nonsyndromic genetic hearing loss|Pituitary adenoma 5, multiple types|Usher syndrome",single nucleotide variant,GRCh38
na,na,10,55617025,55617025,PCDH15,Pathogenic,Usher syndrome type 1F,single nucleotide variant,GRCh37
na,na,10,53857265,53857265,PCDH15,Pathogenic,Usher syndrome type 1F,single nucleotide variant,GRCh38
na,na,10,56424016,56424016,PCDH15,Pathogenic,Usher syndrome type 1F|Autosomal recessive nonsyndromic hearing loss 23|not provided|Rare genetic deafness|Usher syndrome type 1D;Usher syndrome type 1F;Autosomal recessive nonsyndromic hearing loss 23,single nucleotide variant,GRCh37
na,na,10,54664256,54664256,PCDH15,Pathogenic,Usher syndrome type 1F|Autosomal recessive nonsyndromic hearing loss 23|not provided|Rare genetic deafness|Usher syndrome type 1D;Usher syndrome type 1F;Autosomal recessive nonsyndromic hearing loss 23,single nucleotide variant,GRCh38
na,na,10,55973706,55973706,PCDH15,Pathogenic,Usher syndrome type 1F|Usher syndrome type 1D|Autosomal recessive nonsyndromic hearing loss 23|not provided|Usher syndrome type 1F;Autosomal recessive nonsyndromic hearing loss 23;Usher syndrome type 1D,Deletion,GRCh37
na,na,10,54213946,54213946,PCDH15,Pathogenic,Usher syndrome type 1F|Usher syndrome type 1D|Autosomal recessive nonsyndromic hearing loss 23|not provided|Usher syndrome type 1F;Autosomal recessive nonsyndromic hearing loss 23;Usher syndrome type 1D,Deletion,GRCh38
na,na,10,56077174,56077174,PCDH15,Pathogenic,Usher syndrome type 1F|Usher syndrome type 1G|Usher syndrome type 1D;Usher syndrome type 1F;Autosomal recessive nonsyndromic hearing loss 23|Usher syndrome type 1|not provided|Autosomal recessive nonsyndromic hearing loss 23|Rare genetic deafness|Usher syndrome type 1D|PCDH15-related disorder,single nucleotide variant,GRCh37
na,na,10,54317414,54317414,PCDH15,Pathogenic,Usher syndrome type 1F|Usher syndrome type 1G|Usher syndrome type 1D;Usher syndrome type 1F;Autosomal recessive nonsyndromic hearing loss 23|Usher syndrome type 1|not provided|Autosomal recessive nonsyndromic hearing loss 23|Rare genetic deafness|Usher syndrome type 1D|PCDH15-related disorder,single nucleotide variant,GRCh38
na,na,10,56077122,56077122,PCDH15,Pathogenic,Autosomal recessive nonsyndromic hearing loss 23,single nucleotide variant,GRCh37
na,na,10,54317362,54317362,PCDH15,Pathogenic,Autosomal recessive nonsyndromic hearing loss 23,single nucleotide variant,GRCh38
na,na,10,56128954,56128954,PCDH15,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 23|Rare genetic deafness|Usher syndrome type 1F,single nucleotide variant,GRCh37
na,na,10,54369194,54369194,PCDH15,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 23|Rare genetic deafness|Usher syndrome type 1F,single nucleotide variant,GRCh38
na,na,10,55849801,55849801,PCDH15,Pathogenic,Usher syndrome type 1F,single nucleotide variant,GRCh37
na,na,10,54090041,54090041,PCDH15,Pathogenic,Usher syndrome type 1F,single nucleotide variant,GRCh38
na,na,6,80626476,80626480,ELOVL4,Pathogenic,Stargardt disease 3|not provided|Retinal dystrophy,Deletion,GRCh37
na,na,6,79916759,79916763,ELOVL4,Pathogenic,Stargardt disease 3|not provided|Retinal dystrophy,Deletion,GRCh38
na,na,6,80626477,80626481,ELOVL4,Pathogenic,Stargardt disease 3,Indel,GRCh37
na,na,6,79916760,79916764,ELOVL4,Pathogenic,Stargardt disease 3,Indel,GRCh38
na,na,6,80626460,80626460,ELOVL4,Pathogenic/Likely pathogenic,Stargardt disease 3|not provided,single nucleotide variant,GRCh37
na,na,6,79916743,79916743,ELOVL4,Pathogenic/Likely pathogenic,Stargardt disease 3|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,TMPRSS3,Pathogenic,Autosomal recessive nonsyndromic hearing loss 8,Indel,na
na,na,21,43803171,43803171,TMPRSS3,Pathogenic,Autosomal recessive nonsyndromic hearing loss 8|not provided|Hearing impairment,single nucleotide variant,GRCh37
na,na,21,42383062,42383062,TMPRSS3,Pathogenic,Autosomal recessive nonsyndromic hearing loss 8|not provided|Hearing impairment,single nucleotide variant,GRCh38
na,na,21,43795961,43795961,TMPRSS3,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 8|Ear malformation|not provided,single nucleotide variant,GRCh37
na,na,21,42375852,42375852,TMPRSS3,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 8|Ear malformation|not provided,single nucleotide variant,GRCh38
na,na,21,43803277,43803277,TMPRSS3,Pathogenic,Autosomal recessive nonsyndromic hearing loss 8,single nucleotide variant,GRCh37
na,na,21,42383168,42383168,TMPRSS3,Pathogenic,Autosomal recessive nonsyndromic hearing loss 8,single nucleotide variant,GRCh38
na,na,3,33160815,33160815,CRTAP,Likely pathogenic,Osteogenesis imperfecta type 7|CRTAP-related disorder,single nucleotide variant,GRCh37
na,na,3,33119323,33119323,CRTAP,Likely pathogenic,Osteogenesis imperfecta type 7|CRTAP-related disorder,single nucleotide variant,GRCh38
na,na,3,33171514,33171514,CRTAP,Pathogenic,Osteogenesis imperfecta type 7,Deletion,GRCh37
na,na,3,33130022,33130022,CRTAP,Pathogenic,Osteogenesis imperfecta type 7,Deletion,GRCh38
na,na,3,33156041,33156041,CRTAP,Pathogenic,Osteogenesis imperfecta type 7,single nucleotide variant,GRCh37
na,na,3,33114549,33114549,CRTAP,Pathogenic,Osteogenesis imperfecta type 7,single nucleotide variant,GRCh38
na,na,3,33171463,33171463,CRTAP,Pathogenic,Osteogenesis imperfecta type 7|not provided,single nucleotide variant,GRCh37
na,na,3,33129971,33129971,CRTAP,Pathogenic,Osteogenesis imperfecta type 7|not provided,single nucleotide variant,GRCh38
na,na,3,33155572,33155572,CRTAP,Pathogenic/Likely pathogenic,Osteogenesis imperfecta type 7|Osteogenesis imperfecta,single nucleotide variant,GRCh37
na,na,3,33114080,33114080,CRTAP,Pathogenic/Likely pathogenic,Osteogenesis imperfecta type 7|Osteogenesis imperfecta,single nucleotide variant,GRCh38
na,na,3,33155840,33155841,CRTAP,Pathogenic,Osteogenesis imperfecta type 7,Duplication,GRCh37
na,na,3,33114348,33114349,CRTAP,Pathogenic,Osteogenesis imperfecta type 7,Duplication,GRCh38
na,na,17,72306303,72306303,DNAI2,Pathogenic,Primary ciliary dyskinesia 9|Primary ciliary dyskinesia|not provided,single nucleotide variant,GRCh37
na,na,17,74310164,74310164,DNAI2,Pathogenic,Primary ciliary dyskinesia 9|Primary ciliary dyskinesia|not provided,single nucleotide variant,GRCh38
na,na,17,72283113,72283113,DNAI2,Pathogenic,Primary ciliary dyskinesia 9|Primary ciliary dyskinesia|not provided,single nucleotide variant,GRCh37
na,na,17,74286974,74286974,DNAI2,Pathogenic,Primary ciliary dyskinesia 9|Primary ciliary dyskinesia|not provided,single nucleotide variant,GRCh38
na,na,17,72295919,72295919,DNAI2,Pathogenic,Primary ciliary dyskinesia 9|Primary ciliary dyskinesia|not provided,single nucleotide variant,GRCh37
na,na,17,74299780,74299780,DNAI2,Pathogenic,Primary ciliary dyskinesia 9|Primary ciliary dyskinesia|not provided,single nucleotide variant,GRCh38
na,na,1,197112662,197112663,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",Microsatellite,GRCh37
na,na,1,197143532,197143533,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",Microsatellite,GRCh38
na,na,1,197070620,197070620,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,197101490,197101490,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",single nucleotide variant,GRCh38
na,na,1,197062317,197062317,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",Deletion,GRCh37
na,na,1,197093187,197093187,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",Deletion,GRCh38
na,na,1,197062298,197062298,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive|not provided|Inborn genetic diseases|Autosomal recessive primary microcephaly",single nucleotide variant,GRCh37
na,na,1,197093168,197093168,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive|not provided|Inborn genetic diseases|Autosomal recessive primary microcephaly",single nucleotide variant,GRCh38
na,na,1,197087006,197087006,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,1,197117876,197117876,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,1,197113179,197113179,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,197144049,197144049,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",single nucleotide variant,GRCh38
na,na,1,197072192,197072192,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,197103062,197103062,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive",single nucleotide variant,GRCh38
na,na,1,197074185,197074186,ASPM,Conflicting classifications of pathogenicity,"Microcephaly 5, primary, autosomal recessive",Duplication,GRCh37
na,na,1,197105055,197105056,ASPM,Conflicting classifications of pathogenicity,"Microcephaly 5, primary, autosomal recessive",Duplication,GRCh38
na,na,1,197102510,197102510,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,1,197133380,197133380,ASPM,Pathogenic,"Microcephaly 5, primary, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,2,44099233,44099233,ABCG8,Pathogenic/Likely pathogenic,Sitosterolemia|not provided|Sitosterolemia 1|Cardiovascular phenotype|Sitosterolemia 1;Gallbladder disease 4|ABCG8-related disorder,single nucleotide variant,GRCh37
na,na,2,43872094,43872094,ABCG8,Pathogenic/Likely pathogenic,Sitosterolemia|not provided|Sitosterolemia 1|Cardiovascular phenotype|Sitosterolemia 1;Gallbladder disease 4|ABCG8-related disorder,single nucleotide variant,GRCh38
na,na,2,44102516,44102516,ABCG8,Pathogenic/Likely pathogenic,Sitosterolemia|not provided|Sitosterolemia 1|Cardiovascular phenotype|ABCG8-related disorder|Early-onset coronary artery disease,single nucleotide variant,GRCh37
na,na,2,43875377,43875377,ABCG8,Pathogenic/Likely pathogenic,Sitosterolemia|not provided|Sitosterolemia 1|Cardiovascular phenotype|ABCG8-related disorder|Early-onset coronary artery disease,single nucleotide variant,GRCh38
na,na,2,44105004,44105004,ABCG8,Conflicting classifications of pathogenicity,not provided|Sitosterolemia 1|Sitosterolemia|ABCG8-related disorder|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,2,43877865,43877865,ABCG8,Conflicting classifications of pathogenicity,not provided|Sitosterolemia 1|Sitosterolemia|ABCG8-related disorder|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,2,44079831,44079831,ABCG8,Conflicting classifications of pathogenicity,Sitosterolemia 1|not provided|ABCG8-related disorder|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,2,43852692,43852692,ABCG8,Conflicting classifications of pathogenicity,Sitosterolemia 1|not provided|ABCG8-related disorder|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,2,44078945,44078945,ABCG8,Pathogenic/Likely pathogenic,Sitosterolemia 1|not provided,Deletion,GRCh37
na,na,2,43851806,43851806,ABCG8,Pathogenic/Likely pathogenic,Sitosterolemia 1|not provided,Deletion,GRCh38
na,na,2,44100948,44100948,ABCG8,Pathogenic/Likely pathogenic,Sitosterolemia|Sitosterolemia 1|not provided|Cardiovascular phenotype|ABCG8-related disorder,single nucleotide variant,GRCh37
na,na,2,43873809,43873809,ABCG8,Pathogenic/Likely pathogenic,Sitosterolemia|Sitosterolemia 1|not provided|Cardiovascular phenotype|ABCG8-related disorder,single nucleotide variant,GRCh38
na,na,2,44104730,44104730,ABCG8,Pathogenic,Sitosterolemia 1,single nucleotide variant,GRCh37
na,na,2,43877591,43877591,ABCG8,Pathogenic,Sitosterolemia 1,single nucleotide variant,GRCh38
na,na,2,44079622,44079622,ABCG8,Pathogenic,Sitosterolemia 1,single nucleotide variant,GRCh37
na,na,2,43852483,43852483,ABCG8,Pathogenic,Sitosterolemia 1,single nucleotide variant,GRCh38
na,na,2,44066247,44066247,ABCG5;ABCG8,Benign/Likely benign; association,Gallbladder disease 4|not specified|Sitosterolemia|Sitosterolemia 1|Cardiovascular phenotype|Sitosterolemia 2|ABCG8-related disorder|not provided,single nucleotide variant,GRCh37
na,na,2,43839108,43839108,ABCG5;ABCG8,Benign/Likely benign; association,Gallbladder disease 4|not specified|Sitosterolemia|Sitosterolemia 1|Cardiovascular phenotype|Sitosterolemia 2|ABCG8-related disorder|not provided,single nucleotide variant,GRCh38
na,na,2,44051154,44051154,ABCG5,Pathogenic/Likely pathogenic,Sitosterolemia 2|not provided|Sitosterolemia,single nucleotide variant,GRCh37
na,na,2,43824015,43824015,ABCG5,Pathogenic/Likely pathogenic,Sitosterolemia 2|not provided|Sitosterolemia,single nucleotide variant,GRCh38
na,na,2,44053568,44053568,ABCG5,Pathogenic,Sitosterolemia 2|ABCG5-related disorder,single nucleotide variant,GRCh37
na,na,2,43826429,43826429,ABCG5,Pathogenic,Sitosterolemia 2|ABCG5-related disorder,single nucleotide variant,GRCh38
na,na,2,44051120,44051120,ABCG5,Pathogenic,Sitosterolemia 2,single nucleotide variant,GRCh37
na,na,2,43823981,43823981,ABCG5,Pathogenic,Sitosterolemia 2,single nucleotide variant,GRCh38
na,na,2,44051120,44051120,ABCG5,Pathogenic,Sitosterolemia 2,single nucleotide variant,GRCh37
na,na,2,43823981,43823981,ABCG5,Pathogenic,Sitosterolemia 2,single nucleotide variant,GRCh38
na,na,2,44051210,44051210,ABCG5,Pathogenic/Likely pathogenic,Sitosterolemia 2|not provided|Sitosterolemia|Cardiovascular phenotype|ABCG5-related disorder,single nucleotide variant,GRCh37
na,na,2,43824071,43824071,ABCG5,Pathogenic/Likely pathogenic,Sitosterolemia 2|not provided|Sitosterolemia|Cardiovascular phenotype|ABCG5-related disorder,single nucleotide variant,GRCh38
na,na,2,44065009,44065009,ABCG5,Pathogenic,Sitosterolemia 2,single nucleotide variant,GRCh37
na,na,2,43837870,43837870,ABCG5,Pathogenic,Sitosterolemia 2,single nucleotide variant,GRCh38
na,na,14,21762944,21762944,RPGRIP1,Pathogenic,Leber congenital amaurosis 6|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,14,21294785,21294785,RPGRIP1,Pathogenic,Leber congenital amaurosis 6|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,14,21794102,21794102,RPGRIP1,Likely pathogenic,Cone-rod dystrophy 13|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,14,21325943,21325943,RPGRIP1,Likely pathogenic,Cone-rod dystrophy 13|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,14,21790040,21790040,RPGRIP1,Benign/Likely benign,Cone-rod dystrophy 13|not provided|not specified|Leber congenital amaurosis 6|Leber congenital amaurosis 1|Leber congenital amaurosis 6;Cone-rod dystrophy 13|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,14,21321881,21321881,RPGRIP1,Benign/Likely benign,Cone-rod dystrophy 13|not provided|not specified|Leber congenital amaurosis 6|Leber congenital amaurosis 1|Leber congenital amaurosis 6;Cone-rod dystrophy 13|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,14,21811196,21811196,RPGRIP1,Benign/Likely benign,Leber congenital amaurosis 6|not specified|not provided|Leber congenital amaurosis 6;Cone-rod dystrophy 13|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,14,21343037,21343037,RPGRIP1,Benign/Likely benign,Leber congenital amaurosis 6|not specified|not provided|Leber congenital amaurosis 6;Cone-rod dystrophy 13|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,186572092,186572092,ADIPOQ,Pathogenic,Adiponectin deficiency,single nucleotide variant,GRCh37
na,na,3,186854303,186854303,ADIPOQ,Pathogenic,Adiponectin deficiency,single nucleotide variant,GRCh38
na,na,14,61924239,61924239,PRKCH,risk factor,"Cerebral infarction, susceptibility to",single nucleotide variant,GRCh37
na,na,14,61457521,61457521,PRKCH,risk factor,"Cerebral infarction, susceptibility to",single nucleotide variant,GRCh38
na,na,12,110230212,110230212,TRPV4,Pathogenic,Brachyrachia (short spine dysplasia)|Skeletal dysplasia|not provided|Charcot-Marie-Tooth disease axonal type 2C,single nucleotide variant,GRCh37
na,na,12,109792407,109792407,TRPV4,Pathogenic,Brachyrachia (short spine dysplasia)|Skeletal dysplasia|not provided|Charcot-Marie-Tooth disease axonal type 2C,single nucleotide variant,GRCh38
na,na,12,110230201,110230201,TRPV4,Pathogenic/Likely pathogenic,Brachyrachia (short spine dysplasia)|Skeletal dysplasia;Neuromuscular disease|Skeletal dysplasia|Charcot-Marie-Tooth disease axonal type 2C|not provided|Charcot-Marie-Tooth disease|Metatropic dysplasia,single nucleotide variant,GRCh37
na,na,12,109792396,109792396,TRPV4,Pathogenic/Likely pathogenic,Brachyrachia (short spine dysplasia)|Skeletal dysplasia;Neuromuscular disease|Skeletal dysplasia|Charcot-Marie-Tooth disease axonal type 2C|not provided|Charcot-Marie-Tooth disease|Metatropic dysplasia,single nucleotide variant,GRCh38
na,na,12,110230500,110230500,TRPV4,Pathogenic/Likely pathogenic,"Spondylometaphyseal dysplasia, Kozlowski type|Parastremmatic dwarfism|Skeletal dysplasia;Neuromuscular disease|not provided|Charcot-Marie-Tooth disease axonal type 2C|Metatropic dysplasia|Neuronopathy, distal hereditary motor, autosomal dominant 8|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,12,109792695,109792695,TRPV4,Pathogenic/Likely pathogenic,"Spondylometaphyseal dysplasia, Kozlowski type|Parastremmatic dwarfism|Skeletal dysplasia;Neuromuscular disease|not provided|Charcot-Marie-Tooth disease axonal type 2C|Metatropic dysplasia|Neuronopathy, distal hereditary motor, autosomal dominant 8|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,12,110236573,110236573,TRPV4,Pathogenic,"Spondylometaphyseal dysplasia, Kozlowski type|Skeletal dysplasia",single nucleotide variant,GRCh37
na,na,12,109798768,109798768,TRPV4,Pathogenic,"Spondylometaphyseal dysplasia, Kozlowski type|Skeletal dysplasia",single nucleotide variant,GRCh38
na,na,12,110226267,110226267,TRPV4,Uncertain significance,"Spondylometaphyseal dysplasia, Kozlowski type|Skeletal dysplasia|Charcot-Marie-Tooth disease axonal type 2C",single nucleotide variant,GRCh37
na,na,12,109788462,109788462,TRPV4,Uncertain significance,"Spondylometaphyseal dysplasia, Kozlowski type|Skeletal dysplasia|Charcot-Marie-Tooth disease axonal type 2C",single nucleotide variant,GRCh38
na,na,12,110236580,110236580,TRPV4,Pathogenic,Metatropic dysplasia|Skeletal dysplasia,single nucleotide variant,GRCh37
na,na,12,109798775,109798775,TRPV4,Pathogenic,Metatropic dysplasia|Skeletal dysplasia,single nucleotide variant,GRCh38
na,na,12,110222183,110222183,TRPV4,Pathogenic,"Metatropic dysplasia|Spondyloepimetaphyseal dysplasia, Maroteaux type|Skeletal dysplasia|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2C|Parastremmatic dwarfism|not provided|Spondylometaphyseal dysplasia, Kozlowski type",single nucleotide variant,GRCh37
na,na,12,109784378,109784378,TRPV4,Pathogenic,"Metatropic dysplasia|Spondyloepimetaphyseal dysplasia, Maroteaux type|Skeletal dysplasia|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2C|Parastremmatic dwarfism|not provided|Spondylometaphyseal dysplasia, Kozlowski type",single nucleotide variant,GRCh38
na,na,12,110236628,110236628,TRPV4,Pathogenic/Likely pathogenic,"Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease axonal type 2C|Neuronopathy, distal hereditary motor, autosomal dominant 8|Neuromuscular disease|not provided|Neuronopathy, distal hereditary motor, autosomal dominant|Inborn genetic diseases|TRPV4-related disorder|TRPV4-Associated Disorders|Scapuloperoneal spinal muscular atrophy;Neuronopathy, distal hereditary motor, autosomal dominant 8",single nucleotide variant,GRCh37
na,na,12,109798823,109798823,TRPV4,Pathogenic/Likely pathogenic,"Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease axonal type 2C|Neuronopathy, distal hereditary motor, autosomal dominant 8|Neuromuscular disease|not provided|Neuronopathy, distal hereditary motor, autosomal dominant|Inborn genetic diseases|TRPV4-related disorder|TRPV4-Associated Disorders|Scapuloperoneal spinal muscular atrophy;Neuronopathy, distal hereditary motor, autosomal dominant 8",single nucleotide variant,GRCh38
na,na,12,110238470,110238470,TRPV4,Pathogenic/Likely pathogenic,"Neuronopathy, distal hereditary motor, autosomal dominant 8|Charcot-Marie-Tooth disease axonal type 2C|Charcot-Marie-Tooth disease|Neuromuscular disease|not provided|11 conditions|Inborn genetic diseases|TRPV4-related bone disorder",single nucleotide variant,GRCh37
na,na,12,109800665,109800665,TRPV4,Pathogenic/Likely pathogenic,"Neuronopathy, distal hereditary motor, autosomal dominant 8|Charcot-Marie-Tooth disease axonal type 2C|Charcot-Marie-Tooth disease|Neuromuscular disease|not provided|11 conditions|Inborn genetic diseases|TRPV4-related bone disorder",single nucleotide variant,GRCh38
na,na,12,110236625,110236625,TRPV4,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2C|Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease|Neuromuscular disease|not provided|Neuronopathy, distal hereditary motor, autosomal dominant|TRPV4-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,12,109798820,109798820,TRPV4,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2C|Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease|Neuromuscular disease|not provided|Neuronopathy, distal hereditary motor, autosomal dominant|TRPV4-related disorder|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,12,110238471,110238471,TRPV4,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2C|Scapuloperoneal spinal muscular atrophy|Neuronopathy, distal hereditary motor, autosomal dominant 8|Neuromuscular disease|not provided|Distal spinal muscular atrophy|Hereditary motor neuron disease|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,12,109800666,109800666,TRPV4,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2C|Scapuloperoneal spinal muscular atrophy|Neuronopathy, distal hereditary motor, autosomal dominant 8|Neuromuscular disease|not provided|Distal spinal muscular atrophy|Hereditary motor neuron disease|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,12,110252547,110252547,TRPV4,Benign,"Sodium serum level quantitative trait locus 1|Neuronopathy, distal hereditary motor, autosomal dominant 8|Spondylometaphyseal dysplasia, Kozlowski type|Scapuloperoneal spinal muscular atrophy|Brachyrachia (short spine dysplasia)|Metatropic dysplasia|not specified|not provided|Charcot-Marie-Tooth disease axonal type 2C|Connective tissue disorder|Charcot-Marie-Tooth disease",single nucleotide variant,GRCh37
na,na,12,109814742,109814742,TRPV4,Benign,"Sodium serum level quantitative trait locus 1|Neuronopathy, distal hereditary motor, autosomal dominant 8|Spondylometaphyseal dysplasia, Kozlowski type|Scapuloperoneal spinal muscular atrophy|Brachyrachia (short spine dysplasia)|Metatropic dysplasia|not specified|not provided|Charcot-Marie-Tooth disease axonal type 2C|Connective tissue disorder|Charcot-Marie-Tooth disease",single nucleotide variant,GRCh38
na,na,1,35227264,35227264,GJB4,Likely pathogenic,Erythrokeratodermia variabilis et progressiva 2|not provided,single nucleotide variant,GRCh37
na,na,1,34761663,34761663,GJB4,Likely pathogenic,Erythrokeratodermia variabilis et progressiva 2|not provided,single nucleotide variant,GRCh38
na,na,1,35227266,35227266,GJB4,Pathogenic,Erythrokeratodermia variabilis et progressiva 2,single nucleotide variant,GRCh37
na,na,1,34761665,34761665,GJB4,Pathogenic,Erythrokeratodermia variabilis et progressiva 2,single nucleotide variant,GRCh38
na,na,1,35227108,35227108,GJB4,Pathogenic,Erythrokeratodermia variabilis et progressiva 2|not provided,single nucleotide variant,GRCh37
na,na,1,34761507,34761507,GJB4,Pathogenic,Erythrokeratodermia variabilis et progressiva 2|not provided,single nucleotide variant,GRCh38
na,na,1,35226890,35226890,GJB4,Pathogenic,Erythrokeratodermia variabilis et progressiva 2|not provided,single nucleotide variant,GRCh37
na,na,1,34761289,34761289,GJB4,Pathogenic,Erythrokeratodermia variabilis et progressiva 2|not provided,single nucleotide variant,GRCh38
na,na,1,35226920,35226920,GJB4,Uncertain significance,Erythrokeratodermia variabilis et progressiva 2|not provided,single nucleotide variant,GRCh37
na,na,1,34761319,34761319,GJB4,Uncertain significance,Erythrokeratodermia variabilis et progressiva 2|not provided,single nucleotide variant,GRCh38
na,na,1,35227421,35227421,GJB4,Pathogenic,Erythrokeratodermia variabilis et progressiva 2,single nucleotide variant,GRCh37
na,na,1,34761820,34761820,GJB4,Pathogenic,Erythrokeratodermia variabilis et progressiva 2,single nucleotide variant,GRCh38
na,na,12,49488294,49488294,DHH,Pathogenic,"46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome",single nucleotide variant,GRCh37
na,na,12,49094511,49094511,DHH,Pathogenic,"46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome",single nucleotide variant,GRCh38
na,na,12,49484991,49484991,DHH,Pathogenic,"46,XY sex reversal 7",single nucleotide variant,GRCh37
na,na,12,49091208,49091208,DHH,Pathogenic,"46,XY sex reversal 7",single nucleotide variant,GRCh38
na,na,12,49483747,49483747,DHH,Pathogenic,"46,XY sex reversal 7",Deletion,GRCh37
na,na,12,49089964,49089964,DHH,Pathogenic,"46,XY sex reversal 7",Deletion,GRCh38
na,na,11,44331195,44331195,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh37
na,na,11,44309645,44309645,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh38
na,na,11,44296939,44296939,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh37
na,na,11,44275389,44275389,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh38
na,na,11,44297022,44297022,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh37
na,na,11,44275472,44275472,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh38
na,na,11,44297171,44297171,ALX4,Pathogenic,Parietal foramina 2,Deletion,GRCh37
na,na,11,44275621,44275621,ALX4,Pathogenic,Parietal foramina 2,Deletion,GRCh38
na,na,11,44289135,44289135,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh37
na,na,11,44267585,44267585,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh38
na,na,11,44297055,44297055,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh37
na,na,11,44275505,44275505,ALX4,Pathogenic,Parietal foramina 2,single nucleotide variant,GRCh38
na,na,11,44331219,44331228,ALX4,Pathogenic,Parietal foramina 2,Deletion,GRCh37
na,na,11,44309669,44309678,ALX4,Pathogenic,Parietal foramina 2,Deletion,GRCh38
na,na,11,44289157,44289157,ALX4,Pathogenic,Frontonasal dysplasia with alopecia and genital anomaly|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,11,44267607,44267607,ALX4,Pathogenic,Frontonasal dysplasia with alopecia and genital anomaly|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,10,89264794,89264794,MINPP1,Pathogenic,"Thyroid cancer, nonmedullary, 2",single nucleotide variant,GRCh37
na,na,10,87505037,87505037,MINPP1,Pathogenic,"Thyroid cancer, nonmedullary, 2",single nucleotide variant,GRCh38
na,na,10,89268264,89268264,MINPP1,Pathogenic,"Thyroid cancer, nonmedullary, 2",single nucleotide variant,GRCh37
na,na,10,87508507,87508507,MINPP1,Pathogenic,"Thyroid cancer, nonmedullary, 2",single nucleotide variant,GRCh38
na,na,12,4479738,4479738,FGF23,Pathogenic,Autosomal dominant hypophosphatemic rickets|not provided,single nucleotide variant,GRCh37
na,na,12,4370572,4370572,FGF23,Pathogenic,Autosomal dominant hypophosphatemic rickets|not provided,single nucleotide variant,GRCh38
na,na,12,4479730,4479730,FGF23,Pathogenic/Likely pathogenic,Autosomal dominant hypophosphatemic rickets|not provided,single nucleotide variant,GRCh37
na,na,12,4370564,4370564,FGF23,Pathogenic/Likely pathogenic,Autosomal dominant hypophosphatemic rickets|not provided,single nucleotide variant,GRCh38
na,na,12,4488538,4488538,FGF23,Conflicting classifications of pathogenicity,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided|Tumoral calcinosis, hyperphosphatemic, familial, 2|Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome|Autosomal dominant hypophosphatemic rickets;Tumoral calcinosis, hyperphosphatemic, familial, 2",single nucleotide variant,GRCh37
na,na,12,4379372,4379372,FGF23,Conflicting classifications of pathogenicity,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided|Tumoral calcinosis, hyperphosphatemic, familial, 2|Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome|Autosomal dominant hypophosphatemic rickets;Tumoral calcinosis, hyperphosphatemic, familial, 2",single nucleotide variant,GRCh38
na,na,12,4481788,4481788,FGF23,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 2|not provided",single nucleotide variant,GRCh37
na,na,12,4372622,4372622,FGF23,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 2|not provided",single nucleotide variant,GRCh38
na,na,12,4479879,4479879,FGF23,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 2",single nucleotide variant,GRCh37
na,na,12,4370713,4370713,FGF23,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 2",single nucleotide variant,GRCh38
na,na,16,81399037,81399037,GAN,Pathogenic/Likely pathogenic,Giant axonal neuropathy 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,81365432,81365432,GAN,Pathogenic/Likely pathogenic,Giant axonal neuropathy 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,16,81399028,81399028,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh37
na,na,16,81365423,81365423,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh38
na,na,16,81388328,81388328,GAN,Pathogenic,Giant axonal neuropathy 1,single nucleotide variant,GRCh37
na,na,16,81354723,81354723,GAN,Pathogenic,Giant axonal neuropathy 1,single nucleotide variant,GRCh38
na,na,16,81398610,81398610,GAN,Uncertain significance,Giant axonal neuropathy 1,single nucleotide variant,GRCh37
na,na,16,81365005,81365005,GAN,Uncertain significance,Giant axonal neuropathy 1,single nucleotide variant,GRCh38
na,na,16,81388140,81388140,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh37
na,na,16,81354535,81354535,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh38
na,na,16,81348761,81348761,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh37
na,na,16,81315156,81315156,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh38
na,na,16,81399010,81399010,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh37
na,na,16,81365405,81365405,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh38
na,na,16,81388232,81388232,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh37
na,na,16,81354627,81354627,GAN,Conflicting classifications of pathogenicity,Giant axonal neuropathy 1,single nucleotide variant,GRCh38
na,na,12,53702942,53702942,AAAS,Pathogenic/Likely pathogenic,Glucocorticoid deficiency with achalasia|not provided,single nucleotide variant,GRCh37
na,na,12,53309158,53309158,AAAS,Pathogenic/Likely pathogenic,Glucocorticoid deficiency with achalasia|not provided,single nucleotide variant,GRCh38
na,na,12,53701482,53701482,AAAS,Pathogenic,Glucocorticoid deficiency with achalasia|not provided|Neurodevelopmental disorder,single nucleotide variant,GRCh37
na,na,12,53307698,53307698,AAAS,Pathogenic,Glucocorticoid deficiency with achalasia|not provided|Neurodevelopmental disorder,single nucleotide variant,GRCh38
na,na,12,53702759,53702760,AAAS,Pathogenic,Glucocorticoid deficiency with achalasia,Duplication,GRCh37
na,na,12,53308975,53308976,AAAS,Pathogenic,Glucocorticoid deficiency with achalasia,Duplication,GRCh38
na,na,12,53708926,53708926,AAAS,Pathogenic,Glucocorticoid deficiency with achalasia,single nucleotide variant,GRCh37
na,na,12,53315142,53315142,AAAS,Pathogenic,Glucocorticoid deficiency with achalasia,single nucleotide variant,GRCh38
na,na,12,53715207,53715207,AAAS,Pathogenic,Glucocorticoid deficiency with achalasia|not provided|AAAS-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,53321423,53321423,AAAS,Pathogenic,Glucocorticoid deficiency with achalasia|not provided|AAAS-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,53703408,53703408,AAAS,Pathogenic/Likely pathogenic,Glucocorticoid deficiency with achalasia|Babinski sign;Spastic paraparesis;Hyperreflexia|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,53309624,53309624,AAAS,Pathogenic/Likely pathogenic,Glucocorticoid deficiency with achalasia|Babinski sign;Spastic paraparesis;Hyperreflexia|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,53702508,53702508,AAAS,Likely pathogenic,Glucocorticoid deficiency with achalasia|not provided,single nucleotide variant,GRCh37
na,na,12,53308724,53308724,AAAS,Likely pathogenic,Glucocorticoid deficiency with achalasia|not provided,single nucleotide variant,GRCh38
na,na,12,53701879,53701879,AAAS,Pathogenic,Achalasia-alacrima syndrome,single nucleotide variant,GRCh37
na,na,12,53308095,53308095,AAAS,Pathogenic,Achalasia-alacrima syndrome,single nucleotide variant,GRCh38
na,na,12,53714349,53714349,AAAS,Pathogenic/Likely pathogenic,Glucocorticoid deficiency with achalasia|Achalasia-alacrima syndrome|not provided,single nucleotide variant,GRCh37
na,na,12,53320565,53320565,AAAS,Pathogenic/Likely pathogenic,Glucocorticoid deficiency with achalasia|Achalasia-alacrima syndrome|not provided,single nucleotide variant,GRCh38
na,na,19,46273463,46273465,DMPK,Pathogenic,Steinert myotonic dystrophy syndrome,Microsatellite,GRCh37
na,na,19,45770205,45770207,DMPK,Pathogenic,Steinert myotonic dystrophy syndrome,Microsatellite,GRCh38
na,na,20,47570114,47570114,ARFGEF2,Conflicting classifications of pathogenicity,"Periventricular heterotopia with microcephaly, autosomal recessive|not specified|not provided",single nucleotide variant,GRCh37
na,na,20,48953577,48953577,ARFGEF2,Conflicting classifications of pathogenicity,"Periventricular heterotopia with microcephaly, autosomal recessive|not specified|not provided",single nucleotide variant,GRCh38
na,na,20,47558490,47558490,ARFGEF2,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,20,48941953,48941953,ARFGEF2,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,5,142421420,142421420,ARHGAP26,Pathogenic,Juvenile myelomonocytic leukemia,single nucleotide variant,GRCh37
na,na,5,143041855,143041855,ARHGAP26,Pathogenic,Juvenile myelomonocytic leukemia,single nucleotide variant,GRCh38
na,na,na,-1,-1,ARHGAP26,Pathogenic,Juvenile myelomonocytic leukemia,Insertion,na
na,na,na,-1,-1,ARHGAP26,Pathogenic,Juvenile myelomonocytic leukemia,Insertion,na
na,na,17,12915009,12915009,ELAC2,Benign,"Prostate cancer, hereditary, 2|not provided|not specified|Combined oxidative phosphorylation defect type 17|Combined oxidative phosphorylation defect type 17;Prostate cancer, hereditary, 2",single nucleotide variant,GRCh37
na,na,17,13011692,13011692,ELAC2,Benign,"Prostate cancer, hereditary, 2|not provided|not specified|Combined oxidative phosphorylation defect type 17|Combined oxidative phosphorylation defect type 17;Prostate cancer, hereditary, 2",single nucleotide variant,GRCh38
na,na,17,12899902,12899902,ELAC2,Benign/Likely benign,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17|not specified|not provided|Prostate cancer, hereditary, 2;Combined oxidative phosphorylation defect type 17",single nucleotide variant,GRCh37
na,na,17,12996585,12996585,ELAC2,Benign/Likely benign,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17|not specified|not provided|Prostate cancer, hereditary, 2;Combined oxidative phosphorylation defect type 17",single nucleotide variant,GRCh38
na,na,17,12899881,12899882,ELAC2,Pathogenic,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17",Duplication,GRCh37
na,na,17,12996564,12996565,ELAC2,Pathogenic,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17",Duplication,GRCh38
na,na,17,12896274,12896274,ELAC2,Conflicting classifications of pathogenicity,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,17,12992957,12992957,ELAC2,Conflicting classifications of pathogenicity,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,17,12898323,12898323,ELAC2,Benign,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17",single nucleotide variant,GRCh37
na,na,17,12995006,12995006,ELAC2,Benign,"Prostate cancer, hereditary, 2|Combined oxidative phosphorylation defect type 17",single nucleotide variant,GRCh38
na,na,2,171675136,171675136,GAD1,Uncertain significance,Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,single nucleotide variant,GRCh37
na,na,2,170818626,170818626,GAD1,Uncertain significance,Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,single nucleotide variant,GRCh38
na,na,3,10331519,10331519,GHRL,risk factor,"Metabolic syndrome, susceptibility to|Obesity",single nucleotide variant,GRCh37
na,na,3,10289835,10289835,GHRL,risk factor,"Metabolic syndrome, susceptibility to|Obesity",single nucleotide variant,GRCh38
na,na,3,10331457,10331457,GHRL,Conflicting classifications of pathogenicity,"Metabolic syndrome, susceptibility to|Obesity, age at onset of|not provided|Obesity|Inherited obesity",single nucleotide variant,GRCh37
na,na,3,10289773,10289773,GHRL,Conflicting classifications of pathogenicity,"Metabolic syndrome, susceptibility to|Obesity, age at onset of|not provided|Obesity|Inherited obesity",single nucleotide variant,GRCh38
na,na,3,10328453,10328453,GHRL,Benign,Obesity|not provided,single nucleotide variant,GRCh37
na,na,3,10286769,10286769,GHRL,Benign,Obesity|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,GHRL,Benign,GHRELIN POLYMORPHISM,Deletion,na
na,na,1,196722206,196808505,CFHR1;CFHR3,Pathogenic; risk factor,"Hemolytic uremic syndrome, atypical, susceptibility to|Age-related macular degeneration",Deletion,GRCh37
na,na,1,196753076,196839375,CFHR1;CFHR3,Pathogenic; risk factor,"Hemolytic uremic syndrome, atypical, susceptibility to|Age-related macular degeneration",Deletion,GRCh38
na,na,7,99270539,99270539,CYP3A5,association; drug response; risk factor,"Hypertension, salt-sensitive essential, susceptibility to|refractory myasthenia gravis|Tacrolimus response",single nucleotide variant,GRCh37
na,na,7,99672916,99672916,CYP3A5,association; drug response; risk factor,"Hypertension, salt-sensitive essential, susceptibility to|refractory myasthenia gravis|Tacrolimus response",single nucleotide variant,GRCh38
na,na,7,114302130,114302130,FOXP2,Pathogenic/Likely pathogenic,Childhood apraxia of speech|FOXP2-related disorder,single nucleotide variant,GRCh37
na,na,7,114662075,114662075,FOXP2,Pathogenic/Likely pathogenic,Childhood apraxia of speech|FOXP2-related disorder,single nucleotide variant,GRCh38
na,na,7,114282671,114282671,FOXP2,Pathogenic,Childhood apraxia of speech|not provided|Inborn genetic diseases|See cases,single nucleotide variant,GRCh37
na,na,7,114642616,114642616,FOXP2,Pathogenic,Childhood apraxia of speech|not provided|Inborn genetic diseases|See cases,single nucleotide variant,GRCh38
na,na,2,240009284,240009285,HDAC4,Pathogenic,Chromosome 2q37 deletion syndrome|not provided,Duplication,GRCh37
na,na,2,239087588,239087589,HDAC4,Pathogenic,Chromosome 2q37 deletion syndrome|not provided,Duplication,GRCh38
na,na,2,240097989,240098053,HDAC4,Uncertain significance,Chromosome 2q37 deletion syndrome,Deletion,GRCh37
na,na,2,239176293,239176357,HDAC4,Uncertain significance,Chromosome 2q37 deletion syndrome,Deletion,GRCh38
na,na,16,75513206,75513206,CHST6,Pathogenic,Macular corneal dystrophy,single nucleotide variant,GRCh37
na,na,16,75479308,75479308,CHST6,Pathogenic,Macular corneal dystrophy,single nucleotide variant,GRCh38
na,na,16,75513118,75513118,CHST6,Pathogenic,Macular corneal dystrophy,single nucleotide variant,GRCh37
na,na,16,75479220,75479220,CHST6,Pathogenic,Macular corneal dystrophy,single nucleotide variant,GRCh38
na,na,na,-1,-1,CHST6,Pathogenic,"Macular corneal dystrophy, type II",Complex,na
na,na,na,-1,-1,CHST6,Pathogenic,"Macular corneal dystrophy, type II",Deletion,na
na,na,16,75513128,75513128,CHST6,Pathogenic,"Macular corneal dystrophy, type II|Macular corneal dystrophy|not provided|CHST6-related disorder",single nucleotide variant,GRCh37
na,na,16,75479230,75479230,CHST6,Pathogenic,"Macular corneal dystrophy, type II|Macular corneal dystrophy|not provided|CHST6-related disorder",single nucleotide variant,GRCh38
na,na,16,75513423,75513423,CHST6,Pathogenic,Macular corneal dystrophy,single nucleotide variant,GRCh37
na,na,16,75479525,75479525,CHST6,Pathogenic,Macular corneal dystrophy,single nucleotide variant,GRCh38
na,na,16,75513398,75513398,CHST6,Pathogenic,Macular corneal dystrophy,single nucleotide variant,GRCh37
na,na,16,75479500,75479500,CHST6,Pathogenic,Macular corneal dystrophy,single nucleotide variant,GRCh38
na,na,16,75512900,75512900,CHST6,Conflicting classifications of pathogenicity,Macular corneal dystrophy,single nucleotide variant,GRCh37
na,na,16,75479002,75479002,CHST6,Conflicting classifications of pathogenicity,Macular corneal dystrophy,single nucleotide variant,GRCh38
na,na,16,75513450,75513450,CHST6,Pathogenic,"Macular corneal dystrophy, type II",single nucleotide variant,GRCh37
na,na,16,75479552,75479552,CHST6,Pathogenic,"Macular corneal dystrophy, type II",single nucleotide variant,GRCh38
na,na,3,193355769,193355769,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form|not provided,single nucleotide variant,GRCh37
na,na,3,193637980,193637980,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form|not provided,single nucleotide variant,GRCh38
na,na,3,193360553,193360553,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form|not provided,single nucleotide variant,GRCh37
na,na,3,193642764,193642764,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form|not provided,single nucleotide variant,GRCh38
na,na,3,193384957,193384960,OPA1,Pathogenic/Likely pathogenic,"Autosomal dominant optic atrophy classic form|not provided|Abortive cerebellar ataxia|Mitochondrial disease|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy;Mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type);Autosomal dominant optic atrophy classic form;Glaucoma, normal tension, susceptibility to;Abortive cerebellar ataxia|Retinal dystrophy|Tip-toe gait|OPA1-related disorder|See cases|Optic atrophy|3-Methylglutaconic aciduria type 3",Deletion,GRCh37
na,na,3,193667168,193667171,OPA1,Pathogenic/Likely pathogenic,"Autosomal dominant optic atrophy classic form|not provided|Abortive cerebellar ataxia|Mitochondrial disease|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy;Mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type);Autosomal dominant optic atrophy classic form;Glaucoma, normal tension, susceptibility to;Abortive cerebellar ataxia|Retinal dystrophy|Tip-toe gait|OPA1-related disorder|See cases|Optic atrophy|3-Methylglutaconic aciduria type 3",Deletion,GRCh38
na,na,3,193409856,193409859,OPA1,Pathogenic/Likely pathogenic,Autosomal dominant optic atrophy classic form|not provided|Optic atrophy,Deletion,GRCh37
na,na,3,193692067,193692070,OPA1,Pathogenic/Likely pathogenic,Autosomal dominant optic atrophy classic form|not provided|Optic atrophy,Deletion,GRCh38
na,na,3,193355069,193355069,OPA1,Pathogenic/Likely pathogenic,"Autosomal dominant optic atrophy classic form|not provided|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,3,193637280,193637280,OPA1,Pathogenic/Likely pathogenic,"Autosomal dominant optic atrophy classic form|not provided|Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,3,193360794,193360794,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form|not provided|OPA1-related optic atrophy with or without extraocular features|Optic atrophy,single nucleotide variant,GRCh37
na,na,3,193643005,193643005,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form|not provided|OPA1-related optic atrophy with or without extraocular features|Optic atrophy,single nucleotide variant,GRCh38
na,na,3,193361397,193361399,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form,Microsatellite,GRCh37
na,na,3,193643608,193643610,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form,Microsatellite,GRCh38
na,na,3,193361804,193361804,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form,Deletion,GRCh37
na,na,3,193644015,193644015,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form,Deletion,GRCh38
na,na,3,193409858,193409858,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form,Deletion,GRCh37
na,na,3,193692069,193692069,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form,Deletion,GRCh38
na,na,3,193355074,193355074,OPA1,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,3,193637285,193637285,OPA1,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,3,193365898,193365898,OPA1,Pathogenic,"Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy",single nucleotide variant,GRCh37
na,na,3,193648109,193648109,OPA1,Pathogenic,"Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy",single nucleotide variant,GRCh38
na,na,3,193361785,193361785,OPA1,Pathogenic/Likely pathogenic,"Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|not provided|Mitochondrial disease|OPA1-related disorder|Autosomal dominant optic atrophy classic form|Optic atrophy|Centronuclear myopathy",single nucleotide variant,GRCh37
na,na,3,193643996,193643996,OPA1,Pathogenic/Likely pathogenic,"Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy|not provided|Mitochondrial disease|OPA1-related disorder|Autosomal dominant optic atrophy classic form|Optic atrophy|Centronuclear myopathy",single nucleotide variant,GRCh38
na,na,3,193409881,193409882,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form,Deletion,GRCh37
na,na,3,193692092,193692093,OPA1,Pathogenic,Autosomal dominant optic atrophy classic form,Deletion,GRCh38
na,na,2,241531174,241531174,CAPN10,risk factor,"Type 2 diabetes mellitus 1, susceptibility to",single nucleotide variant,GRCh37
na,na,2,240591757,240591757,CAPN10,risk factor,"Type 2 diabetes mellitus 1, susceptibility to",single nucleotide variant,GRCh38
na,na,2,241534241,241534242,CAPN10,risk factor,"Type 2 diabetes mellitus 1, susceptibility to",Duplication,GRCh37
na,na,2,240594824,240594825,CAPN10,risk factor,"Type 2 diabetes mellitus 1, susceptibility to",Duplication,GRCh38
na,na,2,241542703,241542703,CAPN10,risk factor,"Type 2 diabetes mellitus 1, susceptibility to",single nucleotide variant,GRCh37
na,na,2,240603286,240603286,CAPN10,risk factor,"Type 2 diabetes mellitus 1, susceptibility to",single nucleotide variant,GRCh38
na,na,2,241531163,241531163,CAPN10,risk factor,"|Type 2 diabetes mellitus 1, susceptibility to",single nucleotide variant,GRCh37
na,na,2,240591746,240591746,CAPN10,risk factor,"|Type 2 diabetes mellitus 1, susceptibility to",single nucleotide variant,GRCh38
na,na,9,135781074,135781077,TSC1,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome|not provided,Microsatellite,GRCh37
na,na,9,132905687,132905690,TSC1,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome|not provided,Microsatellite,GRCh38
na,na,9,135787833,135787833,TSC1,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome,single nucleotide variant,GRCh37
na,na,9,132912446,132912446,TSC1,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome,single nucleotide variant,GRCh38
na,na,9,135781205,135781205,TSC1,Benign,Tuberous sclerosis 1|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Lung lymphangioleiomyomatosis,single nucleotide variant,GRCh37
na,na,9,132905818,132905818,TSC1,Benign,Tuberous sclerosis 1|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Lung lymphangioleiomyomatosis,single nucleotide variant,GRCh38
na,na,9,135781060,135781061,TSC1,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|TSC1-related disorder,Microsatellite,GRCh37
na,na,9,132905673,132905674,TSC1,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|TSC1-related disorder,Microsatellite,GRCh38
na,na,9,135798748,135798748,TSC1,Pathogenic,Lymphangiomyomatosis,single nucleotide variant,GRCh37
na,na,9,132923361,132923361,TSC1,Pathogenic,Lymphangiomyomatosis,single nucleotide variant,GRCh38
na,na,9,135779052,135779052,TSC1,Conflicting classifications of pathogenicity,Focal cortical dysplasia of Taylor type 2B|Tuberous sclerosis 1|not provided|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II,single nucleotide variant,GRCh37
na,na,9,132903665,132903665,TSC1,Conflicting classifications of pathogenicity,Focal cortical dysplasia of Taylor type 2B|Tuberous sclerosis 1|not provided|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II,single nucleotide variant,GRCh38
na,na,9,135796816,135796816,TSC1,Likely pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome,single nucleotide variant,GRCh37
na,na,9,132921429,132921429,TSC1,Likely pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome,single nucleotide variant,GRCh38
na,na,9,135797330,135797330,TSC1,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome,single nucleotide variant,GRCh37
na,na,9,132921943,132921943,TSC1,Pathogenic,Tuberous sclerosis 1|Tuberous sclerosis syndrome,single nucleotide variant,GRCh38
na,na,14,94754643,94754643,SERPINA10,Uncertain significance,"Venous thrombosis, susceptibility to|not provided",single nucleotide variant,GRCh37
na,na,14,94288306,94288306,SERPINA10,Uncertain significance,"Venous thrombosis, susceptibility to|not provided",single nucleotide variant,GRCh38
na,na,17,78187614,78187614,CARD14;SGSH,Pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Sanfilippo syndrome|Inborn genetic diseases|Mucopolysaccharidosis|Neurodegeneration|SGSH-related disorder",single nucleotide variant,GRCh37
na,na,17,80213815,80213815,CARD14;SGSH,Pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Sanfilippo syndrome|Inborn genetic diseases|Mucopolysaccharidosis|Neurodegeneration|SGSH-related disorder",single nucleotide variant,GRCh38
na,na,17,78190860,78190860,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Abnormal circulating carbohydrate concentration|Mucopolysaccharidosis",single nucleotide variant,GRCh37
na,na,17,80217061,80217061,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Abnormal circulating carbohydrate concentration|Mucopolysaccharidosis",single nucleotide variant,GRCh38
na,na,17,78184462,78184462,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,17,80210663,80210663,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,17,78188537,78188537,SGSH,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-A|not specified",single nucleotide variant,GRCh37
na,na,17,80214738,80214738,SGSH,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-III-A|not specified",single nucleotide variant,GRCh38
na,na,17,78190883,78190883,SGSH;SLC26A11,Pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Sanfilippo syndrome|Mucopolysaccharidosis|Inborn genetic diseases|SGSH-related disorder",single nucleotide variant,GRCh37
na,na,17,80217084,80217084,SGSH;SLC26A11,Pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|Sanfilippo syndrome|Mucopolysaccharidosis|Inborn genetic diseases|SGSH-related disorder",single nucleotide variant,GRCh38
na,na,17,78188471,78188471,SGSH,Pathogenic,"Mucopolysaccharidosis, MPS-III-A|SGSH-related disorder",single nucleotide variant,GRCh37
na,na,17,80214672,80214672,SGSH,Pathogenic,"Mucopolysaccharidosis, MPS-III-A|SGSH-related disorder",single nucleotide variant,GRCh38
na,na,17,78184421,78184421,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|Inborn genetic diseases|not provided",single nucleotide variant,GRCh37
na,na,17,80210622,80210622,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|Inborn genetic diseases|not provided",single nucleotide variant,GRCh38
na,na,17,78184655,78184655,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|SGSH-related disorder",single nucleotide variant,GRCh37
na,na,17,80210856,80210856,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A|not provided|SGSH-related disorder",single nucleotide variant,GRCh38
na,na,17,78188017,78188017,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A",single nucleotide variant,GRCh37
na,na,17,80214218,80214218,SGSH,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-III-A",single nucleotide variant,GRCh38
na,na,16,87637894,87637896,JPH3,Pathogenic,Huntington disease-like 2,Microsatellite,GRCh37
na,na,16,87604288,87604290,JPH3,Pathogenic,Huntington disease-like 2,Microsatellite,GRCh38
na,na,8,134270617,134270617,NDRG1,Pathogenic,Charcot-Marie-Tooth disease type 4D|Charcot-Marie-Tooth disease type 4|not provided,single nucleotide variant,GRCh37
na,na,8,133258374,133258374,NDRG1,Pathogenic,Charcot-Marie-Tooth disease type 4D|Charcot-Marie-Tooth disease type 4|not provided,single nucleotide variant,GRCh38
na,na,8,134266839,134266839,NDRG1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4D|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,8,133254596,133254596,NDRG1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 4D|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,12,8759547,8759547,AICDA,Pathogenic,Hyper-IgM syndrome type 2,single nucleotide variant,GRCh37
na,na,12,8606951,8606951,AICDA,Pathogenic,Hyper-IgM syndrome type 2,single nucleotide variant,GRCh38
na,na,12,8758035,8758035,AICDA,Pathogenic,Hyper-IgM syndrome type 2|not provided,single nucleotide variant,GRCh37
na,na,12,8605439,8605439,AICDA,Pathogenic,Hyper-IgM syndrome type 2|not provided,single nucleotide variant,GRCh38
na,na,12,8758000,8758000,AICDA,Uncertain significance,Hyper-IgM syndrome type 2,single nucleotide variant,GRCh37
na,na,12,8605404,8605404,AICDA,Uncertain significance,Hyper-IgM syndrome type 2,single nucleotide variant,GRCh38
na,na,12,8757921,8757921,AICDA,Pathogenic,Hyper-IgM syndrome type 2,single nucleotide variant,GRCh37
na,na,12,8605325,8605325,AICDA,Pathogenic,Hyper-IgM syndrome type 2,single nucleotide variant,GRCh38
na,na,12,8757823,8757823,AICDA,Pathogenic,Hyper-IgM syndrome type 2|not provided,single nucleotide variant,GRCh37
na,na,12,8605227,8605227,AICDA,Pathogenic,Hyper-IgM syndrome type 2|not provided,single nucleotide variant,GRCh38
na,na,12,8757505,8757505,AICDA,Pathogenic,Hyper-IgM syndrome type 2|not provided,single nucleotide variant,GRCh37
na,na,12,8604909,8604909,AICDA,Pathogenic,Hyper-IgM syndrome type 2|not provided,single nucleotide variant,GRCh38
na,na,12,8757494,8757494,AICDA,Pathogenic,Hyper-IgM syndrome type 2,single nucleotide variant,GRCh37
na,na,12,8604898,8604898,AICDA,Pathogenic,Hyper-IgM syndrome type 2,single nucleotide variant,GRCh38
na,na,12,8759577,8759595,AICDA,Pathogenic,Hyper-IgM syndrome type 2,Deletion,GRCh37
na,na,12,8606981,8606999,AICDA,Pathogenic,Hyper-IgM syndrome type 2,Deletion,GRCh38
na,na,12,8758053,8758061,AICDA,Pathogenic,Hyper-IgM syndrome type 2,Deletion,GRCh37
na,na,12,8605457,8605465,AICDA,Pathogenic,Hyper-IgM syndrome type 2,Deletion,GRCh38
na,na,19,7591645,7591645,MCOLN1,Pathogenic,Mucolipidosis type IV|not provided|Mucolipidosis|Mucolipidosis type IV;Lisch epithelial corneal dystrophy,single nucleotide variant,GRCh37
na,na,19,7526759,7526759,MCOLN1,Pathogenic,Mucolipidosis type IV|not provided|Mucolipidosis|Mucolipidosis type IV;Lisch epithelial corneal dystrophy,single nucleotide variant,GRCh38
na,na,19,7586622,7593055,MCOLN1,Pathogenic,Mucolipidosis type IV,Deletion,GRCh37
na,na,19,7521736,7528169,MCOLN1,Pathogenic,Mucolipidosis type IV,Deletion,GRCh38
na,na,19,7593569,7593569,MCOLN1,Pathogenic,Mucolipidosis type IV|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,7528683,7528683,MCOLN1,Pathogenic,Mucolipidosis type IV|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,7593806,7593806,MCOLN1,Pathogenic/Likely pathogenic,Mucolipidosis type IV|not provided|MCOLN1-related disorder|Lisch epithelial corneal dystrophy;Mucolipidosis type IV,single nucleotide variant,GRCh37
na,na,19,7528920,7528920,MCOLN1,Pathogenic/Likely pathogenic,Mucolipidosis type IV|not provided|MCOLN1-related disorder|Lisch epithelial corneal dystrophy;Mucolipidosis type IV,single nucleotide variant,GRCh38
na,na,19,7591391,7591391,MCOLN1,Pathogenic,Mucolipidosis type IV|not provided,single nucleotide variant,GRCh37
na,na,19,7526505,7526505,MCOLN1,Pathogenic,Mucolipidosis type IV|not provided,single nucleotide variant,GRCh38
na,na,19,7594059,7594059,MCOLN1,Pathogenic/Likely pathogenic,Mucolipidosis type IV,single nucleotide variant,GRCh37
na,na,19,7529173,7529173,MCOLN1,Pathogenic/Likely pathogenic,Mucolipidosis type IV,single nucleotide variant,GRCh38
na,na,na,-1,-1,MCOLN1,Pathogenic,Mucolipidosis type IV,Insertion,na
na,na,11,17548589,17548589,USH1C,Pathogenic,Usher syndrome type 1C|Usher syndrome type 1|not provided|Retinal dystrophy|Usher syndrome type 1C;Autosomal recessive nonsyndromic hearing loss 18A|Autosomal recessive nonsyndromic hearing loss 18A,Deletion,GRCh37
na,na,11,17527042,17527042,USH1C,Pathogenic,Usher syndrome type 1C|Usher syndrome type 1|not provided|Retinal dystrophy|Usher syndrome type 1C;Autosomal recessive nonsyndromic hearing loss 18A|Autosomal recessive nonsyndromic hearing loss 18A,Deletion,GRCh38
na,na,11,17552955,17552956,USH1C,Pathogenic,"Usher syndrome type 1C|Usher syndrome type 1|Usher syndrome|Retinal dystrophy|Retinitis pigmentosa|Hearing loss, autosomal recessive|not provided|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 18A|Autosomal recessive nonsyndromic hearing loss 18A;Usher syndrome type 1C|USH1C-related disorder",Duplication,GRCh37
na,na,11,17531408,17531409,USH1C,Pathogenic,"Usher syndrome type 1C|Usher syndrome type 1|Usher syndrome|Retinal dystrophy|Retinitis pigmentosa|Hearing loss, autosomal recessive|not provided|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 18A|Autosomal recessive nonsyndromic hearing loss 18A;Usher syndrome type 1C|USH1C-related disorder",Duplication,GRCh38
na,na,11,17548737,17548737,USH1C,Pathogenic,Usher syndrome type 1C|Usher syndrome type 1,Microsatellite,GRCh37
na,na,11,17527112,17527113,USH1C,Pathogenic,Usher syndrome type 1C|Usher syndrome type 1,Microsatellite,GRCh38
na,na,11,17552978,17552978,USH1C,Pathogenic,Usher syndrome type 1C|Usher syndrome|not provided|Usher syndrome type 1|Rare genetic deafness|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A;Usher syndrome type 1C|Autosomal recessive nonsyndromic hearing loss 18A|USH1C-related disorder,single nucleotide variant,GRCh37
na,na,11,17531431,17531431,USH1C,Pathogenic,Usher syndrome type 1C|Usher syndrome|not provided|Usher syndrome type 1|Rare genetic deafness|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A;Usher syndrome type 1C|Autosomal recessive nonsyndromic hearing loss 18A|USH1C-related disorder,single nucleotide variant,GRCh38
na,na,11,17565818,17565818,USH1C,Pathogenic,Usher syndrome type 1C,single nucleotide variant,GRCh37
na,na,11,17544271,17544271,USH1C,Pathogenic,Usher syndrome type 1C,single nucleotide variant,GRCh38
na,na,11,17554815,17554815,USH1C,Pathogenic,Usher syndrome type 1C|Autosomal recessive nonsyndromic hearing loss 18A|not provided|Autosomal recessive nonsyndromic hearing loss 18A;Usher syndrome type 1;Usher syndrome type 1C,single nucleotide variant,GRCh37
na,na,11,17533268,17533268,USH1C,Pathogenic,Usher syndrome type 1C|Autosomal recessive nonsyndromic hearing loss 18A|not provided|Autosomal recessive nonsyndromic hearing loss 18A;Usher syndrome type 1;Usher syndrome type 1C,single nucleotide variant,GRCh38
na,na,11,17544326,17544326,USH1C,no classifications from unflagged records,Autosomal recessive nonsyndromic hearing loss 18A,single nucleotide variant,GRCh37
na,na,11,17522779,17522779,USH1C,no classifications from unflagged records,Autosomal recessive nonsyndromic hearing loss 18A,single nucleotide variant,GRCh38
na,na,11,17531093,17531093,USH1C,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 18A|not specified|not provided|Usher syndrome type 1C|Meniere disease|Optic atrophy|Retinal dystrophy|Usher syndrome type 1C;Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A,single nucleotide variant,GRCh37
na,na,11,17509546,17509546,USH1C,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 18A|not specified|not provided|Usher syndrome type 1C|Meniere disease|Optic atrophy|Retinal dystrophy|Usher syndrome type 1C;Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A,single nucleotide variant,GRCh38
na,na,11,17548878,17548878,USH1C,Benign/Likely benign,Usher syndrome type 1C|not specified|not provided|Usher syndrome type 1C;Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A,single nucleotide variant,GRCh37
na,na,11,17527331,17527331,USH1C,Benign/Likely benign,Usher syndrome type 1C|not specified|not provided|Usher syndrome type 1C;Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 18A,single nucleotide variant,GRCh38
na,na,7,138400509,138400509,ATP6V0A4,Pathogenic,"Autosomal recessive distal renal tubular acidosis|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided",single nucleotide variant,GRCh37
na,na,7,138715764,138715764,ATP6V0A4,Pathogenic,"Autosomal recessive distal renal tubular acidosis|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided",single nucleotide variant,GRCh38
na,na,7,138391434,138391434,ATP6V0A4,Uncertain significance,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided",single nucleotide variant,GRCh37
na,na,7,138706689,138706689,ATP6V0A4,Uncertain significance,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided",single nucleotide variant,GRCh38
na,na,7,138418880,138418880,ATP6V0A4,Pathogenic/Likely pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh37
na,na,7,138734135,138734135,ATP6V0A4,Pathogenic/Likely pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh38
na,na,7,138455888,138455888,ATP6V0A4,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",Deletion,GRCh37
na,na,7,138771143,138771143,ATP6V0A4,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",Deletion,GRCh38
na,na,7,138417791,138417791,ATP6V0A4,Benign/Likely benign,"Autosomal recessive distal renal tubular acidosis|not specified|not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh37
na,na,7,138733046,138733046,ATP6V0A4,Benign/Likely benign,"Autosomal recessive distal renal tubular acidosis|not specified|not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh38
na,na,7,138447180,138447180,ATP6V0A4,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh37
na,na,7,138762435,138762435,ATP6V0A4,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh38
na,na,7,138437570,138437570,ATP6V0A4,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",Deletion,GRCh37
na,na,7,138752825,138752825,ATP6V0A4,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",Deletion,GRCh38
na,na,7,138424286,138424286,ATP6V0A4,Conflicting classifications of pathogenicity,"not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|Renal tubular acidosis with progressive nerve deafness;Autosomal recessive distal renal tubular acidosis",single nucleotide variant,GRCh37
na,na,7,138739541,138739541,ATP6V0A4,Conflicting classifications of pathogenicity,"not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|Renal tubular acidosis with progressive nerve deafness;Autosomal recessive distal renal tubular acidosis",single nucleotide variant,GRCh38
na,na,7,138424351,138424351,ATP6V0A4,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh37
na,na,7,138739606,138739606,ATP6V0A4,Pathogenic,"Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh38
na,na,7,138394378,138394378,ATP6V0A4,Pathogenic/Likely pathogenic,"Autosomal recessive distal renal tubular acidosis|not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh37
na,na,7,138709633,138709633,ATP6V0A4,Pathogenic/Likely pathogenic,"Autosomal recessive distal renal tubular acidosis|not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss",single nucleotide variant,GRCh38
na,na,2,138759649,138759649,HNMT,Benign; risk factor,Inherited susceptibility to asthma|HNMT-related disorder,single nucleotide variant,GRCh37
na,na,2,138002079,138002079,HNMT,Benign; risk factor,Inherited susceptibility to asthma|HNMT-related disorder,single nucleotide variant,GRCh38
na,na,12,875762,917034,WNK1,Pathogenic,Pseudohypoaldosteronism type 2C,Deletion,GRCh37
na,na,12,766596,807868,WNK1,Pathogenic,Pseudohypoaldosteronism type 2C,Deletion,GRCh38
na,na,12,885724,907501,WNK1,Pathogenic,Pseudohypoaldosteronism type 2C,Deletion,GRCh37
na,na,12,776558,798335,WNK1,Pathogenic,Pseudohypoaldosteronism type 2C,Deletion,GRCh38
na,na,12,977212,977212,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A",single nucleotide variant,GRCh37
na,na,12,868046,868046,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A",single nucleotide variant,GRCh38
na,na,12,977938,977938,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A|Inborn genetic diseases|Pseudohypoaldosteronism type 2C;Neuropathy, hereditary sensory and autonomic, type 2A",single nucleotide variant,GRCh37
na,na,12,868772,868772,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A|Inborn genetic diseases|Pseudohypoaldosteronism type 2C;Neuropathy, hereditary sensory and autonomic, type 2A",single nucleotide variant,GRCh38
na,na,12,977863,977863,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A|not provided|Pseudohypoaldosteronism type 2C;Neuropathy, hereditary sensory and autonomic, type 2A",single nucleotide variant,GRCh37
na,na,12,868697,868697,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A|not provided|Pseudohypoaldosteronism type 2C;Neuropathy, hereditary sensory and autonomic, type 2A",single nucleotide variant,GRCh38
na,na,na,-1,-1,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A",Insertion,na
na,na,12,977636,977636,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A",Deletion,GRCh37
na,na,12,868470,868470,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A",Deletion,GRCh38
na,na,12,968594,968595,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A",Microsatellite,GRCh37
na,na,12,859428,859429,WNK1,Pathogenic,"Neuropathy, hereditary sensory and autonomic, type 2A",Microsatellite,GRCh38
na,na,1,231768539,231768539,DISC1,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,1,231632793,231632793,DISC1,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,15,73616557,73616557,HCN4,Pathogenic,"Sick sinus syndrome 2, autosomal dominant",single nucleotide variant,GRCh37
na,na,15,73324216,73324216,HCN4,Pathogenic,"Sick sinus syndrome 2, autosomal dominant",single nucleotide variant,GRCh38
na,na,15,73617745,73617745,HCN4,Pathogenic,"Sick sinus syndrome 2, autosomal dominant",Deletion,GRCh37
na,na,15,73325404,73325404,HCN4,Pathogenic,"Sick sinus syndrome 2, autosomal dominant",Deletion,GRCh38
na,na,15,73617719,73617719,HCN4,Uncertain significance,"Sick sinus syndrome 2, autosomal dominant|Brugada syndrome 8",single nucleotide variant,GRCh37
na,na,15,73325378,73325378,HCN4,Uncertain significance,"Sick sinus syndrome 2, autosomal dominant|Brugada syndrome 8",single nucleotide variant,GRCh38
na,na,15,73622066,73622066,HCN4,Pathogenic,"Sick sinus syndrome 2, autosomal dominant",single nucleotide variant,GRCh37
na,na,15,73329725,73329725,HCN4,Pathogenic,"Sick sinus syndrome 2, autosomal dominant",single nucleotide variant,GRCh38
na,na,15,73635723,73635724,HCN4,Uncertain significance,Brugada syndrome 8|Ventricular tachycardia|Cardiovascular phenotype,Insertion,GRCh37
na,na,15,73343382,73343383,HCN4,Uncertain significance,Brugada syndrome 8|Ventricular tachycardia|Cardiovascular phenotype,Insertion,GRCh38
na,na,na,-1,-1,ADCY10,risk factor,Familial idiopathic hypercalciuria,single nucleotide variant,na
na,na,9,132576341,132576343,TOR1A,Pathogenic/Likely pathogenic,Early-onset generalized limb-onset dystonia|not provided|Dystonic disorder|Inborn genetic diseases|TOR1A-related disorder|Early-onset generalized limb-onset dystonia;Arthrogryposis multiplex congenita 5|Arthrogryposis multiplex congenita 5,Microsatellite,GRCh37
na,na,9,129814062,129814064,TOR1A,Pathogenic/Likely pathogenic,Early-onset generalized limb-onset dystonia|not provided|Dystonic disorder|Inborn genetic diseases|TOR1A-related disorder|Early-onset generalized limb-onset dystonia;Arthrogryposis multiplex congenita 5|Arthrogryposis multiplex congenita 5,Microsatellite,GRCh38
na,na,9,132576267,132576284,TOR1A,Uncertain significance,"Dystonia, early-onset atypical, with myoclonic features|Early-onset generalized limb-onset dystonia",Deletion,GRCh37
na,na,9,129813988,129814005,TOR1A,Uncertain significance,"Dystonia, early-onset atypical, with myoclonic features|Early-onset generalized limb-onset dystonia",Deletion,GRCh38
na,na,9,132580901,132580901,TOR1A,Benign,|Early-onset generalized limb-onset dystonia|not specified|Dystonic disorder|not provided|Early-onset generalized limb-onset dystonia;Arthrogryposis multiplex congenita 5,single nucleotide variant,GRCh37
na,na,9,129818622,129818622,TOR1A,Benign,|Early-onset generalized limb-onset dystonia|not specified|Dystonic disorder|not provided|Early-onset generalized limb-onset dystonia;Arthrogryposis multiplex congenita 5,single nucleotide variant,GRCh38
na,na,15,90320084,90320085,MESP2,Pathogenic,"Spondylocostal dysostosis 2, autosomal recessive",Duplication,GRCh37
na,na,15,89776853,89776854,MESP2,Pathogenic,"Spondylocostal dysostosis 2, autosomal recessive",Duplication,GRCh38
na,na,15,90319895,90319895,MESP2,Pathogenic,"Spondylocostal dysostosis 2, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,15,89776664,89776664,MESP2,Pathogenic,"Spondylocostal dysostosis 2, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,15,90319961,90319961,MESP2,Uncertain significance,"Spondylocostal dysostosis 2, autosomal recessive|not specified",single nucleotide variant,GRCh37
na,na,15,89776730,89776730,MESP2,Uncertain significance,"Spondylocostal dysostosis 2, autosomal recessive|not specified",single nucleotide variant,GRCh38
na,na,15,90320288,90320288,MESP2,Pathogenic,"Spondylocostal dysostosis 2, autosomal recessive",single nucleotide variant,GRCh37
na,na,15,89777057,89777057,MESP2,Pathogenic,"Spondylocostal dysostosis 2, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,131355469,131355469,CFC1,Pathogenic,"Heterotaxy, visceral, 2, autosomal",single nucleotide variant,GRCh37
na,na,2,130597896,130597896,CFC1,Pathogenic,"Heterotaxy, visceral, 2, autosomal",single nucleotide variant,GRCh38
na,na,2,131350600,131350600,CFC1,Conflicting classifications of pathogenicity,"Heterotaxy, visceral, 2, autosomal|not provided|not specified",Deletion,GRCh37
na,na,2,130593027,130593027,CFC1,Conflicting classifications of pathogenicity,"Heterotaxy, visceral, 2, autosomal|not provided|not specified",Deletion,GRCh38
na,na,2,131355422,131355423,CFC1,Pathogenic,"Heterotaxy, visceral, 2, autosomal",Duplication,GRCh37
na,na,2,130597849,130597850,CFC1,Pathogenic,"Heterotaxy, visceral, 2, autosomal",Duplication,GRCh38
na,na,5,14716825,14716827,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|not provided|Chondrocalcinosis 2",Microsatellite,GRCh37
na,na,5,14716716,14716718,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|not provided|Chondrocalcinosis 2",Microsatellite,GRCh38
na,na,5,14713753,14713753,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|Chondrocalcinosis 2",single nucleotide variant,GRCh37
na,na,5,14713644,14713644,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|Chondrocalcinosis 2",single nucleotide variant,GRCh38
na,na,5,14713780,14713780,ANKH,Pathogenic/Likely pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|not provided",single nucleotide variant,GRCh37
na,na,5,14713671,14713671,ANKH,Pathogenic/Likely pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|not provided",single nucleotide variant,GRCh38
na,na,5,14716830,14716832,ANKH,Pathogenic/Likely pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|not provided",Deletion,GRCh37
na,na,5,14716721,14716723,ANKH,Pathogenic/Likely pathogenic,"Craniometaphyseal dysplasia, autosomal dominant|not provided",Deletion,GRCh38
na,na,5,14769254,14769254,ANKH,Pathogenic,Chondrocalcinosis 2,single nucleotide variant,GRCh37
na,na,5,14769145,14769145,ANKH,Pathogenic,Chondrocalcinosis 2,single nucleotide variant,GRCh38
na,na,5,14871567,14871567,ANKH,Pathogenic,Chondrocalcinosis 2,single nucleotide variant,GRCh37
na,na,5,14871458,14871458,ANKH,Pathogenic,Chondrocalcinosis 2,single nucleotide variant,GRCh38
na,na,5,14711315,14711317,ANKH,Pathogenic,"Chondrocalcinosis 2, sporadic",Microsatellite,GRCh37
na,na,5,14711206,14711208,ANKH,Pathogenic,"Chondrocalcinosis 2, sporadic",Microsatellite,GRCh38
na,na,5,14871543,14871543,ANKH,Likely pathogenic,Chondrocalcinosis 2|not provided,single nucleotide variant,GRCh37
na,na,5,14871434,14871434,ANKH,Likely pathogenic,Chondrocalcinosis 2|not provided,single nucleotide variant,GRCh38
na,na,5,14871544,14871544,ANKH,Pathogenic/Likely pathogenic,Chondrocalcinosis 2|ANKH-related disorder,single nucleotide variant,GRCh37
na,na,5,14871435,14871435,ANKH,Pathogenic/Likely pathogenic,Chondrocalcinosis 2|ANKH-related disorder,single nucleotide variant,GRCh38
na,na,5,14716941,14716941,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant",single nucleotide variant,GRCh37
na,na,5,14716832,14716832,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant",single nucleotide variant,GRCh38
na,na,5,14713746,14713746,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant",single nucleotide variant,GRCh37
na,na,5,14713637,14713637,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant",single nucleotide variant,GRCh38
na,na,5,14741946,14741946,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant",single nucleotide variant,GRCh37
na,na,5,14741837,14741837,ANKH,Pathogenic,"Craniometaphyseal dysplasia, autosomal dominant",single nucleotide variant,GRCh38
na,na,16,78466465,78466465,WWOX,Uncertain significance,"Esophageal squamous cell carcinoma, somatic|Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12",single nucleotide variant,GRCh37
na,na,16,78432568,78432568,WWOX,Uncertain significance,"Esophageal squamous cell carcinoma, somatic|Developmental and epileptic encephalopathy, 1;Autosomal recessive spinocerebellar ataxia 12",single nucleotide variant,GRCh38
na,na,19,38782479,38782479,SPINT2,Pathogenic,Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh37
na,na,19,38291839,38291839,SPINT2,Pathogenic,Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh38
na,na,19,38780855,38780855,SPINT2,Pathogenic,not provided|Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh37
na,na,19,38290215,38290215,SPINT2,Pathogenic,not provided|Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh38
na,na,19,38778577,38778577,SPINT2,Pathogenic,Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh37
na,na,19,38287937,38287937,SPINT2,Pathogenic,Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh38
na,na,19,38780922,38780922,SPINT2,Pathogenic,Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh37
na,na,19,38290282,38290282,SPINT2,Pathogenic,Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh38
na,na,19,38755533,38755533,SPINT2,Pathogenic,Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh37
na,na,19,38264893,38264893,SPINT2,Pathogenic,Congenital secretory sodium diarrhea 3,single nucleotide variant,GRCh38
na,na,7,121738550,121738558,AASS,Pathogenic,Hyperlysinemia,Deletion,GRCh37
na,na,7,122098496,122098504,AASS,Pathogenic,Hyperlysinemia,Deletion,GRCh38
na,na,1,11106666,11106666,MASP2,Conflicting classifications of pathogenicity,Immunodeficiency due to MASP-2 deficiency|not specified|not provided|MASP2-related disorder,single nucleotide variant,GRCh37
na,na,1,11046609,11046609,MASP2,Conflicting classifications of pathogenicity,Immunodeficiency due to MASP-2 deficiency|not specified|not provided|MASP2-related disorder,single nucleotide variant,GRCh38
na,na,6,149699673,149699673,TAB2,Pathogenic,"Congenital heart defects, multiple types, 2",single nucleotide variant,GRCh37
na,na,6,149378537,149378537,TAB2,Pathogenic,"Congenital heart defects, multiple types, 2",single nucleotide variant,GRCh38
na,na,6,149699739,149699739,TAB2,Uncertain significance,"Congenital heart defects, multiple types, 2|not provided",single nucleotide variant,GRCh37
na,na,6,149378603,149378603,TAB2,Uncertain significance,"Congenital heart defects, multiple types, 2|not provided",single nucleotide variant,GRCh38
na,na,6,41129159,41129159,TREM2,Likely pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,single nucleotide variant,GRCh37
na,na,6,41161421,41161421,TREM2,Likely pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,single nucleotide variant,GRCh38
na,na,6,41126729,41126729,TREM2,Uncertain significance,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,single nucleotide variant,GRCh37
na,na,6,41158991,41158991,TREM2,Uncertain significance,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,single nucleotide variant,GRCh38
na,na,6,41127611,41127611,TREM2,Uncertain significance,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,single nucleotide variant,GRCh37
na,na,6,41159873,41159873,TREM2,Uncertain significance,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,single nucleotide variant,GRCh38
na,na,6,41129260,41129260,TREM2,Likely pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,single nucleotide variant,GRCh37
na,na,6,41161522,41161522,TREM2,Likely pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2,single nucleotide variant,GRCh38
na,na,6,41129015,41129015,TREM2,Pathogenic/Likely pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2|TREM2-related disorder,single nucleotide variant,GRCh37
na,na,6,41161277,41161277,TREM2,Pathogenic/Likely pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2|TREM2-related disorder,single nucleotide variant,GRCh38
na,na,6,41129295,41129295,TREM2,Pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2|Inborn genetic diseases|not provided|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly,single nucleotide variant,GRCh37
na,na,6,41161557,41161557,TREM2,Pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2|Inborn genetic diseases|not provided|Polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly,single nucleotide variant,GRCh38
na,na,2,183699584,183699584,FRZB,Benign; risk factor,FRZB-related disorder|Osteoarthritis susceptibility 1,single nucleotide variant,GRCh37
na,na,2,182834857,182834857,FRZB,Benign; risk factor,FRZB-related disorder|Osteoarthritis susceptibility 1,single nucleotide variant,GRCh38
na,na,2,183703336,183703336,FRZB,Benign; risk factor,Osteoarthritis susceptibility 1|FRZB-related disorder,single nucleotide variant,GRCh37
na,na,2,182838608,182838608,FRZB,Benign; risk factor,Osteoarthritis susceptibility 1|FRZB-related disorder,single nucleotide variant,GRCh38
na,na,8,87644996,87644996,CNGB3,Pathogenic,Achromatopsia 3|not provided,single nucleotide variant,GRCh37
na,na,8,86632768,86632768,CNGB3,Pathogenic,Achromatopsia 3|not provided,single nucleotide variant,GRCh38
na,na,8,87680283,87680283,CNGB3,Pathogenic,Achromatopsia 3|not provided|Retinal dystrophy|Achromatopsia,single nucleotide variant,GRCh37
na,na,8,86668055,86668055,CNGB3,Pathogenic,Achromatopsia 3|not provided|Retinal dystrophy|Achromatopsia,single nucleotide variant,GRCh38
na,na,8,87656009,87656009,CNGB3,Pathogenic/Likely pathogenic,Achromatopsia 3|not provided|Achromatopsia|Leber congenital amaurosis|Abnormality of the eye|Retinitis pigmentosa|Retinal dystrophy|CNGB3-related disorder|Cone-rod dystrophy|Optic atrophy|Inborn genetic diseases,Deletion,GRCh37
na,na,8,86643781,86643781,CNGB3,Pathogenic/Likely pathogenic,Achromatopsia 3|not provided|Achromatopsia|Leber congenital amaurosis|Abnormality of the eye|Retinitis pigmentosa|Retinal dystrophy|CNGB3-related disorder|Cone-rod dystrophy|Optic atrophy|Inborn genetic diseases,Deletion,GRCh38
na,na,8,87641222,87641222,CNGB3,Benign/Likely benign,Severe early-childhood-onset retinal dystrophy|not specified|Achromatopsia 3|not provided|Achromatopsia,single nucleotide variant,GRCh37
na,na,8,86628994,86628994,CNGB3,Benign/Likely benign,Severe early-childhood-onset retinal dystrophy|not specified|Achromatopsia 3|not provided|Achromatopsia,single nucleotide variant,GRCh38
na,na,1,11082475,11082475,TARDBP,Pathogenic,"Amyotrophic lateral sclerosis type 10|not provided|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh37
na,na,1,11022418,11022418,TARDBP,Pathogenic,"Amyotrophic lateral sclerosis type 10|not provided|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh38
na,na,1,11082457,11082457,TARDBP,Pathogenic,Amyotrophic lateral sclerosis type 10,single nucleotide variant,GRCh37
na,na,1,11022400,11022400,TARDBP,Pathogenic,Amyotrophic lateral sclerosis type 10,single nucleotide variant,GRCh38
na,na,1,11082347,11082347,TARDBP,Uncertain significance,Amyotrophic lateral sclerosis type 10|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,1,11022290,11022290,TARDBP,Uncertain significance,Amyotrophic lateral sclerosis type 10|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,11082335,11082335,TARDBP,Uncertain significance,"Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh37
na,na,1,11022278,11022278,TARDBP,Uncertain significance,"Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh38
na,na,1,11082358,11082358,TARDBP,Pathogenic,"Amyotrophic lateral sclerosis type 10|not provided|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED|TARDBP-related disorder",single nucleotide variant,GRCh37
na,na,1,11022301,11022301,TARDBP,Pathogenic,"Amyotrophic lateral sclerosis type 10|not provided|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED|TARDBP-related disorder",single nucleotide variant,GRCh38
na,na,1,11078893,11078893,TARDBP,Pathogenic,Amyotrophic lateral sclerosis type 10,single nucleotide variant,GRCh37
na,na,1,11018836,11018836,TARDBP,Pathogenic,Amyotrophic lateral sclerosis type 10,single nucleotide variant,GRCh38
na,na,1,11082508,11082508,TARDBP,Pathogenic/Likely pathogenic,"Amyotrophic lateral sclerosis type 10|not provided|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh37
na,na,1,11022451,11022451,TARDBP,Pathogenic/Likely pathogenic,"Amyotrophic lateral sclerosis type 10|not provided|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh38
na,na,1,11082494,11082494,TARDBP,Pathogenic,Amyotrophic lateral sclerosis type 10,single nucleotide variant,GRCh37
na,na,1,11022437,11022437,TARDBP,Pathogenic,Amyotrophic lateral sclerosis type 10,single nucleotide variant,GRCh38
na,na,1,11082409,11082409,TARDBP,Pathogenic,"Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED|not provided",single nucleotide variant,GRCh37
na,na,1,11022352,11022352,TARDBP,Pathogenic,"Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED|not provided",single nucleotide variant,GRCh38
na,na,1,11082253,11082253,TARDBP,Pathogenic,"FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh37
na,na,1,11022196,11022196,TARDBP,Pathogenic,"FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh38
na,na,1,11083408,11083408,TARDBP,Uncertain significance,"Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh37
na,na,1,11023351,11023351,TARDBP,Uncertain significance,"Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED|Amyotrophic lateral sclerosis type 10;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED",single nucleotide variant,GRCh38
na,na,17,57157240,57157240,TRIM37,Pathogenic,Mulibrey nanism syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,59079879,59079879,TRIM37,Pathogenic,Mulibrey nanism syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,57161406,57161406,TRIM37,Conflicting classifications of pathogenicity,Mulibrey nanism syndrome|not specified,single nucleotide variant,GRCh37
na,na,17,59084045,59084045,TRIM37,Conflicting classifications of pathogenicity,Mulibrey nanism syndrome|not specified,single nucleotide variant,GRCh38
na,na,17,57141716,57141716,TRIM37,Likely pathogenic,Mulibrey nanism syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,59064355,59064355,TRIM37,Likely pathogenic,Mulibrey nanism syndrome|not provided,single nucleotide variant,GRCh38
na,na,20,25060079,25060079,VSX1,Uncertain significance,Keratoconus 1|Polymorphous corneal dystrophy,single nucleotide variant,GRCh37
na,na,20,25079443,25079443,VSX1,Uncertain significance,Keratoconus 1|Polymorphous corneal dystrophy,single nucleotide variant,GRCh38
na,na,20,25060096,25060096,VSX1,Conflicting classifications of pathogenicity,Posterior polymorphous corneal dystrophy 1|Polymorphous corneal dystrophy|not specified|not provided,single nucleotide variant,GRCh37
na,na,20,25079460,25079460,VSX1,Conflicting classifications of pathogenicity,Posterior polymorphous corneal dystrophy 1|Polymorphous corneal dystrophy|not specified|not provided,single nucleotide variant,GRCh38
na,na,20,25060100,25060100,VSX1,Likely benign,Keratoconus 1|Polymorphous corneal dystrophy,single nucleotide variant,GRCh37
na,na,20,25079464,25079464,VSX1,Likely benign,Keratoconus 1|Polymorphous corneal dystrophy,single nucleotide variant,GRCh38
na,na,20,25058363,25058363,VSX1,Uncertain significance,Craniofacial anomalies and anterior segment dysgenesis syndrome|not specified,single nucleotide variant,GRCh37
na,na,20,25077727,25077727,VSX1,Uncertain significance,Craniofacial anomalies and anterior segment dysgenesis syndrome|not specified,single nucleotide variant,GRCh38
na,na,20,25062683,25062683,VSX1,Likely benign,Keratoconus 1|Polymorphous corneal dystrophy|VSX1-related disorder,single nucleotide variant,GRCh37
na,na,20,25082047,25082047,VSX1,Likely benign,Keratoconus 1|Polymorphous corneal dystrophy|VSX1-related disorder,single nucleotide variant,GRCh38
na,na,16,50827576,50827576,CYLD,Pathogenic,Familial cylindromatosis,single nucleotide variant,GRCh37
na,na,16,50793665,50793665,CYLD,Pathogenic,Familial cylindromatosis,single nucleotide variant,GRCh38
na,na,16,50826538,50826538,CYLD,Pathogenic,Familial cylindromatosis|not specified|not provided|Brooke-Spiegler syndrome,single nucleotide variant,GRCh37
na,na,16,50792627,50792627,CYLD,Pathogenic,Familial cylindromatosis|not specified|not provided|Brooke-Spiegler syndrome,single nucleotide variant,GRCh38
na,na,16,50826518,50826518,CYLD,Pathogenic,Familial cylindromatosis|Brooke-Spiegler syndrome,Deletion,GRCh37
na,na,16,50792607,50792607,CYLD,Pathogenic,Familial cylindromatosis|Brooke-Spiegler syndrome,Deletion,GRCh38
na,na,16,50825530,50825530,CYLD,Pathogenic,Brooke-Spiegler syndrome,Deletion,GRCh37
na,na,16,50791619,50791619,CYLD,Pathogenic,Brooke-Spiegler syndrome,Deletion,GRCh38
na,na,16,50825598,50825599,CYLD,Pathogenic,Familial multiple trichoepitheliomata,Microsatellite,GRCh37
na,na,16,50791687,50791688,CYLD,Pathogenic,Familial multiple trichoepitheliomata,Microsatellite,GRCh38
na,na,16,50816379,50816379,CYLD,Pathogenic,Familial multiple trichoepitheliomata,single nucleotide variant,GRCh37
na,na,16,50782468,50782468,CYLD,Pathogenic,Familial multiple trichoepitheliomata,single nucleotide variant,GRCh38
na,na,16,50825600,50825600,CYLD,Pathogenic,Familial multiple trichoepitheliomata|Brooke-Spiegler syndrome,single nucleotide variant,GRCh37
na,na,16,50791689,50791689,CYLD,Pathogenic,Familial multiple trichoepitheliomata|Brooke-Spiegler syndrome,single nucleotide variant,GRCh38
na,na,16,50830354,50830354,CYLD,Pathogenic,"Familial cylindromatosis|Familial multiple trichoepitheliomata|Brooke-Spiegler syndrome|Familial cylindromatosis;Brooke-Spiegler syndrome;Trichoepithelioma, multiple familial, 1;Frontotemporal dementia and/or amyotrophic lateral sclerosis 8|not provided",single nucleotide variant,GRCh37
na,na,16,50796443,50796443,CYLD,Pathogenic,"Familial cylindromatosis|Familial multiple trichoepitheliomata|Brooke-Spiegler syndrome|Familial cylindromatosis;Brooke-Spiegler syndrome;Trichoepithelioma, multiple familial, 1;Frontotemporal dementia and/or amyotrophic lateral sclerosis 8|not provided",single nucleotide variant,GRCh38
na,na,16,50785566,50785567,CYLD,Pathogenic,Familial cylindromatosis,Duplication,GRCh37
na,na,16,50751655,50751656,CYLD,Pathogenic,Familial cylindromatosis,Duplication,GRCh38
na,na,16,50813828,50813829,CYLD,Pathogenic,Brooke-Spiegler syndrome,Duplication,GRCh37
na,na,16,50779917,50779918,CYLD,Pathogenic,Brooke-Spiegler syndrome,Duplication,GRCh38
na,na,16,50820763,50820766,CYLD,Pathogenic,Familial cylindromatosis,Deletion,GRCh37
na,na,16,50786852,50786855,CYLD,Pathogenic,Familial cylindromatosis,Deletion,GRCh38
na,na,6,144508133,144508140,STX11,Pathogenic,Familial hemophagocytic lymphohistiocytosis 4|not provided,Indel,GRCh37
na,na,6,144186996,144187003,STX11,Pathogenic,Familial hemophagocytic lymphohistiocytosis 4|not provided,Indel,GRCh38
na,na,6,144498026,144517214,STX11,Pathogenic,Familial hemophagocytic lymphohistiocytosis 4,Deletion,GRCh37
na,na,6,144176889,144196077,STX11,Pathogenic,Familial hemophagocytic lymphohistiocytosis 4,Deletion,GRCh38
na,na,6,144508566,144508566,STX11,Pathogenic,Familial hemophagocytic lymphohistiocytosis 4,single nucleotide variant,GRCh37
na,na,6,144187429,144187429,STX11,Pathogenic,Familial hemophagocytic lymphohistiocytosis 4,single nucleotide variant,GRCh38
na,na,5,147499626,147499626,SPINK5,Pathogenic,Netherton syndrome|not provided|Ichthyosis linearis circumflexa,single nucleotide variant,GRCh37
na,na,5,148120063,148120063,SPINK5,Pathogenic,Netherton syndrome|not provided|Ichthyosis linearis circumflexa,single nucleotide variant,GRCh38
na,na,5,147465966,147465966,SPINK5,Pathogenic,Netherton syndrome,single nucleotide variant,GRCh37
na,na,5,148086403,148086403,SPINK5,Pathogenic,Netherton syndrome,single nucleotide variant,GRCh38
na,na,5,147499874,147499875,SPINK5,Pathogenic,Netherton syndrome|not provided|Ichthyosis linearis circumflexa,Duplication,GRCh37
na,na,5,148120311,148120312,SPINK5,Pathogenic,Netherton syndrome|not provided|Ichthyosis linearis circumflexa,Duplication,GRCh38
na,na,5,147480955,147480955,SPINK5,Benign,SPINK5 POLYMORPHISM|not specified|not provided|Netherton syndrome|Ichthyosis linearis circumflexa,single nucleotide variant,GRCh37
na,na,5,148101392,148101392,SPINK5,Benign,SPINK5 POLYMORPHISM|not specified|not provided|Netherton syndrome|Ichthyosis linearis circumflexa,single nucleotide variant,GRCh38
na,na,17,72745313,72745313,NHERF1,Benign,Hypophosphatemic nephrolithiasis/osteoporosis 2|not provided|not specified,single nucleotide variant,GRCh37
na,na,17,74749174,74749174,NHERF1,Benign,Hypophosphatemic nephrolithiasis/osteoporosis 2|not provided|not specified,single nucleotide variant,GRCh38
na,na,17,72758167,72758167,NHERF1,Conflicting classifications of pathogenicity,Hypophosphatemic nephrolithiasis/osteoporosis 2|not provided|Chronic kidney disease|NHERF1-related disorder,single nucleotide variant,GRCh37
na,na,17,74762028,74762028,NHERF1,Conflicting classifications of pathogenicity,Hypophosphatemic nephrolithiasis/osteoporosis 2|not provided|Chronic kidney disease|NHERF1-related disorder,single nucleotide variant,GRCh38
na,na,17,72759575,72759575,NHERF1,Benign/Likely benign,Hypophosphatemic nephrolithiasis/osteoporosis 2|not specified|Hypophosphatemia;Nephrolithiasis|not provided|NHERF1-related disorder|Dominant hypophosphatemia with nephrolithiasis or osteoporosis,single nucleotide variant,GRCh37
na,na,17,74763436,74763436,NHERF1,Benign/Likely benign,Hypophosphatemic nephrolithiasis/osteoporosis 2|not specified|Hypophosphatemia;Nephrolithiasis|not provided|NHERF1-related disorder|Dominant hypophosphatemia with nephrolithiasis or osteoporosis,single nucleotide variant,GRCh38
na,na,11,66472847,66472861,SPTBN2,Pathogenic,Spinocerebellar ataxia type 5,Deletion,GRCh37
na,na,11,66705376,66705390,SPTBN2,Pathogenic,Spinocerebellar ataxia type 5,Deletion,GRCh38
na,na,11,66481116,66481116,SPTBN2,Pathogenic,Spinocerebellar ataxia type 5|not provided,single nucleotide variant,GRCh37
na,na,11,66713645,66713645,SPTBN2,Pathogenic,Spinocerebellar ataxia type 5|not provided,single nucleotide variant,GRCh38
na,na,17,62474046,62474046,POLG2,Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4|POLG2-related disorder|not provided",single nucleotide variant,GRCh37
na,na,17,64477929,64477929,POLG2,Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4|POLG2-related disorder|not provided",single nucleotide variant,GRCh38
na,na,10,100183554,100183555,HPS1,Pathogenic,Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome|Inborn genetic diseases|not provided|HPS1-related disorder,Duplication,GRCh37
na,na,10,98423797,98423798,HPS1,Pathogenic,Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome|Inborn genetic diseases|not provided|HPS1-related disorder,Duplication,GRCh38
na,na,10,100186986,100186987,HPS1;MIR4685,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 1|not provided|Hermansky-Pudlak syndrome|HPS1-related disorder,Duplication,GRCh37
na,na,10,98427229,98427230,HPS1;MIR4685,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 1|not provided|Hermansky-Pudlak syndrome|HPS1-related disorder,Duplication,GRCh38
na,na,10,100177428,100177428,HPS1,Likely pathogenic,Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome,single nucleotide variant,GRCh37
na,na,10,98417671,98417671,HPS1,Likely pathogenic,Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome,single nucleotide variant,GRCh38
na,na,10,100186987,100186987,HPS1,Pathogenic,Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome|not provided|HPS1-related disorder,Deletion,GRCh37
na,na,10,98427230,98427230,HPS1,Pathogenic,Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome|not provided|HPS1-related disorder,Deletion,GRCh38
na,na,10,100195030,100195030,HPS1,Pathogenic,Hermansky-Pudlak syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,10,98435273,98435273,HPS1,Pathogenic,Hermansky-Pudlak syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,10,100186996,100186997,HPS1,Pathogenic,Hermansky-Pudlak syndrome 1|not provided,Duplication,GRCh37
na,na,10,98427239,98427240,HPS1,Pathogenic,Hermansky-Pudlak syndrome 1|not provided,Duplication,GRCh38
na,na,10,100195024,100195024,HPS1,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 1|not provided|Hermansky-Pudlak syndrome,single nucleotide variant,GRCh37
na,na,10,98435267,98435267,HPS1,Pathogenic/Likely pathogenic,Hermansky-Pudlak syndrome 1|not provided|Hermansky-Pudlak syndrome,single nucleotide variant,GRCh38
na,na,2,219693284,219693284,PRKAG3,association,SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS,single nucleotide variant,GRCh37
na,na,2,218828561,218828561,PRKAG3,association,SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS,single nucleotide variant,GRCh38
na,na,1,27699671,27699671,FCN3,Uncertain significance,Immunodeficiency due to ficolin3 deficiency,Deletion,GRCh37
na,na,1,27373180,27373180,FCN3,Uncertain significance,Immunodeficiency due to ficolin3 deficiency,Deletion,GRCh38
na,na,2,178879181,178879181,PDE11A,Conflicting classifications of pathogenicity,"Pigmented nodular adrenocortical disease, primary, 2|not provided|See cases",single nucleotide variant,GRCh37
na,na,2,178014454,178014454,PDE11A,Conflicting classifications of pathogenicity,"Pigmented nodular adrenocortical disease, primary, 2|not provided|See cases",single nucleotide variant,GRCh38
na,na,7,103062016,103062016,SLC26A5,Benign/Likely benign,Autosomal recessive nonsyndromic hearing loss 61|not specified|not provided,single nucleotide variant,GRCh37
na,na,7,103421569,103421569,SLC26A5,Benign/Likely benign,Autosomal recessive nonsyndromic hearing loss 61|not specified|not provided,single nucleotide variant,GRCh38
na,na,1,235564868,235564879,TBCE,Pathogenic/Likely pathogenic,"Hypoparathyroidism-retardation-dysmorphism syndrome|Autosomal recessive Kenny-Caffey syndrome|not provided|Encephalopathy, progressive, with amyotrophy and optic atrophy|TBCE-related disorder",Deletion,GRCh37
na,na,1,235401553,235401564,TBCE,Pathogenic/Likely pathogenic,"Hypoparathyroidism-retardation-dysmorphism syndrome|Autosomal recessive Kenny-Caffey syndrome|not provided|Encephalopathy, progressive, with amyotrophy and optic atrophy|TBCE-related disorder",Deletion,GRCh38
na,na,1,235543430,235543431,TBCE,Pathogenic,Hypoparathyroidism-retardation-dysmorphism syndrome|not provided,Deletion,GRCh37
na,na,1,235380115,235380116,TBCE,Pathogenic,Hypoparathyroidism-retardation-dysmorphism syndrome|not provided,Deletion,GRCh38
na,na,1,235600786,235600786,TBCE,Pathogenic,Hypoparathyroidism-retardation-dysmorphism syndrome,single nucleotide variant,GRCh37
na,na,1,235437471,235437471,TBCE,Pathogenic,Hypoparathyroidism-retardation-dysmorphism syndrome,single nucleotide variant,GRCh38
na,na,1,45798475,45798475,MUTYH,Pathogenic/Likely pathogenic,Familial adenomatous polyposis 2|Endometrial carcinoma|Hereditary cancer-predisposing syndrome|not provided|not specified|Carcinoma of colon|Gastric cancer|Familial adenomatous polyposis 2;Gastric cancer|MUTYH-related disorder|Inherited polyposis and early onset colorectal cancer - germline testing,single nucleotide variant,GRCh37
na,na,1,45332803,45332803,MUTYH,Pathogenic/Likely pathogenic,Familial adenomatous polyposis 2|Endometrial carcinoma|Hereditary cancer-predisposing syndrome|not provided|not specified|Carcinoma of colon|Gastric cancer|Familial adenomatous polyposis 2;Gastric cancer|MUTYH-related disorder|Inherited polyposis and early onset colorectal cancer - germline testing,single nucleotide variant,GRCh38
na,na,1,45797228,45797228,MUTYH,Pathogenic/Likely pathogenic,"Endometrial cancer|Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|not provided|not specified|Carcinoma of colon|Small intestine carcinoid|Familial adenomatous polyposis 2;Neoplasm of stomach;Pilomatrixoma|Familial adenomatous polyposis 2;Neoplasm of stomach|Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas|Breast carcinoma|Ovarian carcinoma|Colon cancer|Familial colorectal cancer|MUTYH-related disorder|Familial adenomatous polyposis 2;Gastric cancer|Diffuse midline glioma, H3 K27-altered|Inherited polyposis and early onset colorectal cancer - germline testing",single nucleotide variant,GRCh37
na,na,1,45331556,45331556,MUTYH,Pathogenic/Likely pathogenic,"Endometrial cancer|Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|not provided|not specified|Carcinoma of colon|Small intestine carcinoid|Familial adenomatous polyposis 2;Neoplasm of stomach;Pilomatrixoma|Familial adenomatous polyposis 2;Neoplasm of stomach|Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas|Breast carcinoma|Ovarian carcinoma|Colon cancer|Familial colorectal cancer|MUTYH-related disorder|Familial adenomatous polyposis 2;Gastric cancer|Diffuse midline glioma, H3 K27-altered|Inherited polyposis and early onset colorectal cancer - germline testing",single nucleotide variant,GRCh38
na,na,1,45796869,45796869,MUTYH,Pathogenic,Familial adenomatous polyposis 2,Deletion,GRCh37
na,na,1,45331197,45331197,MUTYH,Pathogenic,Familial adenomatous polyposis 2,Deletion,GRCh38
na,na,1,45799121,45799121,MUTYH,Pathogenic/Likely pathogenic,Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|Familial colorectal cancer|not provided|Carcinoma of colon|Familial adenomatous polyposis 2;Gastric cancer,single nucleotide variant,GRCh37
na,na,1,45333449,45333449,MUTYH,Pathogenic/Likely pathogenic,Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|Familial colorectal cancer|not provided|Carcinoma of colon|Familial adenomatous polyposis 2;Gastric cancer,single nucleotide variant,GRCh38
na,na,1,45796892,45796892,MUTYH,Pathogenic,Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|not provided|Carcinoma of colon|Familial adenomatous polyposis 2;Gastric cancer|MUTYH-related disorder,single nucleotide variant,GRCh37
na,na,1,45331220,45331220,MUTYH,Pathogenic,Familial adenomatous polyposis 2|Hereditary cancer-predisposing syndrome|not provided|Carcinoma of colon|Familial adenomatous polyposis 2;Gastric cancer|MUTYH-related disorder,single nucleotide variant,GRCh38
na,na,1,45797202,45797202,MUTYH,Uncertain significance,Gastric cancer|Familial adenomatous polyposis 2,single nucleotide variant,GRCh37
na,na,1,45331530,45331530,MUTYH,Uncertain significance,Gastric cancer|Familial adenomatous polyposis 2,single nucleotide variant,GRCh38
na,na,1,45797174,45797174,MUTYH,Pathogenic,Gastric cancer,single nucleotide variant,GRCh37
na,na,1,45331502,45331502,MUTYH,Pathogenic,Gastric cancer,single nucleotide variant,GRCh38
na,na,18,77470825,77470825,CTDP1,Pathogenic,Congenital cataracts-facial dysmorphism-neuropathy syndrome|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,18,79710825,79710825,CTDP1,Pathogenic,Congenital cataracts-facial dysmorphism-neuropathy syndrome|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,17,16852187,16852187,TNFRSF13B,Conflicting classifications of pathogenicity; risk factor,"Immunodeficiency, common variable, 2|Immunoglobulin A deficiency 2|not provided|not specified|Severe SARS-CoV-2 infection, susceptibility to|Immunodeficiency, common variable, 2;Immunodeficiency, common variable, 1|Immunodeficiency, common variable, 2;Immunoglobulin A deficiency 2|Common variable immunodeficiency|Immunodeficiency, common variable, 1|TNFRSF13B-related disorder|Immune deficiency, familial variable",single nucleotide variant,GRCh37
na,na,17,16948873,16948873,TNFRSF13B,Conflicting classifications of pathogenicity; risk factor,"Immunodeficiency, common variable, 2|Immunoglobulin A deficiency 2|not provided|not specified|Severe SARS-CoV-2 infection, susceptibility to|Immunodeficiency, common variable, 2;Immunodeficiency, common variable, 1|Immunodeficiency, common variable, 2;Immunoglobulin A deficiency 2|Common variable immunodeficiency|Immunodeficiency, common variable, 1|TNFRSF13B-related disorder|Immune deficiency, familial variable",single nucleotide variant,GRCh38
na,na,17,16843729,16843729,TNFRSF13B,Pathogenic/Likely pathogenic,"Immunodeficiency, common variable, 2|Immunoglobulin A deficiency 2|not provided|Common variable immunodeficiency|Immunodeficiency, common variable, 2;Immunoglobulin A deficiency 2|See cases",single nucleotide variant,GRCh37
na,na,17,16940415,16940415,TNFRSF13B,Pathogenic/Likely pathogenic,"Immunodeficiency, common variable, 2|Immunoglobulin A deficiency 2|not provided|Common variable immunodeficiency|Immunodeficiency, common variable, 2;Immunoglobulin A deficiency 2|See cases",single nucleotide variant,GRCh38
na,na,17,16843666,16843666,TNFRSF13B,Conflicting classifications of pathogenicity,"Immunodeficiency, common variable, 2|Common Variable Immune Deficiency, Dominant|not provided|not specified",single nucleotide variant,GRCh37
na,na,17,16940352,16940352,TNFRSF13B,Conflicting classifications of pathogenicity,"Immunodeficiency, common variable, 2|Common Variable Immune Deficiency, Dominant|not provided|not specified",single nucleotide variant,GRCh38
na,na,17,16843689,16843690,TNFRSF13B,Pathogenic,"Immunodeficiency, common variable, 2|not provided",Indel,GRCh37
na,na,17,16940375,16940376,TNFRSF13B,Pathogenic,"Immunodeficiency, common variable, 2|not provided",Indel,GRCh38
na,na,17,16852066,16852066,TNFRSF13B,Pathogenic,"Immunodeficiency, common variable, 2",single nucleotide variant,GRCh37
na,na,17,16948752,16948752,TNFRSF13B,Pathogenic,"Immunodeficiency, common variable, 2",single nucleotide variant,GRCh38
na,na,20,10393913,10393913,MKKS,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome;McKusick-Kaufman syndrome|Bardet-Biedl syndrome 6|not provided|Bardet-Biedl syndrome,single nucleotide variant,GRCh37
na,na,20,10413265,10413265,MKKS,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome;McKusick-Kaufman syndrome|Bardet-Biedl syndrome 6|not provided|Bardet-Biedl syndrome,single nucleotide variant,GRCh38
na,na,20,10394053,10394053,MKKS,Pathogenic/Likely pathogenic,McKusick-Kaufman syndrome|Bardet-Biedl syndrome 6|not provided|McKusick-Kaufman syndrome;Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome;Bardet-Biedl syndrome|Retinal dystrophy|Inborn genetic diseases|Nephronophthisis|Bardet-Biedl syndrome|MKKS-related disorder|Syndromic inherited retinal disease,single nucleotide variant,GRCh37
na,na,20,10413405,10413405,MKKS,Pathogenic/Likely pathogenic,McKusick-Kaufman syndrome|Bardet-Biedl syndrome 6|not provided|McKusick-Kaufman syndrome;Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome;Bardet-Biedl syndrome|Retinal dystrophy|Inborn genetic diseases|Nephronophthisis|Bardet-Biedl syndrome|MKKS-related disorder|Syndromic inherited retinal disease,single nucleotide variant,GRCh38
na,na,20,10388310,10388311,MKKS,Pathogenic,McKusick-Kaufman syndrome|McKusick-Kaufman syndrome;Bardet-Biedl syndrome,Deletion,GRCh37
na,na,20,10407662,10407663,MKKS,Pathogenic,McKusick-Kaufman syndrome|McKusick-Kaufman syndrome;Bardet-Biedl syndrome,Deletion,GRCh38
na,na,20,10394008,10394008,MKKS,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 6|Bardet-Biedl syndrome;McKusick-Kaufman syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 6;McKusick-Kaufman syndrome,single nucleotide variant,GRCh37
na,na,20,10413360,10413360,MKKS,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 6|Bardet-Biedl syndrome;McKusick-Kaufman syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 6;McKusick-Kaufman syndrome,single nucleotide variant,GRCh38
na,na,20,10393371,10393371,MKKS,Pathogenic,Bardet-Biedl syndrome 6,single nucleotide variant,GRCh37
na,na,20,10412723,10412723,MKKS,Pathogenic,Bardet-Biedl syndrome 6,single nucleotide variant,GRCh38
na,na,20,10393882,10393882,MKKS,Pathogenic,Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome;Bardet-Biedl syndrome|McKusick-Kaufman syndrome;Bardet-Biedl syndrome 6,Deletion,GRCh37
na,na,20,10413234,10413234,MKKS,Pathogenic,Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome;Bardet-Biedl syndrome|McKusick-Kaufman syndrome;Bardet-Biedl syndrome 6,Deletion,GRCh38
na,na,20,10393333,10393333,MKKS,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 6|not provided|Inborn genetic diseases|Bardet-Biedl syndrome;McKusick-Kaufman syndrome|McKusick-Kaufman syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 6;McKusick-Kaufman syndrome|MKKS-related disorder,single nucleotide variant,GRCh37
na,na,20,10412685,10412685,MKKS,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 6|not provided|Inborn genetic diseases|Bardet-Biedl syndrome;McKusick-Kaufman syndrome|McKusick-Kaufman syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 6;McKusick-Kaufman syndrome|MKKS-related disorder,single nucleotide variant,GRCh38
na,na,20,10393994,10393994,MKKS,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome|McKusick-Kaufman syndrome;Bardet-Biedl syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,10413346,10413346,MKKS,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome|McKusick-Kaufman syndrome;Bardet-Biedl syndrome|not provided,single nucleotide variant,GRCh38
na,na,20,10393721,10393721,MKKS,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC",single nucleotide variant,GRCh37
na,na,20,10413073,10413073,MKKS,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC",single nucleotide variant,GRCh38
na,na,20,10386112,10386112,MKKS,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC",single nucleotide variant,GRCh37
na,na,20,10405464,10405464,MKKS,Pathogenic,"BARDET-BIEDL SYNDROME 2/6, DIGENIC",single nucleotide variant,GRCh38
na,na,20,10393190,10393190,MKKS,risk factor,"Bardet-Biedl syndrome 1, modifier of",single nucleotide variant,GRCh37
na,na,20,10412542,10412542,MKKS,risk factor,"Bardet-Biedl syndrome 1, modifier of",single nucleotide variant,GRCh38
na,na,17,45808828,45808828,TBX21,Uncertain significance,"Asthma, aspirin-induced, susceptibility to|Asthma and nasal polyps|Immunodeficiency 88",single nucleotide variant,GRCh37
na,na,17,47731462,47731462,TBX21,Uncertain significance,"Asthma, aspirin-induced, susceptibility to|Asthma and nasal polyps|Immunodeficiency 88",single nucleotide variant,GRCh38
na,na,10,71332481,71332481,NEUROG3,Pathogenic/Likely pathogenic,Congenital malabsorptive diarrhea 4|NEUROG3-related disorder,single nucleotide variant,GRCh37
na,na,10,69572725,69572725,NEUROG3,Pathogenic/Likely pathogenic,Congenital malabsorptive diarrhea 4|NEUROG3-related disorder,single nucleotide variant,GRCh38
na,na,10,71332522,71332522,NEUROG3,Pathogenic/Likely pathogenic,Congenital malabsorptive diarrhea 4|not provided,single nucleotide variant,GRCh37
na,na,10,69572766,69572766,NEUROG3,Pathogenic/Likely pathogenic,Congenital malabsorptive diarrhea 4|not provided,single nucleotide variant,GRCh38
na,na,15,34528920,34528920,SLC12A6,Pathogenic,"Agenesis of the corpus callosum with peripheral neuropathy|not provided|See cases|Agenesis of the corpus callosum with peripheral neuropathy;Charcot-Marie-Tooth disease, axonal, IIa 2II",single nucleotide variant,GRCh37
na,na,15,34236719,34236719,SLC12A6,Pathogenic,"Agenesis of the corpus callosum with peripheral neuropathy|not provided|See cases|Agenesis of the corpus callosum with peripheral neuropathy;Charcot-Marie-Tooth disease, axonal, IIa 2II",single nucleotide variant,GRCh38
na,na,15,34536194,34536194,SLC12A6,Pathogenic,Agenesis of the corpus callosum with peripheral neuropathy|not provided|SLC12A6-related disorder,single nucleotide variant,GRCh37
na,na,15,34243993,34243993,SLC12A6,Pathogenic,Agenesis of the corpus callosum with peripheral neuropathy|not provided|SLC12A6-related disorder,single nucleotide variant,GRCh38
na,na,15,34546766,34546766,SLC12A6,Likely pathogenic,Agenesis of the corpus callosum with peripheral neuropathy|Charcot-Marie-Tooth disease,Deletion,GRCh37
na,na,15,34254565,34254565,SLC12A6,Likely pathogenic,Agenesis of the corpus callosum with peripheral neuropathy|Charcot-Marie-Tooth disease,Deletion,GRCh38
na,na,15,34549914,34549914,SLC12A6,Conflicting classifications of pathogenicity,Agenesis of the corpus callosum with peripheral neuropathy|Charcot-Marie-Tooth disease|not provided,single nucleotide variant,GRCh37
na,na,15,34257713,34257713,SLC12A6,Conflicting classifications of pathogenicity,Agenesis of the corpus callosum with peripheral neuropathy|Charcot-Marie-Tooth disease|not provided,single nucleotide variant,GRCh38
na,na,15,34528947,34528956,SLC12A6,Likely pathogenic,Agenesis of the corpus callosum with peripheral neuropathy|Charcot-Marie-Tooth disease,Deletion,GRCh37
na,na,15,34236746,34236755,SLC12A6,Likely pathogenic,Agenesis of the corpus callosum with peripheral neuropathy|Charcot-Marie-Tooth disease,Deletion,GRCh38
na,na,7,122635173,122635173,TAS2R16,Uncertain significance,"BETA-GLUCOPYRANOSIDE TASTING|Alcohol dependence, susceptibility to|Alcohol dependence",single nucleotide variant,GRCh37
na,na,7,122995119,122995119,TAS2R16,Uncertain significance,"BETA-GLUCOPYRANOSIDE TASTING|Alcohol dependence, susceptibility to|Alcohol dependence",single nucleotide variant,GRCh38
na,na,4,155666003,155666003,LRAT,Pathogenic,"RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED|not provided",single nucleotide variant,GRCh37
na,na,4,154744851,154744851,LRAT,Pathogenic,"RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED|not provided",single nucleotide variant,GRCh38
na,na,4,155665875,155665876,LRAT,Pathogenic,"RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED|not provided",Deletion,GRCh37
na,na,4,154744723,154744724,LRAT,Pathogenic,"RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED|not provided",Deletion,GRCh38
na,na,4,155665695,155665696,LRAT,Pathogenic/Likely pathogenic,"RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED|Leber congenital amaurosis 14|not provided|LRAT-related disorder",Deletion,GRCh37
na,na,4,154744543,154744544,LRAT,Pathogenic/Likely pathogenic,"RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED|Leber congenital amaurosis 14|not provided|LRAT-related disorder",Deletion,GRCh38
na,na,2,71058878,71058878,CD207,Uncertain significance,Birbeck granule deficiency|not provided,single nucleotide variant,GRCh37
na,na,2,70831747,70831747,CD207,Uncertain significance,Birbeck granule deficiency|not provided,single nucleotide variant,GRCh38
na,na,4,5795449,5795449,EVC,Pathogenic/Likely pathogenic,Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome|not provided|Short-rib thoracic dysplasia 6 with or without polydactyly,single nucleotide variant,GRCh37
na,na,4,5793722,5793722,EVC,Pathogenic/Likely pathogenic,Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome|not provided|Short-rib thoracic dysplasia 6 with or without polydactyly,single nucleotide variant,GRCh38
na,na,4,5810001,5810001,EVC,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome,single nucleotide variant,GRCh37
na,na,4,5808274,5808274,EVC,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome,single nucleotide variant,GRCh38
na,na,4,5749953,5749953,EVC,Pathogenic,Ellis-van Creveld syndrome|not provided|Short-rib thoracic dysplasia 6 with or without polydactyly|Curry-Hall syndrome;Ellis-van Creveld syndrome,single nucleotide variant,GRCh37
na,na,4,5748226,5748226,EVC,Pathogenic,Ellis-van Creveld syndrome|not provided|Short-rib thoracic dysplasia 6 with or without polydactyly|Curry-Hall syndrome;Ellis-van Creveld syndrome,single nucleotide variant,GRCh38
na,na,4,5743474,5743474,EVC,Pathogenic,Ellis-van Creveld syndrome,Deletion,GRCh37
na,na,4,5741747,5741747,EVC,Pathogenic,Ellis-van Creveld syndrome,Deletion,GRCh38
na,na,4,5755524,5755524,EVC,Benign,Ellis-van Creveld syndrome|not specified|Curry-Hall syndrome;Ellis-van Creveld syndrome|Curry-Hall syndrome|not provided,single nucleotide variant,GRCh37
na,na,4,5753797,5753797,EVC,Benign,Ellis-van Creveld syndrome|not specified|Curry-Hall syndrome;Ellis-van Creveld syndrome|Curry-Hall syndrome|not provided,single nucleotide variant,GRCh38
na,na,4,5747048,5747048,EVC,Pathogenic,Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome|Curry-Hall syndrome,single nucleotide variant,GRCh37
na,na,4,5745321,5745321,EVC,Pathogenic,Ellis-van Creveld syndrome|Ellis-van Creveld syndrome;Curry-Hall syndrome|Curry-Hall syndrome,single nucleotide variant,GRCh38
na,na,4,5806463,5806463,EVC,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome,Deletion,GRCh37
na,na,4,5804736,5804736,EVC,Pathogenic,Ellis-van Creveld syndrome|Curry-Hall syndrome;Ellis-van Creveld syndrome,Deletion,GRCh38
na,na,13,33591156,33591156,KL,Conflicting classifications of pathogenicity,"Tumoral calcinosis, hyperphosphatemic, familial, 3|Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh37
na,na,13,33017018,33017018,KL,Conflicting classifications of pathogenicity,"Tumoral calcinosis, hyperphosphatemic, familial, 3|Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh38
na,na,3,43759162,43759162,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh37
na,na,3,43717670,43717670,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh38
na,na,3,43740818,43740818,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh37
na,na,3,43699326,43699326,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh38
na,na,3,43743705,43743705,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh37
na,na,3,43702213,43702213,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh38
na,na,3,43743962,43743962,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh37
na,na,3,43702470,43702470,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh38
na,na,3,43732503,43732503,ABHD5,Likely benign,Triglyceride storage disease with ichthyosis|not provided,single nucleotide variant,GRCh37
na,na,3,43691011,43691011,ABHD5,Likely benign,Triglyceride storage disease with ichthyosis|not provided,single nucleotide variant,GRCh38
na,na,3,43753287,43753288,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,Duplication,GRCh37
na,na,3,43711795,43711796,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,Duplication,GRCh38
na,na,3,43759167,43759167,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh37
na,na,3,43717675,43717675,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,single nucleotide variant,GRCh38
na,na,3,43732525,43732526,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,Microsatellite,GRCh37
na,na,3,43691033,43691034,ABHD5,Pathogenic,Triglyceride storage disease with ichthyosis,Microsatellite,GRCh38
na,na,11,134128483,134128483,ACAD8,Uncertain significance,Deficiency of isobutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh37
na,na,11,134258589,134258589,ACAD8,Uncertain significance,Deficiency of isobutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh38
na,na,11,134132450,134132450,ACAD8,Pathogenic/Likely pathogenic,Deficiency of isobutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh37
na,na,11,134262556,134262556,ACAD8,Pathogenic/Likely pathogenic,Deficiency of isobutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh38
na,na,11,134131680,134131680,ACAD8,Conflicting classifications of pathogenicity,Deficiency of isobutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh37
na,na,11,134261786,134261786,ACAD8,Conflicting classifications of pathogenicity,Deficiency of isobutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh38
na,na,11,134131194,134131194,ACAD8,Pathogenic,Deficiency of isobutyryl-CoA dehydrogenase,single nucleotide variant,GRCh37
na,na,11,134261300,134261300,ACAD8,Pathogenic,Deficiency of isobutyryl-CoA dehydrogenase,single nucleotide variant,GRCh38
na,na,11,134131232,134131232,ACAD8,Conflicting classifications of pathogenicity,Deficiency of isobutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh37
na,na,11,134261338,134261338,ACAD8,Conflicting classifications of pathogenicity,Deficiency of isobutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh38
na,na,1,179530462,179530462,NPHS2,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 2|not provided|Nephrotic range proteinuria|Steroid-resistant nephrotic syndrome|Chronic kidney disease|Nephrotic syndrome|See cases|NPHS2-related disorder",single nucleotide variant,GRCh37
na,na,1,179561327,179561327,NPHS2,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 2|not provided|Nephrotic range proteinuria|Steroid-resistant nephrotic syndrome|Chronic kidney disease|Nephrotic syndrome|See cases|NPHS2-related disorder",single nucleotide variant,GRCh38
na,na,1,179530463,179530463,NPHS2,Pathogenic,"Nephrotic syndrome, type 2|not provided|Steroid-resistant nephrotic syndrome|Idiopathic nephrotic syndrome|Focal segmental glomerulosclerosis",single nucleotide variant,GRCh37
na,na,1,179561328,179561328,NPHS2,Pathogenic,"Nephrotic syndrome, type 2|not provided|Steroid-resistant nephrotic syndrome|Idiopathic nephrotic syndrome|Focal segmental glomerulosclerosis",single nucleotide variant,GRCh38
na,na,1,179544941,179544941,NPHS2,Conflicting classifications of pathogenicity,"Nephrotic syndrome, type 2|not provided|Steroid-resistant nephrotic syndrome|Focal segmental glomerulosclerosis|Finnish congenital nephrotic syndrome|not specified|NPHS2-related disorder",single nucleotide variant,GRCh37
na,na,1,179575806,179575806,NPHS2,Conflicting classifications of pathogenicity,"Nephrotic syndrome, type 2|not provided|Steroid-resistant nephrotic syndrome|Focal segmental glomerulosclerosis|Finnish congenital nephrotic syndrome|not specified|NPHS2-related disorder",single nucleotide variant,GRCh38
na,na,1,179544726,179544726,NPHS2,Pathogenic,"Nephrotic syndrome, type 2",single nucleotide variant,GRCh37
na,na,1,179575591,179575591,NPHS2,Pathogenic,"Nephrotic syndrome, type 2",single nucleotide variant,GRCh38
na,na,1,179528869,179528869,NPHS2,Likely pathogenic,"Nephrotic syndrome, type 2",single nucleotide variant,GRCh37
na,na,1,179559734,179559734,NPHS2,Likely pathogenic,"Nephrotic syndrome, type 2",single nucleotide variant,GRCh38
na,na,1,179526362,179526362,NPHS2,Pathogenic,"Nephrotic syndrome, type 2|not provided|Steroid-resistant nephrotic syndrome",single nucleotide variant,GRCh37
na,na,1,179557227,179557227,NPHS2,Pathogenic,"Nephrotic syndrome, type 2|not provided|Steroid-resistant nephrotic syndrome",single nucleotide variant,GRCh38
na,na,1,179521740,179521740,NPHS2,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 2|not provided|Inborn genetic diseases|Steroid-resistant nephrotic syndrome",single nucleotide variant,GRCh37
na,na,1,179552605,179552605,NPHS2,Pathogenic/Likely pathogenic,"Nephrotic syndrome, type 2|not provided|Inborn genetic diseases|Steroid-resistant nephrotic syndrome",single nucleotide variant,GRCh38
na,na,1,179526214,179526214,NPHS2,Conflicting classifications of pathogenicity,"|Proteinuria|Nephrotic syndrome, type 2|not provided|not specified|NPHS2-related disorder|Focal segmental glomerulosclerosis|Nephrotic syndrome|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,1,179557079,179557079,NPHS2,Conflicting classifications of pathogenicity,"|Proteinuria|Nephrotic syndrome, type 2|not provided|not specified|NPHS2-related disorder|Focal segmental glomerulosclerosis|Nephrotic syndrome|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,12,102122901,102122901,SYCP3,Pathogenic,Spermatogenic failure 4,Deletion,GRCh37
na,na,12,101729123,101729123,SYCP3,Pathogenic,Spermatogenic failure 4,Deletion,GRCh38
na,na,12,102123009,102123012,SYCP3,Pathogenic,Spermatogenic failure 4,Deletion,GRCh37
na,na,12,101729231,101729234,SYCP3,Pathogenic,Spermatogenic failure 4,Deletion,GRCh38
na,na,12,102122887,102122887,SYCP3,Pathogenic,Spermatogenic failure 4,single nucleotide variant,GRCh37
na,na,12,101729109,101729109,SYCP3,Pathogenic,Spermatogenic failure 4,single nucleotide variant,GRCh38
na,na,7,137791367,137791367,AKR1D1,Conflicting classifications of pathogenicity,Congenital bile acid synthesis defect 2|not provided,single nucleotide variant,GRCh37
na,na,7,138106621,138106621,AKR1D1,Conflicting classifications of pathogenicity,Congenital bile acid synthesis defect 2|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,AKR1D1,Pathogenic,Congenital bile acid synthesis defect 2,Deletion,na
na,na,7,137776568,137776568,AKR1D1,Pathogenic,Congenital bile acid synthesis defect 2,single nucleotide variant,GRCh37
na,na,7,138091822,138091822,AKR1D1,Pathogenic,Congenital bile acid synthesis defect 2,single nucleotide variant,GRCh38
na,na,7,137782631,137782631,AKR1D1,Conflicting classifications of pathogenicity,Congenital bile acid synthesis defect 2|not provided,single nucleotide variant,GRCh37
na,na,7,138097885,138097885,AKR1D1,Conflicting classifications of pathogenicity,Congenital bile acid synthesis defect 2|not provided,single nucleotide variant,GRCh38
na,na,7,137792252,137792252,AKR1D1,Pathogenic/Likely pathogenic,Congenital bile acid synthesis defect 2|Congenital bile acid synthesis defect,single nucleotide variant,GRCh37
na,na,7,138107506,138107506,AKR1D1,Pathogenic/Likely pathogenic,Congenital bile acid synthesis defect 2|Congenital bile acid synthesis defect,single nucleotide variant,GRCh38
na,na,12,58190322,58190322,TSFM,Pathogenic,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,57796539,57796539,TSFM,Pathogenic,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,7,100230723,100230723,TFR2,Pathogenic,Hemochromatosis type 3,single nucleotide variant,GRCh37
na,na,7,100633100,100633100,TFR2,Pathogenic,Hemochromatosis type 3,single nucleotide variant,GRCh38
na,na,7,100238796,100238797,TFR2,Pathogenic,Hemochromatosis type 3|Hereditary hemochromatosis,Duplication,GRCh37
na,na,7,100641173,100641174,TFR2,Pathogenic,Hemochromatosis type 3|Hereditary hemochromatosis,Duplication,GRCh38
na,na,7,100231138,100231138,TFR2,Pathogenic,Hemochromatosis type 3,single nucleotide variant,GRCh37
na,na,7,100633515,100633515,TFR2,Pathogenic,Hemochromatosis type 3,single nucleotide variant,GRCh38
na,na,7,100226902,100226902,TFR2,Conflicting classifications of pathogenicity,"Hemochromatosis, type 1, modifier of|Hemochromatosis type 3|not provided|Hereditary hemochromatosis|TFR2-related disorder",single nucleotide variant,GRCh37
na,na,7,100629279,100629279,TFR2,Conflicting classifications of pathogenicity,"Hemochromatosis, type 1, modifier of|Hemochromatosis type 3|not provided|Hereditary hemochromatosis|TFR2-related disorder",single nucleotide variant,GRCh38
na,na,7,100224453,100224453,TFR2,Pathogenic,Hemochromatosis type 3,single nucleotide variant,GRCh37
na,na,7,100626830,100626830,TFR2,Pathogenic,Hemochromatosis type 3,single nucleotide variant,GRCh38
na,na,6,116600533,116600534,TSPYL1,Pathogenic,Sudden infant death-dysgenesis of the testes syndrome,Duplication,GRCh37
na,na,6,116279370,116279371,TSPYL1,Pathogenic,Sudden infant death-dysgenesis of the testes syndrome,Duplication,GRCh38
na,na,8,103225057,103225057,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease,single nucleotide variant,GRCh37
na,na,8,102212829,102212829,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease,single nucleotide variant,GRCh38
na,na,8,103237248,103237248,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8a|not provided,single nucleotide variant,GRCh37
na,na,8,102225020,102225020,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8a|not provided,single nucleotide variant,GRCh38
na,na,8,103231146,103231146,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease,single nucleotide variant,GRCh37
na,na,8,102218918,102218918,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease,single nucleotide variant,GRCh38
na,na,8,103226364,103226364,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease,single nucleotide variant,GRCh37
na,na,8,102214136,102214136,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease,single nucleotide variant,GRCh38
na,na,8,103220438,103220438,RRM2B,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5|RRM2B-related mitochondrial disease|not provided",single nucleotide variant,GRCh37
na,na,8,102208210,102208210,RRM2B,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5|RRM2B-related mitochondrial disease|not provided",single nucleotide variant,GRCh38
na,na,8,103226385,103226385,RRM2B,Conflicting classifications of pathogenicity,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease|not provided,single nucleotide variant,GRCh37
na,na,8,102214157,102214157,RRM2B,Conflicting classifications of pathogenicity,Mitochondrial DNA depletion syndrome 8a|RRM2B-related mitochondrial disease|not provided,single nucleotide variant,GRCh38
na,na,8,103237239,103237239,RRM2B,Conflicting classifications of pathogenicity,Mitochondrial DNA depletion syndrome 8B (MNGIE type)|RRM2B-related mitochondrial disease|not provided|Mitochondrial DNA depletion syndrome 8a,single nucleotide variant,GRCh37
na,na,8,102225011,102225011,RRM2B,Conflicting classifications of pathogenicity,Mitochondrial DNA depletion syndrome 8B (MNGIE type)|RRM2B-related mitochondrial disease|not provided|Mitochondrial DNA depletion syndrome 8a,single nucleotide variant,GRCh38
na,na,8,103237206,103237206,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8B (MNGIE type)|RRM2B-related mitochondrial disease,single nucleotide variant,GRCh37
na,na,8,102224978,102224978,RRM2B,Pathogenic,Mitochondrial DNA depletion syndrome 8B (MNGIE type)|RRM2B-related mitochondrial disease,single nucleotide variant,GRCh38
na,na,19,41128552,41128552,LTBP4,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",Deletion,GRCh37
na,na,19,40622647,40622647,LTBP4,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",Deletion,GRCh38
na,na,19,41111642,41111642,LTBP4,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",Deletion,GRCh37
na,na,19,40605736,40605736,LTBP4,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",Deletion,GRCh38
na,na,19,41119359,41119359,LTBP4,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",single nucleotide variant,GRCh37
na,na,19,40613453,40613453,LTBP4,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",single nucleotide variant,GRCh38
na,na,19,41111674,41111674,LTBP4,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",single nucleotide variant,GRCh37
na,na,19,40605768,40605768,LTBP4,Pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",single nucleotide variant,GRCh38
na,na,19,41132925,41132926,LTBP4,Pathogenic/Likely pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies|not provided",Duplication,GRCh37
na,na,19,40627020,40627021,LTBP4,Pathogenic/Likely pathogenic,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies|not provided",Duplication,GRCh38
na,na,2,112758776,112758776,MERTK,Pathogenic,Retinitis pigmentosa 38|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,112001199,112001199,MERTK,Pathogenic,Retinitis pigmentosa 38|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,2,112766043,112766043,MERTK,Pathogenic,Retinitis pigmentosa 38|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,112008466,112008466,MERTK,Pathogenic,Retinitis pigmentosa 38|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,2,112777100,112777100,MERTK,Pathogenic,Retinitis pigmentosa 38|Inborn genetic diseases|Retinal dystrophy|Autosomal recessive retinitis pigmentosa|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,2,112019523,112019523,MERTK,Pathogenic,Retinitis pigmentosa 38|Inborn genetic diseases|Retinal dystrophy|Autosomal recessive retinitis pigmentosa|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,17,19812541,19812541,AKAP10,Conflicting classifications of pathogenicity,Reclassified - variant of unknown significance|AKAP10-related disorder,single nucleotide variant,GRCh37
na,na,17,19909228,19909228,AKAP10,Conflicting classifications of pathogenicity,Reclassified - variant of unknown significance|AKAP10-related disorder,single nucleotide variant,GRCh38
na,na,14,52733984,52733984,PTGDR,no classification for the single variant,-,Variation,GRCh37
na,na,14,52267266,52267266,PTGDR,no classification for the single variant,-,Variation,GRCh38
na,na,7,27140920,27140920,HOXA2,Pathogenic,Bilateral microtia-deafness-cleft palate syndrome,single nucleotide variant,GRCh37
na,na,7,27101301,27101301,HOXA2,Pathogenic,Bilateral microtia-deafness-cleft palate syndrome,single nucleotide variant,GRCh38
na,na,19,7812733,7812733,CD209,protective; risk factor,"Susceptibility to HIV infection|Mycobacterium tuberculosis, susceptibility to|Dengue fever, protection against",single nucleotide variant,GRCh37
na,na,19,7747847,7747847,CD209,protective; risk factor,"Susceptibility to HIV infection|Mycobacterium tuberculosis, susceptibility to|Dengue fever, protection against",single nucleotide variant,GRCh38
na,na,19,7813268,7813268,CD209,risk factor,"Mycobacterium tuberculosis, susceptibility to",single nucleotide variant,GRCh37
na,na,19,7748382,7748382,CD209,risk factor,"Mycobacterium tuberculosis, susceptibility to",single nucleotide variant,GRCh38
na,na,2,190436525,190436525,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh37
na,na,2,189571799,189571799,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh38
na,na,2,190439928,190439928,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh37
na,na,2,189575202,189575202,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh38
na,na,2,190436485,190436485,SLC40A1,Likely pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh37
na,na,2,189571759,189571759,SLC40A1,Likely pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh38
na,na,2,190430294,190430294,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh37
na,na,2,189565568,189565568,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh38
na,na,2,190436468,190436470,SLC40A1,Pathogenic/Likely pathogenic,Hemochromatosis type 4|SLC40A1-related disorder,Microsatellite,GRCh37
na,na,2,189571742,189571744,SLC40A1,Pathogenic/Likely pathogenic,Hemochromatosis type 4|SLC40A1-related disorder,Microsatellite,GRCh38
na,na,2,190428744,190428744,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh37
na,na,2,189564018,189564018,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh38
na,na,2,190430298,190430298,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh37
na,na,2,189565572,189565572,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh38
na,na,2,190439919,190439919,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh37
na,na,2,189575193,189575193,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh38
na,na,2,190428912,190428912,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh37
na,na,2,189564186,189564186,SLC40A1,Pathogenic,Hemochromatosis type 4,single nucleotide variant,GRCh38
na,na,11,45919710,45919710,MAPK8IP1,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh37
na,na,11,45898159,45898159,MAPK8IP1,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh38
na,na,19,39200926,39200926,ACTN4,Pathogenic,Focal segmental glomerulosclerosis 1|not provided,single nucleotide variant,GRCh37
na,na,19,38710286,38710286,ACTN4,Pathogenic,Focal segmental glomerulosclerosis 1|not provided,single nucleotide variant,GRCh38
na,na,19,39200939,39200939,ACTN4,Pathogenic,Focal segmental glomerulosclerosis 1|not provided,single nucleotide variant,GRCh37
na,na,19,38710299,38710299,ACTN4,Pathogenic,Focal segmental glomerulosclerosis 1|not provided,single nucleotide variant,GRCh38
na,na,19,39200947,39200947,ACTN4,Pathogenic,Focal segmental glomerulosclerosis 1,single nucleotide variant,GRCh37
na,na,19,38710307,38710307,ACTN4,Pathogenic,Focal segmental glomerulosclerosis 1,single nucleotide variant,GRCh38
na,na,11,65638826,65638826,EFEMP2,Pathogenic,"Cutis laxa, autosomal recessive, type 1A|Cutis laxa, autosomal recessive, type 1B",single nucleotide variant,GRCh37
na,na,11,65871355,65871355,EFEMP2,Pathogenic,"Cutis laxa, autosomal recessive, type 1A|Cutis laxa, autosomal recessive, type 1B",single nucleotide variant,GRCh38
na,na,11,65635993,65635993,EFEMP2,Likely pathogenic,"Cutis laxa, autosomal recessive, type 1B|Cutis laxa, autosomal recessive, type 1A",single nucleotide variant,GRCh37
na,na,11,65868522,65868522,EFEMP2,Likely pathogenic,"Cutis laxa, autosomal recessive, type 1B|Cutis laxa, autosomal recessive, type 1A",single nucleotide variant,GRCh38
na,na,11,65635428,65635429,EFEMP2,Pathogenic,"Cutis laxa, autosomal recessive, type 1B|Cutis laxa, autosomal recessive, type 1A",Duplication,GRCh37
na,na,11,65867957,65867958,EFEMP2,Pathogenic,"Cutis laxa, autosomal recessive, type 1B|Cutis laxa, autosomal recessive, type 1A",Duplication,GRCh38
na,na,1,27240332,27240332,NR0B2,Pathogenic,"Obesity, mild, early-onset",single nucleotide variant,GRCh37
na,na,1,26913841,26913841,NR0B2,Pathogenic,"Obesity, mild, early-onset",single nucleotide variant,GRCh38
na,na,1,27238527,27238527,NR0B2,Uncertain significance,"Obesity, mild, early-onset|not specified",single nucleotide variant,GRCh37
na,na,1,26912036,26912036,NR0B2,Uncertain significance,"Obesity, mild, early-onset|not specified",single nucleotide variant,GRCh38
na,na,11,102465490,102465490,MMP20,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A2|not provided|MMP20-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,11,102594759,102594759,MMP20,Pathogenic,Amelogenesis imperfecta hypomaturation type 2A2|not provided|MMP20-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,5,53751640,53751640,HSPB3,Likely benign,"Neuronopathy, distal hereditary motor, type 2C|not provided",single nucleotide variant,GRCh37
na,na,5,54455810,54455810,HSPB3,Likely benign,"Neuronopathy, distal hereditary motor, type 2C|not provided",single nucleotide variant,GRCh38
na,na,10,95557034,95557034,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh37
na,na,10,93797277,93797277,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh38
na,na,10,95552602,95552602,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",Deletion,GRCh37
na,na,10,93792845,93792845,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",Deletion,GRCh38
na,na,10,95537300,95537300,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh37
na,na,10,93777543,93777543,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh38
na,na,10,95518037,95518037,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1|Autosomal dominant epilepsy with auditory features",single nucleotide variant,GRCh37
na,na,10,93758280,93758280,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1|Autosomal dominant epilepsy with auditory features",single nucleotide variant,GRCh38
na,na,10,95556839,95556839,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh37
na,na,10,93797082,93797082,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh38
na,na,10,95537375,95537375,LGI1,Likely pathogenic,"Epilepsy, familial temporal lobe, 1|not provided",single nucleotide variant,GRCh37
na,na,10,93777618,93777618,LGI1,Likely pathogenic,"Epilepsy, familial temporal lobe, 1|not provided",single nucleotide variant,GRCh38
na,na,10,95552964,95552964,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh37
na,na,10,93793207,93793207,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh38
na,na,10,95537349,95537349,LGI1,Pathogenic/Likely pathogenic,"Epilepsy, familial temporal lobe, 1|not provided|Autosomal dominant epilepsy with auditory features|LGI1-related disorder",single nucleotide variant,GRCh37
na,na,10,93777592,93777592,LGI1,Pathogenic/Likely pathogenic,"Epilepsy, familial temporal lobe, 1|not provided|Autosomal dominant epilepsy with auditory features|LGI1-related disorder",single nucleotide variant,GRCh38
na,na,10,95537308,95537308,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh37
na,na,10,93777551,93777551,LGI1,Pathogenic,"Epilepsy, familial temporal lobe, 1",single nucleotide variant,GRCh38
na,na,1,168274374,168274374,TBX19,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,168305136,168305136,TBX19,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,168260577,168260577,TBX19,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency,single nucleotide variant,GRCh37
na,na,1,168291339,168291339,TBX19,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency,single nucleotide variant,GRCh38
na,na,1,168260451,168260451,TBX19,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency,single nucleotide variant,GRCh37
na,na,1,168291213,168291213,TBX19,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency,single nucleotide variant,GRCh38
na,na,1,168274299,168274299,TBX19,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency|not provided|TBX19-related disorder,Deletion,GRCh37
na,na,1,168305061,168305061,TBX19,Pathogenic,Congenital isolated adrenocorticotropic hormone deficiency|not provided|TBX19-related disorder,Deletion,GRCh38
na,na,8,31014977,31014977,WRN,Pathogenic,Werner syndrome,single nucleotide variant,GRCh37
na,na,8,31157461,31157461,WRN,Pathogenic,Werner syndrome,single nucleotide variant,GRCh38
na,na,8,31004913,31004913,WRN,Pathogenic,Werner syndrome,single nucleotide variant,GRCh37
na,na,8,31147397,31147397,WRN,Pathogenic,Werner syndrome,single nucleotide variant,GRCh38
na,na,8,31012142,31012145,WRN,Pathogenic,Werner syndrome,Microsatellite,GRCh37
na,na,8,31154622,31154625,WRN,Pathogenic,Werner syndrome,Microsatellite,GRCh38
na,na,8,30999196,30999196,WRN,Pathogenic,Werner syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,31141680,31141680,WRN,Pathogenic,Werner syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,31014978,31014979,WRN,Pathogenic,Werner syndrome,Duplication,GRCh37
na,na,8,31157462,31157463,WRN,Pathogenic,Werner syndrome,Duplication,GRCh38
na,na,8,30938648,30938648,WRN,Pathogenic/Likely pathogenic,Werner syndrome|Medulloblastoma|not provided,single nucleotide variant,GRCh37
na,na,8,31081132,31081132,WRN,Pathogenic/Likely pathogenic,Werner syndrome|Medulloblastoma|not provided,single nucleotide variant,GRCh38
na,na,8,31007970,31007970,WRN,Pathogenic,Werner syndrome,single nucleotide variant,GRCh37
na,na,8,31150454,31150454,WRN,Pathogenic,Werner syndrome,single nucleotide variant,GRCh38
na,na,8,30948359,30948359,WRN,Pathogenic,Werner syndrome,single nucleotide variant,GRCh37
na,na,8,31090843,31090843,WRN,Pathogenic,Werner syndrome,single nucleotide variant,GRCh38
na,na,8,30922450,30922450,WRN,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,8,31064934,31064934,WRN,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,15,91310153,91310158,BLM,Pathogenic/Likely pathogenic,Bloom syndrome|not provided|Hereditary cancer-predisposing syndrome|BLM-related disorder,Indel,GRCh37
na,na,15,90766923,90766928,BLM,Pathogenic/Likely pathogenic,Bloom syndrome|not provided|Hereditary cancer-predisposing syndrome|BLM-related disorder,Indel,GRCh38
na,na,15,91293055,91293057,BLM,Pathogenic,Bloom syndrome,Deletion,GRCh37
na,na,15,90749825,90749827,BLM,Pathogenic,Bloom syndrome,Deletion,GRCh38
na,na,15,91312783,91312783,BLM,Conflicting classifications of pathogenicity,Bloom syndrome|not specified,single nucleotide variant,GRCh37
na,na,15,90769553,90769553,BLM,Conflicting classifications of pathogenicity,Bloom syndrome|not specified,single nucleotide variant,GRCh38
na,na,15,91337484,91337484,BLM,Pathogenic,Bloom syndrome,single nucleotide variant,GRCh37
na,na,15,90794254,90794254,BLM,Pathogenic,Bloom syndrome,single nucleotide variant,GRCh38
na,na,3,123774078,123774078,KALRN,Benign,"Coronary heart disease, susceptibility to, 5|KALRN-related disorder",single nucleotide variant,GRCh37
na,na,3,124055231,124055231,KALRN,Benign,"Coronary heart disease, susceptibility to, 5|KALRN-related disorder",single nucleotide variant,GRCh38
na,na,11,67811712,67811712,TCIRG1,Pathogenic,Autosomal recessive osteopetrosis 1|not provided,Deletion,GRCh37
na,na,11,68044245,68044245,TCIRG1,Pathogenic,Autosomal recessive osteopetrosis 1|not provided,Deletion,GRCh38
na,na,11,67815200,67815200,TCIRG1,Pathogenic,Autosomal recessive osteopetrosis 1,single nucleotide variant,GRCh37
na,na,11,68047733,68047733,TCIRG1,Pathogenic,Autosomal recessive osteopetrosis 1,single nucleotide variant,GRCh38
na,na,11,67816548,67816548,TCIRG1,Uncertain significance,Autosomal recessive osteopetrosis 1|not provided,single nucleotide variant,GRCh37
na,na,11,68049081,68049081,TCIRG1,Uncertain significance,Autosomal recessive osteopetrosis 1|not provided,single nucleotide variant,GRCh38
na,na,11,67808859,67808859,TCIRG1,Pathogenic/Likely pathogenic,Autosomal recessive osteopetrosis 1|not provided|Inborn genetic diseases|Autosomal recessive osteopetrosis|TCIRG1-related disorder,single nucleotide variant,GRCh37
na,na,11,68041392,68041392,TCIRG1,Pathogenic/Likely pathogenic,Autosomal recessive osteopetrosis 1|not provided|Inborn genetic diseases|Autosomal recessive osteopetrosis|TCIRG1-related disorder,single nucleotide variant,GRCh38
na,na,11,67814947,67814947,TCIRG1,Pathogenic/Likely pathogenic,Autosomal recessive osteopetrosis 1|not provided|Osteopetrosis,single nucleotide variant,GRCh37
na,na,11,68047480,68047480,TCIRG1,Pathogenic/Likely pathogenic,Autosomal recessive osteopetrosis 1|not provided|Osteopetrosis,single nucleotide variant,GRCh38
na,na,11,67815139,67815139,TCIRG1,Pathogenic/Likely pathogenic,Autosomal recessive osteopetrosis 1|not provided,single nucleotide variant,GRCh37
na,na,11,68047672,68047672,TCIRG1,Pathogenic/Likely pathogenic,Autosomal recessive osteopetrosis 1|not provided,single nucleotide variant,GRCh38
na,na,11,67811056,67811081,TCIRG1,Pathogenic,Autosomal recessive osteopetrosis 1,Deletion,GRCh37
na,na,11,68043587,68043612,TCIRG1,Pathogenic,Autosomal recessive osteopetrosis 1,Deletion,GRCh38
na,na,1,161632646,161632646,FCGR2B,risk factor,"Systemic lupus erythematosus, susceptibility to",single nucleotide variant,GRCh37
na,na,1,161662856,161662856,FCGR2B,risk factor,"Systemic lupus erythematosus, susceptibility to",single nucleotide variant,GRCh38
na,na,1,161643798,161643798,FCGR2B,protective; risk factor,"Systemic lupus erythematosus, susceptibility to|Malaria, resistance to",single nucleotide variant,GRCh37
na,na,1,161674008,161674008,FCGR2B,protective; risk factor,"Systemic lupus erythematosus, susceptibility to|Malaria, resistance to",single nucleotide variant,GRCh38
na,na,8,17446988,17446988,PDGFRL,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh37
na,na,8,17589479,17589479,PDGFRL,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh38
na,na,na,-1,-1,PDGFRL,Pathogenic,Hepatocellular carcinoma,Deletion,na
na,na,18,12337444,12337444,AFG3L2,Pathogenic,Spinocerebellar ataxia type 28,single nucleotide variant,GRCh37
na,na,18,12337445,12337445,AFG3L2,Pathogenic,Spinocerebellar ataxia type 28,single nucleotide variant,GRCh38
na,na,18,12337493,12337494,AFG3L2,Pathogenic,Spinocerebellar ataxia type 28,Indel,GRCh37
na,na,18,12337494,12337495,AFG3L2,Pathogenic,Spinocerebellar ataxia type 28,Indel,GRCh38
na,na,18,12337434,12337434,AFG3L2,Pathogenic,Spinocerebellar ataxia type 28,single nucleotide variant,GRCh37
na,na,18,12337435,12337435,AFG3L2,Pathogenic,Spinocerebellar ataxia type 28,single nucleotide variant,GRCh38
na,na,18,12337410,12337410,AFG3L2,Pathogenic/Likely pathogenic,Spinocerebellar ataxia type 28|not provided,single nucleotide variant,GRCh37
na,na,18,12337411,12337411,AFG3L2,Pathogenic/Likely pathogenic,Spinocerebellar ataxia type 28|not provided,single nucleotide variant,GRCh38
na,na,18,12353027,12353027,AFG3L2,Pathogenic,Spinocerebellar ataxia type 28,single nucleotide variant,GRCh37
na,na,18,12353028,12353028,AFG3L2,Pathogenic,Spinocerebellar ataxia type 28,single nucleotide variant,GRCh38
na,na,14,92353597,92353597,FBLN5,Conflicting classifications of pathogenicity,"Cutis laxa, autosomal recessive, type 1A|Cutis laxa, autosomal dominant",single nucleotide variant,GRCh37
na,na,14,91887253,91887253,FBLN5,Conflicting classifications of pathogenicity,"Cutis laxa, autosomal recessive, type 1A|Cutis laxa, autosomal dominant",single nucleotide variant,GRCh38
na,na,14,92403492,92403492,FBLN5,Uncertain significance,"Macular degeneration, age-related, 3|not provided|Age-related macular degeneration|FBLN5-related disorder",single nucleotide variant,GRCh37
na,na,14,91937148,91937148,FBLN5,Uncertain significance,"Macular degeneration, age-related, 3|not provided|Age-related macular degeneration|FBLN5-related disorder",single nucleotide variant,GRCh38
na,na,14,92403458,92403458,FBLN5,Uncertain significance,"Macular degeneration, age-related, 3|not provided|Age-related macular degeneration",single nucleotide variant,GRCh37
na,na,14,91937114,91937114,FBLN5,Uncertain significance,"Macular degeneration, age-related, 3|not provided|Age-related macular degeneration",single nucleotide variant,GRCh38
na,na,14,92403411,92403411,FBLN5,Conflicting classifications of pathogenicity,"Macular degeneration, age-related, 3|Age-related macular degeneration",single nucleotide variant,GRCh37
na,na,14,91937067,91937067,FBLN5,Conflicting classifications of pathogenicity,"Macular degeneration, age-related, 3|Age-related macular degeneration",single nucleotide variant,GRCh38
na,na,14,92357678,92357678,FBLN5,Conflicting classifications of pathogenicity,"Macular degeneration, age-related, 3|Age-related macular degeneration",single nucleotide variant,GRCh37
na,na,14,91891334,91891334,FBLN5,Conflicting classifications of pathogenicity,"Macular degeneration, age-related, 3|Age-related macular degeneration",single nucleotide variant,GRCh38
na,na,14,92343965,92343965,FBLN5,Uncertain significance,"Macular degeneration, age-related, 3|Cutis laxa|not provided|See cases|not specified|Charcot-Marie-Tooth disease, demyelinating, IIA 1H;Cutis laxa, autosomal dominant 2;Macular degeneration, age-related, 3;Cutis laxa, autosomal recessive, type 1A|Age-related macular degeneration",single nucleotide variant,GRCh37
na,na,14,91877621,91877621,FBLN5,Uncertain significance,"Macular degeneration, age-related, 3|Cutis laxa|not provided|See cases|not specified|Charcot-Marie-Tooth disease, demyelinating, IIA 1H;Cutis laxa, autosomal dominant 2;Macular degeneration, age-related, 3;Cutis laxa, autosomal recessive, type 1A|Age-related macular degeneration",single nucleotide variant,GRCh38
na,na,14,92343929,92343929,FBLN5,Conflicting classifications of pathogenicity,"Macular degeneration, age-related, 3|not provided|Age-related macular degeneration",single nucleotide variant,GRCh37
na,na,14,91877585,91877585,FBLN5,Conflicting classifications of pathogenicity,"Macular degeneration, age-related, 3|not provided|Age-related macular degeneration",single nucleotide variant,GRCh38
na,na,14,92336680,92336680,FBLN5,Uncertain significance,"Macular degeneration, age-related, 3|Age-related macular degeneration|not provided",single nucleotide variant,GRCh37
na,na,14,91870336,91870336,FBLN5,Uncertain significance,"Macular degeneration, age-related, 3|Age-related macular degeneration|not provided",single nucleotide variant,GRCh38
na,na,11,86662314,86662319,FZD4,Pathogenic,Exudative vitreoretinopathy 1|not provided,Deletion,GRCh37
na,na,11,86951272,86951277,FZD4,Pathogenic,Exudative vitreoretinopathy 1|not provided,Deletion,GRCh38
na,na,11,86662296,86662297,FZD4,Pathogenic/Likely pathogenic,Exudative vitreoretinopathy 1|not provided,Microsatellite,GRCh37
na,na,11,86951254,86951255,FZD4,Pathogenic/Likely pathogenic,Exudative vitreoretinopathy 1|not provided,Microsatellite,GRCh38
na,na,11,86662548,86662548,FZD4,Pathogenic,"Exudative vitreoretinopathy 1|Exudative vitreoretinopathy, digenic",single nucleotide variant,GRCh37
na,na,11,86951506,86951506,FZD4,Pathogenic,"Exudative vitreoretinopathy 1|Exudative vitreoretinopathy, digenic",single nucleotide variant,GRCh38
na,na,11,86662774,86662774,FZD4,Uncertain significance,Exudative vitreoretinopathy 1|not provided,single nucleotide variant,GRCh37
na,na,11,86951732,86951732,FZD4,Uncertain significance,Exudative vitreoretinopathy 1|not provided,single nucleotide variant,GRCh38
na,na,11,86662793,86662793,FZD4,Pathogenic,Exudative vitreoretinopathy 1,single nucleotide variant,GRCh37
na,na,11,86951751,86951751,FZD4,Pathogenic,Exudative vitreoretinopathy 1,single nucleotide variant,GRCh38
na,na,11,86663032,86663032,FZD4,Conflicting classifications of pathogenicity,Retinopathy of prematurity|not provided|FZD4-related disorder,single nucleotide variant,GRCh37
na,na,11,86951990,86951990,FZD4,Conflicting classifications of pathogenicity,Retinopathy of prematurity|not provided|FZD4-related disorder,single nucleotide variant,GRCh38
na,na,7,148080973,148080973,CNTNAP2,Pathogenic,not provided|Cortical dysplasia-focal epilepsy syndrome,Deletion,GRCh37
na,na,7,148383881,148383881,CNTNAP2,Pathogenic,not provided|Cortical dysplasia-focal epilepsy syndrome,Deletion,GRCh38
na,na,7,147574390,147574390,CNTNAP2,risk factor,"Autism, susceptibility to, 15",single nucleotide variant,GRCh37
na,na,7,147877298,147877298,CNTNAP2,risk factor,"Autism, susceptibility to, 15",single nucleotide variant,GRCh38
na,na,7,146489606,146489606,CNTNAP2,risk factor,"Autism, susceptibility to, 15",single nucleotide variant,GRCh37
na,na,7,146792514,146792514,CNTNAP2,risk factor,"Autism, susceptibility to, 15",single nucleotide variant,GRCh38
na,na,7,147844634,147844634,CNTNAP2,Conflicting classifications of pathogenicity,"Autism, susceptibility to, 15|not provided|Cortical dysplasia-focal epilepsy syndrome|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,7,148147542,148147542,CNTNAP2,Conflicting classifications of pathogenicity,"Autism, susceptibility to, 15|not provided|Cortical dysplasia-focal epilepsy syndrome|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,7,145931708,147099477,CNTNAP2,Pathogenic,Cortical dysplasia-focal epilepsy syndrome,Deletion,GRCh37
na,na,7,146234616,147402385,CNTNAP2,Pathogenic,Cortical dysplasia-focal epilepsy syndrome,Deletion,GRCh38
na,na,7,147183026,147183026,CNTNAP2,Pathogenic,Cortical dysplasia-focal epilepsy syndrome|not provided,single nucleotide variant,GRCh37
na,na,7,147485934,147485934,CNTNAP2,Pathogenic,Cortical dysplasia-focal epilepsy syndrome|not provided,single nucleotide variant,GRCh38
na,na,7,146756421,146935930,CNTNAP2,Pathogenic,Cortical dysplasia-focal epilepsy syndrome,Deletion,GRCh37
na,na,7,147059329,147238838,CNTNAP2,Pathogenic,Cortical dysplasia-focal epilepsy syndrome,Deletion,GRCh38
na,na,1,63885051,63885051,ALG6,Pathogenic,ALG6-congenital disorder of glycosylation 1C|not provided|ALG6-related disorder,single nucleotide variant,GRCh37
na,na,1,63419380,63419380,ALG6,Pathogenic,ALG6-congenital disorder of glycosylation 1C|not provided|ALG6-related disorder,single nucleotide variant,GRCh38
na,na,1,63902599,63902599,ALG6,Likely pathogenic,ALG6-congenital disorder of glycosylation 1C,single nucleotide variant,GRCh37
na,na,1,63436928,63436928,ALG6,Likely pathogenic,ALG6-congenital disorder of glycosylation 1C,single nucleotide variant,GRCh38
na,na,1,63862273,63862273,ALG6,Pathogenic,ALG6-congenital disorder of glycosylation 1C,single nucleotide variant,GRCh37
na,na,1,63396602,63396602,ALG6,Pathogenic,ALG6-congenital disorder of glycosylation 1C,single nucleotide variant,GRCh38
na,na,2,204819752,204821568,ICOS,Pathogenic,"Immunodeficiency, common variable, 1",Deletion,GRCh37
na,na,2,203955029,203956845,ICOS,Pathogenic,"Immunodeficiency, common variable, 1",Deletion,GRCh38
na,na,5,178699927,178699927,ADAMTS2,Pathogenic,"Ehlers-Danlos syndrome, dermatosparaxis type|not provided",single nucleotide variant,GRCh37
na,na,5,179272926,179272926,ADAMTS2,Pathogenic,"Ehlers-Danlos syndrome, dermatosparaxis type|not provided",single nucleotide variant,GRCh38
na,na,5,178557006,178557006,ADAMTS2,Pathogenic/Likely pathogenic,"Ehlers-Danlos syndrome, dermatosparaxis type",single nucleotide variant,GRCh37
na,na,5,179130005,179130005,ADAMTS2,Pathogenic/Likely pathogenic,"Ehlers-Danlos syndrome, dermatosparaxis type",single nucleotide variant,GRCh38
na,na,5,178585881,178770767,ADAMTS2,Pathogenic,"Ehlers-Danlos syndrome, dermatosparaxis type",Deletion,GRCh37
na,na,5,179158880,179343766,ADAMTS2,Pathogenic,"Ehlers-Danlos syndrome, dermatosparaxis type",Deletion,GRCh38
na,na,20,2641179,2641179,IDH3B,Pathogenic,Retinitis pigmentosa 46,Deletion,GRCh37
na,na,20,2660533,2660533,IDH3B,Pathogenic,Retinitis pigmentosa 46,Deletion,GRCh38
na,na,20,2641558,2641558,IDH3B,Uncertain significance,Retinitis pigmentosa 46|not provided,single nucleotide variant,GRCh37
na,na,20,2660912,2660912,IDH3B,Uncertain significance,Retinitis pigmentosa 46|not provided,single nucleotide variant,GRCh38
na,na,10,98031106,98031106,BLNK,Pathogenic,"Agammaglobulinemia 4, autosomal recessive",single nucleotide variant,GRCh37
na,na,10,96271349,96271349,BLNK,Pathogenic,"Agammaglobulinemia 4, autosomal recessive",single nucleotide variant,GRCh38
na,na,14,92482073,92482073,TRIP11,Pathogenic,"Achondrogenesis, type IA|Odontochondrodysplasia 1",single nucleotide variant,GRCh37
na,na,14,92015729,92015729,TRIP11,Pathogenic,"Achondrogenesis, type IA|Odontochondrodysplasia 1",single nucleotide variant,GRCh38
na,na,14,92491766,92491766,TRIP11,Likely pathogenic,"Achondrogenesis, type IA",single nucleotide variant,GRCh37
na,na,14,92025422,92025422,TRIP11,Likely pathogenic,"Achondrogenesis, type IA",single nucleotide variant,GRCh38
na,na,14,92472218,92472218,TRIP11,Conflicting classifications of pathogenicity,"Achondrogenesis, type IA|not provided|Connective tissue disorder",single nucleotide variant,GRCh37
na,na,14,92005874,92005874,TRIP11,Conflicting classifications of pathogenicity,"Achondrogenesis, type IA|not provided|Connective tissue disorder",single nucleotide variant,GRCh38
na,na,13,23909171,23909171,SACS,Pathogenic,Spastic paraplegia|Charlevoix-Saguenay spastic ataxia|not provided|SACS-related disorder|Hereditary spastic paraplegia,Deletion,GRCh37
na,na,13,23335032,23335032,SACS,Pathogenic,Spastic paraplegia|Charlevoix-Saguenay spastic ataxia|not provided|SACS-related disorder|Hereditary spastic paraplegia,Deletion,GRCh38
na,na,13,23910511,23910511,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia|Hereditary spastic paraplegia|not provided|Spastic paraplegia,single nucleotide variant,GRCh37
na,na,13,23336372,23336372,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia|Hereditary spastic paraplegia|not provided|Spastic paraplegia,single nucleotide variant,GRCh38
na,na,13,23905795,23905795,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,single nucleotide variant,GRCh37
na,na,13,23331656,23331656,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,single nucleotide variant,GRCh38
na,na,13,23914430,23914430,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,Deletion,GRCh37
na,na,13,23340291,23340291,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,Deletion,GRCh38
na,na,13,23912179,23912179,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia|Spastic paraplegia|SACS-related disorder,single nucleotide variant,GRCh37
na,na,13,23338040,23338040,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia|Spastic paraplegia|SACS-related disorder,single nucleotide variant,GRCh38
na,na,13,23913981,23913982,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,Duplication,GRCh37
na,na,13,23339842,23339843,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,Duplication,GRCh38
na,na,13,23908273,23908273,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,single nucleotide variant,GRCh37
na,na,13,23334134,23334134,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,single nucleotide variant,GRCh38
na,na,13,23914854,23914854,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,single nucleotide variant,GRCh37
na,na,13,23340715,23340715,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,single nucleotide variant,GRCh38
na,na,13,23929557,23929566,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,Deletion,GRCh37
na,na,13,23355418,23355427,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,Deletion,GRCh38
na,na,13,23928691,23928691,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,Deletion,GRCh37
na,na,13,23354552,23354552,SACS,Pathogenic,Charlevoix-Saguenay spastic ataxia,Deletion,GRCh38
na,na,5,34007971,34007971,AMACR,Pathogenic/Likely pathogenic,Congenital bile acid synthesis defect 4|Alpha-methylacyl-CoA racemase deficiency|not provided|AMACR-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,5,34007866,34007866,AMACR,Pathogenic/Likely pathogenic,Congenital bile acid synthesis defect 4|Alpha-methylacyl-CoA racemase deficiency|not provided|AMACR-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,5,34005932,34005932,AMACR,Pathogenic,Congenital bile acid synthesis defect 4,single nucleotide variant,GRCh37
na,na,5,34005827,34005827,AMACR,Pathogenic,Congenital bile acid synthesis defect 4,single nucleotide variant,GRCh38
na,na,17,37822015,37822015,TCAP,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2G|Hypertrophic cardiomyopathy 25|Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy;Hypertrophic cardiomyopathy 25|Hypertrophic cardiomyopathy 25;Autosomal recessive limb-girdle muscular dystrophy type 2G,single nucleotide variant,GRCh37
na,na,17,39665762,39665762,TCAP,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2G|Hypertrophic cardiomyopathy 25|Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy;Hypertrophic cardiomyopathy 25|Hypertrophic cardiomyopathy 25;Autosomal recessive limb-girdle muscular dystrophy type 2G,single nucleotide variant,GRCh38
na,na,17,37821720,37821721,TCAP,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2G|Hypertrophic cardiomyopathy 25;Autosomal recessive limb-girdle muscular dystrophy type 2G|Primary familial hypertrophic cardiomyopathy;Hypertrophic cardiomyopathy 25|Cardiovascular phenotype,Deletion,GRCh37
na,na,17,39665467,39665468,TCAP,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2G|Hypertrophic cardiomyopathy 25;Autosomal recessive limb-girdle muscular dystrophy type 2G|Primary familial hypertrophic cardiomyopathy;Hypertrophic cardiomyopathy 25|Cardiovascular phenotype,Deletion,GRCh38
na,na,17,37822118,37822118,TCAP,Uncertain significance,Hypertrophic cardiomyopathy 25|Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy 25;Primary familial hypertrophic cardiomyopathy,single nucleotide variant,GRCh37
na,na,17,39665865,39665865,TCAP,Uncertain significance,Hypertrophic cardiomyopathy 25|Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy 25;Primary familial hypertrophic cardiomyopathy,single nucleotide variant,GRCh38
na,na,15,72103930,72103930,NR2E3,Pathogenic/Likely pathogenic,Enhanced S-cone syndrome|not provided|Retinal dystrophy|Retinitis pigmentosa|NR2E3-related disorder,single nucleotide variant,GRCh37
na,na,15,71811590,71811590,NR2E3,Pathogenic/Likely pathogenic,Enhanced S-cone syndrome|not provided|Retinal dystrophy|Retinitis pigmentosa|NR2E3-related disorder,single nucleotide variant,GRCh38
na,na,15,72103931,72103931,NR2E3,Pathogenic/Likely pathogenic,Enhanced S-cone syndrome|NR2E3-related disorder|Retinitis pigmentosa 37;Enhanced S-cone syndrome|Retinal dystrophy|not provided|Goldmann-Favre syndrome|Retinitis pigmentosa 37,single nucleotide variant,GRCh37
na,na,15,71811591,71811591,NR2E3,Pathogenic/Likely pathogenic,Enhanced S-cone syndrome|NR2E3-related disorder|Retinitis pigmentosa 37;Enhanced S-cone syndrome|Retinal dystrophy|not provided|Goldmann-Favre syndrome|Retinitis pigmentosa 37,single nucleotide variant,GRCh38
na,na,15,72103899,72103907,NR2E3,Pathogenic,Enhanced S-cone syndrome,Deletion,GRCh37
na,na,15,71811559,71811567,NR2E3,Pathogenic,Enhanced S-cone syndrome,Deletion,GRCh38
na,na,15,72105913,72105913,NR2E3,Pathogenic/Likely pathogenic,Enhanced S-cone syndrome|Goldmann-Favre syndrome|not provided|NR2E3-related disorder|Retinitis pigmentosa|Retinitis pigmentosa 37;Enhanced S-cone syndrome|Autosomal recessive retinitis pigmentosa|Enhanced S-cone syndrome;NR2E3-related disorder|Retinal dystrophy|Retinitis pigmentosa 37,single nucleotide variant,GRCh37
na,na,15,71813573,71813573,NR2E3,Pathogenic/Likely pathogenic,Enhanced S-cone syndrome|Goldmann-Favre syndrome|not provided|NR2E3-related disorder|Retinitis pigmentosa|Retinitis pigmentosa 37;Enhanced S-cone syndrome|Autosomal recessive retinitis pigmentosa|Enhanced S-cone syndrome;NR2E3-related disorder|Retinal dystrophy|Retinitis pigmentosa 37,single nucleotide variant,GRCh38
na,na,15,72103870,72103870,NR2E3,Pathogenic/Likely pathogenic,Retinitis pigmentosa 37|Retinal dystrophy|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh37
na,na,15,71811530,71811530,NR2E3,Pathogenic/Likely pathogenic,Retinitis pigmentosa 37|Retinal dystrophy|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh38
na,na,15,72106392,72106396,NR2E3,Pathogenic,Retinitis pigmentosa 37,Deletion,GRCh37
na,na,15,71814051,71814055,NR2E3,Pathogenic,Retinitis pigmentosa 37,Deletion,GRCh38
na,na,12,66597584,66597584,IRAK3,risk factor,"Asthma-related traits, susceptibility to, 5",single nucleotide variant,GRCh37
na,na,12,66203804,66203804,IRAK3,risk factor,"Asthma-related traits, susceptibility to, 5",single nucleotide variant,GRCh38
na,na,12,66603301,66603301,IRAK3,risk factor,"Asthma-related traits, susceptibility to, 5",single nucleotide variant,GRCh37
na,na,12,66209521,66209521,IRAK3,risk factor,"Asthma-related traits, susceptibility to, 5",single nucleotide variant,GRCh38
na,na,2,231077087,231077087,SP110,Pathogenic,Hepatic veno-occlusive disease-immunodeficiency syndrome,Deletion,GRCh37
na,na,2,230212372,230212372,SP110,Pathogenic,Hepatic veno-occlusive disease-immunodeficiency syndrome,Deletion,GRCh38
na,na,2,231081603,231081603,SP110,Pathogenic,Hepatic veno-occlusive disease-immunodeficiency syndrome,Deletion,GRCh37
na,na,2,230216888,230216888,SP110,Pathogenic,Hepatic veno-occlusive disease-immunodeficiency syndrome,Deletion,GRCh38
na,na,2,231050715,231050715,SP110,Benign,"Mycobacterium tuberculosis, susceptibility to|not specified|Hepatic veno-occlusive disease-immunodeficiency syndrome|not provided",single nucleotide variant,GRCh37
na,na,2,230185999,230185999,SP110,Benign,"Mycobacterium tuberculosis, susceptibility to|not specified|Hepatic veno-occlusive disease-immunodeficiency syndrome|not provided",single nucleotide variant,GRCh38
na,na,2,231075206,231075206,SP110,Uncertain significance,"Mycobacterium tuberculosis, susceptibility to",single nucleotide variant,GRCh37
na,na,2,230210491,230210491,SP110,Uncertain significance,"Mycobacterium tuberculosis, susceptibility to",single nucleotide variant,GRCh38
na,na,11,74168361,74168361,KCNE3;LIPT2,Conflicting classifications of pathogenicity,"not provided|Periodic paralysis|not specified|Cardiovascular phenotype|Syncope;Ventricular fibrillation|Brugada syndrome 6|Cardiomyopathy|Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities",single nucleotide variant,GRCh37
na,na,11,74457316,74457316,KCNE3;LIPT2,Conflicting classifications of pathogenicity,"not provided|Periodic paralysis|not specified|Cardiovascular phenotype|Syncope;Ventricular fibrillation|Brugada syndrome 6|Cardiomyopathy|Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities",single nucleotide variant,GRCh38
na,na,11,74168313,74168313,KCNE3,Conflicting classifications of pathogenicity,Brugada syndrome 6|not provided|Brugada syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,11,74457268,74457268,KCNE3,Conflicting classifications of pathogenicity,Brugada syndrome 6|not provided|Brugada syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,13,20797606,20797606,GJB6,Pathogenic,Autosomal dominant nonsyndromic hearing loss 3B,single nucleotide variant,GRCh37
na,na,13,20223467,20223467,GJB6,Pathogenic,Autosomal dominant nonsyndromic hearing loss 3B,single nucleotide variant,GRCh38
na,na,13,20797589,20797589,GJB6,Pathogenic,Hidrotic ectodermal dysplasia syndrome|not provided|Autosomal dominant nonsyndromic hearing loss 3B;Hidrotic ectodermal dysplasia syndrome;Autosomal recessive nonsyndromic hearing loss 1B;Autosomal recessive nonsyndromic hearing loss 1A|GJB6-related disorder,single nucleotide variant,GRCh37
na,na,13,20223450,20223450,GJB6,Pathogenic,Hidrotic ectodermal dysplasia syndrome|not provided|Autosomal dominant nonsyndromic hearing loss 3B;Hidrotic ectodermal dysplasia syndrome;Autosomal recessive nonsyndromic hearing loss 1B;Autosomal recessive nonsyndromic hearing loss 1A|GJB6-related disorder,single nucleotide variant,GRCh38
na,na,13,20797357,20797357,GJB6,Pathogenic,Hidrotic ectodermal dysplasia syndrome|Hidrotic ectodermal dysplasia syndrome;Autosomal recessive nonsyndromic hearing loss 1B;Autosomal dominant nonsyndromic hearing loss 3B;Autosomal recessive nonsyndromic hearing loss 1A|Hidrotic ectodermal dysplasia syndrome;Autosomal recessive nonsyndromic hearing loss 1B;Autosomal dominant nonsyndromic hearing loss 3B;X-linked mixed hearing loss with perilymphatic gusher;Autosomal recessive nonsyndromic hearing loss 1A,single nucleotide variant,GRCh37
na,na,13,20223218,20223218,GJB6,Pathogenic,Hidrotic ectodermal dysplasia syndrome|Hidrotic ectodermal dysplasia syndrome;Autosomal recessive nonsyndromic hearing loss 1B;Autosomal dominant nonsyndromic hearing loss 3B;Autosomal recessive nonsyndromic hearing loss 1A|Hidrotic ectodermal dysplasia syndrome;Autosomal recessive nonsyndromic hearing loss 1B;Autosomal dominant nonsyndromic hearing loss 3B;X-linked mixed hearing loss with perilymphatic gusher;Autosomal recessive nonsyndromic hearing loss 1A,single nucleotide variant,GRCh38
na,na,13,20223038,20531806,"covers 17 genes, none of which curated to show dosage sensitivity",Pathogenic,"Autosomal recessive nonsyndromic hearing loss 1B|Deafness, digenic, GJB2/GJB6|Autosomal recessive nonsyndromic hearing loss 1A",Deletion,GRCh38
na,na,13,20797510,20797510,GJB6,Pathogenic,Hidrotic ectodermal dysplasia syndrome,single nucleotide variant,GRCh37
na,na,13,20223371,20223371,GJB6,Pathogenic,Hidrotic ectodermal dysplasia syndrome,single nucleotide variant,GRCh38
na,na,13,20802713,21034768,GJB6,Pathogenic,"Deafness, digenic, GJB2/GJB6",Deletion,GRCh37
na,na,13,20228574,20460629,GJB6,Pathogenic,"Deafness, digenic, GJB2/GJB6",Deletion,GRCh38
na,na,13,94680049,94680049,GPC6,Pathogenic,Autosomal recessive omodysplasia,Deletion,GRCh37
na,na,13,94027795,94027795,GPC6,Pathogenic,Autosomal recessive omodysplasia,Deletion,GRCh38
na,ATAAATCACTTAGAGATGT,13,94649261,94715755,GPC6,Pathogenic,Autosomal recessive omodysplasia,Indel,GRCh37
na,ATAAATCACTTAGAGATGT,13,93997007,94063501,GPC6,Pathogenic,Autosomal recessive omodysplasia,Indel,GRCh38
na,CTA,13,94905238,95004553,GPC6,Pathogenic,Autosomal recessive omodysplasia,Indel,GRCh37
na,CTA,13,94252984,94352299,GPC6,Pathogenic,Autosomal recessive omodysplasia,Indel,GRCh38
na,na,13,94482787,94482787,GPC6,Pathogenic,Autosomal recessive omodysplasia,single nucleotide variant,GRCh37
na,na,13,93830534,93830534,GPC6,Pathogenic,Autosomal recessive omodysplasia,single nucleotide variant,GRCh38
na,na,13,94011504,94038749,GPC6,Pathogenic,Autosomal recessive omodysplasia,Duplication,GRCh38
na,na,13,94393571,94483201,GPC6,Pathogenic,Autosomal recessive omodysplasia,Deletion,GRCh37
na,na,13,93741318,93830948,GPC6,Pathogenic,Autosomal recessive omodysplasia,Deletion,GRCh38
na,na,13,94255566,94512583,GPC6,Pathogenic,Autosomal recessive omodysplasia,Deletion,GRCh37
na,na,13,93603313,93860330,GPC6,Pathogenic,Autosomal recessive omodysplasia,Deletion,GRCh38
na,na,2,86071665,86071665,ST3GAL5,Pathogenic,GM3 synthase deficiency|not provided|ST3GAL5-related disorder,single nucleotide variant,GRCh37
na,na,2,85844542,85844542,ST3GAL5,Pathogenic,GM3 synthase deficiency|not provided|ST3GAL5-related disorder,single nucleotide variant,GRCh38
na,na,14,75513877,75513877,MLH3,Uncertain significance,"Carcinoma of colon|Colorectal cancer, hereditary nonpolyposis, type 7|not specified",single nucleotide variant,GRCh37
na,na,14,75047174,75047174,MLH3,Uncertain significance,"Carcinoma of colon|Colorectal cancer, hereditary nonpolyposis, type 7|not specified",single nucleotide variant,GRCh38
na,na,14,75516289,75516289,MLH3,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7|not specified",single nucleotide variant,GRCh37
na,na,14,75049586,75049586,MLH3,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7|not specified",single nucleotide variant,GRCh38
na,na,14,75514863,75514863,MLH3,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7",single nucleotide variant,GRCh37
na,na,14,75048160,75048160,MLH3,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7",single nucleotide variant,GRCh38
na,na,14,75514489,75514489,MLH3,Benign/Likely benign,"Colorectal cancer, hereditary nonpolyposis, type 7|not provided|not specified",single nucleotide variant,GRCh37
na,na,14,75047786,75047786,MLH3,Benign/Likely benign,"Colorectal cancer, hereditary nonpolyposis, type 7|not provided|not specified",single nucleotide variant,GRCh38
na,na,14,75514138,75514138,AREL1;MLH3,Benign/Likely benign,"Endometrial carcinoma|Colorectal cancer, hereditary nonpolyposis, type 7|not provided|not specified|Colorectal cancer;Endometrial carcinoma;Colorectal cancer, hereditary nonpolyposis, type 7",single nucleotide variant,GRCh37
na,na,14,75047435,75047435,AREL1;MLH3,Benign/Likely benign,"Endometrial carcinoma|Colorectal cancer, hereditary nonpolyposis, type 7|not provided|not specified|Colorectal cancer;Endometrial carcinoma;Colorectal cancer, hereditary nonpolyposis, type 7",single nucleotide variant,GRCh38
na,na,14,75483796,75483796,MLH3,Conflicting classifications of pathogenicity,"Colorectal cancer, hereditary nonpolyposis, type 7|not specified|not provided|Endometrial carcinoma;Colorectal cancer, hereditary nonpolyposis, type 7;Colorectal cancer",single nucleotide variant,GRCh37
na,na,14,75017093,75017093,MLH3,Conflicting classifications of pathogenicity,"Colorectal cancer, hereditary nonpolyposis, type 7|not specified|not provided|Endometrial carcinoma;Colorectal cancer, hereditary nonpolyposis, type 7;Colorectal cancer",single nucleotide variant,GRCh38
na,na,14,75515474,75515474,MLH3,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7|Endometrial cancer|not specified",Deletion,GRCh37
na,na,14,75048771,75048771,MLH3,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7|Endometrial cancer|not specified",Deletion,GRCh38
na,na,14,75498772,75498772,MLH3,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7|not specified",single nucleotide variant,GRCh37
na,na,14,75032069,75032069,MLH3,Uncertain significance,"Colorectal cancer, hereditary nonpolyposis, type 7|not specified",single nucleotide variant,GRCh38
na,na,17,6329101,6329101,AIPL1,Pathogenic,Leber congenital amaurosis 4|not provided|AIPL1-related disorder|Leber congenital amaurosis|Retinal dystrophy|Leber congenital amaurosis 4;Retinitis pigmentosa|AIPL1-related retinopathy,single nucleotide variant,GRCh37
na,na,17,6425781,6425781,AIPL1,Pathogenic,Leber congenital amaurosis 4|not provided|AIPL1-related disorder|Leber congenital amaurosis|Retinal dystrophy|Leber congenital amaurosis 4;Retinitis pigmentosa|AIPL1-related retinopathy,single nucleotide variant,GRCh38
na,na,17,6328924,6328925,AIPL1,Pathogenic/Likely pathogenic,Leber congenital amaurosis 4|not provided,Microsatellite,GRCh37
na,na,17,6425604,6425605,AIPL1,Pathogenic/Likely pathogenic,Leber congenital amaurosis 4|not provided,Microsatellite,GRCh38
na,na,17,6330004,6330004,AIPL1,Conflicting classifications of pathogenicity,Leber congenital amaurosis 4|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,17,6426684,6426684,AIPL1,Conflicting classifications of pathogenicity,Leber congenital amaurosis 4|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,17,6328871,6328882,AIPL1,Conflicting classifications of pathogenicity,"Juvenile retinitis pigmentosa, AIPL1-related|CONE-ROD DYSTROPHY, AIPL1-RELATED|not provided|Leber congenital amaurosis 4|Retinal dystrophy|AIPL1-related disorder|Leber congenital amaurosis 4;Retinitis pigmentosa|not specified",Deletion,GRCh37
na,na,17,6425551,6425562,AIPL1,Conflicting classifications of pathogenicity,"Juvenile retinitis pigmentosa, AIPL1-related|CONE-ROD DYSTROPHY, AIPL1-RELATED|not provided|Leber congenital amaurosis 4|Retinal dystrophy|AIPL1-related disorder|Leber congenital amaurosis 4;Retinitis pigmentosa|not specified",Deletion,GRCh38
na,na,8,116617143,116617143,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,single nucleotide variant,GRCh37
na,na,8,115604916,115604916,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,single nucleotide variant,GRCh38
na,na,8,116616326,116616326,TRPS1,Pathogenic,"Trichorhinophalangeal dysplasia type I|not provided|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,8,115604099,115604099,TRPS1,Pathogenic,"Trichorhinophalangeal dysplasia type I|not provided|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,8,116599482,116599483,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,Duplication,GRCh37
na,na,8,115587255,115587256,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,Duplication,GRCh38
na,na,8,116599447,116599448,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,Duplication,GRCh37
na,na,8,115587220,115587221,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,Duplication,GRCh38
na,na,8,116599371,116599371,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I|not provided|TRPS1-related disorder,single nucleotide variant,GRCh37
na,na,8,115587144,115587144,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I|not provided|TRPS1-related disorder,single nucleotide variant,GRCh38
na,na,8,116426735,116426736,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,Insertion,GRCh37
na,na,8,115414507,115414508,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,Insertion,GRCh38
na,na,8,116430641,116430641,TRPS1,Pathogenic,"Trichorhinophalangeal syndrome, type III",single nucleotide variant,GRCh37
na,na,8,115418413,115418413,TRPS1,Pathogenic,"Trichorhinophalangeal syndrome, type III",single nucleotide variant,GRCh38
na,na,8,116426821,116426821,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,single nucleotide variant,GRCh37
na,na,8,115414593,115414593,TRPS1,Pathogenic,Trichorhinophalangeal dysplasia type I,single nucleotide variant,GRCh38
na,na,8,116430619,116430619,TRPS1,Pathogenic,"Trichorhinophalangeal syndrome, type III|Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|not provided",single nucleotide variant,GRCh37
na,na,8,115418391,115418391,TRPS1,Pathogenic,"Trichorhinophalangeal syndrome, type III|Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|not provided",single nucleotide variant,GRCh38
na,na,8,116430586,116430586,TRPS1,Pathogenic,"Trichorhinophalangeal syndrome, type III|Trichorhinophalangeal dysplasia type I|not provided|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|Congenital anomaly of kidney and urinary tract",single nucleotide variant,GRCh37
na,na,8,115418358,115418358,TRPS1,Pathogenic,"Trichorhinophalangeal syndrome, type III|Trichorhinophalangeal dysplasia type I|not provided|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|Congenital anomaly of kidney and urinary tract",single nucleotide variant,GRCh38
na,na,8,116427243,116427243,TRPS1,Pathogenic,"Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III",single nucleotide variant,GRCh37
na,na,8,115415015,115415015,TRPS1,Pathogenic,"Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III",single nucleotide variant,GRCh38
na,na,8,116427242,116427242,TRPS1,Pathogenic/Likely pathogenic,"Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|not provided",single nucleotide variant,GRCh37
na,na,8,115415014,115415014,TRPS1,Pathogenic/Likely pathogenic,"Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal dysplasia type I;Trichorhinophalangeal syndrome, type III|not provided",single nucleotide variant,GRCh38
na,na,3,130674958,130674959,ATP2C1,Pathogenic,Familial benign pemphigus,Duplication,GRCh37
na,na,3,130956114,130956115,ATP2C1,Pathogenic,Familial benign pemphigus,Duplication,GRCh38
na,na,3,130682825,130682825,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh37
na,na,3,130963981,130963981,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh38
na,na,3,130688229,130688229,ATP2C1,Pathogenic,Familial benign pemphigus|not provided,single nucleotide variant,GRCh37
na,na,3,130969385,130969385,ATP2C1,Pathogenic,Familial benign pemphigus|not provided,single nucleotide variant,GRCh38
na,na,3,130682814,130682814,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh37
na,na,3,130963970,130963970,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh38
na,na,3,130694231,130694231,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh37
na,na,3,130975387,130975387,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh38
na,na,3,130717206,130717206,ATP2C1,Pathogenic,Familial benign pemphigus,Deletion,GRCh37
na,na,3,130998362,130998362,ATP2C1,Pathogenic,Familial benign pemphigus,Deletion,GRCh38
na,na,3,130699435,130699435,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh37
na,na,3,130980591,130980591,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh38
na,na,3,130714956,130714956,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh37
na,na,3,130996112,130996112,ATP2C1,Pathogenic,Familial benign pemphigus,single nucleotide variant,GRCh38
na,na,22,29121087,29121087,CHEK2,Conflicting classifications of pathogenicity; risk factor,"CHEK2-related cancer predisposition|not specified|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Breast and colorectal cancer, susceptibility to|Adrenal cortex carcinoma;Gastrointestinal carcinoma|Malignant tumor of breast|Breast and/or ovarian cancer|Predisposition to cancer|TUMOR PREDISPOSITION SYNDROME 4, BREAST/PROSTATE/COLORECTAL|Prostate cancer|CHEK2-related cancer predisposition;Bone osteosarcoma;Familial prostate cancer|CHEK2-related cancer predisposition;Bone osteosarcoma;Familial prostate cancer;Familial cancer of breast|CHEK2-related cancer predisposition;Bone osteosarcoma;Colorectal cancer;Familial prostate cancer;Familial cancer of breast|CHEK2-related disorder",single nucleotide variant,GRCh37
na,na,22,28725099,28725099,CHEK2,Conflicting classifications of pathogenicity; risk factor,"CHEK2-related cancer predisposition|not specified|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Breast and colorectal cancer, susceptibility to|Adrenal cortex carcinoma;Gastrointestinal carcinoma|Malignant tumor of breast|Breast and/or ovarian cancer|Predisposition to cancer|TUMOR PREDISPOSITION SYNDROME 4, BREAST/PROSTATE/COLORECTAL|Prostate cancer|CHEK2-related cancer predisposition;Bone osteosarcoma;Familial prostate cancer|CHEK2-related cancer predisposition;Bone osteosarcoma;Familial prostate cancer;Familial cancer of breast|CHEK2-related cancer predisposition;Bone osteosarcoma;Colorectal cancer;Familial prostate cancer;Familial cancer of breast|CHEK2-related disorder",single nucleotide variant,GRCh38
na,na,22,29121242,29121242,CHEK2,Likely pathogenic,CHEK2-related cancer predisposition|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided|Li-Fraumeni syndrome|Malignant tumor of breast|Li-Fraumeni syndrome 1|Breast and/or ovarian cancer|Gastric cancer,single nucleotide variant,GRCh37
na,na,22,28725254,28725254,CHEK2,Likely pathogenic,CHEK2-related cancer predisposition|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|not provided|Li-Fraumeni syndrome|Malignant tumor of breast|Li-Fraumeni syndrome 1|Breast and/or ovarian cancer|Gastric cancer,single nucleotide variant,GRCh38
na,na,22,29090056,29090056,CHEK2,Pathogenic,CHEK2-related cancer predisposition|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,22,28694068,28694068,CHEK2,Pathogenic,CHEK2-related cancer predisposition|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,22,29130456,29130456,CHEK2,Benign/Likely benign,Bone osteosarcoma|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Malignant tumor of breast|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome,single nucleotide variant,GRCh37
na,na,22,28734468,28734468,CHEK2,Benign/Likely benign,Bone osteosarcoma|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Malignant tumor of breast|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome,single nucleotide variant,GRCh38
na,na,22,29130661,29130661,CHEK2,Pathogenic,Bone osteosarcoma,single nucleotide variant,GRCh37
na,na,22,28734673,28734673,CHEK2,Pathogenic,Bone osteosarcoma,single nucleotide variant,GRCh38
na,na,22,29121018,29121018,CHEK2,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|not specified|Malignant tumor of breast|Prostate cancer|Hereditary breast ovarian cancer syndrome,single nucleotide variant,GRCh37
na,na,22,28725030,28725030,CHEK2,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|not specified|Malignant tumor of breast|Prostate cancer|Hereditary breast ovarian cancer syndrome,single nucleotide variant,GRCh38
na,na,22,29121016,29121016,CHEK2,Conflicting classifications of pathogenicity,"Prostate cancer, somatic|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified|Hereditary breast ovarian cancer syndrome|Predisposition to cancer|CHEK2-related disorder|CHEK2-related cancer predisposition",single nucleotide variant,GRCh37
na,na,22,28725028,28725028,CHEK2,Conflicting classifications of pathogenicity,"Prostate cancer, somatic|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|not specified|Hereditary breast ovarian cancer syndrome|Predisposition to cancer|CHEK2-related disorder|CHEK2-related cancer predisposition",single nucleotide variant,GRCh38
na,na,22,29121015,29121015,CHEK2,Conflicting classifications of pathogenicity,"not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Prostate cancer;CHEK2-related cancer predisposition;Bone osteosarcoma;Familial cancer of breast|not specified|CHEK2-related cancer predisposition|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Malignant tumor of breast|Prostate cancer|CHEK2-related cancer predisposition;Bone osteosarcoma;Familial prostate cancer|Breast-ovarian cancer, familial, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,22,28725027,28725027,CHEK2,Conflicting classifications of pathogenicity,"not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Prostate cancer;CHEK2-related cancer predisposition;Bone osteosarcoma;Familial cancer of breast|not specified|CHEK2-related cancer predisposition|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Malignant tumor of breast|Prostate cancer|CHEK2-related cancer predisposition;Bone osteosarcoma;Familial prostate cancer|Breast-ovarian cancer, familial, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,22,29107974,29107974,CHEK2,Pathogenic,Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Colorectal cancer|Prostate cancer,single nucleotide variant,GRCh37
na,na,22,28711986,28711986,CHEK2,Pathogenic,Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Colorectal cancer|Prostate cancer,single nucleotide variant,GRCh38
na,na,22,29107974,29107974,CHEK2,Conflicting classifications of pathogenicity,not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Predisposition to cancer|not specified|Prostate cancer;CHEK2-related cancer predisposition;Bone osteosarcoma;Colorectal cancer;Familial cancer of breast|CHEK2-related disorder|Prostate cancer|CHEK2-related cancer predisposition,single nucleotide variant,GRCh37
na,na,22,28711986,28711986,CHEK2,Conflicting classifications of pathogenicity,not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Predisposition to cancer|not specified|Prostate cancer;CHEK2-related cancer predisposition;Bone osteosarcoma;Colorectal cancer;Familial cancer of breast|CHEK2-related disorder|Prostate cancer|CHEK2-related cancer predisposition,single nucleotide variant,GRCh38
na,na,22,29091207,29091207,CHEK2,Conflicting classifications of pathogenicity,"Breast cancer, susceptibility to|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast neoplasm|Prostate cancer;CHEK2-related cancer predisposition;Bone osteosarcoma;Familial cancer of breast|Breast and colorectal cancer, susceptibility to|not provided|Hereditary breast ovarian cancer syndrome|CHEK2-related cancer risk|Malignant tumor of breast|TUMOR PREDISPOSITION SYNDROME 4, BREAST|CHEK2-related disorder|Breast and/or ovarian cancer|CHEK2-related cancer predisposition;Bone osteosarcoma;Familial prostate cancer|CHEK2-related cancer predisposition|Inherited breast cancer and ovarian cancer",single nucleotide variant,GRCh37
na,na,22,28695219,28695219,CHEK2,Conflicting classifications of pathogenicity,"Breast cancer, susceptibility to|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast neoplasm|Prostate cancer;CHEK2-related cancer predisposition;Bone osteosarcoma;Familial cancer of breast|Breast and colorectal cancer, susceptibility to|not provided|Hereditary breast ovarian cancer syndrome|CHEK2-related cancer risk|Malignant tumor of breast|TUMOR PREDISPOSITION SYNDROME 4, BREAST|CHEK2-related disorder|Breast and/or ovarian cancer|CHEK2-related cancer predisposition;Bone osteosarcoma;Familial prostate cancer|CHEK2-related cancer predisposition|Inherited breast cancer and ovarian cancer",single nucleotide variant,GRCh38
na,na,9,34459052,34459053,DNAI1,Pathogenic,Kartagener syndrome|Primary ciliary dyskinesia|not provided|Inborn genetic diseases|DNAI1-related disorder,Duplication,GRCh37
na,na,9,34459054,34459055,DNAI1,Pathogenic,Kartagener syndrome|Primary ciliary dyskinesia|not provided|Inborn genetic diseases|DNAI1-related disorder,Duplication,GRCh38
na,na,9,34489341,34489342,DNAI1,Pathogenic,Kartagener syndrome,Insertion,GRCh37
na,na,9,34489343,34489344,DNAI1,Pathogenic,Kartagener syndrome,Insertion,GRCh38
na,na,9,34513163,34513163,DNAI1,Pathogenic/Likely pathogenic,Kartagener syndrome|Primary ciliary dyskinesia|DNAI1-related disorder,single nucleotide variant,GRCh37
na,na,9,34513165,34513165,DNAI1,Pathogenic/Likely pathogenic,Kartagener syndrome|Primary ciliary dyskinesia|DNAI1-related disorder,single nucleotide variant,GRCh38
na,na,9,34514478,34514489,DNAI1,Pathogenic,Kartagener syndrome,Deletion,GRCh37
na,na,9,34514480,34514491,DNAI1,Pathogenic,Kartagener syndrome,Deletion,GRCh38
na,na,4,15993941,15993941,PROM1,Pathogenic,Retinitis pigmentosa 41,Deletion,GRCh37
na,na,4,15992318,15992318,PROM1,Pathogenic,Retinitis pigmentosa 41,Deletion,GRCh38
na,na,4,15995651,15995651,PROM1,Pathogenic,Retinitis pigmentosa 41|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,4,15994028,15994028,PROM1,Pathogenic,Retinitis pigmentosa 41|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,4,16014922,16014922,PROM1,Pathogenic/Likely pathogenic,Stargardt disease 4|Retinal macular dystrophy type 2|Cone-rod dystrophy 12|not provided|Retinal dystrophy|Macular dystrophy|Stargardt disease|Retinitis pigmentosa|Retinitis pigmentosa 41;Retinal macular dystrophy type 2;Cone-rod dystrophy 12;Stargardt disease 4,single nucleotide variant,GRCh37
na,na,4,16013299,16013299,PROM1,Pathogenic/Likely pathogenic,Stargardt disease 4|Retinal macular dystrophy type 2|Cone-rod dystrophy 12|not provided|Retinal dystrophy|Macular dystrophy|Stargardt disease|Retinitis pigmentosa|Retinitis pigmentosa 41;Retinal macular dystrophy type 2;Cone-rod dystrophy 12;Stargardt disease 4,single nucleotide variant,GRCh38
na,na,5,177034446,177034446,B4GALT7,Pathogenic,Ehlers-Danlos syndrome progeroid type,single nucleotide variant,GRCh37
na,na,5,177607445,177607445,B4GALT7,Pathogenic,Ehlers-Danlos syndrome progeroid type,single nucleotide variant,GRCh38
na,na,5,177034506,177034506,B4GALT7,Pathogenic,Ehlers-Danlos syndrome progeroid type,single nucleotide variant,GRCh37
na,na,5,177607505,177607505,B4GALT7,Pathogenic,Ehlers-Danlos syndrome progeroid type,single nucleotide variant,GRCh38
na,na,5,177035995,177035995,B4GALT7,Pathogenic,"Ehlers-Danlos syndrome progeroid type|Larsen-like syndrome, B3GAT3 type|not provided|Lethal skeletal dysplasia|Ehlers-Danlos syndrome, spondylodysplastic type, 1|",single nucleotide variant,GRCh37
na,na,5,177608994,177608994,B4GALT7,Pathogenic,"Ehlers-Danlos syndrome progeroid type|Larsen-like syndrome, B3GAT3 type|not provided|Lethal skeletal dysplasia|Ehlers-Danlos syndrome, spondylodysplastic type, 1|",single nucleotide variant,GRCh38
na,na,5,146258292,146258294,PPP2R2B,Benign,Spinocerebellar ataxia type 12,Microsatellite,GRCh37
na,na,5,146878729,146878731,PPP2R2B,Benign,Spinocerebellar ataxia type 12,Microsatellite,GRCh38
na,na,6,74354306,74354306,SLC17A5,Pathogenic,"Salla disease|not provided|Sialic acid storage disease, severe infantile type|Salla disease;Sialic acid storage disease, severe infantile type",single nucleotide variant,GRCh37
na,na,6,73644583,73644583,SLC17A5,Pathogenic,"Salla disease|not provided|Sialic acid storage disease, severe infantile type|Salla disease;Sialic acid storage disease, severe infantile type",single nucleotide variant,GRCh38
na,na,6,74348200,74348200,SLC17A5,Likely pathogenic,"Sialic acid storage disease, severe infantile type|Salla disease",single nucleotide variant,GRCh37
na,na,6,73638477,73638477,SLC17A5,Likely pathogenic,"Sialic acid storage disease, severe infantile type|Salla disease",single nucleotide variant,GRCh38
na,na,6,74325148,74325148,SLC17A5,Pathogenic/Likely pathogenic,"Sialic acid storage disease, severe infantile type|Salla disease|Salla disease;Sialic acid storage disease, severe infantile type",single nucleotide variant,GRCh37
na,na,6,73615425,73615425,SLC17A5,Pathogenic/Likely pathogenic,"Sialic acid storage disease, severe infantile type|Salla disease|Salla disease;Sialic acid storage disease, severe infantile type",single nucleotide variant,GRCh38
na,na,na,-1,-1,SLC17A5,Pathogenic,"Sialic acid storage disease, severe infantile type",Insertion,na
na,na,14,24709848,24709848,TINF2,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Dyskeratosis congenita, autosomal dominant 1|not provided",single nucleotide variant,GRCh37
na,na,14,24240642,24240642,TINF2,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Dyskeratosis congenita, autosomal dominant 1|not provided",single nucleotide variant,GRCh38
na,na,14,24709841,24709841,TINF2,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Revesz syndrome|not provided|Dyskeratosis congenita|Dyskeratosis congenita, autosomal dominant 1;Revesz syndrome;Dyskeratosis congenita, autosomal dominant 3",single nucleotide variant,GRCh37
na,na,14,24240635,24240635,TINF2,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Revesz syndrome|not provided|Dyskeratosis congenita|Dyskeratosis congenita, autosomal dominant 1;Revesz syndrome;Dyskeratosis congenita, autosomal dominant 3",single nucleotide variant,GRCh38
na,na,14,24709842,24709842,TINF2,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Dyskeratosis congenita, autosomal dominant 1|Dyskeratosis congenita",single nucleotide variant,GRCh37
na,na,14,24240636,24240636,TINF2,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Dyskeratosis congenita, autosomal dominant 1|Dyskeratosis congenita",single nucleotide variant,GRCh38
na,na,14,24709842,24709842,TINF2,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Dyskeratosis congenita, autosomal dominant 1|Dyskeratosis congenita|not provided",single nucleotide variant,GRCh37
na,na,14,24240636,24240636,TINF2,Pathogenic,"Dyskeratosis congenita, autosomal dominant 3|Dyskeratosis congenita, autosomal dominant 1|Dyskeratosis congenita|not provided",single nucleotide variant,GRCh38
na,na,17,73761124,73761124,GALK1,Conflicting classifications of pathogenicity,Deficiency of galactokinase,single nucleotide variant,GRCh37
na,na,17,75765043,75765043,GALK1,Conflicting classifications of pathogenicity,Deficiency of galactokinase,single nucleotide variant,GRCh38
na,na,17,73760095,73760095,GALK1,Pathogenic,Deficiency of galactokinase,single nucleotide variant,GRCh37
na,na,17,75764014,75764014,GALK1,Pathogenic,Deficiency of galactokinase,single nucleotide variant,GRCh38
na,na,17,73761136,73761136,GALK1,Pathogenic,Deficiency of galactokinase|not provided,single nucleotide variant,GRCh37
na,na,17,75765055,75765055,GALK1,Pathogenic,Deficiency of galactokinase|not provided,single nucleotide variant,GRCh38
na,na,17,73754172,73754172,GALK1,Pathogenic,Deficiency of galactokinase,single nucleotide variant,GRCh37
na,na,17,75758091,75758091,GALK1,Pathogenic,Deficiency of galactokinase,single nucleotide variant,GRCh38
na,na,17,73758817,73758817,GALK1,Pathogenic,Deficiency of galactokinase,Deletion,GRCh37
na,na,17,75762736,75762736,GALK1,Pathogenic,Deficiency of galactokinase,Deletion,GRCh38
na,na,17,73759113,73759113,GALK1,Conflicting classifications of pathogenicity,Deficiency of galactokinase|not specified|GALK1-related disorder,single nucleotide variant,GRCh37
na,na,17,75763032,75763032,GALK1,Conflicting classifications of pathogenicity,Deficiency of galactokinase|not specified|GALK1-related disorder,single nucleotide variant,GRCh38
na,na,20,23615967,23615967,CST3,Pathogenic,"Hereditary cerebral amyloid angiopathy, Icelandic type",single nucleotide variant,GRCh37
na,na,20,23635330,23635330,CST3,Pathogenic,"Hereditary cerebral amyloid angiopathy, Icelandic type",single nucleotide variant,GRCh38
na,na,20,23618427,23618427,CST3,Benign,"Age related macular degeneration 11|not provided|Hereditary cerebral amyloid angiopathy, Icelandic type|not specified|Hereditary cerebral amyloid angiopathy, Icelandic type;Age related macular degeneration 11",single nucleotide variant,GRCh37
na,na,20,23637790,23637790,CST3,Benign,"Age related macular degeneration 11|not provided|Hereditary cerebral amyloid angiopathy, Icelandic type|not specified|Hereditary cerebral amyloid angiopathy, Icelandic type;Age related macular degeneration 11",single nucleotide variant,GRCh38
na,na,9,37424859,37424859,GRHPR,Pathogenic,"Primary hyperoxaluria, type II|Nephrolithiasis;Nephrocalcinosis|not provided",Deletion,GRCh37
na,na,9,37424862,37424862,GRHPR,Pathogenic,"Primary hyperoxaluria, type II|Nephrolithiasis;Nephrocalcinosis|not provided",Deletion,GRCh38
na,na,9,37426542,37426542,GRHPR,Pathogenic,"Primary hyperoxaluria, type II|not provided|Primary hyperoxaluria",single nucleotide variant,GRCh37
na,na,9,37426545,37426545,GRHPR,Pathogenic,"Primary hyperoxaluria, type II|not provided|Primary hyperoxaluria",single nucleotide variant,GRCh38
na,na,8,95403868,95403868,RAD54B,Benign,Non-Hodgkin lymphoma|not provided,single nucleotide variant,GRCh37
na,na,8,94391640,94391640,RAD54B,Benign,Non-Hodgkin lymphoma|not provided,single nucleotide variant,GRCh38
na,na,8,95411768,95411768,RAD54B,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh37
na,na,8,94399540,94399540,RAD54B,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh38
na,na,2,241813412,241813412,AGXT,Pathogenic/Likely pathogenic,"Primary hyperoxaluria, type I|not provided",single nucleotide variant,GRCh37
na,na,2,240873995,240873995,AGXT,Pathogenic/Likely pathogenic,"Primary hyperoxaluria, type I|not provided",single nucleotide variant,GRCh38
na,na,2,241808314,241808314,AGXT,Benign/Likely benign,"Primary hyperoxaluria, type I|not specified|not provided",single nucleotide variant,GRCh37
na,na,2,240868897,240868897,AGXT,Benign/Likely benign,"Primary hyperoxaluria, type I|not specified|not provided",single nucleotide variant,GRCh38
na,na,2,241808619,241808619,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided",single nucleotide variant,GRCh37
na,na,2,240869202,240869202,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided",single nucleotide variant,GRCh38
na,na,2,241808666,241808666,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria",single nucleotide variant,GRCh37
na,na,2,240869249,240869249,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria",single nucleotide variant,GRCh38
na,na,2,241808403,241808403,AGXT,Pathogenic,"Primary hyperoxaluria, type I|Nephrolithiasis;Nephrocalcinosis|not provided|Primary hyperoxaluria",single nucleotide variant,GRCh37
na,na,2,240868986,240868986,AGXT,Pathogenic,"Primary hyperoxaluria, type I|Nephrolithiasis;Nephrocalcinosis|not provided|Primary hyperoxaluria",single nucleotide variant,GRCh38
na,na,2,241810796,241810796,AGXT,Pathogenic,"Primary hyperoxaluria, type I|Primary hyperoxaluria|not provided",single nucleotide variant,GRCh37
na,na,2,240871379,240871379,AGXT,Pathogenic,"Primary hyperoxaluria, type I|Primary hyperoxaluria|not provided",single nucleotide variant,GRCh38
na,na,2,241814576,241814576,AGXT,Pathogenic,"Primary hyperoxaluria, type I|Nephrolithiasis;Nephrocalcinosis|Primary hyperoxaluria|not provided|AGXT-related disorder",single nucleotide variant,GRCh37
na,na,2,240875159,240875159,AGXT,Pathogenic,"Primary hyperoxaluria, type I|Nephrolithiasis;Nephrocalcinosis|Primary hyperoxaluria|not provided|AGXT-related disorder",single nucleotide variant,GRCh38
na,na,2,241814542,241814542,AGXT,Pathogenic/Likely pathogenic,"Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria",single nucleotide variant,GRCh37
na,na,2,240875125,240875125,AGXT,Pathogenic/Likely pathogenic,"Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria",single nucleotide variant,GRCh38
na,na,2,241814543,241814543,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided",single nucleotide variant,GRCh37
na,na,2,240875126,240875126,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided",single nucleotide variant,GRCh38
na,na,2,241814583,241814583,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided",single nucleotide variant,GRCh37
na,na,2,240875166,240875166,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided",single nucleotide variant,GRCh38
na,na,2,241810808,241810808,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria|Hyperoxaluria",single nucleotide variant,GRCh37
na,na,2,240871391,240871391,AGXT,Pathogenic,"Primary hyperoxaluria, type I|not provided|Primary hyperoxaluria|Hyperoxaluria",single nucleotide variant,GRCh38
na,na,1,186277656,186277660,PRG4,Pathogenic,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,Deletion,GRCh37
na,na,1,186308524,186308528,PRG4,Pathogenic,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,Deletion,GRCh38
na,na,na,-1,-1,PRG4,Pathogenic,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,Deletion,na
na,na,1,186282885,186282886,PRG4,Pathogenic,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,Indel,GRCh37
na,na,1,186313753,186313754,PRG4,Pathogenic,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,Indel,GRCh38
na,na,na,-1,-1,PRG4,Pathogenic,Camptodactyly-arthropathy-coxa vara-pericarditis syndrome,Insertion,na
na,na,2,32341268,32341268,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh37
na,na,2,32116199,32116199,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh38
na,na,2,32361967,32361967,SPAST,Pathogenic,Hereditary spastic paraplegia 4|not provided,single nucleotide variant,GRCh37
na,na,2,32136898,32136898,SPAST,Pathogenic,Hereditary spastic paraplegia 4|not provided,single nucleotide variant,GRCh38
na,na,2,32362017,32362017,SPAST,Pathogenic,Hereditary spastic paraplegia 4,Deletion,GRCh37
na,na,2,32136948,32136948,SPAST,Pathogenic,Hereditary spastic paraplegia 4,Deletion,GRCh38
na,na,2,32366974,32366974,SPAST,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 4|Spastic paraparesis|not provided|Hereditary spastic paraplegia,single nucleotide variant,GRCh37
na,na,2,32141905,32141905,SPAST,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 4|Spastic paraparesis|not provided|Hereditary spastic paraplegia,single nucleotide variant,GRCh38
na,na,2,32372285,32372285,SPAST,Pathogenic,Hereditary spastic paraplegia 4|not provided,single nucleotide variant,GRCh37
na,na,2,32147216,32147216,SPAST,Pathogenic,Hereditary spastic paraplegia 4|not provided,single nucleotide variant,GRCh38
na,na,2,32312595,32312596,SPAST,Pathogenic,Hereditary spastic paraplegia 4,Duplication,GRCh37
na,na,2,32087526,32087527,SPAST,Pathogenic,Hereditary spastic paraplegia 4,Duplication,GRCh38
na,na,2,32361946,32361946,SPAST,Pathogenic,Hereditary spastic paraplegia 4|Tics|not provided,single nucleotide variant,GRCh37
na,na,2,32136877,32136877,SPAST,Pathogenic,Hereditary spastic paraplegia 4|Tics|not provided,single nucleotide variant,GRCh38
na,na,2,32372328,32372328,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh37
na,na,2,32147259,32147259,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh38
na,na,2,32353552,32353552,SPAST,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 4|not provided,single nucleotide variant,GRCh37
na,na,2,32128483,32128483,SPAST,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 4|not provided,single nucleotide variant,GRCh38
na,na,2,32362038,32362039,SPAST,Pathogenic,Hereditary spastic paraplegia 4|not provided,Duplication,GRCh37
na,na,2,32136969,32136970,SPAST,Pathogenic,Hereditary spastic paraplegia 4|not provided,Duplication,GRCh38
na,na,2,32341214,32341214,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh37
na,na,2,32116145,32116145,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh38
na,na,2,32352075,32352075,SPAST,Pathogenic,Hereditary spastic paraplegia 4|Hereditary spastic paraplegia,single nucleotide variant,GRCh37
na,na,2,32127006,32127006,SPAST,Pathogenic,Hereditary spastic paraplegia 4|Hereditary spastic paraplegia,single nucleotide variant,GRCh38
na,na,2,32362033,32362033,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh37
na,na,2,32136964,32136964,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh38
na,na,2,32289031,32289031,SPAST,Benign/Likely benign; other; risk factor,|Hereditary spastic paraplegia 4|not specified|not provided|Cerebral palsy|Hereditary spastic paraplegia|SPAST-related disorder,single nucleotide variant,GRCh37
na,na,2,32063962,32063962,SPAST,Benign/Likely benign; other; risk factor,|Hereditary spastic paraplegia 4|not specified|not provided|Cerebral palsy|Hereditary spastic paraplegia|SPAST-related disorder,single nucleotide variant,GRCh38
na,na,2,32289034,32289034,SPAST,Conflicting classifications of pathogenicity,|not provided|Hereditary spastic paraplegia 4|Hereditary spastic paraplegia|not specified,single nucleotide variant,GRCh37
na,na,2,32063965,32063965,SPAST,Conflicting classifications of pathogenicity,|not provided|Hereditary spastic paraplegia 4|Hereditary spastic paraplegia|not specified,single nucleotide variant,GRCh38
na,na,2,32370073,32370073,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh37
na,na,2,32145004,32145004,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh38
na,na,2,32288788,32291093,SPAST,Pathogenic,Hereditary spastic paraplegia 4,Deletion,GRCh37
na,na,2,32063720,32066025,SPAST,Pathogenic,Hereditary spastic paraplegia 4,Deletion,GRCh38
na,na,2,32353519,32353519,SPAST,Pathogenic,Hereditary spastic paraplegia 4|not provided|Hereditary spastic paraplegia,single nucleotide variant,GRCh37
na,na,2,32128450,32128450,SPAST,Pathogenic,Hereditary spastic paraplegia 4|not provided|Hereditary spastic paraplegia,single nucleotide variant,GRCh38
na,na,2,32361959,32361959,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh37
na,na,2,32136890,32136890,SPAST,Pathogenic,Hereditary spastic paraplegia 4,single nucleotide variant,GRCh38
na,na,2,32358735,32358736,SPAST,Pathogenic,Hereditary spastic paraplegia 4,Duplication,GRCh37
na,na,2,32133666,32133667,SPAST,Pathogenic,Hereditary spastic paraplegia 4,Duplication,GRCh38
na,na,22,50962684,50962684,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1;Myopia 6",single nucleotide variant,GRCh37
na,na,22,50524255,50524255,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1;Myopia 6",single nucleotide variant,GRCh38
na,na,22,50962167,50962167,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",single nucleotide variant,GRCh37
na,na,22,50523738,50523738,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",single nucleotide variant,GRCh38
na,na,22,50962330,50962330,SCO2,Conflicting classifications of pathogenicity,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|not provided",single nucleotide variant,GRCh37
na,na,22,50523901,50523901,SCO2,Conflicting classifications of pathogenicity,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|not provided",single nucleotide variant,GRCh38
na,na,22,50962423,50962423,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided|Severe global developmental delay;Seizure|Tip-toe gait|SCO2-related disorder|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1;Myopia 6",single nucleotide variant,GRCh37
na,na,22,50523994,50523994,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided|Severe global developmental delay;Seizure|Tip-toe gait|SCO2-related disorder|Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1;Myopia 6",single nucleotide variant,GRCh38
na,na,22,50962573,50962573,SCO2,Pathogenic/Likely pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided",single nucleotide variant,GRCh37
na,na,22,50524144,50524144,SCO2,Pathogenic/Likely pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1|Myopia 6|not provided",single nucleotide variant,GRCh38
na,na,22,50962652,50962653,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",Duplication,GRCh37
na,na,22,50524223,50524224,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",Duplication,GRCh38
na,na,22,50962443,50962443,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",single nucleotide variant,GRCh37
na,na,22,50524014,50524014,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",single nucleotide variant,GRCh38
na,na,22,50962734,50962734,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",single nucleotide variant,GRCh37
na,na,22,50524305,50524305,SCO2,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1",single nucleotide variant,GRCh38
na,na,11,46914636,46914636,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh37
na,na,11,46893085,46893085,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh38
na,na,11,46921435,46921435,LRP4,Likely pathogenic,Cenani-Lenz syndactyly syndrome|Sclerosteosis 2;Cenani-Lenz syndactyly syndrome;Congenital myasthenic syndrome 17,single nucleotide variant,GRCh37
na,na,11,46899884,46899884,LRP4,Likely pathogenic,Cenani-Lenz syndactyly syndrome|Sclerosteosis 2;Cenani-Lenz syndactyly syndrome;Congenital myasthenic syndrome 17,single nucleotide variant,GRCh38
na,na,11,46889658,46889658,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh37
na,na,11,46868107,46868107,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh38
na,na,11,46920937,46920937,LRP4,Likely pathogenic,Cenani-Lenz syndactyly syndrome|Sclerosteosis 2;Cenani-Lenz syndactyly syndrome;Congenital myasthenic syndrome 17,single nucleotide variant,GRCh37
na,na,11,46899386,46899386,LRP4,Likely pathogenic,Cenani-Lenz syndactyly syndrome|Sclerosteosis 2;Cenani-Lenz syndactyly syndrome;Congenital myasthenic syndrome 17,single nucleotide variant,GRCh38
na,na,11,46921006,46921006,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh37
na,na,11,46899455,46899455,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh38
na,na,11,46916335,46916335,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh37
na,na,11,46894784,46894784,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh38
na,na,11,46916299,46916299,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh37
na,na,11,46894748,46894748,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh38
na,na,11,46921938,46921938,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh37
na,na,11,46900387,46900387,LRP4,Pathogenic,Cenani-Lenz syndactyly syndrome,single nucleotide variant,GRCh38
na,na,17,40362207,40362207,STAT5B,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",single nucleotide variant,GRCh37
na,na,17,42210189,42210189,STAT5B,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",single nucleotide variant,GRCh38
na,na,17,40369460,40369461,STAT5B,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",Duplication,GRCh37
na,na,17,42217442,42217443,STAT5B,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",Duplication,GRCh38
na,na,17,40375496,40375496,STAT5B,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",single nucleotide variant,GRCh37
na,na,17,42223478,42223478,STAT5B,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",single nucleotide variant,GRCh38
na,na,17,40364001,40364001,STAT5B,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",Deletion,GRCh37
na,na,17,42211983,42211983,STAT5B,Pathogenic,"Growth hormone insensitivity with immune dysregulation 1, autosomal recessive",Deletion,GRCh38
na,na,8,12956971,12956971,DLC1,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh37
na,na,8,13099462,13099462,DLC1,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh38
na,na,13,26789714,26789714,RNF6,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh37
na,na,13,26215577,26215577,RNF6,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh38
na,na,13,26789295,26789295,RNF6,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh37
na,na,13,26215158,26215158,RNF6,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh38
na,na,13,26789288,26789288,RNF6,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh37
na,na,13,26215151,26215151,RNF6,Pathogenic,"Esophageal squamous cell carcinoma, somatic",single nucleotide variant,GRCh38
na,na,6,47544259,47544260,CD2AP,Pathogenic,"Focal segmental glomerulosclerosis 3|Focal segmental glomerulosclerosis 3, susceptibility to",Indel,GRCh37
na,na,6,47576523,47576524,CD2AP,Pathogenic,"Focal segmental glomerulosclerosis 3|Focal segmental glomerulosclerosis 3, susceptibility to",Indel,GRCh38
na,na,6,47580228,47580228,CD2AP,Conflicting classifications of pathogenicity,"Focal segmental glomerulosclerosis 3|not provided|Focal segmental glomerulosclerosis 3, susceptibility to",single nucleotide variant,GRCh37
na,na,6,47612492,47612492,CD2AP,Conflicting classifications of pathogenicity,"Focal segmental glomerulosclerosis 3|not provided|Focal segmental glomerulosclerosis 3, susceptibility to",single nucleotide variant,GRCh38
na,na,19,18710530,18710530,CRLF1,Uncertain significance,Cold-induced sweating syndrome 1|not specified,single nucleotide variant,GRCh37
na,na,19,18599720,18599720,CRLF1,Uncertain significance,Cold-induced sweating syndrome 1|not specified,single nucleotide variant,GRCh38
na,na,19,18709262,18709263,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,Duplication,GRCh37
na,na,19,18598452,18598453,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,Duplication,GRCh38
na,na,19,18710546,18710546,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,single nucleotide variant,GRCh37
na,na,19,18599736,18599736,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,single nucleotide variant,GRCh38
na,na,19,18709577,18709577,CRLF1,Uncertain significance,Cold-induced sweating syndrome 1|not specified,single nucleotide variant,GRCh37
na,na,19,18598767,18598767,CRLF1,Uncertain significance,Cold-induced sweating syndrome 1|not specified,single nucleotide variant,GRCh38
na,na,19,18705167,18705167,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,single nucleotide variant,GRCh37
na,na,19,18594357,18594357,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,single nucleotide variant,GRCh38
na,na,19,18707848,18707849,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,Indel,GRCh37
na,na,19,18597038,18597039,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,Indel,GRCh38
na,na,19,18707728,18707728,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,single nucleotide variant,GRCh37
na,na,19,18596918,18596918,CRLF1,Pathogenic,Cold-induced sweating syndrome 1,single nucleotide variant,GRCh38
na,na,4,25657344,25657529,SLC34A2,Pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,Deletion,GRCh37
na,na,4,25655722,25655907,SLC34A2,Pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,Deletion,GRCh38
na,na,4,25664328,25664328,SLC34A2,Pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,Deletion,GRCh37
na,na,4,25662706,25662706,SLC34A2,Pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,Deletion,GRCh38
na,na,4,25664440,25664440,SLC34A2,Pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,single nucleotide variant,GRCh37
na,na,4,25662818,25662818,SLC34A2,Pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,single nucleotide variant,GRCh38
na,na,4,25665889,25665889,SLC34A2,Likely pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,single nucleotide variant,GRCh37
na,na,4,25664267,25664267,SLC34A2,Likely pathogenic,PULMONARY ALVEOLAR MICROLITHIASIS,single nucleotide variant,GRCh38
na,na,7,91842655,91842655,KRIT1,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh37
na,na,7,92213341,92213341,KRIT1,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh38
na,na,7,91842594,91842594,KRIT1,Pathogenic,Cerebral cavernous malformation 1,Deletion,GRCh37
na,na,7,92213280,92213280,KRIT1,Pathogenic,Cerebral cavernous malformation 1,Deletion,GRCh38
na,na,7,91842666,91842667,KRIT1,Pathogenic,Cerebral cavernous malformation 1,Duplication,GRCh37
na,na,7,92213352,92213353,KRIT1,Pathogenic,Cerebral cavernous malformation 1,Duplication,GRCh38
na,na,7,91852184,91852184,KRIT1,Pathogenic,Cerebral cavernous malformation 1|not provided|Cerebral cavernous malformation|KRIT1-related disorder,single nucleotide variant,GRCh37
na,na,7,92222870,92222870,KRIT1,Pathogenic,Cerebral cavernous malformation 1|not provided|Cerebral cavernous malformation|KRIT1-related disorder,single nucleotide variant,GRCh38
na,na,7,91864120,91864120,KRIT1,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh37
na,na,7,92234806,92234806,KRIT1,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh38
na,na,7,91865802,91865802,KRIT1,Likely pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh37
na,na,7,92236488,92236488,KRIT1,Likely pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh38
na,na,7,91864845,91864845,KRIT1,Pathogenic,not provided|Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh37
na,na,7,92235531,92235531,KRIT1,Pathogenic,not provided|Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh38
na,na,na,-1,-1,KRIT1,Pathogenic,Cavernous malformations of CNS and retina,Insertion,na
na,na,7,91863765,91863765,KRIT1,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh37
na,na,7,92234451,92234451,KRIT1,Pathogenic,Cerebral cavernous malformation 1|Cerebral cavernous malformation,single nucleotide variant,GRCh38
na,na,na,-1,-1,CRB1,Pathogenic,Retinitis pigmentosa 12,Insertion,na
na,na,1,197404115,197404115,CRB1,Pathogenic,Retinitis pigmentosa 12|not provided|Retinitis pigmentosa 12;Leber congenital amaurosis 8|Leber congenital amaurosis 8|Pigmented paravenous retinochoroidal atrophy|CRB1-related disorder|Retinal dystrophy|Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8,single nucleotide variant,GRCh37
na,na,1,197434985,197434985,CRB1,Pathogenic,Retinitis pigmentosa 12|not provided|Retinitis pigmentosa 12;Leber congenital amaurosis 8|Leber congenital amaurosis 8|Pigmented paravenous retinochoroidal atrophy|CRB1-related disorder|Retinal dystrophy|Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8,single nucleotide variant,GRCh38
na,na,1,197403976,197403976,CRB1,Pathogenic,Retinitis pigmentosa 12|not provided,single nucleotide variant,GRCh37
na,na,1,197434846,197434846,CRB1,Pathogenic,Retinitis pigmentosa 12|not provided,single nucleotide variant,GRCh38
na,na,1,197396745,197396745,CRB1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 12|not provided|Retinal dystrophy|Leber congenital amaurosis 8|Retinitis pigmentosa|Leber congenital amaurosis 8;Retinitis pigmentosa 12|Macular dystrophy|CRB1-related maculopathy|Retinitis pigmentosa-deafness syndrome|Leber congenital amaurosis 8;Pigmented paravenous retinochoroidal atrophy;Retinitis pigmentosa 12|CRB1-related disorder|Pigmented paravenous retinochoroidal atrophy|Cone-rod dystrophy,single nucleotide variant,GRCh37
na,na,1,197427615,197427615,CRB1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 12|not provided|Retinal dystrophy|Leber congenital amaurosis 8|Retinitis pigmentosa|Leber congenital amaurosis 8;Retinitis pigmentosa 12|Macular dystrophy|CRB1-related maculopathy|Retinitis pigmentosa-deafness syndrome|Leber congenital amaurosis 8;Pigmented paravenous retinochoroidal atrophy;Retinitis pigmentosa 12|CRB1-related disorder|Pigmented paravenous retinochoroidal atrophy|Cone-rod dystrophy,single nucleotide variant,GRCh38
na,na,1,197396689,197396689,CRB1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 12|not provided|Leber congenital amaurosis 8;Retinitis pigmentosa 12|Retinitis pigmentosa|Leber congenital amaurosis 8|Retinal dystrophy|Autosomal recessive retinitis pigmentosa|Pigmented paravenous retinochoroidal atrophy|Leber congenital amaurosis|Leber congenital amaurosis 8;Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy,single nucleotide variant,GRCh37
na,na,1,197427559,197427559,CRB1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 12|not provided|Leber congenital amaurosis 8;Retinitis pigmentosa 12|Retinitis pigmentosa|Leber congenital amaurosis 8|Retinal dystrophy|Autosomal recessive retinitis pigmentosa|Pigmented paravenous retinochoroidal atrophy|Leber congenital amaurosis|Leber congenital amaurosis 8;Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy,single nucleotide variant,GRCh38
na,na,1,197404292,197404292,CRB1,Likely pathogenic,Leber congenital amaurosis 8|not provided|Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8,single nucleotide variant,GRCh37
na,na,1,197435162,197435162,CRB1,Likely pathogenic,Leber congenital amaurosis 8|not provided|Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8,single nucleotide variant,GRCh38
na,na,1,197411414,197411414,CRB1,Pathogenic,Leber congenital amaurosis 8,single nucleotide variant,GRCh37
na,na,1,197442284,197442284,CRB1,Pathogenic,Leber congenital amaurosis 8,single nucleotide variant,GRCh38
na,na,1,197396856,197396856,CRB1,Pathogenic,Retinitis pigmentosa 12|not provided|Leber congenital amaurosis 8;Retinitis pigmentosa 12|Retinal dystrophy|Leber congenital amaurosis 8|Retinitis pigmentosa|Leber congenital amaurosis|Leber congenital amaurosis 8;Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy|Pigmented paravenous retinochoroidal atrophy|CRB1-related disorder,single nucleotide variant,GRCh37
na,na,1,197427726,197427726,CRB1,Pathogenic,Retinitis pigmentosa 12|not provided|Leber congenital amaurosis 8;Retinitis pigmentosa 12|Retinal dystrophy|Leber congenital amaurosis 8|Retinitis pigmentosa|Leber congenital amaurosis|Leber congenital amaurosis 8;Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy|Pigmented paravenous retinochoroidal atrophy|CRB1-related disorder,single nucleotide variant,GRCh38
na,na,1,197404534,197404534,CRB1,Likely pathogenic,Retinitis pigmentosa 12|not provided|Retinal dystrophy|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,1,197435404,197435404,CRB1,Likely pathogenic,Retinitis pigmentosa 12|not provided|Retinal dystrophy|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,1,197297965,197297965,CRB1,Conflicting classifications of pathogenicity,Pigmented paravenous retinochoroidal atrophy|not specified|Leber congenital amaurosis 8|Retinitis pigmentosa|not provided|Leber congenital amaurosis 8;Retinitis pigmentosa 12,single nucleotide variant,GRCh37
na,na,1,197328835,197328835,CRB1,Conflicting classifications of pathogenicity,Pigmented paravenous retinochoroidal atrophy|not specified|Leber congenital amaurosis 8|Retinitis pigmentosa|not provided|Leber congenital amaurosis 8;Retinitis pigmentosa 12,single nucleotide variant,GRCh38
na,na,1,197404300,197404300,CRB1,Pathogenic,Leber congenital amaurosis 8|Retinitis pigmentosa 12|not provided|Retinitis pigmentosa 12;Leber congenital amaurosis 8|Leber congenital amaurosis|Retinal dystrophy|Pigmented paravenous retinochoroidal atrophy|Early-onset retinal dystrophy|Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8,single nucleotide variant,GRCh37
na,na,1,197435170,197435170,CRB1,Pathogenic,Leber congenital amaurosis 8|Retinitis pigmentosa 12|not provided|Retinitis pigmentosa 12;Leber congenital amaurosis 8|Leber congenital amaurosis|Retinal dystrophy|Pigmented paravenous retinochoroidal atrophy|Early-onset retinal dystrophy|Retinitis pigmentosa 12;Pigmented paravenous retinochoroidal atrophy;Leber congenital amaurosis 8,single nucleotide variant,GRCh38
na,na,1,197446905,197446914,CRB1,Pathogenic,Retinitis pigmentosa 12|Leber congenital amaurosis 8|not provided|Retinitis pigmentosa 12;Leber congenital amaurosis 8|Leber congenital amaurosis,Deletion,GRCh37
na,na,1,197477775,197477784,CRB1,Pathogenic,Retinitis pigmentosa 12|Leber congenital amaurosis 8|not provided|Retinitis pigmentosa 12;Leber congenital amaurosis 8|Leber congenital amaurosis,Deletion,GRCh38
na,na,9,131107776,131107776,SLC27A4,Pathogenic/Likely pathogenic,Ichthyosis prematurity syndrome|not provided|Autosomal recessive congenital ichthyosis,single nucleotide variant,GRCh37
na,na,9,128345497,128345497,SLC27A4,Pathogenic/Likely pathogenic,Ichthyosis prematurity syndrome|not provided|Autosomal recessive congenital ichthyosis,single nucleotide variant,GRCh38
na,na,9,131112590,131112590,SLC27A4,Likely pathogenic,Ichthyosis prematurity syndrome,single nucleotide variant,GRCh37
na,na,9,128350311,128350311,SLC27A4,Likely pathogenic,Ichthyosis prematurity syndrome,single nucleotide variant,GRCh38
na,na,9,131107546,131107546,SLC27A4,Pathogenic,Ichthyosis prematurity syndrome,single nucleotide variant,GRCh37
na,na,9,128345267,128345267,SLC27A4,Pathogenic,Ichthyosis prematurity syndrome,single nucleotide variant,GRCh38
na,na,9,131112614,131112614,SLC27A4,Uncertain significance,Ichthyosis prematurity syndrome|not specified,single nucleotide variant,GRCh37
na,na,9,128350335,128350335,SLC27A4,Uncertain significance,Ichthyosis prematurity syndrome|not specified,single nucleotide variant,GRCh38
na,na,9,131114938,131114938,SLC27A4,Pathogenic/Likely pathogenic,Ichthyosis prematurity syndrome|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,9,128352659,128352659,SLC27A4,Pathogenic/Likely pathogenic,Ichthyosis prematurity syndrome|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,9,131115302,131115302,SLC27A4,Pathogenic,Ichthyosis prematurity syndrome,single nucleotide variant,GRCh37
na,na,9,128353023,128353023,SLC27A4,Pathogenic,Ichthyosis prematurity syndrome,single nucleotide variant,GRCh38
na,na,9,131118049,131118049,SLC27A4,Uncertain significance,Ichthyosis prematurity syndrome|not specified,single nucleotide variant,GRCh37
na,na,9,128355770,128355770,SLC27A4,Uncertain significance,Ichthyosis prematurity syndrome|not specified,single nucleotide variant,GRCh38
na,na,5,131637309,131637309,SLC22A4,risk factor,Rheumatoid arthritis,single nucleotide variant,GRCh37
na,na,5,132301616,132301616,SLC22A4,risk factor,Rheumatoid arthritis,single nucleotide variant,GRCh38
na,na,5,131676320,131676320,SLC22A4,Benign,SLC22A4 POLYMORPHISM|not provided,single nucleotide variant,GRCh37
na,na,5,132340627,132340627,SLC22A4,Benign,SLC22A4 POLYMORPHISM|not provided,single nucleotide variant,GRCh38
na,na,1,24020362,24020362,RPL11,Pathogenic,Diamond-Blackfan anemia 7|not provided|Diamond-Blackfan anemia,single nucleotide variant,GRCh37
na,na,1,23693872,23693872,RPL11,Pathogenic,Diamond-Blackfan anemia 7|not provided|Diamond-Blackfan anemia,single nucleotide variant,GRCh38
na,na,1,24019150,24019151,RPL11,Pathogenic,Diamond-Blackfan anemia 7|not provided|Diamond-Blackfan anemia|RPL11-related disorder,Microsatellite,GRCh37
na,na,1,23692660,23692661,RPL11,Pathogenic,Diamond-Blackfan anemia 7|not provided|Diamond-Blackfan anemia|RPL11-related disorder,Microsatellite,GRCh38
na,na,1,24022369,24022371,RPL11,Uncertain significance,Diamond-Blackfan anemia 7|Diamond-Blackfan anemia,Microsatellite,GRCh37
na,na,1,23695879,23695881,RPL11,Uncertain significance,Diamond-Blackfan anemia 7|Diamond-Blackfan anemia,Microsatellite,GRCh38
na,na,1,24020296,24020296,RPL11,Pathogenic,Diamond-Blackfan anemia 7|Diamond-Blackfan anemia,single nucleotide variant,GRCh37
na,na,1,23693806,23693806,RPL11,Pathogenic,Diamond-Blackfan anemia 7|Diamond-Blackfan anemia,single nucleotide variant,GRCh38
na,na,19,919563,919563,KISS1R,Pathogenic,Hypogonadotropic hypogonadism 8 without anosmia,single nucleotide variant,GRCh37
na,na,19,919563,919563,KISS1R,Pathogenic,Hypogonadotropic hypogonadism 8 without anosmia,single nucleotide variant,GRCh38
na,na,19,920542,920542,KISS1R,Pathogenic,Hypogonadotropic hypogonadism 8 without anosmia,single nucleotide variant,GRCh37
na,na,19,920542,920542,KISS1R,Pathogenic,Hypogonadotropic hypogonadism 8 without anosmia,single nucleotide variant,GRCh38
na,na,19,920746,920746,KISS1R,Pathogenic/Likely pathogenic,Hypogonadotropic hypogonadism 8 without anosmia|not provided|KISS1R-related disorder|Hypogonadotropic hypogonadism,single nucleotide variant,GRCh37
na,na,19,920746,920746,KISS1R,Pathogenic/Likely pathogenic,Hypogonadotropic hypogonadism 8 without anosmia|not provided|KISS1R-related disorder|Hypogonadotropic hypogonadism,single nucleotide variant,GRCh38
na,na,19,920277,920431,KISS1R,Pathogenic,Hypogonadotropic hypogonadism 8 without anosmia,Deletion,GRCh37
na,na,19,920277,920431,KISS1R,Pathogenic,Hypogonadotropic hypogonadism 8 without anosmia,Deletion,GRCh38
na,na,19,918604,918604,KISS1R,Pathogenic/Likely pathogenic,Hypogonadotropic hypogonadism 8 without anosmia|Central precocious puberty 1|not provided|Hypogonadotropic hypogonadism 8 with or without anosmia,single nucleotide variant,GRCh37
na,na,19,918604,918604,KISS1R,Pathogenic/Likely pathogenic,Hypogonadotropic hypogonadism 8 without anosmia|Central precocious puberty 1|not provided|Hypogonadotropic hypogonadism 8 with or without anosmia,single nucleotide variant,GRCh38
na,na,19,920708,920708,KISS1R,Conflicting classifications of pathogenicity,Central precocious puberty 1|not provided|Hypogonadotropic hypogonadism 8 with or without anosmia,single nucleotide variant,GRCh37
na,na,19,920708,920708,KISS1R,Conflicting classifications of pathogenicity,Central precocious puberty 1|not provided|Hypogonadotropic hypogonadism 8 with or without anosmia,single nucleotide variant,GRCh38
na,na,11,20639301,20639301,SLC6A5,Pathogenic,Hyperekplexia 3,single nucleotide variant,GRCh37
na,na,11,20617755,20617755,SLC6A5,Pathogenic,Hyperekplexia 3,single nucleotide variant,GRCh38
na,na,11,20648287,20648287,SLC6A5,Pathogenic,Hyperekplexia 3,Indel,GRCh37
na,na,11,20626741,20626741,SLC6A5,Pathogenic,Hyperekplexia 3,Indel,GRCh38
na,na,11,20649602,20649602,SLC6A5,Conflicting classifications of pathogenicity,Hyperekplexia 3,single nucleotide variant,GRCh37
na,na,11,20628056,20628056,SLC6A5,Conflicting classifications of pathogenicity,Hyperekplexia 3,single nucleotide variant,GRCh38
na,na,11,20660023,20660023,SLC6A5,Pathogenic,Hyperekplexia 3,single nucleotide variant,GRCh37
na,na,11,20638477,20638477,SLC6A5,Pathogenic,Hyperekplexia 3,single nucleotide variant,GRCh38
na,na,11,20629129,20629129,SLC6A5,Pathogenic,Hyperekplexia 3,single nucleotide variant,GRCh37
na,na,11,20607583,20607583,SLC6A5,Pathogenic,Hyperekplexia 3,single nucleotide variant,GRCh38
na,na,11,20652263,20652263,SLC6A5,Pathogenic,Hyperekplexia 3,single nucleotide variant,GRCh37
na,na,11,20630717,20630717,SLC6A5,Pathogenic,Hyperekplexia 3,single nucleotide variant,GRCh38
na,na,11,20648267,20648267,SLC6A5,Uncertain significance,Hyperekplexia 3,single nucleotide variant,GRCh37
na,na,11,20626721,20626721,SLC6A5,Uncertain significance,Hyperekplexia 3,single nucleotide variant,GRCh38
na,na,7,94257615,94257615,SGCE,Pathogenic,Myoclonic dystonia 11|not provided|Inborn genetic diseases|SGCE-related disorder,single nucleotide variant,GRCh37
na,na,7,94628303,94628303,SGCE,Pathogenic,Myoclonic dystonia 11|not provided|Inborn genetic diseases|SGCE-related disorder,single nucleotide variant,GRCh38
na,na,7,94257600,94257600,SGCE,Pathogenic,Myoclonic dystonia 11|not provided|SGCE-related disorder,single nucleotide variant,GRCh37
na,na,7,94628288,94628288,SGCE,Pathogenic,Myoclonic dystonia 11|not provided|SGCE-related disorder,single nucleotide variant,GRCh38
na,na,7,94252695,94252791,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh37
na,na,7,94623383,94623479,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh38
na,na,7,94230156,94230160,SGCE,Pathogenic/Likely pathogenic,Myoclonic dystonia 11|not provided,Deletion,GRCh37
na,na,7,94600844,94600848,SGCE,Pathogenic/Likely pathogenic,Myoclonic dystonia 11|not provided,Deletion,GRCh38
na,na,7,94248145,94248145,SGCE,Pathogenic,Myoclonic dystonia 11,single nucleotide variant,GRCh37
na,na,7,94618833,94618833,SGCE,Pathogenic,Myoclonic dystonia 11,single nucleotide variant,GRCh38
na,na,7,94230110,94230111,SGCE,Pathogenic,Myoclonic dystonia 11,Duplication,GRCh37
na,na,7,94600798,94600799,SGCE,Pathogenic,Myoclonic dystonia 11,Duplication,GRCh38
na,na,7,94230021,94230021,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh37
na,na,7,94600709,94600709,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh38
na,na,7,94228226,94228226,SGCE,Pathogenic,Myoclonic dystonia 11|not provided,single nucleotide variant,GRCh37
na,na,7,94598914,94598914,SGCE,Pathogenic,Myoclonic dystonia 11|not provided,single nucleotide variant,GRCh38
na,na,7,94233566,94248585,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh37
na,na,7,94604254,94619273,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh38
na,na,7,94232052,94238873,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh37
na,na,7,94602740,94609561,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh38
na,na,7,94248112,94248113,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh37
na,na,7,94618800,94618801,SGCE,Pathogenic,Myoclonic dystonia 11,Deletion,GRCh38
na,na,19,33353463,33353463,SLC7A9,Pathogenic,Cystinuria,single nucleotide variant,GRCh37
na,na,19,32862557,32862557,SLC7A9,Pathogenic,Cystinuria,single nucleotide variant,GRCh38
na,na,19,33355167,33355167,SLC7A9,Pathogenic/Likely pathogenic,Cystinuria|not provided|SLC7A9-related disorder,single nucleotide variant,GRCh37
na,na,19,32864261,32864261,SLC7A9,Pathogenic/Likely pathogenic,Cystinuria|not provided|SLC7A9-related disorder,single nucleotide variant,GRCh38
na,na,19,33353427,33353427,SLC7A9,Conflicting classifications of pathogenicity,Cystinuria|not provided|SLC7A9-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,32862521,32862521,SLC7A9,Conflicting classifications of pathogenicity,Cystinuria|not provided|SLC7A9-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,33353388,33353388,SLC7A9,Likely pathogenic,Cystinuria,single nucleotide variant,GRCh37
na,na,19,32862482,32862482,SLC7A9,Likely pathogenic,Cystinuria,single nucleotide variant,GRCh38
na,na,19,33350845,33350845,SLC7A9,Likely pathogenic,Cystinuria|not provided,single nucleotide variant,GRCh37
na,na,19,32859939,32859939,SLC7A9,Likely pathogenic,Cystinuria|not provided,single nucleotide variant,GRCh38
na,na,19,33355144,33355145,SLC7A9,Pathogenic,Cystinuria,Duplication,GRCh37
na,na,19,32864238,32864239,SLC7A9,Pathogenic,Cystinuria,Duplication,GRCh38
na,na,19,33334838,33334838,SLC7A9,Pathogenic/Likely pathogenic,Cystinuria|not provided|SLC7A9-related disorder,single nucleotide variant,GRCh37
na,na,19,32843932,32843932,SLC7A9,Pathogenic/Likely pathogenic,Cystinuria|not provided|SLC7A9-related disorder,single nucleotide variant,GRCh38
na,na,19,33355639,33355639,SLC7A9,Pathogenic,Cystinuria,single nucleotide variant,GRCh37
na,na,19,32864733,32864733,SLC7A9,Pathogenic,Cystinuria,single nucleotide variant,GRCh38
na,na,19,33350838,33350838,SLC7A9,Uncertain significance,Cystinuria|not provided,single nucleotide variant,GRCh37
na,na,19,32859932,32859932,SLC7A9,Uncertain significance,Cystinuria|not provided,single nucleotide variant,GRCh38
na,na,19,33353033,33353033,SLC7A9,Conflicting classifications of pathogenicity,Cystinuria|not provided,single nucleotide variant,GRCh37
na,na,19,32862127,32862127,SLC7A9,Conflicting classifications of pathogenicity,Cystinuria|not provided,single nucleotide variant,GRCh38
na,na,19,33355112,33355112,SLC7A9,Conflicting classifications of pathogenicity,Cystinuria|not provided,single nucleotide variant,GRCh37
na,na,19,32864206,32864206,SLC7A9,Conflicting classifications of pathogenicity,Cystinuria|not provided,single nucleotide variant,GRCh38
na,na,19,36396763,36402028,TYROBP,Pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1,Deletion,GRCh37
na,na,19,35905861,35911126,TYROBP,Pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1,Deletion,GRCh38
na,na,19,36399129,36399129,TYROBP,Pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1,single nucleotide variant,GRCh37
na,na,19,35908227,35908227,TYROBP,Pathogenic,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1,single nucleotide variant,GRCh38
na,na,9,136289554,136289554,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133424434,133424434,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136313839,136313839,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133448718,133448718,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136289572,136289572,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133424452,133424452,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136291366,136291366,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh37
na,na,9,133426246,133426246,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh38
na,na,9,136298598,136298598,ADAMTS13,Likely pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133433478,133433478,ADAMTS13,Likely pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136319562,136319562,ADAMTS13,Pathogenic/Likely pathogenic,Upshaw-Schulman syndrome|not provided|Thrombotic thrombocytopenic purpura,single nucleotide variant,GRCh37
na,na,9,133454440,133454440,ADAMTS13,Pathogenic/Likely pathogenic,Upshaw-Schulman syndrome|not provided|Thrombotic thrombocytopenic purpura,single nucleotide variant,GRCh38
na,na,9,136303015,136303015,ADAMTS13,Uncertain significance,Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh37
na,na,9,133437895,133437895,ADAMTS13,Uncertain significance,Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh38
na,na,9,136321718,136321719,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Duplication,GRCh37
na,na,9,133456596,133456597,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Duplication,GRCh38
na,na,9,136308636,136308661,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Deletion,GRCh37
na,na,9,133443515,133443540,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Deletion,GRCh38
na,na,9,136324160,136324161,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome|not provided,Duplication,GRCh37
na,na,9,133459038,133459039,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome|not provided,Duplication,GRCh38
na,na,9,136321260,136321260,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133456138,133456138,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136307625,136307625,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh37
na,na,9,133442504,133442504,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh38
na,na,9,136303022,136303022,ADAMTS13,Conflicting classifications of pathogenicity,Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh37
na,na,9,133437902,133437902,ADAMTS13,Conflicting classifications of pathogenicity,Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh38
na,na,9,136301985,136301985,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133436865,133436865,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136293870,136293870,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133428750,133428750,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136301982,136301982,ADAMTS13,Benign,not specified|Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh37
na,na,9,133436862,133436862,ADAMTS13,Benign,not specified|Upshaw-Schulman syndrome|not provided,single nucleotide variant,GRCh38
na,na,9,136302063,136302063,ADAMTS13,Conflicting classifications of pathogenicity,Upshaw-Schulman syndrome|not provided|not specified,single nucleotide variant,GRCh37
na,na,9,133436943,133436943,ADAMTS13,Conflicting classifications of pathogenicity,Upshaw-Schulman syndrome|not provided|not specified,single nucleotide variant,GRCh38
na,na,9,136304564,136304565,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Deletion,GRCh37
na,na,9,133439443,133439444,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Deletion,GRCh38
na,na,9,136290733,136290733,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133425613,133425613,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136293816,136293816,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133428696,133428696,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136290648,136290648,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh37
na,na,9,133425528,133425528,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,single nucleotide variant,GRCh38
na,na,9,136289551,136289579,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Deletion,GRCh37
na,na,9,133424431,133424459,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Deletion,GRCh38
na,na,9,136314972,136314977,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Deletion,GRCh37
na,na,9,133449851,133449856,ADAMTS13,Pathogenic,Upshaw-Schulman syndrome,Deletion,GRCh38
na,na,1,119427816,119427816,TBX15,Pathogenic,Pelviscapular dysplasia,Deletion,GRCh37
na,na,1,118885193,118885193,TBX15,Pathogenic,Pelviscapular dysplasia,Deletion,GRCh38
na,na,1,119427814,119427814,TBX15,Pathogenic,Pelviscapular dysplasia,Deletion,GRCh37
na,na,1,118885191,118885191,TBX15,Pathogenic,Pelviscapular dysplasia,Deletion,GRCh38
na,na,18,20572799,20572799,RBBP8,Uncertain significance,Carcinoma of pancreas|not provided,single nucleotide variant,GRCh37
na,na,18,22992836,22992836,RBBP8,Uncertain significance,Carcinoma of pancreas|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,KCNQ1OT1,Pathogenic,Beckwith-Wiedemann syndrome,Deletion,na
na,na,16,57690532,57690532,ADGRG1,Likely pathogenic,Bilateral frontoparietal polymicrogyria|not provided,single nucleotide variant,GRCh37
na,na,16,57656620,57656620,ADGRG1,Likely pathogenic,Bilateral frontoparietal polymicrogyria|not provided,single nucleotide variant,GRCh38
na,na,16,57687897,57687897,ADGRG1,Pathogenic,Bilateral frontoparietal polymicrogyria,single nucleotide variant,GRCh37
na,na,16,57653985,57653985,ADGRG1,Pathogenic,Bilateral frontoparietal polymicrogyria,single nucleotide variant,GRCh38
na,na,16,57688015,57688021,ADGRG1,Pathogenic,"Bilateral frontoparietal polymicrogyria|not provided|Bilateral frontoparietal polymicrogyria;Polymicrogyria, bilateral perisylvian, autosomal recessive",Deletion,GRCh37
na,na,16,57654103,57654109,ADGRG1,Pathogenic,"Bilateral frontoparietal polymicrogyria|not provided|Bilateral frontoparietal polymicrogyria;Polymicrogyria, bilateral perisylvian, autosomal recessive",Deletion,GRCh38
na,na,16,57685159,57685159,ADGRG1,Conflicting classifications of pathogenicity,Bilateral frontoparietal polymicrogyria|Abnormality of the nervous system|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,57651247,57651247,ADGRG1,Conflicting classifications of pathogenicity,Bilateral frontoparietal polymicrogyria|Abnormality of the nervous system|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,16,57690156,57690156,ADGRG1,Likely pathogenic,Bilateral frontoparietal polymicrogyria,single nucleotide variant,GRCh37
na,na,16,57656244,57656244,ADGRG1,Likely pathogenic,Bilateral frontoparietal polymicrogyria,single nucleotide variant,GRCh38
na,na,16,57695619,57695619,ADGRG1,Pathogenic/Likely pathogenic,Bilateral frontoparietal polymicrogyria|not provided,single nucleotide variant,GRCh37
na,na,16,57661707,57661707,ADGRG1,Pathogenic/Likely pathogenic,Bilateral frontoparietal polymicrogyria|not provided,single nucleotide variant,GRCh38
na,na,16,57685319,57685319,ADGRG1,Pathogenic/Likely pathogenic,Bilateral frontoparietal polymicrogyria|not provided,single nucleotide variant,GRCh37
na,na,16,57651407,57651407,ADGRG1,Pathogenic/Likely pathogenic,Bilateral frontoparietal polymicrogyria|not provided,single nucleotide variant,GRCh38
na,na,16,57685310,57685310,ADGRG1,Pathogenic,Bilateral frontoparietal polymicrogyria,single nucleotide variant,GRCh37
na,na,16,57651398,57651398,ADGRG1,Pathogenic,Bilateral frontoparietal polymicrogyria,single nucleotide variant,GRCh38
na,na,5,137206510,137206510,MYOT,Pathogenic,not provided|Myofibrillar myopathy 3,single nucleotide variant,GRCh37
na,na,5,137870821,137870821,MYOT,Pathogenic,not provided|Myofibrillar myopathy 3,single nucleotide variant,GRCh38
na,na,5,137206504,137206504,MYOT,Pathogenic/Likely pathogenic,Progressive distal muscle weakness;Progressive proximal muscle weakness|8 conditions|Myofibrillar myopathy 3|not provided,single nucleotide variant,GRCh37
na,na,5,137870815,137870815,MYOT,Pathogenic/Likely pathogenic,Progressive distal muscle weakness;Progressive proximal muscle weakness|8 conditions|Myofibrillar myopathy 3|not provided,single nucleotide variant,GRCh38
na,na,5,137206519,137206519,MYOT,Pathogenic,Myofibrillar myopathy 3|Myofibrillar myopathy|not provided,single nucleotide variant,GRCh37
na,na,5,137870830,137870830,MYOT,Pathogenic,Myofibrillar myopathy 3|Myofibrillar myopathy|not provided,single nucleotide variant,GRCh38
na,na,5,137206519,137206519,MYOT,Pathogenic/Likely pathogenic,Myofibrillar myopathy 3|not provided|MYOT-related disorder,single nucleotide variant,GRCh37
na,na,5,137870830,137870830,MYOT,Pathogenic/Likely pathogenic,Myofibrillar myopathy 3|not provided|MYOT-related disorder,single nucleotide variant,GRCh38
na,na,5,137206624,137206624,MYOT,Pathogenic,Myofibrillar myopathy 3,single nucleotide variant,GRCh37
na,na,5,137870935,137870935,MYOT,Pathogenic,Myofibrillar myopathy 3,single nucleotide variant,GRCh38
na,na,5,137206456,137206456,MYOT,Pathogenic/Likely pathogenic,not provided|Myofibrillar myopathy 3,single nucleotide variant,GRCh37
na,na,5,137870767,137870767,MYOT,Pathogenic/Likely pathogenic,not provided|Myofibrillar myopathy 3,single nucleotide variant,GRCh38
na,na,5,178413394,178413394,GRM6,Pathogenic,Congenital stationary night blindness 1B|not provided|Leber congenital amaurosis|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,5,178986393,178986393,GRM6,Pathogenic,Congenital stationary night blindness 1B|not provided|Leber congenital amaurosis|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,5,178410006,178410006,GRM6,Uncertain significance,Congenital stationary night blindness 1B|not provided,single nucleotide variant,GRCh37
na,na,5,178983005,178983005,GRM6,Uncertain significance,Congenital stationary night blindness 1B|not provided,single nucleotide variant,GRCh38
na,na,5,178413133,178413133,GRM6,Pathogenic,Congenital stationary night blindness 1B|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,5,178986132,178986132,GRM6,Pathogenic,Congenital stationary night blindness 1B|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,5,178421498,178421498,GRM6,Likely pathogenic,Congenital stationary night blindness 1B|not provided,single nucleotide variant,GRCh37
na,na,5,178994497,178994497,GRM6,Likely pathogenic,Congenital stationary night blindness 1B|not provided,single nucleotide variant,GRCh38
na,na,5,178421809,178421809,GRM6,Likely pathogenic,Congenital stationary night blindness 1B|not provided|Congenital stationary night blindness,single nucleotide variant,GRCh37
na,na,5,178994808,178994808,GRM6,Likely pathogenic,Congenital stationary night blindness 1B|not provided|Congenital stationary night blindness,single nucleotide variant,GRCh38
na,na,5,178413690,178413690,GRM6,Uncertain significance,Congenital stationary night blindness 1B|not provided,single nucleotide variant,GRCh37
na,na,5,178986689,178986689,GRM6,Uncertain significance,Congenital stationary night blindness 1B|not provided,single nucleotide variant,GRCh38
na,na,5,178416076,178416076,GRM6,Conflicting classifications of pathogenicity,Congenital stationary night blindness 1B|not provided,single nucleotide variant,GRCh37
na,na,5,178989075,178989075,GRM6,Conflicting classifications of pathogenicity,Congenital stationary night blindness 1B|not provided,single nucleotide variant,GRCh38
na,na,2,109546706,109546723,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",Deletion,GRCh37
na,na,2,108930250,108930267,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",Deletion,GRCh38
na,na,2,109545744,109545744,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant|Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,108929288,108929288,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant|Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,108894471,108989220,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",Deletion,GRCh38
na,na,2,109545751,109545751,EDAR,Uncertain significance,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,108929295,108929295,EDAR,Uncertain significance,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,109513638,109513638,EDAR,Pathogenic,"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant|not provided|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant;Autosomal recessive hypohidrotic ectodermal dysplasia syndrome|Non-syndromic oligodontia|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,108897182,108897182,EDAR,Pathogenic,"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant|not provided|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant;Autosomal recessive hypohidrotic ectodermal dysplasia syndrome|Non-syndromic oligodontia|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,109513451,109513451,EDAR,Pathogenic/Likely pathogenic,"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant|not provided|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant;Autosomal recessive hypohidrotic ectodermal dysplasia syndrome|Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,108896995,108896995,EDAR,Pathogenic/Likely pathogenic,"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant|not provided|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant;Autosomal recessive hypohidrotic ectodermal dysplasia syndrome|Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,109547419,109547419,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",single nucleotide variant,GRCh37
na,na,2,108930963,108930963,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,109513586,109513586,EDAR,Likely pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,2,108897130,108897130,EDAR,Likely pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,2,109545681,109545681,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",single nucleotide variant,GRCh37
na,na,2,108929225,108929225,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,109513650,109513650,EDAR,Pathogenic,"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,108897194,108897194,EDAR,Pathogenic,"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,109513601,109513601,EDAR,Benign,"Hair morphology 1, hair thickness|Hypohidrotic Ectodermal Dysplasia, Dominant|not specified|Hypohidrotic ectodermal dysplasia|Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|not provided|Non-syndromic oligodontia|Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh37
na,na,2,108897145,108897145,EDAR,Benign,"Hair morphology 1, hair thickness|Hypohidrotic Ectodermal Dysplasia, Dominant|not specified|Hypohidrotic ectodermal dysplasia|Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|not provided|Non-syndromic oligodontia|Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant",single nucleotide variant,GRCh38
na,na,2,109527240,109527243,EDAR,Pathogenic/Likely pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",Microsatellite,GRCh37
na,na,2,108910784,108910787,EDAR,Pathogenic/Likely pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive",Microsatellite,GRCh38
na,na,2,109526915,109526915,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia",single nucleotide variant,GRCh37
na,na,2,108910459,108910459,EDAR,Pathogenic,"Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive|Ectodermal dysplasia",single nucleotide variant,GRCh38
na,na,na,-1,-1,PPP1R17,risk factor,"Hypercholesterolemia, susceptibility to",single nucleotide variant,na
na,na,17,63193278,63193278,RGS9,Pathogenic,Bradyopsia|Leber congenital amaurosis|not provided,single nucleotide variant,GRCh37
na,na,17,65197160,65197160,RGS9,Pathogenic,Bradyopsia|Leber congenital amaurosis|not provided,single nucleotide variant,GRCh38
na,na,17,75398380,75398380,SEPTIN9,Pathogenic,Amyotrophic neuralgia|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,17,77402298,77402298,SEPTIN9,Pathogenic,Amyotrophic neuralgia|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,17,75398396,75398396,SEPTIN9,Pathogenic,Amyotrophic neuralgia,single nucleotide variant,GRCh37
na,na,17,77402314,77402314,SEPTIN9,Pathogenic,Amyotrophic neuralgia,single nucleotide variant,GRCh38
na,na,17,75316275,75316275,SEPTIN9,Pathogenic,Amyotrophic neuralgia,single nucleotide variant,GRCh37
na,na,17,77320193,77320193,SEPTIN9,Pathogenic,Amyotrophic neuralgia,single nucleotide variant,GRCh38
na,na,17,77368961,77406564,SEPTIN9,Pathogenic,Amyotrophic neuralgia,Duplication,GRCh38
na,na,17,7489312,7489312,MPDU1,Conflicting classifications of pathogenicity,MPDU1-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,17,7585994,7585994,MPDU1,Conflicting classifications of pathogenicity,MPDU1-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,17,7490063,7490063,MPDU1,Pathogenic,MPDU1-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,17,7586745,7586745,MPDU1,Pathogenic,MPDU1-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,17,7487182,7487182,MPDU1,Pathogenic,MPDU1-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,17,7583864,7583864,MPDU1,Pathogenic,MPDU1-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,17,7489315,7489315,MPDU1,Pathogenic,MPDU1-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,17,7585997,7585997,MPDU1,Pathogenic,MPDU1-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,5,131953874,131953874,RAD50,Pathogenic,Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,5,132618182,132618182,RAD50,Pathogenic,Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,5,131978056,131978056,RAD50,Conflicting classifications of pathogenicity,Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,5,132642364,132642364,RAD50,Conflicting classifications of pathogenicity,Nijmegen breakage syndrome-like disorder|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,2,88890090,88890091,EIF2AK3,Pathogenic,Wolcott-Rallison dysplasia,Duplication,GRCh37
na,na,2,88590572,88590573,EIF2AK3,Pathogenic,Wolcott-Rallison dysplasia,Duplication,GRCh38
na,na,2,88882948,88882948,EIF2AK3,Pathogenic,Wolcott-Rallison dysplasia|not provided,single nucleotide variant,GRCh37
na,na,2,88583430,88583430,EIF2AK3,Pathogenic,Wolcott-Rallison dysplasia|not provided,single nucleotide variant,GRCh38
na,na,2,88870391,88870391,EIF2AK3,Likely pathogenic,Wolcott-Rallison dysplasia|not provided,single nucleotide variant,GRCh37
na,na,2,88570873,88570873,EIF2AK3,Likely pathogenic,Wolcott-Rallison dysplasia|not provided,single nucleotide variant,GRCh38
na,na,2,88885436,88885439,EIF2AK3,Pathogenic/Likely pathogenic,Wolcott-Rallison dysplasia|not provided,Microsatellite,GRCh37
na,na,2,88585918,88585921,EIF2AK3,Pathogenic/Likely pathogenic,Wolcott-Rallison dysplasia|not provided,Microsatellite,GRCh38
na,na,2,88890344,88890344,EIF2AK3,Pathogenic,Wolcott-Rallison dysplasia,single nucleotide variant,GRCh37
na,na,2,88590826,88590826,EIF2AK3,Pathogenic,Wolcott-Rallison dysplasia,single nucleotide variant,GRCh38
na,na,17,63532463,63532463,AXIN2,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh37
na,na,17,65536345,65536345,AXIN2,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh38
na,na,17,63532585,63532585,AXIN2,Pathogenic/Likely pathogenic,Carcinoma of colon|Oligodontia-cancer predisposition syndrome|Colorectal cancer|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,17,65536467,65536467,AXIN2,Pathogenic/Likely pathogenic,Carcinoma of colon|Oligodontia-cancer predisposition syndrome|Colorectal cancer|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,17,63532613,63532613,AXIN2,Pathogenic,Oligodontia-cancer predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,65536495,65536495,AXIN2,Pathogenic,Oligodontia-cancer predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,26879407,26879407,UNC119,Uncertain significance,not provided|Cone-rod dystrophy 24,single nucleotide variant,GRCh37
na,na,17,28552389,28552389,UNC119,Uncertain significance,not provided|Cone-rod dystrophy 24,single nucleotide variant,GRCh38
na,na,7,91670004,91670004,AKAP9,Conflicting classifications of pathogenicity,Long QT syndrome 11|not provided|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,7,92040690,92040690,AKAP9,Conflicting classifications of pathogenicity,Long QT syndrome 11|not provided|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,6,43550160,43550172,POLH,Pathogenic,Xeroderma pigmentosum variant type|not provided,Deletion,GRCh37
na,na,6,43582423,43582435,POLH,Pathogenic,Xeroderma pigmentosum variant type|not provided,Deletion,GRCh38
na,na,6,43550108,43550111,POLH,Pathogenic,Xeroderma pigmentosum variant type,Deletion,GRCh37
na,na,6,43582371,43582374,POLH,Pathogenic,Xeroderma pigmentosum variant type,Deletion,GRCh38
na,na,na,-1,-1,POLH,Pathogenic,Xeroderma pigmentosum variant type,Deletion,na
na,na,6,43572383,43572383,POLH,Pathogenic,Xeroderma pigmentosum variant type,single nucleotide variant,GRCh37
na,na,6,43604646,43604646,POLH,Pathogenic,Xeroderma pigmentosum variant type,single nucleotide variant,GRCh38
na,na,na,-1,-1,POLH,Pathogenic,Xeroderma pigmentosum variant type,Complex,na
na,na,6,43555112,43555112,POLH,Pathogenic,Xeroderma pigmentosum variant type|not provided,single nucleotide variant,GRCh37
na,na,6,43587375,43587375,POLH,Pathogenic,Xeroderma pigmentosum variant type|not provided,single nucleotide variant,GRCh38
na,na,6,43578333,43578333,POLH,Pathogenic,Xeroderma pigmentosum variant type|not provided,single nucleotide variant,GRCh37
na,na,6,43610596,43610596,POLH,Pathogenic,Xeroderma pigmentosum variant type|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,POLH,Pathogenic,Xeroderma pigmentosum variant type,Deletion,na
na,na,6,43550813,43550813,POLH,Pathogenic,Xeroderma pigmentosum variant type|not provided,Deletion,GRCh37
na,na,6,43583076,43583076,POLH,Pathogenic,Xeroderma pigmentosum variant type|not provided,Deletion,GRCh38
na,na,6,43550828,43550830,POLH,Pathogenic,Xeroderma pigmentosum variant type,Microsatellite,GRCh37
na,na,6,43583091,43583093,POLH,Pathogenic,Xeroderma pigmentosum variant type,Microsatellite,GRCh38
na,na,6,43581755,43581755,POLH,Benign/Likely benign,Xeroderma pigmentosum variant type|not provided|POLH-related disorder|Xeroderma pigmentosum|not specified,single nucleotide variant,GRCh37
na,na,6,43614018,43614018,POLH,Benign/Likely benign,Xeroderma pigmentosum variant type|not provided|POLH-related disorder|Xeroderma pigmentosum|not specified,single nucleotide variant,GRCh38
na,na,6,43581918,43581918,POLH,Uncertain significance,Xeroderma pigmentosum variant type,single nucleotide variant,GRCh37
na,na,6,43614181,43614181,POLH,Uncertain significance,Xeroderma pigmentosum variant type,single nucleotide variant,GRCh38
na,na,17,62034787,62034787,SCN4A,Pathogenic/Likely pathogenic,"Familial hyperkalemic periodic paralysis|Paramyotonia congenita/hyperkalemic periodic paralysis|not provided|6 conditions|Sotos syndrome|Hypokalemic periodic paralysis, type 2|SCN4A-related disorder",single nucleotide variant,GRCh37
na,na,17,63957427,63957427,SCN4A,Pathogenic/Likely pathogenic,"Familial hyperkalemic periodic paralysis|Paramyotonia congenita/hyperkalemic periodic paralysis|not provided|6 conditions|Sotos syndrome|Hypokalemic periodic paralysis, type 2|SCN4A-related disorder",single nucleotide variant,GRCh38
na,na,17,62018868,62018868,SCN4A,Pathogenic,"Familial hyperkalemic periodic paralysis|Paramyotonia congenita/hyperkalemic periodic paralysis|not provided|6 conditions|Congenital myopathy 22A, classic|7 conditions",single nucleotide variant,GRCh37
na,na,17,63941508,63941508,SCN4A,Pathogenic,"Familial hyperkalemic periodic paralysis|Paramyotonia congenita/hyperkalemic periodic paralysis|not provided|6 conditions|Congenital myopathy 22A, classic|7 conditions",single nucleotide variant,GRCh38
na,na,17,62019300,62019300,SCN4A,Pathogenic,"Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|Hypokalemic periodic paralysis, type 1|Hypokalemic periodic paralysis, type 2",single nucleotide variant,GRCh37
na,na,17,63941940,63941940,SCN4A,Pathogenic,"Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|Hypokalemic periodic paralysis, type 1|Hypokalemic periodic paralysis, type 2",single nucleotide variant,GRCh38
na,na,17,62019299,62019299,SCN4A,Pathogenic,"Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|Rhabdomyolysis|not provided|Delayed gross motor development|SCN4A-related non-dystrophic myotonia|Potassium-aggravated myotonia|SCN4A-related disorder|Hypokalemic periodic paralysis, type 2;Paramyotonia congenita of Von Eulenburg;Congenital myasthenic syndrome 16;Familial hyperkalemic periodic paralysis;Potassium-aggravated myotonia",single nucleotide variant,GRCh37
na,na,17,63941939,63941939,SCN4A,Pathogenic,"Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|Rhabdomyolysis|not provided|Delayed gross motor development|SCN4A-related non-dystrophic myotonia|Potassium-aggravated myotonia|SCN4A-related disorder|Hypokalemic periodic paralysis, type 2;Paramyotonia congenita of Von Eulenburg;Congenital myasthenic syndrome 16;Familial hyperkalemic periodic paralysis;Potassium-aggravated myotonia",single nucleotide variant,GRCh38
na,na,17,62022974,62022974,SCN4A,Pathogenic/Likely pathogenic,Paramyotonia congenita/hyperkalemic periodic paralysis|Familial hyperkalemic periodic paralysis|not provided|Focal-onset seizure|6 conditions|Inborn genetic diseases|SCN4A-related disorder|Potassium-aggravated myotonia,single nucleotide variant,GRCh37
na,na,17,63945614,63945614,SCN4A,Pathogenic/Likely pathogenic,Paramyotonia congenita/hyperkalemic periodic paralysis|Familial hyperkalemic periodic paralysis|not provided|Focal-onset seizure|6 conditions|Inborn genetic diseases|SCN4A-related disorder|Potassium-aggravated myotonia,single nucleotide variant,GRCh38
na,na,17,62029226,62029226,SCN4A,Pathogenic/Likely pathogenic,Paramyotonia congenita/myotonia congenita|not provided|Myotonia fluctuans|Familial hyperkalemic periodic paralysis,single nucleotide variant,GRCh37
na,na,17,63951866,63951866,SCN4A,Pathogenic/Likely pathogenic,Paramyotonia congenita/myotonia congenita|not provided|Myotonia fluctuans|Familial hyperkalemic periodic paralysis,single nucleotide variant,GRCh38
na,na,17,62034875,62034875,SCN4A,Pathogenic/Likely pathogenic,"Normokalemic periodic paralysis, potassium-sensitive|Familial hyperkalemic periodic paralysis|not provided|Paramyotonia congenita of Von Eulenburg",single nucleotide variant,GRCh37
na,na,17,63957515,63957515,SCN4A,Pathogenic/Likely pathogenic,"Normokalemic periodic paralysis, potassium-sensitive|Familial hyperkalemic periodic paralysis|not provided|Paramyotonia congenita of Von Eulenburg",single nucleotide variant,GRCh38
na,na,17,62021206,62021206,SCN4A,Pathogenic,"Potassium-aggravated myotonia|Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|SCN4A-related non-dystrophic myotonia|7 conditions|Paramyotonia congenita of Von Eulenburg;Familial hyperkalemic periodic paralysis;Hypokalemic periodic paralysis, type 2;Congenital myopathy 22A, classic;Potassium-aggravated myotonia",single nucleotide variant,GRCh37
na,na,17,63943846,63943846,SCN4A,Pathogenic,"Potassium-aggravated myotonia|Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|SCN4A-related non-dystrophic myotonia|7 conditions|Paramyotonia congenita of Von Eulenburg;Familial hyperkalemic periodic paralysis;Hypokalemic periodic paralysis, type 2;Congenital myopathy 22A, classic;Potassium-aggravated myotonia",single nucleotide variant,GRCh38
na,na,17,62021185,62021185,SCN4A,Pathogenic,"Paramyotonia congenita of Von Eulenburg|not provided|Familial hyperkalemic periodic paralysis|6 conditions|SCN4A-related non-dystrophic myotonia|Congenital myasthenic syndrome 16|SCN4A-related myopathy, autosomal recessive|SCN4A-related disorder",single nucleotide variant,GRCh37
na,na,17,63943825,63943825,SCN4A,Pathogenic,"Paramyotonia congenita of Von Eulenburg|not provided|Familial hyperkalemic periodic paralysis|6 conditions|SCN4A-related non-dystrophic myotonia|Congenital myasthenic syndrome 16|SCN4A-related myopathy, autosomal recessive|SCN4A-related disorder",single nucleotide variant,GRCh38
na,na,17,62018877,62018877,SCN4A,Pathogenic,"Potassium-aggravated myotonia|Paramyotonia congenita of Von Eulenburg|not provided|Familial hyperkalemic periodic paralysis|Hypokalemic periodic paralysis, type 2",single nucleotide variant,GRCh37
na,na,17,63941517,63941517,SCN4A,Pathogenic,"Potassium-aggravated myotonia|Paramyotonia congenita of Von Eulenburg|not provided|Familial hyperkalemic periodic paralysis|Hypokalemic periodic paralysis, type 2",single nucleotide variant,GRCh38
na,na,17,62022962,62022962,SCN4A,Pathogenic,"Myotonia congenita, atypical, acetazolamide-responsive|not provided|Familial hyperkalemic periodic paralysis",single nucleotide variant,GRCh37
na,na,17,63945602,63945602,SCN4A,Pathogenic,"Myotonia congenita, atypical, acetazolamide-responsive|not provided|Familial hyperkalemic periodic paralysis",single nucleotide variant,GRCh38
na,na,17,62019344,62019344,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg|SCN4A-related non-dystrophic myotonia,single nucleotide variant,GRCh37
na,na,17,63941984,63941984,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg|SCN4A-related non-dystrophic myotonia,single nucleotide variant,GRCh38
na,na,17,62021206,62021206,SCN4A,Pathogenic/Likely pathogenic,"not provided|Familial hyperkalemic periodic paralysis|Hypokalemic periodic paralysis, type 2;Paramyotonia congenita of Von Eulenburg;Familial hyperkalemic periodic paralysis;Potassium-aggravated myotonia|Myotonia fluctuans|Potassium-aggravated myotonia|Inborn genetic diseases|SCN4A-related channelopathy",single nucleotide variant,GRCh37
na,na,17,63943846,63943846,SCN4A,Pathogenic/Likely pathogenic,"not provided|Familial hyperkalemic periodic paralysis|Hypokalemic periodic paralysis, type 2;Paramyotonia congenita of Von Eulenburg;Familial hyperkalemic periodic paralysis;Potassium-aggravated myotonia|Myotonia fluctuans|Potassium-aggravated myotonia|Inborn genetic diseases|SCN4A-related channelopathy",single nucleotide variant,GRCh38
na,na,17,62022068,62022068,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg|SCN4A-related disorder|not provided|Familial hyperkalemic periodic paralysis,single nucleotide variant,GRCh37
na,na,17,63944708,63944708,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg|SCN4A-related disorder|not provided|Familial hyperkalemic periodic paralysis,single nucleotide variant,GRCh38
na,na,17,62041947,62041947,SCN4A,Pathogenic,Potassium-aggravated myotonia|not provided|Familial hyperkalemic periodic paralysis|6 conditions|SCN4A-related non-dystrophic myotonia,single nucleotide variant,GRCh37
na,na,17,63964587,63964587,SCN4A,Pathogenic,Potassium-aggravated myotonia|not provided|Familial hyperkalemic periodic paralysis|6 conditions|SCN4A-related non-dystrophic myotonia,single nucleotide variant,GRCh38
na,na,17,62036638,62036638,SCN4A,Pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|not provided|7 conditions",single nucleotide variant,GRCh37
na,na,17,63959278,63959278,SCN4A,Pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|not provided|7 conditions",single nucleotide variant,GRCh38
na,na,17,62036629,62036629,SCN4A,Pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|not provided|6 conditions|Acetazolamide-responsive myotonia|Paramyotonia congenita of Von Eulenburg",single nucleotide variant,GRCh37
na,na,17,63959269,63959269,SCN4A,Pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|not provided|6 conditions|Acetazolamide-responsive myotonia|Paramyotonia congenita of Von Eulenburg",single nucleotide variant,GRCh38
na,na,17,62036630,62036630,SCN4A,Pathogenic,"Hypokalemic periodic paralysis, type 2|Hypokalemic periodic paralysis, type 1|Familial hyperkalemic periodic paralysis|not provided",single nucleotide variant,GRCh37
na,na,17,63959270,63959270,SCN4A,Pathogenic,"Hypokalemic periodic paralysis, type 2|Hypokalemic periodic paralysis, type 1|Familial hyperkalemic periodic paralysis|not provided",single nucleotide variant,GRCh38
na,na,17,62019317,62019317,SCN4A,Pathogenic,Congenital myasthenic syndrome 16|Congenital myasthenic syndrome,single nucleotide variant,GRCh37
na,na,17,63941957,63941957,SCN4A,Pathogenic,Congenital myasthenic syndrome 16|Congenital myasthenic syndrome,single nucleotide variant,GRCh38
na,na,17,62019275,62019275,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg,single nucleotide variant,GRCh37
na,na,17,63941915,63941915,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg,single nucleotide variant,GRCh38
na,na,17,62036630,62036630,SCN4A,Pathogenic/Likely pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|Hypokalemic periodic paralysis|not provided",single nucleotide variant,GRCh37
na,na,17,63959270,63959270,SCN4A,Pathogenic/Likely pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|Hypokalemic periodic paralysis|not provided",single nucleotide variant,GRCh38
na,na,17,62022968,62022968,SCN4A,Pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,17,63945608,63945608,SCN4A,Pathogenic,"Hypokalemic periodic paralysis, type 2|Familial hyperkalemic periodic paralysis|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,17,62034875,62034875,SCN4A,Pathogenic/Likely pathogenic,"Normokalemic periodic paralysis, potassium-sensitive|Familial hyperkalemic periodic paralysis|not provided|Abnormality of the musculature",single nucleotide variant,GRCh37
na,na,17,63957515,63957515,SCN4A,Pathogenic/Likely pathogenic,"Normokalemic periodic paralysis, potassium-sensitive|Familial hyperkalemic periodic paralysis|not provided|Abnormality of the musculature",single nucleotide variant,GRCh38
na,na,17,62034874,62034874,SCN4A,Pathogenic,"Normokalemic periodic paralysis, potassium-sensitive|Familial hyperkalemic periodic paralysis|not provided|Myopathy|Hypokalemic periodic paralysis, type 2|Congenital myasthenic syndrome 16|7 conditions",single nucleotide variant,GRCh37
na,na,17,63957514,63957514,SCN4A,Pathogenic,"Normokalemic periodic paralysis, potassium-sensitive|Familial hyperkalemic periodic paralysis|not provided|Myopathy|Hypokalemic periodic paralysis, type 2|Congenital myasthenic syndrome 16|7 conditions",single nucleotide variant,GRCh38
na,na,17,62021206,62021206,SCN4A,Pathogenic,"not provided|Familial hyperkalemic periodic paralysis|Paramyotonia congenita of Von Eulenburg|Myotonia permanens|Potassium-aggravated myotonia|6 conditions|SCN4A-related myopathy, autosomal recessive",single nucleotide variant,GRCh37
na,na,17,63943846,63943846,SCN4A,Pathogenic,"not provided|Familial hyperkalemic periodic paralysis|Paramyotonia congenita of Von Eulenburg|Myotonia permanens|Potassium-aggravated myotonia|6 conditions|SCN4A-related myopathy, autosomal recessive",single nucleotide variant,GRCh38
na,na,17,62019214,62019214,SCN4A,Pathogenic/Likely pathogenic,Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|Acetazolamide-responsive myotonia,single nucleotide variant,GRCh37
na,na,17,63941854,63941854,SCN4A,Pathogenic/Likely pathogenic,Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|Acetazolamide-responsive myotonia,single nucleotide variant,GRCh38
na,na,17,62022054,62022054,SCN4A,Pathogenic,Paramyotonia congenita/hyperkalemic periodic paralysis|Paramyotonia congenita of Von Eulenburg,single nucleotide variant,GRCh37
na,na,17,63944694,63944694,SCN4A,Pathogenic,Paramyotonia congenita/hyperkalemic periodic paralysis|Paramyotonia congenita of Von Eulenburg,single nucleotide variant,GRCh38
na,na,17,62034820,62034820,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|SCN4A-related non-dystrophic myotonia,single nucleotide variant,GRCh37
na,na,17,63957460,63957460,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg|Familial hyperkalemic periodic paralysis|not provided|SCN4A-related non-dystrophic myotonia,single nucleotide variant,GRCh38
na,na,17,62049557,62049557,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg,single nucleotide variant,GRCh37
na,na,17,63972197,63972197,SCN4A,Pathogenic,Paramyotonia congenita of Von Eulenburg,single nucleotide variant,GRCh38
na,na,3,190122568,190122568,CLDN16,Pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,3,190404779,190404779,CLDN16,Pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,3,190126225,190126225,CLDN16,Pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,3,190408436,190408436,CLDN16,Pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,3,190122694,190122694,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh37
na,na,3,190404905,190404905,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh38
na,na,3,190126103,190126103,CLDN16,Likely pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,3,190408314,190408314,CLDN16,Likely pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,3,190106120,190106120,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh37
na,na,3,190388331,190388331,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh38
na,na,3,190122623,190122623,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh37
na,na,3,190404834,190404834,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh38
na,na,3,190126205,190126205,CLDN16,Uncertain significance,Primary hypomagnesemia|Nephrolithiasis;Nephrocalcinosis,single nucleotide variant,GRCh37
na,na,3,190408416,190408416,CLDN16,Uncertain significance,Primary hypomagnesemia|Nephrolithiasis;Nephrocalcinosis,single nucleotide variant,GRCh38
na,na,3,190126208,190126208,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh37
na,na,3,190408419,190408419,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh38
na,na,3,190126214,190126214,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh37
na,na,3,190408425,190408425,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh38
na,na,3,190122576,190122576,CLDN16,Pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,3,190404787,190404787,CLDN16,Pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,3,190122575,190122575,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh37
na,na,3,190404786,190404786,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh38
na,na,3,190122557,190122557,CLDN16,Pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,3,190404768,190404768,CLDN16,Pathogenic,Primary hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,3,190120151,190120151,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh37
na,na,3,190402362,190402362,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh38
na,na,3,190126173,190126173,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh37
na,na,3,190408384,190408384,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh38
na,na,3,190127815,190127815,CLDN16,Pathogenic,"HYPERCALCIURIA, CHILDHOOD, SELF-LIMITING",single nucleotide variant,GRCh37
na,na,3,190410026,190410026,CLDN16,Pathogenic,"HYPERCALCIURIA, CHILDHOOD, SELF-LIMITING",single nucleotide variant,GRCh38
na,na,3,190127738,190127738,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh37
na,na,3,190409949,190409949,CLDN16,Pathogenic,Primary hypomagnesemia,single nucleotide variant,GRCh38
na,na,5,169810796,169810796,KCNMB1,Benign; protective,"HYPERTENSION, DIASTOLIC, RESISTANCE TO|KCNMB1-related disorder",single nucleotide variant,GRCh37
na,na,5,170383792,170383792,KCNMB1,Benign; protective,"HYPERTENSION, DIASTOLIC, RESISTANCE TO|KCNMB1-related disorder",single nucleotide variant,GRCh38
na,na,3,183854475,183854475,EIF2B5,Pathogenic/Likely pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh37
na,na,3,184136687,184136687,EIF2B5,Pathogenic/Likely pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh38
na,na,3,183861899,183861899,EIF2B5,Pathogenic,Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh37
na,na,3,184144111,184144111,EIF2B5,Pathogenic,Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh38
na,na,3,183859713,183859713,EIF2B5,Likely pathogenic,Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh37
na,na,3,184141925,184141925,EIF2B5,Likely pathogenic,Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh38
na,na,3,183855425,183855425,EIF2B5,Pathogenic,Vanishing white matter disease|not provided|See cases|Leukoencephalopathy with vanishing white matter 5|Inborn genetic diseases|EIF2B5-related disorder,single nucleotide variant,GRCh37
na,na,3,184137637,184137637,EIF2B5,Pathogenic,Vanishing white matter disease|not provided|See cases|Leukoencephalopathy with vanishing white matter 5|Inborn genetic diseases|EIF2B5-related disorder,single nucleotide variant,GRCh38
na,na,3,183855763,183855763,EIF2B5,Pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh37
na,na,3,184137975,184137975,EIF2B5,Pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh38
na,na,3,183858287,183858287,EIF2B5,Likely pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh37
na,na,3,184140499,184140499,EIF2B5,Likely pathogenic,Vanishing white matter disease|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh38
na,na,3,183855762,183855762,EIF2B5,Likely pathogenic,not provided|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh37
na,na,3,184137974,184137974,EIF2B5,Likely pathogenic,not provided|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh38
na,na,3,183855724,183855724,EIF2B5,Pathogenic/Likely pathogenic,not provided|Leukoencephalopathy with vanishing white matter 5|Vanishing white matter disease,single nucleotide variant,GRCh37
na,na,3,184137936,184137936,EIF2B5,Pathogenic/Likely pathogenic,not provided|Leukoencephalopathy with vanishing white matter 5|Vanishing white matter disease,single nucleotide variant,GRCh38
na,na,3,183858306,183858306,EIF2B5,Pathogenic/Likely pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh37
na,na,3,184140518,184140518,EIF2B5,Pathogenic/Likely pathogenic,Vanishing white matter disease|not provided|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh38
na,na,3,183853339,183853339,EIF2B5,Conflicting classifications of pathogenicity,not provided|not specified|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh37
na,na,3,184135551,184135551,EIF2B5,Conflicting classifications of pathogenicity,not provided|not specified|Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh38
na,na,3,183853340,183853340,EIF2B5,Pathogenic,Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh37
na,na,3,184135552,184135552,EIF2B5,Pathogenic,Leukoencephalopathy with vanishing white matter 5,single nucleotide variant,GRCh38
na,na,3,148714193,148714193,GYG1,Uncertain significance,Glycogen storage disease XV|not provided,single nucleotide variant,GRCh37
na,na,3,148996406,148996406,GYG1,Uncertain significance,Glycogen storage disease XV|not provided,single nucleotide variant,GRCh38
na,na,1,169446716,169446716,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",single nucleotide variant,GRCh37
na,na,1,169477478,169477478,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",single nucleotide variant,GRCh38
na,na,1,169446475,169446475,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",Deletion,GRCh37
na,na,1,169477237,169477237,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",Deletion,GRCh38
na,na,1,169446685,169446685,SLC19A2,Pathogenic/Likely pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",single nucleotide variant,GRCh37
na,na,1,169477447,169477447,SLC19A2,Pathogenic/Likely pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",single nucleotide variant,GRCh38
na,na,1,169446450,169446450,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",single nucleotide variant,GRCh37
na,na,1,169477212,169477212,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",single nucleotide variant,GRCh38
na,na,1,169439347,169439347,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",Deletion,GRCh37
na,na,1,169470109,169470109,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",Deletion,GRCh38
na,na,1,169437956,169437957,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",Microsatellite,GRCh37
na,na,1,169468718,169468719,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",Microsatellite,GRCh38
na,na,1,169446957,169446958,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",Duplication,GRCh37
na,na,1,169477719,169477720,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",Duplication,GRCh38
na,na,1,169446770,169446771,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",Deletion,GRCh37
na,na,1,169477532,169477533,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",Deletion,GRCh38
na,na,1,169438031,169438031,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",single nucleotide variant,GRCh37
na,na,1,169468793,169468793,SLC19A2,Pathogenic,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",single nucleotide variant,GRCh38
na,na,1,169454853,169454853,SLC19A2,Uncertain significance,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",single nucleotide variant,GRCh37
na,na,1,169485615,169485615,SLC19A2,Uncertain significance,"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided",single nucleotide variant,GRCh38
na,na,8,55538471,55538471,RP1,Pathogenic,Retinitis pigmentosa 1|not provided|Retinal dystrophy|RP1-related disorder,single nucleotide variant,GRCh37
na,na,8,54625911,54625911,RP1,Pathogenic,Retinitis pigmentosa 1|not provided|Retinal dystrophy|RP1-related disorder,single nucleotide variant,GRCh38
na,na,8,55538722,55538726,RP1,Pathogenic,Retinitis pigmentosa 1|Retinitis pigmentosa|Retinal dystrophy|not provided,Microsatellite,GRCh37
na,na,8,54626162,54626166,RP1,Pathogenic,Retinitis pigmentosa 1|Retinitis pigmentosa|Retinal dystrophy|not provided,Microsatellite,GRCh38
na,na,8,55538727,55538730,RP1,Pathogenic,Retinitis pigmentosa 1,Deletion,GRCh37
na,na,8,54626167,54626170,RP1,Pathogenic,Retinitis pigmentosa 1,Deletion,GRCh38
na,na,8,55538477,55538477,RP1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 1|not provided,single nucleotide variant,GRCh37
na,na,8,54625917,54625917,RP1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 1|not provided,single nucleotide variant,GRCh38
na,na,8,55539395,55539395,RP1,Benign/Likely benign,not specified|Retinitis pigmentosa|not provided|Retinitis pigmentosa 1|Hypertriglyceridemia 1|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,8,54626835,54626835,RP1,Benign/Likely benign,not specified|Retinitis pigmentosa|not provided|Retinitis pigmentosa 1|Hypertriglyceridemia 1|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,8,55537560,55537560,RP1,Benign/Likely benign,Retinitis pigmentosa 1|not specified|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh37
na,na,8,54625000,54625000,RP1,Benign/Likely benign,Retinitis pigmentosa 1|not specified|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh38
na,na,8,55537899,55537900,RP1,Pathogenic,Retinitis pigmentosa 1,Duplication,GRCh37
na,na,8,54625339,54625340,RP1,Pathogenic,Retinitis pigmentosa 1,Duplication,GRCh38
na,na,14,66975310,67291191,GPHN,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,Deletion,GRCh37
na,na,14,66508592,66824473,GPHN,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,Deletion,GRCh38
na,na,14,66975273,66975273,GPHN,Uncertain significance,Hyperekplexia|Hyperekplexia 1|Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C|Hyperekplexia 1;Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,14,66508555,66508555,GPHN,Uncertain significance,Hyperekplexia|Hyperekplexia 1|Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C|Hyperekplexia 1;Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,10,115348046,115348046,HABP2,Conflicting classifications of pathogenicity,"Venous thromboembolism, susceptibility to|FACTOR VII-ACTIVATING PROTEASE MARBURG I POLYMORPHISM|THYROID CANCER, NONMEDULLARY, 5, SUSCEPTIBILITY TO|Factor VII Marburg I Variant Thrombophilia|not provided|Thyroid cancer, nonmedullary, 5",single nucleotide variant,GRCh37
na,na,10,113588287,113588287,HABP2,Conflicting classifications of pathogenicity,"Venous thromboembolism, susceptibility to|FACTOR VII-ACTIVATING PROTEASE MARBURG I POLYMORPHISM|THYROID CANCER, NONMEDULLARY, 5, SUSCEPTIBILITY TO|Factor VII Marburg I Variant Thrombophilia|not provided|Thyroid cancer, nonmedullary, 5",single nucleotide variant,GRCh38
na,na,13,48542701,48542743,SUCLA2,Pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",Indel,GRCh37
na,na,13,47968566,47968608,SUCLA2,Pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",Indel,GRCh38
na,na,13,48562675,48562675,SUCLA2,Pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",single nucleotide variant,GRCh37
na,na,13,47988540,47988540,SUCLA2,Pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",single nucleotide variant,GRCh38
na,na,13,48563036,48563036,SUCLA2,Pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",single nucleotide variant,GRCh37
na,na,13,47988901,47988901,SUCLA2,Pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",single nucleotide variant,GRCh38
na,na,13,48528645,48528645,SUCLA2,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria|not provided",single nucleotide variant,GRCh37
na,na,13,47954510,47954510,SUCLA2,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria|not provided",single nucleotide variant,GRCh38
na,na,13,48835358,48835358,ITM2B,Pathogenic,ABri amyloidosis,single nucleotide variant,GRCh37
na,na,13,48261222,48261222,ITM2B,Pathogenic,ABri amyloidosis,single nucleotide variant,GRCh38
na,na,13,48835344,48835345,ITM2B,Pathogenic,ADan amyloidosis,Duplication,GRCh37
na,na,13,48261208,48261209,ITM2B,Pathogenic,ADan amyloidosis,Duplication,GRCh38
na,na,10,121431885,121431885,BAG3,Pathogenic,Myofibrillar myopathy 6|not provided|Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH|Cardiovascular phenotype|Peripheral neuropathy,single nucleotide variant,GRCh37
na,na,10,119672373,119672373,BAG3,Pathogenic,Myofibrillar myopathy 6|not provided|Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH|Cardiovascular phenotype|Peripheral neuropathy,single nucleotide variant,GRCh38
na,na,15,55522621,55522621,RAB27A,Pathogenic,Griscelli syndrome type 2,single nucleotide variant,GRCh37
na,na,15,55230423,55230423,RAB27A,Pathogenic,Griscelli syndrome type 2,single nucleotide variant,GRCh38
na,na,15,55522596,55522596,RAB27A,Likely pathogenic,Griscelli syndrome type 2,single nucleotide variant,GRCh37
na,na,15,55230398,55230398,RAB27A,Likely pathogenic,Griscelli syndrome type 2,single nucleotide variant,GRCh38
na,na,na,-1,-1,RAB27A,Pathogenic,Griscelli syndrome type 2,Deletion,na
na,na,15,55516165,55516165,RAB27A,Pathogenic,Griscelli syndrome type 2,single nucleotide variant,GRCh37
na,na,15,55223967,55223967,RAB27A,Pathogenic,Griscelli syndrome type 2,single nucleotide variant,GRCh38
na,na,15,55516100,55516100,RAB27A,Pathogenic,Griscelli syndrome type 2,single nucleotide variant,GRCh37
na,na,15,55223902,55223902,RAB27A,Pathogenic,Griscelli syndrome type 2,single nucleotide variant,GRCh38
na,na,15,55527079,55527080,RAB27A,Pathogenic,Griscelli syndrome type 2,Microsatellite,GRCh37
na,na,15,55234881,55234882,RAB27A,Pathogenic,Griscelli syndrome type 2,Microsatellite,GRCh38
na,na,15,55516202,55516202,RAB27A,Pathogenic,Griscelli syndrome type 2|See cases|Multisystem inflammatory syndrome in children,single nucleotide variant,GRCh37
na,na,15,55224004,55224004,RAB27A,Pathogenic,Griscelli syndrome type 2|See cases|Multisystem inflammatory syndrome in children,single nucleotide variant,GRCh38
na,na,15,55520891,55520891,RAB27A,Conflicting classifications of pathogenicity,Griscelli syndrome type 2|not specified|not provided,single nucleotide variant,GRCh37
na,na,15,55228693,55228693,RAB27A,Conflicting classifications of pathogenicity,Griscelli syndrome type 2|not specified|not provided,single nucleotide variant,GRCh38
na,na,13,41381530,41381532,SLC25A15,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome|not provided|SLC25A15-related disorder,Microsatellite,GRCh37
na,na,13,40807394,40807396,SLC25A15,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome|not provided|SLC25A15-related disorder,Microsatellite,GRCh38
na,na,13,41381515,41381515,SLC25A15,Conflicting classifications of pathogenicity,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome|not provided,single nucleotide variant,GRCh37
na,na,13,40807379,40807379,SLC25A15,Conflicting classifications of pathogenicity,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome|not provided,single nucleotide variant,GRCh38
na,na,13,41381512,41381512,SLC25A15,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome|SLC25A15-related disorder,single nucleotide variant,GRCh37
na,na,13,40807376,40807376,SLC25A15,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome|SLC25A15-related disorder,single nucleotide variant,GRCh38
na,na,13,41373216,41373216,SLC25A15,Pathogenic/Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh37
na,na,13,40799080,40799080,SLC25A15,Pathogenic/Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh38
na,na,13,41383721,41383721,SLC25A15,Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh37
na,na,13,40809585,40809585,SLC25A15,Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh38
na,na,13,41373247,41373247,SLC25A15,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh37
na,na,13,40799111,40799111,SLC25A15,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh38
na,na,13,41373349,41373349,SLC25A15,Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh37
na,na,13,40799213,40799213,SLC25A15,Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh38
na,na,13,41383712,41383712,SLC25A15,Pathogenic/Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh37
na,na,13,40809576,40809576,SLC25A15,Pathogenic/Likely pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh38
na,na,13,41373232,41373232,SLC25A15,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh37
na,na,13,40799096,40799096,SLC25A15,Pathogenic,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,single nucleotide variant,GRCh38
na,na,7,95813588,95813588,SLC25A13,Pathogenic,"Citrullinemia type II|Neonatal intrahepatic cholestasis due to citrin deficiency|Citrin deficiency|Citrullinemia, type II, adult-onset|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency|SLC25A13-related disorder|Late-onset citrullinemia|CITRIN DEFICIENCY, NEONATAL ONSET",single nucleotide variant,GRCh37
na,na,7,96184276,96184276,SLC25A13,Pathogenic,"Citrullinemia type II|Neonatal intrahepatic cholestasis due to citrin deficiency|Citrin deficiency|Citrullinemia, type II, adult-onset|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency|SLC25A13-related disorder|Late-onset citrullinemia|CITRIN DEFICIENCY, NEONATAL ONSET",single nucleotide variant,GRCh38
na,na,7,95751240,95751241,SLC25A13,Pathogenic,"Citrullinemia type II|Citrin deficiency|Neonatal intrahepatic cholestasis due to citrin deficiency|Citrullinemia, type II, adult-onset|not provided|SLC25A13-related disorder|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency",Duplication,GRCh37
na,na,7,96121928,96121929,SLC25A13,Pathogenic,"Citrullinemia type II|Citrin deficiency|Neonatal intrahepatic cholestasis due to citrin deficiency|Citrullinemia, type II, adult-onset|not provided|SLC25A13-related disorder|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency",Duplication,GRCh38
na,na,7,95820501,95820501,SLC25A13,Pathogenic,"Citrullinemia type II|Neonatal intrahepatic cholestasis due to citrin deficiency|Citrin deficiency|Citrullinemia|Citrullinemia, type II, adult-onset|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency",single nucleotide variant,GRCh37
na,na,7,96191189,96191189,SLC25A13,Pathogenic,"Citrullinemia type II|Neonatal intrahepatic cholestasis due to citrin deficiency|Citrin deficiency|Citrullinemia|Citrullinemia, type II, adult-onset|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency",single nucleotide variant,GRCh38
na,na,7,95799356,95799356,SLC25A13,Pathogenic,"Citrullinemia type II|Citrin deficiency|Late-onset citrullinemia|Citrullinemia, type II, adult-onset|not provided|Neonatal intrahepatic cholestasis due to citrin deficiency",single nucleotide variant,GRCh37
na,na,7,96170044,96170044,SLC25A13,Pathogenic,"Citrullinemia type II|Citrin deficiency|Late-onset citrullinemia|Citrullinemia, type II, adult-onset|not provided|Neonatal intrahepatic cholestasis due to citrin deficiency",single nucleotide variant,GRCh38
na,na,7,95751008,95751009,SLC25A13,Pathogenic/Likely pathogenic,"Neonatal intrahepatic cholestasis due to citrin deficiency|Citrullinemia type II|Citrin deficiency|Citrullinemia, type II, adult-onset|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency|SLC25A13-related disorder|CITRIN DEFICIENCY, NEONATAL ONSET|Citrullinemia",Duplication,GRCh37
na,na,7,96121696,96121697,SLC25A13,Pathogenic/Likely pathogenic,"Neonatal intrahepatic cholestasis due to citrin deficiency|Citrullinemia type II|Citrin deficiency|Citrullinemia, type II, adult-onset|Citrullinemia, type II, adult-onset;Neonatal intrahepatic cholestasis due to citrin deficiency|SLC25A13-related disorder|CITRIN DEFICIENCY, NEONATAL ONSET|Citrullinemia",Duplication,GRCh38
na,na,7,95751045,95751045,SLC25A13,Conflicting classifications of pathogenicity,Citrullinemia type II|not provided|Citrullinemia|Neonatal intrahepatic cholestasis due to citrin deficiency|Inborn genetic diseases|Citrin deficiency,single nucleotide variant,GRCh37
na,na,7,96121733,96121733,SLC25A13,Conflicting classifications of pathogenicity,Citrullinemia type II|not provided|Citrullinemia|Neonatal intrahepatic cholestasis due to citrin deficiency|Inborn genetic diseases|Citrin deficiency,single nucleotide variant,GRCh38
na,na,4,41745972,41746045,PHOX2B,Pathogenic,"Congenital central hypoventilation|Haddad syndrome|Central hypoventilation syndrome, late-onset",Insertion,GRCh38
na,na,4,41748150,41748151,PHOX2B,Pathogenic,Congenital central hypoventilation|not provided,Duplication,GRCh37
na,na,4,41746133,41746134,PHOX2B,Pathogenic,Congenital central hypoventilation|not provided,Duplication,GRCh38
na,na,4,41748010,41748047,PHOX2B,Pathogenic,Congenital central hypoventilation|not provided|PHOX2B-related disorder,Deletion,GRCh37
na,na,4,41745993,41746030,PHOX2B,Pathogenic,Congenital central hypoventilation|not provided|PHOX2B-related disorder,Deletion,GRCh38
na,na,4,41749496,41749496,PHOX2B,Conflicting classifications of pathogenicity,"Neuroblastoma, susceptibility to, 2|Haddad syndrome|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,4,41747479,41747479,PHOX2B,Conflicting classifications of pathogenicity,"Neuroblastoma, susceptibility to, 2|Haddad syndrome|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,4,41749374,41749374,PHOX2B,Pathogenic,Hirschsprung disease-ganglioneuroblastoma syndrome,single nucleotide variant,GRCh37
na,na,4,41747357,41747357,PHOX2B,Pathogenic,Hirschsprung disease-ganglioneuroblastoma syndrome,single nucleotide variant,GRCh38
na,na,4,41748093,41748093,PHOX2B,Pathogenic,Hirschsprung disease-ganglioneuroblastoma syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,4,41746076,41746076,PHOX2B,Pathogenic,Hirschsprung disease-ganglioneuroblastoma syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,4,41748179,41748179,PHOX2B,Uncertain significance,"Neuroblastoma, susceptibility to, 2|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,4,41746162,41746162,PHOX2B,Uncertain significance,"Neuroblastoma, susceptibility to, 2|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,12,32884052,32884052,DNM1L,Pathogenic,"Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1",single nucleotide variant,GRCh37
na,na,12,32731118,32731118,DNM1L,Pathogenic,"Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1",single nucleotide variant,GRCh38
na,na,5,1802490,1802490,NDUFS6,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 9|not provided",single nucleotide variant,GRCh37
na,na,5,1802376,1802376,NDUFS6,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 9|not provided",single nucleotide variant,GRCh38
na,na,5,1812546,1816720,NDUFS6,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 9",Deletion,GRCh37
na,na,5,1812432,1816606,NDUFS6,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 9",Deletion,GRCh38
na,na,5,1815999,1815999,NDUFS6,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 9|not provided",single nucleotide variant,GRCh37
na,na,5,1815885,1815885,NDUFS6,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 9|not provided",single nucleotide variant,GRCh38
na,na,11,47603692,47603692,NDUFS3,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 8|Neurodevelopmental delay",single nucleotide variant,GRCh37
na,na,11,47582140,47582140,NDUFS3,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 8|Neurodevelopmental delay",single nucleotide variant,GRCh38
na,na,11,47603988,47603988,NDUFS3,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 8|not provided",single nucleotide variant,GRCh37
na,na,11,47582436,47582436,NDUFS3,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 8|not provided",single nucleotide variant,GRCh38
na,na,9,36234103,36234103,GNE,Pathogenic,Sialuria|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,36234106,36234106,GNE,Pathogenic,Sialuria|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,36234102,36234102,GNE,Pathogenic,Sialuria|Sialuria;GNE myopathy,single nucleotide variant,GRCh37
na,na,9,36234105,36234105,GNE,Pathogenic,Sialuria|Sialuria;GNE myopathy,single nucleotide variant,GRCh38
na,na,9,36234111,36234111,GNE,Likely pathogenic,Sialuria,single nucleotide variant,GRCh37
na,na,9,36234114,36234114,GNE,Likely pathogenic,Sialuria,single nucleotide variant,GRCh38
na,na,9,36217396,36217396,GNE,Pathogenic,GNE myopathy|not provided|Sialuria;GNE myopathy|GNE-related disorder|Sialuria|Thrombocytopenia 12 with or without myopathy;Sialuria;GNE myopathy,single nucleotide variant,GRCh37
na,na,9,36217399,36217399,GNE,Pathogenic,GNE myopathy|not provided|Sialuria;GNE myopathy|GNE-related disorder|Sialuria|Thrombocytopenia 12 with or without myopathy;Sialuria;GNE myopathy,single nucleotide variant,GRCh38
na,na,9,36219924,36219924,GNE,Conflicting classifications of pathogenicity,GNE myopathy|Sialuria;GNE myopathy,single nucleotide variant,GRCh37
na,na,9,36219927,36219927,GNE,Conflicting classifications of pathogenicity,GNE myopathy|Sialuria;GNE myopathy,single nucleotide variant,GRCh38
na,na,9,36218222,36218222,GNE,Pathogenic/Likely pathogenic,GNE myopathy|Sialuria;GNE myopathy,single nucleotide variant,GRCh37
na,na,9,36218225,36218225,GNE,Pathogenic/Likely pathogenic,GNE myopathy|Sialuria;GNE myopathy,single nucleotide variant,GRCh38
na,na,9,36217445,36217445,GNE,Conflicting classifications of pathogenicity,GNE myopathy|not provided|Sialuria;GNE myopathy|Sialuria|Thrombocytopenia 12 with or without myopathy;Sialuria;GNE myopathy|GNE-related disorder,single nucleotide variant,GRCh37
na,na,9,36217448,36217448,GNE,Conflicting classifications of pathogenicity,GNE myopathy|not provided|Sialuria;GNE myopathy|Sialuria|Thrombocytopenia 12 with or without myopathy;Sialuria;GNE myopathy|GNE-related disorder,single nucleotide variant,GRCh38
na,na,9,36233990,36233990,GNE,Pathogenic,GNE myopathy,single nucleotide variant,GRCh37
na,na,9,36233993,36233993,GNE,Pathogenic,GNE myopathy,single nucleotide variant,GRCh38
na,na,9,36236861,36236861,GNE,Pathogenic/Likely pathogenic,"GNE myopathy|not provided|Sialuria;GNE myopathy|Sialuria;Thrombocytopenia 12 with or without myopathy;GNE myopathy|Myopathy, autophagic vacuolar, infantile-onset",single nucleotide variant,GRCh37
na,na,9,36236864,36236864,GNE,Pathogenic/Likely pathogenic,"GNE myopathy|not provided|Sialuria;GNE myopathy|Sialuria;Thrombocytopenia 12 with or without myopathy;GNE myopathy|Myopathy, autophagic vacuolar, infantile-onset",single nucleotide variant,GRCh38
na,na,9,36236925,36236925,GNE,Conflicting classifications of pathogenicity,GNE myopathy|not provided|GNE myopathy;Sialuria,single nucleotide variant,GRCh37
na,na,9,36236928,36236928,GNE,Conflicting classifications of pathogenicity,GNE myopathy|not provided|GNE myopathy;Sialuria,single nucleotide variant,GRCh38
na,na,9,36223402,36223402,GNE,Uncertain significance,GNE myopathy|not provided,single nucleotide variant,GRCh37
na,na,9,36223405,36223405,GNE,Uncertain significance,GNE myopathy|not provided,single nucleotide variant,GRCh38
na,na,9,36219937,36219937,GNE,Pathogenic,GNE myopathy|not provided|Sialuria;GNE myopathy|Thrombocytopenia 12 with or without myopathy;Sialuria;GNE myopathy,single nucleotide variant,GRCh37
na,na,9,36219940,36219940,GNE,Pathogenic,GNE myopathy|not provided|Sialuria;GNE myopathy|Thrombocytopenia 12 with or without myopathy;Sialuria;GNE myopathy,single nucleotide variant,GRCh38
na,na,9,36233991,36233992,GNE,Pathogenic,GNE myopathy,Indel,GRCh37
na,na,9,36233994,36233995,GNE,Pathogenic,GNE myopathy,Indel,GRCh38
na,na,9,36218221,36218221,GNE,Pathogenic,GNE myopathy|not provided|GNE myopathy;Sialuria|Thrombocytopenia 12 with or without myopathy|Hereditary nonpolyposis colon cancer|GNE myopathy;Thrombocytopenia 12 with or without myopathy;Sialuria,single nucleotide variant,GRCh37
na,na,9,36218224,36218224,GNE,Pathogenic,GNE myopathy|not provided|GNE myopathy;Sialuria|Thrombocytopenia 12 with or without myopathy|Hereditary nonpolyposis colon cancer|GNE myopathy;Thrombocytopenia 12 with or without myopathy;Sialuria,single nucleotide variant,GRCh38
na,na,9,36246133,36246133,GNE,Pathogenic,GNE myopathy,single nucleotide variant,GRCh37
na,na,9,36246136,36246136,GNE,Pathogenic,GNE myopathy,single nucleotide variant,GRCh38
na,na,16,359973,360004,AXIN1,Pathogenic,Hepatocellular carcinoma,Deletion,GRCh37
na,na,16,309973,310004,AXIN1,Pathogenic,Hepatocellular carcinoma,Deletion,GRCh38
na,na,na,-1,-1,AXIN1,Pathogenic,Caudal duplication,Variation,na
na,na,15,43552349,43552349,TGM5,Pathogenic,Acral peeling skin syndrome|not provided|Inborn genetic diseases|TGM5-related disorder,single nucleotide variant,GRCh37
na,na,15,43260151,43260151,TGM5,Pathogenic,Acral peeling skin syndrome|not provided|Inborn genetic diseases|TGM5-related disorder,single nucleotide variant,GRCh38
na,na,10,73767700,73767700,CHST3,Conflicting classifications of pathogenicity,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72007942,72007942,CHST3,Conflicting classifications of pathogenicity,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,10,73767565,73767565,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72007807,72007807,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,10,73767903,73767903,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72008145,72008145,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,10,73767453,73767453,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72007695,72007695,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,10,73767709,73767709,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72007951,72007951,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,10,73767875,73767875,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,Deletion,GRCh37
na,na,10,72008117,72008117,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,Deletion,GRCh38
na,na,10,73767392,73767392,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72007634,72007634,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,10,73767646,73767646,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72007888,72007888,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,10,73767211,73767211,CHST3,Uncertain significance,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72007453,72007453,CHST3,Uncertain significance,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,10,73767264,73767264,CHST3,Pathogenic/Likely pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations|not provided,single nucleotide variant,GRCh37
na,na,10,72007506,72007506,CHST3,Pathogenic/Likely pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations|not provided,single nucleotide variant,GRCh38
na,na,10,73767270,73767270,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72007512,72007512,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,10,73767777,73767777,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh37
na,na,10,72008019,72008019,CHST3,Pathogenic,Spondyloepiphyseal dysplasia with congenital joint dislocations,single nucleotide variant,GRCh38
na,na,21,35742802,35742802,KCNE2,Benign/Likely benign,"Long QT syndrome 6, acquired, susceptibility to|not provided|Cardiovascular phenotype|Atrial fibrillation, familial, 4|Long QT syndrome 6|not specified",single nucleotide variant,GRCh37
na,na,21,34370503,34370503,KCNE2,Benign/Likely benign,"Long QT syndrome 6, acquired, susceptibility to|not provided|Cardiovascular phenotype|Atrial fibrillation, familial, 4|Long QT syndrome 6|not specified",single nucleotide variant,GRCh38
na,na,21,35742938,35742938,KCNE2,Conflicting classifications of pathogenicity; risk factor,Long QT syndrome 6|not provided|KCNE2-related disorder|Congenital long QT syndrome|Long QT syndrome|Cardiac arrhythmia|Cardiovascular phenotype|not specified,single nucleotide variant,GRCh37
na,na,21,34370639,34370639,KCNE2,Conflicting classifications of pathogenicity; risk factor,Long QT syndrome 6|not provided|KCNE2-related disorder|Congenital long QT syndrome|Long QT syndrome|Cardiac arrhythmia|Cardiovascular phenotype|not specified,single nucleotide variant,GRCh38
na,na,21,35742947,35742947,KCNE2,Conflicting classifications of pathogenicity,"Long QT syndrome 6|not provided|Cardiovascular phenotype|Atrial fibrillation, familial, 4|KCNE2-related disorder|Cardiac arrhythmia",single nucleotide variant,GRCh37
na,na,21,34370648,34370648,KCNE2,Conflicting classifications of pathogenicity,"Long QT syndrome 6|not provided|Cardiovascular phenotype|Atrial fibrillation, familial, 4|KCNE2-related disorder|Cardiac arrhythmia",single nucleotide variant,GRCh38
na,na,21,35742856,35742856,KCNE2,Conflicting classifications of pathogenicity,"Atrial fibrillation, familial, 4|Long QT syndrome;Primary familial hypertrophic cardiomyopathy|Atrial fibrillation|Long QT syndrome 6|Atrial fibrillation, familial, 4;Long QT syndrome 6|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,21,34370557,34370557,KCNE2,Conflicting classifications of pathogenicity,"Atrial fibrillation, familial, 4|Long QT syndrome;Primary familial hypertrophic cardiomyopathy|Atrial fibrillation|Long QT syndrome 6|Atrial fibrillation, familial, 4;Long QT syndrome 6|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,21,35742955,35742955,KCNE2,Pathogenic,"Long QT syndrome 3/6, digenic|Congenital long QT syndrome",single nucleotide variant,GRCh37
na,na,21,34370656,34370656,KCNE2,Pathogenic,"Long QT syndrome 3/6, digenic|Congenital long QT syndrome",single nucleotide variant,GRCh38
na,na,16,11647432,11647432,LITAF,Pathogenic,Charcot-Marie-Tooth disease type 1C|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,16,11553576,11553576,LITAF,Pathogenic,Charcot-Marie-Tooth disease type 1C|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,16,11647422,11647422,LITAF,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 1C|not provided,single nucleotide variant,GRCh37
na,na,16,11553566,11553566,LITAF,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 1C|not provided,single nucleotide variant,GRCh38
na,na,16,11647420,11647420,LITAF,Pathogenic,Charcot-Marie-Tooth disease type 1C,single nucleotide variant,GRCh37
na,na,16,11553564,11553564,LITAF,Pathogenic,Charcot-Marie-Tooth disease type 1C,single nucleotide variant,GRCh38
na,na,16,11647402,11647402,LITAF,Pathogenic,Charcot-Marie-Tooth disease type 1C,single nucleotide variant,GRCh37
na,na,16,11553546,11553546,LITAF,Pathogenic,Charcot-Marie-Tooth disease type 1C,single nucleotide variant,GRCh38
na,na,16,11643549,11643549,LITAF,Uncertain significance,Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,16,11549693,11549693,LITAF,Uncertain significance,Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,8,145739874,145739880,RECQL4,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,Deletion,GRCh37
na,na,8,144514490,144514496,RECQL4,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,Deletion,GRCh38
na,na,8,145738796,145738796,RECQL4,Pathogenic,Rothmund-Thomson syndrome|Baller-Gerold syndrome|Inborn genetic diseases|Rothmund-Thomson syndrome;Baller-Gerold syndrome;Rapadilino syndrome|Rothmund-Thomson syndrome type 2|not provided|Hereditary cancer-predisposing syndrome|Rothmund-Thomson syndrome type 2;Baller-Gerold syndrome;Rapadilino syndrome|RECQL4-related disorder,single nucleotide variant,GRCh37
na,na,8,144513412,144513412,RECQL4,Pathogenic,Rothmund-Thomson syndrome|Baller-Gerold syndrome|Inborn genetic diseases|Rothmund-Thomson syndrome;Baller-Gerold syndrome;Rapadilino syndrome|Rothmund-Thomson syndrome type 2|not provided|Hereditary cancer-predisposing syndrome|Rothmund-Thomson syndrome type 2;Baller-Gerold syndrome;Rapadilino syndrome|RECQL4-related disorder,single nucleotide variant,GRCh38
na,na,8,145738492,145738493,RECQL4,Pathogenic/Likely pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome|Rapadilino syndrome|not provided|Hereditary cancer-predisposing syndrome|Inborn genetic diseases,Deletion,GRCh37
na,na,8,144513109,144513110,RECQL4,Pathogenic/Likely pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome|Rapadilino syndrome|not provided|Hereditary cancer-predisposing syndrome|Inborn genetic diseases,Deletion,GRCh38
na,na,8,145739097,145739097,RECQL4,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,single nucleotide variant,GRCh37
na,na,8,144513713,144513713,RECQL4,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,single nucleotide variant,GRCh38
na,na,8,145740367,145740367,RECQL4,Pathogenic,Rothmund-Thomson syndrome|Rapadilino syndrome|Baller-Gerold syndrome|B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)|High grade surface osteosarcoma|Rothmund-Thomson syndrome type 2|not provided|Rothmund-Thomson syndrome type 2;Baller-Gerold syndrome;Rapadilino syndrome|Inborn genetic diseases|RECQL4-related disorder,Deletion,GRCh37
na,na,8,144514983,144514983,RECQL4,Pathogenic,Rothmund-Thomson syndrome|Rapadilino syndrome|Baller-Gerold syndrome|B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)|High grade surface osteosarcoma|Rothmund-Thomson syndrome type 2|not provided|Rothmund-Thomson syndrome type 2;Baller-Gerold syndrome;Rapadilino syndrome|Inborn genetic diseases|RECQL4-related disorder,Deletion,GRCh38
na,na,8,145740627,145740627,RECQL4,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,144515243,144515243,RECQL4,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,145739097,145739097,RECQL4,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,single nucleotide variant,GRCh37
na,na,8,144513713,144513713,RECQL4,Pathogenic,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,single nucleotide variant,GRCh38
na,na,8,145741697,145741697,RECQL4,Pathogenic,Rapadilino syndrome|Baller-Gerold syndrome,single nucleotide variant,GRCh37
na,na,8,144516313,144516313,RECQL4,Pathogenic,Rapadilino syndrome|Baller-Gerold syndrome,single nucleotide variant,GRCh38
na,na,8,145737702,145737702,RECQL4,Pathogenic,Baller-Gerold syndrome|RECQL4-related disorder|Rothmund-Thomson syndrome type 2,single nucleotide variant,GRCh37
na,na,8,144512319,144512319,RECQL4,Pathogenic,Baller-Gerold syndrome|RECQL4-related disorder|Rothmund-Thomson syndrome type 2,single nucleotide variant,GRCh38
na,na,8,145737709,145737709,RECQL4,Pathogenic/Likely pathogenic,Baller-Gerold syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,144512326,144512326,RECQL4,Pathogenic/Likely pathogenic,Baller-Gerold syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,145739446,145739451,RECQL4,Uncertain significance,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,Deletion,GRCh37
na,na,8,144514062,144514067,RECQL4,Uncertain significance,Rothmund-Thomson syndrome type 2|Baller-Gerold syndrome,Deletion,GRCh38
na,na,8,145739825,145739825,RECQL4,Pathogenic/Likely pathogenic,Rothmund-Thomson syndrome type 2|not provided|Baller-Gerold syndrome,single nucleotide variant,GRCh37
na,na,8,144514441,144514441,RECQL4,Pathogenic/Likely pathogenic,Rothmund-Thomson syndrome type 2|not provided|Baller-Gerold syndrome,single nucleotide variant,GRCh38
na,na,5,121786403,121786403,SNCAIP,Likely benign,"Parkinson disease, late-onset|Parkinson Disease, Dominant/Recessive|not provided",single nucleotide variant,GRCh37
na,na,5,122450708,122450708,SNCAIP,Likely benign,"Parkinson disease, late-onset|Parkinson Disease, Dominant/Recessive|not provided",single nucleotide variant,GRCh38
na,na,19,51411852,51411852,KLK4,Likely pathogenic,Amelogenesis imperfecta type 2A1|not provided,single nucleotide variant,GRCh37
na,na,19,50908596,50908596,KLK4,Likely pathogenic,Amelogenesis imperfecta type 2A1|not provided,single nucleotide variant,GRCh38
na,na,22,36661906,36661906,APOL1,Conflicting classifications of pathogenicity; risk factor,"Hyalinosis, Segmental Glomerular|not provided|Focal segmental glomerulosclerosis;Sickled erythrocytes|Nephrotic range proteinuria|Proteinuria|Focal segmental glomerulosclerosis|not specified|Focal segmental glomerulosclerosis;Steroid-resistant nephrotic syndrome|Glomerulonephritis|APOL1-associated kidney disease|Focal segmental glomerulosclerosis 4, susceptibility to",single nucleotide variant,GRCh37
na,na,22,36265860,36265860,APOL1,Conflicting classifications of pathogenicity; risk factor,"Hyalinosis, Segmental Glomerular|not provided|Focal segmental glomerulosclerosis;Sickled erythrocytes|Nephrotic range proteinuria|Proteinuria|Focal segmental glomerulosclerosis|not specified|Focal segmental glomerulosclerosis;Steroid-resistant nephrotic syndrome|Glomerulonephritis|APOL1-associated kidney disease|Focal segmental glomerulosclerosis 4, susceptibility to",single nucleotide variant,GRCh38
na,na,22,36662042,36662047,APOL1,Conflicting classifications of pathogenicity; risk factor,"Focal segmental glomerulosclerosis 4, susceptibility to|Focal segmental glomerulosclerosis|Nephrotic range proteinuria|not provided|Hyalinosis, Segmental Glomerular|not specified",Deletion,GRCh37
na,na,22,36265996,36266001,APOL1,Conflicting classifications of pathogenicity; risk factor,"Focal segmental glomerulosclerosis 4, susceptibility to|Focal segmental glomerulosclerosis|Nephrotic range proteinuria|not provided|Hyalinosis, Segmental Glomerular|not specified",Deletion,GRCh38
na,na,17,7979636,7979636,ALOX12B,Pathogenic,Autosomal recessive congenital ichthyosis 2,Deletion,GRCh37
na,na,17,8076318,8076318,ALOX12B,Pathogenic,Autosomal recessive congenital ichthyosis 2,Deletion,GRCh38
na,na,17,7980060,7980060,ALOX12B,Pathogenic,Autosomal recessive congenital ichthyosis 2,single nucleotide variant,GRCh37
na,na,17,8076742,8076742,ALOX12B,Pathogenic,Autosomal recessive congenital ichthyosis 2,single nucleotide variant,GRCh38
na,na,17,7976996,7976996,ALOX12B,Pathogenic,Autosomal recessive congenital ichthyosis 2,single nucleotide variant,GRCh37
na,na,17,8073678,8073678,ALOX12B,Pathogenic,Autosomal recessive congenital ichthyosis 2,single nucleotide variant,GRCh38
na,na,9,111662096,111662096,ELP1,Pathogenic,Familial dysautonomia|not provided|Charcot-Marie-Tooth disease|Medulloblastoma|not specified|Medulloblastoma;Familial dysautonomia|Primary dysautonomia,single nucleotide variant,GRCh37
na,na,9,108899816,108899816,ELP1,Pathogenic,Familial dysautonomia|not provided|Charcot-Marie-Tooth disease|Medulloblastoma|not specified|Medulloblastoma;Familial dysautonomia|Primary dysautonomia,single nucleotide variant,GRCh38
na,na,9,111662583,111662583,ELP1,Pathogenic/Likely pathogenic,Familial dysautonomia|Charcot-Marie-Tooth disease|Medulloblastoma;Familial dysautonomia|not provided,single nucleotide variant,GRCh37
na,na,9,108900303,108900303,ELP1,Pathogenic/Likely pathogenic,Familial dysautonomia|Charcot-Marie-Tooth disease|Medulloblastoma;Familial dysautonomia|not provided,single nucleotide variant,GRCh38
na,na,9,111656342,111656342,ELP1,Likely pathogenic,Familial dysautonomia|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,9,108894062,108894062,ELP1,Likely pathogenic,Familial dysautonomia|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,3,190039795,190039796,CLDN1,Pathogenic,Neonatal ichthyosis-sclerosing cholangitis syndrome,Deletion,GRCh37
na,na,3,190322006,190322007,CLDN1,Pathogenic,Neonatal ichthyosis-sclerosing cholangitis syndrome,Deletion,GRCh38
na,na,3,190030691,190030691,CLDN1,Pathogenic,Neonatal ichthyosis-sclerosing cholangitis syndrome,Deletion,GRCh37
na,na,3,190312902,190312902,CLDN1,Pathogenic,Neonatal ichthyosis-sclerosing cholangitis syndrome,Deletion,GRCh38
na,na,na,-1,-1,GCM2,Pathogenic,"Hypoparathyroidism, familial isolated, 2",Deletion,na
na,na,6,10877576,10877576,GCM2,Pathogenic,"Hypoparathyroidism, familial isolated, 2|not provided",single nucleotide variant,GRCh37
na,na,6,10877343,10877343,GCM2,Pathogenic,"Hypoparathyroidism, familial isolated, 2|not provided",single nucleotide variant,GRCh38
na,na,6,10877529,10877529,GCM2,Conflicting classifications of pathogenicity,"Hypoparathyroidism, familial isolated, 2|Hypoparathyroidism, familial isolated, 2;Hyperparathyroidism 4|Hyperparathyroidism 4",single nucleotide variant,GRCh37
na,na,6,10877296,10877296,GCM2,Conflicting classifications of pathogenicity,"Hypoparathyroidism, familial isolated, 2|Hypoparathyroidism, familial isolated, 2;Hyperparathyroidism 4|Hyperparathyroidism 4",single nucleotide variant,GRCh38
na,na,2,45169919,45169919,SIX3,Pathogenic,Holoprosencephaly 2,single nucleotide variant,GRCh37
na,na,2,44942780,44942780,SIX3,Pathogenic,Holoprosencephaly 2,single nucleotide variant,GRCh38
na,na,2,45170013,45170013,SIX3,Likely pathogenic,Holoprosencephaly 2,single nucleotide variant,GRCh37
na,na,2,44942874,44942874,SIX3,Likely pathogenic,Holoprosencephaly 2,single nucleotide variant,GRCh38
na,na,2,45169992,45169992,SIX3,Pathogenic,Holoprosencephaly 2,single nucleotide variant,GRCh37
na,na,2,44942853,44942853,SIX3,Pathogenic,Holoprosencephaly 2,single nucleotide variant,GRCh38
na,na,2,45169798,45169799,SIX3,Pathogenic,Holoprosencephaly 2,Duplication,GRCh37
na,na,2,44942659,44942660,SIX3,Pathogenic,Holoprosencephaly 2,Duplication,GRCh38
na,na,2,45169638,45169639,SIX3,Pathogenic,not provided,Microsatellite,GRCh37
na,na,2,44942499,44942500,SIX3,Pathogenic,not provided,Microsatellite,GRCh38
na,na,2,45169449,45169449,SIX3,Uncertain significance,Holoprosencephaly 2|Holoprosencephaly 2;Schizencephaly,single nucleotide variant,GRCh37
na,na,2,44942310,44942310,SIX3,Uncertain significance,Holoprosencephaly 2|Holoprosencephaly 2;Schizencephaly,single nucleotide variant,GRCh38
na,na,2,45169582,45169582,SIX3,Pathogenic,Holoprosencephaly 2|not specified,single nucleotide variant,GRCh37
na,na,2,44942443,44942443,SIX3,Pathogenic,Holoprosencephaly 2|not specified,single nucleotide variant,GRCh38
na,na,8,65517310,65517310,CYP7B1,Pathogenic,Congenital bile acid synthesis defect 3|Hereditary spastic paraplegia 5A|Spastic paraplegia,single nucleotide variant,GRCh37
na,na,8,64604753,64604753,CYP7B1,Pathogenic,Congenital bile acid synthesis defect 3|Hereditary spastic paraplegia 5A|Spastic paraplegia,single nucleotide variant,GRCh38
na,na,8,65517384,65517384,CYP7B1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 5A|Hereditary spastic paraplegia|Spastic paraplegia,single nucleotide variant,GRCh37
na,na,8,64604827,64604827,CYP7B1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 5A|Hereditary spastic paraplegia|Spastic paraplegia,single nucleotide variant,GRCh38
na,na,8,65537050,65537050,CYP7B1,Pathogenic,Hereditary spastic paraplegia 5A,single nucleotide variant,GRCh37
na,na,8,64624493,64624493,CYP7B1,Pathogenic,Hereditary spastic paraplegia 5A,single nucleotide variant,GRCh38
na,na,8,65509470,65509470,CYP7B1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 5A|Spastic paraplegia|not provided|Hereditary spastic paraplegia|CYP7B1-related disorder|Hereditary spastic paraplegia 5A;Congenital bile acid synthesis defect 3,single nucleotide variant,GRCh37
na,na,8,64596913,64596913,CYP7B1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 5A|Spastic paraplegia|not provided|Hereditary spastic paraplegia|CYP7B1-related disorder|Hereditary spastic paraplegia 5A;Congenital bile acid synthesis defect 3,single nucleotide variant,GRCh38
na,na,8,65528451,65528451,CYP7B1,Pathogenic,Hereditary spastic paraplegia 5A,single nucleotide variant,GRCh37
na,na,8,64615894,64615894,CYP7B1,Pathogenic,Hereditary spastic paraplegia 5A,single nucleotide variant,GRCh38
na,na,8,65528273,65528273,CYP7B1,Pathogenic,Hereditary spastic paraplegia 5A|not provided|Hereditary spastic paraplegia|Spastic paraplegia|Hereditary spastic paraplegia 5A;Congenital bile acid synthesis defect 3,single nucleotide variant,GRCh37
na,na,8,64615716,64615716,CYP7B1,Pathogenic,Hereditary spastic paraplegia 5A|not provided|Hereditary spastic paraplegia|Spastic paraplegia|Hereditary spastic paraplegia 5A;Congenital bile acid synthesis defect 3,single nucleotide variant,GRCh38
na,na,8,65509312,65509312,CYP7B1,Pathogenic,Hereditary spastic paraplegia 5A,single nucleotide variant,GRCh37
na,na,8,64596755,64596755,CYP7B1,Pathogenic,Hereditary spastic paraplegia 5A,single nucleotide variant,GRCh38
na,na,8,65509264,65509264,CYP7B1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 5A|Spastic paraplegia|not provided|Hereditary spastic paraplegia|Hereditary spastic paraplegia 5A;Congenital bile acid synthesis defect 3|CYP7B1-related disorder,single nucleotide variant,GRCh37
na,na,8,64596707,64596707,CYP7B1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 5A|Spastic paraplegia|not provided|Hereditary spastic paraplegia|Hereditary spastic paraplegia 5A;Congenital bile acid synthesis defect 3|CYP7B1-related disorder,single nucleotide variant,GRCh38
na,na,5,52394459,52394460,MOCS2,Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|not provided|Abnormality of metabolism/homeostasis,Deletion,GRCh37
na,na,5,53098629,53098630,MOCS2,Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|not provided|Abnormality of metabolism/homeostasis,Deletion,GRCh38
na,na,5,52394497,52394497,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,single nucleotide variant,GRCh37
na,na,5,53098667,53098667,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,single nucleotide variant,GRCh38
na,na,5,52397217,52397220,MOCS2,Conflicting classifications of pathogenicity,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|Combined molybdoflavoprotein enzyme deficiency|not provided,Deletion,GRCh37
na,na,5,53101387,53101390,MOCS2,Conflicting classifications of pathogenicity,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|Combined molybdoflavoprotein enzyme deficiency|not provided,Deletion,GRCh38
na,na,5,52402939,52402940,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|not provided,Duplication,GRCh37
na,na,5,53107109,53107110,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|not provided,Duplication,GRCh38
na,na,5,52403002,52403002,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,single nucleotide variant,GRCh37
na,na,5,53107172,53107172,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,single nucleotide variant,GRCh38
na,na,5,52405544,52405544,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|not provided,single nucleotide variant,GRCh37
na,na,5,53109714,53109714,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|not provided,single nucleotide variant,GRCh38
na,na,5,52404473,52404473,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,single nucleotide variant,GRCh37
na,na,5,53108643,53108643,MOCS2,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,single nucleotide variant,GRCh38
na,na,5,52394432,52394432,MOCS2,Pathogenic/Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|not provided,single nucleotide variant,GRCh37
na,na,5,53098602,53098602,MOCS2,Pathogenic/Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B|not provided,single nucleotide variant,GRCh38
na,na,5,52405545,52405567,MOCS2,Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,Deletion,GRCh37
na,na,5,53109715,53109737,MOCS2,Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,Deletion,GRCh38
na,na,6,39881096,39881096,MOCS1,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A,Deletion,GRCh37
na,na,6,39913352,39913352,MOCS1,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A,Deletion,GRCh38
na,na,6,39874535,39874536,MOCS1,Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|Combined molybdoflavoprotein enzyme deficiency,Microsatellite,GRCh37
na,na,6,39906759,39906760,MOCS1,Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|Combined molybdoflavoprotein enzyme deficiency,Microsatellite,GRCh38
na,na,6,39880033,39880033,MOCS1,Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|MOCS1-related disorder,single nucleotide variant,GRCh37
na,na,6,39912289,39912289,MOCS1,Likely pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|MOCS1-related disorder,single nucleotide variant,GRCh38
na,na,6,39893421,39893421,MOCS1,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|not provided|MOCS1-related disorder,single nucleotide variant,GRCh37
na,na,6,39925677,39925677,MOCS1,Pathogenic,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|not provided|MOCS1-related disorder,single nucleotide variant,GRCh38
na,na,6,39895101,39895101,MOCS1,Conflicting classifications of pathogenicity,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,6,39927362,39927362,MOCS1,Conflicting classifications of pathogenicity,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,56435951,56435951,RPS26,Pathogenic,Diamond-Blackfan anemia 10|Diamond-Blackfan anemia|not provided,single nucleotide variant,GRCh37
na,na,12,56042167,56042167,RPS26,Pathogenic,Diamond-Blackfan anemia 10|Diamond-Blackfan anemia|not provided,single nucleotide variant,GRCh38
na,na,12,56435951,56435951,RPS26,Pathogenic,Diamond-Blackfan anemia 10|not provided,single nucleotide variant,GRCh37
na,na,12,56042167,56042167,RPS26,Pathogenic,Diamond-Blackfan anemia 10|not provided,single nucleotide variant,GRCh38
na,na,12,56436302,56436302,RPS26,Pathogenic,Diamond-Blackfan anemia 10,single nucleotide variant,GRCh37
na,na,12,56042518,56042518,RPS26,Pathogenic,Diamond-Blackfan anemia 10,single nucleotide variant,GRCh38
na,na,12,56436235,56436236,RPS26,Pathogenic,Diamond-Blackfan anemia 10,Duplication,GRCh37
na,na,12,56042451,56042452,RPS26,Pathogenic,Diamond-Blackfan anemia 10,Duplication,GRCh38
na,na,12,56435954,56435954,RPS26,Pathogenic,Diamond-Blackfan anemia 10,single nucleotide variant,GRCh37
na,na,12,56042170,56042170,RPS26,Pathogenic,Diamond-Blackfan anemia 10,single nucleotide variant,GRCh38
na,na,8,106814279,106814279,ZFPM2,Benign/Likely benign,"Tetralogy of Fallot|46,XY sex reversal 9|not specified|46,XY sex reversal 9;Tetralogy of Fallot;Diaphragmatic hernia 3|not provided",single nucleotide variant,GRCh37
na,na,8,105802051,105802051,ZFPM2,Benign/Likely benign,"Tetralogy of Fallot|46,XY sex reversal 9|not specified|46,XY sex reversal 9;Tetralogy of Fallot;Diaphragmatic hernia 3|not provided",single nucleotide variant,GRCh38
na,na,8,106431420,106431420,ZFPM2,Benign/Likely benign,"Tetralogy of Fallot|Double outlet right ventricle|Diaphragmatic hernia 3|46,XY sex reversal 9|46,XY sex reversal 3|not provided|not specified|ZFPM2-related disorder",single nucleotide variant,GRCh37
na,na,8,105419192,105419192,ZFPM2,Benign/Likely benign,"Tetralogy of Fallot|Double outlet right ventricle|Diaphragmatic hernia 3|46,XY sex reversal 9|46,XY sex reversal 3|not provided|not specified|ZFPM2-related disorder",single nucleotide variant,GRCh38
na,na,8,106573623,106573623,ZFPM2,Pathogenic/Likely pathogenic,Diaphragmatic hernia 3|not provided,single nucleotide variant,GRCh37
na,na,8,105561395,105561395,ZFPM2,Pathogenic/Likely pathogenic,Diaphragmatic hernia 3|not provided,single nucleotide variant,GRCh38
na,na,8,106814417,106814417,ZFPM2,Conflicting classifications of pathogenicity,"Diaphragmatic hernia 3|Double outlet right ventricle|46,XY sex reversal 3|not provided|46,XY sex reversal 9|not specified|46,XY sex reversal 9;Tetralogy of Fallot;Diaphragmatic hernia 3|ZFPM2-related disorder",single nucleotide variant,GRCh37
na,na,8,105802189,105802189,ZFPM2,Conflicting classifications of pathogenicity,"Diaphragmatic hernia 3|Double outlet right ventricle|46,XY sex reversal 3|not provided|46,XY sex reversal 9|not specified|46,XY sex reversal 9;Tetralogy of Fallot;Diaphragmatic hernia 3|ZFPM2-related disorder",single nucleotide variant,GRCh38
na,na,8,106814837,106814837,ZFPM2,Pathogenic,Diaphragmatic hernia 3,single nucleotide variant,GRCh37
na,na,8,105802609,105802609,ZFPM2,Pathogenic,Diaphragmatic hernia 3,single nucleotide variant,GRCh38
na,na,3,155571448,155571448,SLC33A1,Pathogenic,Hereditary spastic paraplegia 42,single nucleotide variant,GRCh37
na,na,3,155853659,155853659,SLC33A1,Pathogenic,Hereditary spastic paraplegia 42,single nucleotide variant,GRCh38
na,na,2,26689591,26689591,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9|Rare genetic deafness|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh37
na,na,2,26466723,26466723,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9|Rare genetic deafness|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh38
na,na,2,26717943,26717943,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9|not provided,single nucleotide variant,GRCh37
na,na,2,26495075,26495075,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9|not provided,single nucleotide variant,GRCh38
na,na,2,26698995,26698995,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9,single nucleotide variant,GRCh37
na,na,2,26476127,26476127,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9,single nucleotide variant,GRCh38
na,na,2,26683071,26683071,OTOF,Pathogenic/Likely pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9|not provided",single nucleotide variant,GRCh37
na,na,2,26460203,26460203,OTOF,Pathogenic/Likely pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9|not provided",single nucleotide variant,GRCh38
na,na,2,26700078,26700078,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9|not provided|Rare genetic deafness|Nonsyndromic genetic hearing loss|OTOF-related disorder,single nucleotide variant,GRCh37
na,na,2,26477210,26477210,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9|not provided|Rare genetic deafness|Nonsyndromic genetic hearing loss|OTOF-related disorder,single nucleotide variant,GRCh38
na,na,2,26684624,26684624,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9,single nucleotide variant,GRCh37
na,na,2,26461756,26461756,OTOF,Pathogenic,Autosomal recessive nonsyndromic hearing loss 9,single nucleotide variant,GRCh38
na,na,2,26687736,26687736,OTOF,Pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9",single nucleotide variant,GRCh37
na,na,2,26464868,26464868,OTOF,Pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9",single nucleotide variant,GRCh38
na,na,2,26680942,26680942,OTOF,Pathogenic,"Auditory neuropathy, autosomal recessive, 1",single nucleotide variant,GRCh37
na,na,2,26458074,26458074,OTOF,Pathogenic,"Auditory neuropathy, autosomal recessive, 1",single nucleotide variant,GRCh38
na,na,2,26698321,26698321,OTOF,Pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9",single nucleotide variant,GRCh37
na,na,2,26475453,26475453,OTOF,Pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9",single nucleotide variant,GRCh38
na,na,2,26705309,26705309,OTOF,Likely pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9|Rare genetic deafness|not provided",single nucleotide variant,GRCh37
na,na,2,26482441,26482441,OTOF,Likely pathogenic,"Auditory neuropathy, autosomal recessive, 1|Autosomal recessive nonsyndromic hearing loss 9|Rare genetic deafness|not provided",single nucleotide variant,GRCh38
na,na,1,45295116,45295117,PTCH2,Conflicting classifications of pathogenicity,"Medulloblastoma|Gorlin syndrome|Basal cell carcinoma, susceptibility to, 1|Medulloblastoma;Basal cell carcinoma, susceptibility to, 1",Microsatellite,GRCh37
na,na,1,44829444,44829445,PTCH2,Conflicting classifications of pathogenicity,"Medulloblastoma|Gorlin syndrome|Basal cell carcinoma, susceptibility to, 1|Medulloblastoma;Basal cell carcinoma, susceptibility to, 1",Microsatellite,GRCh38
na,na,1,45288736,45288736,PTCH2,Pathogenic,"Basal cell carcinoma, somatic",single nucleotide variant,GRCh37
na,na,1,44823064,44823064,PTCH2,Pathogenic,"Basal cell carcinoma, somatic",single nucleotide variant,GRCh38
na,na,1,45293289,45293289,PTCH2,Uncertain significance,Gorlin syndrome|Basal cell nevus syndrome 1,single nucleotide variant,GRCh37
na,na,1,44827617,44827617,PTCH2,Uncertain significance,Gorlin syndrome|Basal cell nevus syndrome 1,single nucleotide variant,GRCh38
na,na,2,172644147,172644147,SLC25A12,Pathogenic,"Developmental and epileptic encephalopathy, 39",single nucleotide variant,GRCh37
na,na,2,171787637,171787637,SLC25A12,Pathogenic,"Developmental and epileptic encephalopathy, 39",single nucleotide variant,GRCh38
na,na,20,57240484,57244850,STX16,Pathogenic,Pseudohypoparathyroidism type 1B,Deletion,GRCh37
na,na,20,58665428,58669794,STX16,Pathogenic,Pseudohypoparathyroidism type 1B,Deletion,GRCh38
na,na,2,3623479,3623479,RPS7,Pathogenic,Diamond-Blackfan anemia 8,single nucleotide variant,GRCh37
na,na,2,3575889,3575889,RPS7,Pathogenic,Diamond-Blackfan anemia 8,single nucleotide variant,GRCh38
na,na,11,101375365,101375365,TRPC6,Pathogenic,Focal segmental glomerulosclerosis 2,single nucleotide variant,GRCh37
na,na,11,101504634,101504634,TRPC6,Pathogenic,Focal segmental glomerulosclerosis 2,single nucleotide variant,GRCh38
na,na,11,101375272,101375272,TRPC6,Uncertain significance,Focal segmental glomerulosclerosis 2|not provided,single nucleotide variant,GRCh37
na,na,11,101504541,101504541,TRPC6,Uncertain significance,Focal segmental glomerulosclerosis 2|not provided,single nucleotide variant,GRCh38
na,na,11,101374892,101374892,TRPC6,Pathogenic,Focal segmental glomerulosclerosis 2,single nucleotide variant,GRCh37
na,na,11,101504161,101504161,TRPC6,Pathogenic,Focal segmental glomerulosclerosis 2,single nucleotide variant,GRCh38
na,na,11,101324405,101324405,TRPC6,Pathogenic,Focal segmental glomerulosclerosis 2|not provided,single nucleotide variant,GRCh37
na,na,11,101453674,101453674,TRPC6,Pathogenic,Focal segmental glomerulosclerosis 2|not provided,single nucleotide variant,GRCh38
na,na,11,101323799,101323799,TRPC6,Pathogenic,Focal segmental glomerulosclerosis 2|Nephrotic syndrome|not provided|TRPC6-related disorder,single nucleotide variant,GRCh37
na,na,11,101453068,101453068,TRPC6,Pathogenic,Focal segmental glomerulosclerosis 2|Nephrotic syndrome|not provided|TRPC6-related disorder,single nucleotide variant,GRCh38
na,na,11,101323793,101323793,TRPC6,Likely pathogenic,Focal segmental glomerulosclerosis 2|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,11,101453062,101453062,TRPC6,Likely pathogenic,Focal segmental glomerulosclerosis 2|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,2,170349522,170349522,BBS5,Pathogenic,Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,single nucleotide variant,GRCh37
na,na,2,169493012,169493012,BBS5,Pathogenic,Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,single nucleotide variant,GRCh38
na,na,2,170349422,170349422,BBS5,Pathogenic,Bardet-Biedl syndrome 5,single nucleotide variant,GRCh37
na,na,2,169492912,169492912,BBS5,Pathogenic,Bardet-Biedl syndrome 5,single nucleotide variant,GRCh38
na,na,na,-1,-1,BBS5,Pathogenic,Bardet-Biedl syndrome 5,Indel,na
na,na,2,170343613,170343613,BBS5,Pathogenic,Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,single nucleotide variant,GRCh37
na,na,2,169487103,169487103,BBS5,Pathogenic,Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,single nucleotide variant,GRCh38
na,na,2,170344321,170344321,BBS5,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,single nucleotide variant,GRCh37
na,na,2,169487811,169487811,BBS5,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 5|Bardet-Biedl syndrome,single nucleotide variant,GRCh38
na,na,2,170350275,170350275,BBS5,Pathogenic,Bardet-Biedl syndrome 5,single nucleotide variant,GRCh37
na,na,2,169493765,169493765,BBS5,Pathogenic,Bardet-Biedl syndrome 5,single nucleotide variant,GRCh38
na,na,2,219527343,219527343,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1,single nucleotide variant,GRCh37
na,na,2,218662620,218662620,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1,single nucleotide variant,GRCh38
na,na,2,219526006,219526006,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1|GRACILE syndrome|not provided|Pili torti-deafness syndrome,single nucleotide variant,GRCh37
na,na,2,218661283,218661283,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1|GRACILE syndrome|not provided|Pili torti-deafness syndrome,single nucleotide variant,GRCh38
na,na,2,219526485,219526485,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1,single nucleotide variant,GRCh37
na,na,2,218661762,218661762,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1,single nucleotide variant,GRCh38
na,na,2,219527906,219527906,BCS1L,Conflicting classifications of pathogenicity,Mitochondrial complex III deficiency nuclear type 1|not provided|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome,single nucleotide variant,GRCh37
na,na,2,218663183,218663183,BCS1L,Conflicting classifications of pathogenicity,Mitochondrial complex III deficiency nuclear type 1|not provided|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome,single nucleotide variant,GRCh38
na,na,2,219525942,219525942,BCS1L,Pathogenic,GRACILE syndrome|not provided|Mitochondrial complex III deficiency nuclear type 1|Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;GRACILE syndrome|Pili torti-deafness syndrome|BCS1L-related disorder,single nucleotide variant,GRCh37
na,na,2,218661219,218661219,BCS1L,Pathogenic,GRACILE syndrome|not provided|Mitochondrial complex III deficiency nuclear type 1|Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;GRACILE syndrome|Pili torti-deafness syndrome|BCS1L-related disorder,single nucleotide variant,GRCh38
na,na,2,219525843,219525843,BCS1L,Pathogenic/Likely pathogenic,Mitochondrial complex III deficiency nuclear type 1|not provided|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome,single nucleotide variant,GRCh37
na,na,2,218661120,218661120,BCS1L,Pathogenic/Likely pathogenic,Mitochondrial complex III deficiency nuclear type 1|not provided|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome,single nucleotide variant,GRCh38
na,na,2,219525876,219525876,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1|not provided|BCS1L-related disorder|GRACILE syndrome|Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;Leigh syndrome;GRACILE syndrome|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;GRACILE syndrome,single nucleotide variant,GRCh37
na,na,2,218661153,218661153,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1|not provided|BCS1L-related disorder|GRACILE syndrome|Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;Leigh syndrome;GRACILE syndrome|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;Pili torti-deafness syndrome;GRACILE syndrome,single nucleotide variant,GRCh38
na,na,2,219526569,219526569,BCS1L,Pathogenic,Pili torti-deafness syndrome|GRACILE syndrome|Mitochondrial complex III deficiency nuclear type 1|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome|not provided|Leigh syndrome,single nucleotide variant,GRCh37
na,na,2,218661846,218661846,BCS1L,Pathogenic,Pili torti-deafness syndrome|GRACILE syndrome|Mitochondrial complex III deficiency nuclear type 1|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome|not provided|Leigh syndrome,single nucleotide variant,GRCh38
na,na,2,219526571,219526571,BCS1L,Pathogenic/Likely pathogenic,Mitochondrial complex III deficiency nuclear type 1|Bjornstad syndrome with mild mitochondrial complex III deficiency|GRACILE syndrome|not provided|BCS1L-related disorder|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome,single nucleotide variant,GRCh37
na,na,2,218661848,218661848,BCS1L,Pathogenic/Likely pathogenic,Mitochondrial complex III deficiency nuclear type 1|Bjornstad syndrome with mild mitochondrial complex III deficiency|GRACILE syndrome|not provided|BCS1L-related disorder|Pili torti-deafness syndrome|Mitochondrial complex III deficiency nuclear type 1;GRACILE syndrome;Pili torti-deafness syndrome,single nucleotide variant,GRCh38
na,na,2,219525813,219525813,BCS1L,Pathogenic,Bjornstad syndrome with mild mitochondrial complex III deficiency,single nucleotide variant,GRCh37
na,na,2,218661090,218661090,BCS1L,Pathogenic,Bjornstad syndrome with mild mitochondrial complex III deficiency,single nucleotide variant,GRCh38
na,na,2,219525858,219525858,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1,single nucleotide variant,GRCh37
na,na,2,218661135,218661135,BCS1L,Pathogenic,Mitochondrial complex III deficiency nuclear type 1,single nucleotide variant,GRCh38
na,na,2,219526568,219526568,BCS1L,Pathogenic/Likely pathogenic,Mitochondrial complex III deficiency nuclear type 1|not provided|GRACILE syndrome|Pili torti-deafness syndrome|GRACILE syndrome;Pili torti-deafness syndrome;Mitochondrial complex III deficiency nuclear type 1,single nucleotide variant,GRCh37
na,na,2,218661845,218661845,BCS1L,Pathogenic/Likely pathogenic,Mitochondrial complex III deficiency nuclear type 1|not provided|GRACILE syndrome|Pili torti-deafness syndrome|GRACILE syndrome;Pili torti-deafness syndrome;Mitochondrial complex III deficiency nuclear type 1,single nucleotide variant,GRCh38
na,na,10,101483814,101483814,COX15,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2|Inborn genetic diseases|not provided",single nucleotide variant,GRCh37
na,na,10,99724057,99724057,COX15,Pathogenic,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2|Inborn genetic diseases|not provided",single nucleotide variant,GRCh38
na,na,17,10599057,10599058,SCO1,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 4|not provided",Microsatellite,GRCh37
na,na,17,10695740,10695741,SCO1,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 4|not provided",Microsatellite,GRCh38
na,na,17,10596122,10596122,SCO1,Pathogenic/Likely pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 4|not provided",single nucleotide variant,GRCh37
na,na,17,10692805,10692805,SCO1,Pathogenic/Likely pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 4|not provided",single nucleotide variant,GRCh38
na,na,1,93299009,93299009,RPL5,Pathogenic,Diamond-Blackfan anemia 6|not provided|Diamond-Blackfan anemia,single nucleotide variant,GRCh37
na,na,1,92833452,92833452,RPL5,Pathogenic,Diamond-Blackfan anemia 6|not provided|Diamond-Blackfan anemia,single nucleotide variant,GRCh38
na,na,1,93301840,93301840,DIPK1A;RPL5,Conflicting classifications of pathogenicity,Diamond-Blackfan anemia 6|not specified|Diamond-Blackfan anemia|not provided,single nucleotide variant,GRCh37
na,na,1,92836283,92836283,DIPK1A;RPL5,Conflicting classifications of pathogenicity,Diamond-Blackfan anemia 6|not specified|Diamond-Blackfan anemia|not provided,single nucleotide variant,GRCh38
na,na,1,93300380,93300381,RPL5,Pathogenic,Diamond-Blackfan anemia 6,Duplication,GRCh37
na,na,1,92834823,92834824,RPL5,Pathogenic,Diamond-Blackfan anemia 6,Duplication,GRCh38
na,na,na,-1,-1,RPL5,Pathogenic,Diamond-Blackfan anemia 6,Indel,na
na,na,1,93299017,93299017,RPL5,Pathogenic,Diamond-Blackfan anemia 6,single nucleotide variant,GRCh37
na,na,1,92833460,92833460,RPL5,Pathogenic,Diamond-Blackfan anemia 6,single nucleotide variant,GRCh38
na,na,6,34392996,34392996,RPS10,Pathogenic,Diamond-Blackfan anemia 9,single nucleotide variant,GRCh37
na,na,6,34425219,34425219,RPS10,Pathogenic,Diamond-Blackfan anemia 9,single nucleotide variant,GRCh38
na,na,6,34392507,34392508,RPS10,Pathogenic,Diamond-Blackfan anemia 9,Duplication,GRCh37
na,na,6,34424730,34424731,RPS10,Pathogenic,Diamond-Blackfan anemia 9,Duplication,GRCh38
na,na,6,34389570,34389570,RPS10,Pathogenic,Diamond-Blackfan anemia 9|Diamond-Blackfan anemia,single nucleotide variant,GRCh37
na,na,6,34421793,34421793,RPS10,Pathogenic,Diamond-Blackfan anemia 9|Diamond-Blackfan anemia,single nucleotide variant,GRCh38
na,na,1,33276595,33276595,YARS1,Pathogenic,Charcot-Marie-Tooth disease dominant intermediate C|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,1,32810994,32810994,YARS1,Pathogenic,Charcot-Marie-Tooth disease dominant intermediate C|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,1,33263369,33263369,YARS1,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease dominant intermediate C|Charcot-Marie-Tooth disease|Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2",single nucleotide variant,GRCh37
na,na,1,32797768,32797768,YARS1,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease dominant intermediate C|Charcot-Marie-Tooth disease|Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2",single nucleotide variant,GRCh38
na,na,1,33272124,33272135,YARS1,Pathogenic,Charcot-Marie-Tooth disease dominant intermediate C,Deletion,GRCh37
na,na,1,32806523,32806534,YARS1,Pathogenic,Charcot-Marie-Tooth disease dominant intermediate C,Deletion,GRCh38
na,na,1,46715769,46715769,RAD54L,Pathogenic,Colon adenocarcinoma,single nucleotide variant,GRCh37
na,na,1,46250097,46250097,RAD54L,Pathogenic,Colon adenocarcinoma,single nucleotide variant,GRCh38
na,na,1,46738430,46738430,RAD54L,Pathogenic,Non-Hodgkin lymphoma,single nucleotide variant,GRCh37
na,na,1,46272758,46272758,RAD54L,Pathogenic,Non-Hodgkin lymphoma,single nucleotide variant,GRCh38
na,na,1,46733212,46733212,RAD54L,Pathogenic,Breast ductal adenocarcinoma,single nucleotide variant,GRCh37
na,na,1,46267540,46267540,RAD54L,Pathogenic,Breast ductal adenocarcinoma,single nucleotide variant,GRCh38
na,na,8,22880355,22880356,TNFRSF10B,Pathogenic,Squamous cell carcinoma of the head and neck,Microsatellite,GRCh37
na,na,8,23022842,23022843,TNFRSF10B,Pathogenic,Squamous cell carcinoma of the head and neck,Microsatellite,GRCh38
na,na,22,38508219,38508219,PLA2G6,Pathogenic/Likely pathogenic,Infantile neuroaxonal dystrophy|Iron accumulation in brain|not provided|Inborn genetic diseases|PLA2G6-associated neurodegeneration|Autism;Seizure|Abnormality of the nervous system|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B|Neurodegeneration with brain iron accumulation|Neurodegeneration with brain iron accumulation 2B|PLA2G6-related disorder,single nucleotide variant,GRCh37
na,na,22,38112212,38112212,PLA2G6,Pathogenic/Likely pathogenic,Infantile neuroaxonal dystrophy|Iron accumulation in brain|not provided|Inborn genetic diseases|PLA2G6-associated neurodegeneration|Autism;Seizure|Abnormality of the nervous system|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B|Neurodegeneration with brain iron accumulation|Neurodegeneration with brain iron accumulation 2B|PLA2G6-related disorder,single nucleotide variant,GRCh38
na,na,22,38516874,38516874,PLA2G6,Pathogenic/Likely pathogenic,Neurodegeneration with brain iron accumulation 2B|Cerebellar ataxia;Congenital cerebellar hypoplasia;Global developmental delay;Developmental regression;Microcephaly|not provided|Autosomal recessive Parkinson disease 14,single nucleotide variant,GRCh37
na,na,22,38120867,38120867,PLA2G6,Pathogenic/Likely pathogenic,Neurodegeneration with brain iron accumulation 2B|Cerebellar ataxia;Congenital cerebellar hypoplasia;Global developmental delay;Developmental regression;Microcephaly|not provided|Autosomal recessive Parkinson disease 14,single nucleotide variant,GRCh38
na,na,22,38528986,38528986,PLA2G6,Conflicting classifications of pathogenicity,Infantile neuroaxonal dystrophy|PLA2G6-associated neurodegeneration,single nucleotide variant,GRCh37
na,na,22,38132979,38132979,PLA2G6,Conflicting classifications of pathogenicity,Infantile neuroaxonal dystrophy|PLA2G6-associated neurodegeneration,single nucleotide variant,GRCh38
na,na,22,38509624,38509626,PLA2G6,Pathogenic,Infantile neuroaxonal dystrophy|Iron accumulation in brain|not provided|Neurodegeneration with brain iron accumulation 2B|Neurodegeneration with brain iron accumulation,Deletion,GRCh37
na,na,22,38113617,38113619,PLA2G6,Pathogenic,Infantile neuroaxonal dystrophy|Iron accumulation in brain|not provided|Neurodegeneration with brain iron accumulation 2B|Neurodegeneration with brain iron accumulation,Deletion,GRCh38
na,na,22,38511674,38511674,PLA2G6,Pathogenic/Likely pathogenic,Karak syndrome|Neurodegeneration with brain iron accumulation|not provided|PLA2G6-associated neurodegeneration|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B|Infantile neuroaxonal dystrophy,single nucleotide variant,GRCh37
na,na,22,38115667,38115667,PLA2G6,Pathogenic/Likely pathogenic,Karak syndrome|Neurodegeneration with brain iron accumulation|not provided|PLA2G6-associated neurodegeneration|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B|Infantile neuroaxonal dystrophy,single nucleotide variant,GRCh38
na,na,22,38508218,38508219,PLA2G6,Pathogenic/Likely pathogenic,Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2B|Iron accumulation in brain|not provided|Inborn genetic diseases|PLA2G6-associated neurodegeneration|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B,Deletion,GRCh37
na,na,22,38112211,38112212,PLA2G6,Pathogenic/Likely pathogenic,Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2B|Iron accumulation in brain|not provided|Inborn genetic diseases|PLA2G6-associated neurodegeneration|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B,Deletion,GRCh38
na,na,22,38541632,38541632,PLA2G6,Pathogenic/Likely pathogenic,Neurodegeneration with brain iron accumulation 2B|Infantile neuroaxonal dystrophy|Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B;Autosomal recessive Parkinson disease 14|PLA2G6-associated neurodegeneration|not provided,single nucleotide variant,GRCh37
na,na,22,38145625,38145625,PLA2G6,Pathogenic/Likely pathogenic,Neurodegeneration with brain iron accumulation 2B|Infantile neuroaxonal dystrophy|Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B;Autosomal recessive Parkinson disease 14|PLA2G6-associated neurodegeneration|not provided,single nucleotide variant,GRCh38
na,na,22,38508565,38508565,PLA2G6,Pathogenic/Likely pathogenic,Autosomal recessive Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2B|not provided|Neurodegeneration with brain iron accumulation|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B,single nucleotide variant,GRCh37
na,na,22,38112558,38112558,PLA2G6,Pathogenic/Likely pathogenic,Autosomal recessive Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2B|not provided|Neurodegeneration with brain iron accumulation|Autosomal recessive Parkinson disease 14;Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B,single nucleotide variant,GRCh38
na,na,22,38508548,38508548,PLA2G6,Pathogenic/Likely pathogenic,Autosomal recessive Parkinson disease 14|Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B;Autosomal recessive Parkinson disease 14|not provided|PLA2G6-associated neurodegeneration|Infantile neuroaxonal dystrophy,single nucleotide variant,GRCh37
na,na,22,38112541,38112541,PLA2G6,Pathogenic/Likely pathogenic,Autosomal recessive Parkinson disease 14|Infantile neuroaxonal dystrophy;Neurodegeneration with brain iron accumulation 2B;Autosomal recessive Parkinson disease 14|not provided|PLA2G6-associated neurodegeneration|Infantile neuroaxonal dystrophy,single nucleotide variant,GRCh38
na,na,na,-1,-1,SLC7A7,Pathogenic,Lysinuric protein intolerance,Deletion,na
na,na,14,23282607,23282607,SLC7A7,Pathogenic,Lysinuric protein intolerance,single nucleotide variant,GRCh37
na,na,14,22813398,22813398,SLC7A7,Pathogenic,Lysinuric protein intolerance,single nucleotide variant,GRCh38
na,na,14,23244747,23244747,SLC7A7,Pathogenic,Lysinuric protein intolerance,single nucleotide variant,GRCh37
na,na,14,22775538,22775538,SLC7A7,Pathogenic,Lysinuric protein intolerance,single nucleotide variant,GRCh38
na,na,14,23282447,23282447,SLC7A7,Uncertain significance,Lysinuric protein intolerance,single nucleotide variant,GRCh37
na,na,14,22813238,22813238,SLC7A7,Uncertain significance,Lysinuric protein intolerance,single nucleotide variant,GRCh38
na,na,14,23243580,23243580,SLC7A7,Pathogenic/Likely pathogenic,Lysinuric protein intolerance,single nucleotide variant,GRCh37
na,na,14,22774371,22774371,SLC7A7,Pathogenic/Likely pathogenic,Lysinuric protein intolerance,single nucleotide variant,GRCh38
na,na,14,23248046,23248046,SLC7A7,Pathogenic,Lysinuric protein intolerance|Autoinflammatory syndrome|not provided,single nucleotide variant,GRCh37
na,na,14,22778837,22778837,SLC7A7,Pathogenic,Lysinuric protein intolerance|Autoinflammatory syndrome|not provided,single nucleotide variant,GRCh38
na,na,14,23241705,23246351,SLC7A7,Pathogenic,Lysinuric protein intolerance,Deletion,GRCh37
na,na,14,22772496,22777142,SLC7A7,Pathogenic,Lysinuric protein intolerance,Deletion,GRCh38
na,na,22,33700420,33700420,LARGE1,Pathogenic/Likely pathogenic,Muscular dystrophy-dystroglycanopathy type B6|LARGE1-Related Disorders,single nucleotide variant,GRCh37
na,na,22,33304434,33304434,LARGE1,Pathogenic/Likely pathogenic,Muscular dystrophy-dystroglycanopathy type B6|LARGE1-Related Disorders,single nucleotide variant,GRCh38
na,na,22,33673119,33673120,LARGE1,Pathogenic,Muscular dystrophy-dystroglycanopathy type B6,Duplication,GRCh37
na,na,22,33277133,33277134,LARGE1,Pathogenic,Muscular dystrophy-dystroglycanopathy type B6,Duplication,GRCh38
na,na,na,-1,-1,LARGE1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6",Deletion,na
na,na,22,33700462,33700462,LARGE1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6",single nucleotide variant,GRCh37
na,na,22,33304476,33304476,LARGE1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6",single nucleotide variant,GRCh38
na,na,na,-1,-1,LARGE1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6",Variation,na
na,na,22,33780191,33780191,LARGE1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6",single nucleotide variant,GRCh37
na,na,22,33384205,33384205,LARGE1,Pathogenic,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6",single nucleotide variant,GRCh38
na,na,15,31334152,31334152,TRPM1,Pathogenic,Congenital stationary night blindness 1C,single nucleotide variant,GRCh37
na,na,15,31041949,31041949,TRPM1,Pathogenic,Congenital stationary night blindness 1C,single nucleotide variant,GRCh38
na,na,15,31320657,31320657,TRPM1,Pathogenic,Congenital stationary night blindness 1C|not provided,single nucleotide variant,GRCh37
na,na,15,31028454,31028454,TRPM1,Pathogenic,Congenital stationary night blindness 1C|not provided,single nucleotide variant,GRCh38
na,na,15,31362416,31362416,TRPM1,Pathogenic,Congenital stationary night blindness 1C,single nucleotide variant,GRCh37
na,na,15,31070213,31070213,TRPM1,Pathogenic,Congenital stationary night blindness 1C,single nucleotide variant,GRCh38
na,na,15,31360213,31360213,TRPM1,Conflicting classifications of pathogenicity,Congenital stationary night blindness 1C|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,15,31068010,31068010,TRPM1,Conflicting classifications of pathogenicity,Congenital stationary night blindness 1C|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,15,31334343,31334343,TRPM1,Uncertain significance,Congenital stationary night blindness 1C|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,15,31042140,31042140,TRPM1,Uncertain significance,Congenital stationary night blindness 1C|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,na,-1,-1,TRPM1,Pathogenic,Congenital stationary night blindness 1C,Deletion,na
na,na,6,133035325,133035325,VNN1,Benign,RECLASSIFIED - VNN1 POLYMORPHISM,single nucleotide variant,GRCh37
na,na,6,132714186,132714186,VNN1,Benign,RECLASSIFIED - VNN1 POLYMORPHISM,single nucleotide variant,GRCh38
na,na,11,95578227,95578227,MTMR2,Pathogenic,Charcot-Marie-Tooth disease type 4B1|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh37
na,na,11,95845063,95845063,MTMR2,Pathogenic,Charcot-Marie-Tooth disease type 4B1|Charcot-Marie-Tooth disease type 4,single nucleotide variant,GRCh38
na,na,11,95583005,95583005,MTMR2,Pathogenic,Charcot-Marie-Tooth disease type 4B1,single nucleotide variant,GRCh37
na,na,11,95849841,95849841,MTMR2,Pathogenic,Charcot-Marie-Tooth disease type 4B1,single nucleotide variant,GRCh38
na,na,11,95574816,95574816,MTMR2,Pathogenic,Charcot-Marie-Tooth disease type 4B1,single nucleotide variant,GRCh37
na,na,11,95841652,95841652,MTMR2,Pathogenic,Charcot-Marie-Tooth disease type 4B1,single nucleotide variant,GRCh38
na,na,6,133783902,133788747,EYA4,Pathogenic,Dilated cardiomyopathy 1J,Deletion,GRCh37
na,na,6,133462764,133467609,EYA4,Pathogenic,Dilated cardiomyopathy 1J,Deletion,GRCh38
na,na,6,133833847,133833847,EYA4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 10,single nucleotide variant,GRCh37
na,na,6,133512709,133512709,EYA4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 10,single nucleotide variant,GRCh38
na,na,1,41285565,41285565,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|Nonsyndromic genetic hearing loss|Rare genetic deafness|not provided,single nucleotide variant,GRCh37
na,na,1,40819893,40819893,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|Nonsyndromic genetic hearing loss|Rare genetic deafness|not provided,single nucleotide variant,GRCh38
na,na,1,41285137,41285137,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|Rare genetic deafness|not provided,single nucleotide variant,GRCh37
na,na,1,40819465,40819465,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|Rare genetic deafness|not provided,single nucleotide variant,GRCh38
na,na,1,41285852,41285852,KCNQ4,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|Rare genetic deafness|not provided,single nucleotide variant,GRCh37
na,na,1,40820180,40820180,KCNQ4,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|Rare genetic deafness|not provided,single nucleotide variant,GRCh38
na,na,1,41285565,41285565,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|not provided,single nucleotide variant,GRCh37
na,na,1,40819893,40819893,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|not provided,single nucleotide variant,GRCh38
na,na,1,41249976,41249988,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,Deletion,GRCh37
na,na,1,40784304,40784316,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,Deletion,GRCh38
na,na,1,41285554,41285554,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|not provided,single nucleotide variant,GRCh37
na,na,1,40819882,40819882,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A|not provided,single nucleotide variant,GRCh38
na,na,1,41285131,41285131,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,single nucleotide variant,GRCh37
na,na,1,40819459,40819459,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,single nucleotide variant,GRCh38
na,na,1,41249975,41249975,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,Deletion,GRCh37
na,na,1,40784303,40784303,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,Deletion,GRCh38
na,na,1,41285598,41285598,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,single nucleotide variant,GRCh37
na,na,1,40819926,40819926,KCNQ4,Pathogenic,Autosomal dominant nonsyndromic hearing loss 2A,single nucleotide variant,GRCh38
na,na,1,85733512,85733513,BCL10,Pathogenic,"Mucosa-associated lymphoma|Mesothelioma|MALE GERM CELL TUMOR, SOMATIC",Duplication,GRCh37
na,na,1,85267829,85267830,BCL10,Pathogenic,"Mucosa-associated lymphoma|Mesothelioma|MALE GERM CELL TUMOR, SOMATIC",Duplication,GRCh38
na,na,1,85736483,85736484,BCL10,Pathogenic,Mucosa-associated lymphoma,Duplication,GRCh37
na,na,1,85270800,85270801,BCL10,Pathogenic,Mucosa-associated lymphoma,Duplication,GRCh38
na,na,1,85736302,85736302,BCL10,Pathogenic,Mucosa-associated lymphoma,Deletion,GRCh37
na,na,1,85270619,85270619,BCL10,Pathogenic,Mucosa-associated lymphoma,Deletion,GRCh38
na,na,1,85733583,85733584,BCL10,Pathogenic,Follicular lymphoma,Duplication,GRCh37
na,na,1,85267900,85267901,BCL10,Pathogenic,Follicular lymphoma,Duplication,GRCh38
na,na,1,85736415,85736416,BCL10,Pathogenic,Follicular lymphoma,Duplication,GRCh37
na,na,1,85270732,85270733,BCL10,Pathogenic,Follicular lymphoma,Duplication,GRCh38
na,na,1,85733471,85733487,BCL10,Pathogenic,Follicular lymphoma,Deletion,GRCh37
na,na,1,85267788,85267804,BCL10,Pathogenic,Follicular lymphoma,Deletion,GRCh38
na,na,1,85733602,85733602,BCL10,Pathogenic,Follicular lymphoma,Deletion,GRCh37
na,na,1,85267919,85267919,BCL10,Pathogenic,Follicular lymphoma,Deletion,GRCh38
na,na,1,85733613,85733614,BCL10,Pathogenic,Follicular lymphoma,Duplication,GRCh37
na,na,1,85267930,85267931,BCL10,Pathogenic,Follicular lymphoma,Duplication,GRCh38
na,na,1,85733375,85733377,BCL10,Pathogenic,Follicular lymphoma,Microsatellite,GRCh37
na,na,1,85267692,85267694,BCL10,Pathogenic,Follicular lymphoma,Microsatellite,GRCh38
na,na,1,85736510,85736511,BCL10,Pathogenic,T-cell acute lymphoblastic leukemia|Carcinoma of colon,Duplication,GRCh37
na,na,1,85270827,85270828,BCL10,Pathogenic,T-cell acute lymphoblastic leukemia|Carcinoma of colon,Duplication,GRCh38
na,na,1,85733584,85733584,BCL10,Pathogenic,Sezary syndrome,Deletion,GRCh37
na,na,1,85267901,85267901,BCL10,Pathogenic,Sezary syndrome,Deletion,GRCh38
na,na,1,85736511,85736511,BCL10,Pathogenic,Mesothelioma,Deletion,GRCh37
na,na,1,85270828,85270828,BCL10,Pathogenic,Mesothelioma,Deletion,GRCh38
na,na,1,85736475,85736475,BCL10,Pathogenic,"MALE GERM CELL TUMOR, SOMATIC",single nucleotide variant,GRCh37
na,na,1,85270792,85270792,BCL10,Pathogenic,"MALE GERM CELL TUMOR, SOMATIC",single nucleotide variant,GRCh38
na,na,1,85736475,85736475,BCL10,Pathogenic,"MALE GERM CELL TUMOR, SOMATIC|Immunodeficiency 37",single nucleotide variant,GRCh37
na,na,1,85270792,85270792,BCL10,Pathogenic,"MALE GERM CELL TUMOR, SOMATIC|Immunodeficiency 37",single nucleotide variant,GRCh38
na,na,12,12317428,12317428,LRP6,Pathogenic,"Coronary artery disease, autosomal dominant 2|LRP6-related disorder",single nucleotide variant,GRCh37
na,na,12,12164494,12164494,LRP6,Pathogenic,"Coronary artery disease, autosomal dominant 2|LRP6-related disorder",single nucleotide variant,GRCh38
na,na,11,68080211,68080211,LRP5,Pathogenic,Osteoporosis with pseudoglioma,single nucleotide variant,GRCh37
na,na,11,68312743,68312743,LRP5,Pathogenic,Osteoporosis with pseudoglioma,single nucleotide variant,GRCh38
na,na,11,68154050,68154050,LRP5,Pathogenic,Osteoporosis with pseudoglioma|not provided|8 conditions|LRP5-related disorder,single nucleotide variant,GRCh37
na,na,11,68386582,68386582,LRP5,Pathogenic,Osteoporosis with pseudoglioma|not provided|8 conditions|LRP5-related disorder,single nucleotide variant,GRCh38
na,na,11,68157403,68157403,LRP5,Pathogenic,Osteoporosis with pseudoglioma,Deletion,GRCh37
na,na,11,68389935,68389935,LRP5,Pathogenic,Osteoporosis with pseudoglioma,Deletion,GRCh38
na,na,11,68177439,68177440,LRP5,Pathogenic,Osteoporosis with pseudoglioma,Duplication,GRCh37
na,na,11,68409971,68409972,LRP5,Pathogenic,Osteoporosis with pseudoglioma,Duplication,GRCh38
na,na,11,68181210,68181210,LRP5,Pathogenic,Osteoporosis with pseudoglioma,single nucleotide variant,GRCh37
na,na,11,68413742,68413742,LRP5,Pathogenic,Osteoporosis with pseudoglioma,single nucleotide variant,GRCh38
na,na,11,68201110,68201110,LRP5,Pathogenic,Osteoporosis with pseudoglioma,Deletion,GRCh37
na,na,11,68433642,68433642,LRP5,Pathogenic,Osteoporosis with pseudoglioma,Deletion,GRCh38
na,na,11,68157417,68157417,LRP5,Pathogenic/Likely pathogenic,Osteoporosis with pseudoglioma|not provided|6 conditions|LRP5-related disorder|Exudative vitreoretinopathy 1,single nucleotide variant,GRCh37
na,na,11,68389949,68389949,LRP5,Pathogenic/Likely pathogenic,Osteoporosis with pseudoglioma|not provided|6 conditions|LRP5-related disorder|Exudative vitreoretinopathy 1,single nucleotide variant,GRCh38
na,na,11,68171074,68171074,LRP5,Conflicting classifications of pathogenicity,Osteoporosis with pseudoglioma|not provided|Osteogenesis imperfecta,single nucleotide variant,GRCh37
na,na,11,68403606,68403606,LRP5,Conflicting classifications of pathogenicity,Osteoporosis with pseudoglioma|not provided|Osteogenesis imperfecta,single nucleotide variant,GRCh38
na,na,11,68174189,68174189,LRP5,Conflicting classifications of pathogenicity,Osteoporosis with pseudoglioma|not provided|not specified|Increased bone mineral density|8 conditions|Osteogenesis imperfecta|Retinal dystrophy|6 conditions,single nucleotide variant,GRCh37
na,na,11,68406721,68406721,LRP5,Conflicting classifications of pathogenicity,Osteoporosis with pseudoglioma|not provided|not specified|Increased bone mineral density|8 conditions|Osteogenesis imperfecta|Retinal dystrophy|6 conditions,single nucleotide variant,GRCh38
na,na,11,68157389,68157389,LRP5,Pathogenic,Osteoporosis with pseudoglioma,single nucleotide variant,GRCh37
na,na,11,68389921,68389921,LRP5,Pathogenic,Osteoporosis with pseudoglioma,single nucleotide variant,GRCh38
na,na,11,68177492,68177492,LRP5,Pathogenic,Osteoporosis with pseudoglioma,single nucleotide variant,GRCh37
na,na,11,68410024,68410024,LRP5,Pathogenic,Osteoporosis with pseudoglioma,single nucleotide variant,GRCh38
na,na,11,68177594,68177594,LRP5,Pathogenic,Osteoporosis with pseudoglioma,Deletion,GRCh37
na,na,11,68410126,68410126,LRP5,Pathogenic,Osteoporosis with pseudoglioma,Deletion,GRCh38
na,na,11,68125141,68125141,LRP5,Pathogenic/Likely pathogenic,High bone mass|Increased bone mineral density|not provided,single nucleotide variant,GRCh37
na,na,11,68357673,68357673,LRP5,Pathogenic/Likely pathogenic,High bone mass|Increased bone mineral density|not provided,single nucleotide variant,GRCh38
na,na,11,68125140,68125140,LRP5,Pathogenic,Autosomal dominant osteopetrosis 1,single nucleotide variant,GRCh37
na,na,11,68357672,68357672,LRP5,Pathogenic,Autosomal dominant osteopetrosis 1,single nucleotide variant,GRCh38
na,na,11,68131252,68131252,LRP5,Pathogenic/Likely pathogenic,Worth disease|Autosomal dominant osteopetrosis 1|not provided|LRP5-related disorder,single nucleotide variant,GRCh37
na,na,11,68363784,68363784,LRP5,Pathogenic/Likely pathogenic,Worth disease|Autosomal dominant osteopetrosis 1|not provided|LRP5-related disorder,single nucleotide variant,GRCh38
na,na,11,68125269,68125269,LRP5,Pathogenic,Worth disease|Autosomal dominant osteopetrosis 1|not provided,single nucleotide variant,GRCh37
na,na,11,68357801,68357801,LRP5,Pathogenic,Worth disease|Autosomal dominant osteopetrosis 1|not provided,single nucleotide variant,GRCh38
na,na,11,68125270,68125270,LRP5,Pathogenic,Worth disease,single nucleotide variant,GRCh37
na,na,11,68357802,68357802,LRP5,Pathogenic,Worth disease,single nucleotide variant,GRCh38
na,na,11,68131286,68131286,LRP5,Pathogenic,Autosomal dominant osteopetrosis 1,single nucleotide variant,GRCh37
na,na,11,68363818,68363818,LRP5,Pathogenic,Autosomal dominant osteopetrosis 1,single nucleotide variant,GRCh38
na,na,11,68207386,68207386,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal dominant|Inborn genetic diseases|not provided|Familial exudative vitreoretinopathy|Retinal dystrophy|Osteoporosis with pseudoglioma|Exudative vitreoretinopathy 4",single nucleotide variant,GRCh37
na,na,11,68439918,68439918,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal dominant|Inborn genetic diseases|not provided|Familial exudative vitreoretinopathy|Retinal dystrophy|Osteoporosis with pseudoglioma|Exudative vitreoretinopathy 4",single nucleotide variant,GRCh38
na,na,11,68205919,68205920,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal dominant|not provided",Duplication,GRCh37
na,na,11,68438451,68438452,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal dominant|not provided",Duplication,GRCh38
na,na,11,68171075,68171075,LRP5,Pathogenic/Likely pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive|Inborn genetic diseases|Retinal dystrophy|not provided",single nucleotide variant,GRCh37
na,na,11,68403607,68403607,LRP5,Pathogenic/Likely pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive|Inborn genetic diseases|Retinal dystrophy|not provided",single nucleotide variant,GRCh38
na,na,11,68177544,68177544,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,11,68410076,68410076,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,11,68204455,68204455,LRP5,Likely pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,11,68436987,68436987,LRP5,Likely pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,11,68115656,68115656,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal dominant|Osteoporosis with pseudoglioma",single nucleotide variant,GRCh37
na,na,11,68348188,68348188,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal dominant|Osteoporosis with pseudoglioma",single nucleotide variant,GRCh38
na,na,11,68154098,68154098,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, digenic|not provided|LRP5-related disorder",single nucleotide variant,GRCh37
na,na,11,68386630,68386630,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, digenic|not provided|LRP5-related disorder",single nucleotide variant,GRCh38
na,na,11,68174018,68174018,LRP5,Conflicting classifications of pathogenicity,"Exudative vitreoretinopathy 4, autosomal recessive|not provided|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,11,68406550,68406550,LRP5,Conflicting classifications of pathogenicity,"Exudative vitreoretinopathy 4, autosomal recessive|not provided|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,11,68131330,68131339,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive",Deletion,GRCh37
na,na,11,68363862,68363871,LRP5,Pathogenic,"Exudative vitreoretinopathy 4, autosomal recessive",Deletion,GRCh38
na,na,20,49565187,49565187,DPM1,Pathogenic,Congenital disorder of glycosylation type 1E|not provided|DPM1-related disorder,single nucleotide variant,GRCh37
na,na,20,50948650,50948650,DPM1,Pathogenic,Congenital disorder of glycosylation type 1E|not provided|DPM1-related disorder,single nucleotide variant,GRCh38
na,na,20,49552735,49552735,DPM1,Pathogenic,Congenital disorder of glycosylation type 1E,Deletion,GRCh37
na,na,20,50936198,50936198,DPM1,Pathogenic,Congenital disorder of glycosylation type 1E,Deletion,GRCh38
na,na,18,59992630,59992631,TNFRSF11A,Likely pathogenic,Familial expansile osteolysis,Duplication,GRCh37
na,na,18,62325397,62325398,TNFRSF11A,Likely pathogenic,Familial expansile osteolysis,Duplication,GRCh38
na,na,18,59992619,59992620,TNFRSF11A,Pathogenic,"Paget disease of bone 2, early-onset|not provided",Duplication,GRCh37
na,na,18,62325386,62325387,TNFRSF11A,Pathogenic,"Paget disease of bone 2, early-onset|not provided",Duplication,GRCh38
na,na,18,60025561,60025561,TNFRSF11A,Pathogenic,Autosomal recessive osteopetrosis 7,single nucleotide variant,GRCh37
na,na,18,62358328,62358328,TNFRSF11A,Pathogenic,Autosomal recessive osteopetrosis 7,single nucleotide variant,GRCh38
na,na,18,60027189,60027189,TNFRSF11A,Pathogenic,Autosomal recessive osteopetrosis 7,single nucleotide variant,GRCh37
na,na,18,62359956,62359956,TNFRSF11A,Pathogenic,Autosomal recessive osteopetrosis 7,single nucleotide variant,GRCh38
na,na,18,60021725,60021725,TNFRSF11A,Uncertain significance,Autosomal recessive osteopetrosis 7|not provided,single nucleotide variant,GRCh37
na,na,18,62354492,62354492,TNFRSF11A,Uncertain significance,Autosomal recessive osteopetrosis 7|not provided,single nucleotide variant,GRCh38
na,na,18,60029026,60029026,TNFRSF11A,Pathogenic,Autosomal recessive osteopetrosis 7,single nucleotide variant,GRCh37
na,na,18,62361793,62361793,TNFRSF11A,Pathogenic,Autosomal recessive osteopetrosis 7,single nucleotide variant,GRCh38
na,na,18,60015482,60015482,TNFRSF11A,Pathogenic,Autosomal recessive osteopetrosis 7,single nucleotide variant,GRCh37
na,na,18,62348249,62348249,TNFRSF11A,Pathogenic,Autosomal recessive osteopetrosis 7,single nucleotide variant,GRCh38
na,na,19,57743438,57743438,AURKC,Pathogenic/Likely pathogenic,Infertility associated with multi-tailed spermatozoa and excessive DNA|not provided,Deletion,GRCh37
na,na,19,57232070,57232070,AURKC,Pathogenic/Likely pathogenic,Infertility associated with multi-tailed spermatozoa and excessive DNA|not provided,Deletion,GRCh38
na,na,19,57746353,57746353,AURKC,Pathogenic,Infertility associated with multi-tailed spermatozoa and excessive DNA,single nucleotide variant,GRCh37
na,na,19,57234985,57234985,AURKC,Pathogenic,Infertility associated with multi-tailed spermatozoa and excessive DNA,single nucleotide variant,GRCh38
na,na,1,22446952,22446952,WNT4,Pathogenic,Mullerian aplasia and hyperandrogenism,single nucleotide variant,GRCh37
na,na,1,22120459,22120459,WNT4,Pathogenic,Mullerian aplasia and hyperandrogenism,single nucleotide variant,GRCh38
na,na,1,22448042,22448042,WNT4,Pathogenic,SERKAL syndrome,single nucleotide variant,GRCh37
na,na,1,22121549,22121549,WNT4,Pathogenic,SERKAL syndrome,single nucleotide variant,GRCh38
na,na,1,22456175,22456175,WNT4,Pathogenic,Mullerian aplasia and hyperandrogenism,single nucleotide variant,GRCh37
na,na,1,22129682,22129682,WNT4,Pathogenic,Mullerian aplasia and hyperandrogenism,single nucleotide variant,GRCh38
na,na,1,22469381,22469381,WNT4,Pathogenic,Mullerian aplasia and hyperandrogenism,single nucleotide variant,GRCh37
na,na,1,22142888,22142888,WNT4,Pathogenic,Mullerian aplasia and hyperandrogenism,single nucleotide variant,GRCh38
na,na,15,65494212,65494212,CILP,Benign; risk factor,"Lumbar disc disease, susceptibility to|CILP-related disorder",single nucleotide variant,GRCh37
na,na,15,65201874,65201874,CILP,Benign; risk factor,"Lumbar disc disease, susceptibility to|CILP-related disorder",single nucleotide variant,GRCh38
na,na,19,42373208,42373208,RPS19,Pathogenic,Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia,single nucleotide variant,GRCh37
na,na,19,41869138,41869138,RPS19,Pathogenic,Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia,single nucleotide variant,GRCh38
na,na,19,42373112,42373112,RPS19,Pathogenic,Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder,single nucleotide variant,GRCh37
na,na,19,41869042,41869042,RPS19,Pathogenic,Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder,single nucleotide variant,GRCh38
na,na,19,42365207,42365207,RPS19,Pathogenic,Diamond-Blackfan anemia 1|Diamond-Blackfan anemia,single nucleotide variant,GRCh37
na,na,19,41861138,41861138,RPS19,Pathogenic,Diamond-Blackfan anemia 1|Diamond-Blackfan anemia,single nucleotide variant,GRCh38
na,na,19,42373178,42373178,RPS19,Pathogenic,Diamond-Blackfan anemia 1,single nucleotide variant,GRCh37
na,na,19,41869108,41869108,RPS19,Pathogenic,Diamond-Blackfan anemia 1,single nucleotide variant,GRCh38
na,na,19,42373233,42373233,RPS19,Pathogenic,Diamond-Blackfan anemia 1,Deletion,GRCh37
na,na,19,41869163,41869163,RPS19,Pathogenic,Diamond-Blackfan anemia 1,Deletion,GRCh38
na,na,19,42365243,42365244,RPS19,no classification for the single variant,-,Inversion,GRCh37
na,na,19,41861174,41861175,RPS19,no classification for the single variant,-,Inversion,GRCh38
na,na,19,42364887,42364887,RPS19,Pathogenic,not provided,single nucleotide variant,GRCh37
na,na,19,41860817,41860817,RPS19,Pathogenic,not provided,single nucleotide variant,GRCh38
na,na,19,42373792,42373792,RPS19,Likely pathogenic,Diamond-Blackfan anemia 1|Diamond-Blackfan anemia,single nucleotide variant,GRCh37
na,na,19,41869722,41869722,RPS19,Likely pathogenic,Diamond-Blackfan anemia 1|Diamond-Blackfan anemia,single nucleotide variant,GRCh38
na,na,na,-1,-1,ASS1,Pathogenic,Citrullinemia type I,Deletion,na
na,na,na,-1,-1,ASS1,Pathogenic,Citrullinemia type I,Deletion,na
na,na,9,133327655,133327655,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh37
na,na,9,130452268,130452268,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh38
na,na,9,133342161,133342161,ASS1,Conflicting classifications of pathogenicity,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh37
na,na,9,130466774,130466774,ASS1,Conflicting classifications of pathogenicity,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh38
na,na,9,133346264,133346264,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh37
na,na,9,130470877,130470877,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh38
na,na,9,133364851,133364851,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|Citrullinemia|not provided|ASS1-related disorder,single nucleotide variant,GRCh37
na,na,9,130489464,130489464,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|Citrullinemia|not provided|ASS1-related disorder,single nucleotide variant,GRCh38
na,na,9,133370370,133370370,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh37
na,na,9,130494983,130494983,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh38
na,na,9,133374932,133374932,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,130499545,130499545,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|not provided|Citrullinemia|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,133364791,133364791,ASS1,Pathogenic,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh37
na,na,9,130489404,130489404,ASS1,Pathogenic,Citrullinemia type I|not provided|Citrullinemia,single nucleotide variant,GRCh38
na,na,9,133327668,133327668,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|Citrullinemia|ASS1-related disorder,single nucleotide variant,GRCh37
na,na,9,130452281,130452281,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|Citrullinemia|ASS1-related disorder,single nucleotide variant,GRCh38
na,na,9,133333869,133333869,ASS1,Pathogenic,Citrullinemia type I|Citrullinemia|not provided,single nucleotide variant,GRCh37
na,na,9,130458482,130458482,ASS1,Pathogenic,Citrullinemia type I|Citrullinemia|not provided,single nucleotide variant,GRCh38
na,na,9,133355833,133355833,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|Citrullinemia,single nucleotide variant,GRCh37
na,na,9,130480446,130480446,ASS1,Pathogenic/Likely pathogenic,Citrullinemia type I|Citrullinemia,single nucleotide variant,GRCh38
na,na,9,133333936,133333936,ASS1,Conflicting classifications of pathogenicity,Citrullinemia type I|not specified|Citrullinemia|not provided,single nucleotide variant,GRCh37
na,na,9,130458549,130458549,ASS1,Conflicting classifications of pathogenicity,Citrullinemia type I|not specified|Citrullinemia|not provided,single nucleotide variant,GRCh38
na,na,9,133346260,133346260,ASS1,Pathogenic,"Citrullinemia, mild|Citrullinemia type I|not provided|Citrullinemia|ASS1-related disorder",single nucleotide variant,GRCh37
na,na,9,130470873,130470873,ASS1,Pathogenic,"Citrullinemia, mild|Citrullinemia type I|not provided|Citrullinemia|ASS1-related disorder",single nucleotide variant,GRCh38
na,na,9,133370368,133370368,ASS1,Pathogenic,"Citrullinemia, mild|Citrullinemia type I|not provided|Citrullinemia",single nucleotide variant,GRCh37
na,na,9,130494981,130494981,ASS1,Pathogenic,"Citrullinemia, mild|Citrullinemia type I|not provided|Citrullinemia",single nucleotide variant,GRCh38
na,na,9,133364809,133364809,ASS1,Likely pathogenic,Citrullinemia type I|Citrullinemia,single nucleotide variant,GRCh37
na,na,9,130489422,130489422,ASS1,Likely pathogenic,Citrullinemia type I|Citrullinemia,single nucleotide variant,GRCh38
na,na,11,22647105,22647127,FANCF,Pathogenic,Fanconi anemia complementation group F|Fanconi anemia,Deletion,GRCh37
na,na,11,22625559,22625581,FANCF,Pathogenic,Fanconi anemia complementation group F|Fanconi anemia,Deletion,GRCh38
na,na,11,22646960,22647006,FANCF,Pathogenic,Fanconi anemia complementation group F|Fanconi anemia,Deletion,GRCh37
na,na,11,22625414,22625460,FANCF,Pathogenic,Fanconi anemia complementation group F|Fanconi anemia,Deletion,GRCh38
na,na,11,22647341,22647341,FANCF,Pathogenic,Fanconi anemia complementation group F,single nucleotide variant,GRCh37
na,na,11,22625795,22625795,FANCF,Pathogenic,Fanconi anemia complementation group F,single nucleotide variant,GRCh38
na,na,11,22646872,22646873,FANCF,Pathogenic,Fanconi anemia complementation group F|Fanconi anemia|not specified|not provided|FANCF-related disorder,Microsatellite,GRCh37
na,na,11,22625326,22625327,FANCF,Pathogenic,Fanconi anemia complementation group F|Fanconi anemia|not specified|not provided|FANCF-related disorder,Microsatellite,GRCh38
na,na,11,22647030,22647030,FANCF,Pathogenic,Fanconi anemia complementation group F,single nucleotide variant,GRCh37
na,na,11,22625484,22625484,FANCF,Pathogenic,Fanconi anemia complementation group F,single nucleotide variant,GRCh38
na,na,2,239165644,239165644,PER2,Pathogenic,Advanced sleep phase syndrome 1,single nucleotide variant,GRCh37
na,na,2,238257003,238257003,PER2,Pathogenic,Advanced sleep phase syndrome 1,single nucleotide variant,GRCh38
na,na,2,179300991,179300991,PRKRA,Pathogenic/Likely pathogenic,Dystonia 16|not provided|PRKRA-related disorder,single nucleotide variant,GRCh37
na,na,2,178436264,178436264,PRKRA,Pathogenic/Likely pathogenic,Dystonia 16|not provided|PRKRA-related disorder,single nucleotide variant,GRCh38
na,na,2,179312281,179312282,PRKRA,Pathogenic,Dystonia 16,Deletion,GRCh37
na,na,2,178447554,178447555,PRKRA,Pathogenic,Dystonia 16,Deletion,GRCh38
na,na,5,131587064,131587064,PDLIM4,risk factor,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15,single nucleotide variant,GRCh37
na,na,5,132251371,132251371,PDLIM4,risk factor,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15,single nucleotide variant,GRCh38
na,na,2,167133761,167133761,SCN9A,Pathogenic,"Primary erythromelalgia|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",single nucleotide variant,GRCh37
na,na,2,166277251,166277251,SCN9A,Pathogenic,"Primary erythromelalgia|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",single nucleotide variant,GRCh38
na,na,2,167133791,167133791,SCN9A,Pathogenic,"Primary erythromelalgia|Acute episodes of neuropathic symptoms;Abnormality of pain sensation|Generalized epilepsy with febrile seizures plus, type 7;Neuropathy, hereditary sensory and autonomic, type 2A|SCN9A-related peripheral neuropathies associated with increased pain|not provided",single nucleotide variant,GRCh37
na,na,2,166277281,166277281,SCN9A,Pathogenic,"Primary erythromelalgia|Acute episodes of neuropathic symptoms;Abnormality of pain sensation|Generalized epilepsy with febrile seizures plus, type 7;Neuropathy, hereditary sensory and autonomic, type 2A|SCN9A-related peripheral neuropathies associated with increased pain|not provided",single nucleotide variant,GRCh38
na,na,2,167159780,167159780,SCN9A,Conflicting classifications of pathogenicity,Primary erythromelalgia,single nucleotide variant,GRCh37
na,na,2,166303270,166303270,SCN9A,Conflicting classifications of pathogenicity,Primary erythromelalgia,single nucleotide variant,GRCh38
na,na,2,167083097,167083097,SCN9A,Pathogenic,Primary erythromelalgia,single nucleotide variant,GRCh37
na,na,2,166226587,166226587,SCN9A,Pathogenic,Primary erythromelalgia,single nucleotide variant,GRCh38
na,na,2,167143072,167143072,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive",single nucleotide variant,GRCh37
na,na,2,166286562,166286562,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,167136879,167136879,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive",Deletion,GRCh37
na,na,2,166280369,166280369,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive",Deletion,GRCh38
na,na,2,167133643,167133643,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive",single nucleotide variant,GRCh37
na,na,2,166277133,166277133,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,167129241,167129241,SCN9A,Conflicting classifications of pathogenicity,"Paroxysmal extreme pain disorder|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|not provided",single nucleotide variant,GRCh37
na,na,2,166272731,166272731,SCN9A,Conflicting classifications of pathogenicity,"Paroxysmal extreme pain disorder|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|not provided",single nucleotide variant,GRCh38
na,na,2,167085481,167085481,SCN9A,Pathogenic,Paroxysmal extreme pain disorder,single nucleotide variant,GRCh37
na,na,2,166228971,166228971,SCN9A,Pathogenic,Paroxysmal extreme pain disorder,single nucleotide variant,GRCh38
na,na,2,167085482,167085482,SCN9A,Pathogenic,Paroxysmal extreme pain disorder,single nucleotide variant,GRCh37
na,na,2,166228972,166228972,SCN9A,Pathogenic,Paroxysmal extreme pain disorder,single nucleotide variant,GRCh38
na,na,2,167085479,167085479,SCN9A,Pathogenic,"Paroxysmal extreme pain disorder|Generalized epilepsy with febrile seizures plus, type 7;Neuropathy, hereditary sensory and autonomic, type 2A|not provided",single nucleotide variant,GRCh37
na,na,2,166228969,166228969,SCN9A,Pathogenic,"Paroxysmal extreme pain disorder|Generalized epilepsy with febrile seizures plus, type 7;Neuropathy, hereditary sensory and autonomic, type 2A|not provided",single nucleotide variant,GRCh38
na,na,2,167060958,167060958,SCN9A,Pathogenic,"Paroxysmal extreme pain disorder|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",single nucleotide variant,GRCh37
na,na,2,166204448,166204448,SCN9A,Pathogenic,"Paroxysmal extreme pain disorder|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",single nucleotide variant,GRCh38
na,na,2,167060949,167060949,SCN9A,Pathogenic,Paroxysmal extreme pain disorder,single nucleotide variant,GRCh37
na,na,2,166204439,166204439,SCN9A,Pathogenic,Paroxysmal extreme pain disorder,single nucleotide variant,GRCh38
na,na,2,167159672,167159672,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,2,166303162,166303162,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,2,167149864,167149864,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,2,166293354,166293354,SCN9A,Pathogenic,"Channelopathy-associated congenital insensitivity to pain, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,2,167133762,167133762,SCN9A,Pathogenic,Primary erythromelalgia,single nucleotide variant,GRCh37
na,na,2,166277252,166277252,SCN9A,Pathogenic,Primary erythromelalgia,single nucleotide variant,GRCh38
na,na,2,167160789,167160789,SCN9A,Pathogenic,Primary erythromelalgia,single nucleotide variant,GRCh37
na,na,2,166304279,166304279,SCN9A,Pathogenic,Primary erythromelalgia,single nucleotide variant,GRCh38
na,na,2,167141016,167141016,SCN9A,Conflicting classifications of pathogenicity,"Generalized epilepsy with febrile seizures plus, type 7|Primary erythromelalgia;Neuropathy, hereditary sensory and autonomic, type 2A;Paroxysmal extreme pain disorder;Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Inborn genetic diseases|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",single nucleotide variant,GRCh37
na,na,2,166284506,166284506,SCN9A,Conflicting classifications of pathogenicity,"Generalized epilepsy with febrile seizures plus, type 7|Primary erythromelalgia;Neuropathy, hereditary sensory and autonomic, type 2A;Paroxysmal extreme pain disorder;Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Inborn genetic diseases|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",single nucleotide variant,GRCh38
na,na,2,167138296,167138296,SCN9A,Benign/Likely benign,"Generalized epilepsy with febrile seizures plus, type 7|not specified|Global developmental delay;Seizure;Hypoglycemia|not provided|Primary erythromelalgia|Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Paroxysmal extreme pain disorder|Generalized epilepsy with febrile seizures plus, type 7;Neuropathy, hereditary sensory and autonomic, type 2A|Inborn genetic diseases|SCN9A-related disorder",single nucleotide variant,GRCh37
na,na,2,166281786,166281786,SCN9A,Benign/Likely benign,"Generalized epilepsy with febrile seizures plus, type 7|not specified|Global developmental delay;Seizure;Hypoglycemia|not provided|Primary erythromelalgia|Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Paroxysmal extreme pain disorder|Generalized epilepsy with febrile seizures plus, type 7;Neuropathy, hereditary sensory and autonomic, type 2A|Inborn genetic diseases|SCN9A-related disorder",single nucleotide variant,GRCh38
na,na,2,167168083,167168083,SCN9A,Uncertain significance,"Febrile seizures, familial, 3b|not provided|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|6 conditions|Inborn genetic diseases|not specified",single nucleotide variant,GRCh37
na,na,2,166311573,166311573,SCN9A,Uncertain significance,"Febrile seizures, familial, 3b|not provided|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7|6 conditions|Inborn genetic diseases|not specified",single nucleotide variant,GRCh38
na,na,2,167163041,167163041,SCN9A,Uncertain significance,"Febrile seizures, familial, 3b",single nucleotide variant,GRCh37
na,na,2,166306531,166306531,SCN9A,Uncertain significance,"Febrile seizures, familial, 3b",single nucleotide variant,GRCh38
na,na,2,167168238,167168238,SCN9A,Likely benign,"Primary erythromelalgia|Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Paroxysmal extreme pain disorder|Inherited Erythromelalgia|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",single nucleotide variant,GRCh37
na,na,2,166311728,166311728,SCN9A,Likely benign,"Primary erythromelalgia|Channelopathy-associated congenital insensitivity to pain, autosomal recessive|Paroxysmal extreme pain disorder|Inherited Erythromelalgia|Neuropathy, hereditary sensory and autonomic, type 2A;Generalized epilepsy with febrile seizures plus, type 7",single nucleotide variant,GRCh38
na,na,na,-1,-1,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,Deletion,na
na,na,5,77425043,77425043,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh37
na,na,5,78129219,78129219,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh38
na,na,5,77452076,77452076,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh37
na,na,5,78156252,78156252,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh38
na,na,5,77436046,77444215,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,Deletion,GRCh37
na,na,5,78140222,78148391,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,Deletion,GRCh38
na,na,5,77477369,77477369,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh37
na,na,5,78181545,78181545,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh38
na,na,5,77437092,77437092,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh37
na,na,5,78141268,78141268,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh38
na,na,5,77412052,77412052,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh37
na,na,5,78116228,78116228,AP3B1,Pathogenic,Hermansky-Pudlak syndrome 2,single nucleotide variant,GRCh38
na,na,6,112386045,112386045,CCN6,Uncertain significance,Progressive pseudorheumatoid dysplasia|not specified,single nucleotide variant,GRCh37
na,na,6,112064842,112064842,CCN6,Uncertain significance,Progressive pseudorheumatoid dysplasia|not specified,single nucleotide variant,GRCh38
na,na,6,112390751,112390751,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia,single nucleotide variant,GRCh37
na,na,6,112069548,112069548,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia,single nucleotide variant,GRCh38
na,na,6,112382301,112382301,CCN6,Pathogenic/Likely pathogenic,Progressive pseudorheumatoid dysplasia|See cases|not provided,single nucleotide variant,GRCh37
na,na,6,112061098,112061098,CCN6,Pathogenic/Likely pathogenic,Progressive pseudorheumatoid dysplasia|See cases|not provided,single nucleotide variant,GRCh38
na,na,6,112382377,112382377,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia,single nucleotide variant,GRCh37
na,na,6,112061174,112061174,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia,single nucleotide variant,GRCh38
na,na,6,112382391,112382391,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia|not provided,Deletion,GRCh37
na,na,6,112061188,112061188,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia|not provided,Deletion,GRCh38
na,na,6,112375609,112375610,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia,Duplication,GRCh37
na,na,6,112054406,112054407,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia,Duplication,GRCh38
na,na,6,112390619,112390620,CCN6,Pathogenic/Likely pathogenic,Progressive pseudorheumatoid dysplasia|not provided|CCN6-related disorder,Duplication,GRCh37
na,na,6,112069416,112069417,CCN6,Pathogenic/Likely pathogenic,Progressive pseudorheumatoid dysplasia|not provided|CCN6-related disorder,Duplication,GRCh38
na,na,6,112375603,112375604,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia|not provided,Deletion,GRCh37
na,na,6,112054400,112054401,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia|not provided,Deletion,GRCh38
na,na,6,112390758,112390758,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia|not provided,single nucleotide variant,GRCh37
na,na,6,112069555,112069555,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia|not provided,single nucleotide variant,GRCh38
na,na,6,112390596,112390596,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia,Deletion,GRCh37
na,na,6,112069393,112069393,CCN6,Pathogenic,Progressive pseudorheumatoid dysplasia,Deletion,GRCh38
na,na,5,76645281,76645281,PDE8B,Pathogenic,"Pigmented nodular adrenocortical disease, primary, 3",single nucleotide variant,GRCh37
na,na,5,77349456,77349456,PDE8B,Pathogenic,"Pigmented nodular adrenocortical disease, primary, 3",single nucleotide variant,GRCh38
na,na,5,76506844,76506845,PDE8B,Pathogenic,Autosomal dominant striatal neurodegeneration type 1,Indel,GRCh37
na,na,5,77211019,77211020,PDE8B,Pathogenic,Autosomal dominant striatal neurodegeneration type 1,Indel,GRCh38
na,na,6,33400486,33400486,SYNGAP1,Pathogenic,"Intellectual disability, autosomal dominant 5",single nucleotide variant,GRCh37
na,na,6,33432709,33432709,SYNGAP1,Pathogenic,"Intellectual disability, autosomal dominant 5",single nucleotide variant,GRCh38
na,na,6,33408564,33408564,SYNGAP1,Pathogenic,"Intellectual disability, autosomal dominant 5|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,6,33440787,33440787,SYNGAP1,Pathogenic,"Intellectual disability, autosomal dominant 5|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,6,33410767,33410767,SYNGAP1,Pathogenic,"Intellectual disability, autosomal dominant 5|not provided",Deletion,GRCh37
na,na,6,33442990,33442990,SYNGAP1,Pathogenic,"Intellectual disability, autosomal dominant 5|not provided",Deletion,GRCh38
na,na,3,58139139,58139139,FLNB,Pathogenic,Spondylocarpotarsal synostosis syndrome,Deletion,GRCh37
na,na,3,58153412,58153412,FLNB,Pathogenic,Spondylocarpotarsal synostosis syndrome,Deletion,GRCh38
na,na,3,58095865,58095865,FLNB,Pathogenic,Spondylocarpotarsal synostosis syndrome|not provided,single nucleotide variant,GRCh37
na,na,3,58110138,58110138,FLNB,Pathogenic,Spondylocarpotarsal synostosis syndrome|not provided,single nucleotide variant,GRCh38
na,na,3,58121853,58121853,FLNB,Likely pathogenic,Spondylocarpotarsal synostosis syndrome,single nucleotide variant,GRCh37
na,na,3,58136126,58136126,FLNB,Likely pathogenic,Spondylocarpotarsal synostosis syndrome,single nucleotide variant,GRCh38
na,na,3,58062962,58062962,FLNB,Likely pathogenic,Larsen syndrome|Connective tissue disorder,single nucleotide variant,GRCh37
na,na,3,58077235,58077235,FLNB,Likely pathogenic,Larsen syndrome|Connective tissue disorder,single nucleotide variant,GRCh38
na,na,3,58121790,58121790,FLNB,Pathogenic,Larsen syndrome,single nucleotide variant,GRCh37
na,na,3,58136063,58136063,FLNB,Pathogenic,Larsen syndrome,single nucleotide variant,GRCh38
na,na,3,58062998,58062998,FLNB,Pathogenic,Atelosteogenesis type I|not provided,single nucleotide variant,GRCh37
na,na,3,58077271,58077271,FLNB,Pathogenic,Atelosteogenesis type I|not provided,single nucleotide variant,GRCh38
na,na,3,58064506,58064506,FLNB,Pathogenic,Atelosteogenesis type I|Atelosteogenesis type III,single nucleotide variant,GRCh37
na,na,3,58078779,58078779,FLNB,Pathogenic,Atelosteogenesis type I|Atelosteogenesis type III,single nucleotide variant,GRCh38
na,na,3,58095354,58095354,FLNB,Likely pathogenic,Atelosteogenesis type III|not specified,single nucleotide variant,GRCh37
na,na,3,58109627,58109627,FLNB,Likely pathogenic,Atelosteogenesis type III|not specified,single nucleotide variant,GRCh38
na,na,3,58062992,58062992,FLNB,Pathogenic,Boomerang dysplasia,single nucleotide variant,GRCh37
na,na,3,58077265,58077265,FLNB,Pathogenic,Boomerang dysplasia,single nucleotide variant,GRCh38
na,na,3,58067419,58067419,FLNB,Pathogenic,Boomerang dysplasia,single nucleotide variant,GRCh37
na,na,3,58081692,58081692,FLNB,Pathogenic,Boomerang dysplasia,single nucleotide variant,GRCh38
na,na,3,58067395,58067395,FLNB,Pathogenic,Larsen syndrome|FLNB-related disorder|not provided,single nucleotide variant,GRCh37
na,na,3,58081668,58081668,FLNB,Pathogenic,Larsen syndrome|FLNB-related disorder|not provided,single nucleotide variant,GRCh38
na,na,3,58124218,58124218,FLNB,Pathogenic,Larsen syndrome|not provided|Larsen syndrome;Spondylocarpotarsal synostosis syndrome;Boomerang dysplasia;Atelosteogenesis type I;Atelosteogenesis type III,single nucleotide variant,GRCh37
na,na,3,58138491,58138491,FLNB,Pathogenic,Larsen syndrome|not provided|Larsen syndrome;Spondylocarpotarsal synostosis syndrome;Boomerang dysplasia;Atelosteogenesis type I;Atelosteogenesis type III,single nucleotide variant,GRCh38
na,na,3,58134498,58134498,FLNB,Pathogenic,Spondylocarpotarsal synostosis syndrome|not provided,single nucleotide variant,GRCh37
na,na,3,58148771,58148771,FLNB,Pathogenic,Spondylocarpotarsal synostosis syndrome|not provided,single nucleotide variant,GRCh38
na,na,3,58131770,58131770,FLNB,Pathogenic,Spondylocarpotarsal synostosis syndrome,single nucleotide variant,GRCh37
na,na,3,58146043,58146043,FLNB,Pathogenic,Spondylocarpotarsal synostosis syndrome,single nucleotide variant,GRCh38
na,na,5,131714072,131714072,SLC22A5,Pathogenic,Renal carnitine transport defect|not provided,single nucleotide variant,GRCh37
na,na,5,132378380,132378380,SLC22A5,Pathogenic,Renal carnitine transport defect|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,SLC22A5,Pathogenic,Renal carnitine transport defect,Deletion,na
na,na,5,131721019,131721020,SLC22A5,Pathogenic,Renal carnitine transport defect,Insertion,GRCh37
na,na,5,132385327,132385328,SLC22A5,Pathogenic,Renal carnitine transport defect,Insertion,GRCh38
na,na,na,-1,-1,SLC22A5,Pathogenic,Renal carnitine transport defect,Deletion,na
na,na,5,131722736,131722736,SLC22A5,Pathogenic,Renal carnitine transport defect|not provided|SLC22A5-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,5,132387044,132387044,SLC22A5,Pathogenic,Renal carnitine transport defect|not provided|SLC22A5-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,5,131726530,131726531,SLC22A5,Pathogenic,Renal carnitine transport defect|Decreased circulating carnitine concentration|not provided,Duplication,GRCh37
na,na,5,132390838,132390839,SLC22A5,Pathogenic,Renal carnitine transport defect|Decreased circulating carnitine concentration|not provided,Duplication,GRCh38
na,na,5,131728159,131728159,SLC22A5,Pathogenic,Renal carnitine transport defect,Deletion,GRCh37
na,na,5,132392467,132392467,SLC22A5,Pathogenic,Renal carnitine transport defect,Deletion,GRCh38
na,na,5,131728290,131728290,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect,single nucleotide variant,GRCh37
na,na,5,132392598,132392598,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect,single nucleotide variant,GRCh38
na,na,5,131719973,131719973,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided|Decreased circulating carnitine concentration,single nucleotide variant,GRCh37
na,na,5,132384281,132384281,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided|Decreased circulating carnitine concentration,single nucleotide variant,GRCh38
na,na,5,131719847,131719847,SLC22A5,Pathogenic,not provided|Renal carnitine transport defect,single nucleotide variant,GRCh37
na,na,5,132384155,132384155,SLC22A5,Pathogenic,not provided|Renal carnitine transport defect,single nucleotide variant,GRCh38
na,na,5,131719846,131719846,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect,single nucleotide variant,GRCh37
na,na,5,132384154,132384154,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect,single nucleotide variant,GRCh38
na,na,5,131724712,131724712,SLC22A5,Pathogenic,Renal carnitine transport defect,single nucleotide variant,GRCh37
na,na,5,132389020,132389020,SLC22A5,Pathogenic,Renal carnitine transport defect,single nucleotide variant,GRCh38
na,na,5,131726525,131726525,SLC22A5,Pathogenic,Renal carnitine transport defect|not provided|Decreased circulating carnitine concentration,single nucleotide variant,GRCh37
na,na,5,132390833,132390833,SLC22A5,Pathogenic,Renal carnitine transport defect|not provided|Decreased circulating carnitine concentration,single nucleotide variant,GRCh38
na,na,5,131705667,131705667,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect,single nucleotide variant,GRCh37
na,na,5,132369975,132369975,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect,single nucleotide variant,GRCh38
na,na,5,131721127,131721127,SLC22A5,Pathogenic,not specified|Renal carnitine transport defect|not provided,single nucleotide variant,GRCh37
na,na,5,132385435,132385435,SLC22A5,Pathogenic,not specified|Renal carnitine transport defect|not provided,single nucleotide variant,GRCh38
na,na,5,131726524,131726524,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided,single nucleotide variant,GRCh37
na,na,5,132390832,132390832,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided,single nucleotide variant,GRCh38
na,na,5,131728181,131728182,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided|Inborn genetic diseases,Indel,GRCh37
na,na,5,132392489,132392490,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided|Inborn genetic diseases,Indel,GRCh38
na,na,5,131705707,131705707,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided,single nucleotide variant,GRCh37
na,na,5,132370015,132370015,SLC22A5,Pathogenic/Likely pathogenic,Renal carnitine transport defect|not provided,single nucleotide variant,GRCh38
na,na,14,81422130,81422130,TSHR,Benign/Likely benign,"not specified|Familial hyperthyroidism due to mutations in TSH receptor|Hypothyroidism due to TSH receptor mutations|not provided|Graves disease, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,14,80955786,80955786,TSHR,Benign/Likely benign,"not specified|Familial hyperthyroidism due to mutations in TSH receptor|Hypothyroidism due to TSH receptor mutations|not provided|Graves disease, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,14,81610258,81610258,TSHR,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic",single nucleotide variant,GRCh37
na,na,14,81143914,81143914,TSHR,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic",single nucleotide variant,GRCh38
na,na,14,81610269,81610270,TSHR,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic",Indel,GRCh37
na,na,14,81143925,81143926,TSHR,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic",Indel,GRCh38
na,na,14,81610293,81610293,TSHR,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic|Familial hyperthyroidism due to mutations in TSH receptor",single nucleotide variant,GRCh37
na,na,14,81143949,81143949,TSHR,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic|Familial hyperthyroidism due to mutations in TSH receptor",single nucleotide variant,GRCh38
na,na,14,81558907,81558907,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh37
na,na,14,81092563,81092563,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh38
na,na,14,81558891,81558891,TSHR,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided|Hypothyroidism due to TSH receptor mutations;Familial hyperthyroidism due to mutations in TSH receptor;Familial gestational hyperthyroidism|Familial gestational hyperthyroidism,single nucleotide variant,GRCh37
na,na,14,81092547,81092547,TSHR,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided|Hypothyroidism due to TSH receptor mutations;Familial hyperthyroidism due to mutations in TSH receptor;Familial gestational hyperthyroidism|Familial gestational hyperthyroidism,single nucleotide variant,GRCh38
na,na,14,81609760,81609760,TSHR,Likely pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh37
na,na,14,81143416,81143416,TSHR,Likely pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh38
na,na,14,81610299,81610299,TSHR,Pathogenic,"THYROID CARCINOMA WITH THYROTOXICOSIS, SOMATIC",single nucleotide variant,GRCh37
na,na,14,81143955,81143955,TSHR,Pathogenic,"THYROID CARCINOMA WITH THYROTOXICOSIS, SOMATIC",single nucleotide variant,GRCh38
na,na,14,81554306,81554306,TSHR,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh37
na,na,14,81087962,81087962,TSHR,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh38
na,na,14,81610039,81610039,TSHR,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided|Inborn genetic diseases|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations|TSHR-related disorder,single nucleotide variant,GRCh37
na,na,14,81143695,81143695,TSHR,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided|Inborn genetic diseases|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations|TSHR-related disorder,single nucleotide variant,GRCh38
na,na,14,81609372,81609372,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh37
na,na,14,81143028,81143028,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh38
na,na,14,81609630,81609630,TSHR,Uncertain significance,Hypothyroidism due to TSH receptor mutations|not specified,single nucleotide variant,GRCh37
na,na,14,81143286,81143286,TSHR,Uncertain significance,Hypothyroidism due to TSH receptor mutations|not specified,single nucleotide variant,GRCh38
na,na,14,81422146,81422146,TSHR,Conflicting classifications of pathogenicity,Hypothyroidism due to TSH receptor mutations|Epilepsy;Developmental delay;autistic features|not provided|not specified|Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh37
na,na,14,80955802,80955802,TSHR,Conflicting classifications of pathogenicity,Hypothyroidism due to TSH receptor mutations|Epilepsy;Developmental delay;autistic features|not provided|not specified|Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh38
na,na,14,81609977,81609977,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh37
na,na,14,81143633,81143633,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh38
na,na,14,81609572,81609572,TSHR,Likely pathogenic,Hypothyroidism due to TSH receptor mutations|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh37
na,na,14,81143228,81143228,TSHR,Likely pathogenic,Hypothyroidism due to TSH receptor mutations|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh38
na,na,14,81610059,81610059,TSHR,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|Inborn genetic diseases|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations|TSHR-related disorder|not provided|Familial gestational hyperthyroidism,single nucleotide variant,GRCh37
na,na,14,81143715,81143715,TSHR,Pathogenic/Likely pathogenic,Hypothyroidism due to TSH receptor mutations|Inborn genetic diseases|Familial gestational hyperthyroidism;Familial hyperthyroidism due to mutations in TSH receptor;Hypothyroidism due to TSH receptor mutations|TSHR-related disorder|not provided|Familial gestational hyperthyroidism,single nucleotide variant,GRCh38
na,na,14,81606172,81606172,TSHR,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic",single nucleotide variant,GRCh37
na,na,14,81139828,81139828,TSHR,Pathogenic,"Thyroid adenoma, hyperfunctioning, somatic",single nucleotide variant,GRCh38
na,na,14,81609619,81609636,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,Indel,GRCh37
na,na,14,81143275,81143292,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,Indel,GRCh38
na,na,14,81609928,81609928,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh37
na,na,14,81143584,81143584,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh38
na,na,14,81610417,81610417,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh37
na,na,14,81144073,81144073,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh38
na,na,14,81609916,81609916,TSHR,Likely pathogenic,Familial hyperthyroidism due to mutations in TSH receptor|not provided,single nucleotide variant,GRCh37
na,na,14,81143572,81143572,TSHR,Likely pathogenic,Familial hyperthyroidism due to mutations in TSH receptor|not provided,single nucleotide variant,GRCh38
na,na,14,81610289,81610289,TSHR,Pathogenic,"Familial hyperthyroidism due to mutations in TSH receptor|Thyroid adenoma, hyperfunctioning, somatic",single nucleotide variant,GRCh37
na,na,14,81143945,81143945,TSHR,Pathogenic,"Familial hyperthyroidism due to mutations in TSH receptor|Thyroid adenoma, hyperfunctioning, somatic",single nucleotide variant,GRCh38
na,na,14,81606172,81606172,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh37
na,na,14,81139828,81139828,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh38
na,na,14,81562985,81562985,TSHR,Pathogenic,Familial gestational hyperthyroidism,single nucleotide variant,GRCh37
na,na,14,81096641,81096641,TSHR,Pathogenic,Familial gestational hyperthyroidism,single nucleotide variant,GRCh38
na,na,14,81610317,81610317,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh37
na,na,14,81143973,81143973,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh38
na,na,14,81609832,81609832,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh37
na,na,14,81143488,81143488,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh38
na,na,14,81609330,81609330,TSHR,Conflicting classifications of pathogenicity,Hypothyroidism due to TSH receptor mutations|not specified|not provided,single nucleotide variant,GRCh37
na,na,14,81142986,81142986,TSHR,Conflicting classifications of pathogenicity,Hypothyroidism due to TSH receptor mutations|not specified|not provided,single nucleotide variant,GRCh38
na,na,14,81609693,81609693,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh37
na,na,14,81143349,81143349,TSHR,Pathogenic,Familial hyperthyroidism due to mutations in TSH receptor,single nucleotide variant,GRCh38
na,na,14,81610200,81610200,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh37
na,na,14,81143856,81143856,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh38
na,na,14,81609802,81609802,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh37
na,na,14,81143458,81143458,TSHR,Pathogenic,Hypothyroidism due to TSH receptor mutations,single nucleotide variant,GRCh38
na,na,14,81558955,81558955,TSHR,Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided,single nucleotide variant,GRCh37
na,na,14,81092611,81092611,TSHR,Likely pathogenic,Hypothyroidism due to TSH receptor mutations|not provided,single nucleotide variant,GRCh38
na,na,9,131284937,131284937,GLE1,Pathogenic,Lethal congenital contracture syndrome 1|Lethal arthrogryposis-anterior horn cell disease syndrome|Lethal congenital contractural syndrome Finnish type|not provided,single nucleotide variant,GRCh37
na,na,9,128522658,128522658,GLE1,Pathogenic,Lethal congenital contracture syndrome 1|Lethal arthrogryposis-anterior horn cell disease syndrome|Lethal congenital contractural syndrome Finnish type|not provided,single nucleotide variant,GRCh38
na,na,9,131298693,131298693,GLE1,Pathogenic/Likely pathogenic,Lethal congenital contracture syndrome 1|Lethal arthrogryposis-anterior horn cell disease syndrome|Inborn genetic diseases|not provided|Lethal congenital contractural syndrome Finnish type|Lethal arthrogryposis-anterior horn cell disease syndrome;Lethal congenital contracture syndrome 1,single nucleotide variant,GRCh37
na,na,9,128536414,128536414,GLE1,Pathogenic/Likely pathogenic,Lethal congenital contracture syndrome 1|Lethal arthrogryposis-anterior horn cell disease syndrome|Inborn genetic diseases|not provided|Lethal congenital contractural syndrome Finnish type|Lethal arthrogryposis-anterior horn cell disease syndrome;Lethal congenital contracture syndrome 1,single nucleotide variant,GRCh38
na,na,9,131300337,131300337,GLE1,Pathogenic,Lethal arthrogryposis-anterior horn cell disease syndrome,single nucleotide variant,GRCh37
na,na,9,128538058,128538058,GLE1,Pathogenic,Lethal arthrogryposis-anterior horn cell disease syndrome,single nucleotide variant,GRCh38
na,na,9,131303403,131303403,GLE1,Pathogenic,Lethal arthrogryposis-anterior horn cell disease syndrome|not provided,single nucleotide variant,GRCh37
na,na,9,128541124,128541124,GLE1,Pathogenic,Lethal arthrogryposis-anterior horn cell disease syndrome|not provided,single nucleotide variant,GRCh38
na,na,11,45936170,45936170,PEX16,Pathogenic,Peroxisome biogenesis disorder 8A (Zellweger)|not provided|Peroxisome biogenesis disorder,single nucleotide variant,GRCh37
na,na,11,45914619,45914619,PEX16,Pathogenic,Peroxisome biogenesis disorder 8A (Zellweger)|not provided|Peroxisome biogenesis disorder,single nucleotide variant,GRCh38
na,na,11,45932447,45932447,PEX16,Pathogenic,Peroxisome biogenesis disorder 8A (Zellweger),single nucleotide variant,GRCh37
na,na,11,45910896,45910896,PEX16,Pathogenic,Peroxisome biogenesis disorder 8A (Zellweger),single nucleotide variant,GRCh38
na,na,2,46607420,46607420,EPAS1,Pathogenic,"Erythrocytosis, familial, 4",single nucleotide variant,GRCh37
na,na,2,46380281,46380281,EPAS1,Pathogenic,"Erythrocytosis, familial, 4",single nucleotide variant,GRCh38
na,na,2,46607420,46607420,EPAS1,Pathogenic,"Erythrocytosis, familial, 4|not provided",single nucleotide variant,GRCh37
na,na,2,46380281,46380281,EPAS1,Pathogenic,"Erythrocytosis, familial, 4|not provided",single nucleotide variant,GRCh38
na,na,2,46607414,46607414,EPAS1,Pathogenic,"Erythrocytosis, familial, 4",single nucleotide variant,GRCh37
na,na,2,46380275,46380275,EPAS1,Pathogenic,"Erythrocytosis, familial, 4",single nucleotide variant,GRCh38
na,na,4,72313423,72313423,SLC4A4,Pathogenic,Autosomal recessive proximal renal tubular acidosis,single nucleotide variant,GRCh37
na,na,4,71447706,71447706,SLC4A4,Pathogenic,Autosomal recessive proximal renal tubular acidosis,single nucleotide variant,GRCh38
na,na,4,72338445,72338445,SLC4A4,Pathogenic,Autosomal recessive proximal renal tubular acidosis,single nucleotide variant,GRCh37
na,na,4,71472728,71472728,SLC4A4,Pathogenic,Autosomal recessive proximal renal tubular acidosis,single nucleotide variant,GRCh38
na,na,4,72205050,72205050,SLC4A4,Pathogenic,Autosomal recessive proximal renal tubular acidosis,single nucleotide variant,GRCh37
na,na,4,71339333,71339333,SLC4A4,Pathogenic,Autosomal recessive proximal renal tubular acidosis,single nucleotide variant,GRCh38
na,na,7,21788220,21788220,DNAH11,Pathogenic,"Primary ciliary dyskinesia 7|CILIARY DYSKINESIA, PRIMARY, 7, WITH SITUS INVERSUS",single nucleotide variant,GRCh37
na,na,7,21748602,21748602,DNAH11,Pathogenic,"Primary ciliary dyskinesia 7|CILIARY DYSKINESIA, PRIMARY, 7, WITH SITUS INVERSUS",single nucleotide variant,GRCh38
na,na,7,21920487,21920487,DNAH11,Pathogenic,Primary ciliary dyskinesia 7|Primary ciliary dyskinesia,single nucleotide variant,GRCh37
na,na,7,21880869,21880869,DNAH11,Pathogenic,Primary ciliary dyskinesia 7|Primary ciliary dyskinesia,single nucleotide variant,GRCh38
na,na,7,21940843,21940899,DNAH11,Likely pathogenic,Primary ciliary dyskinesia 7,Deletion,GRCh37
na,na,7,21901225,21901281,DNAH11,Likely pathogenic,Primary ciliary dyskinesia 7,Deletion,GRCh38
na,na,5,13754312,13754312,DNAH5,Likely pathogenic,Primary ciliary dyskinesia 3|Primary ciliary dyskinesia,single nucleotide variant,GRCh37
na,na,5,13754203,13754203,DNAH5,Likely pathogenic,Primary ciliary dyskinesia 3|Primary ciliary dyskinesia,single nucleotide variant,GRCh38
na,na,5,13901585,13901585,DNAH5,Pathogenic,Primary ciliary dyskinesia 3|Primary ciliary dyskinesia,single nucleotide variant,GRCh37
na,na,5,13901476,13901476,DNAH5,Pathogenic,Primary ciliary dyskinesia 3|Primary ciliary dyskinesia,single nucleotide variant,GRCh38
na,na,5,13845086,13845087,DNAH5,Pathogenic,Primary ciliary dyskinesia 3|Primary ciliary dyskinesia,Duplication,GRCh37
na,na,5,13844977,13844978,DNAH5,Pathogenic,Primary ciliary dyskinesia 3|Primary ciliary dyskinesia,Duplication,GRCh38
na,na,1,35250397,35250397,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1,single nucleotide variant,GRCh37
na,na,1,34784796,34784796,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1,single nucleotide variant,GRCh38
na,na,1,35250398,35250398,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1|not provided,single nucleotide variant,GRCh37
na,na,1,34784797,34784797,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1|not provided,single nucleotide variant,GRCh38
na,na,1,35250619,35250619,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1,single nucleotide variant,GRCh37
na,na,1,34785018,34785018,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1,single nucleotide variant,GRCh38
na,na,1,35250910,35250910,GJB3,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 2B|Erythrokeratodermia variabilis et progressiva 1|not specified|GJB3-related disorder|not provided,single nucleotide variant,GRCh37
na,na,1,34785309,34785309,GJB3,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 2B|Erythrokeratodermia variabilis et progressiva 1|not specified|GJB3-related disorder|not provided,single nucleotide variant,GRCh38
na,na,1,35250901,35250901,GJB3,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 2B|not specified|not provided,single nucleotide variant,GRCh37
na,na,1,34785300,34785300,GJB3,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 2B|not specified|not provided,single nucleotide variant,GRCh38
na,na,1,35250784,35250786,GJB3,Uncertain significance,"Hearing loss, autosomal recessive",Deletion,GRCh37
na,na,1,34785183,34785185,GJB3,Uncertain significance,"Hearing loss, autosomal recessive",Deletion,GRCh38
na,na,1,35250784,35250784,GJB3,Uncertain significance,"Hearing loss, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,34785183,34785183,GJB3,Uncertain significance,"Hearing loss, autosomal recessive",single nucleotide variant,GRCh38
na,na,1,35250488,35250488,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1,single nucleotide variant,GRCh37
na,na,1,34784887,34784887,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1,single nucleotide variant,GRCh38
na,na,1,35250557,35250559,GJB3,Conflicting classifications of pathogenicity,"Deafness, autosomal dominant, with peripheral neuropathy|not provided|not specified|Hearing impairment",Deletion,GRCh37
na,na,1,34784956,34784958,GJB3,Conflicting classifications of pathogenicity,"Deafness, autosomal dominant, with peripheral neuropathy|not provided|not specified|Hearing impairment",Deletion,GRCh38
na,na,1,35250464,35250464,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1|Autosomal dominant nonsyndromic hearing loss 2B,single nucleotide variant,GRCh37
na,na,1,34784863,34784863,GJB3,Pathogenic,Erythrokeratodermia variabilis et progressiva 1|Autosomal dominant nonsyndromic hearing loss 2B,single nucleotide variant,GRCh38
na,na,1,35250860,35250860,GJB3,Pathogenic,"Deafness, digenic, GJB2/GJB3",single nucleotide variant,GRCh37
na,na,1,34785259,34785259,GJB3,Pathogenic,"Deafness, digenic, GJB2/GJB3",single nucleotide variant,GRCh38
na,na,1,35250943,35250943,GJB3,Conflicting classifications of pathogenicity,"Deafness, digenic, GJB2/GJB3|Erythrokeratodermia variabilis et progressiva 1|not provided|Autosomal recessive nonsyndromic hearing loss 1A;Autosomal dominant nonsyndromic hearing loss 2B;Erythrokeratodermia variabilis et progressiva 1",single nucleotide variant,GRCh37
na,na,1,34785342,34785342,GJB3,Conflicting classifications of pathogenicity,"Deafness, digenic, GJB2/GJB3|Erythrokeratodermia variabilis et progressiva 1|not provided|Autosomal recessive nonsyndromic hearing loss 1A;Autosomal dominant nonsyndromic hearing loss 2B;Erythrokeratodermia variabilis et progressiva 1",single nucleotide variant,GRCh38
na,na,12,34179767,34179767,ALG10,Benign,Long QT syndrome 2,single nucleotide variant,GRCh37
na,na,12,34026832,34026832,ALG10,Benign,Long QT syndrome 2,single nucleotide variant,GRCh38
na,na,20,17477734,17481069,BFSP1,Pathogenic,Cataract 33,Deletion,GRCh37
na,na,20,17497089,17500424,BFSP1,Pathogenic,Cataract 33,Deletion,GRCh38
na,na,2,10188503,10188503,KLF11,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 7|not provided,single nucleotide variant,GRCh37
na,na,2,10048376,10048376,KLF11,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 7|not provided,single nucleotide variant,GRCh38
na,na,2,10188123,10188123,KLF11,Benign/Likely benign,Maturity-onset diabetes of the young type 7|not specified|not provided|Monogenic diabetes,single nucleotide variant,GRCh37
na,na,2,10047996,10047996,KLF11,Benign/Likely benign,Maturity-onset diabetes of the young type 7|not specified|not provided|Monogenic diabetes,single nucleotide variant,GRCh38
na,na,11,103048381,103048381,DYNC2H1,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,single nucleotide variant,GRCh37
na,na,11,103177652,103177652,DYNC2H1,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,single nucleotide variant,GRCh38
na,na,11,103175330,103175330,DYNC2H1,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy|not provided|not specified,single nucleotide variant,GRCh37
na,na,11,103304601,103304601,DYNC2H1,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy|not provided|not specified,single nucleotide variant,GRCh38
na,na,11,102987302,102987303,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,Duplication,GRCh37
na,na,11,103116573,103116574,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,Duplication,GRCh38
na,na,11,103091449,103091449,DYNC2H1,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 3|not provided|Jeune thoracic dystrophy|Fetal growth restriction;Narrow chest;Bowing of the long bones|Short rib-polydactyly syndrome|DYNC2H1-related disorder,single nucleotide variant,GRCh37
na,na,11,103220720,103220720,DYNC2H1,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 3|not provided|Jeune thoracic dystrophy|Fetal growth restriction;Narrow chest;Bowing of the long bones|Short rib-polydactyly syndrome|DYNC2H1-related disorder,single nucleotide variant,GRCh38
na,na,11,103026205,103026205,DYNC2H1,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,single nucleotide variant,GRCh37
na,na,11,103155476,103155476,DYNC2H1,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,single nucleotide variant,GRCh38
na,na,11,103116103,103116103,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,single nucleotide variant,GRCh37
na,na,11,103245374,103245374,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,single nucleotide variant,GRCh38
na,na,11,102995926,102995926,DYNC2H1,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,single nucleotide variant,GRCh37
na,na,11,103125197,103125197,DYNC2H1,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,single nucleotide variant,GRCh38
na,na,11,103055761,103055761,DYNC2H1,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|not provided|Jeune thoracic dystrophy,single nucleotide variant,GRCh37
na,na,11,103185032,103185032,DYNC2H1,Pathogenic/Likely pathogenic,Asphyxiating thoracic dystrophy 3|not provided|Jeune thoracic dystrophy,single nucleotide variant,GRCh38
na,na,11,103080662,103080662,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,single nucleotide variant,GRCh37
na,na,11,103209933,103209933,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,single nucleotide variant,GRCh38
na,na,11,102987301,102987302,DYNC2H1,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,Indel,GRCh37
na,na,11,103116572,103116573,DYNC2H1,Conflicting classifications of pathogenicity,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy,Indel,GRCh38
na,na,11,103041020,103041020,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,single nucleotide variant,GRCh37
na,na,11,103170291,103170291,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,single nucleotide variant,GRCh38
na,na,11,103033875,103033875,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,single nucleotide variant,GRCh37
na,na,11,103163146,103163146,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,single nucleotide variant,GRCh38
na,na,11,103060490,103060490,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,single nucleotide variant,GRCh37
na,na,11,103189761,103189761,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3,single nucleotide variant,GRCh38
na,na,11,103048369,103048369,DYNC2H1,Likely pathogenic,Asphyxiating thoracic dystrophy 3|not provided,single nucleotide variant,GRCh37
na,na,11,103177640,103177640,DYNC2H1,Likely pathogenic,Asphyxiating thoracic dystrophy 3|not provided,single nucleotide variant,GRCh38
na,na,11,103124076,103124076,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy|not provided,Deletion,GRCh37
na,na,11,103253347,103253347,DYNC2H1,Pathogenic,Asphyxiating thoracic dystrophy 3|Jeune thoracic dystrophy|not provided,Deletion,GRCh38
na,na,13,37446859,37446859,SMAD9,Pathogenic,"Pulmonary hypertension, primary, 2",single nucleotide variant,GRCh37
na,na,13,36872722,36872722,SMAD9,Pathogenic,"Pulmonary hypertension, primary, 2",single nucleotide variant,GRCh38
na,na,na,-1,-1,SHANK2,risk factor,"Autism, susceptibility to, 17",Deletion,na
na,na,na,-1,-1,SHANK2,risk factor,"Autism, susceptibility to, 17",Deletion,na
na,na,12,91449319,91449319,KERA,Pathogenic,Cornea plana 2|not provided,single nucleotide variant,GRCh37
na,na,12,91055542,91055542,KERA,Pathogenic,Cornea plana 2|not provided,single nucleotide variant,GRCh38
na,na,12,91449539,91449539,KERA,Pathogenic,Cornea plana 2,single nucleotide variant,GRCh37
na,na,12,91055762,91055762,KERA,Pathogenic,Cornea plana 2,single nucleotide variant,GRCh38
na,na,12,91449415,91449415,KERA,Pathogenic,Cornea plana 2,single nucleotide variant,GRCh37
na,na,12,91055638,91055638,KERA,Pathogenic,Cornea plana 2,single nucleotide variant,GRCh38
na,na,12,91445245,91445245,KERA,Pathogenic,Cornea plana 2,single nucleotide variant,GRCh37
na,na,12,91051468,91051468,KERA,Pathogenic,Cornea plana 2,single nucleotide variant,GRCh38
na,na,17,46024047,46024047,PNPO,Pathogenic/Likely pathogenic,Pyridoxal phosphate-responsive seizures|not provided,single nucleotide variant,GRCh37
na,na,17,47946681,47946681,PNPO,Pathogenic/Likely pathogenic,Pyridoxal phosphate-responsive seizures|not provided,single nucleotide variant,GRCh38
na,na,17,46022924,46022924,PNPO,Pathogenic,Pyridoxal phosphate-responsive seizures,single nucleotide variant,GRCh37
na,na,17,47945558,47945558,PNPO,Pathogenic,Pyridoxal phosphate-responsive seizures,single nucleotide variant,GRCh38
na,na,17,46024146,46024146,PNPO,Pathogenic,Pyridoxal phosphate-responsive seizures,single nucleotide variant,GRCh37
na,na,17,47946780,47946780,PNPO,Pathogenic,Pyridoxal phosphate-responsive seizures,single nucleotide variant,GRCh38
na,na,17,46023329,46023329,PNPO,Pathogenic,Pyridoxal phosphate-responsive seizures,single nucleotide variant,GRCh37
na,na,17,47945963,47945963,PNPO,Pathogenic,Pyridoxal phosphate-responsive seizures,single nucleotide variant,GRCh38
na,na,3,189582168,189582168,TP63,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|not provided|TP63-Related Spectrum Disorders|Rapp-Hodgkin syndrome|8 conditions",single nucleotide variant,GRCh37
na,na,3,189864379,189864379,TP63,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|not provided|TP63-Related Spectrum Disorders|Rapp-Hodgkin syndrome|8 conditions",single nucleotide variant,GRCh38
na,na,3,189582169,189582169,TP63,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|not provided|TP63-Related Spectrum Disorders|Split hand-foot malformation 4",single nucleotide variant,GRCh37
na,na,3,189864380,189864380,TP63,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|not provided|TP63-Related Spectrum Disorders|Split hand-foot malformation 4",single nucleotide variant,GRCh38
na,na,3,189586409,189586409,TP63,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",single nucleotide variant,GRCh37
na,na,3,189868620,189868620,TP63,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",single nucleotide variant,GRCh38
na,na,3,189608615,189608616,TP63,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",Duplication,GRCh37
na,na,3,189890826,189890827,TP63,Pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",Duplication,GRCh38
na,na,3,189582138,189582138,TP63,Pathogenic,Split hand-foot malformation 4,single nucleotide variant,GRCh37
na,na,3,189864349,189864349,TP63,Pathogenic,Split hand-foot malformation 4,single nucleotide variant,GRCh38
na,na,3,189585694,189585694,TP63,Pathogenic,"Split hand-foot malformation 4|not provided|TP63-Related Spectrum Disorders|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",single nucleotide variant,GRCh37
na,na,3,189867905,189867905,TP63,Pathogenic,"Split hand-foot malformation 4|not provided|TP63-Related Spectrum Disorders|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",single nucleotide variant,GRCh38
na,na,3,189585692,189585692,TP63,Pathogenic/Likely pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|Rapp-Hodgkin syndrome|not provided|TP63-Related Spectrum Disorders",single nucleotide variant,GRCh37
na,na,3,189867903,189867903,TP63,Pathogenic/Likely pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|Rapp-Hodgkin syndrome|not provided|TP63-Related Spectrum Disorders",single nucleotide variant,GRCh38
na,na,3,189586404,189586404,TP63,Pathogenic/Likely pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|not provided|TP63-Related Spectrum Disorders|Inborn genetic diseases|8 conditions",single nucleotide variant,GRCh37
na,na,3,189868615,189868615,TP63,Pathogenic/Likely pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|not provided|TP63-Related Spectrum Disorders|Inborn genetic diseases|8 conditions",single nucleotide variant,GRCh38
na,na,3,189608584,189608584,TP63,Pathogenic,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome,single nucleotide variant,GRCh37
na,na,3,189890795,189890795,TP63,Pathogenic,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome,single nucleotide variant,GRCh38
na,na,3,189608606,189608606,TP63,Likely pathogenic,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome|TP63-Related Spectrum Disorders,single nucleotide variant,GRCh37
na,na,3,189890817,189890817,TP63,Likely pathogenic,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome|TP63-Related Spectrum Disorders,single nucleotide variant,GRCh38
na,na,3,189507605,189507605,TP63,Pathogenic,ADULT syndrome,single nucleotide variant,GRCh37
na,na,3,189789816,189789816,TP63,Pathogenic,ADULT syndrome,single nucleotide variant,GRCh38
na,na,3,189608617,189608618,TP63,Pathogenic,Limb-mammary syndrome,Deletion,GRCh37
na,na,3,189890828,189890829,TP63,Pathogenic,Limb-mammary syndrome,Deletion,GRCh38
na,na,3,189586386,189586386,TP63,Pathogenic/Likely pathogenic,ADULT syndrome|TP63-Related Spectrum Disorders|not provided,single nucleotide variant,GRCh37
na,na,3,189868597,189868597,TP63,Pathogenic/Likely pathogenic,ADULT syndrome|TP63-Related Spectrum Disorders|not provided,single nucleotide variant,GRCh38
na,na,3,189586428,189586428,TP63,Pathogenic,"not provided|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",single nucleotide variant,GRCh37
na,na,3,189868639,189868639,TP63,Pathogenic,"not provided|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",single nucleotide variant,GRCh38
na,na,3,189612074,189612074,TP63,Pathogenic,Rapp-Hodgkin syndrome,Deletion,GRCh37
na,na,3,189894285,189894285,TP63,Pathogenic,Rapp-Hodgkin syndrome,Deletion,GRCh38
na,na,3,189612223,189612223,TP63,Pathogenic,Rapp-Hodgkin syndrome,Deletion,GRCh37
na,na,3,189894434,189894434,TP63,Pathogenic,Rapp-Hodgkin syndrome,Deletion,GRCh38
na,na,3,189607267,189607267,TP63,Pathogenic,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome|Rapp-Hodgkin syndrome,single nucleotide variant,GRCh37
na,na,3,189889478,189889478,TP63,Pathogenic,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome|Rapp-Hodgkin syndrome,single nucleotide variant,GRCh38
na,na,3,189608663,189608663,TP63,Pathogenic,Rapp-Hodgkin syndrome,single nucleotide variant,GRCh37
na,na,3,189890874,189890874,TP63,Pathogenic,Rapp-Hodgkin syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,TP63,Pathogenic,ADULT syndrome,single nucleotide variant,na
na,na,3,189586430,189586430,TP63,Uncertain significance,"Orofacial cleft 8|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",single nucleotide variant,GRCh37
na,na,3,189868641,189868641,TP63,Uncertain significance,"Orofacial cleft 8|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3",single nucleotide variant,GRCh38
na,na,3,189586385,189586385,TP63,Pathogenic,ADULT syndrome|not provided,single nucleotide variant,GRCh37
na,na,3,189868596,189868596,TP63,Pathogenic,ADULT syndrome|not provided,single nucleotide variant,GRCh38
na,na,3,189456528,189456528,TP63,Uncertain significance,Split hand-foot malformation 4|TP63-Related Spectrum Disorders|8 conditions,single nucleotide variant,GRCh37
na,na,3,189738739,189738739,TP63,Uncertain significance,Split hand-foot malformation 4|TP63-Related Spectrum Disorders|8 conditions,single nucleotide variant,GRCh38
na,na,3,189584501,189584501,TP63,Pathogenic/Likely pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|ADULT syndrome|not provided|TP63-Related Spectrum Disorders",single nucleotide variant,GRCh37
na,na,3,189866712,189866712,TP63,Pathogenic/Likely pathogenic,"Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3|ADULT syndrome|not provided|TP63-Related Spectrum Disorders",single nucleotide variant,GRCh38
na,na,3,189612146,189612146,TP63,Pathogenic,Rapp-Hodgkin syndrome,Deletion,GRCh37
na,na,3,189894357,189894357,TP63,Pathogenic,Rapp-Hodgkin syndrome,Deletion,GRCh38
na,na,na,-1,-1,TP63,Pathogenic,ADULT syndrome,single nucleotide variant,na
na,na,3,189612075,189612076,TP63,Pathogenic,Rapp-Hodgkin syndrome|Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome,Duplication,GRCh37
na,na,3,189894286,189894287,TP63,Pathogenic,Rapp-Hodgkin syndrome|Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome,Duplication,GRCh38
na,na,19,11143984,11143984,SMARCA4,Pathogenic,Rhabdoid tumor predisposition syndrome 2|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,19,11033308,11033308,SMARCA4,Pathogenic,Rhabdoid tumor predisposition syndrome 2|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,4,96051026,96051026,BMPR1B,Likely pathogenic,Type A2 brachydactyly|not provided,single nucleotide variant,GRCh37
na,na,4,95129875,95129875,BMPR1B,Likely pathogenic,Type A2 brachydactyly|not provided,single nucleotide variant,GRCh38
na,na,4,96075771,96075771,BMPR1B,Pathogenic,Type A2 brachydactyly|Acromesomelic dysplasia 3;Type A2 brachydactyly|not provided,single nucleotide variant,GRCh37
na,na,4,95154620,95154620,BMPR1B,Pathogenic,Type A2 brachydactyly|Acromesomelic dysplasia 3;Type A2 brachydactyly|not provided,single nucleotide variant,GRCh38
na,na,4,96044970,96044977,BMPR1B,Pathogenic,Acromesomelic dysplasia 3,Deletion,GRCh37
na,na,4,95123819,95123826,BMPR1B,Pathogenic,Acromesomelic dysplasia 3,Deletion,GRCh38
na,na,4,96075772,96075772,BMPR1B,Likely pathogenic,Type A2 brachydactyly|BMPR1B-related disorder,single nucleotide variant,GRCh37
na,na,4,95154621,95154621,BMPR1B,Likely pathogenic,Type A2 brachydactyly|BMPR1B-related disorder,single nucleotide variant,GRCh38
na,na,16,16256935,16256935,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|not provided|Cutis laxa;Papule|Pseudoxanthoma elasticum, forme fruste;Autosomal recessive inherited pseudoxanthoma elasticum;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder|See cases",single nucleotide variant,GRCh37
na,na,16,16163078,16163078,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|not provided|Cutis laxa;Papule|Pseudoxanthoma elasticum, forme fruste;Autosomal recessive inherited pseudoxanthoma elasticum;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder|See cases",single nucleotide variant,GRCh38
na,na,16,16267140,16267140,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|not provided|Pseudoxanthoma elasticum, forme fruste;Autosomal recessive inherited pseudoxanthoma elasticum;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder|Pseudoxanthoma elasticum",single nucleotide variant,GRCh37
na,na,16,16173283,16173283,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|not provided|Pseudoxanthoma elasticum, forme fruste;Autosomal recessive inherited pseudoxanthoma elasticum;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder|Pseudoxanthoma elasticum",single nucleotide variant,GRCh38
na,na,16,16256943,16256943,ABCC6,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2",single nucleotide variant,GRCh37
na,na,16,16163086,16163086,ABCC6,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2",single nucleotide variant,GRCh38
na,na,16,16257015,16257015,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum|not provided|ABCC6-related disorder,single nucleotide variant,GRCh37
na,na,16,16163158,16163158,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum|not provided|ABCC6-related disorder,single nucleotide variant,GRCh38
na,na,16,16251627,16251627,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Arterial calcification, generalized, of infancy, 2;Pseudoxanthoma elasticum, forme fruste;Autosomal recessive inherited pseudoxanthoma elasticum|Retinal dystrophy",Deletion,GRCh37
na,na,16,16157770,16157770,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Arterial calcification, generalized, of infancy, 2;Pseudoxanthoma elasticum, forme fruste;Autosomal recessive inherited pseudoxanthoma elasticum|Retinal dystrophy",Deletion,GRCh38
na,na,16,16248831,16248831,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2",single nucleotide variant,GRCh37
na,na,16,16154974,16154974,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2",single nucleotide variant,GRCh38
na,na,16,16244594,16244595,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,Insertion,GRCh37
na,na,16,16150737,16150738,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,Insertion,GRCh38
na,na,16,15796991,16317329,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,Deletion,GRCh37
na,na,16,15703134,16223472,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,Deletion,GRCh38
na,na,16,16256967,16256967,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Abnormality of the eye|Arterial calcification, generalized, of infancy, 2;Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste|not provided|Arterial calcification, generalized, of infancy, 2",single nucleotide variant,GRCh37
na,na,16,16163110,16163110,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Abnormality of the eye|Arterial calcification, generalized, of infancy, 2;Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste|not provided|Arterial calcification, generalized, of infancy, 2",single nucleotide variant,GRCh38
na,na,16,16251599,16251599,ABCC6,Benign,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Pseudoxanthoma elasticum, forme fruste|Arterial calcification, generalized, of infancy, 2|Pseudoxanthoma elasticum, forme fruste;Autosomal recessive inherited pseudoxanthoma elasticum;Arterial calcification, generalized, of infancy, 2|not specified",single nucleotide variant,GRCh37
na,na,16,16157742,16157742,ABCC6,Benign,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Pseudoxanthoma elasticum, forme fruste|Arterial calcification, generalized, of infancy, 2|Pseudoxanthoma elasticum, forme fruste;Autosomal recessive inherited pseudoxanthoma elasticum;Arterial calcification, generalized, of infancy, 2|not specified",single nucleotide variant,GRCh38
na,na,16,16256944,16256944,ABCC6,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|not provided|ABCC6-related disorder",single nucleotide variant,GRCh37
na,na,16,16163087,16163087,ABCC6,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|not provided|ABCC6-related disorder",single nucleotide variant,GRCh38
na,na,16,16256866,16256866,ABCC6,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|See cases|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder",single nucleotide variant,GRCh37
na,na,16,16163009,16163009,ABCC6,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|See cases|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder",single nucleotide variant,GRCh38
na,na,16,16245108,16261530,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,Deletion,GRCh37
na,na,16,16151251,16167673,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,Deletion,GRCh38
na,na,16,16251667,16251667,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|not provided",single nucleotide variant,GRCh37
na,na,16,16157810,16157810,ABCC6,Pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|Arterial calcification, generalized, of infancy, 2|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|not provided",single nucleotide variant,GRCh38
na,na,16,16248756,16248756,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum|not provided,single nucleotide variant,GRCh37
na,na,16,16154899,16154899,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum|not provided,single nucleotide variant,GRCh38
na,na,16,16244463,16244463,ABCC6,Uncertain significance,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|not specified|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2",single nucleotide variant,GRCh37
na,na,16,16150606,16150606,ABCC6,Uncertain significance,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|not specified|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2",single nucleotide variant,GRCh38
na,na,16,16248879,16248879,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,single nucleotide variant,GRCh37
na,na,16,16155022,16155022,ABCC6,Pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,single nucleotide variant,GRCh38
na,na,16,16248867,16248867,ABCC6,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder",single nucleotide variant,GRCh37
na,na,16,16155010,16155010,ABCC6,Pathogenic/Likely pathogenic,"Autosomal recessive inherited pseudoxanthoma elasticum|not provided|Autosomal recessive inherited pseudoxanthoma elasticum;Pseudoxanthoma elasticum, forme fruste;Arterial calcification, generalized, of infancy, 2|ABCC6-related disorder",single nucleotide variant,GRCh38
na,na,16,16248810,16248810,ABCC6,Likely pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,single nucleotide variant,GRCh37
na,na,16,16154953,16154953,ABCC6,Likely pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,single nucleotide variant,GRCh38
na,na,16,16253362,16253362,ABCC6,Pathogenic/Likely pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,single nucleotide variant,GRCh37
na,na,16,16159505,16159505,ABCC6,Pathogenic/Likely pathogenic,Autosomal recessive inherited pseudoxanthoma elasticum,single nucleotide variant,GRCh38
na,na,3,133169276,133169276,BFSP2,Pathogenic,Cataract 12 multiple types|not provided,single nucleotide variant,GRCh37
na,na,3,133450432,133450432,BFSP2,Pathogenic,Cataract 12 multiple types|not provided,single nucleotide variant,GRCh38
na,na,3,133167452,133167454,BFSP2,Pathogenic,not provided|Cataract 12 multiple types|BFSP2-related disorder,Microsatellite,GRCh37
na,na,3,133448608,133448610,BFSP2,Pathogenic,not provided|Cataract 12 multiple types|BFSP2-related disorder,Microsatellite,GRCh38
na,na,2,233633500,233633500,KCNJ13,Pathogenic/Likely pathogenic,Snowflake vitreoretinal degeneration|not provided,single nucleotide variant,GRCh37
na,na,2,232768790,232768790,KCNJ13,Pathogenic/Likely pathogenic,Snowflake vitreoretinal degeneration|not provided,single nucleotide variant,GRCh38
na,na,2,136564701,136564701,LCT,Pathogenic,Congenital lactase deficiency|not provided,single nucleotide variant,GRCh37
na,na,2,135807131,135807131,LCT,Pathogenic,Congenital lactase deficiency|not provided,single nucleotide variant,GRCh38
na,na,2,136587163,136587163,LCT,Pathogenic,Congenital lactase deficiency,single nucleotide variant,GRCh37
na,na,2,135829593,135829593,LCT,Pathogenic,Congenital lactase deficiency,single nucleotide variant,GRCh38
na,na,2,169826641,169826641,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2|ABCB11-related disorder|See cases|Benign recurrent intrahepatic cholestasis type 2;Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2,single nucleotide variant,GRCh37
na,na,2,168970131,168970131,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2|ABCB11-related disorder|See cases|Benign recurrent intrahepatic cholestasis type 2;Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2,single nucleotide variant,GRCh38
na,na,2,169847329,169847329,ABCB11,Pathogenic,"Progressive familial intrahepatic cholestasis type 2|Benign recurrent intrahepatic cholestasis type 2|Progressive familial intrahepatic cholestasis|not provided|Cholestasis, intrahepatic, of pregnancy, 3|ABCB11-related disorder|Progressive familial intrahepatic cholestasis type 2;Benign recurrent intrahepatic cholestasis type 2",single nucleotide variant,GRCh37
na,na,2,168990819,168990819,ABCB11,Pathogenic,"Progressive familial intrahepatic cholestasis type 2|Benign recurrent intrahepatic cholestasis type 2|Progressive familial intrahepatic cholestasis|not provided|Cholestasis, intrahepatic, of pregnancy, 3|ABCB11-related disorder|Progressive familial intrahepatic cholestasis type 2;Benign recurrent intrahepatic cholestasis type 2",single nucleotide variant,GRCh38
na,na,2,169847310,169847310,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2,Deletion,GRCh37
na,na,2,168990800,168990800,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2,Deletion,GRCh38
na,na,2,169780330,169780331,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided,Duplication,GRCh37
na,na,2,168923820,168923821,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided,Duplication,GRCh38
na,na,2,169870810,169870810,ABCB11,Pathogenic/Likely pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2;Progressive familial intrahepatic cholestasis type 2,single nucleotide variant,GRCh37
na,na,2,169014300,169014300,ABCB11,Pathogenic/Likely pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2;Progressive familial intrahepatic cholestasis type 2,single nucleotide variant,GRCh38
na,na,2,169792766,169792767,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2,Duplication,GRCh37
na,na,2,168936256,168936257,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2,Duplication,GRCh38
na,na,2,169833100,169833100,ABCB11,Likely pathogenic,Benign recurrent intrahepatic cholestasis type 2|not provided,single nucleotide variant,GRCh37
na,na,2,168976590,168976590,ABCB11,Likely pathogenic,Benign recurrent intrahepatic cholestasis type 2|not provided,single nucleotide variant,GRCh38
na,na,2,169788931,169788931,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2,single nucleotide variant,GRCh37
na,na,2,168932421,168932421,ABCB11,Pathogenic,Progressive familial intrahepatic cholestasis type 2|not provided|Benign recurrent intrahepatic cholestasis type 2,single nucleotide variant,GRCh38
na,na,19,19307856,19307856,RFXANK,Pathogenic/Likely pathogenic,MHC class II deficiency|MHC class II deficiency 2|MHC class II deficiency 3,single nucleotide variant,GRCh37
na,na,19,19197047,19197047,RFXANK,Pathogenic/Likely pathogenic,MHC class II deficiency|MHC class II deficiency 2|MHC class II deficiency 3,single nucleotide variant,GRCh38
na,na,19,19308354,19308354,RFXANK,Pathogenic/Likely pathogenic,MHC class II deficiency|not provided|MHC class II deficiency 2,single nucleotide variant,GRCh37
na,na,19,19197545,19197545,RFXANK,Pathogenic/Likely pathogenic,MHC class II deficiency|not provided|MHC class II deficiency 2,single nucleotide variant,GRCh38
na,na,17,40557181,40557182,CAVIN1,Pathogenic,Congenital generalized lipodystrophy type 4,Duplication,GRCh37
na,na,17,42405163,42405164,CAVIN1,Pathogenic,Congenital generalized lipodystrophy type 4,Duplication,GRCh38
na,na,17,40557352,40557352,CAVIN1,Pathogenic,Congenital generalized lipodystrophy type 4,Deletion,GRCh37
na,na,17,42405334,42405334,CAVIN1,Pathogenic,Congenital generalized lipodystrophy type 4,Deletion,GRCh38
na,na,17,40574956,40574956,CAVIN1,Pathogenic,Congenital generalized lipodystrophy type 4,Deletion,GRCh37
na,na,17,42422938,42422938,CAVIN1,Pathogenic,Congenital generalized lipodystrophy type 4,Deletion,GRCh38
na,na,17,40574753,40574754,CAVIN1,Pathogenic,Congenital generalized lipodystrophy type 4,Duplication,GRCh37
na,na,17,42422735,42422736,CAVIN1,Pathogenic,Congenital generalized lipodystrophy type 4,Duplication,GRCh38
na,na,19,7621393,7621393,PNPLA6,Pathogenic,Hereditary spastic paraplegia 39|Ataxia-hypogonadism-choroidal dystrophy syndrome,single nucleotide variant,GRCh37
na,na,19,7556507,7556507,PNPLA6,Pathogenic,Hereditary spastic paraplegia 39|Ataxia-hypogonadism-choroidal dystrophy syndrome,single nucleotide variant,GRCh38
na,na,19,7619927,7619927,PNPLA6,Pathogenic,Hereditary spastic paraplegia 39,single nucleotide variant,GRCh37
na,na,19,7555041,7555041,PNPLA6,Pathogenic,Hereditary spastic paraplegia 39,single nucleotide variant,GRCh38
na,na,19,7620610,7620611,PNPLA6,Pathogenic,Hereditary spastic paraplegia 39|Laurence-Moon syndrome|Trichomegaly-retina pigmentary degeneration-dwarfism syndrome|not provided|PNPLA6-related disorder|Inborn genetic diseases|Hereditary spastic paraplegia|Ataxia-hypogonadism-choroidal dystrophy syndrome|Hereditary spastic paraplegia 39;Trichomegaly-retina pigmentary degeneration-dwarfism syndrome;Laurence-Moon syndrome;Ataxia-hypogonadism-choroidal dystrophy syndrome|Retinal dystrophy,Duplication,GRCh37
na,na,19,7555724,7555725,PNPLA6,Pathogenic,Hereditary spastic paraplegia 39|Laurence-Moon syndrome|Trichomegaly-retina pigmentary degeneration-dwarfism syndrome|not provided|PNPLA6-related disorder|Inborn genetic diseases|Hereditary spastic paraplegia|Ataxia-hypogonadism-choroidal dystrophy syndrome|Hereditary spastic paraplegia 39;Trichomegaly-retina pigmentary degeneration-dwarfism syndrome;Laurence-Moon syndrome;Ataxia-hypogonadism-choroidal dystrophy syndrome|Retinal dystrophy,Duplication,GRCh38
na,na,14,31346892,31346892,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9,single nucleotide variant,GRCh37
na,na,14,30877686,30877686,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9,single nucleotide variant,GRCh38
na,na,14,31348040,31348040,COCH,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 9|not provided,single nucleotide variant,GRCh37
na,na,14,30878834,30878834,COCH,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 9|not provided,single nucleotide variant,GRCh38
na,na,14,31348126,31348126,COCH,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 9|Hereditary hearing loss and deafness|not provided,single nucleotide variant,GRCh37
na,na,14,30878920,30878920,COCH,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 9|Hereditary hearing loss and deafness|not provided,single nucleotide variant,GRCh38
na,na,14,31346846,31346846,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9|Nonsyndromic genetic hearing loss|not provided|Rare genetic deafness|Hearing impairment,single nucleotide variant,GRCh37
na,na,14,30877640,30877640,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9|Nonsyndromic genetic hearing loss|not provided|Rare genetic deafness|Hearing impairment,single nucleotide variant,GRCh38
na,na,14,31348103,31348103,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9|not provided,single nucleotide variant,GRCh37
na,na,14,30878897,30878897,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9|not provided,single nucleotide variant,GRCh38
na,na,14,31348132,31348132,COCH,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 9|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh37
na,na,14,30878926,30878926,COCH,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 9|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh38
na,na,14,31358969,31358969,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9|Rare genetic deafness|not provided,single nucleotide variant,GRCh37
na,na,14,30889763,30889763,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9|Rare genetic deafness|not provided,single nucleotide variant,GRCh38
na,na,14,31358969,31358969,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9,single nucleotide variant,GRCh37
na,na,14,30889763,30889763,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9,single nucleotide variant,GRCh38
na,na,14,31358879,31358879,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9,single nucleotide variant,GRCh37
na,na,14,30889673,30889673,COCH,Pathogenic,Autosomal dominant nonsyndromic hearing loss 9,single nucleotide variant,GRCh38
na,na,14,74531952,74531952,ALDH6A1,Pathogenic,Methylmalonate semialdehyde dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,14,74065249,74065249,ALDH6A1,Pathogenic,Methylmalonate semialdehyde dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,6,143792712,143792713,PEX3,Pathogenic,Peroxisome biogenesis disorder 10A (Zellweger),Duplication,GRCh37
na,na,6,143471575,143471576,PEX3,Pathogenic,Peroxisome biogenesis disorder 10A (Zellweger),Duplication,GRCh38
na,na,1,214574151,214576166,PTPN14,Pathogenic,Lymphedema-posterior choanal atresia syndrome,Deletion,GRCh37
na,na,1,214400808,214402823,PTPN14,Pathogenic,Lymphedema-posterior choanal atresia syndrome,Deletion,GRCh38
na,na,11,111635566,111635566,PPP2R1B,Pathogenic,Lung carcinoma,single nucleotide variant,GRCh37
na,na,11,111764842,111764842,PPP2R1B,Pathogenic,Lung carcinoma,single nucleotide variant,GRCh38
na,na,10,101841209,101841210,CPN1,Pathogenic,Anaphylotoxin inactivator deficiency,Duplication,GRCh37
na,na,10,100081452,100081453,CPN1,Pathogenic,Anaphylotoxin inactivator deficiency,Duplication,GRCh38
na,na,10,101829514,101829514,CPN1,Benign,Anaphylotoxin inactivator deficiency|not specified|not provided|CPN1-related disorder,single nucleotide variant,GRCh37
na,na,10,100069757,100069757,CPN1,Benign,Anaphylotoxin inactivator deficiency|not specified|not provided|CPN1-related disorder,single nucleotide variant,GRCh38
na,na,9,139571989,139571989,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1|not provided,single nucleotide variant,GRCh37
na,na,9,136677537,136677537,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1|not provided,single nucleotide variant,GRCh38
na,na,9,139569261,139569261,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1|Congenital generalized lipodystrophy|not provided,single nucleotide variant,GRCh37
na,na,9,136674809,136674809,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1|Congenital generalized lipodystrophy|not provided,single nucleotide variant,GRCh38
na,na,9,139571527,139571528,AGPAT2,Pathogenic/Likely pathogenic,Congenital generalized lipodystrophy type 1|not provided,Duplication,GRCh37
na,na,9,136677075,136677076,AGPAT2,Pathogenic/Likely pathogenic,Congenital generalized lipodystrophy type 1|not provided,Duplication,GRCh38
na,na,9,139568358,139568358,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1,single nucleotide variant,GRCh37
na,na,9,136673906,136673906,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1,single nucleotide variant,GRCh38
na,na,9,139571485,139571487,AGPAT2,Uncertain significance,Congenital generalized lipodystrophy type 1,Microsatellite,GRCh37
na,na,9,136677033,136677035,AGPAT2,Uncertain significance,Congenital generalized lipodystrophy type 1,Microsatellite,GRCh38
na,na,9,139569205,139569205,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1,single nucleotide variant,GRCh37
na,na,9,136674753,136674753,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1,single nucleotide variant,GRCh38
na,na,9,139571133,139571133,AGPAT2,Pathogenic/Likely pathogenic,Congenital generalized lipodystrophy type 1,single nucleotide variant,GRCh37
na,na,9,136676681,136676681,AGPAT2,Pathogenic/Likely pathogenic,Congenital generalized lipodystrophy type 1,single nucleotide variant,GRCh38
na,na,9,139571055,139571055,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1,single nucleotide variant,GRCh37
na,na,9,136676603,136676603,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1,single nucleotide variant,GRCh38
na,na,9,139570503,139571539,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1,Deletion,GRCh37
na,na,9,136676051,136677087,AGPAT2,Pathogenic,Congenital generalized lipodystrophy type 1,Deletion,GRCh38
na,na,3,160804341,160804341,B3GALNT1,Affects,p phenotype,single nucleotide variant,GRCh37
na,na,3,161086553,161086553,B3GALNT1,Affects,p phenotype,single nucleotide variant,GRCh38
na,na,3,160804005,160804006,B3GALNT1,Affects,p phenotype,Duplication,GRCh37
na,na,3,161086217,161086218,B3GALNT1,Affects,p phenotype,Duplication,GRCh38
na,na,3,160803732,160803732,B3GALNT1,Affects,p phenotype,single nucleotide variant,GRCh37
na,na,3,161085944,161085944,B3GALNT1,Affects,p phenotype,single nucleotide variant,GRCh38
na,na,3,160803746,160803746,B3GALNT1,Affects,p phenotype,single nucleotide variant,GRCh37
na,na,3,161085958,161085958,B3GALNT1,Affects,p phenotype,single nucleotide variant,GRCh38
na,na,13,100634495,100634496,ZIC2,Pathogenic,Holoprosencephaly 5,Insertion,GRCh37
na,na,13,99982241,99982242,ZIC2,Pathogenic,Holoprosencephaly 5,Insertion,GRCh38
na,na,13,100637654,100637655,ZIC2,Pathogenic,Holoprosencephaly 5,Duplication,GRCh37
na,na,13,99985400,99985401,ZIC2,Pathogenic,Holoprosencephaly 5,Duplication,GRCh38
na,na,13,100637703,100637705,ZIC2,Pathogenic,Holoprosencephaly 5,Microsatellite,GRCh37
na,na,13,99985449,99985451,ZIC2,Pathogenic,Holoprosencephaly 5,Microsatellite,GRCh38
na,na,13,100635358,100635364,ZIC2,Pathogenic,Holoprosencephaly 5,Deletion,GRCh37
na,na,13,99983104,99983110,ZIC2,Pathogenic,Holoprosencephaly 5,Deletion,GRCh38
na,na,13,100635171,100635172,ZIC2,Pathogenic,Holoprosencephaly 5,Microsatellite,GRCh37
na,na,13,99982917,99982918,ZIC2,Pathogenic,Holoprosencephaly 5,Microsatellite,GRCh38
na,na,20,54961541,54961541,AURKA,Benign,"Colon cancer, susceptibility to|not provided|AURKA-related disorder",single nucleotide variant,GRCh37
na,na,20,56386485,56386485,AURKA,Benign,"Colon cancer, susceptibility to|not provided|AURKA-related disorder",single nucleotide variant,GRCh38
na,na,7,100858381,100858381,PLOD3,Uncertain significance,"Bone fragility with contractures, arterial rupture, and deafness|not provided",single nucleotide variant,GRCh37
na,na,7,101215100,101215100,PLOD3,Uncertain significance,"Bone fragility with contractures, arterial rupture, and deafness|not provided",single nucleotide variant,GRCh38
na,na,7,100849708,100849708,PLOD3,Pathogenic,"Bone fragility with contractures, arterial rupture, and deafness",Deletion,GRCh37
na,na,7,101206427,101206427,PLOD3,Pathogenic,"Bone fragility with contractures, arterial rupture, and deafness",Deletion,GRCh38
na,na,2,178357898,178357898,AGPS,Likely pathogenic,Rhizomelic chondrodysplasia punctata type 3,single nucleotide variant,GRCh37
na,na,2,177493170,177493170,AGPS,Likely pathogenic,Rhizomelic chondrodysplasia punctata type 3,single nucleotide variant,GRCh38
na,na,2,178326676,178326676,AGPS,Likely pathogenic,Rhizomelic chondrodysplasia punctata type 3,single nucleotide variant,GRCh37
na,na,2,177461948,177461948,AGPS,Likely pathogenic,Rhizomelic chondrodysplasia punctata type 3,single nucleotide variant,GRCh38
na,na,2,178364389,178364389,AGPS,Pathogenic,Rhizomelic chondrodysplasia punctata type 3,single nucleotide variant,GRCh37
na,na,2,177499661,177499661,AGPS,Pathogenic,Rhizomelic chondrodysplasia punctata type 3,single nucleotide variant,GRCh38
na,na,na,-1,-1,COLQ,Pathogenic,Congenital myasthenic syndrome 5,Deletion,na
na,na,3,15512120,15512120,COLQ,Pathogenic,Congenital myasthenic syndrome 5,single nucleotide variant,GRCh37
na,na,3,15470613,15470613,COLQ,Pathogenic,Congenital myasthenic syndrome 5,single nucleotide variant,GRCh38
na,na,3,15516954,15516954,COLQ,Pathogenic,Congenital myasthenic syndrome 5,single nucleotide variant,GRCh37
na,na,3,15475447,15475447,COLQ,Pathogenic,Congenital myasthenic syndrome 5,single nucleotide variant,GRCh38
na,na,3,15499803,15499803,COLQ,Pathogenic,Congenital myasthenic syndrome 5,single nucleotide variant,GRCh37
na,na,3,15458296,15458296,COLQ,Pathogenic,Congenital myasthenic syndrome 5,single nucleotide variant,GRCh38
na,na,3,15497519,15497519,COLQ,Pathogenic,Congenital myasthenic syndrome 5|Congenital myasthenic syndrome|not provided|Abnormality of the musculature,Deletion,GRCh37
na,na,3,15456012,15456012,COLQ,Pathogenic,Congenital myasthenic syndrome 5|Congenital myasthenic syndrome|not provided|Abnormality of the musculature,Deletion,GRCh38
na,na,3,15507873,15507874,COLQ,Pathogenic,Congenital myasthenic syndrome 5|not provided,Duplication,GRCh37
na,na,3,15466366,15466367,COLQ,Pathogenic,Congenital myasthenic syndrome 5|not provided,Duplication,GRCh38
na,na,3,15495345,15495345,COLQ,Pathogenic,Congenital myasthenic syndrome 5|Congenital myasthenic syndrome|COLQ-related disorder|Slow-Channel Congenital Myasthenia Syndrome,single nucleotide variant,GRCh37
na,na,3,15453838,15453838,COLQ,Pathogenic,Congenital myasthenic syndrome 5|Congenital myasthenic syndrome|COLQ-related disorder|Slow-Channel Congenital Myasthenia Syndrome,single nucleotide variant,GRCh38
na,na,3,15499704,15499704,COLQ,Pathogenic,Congenital myasthenic syndrome 5|not provided|Synaptic congenital myasthenic syndromes,single nucleotide variant,GRCh37
na,na,3,15458197,15458197,COLQ,Pathogenic,Congenital myasthenic syndrome 5|not provided|Synaptic congenital myasthenic syndromes,single nucleotide variant,GRCh38
na,na,3,15495333,15495333,COLQ,Pathogenic,Congenital myasthenic syndrome 5|Congenital myasthenic syndrome,single nucleotide variant,GRCh37
na,na,3,15453826,15453826,COLQ,Pathogenic,Congenital myasthenic syndrome 5|Congenital myasthenic syndrome,single nucleotide variant,GRCh38
na,na,3,15507944,15507944,COLQ,Pathogenic,Congenital myasthenic syndrome 5,single nucleotide variant,GRCh37
na,na,3,15466437,15466437,COLQ,Pathogenic,Congenital myasthenic syndrome 5,single nucleotide variant,GRCh38
na,na,1,223285200,223285200,TLR5,protective; risk factor,"Legionnaire disease, susceptibility to|Systemic lupus erythematosus, resistance to, 1|Melioidosis, resistance to",single nucleotide variant,GRCh37
na,na,1,223111858,223111858,TLR5,protective; risk factor,"Legionnaire disease, susceptibility to|Systemic lupus erythematosus, resistance to, 1|Melioidosis, resistance to",single nucleotide variant,GRCh38
na,na,1,223284599,223284599,TLR5,Benign; risk factor,"Legionnaire disease, susceptibility to|TLR5-related disorder",single nucleotide variant,GRCh37
na,na,1,223111257,223111257,TLR5,Benign; risk factor,"Legionnaire disease, susceptibility to|TLR5-related disorder",single nucleotide variant,GRCh38
na,na,9,120475302,120475302,TLR4,Benign,"TLR4 POLYMORPHISM|Pericementitis|COPD, severe early onset|not provided|Susceptibility to severe coronavirus disease (COVID-19)",single nucleotide variant,GRCh37
na,na,9,117713024,117713024,TLR4,Benign,"TLR4 POLYMORPHISM|Pericementitis|COPD, severe early onset|not provided|Susceptibility to severe coronavirus disease (COVID-19)",single nucleotide variant,GRCh38
na,na,9,120475602,120475602,TLR4,Benign,"TLR4 POLYMORPHISM|not provided|COPD, severe early onset",single nucleotide variant,GRCh37
na,na,9,117713324,117713324,TLR4,Benign,"TLR4 POLYMORPHISM|not provided|COPD, severe early onset",single nucleotide variant,GRCh38
na,na,4,187004500,187004500,TLR3,Uncertain significance,"Immunodeficiency 83, susceptibility to viral infections|Herpes simplex encephalitis, susceptibility to, 1|Immunodeficiency 83, susceptibility to viral infections;Susceptibility to HIV infection|not specified|TLR3-related disorder|not provided",single nucleotide variant,GRCh37
na,na,4,186083346,186083346,TLR3,Uncertain significance,"Immunodeficiency 83, susceptibility to viral infections|Herpes simplex encephalitis, susceptibility to, 1|Immunodeficiency 83, susceptibility to viral infections;Susceptibility to HIV infection|not specified|TLR3-related disorder|not provided",single nucleotide variant,GRCh38
na,na,4,154626088,154626088,TLR2,risk factor,"Leprosy, susceptibility to, 3",single nucleotide variant,GRCh37
na,na,4,153704936,153704936,TLR2,risk factor,"Leprosy, susceptibility to, 3",single nucleotide variant,GRCh38
na,na,na,-1,-1,TLR2,risk factor,"Colorectal cancer, susceptibility to",Microsatellite,na
na,na,2,71780201,71780201,DYSF,Pathogenic,Miyoshi muscular dystrophy 1|not provided|Qualitative or quantitative defects of dysferlin,single nucleotide variant,GRCh37
na,na,2,71553071,71553071,DYSF,Pathogenic,Miyoshi muscular dystrophy 1|not provided|Qualitative or quantitative defects of dysferlin,single nucleotide variant,GRCh38
na,na,2,71896802,71896802,DYSF,Pathogenic,Distal myopathy with anterior tibial onset|Qualitative or quantitative defects of dysferlin|not provided|Miyoshi muscular dystrophy 1,Deletion,GRCh37
na,na,2,71669672,71669672,DYSF,Pathogenic,Distal myopathy with anterior tibial onset|Qualitative or quantitative defects of dysferlin|not provided|Miyoshi muscular dystrophy 1,Deletion,GRCh38
na,na,2,71829924,71829924,DYSF,Benign,Miyoshi muscular dystrophy 1|not specified|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Distal myopathy with anterior tibial onset|DYSF-related disorder|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,2,71602794,71602794,DYSF,Benign,Miyoshi muscular dystrophy 1|not specified|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B|Distal myopathy with anterior tibial onset|DYSF-related disorder|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,2,71909727,71909727,DYSF,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Abnormality of the musculature|Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh37
na,na,2,71682597,71682597,DYSF,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Abnormality of the musculature|Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh38
na,na,2,71887767,71887771,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B;Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1,Indel,GRCh37
na,na,2,71660637,71660641,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B;Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1,Indel,GRCh38
na,na,2,71891547,71891548,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,Duplication,GRCh37
na,na,2,71664417,71664418,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,Duplication,GRCh38
na,na,2,71791204,71791204,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,2,71564074,71564074,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,2,71891573,71891573,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy|Miyoshi muscular dystrophy 1,single nucleotide variant,GRCh37
na,na,2,71664443,71664443,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy|Miyoshi muscular dystrophy 1,single nucleotide variant,GRCh38
na,na,2,71709064,71709065,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1,Indel,GRCh37
na,na,2,71481934,71481935,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1,Indel,GRCh38
na,na,2,71797430,71797430,DYSF,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy|Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh37
na,na,2,71570300,71570300,DYSF,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy|Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh38
na,na,2,71797834,71797834,DYSF,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin,single nucleotide variant,GRCh37
na,na,2,71570704,71570704,DYSF,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy type 2B|Distal myopathy with anterior tibial onset;Miyoshi muscular dystrophy 1;Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Qualitative or quantitative defects of dysferlin,single nucleotide variant,GRCh38
na,na,2,71901372,71901372,DYSF,Pathogenic,Distal myopathy with anterior tibial onset|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|Distal myopathy with anterior tibial onset;Autosomal recessive limb-girdle muscular dystrophy type 2B;Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,2,71674242,71674242,DYSF,Pathogenic,Distal myopathy with anterior tibial onset|Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|Distal myopathy with anterior tibial onset;Autosomal recessive limb-girdle muscular dystrophy type 2B;Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,2,71780261,71780261,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh37
na,na,2,71553131,71553131,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh38
na,na,2,71894506,71894506,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh37
na,na,2,71667376,71667376,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh38
na,na,2,71778203,71778203,DYSF,Conflicting classifications of pathogenicity,Miyoshi muscular dystrophy 1|not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,2,71551073,71551073,DYSF,Conflicting classifications of pathogenicity,Miyoshi muscular dystrophy 1|not provided|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,2,71817308,71817308,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh37
na,na,2,71590178,71590178,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh38
na,na,2,71744158,71744158,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin,single nucleotide variant,GRCh37
na,na,2,71517028,71517028,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|not provided|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin,single nucleotide variant,GRCh38
na,na,2,71744158,71744158,DYSF,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh37
na,na,2,71517028,71517028,DYSF,Pathogenic/Likely pathogenic,Miyoshi muscular dystrophy 1|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B,single nucleotide variant,GRCh38
na,na,2,71762149,71762149,DYSF,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,2,71535019,71535019,DYSF,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Qualitative or quantitative defects of dysferlin|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,2,71743372,71743372,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B;Miyoshi muscular dystrophy 1;Distal myopathy with anterior tibial onset,Deletion,GRCh37
na,na,2,71516242,71516242,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1|Autosomal recessive limb-girdle muscular dystrophy|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2B;Miyoshi muscular dystrophy 1;Distal myopathy with anterior tibial onset,Deletion,GRCh38
na,na,2,71795435,71795435,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy,Deletion,GRCh37
na,na,2,71568305,71568305,DYSF,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2B|Miyoshi muscular dystrophy 1|Qualitative or quantitative defects of dysferlin|not provided|Autosomal recessive limb-girdle muscular dystrophy,Deletion,GRCh38
na,na,10,89503346,89503346,PAPSS2,Pathogenic,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",single nucleotide variant,GRCh37
na,na,10,87743589,87743589,PAPSS2,Pathogenic,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",single nucleotide variant,GRCh38
na,na,10,89469068,89469068,PAPSS2,Pathogenic,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",single nucleotide variant,GRCh37
na,na,10,87709311,87709311,PAPSS2,Pathogenic,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",single nucleotide variant,GRCh38
na,na,10,89487160,89487160,PAPSS2,Pathogenic,"Spondyloepimetaphyseal dysplasia, PAPSS2 type|not provided|Autosomal recessive brachyolmia",single nucleotide variant,GRCh37
na,na,10,87727403,87727403,PAPSS2,Pathogenic,"Spondyloepimetaphyseal dysplasia, PAPSS2 type|not provided|Autosomal recessive brachyolmia",single nucleotide variant,GRCh38
na,na,10,17083159,17083159,CUBN,Pathogenic/Likely pathogenic,"Imerslund-Grasbeck syndrome|Imerslund-Grasbeck syndrome type 1|Proteinuria, chronic benign;Imerslund-Grasbeck syndrome type 1",single nucleotide variant,GRCh37
na,na,10,17041160,17041160,CUBN,Pathogenic/Likely pathogenic,"Imerslund-Grasbeck syndrome|Imerslund-Grasbeck syndrome type 1|Proteinuria, chronic benign;Imerslund-Grasbeck syndrome type 1",single nucleotide variant,GRCh38
na,na,17,54672249,54672249,NOG,Pathogenic/Likely pathogenic,Tarsal-carpal coalition syndrome|Proximal symphalangism 1A|not provided,single nucleotide variant,GRCh37
na,na,17,56594888,56594888,NOG,Pathogenic/Likely pathogenic,Tarsal-carpal coalition syndrome|Proximal symphalangism 1A|not provided,single nucleotide variant,GRCh38
na,na,17,54672248,54672248,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh37
na,na,17,56594887,56594887,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh38
na,na,17,54672233,54672233,NOG,Pathogenic,Symphalangism-brachydactyly syndrome,single nucleotide variant,GRCh37
na,na,17,56594872,56594872,NOG,Pathogenic,Symphalangism-brachydactyly syndrome,single nucleotide variant,GRCh38
na,na,17,54672252,54672252,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh37
na,na,17,56594891,56594891,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh38
na,na,17,54672149,54672149,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh37
na,na,17,56594788,56594788,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh38
na,na,17,54672195,54672195,NOG,Pathogenic,Tarsal-carpal coalition syndrome,single nucleotide variant,GRCh37
na,na,17,56594834,56594834,NOG,Pathogenic,Tarsal-carpal coalition syndrome,single nucleotide variant,GRCh38
na,na,17,54671688,54671688,NOG,Pathogenic/Likely pathogenic,Tarsal-carpal coalition syndrome|Proximal symphalangism 1A|not provided,single nucleotide variant,GRCh37
na,na,17,56594327,56594327,NOG,Pathogenic/Likely pathogenic,Tarsal-carpal coalition syndrome|Proximal symphalangism 1A|not provided,single nucleotide variant,GRCh38
na,na,17,54672135,54672135,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh37
na,na,17,56594774,56594774,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh38
na,na,17,54671970,54671970,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh37
na,na,17,56594609,56594609,NOG,Pathogenic,Proximal symphalangism 1A,single nucleotide variant,GRCh38
na,na,17,54671642,54671642,NOG,Pathogenic,Symphalangism-brachydactyly syndrome,Deletion,GRCh37
na,na,17,56594281,56594281,NOG,Pathogenic,Symphalangism-brachydactyly syndrome,Deletion,GRCh38
na,na,17,54672083,54672083,NOG,Pathogenic,Brachydactyly type B2,single nucleotide variant,GRCh37
na,na,17,56594722,56594722,NOG,Pathogenic,Brachydactyly type B2,single nucleotide variant,GRCh38
na,na,17,54671687,54671687,NOG,Pathogenic,Proximal symphalangism 1A|Brachydactyly type B2|Stapes ankylosis with broad thumbs and toes|not provided,single nucleotide variant,GRCh37
na,na,17,56594326,56594326,NOG,Pathogenic,Proximal symphalangism 1A|Brachydactyly type B2|Stapes ankylosis with broad thumbs and toes|not provided,single nucleotide variant,GRCh38
na,na,17,54671912,54671912,NOG,Pathogenic,Stapes ankylosis with broad thumbs and toes|not provided,single nucleotide variant,GRCh37
na,na,17,56594551,56594551,NOG,Pathogenic,Stapes ankylosis with broad thumbs and toes|not provided,single nucleotide variant,GRCh38
na,na,17,54671830,54671831,NOG,Pathogenic,Stapes ankylosis with broad thumbs and toes,Duplication,GRCh37
na,na,17,56594469,56594470,NOG,Pathogenic,Stapes ankylosis with broad thumbs and toes,Duplication,GRCh38
na,na,17,54672198,54672198,NOG,Pathogenic,Symphalangism-brachydactyly syndrome,single nucleotide variant,GRCh37
na,na,17,56594837,56594837,NOG,Pathogenic,Symphalangism-brachydactyly syndrome,single nucleotide variant,GRCh38
na,na,17,54672199,54672199,NOG,Pathogenic,Symphalangism-brachydactyly syndrome,single nucleotide variant,GRCh37
na,na,17,56594838,56594838,NOG,Pathogenic,Symphalangism-brachydactyly syndrome,single nucleotide variant,GRCh38
na,na,17,54671687,54671687,NOG,Pathogenic,Brachydactyly type B2,single nucleotide variant,GRCh37
na,na,17,56594326,56594326,NOG,Pathogenic,Brachydactyly type B2,single nucleotide variant,GRCh38
na,na,1,161179702,161179702,NDUFS2,Conflicting classifications of pathogenicity,"Mitochondrial complex 1 deficiency, nuclear type 6|not provided",single nucleotide variant,GRCh37
na,na,1,161209912,161209912,NDUFS2,Conflicting classifications of pathogenicity,"Mitochondrial complex 1 deficiency, nuclear type 6|not provided",single nucleotide variant,GRCh38
na,na,1,161179705,161179705,NDUFS2,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 6",single nucleotide variant,GRCh37
na,na,1,161209915,161209915,NDUFS2,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 6",single nucleotide variant,GRCh38
na,na,1,161183463,161183463,NDUFS2,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 6|not provided",single nucleotide variant,GRCh37
na,na,1,161213673,161213673,NDUFS2,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 6|not provided",single nucleotide variant,GRCh38
na,na,9,35078335,35078335,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia|not provided,single nucleotide variant,GRCh37
na,na,9,35078338,35078338,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia|not provided,single nucleotide variant,GRCh38
na,na,9,35078601,35078601,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia,single nucleotide variant,GRCh37
na,na,9,35078604,35078604,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia,single nucleotide variant,GRCh38
na,na,9,35076439,35076439,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia,single nucleotide variant,GRCh37
na,na,9,35076442,35076442,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia,single nucleotide variant,GRCh38
na,na,9,35076582,35076582,FANCG,Pathogenic,Fanconi anemia complementation group G,single nucleotide variant,GRCh37
na,na,9,35076585,35076585,FANCG,Pathogenic,Fanconi anemia complementation group G,single nucleotide variant,GRCh38
na,na,9,35075275,35075275,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia|FANCG-related disorder|not provided,single nucleotide variant,GRCh37
na,na,9,35075278,35075278,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia|FANCG-related disorder|not provided,single nucleotide variant,GRCh38
na,na,9,35074170,35074179,FANCG,Pathogenic,Fanconi anemia complementation group G|not provided|Fanconi anemia|FANCG-related disorder,Deletion,GRCh37
na,na,9,35074173,35074182,FANCG,Pathogenic,Fanconi anemia complementation group G|not provided|Fanconi anemia|FANCG-related disorder,Deletion,GRCh38
na,na,9,35077264,35077270,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia|not provided,Deletion,GRCh37
na,na,9,35077267,35077273,FANCG,Pathogenic,Fanconi anemia complementation group G|Fanconi anemia|not provided,Deletion,GRCh38
na,na,9,104133461,104133461,BAAT,Pathogenic,Bile acid conjugation defect 1,single nucleotide variant,GRCh37
na,na,9,101371179,101371179,BAAT,Pathogenic,Bile acid conjugation defect 1,single nucleotide variant,GRCh38
na,na,6,139694546,139694572,CITED2,Uncertain significance,Ventricular septal defect 2|not provided,Deletion,GRCh37
na,na,6,139373409,139373435,CITED2,Uncertain significance,Ventricular septal defect 2|not provided,Deletion,GRCh38
na,na,na,-1,-1,CITED2,Pathogenic,Atrial septal defect 8,Insertion,na
na,na,6,139694484,139694489,CITED2,Likely benign,Atrial septal defect 8|not provided|Ventricular septal defect 2,Microsatellite,GRCh37
na,na,6,139373347,139373352,CITED2,Likely benign,Atrial septal defect 8|not provided|Ventricular septal defect 2,Microsatellite,GRCh38
na,na,1,46870761,46870761,FAAH,Benign/Likely benign,"FAAH POLYMORPHISM|Polysubstance abuse, susceptibility to|FAAH-related disorder|not provided",single nucleotide variant,GRCh37
na,na,1,46405089,46405089,FAAH,Benign/Likely benign,"FAAH POLYMORPHISM|Polysubstance abuse, susceptibility to|FAAH-related disorder|not provided",single nucleotide variant,GRCh38
na,na,18,46453463,46453463,SMAD7,risk factor,"Colorectal cancer, susceptibility to, 3",single nucleotide variant,GRCh37
na,na,18,48927093,48927093,SMAD7,risk factor,"Colorectal cancer, susceptibility to, 3",single nucleotide variant,GRCh38
na,na,9,130444768,130444768,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4|Developmental and epileptic encephalopathy",single nucleotide variant,GRCh37
na,na,9,127682489,127682489,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4|Developmental and epileptic encephalopathy",single nucleotide variant,GRCh38
na,na,9,130425593,130425593,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,9,127663314,127663314,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,9,130439001,130439001,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4",single nucleotide variant,GRCh37
na,na,9,127676722,127676722,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4",single nucleotide variant,GRCh38
na,na,9,130422313,130422313,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4",single nucleotide variant,GRCh37
na,na,9,127660034,127660034,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4",single nucleotide variant,GRCh38
na,na,9,130438134,130438134,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4|not provided|Developmental and epileptic encephalopathy|Infantile epilepsy syndrome|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,9,127675855,127675855,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4|not provided|Developmental and epileptic encephalopathy|Infantile epilepsy syndrome|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,9,130416076,130416076,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4",single nucleotide variant,GRCh37
na,na,9,127653797,127653797,STXBP1,Pathogenic,"Developmental and epileptic encephalopathy, 4",single nucleotide variant,GRCh38
na,na,9,33385241,33385241,AQP7,Affects,GLYCEROL QUANTITATIVE TRAIT LOCUS,single nucleotide variant,GRCh37
na,na,9,33385243,33385243,AQP7,Affects,GLYCEROL QUANTITATIVE TRAIT LOCUS,single nucleotide variant,GRCh38
na,na,20,31395597,31395597,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh37
na,na,20,32807791,32807791,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh38
na,na,20,31395599,31395599,DNMT3B,Pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency",single nucleotide variant,GRCh37
na,na,20,32807793,32807793,DNMT3B,Pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency",single nucleotide variant,GRCh38
na,na,20,31390222,31390222,DNMT3B,Pathogenic/Likely pathogenic,"Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency|Immunodeficiency-centromeric instability-facial anomalies syndrome 1",single nucleotide variant,GRCh37
na,na,20,32802416,32802416,DNMT3B,Pathogenic/Likely pathogenic,"Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency|Immunodeficiency-centromeric instability-facial anomalies syndrome 1",single nucleotide variant,GRCh38
na,na,20,31388722,31388722,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh37
na,na,20,32800916,32800916,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh38
na,na,na,-1,-1,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,Variation,na
na,na,na,-1,-1,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,Deletion,na
na,na,na,-1,-1,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,Insertion,na
na,na,20,31388006,31388006,DNMT3B,Pathogenic/Likely pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency|Facioscapulohumeral muscular dystrophy 4, digenic;Immunodeficiency-centromeric instability-facial anomalies syndrome 1",single nucleotide variant,GRCh37
na,na,20,32800200,32800200,DNMT3B,Pathogenic/Likely pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency|Facioscapulohumeral muscular dystrophy 4, digenic;Immunodeficiency-centromeric instability-facial anomalies syndrome 1",single nucleotide variant,GRCh38
na,na,20,31395557,31395557,DNMT3B,Pathogenic/Likely pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|not provided|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency",single nucleotide variant,GRCh37
na,na,20,32807751,32807751,DNMT3B,Pathogenic/Likely pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|not provided|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency",single nucleotide variant,GRCh38
na,na,20,31393149,31393149,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh37
na,na,20,32805343,32805343,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh38
na,na,20,31368217,31368217,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh37
na,na,20,32780411,32780411,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh38
na,na,20,31395666,31395666,DNMT3B,Likely pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency",single nucleotide variant,GRCh37
na,na,20,32807860,32807860,DNMT3B,Likely pathogenic,"Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency",single nucleotide variant,GRCh38
na,na,20,31376813,31376813,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh37
na,na,20,32789007,32789007,DNMT3B,Pathogenic,Immunodeficiency-centromeric instability-facial anomalies syndrome 1,single nucleotide variant,GRCh38
na,na,4,86010404,86098523,MAPK10,Uncertain significance,Macrocephaly and epileptic encephalopathy,Deletion,GRCh38
na,na,19,18979844,18979844,CERS1;GDF1;UPF1,Pathogenic/Likely pathogenic,"Congenital heart defects, multiple types, 6|Right atrial isomerism|not provided|GDF1-related disorder|GDF1-RELATED DISORDERS|Transposition of the great arteries|Right atrial isomerism;Congenital heart defects, multiple types, 6",single nucleotide variant,GRCh37
na,na,19,18869035,18869035,CERS1;GDF1;UPF1,Pathogenic/Likely pathogenic,"Congenital heart defects, multiple types, 6|Right atrial isomerism|not provided|GDF1-related disorder|GDF1-RELATED DISORDERS|Transposition of the great arteries|Right atrial isomerism;Congenital heart defects, multiple types, 6",single nucleotide variant,GRCh38
na,na,19,18979725,18979725,GDF1,Uncertain significance,Double outlet right ventricle|GDF1-related disorder,single nucleotide variant,GRCh37
na,na,19,18868916,18868916,GDF1,Uncertain significance,Double outlet right ventricle|GDF1-related disorder,single nucleotide variant,GRCh38
na,na,19,18980040,18980040,CERS1;GDF1,Conflicting classifications of pathogenicity,Tetralogy of Fallot|not provided|Progressive myoclonic epilepsy type 8|GDF1-related disorder,single nucleotide variant,GRCh37
na,na,19,18869231,18869231,CERS1;GDF1,Conflicting classifications of pathogenicity,Tetralogy of Fallot|not provided|Progressive myoclonic epilepsy type 8|GDF1-related disorder,single nucleotide variant,GRCh38
na,na,5,68805087,68805109,OCLN,Pathogenic,Pseudo-TORCH syndrome 1,Deletion,GRCh37
na,na,5,69509260,69509282,OCLN,Pathogenic,Pseudo-TORCH syndrome 1,Deletion,GRCh38
na,na,5,68805428,68805429,OCLN,Pathogenic,Pseudo-TORCH syndrome 1,Duplication,GRCh37
na,na,5,69509601,69509602,OCLN,Pathogenic,Pseudo-TORCH syndrome 1,Duplication,GRCh38
na,na,5,68805573,68805573,OCLN,Pathogenic,Pseudo-TORCH syndrome 1,single nucleotide variant,GRCh37
na,na,5,69509746,69509746,OCLN,Pathogenic,Pseudo-TORCH syndrome 1,single nucleotide variant,GRCh38
na,na,12,33031955,33031955,PKP2,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|not provided|Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|Cardiac arrhythmia,single nucleotide variant,GRCh37
na,na,12,32879021,32879021,PKP2,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|not provided|Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|Cardiac arrhythmia,single nucleotide variant,GRCh38
na,na,12,32955433,32955433,PKP2,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype|not provided|PKP2-related disorder|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,12,32802499,32802499,PKP2,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype|not provided|PKP2-related disorder|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,12,32955491,32955491,PKP2,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype|Cardiomyopathy|PKP2-related disorder,single nucleotide variant,GRCh37
na,na,12,32802557,32802557,PKP2,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype|Cardiomyopathy|PKP2-related disorder,single nucleotide variant,GRCh38
na,na,12,32949042,32949042,PKP2,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype|Arrhythmogenic ventricular cardiomyopathy|Cardiomyopathy|Familial isolated arrhythmogenic right ventricular dysplasia|Sudden unexplained death,single nucleotide variant,GRCh37
na,na,12,32796108,32796108,PKP2,Pathogenic,Arrhythmogenic right ventricular dysplasia 9|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype|Arrhythmogenic ventricular cardiomyopathy|Cardiomyopathy|Familial isolated arrhythmogenic right ventricular dysplasia|Sudden unexplained death,single nucleotide variant,GRCh38
na,na,15,40457337,40457337,BUB1B,Benign/Likely benign,Carcinoma of colon|not provided|not specified|Mosaic variegated aneuploidy syndrome 1|Mosaic variegated aneuploidy syndrome 1;Premature chromatid separation trait;Colorectal cancer,single nucleotide variant,GRCh37
na,na,15,40165136,40165136,BUB1B,Benign/Likely benign,Carcinoma of colon|not provided|not specified|Mosaic variegated aneuploidy syndrome 1|Mosaic variegated aneuploidy syndrome 1;Premature chromatid separation trait;Colorectal cancer,single nucleotide variant,GRCh38
na,na,2,111395730,111395730,BUB1,Pathogenic,Carcinoma of colon,Deletion,GRCh37
na,na,2,110638153,110638153,BUB1,Pathogenic,Carcinoma of colon,Deletion,GRCh38
na,na,15,40468873,40468873,BUB1B,Pathogenic/Likely pathogenic,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,single nucleotide variant,GRCh37
na,na,15,40176672,40176672,BUB1B,Pathogenic/Likely pathogenic,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,single nucleotide variant,GRCh38
na,na,15,40504844,40504844,BUB1B,Uncertain significance,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait|Colorectal cancer;Premature chromatid separation trait;Mosaic variegated aneuploidy syndrome 1,single nucleotide variant,GRCh37
na,na,15,40212643,40212643,BUB1B,Uncertain significance,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait|Colorectal cancer;Premature chromatid separation trait;Mosaic variegated aneuploidy syndrome 1,single nucleotide variant,GRCh38
na,na,15,40509781,40509781,BUB1B,Conflicting classifications of pathogenicity,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait|not provided|Inborn genetic diseases|Colorectal cancer;Premature chromatid separation trait;Mosaic variegated aneuploidy syndrome 1,single nucleotide variant,GRCh37
na,na,15,40217580,40217580,BUB1B,Conflicting classifications of pathogenicity,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait|not provided|Inborn genetic diseases|Colorectal cancer;Premature chromatid separation trait;Mosaic variegated aneuploidy syndrome 1,single nucleotide variant,GRCh38
na,na,15,40501898,40501899,BUB1B,Pathogenic,Premature chromatid separation trait|Mosaic variegated aneuploidy syndrome 1,Duplication,GRCh37
na,na,15,40209697,40209698,BUB1B,Pathogenic,Premature chromatid separation trait|Mosaic variegated aneuploidy syndrome 1,Duplication,GRCh38
na,na,15,40504755,40504755,BUB1B,Conflicting classifications of pathogenicity,Premature chromatid separation trait|Mosaic variegated aneuploidy syndrome 1,single nucleotide variant,GRCh37
na,na,15,40212554,40212554,BUB1B,Conflicting classifications of pathogenicity,Premature chromatid separation trait|Mosaic variegated aneuploidy syndrome 1,single nucleotide variant,GRCh38
na,na,15,40512842,40512842,BUB1B,Uncertain significance,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait|Premature chromatid separation trait;Mosaic variegated aneuploidy syndrome 1;Colorectal cancer|not specified,single nucleotide variant,GRCh37
na,na,15,40220641,40220641,BUB1B,Uncertain significance,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait|Premature chromatid separation trait;Mosaic variegated aneuploidy syndrome 1;Colorectal cancer|not specified,single nucleotide variant,GRCh38
na,na,15,40494810,40494810,BUB1B,Benign/Likely benign,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,single nucleotide variant,GRCh37
na,na,15,40202609,40202609,BUB1B,Benign/Likely benign,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,single nucleotide variant,GRCh38
na,na,15,40492444,40492444,BUB1B,Pathogenic; Affects,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,single nucleotide variant,GRCh37
na,na,15,40200243,40200243,BUB1B,Pathogenic; Affects,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,single nucleotide variant,GRCh38
na,na,15,40498481,40498481,BUB1B,Pathogenic; Affects,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,Deletion,GRCh37
na,na,15,40206280,40206280,BUB1B,Pathogenic; Affects,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,Deletion,GRCh38
na,na,15,40492440,40492440,BUB1B,Pathogenic; Affects,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,single nucleotide variant,GRCh37
na,na,15,40200239,40200239,BUB1B,Pathogenic; Affects,Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait,single nucleotide variant,GRCh38
na,na,1,2339890,2339890,PEX10,Pathogenic,"Peroxisome biogenesis disorder 6A (Zellweger)|Zellweger spectrum disorders|Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B|not provided|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder",single nucleotide variant,GRCh37
na,na,1,2408451,2408451,PEX10,Pathogenic,"Peroxisome biogenesis disorder 6A (Zellweger)|Zellweger spectrum disorders|Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B|not provided|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder",single nucleotide variant,GRCh38
na,na,1,2337965,2337965,PEX10,Pathogenic,Peroxisome biogenesis disorder 6B,single nucleotide variant,GRCh37
na,na,1,2406526,2406526,PEX10,Pathogenic,Peroxisome biogenesis disorder 6B,single nucleotide variant,GRCh38
na,na,1,2340118,2340118,PEX10,Pathogenic/Likely pathogenic,"Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder|Peroxisome biogenesis disorder 6A (Zellweger)",single nucleotide variant,GRCh37
na,na,1,2408679,2408679,PEX10,Pathogenic/Likely pathogenic,"Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder|Peroxisome biogenesis disorder 6A (Zellweger)",single nucleotide variant,GRCh38
na,na,1,2338230,2338231,PEX10,Pathogenic,"Peroxisome biogenesis disorder 6A (Zellweger)|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder 6B|not provided|Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder|Zellweger spectrum disorders|PEX10-related disorder",Duplication,GRCh37
na,na,1,2406791,2406792,PEX10,Pathogenic,"Peroxisome biogenesis disorder 6A (Zellweger)|Peroxisome biogenesis disorder, complementation group 7|Peroxisome biogenesis disorder 6B|not provided|Peroxisome biogenesis disorder 6A (Zellweger);Peroxisome biogenesis disorder 6B|Peroxisome biogenesis disorder|Zellweger spectrum disorders|PEX10-related disorder",Duplication,GRCh38
na,na,na,-1,-1,PEX10,Pathogenic,Peroxisome biogenesis disorder 6A (Zellweger),Indel,na
na,na,11,71148990,71148990,DHCR7,not provided,Smith-Lemli-Opitz syndrome,single nucleotide variant,GRCh37
na,na,11,71437944,71437944,DHCR7,not provided,Smith-Lemli-Opitz syndrome,single nucleotide variant,GRCh38
na,na,11,71155166,71155261,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,Deletion,GRCh37
na,na,11,71444120,71444215,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,Deletion,GRCh38
na,na,11,71150075,71150076,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,Duplication,GRCh37
na,na,11,71439029,71439030,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,Duplication,GRCh38
na,na,11,71149994,71149995,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,Insertion,GRCh37
na,na,11,71438948,71438949,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,Insertion,GRCh38
na,na,11,71153365,71153365,DHCR7,Conflicting classifications of pathogenicity,Smith-Lemli-Opitz syndrome|not provided|not specified,single nucleotide variant,GRCh37
na,na,11,71442319,71442319,DHCR7,Conflicting classifications of pathogenicity,Smith-Lemli-Opitz syndrome|not provided|not specified,single nucleotide variant,GRCh38
na,na,11,71150026,71150026,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|DHCR7-related disorder,single nucleotide variant,GRCh37
na,na,11,71438980,71438980,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|DHCR7-related disorder,single nucleotide variant,GRCh38
na,na,11,71150012,71150012,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,single nucleotide variant,GRCh37
na,na,11,71438966,71438966,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,single nucleotide variant,GRCh38
na,na,11,71155082,71155082,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|Abnormal brain morphology|See cases,single nucleotide variant,GRCh37
na,na,11,71444036,71444036,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|Abnormal brain morphology|See cases,single nucleotide variant,GRCh38
na,na,11,71152446,71152446,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,single nucleotide variant,GRCh37
na,na,11,71441400,71441400,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome,single nucleotide variant,GRCh38
na,na,11,71146873,71146873,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|DHCR7-related disorder,single nucleotide variant,GRCh37
na,na,11,71435827,71435827,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|DHCR7-related disorder,single nucleotide variant,GRCh38
na,na,11,71146795,71146795,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome|Microcephaly|not provided|DHCR7-related disorder,single nucleotide variant,GRCh37
na,na,11,71435749,71435749,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome|Microcephaly|not provided|DHCR7-related disorder,single nucleotide variant,GRCh38
na,na,11,71146639,71146639,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome|not provided|Inborn genetic diseases|DHCR7-related disorder,single nucleotide variant,GRCh37
na,na,11,71435593,71435593,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome|not provided|Inborn genetic diseases|DHCR7-related disorder,single nucleotide variant,GRCh38
na,na,11,71148955,71148955,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,11,71437909,71437909,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,11,71148982,71148982,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|DHCR7-related disorder,single nucleotide variant,GRCh37
na,na,11,71437936,71437936,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|DHCR7-related disorder,single nucleotide variant,GRCh38
na,na,11,71155996,71155996,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided,single nucleotide variant,GRCh37
na,na,11,71444950,71444950,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided,single nucleotide variant,GRCh38
na,na,11,71146507,71146507,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided,single nucleotide variant,GRCh37
na,na,11,71435461,71435461,DHCR7,Pathogenic/Likely pathogenic,Smith-Lemli-Opitz syndrome|not provided,single nucleotide variant,GRCh38
na,na,11,71155998,71155998,DHCR7,Pathogenic/Likely pathogenic,not provided|Smith-Lemli-Opitz syndrome|Inborn genetic diseases|DHCR7-related disorder,single nucleotide variant,GRCh37
na,na,11,71444952,71444952,DHCR7,Pathogenic/Likely pathogenic,not provided|Smith-Lemli-Opitz syndrome|Inborn genetic diseases|DHCR7-related disorder,single nucleotide variant,GRCh38
na,na,11,71146794,71146794,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome|not provided,single nucleotide variant,GRCh37
na,na,11,71435748,71435748,DHCR7,Pathogenic,Smith-Lemli-Opitz syndrome|not provided,single nucleotide variant,GRCh38
na,na,14,35761675,35761675,PSMA6,Benign; risk factor,"Myocardial infarction, susceptibility to|PSMA6-related disorder",single nucleotide variant,GRCh37
na,na,14,35292469,35292469,PSMA6,Benign; risk factor,"Myocardial infarction, susceptibility to|PSMA6-related disorder",single nucleotide variant,GRCh38
na,na,5,90001325,90001325,ADGRV1,Pathogenic,"Febrile seizures, familial, 4",single nucleotide variant,GRCh37
na,na,5,90705508,90705508,ADGRV1,Pathogenic,"Febrile seizures, familial, 4",single nucleotide variant,GRCh38
na,na,5,89986808,89986808,ADGRV1,Pathogenic/Likely pathogenic,"Usher syndrome type 2C|Usher syndrome|not provided|Rare genetic deafness|Febrile seizures, familial, 4;Usher syndrome type 2C",single nucleotide variant,GRCh37
na,na,5,90690991,90690991,ADGRV1,Pathogenic/Likely pathogenic,"Usher syndrome type 2C|Usher syndrome|not provided|Rare genetic deafness|Febrile seizures, familial, 4;Usher syndrome type 2C",single nucleotide variant,GRCh38
na,na,5,90002193,90002194,ADGRV1,Pathogenic,Usher syndrome type 2C|not provided,Duplication,GRCh37
na,na,5,90706376,90706377,ADGRV1,Pathogenic,Usher syndrome type 2C|not provided,Duplication,GRCh38
na,na,5,90004691,90004691,ADGRV1,Pathogenic,Usher syndrome type 2C,Deletion,GRCh37
na,na,5,90708874,90708874,ADGRV1,Pathogenic,Usher syndrome type 2C,Deletion,GRCh38
na,na,5,90449141,90449159,ADGRV1,Pathogenic/Likely pathogenic,Usher syndrome type 2C|not provided,Deletion,GRCh37
na,na,5,91153324,91153342,ADGRV1,Pathogenic/Likely pathogenic,Usher syndrome type 2C|not provided,Deletion,GRCh38
na,na,5,90281318,90281318,ADGRV1,Pathogenic,Usher syndrome type 2C,single nucleotide variant,GRCh37
na,na,5,90985501,90985501,ADGRV1,Pathogenic,Usher syndrome type 2C,single nucleotide variant,GRCh38
na,na,5,90221274,90357290,ADGRV1,Pathogenic,Usher syndrome type 2C,Deletion,GRCh37
na,na,5,90925457,91061473,ADGRV1,Pathogenic,Usher syndrome type 2C,Deletion,GRCh38
na,na,5,89938469,89938481,ADGRV1,Pathogenic,Usher syndrome type 2C|Retinal dystrophy|not provided,Deletion,GRCh37
na,na,5,90642652,90642664,ADGRV1,Pathogenic,Usher syndrome type 2C|Retinal dystrophy|not provided,Deletion,GRCh38
na,na,5,89971939,89971940,ADGRV1,Pathogenic,Usher syndrome type 2C,Deletion,GRCh37
na,na,5,90676122,90676123,ADGRV1,Pathogenic,Usher syndrome type 2C,Deletion,GRCh38
na,na,12,57962798,57962798,KIF5A,Pathogenic,Hereditary spastic paraplegia 10,single nucleotide variant,GRCh37
na,na,12,57569015,57569015,KIF5A,Pathogenic,Hereditary spastic paraplegia 10,single nucleotide variant,GRCh38
na,na,12,57963057,57963057,KIF5A,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 10|not provided|Hereditary spastic paraplegia|Spastic paraplegia,single nucleotide variant,GRCh37
na,na,12,57569274,57569274,KIF5A,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 10|not provided|Hereditary spastic paraplegia|Spastic paraplegia,single nucleotide variant,GRCh38
na,na,12,57963046,57963046,KIF5A,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 10|not provided|Spastic paraplegia|KIF5A-related disorder,single nucleotide variant,GRCh37
na,na,12,57569263,57569263,KIF5A,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 10|not provided|Spastic paraplegia|KIF5A-related disorder,single nucleotide variant,GRCh38
na,na,12,57963431,57963431,KIF5A,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 10|Spastic paraplegia|not specified|not provided|KIF5A-related disorder,single nucleotide variant,GRCh37
na,na,12,57569648,57569648,KIF5A,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 10|Spastic paraplegia|not specified|not provided|KIF5A-related disorder,single nucleotide variant,GRCh38
na,na,na,-1,-1,SPG7,Pathogenic,Hereditary spastic paraplegia 7,Deletion,na
na,na,16,89616977,89616979,SPG7,Pathogenic,Hereditary spastic paraplegia 7,Microsatellite,GRCh37
na,na,16,89550569,89550571,SPG7,Pathogenic,Hereditary spastic paraplegia 7,Microsatellite,GRCh38
na,na,16,89620340,89620340,SPG7,Likely pathogenic,Hereditary spastic paraplegia 7,single nucleotide variant,GRCh37
na,na,16,89553932,89553932,SPG7,Likely pathogenic,Hereditary spastic paraplegia 7,single nucleotide variant,GRCh38
na,na,16,89576947,89576947,SPG7,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 7|not provided|Proximal spinal muscular atrophy|Hereditary spastic paraplegia|SPG7-related disorder|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,16,89510539,89510539,SPG7,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 7|not provided|Proximal spinal muscular atrophy|Hereditary spastic paraplegia|SPG7-related disorder|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,16,89612620,89617763,SPG7,Pathogenic,Hereditary spastic paraplegia 7,Indel,GRCh37
na,na,16,89546212,89551355,SPG7,Pathogenic,Hereditary spastic paraplegia 7,Indel,GRCh38
na,na,16,89598369,89598369,SPG7,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 7|not provided|Hereditary spastic paraplegia|Inborn genetic diseases|Retinal dystrophy|SPG7-related disorder,single nucleotide variant,GRCh37
na,na,16,89531961,89531961,SPG7,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 7|not provided|Hereditary spastic paraplegia|Inborn genetic diseases|Retinal dystrophy|SPG7-related disorder,single nucleotide variant,GRCh38
na,na,16,89616987,89616987,SPG7,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 7|not provided,single nucleotide variant,GRCh37
na,na,16,89550579,89550579,SPG7,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 7|not provided,single nucleotide variant,GRCh38
na,na,10,112724120,112724120,SHOC2,Pathogenic,Noonan syndrome-like disorder with loose anagen hair 1|RASopathy|Noonan syndrome|not provided|Noonan syndrome-like disorder with loose anagen hair|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Noonan syndrome-like disorder with loose anagen hair 1;Pectus excavatum|Polycystic kidney disease 4|SHOC2-related disorder,single nucleotide variant,GRCh37
na,na,10,110964362,110964362,SHOC2,Pathogenic,Noonan syndrome-like disorder with loose anagen hair 1|RASopathy|Noonan syndrome|not provided|Noonan syndrome-like disorder with loose anagen hair|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Noonan syndrome-like disorder with loose anagen hair 1;Pectus excavatum|Polycystic kidney disease 4|SHOC2-related disorder,single nucleotide variant,GRCh38
na,na,17,56787287,56787287,RAD51C,Conflicting classifications of pathogenicity,"Fanconi anemia complementation group O|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 3|Hereditary breast ovarian cancer syndrome|Fanconi anemia complementation group O;Breast-ovarian cancer, familial, susceptibility to, 3|Familial ovarian cancer",single nucleotide variant,GRCh37
na,na,17,58709926,58709926,RAD51C,Conflicting classifications of pathogenicity,"Fanconi anemia complementation group O|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 3|Hereditary breast ovarian cancer syndrome|Fanconi anemia complementation group O;Breast-ovarian cancer, familial, susceptibility to, 3|Familial ovarian cancer",single nucleotide variant,GRCh38
na,na,17,56772520,56772520,RAD51C,Likely pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 3|not provided|Hereditary breast ovarian cancer syndrome|Fanconi anemia complementation group O",single nucleotide variant,GRCh37
na,na,17,58695159,58695159,RAD51C,Likely pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 3|not provided|Hereditary breast ovarian cancer syndrome|Fanconi anemia complementation group O",single nucleotide variant,GRCh38
na,na,17,56774063,56774063,RAD51C,Pathogenic/Likely pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group O|Fanconi anemia complementation group O;Breast-ovarian cancer, familial, susceptibility to, 3|not provided|Familial ovarian cancer",single nucleotide variant,GRCh37
na,na,17,58696702,58696702,RAD51C,Pathogenic/Likely pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 3|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group O|Fanconi anemia complementation group O;Breast-ovarian cancer, familial, susceptibility to, 3|not provided|Familial ovarian cancer",single nucleotide variant,GRCh38
na,na,17,77757535,77757535,CBX2,Pathogenic,"46,XY sex reversal 5",single nucleotide variant,GRCh37
na,na,17,79783736,79783736,CBX2,Pathogenic,"46,XY sex reversal 5",single nucleotide variant,GRCh38
na,na,17,77758570,77758570,CBX2,Pathogenic,"46,XY sex reversal 5",single nucleotide variant,GRCh37
na,na,17,79784771,79784771,CBX2,Pathogenic,"46,XY sex reversal 5",single nucleotide variant,GRCh38
na,na,19,39993644,39993648,LOC130064417;DLL3;PLEKHG2,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|Leukodystrophy and acquired microcephaly with or without dystonia;|not provided",Microsatellite,GRCh37
na,na,19,39502998,39502999,LOC130064417;DLL3;PLEKHG2,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|Leukodystrophy and acquired microcephaly with or without dystonia;|not provided",Microsatellite,GRCh38
na,na,19,39995943,39995944,DLL3,Pathogenic/Likely pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",Deletion,GRCh37
na,na,19,39505303,39505304,DLL3,Pathogenic/Likely pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",Deletion,GRCh38
na,na,19,39997739,39997739,DLL3,Uncertain significance,"Spondylocostal dysostosis 1, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,19,39507099,39507099,DLL3,Uncertain significance,"Spondylocostal dysostosis 1, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,19,39997869,39997870,DLL3,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",Duplication,GRCh37
na,na,19,39507229,39507230,DLL3,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",Duplication,GRCh38
na,na,19,39993660,39993660,DLL3,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",Deletion,GRCh37
na,na,19,39503020,39503020,DLL3,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",Deletion,GRCh38
na,na,19,39994770,39994770,DLL3,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,19,39504130,39504130,DLL3,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,19,39998025,39998025,DLL3,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive",Deletion,GRCh37
na,na,19,39507385,39507385,DLL3,Pathogenic,"Spondylocostal dysostosis 1, autosomal recessive",Deletion,GRCh38
na,na,19,39998096,39998096,DLL3,Pathogenic/Likely pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,19,39507456,39507456,DLL3,Pathogenic/Likely pathogenic,"Spondylocostal dysostosis 1, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,12,52760957,52760957,KRT85,Benign/Likely benign,"Ectodermal dysplasia 4, hair/nail type|not provided|not specified",single nucleotide variant,GRCh37
na,na,12,52367173,52367173,KRT85,Benign/Likely benign,"Ectodermal dysplasia 4, hair/nail type|not provided|not specified",single nucleotide variant,GRCh38
na,na,12,52709720,52709720,KRT83,Likely pathogenic,Monilethrix|not provided|Monilethrix-3,single nucleotide variant,GRCh37
na,na,12,52315936,52315936,KRT83,Likely pathogenic,Monilethrix|not provided|Monilethrix-3,single nucleotide variant,GRCh38
na,na,11,71954831,71954831,PHOX2A,Pathogenic,"Fibrosis of extraocular muscles, congenital, 2",single nucleotide variant,GRCh37
na,na,11,72243787,72243787,PHOX2A,Pathogenic,"Fibrosis of extraocular muscles, congenital, 2",single nucleotide variant,GRCh38
na,na,11,71951243,71951243,PHOX2A,Pathogenic,"Fibrosis of extraocular muscles, congenital, 2",single nucleotide variant,GRCh37
na,na,11,72240199,72240199,PHOX2A,Pathogenic,"Fibrosis of extraocular muscles, congenital, 2",single nucleotide variant,GRCh38
na,na,11,71954834,71954834,PHOX2A,Uncertain significance,"Fibrosis of extraocular muscles, congenital, 2",single nucleotide variant,GRCh37
na,na,11,72243790,72243790,PHOX2A,Uncertain significance,"Fibrosis of extraocular muscles, congenital, 2",single nucleotide variant,GRCh38
na,na,1,231401102,231401102,GNPAT,Pathogenic,Rhizomelic chondrodysplasia punctata type 2|not provided,single nucleotide variant,GRCh37
na,na,1,231265356,231265356,GNPAT,Pathogenic,Rhizomelic chondrodysplasia punctata type 2|not provided,single nucleotide variant,GRCh38
na,na,1,231401101,231401101,GNPAT,Likely pathogenic,Rhizomelic chondrodysplasia punctata type 2|Rhizomelic chondrodysplasia punctata,single nucleotide variant,GRCh37
na,na,1,231265355,231265355,GNPAT,Likely pathogenic,Rhizomelic chondrodysplasia punctata type 2|Rhizomelic chondrodysplasia punctata,single nucleotide variant,GRCh38
na,na,1,231401835,231401836,GNPAT,Pathogenic,Rhizomelic chondrodysplasia punctata type 2|not provided,Duplication,GRCh37
na,na,1,231266089,231266090,GNPAT,Pathogenic,Rhizomelic chondrodysplasia punctata type 2|not provided,Duplication,GRCh38
na,na,1,231401767,231401767,GNPAT,Pathogenic,Rhizomelic chondrodysplasia punctata type 2,Deletion,GRCh37
na,na,1,231266021,231266021,GNPAT,Pathogenic,Rhizomelic chondrodysplasia punctata type 2,Deletion,GRCh38
na,na,1,231408110,231408110,GNPAT,Pathogenic,Rhizomelic chondrodysplasia punctata type 2|not provided,Deletion,GRCh37
na,na,1,231272364,231272364,GNPAT,Pathogenic,Rhizomelic chondrodysplasia punctata type 2|not provided,Deletion,GRCh38
na,na,7,151273498,151273498,PRKAG2,Pathogenic,Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy 6|not provided|Primary familial hypertrophic cardiomyopathy|Lethal congenital glycogen storage disease of heart|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome,single nucleotide variant,GRCh37
na,na,7,151576412,151576412,PRKAG2,Pathogenic,Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy 6|not provided|Primary familial hypertrophic cardiomyopathy|Lethal congenital glycogen storage disease of heart|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome,single nucleotide variant,GRCh38
na,na,7,151265887,151265887,PRKAG2,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 6|not specified|not provided|Lethal congenital glycogen storage disease of heart,single nucleotide variant,GRCh37
na,na,7,151568801,151568801,PRKAG2,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 6|not specified|not provided|Lethal congenital glycogen storage disease of heart,single nucleotide variant,GRCh38
na,na,7,151269750,151269751,PRKAG2,Pathogenic,Hypertrophic cardiomyopathy 6,Insertion,GRCh37
na,na,7,151572664,151572665,PRKAG2,Pathogenic,Hypertrophic cardiomyopathy 6,Insertion,GRCh38
na,na,7,151265836,151265836,PRKAG2,Likely pathogenic,Hypertrophic cardiomyopathy 6|Hypertrophic cardiomyopathy|PRKAG2-related disorder,single nucleotide variant,GRCh37
na,na,7,151568750,151568750,PRKAG2,Likely pathogenic,Hypertrophic cardiomyopathy 6|Hypertrophic cardiomyopathy|PRKAG2-related disorder,single nucleotide variant,GRCh38
na,na,7,151261285,151261285,PRKAG2,Pathogenic,Hypertrophic cardiomyopathy 6,single nucleotide variant,GRCh37
na,na,7,151564199,151564199,PRKAG2,Pathogenic,Hypertrophic cardiomyopathy 6,single nucleotide variant,GRCh38
na,na,7,151257697,151257697,PRKAG2,Pathogenic,"Wolff-Parkinson-White syndrome, childhood-onset|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,7,151560611,151560611,PRKAG2,Pathogenic,"Wolff-Parkinson-White syndrome, childhood-onset|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,7,151257696,151257696,PRKAG2,Pathogenic,Lethal congenital glycogen storage disease of heart|Hypertrophic cardiomyopathy|not provided,single nucleotide variant,GRCh37
na,na,7,151560610,151560610,PRKAG2,Pathogenic,Lethal congenital glycogen storage disease of heart|Hypertrophic cardiomyopathy|not provided,single nucleotide variant,GRCh38
na,na,7,151261289,151261289,PRKAG2,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 6|not provided|Cardiomyopathy|Lethal congenital glycogen storage disease of heart|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,7,151564203,151564203,PRKAG2,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 6|not provided|Cardiomyopathy|Lethal congenital glycogen storage disease of heart|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,7,151257699,151257699,PRKAG2,Pathogenic,Hypertrophic cardiomyopathy 6|not provided|Lethal congenital glycogen storage disease of heart|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,7,151560613,151560613,PRKAG2,Pathogenic,Hypertrophic cardiomyopathy 6|not provided|Lethal congenital glycogen storage disease of heart|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,7,151261232,151261232,PRKAG2,Likely pathogenic,Hypertrophic cardiomyopathy 6|not provided|Hypertrophic cardiomyopathy,single nucleotide variant,GRCh37
na,na,7,151564146,151564146,PRKAG2,Likely pathogenic,Hypertrophic cardiomyopathy 6|not provided|Hypertrophic cardiomyopathy,single nucleotide variant,GRCh38
na,na,7,151257646,151257646,PRKAG2,Uncertain significance,Hypertrophic cardiomyopathy 6|Lethal congenital glycogen storage disease of heart,single nucleotide variant,GRCh37
na,na,7,151560560,151560560,PRKAG2,Uncertain significance,Hypertrophic cardiomyopathy 6|Lethal congenital glycogen storage disease of heart,single nucleotide variant,GRCh38
na,na,1,165652256,165652256,ALDH9A1,Affects,ALDH9A1*2 POLYMORPHISM,single nucleotide variant,GRCh37
na,na,1,165683019,165683019,ALDH9A1,Affects,ALDH9A1*2 POLYMORPHISM,single nucleotide variant,GRCh38
na,na,3,38518844,38518844,ACVR2B,Benign/Likely benign,"Heterotaxy, visceral, 4, autosomal|not specified|not provided",single nucleotide variant,GRCh37
na,na,3,38477353,38477353,ACVR2B,Benign/Likely benign,"Heterotaxy, visceral, 4, autosomal|not specified|not provided",single nucleotide variant,GRCh38
na,na,3,38524764,38524764,ACVR2B,Uncertain significance,"Heterotaxy, visceral, 4, autosomal|not provided",single nucleotide variant,GRCh37
na,na,3,38483273,38483273,ACVR2B,Uncertain significance,"Heterotaxy, visceral, 4, autosomal|not provided",single nucleotide variant,GRCh38
na,na,16,1499283,1499283,CLCN7,Pathogenic,Autosomal recessive osteopetrosis 4,single nucleotide variant,GRCh37
na,na,16,1449282,1449282,CLCN7,Pathogenic,Autosomal recessive osteopetrosis 4,single nucleotide variant,GRCh38
na,na,16,1497053,1497053,CLCN7,Pathogenic,Autosomal recessive osteopetrosis 4,single nucleotide variant,GRCh37
na,na,16,1447052,1447052,CLCN7,Pathogenic,Autosomal recessive osteopetrosis 4,single nucleotide variant,GRCh38
na,na,16,1497041,1497041,CLCN7,Pathogenic,Autosomal recessive osteopetrosis 4,single nucleotide variant,GRCh37
na,na,16,1447040,1447040,CLCN7,Pathogenic,Autosomal recessive osteopetrosis 4,single nucleotide variant,GRCh38
na,na,16,1497039,1497039,CLCN7,Pathogenic,Autosomal dominant osteopetrosis 2|Autosomal recessive osteopetrosis 4|not provided,single nucleotide variant,GRCh37
na,na,16,1447038,1447038,CLCN7,Pathogenic,Autosomal dominant osteopetrosis 2|Autosomal recessive osteopetrosis 4|not provided,single nucleotide variant,GRCh38
na,na,16,1507296,1507296,CLCN7,Pathogenic,Autosomal recessive osteopetrosis 4,single nucleotide variant,GRCh37
na,na,16,1457295,1457295,CLCN7,Pathogenic,Autosomal recessive osteopetrosis 4,single nucleotide variant,GRCh38
na,na,19,36322260,36322260,NPHS1,Pathogenic,Finnish congenital nephrotic syndrome|not provided,single nucleotide variant,GRCh37
na,na,19,35831358,35831358,NPHS1,Pathogenic,Finnish congenital nephrotic syndrome|not provided,single nucleotide variant,GRCh38
na,na,19,36339044,36339044,NPHS1,Conflicting classifications of pathogenicity,not specified|Finnish congenital nephrotic syndrome|Congenital nephrotic syndrome|Proteinuria|Focal segmental glomerulosclerosis|not provided,single nucleotide variant,GRCh37
na,na,19,35848142,35848142,NPHS1,Conflicting classifications of pathogenicity,not specified|Finnish congenital nephrotic syndrome|Congenital nephrotic syndrome|Proteinuria|Focal segmental glomerulosclerosis|not provided,single nucleotide variant,GRCh38
na,na,19,36321958,36321958,NPHS1,Pathogenic,Finnish congenital nephrotic syndrome|not provided|Nephrotic syndrome|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,35831056,35831056,NPHS1,Pathogenic,Finnish congenital nephrotic syndrome|not provided|Nephrotic syndrome|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,36340185,36340185,NPHS1,Pathogenic,Finnish congenital nephrotic syndrome,single nucleotide variant,GRCh37
na,na,19,35849283,35849283,NPHS1,Pathogenic,Finnish congenital nephrotic syndrome,single nucleotide variant,GRCh38
na,na,19,36333323,36333323,NPHS1,Pathogenic,Finnish congenital nephrotic syndrome|not provided,single nucleotide variant,GRCh37
na,na,19,35842421,35842421,NPHS1,Pathogenic,Finnish congenital nephrotic syndrome|not provided,single nucleotide variant,GRCh38
na,na,8,38884330,38884330,ADAM9,Pathogenic,Cone-rod dystrophy 9,single nucleotide variant,GRCh37
na,na,8,39026811,39026811,ADAM9,Pathogenic,Cone-rod dystrophy 9,single nucleotide variant,GRCh38
na,na,8,38880696,38880696,ADAM9,Pathogenic,Cone-rod dystrophy 9,single nucleotide variant,GRCh37
na,na,8,39023177,39023177,ADAM9,Pathogenic,Cone-rod dystrophy 9,single nucleotide variant,GRCh38
na,na,8,38874817,38874817,ADAM9,Pathogenic,Cone-rod dystrophy 9|not provided|Cone-rod dystrophy,single nucleotide variant,GRCh37
na,na,8,39017298,39017298,ADAM9,Pathogenic,Cone-rod dystrophy 9|not provided|Cone-rod dystrophy,single nucleotide variant,GRCh38
na,na,8,38874730,38874730,ADAM9,Pathogenic,Cone-rod dystrophy 9|Cone-rod dystrophy,single nucleotide variant,GRCh37
na,na,8,39017211,39017211,ADAM9,Pathogenic,Cone-rod dystrophy 9|Cone-rod dystrophy,single nucleotide variant,GRCh38
na,na,22,41533772,41533772,EP300,Pathogenic,Carcinoma of colon|Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,single nucleotide variant,GRCh37
na,na,22,41137768,41137768,EP300,Pathogenic,Carcinoma of colon|Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,single nucleotide variant,GRCh38
na,na,22,41574377,41574377,EP300,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh37
na,na,22,41178373,41178373,EP300,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh38
na,na,22,41537115,41537115,EP300,Pathogenic,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,single nucleotide variant,GRCh37
na,na,22,41141111,41141111,EP300,Pathogenic,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,single nucleotide variant,GRCh38
na,na,22,41547894,41547901,EP300,Pathogenic,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,Deletion,GRCh37
na,na,22,41151890,41151897,EP300,Pathogenic,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,Deletion,GRCh38
na,na,22,41092585,41117186,EP300,Pathogenic,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,Deletion,GRCh38
na,na,22,41574813,41574813,EP300,Pathogenic,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency|not provided,Deletion,GRCh37
na,na,22,41178809,41178809,EP300,Pathogenic,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency|not provided,Deletion,GRCh38
na,na,na,-1,-1,EP300,Pathogenic,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,Deletion,na
na,na,5,52978987,52978988,NDUFS4,Pathogenic/Likely pathogenic,"Mitochondrial complex I deficiency, nuclear type 1|Leigh syndrome|not provided",Duplication,GRCh37
na,na,5,53683157,53683158,NDUFS4,Pathogenic/Likely pathogenic,"Mitochondrial complex I deficiency, nuclear type 1|Leigh syndrome|not provided",Duplication,GRCh38
na,na,5,52942175,52942175,NDUFS4,Pathogenic,"Mitochondrial complex I deficiency, nuclear type 1|not provided|Leigh syndrome",Deletion,GRCh37
na,na,5,53646345,53646345,NDUFS4,Pathogenic,"Mitochondrial complex I deficiency, nuclear type 1|not provided|Leigh syndrome",Deletion,GRCh38
na,na,5,52942201,52942201,NDUFS4,Pathogenic,"Mitochondrial complex I deficiency|Mitochondrial complex I deficiency, nuclear type 1|Leigh syndrome|not provided",single nucleotide variant,GRCh37
na,na,5,53646371,53646371,NDUFS4,Pathogenic,"Mitochondrial complex I deficiency|Mitochondrial complex I deficiency, nuclear type 1|Leigh syndrome|not provided",single nucleotide variant,GRCh38
na,na,5,52856536,52856536,NDUFS4,Pathogenic,"Mitochondrial complex I deficiency, nuclear type 1",single nucleotide variant,GRCh37
na,na,5,53560706,53560706,NDUFS4,Pathogenic,"Mitochondrial complex I deficiency, nuclear type 1",single nucleotide variant,GRCh38
na,na,11,111958634,111958634,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh37
na,na,11,112087910,112087910,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh38
na,na,11,111958640,111958640,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|not provided|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh37
na,na,11,112087916,112087916,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|not provided|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh38
na,na,11,111957685,111957685,SDHD,Likely pathogenic,Paragangliomas 1|Pheochromocytoma,single nucleotide variant,GRCh37
na,na,11,112086961,112086961,SDHD,Likely pathogenic,Paragangliomas 1|Pheochromocytoma,single nucleotide variant,GRCh38
na,na,11,111957665,111957665,SDHD,Conflicting classifications of pathogenicity,"Cowden syndrome 3|Paragangliomas 1|Pheochromocytoma|not provided|not specified|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome|Mitochondrial complex 2 deficiency, nuclear type 3|Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Pheochromocytoma|Carney-Stratakis syndrome;Paragangliomas 1;Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary pheochromocytoma-paraganglioma",single nucleotide variant,GRCh37
na,na,11,112086941,112086941,SDHD,Conflicting classifications of pathogenicity,"Cowden syndrome 3|Paragangliomas 1|Pheochromocytoma|not provided|not specified|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome|Mitochondrial complex 2 deficiency, nuclear type 3|Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Pheochromocytoma|Carney-Stratakis syndrome;Paragangliomas 1;Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary pheochromocytoma-paraganglioma",single nucleotide variant,GRCh38
na,na,11,111959663,111959663,SDHD,Pathogenic/Likely pathogenic,"Pheochromocytoma|Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|not provided|Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 1;Pheochromocytoma;Carney-Stratakis syndrome|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Mitochondrial complex 2 deficiency, nuclear type 3|Mitochondrial complex 2 deficiency, nuclear type 3;Paragangliomas 1;Carney-Stratakis syndrome|SDHD-related disorder",single nucleotide variant,GRCh37
na,na,11,112088939,112088939,SDHD,Pathogenic/Likely pathogenic,"Pheochromocytoma|Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|not provided|Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 1;Pheochromocytoma;Carney-Stratakis syndrome|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Mitochondrial complex 2 deficiency, nuclear type 3|Mitochondrial complex 2 deficiency, nuclear type 3;Paragangliomas 1;Carney-Stratakis syndrome|SDHD-related disorder",single nucleotide variant,GRCh38
na,na,11,111959695,111959695,SDHD,Pathogenic/Likely pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas 4|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|not provided,single nucleotide variant,GRCh37
na,na,11,112088971,112088971,SDHD,Pathogenic/Likely pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas 4|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|not provided,single nucleotide variant,GRCh38
na,na,11,111959726,111959726,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh37
na,na,11,112089002,112089002,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh38
na,na,11,111965551,111965552,SDHD,Pathogenic,Paragangliomas 1,Insertion,GRCh37
na,na,11,112094827,112094828,SDHD,Pathogenic,Paragangliomas 1,Insertion,GRCh38
na,na,11,111965555,111965555,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|not provided|Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Pheochromocytoma,single nucleotide variant,GRCh37
na,na,11,112094831,112094831,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|not provided|Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Pheochromocytoma,single nucleotide variant,GRCh38
na,na,11,111958623,111958623,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,11,112087899,112087899,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,11,111965655,111965655,SDHD,Likely pathogenic,Paragangliomas 1,Deletion,GRCh37
na,na,11,112094931,112094931,SDHD,Likely pathogenic,Paragangliomas 1,Deletion,GRCh38
na,na,11,111958592,111958592,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Pheochromocytoma|not provided|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma,single nucleotide variant,GRCh37
na,na,11,112087868,112087868,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Pheochromocytoma|not provided|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma,single nucleotide variant,GRCh38
na,na,11,111959608,111959609,SDHD,Pathogenic,not provided|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss,Microsatellite,GRCh37
na,na,11,112088884,112088885,SDHD,Pathogenic,not provided|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss,Microsatellite,GRCh38
na,na,11,111959698,111959700,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,11,112088974,112088976,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,11,111957634,111957634,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome|not provided,single nucleotide variant,GRCh37
na,na,11,112086910,112086910,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome|not provided,single nucleotide variant,GRCh38
na,na,11,111965630,111965630,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|not provided,single nucleotide variant,GRCh37
na,na,11,112094906,112094906,SDHD,Pathogenic,Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|not provided,single nucleotide variant,GRCh38
na,na,11,111958620,111958621,SDHD,Pathogenic,"Paragangliomas 1|not provided|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Mitochondrial complex 2 deficiency, nuclear type 3;Paragangliomas 1;Carney-Stratakis syndrome",Microsatellite,GRCh37
na,na,11,112087896,112087897,SDHD,Pathogenic,"Paragangliomas 1|not provided|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Mitochondrial complex 2 deficiency, nuclear type 3;Paragangliomas 1;Carney-Stratakis syndrome",Microsatellite,GRCh38
na,na,11,111958677,111958677,SDHD,Benign/Likely benign,"Carcinoid tumor of intestine|Pheochromocytoma|not provided|not specified|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carney-Stratakis syndrome|Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Pheochromocytoma|SDHD-related disorder|Carney-Stratakis syndrome;Paragangliomas 1;Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary pheochromocytoma-paraganglioma",single nucleotide variant,GRCh37
na,na,11,112087953,112087953,SDHD,Benign/Likely benign,"Carcinoid tumor of intestine|Pheochromocytoma|not provided|not specified|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carney-Stratakis syndrome|Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Pheochromocytoma|SDHD-related disorder|Carney-Stratakis syndrome;Paragangliomas 1;Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary pheochromocytoma-paraganglioma",single nucleotide variant,GRCh38
na,na,11,111965677,111965677,SDHD,Uncertain significance,Paragangliomas 1|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,11,112094953,112094953,SDHD,Uncertain significance,Paragangliomas 1|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,11,111957632,111957632,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh37
na,na,11,112086908,112086908,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh38
na,na,11,111965548,111965551,SDHD,Pathogenic,"Paragangliomas 1|not provided|Mitochondrial complex 2 deficiency, nuclear type 3;Paragangliomas 1;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome",Deletion,GRCh37
na,na,11,112094824,112094827,SDHD,Pathogenic,"Paragangliomas 1|not provided|Mitochondrial complex 2 deficiency, nuclear type 3;Paragangliomas 1;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome",Deletion,GRCh38
na,na,11,111958657,111958657,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|not provided|Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss,single nucleotide variant,GRCh37
na,na,11,112087933,112087933,SDHD,Pathogenic,Paragangliomas 1|Hereditary cancer-predisposing syndrome|not provided|Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss,single nucleotide variant,GRCh38
na,na,11,111957571,111966518,SDHD,Pathogenic,Paragangliomas 1,Deletion,GRCh37
na,na,11,111957664,111957664,SDHD,Pathogenic,Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh37
na,na,11,112086940,112086940,SDHD,Pathogenic,Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh38
na,na,11,111957645,111957645,SDHD,Pathogenic,Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh37
na,na,11,112086921,112086921,SDHD,Pathogenic,Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome,single nucleotide variant,GRCh38
na,na,11,111958585,111958585,SDHD,Pathogenic,"Carney-Stratakis syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma|Mitochondrial complex 2 deficiency, nuclear type 3;Paragangliomas 1;Carney-Stratakis syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome",Deletion,GRCh37
na,na,11,112087861,112087861,SDHD,Pathogenic,"Carney-Stratakis syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma|Mitochondrial complex 2 deficiency, nuclear type 3;Paragangliomas 1;Carney-Stratakis syndrome|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome",Deletion,GRCh38
na,na,11,111965647,111965647,SDHD,Uncertain significance,"Cowden syndrome 3|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary cancer-predisposing syndrome|Mitochondrial complex 2 deficiency, nuclear type 3",single nucleotide variant,GRCh37
na,na,11,112094923,112094923,SDHD,Uncertain significance,"Cowden syndrome 3|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome|Hereditary cancer-predisposing syndrome|Mitochondrial complex 2 deficiency, nuclear type 3",single nucleotide variant,GRCh38
na,na,7,1937887,1937887,MAD1L1,Pathogenic,"LYMPHOMA, DIFFUSE LARGE B-CELL, SOMATIC",single nucleotide variant,GRCh37
na,na,7,1898251,1898251,MAD1L1,Pathogenic,"LYMPHOMA, DIFFUSE LARGE B-CELL, SOMATIC",single nucleotide variant,GRCh38
na,na,7,2265161,2265161,MAD1L1,Benign/Likely benign,"Prostate cancer, somatic|Prostate cancer|not provided",single nucleotide variant,GRCh37
na,na,7,2225526,2225526,MAD1L1,Benign/Likely benign,"Prostate cancer, somatic|Prostate cancer|not provided",single nucleotide variant,GRCh38
na,na,11,118896009,118896009,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect|not provided,single nucleotide variant,GRCh37
na,na,11,119025299,119025299,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect|not provided,single nucleotide variant,GRCh38
na,na,11,118895961,118895961,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect,single nucleotide variant,GRCh37
na,na,11,119025251,119025251,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect,single nucleotide variant,GRCh38
na,na,11,118898933,118898933,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect|not provided,single nucleotide variant,GRCh37
na,na,11,119028223,119028223,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect|not provided,single nucleotide variant,GRCh38
na,na,11,118896733,118896736,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect,Indel,GRCh37
na,na,11,119026023,119026026,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect,Indel,GRCh38
na,na,11,118895981,118895982,SLC37A4,Pathogenic,"Phosphate transport defect|Glucose-6-phosphate transport defect|Inborn genetic diseases|Glycogen storage disease|not provided|Congenital disorder of glycosylation, type IIw|Phosphate transport defect;Congenital disorder of glycosylation, type IIw;Glucose-6-phosphate transport defect|Glycogen storage disease, type I",Deletion,GRCh37
na,na,11,119025271,119025272,SLC37A4,Pathogenic,"Phosphate transport defect|Glucose-6-phosphate transport defect|Inborn genetic diseases|Glycogen storage disease|not provided|Congenital disorder of glycosylation, type IIw|Phosphate transport defect;Congenital disorder of glycosylation, type IIw;Glucose-6-phosphate transport defect|Glycogen storage disease, type I",Deletion,GRCh38
na,na,11,118898998,118898998,SLC37A4,Pathogenic,Phosphate transport defect|Glucose-6-phosphate transport defect,single nucleotide variant,GRCh37
na,na,11,119028288,119028288,SLC37A4,Pathogenic,Phosphate transport defect|Glucose-6-phosphate transport defect,single nucleotide variant,GRCh38
na,na,11,118897723,118897725,SLC37A4,Likely pathogenic,Glucose-6-phosphate transport defect,Microsatellite,GRCh37
na,na,11,119027013,119027015,SLC37A4,Likely pathogenic,Glucose-6-phosphate transport defect,Microsatellite,GRCh38
na,na,11,118897312,118897312,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect,single nucleotide variant,GRCh37
na,na,11,119026602,119026602,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect,single nucleotide variant,GRCh38
na,na,11,118899931,118899931,SLC37A4,Pathogenic/Likely pathogenic,"Glucose-6-phosphate transport defect|Glucose-6-phosphate transport defect;Phosphate transport defect;Congenital disorder of glycosylation, type IIw|Phosphate transport defect",single nucleotide variant,GRCh37
na,na,11,119029221,119029221,SLC37A4,Pathogenic/Likely pathogenic,"Glucose-6-phosphate transport defect|Glucose-6-phosphate transport defect;Phosphate transport defect;Congenital disorder of glycosylation, type IIw|Phosphate transport defect",single nucleotide variant,GRCh38
na,na,11,118899997,118899997,SLC37A4,Pathogenic,"Glucose-6-phosphate transport defect|not provided|Glucose-6-phosphate transport defect;Congenital disorder of glycosylation, type IIw;Phosphate transport defect",single nucleotide variant,GRCh37
na,na,11,119029287,119029287,SLC37A4,Pathogenic,"Glucose-6-phosphate transport defect|not provided|Glucose-6-phosphate transport defect;Congenital disorder of glycosylation, type IIw;Phosphate transport defect",single nucleotide variant,GRCh38
na,na,11,118895667,118895667,SLC37A4,Pathogenic/Likely pathogenic,"Glucose-6-phosphate transport defect|Phosphate transport defect|Glucose-6-phosphate transport defect;Congenital disorder of glycosylation, type IIw;Phosphate transport defect|Congenital disorder of glycosylation, type IIw",single nucleotide variant,GRCh37
na,na,11,119024957,119024957,SLC37A4,Pathogenic/Likely pathogenic,"Glucose-6-phosphate transport defect|Phosphate transport defect|Glucose-6-phosphate transport defect;Congenital disorder of glycosylation, type IIw;Phosphate transport defect|Congenital disorder of glycosylation, type IIw",single nucleotide variant,GRCh38
na,na,11,118896008,118896008,SLC37A4,Pathogenic/Likely pathogenic,"Glucose-6-phosphate transport defect|not provided|Phosphate transport defect;Congenital disorder of glycosylation, type IIw;Glucose-6-phosphate transport defect",single nucleotide variant,GRCh37
na,na,11,119025298,119025298,SLC37A4,Pathogenic/Likely pathogenic,"Glucose-6-phosphate transport defect|not provided|Phosphate transport defect;Congenital disorder of glycosylation, type IIw;Glucose-6-phosphate transport defect",single nucleotide variant,GRCh38
na,na,11,118898338,118898338,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect,single nucleotide variant,GRCh37
na,na,11,119027628,119027628,SLC37A4,Pathogenic,Glucose-6-phosphate transport defect,single nucleotide variant,GRCh38
na,na,10,103991800,103991800,PITX3,Likely pathogenic,Cataract 11 multiple types|not provided,single nucleotide variant,GRCh37
na,na,10,102232043,102232043,PITX3,Likely pathogenic,Cataract 11 multiple types|not provided,single nucleotide variant,GRCh38
na,na,10,103990530,103990530,PITX3,Pathogenic,"Cataract 11, posterior polar, with microphthalmia and neurodevelopmental abnormalities|Cataract 11, posterior polar",Deletion,GRCh37
na,na,10,102230773,102230773,PITX3,Pathogenic,"Cataract 11, posterior polar, with microphthalmia and neurodevelopmental abnormalities|Cataract 11, posterior polar",Deletion,GRCh38
na,na,8,90983442,90983446,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Microcephaly;Lissencephaly|not provided|Microcephaly, normal intelligence and immunodeficiency;Familial cancer of breast|Breast carcinoma|Breast and/or ovarian cancer|Malignant tumor of breast|Hepatocellular carcinoma|Carcinoma of pancreas|Aplastic anemia|NBN-related disorder|Familial prostate cancer|Microcephaly, normal intelligence and immunodeficiency;Acute lymphoid leukemia;Aplastic anemia",Deletion,GRCh37
na,na,8,89971214,89971218,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Microcephaly;Lissencephaly|not provided|Microcephaly, normal intelligence and immunodeficiency;Familial cancer of breast|Breast carcinoma|Breast and/or ovarian cancer|Malignant tumor of breast|Hepatocellular carcinoma|Carcinoma of pancreas|Aplastic anemia|NBN-related disorder|Familial prostate cancer|Microcephaly, normal intelligence and immunodeficiency;Acute lymphoid leukemia;Aplastic anemia",Deletion,GRCh38
na,na,8,90982649,90982652,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Aplastic anemia",Deletion,GRCh37
na,na,8,89970421,89970424,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Aplastic anemia",Deletion,GRCh38
na,na,8,90982645,90982646,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome",Duplication,GRCh37
na,na,8,89970417,89970418,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome",Duplication,GRCh38
na,na,8,90976656,90976656,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,8,89964428,89964428,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,8,90990521,90990521,NBN,Conflicting classifications of pathogenicity,"Aplastic anemia|Leukemia, acute lymphoblastic, susceptibility to|Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not specified|Acute lymphoid leukemia|not provided|Hereditary breast ovarian cancer syndrome|Breast carcinoma|Carcinoma of colon|Hereditary cancer|NBN-related disorder|Diffuse midline glioma, H3 K27-altered|Pediatric high-grade glioma",single nucleotide variant,GRCh37
na,na,8,89978293,89978293,NBN,Conflicting classifications of pathogenicity,"Aplastic anemia|Leukemia, acute lymphoblastic, susceptibility to|Hereditary cancer-predisposing syndrome|Microcephaly, normal intelligence and immunodeficiency|not specified|Acute lymphoid leukemia|not provided|Hereditary breast ovarian cancer syndrome|Breast carcinoma|Carcinoma of colon|Hereditary cancer|NBN-related disorder|Diffuse midline glioma, H3 K27-altered|Pediatric high-grade glioma",single nucleotide variant,GRCh38
na,na,8,90970988,90970988,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Aplastic anemia|not provided",single nucleotide variant,GRCh37
na,na,8,89958760,89958760,NBN,Pathogenic,"Microcephaly, normal intelligence and immunodeficiency|Aplastic anemia|not provided",single nucleotide variant,GRCh38
na,na,8,90983460,90983460,NBN,Conflicting classifications of pathogenicity,"Microcephaly, normal intelligence and immunodeficiency|not specified|Hereditary cancer-predisposing syndrome|not provided|NBN-related disorder",single nucleotide variant,GRCh37
na,na,8,89971232,89971232,NBN,Conflicting classifications of pathogenicity,"Microcephaly, normal intelligence and immunodeficiency|not specified|Hereditary cancer-predisposing syndrome|not provided|NBN-related disorder",single nucleotide variant,GRCh38
na,na,8,90982745,90982746,NBN,Pathogenic/Likely pathogenic,"Microcephaly, normal intelligence and immunodeficiency|not provided|Hereditary cancer-predisposing syndrome",Duplication,GRCh37
na,na,8,89970517,89970518,NBN,Pathogenic/Likely pathogenic,"Microcephaly, normal intelligence and immunodeficiency|not provided|Hereditary cancer-predisposing syndrome",Duplication,GRCh38
na,na,17,18049249,18049249,MYO15A,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 3|Nonsyndromic genetic hearing loss|not provided,single nucleotide variant,GRCh37
na,na,17,18145935,18145935,MYO15A,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 3|Nonsyndromic genetic hearing loss|not provided,single nucleotide variant,GRCh38
na,na,17,18049243,18049243,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh37
na,na,17,18145929,18145929,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh38
na,na,17,18055173,18055173,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh37
na,na,17,18151859,18151859,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh38
na,na,17,18027872,18027872,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh37
na,na,17,18124558,18124558,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh38
na,na,17,18028546,18028546,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3|not provided,single nucleotide variant,GRCh37
na,na,17,18125232,18125232,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3|not provided,single nucleotide variant,GRCh38
na,na,17,18057504,18057504,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh37
na,na,17,18154190,18154190,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh38
na,na,17,18051447,18051447,MYO15A,Conflicting classifications of pathogenicity,"Deafness, with smith-magenis syndrome|not specified|not provided|Autosomal recessive nonsyndromic hearing loss 3|Nonsyndromic genetic hearing loss",single nucleotide variant,GRCh37
na,na,17,18148133,18148133,MYO15A,Conflicting classifications of pathogenicity,"Deafness, with smith-magenis syndrome|not specified|not provided|Autosomal recessive nonsyndromic hearing loss 3|Nonsyndromic genetic hearing loss",single nucleotide variant,GRCh38
na,na,17,18025427,18025427,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh37
na,na,17,18122113,18122113,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh38
na,na,17,18025448,18025448,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3|not provided,Deletion,GRCh37
na,na,17,18122134,18122134,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3|not provided,Deletion,GRCh38
na,na,17,18044418,18044418,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh37
na,na,17,18141104,18141104,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh38
na,na,17,18061836,18061836,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh37
na,na,17,18158522,18158522,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,single nucleotide variant,GRCh38
na,na,17,18082164,18082164,MYO15A,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 3|MYO15A-related disorder|not provided,Deletion,GRCh37
na,na,17,18178850,18178850,MYO15A,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 3|MYO15A-related disorder|not provided,Deletion,GRCh38
na,na,17,18070911,18070914,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,Deletion,GRCh37
na,na,17,18167597,18167600,MYO15A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 3,Deletion,GRCh38
na,na,16,90001643,90001643,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|not provided",single nucleotide variant,GRCh37
na,na,16,89935235,89935235,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|not provided",single nucleotide variant,GRCh38
na,na,16,90001763,90001763,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|not provided",single nucleotide variant,GRCh37
na,na,16,89935355,89935355,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|not provided",single nucleotide variant,GRCh38
na,na,16,90002108,90002108,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",single nucleotide variant,GRCh37
na,na,16,89935700,89935700,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",single nucleotide variant,GRCh38
na,na,16,90002108,90002108,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|not provided|Complex cortical dysplasia with other brain malformations 1|TUBB3-related tubulinopathy",single nucleotide variant,GRCh37
na,na,16,89935700,89935700,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|not provided|Complex cortical dysplasia with other brain malformations 1|TUBB3-related tubulinopathy",single nucleotide variant,GRCh38
na,na,16,90002087,90002087,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|Complex cortical dysplasia with other brain malformations 1|TUBB3-Releated Disorders|not provided|TUBB3-related disorder",single nucleotide variant,GRCh37
na,na,16,89935679,89935679,TUBB3,Pathogenic,"Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement|Complex cortical dysplasia with other brain malformations 1|TUBB3-Releated Disorders|not provided|TUBB3-related disorder",single nucleotide variant,GRCh38
na,na,8,119932595,120030098,TNFRSF11B,Pathogenic,Hyperphosphatasemia with bone disease,Deletion,GRCh37
na,na,8,118920356,119017859,TNFRSF11B,Pathogenic,Hyperphosphatasemia with bone disease,Deletion,GRCh38
na,na,8,119941023,119941025,TNFRSF11B,Pathogenic,Hyperphosphatasemia with bone disease,Deletion,GRCh37
na,na,8,118928784,118928786,TNFRSF11B,Pathogenic,Hyperphosphatasemia with bone disease,Deletion,GRCh38
na,na,8,119945310,119945310,TNFRSF11B,Pathogenic,Hyperphosphatasemia with bone disease,single nucleotide variant,GRCh37
na,na,8,118933071,118933071,TNFRSF11B,Pathogenic,Hyperphosphatasemia with bone disease,single nucleotide variant,GRCh38
na,na,8,119945221,119945221,TNFRSF11B,Uncertain significance,Hyperphosphatasemia with bone disease|not provided,single nucleotide variant,GRCh37
na,na,8,118932982,118932982,TNFRSF11B,Uncertain significance,Hyperphosphatasemia with bone disease|not provided,single nucleotide variant,GRCh38
na,na,8,119936850,119936853,TNFRSF11B,Pathogenic,Hyperphosphatasemia with bone disease,Indel,GRCh37
na,na,8,118924611,118924614,TNFRSF11B,Pathogenic,Hyperphosphatasemia with bone disease,Indel,GRCh38
na,na,13,43175121,43175125,TNFSF11,Pathogenic,Autosomal recessive osteopetrosis 2,Deletion,GRCh37
na,na,13,42600985,42600989,TNFSF11,Pathogenic,Autosomal recessive osteopetrosis 2,Deletion,GRCh38
na,na,13,43180696,43180696,TNFSF11,Pathogenic,Autosomal recessive osteopetrosis 2,single nucleotide variant,GRCh37
na,na,13,42606560,42606560,TNFSF11,Pathogenic,Autosomal recessive osteopetrosis 2,single nucleotide variant,GRCh38
na,na,13,43180928,43180929,TNFSF11,Pathogenic,Autosomal recessive osteopetrosis 2,Deletion,GRCh37
na,na,13,42606792,42606793,TNFSF11,Pathogenic,Autosomal recessive osteopetrosis 2,Deletion,GRCh38
na,na,na,-1,-1,SLC22A18,Pathogenic,Breast adenocarcinoma,Insertion,na
na,na,11,2930440,2930440,SLC67A1,Conflicting classifications of pathogenicity,"Rhabdomyosarcoma, somatic|SLC22A18-related disorder",single nucleotide variant,GRCh37
na,na,11,2909210,2909210,SLC67A1,Conflicting classifications of pathogenicity,"Rhabdomyosarcoma, somatic|SLC22A18-related disorder",single nucleotide variant,GRCh38
na,na,11,2939260,2939260,SLC22A18,Pathogenic,Lung carcinoma,single nucleotide variant,GRCh37
na,na,11,2918030,2918030,SLC22A18,Pathogenic,Lung carcinoma,single nucleotide variant,GRCh38
na,na,18,3456418,3456418,TGIF1,Conflicting classifications of pathogenicity,Holoprosencephaly 4|not specified,single nucleotide variant,GRCh37
na,na,18,3456420,3456420,TGIF1,Conflicting classifications of pathogenicity,Holoprosencephaly 4|not specified,single nucleotide variant,GRCh38
na,na,18,3456523,3456523,TGIF1,Pathogenic,Holoprosencephaly 4,single nucleotide variant,GRCh37
na,na,18,3456525,3456525,TGIF1,Pathogenic,Holoprosencephaly 4,single nucleotide variant,GRCh38
na,na,18,3457570,3457570,TGIF1,Benign/Likely benign,Holoprosencephaly 4|not specified,single nucleotide variant,GRCh37
na,na,18,3457572,3457572,TGIF1,Benign/Likely benign,Holoprosencephaly 4|not specified,single nucleotide variant,GRCh38
na,na,18,3457604,3457604,TGIF1,Uncertain significance,Holoprosencephaly 4,single nucleotide variant,GRCh37
na,na,18,3457606,3457606,TGIF1,Uncertain significance,Holoprosencephaly 4,single nucleotide variant,GRCh38
na,na,18,3452154,3452154,TGIF1,Pathogenic,Holoprosencephaly 4,single nucleotide variant,GRCh37
na,na,18,3452156,3452156,TGIF1,Pathogenic,Holoprosencephaly 4,single nucleotide variant,GRCh38
na,na,18,3457439,3457439,TGIF1,Benign/Likely benign,Holoprosencephaly 4|not specified|not provided,single nucleotide variant,GRCh37
na,na,18,3457441,3457441,TGIF1,Benign/Likely benign,Holoprosencephaly 4|not specified|not provided,single nucleotide variant,GRCh38
na,na,6,35607571,35607571,FKBP5,drug response; risk factor,"|Antidepressant drug treatment, accelerated response to",single nucleotide variant,GRCh37
na,na,6,35639794,35639794,FKBP5,drug response; risk factor,"|Antidepressant drug treatment, accelerated response to",single nucleotide variant,GRCh38
na,na,9,100616390,100616390,FOXE1,Pathogenic,Bamforth-Lazarus syndrome,single nucleotide variant,GRCh37
na,na,9,97854108,97854108,FOXE1,Pathogenic,Bamforth-Lazarus syndrome,single nucleotide variant,GRCh38
na,na,9,100616366,100616366,FOXE1,Pathogenic,Bamforth-Lazarus syndrome,single nucleotide variant,GRCh37
na,na,9,97854084,97854084,FOXE1,Pathogenic,Bamforth-Lazarus syndrome,single nucleotide variant,GRCh38
na,na,9,100616500,100616500,FOXE1,Pathogenic,Bamforth-Lazarus syndrome,single nucleotide variant,GRCh37
na,na,9,97854218,97854218,FOXE1,Pathogenic,Bamforth-Lazarus syndrome,single nucleotide variant,GRCh38
na,na,14,50088855,50088855,MGAT2,Uncertain significance,MGAT2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,14,49622137,49622137,MGAT2,Uncertain significance,MGAT2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,14,50088771,50088771,MGAT2,Pathogenic,MGAT2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,14,49622053,49622053,MGAT2,Pathogenic,MGAT2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,14,50088938,50088938,MGAT2,Pathogenic,MGAT2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,14,49622220,49622220,MGAT2,Pathogenic,MGAT2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,14,50089003,50089003,MGAT2,Pathogenic,MGAT2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,14,49622285,49622285,MGAT2,Pathogenic,MGAT2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,5,71015730,71015730,CARTPT,Uncertain significance,Obesity,single nucleotide variant,GRCh37
na,na,5,71719903,71719903,CARTPT,Uncertain significance,Obesity,single nucleotide variant,GRCh38
na,na,12,10313448,10313448,OLR1,Benign; risk factor,"Myocardial infarction, susceptibility to|OLR1-related disorder",single nucleotide variant,GRCh37
na,na,12,10160849,10160849,OLR1,Benign; risk factor,"Myocardial infarction, susceptibility to|OLR1-related disorder",single nucleotide variant,GRCh38
na,na,12,10312291,10312291,OLR1,risk factor,"Myocardial infarction, susceptibility to",single nucleotide variant,GRCh37
na,na,12,10159692,10159692,OLR1,risk factor,"Myocardial infarction, susceptibility to",single nucleotide variant,GRCh38
na,na,1,53712727,53712727,LRP8,risk factor,"Myocardial infarction, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,1,53247055,53247055,LRP8,risk factor,"Myocardial infarction, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,6,31084749,31084749,CDSN,Pathogenic,Hypotrichosis 2,single nucleotide variant,GRCh37
na,na,6,31116972,31116972,CDSN,Pathogenic,Hypotrichosis 2,single nucleotide variant,GRCh38
na,na,6,31084794,31084794,CDSN,Pathogenic,Hypotrichosis 2,single nucleotide variant,GRCh37
na,na,6,31117017,31117017,CDSN,Pathogenic,Hypotrichosis 2,single nucleotide variant,GRCh38
na,na,7,2564935,2564935,LFNG,Pathogenic,"Spondylocostal dysostosis 3, autosomal recessive|Spondylocostal dysostosis 2, autosomal recessive",single nucleotide variant,GRCh37
na,na,7,2525301,2525301,LFNG,Pathogenic,"Spondylocostal dysostosis 3, autosomal recessive|Spondylocostal dysostosis 2, autosomal recessive",single nucleotide variant,GRCh38
na,na,9,129455868,129455868,LMX1B,Pathogenic/Likely pathogenic,Nail-patella syndrome|not provided|Nail-patella syndrome;Nail-patella-like renal disease,single nucleotide variant,GRCh37
na,na,9,126693589,126693589,LMX1B,Pathogenic/Likely pathogenic,Nail-patella syndrome|not provided|Nail-patella syndrome;Nail-patella-like renal disease,single nucleotide variant,GRCh38
na,na,9,129455522,129455522,LMX1B,Pathogenic,Nail-patella syndrome|not provided,single nucleotide variant,GRCh37
na,na,9,126693243,126693243,LMX1B,Pathogenic,Nail-patella syndrome|not provided,single nucleotide variant,GRCh38
na,na,9,129455826,129455827,LMX1B,Pathogenic,Nail-patella syndrome,Duplication,GRCh37
na,na,9,126693547,126693548,LMX1B,Pathogenic,Nail-patella syndrome,Duplication,GRCh38
na,na,9,129453141,129453141,LMX1B,Pathogenic,Nail-patella syndrome,single nucleotide variant,GRCh37
na,na,9,126690862,126690862,LMX1B,Pathogenic,Nail-patella syndrome,single nucleotide variant,GRCh38
na,na,9,129377824,129377825,LMX1B,Pathogenic,Nail-patella syndrome|not provided,Deletion,GRCh37
na,na,9,126615545,126615546,LMX1B,Pathogenic,Nail-patella syndrome|not provided,Deletion,GRCh38
na,na,9,129377766,129377766,LMX1B,Pathogenic,Nail-patella syndrome|not provided|Nail-patella syndrome;Nail-patella-like renal disease,single nucleotide variant,GRCh37
na,na,9,126615487,126615487,LMX1B,Pathogenic,Nail-patella syndrome|not provided|Nail-patella syndrome;Nail-patella-like renal disease,single nucleotide variant,GRCh38
na,na,9,129455552,129455552,LMX1B,Pathogenic,Nail-patella syndrome|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,126693273,126693273,LMX1B,Pathogenic,Nail-patella syndrome|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,129455529,129455529,LMX1B,Pathogenic,Nail-patella syndrome|not provided|LMX1B-related disorder|Nail-patella syndrome;Nail-patella-like renal disease,single nucleotide variant,GRCh37
na,na,9,126693250,126693250,LMX1B,Pathogenic,Nail-patella syndrome|not provided|LMX1B-related disorder|Nail-patella syndrome;Nail-patella-like renal disease,single nucleotide variant,GRCh38
na,na,9,129455603,129455603,LMX1B,Pathogenic,Nail-patella syndrome,single nucleotide variant,GRCh37
na,na,9,126693324,126693324,LMX1B,Pathogenic,Nail-patella syndrome,single nucleotide variant,GRCh38
na,na,9,129455806,129455806,LMX1B,Pathogenic,Nail-patella syndrome|not provided,single nucleotide variant,GRCh37
na,na,9,126693527,126693527,LMX1B,Pathogenic,Nail-patella syndrome|not provided,single nucleotide variant,GRCh38
na,na,9,129377617,129377633,LMX1B,Pathogenic,Nail-patella syndrome,Deletion,GRCh37
na,na,9,126615338,126615354,LMX1B,Pathogenic,Nail-patella syndrome,Deletion,GRCh38
na,na,9,126507040,126804072,LMX1B,Pathogenic,Nail-patella syndrome,Deletion,GRCh38
na,na,11,121037361,121037361,TECTA,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,11,121166652,121166652,TECTA,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,11,121038785,121038785,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh37
na,na,11,121168076,121168076,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh38
na,na,11,121000921,121000921,TECTA,Pathogenic,"Deafness, neurosensory autosomal recessive 21|Autosomal dominant nonsyndromic hearing loss 12;Autosomal recessive nonsyndromic hearing loss 21|not provided",single nucleotide variant,GRCh37
na,na,11,121130212,121130212,TECTA,Pathogenic,"Deafness, neurosensory autosomal recessive 21|Autosomal dominant nonsyndromic hearing loss 12;Autosomal recessive nonsyndromic hearing loss 21|not provided",single nucleotide variant,GRCh38
na,na,11,121008357,121008357,TECTA,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 12|not provided,single nucleotide variant,GRCh37
na,na,11,121137648,121137648,TECTA,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 12|not provided,single nucleotide variant,GRCh38
na,na,11,121031010,121031010,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh37
na,na,11,121160301,121160301,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh38
na,na,11,120984286,120984287,TECTA,Pathogenic,"Deafness, neurosensory autosomal recessive 21",Duplication,GRCh37
na,na,11,121113577,121113578,TECTA,Pathogenic,"Deafness, neurosensory autosomal recessive 21",Duplication,GRCh38
na,na,11,121058577,121058577,TECTA,Pathogenic,"Deafness, neurosensory autosomal recessive 21",Deletion,GRCh37
na,na,11,121187868,121187868,TECTA,Pathogenic,"Deafness, neurosensory autosomal recessive 21",Deletion,GRCh38
na,na,11,121037412,121037412,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh37
na,na,11,121166703,121166703,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh38
na,na,11,121058603,121058603,TECTA,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 12|not provided|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh37
na,na,11,121187894,121187894,TECTA,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 12|not provided|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh38
na,na,11,121038844,121038844,TECTA,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 12|not provided|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh37
na,na,11,121168135,121168135,TECTA,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 12|not provided|Nonsyndromic genetic hearing loss,single nucleotide variant,GRCh38
na,na,11,121037412,121037412,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh37
na,na,11,121166703,121166703,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh38
na,na,11,121036040,121036040,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh37
na,na,11,121165331,121165331,TECTA,Pathogenic,Autosomal dominant nonsyndromic hearing loss 12,single nucleotide variant,GRCh38
na,na,5,176053473,176053473,SNCB,Pathogenic,Lewy body dementia,single nucleotide variant,GRCh37
na,na,5,176626472,176626472,SNCB,Pathogenic,Lewy body dementia,single nucleotide variant,GRCh38
na,na,5,176048219,176048219,SNCB,Conflicting classifications of pathogenicity,Lewy body dementia|not provided|SNCB-related disorder,single nucleotide variant,GRCh37
na,na,5,176621218,176621218,SNCB,Conflicting classifications of pathogenicity,Lewy body dementia|not provided|SNCB-related disorder,single nucleotide variant,GRCh38
na,na,na,-1,-1,MTRR,Pathogenic,Methylcobalamin deficiency type cblE,Deletion,na
na,na,5,7897025,7897027,MTRR,Pathogenic,Methylcobalamin deficiency type cblE,Microsatellite,GRCh37
na,na,5,7896912,7896914,MTRR,Pathogenic,Methylcobalamin deficiency type cblE,Microsatellite,GRCh38
na,na,5,7870973,7870973,MTRR,Benign/Likely benign,"Down syndrome, susceptibility to|Neural tube defects, folate-sensitive, susceptibility to|Gastrointestinal stromal tumor|not specified|Disorders of Intracellular Cobalamin Metabolism|Methylcobalamin deficiency type cblE|not provided|Methotrexate response",single nucleotide variant,GRCh37
na,na,5,7870860,7870860,MTRR,Benign/Likely benign,"Down syndrome, susceptibility to|Neural tube defects, folate-sensitive, susceptibility to|Gastrointestinal stromal tumor|not specified|Disorders of Intracellular Cobalamin Metabolism|Methylcobalamin deficiency type cblE|not provided|Methotrexate response",single nucleotide variant,GRCh38
na,na,5,7892928,7892928,MTRR,Pathogenic/Likely pathogenic,"Methylcobalamin deficiency type cblE|Inborn genetic diseases|not provided|Neural tube defects, folate-sensitive",single nucleotide variant,GRCh37
na,na,5,7892815,7892815,MTRR,Pathogenic/Likely pathogenic,"Methylcobalamin deficiency type cblE|Inborn genetic diseases|not provided|Neural tube defects, folate-sensitive",single nucleotide variant,GRCh38
na,na,5,7895909,7895910,MTRR,Pathogenic,Methylcobalamin deficiency type cblE,Duplication,GRCh37
na,na,5,7895796,7895797,MTRR,Pathogenic,Methylcobalamin deficiency type cblE,Duplication,GRCh38
na,na,5,7891518,7891518,MTRR,Pathogenic,"Methylcobalamin deficiency type cblE|not provided|Neural tube defects, folate-sensitive|Disorders of Intracellular Cobalamin Metabolism",single nucleotide variant,GRCh37
na,na,5,7891405,7891405,MTRR,Pathogenic,"Methylcobalamin deficiency type cblE|not provided|Neural tube defects, folate-sensitive|Disorders of Intracellular Cobalamin Metabolism",single nucleotide variant,GRCh38
na,na,6,162206804,162683797,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh37
na,na,6,161785772,162262765,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh38
na,na,6,162622163,162622284,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh37
na,na,6,162201131,162201252,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh38
na,na,6,162394349,162394349,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh37
na,na,6,161973317,161973317,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh38
na,na,6,161990389,161990389,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh37
na,na,6,161569357,161569357,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh38
na,na,6,162683724,162683724,PRKN,Benign/Likely benign,Autosomal recessive juvenile Parkinson disease 2|not specified|not provided,single nucleotide variant,GRCh37
na,na,6,162262692,162262692,PRKN,Benign/Likely benign,Autosomal recessive juvenile Parkinson disease 2|not specified|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,PRKN,Pathogenic,Ovarian neoplasm,Deletion,na
na,na,6,162864342,162864505,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh37
na,na,6,162443310,162443473,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh38
na,na,6,161969886,161990448,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh37
na,na,6,161548854,161569416,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh38
na,na,6,161771171,161771171,PRKN,Likely pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided,single nucleotide variant,GRCh37
na,na,6,161350139,161350139,PRKN,Likely pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided,single nucleotide variant,GRCh38
na,na,6,162622214,162622214,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh37
na,na,6,162201182,162201182,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh38
na,na,6,162206804,162206940,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh37
na,na,6,161785772,161785908,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,GRCh38
na,na,6,162394433,162394433,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided,single nucleotide variant,GRCh37
na,na,6,161973401,161973401,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided,single nucleotide variant,GRCh38
na,na,6,162864346,162864346,PRKN,Pathogenic/Likely pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided,single nucleotide variant,GRCh37
na,na,6,162443314,162443314,PRKN,Pathogenic/Likely pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided,single nucleotide variant,GRCh38
na,na,6,162262766,162727661,PRKN,Pathogenic,Lung adenocarcinoma,Deletion,GRCh38
na,na,6,162206852,162206852,PRKN,Pathogenic/Likely pathogenic,"Autosomal recessive juvenile Parkinson disease 2|Lung carcinoma;Leprosy, susceptibility to, 2;Ovarian neoplasm;Autosomal recessive juvenile Parkinson disease 2|not provided|Young-onset Parkinson disease|See cases|Ovarian cancer;Autosomal recessive juvenile Parkinson disease 2;Lung cancer|PRKN-related disorder|Parkinson disease 12|Ovarian cancer",single nucleotide variant,GRCh37
na,na,6,161785820,161785820,PRKN,Pathogenic/Likely pathogenic,"Autosomal recessive juvenile Parkinson disease 2|Lung carcinoma;Leprosy, susceptibility to, 2;Ovarian neoplasm;Autosomal recessive juvenile Parkinson disease 2|not provided|Young-onset Parkinson disease|See cases|Ovarian cancer;Autosomal recessive juvenile Parkinson disease 2;Lung cancer|PRKN-related disorder|Parkinson disease 12|Ovarian cancer",single nucleotide variant,GRCh38
na,na,6,162394435,162394435,PRKN,Pathogenic/Likely pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided|Ovarian cancer|Ovarian cancer;Lung cancer;Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh37
na,na,6,161973403,161973403,PRKN,Pathogenic/Likely pathogenic,Autosomal recessive juvenile Parkinson disease 2|not provided|Ovarian cancer|Ovarian cancer;Lung cancer;Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh38
na,na,6,163148693,163148693,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh37
na,na,6,162727661,162727661,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,single nucleotide variant,GRCh38
na,na,6,162394349,162394349,PRKN,Conflicting classifications of pathogenicity,Autosomal recessive juvenile Parkinson disease 2|not provided|Ovarian neoplasm|Young-onset Parkinson disease,single nucleotide variant,GRCh37
na,na,6,161973317,161973317,PRKN,Conflicting classifications of pathogenicity,Autosomal recessive juvenile Parkinson disease 2|not provided|Ovarian neoplasm|Young-onset Parkinson disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,PRKN,Pathogenic,Autosomal recessive juvenile Parkinson disease 2,Deletion,na
na,na,2,135926202,135926202,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,Deletion,GRCh37
na,na,2,135168632,135168632,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,Deletion,GRCh38
na,na,2,135878387,135878387,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,single nucleotide variant,GRCh37
na,na,2,135120817,135120817,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,single nucleotide variant,GRCh38
na,na,2,135878489,135878489,RAB3GAP1,Pathogenic,Warburg micro syndrome 1|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,2,135120919,135120919,RAB3GAP1,Pathogenic,Warburg micro syndrome 1|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,2,135908026,135908026,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,single nucleotide variant,GRCh37
na,na,2,135150456,135150456,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,single nucleotide variant,GRCh38
na,na,2,135893313,135893313,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,single nucleotide variant,GRCh37
na,na,2,135135743,135135743,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,single nucleotide variant,GRCh38
na,na,2,135891514,135891514,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,single nucleotide variant,GRCh37
na,na,2,135133944,135133944,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,single nucleotide variant,GRCh38
na,na,2,135848681,135848687,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,Indel,GRCh37
na,na,2,135091111,135091117,RAB3GAP1,Pathogenic,Warburg micro syndrome 1,Indel,GRCh38
na,na,1,8018845,8044954,PARK7,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,Deletion,GRCh37
na,na,1,8045041,8045041,PARK7,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,single nucleotide variant,GRCh37
na,na,1,7984981,7984981,PARK7,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,single nucleotide variant,GRCh38
na,na,1,8022923,8022923,PARK7,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,single nucleotide variant,GRCh37
na,na,1,7962863,7962863,PARK7,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,single nucleotide variant,GRCh38
na,na,1,8044990,8044990,PARK7,Likely benign,Autosomal recessive early-onset Parkinson disease 7,single nucleotide variant,GRCh37
na,na,1,7984930,7984930,PARK7,Likely benign,Autosomal recessive early-onset Parkinson disease 7,single nucleotide variant,GRCh38
na,na,1,8025485,8025485,PARK7,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,single nucleotide variant,GRCh37
na,na,1,7965425,7965425,PARK7,Pathogenic,Autosomal recessive early-onset Parkinson disease 7,single nucleotide variant,GRCh38
na,na,1,8045031,8045031,PARK7,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,1,7984971,7984971,PARK7,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,1,8025408,8025408,PARK7,Pathogenic,"Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1",single nucleotide variant,GRCh37
na,na,1,7965348,7965348,PARK7,Pathogenic,"Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1",single nucleotide variant,GRCh38
na,na,12,49579359,49579359,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Inborn genetic diseases|Tubulinopathy|not provided|Lissencephaly,single nucleotide variant,GRCh37
na,na,12,49185576,49185576,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Inborn genetic diseases|Tubulinopathy|not provided|Lissencephaly,single nucleotide variant,GRCh38
na,na,12,49578944,49578944,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy|not provided|Lissencephaly|Tubulinopathy-associated dysgyria,single nucleotide variant,GRCh37
na,na,12,49185161,49185161,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy|not provided|Lissencephaly|Tubulinopathy-associated dysgyria,single nucleotide variant,GRCh38
na,na,12,49579587,49579587,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy,single nucleotide variant,GRCh37
na,na,12,49185804,49185804,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy,single nucleotide variant,GRCh38
na,na,12,49579362,49579362,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy,single nucleotide variant,GRCh37
na,na,12,49185579,49185579,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy,single nucleotide variant,GRCh38
na,na,12,49578893,49578893,TUBA1A,Pathogenic/Likely pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy|not provided,single nucleotide variant,GRCh37
na,na,12,49185110,49185110,TUBA1A,Pathogenic/Likely pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy|not provided,single nucleotide variant,GRCh38
na,na,12,49578959,49578959,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy,single nucleotide variant,GRCh37
na,na,12,49185176,49185176,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|Tubulinopathy,single nucleotide variant,GRCh38
na,na,12,49578885,49578885,TUBA1A,Pathogenic/Likely pathogenic,Lissencephaly due to TUBA1A mutation|Inborn genetic diseases|not provided|Tubulinopathy,single nucleotide variant,GRCh37
na,na,12,49185102,49185102,TUBA1A,Pathogenic/Likely pathogenic,Lissencephaly due to TUBA1A mutation|Inborn genetic diseases|not provided|Tubulinopathy,single nucleotide variant,GRCh38
na,na,12,49578884,49578884,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|not provided|Tubulinopathy|Lissencephaly,single nucleotide variant,GRCh37
na,na,12,49185101,49185101,TUBA1A,Pathogenic,Lissencephaly due to TUBA1A mutation|not provided|Tubulinopathy|Lissencephaly,single nucleotide variant,GRCh38
na,na,5,145719870,145719877,POU4F3,Pathogenic,Autosomal dominant nonsyndromic hearing loss 15,Deletion,GRCh37
na,na,5,146340307,146340314,POU4F3,Pathogenic,Autosomal dominant nonsyndromic hearing loss 15,Deletion,GRCh38
na,na,5,145719855,145719855,POU4F3,Pathogenic,Autosomal dominant nonsyndromic hearing loss 15,single nucleotide variant,GRCh37
na,na,5,146340292,146340292,POU4F3,Pathogenic,Autosomal dominant nonsyndromic hearing loss 15,single nucleotide variant,GRCh38
na,na,5,145719658,145719658,POU4F3,Pathogenic,Autosomal dominant nonsyndromic hearing loss 15|not provided,single nucleotide variant,GRCh37
na,na,5,146340095,146340095,POU4F3,Pathogenic,Autosomal dominant nonsyndromic hearing loss 15|not provided,single nucleotide variant,GRCh38
na,na,1,109817590,109817590,SORT1,association,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6,single nucleotide variant,GRCh37
na,na,1,109274968,109274968,SORT1,association,LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6,single nucleotide variant,GRCh38
na,na,2,111430237,111430237,BUB1,Pathogenic,"Colorectal cancer with chromosomal instability, somatic",single nucleotide variant,GRCh37
na,na,2,110672660,110672660,BUB1,Pathogenic,"Colorectal cancer with chromosomal instability, somatic",single nucleotide variant,GRCh38
na,na,2,111416028,111416028,BUB1,Pathogenic,"Colorectal cancer with chromosomal instability, somatic",single nucleotide variant,GRCh37
na,na,2,110658451,110658451,BUB1,Pathogenic,"Colorectal cancer with chromosomal instability, somatic",single nucleotide variant,GRCh38
na,na,7,95034775,95034775,PON2,Benign,PARAOXONASE 2 POLYMORPHISM|not provided,single nucleotide variant,GRCh37
na,na,7,95405463,95405463,PON2,Benign,PARAOXONASE 2 POLYMORPHISM|not provided,single nucleotide variant,GRCh38
na,na,7,95041016,95041016,PON2,Benign,PARAOXONASE 2 POLYMORPHISM|not provided,single nucleotide variant,GRCh37
na,na,7,95411704,95411704,PON2,Benign,PARAOXONASE 2 POLYMORPHISM|not provided,single nucleotide variant,GRCh38
na,na,3,167507061,167507061,SERPINI1,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,single nucleotide variant,GRCh37
na,na,3,167789273,167789273,SERPINI1,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,single nucleotide variant,GRCh38
na,na,3,167507070,167507070,SERPINI1,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,single nucleotide variant,GRCh37
na,na,3,167789282,167789282,SERPINI1,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,single nucleotide variant,GRCh38
na,na,3,167540807,167540807,SERPINI1,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,single nucleotide variant,GRCh37
na,na,3,167823019,167823019,SERPINI1,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,single nucleotide variant,GRCh38
na,na,3,167543053,167543053,SERPINI1,Pathogenic/Likely pathogenic,Familial encephalopathy with neuroserpin inclusion bodies|Abnormality of the nervous system,single nucleotide variant,GRCh37
na,na,3,167825265,167825265,SERPINI1,Pathogenic/Likely pathogenic,Familial encephalopathy with neuroserpin inclusion bodies|Abnormality of the nervous system,single nucleotide variant,GRCh38
na,na,3,167543052,167543052,SERPINI1,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,single nucleotide variant,GRCh37
na,na,3,167825264,167825264,SERPINI1,Pathogenic,Familial encephalopathy with neuroserpin inclusion bodies,single nucleotide variant,GRCh38
na,na,3,50649499,50649499,CISH,risk factor,"Tuberculosis, susceptibility to|Malaria, susceptibility to|Bacteremia, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,3,50612068,50612068,CISH,risk factor,"Tuberculosis, susceptibility to|Malaria, susceptibility to|Bacteremia, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,16,67199730,67199730,HSF4,Pathogenic,Cataract 5 multiple types,single nucleotide variant,GRCh37
na,na,16,67165827,67165827,HSF4,Pathogenic,Cataract 5 multiple types,single nucleotide variant,GRCh38
na,na,16,67199744,67199744,HSF4,Pathogenic,Cataract 5 multiple types,single nucleotide variant,GRCh37
na,na,16,67165841,67165841,HSF4,Pathogenic,Cataract 5 multiple types,single nucleotide variant,GRCh38
na,na,16,67198770,67198770,HSF4,Pathogenic,Cataract 5 multiple types,single nucleotide variant,GRCh37
na,na,16,67164867,67164867,HSF4,Pathogenic,Cataract 5 multiple types,single nucleotide variant,GRCh38
na,na,16,67199645,67199645,HSF4,Pathogenic,Cataract 5 multiple types,single nucleotide variant,GRCh37
na,na,16,67165742,67165742,HSF4,Pathogenic,Cataract 5 multiple types,single nucleotide variant,GRCh38
na,na,10,13151270,13151270,OPTN,Pathogenic,"Glaucoma 1, open angle, E",single nucleotide variant,GRCh37
na,na,10,13109270,13109270,OPTN,Pathogenic,"Glaucoma 1, open angle, E",single nucleotide variant,GRCh38
na,na,10,13178766,13178766,OPTN,Conflicting classifications of pathogenicity,"Glaucoma 1, open angle, E|Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E;Primary open angle glaucoma|not specified|not provided|Amyotrophic lateral sclerosis type 12|OPTN-related disorder",single nucleotide variant,GRCh37
na,na,10,13136766,13136766,OPTN,Conflicting classifications of pathogenicity,"Glaucoma 1, open angle, E|Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E;Primary open angle glaucoma|not specified|not provided|Amyotrophic lateral sclerosis type 12|OPTN-related disorder",single nucleotide variant,GRCh38
na,na,10,13152400,13152400,OPTN,Benign/Likely benign,"Glaucoma, normal tension, susceptibility to|Glaucoma 1, open angle, E|Primary open angle glaucoma|not specified|Amyotrophic lateral sclerosis type 12|Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E;Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12;Glaucoma, normal tension, susceptibility to;Primary open angle glaucoma|not provided|Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma",single nucleotide variant,GRCh37
na,na,10,13110400,13110400,OPTN,Benign/Likely benign,"Glaucoma, normal tension, susceptibility to|Glaucoma 1, open angle, E|Primary open angle glaucoma|not specified|Amyotrophic lateral sclerosis type 12|Amyotrophic lateral sclerosis type 12;Glaucoma 1, open angle, E;Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12;Glaucoma, normal tension, susceptibility to;Primary open angle glaucoma|not provided|Amyotrophic lateral sclerosis type 12;Primary open angle glaucoma",single nucleotide variant,GRCh38
na,na,10,13151625,13153496,OPTN,Pathogenic,Amyotrophic lateral sclerosis type 12,Deletion,GRCh37
na,na,10,13109625,13111496,OPTN,Pathogenic,Amyotrophic lateral sclerosis type 12,Deletion,GRCh38
na,na,10,13167989,13167989,OPTN,Pathogenic,Amyotrophic lateral sclerosis type 12,single nucleotide variant,GRCh37
na,na,10,13125989,13125989,OPTN,Pathogenic,Amyotrophic lateral sclerosis type 12,single nucleotide variant,GRCh38
na,na,10,13174098,13174098,OPTN,Pathogenic,Amyotrophic lateral sclerosis type 12,single nucleotide variant,GRCh37
na,na,10,13132098,13132098,OPTN,Pathogenic,Amyotrophic lateral sclerosis type 12,single nucleotide variant,GRCh38
na,na,3,77645881,77645881,ROBO2,Uncertain significance,Vesicoureteral reflux 2|Congenital anomaly of kidney and urinary tract,single nucleotide variant,GRCh37
na,na,3,77596730,77596730,ROBO2,Uncertain significance,Vesicoureteral reflux 2|Congenital anomaly of kidney and urinary tract,single nucleotide variant,GRCh38
na,na,3,77671529,77671529,ROBO2,Uncertain significance,Vesicoureteral reflux 2|Congenital anomaly of kidney and urinary tract,single nucleotide variant,GRCh37
na,na,3,77622378,77622378,ROBO2,Uncertain significance,Vesicoureteral reflux 2|Congenital anomaly of kidney and urinary tract,single nucleotide variant,GRCh38
na,na,7,117199645,117199647,CFTR,Pathogenic,"Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1, modifier of|Hereditary pancreatitis|not provided|Duodenal stenosis|Recurrent pancreatitis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Obstructive azoospermia|ivacaftor / lumacaftor response - Efficacy|ivacaftor / tezacaftor response - Efficacy|Cystic fibrosis;Hereditary pancreatitis|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|See cases|Bronchiectasis with or without elevated sweat chloride 1",Deletion,GRCh37
na,na,7,117559591,117559593,CFTR,Pathogenic,"Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1, modifier of|Hereditary pancreatitis|not provided|Duodenal stenosis|Recurrent pancreatitis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Obstructive azoospermia|ivacaftor / lumacaftor response - Efficacy|ivacaftor / tezacaftor response - Efficacy|Cystic fibrosis;Hereditary pancreatitis|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|See cases|Bronchiectasis with or without elevated sweat chloride 1",Deletion,GRCh38
na,na,7,117199641,117199643,CFTR,Pathogenic,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|not specified|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1,Microsatellite,GRCh37
na,na,7,117559587,117559589,CFTR,Pathogenic,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|not specified|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1,Microsatellite,GRCh38
na,na,7,117199602,117199602,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117559548,117559548,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117171007,117171007,CFTR,Pathogenic; drug response,Cystic fibrosis|not provided|ivacaftor response - Efficacy|Cystic fibrosis;CFTR-related disorder|CFTR-related disorder|not specified|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,single nucleotide variant,GRCh37
na,na,7,117530953,117530953,CFTR,Pathogenic; drug response,Cystic fibrosis|not provided|ivacaftor response - Efficacy|Cystic fibrosis;CFTR-related disorder|CFTR-related disorder|not specified|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,single nucleotide variant,GRCh38
na,na,7,117171029,117171029,CFTR,Pathogenic,"Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|not provided|ivacaftor response - Efficacy|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Obstructive azoospermia|Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh37
na,na,7,117530975,117530975,CFTR,Pathogenic,"Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|not provided|ivacaftor response - Efficacy|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Obstructive azoospermia|Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh38
na,na,7,117180324,117180324,CFTR,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1|not provided,single nucleotide variant,GRCh37
na,na,7,117540270,117540270,CFTR,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1|not provided,single nucleotide variant,GRCh38
na,na,7,117188849,117188849,CFTR,Pathogenic,Cystic fibrosis|ivacaftor response - Efficacy|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117548795,117548795,CFTR,Pathogenic,Cystic fibrosis|ivacaftor response - Efficacy|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117227792,117227792,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117587738,117587738,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117227887,117227887,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117587833,117587833,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117230414,117230414,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder;Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117590360,117590360,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder;Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117227832,117227832,CFTR,Pathogenic,Cystic fibrosis|not provided|Hereditary pancreatitis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117587778,117587778,CFTR,Pathogenic,Cystic fibrosis|not provided|Hereditary pancreatitis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117227854,117227854,CFTR,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|CFTR-related disorder|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117587800,117587800,CFTR,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|CFTR-related disorder|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117227854,117227854,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117587800,117587800,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117227855,117227855,CFTR,Pathogenic; drug response,ivacaftor response - Efficacy|Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Hereditary pancreatitis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117587801,117587801,CFTR,Pathogenic; drug response,ivacaftor response - Efficacy|Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Hereditary pancreatitis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117230448,117230448,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117590394,117590394,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117227860,117227860,CFTR,Pathogenic,Cystic fibrosis|Hereditary pancreatitis|ivacaftor response - Efficacy|not provided|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117587806,117587806,CFTR,Pathogenic,Cystic fibrosis|Hereditary pancreatitis|ivacaftor response - Efficacy|not provided|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117227865,117227865,CFTR,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|not provided|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117587811,117587811,CFTR,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|not provided|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117227883,117227883,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117587829,117587829,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117267766,117267766,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|not provided|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,Deletion,GRCh37
na,na,7,117627712,117627712,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|not provided|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,Deletion,GRCh38
na,na,7,117282538,117282538,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117642484,117642484,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117199648,117199648,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not specified|CFTR-related disorder|not provided|Obstructive azoospermia|Hereditary pancreatitis|Infertility disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117559594,117559594,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not specified|CFTR-related disorder|not provided|Obstructive azoospermia|Hereditary pancreatitis|Infertility disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117235031,117235031,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117594977,117594977,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117243666,117243666,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117603612,117603612,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117282620,117282620,CFTR,Pathogenic,Cystic fibrosis|not provided|not specified|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117642566,117642566,CFTR,Pathogenic,Cystic fibrosis|not provided|not specified|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117199533,117199533,CFTR,Benign/Likely benign,Cystic fibrosis|not specified|CFTR-related disorder|not provided,single nucleotide variant,GRCh37
na,na,7,117559479,117559479,CFTR,Benign/Likely benign,Cystic fibrosis|not specified|CFTR-related disorder|not provided,single nucleotide variant,GRCh38
na,na,7,117199641,117199641,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not specified|not provided|Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117559587,117559587,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not specified|not provided|Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117188858,117188858,CFTR,Likely pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117548804,117548804,CFTR,Likely pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117292969,117292969,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117652915,117652915,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117180302,117180303,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,Microsatellite,GRCh37
na,na,7,117540248,117540249,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,Microsatellite,GRCh38
na,na,7,117180365,117180365,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh37
na,na,7,117540311,117540311,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh38
na,na,7,117292931,117292931,CFTR,Pathogenic,"Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Spermatogenic failure, Y-linked, 2|CFTR-related disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation",single nucleotide variant,GRCh37
na,na,7,117652877,117652877,CFTR,Pathogenic,"Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Spermatogenic failure, Y-linked, 2|CFTR-related disorder|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation",single nucleotide variant,GRCh38
na,na,7,117267591,117267591,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117627537,117627537,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117267828,117267828,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117627774,117627774,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117180284,117180284,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117540230,117540230,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|not specified|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117199667,117199668,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Abnormality of metabolism/homeostasis|Bronchiectasis with or without elevated sweat chloride 1,Microsatellite,GRCh37
na,na,7,117559613,117559614,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Abnormality of metabolism/homeostasis|Bronchiectasis with or without elevated sweat chloride 1,Microsatellite,GRCh38
na,na,7,117235044,117235044,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided,single nucleotide variant,GRCh37
na,na,7,117594990,117594990,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided,single nucleotide variant,GRCh38
na,na,7,117227859,117227859,CFTR,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117587805,117587805,CFTR,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117149177,117149177,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117509123,117509123,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117267579,117267579,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117627525,117627525,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117175442,117175463,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,Deletion,GRCh37
na,na,7,117535388,117535409,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,Deletion,GRCh38
na,na,7,117171103,117171103,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,Deletion,GRCh37
na,na,7,117531049,117531049,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,Deletion,GRCh38
na,na,7,117171104,117171104,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh37
na,na,7,117531050,117531050,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh38
na,na,7,117243665,117243666,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,Insertion,GRCh37
na,na,7,117603611,117603612,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,Insertion,GRCh38
na,na,7,117199683,117199683,CFTR,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|not specified|Bronchiectasis with or without elevated sweat chloride 1|not provided|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117559629,117559629,CFTR,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|not specified|Bronchiectasis with or without elevated sweat chloride 1|not provided|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117199697,117199697,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117559643,117559643,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117282647,117282647,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|not specified|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117642593,117642593,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|not specified|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117180217,117180217,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Obstructive azoospermia,single nucleotide variant,GRCh37
na,na,7,117540163,117540163,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Obstructive azoospermia,single nucleotide variant,GRCh38
na,na,7,117180373,117180374,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,Microsatellite,GRCh37
na,na,7,117540319,117540320,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,Microsatellite,GRCh38
na,na,7,117199600,117199600,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|not provided|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117559546,117559546,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|not provided|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117227887,117227887,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117587833,117587833,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117232700,117232700,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117592646,117592646,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117251692,117251692,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|not specified|Bronchiectasis with or without elevated sweat chloride 1|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117611638,117611638,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|not specified|Bronchiectasis with or without elevated sweat chloride 1|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117251694,117251694,CFTR,drug response,Cystic fibrosis|not specified|ivacaftor response - Efficacy|not provided|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117611640,117611640,CFTR,drug response,Cystic fibrosis|not specified|ivacaftor response - Efficacy|not provided|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117282648,117282648,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|not provided,single nucleotide variant,GRCh37
na,na,7,117642594,117642594,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|not provided,single nucleotide variant,GRCh38
na,na,7,117251678,117251679,CFTR,Pathogenic,Cystic fibrosis,Duplication,GRCh37
na,na,7,117611624,117611625,CFTR,Pathogenic,Cystic fibrosis,Duplication,GRCh38
na,na,7,117251691,117251691,CFTR,Pathogenic,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|not specified|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117611637,117611637,CFTR,Pathogenic,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|not specified|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117180230,117180230,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh37
na,na,7,117540176,117540176,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh38
na,na,7,117282582,117282582,CFTR,Conflicting classifications of pathogenicity,Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|Hereditary pancreatitis|not specified|not provided|CFTR-related disorder|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,single nucleotide variant,GRCh37
na,na,7,117642528,117642528,CFTR,Conflicting classifications of pathogenicity,Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|Hereditary pancreatitis|not specified|not provided|CFTR-related disorder|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,single nucleotide variant,GRCh38
na,na,7,117230454,117230454,CFTR,Conflicting classifications of pathogenicity,"Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|not provided|not specified|Chronic sinusitis|Lung disease, non-specific|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis",single nucleotide variant,GRCh37
na,na,7,117590400,117590400,CFTR,Conflicting classifications of pathogenicity,"Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|not provided|not specified|Chronic sinusitis|Lung disease, non-specific|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis",single nucleotide variant,GRCh38
na,na,7,117280015,117280015,CFTR,Pathogenic,Cystic fibrosis|not specified|not provided|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;CFTR-related disorder|Hereditary pancreatitis|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117639961,117639961,CFTR,Pathogenic,Cystic fibrosis|not specified|not provided|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis;CFTR-related disorder|Hereditary pancreatitis|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117282622,117282622,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117642568,117642568,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117230494,117230494,CFTR,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117590440,117590440,CFTR,Pathogenic,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117180359,117180359,CFTR,Conflicting classifications of pathogenicity,not specified|Cystic fibrosis|Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117540305,117540305,CFTR,Conflicting classifications of pathogenicity,not specified|Cystic fibrosis|Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117176588,117176599,CFTR,Pathogenic,Cystic fibrosis,Deletion,GRCh37
na,na,7,117536534,117536545,CFTR,Pathogenic,Cystic fibrosis,Deletion,GRCh38
na,na,7,117180324,117180324,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117540270,117540270,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117180330,117180330,CFTR,Uncertain significance,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|not specified|not provided|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117540276,117540276,CFTR,Uncertain significance,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|not specified|not provided|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117227809,117227809,CFTR,Uncertain significance,Cystic fibrosis|not provided|not specified|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117587755,117587755,CFTR,Uncertain significance,Cystic fibrosis|not provided|not specified|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117232367,117232367,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117592313,117592313,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117232712,117232712,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117592658,117592658,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117267819,117267819,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117627765,117627765,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117282491,117282491,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Cystic fibrosis;Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117642437,117642437,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Cystic fibrosis;Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117282540,117282541,CFTR,Pathogenic,Cystic fibrosis,Duplication,GRCh37
na,na,7,117642486,117642487,CFTR,Pathogenic,Cystic fibrosis,Duplication,GRCh38
na,na,7,117149094,117149094,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117509040,117509040,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117292959,117292959,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117652905,117652905,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117170953,117170953,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;CFTR-related disorder|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117530899,117530899,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;CFTR-related disorder|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117180324,117180324,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;CFTR-related disorder|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,single nucleotide variant,GRCh37
na,na,7,117540270,117540270,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;CFTR-related disorder|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation,single nucleotide variant,GRCh38
na,na,7,117149194,117149194,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117509140,117509140,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117282631,117282631,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117642577,117642577,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117232394,117232395,CFTR,Pathogenic,Cystic fibrosis|not provided|not specified|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,Duplication,GRCh37
na,na,7,117592340,117592341,CFTR,Pathogenic,Cystic fibrosis|not provided|not specified|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,Duplication,GRCh38
na,na,7,117170953,117170953,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117530899,117530899,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117199563,117199563,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117559509,117559509,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117171138,117171155,CFTR,Pathogenic,Cystic fibrosis,Deletion,GRCh37
na,na,7,117531084,117531101,CFTR,Pathogenic,Cystic fibrosis,Deletion,GRCh38
na,na,7,117175339,117175339,CFTR,Pathogenic; drug response,Cystic fibrosis|not provided|ivacaftor response - Efficacy|CFTR-related disorder;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117535285,117535285,CFTR,Pathogenic; drug response,Cystic fibrosis|not provided|ivacaftor response - Efficacy|CFTR-related disorder;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,na,-1,-1,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,na
na,na,7,117282537,117282537,CFTR,Pathogenic; drug response,Cystic fibrosis|Hereditary pancreatitis|ivacaftor response - Efficacy,single nucleotide variant,GRCh37
na,na,7,117642483,117642483,CFTR,Pathogenic; drug response,Cystic fibrosis|Hereditary pancreatitis|ivacaftor response - Efficacy,single nucleotide variant,GRCh38
na,na,7,117180297,117180297,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1|not specified|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117540243,117540243,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|not provided|Bronchiectasis with or without elevated sweat chloride 1|not specified|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117251761,117251761,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117611707,117611707,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117227874,117227874,CFTR,Benign/Likely benign,Cystic fibrosis|not provided|not specified|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117587820,117587820,CFTR,Benign/Likely benign,Cystic fibrosis|not provided|not specified|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117171005,117171005,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117530951,117530951,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117180339,117180339,CFTR,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117540285,117540285,CFTR,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117149200,117149200,CFTR,Uncertain significance,Cystic fibrosis|not provided|CFTR-related disorder|not specified,single nucleotide variant,GRCh37
na,na,7,117509146,117509146,CFTR,Uncertain significance,Cystic fibrosis|not provided|CFTR-related disorder|not specified,single nucleotide variant,GRCh38
na,na,7,117227862,117227862,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117587808,117587808,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117232164,117232164,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117592110,117592110,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117232349,117232349,CFTR,Pathogenic,not provided|Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117592295,117592295,CFTR,Pathogenic,not provided|Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117243596,117243596,CFTR,Pathogenic,Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117603542,117603542,CFTR,Pathogenic,Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117243663,117243663,CFTR,Uncertain significance,Cystic fibrosis|not provided|not specified|CFTR-related disorder|Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117603609,117603609,CFTR,Uncertain significance,Cystic fibrosis|not provided|not specified|CFTR-related disorder|Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117176661,117176662,CFTR,Pathogenic,Cystic fibrosis,Microsatellite,GRCh37
na,na,7,117536607,117536608,CFTR,Pathogenic,Cystic fibrosis,Microsatellite,GRCh38
na,na,7,117243773,117243773,CFTR,Uncertain significance,Cystic fibrosis|not specified,single nucleotide variant,GRCh37
na,na,7,117603719,117603719,CFTR,Uncertain significance,Cystic fibrosis|not specified,single nucleotide variant,GRCh38
na,na,7,117251689,117251689,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117611635,117611635,CFTR,Pathogenic,Cystic fibrosis|not provided|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117251707,117251707,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117611653,117611653,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117251749,117251749,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117611695,117611695,CFTR,Pathogenic/Likely pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117251771,117251771,CFTR,Pathogenic,Cystic fibrosis|not specified|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117611717,117611717,CFTR,Pathogenic,Cystic fibrosis|not specified|CFTR-related disorder;Cystic fibrosis|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117267718,117267718,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117627664,117627664,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117180366,117180366,CFTR,Pathogenic,Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh37
na,na,7,117540312,117540312,CFTR,Pathogenic,Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh38
na,na,7,117267766,117267766,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not provided|not specified|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117627712,117627712,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not provided|not specified|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117267807,117267807,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117627753,117627753,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117282520,117282520,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117642466,117642466,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117282526,117282526,CFTR,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117642472,117642472,CFTR,Pathogenic; drug response,Cystic fibrosis|ivacaftor response - Efficacy|not provided|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,7,117292929,117292929,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117652875,117652875,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117199602,117199603,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,Deletion,GRCh37
na,na,7,117559548,117559549,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,Deletion,GRCh38
na,na,7,117232512,117232512,CFTR,Pathogenic,Cystic fibrosis,Deletion,GRCh37
na,na,7,117592458,117592458,CFTR,Pathogenic,Cystic fibrosis,Deletion,GRCh38
na,na,7,117251656,117251656,CFTR,Pathogenic,Cystic fibrosis|not provided,Deletion,GRCh37
na,na,7,117611602,117611602,CFTR,Pathogenic,Cystic fibrosis|not provided,Deletion,GRCh38
na,na,7,117267638,117267639,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,Duplication,GRCh37
na,na,7,117627584,117627585,CFTR,Pathogenic,Cystic fibrosis|CFTR-related disorder,Duplication,GRCh38
na,na,7,117307083,117307083,CFTR,Pathogenic/Likely pathogenic,Sweat chloride elevation without cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Respiratory ciliopathies including non-CF bronchiectasis|not provided,single nucleotide variant,GRCh37
na,na,7,117667029,117667029,CFTR,Pathogenic/Likely pathogenic,Sweat chloride elevation without cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|Respiratory ciliopathies including non-CF bronchiectasis|not provided,single nucleotide variant,GRCh38
na,na,7,117227866,117227866,CFTR,Uncertain significance,Cystic fibrosis|not specified,single nucleotide variant,GRCh37
na,na,7,117587812,117587812,CFTR,Uncertain significance,Cystic fibrosis|not specified,single nucleotide variant,GRCh38
na,na,7,117120047,117120047,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117479993,117479993,CFTR,Pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117138363,117159446,CFTR,Pathogenic,Cystic fibrosis,Deletion,GRCh37
na,na,7,117498309,117519392,CFTR,Pathogenic,Cystic fibrosis,Deletion,GRCh38
na,na,7,117267556,117267556,CFTR,Benign/Likely benign,Cystic fibrosis|not specified|not provided|CFTR-related disorder|Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117627502,117627502,CFTR,Benign/Likely benign,Cystic fibrosis|not specified|not provided|CFTR-related disorder|Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117250575,117250575,CFTR,Conflicting classifications of pathogenicity,||Cystic fibrosis|not provided|not specified|Pancreatitis|CFTR-related disorder|Infertility disorder|Obstructive azoospermia|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,117610521,117610521,CFTR,Conflicting classifications of pathogenicity,||Cystic fibrosis|not provided|not specified|Pancreatitis|CFTR-related disorder|Infertility disorder|Obstructive azoospermia|Bronchiectasis with or without elevated sweat chloride 1;Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,117267596,117267597,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,Duplication,GRCh37
na,na,7,117627542,117627543,CFTR,Pathogenic,Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1,Duplication,GRCh38
na,na,7,117282518,117282518,CFTR,Pathogenic,not provided|Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis,Deletion,GRCh37
na,na,7,117642464,117642464,CFTR,Pathogenic,not provided|Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis|CFTR-related disorder|Bronchiectasis with or without elevated sweat chloride 1|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation;Cystic fibrosis,Deletion,GRCh38
na,na,7,117149182,117149183,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|CFTR-related disorder|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh37
na,na,7,117509128,117509129,CFTR,Pathogenic,Cystic fibrosis|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|CFTR-related disorder|Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,Deletion,GRCh38
na,na,na,-1,-1,CFTR,Pathogenic,Cystic fibrosis,Variation,na
na,na,7,117120167,117120167,CFTR,Pathogenic,Cystic fibrosis|not provided,single nucleotide variant,GRCh37
na,na,7,117480113,117480113,CFTR,Pathogenic,Cystic fibrosis|not provided,single nucleotide variant,GRCh38
na,na,7,117176714,117176715,CFTR,Pathogenic,Cystic fibrosis,Duplication,GRCh37
na,na,7,117536660,117536661,CFTR,Pathogenic,Cystic fibrosis,Duplication,GRCh38
na,na,7,117304834,117304834,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|not specified,single nucleotide variant,GRCh37
na,na,7,117664780,117664780,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not provided|Congenital bilateral aplasia of vas deferens from CFTR mutation;Hereditary pancreatitis;Cystic fibrosis;Bronchiectasis with or without elevated sweat chloride 1|CFTR-related disorder|not specified,single nucleotide variant,GRCh38
na,na,7,117175372,117175372,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not specified|not provided|CFTR-related disorder,single nucleotide variant,GRCh37
na,na,7,117535318,117535318,CFTR,Conflicting classifications of pathogenicity,Cystic fibrosis|not specified|not provided|CFTR-related disorder,single nucleotide variant,GRCh38
na,na,7,117282505,117282505,CFTR,Likely pathogenic,Cystic fibrosis,single nucleotide variant,GRCh37
na,na,7,117642451,117642451,CFTR,Likely pathogenic,Cystic fibrosis,single nucleotide variant,GRCh38
na,na,7,117230409,117230409,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,7,117590355,117590355,CFTR,Pathogenic,Cystic fibrosis|not provided|CFTR-related disorder|Cystic fibrosis;Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,1,161284198,161284198,SDHC,Pathogenic,Paragangliomas 3|Gastrointestinal stromal tumor;Paragangliomas 3|not provided,single nucleotide variant,GRCh37
na,na,1,161314408,161314408,SDHC,Pathogenic,Paragangliomas 3|Gastrointestinal stromal tumor;Paragangliomas 3|not provided,single nucleotide variant,GRCh38
na,na,1,161326631,161326631,SDHC,Pathogenic/Likely pathogenic,Paragangliomas 3|Hereditary cancer-predisposing syndrome|not provided|Gastrointestinal stromal tumor;Paragangliomas 3|Hereditary pheochromocytoma-paraganglioma,single nucleotide variant,GRCh37
na,na,1,161356841,161356841,SDHC,Pathogenic/Likely pathogenic,Paragangliomas 3|Hereditary cancer-predisposing syndrome|not provided|Gastrointestinal stromal tumor;Paragangliomas 3|Hereditary pheochromocytoma-paraganglioma,single nucleotide variant,GRCh38
na,na,1,161336986,161339990,SDHC,Pathogenic,Paragangliomas 3,Indel,GRCh37
na,na,1,161367196,161370200,SDHC,Pathogenic,Paragangliomas 3,Indel,GRCh38
na,na,1,161326631,161326631,SDHC,Pathogenic,Carney-Stratakis syndrome|Carney triad|Gastrointestinal stromal tumor|Hereditary pheochromocytoma-paraganglioma|Gastrointestinal stromal tumor;Paragangliomas 3|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,1,161356841,161356841,SDHC,Pathogenic,Carney-Stratakis syndrome|Carney triad|Gastrointestinal stromal tumor|Hereditary pheochromocytoma-paraganglioma|Gastrointestinal stromal tumor;Paragangliomas 3|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,10,79796988,79796988,RPS24,Pathogenic,Diamond-Blackfan anemia 3,single nucleotide variant,GRCh37
na,na,10,78037230,78037230,RPS24,Pathogenic,Diamond-Blackfan anemia 3,single nucleotide variant,GRCh38
na,na,10,79795152,79795152,RPS24,Pathogenic,Diamond-Blackfan anemia 3|Diamond-Blackfan anemia|not provided,single nucleotide variant,GRCh37
na,na,10,78035394,78035394,RPS24,Pathogenic,Diamond-Blackfan anemia 3|Diamond-Blackfan anemia|not provided,single nucleotide variant,GRCh38
na,na,10,79795110,79795112,RPS24,Pathogenic,Diamond-Blackfan anemia 3,Indel,GRCh37
na,na,10,78035352,78035354,RPS24,Pathogenic,Diamond-Blackfan anemia 3,Indel,GRCh38
na,na,17,28576076,28576076,BLMH,Benign,not provided|Alzheimer disease type 1,single nucleotide variant,GRCh37
na,na,17,30249058,30249058,BLMH,Benign,not provided|Alzheimer disease type 1,single nucleotide variant,GRCh38
na,na,16,86601238,86601238,FOXC2,Likely pathogenic,Distichiasis-lymphedema syndrome,single nucleotide variant,GRCh37
na,na,16,86567632,86567632,FOXC2,Likely pathogenic,Distichiasis-lymphedema syndrome,single nucleotide variant,GRCh38
na,na,16,86602029,86602030,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Duplication,GRCh37
na,na,16,86568423,86568424,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Duplication,GRCh38
na,na,16,86601230,86601240,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Deletion,GRCh37
na,na,16,86567624,86567634,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Deletion,GRCh38
na,na,16,86602272,86602272,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Deletion,GRCh37
na,na,16,86568666,86568666,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Deletion,GRCh38
na,na,16,86601149,86601150,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Duplication,GRCh37
na,na,16,86567543,86567544,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Duplication,GRCh38
na,na,16,86601140,86601141,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Duplication,GRCh37
na,na,16,86567534,86567535,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Duplication,GRCh38
na,na,16,86601527,86601528,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Duplication,GRCh37
na,na,16,86567921,86567922,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Duplication,GRCh38
na,na,16,86601446,86601446,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Deletion,GRCh37
na,na,16,86567840,86567840,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Deletion,GRCh38
na,na,16,86601855,86601862,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome|Non-immune hydrops fetalis,Deletion,GRCh37
na,na,16,86568249,86568256,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome|Non-immune hydrops fetalis,Deletion,GRCh38
na,na,16,86601946,86601947,FOXC2,Pathogenic,Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus,Duplication,GRCh37
na,na,16,86568340,86568341,FOXC2,Pathogenic,Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus,Duplication,GRCh38
na,na,16,86601543,86601622,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Indel,GRCh37
na,na,16,86567937,86568016,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,Indel,GRCh38
na,na,16,86601315,86601315,FOXC2,Likely pathogenic,Distichiasis-lymphedema syndrome,single nucleotide variant,GRCh37
na,na,16,86567709,86567709,FOXC2,Likely pathogenic,Distichiasis-lymphedema syndrome,single nucleotide variant,GRCh38
na,na,16,86601303,86601303,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,single nucleotide variant,GRCh37
na,na,16,86567697,86567697,FOXC2,Pathogenic,Distichiasis-lymphedema syndrome,single nucleotide variant,GRCh38
na,na,18,55362420,55362420,ATP8B1,Pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder|Progressive familial intrahepatic cholestasis,single nucleotide variant,GRCh37
na,na,18,57695188,57695188,ATP8B1,Pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder|Progressive familial intrahepatic cholestasis,single nucleotide variant,GRCh38
na,na,18,55328439,55328439,ATP8B1,Conflicting classifications of pathogenicity,"Progressive familial intrahepatic cholestasis type 1|not provided|Progressive familial intrahepatic cholestasis|Benign recurrent intrahepatic cholestasis type 1|ATP8B1-related disorder|Progressive familial intrahepatic cholestasis type 1;Benign recurrent intrahepatic cholestasis type 1;Cholestasis, intrahepatic, of pregnancy, 1",single nucleotide variant,GRCh37
na,na,18,57661207,57661207,ATP8B1,Conflicting classifications of pathogenicity,"Progressive familial intrahepatic cholestasis type 1|not provided|Progressive familial intrahepatic cholestasis|Benign recurrent intrahepatic cholestasis type 1|ATP8B1-related disorder|Progressive familial intrahepatic cholestasis type 1;Benign recurrent intrahepatic cholestasis type 1;Cholestasis, intrahepatic, of pregnancy, 1",single nucleotide variant,GRCh38
na,na,18,55362480,55362480,ATP8B1,Pathogenic,Progressive familial intrahepatic cholestasis type 1,single nucleotide variant,GRCh37
na,na,18,57695248,57695248,ATP8B1,Pathogenic,Progressive familial intrahepatic cholestasis type 1,single nucleotide variant,GRCh38
na,na,18,55336548,55336548,ATP8B1,Pathogenic/Likely pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided|Benign recurrent intrahepatic cholestasis type 1,single nucleotide variant,GRCh37
na,na,18,57669316,57669316,ATP8B1,Pathogenic/Likely pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided|Benign recurrent intrahepatic cholestasis type 1,single nucleotide variant,GRCh38
na,na,18,57688508,57803316,ATP8B1,Pathogenic,Progressive familial intrahepatic cholestasis type 1,Deletion,GRCh38
na,na,18,55336665,55336665,ATP8B1,Pathogenic/Likely pathogenic,"Benign recurrent intrahepatic cholestasis type 1|Progressive familial intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder|Progressive familial intrahepatic cholestasis type 1;Benign recurrent intrahepatic cholestasis type 1;Cholestasis, intrahepatic, of pregnancy, 1|Progressive familial intrahepatic cholestasis",single nucleotide variant,GRCh37
na,na,18,57669433,57669433,ATP8B1,Pathogenic/Likely pathogenic,"Benign recurrent intrahepatic cholestasis type 1|Progressive familial intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder|Progressive familial intrahepatic cholestasis type 1;Benign recurrent intrahepatic cholestasis type 1;Cholestasis, intrahepatic, of pregnancy, 1|Progressive familial intrahepatic cholestasis",single nucleotide variant,GRCh38
na,na,18,55329741,55329749,ATP8B1,Pathogenic,Benign recurrent intrahepatic cholestasis type 1,Deletion,GRCh37
na,na,18,57662509,57662517,ATP8B1,Pathogenic,Benign recurrent intrahepatic cholestasis type 1,Deletion,GRCh38
na,na,18,55342225,55342225,ATP8B1,Pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder,single nucleotide variant,GRCh37
na,na,18,57674993,57674993,ATP8B1,Pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder,single nucleotide variant,GRCh38
na,na,18,55321310,55321310,ATP8B1,Pathogenic,Benign recurrent intrahepatic cholestasis type 1,single nucleotide variant,GRCh37
na,na,18,57654078,57654078,ATP8B1,Pathogenic,Benign recurrent intrahepatic cholestasis type 1,single nucleotide variant,GRCh38
na,na,18,55373793,55373793,ATP8B1,Conflicting classifications of pathogenicity,"Cholestasis, intrahepatic, of pregnancy, 1|not specified|Progressive familial intrahepatic cholestasis type 2|Progressive familial intrahepatic cholestasis type 1|Benign recurrent intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder",single nucleotide variant,GRCh37
na,na,18,57706561,57706561,ATP8B1,Conflicting classifications of pathogenicity,"Cholestasis, intrahepatic, of pregnancy, 1|not specified|Progressive familial intrahepatic cholestasis type 2|Progressive familial intrahepatic cholestasis type 1|Benign recurrent intrahepatic cholestasis type 1|not provided|ATP8B1-related disorder",single nucleotide variant,GRCh38
na,na,18,55328514,55328514,ATP8B1,Pathogenic,"Cholestasis, intrahepatic, of pregnancy, 1",single nucleotide variant,GRCh37
na,na,18,57661282,57661282,ATP8B1,Pathogenic,"Cholestasis, intrahepatic, of pregnancy, 1",single nucleotide variant,GRCh38
na,na,18,55355593,55355593,ATP8B1,Pathogenic/Likely pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided,single nucleotide variant,GRCh37
na,na,18,57688361,57688361,ATP8B1,Pathogenic/Likely pathogenic,Progressive familial intrahepatic cholestasis type 1|not provided,single nucleotide variant,GRCh38
na,na,18,55342081,55342081,ATP8B1,Pathogenic,Progressive familial intrahepatic cholestasis type 1|Familial intrahepatic cholestasis type 1|Benign recurrent intrahepatic cholestasis type 1|not provided,single nucleotide variant,GRCh37
na,na,18,57674849,57674849,ATP8B1,Pathogenic,Progressive familial intrahepatic cholestasis type 1|Familial intrahepatic cholestasis type 1|Benign recurrent intrahepatic cholestasis type 1|not provided,single nucleotide variant,GRCh38
na,na,16,28855329,28855329,TUFM,Uncertain significance,Combined oxidative phosphorylation defect type 4|not provided,single nucleotide variant,GRCh37
na,na,16,28844008,28844008,TUFM,Uncertain significance,Combined oxidative phosphorylation defect type 4|not provided,single nucleotide variant,GRCh38
na,na,19,10930668,10930668,DNM2,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease, dominant intermediate B, with neutropenia|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease dominant intermediate B",single nucleotide variant,GRCh37
na,na,19,10819992,10819992,DNM2,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease, dominant intermediate B, with neutropenia|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease dominant intermediate B",single nucleotide variant,GRCh38
na,na,19,10904509,10904509,DNM2,Pathogenic,Autosomal dominant centronuclear myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|not provided,single nucleotide variant,GRCh37
na,na,19,10793833,10793833,DNM2,Pathogenic,Autosomal dominant centronuclear myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|not provided,single nucleotide variant,GRCh38
na,na,19,10904508,10904508,DNM2,Pathogenic,Autosomal dominant centronuclear myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Charcot-Marie-Tooth disease|not provided,single nucleotide variant,GRCh37
na,na,19,10793832,10793832,DNM2,Pathogenic,Autosomal dominant centronuclear myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Charcot-Marie-Tooth disease|not provided,single nucleotide variant,GRCh38
na,na,19,10909219,10909219,DNM2,Pathogenic,Autosomal dominant centronuclear myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Abnormality of the musculature|not provided|DNM2-related disorder,single nucleotide variant,GRCh37
na,na,19,10798543,10798543,DNM2,Pathogenic,Autosomal dominant centronuclear myopathy|Centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Abnormality of the musculature|not provided|DNM2-related disorder,single nucleotide variant,GRCh38
na,na,19,10904505,10904505,DNM2,Pathogenic,Autosomal dominant centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Centronuclear myopathy|Myopathy|not provided|DNM2-related disorder,single nucleotide variant,GRCh37
na,na,19,10793829,10793829,DNM2,Pathogenic,Autosomal dominant centronuclear myopathy|Charcot-Marie-Tooth disease dominant intermediate B|Centronuclear myopathy|Myopathy|not provided|DNM2-related disorder,single nucleotide variant,GRCh38
na,na,19,10922991,10922991,DNM2,Conflicting classifications of pathogenicity,Autosomal dominant Charcot-Marie-Tooth disease type 2M|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease dominant intermediate B,single nucleotide variant,GRCh37
na,na,19,10812315,10812315,DNM2,Conflicting classifications of pathogenicity,Autosomal dominant Charcot-Marie-Tooth disease type 2M|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease dominant intermediate B,single nucleotide variant,GRCh38
na,na,19,10930693,10930693,DNM2,Conflicting classifications of pathogenicity,Autosomal dominant Charcot-Marie-Tooth disease type 2M|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease dominant intermediate B,single nucleotide variant,GRCh37
na,na,19,10820017,10820017,DNM2,Conflicting classifications of pathogenicity,Autosomal dominant Charcot-Marie-Tooth disease type 2M|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease dominant intermediate B,single nucleotide variant,GRCh38
na,na,19,10934538,10934538,DNM2,Pathogenic,Severe X-linked myotubular myopathy|Centronuclear myopathy|not provided|Charcot-Marie-Tooth disease dominant intermediate B|Autosomal dominant centronuclear myopathy|Fetal akinesia-cerebral and retinal hemorrhage syndrome;Charcot-Marie-Tooth disease dominant intermediate B;Autosomal dominant centronuclear myopathy,single nucleotide variant,GRCh37
na,na,19,10823862,10823862,DNM2,Pathogenic,Severe X-linked myotubular myopathy|Centronuclear myopathy|not provided|Charcot-Marie-Tooth disease dominant intermediate B|Autosomal dominant centronuclear myopathy|Fetal akinesia-cerebral and retinal hemorrhage syndrome;Charcot-Marie-Tooth disease dominant intermediate B;Autosomal dominant centronuclear myopathy,single nucleotide variant,GRCh38
na,na,19,10934538,10934538,DNM2,Pathogenic,Severe X-linked myotubular myopathy|Charcot-Marie-Tooth disease dominant intermediate B|not provided,single nucleotide variant,GRCh37
na,na,19,10823862,10823862,DNM2,Pathogenic,Severe X-linked myotubular myopathy|Charcot-Marie-Tooth disease dominant intermediate B|not provided,single nucleotide variant,GRCh38
na,na,19,10904475,10904475,DNM2,Pathogenic/Likely pathogenic,Autosomal dominant Charcot-Marie-Tooth disease type 2M|Charcot-Marie-Tooth disease dominant intermediate B|not provided,single nucleotide variant,GRCh37
na,na,19,10793799,10793799,DNM2,Pathogenic/Likely pathogenic,Autosomal dominant Charcot-Marie-Tooth disease type 2M|Charcot-Marie-Tooth disease dominant intermediate B|not provided,single nucleotide variant,GRCh38
na,na,21,34614250,34614250,IFNAR2,Benign,"Hepatitis B virus, susceptibility to|Immunodeficiency 45|not provided|not specified|Mortality risk in patients with severe coronavirus disease (COVID-19)",single nucleotide variant,GRCh37
na,na,21,33241945,33241945,IFNAR2,Benign,"Hepatitis B virus, susceptibility to|Immunodeficiency 45|not provided|not specified|Mortality risk in patients with severe coronavirus disease (COVID-19)",single nucleotide variant,GRCh38
na,na,11,88042344,88042344,CTSC,Pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh37
na,na,11,88309176,88309176,CTSC,Pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh38
na,na,11,88027677,88027677,CTSC,Pathogenic,Papillon-Lefèvre syndrome,single nucleotide variant,GRCh37
na,na,11,88294509,88294509,CTSC,Pathogenic,Papillon-Lefèvre syndrome,single nucleotide variant,GRCh38
na,na,11,88033700,88033700,CTSC,Pathogenic/Likely pathogenic,"Papillon-Lefèvre syndrome|not provided|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh37
na,na,11,88300532,88300532,CTSC,Pathogenic/Likely pathogenic,"Papillon-Lefèvre syndrome|not provided|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh38
na,na,11,88029334,88029334,CTSC,Pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh37
na,na,11,88296166,88296166,CTSC,Pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh38
na,na,11,88027519,88027519,CTSC,Pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",Deletion,GRCh37
na,na,11,88294351,88294351,CTSC,Pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",Deletion,GRCh38
na,na,11,88029333,88029333,CTSC,Conflicting classifications of pathogenicity,"Haim-Munk syndrome|not provided|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh37
na,na,11,88296165,88296165,CTSC,Conflicting classifications of pathogenicity,"Haim-Munk syndrome|not provided|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh38
na,na,11,88070725,88070725,CTSC,Likely pathogenic,"Papillon-Lefèvre syndrome|CTSC-related disorder|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh37
na,na,11,88337557,88337557,CTSC,Likely pathogenic,"Papillon-Lefèvre syndrome|CTSC-related disorder|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh38
na,na,11,88027665,88027665,CTSC,Pathogenic/Likely pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh37
na,na,11,88294497,88294497,CTSC,Pathogenic/Likely pathogenic,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh38
na,na,11,88027279,88027279,CTSC,Pathogenic,Papillon-Lefèvre syndrome,single nucleotide variant,GRCh37
na,na,11,88294111,88294111,CTSC,Pathogenic,Papillon-Lefèvre syndrome,single nucleotide variant,GRCh38
na,na,11,88045661,88045661,CTSC,Uncertain significance,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh37
na,na,11,88312493,88312493,CTSC,Uncertain significance,"Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh38
na,na,11,88027331,88027331,CTSC,Pathogenic,"Periodontitis, aggressive 1",single nucleotide variant,GRCh37
na,na,11,88294163,88294163,CTSC,Pathogenic,"Periodontitis, aggressive 1",single nucleotide variant,GRCh38
na,na,11,88027526,88027526,CTSC,Pathogenic,"Periodontitis, aggressive 1|Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh37
na,na,11,88294358,88294358,CTSC,Pathogenic,"Periodontitis, aggressive 1|Papillon-Lefèvre syndrome|Periodontitis, aggressive 1;Haim-Munk syndrome;Papillon-Lefèvre syndrome",single nucleotide variant,GRCh38
na,na,15,45661562,45661562,GATM,Pathogenic,Arginine:glycine amidinotransferase deficiency,single nucleotide variant,GRCh37
na,na,15,45369364,45369364,GATM,Pathogenic,Arginine:glycine amidinotransferase deficiency,single nucleotide variant,GRCh38
na,na,17,40336521,40336521,HCRT,Pathogenic,Narcolepsy 1,single nucleotide variant,GRCh37
na,na,17,42184503,42184503,HCRT,Pathogenic,Narcolepsy 1,single nucleotide variant,GRCh38
na,na,9,94486511,94486511,ROR2,Pathogenic,Brachydactyly type B1|not provided,single nucleotide variant,GRCh37
na,na,9,91724229,91724229,ROR2,Pathogenic,Brachydactyly type B1|not provided,single nucleotide variant,GRCh38
na,na,9,94486530,94486530,ROR2,Pathogenic,Brachydactyly type B1,single nucleotide variant,GRCh37
na,na,9,91724248,91724248,ROR2,Pathogenic,Brachydactyly type B1,single nucleotide variant,GRCh38
na,na,9,94486527,94486527,ROR2,Pathogenic,Brachydactyly type B1,Deletion,GRCh37
na,na,9,91724245,91724245,ROR2,Pathogenic,Brachydactyly type B1,Deletion,GRCh38
na,na,9,94487272,94487272,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,single nucleotide variant,GRCh37
na,na,9,91724990,91724990,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,single nucleotide variant,GRCh38
na,na,9,94499745,94499745,ROR2,Likely pathogenic,Autosomal recessive Robinow syndrome|Autosomal recessive Robinow syndrome;Brachydactyly type B1,single nucleotide variant,GRCh37
na,na,9,91737463,91737463,ROR2,Likely pathogenic,Autosomal recessive Robinow syndrome|Autosomal recessive Robinow syndrome;Brachydactyly type B1,single nucleotide variant,GRCh38
na,na,9,94486616,94486616,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,single nucleotide variant,GRCh37
na,na,9,91724334,91724334,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,single nucleotide variant,GRCh38
na,na,9,94499682,94499682,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,single nucleotide variant,GRCh37
na,na,9,91737400,91737400,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,single nucleotide variant,GRCh38
na,na,9,94488884,94488888,ROR2,Pathogenic,"Brachydactyly type B1|Robinow syndrome, autosomal recessive, with aplasia/hypoplasia of phalanges and metacarpals/metatarsals",Deletion,GRCh37
na,na,9,91726602,91726606,ROR2,Pathogenic,"Brachydactyly type B1|Robinow syndrome, autosomal recessive, with aplasia/hypoplasia of phalanges and metacarpals/metatarsals",Deletion,GRCh38
na,na,9,94486529,94486529,ROR2,Pathogenic,Brachydactyly type B1,single nucleotide variant,GRCh37
na,na,9,91724247,91724247,ROR2,Pathogenic,Brachydactyly type B1,single nucleotide variant,GRCh38
na,na,9,94486833,94486839,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,Deletion,GRCh37
na,na,9,91724551,91724557,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,Deletion,GRCh38
na,na,9,94519662,94519662,ROR2,Pathogenic,Autosomal recessive Robinow syndrome|not provided,single nucleotide variant,GRCh37
na,na,9,91757380,91757380,ROR2,Pathogenic,Autosomal recessive Robinow syndrome|not provided,single nucleotide variant,GRCh38
na,na,9,94490061,94498911,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,Deletion,GRCh37
na,na,9,91727779,91736629,ROR2,Pathogenic,Autosomal recessive Robinow syndrome,Deletion,GRCh38
na,na,9,94488842,94488843,ROR2,Pathogenic,Brachydactyly type B1|not provided,Duplication,GRCh37
na,na,9,91726560,91726561,ROR2,Pathogenic,Brachydactyly type B1|not provided,Duplication,GRCh38
na,na,9,94486532,94486532,ROR2,Pathogenic,Brachydactyly type B1,Deletion,GRCh37
na,na,9,91724250,91724250,ROR2,Pathogenic,Brachydactyly type B1,Deletion,GRCh38
na,na,9,94488885,94488885,ROR2,Pathogenic,"Robinow syndrome, autosomal recessive, with brachy-syn-polydactyly|Autosomal recessive Robinow syndrome|Autosomal recessive Robinow syndrome;Brachydactyly type B1|not provided",single nucleotide variant,GRCh37
na,na,9,91726603,91726603,ROR2,Pathogenic,"Robinow syndrome, autosomal recessive, with brachy-syn-polydactyly|Autosomal recessive Robinow syndrome|Autosomal recessive Robinow syndrome;Brachydactyly type B1|not provided",single nucleotide variant,GRCh38
na,na,3,169481651,169482471,TERC,Pathogenic,"Dyskeratosis congenita, autosomal dominant 1",Deletion,GRCh37
na,na,3,169763863,169764683,TERC,Pathogenic,"Dyskeratosis congenita, autosomal dominant 1",Deletion,GRCh38
na,na,3,169482441,169482441,TERC,Pathogenic,"Dyskeratosis congenita, autosomal dominant 1",single nucleotide variant,GRCh37
na,na,3,169764653,169764653,TERC,Pathogenic,"Dyskeratosis congenita, autosomal dominant 1",single nucleotide variant,GRCh38
na,na,3,169482741,169482742,TERC,Pathogenic,"Dyskeratosis congenita, autosomal dominant 1",Indel,GRCh37
na,na,3,169764953,169764954,TERC,Pathogenic,"Dyskeratosis congenita, autosomal dominant 1",Indel,GRCh38
na,na,3,169482645,169482645,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Dyskeratosis congenita, autosomal dominant 1",single nucleotide variant,GRCh37
na,na,3,169764857,169764857,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Dyskeratosis congenita, autosomal dominant 1",single nucleotide variant,GRCh38
na,na,3,169482791,169482791,TERC,Benign/Likely benign,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 1|not specified|not provided|Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2;Dyskeratosis congenita, autosomal dominant 1",single nucleotide variant,GRCh37
na,na,3,169765003,169765003,TERC,Benign/Likely benign,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 1|not specified|not provided|Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2;Dyskeratosis congenita, autosomal dominant 1",single nucleotide variant,GRCh38
na,na,3,169482777,169482777,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Aplastic anemia",single nucleotide variant,GRCh37
na,na,3,169764989,169764989,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Aplastic anemia",single nucleotide variant,GRCh38
na,na,3,169482736,169482739,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 1",Deletion,GRCh37
na,na,3,169764948,169764951,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 1",Deletion,GRCh38
na,na,3,169482733,169482733,TERC,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Dyskeratosis congenita, autosomal dominant 1|Pulmonary fibrosis|not provided",single nucleotide variant,GRCh37
na,na,3,169764945,169764945,TERC,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Dyskeratosis congenita, autosomal dominant 1|Pulmonary fibrosis|not provided",single nucleotide variant,GRCh38
na,na,3,169482751,169482751,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Interstitial lung disease 2",single nucleotide variant,GRCh37
na,na,3,169764963,169764963,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2|Interstitial lung disease 2",single nucleotide variant,GRCh38
na,na,3,169482524,169482524,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2",single nucleotide variant,GRCh37
na,na,3,169764736,169764736,TERC,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2",single nucleotide variant,GRCh38
na,na,16,67516945,67516945,AGRP,Benign,"Leanness, inherited|Obesity, late-onset|AGRP-related condition|Inherited obesity",single nucleotide variant,GRCh37
na,na,16,67483042,67483042,AGRP,Benign,"Leanness, inherited|Obesity, late-onset|AGRP-related condition|Inherited obesity",single nucleotide variant,GRCh38
na,na,8,21976710,21976710,HR,Benign,Alopecia universalis congenita|Atrichia with papular lesions|not provided|HR-related disorder,single nucleotide variant,GRCh37
na,na,8,22119197,22119197,HR,Benign,Alopecia universalis congenita|Atrichia with papular lesions|not provided|HR-related disorder,single nucleotide variant,GRCh38
na,na,8,21973913,21973913,HR,Pathogenic,Alopecia universalis congenita,single nucleotide variant,GRCh37
na,na,8,22116400,22116400,HR,Pathogenic,Alopecia universalis congenita,single nucleotide variant,GRCh38
na,na,8,21984697,21984697,HR,Pathogenic,Atrichia with papular lesions,Deletion,GRCh37
na,na,8,22127184,22127184,HR,Pathogenic,Atrichia with papular lesions,Deletion,GRCh38
na,na,8,21981240,21981240,HR,Pathogenic,Atrichia with papular lesions,single nucleotide variant,GRCh37
na,na,8,22123727,22123727,HR,Pathogenic,Atrichia with papular lesions,single nucleotide variant,GRCh38
na,na,8,21977404,21977405,HR,Pathogenic,Atrichia with papular lesions,Deletion,GRCh37
na,na,8,22119891,22119892,HR,Pathogenic,Atrichia with papular lesions,Deletion,GRCh38
na,na,8,21973257,21973257,HR,Pathogenic,Atrichia with papular lesions,single nucleotide variant,GRCh37
na,na,8,22115744,22115744,HR,Pathogenic,Atrichia with papular lesions,single nucleotide variant,GRCh38
na,na,8,21976740,21976740,HR,Pathogenic,Alopecia universalis congenita,single nucleotide variant,GRCh37
na,na,8,22119227,22119227,HR,Pathogenic,Alopecia universalis congenita,single nucleotide variant,GRCh38
na,na,8,21988220,21988220,HRURF,Pathogenic,Hypotrichosis 4,single nucleotide variant,GRCh37
na,na,8,22130707,22130707,HRURF,Pathogenic,Hypotrichosis 4,single nucleotide variant,GRCh38
na,na,8,21988215,21988215,HRURF,Pathogenic,Hypotrichosis 4,single nucleotide variant,GRCh37
na,na,8,22130702,22130702,HRURF,Pathogenic,Hypotrichosis 4,single nucleotide variant,GRCh38
na,na,8,21988149,21988149,HRURF,Pathogenic,Hypotrichosis 4,single nucleotide variant,GRCh37
na,na,8,22130636,22130636,HRURF,Pathogenic,Hypotrichosis 4,single nucleotide variant,GRCh38
na,na,8,21988118,21988118,HRURF,Pathogenic,Hypotrichosis 4,single nucleotide variant,GRCh37
na,na,8,22130605,22130605,HRURF,Pathogenic,Hypotrichosis 4,single nucleotide variant,GRCh38
na,na,3,128525419,128525419,RAB7A,Pathogenic,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,3,128806576,128806576,RAB7A,Pathogenic,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,3,128526470,128526470,RAB7A,Pathogenic,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,3,128807627,128807627,RAB7A,Pathogenic,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,3,128526468,128526468,RAB7A,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,3,128807625,128807625,RAB7A,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,3,128526457,128526457,RAB7A,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,3,128807614,128807614,RAB7A,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2B|not provided|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,11,116708060,116708060,APOA1;APOA1-AS,Pathogenic,Hereditary spastic paraplegia 50,single nucleotide variant,GRCh37
na,na,11,116837344,116837344,APOA1;APOA1-AS,Pathogenic,Hereditary spastic paraplegia 50,single nucleotide variant,GRCh38
na,na,9,119461480,119461480,TRIM32,Pathogenic,Sarcotubular myopathy|Myopathy|Bardet-Biedl syndrome|not provided|TRIM32-related disorder|Retinal dystrophy|Bardet-Biedl syndrome 11,single nucleotide variant,GRCh37
na,na,9,116699201,116699201,TRIM32,Pathogenic,Sarcotubular myopathy|Myopathy|Bardet-Biedl syndrome|not provided|TRIM32-related disorder|Retinal dystrophy|Bardet-Biedl syndrome 11,single nucleotide variant,GRCh38
na,na,9,119460409,119460409,TRIM32,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 11|Bardet-Biedl syndrome|not provided|TRIM32-related disorder,single nucleotide variant,GRCh37
na,na,9,116698130,116698130,TRIM32,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 11|Bardet-Biedl syndrome|not provided|TRIM32-related disorder,single nucleotide variant,GRCh38
na,na,9,119461580,119461580,TRIM32,Pathogenic/Likely pathogenic,Sarcotubular myopathy|Bardet-Biedl syndrome 11|not provided|Bardet-Biedl syndrome|Bardet-Biedl syndrome 11;Sarcotubular myopathy,Deletion,GRCh37
na,na,9,116699301,116699301,TRIM32,Pathogenic/Likely pathogenic,Sarcotubular myopathy|Bardet-Biedl syndrome 11|not provided|Bardet-Biedl syndrome|Bardet-Biedl syndrome 11;Sarcotubular myopathy,Deletion,GRCh38
na,na,9,119461202,119461202,TRIM32,Conflicting classifications of pathogenicity,Sarcotubular myopathy|not provided|Bardet-Biedl syndrome|TRIM32-related disorder|Bardet-Biedl syndrome 11;Sarcotubular myopathy|Bardet-Biedl syndrome 11,single nucleotide variant,GRCh37
na,na,9,116698923,116698923,TRIM32,Conflicting classifications of pathogenicity,Sarcotubular myopathy|not provided|Bardet-Biedl syndrome|TRIM32-related disorder|Bardet-Biedl syndrome 11;Sarcotubular myopathy|Bardet-Biedl syndrome 11,single nucleotide variant,GRCh38
na,na,11,121174170,121174170,SC5D,Pathogenic,Lathosterolosis,single nucleotide variant,GRCh37
na,na,11,121303461,121303461,SC5D,Pathogenic,Lathosterolosis,single nucleotide variant,GRCh38
na,na,11,121177953,121177953,SC5D,Pathogenic,Lathosterolosis,single nucleotide variant,GRCh37
na,na,11,121307244,121307244,SC5D,Pathogenic,Lathosterolosis,single nucleotide variant,GRCh38
na,na,11,121174221,121174221,SC5D,Pathogenic,Lathosterolosis,single nucleotide variant,GRCh37
na,na,11,121303512,121303512,SC5D,Pathogenic,Lathosterolosis,single nucleotide variant,GRCh38
na,na,6,35471400,35471400,TULP1,Pathogenic,not provided|Retinitis pigmentosa 14,single nucleotide variant,GRCh37
na,na,6,35503623,35503623,TULP1,Pathogenic,not provided|Retinitis pigmentosa 14,single nucleotide variant,GRCh38
na,na,6,35467782,35467782,TEAD3;TULP1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 14|Retinal dystrophy|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,6,35500005,35500005,TEAD3;TULP1,Pathogenic/Likely pathogenic,Retinitis pigmentosa 14|Retinal dystrophy|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,6,35467877,35467877,TULP1,Likely pathogenic,Retinitis pigmentosa 14|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,6,35500100,35500100,TULP1,Likely pathogenic,Retinitis pigmentosa 14|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,6,35471593,35471593,TULP1,Pathogenic,Retinitis pigmentosa 14|Retinitis pigmentosa|Retinal dystrophy|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,6,35503816,35503816,TULP1,Pathogenic,Retinitis pigmentosa 14|Retinitis pigmentosa|Retinal dystrophy|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,6,35467809,35467809,TULP1,Conflicting classifications of pathogenicity,Retinitis pigmentosa 14|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh37
na,na,6,35500032,35500032,TULP1,Conflicting classifications of pathogenicity,Retinitis pigmentosa 14|not provided|Leber congenital amaurosis,single nucleotide variant,GRCh38
na,na,6,35466212,35466222,TULP1,Pathogenic,Retinitis pigmentosa 14|not provided|Leber congenital amaurosis 15,Deletion,GRCh37
na,na,6,35498435,35498445,TULP1,Pathogenic,Retinitis pigmentosa 14|not provided|Leber congenital amaurosis 15,Deletion,GRCh38
na,na,6,35477409,35477409,TULP1,Pathogenic,Retinitis pigmentosa 14|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,6,35509632,35509632,TULP1,Pathogenic,Retinitis pigmentosa 14|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,14,23790681,23790701,PABPN1,Pathogenic,Oculopharyngeal muscular dystrophy 1,Microsatellite,GRCh37
na,na,14,23321472,23321492,PABPN1,Pathogenic,Oculopharyngeal muscular dystrophy 1,Microsatellite,GRCh38
na,na,14,23790713,23790713,PABPN1,Uncertain significance,Oculopharyngeal muscular dystrophy|PABPN1-related disorder|Oculopharyngeal muscular dystrophy 1,single nucleotide variant,GRCh37
na,na,14,23321504,23321504,PABPN1,Uncertain significance,Oculopharyngeal muscular dystrophy|PABPN1-related disorder|Oculopharyngeal muscular dystrophy 1,single nucleotide variant,GRCh38
na,na,6,42153424,42153424,GUCA1B,Conflicting classifications of pathogenicity,Retinitis pigmentosa 48|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,6,42185686,42185686,GUCA1B,Conflicting classifications of pathogenicity,Retinitis pigmentosa 48|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,18,52896219,52896219,TCF4,Pathogenic,Pitt-Hopkins syndrome|not provided|Severe intellectual deficiency|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,18,55228988,55228988,TCF4,Pathogenic,Pitt-Hopkins syndrome|not provided|Severe intellectual deficiency|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,18,52896218,52896218,TCF4,Pathogenic,Pitt-Hopkins syndrome|not provided,single nucleotide variant,GRCh37
na,na,18,55228987,55228987,TCF4,Pathogenic,Pitt-Hopkins syndrome|not provided,single nucleotide variant,GRCh38
na,na,18,52921925,52921925,TCF4,Pathogenic,"Pitt-Hopkins syndrome|not provided|Corneal dystrophy, Fuchs endothelial, 3;Pitt-Hopkins syndrome",single nucleotide variant,GRCh37
na,na,18,55254694,55254694,TCF4,Pathogenic,"Pitt-Hopkins syndrome|not provided|Corneal dystrophy, Fuchs endothelial, 3;Pitt-Hopkins syndrome",single nucleotide variant,GRCh38
na,na,18,52896224,52896224,TCF4,Pathogenic,Pitt-Hopkins syndrome,single nucleotide variant,GRCh37
na,na,18,55228993,55228993,TCF4,Pathogenic,Pitt-Hopkins syndrome,single nucleotide variant,GRCh38
na,na,18,52937076,52937076,TCF4,Pathogenic,Pitt-Hopkins syndrome,Deletion,GRCh37
na,na,18,55269845,55269845,TCF4,Pathogenic,Pitt-Hopkins syndrome,Deletion,GRCh38
na,na,4,77087402,77087402,SCARB2,Pathogenic,Action myoclonus-renal failure syndrome,single nucleotide variant,GRCh37
na,na,4,76166249,76166249,SCARB2,Pathogenic,Action myoclonus-renal failure syndrome,single nucleotide variant,GRCh38
na,na,4,77100846,77100847,SCARB2,Pathogenic,Action myoclonus-renal failure syndrome|not provided|Progressive myoclonic epilepsy|Inborn genetic diseases,Microsatellite,GRCh37
na,na,4,76179693,76179694,SCARB2,Pathogenic,Action myoclonus-renal failure syndrome|not provided|Progressive myoclonic epilepsy|Inborn genetic diseases,Microsatellite,GRCh38
na,na,4,77095429,77095429,SCARB2,Pathogenic,Action myoclonus-renal failure syndrome|not provided|Progressive myoclonic epilepsy,single nucleotide variant,GRCh37
na,na,4,76174276,76174276,SCARB2,Pathogenic,Action myoclonus-renal failure syndrome|not provided|Progressive myoclonic epilepsy,single nucleotide variant,GRCh38
na,na,4,77100749,77100749,SCARB2,Pathogenic,Action myoclonus-renal failure syndrome,single nucleotide variant,GRCh37
na,na,4,76179596,76179596,SCARB2,Pathogenic,Action myoclonus-renal failure syndrome,single nucleotide variant,GRCh38
na,na,11,837278,837279,CD151,Pathogenic,"Epidermolysis bullosa simplex 7, with nephropathy and deafness",Duplication,GRCh37
na,na,11,837278,837279,CD151,Pathogenic,"Epidermolysis bullosa simplex 7, with nephropathy and deafness",Duplication,GRCh38
na,na,20,62071027,62071027,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1|Complex neurodevelopmental disorder",single nucleotide variant,GRCh37
na,na,20,63439674,63439674,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1|Complex neurodevelopmental disorder",single nucleotide variant,GRCh38
na,na,20,62070962,62070962,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1|Developmental and epileptic encephalopathy|not provided|Developmental and epileptic encephalopathy, 7|Complex neurodevelopmental disorder|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,20,63439609,63439609,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1|Developmental and epileptic encephalopathy|not provided|Developmental and epileptic encephalopathy, 7|Complex neurodevelopmental disorder|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,20,62076062,62076062,KCNQ2,Pathogenic/Likely pathogenic,"Seizures, benign familial neonatal, 1|not provided|Developmental and epileptic encephalopathy|Complex neurodevelopmental disorder|Neonatal/infantile epilepsy syndrome",single nucleotide variant,GRCh37
na,na,20,63444709,63444709,KCNQ2,Pathogenic/Likely pathogenic,"Seizures, benign familial neonatal, 1|not provided|Developmental and epileptic encephalopathy|Complex neurodevelopmental disorder|Neonatal/infantile epilepsy syndrome",single nucleotide variant,GRCh38
na,na,20,62076083,62076083,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1, and/or myokymia|not provided|Seizures, benign familial neonatal, 1|Developmental and epileptic encephalopathy|Inborn genetic diseases|Developmental and epileptic encephalopathy, 7|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 7;Seizures, benign familial neonatal, 1",single nucleotide variant,GRCh37
na,na,20,63444730,63444730,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1, and/or myokymia|not provided|Seizures, benign familial neonatal, 1|Developmental and epileptic encephalopathy|Inborn genetic diseases|Developmental and epileptic encephalopathy, 7|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 7;Seizures, benign familial neonatal, 1",single nucleotide variant,GRCh38
na,na,20,62044904,62044904,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1|Seizures, benign familial neonatal, 2|Developmental and epileptic encephalopathy, 7|not provided",single nucleotide variant,GRCh37
na,na,20,63413551,63413551,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1|Seizures, benign familial neonatal, 2|Developmental and epileptic encephalopathy, 7|not provided",single nucleotide variant,GRCh38
na,na,20,62073835,62073835,KCNQ2,Pathogenic,"Developmental and epileptic encephalopathy, 7|Seizures, benign familial neonatal, 2|Developmental and epileptic encephalopathy|not provided",single nucleotide variant,GRCh37
na,na,20,63442482,63442482,KCNQ2,Pathogenic,"Developmental and epileptic encephalopathy, 7|Seizures, benign familial neonatal, 2|Developmental and epileptic encephalopathy|not provided",single nucleotide variant,GRCh38
na,na,20,62038489,62038489,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1|not provided|Developmental and epileptic encephalopathy, 7|Developmental and epileptic encephalopathy",Deletion,GRCh37
na,na,20,63407136,63407136,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1|not provided|Developmental and epileptic encephalopathy, 7|Developmental and epileptic encephalopathy",Deletion,GRCh38
na,na,20,62076082,62076082,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1, and/or myokymia|not provided|Developmental and epileptic encephalopathy, 7|Developmental and epileptic encephalopathy, 7;Seizures, benign familial neonatal, 1|Developmental and epileptic encephalopathy|Complex neurodevelopmental disorder|KCNQ2-related disorder",single nucleotide variant,GRCh37
na,na,20,63444729,63444729,KCNQ2,Pathogenic,"Seizures, benign familial neonatal, 1, and/or myokymia|not provided|Developmental and epileptic encephalopathy, 7|Developmental and epileptic encephalopathy, 7;Seizures, benign familial neonatal, 1|Developmental and epileptic encephalopathy|Complex neurodevelopmental disorder|KCNQ2-related disorder",single nucleotide variant,GRCh38
na,na,8,133187704,133187704,KCNQ3,Pathogenic,"Seizures, benign familial neonatal, 2",single nucleotide variant,GRCh37
na,na,8,132175457,132175457,KCNQ3,Pathogenic,"Seizures, benign familial neonatal, 2",single nucleotide variant,GRCh38
na,na,22,38374006,38374006,SOX10,Pathogenic,Waardenburg syndrome type 4C|not provided,single nucleotide variant,GRCh37
na,na,22,37977999,37977999,SOX10,Pathogenic,Waardenburg syndrome type 4C|not provided,single nucleotide variant,GRCh38
na,na,22,38379543,38379543,SOX10,Pathogenic,Waardenburg syndrome type 4C,single nucleotide variant,GRCh37
na,na,22,37983536,37983536,SOX10,Pathogenic,Waardenburg syndrome type 4C,single nucleotide variant,GRCh38
na,na,22,38374088,38374089,SOX10,Pathogenic,Waardenburg syndrome type 4C,Insertion,GRCh37
na,na,22,37978081,37978082,SOX10,Pathogenic,Waardenburg syndrome type 4C,Insertion,GRCh38
na,na,22,38369825,38369826,SOX10,Pathogenic,Waardenburg syndrome type 4C|not provided,Microsatellite,GRCh37
na,na,22,37973818,37973819,SOX10,Pathogenic,Waardenburg syndrome type 4C|not provided,Microsatellite,GRCh38
na,na,22,38379388,38379388,SOX10,Pathogenic,"Waardenburg syndrome type 2E, without neurologic involvement",single nucleotide variant,GRCh37
na,na,22,37983381,37983381,SOX10,Pathogenic,"Waardenburg syndrome type 2E, without neurologic involvement",single nucleotide variant,GRCh38
na,na,22,38369964,38369964,SOX10,Pathogenic,PCWH syndrome,single nucleotide variant,GRCh37
na,na,22,37973957,37973957,SOX10,Pathogenic,PCWH syndrome,single nucleotide variant,GRCh38
na,na,22,38370151,38370151,SOX10,Pathogenic,PCWH syndrome|not provided,single nucleotide variant,GRCh37
na,na,22,37974144,37974144,SOX10,Pathogenic,PCWH syndrome|not provided,single nucleotide variant,GRCh38
na,na,22,38369492,38369503,SOX10,Likely pathogenic,PCWH syndrome,Deletion,GRCh37
na,na,22,37973485,37973496,SOX10,Likely pathogenic,PCWH syndrome,Deletion,GRCh38
na,na,22,38373950,38373950,SOX10,Pathogenic,Waardenburg syndrome type 4C,single nucleotide variant,GRCh37
na,na,22,37977943,37977943,SOX10,Pathogenic,Waardenburg syndrome type 4C,single nucleotide variant,GRCh38
na,na,22,38369774,38369774,SOX10,Pathogenic,"Waardenburg syndrome type 2E, with neurologic involvement|Waardenburg syndrome type 4C|not provided",single nucleotide variant,GRCh37
na,na,22,37973767,37973767,SOX10,Pathogenic,"Waardenburg syndrome type 2E, with neurologic involvement|Waardenburg syndrome type 4C|not provided",single nucleotide variant,GRCh38
na,na,22,38370155,38370155,SOX10,Pathogenic,PCWH syndrome,single nucleotide variant,GRCh37
na,na,22,37974148,37974148,SOX10,Pathogenic,PCWH syndrome,single nucleotide variant,GRCh38
na,na,22,38369818,38370945,SOX10,Pathogenic,Waardenburg syndrome type 4C,Indel,GRCh37
na,na,22,37973811,37974938,SOX10,Pathogenic,Waardenburg syndrome type 4C,Indel,GRCh38
na,na,22,38379321,38379573,SOX10,Pathogenic,"Waardenburg syndrome type 2E, without neurologic involvement",Deletion,GRCh37
na,na,22,37983314,37983566,SOX10,Pathogenic,"Waardenburg syndrome type 2E, without neurologic involvement",Deletion,GRCh38
na,na,22,38373478,38375254,SOX10,Pathogenic,"Waardenburg syndrome type 2E, without neurologic involvement",Deletion,GRCh37
na,na,22,37977471,37979247,SOX10,Pathogenic,"Waardenburg syndrome type 2E, without neurologic involvement",Deletion,GRCh38
na,na,22,38374065,38374065,SOX10,Pathogenic,"Waardenburg syndrome type 2E, without neurologic involvement",Deletion,GRCh37
na,na,22,37978058,37978058,SOX10,Pathogenic,"Waardenburg syndrome type 2E, without neurologic involvement",Deletion,GRCh38
na,na,22,38374101,38374101,SOX10,Pathogenic,Waardenburg syndrome type 4C|not provided,single nucleotide variant,GRCh37
na,na,22,37978094,37978094,SOX10,Pathogenic,Waardenburg syndrome type 4C|not provided,single nucleotide variant,GRCh38
na,na,22,38370207,38370207,SOX10,Pathogenic,"Waardenburg syndrome type 2E, with neurologic involvement",single nucleotide variant,GRCh37
na,na,22,37974200,37974200,SOX10,Pathogenic,"Waardenburg syndrome type 2E, with neurologic involvement",single nucleotide variant,GRCh38
na,na,22,38374050,38374050,SOX10,Pathogenic,"Waardenburg syndrome type 2E, with neurologic involvement",single nucleotide variant,GRCh37
na,na,22,37978043,37978043,SOX10,Pathogenic,"Waardenburg syndrome type 2E, with neurologic involvement",single nucleotide variant,GRCh38
na,na,22,38370106,38370106,SOX10,Conflicting classifications of pathogenicity,PCWH syndrome|Charcot-Marie-Tooth disease,Deletion,GRCh37
na,na,22,37974099,37974099,SOX10,Conflicting classifications of pathogenicity,PCWH syndrome|Charcot-Marie-Tooth disease,Deletion,GRCh38
na,na,22,38369988,38369988,SOX10,Pathogenic,PCWH syndrome,Deletion,GRCh37
na,na,22,37973981,37973981,SOX10,Pathogenic,PCWH syndrome,Deletion,GRCh38
na,na,10,114758349,114758349,TCF7L2,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh37
na,na,10,112998590,112998590,TCF7L2,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh38
na,na,10,114808902,114808902,TCF7L2,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh37
na,na,10,113049143,113049143,TCF7L2,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh38
na,na,10,114807047,114807047,TCF7L2,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh37
na,na,10,113047288,113047288,TCF7L2,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh38
na,na,19,48339638,48339638,CRX,Pathogenic,Cone-rod dystrophy 2|not provided|Leber congenital amaurosis 7;Cone-rod dystrophy 2,single nucleotide variant,GRCh37
na,na,19,47836381,47836381,CRX,Pathogenic,Cone-rod dystrophy 2|not provided|Leber congenital amaurosis 7;Cone-rod dystrophy 2,single nucleotide variant,GRCh38
na,na,19,48342826,48342826,CRX,Pathogenic,Cone-rod dystrophy 2,Deletion,GRCh37
na,na,19,47839569,47839569,CRX,Pathogenic,Cone-rod dystrophy 2,Deletion,GRCh38
na,na,19,48339520,48339520,CRX,Pathogenic/Likely pathogenic,Cone-rod dystrophy 2|not provided|Cone-rod dystrophy 2;Leber congenital amaurosis 7|Retinal dystrophy|Cone-rod dystrophy|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,19,47836263,47836263,CRX,Pathogenic/Likely pathogenic,Cone-rod dystrophy 2|not provided|Cone-rod dystrophy 2;Leber congenital amaurosis 7|Retinal dystrophy|Cone-rod dystrophy|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,19,48339521,48339521,CRX,Pathogenic/Likely pathogenic,Cone-rod dystrophy 2|not provided|Cone-rod dystrophy 2;Leber congenital amaurosis 7|Retinal dystrophy|CRX-related disorder|Cone-rod dystrophy|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,47836264,47836264,CRX,Pathogenic/Likely pathogenic,Cone-rod dystrophy 2|not provided|Cone-rod dystrophy 2;Leber congenital amaurosis 7|Retinal dystrophy|CRX-related disorder|Cone-rod dystrophy|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,48342592,48342592,CRX,Pathogenic/Likely pathogenic,Leber congenital amaurosis 7|not provided|Retinal dystrophy|Cone-rod dystrophy 2;Leber congenital amaurosis 7,single nucleotide variant,GRCh37
na,na,19,47839335,47839335,CRX,Pathogenic/Likely pathogenic,Leber congenital amaurosis 7|not provided|Retinal dystrophy|Cone-rod dystrophy 2;Leber congenital amaurosis 7,single nucleotide variant,GRCh38
na,na,19,48343140,48343142,CRX,Pathogenic,Cone-rod dystrophy 2|Retinal dystrophy,Indel,GRCh37
na,na,19,47839883,47839885,CRX,Pathogenic,Cone-rod dystrophy 2|Retinal dystrophy,Indel,GRCh38
na,na,16,51174863,51174863,SALL1,Pathogenic,Townes-Brocks syndrome 1,Deletion,GRCh37
na,na,16,51140952,51140952,SALL1,Pathogenic,Townes-Brocks syndrome 1,Deletion,GRCh38
na,na,16,51175018,51175018,SALL1,Pathogenic,Townes-Brocks syndrome 1,single nucleotide variant,GRCh37
na,na,16,51141107,51141107,SALL1,Pathogenic,Townes-Brocks syndrome 1,single nucleotide variant,GRCh38
na,na,16,51175307,51175307,SALL1,Pathogenic/Likely pathogenic,Townes-Brocks syndrome 1|Townes syndrome|not provided,single nucleotide variant,GRCh37
na,na,16,51141396,51141396,SALL1,Pathogenic/Likely pathogenic,Townes-Brocks syndrome 1|Townes syndrome|not provided,single nucleotide variant,GRCh38
na,na,16,51175018,51175018,SALL1,Pathogenic,Townes-Brocks syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,16,51141107,51141107,SALL1,Pathogenic,Townes-Brocks syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,16,51174855,51174856,SALL1,Pathogenic,Townes-Brocks syndrome 1,Deletion,GRCh37
na,na,16,51140944,51140945,SALL1,Pathogenic,Townes-Brocks syndrome 1,Deletion,GRCh38
na,na,16,51174785,51174786,SALL1,Pathogenic,Townes-Brocks syndrome 1,Microsatellite,GRCh37
na,na,16,51140874,51140875,SALL1,Pathogenic,Townes-Brocks syndrome 1,Microsatellite,GRCh38
na,na,16,51174312,51174312,SALL1,Pathogenic,Townes-Brocks-branchiootorenal-like syndrome,Deletion,GRCh37
na,na,16,51140401,51140401,SALL1,Pathogenic,Townes-Brocks-branchiootorenal-like syndrome,Deletion,GRCh38
na,na,16,51175340,51175341,SALL1,Pathogenic,Townes-Brocks syndrome 1,Deletion,GRCh37
na,na,16,51141429,51141430,SALL1,Pathogenic,Townes-Brocks syndrome 1,Deletion,GRCh38
na,na,16,51175166,51175166,SALL1,Pathogenic,Townes-Brocks-branchiootorenal-like syndrome|Townes syndrome|Townes-Brocks syndrome 1,single nucleotide variant,GRCh37
na,na,16,51141255,51141255,SALL1,Pathogenic,Townes-Brocks-branchiootorenal-like syndrome|Townes syndrome|Townes-Brocks syndrome 1,single nucleotide variant,GRCh38
na,na,16,51174877,51174877,SALL1,Pathogenic,Townes-Brocks syndrome 1,single nucleotide variant,GRCh37
na,na,16,51140966,51140966,SALL1,Pathogenic,Townes-Brocks syndrome 1,single nucleotide variant,GRCh38
na,na,16,51175138,51175138,SALL1,Pathogenic,Townes-Brocks syndrome 1,Deletion,GRCh37
na,na,16,51141227,51141227,SALL1,Pathogenic,Townes-Brocks syndrome 1,Deletion,GRCh38
na,na,na,-1,-1,STK11,Pathogenic,Peutz-Jeghers syndrome,Complex,na
na,na,19,1221236,1221236,STK11,Pathogenic,Peutz-Jeghers syndrome,single nucleotide variant,GRCh37
na,na,19,1221237,1221237,STK11,Pathogenic,Peutz-Jeghers syndrome,single nucleotide variant,GRCh38
na,na,19,1221320,1221320,STK11,Pathogenic,Peutz-Jeghers syndrome,Deletion,GRCh37
na,na,19,1221321,1221321,STK11,Pathogenic,Peutz-Jeghers syndrome,Deletion,GRCh38
na,na,19,1220698,1220701,STK11,Pathogenic,Peutz-Jeghers syndrome,Deletion,GRCh37
na,na,19,1220699,1220702,STK11,Pathogenic,Peutz-Jeghers syndrome,Deletion,GRCh38
na,na,19,1220371,1220371,STK11,Pathogenic/Likely pathogenic,Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,19,1220372,1220372,STK11,Pathogenic/Likely pathogenic,Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,19,1207162,1207162,STK11,Pathogenic,Hereditary cancer-predisposing syndrome|Peutz-Jeghers syndrome|not provided,single nucleotide variant,GRCh37
na,na,19,1207163,1207163,STK11,Pathogenic,Hereditary cancer-predisposing syndrome|Peutz-Jeghers syndrome|not provided,single nucleotide variant,GRCh38
na,na,19,1221309,1221310,STK11,Pathogenic,Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome,Microsatellite,GRCh37
na,na,19,1221310,1221311,STK11,Pathogenic,Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome,Microsatellite,GRCh38
na,na,19,1207112,1207112,STK11,Pathogenic/Likely pathogenic,Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,19,1207113,1207113,STK11,Pathogenic/Likely pathogenic,Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,19,1221993,1222001,STK11,Pathogenic,Peutz-Jeghers syndrome,Deletion,GRCh37
na,na,19,1221994,1222002,STK11,Pathogenic,Peutz-Jeghers syndrome,Deletion,GRCh38
na,na,19,1207081,1207081,STK11,Pathogenic,Peutz-Jeghers syndrome,single nucleotide variant,GRCh37
na,na,19,1207082,1207082,STK11,Pathogenic,Peutz-Jeghers syndrome,single nucleotide variant,GRCh38
na,na,19,1220395,1220395,STK11,Pathogenic,Malignant tumor of testis|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,19,1220396,1220396,STK11,Pathogenic,Malignant tumor of testis|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,19,1219366,1219366,STK11,Pathogenic,Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,19,1219367,1219367,STK11,Pathogenic,Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,19,1220487,1220487,STK11,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,19,1220488,1220488,STK11,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,19,1207108,1207109,STK11,Pathogenic,Peutz-Jeghers syndrome,Duplication,GRCh37
na,na,19,1207109,1207110,STK11,Pathogenic,Peutz-Jeghers syndrome,Duplication,GRCh38
na,na,19,1207020,1207020,STK11,Pathogenic,Carcinoma of pancreas,single nucleotide variant,GRCh37
na,na,19,1207021,1207021,STK11,Pathogenic,Carcinoma of pancreas,single nucleotide variant,GRCh38
na,na,19,1220629,1220629,STK11,Pathogenic,Carcinoma of pancreas|Peutz-Jeghers syndrome,Deletion,GRCh37
na,na,19,1220630,1220630,STK11,Pathogenic,Carcinoma of pancreas|Peutz-Jeghers syndrome,Deletion,GRCh38
na,na,19,1222997,1222997,STK11,Pathogenic,Carcinoma of pancreas,Deletion,GRCh37
na,na,19,1222998,1222998,STK11,Pathogenic,Carcinoma of pancreas,Deletion,GRCh38
na,na,19,1220415,1220415,STK11,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1|Peutz-Jeghers syndrome",single nucleotide variant,GRCh37
na,na,19,1220416,1220416,STK11,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1|Peutz-Jeghers syndrome",single nucleotide variant,GRCh38
na,na,19,1207057,1207057,STK11,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,19,1207058,1207058,STK11,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,19,1219351,1219351,STK11,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,19,1219352,1219352,STK11,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,19,1220699,1220699,STK11,Pathogenic,Peutz-Jeghers syndrome,single nucleotide variant,GRCh37
na,na,19,1220700,1220700,STK11,Pathogenic,Peutz-Jeghers syndrome,single nucleotide variant,GRCh38
na,na,19,1221975,1221975,STK11,Pathogenic,Peutz-Jeghers syndrome,Deletion,GRCh37
na,na,19,1221976,1221976,STK11,Pathogenic,Peutz-Jeghers syndrome,Deletion,GRCh38
na,na,19,1221215,1221215,STK11,Pathogenic,Peutz-Jeghers syndrome,single nucleotide variant,GRCh37
na,na,19,1221216,1221216,STK11,Pathogenic,Peutz-Jeghers syndrome,single nucleotide variant,GRCh38
na,na,19,1223125,1223125,STK11,Benign/Likely benign,"Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast and/or ovarian cancer|Malignant tumor of breast|Melanoma, cutaneous malignant, susceptibility to, 1;Peutz-Jeghers syndrome;Carcinoma of pancreas;Germ cell tumor of testis",single nucleotide variant,GRCh37
na,na,19,1223126,1223126,STK11,Benign/Likely benign,"Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast and/or ovarian cancer|Malignant tumor of breast|Melanoma, cutaneous malignant, susceptibility to, 1;Peutz-Jeghers syndrome;Carcinoma of pancreas;Germ cell tumor of testis",single nucleotide variant,GRCh38
na,na,1,160012129,160012129,KCNJ10,Pathogenic,EAST syndrome|Cerebellar ataxia;Bilateral sensorineural hearing impairment;Spastic diplegia;Renal tubular dysfunction;Microcephaly,single nucleotide variant,GRCh37
na,na,1,160042339,160042339,KCNJ10,Pathogenic,EAST syndrome|Cerebellar ataxia;Bilateral sensorineural hearing impairment;Spastic diplegia;Renal tubular dysfunction;Microcephaly,single nucleotide variant,GRCh38
na,na,1,160011728,160011728,KCNJ10,Pathogenic/Likely pathogenic,EAST syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome;EAST syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,160041938,160041938,KCNJ10,Pathogenic/Likely pathogenic,EAST syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome;EAST syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,160011905,160011905,KCNJ10,Pathogenic,EAST syndrome,single nucleotide variant,GRCh37
na,na,1,160042115,160042115,KCNJ10,Pathogenic,EAST syndrome,single nucleotide variant,GRCh38
na,na,1,160011832,160011832,KCNJ10,Pathogenic,EAST syndrome,single nucleotide variant,GRCh37
na,na,1,160042042,160042042,KCNJ10,Pathogenic,EAST syndrome,single nucleotide variant,GRCh38
na,na,1,160011823,160011823,KCNJ10,Pathogenic,EAST syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome;EAST syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,160042033,160042033,KCNJ10,Pathogenic,EAST syndrome|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome;EAST syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,160011434,160011434,KCNJ10,Pathogenic/Likely pathogenic,EAST syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome;EAST syndrome,single nucleotide variant,GRCh37
na,na,1,160041644,160041644,KCNJ10,Pathogenic/Likely pathogenic,EAST syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome;EAST syndrome,single nucleotide variant,GRCh38
na,na,1,160012094,160012094,KCNJ10,Pathogenic,EAST syndrome,single nucleotide variant,GRCh37
na,na,1,160042304,160042304,KCNJ10,Pathogenic,EAST syndrome,single nucleotide variant,GRCh38
na,na,1,160011742,160011742,KCNJ10,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Autosomal recessive nonsyndromic hearing loss 4;EAST syndrome,single nucleotide variant,GRCh37
na,na,1,160041952,160041952,KCNJ10,Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 4|Autosomal recessive nonsyndromic hearing loss 4;EAST syndrome,single nucleotide variant,GRCh38
na,na,1,160011281,160011281,KCNJ10,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 4|EAST syndrome|not provided|not specified|KCNJ10-related disorder,single nucleotide variant,GRCh37
na,na,1,160041491,160041491,KCNJ10,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 4|EAST syndrome|not provided|not specified|KCNJ10-related disorder,single nucleotide variant,GRCh38
na,na,1,150484243,150484243,ECM1,Likely pathogenic,Lipid proteinosis,Deletion,GRCh37
na,na,1,150511767,150511767,ECM1,Likely pathogenic,Lipid proteinosis,Deletion,GRCh38
na,na,1,150484260,150484260,ECM1,Pathogenic,Lipid proteinosis,single nucleotide variant,GRCh37
na,na,1,150511784,150511784,ECM1,Pathogenic,Lipid proteinosis,single nucleotide variant,GRCh38
na,na,1,150485082,150486244,ECM1,Pathogenic,Lipid proteinosis,Deletion,GRCh37
na,na,1,150512606,150513768,ECM1,Pathogenic,Lipid proteinosis,Deletion,GRCh38
na,na,1,150482172,150482172,ECM1,Pathogenic,Lipid proteinosis|not provided,single nucleotide variant,GRCh37
na,na,1,150509696,150509696,ECM1,Pathogenic,Lipid proteinosis|not provided,single nucleotide variant,GRCh38
na,na,1,150483465,150483465,ECM1,Likely pathogenic,Lipid proteinosis,single nucleotide variant,GRCh37
na,na,1,150510989,150510989,ECM1,Likely pathogenic,Lipid proteinosis,single nucleotide variant,GRCh38
na,na,1,150483446,150483446,ECM1,Pathogenic,Lipid proteinosis,single nucleotide variant,GRCh37
na,na,1,150510970,150510970,ECM1,Pathogenic,Lipid proteinosis,single nucleotide variant,GRCh38
na,na,7,75933158,75933158,HSPB1,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2F|Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease|not provided",single nucleotide variant,GRCh37
na,na,7,76303841,76303841,HSPB1,Pathogenic,"Charcot-Marie-Tooth disease axonal type 2F|Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease|not provided",single nucleotide variant,GRCh38
na,na,7,75933133,75933133,HSPB1,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,7,76303816,76303816,HSPB1,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,7,75933324,75933324,HSPB1,Pathogenic/Likely pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease|not provided",single nucleotide variant,GRCh37
na,na,7,76304007,76304007,HSPB1,Pathogenic/Likely pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease|not provided",single nucleotide variant,GRCh38
na,na,7,75933417,75933417,HSPB1,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F",single nucleotide variant,GRCh37
na,na,7,76304100,76304100,HSPB1,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F",single nucleotide variant,GRCh38
na,na,7,75933160,75933160,HSPB1,Pathogenic,Charcot-Marie-Tooth disease axonal type 2F,single nucleotide variant,GRCh37
na,na,7,76303843,76303843,HSPB1,Pathogenic,Charcot-Marie-Tooth disease axonal type 2F,single nucleotide variant,GRCh38
na,na,7,75933416,75933416,HSPB1,Pathogenic/Likely pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F",single nucleotide variant,GRCh37
na,na,7,76304099,76304099,HSPB1,Pathogenic/Likely pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F",single nucleotide variant,GRCh38
na,na,7,75933172,75933172,HSPB1,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease|HSPB1-related axonal neuropathies|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2F;Neuronopathy, distal hereditary motor, type 2B|not provided",single nucleotide variant,GRCh37
na,na,7,76303855,76303855,HSPB1,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease|HSPB1-related axonal neuropathies|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2F;Neuronopathy, distal hereditary motor, type 2B|not provided",single nucleotide variant,GRCh38
na,na,7,75932324,75932324,HSPB1,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B",single nucleotide variant,GRCh37
na,na,7,76303007,76303007,HSPB1,Pathogenic,"Neuronopathy, distal hereditary motor, type 2B",single nucleotide variant,GRCh38
na,na,10,124220544,124220544,HTRA1,risk factor,Age related macular degeneration 7|Susceptibility to neovascular type of age-related macular degeneration,single nucleotide variant,GRCh37
na,na,10,122461028,122461028,HTRA1,risk factor,Age related macular degeneration 7|Susceptibility to neovascular type of age-related macular degeneration,single nucleotide variant,GRCh38
na,na,10,124268274,124268274,HTRA1,Pathogenic/Likely pathogenic,CARASIL syndrome|HTRA1-related cerebral small vessel disease|not provided,single nucleotide variant,GRCh37
na,na,10,122508758,122508758,HTRA1,Pathogenic/Likely pathogenic,CARASIL syndrome|HTRA1-related cerebral small vessel disease|not provided,single nucleotide variant,GRCh38
na,na,10,124266333,124266333,HTRA1,Pathogenic/Likely pathogenic,"CARASIL syndrome|Small vessel cerebrovascular disease|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2|Personality changes;Seizure;Cognitive impairment|not provided",single nucleotide variant,GRCh37
na,na,10,122506817,122506817,HTRA1,Pathogenic/Likely pathogenic,"CARASIL syndrome|Small vessel cerebrovascular disease|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2|Personality changes;Seizure;Cognitive impairment|not provided",single nucleotide variant,GRCh38
na,na,10,124266318,124266318,HTRA1,Pathogenic,CARASIL syndrome,single nucleotide variant,GRCh37
na,na,10,122506802,122506802,HTRA1,Pathogenic,CARASIL syndrome,single nucleotide variant,GRCh38
na,na,10,124249119,124249119,HTRA1,Pathogenic,"CARASIL syndrome|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2",single nucleotide variant,GRCh37
na,na,10,122489603,122489603,HTRA1,Pathogenic,"CARASIL syndrome|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2",single nucleotide variant,GRCh38
na,na,4,13545701,13545702,NKX3-2,Pathogenic,Spondylo-megaepiphyseal-metaphyseal dysplasia,Duplication,GRCh37
na,na,4,13544077,13544078,NKX3-2,Pathogenic,Spondylo-megaepiphyseal-metaphyseal dysplasia,Duplication,GRCh38
na,na,4,13545702,13545703,NKX3-2,Pathogenic,Spondylo-megaepiphyseal-metaphyseal dysplasia,Indel,GRCh37
na,na,4,13544078,13544079,NKX3-2,Pathogenic,Spondylo-megaepiphyseal-metaphyseal dysplasia,Indel,GRCh38
na,na,4,13545929,13545935,NKX3-2,Pathogenic,Spondylo-megaepiphyseal-metaphyseal dysplasia|not provided,Microsatellite,GRCh37
na,na,4,13544305,13544311,NKX3-2,Pathogenic,Spondylo-megaepiphyseal-metaphyseal dysplasia|not provided,Microsatellite,GRCh38
na,na,3,38182001,38182001,MYD88,Uncertain significance,Pyogenic bacterial infections due to MyD88 deficiency,single nucleotide variant,GRCh37
na,na,3,38140510,38140510,MYD88,Uncertain significance,Pyogenic bacterial infections due to MyD88 deficiency,single nucleotide variant,GRCh38
na,na,3,38180469,38180469,MYD88,Pathogenic,Pyogenic bacterial infections due to MyD88 deficiency,single nucleotide variant,GRCh37
na,na,3,38138978,38138978,MYD88,Pathogenic,Pyogenic bacterial infections due to MyD88 deficiency,single nucleotide variant,GRCh38
na,na,14,97342370,97342370,VRK1,Pathogenic,"not provided|Pontocerebellar hypoplasia type 1A|Abnormality of the musculature|Inborn genetic diseases|Congenital pontocerebellar hypoplasia type 1|Neuronopathy, distal hereditary motor, autosomal recessive 10|Neuronopathy, distal hereditary motor, autosomal recessive 10;Pontocerebellar hypoplasia type 1A",single nucleotide variant,GRCh37
na,na,14,96876033,96876033,VRK1,Pathogenic,"not provided|Pontocerebellar hypoplasia type 1A|Abnormality of the musculature|Inborn genetic diseases|Congenital pontocerebellar hypoplasia type 1|Neuronopathy, distal hereditary motor, autosomal recessive 10|Neuronopathy, distal hereditary motor, autosomal recessive 10;Pontocerebellar hypoplasia type 1A",single nucleotide variant,GRCh38
na,na,14,76958018,76958019,ESRRB,Pathogenic,Autosomal recessive nonsyndromic hearing loss 35,Duplication,GRCh37
na,na,14,76491675,76491676,ESRRB,Pathogenic,Autosomal recessive nonsyndromic hearing loss 35,Duplication,GRCh38
na,na,14,76906025,76906025,ESRRB,Pathogenic,Autosomal recessive nonsyndromic hearing loss 35,single nucleotide variant,GRCh37
na,na,14,76439682,76439682,ESRRB,Pathogenic,Autosomal recessive nonsyndromic hearing loss 35,single nucleotide variant,GRCh38
na,na,14,76958026,76958026,ESRRB,Pathogenic,Autosomal recessive nonsyndromic hearing loss 35,single nucleotide variant,GRCh37
na,na,14,76491683,76491683,ESRRB,Pathogenic,Autosomal recessive nonsyndromic hearing loss 35,single nucleotide variant,GRCh38
na,na,12,52680896,52680896,KRT81,Pathogenic,not provided|Monilethrix-2,single nucleotide variant,GRCh37
na,na,12,52287112,52287112,KRT81,Pathogenic,not provided|Monilethrix-2,single nucleotide variant,GRCh38
na,na,12,52680929,52680929,KRT81,Likely pathogenic,not provided|Monilethrix-2,single nucleotide variant,GRCh37
na,na,12,52287145,52287145,KRT81,Likely pathogenic,not provided|Monilethrix-2,single nucleotide variant,GRCh38
na,na,8,49831366,49833824,SNAI2,Uncertain significance,Waardenburg syndrome type 2D,Deletion,GRCh37
na,na,8,48918807,48921265,SNAI2,Uncertain significance,Waardenburg syndrome type 2D,Deletion,GRCh38
na,na,8,49831366,49833824,SNAI2,Uncertain significance,Piebaldism,Deletion,GRCh37
na,na,8,48918807,48921265,SNAI2,Uncertain significance,Piebaldism,Deletion,GRCh38
na,na,5,134366980,134366980,PITX1,Pathogenic,Clubfoot|not provided,single nucleotide variant,GRCh37
na,na,5,135031290,135031290,PITX1,Pathogenic,Clubfoot|not provided,single nucleotide variant,GRCh38
na,na,1,180240969,180240969,LHX4,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,single nucleotide variant,GRCh37
na,na,1,180271834,180271834,LHX4,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,single nucleotide variant,GRCh38
na,na,1,180240991,180240991,LHX4,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,single nucleotide variant,GRCh37
na,na,1,180271856,180271856,LHX4,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,single nucleotide variant,GRCh38
na,na,1,180235528,180235528,LHX4,Conflicting classifications of pathogenicity,Short stature-pituitary and cerebellar defects-small sella turcica syndrome|not provided,single nucleotide variant,GRCh37
na,na,1,180266393,180266393,LHX4,Conflicting classifications of pathogenicity,Short stature-pituitary and cerebellar defects-small sella turcica syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,180240632,180240632,LHX4,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,single nucleotide variant,GRCh37
na,na,1,180271497,180271497,LHX4,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,single nucleotide variant,GRCh38
na,na,1,180243703,180243703,LHX4,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,single nucleotide variant,GRCh37
na,na,1,180274568,180274568,LHX4,Pathogenic,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,single nucleotide variant,GRCh38
na,na,11,67800614,67800614,NDUFS8,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 2|not provided|Leigh syndrome",single nucleotide variant,GRCh37
na,na,11,68033147,68033147,NDUFS8,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 2|not provided|Leigh syndrome",single nucleotide variant,GRCh38
na,na,11,67800683,67800683,NDUFS8,Conflicting classifications of pathogenicity,"Mitochondrial complex 1 deficiency, nuclear type 2|not provided",single nucleotide variant,GRCh37
na,na,11,68033216,68033216,NDUFS8,Conflicting classifications of pathogenicity,"Mitochondrial complex 1 deficiency, nuclear type 2|not provided",single nucleotide variant,GRCh38
na,na,11,67800632,67800632,NDUFS8,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 2",single nucleotide variant,GRCh37
na,na,11,68033165,68033165,NDUFS8,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 2",single nucleotide variant,GRCh38
na,na,11,67803760,67803760,NDUFS8,Conflicting classifications of pathogenicity,"Mitochondrial complex 1 deficiency, nuclear type 2|not provided",single nucleotide variant,GRCh37
na,na,11,68036293,68036293,NDUFS8,Conflicting classifications of pathogenicity,"Mitochondrial complex 1 deficiency, nuclear type 2|not provided",single nucleotide variant,GRCh38
na,na,5,140026836,140026836,NDUFA2,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 13",single nucleotide variant,GRCh37
na,na,5,140647251,140647251,NDUFA2,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 13",single nucleotide variant,GRCh38
na,na,7,92130876,92130876,PEX1,Pathogenic,Peroxisome biogenesis disorder|Leber congenital amaurosis|Peroxisome biogenesis disorder 1A (Zellweger)|not provided|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1B;Heimler syndrome 1;Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisomal disorder|Retinal dystrophy|Heimler syndrome 1|Inborn genetic diseases|Peroxisome biogenesis disorder 1B;Peroxisome biogenesis disorder 1A (Zellweger)|not specified|Zellweger spectrum disorders|PEX1-related disorder|Peroxisome biogenesis disorder due to PEX1 defect,single nucleotide variant,GRCh37
na,na,7,92501562,92501562,PEX1,Pathogenic,Peroxisome biogenesis disorder|Leber congenital amaurosis|Peroxisome biogenesis disorder 1A (Zellweger)|not provided|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1B;Heimler syndrome 1;Peroxisome biogenesis disorder 1A (Zellweger)|Peroxisomal disorder|Retinal dystrophy|Heimler syndrome 1|Inborn genetic diseases|Peroxisome biogenesis disorder 1B;Peroxisome biogenesis disorder 1A (Zellweger)|not specified|Zellweger spectrum disorders|PEX1-related disorder|Peroxisome biogenesis disorder due to PEX1 defect,single nucleotide variant,GRCh38
na,na,7,92134126,92134126,PEX1,Likely pathogenic,Peroxisome biogenesis disorder 1A (Zellweger)|Zellweger spectrum disorders|Heimler syndrome 1|not provided|Peroxisome biogenesis disorder 1A (Zellweger);Peroxisome biogenesis disorder 1B;Heimler syndrome 1,single nucleotide variant,GRCh37
na,na,7,92504812,92504812,PEX1,Likely pathogenic,Peroxisome biogenesis disorder 1A (Zellweger)|Zellweger spectrum disorders|Heimler syndrome 1|not provided|Peroxisome biogenesis disorder 1A (Zellweger);Peroxisome biogenesis disorder 1B;Heimler syndrome 1,single nucleotide variant,GRCh38
na,na,7,92134053,92134211,PEX1,Pathogenic,Peroxisome biogenesis disorder 1A (Zellweger),Deletion,GRCh37
na,na,7,92504739,92504897,PEX1,Pathogenic,Peroxisome biogenesis disorder 1A (Zellweger),Deletion,GRCh38
na,na,7,92132483,92132484,PEX1,Pathogenic,Peroxisome biogenesis disorder 1A (Zellweger)|not provided|Heimler syndrome 1|Peroxisome biogenesis disorder|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1B;Peroxisome biogenesis disorder 1A (Zellweger)|Retinal dystrophy|Peroxisome biogenesis disorder 1B;Heimler syndrome 1;Peroxisome biogenesis disorder 1A (Zellweger)|Zellweger spectrum disorders|Inborn genetic diseases|PEX1-related disorder|Optic atrophy,Duplication,GRCh37
na,na,7,92503169,92503170,PEX1,Pathogenic,Peroxisome biogenesis disorder 1A (Zellweger)|not provided|Heimler syndrome 1|Peroxisome biogenesis disorder|Peroxisome biogenesis disorder 1B|Peroxisome biogenesis disorder 1B;Peroxisome biogenesis disorder 1A (Zellweger)|Retinal dystrophy|Peroxisome biogenesis disorder 1B;Heimler syndrome 1;Peroxisome biogenesis disorder 1A (Zellweger)|Zellweger spectrum disorders|Inborn genetic diseases|PEX1-related disorder|Optic atrophy,Duplication,GRCh38
na,na,19,17313833,17313833,MYO9B,Benign,"Celiac disease, susceptibility to, 4",single nucleotide variant,GRCh37
na,na,19,17203024,17203024,MYO9B,Benign,"Celiac disease, susceptibility to, 4",single nucleotide variant,GRCh38
na,na,17,14005547,14005547,COX10,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh37
na,na,17,14102230,14102230,COX10,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh38
na,na,17,14005522,14005522,COX10,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh37
na,na,17,14102205,14102205,COX10,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh38
na,na,17,14063243,14063243,COX10,Likely pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh37
na,na,17,14159926,14159926,COX10,Likely pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh38
na,na,17,14110205,14110205,COX10,Pathogenic/Likely pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3|Mitochondrial complex IV deficiency, nuclear type 1|not provided",single nucleotide variant,GRCh37
na,na,17,14206888,14206888,COX10,Pathogenic/Likely pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3|Mitochondrial complex IV deficiency, nuclear type 1|not provided",single nucleotide variant,GRCh38
na,na,17,14110205,14110205,COX10,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh37
na,na,17,14206888,14206888,COX10,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh38
na,na,17,13972924,13972924,COX10,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh37
na,na,17,14069607,14069607,COX10,Pathogenic,"Mitochondrial complex 4 deficiency, nuclear type 3",single nucleotide variant,GRCh38
na,na,5,140903709,140903709,DIAPH1,Pathogenic,Autosomal dominant nonsyndromic hearing loss 1|Autosomal dominant nonsyndromic hearing loss 1;Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome,single nucleotide variant,GRCh37
na,na,5,141524142,141524142,DIAPH1,Pathogenic,Autosomal dominant nonsyndromic hearing loss 1|Autosomal dominant nonsyndromic hearing loss 1;Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome,single nucleotide variant,GRCh38
na,na,5,44305147,44305147,FGF10,Pathogenic/Likely pathogenic,Congenital absence of salivary gland|not provided,single nucleotide variant,GRCh37
na,na,5,44305045,44305045,FGF10,Pathogenic/Likely pathogenic,Congenital absence of salivary gland|not provided,single nucleotide variant,GRCh38
na,na,5,44304226,44357323,FGF10,Pathogenic,Congenital absence of salivary gland,Deletion,GRCh38
na,na,5,44388468,44388468,FGF10,Pathogenic,Lacrimoauriculodentodigital syndrome 3,single nucleotide variant,GRCh37
na,na,5,44388366,44388366,FGF10,Pathogenic,Lacrimoauriculodentodigital syndrome 3,single nucleotide variant,GRCh38
na,na,5,44305257,44305257,FGF10,Pathogenic,Lacrimoauriculodentodigital syndrome 3,single nucleotide variant,GRCh37
na,na,5,44305155,44305155,FGF10,Pathogenic,Lacrimoauriculodentodigital syndrome 3,single nucleotide variant,GRCh38
na,na,5,44310549,44310549,FGF10,Pathogenic,Congenital absence of salivary gland|Lacrimoauriculodentodigital syndrome 3,single nucleotide variant,GRCh37
na,na,5,44310447,44310447,FGF10,Pathogenic,Congenital absence of salivary gland|Lacrimoauriculodentodigital syndrome 3,single nucleotide variant,GRCh38
na,na,5,44388545,44388545,FGF10,Conflicting classifications of pathogenicity,Congenital absence of salivary gland|Levy-Hollister syndrome|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,5,44388443,44388443,FGF10,Conflicting classifications of pathogenicity,Congenital absence of salivary gland|Levy-Hollister syndrome|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,5,44310545,44310545,FGF10,Pathogenic,Congenital absence of salivary gland,single nucleotide variant,GRCh37
na,na,5,44310443,44310443,FGF10,Pathogenic,Congenital absence of salivary gland,single nucleotide variant,GRCh38
na,na,12,49420213,49420213,KMT2D,Pathogenic/Likely pathogenic,Kabuki syndrome|not provided|Kabuki syndrome 1,single nucleotide variant,GRCh37
na,na,12,49026430,49026430,KMT2D,Pathogenic/Likely pathogenic,Kabuki syndrome|not provided|Kabuki syndrome 1,single nucleotide variant,GRCh38
na,na,12,49424768,49424768,KMT2D,Pathogenic,Kabuki syndrome 1,single nucleotide variant,GRCh37
na,na,12,49030985,49030985,KMT2D,Pathogenic,Kabuki syndrome 1,single nucleotide variant,GRCh38
na,na,12,49416115,49416115,KMT2D,Pathogenic,Kabuki syndrome 1|Inborn genetic diseases|Kabuki syndrome|not provided,single nucleotide variant,GRCh37
na,na,12,49022332,49022332,KMT2D,Pathogenic,Kabuki syndrome 1|Inborn genetic diseases|Kabuki syndrome|not provided,single nucleotide variant,GRCh38
na,na,12,49416084,49416084,KMT2D,Conflicting classifications of pathogenicity,Kabuki syndrome 1|not provided|Kabuki syndrome,single nucleotide variant,GRCh37
na,na,12,49022301,49022301,KMT2D,Conflicting classifications of pathogenicity,Kabuki syndrome 1|not provided|Kabuki syndrome,single nucleotide variant,GRCh38
na,na,2,20205714,20205714,MATN3,Pathogenic,Multiple epiphyseal dysplasia type 5|Multiple epiphyseal dysplasia,single nucleotide variant,GRCh37
na,na,2,20005953,20005953,MATN3,Pathogenic,Multiple epiphyseal dysplasia type 5|Multiple epiphyseal dysplasia,single nucleotide variant,GRCh38
na,na,2,20205934,20205934,MATN3,Pathogenic/Likely pathogenic,"Multiple epiphyseal dysplasia type 5|not provided|Multiple epiphyseal dysplasia|Spondyloepimetaphyseal dysplasia, matrilin-3 type|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,2,20006173,20006173,MATN3,Pathogenic/Likely pathogenic,"Multiple epiphyseal dysplasia type 5|not provided|Multiple epiphyseal dysplasia|Spondyloepimetaphyseal dysplasia, matrilin-3 type|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,2,20202930,20202930,MATN3,Benign,"Osteoarthritis susceptibility 2|not specified|not provided|Multiple epiphyseal dysplasia type 5|Connective tissue disorder|MATN3-related disorder|Osteoarthritis susceptibility 2;Multiple epiphyseal dysplasia type 5;Spondyloepimetaphyseal dysplasia, matrilin-3 type",single nucleotide variant,GRCh37
na,na,2,20003169,20003169,MATN3,Benign,"Osteoarthritis susceptibility 2|not specified|not provided|Multiple epiphyseal dysplasia type 5|Connective tissue disorder|MATN3-related disorder|Osteoarthritis susceptibility 2;Multiple epiphyseal dysplasia type 5;Spondyloepimetaphyseal dysplasia, matrilin-3 type",single nucleotide variant,GRCh38
na,na,2,20205639,20205639,MATN3,Pathogenic,Multiple epiphyseal dysplasia type 5|Multiple epiphyseal dysplasia|not provided,single nucleotide variant,GRCh37
na,na,2,20005878,20005878,MATN3,Pathogenic,Multiple epiphyseal dysplasia type 5|Multiple epiphyseal dysplasia|not provided,single nucleotide variant,GRCh38
na,na,2,20202928,20202928,MATN3,Pathogenic,"Spondyloepimetaphyseal dysplasia, matrilin-3 type",single nucleotide variant,GRCh37
na,na,2,20003167,20003167,MATN3,Pathogenic,"Spondyloepimetaphyseal dysplasia, matrilin-3 type",single nucleotide variant,GRCh38
na,na,2,20212184,20212184,MATN3,Uncertain significance,Multiple epiphyseal dysplasia type 5|not provided|Multiple epiphyseal dysplasia,single nucleotide variant,GRCh37
na,na,2,20012423,20012423,MATN3,Uncertain significance,Multiple epiphyseal dysplasia type 5|not provided|Multiple epiphyseal dysplasia,single nucleotide variant,GRCh38
na,na,2,20205913,20205913,MATN3,Pathogenic,Multiple epiphyseal dysplasia type 5,single nucleotide variant,GRCh37
na,na,2,20006152,20006152,MATN3,Pathogenic,Multiple epiphyseal dysplasia type 5,single nucleotide variant,GRCh38
na,na,4,2833309,2833309,SH3BP2,Pathogenic/Likely pathogenic,Fibrous dysplasia of jaw,single nucleotide variant,GRCh37
na,na,4,2831582,2831582,SH3BP2,Pathogenic/Likely pathogenic,Fibrous dysplasia of jaw,single nucleotide variant,GRCh38
na,na,4,2833309,2833309,SH3BP2,Pathogenic,Fibrous dysplasia of jaw|not provided,single nucleotide variant,GRCh37
na,na,4,2831582,2831582,SH3BP2,Pathogenic,Fibrous dysplasia of jaw|not provided,single nucleotide variant,GRCh38
na,na,4,2833309,2833309,SH3BP2,Pathogenic,Fibrous dysplasia of jaw,single nucleotide variant,GRCh37
na,na,4,2831582,2831582,SH3BP2,Pathogenic,Fibrous dysplasia of jaw,single nucleotide variant,GRCh38
na,na,4,2833300,2833300,SH3BP2,Pathogenic,Fibrous dysplasia of jaw,single nucleotide variant,GRCh37
na,na,4,2831573,2831573,SH3BP2,Pathogenic,Fibrous dysplasia of jaw,single nucleotide variant,GRCh38
na,na,4,2833300,2833300,SH3BP2,Pathogenic,Fibrous dysplasia of jaw|not provided,single nucleotide variant,GRCh37
na,na,4,2831573,2831573,SH3BP2,Pathogenic,Fibrous dysplasia of jaw|not provided,single nucleotide variant,GRCh38
na,na,4,2833314,2833314,SH3BP2,Pathogenic,Fibrous dysplasia of jaw,single nucleotide variant,GRCh37
na,na,4,2831587,2831587,SH3BP2,Pathogenic,Fibrous dysplasia of jaw,single nucleotide variant,GRCh38
na,na,4,2833315,2833315,SH3BP2,Uncertain significance,Fibrous dysplasia of jaw,single nucleotide variant,GRCh37
na,na,4,2831588,2831588,SH3BP2,Uncertain significance,Fibrous dysplasia of jaw,single nucleotide variant,GRCh38
na,na,14,75022332,75022332,LTBP2,Pathogenic,"Glaucoma 3, primary congenital, D|Microspherophakia|not provided|Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma",single nucleotide variant,GRCh37
na,na,14,74555629,74555629,LTBP2,Pathogenic,"Glaucoma 3, primary congenital, D|Microspherophakia|not provided|Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma",single nucleotide variant,GRCh38
na,na,14,75078236,75078236,LTBP2,Likely pathogenic,"Glaucoma 3, primary congenital, D|Glaucoma 3A",Deletion,GRCh37
na,na,14,74611533,74611533,LTBP2,Likely pathogenic,"Glaucoma 3, primary congenital, D|Glaucoma 3A",Deletion,GRCh38
na,na,14,75019033,75019046,LTBP2,Pathogenic,"Glaucoma 3, primary congenital, D",Deletion,GRCh37
na,na,14,74552330,74552343,LTBP2,Pathogenic,"Glaucoma 3, primary congenital, D",Deletion,GRCh38
na,na,14,75078317,75078317,LTBP2,Pathogenic,"Glaucoma 3, primary congenital, D",single nucleotide variant,GRCh37
na,na,14,74611614,74611614,LTBP2,Pathogenic,"Glaucoma 3, primary congenital, D",single nucleotide variant,GRCh38
na,na,14,74967606,74967607,LTBP2,Pathogenic,Microspherophakia,Duplication,GRCh37
na,na,14,74500903,74500904,LTBP2,Pathogenic,Microspherophakia,Duplication,GRCh38
na,na,14,75018036,75018036,LTBP2,Pathogenic,"Glaucoma 3, primary congenital, D",Deletion,GRCh37
na,na,14,74551333,74551333,LTBP2,Pathogenic,"Glaucoma 3, primary congenital, D",Deletion,GRCh38
na,na,11,65313944,65313944,LTBP3,Pathogenic,Brachyolmia-amelogenesis imperfecta syndrome,single nucleotide variant,GRCh37
na,na,11,65546473,65546473,LTBP3,Pathogenic,Brachyolmia-amelogenesis imperfecta syndrome,single nucleotide variant,GRCh38
na,na,11,763392,763394,TALDO1,Pathogenic,Deficiency of transaldolase,Deletion,GRCh37
na,na,11,763392,763394,TALDO1,Pathogenic,Deficiency of transaldolase,Deletion,GRCh38
na,na,22,19750796,19750796,TBX1,Pathogenic,Conotruncal anomaly face syndrome,single nucleotide variant,GRCh37
na,na,22,19763273,19763273,TBX1,Pathogenic,Conotruncal anomaly face syndrome,single nucleotide variant,GRCh38
na,na,22,19753444,19753444,TBX1,Benign,DiGeorge syndrome|Cardiovascular phenotype|not provided,single nucleotide variant,GRCh37
na,na,22,19765921,19765921,TBX1,Benign,DiGeorge syndrome|Cardiovascular phenotype|not provided,single nucleotide variant,GRCh38
na,na,22,19754125,19754125,TBX1,Pathogenic,Conotruncal anomaly face syndrome,Deletion,GRCh37
na,na,22,19766602,19766602,TBX1,Pathogenic,Conotruncal anomaly face syndrome,Deletion,GRCh38
na,na,22,19754195,19754217,TBX1,Pathogenic,Velocardiofacial syndrome,Deletion,GRCh37
na,na,22,19766672,19766694,TBX1,Pathogenic,Velocardiofacial syndrome,Deletion,GRCh38
na,na,22,19751747,19751747,TBX1,Pathogenic,Velocardiofacial syndrome,single nucleotide variant,GRCh37
na,na,22,19764224,19764224,TBX1,Pathogenic,Velocardiofacial syndrome,single nucleotide variant,GRCh38
na,na,10,3824163,3824163,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh37
na,na,10,3781971,3781971,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh38
na,na,10,3824099,3824099,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh37
na,na,10,3781907,3781907,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh38
na,na,10,3824141,3824141,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh37
na,na,10,3781949,3781949,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh38
na,na,10,3824319,3824319,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh37
na,na,10,3782127,3782127,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh38
na,na,10,3824003,3824003,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh37
na,na,10,3781811,3781811,KLF6,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh38
na,na,10,3824044,3824044,KLF6,Pathogenic,Gastric cancer,single nucleotide variant,GRCh37
na,na,10,3781852,3781852,KLF6,Pathogenic,Gastric cancer,single nucleotide variant,GRCh38
na,na,22,37628897,37628897,RAC2,Pathogenic,Neutrophil immunodeficiency syndrome,single nucleotide variant,GRCh37
na,na,22,37232857,37232857,RAC2,Pathogenic,Neutrophil immunodeficiency syndrome,single nucleotide variant,GRCh38
na,na,11,73717247,73717247,UCP3,Benign,"Obesity, severe, and type II diabetes|UCP3 POLYMORPHISM G/A|Inherited obesity|Short-rib thoracic dysplasia 13 with or without polydactyly|not provided",single nucleotide variant,GRCh37
na,na,11,74006202,74006202,UCP3,Benign,"Obesity, severe, and type II diabetes|UCP3 POLYMORPHISM G/A|Inherited obesity|Short-rib thoracic dysplasia 13 with or without polydactyly|not provided",single nucleotide variant,GRCh38
na,na,11,73716889,73716889,UCP3,Conflicting classifications of pathogenicity,"Obesity, severe, and type II diabetes|not provided|UCP3-related disorder|Inherited obesity",single nucleotide variant,GRCh37
na,na,11,74005844,74005844,UCP3,Conflicting classifications of pathogenicity,"Obesity, severe, and type II diabetes|not provided|UCP3-related disorder|Inherited obesity",single nucleotide variant,GRCh38
na,na,11,73714871,73714871,UCP3,Benign,"not provided|UCP3 POLYMORPHISM, EXON 6 SPLICE DONOR JUNCTION|Morbid obesity|UCP3-related disorder",single nucleotide variant,GRCh37
na,na,11,74003826,74003826,UCP3,Benign,"not provided|UCP3 POLYMORPHISM, EXON 6 SPLICE DONOR JUNCTION|Morbid obesity|UCP3-related disorder",single nucleotide variant,GRCh38
na,na,11,73717343,73717343,UCP3,Uncertain significance,"Obesity, severe, and type II diabetes|not provided|UCP3-related disorder|Inherited obesity",single nucleotide variant,GRCh37
na,na,11,74006298,74006298,UCP3,Uncertain significance,"Obesity, severe, and type II diabetes|not provided|UCP3-related disorder|Inherited obesity",single nucleotide variant,GRCh38
na,na,10,13325695,13325695,PHYH,Pathogenic/Likely pathogenic,"REFSUM DISEASE, ADULT, 1|not provided|Retinitis pigmentosa|Inborn genetic diseases|Phytanic acid storage disease",single nucleotide variant,GRCh37
na,na,10,13283695,13283695,PHYH,Pathogenic/Likely pathogenic,"REFSUM DISEASE, ADULT, 1|not provided|Retinitis pigmentosa|Inborn genetic diseases|Phytanic acid storage disease",single nucleotide variant,GRCh38
na,na,10,13337608,13337608,PHYH,Pathogenic,"REFSUM DISEASE, ADULT, 1|Phytanic acid storage disease|not provided|Retinitis pigmentosa|PHYH-related disorder|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,10,13295608,13295608,PHYH,Pathogenic,"REFSUM DISEASE, ADULT, 1|Phytanic acid storage disease|not provided|Retinitis pigmentosa|PHYH-related disorder|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,10,13340236,13340236,PHYH,Benign,not provided|Phytanic acid storage disease|not specified,single nucleotide variant,GRCh37
na,na,10,13298236,13298236,PHYH,Benign,not provided|Phytanic acid storage disease|not specified,single nucleotide variant,GRCh38
na,na,10,13337577,13337577,PHYH,Pathogenic,"REFSUM DISEASE, ADULT, 1",Deletion,GRCh37
na,na,10,13295577,13295577,PHYH,Pathogenic,"REFSUM DISEASE, ADULT, 1",Deletion,GRCh38
na,na,10,13325713,13325713,PHYH,Pathogenic,"REFSUM DISEASE, ADULT, 1",single nucleotide variant,GRCh37
na,na,10,13283713,13283713,PHYH,Pathogenic,"REFSUM DISEASE, ADULT, 1",single nucleotide variant,GRCh38
na,na,10,13330461,13330462,PHYH,Uncertain significance,"REFSUM DISEASE, ADULT, 1|not provided",Duplication,GRCh37
na,na,10,13288461,13288462,PHYH,Uncertain significance,"REFSUM DISEASE, ADULT, 1|not provided",Duplication,GRCh38
na,na,10,13330512,13330512,PHYH,Pathogenic,"REFSUM DISEASE, ADULT, 1",single nucleotide variant,GRCh37
na,na,10,13288512,13288512,PHYH,Pathogenic,"REFSUM DISEASE, ADULT, 1",single nucleotide variant,GRCh38
na,na,10,13330428,13330428,PHYH,Likely pathogenic,"REFSUM DISEASE, ADULT, 1|Phytanic acid storage disease",single nucleotide variant,GRCh37
na,na,10,13288428,13288428,PHYH,Likely pathogenic,"REFSUM DISEASE, ADULT, 1|Phytanic acid storage disease",single nucleotide variant,GRCh38
na,na,10,13325694,13325694,PHYH,Pathogenic/Likely pathogenic,"REFSUM DISEASE, ADULT, 1|not provided|Phytanic acid storage disease",single nucleotide variant,GRCh37
na,na,10,13283694,13283694,PHYH,Pathogenic/Likely pathogenic,"REFSUM DISEASE, ADULT, 1|not provided|Phytanic acid storage disease",single nucleotide variant,GRCh38
na,na,1,16351268,16351268,CLCNKA,Pathogenic,Bartter disease type 4B,single nucleotide variant,GRCh37
na,na,1,16024773,16024773,CLCNKA,Pathogenic,Bartter disease type 4B,single nucleotide variant,GRCh38
na,na,1,16353927,16353927,CLCNKA,Pathogenic,Bartter disease type 4B,single nucleotide variant,GRCh37
na,na,1,16027432,16027432,CLCNKA,Pathogenic,Bartter disease type 4B,single nucleotide variant,GRCh38
na,na,1,16374412,16374412,CLCNKB,Pathogenic,Bartter disease type 3|not provided,single nucleotide variant,GRCh37
na,na,1,16047917,16047917,CLCNKB,Pathogenic,Bartter disease type 3|not provided,single nucleotide variant,GRCh38
na,na,1,16375032,16375032,CLCNKB,Pathogenic/Likely pathogenic,Bartter disease type 3|not provided|Bartter disease type 4B;Bartter disease type 3,single nucleotide variant,GRCh37
na,na,1,16048537,16048537,CLCNKB,Pathogenic/Likely pathogenic,Bartter disease type 3|not provided|Bartter disease type 4B;Bartter disease type 3,single nucleotide variant,GRCh38
na,na,1,16378219,16378219,CLCNKB,Pathogenic,Bartter disease type 3|not provided|Bartter disease type 4B;Bartter disease type 3,single nucleotide variant,GRCh37
na,na,1,16051724,16051724,CLCNKB,Pathogenic,Bartter disease type 3|not provided|Bartter disease type 4B;Bartter disease type 3,single nucleotide variant,GRCh38
na,na,1,16377088,16377088,CLCNKB,Pathogenic,Bartter disease type 3,single nucleotide variant,GRCh37
na,na,1,16050593,16050593,CLCNKB,Pathogenic,Bartter disease type 3,single nucleotide variant,GRCh38
na,na,1,16378039,16378039,CLCNKB,Pathogenic,Bartter disease type 3,single nucleotide variant,GRCh37
na,na,1,16051544,16051544,CLCNKB,Pathogenic,Bartter disease type 3,single nucleotide variant,GRCh38
na,na,na,-1,-1,CLCNKB,Pathogenic,Bartter disease type 3,Deletion,na
na,na,1,16376111,16376111,CLCNKB,Pathogenic,Bartter disease type 3|Bartter disease type 4B;Bartter disease type 3|not provided,single nucleotide variant,GRCh37
na,na,1,16049616,16049616,CLCNKB,Pathogenic,Bartter disease type 3|Bartter disease type 4B;Bartter disease type 3|not provided,single nucleotide variant,GRCh38
na,na,1,16034051,16043881,CLCNKB,Pathogenic,"BARTTER SYNDROME, TYPE 4B, WITH SENSORINEURAL DEAFNESS",Deletion,GRCh38
na,na,1,16382003,16382003,CLCNKB,Pathogenic,"Bartter syndrome, type 3, with hypocalciuria|not provided|Bartter disease type 4B;Bartter disease type 3|Bartter disease type 3",single nucleotide variant,GRCh37
na,na,1,16055508,16055508,CLCNKB,Pathogenic,"Bartter syndrome, type 3, with hypocalciuria|not provided|Bartter disease type 4B;Bartter disease type 3|Bartter disease type 3",single nucleotide variant,GRCh38
na,na,1,16373029,16373029,CLCNKB,Pathogenic,"Bartter syndrome, type 3, with hypocalciuria",single nucleotide variant,GRCh37
na,na,1,16046534,16046534,CLCNKB,Pathogenic,"Bartter syndrome, type 3, with hypocalciuria",single nucleotide variant,GRCh38
na,na,1,16382254,16382254,CLCNKB,Pathogenic,"BARTTER SYNDROME, TYPE 4B, WITH SENSORINEURAL DEAFNESS",single nucleotide variant,GRCh37
na,na,1,16055759,16055759,CLCNKB,Pathogenic,"BARTTER SYNDROME, TYPE 4B, WITH SENSORINEURAL DEAFNESS",single nucleotide variant,GRCh38
na,na,3,9792107,9792107,OGG1,Uncertain significance,Clear cell carcinoma of kidney|not provided,single nucleotide variant,GRCh37
na,na,3,9750423,9750423,OGG1,Uncertain significance,Clear cell carcinoma of kidney|not provided,single nucleotide variant,GRCh38
na,na,1,201286763,201286763,PKP1,Pathogenic,Epidermolysis bullosa simplex due to plakophilin deficiency,single nucleotide variant,GRCh37
na,na,1,201317635,201317635,PKP1,Pathogenic,Epidermolysis bullosa simplex due to plakophilin deficiency,single nucleotide variant,GRCh38
na,na,1,201287795,201287796,PKP1,Pathogenic,Epidermolysis bullosa simplex due to plakophilin deficiency,Duplication,GRCh37
na,na,1,201318667,201318668,PKP1,Pathogenic,Epidermolysis bullosa simplex due to plakophilin deficiency,Duplication,GRCh38
na,na,1,201289393,201289393,PKP1,Pathogenic,Epidermolysis bullosa simplex due to plakophilin deficiency,single nucleotide variant,GRCh37
na,na,1,201320265,201320265,PKP1,Pathogenic,Epidermolysis bullosa simplex due to plakophilin deficiency,single nucleotide variant,GRCh38
na,na,6,33270280,33277668,TAPBP,Pathogenic,MHC class I deficiency 3,Deletion,GRCh37
na,na,6,33302503,33309891,TAPBP,Pathogenic,MHC class I deficiency 3,Deletion,GRCh38
na,na,2,152695752,152695752,CACNB4,risk factor,"Epilepsy, juvenile myoclonic, susceptibility to, 6",single nucleotide variant,GRCh37
na,na,2,151839238,151839238,CACNB4,risk factor,"Epilepsy, juvenile myoclonic, susceptibility to, 6",single nucleotide variant,GRCh38
na,na,2,152737393,152737393,CACNB4,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 9|Episodic ataxia type 5|not provided|Juvenile myoclonic epilepsy|Idiopathic generalized epilepsy|CACNB4-related disorder",single nucleotide variant,GRCh37
na,na,2,151880879,151880879,CACNB4,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 9|Episodic ataxia type 5|not provided|Juvenile myoclonic epilepsy|Idiopathic generalized epilepsy|CACNB4-related disorder",single nucleotide variant,GRCh38
na,na,12,52700054,52700054,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh37
na,na,12,52306270,52306270,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh38
na,na,12,52700056,52700056,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh37
na,na,12,52306272,52306272,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh38
na,na,12,52700021,52700021,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh37
na,na,12,52306237,52306237,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh38
na,na,12,52696040,52696040,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh37
na,na,12,52302256,52302256,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh38
na,na,12,52700021,52700021,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh37
na,na,12,52306237,52306237,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh38
na,na,12,52696053,52696053,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh37
na,na,12,52302269,52302269,KRT86,Pathogenic,Monilethrix|not provided,single nucleotide variant,GRCh38
na,na,20,10622473,10622474,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation,Deletion,GRCh37
na,na,20,10641825,10641826,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation,Deletion,GRCh38
na,na,20,10622107,10622107,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation,single nucleotide variant,GRCh37
na,na,20,10641459,10641459,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation,single nucleotide variant,GRCh38
na,na,20,10639116,10639117,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation|not provided,Microsatellite,GRCh37
na,na,20,10658468,10658469,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation|not provided,Microsatellite,GRCh38
na,na,20,10628672,10628672,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation,Deletion,GRCh37
na,na,20,10648024,10648024,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation,Deletion,GRCh38
na,na,20,10639260,10639260,JAG1,Pathogenic,"Alagille syndrome due to a JAG1 point mutation|not provided|JAG1-related disorder|Charcot-Marie-Tooth disease, axonal, Type 2HH;Deafness, congenital heart defects, and posterior embryotoxon;Tetralogy of Fallot;Alagille syndrome due to a JAG1 point mutation",single nucleotide variant,GRCh37
na,na,20,10658612,10658612,JAG1,Pathogenic,"Alagille syndrome due to a JAG1 point mutation|not provided|JAG1-related disorder|Charcot-Marie-Tooth disease, axonal, Type 2HH;Deafness, congenital heart defects, and posterior embryotoxon;Tetralogy of Fallot;Alagille syndrome due to a JAG1 point mutation",single nucleotide variant,GRCh38
na,na,20,10639259,10639259,JAG1,Pathogenic,"Alagille syndrome due to a JAG1 point mutation|not provided|Arteriohepatic dysplasia|Charcot-Marie-Tooth disease, axonal, Type 2HH;Deafness, congenital heart defects, and posterior embryotoxon;Tetralogy of Fallot;Alagille syndrome due to a JAG1 point mutation",single nucleotide variant,GRCh37
na,na,20,10658611,10658611,JAG1,Pathogenic,"Alagille syndrome due to a JAG1 point mutation|not provided|Arteriohepatic dysplasia|Charcot-Marie-Tooth disease, axonal, Type 2HH;Deafness, congenital heart defects, and posterior embryotoxon;Tetralogy of Fallot;Alagille syndrome due to a JAG1 point mutation",single nucleotide variant,GRCh38
na,na,20,10626017,10626021,JAG1,Pathogenic,"Alagille syndrome due to a JAG1 point mutation|not provided|Charcot-Marie-Tooth disease, axonal, Type 2HH;Deafness, congenital heart defects, and posterior embryotoxon;Tetralogy of Fallot;Alagille syndrome due to a JAG1 point mutation",Microsatellite,GRCh37
na,na,20,10645369,10645373,JAG1,Pathogenic,"Alagille syndrome due to a JAG1 point mutation|not provided|Charcot-Marie-Tooth disease, axonal, Type 2HH;Deafness, congenital heart defects, and posterior embryotoxon;Tetralogy of Fallot;Alagille syndrome due to a JAG1 point mutation",Microsatellite,GRCh38
na,na,20,10633181,10633181,JAG1,Likely pathogenic,Tetralogy of Fallot|Alagille syndrome due to a JAG1 point mutation,single nucleotide variant,GRCh37
na,na,20,10652533,10652533,JAG1,Likely pathogenic,Tetralogy of Fallot|Alagille syndrome due to a JAG1 point mutation,single nucleotide variant,GRCh38
na,na,20,10653626,10653626,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation|Arteriohepatic dysplasia,single nucleotide variant,GRCh37
na,na,20,10672978,10672978,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation|Arteriohepatic dysplasia,single nucleotide variant,GRCh38
na,na,20,10637100,10637100,JAG1,Likely pathogenic,"Deafness, congenital heart defects, and posterior embryotoxon",single nucleotide variant,GRCh37
na,na,20,10656452,10656452,JAG1,Likely pathogenic,"Deafness, congenital heart defects, and posterior embryotoxon",single nucleotide variant,GRCh38
na,na,na,-1,-1,JAG1,Pathogenic,Alagille syndrome due to a JAG1 point mutation,single nucleotide variant,na
na,na,na,-1,-1,SUMO1,Pathogenic,Orofacial cleft 10,Translocation,na
na,na,12,49360054,49360054,WNT10B,Pathogenic,Split hand-foot malformation 6|not provided,single nucleotide variant,GRCh37
na,na,12,48966271,48966271,WNT10B,Pathogenic,Split hand-foot malformation 6|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,UGT2B17,association,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12,Deletion,na
na,na,3,172165593,172165593,GHSR,Conflicting classifications of pathogenicity,Short stature due to growth hormone secretagogue receptor deficiency|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,3,172447803,172447803,GHSR,Conflicting classifications of pathogenicity,Short stature due to growth hormone secretagogue receptor deficiency|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,3,172166198,172166198,GHSR,Pathogenic,Short stature due to growth hormone secretagogue receptor deficiency,single nucleotide variant,GRCh37
na,na,3,172448408,172448408,GHSR,Pathogenic,Short stature due to growth hormone secretagogue receptor deficiency,single nucleotide variant,GRCh38
na,na,3,172165495,172165495,GHSR,Uncertain significance,Short stature due to growth hormone secretagogue receptor deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,3,172447705,172447705,GHSR,Uncertain significance,Short stature due to growth hormone secretagogue receptor deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,18,56939697,56939697,RAX,Pathogenic,Isolated microphthalmia 3,single nucleotide variant,GRCh37
na,na,18,59272465,59272465,RAX,Pathogenic,Isolated microphthalmia 3,single nucleotide variant,GRCh38
na,na,18,56936702,56936702,RAX,Pathogenic,Isolated microphthalmia 3,single nucleotide variant,GRCh37
na,na,18,59269470,59269470,RAX,Pathogenic,Isolated microphthalmia 3,single nucleotide variant,GRCh38
na,na,18,56936613,56936613,RAX,Pathogenic,Isolated microphthalmia 3,Deletion,GRCh37
na,na,18,59269381,59269381,RAX,Pathogenic,Isolated microphthalmia 3,Deletion,GRCh38
na,na,18,56936368,56936368,RAX,Pathogenic,Isolated microphthalmia 3,single nucleotide variant,GRCh37
na,na,18,59269136,59269136,RAX,Pathogenic,Isolated microphthalmia 3,single nucleotide variant,GRCh38
na,na,1,226125302,226125302,LEFTY2,Uncertain significance,Left-right axis malformations,single nucleotide variant,GRCh37
na,na,1,225937602,225937602,LEFTY2,Uncertain significance,Left-right axis malformations,single nucleotide variant,GRCh38
na,na,1,226125217,226125217,LEFTY2,Uncertain significance,Left-right axis malformations,single nucleotide variant,GRCh37
na,na,1,225937517,225937517,LEFTY2,Uncertain significance,Left-right axis malformations,single nucleotide variant,GRCh38
na,na,3,145789173,145789173,PLOD2,Pathogenic,Bruck syndrome 2,single nucleotide variant,GRCh37
na,na,3,146071386,146071386,PLOD2,Pathogenic,Bruck syndrome 2,single nucleotide variant,GRCh38
na,na,3,145789194,145789194,PLOD2,Pathogenic,Bruck syndrome 2,single nucleotide variant,GRCh37
na,na,3,146071407,146071407,PLOD2,Pathogenic,Bruck syndrome 2,single nucleotide variant,GRCh38
na,na,3,145789203,145789203,PLOD2,Likely pathogenic,Bruck syndrome 2,single nucleotide variant,GRCh37
na,na,3,146071416,146071416,PLOD2,Likely pathogenic,Bruck syndrome 2,single nucleotide variant,GRCh38
na,na,1,151318676,151318676,RFX5,Pathogenic,MHC class II deficiency 3,single nucleotide variant,GRCh37
na,na,1,151346200,151346200,RFX5,Pathogenic,MHC class II deficiency 3,single nucleotide variant,GRCh38
na,na,1,151315481,151315481,RFX5,Likely benign,not specified|MHC class II deficiency 3,single nucleotide variant,GRCh37
na,na,1,151343005,151343005,RFX5,Likely benign,not specified|MHC class II deficiency 3,single nucleotide variant,GRCh38
na,na,1,151317324,151317324,RFX5,Pathogenic,MHC class II deficiency 3|not provided,single nucleotide variant,GRCh37
na,na,1,151344848,151344848,RFX5,Pathogenic,MHC class II deficiency 3|not provided,single nucleotide variant,GRCh38
na,na,1,151317665,151317665,RFX5,Pathogenic,MHC class II deficiency 3,single nucleotide variant,GRCh37
na,na,1,151345189,151345189,RFX5,Pathogenic,MHC class II deficiency 3,single nucleotide variant,GRCh38
na,na,1,151316920,151316920,RFX5,Uncertain significance,MHC class II deficiency|MHC class II deficiency 5,single nucleotide variant,GRCh37
na,na,1,151344444,151344444,RFX5,Uncertain significance,MHC class II deficiency|MHC class II deficiency 5,single nucleotide variant,GRCh38
na,na,13,37393790,37393791,RFXAP,Pathogenic,MHC class II deficiency 4,Duplication,GRCh37
na,na,13,36819653,36819654,RFXAP,Pathogenic,MHC class II deficiency 4,Duplication,GRCh38
na,na,13,37393882,37393883,RFXAP,Pathogenic,MHC class II deficiency 4,Duplication,GRCh37
na,na,13,36819745,36819746,RFXAP,Pathogenic,MHC class II deficiency 4,Duplication,GRCh38
na,na,13,37393862,37393862,RFXAP,Pathogenic,MHC class II deficiency|MHC class II deficiency 4,Deletion,GRCh37
na,na,13,36819725,36819725,RFXAP,Pathogenic,MHC class II deficiency|MHC class II deficiency 4,Deletion,GRCh38
na,na,13,37393657,37393657,RFXAP,Pathogenic,MHC class II deficiency 4,single nucleotide variant,GRCh37
na,na,13,36819520,36819520,RFXAP,Pathogenic,MHC class II deficiency 4,single nucleotide variant,GRCh38
na,na,5,118837734,118837785,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,Deletion,GRCh37
na,na,5,119502039,119502090,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,Deletion,GRCh38
na,na,5,118835010,118835246,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,Deletion,GRCh37
na,na,5,119499315,119499551,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,Deletion,GRCh38
na,na,5,118788316,118788316,HSD17B4,Conflicting classifications of pathogenicity,Bifunctional peroxisomal enzyme deficiency|not provided|Perrault syndrome;Bifunctional peroxisomal enzyme deficiency|HSD17B4-related disorder|Perrault syndrome 1|Perrault syndrome|Perrault syndrome 1;Bifunctional peroxisomal enzyme deficiency,single nucleotide variant,GRCh37
na,na,5,119452621,119452621,HSD17B4,Conflicting classifications of pathogenicity,Bifunctional peroxisomal enzyme deficiency|not provided|Perrault syndrome;Bifunctional peroxisomal enzyme deficiency|HSD17B4-related disorder|Perrault syndrome 1|Perrault syndrome|Perrault syndrome 1;Bifunctional peroxisomal enzyme deficiency,single nucleotide variant,GRCh38
na,na,5,118844871,118844871,HSD17B4,Pathogenic/Likely pathogenic,Bifunctional peroxisomal enzyme deficiency|not provided|Bifunctional peroxisomal enzyme deficiency;Perrault syndrome|Bifunctional peroxisomal enzyme deficiency;Perrault syndrome 1|not specified,single nucleotide variant,GRCh37
na,na,5,119509176,119509176,HSD17B4,Pathogenic/Likely pathogenic,Bifunctional peroxisomal enzyme deficiency|not provided|Bifunctional peroxisomal enzyme deficiency;Perrault syndrome|Bifunctional peroxisomal enzyme deficiency;Perrault syndrome 1|not specified,single nucleotide variant,GRCh38
na,na,5,118811533,118811533,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,single nucleotide variant,GRCh37
na,na,5,119475838,119475838,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,single nucleotide variant,GRCh38
na,na,5,118809635,118809773,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,Deletion,GRCh37
na,na,5,119473940,119474078,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,Deletion,GRCh38
na,na,5,118813184,118813185,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,Deletion,GRCh37
na,na,5,119477489,119477490,HSD17B4,Pathogenic,Bifunctional peroxisomal enzyme deficiency,Deletion,GRCh38
na,na,17,40939512,40939512,WNK4,Pathogenic,Pseudohypoaldosteronism type 2B,single nucleotide variant,GRCh37
na,na,17,42787494,42787494,WNK4,Pathogenic,Pseudohypoaldosteronism type 2B,single nucleotide variant,GRCh38
na,na,17,40939503,40939503,WNK4,Pathogenic,Pseudohypoaldosteronism type 2B,single nucleotide variant,GRCh37
na,na,17,42787485,42787485,WNK4,Pathogenic,Pseudohypoaldosteronism type 2B,single nucleotide variant,GRCh38
na,na,17,40939510,40939510,WNK4,Pathogenic,Pseudohypoaldosteronism type 2B,single nucleotide variant,GRCh37
na,na,17,42787492,42787492,WNK4,Pathogenic,Pseudohypoaldosteronism type 2B,single nucleotide variant,GRCh38
na,na,17,40948262,40948262,WNK4,Conflicting classifications of pathogenicity,Pseudohypoaldosteronism type 2B|not provided,single nucleotide variant,GRCh37
na,na,17,42796244,42796244,WNK4,Conflicting classifications of pathogenicity,Pseudohypoaldosteronism type 2B|not provided,single nucleotide variant,GRCh38
na,na,19,17992770,17992770,SLC5A5,Pathogenic,Thyroid dyshormonogenesis 1|not provided,single nucleotide variant,GRCh37
na,na,19,17881961,17881961,SLC5A5,Pathogenic,Thyroid dyshormonogenesis 1|not provided,single nucleotide variant,GRCh38
na,na,19,17988649,17988649,SLC5A5,Pathogenic,not provided|Thyroid dyshormonogenesis 1,single nucleotide variant,GRCh37
na,na,19,17877840,17877840,SLC5A5,Pathogenic,not provided|Thyroid dyshormonogenesis 1,single nucleotide variant,GRCh38
na,na,19,17988632,17988632,SLC5A5,Likely pathogenic,Thyroid dyshormonogenesis 1|not provided,single nucleotide variant,GRCh37
na,na,19,17877823,17877823,SLC5A5,Likely pathogenic,Thyroid dyshormonogenesis 1|not provided,single nucleotide variant,GRCh38
na,na,19,17999206,17999206,SLC5A5,Pathogenic,Thyroid dyshormonogenesis 1|not provided|SLC5A5-related disorder,single nucleotide variant,GRCh37
na,na,19,17888397,17888397,SLC5A5,Pathogenic,Thyroid dyshormonogenesis 1|not provided|SLC5A5-related disorder,single nucleotide variant,GRCh38
na,na,19,17983405,17983405,SLC5A5,Pathogenic,Thyroid dyshormonogenesis 1,single nucleotide variant,GRCh37
na,na,19,17872596,17872596,SLC5A5,Pathogenic,Thyroid dyshormonogenesis 1,single nucleotide variant,GRCh38
na,na,19,17999241,17999241,SLC5A5,Pathogenic,Thyroid dyshormonogenesis 1,single nucleotide variant,GRCh37
na,na,19,17888432,17888432,SLC5A5,Pathogenic,Thyroid dyshormonogenesis 1,single nucleotide variant,GRCh38
na,na,19,17992969,17992969,SLC5A5,Pathogenic/Likely pathogenic,Thyroid dyshormonogenesis 1|Congenital hypothyroidism|not provided,single nucleotide variant,GRCh37
na,na,19,17882160,17882160,SLC5A5,Pathogenic/Likely pathogenic,Thyroid dyshormonogenesis 1|Congenital hypothyroidism|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,SLC5A5,Pathogenic,Thyroid dyshormonogenesis 1,Indel,na
na,na,13,108861879,108861879,LIG4,Pathogenic/Likely pathogenic,DNA ligase IV deficiency|not provided|Multiple myeloma;DNA ligase IV deficiency,single nucleotide variant,GRCh37
na,na,13,108209531,108209531,LIG4,Pathogenic/Likely pathogenic,DNA ligase IV deficiency|not provided|Multiple myeloma;DNA ligase IV deficiency,single nucleotide variant,GRCh38
na,na,13,108861177,108861177,LIG4,Pathogenic/Likely pathogenic,DNA ligase IV deficiency|not provided|Inborn genetic diseases|Multiple myeloma;DNA ligase IV deficiency|prenatal LIG4 syndrome with aqueductal stenosis|LIG4-related disorder,single nucleotide variant,GRCh37
na,na,13,108208829,108208829,LIG4,Pathogenic/Likely pathogenic,DNA ligase IV deficiency|not provided|Inborn genetic diseases|Multiple myeloma;DNA ligase IV deficiency|prenatal LIG4 syndrome with aqueductal stenosis|LIG4-related disorder,single nucleotide variant,GRCh38
na,na,13,108862211,108862211,LIG4,Pathogenic,DNA ligase IV deficiency,single nucleotide variant,GRCh37
na,na,13,108209863,108209863,LIG4,Pathogenic,DNA ligase IV deficiency,single nucleotide variant,GRCh38
na,na,13,108862784,108862784,LIG4,Pathogenic,DNA ligase IV deficiency|not provided|Severe combined immunodeficiency disease,single nucleotide variant,GRCh37
na,na,13,108210436,108210436,LIG4,Pathogenic,DNA ligase IV deficiency|not provided|Severe combined immunodeficiency disease,single nucleotide variant,GRCh38
na,na,13,108863609,108863609,LIG4,Benign/Likely benign,"Multiple myeloma, resistance to|Severe combined immunodeficiency due to DCLRE1C deficiency|not specified|DNA ligase IV deficiency|not provided",single nucleotide variant,GRCh37
na,na,13,108211261,108211261,LIG4,Benign/Likely benign,"Multiple myeloma, resistance to|Severe combined immunodeficiency due to DCLRE1C deficiency|not specified|DNA ligase IV deficiency|not provided",single nucleotide variant,GRCh38
na,na,13,108863591,108863591,LIG4,Benign/Likely benign,"Multiple myeloma, resistance to|not specified|DNA ligase IV deficiency|Severe combined immunodeficiency due to DCLRE1C deficiency|not provided",single nucleotide variant,GRCh37
na,na,13,108211243,108211243,LIG4,Benign/Likely benign,"Multiple myeloma, resistance to|not specified|DNA ligase IV deficiency|Severe combined immunodeficiency due to DCLRE1C deficiency|not provided",single nucleotide variant,GRCh38
na,na,13,108862317,108862319,LIG4,Pathogenic,DNA ligase IV deficiency,Microsatellite,GRCh37
na,na,13,108209969,108209971,LIG4,Pathogenic,DNA ligase IV deficiency,Microsatellite,GRCh38
na,na,2,157189156,157189156,NR4A2,Uncertain significance,"Parkinson disease, late-onset",Deletion,GRCh37
na,na,2,156332644,156332644,NR4A2,Uncertain significance,"Parkinson disease, late-onset",Deletion,GRCh38
na,na,2,157189110,157189110,NR4A2,Uncertain significance,"Parkinson disease, late-onset",single nucleotide variant,GRCh37
na,na,2,156332598,156332598,NR4A2,Uncertain significance,"Parkinson disease, late-onset",single nucleotide variant,GRCh38
na,na,19,1391005,1391005,NDUFS7,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 3|not provided|Leigh syndrome",single nucleotide variant,GRCh37
na,na,19,1391006,1391006,NDUFS7,Pathogenic/Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 3|not provided|Leigh syndrome",single nucleotide variant,GRCh38
na,na,19,1391143,1391143,NDUFS7,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 3",single nucleotide variant,GRCh37
na,na,19,1391144,1391144,NDUFS7,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 3",single nucleotide variant,GRCh38
na,na,19,1386643,1386643,NDUFS7,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 3|Leigh syndrome",single nucleotide variant,GRCh37
na,na,19,1386644,1386644,NDUFS7,Likely pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 3|Leigh syndrome",single nucleotide variant,GRCh38
na,na,11,117693139,117693139,FXYD2,Pathogenic,Renal hypomagnesemia 2|not provided,single nucleotide variant,GRCh37
na,na,11,117822424,117822424,FXYD2,Pathogenic,Renal hypomagnesemia 2|not provided,single nucleotide variant,GRCh38
na,na,2,136608646,136608646,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh37
na,na,2,135851076,135851076,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh38
na,na,2,136616754,136616754,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh37
na,na,2,135859184,135859184,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh38
na,na,2,136608746,136608746,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh37
na,na,2,135851176,135851176,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh38
na,na,2,136608651,136608651,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh37
na,na,2,135851081,135851081,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh38
na,na,2,136608643,136608643,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh37
na,na,2,135851073,135851073,MCM6,association,LACTASE PERSISTENCE,single nucleotide variant,GRCh38
na,na,3,57232305,57232305,HESX1,Pathogenic,Septo-optic dysplasia sequence|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence,single nucleotide variant,GRCh37
na,na,3,57198277,57198277,HESX1,Pathogenic,Septo-optic dysplasia sequence|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence,single nucleotide variant,GRCh38
na,na,3,57232274,57232274,HESX1,Uncertain significance,"SEPTOOPTIC DYSPLASIA, MILD|not provided|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence|HESX1-related disorder|Septo-optic dysplasia sequence",single nucleotide variant,GRCh37
na,na,3,57198246,57198246,HESX1,Uncertain significance,"SEPTOOPTIC DYSPLASIA, MILD|not provided|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence|HESX1-related disorder|Septo-optic dysplasia sequence",single nucleotide variant,GRCh38
na,na,3,57232242,57232242,HESX1,Conflicting classifications of pathogenicity,GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES|not provided|Septo-optic dysplasia sequence|Inborn genetic diseases|Septo-optic dysplasia sequence;GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES,single nucleotide variant,GRCh37
na,na,3,57198214,57198214,HESX1,Conflicting classifications of pathogenicity,GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES|not provided|Septo-optic dysplasia sequence|Inborn genetic diseases|Septo-optic dysplasia sequence;GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES,single nucleotide variant,GRCh38
na,na,3,57232831,57232832,HESX1,Pathogenic,Septo-optic dysplasia sequence,Microsatellite,GRCh37
na,na,3,57198803,57198804,HESX1,Pathogenic,Septo-optic dysplasia sequence,Microsatellite,GRCh38
na,na,3,57233870,57233870,HESX1,Pathogenic,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5",single nucleotide variant,GRCh37
na,na,3,57199842,57199842,HESX1,Pathogenic,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5",single nucleotide variant,GRCh38
na,na,3,57232258,57232258,HESX1,Pathogenic,Septo-optic dysplasia sequence,Deletion,GRCh37
na,na,3,57198230,57198230,HESX1,Pathogenic,Septo-optic dysplasia sequence,Deletion,GRCh38
na,na,3,57232427,57232428,HESX1,Pathogenic,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5",Deletion,GRCh37
na,na,3,57198399,57198400,HESX1,Pathogenic,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5",Deletion,GRCh38
na,na,3,57232779,57232779,HESX1,Pathogenic,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5",single nucleotide variant,GRCh37
na,na,3,57198751,57198751,HESX1,Pathogenic,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5",single nucleotide variant,GRCh38
na,na,3,57232433,57232433,HESX1,Pathogenic,GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES,single nucleotide variant,GRCh37
na,na,3,57198405,57198405,HESX1,Pathogenic,GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES,single nucleotide variant,GRCh38
na,na,3,57233929,57233929,HESX1,Uncertain significance,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence|not provided|not specified",single nucleotide variant,GRCh37
na,na,3,57199901,57199901,HESX1,Uncertain significance,"PITUITARY HORMONE DEFICIENCY, COMBINED, 5|GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES;Septo-optic dysplasia sequence|not provided|not specified",single nucleotide variant,GRCh38
na,na,1,10684462,10684462,PEX14,Pathogenic,Peroxisome biogenesis disorder 13A (Zellweger),single nucleotide variant,GRCh37
na,na,1,10624405,10624405,PEX14,Pathogenic,Peroxisome biogenesis disorder 13A (Zellweger),single nucleotide variant,GRCh38
na,na,na,-1,-1,PEX14,Pathogenic,Peroxisome biogenesis disorder 13A (Zellweger),Deletion,na
na,na,2,61259163,61259163,PEX13,Pathogenic,Peroxisome biogenesis disorder 11A (Zellweger),single nucleotide variant,GRCh37
na,na,2,61032028,61032028,PEX13,Pathogenic,Peroxisome biogenesis disorder 11A (Zellweger),single nucleotide variant,GRCh38
na,na,2,61275670,61275670,PEX13,Conflicting classifications of pathogenicity,Peroxisome biogenesis disorder 11B|not provided|Peroxisome biogenesis disorder 11A (Zellweger)|Peroxisome biogenesis disorder,single nucleotide variant,GRCh37
na,na,2,61048535,61048535,PEX13,Conflicting classifications of pathogenicity,Peroxisome biogenesis disorder 11B|not provided|Peroxisome biogenesis disorder 11A (Zellweger)|Peroxisome biogenesis disorder,single nucleotide variant,GRCh38
na,na,2,190926945,190926945,MSTN,Pathogenic,Myostatin-related muscle hypertrophy,single nucleotide variant,GRCh37
na,na,2,190062219,190062219,MSTN,Pathogenic,Myostatin-related muscle hypertrophy,single nucleotide variant,GRCh38
na,na,16,8905010,8905010,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided|Inborn genetic diseases|Congenital disorder of glycosylation|Muscular dystrophy;Cerebellar ataxia;Diabetes mellitus;Congenital cerebellar hypoplasia|Cerebellar ataxia|6 conditions|Congenital cerebellar hypoplasia|Congenital disorder of glycosylation type I|PMM2-related disorder|Focal segmental glomerulosclerosis,single nucleotide variant,GRCh37
na,na,16,8811153,8811153,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided|Inborn genetic diseases|Congenital disorder of glycosylation|Muscular dystrophy;Cerebellar ataxia;Diabetes mellitus;Congenital cerebellar hypoplasia|Cerebellar ataxia|6 conditions|Congenital cerebellar hypoplasia|Congenital disorder of glycosylation type I|PMM2-related disorder|Focal segmental glomerulosclerosis,single nucleotide variant,GRCh38
na,na,16,8941588,8941588,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,16,8847731,8847731,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,16,8904973,8904973,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,16,8811116,8811116,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,16,8905531,8905531,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,16,8811674,8811674,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,16,8898638,8898638,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,16,8804781,8804781,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,16,8904945,8904945,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|Inborn genetic diseases|not provided|PMM2-related disorder,single nucleotide variant,GRCh37
na,na,16,8811088,8811088,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|Inborn genetic diseases|not provided|PMM2-related disorder,single nucleotide variant,GRCh38
na,na,16,8906887,8906887,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,16,8813030,8813030,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,16,8904937,8904937,PMM2,Likely pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,8811080,8811080,PMM2,Likely pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,8941610,8941610,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,8847753,8847753,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,8941651,8941651,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided|See cases|Inborn genetic diseases|PMM2-related disorder,single nucleotide variant,GRCh37
na,na,16,8847794,8847794,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|not provided|See cases|Inborn genetic diseases|PMM2-related disorder,single nucleotide variant,GRCh38
na,na,16,8941663,8941663,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided|Inborn genetic diseases|PMM2-related disorder,single nucleotide variant,GRCh37
na,na,16,8847806,8847806,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided|Inborn genetic diseases|PMM2-related disorder,single nucleotide variant,GRCh38
na,na,16,8904983,8904983,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,8811126,8811126,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,8941632,8941632,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh37
na,na,16,8847775,8847775,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided,single nucleotide variant,GRCh38
na,na,16,8891765,8891765,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,8797908,8797908,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,8895684,8895684,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,8801827,8801827,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,8941618,8941618,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,8847761,8847761,PMM2,Pathogenic/Likely pathogenic,PMM2-congenital disorder of glycosylation|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,16,8900255,8900255,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided|6 conditions|PMM2-related disorder,single nucleotide variant,GRCh37
na,na,16,8806398,8806398,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation|not provided|6 conditions|PMM2-related disorder,single nucleotide variant,GRCh38
na,na,16,8895720,8895720,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,8801863,8801863,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,na,-1,-1,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,Deletion,na
na,na,16,8900172,8900172,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,16,8806315,8806315,PMM2,Pathogenic,PMM2-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,2,38302350,38302350,CYP1B1,Pathogenic,"Glaucoma 3A|not provided|Congenital glaucoma|Anterior segment dysgenesis 6|CYP1B1-related disorder|Anterior segment dysgenesis 6;Glaucoma 3A|Primary congenital glaucoma|Anterior segment dysgenesis 6;Glaucoma 3A;Glaucoma 3, primary infantile, B",single nucleotide variant,GRCh37
na,na,2,38075207,38075207,CYP1B1,Pathogenic,"Glaucoma 3A|not provided|Congenital glaucoma|Anterior segment dysgenesis 6|CYP1B1-related disorder|Anterior segment dysgenesis 6;Glaucoma 3A|Primary congenital glaucoma|Anterior segment dysgenesis 6;Glaucoma 3A;Glaucoma 3, primary infantile, B",single nucleotide variant,GRCh38
na,na,2,38298404,38298404,CYP1B1,Pathogenic,Glaucoma 3A,single nucleotide variant,GRCh37
na,na,2,38071261,38071261,CYP1B1,Pathogenic,Glaucoma 3A,single nucleotide variant,GRCh38
na,na,2,38298092,38298092,CYP1B1,Pathogenic,Glaucoma 3A|not provided|Primary congenital glaucoma|Anterior segment dysgenesis 6|Glaucoma 3A;Anterior segment dysgenesis 6|Congenital glaucoma|CYP1B1-related disorder,single nucleotide variant,GRCh37
na,na,2,38070949,38070949,CYP1B1,Pathogenic,Glaucoma 3A|not provided|Primary congenital glaucoma|Anterior segment dysgenesis 6|Glaucoma 3A;Anterior segment dysgenesis 6|Congenital glaucoma|CYP1B1-related disorder,single nucleotide variant,GRCh38
na,na,2,38298377,38298377,CYP1B1,Likely pathogenic,Glaucoma 3A,single nucleotide variant,GRCh37
na,na,2,38071234,38071234,CYP1B1,Likely pathogenic,Glaucoma 3A,single nucleotide variant,GRCh38
na,na,2,38298338,38298338,CYP1B1,Pathogenic/Likely pathogenic,Glaucoma 3A|not provided|Glaucoma of childhood|Primary congenital glaucoma|Congenital glaucoma|Anterior segment dysgenesis 6|CYP1B1-related disorder|Anterior segment dysgenesis 6;Glaucoma 3A,single nucleotide variant,GRCh37
na,na,2,38071195,38071195,CYP1B1,Pathogenic/Likely pathogenic,Glaucoma 3A|not provided|Glaucoma of childhood|Primary congenital glaucoma|Congenital glaucoma|Anterior segment dysgenesis 6|CYP1B1-related disorder|Anterior segment dysgenesis 6;Glaucoma 3A,single nucleotide variant,GRCh38
na,na,2,38302530,38302530,CYP1B1,Pathogenic/Likely pathogenic,Anterior segment dysgenesis 6|Primary congenital glaucoma|Congenital glaucoma,single nucleotide variant,GRCh37
na,na,2,38075387,38075387,CYP1B1,Pathogenic/Likely pathogenic,Anterior segment dysgenesis 6|Primary congenital glaucoma|Congenital glaucoma,single nucleotide variant,GRCh38
na,na,2,38302361,38302361,CYP1B1,Pathogenic/Likely pathogenic,"Irido-corneo-trabecular dysgenesis|Glaucoma 3A|CYP1B1-related disorder|not provided|Glaucoma 3A;Glaucoma 3, primary infantile, B;Anterior segment dysgenesis 6|Anterior segment dysgenesis|Anterior segment dysgenesis 6|Congenital glaucoma|Glaucoma 3A;Anterior segment dysgenesis 6",single nucleotide variant,GRCh37
na,na,2,38075218,38075218,CYP1B1,Pathogenic/Likely pathogenic,"Irido-corneo-trabecular dysgenesis|Glaucoma 3A|CYP1B1-related disorder|not provided|Glaucoma 3A;Glaucoma 3, primary infantile, B;Anterior segment dysgenesis 6|Anterior segment dysgenesis|Anterior segment dysgenesis 6|Congenital glaucoma|Glaucoma 3A;Anterior segment dysgenesis 6",single nucleotide variant,GRCh38
na,na,2,38298394,38298394,CYP1B1,Conflicting classifications of pathogenicity,"Glaucoma, early-onset, digenic|Glaucoma 3A|Congenital ocular coloboma|Glaucoma 3A;Irido-corneo-trabecular dysgenesis|not provided|not specified|CYP1B1-related disorder|Congenital glaucoma|Myopathy, centronuclear, 5|Anterior segment dysgenesis 6|Primary congenital glaucoma|Anterior segment dysgenesis 6;Glaucoma 3A;Glaucoma 3, primary infantile, B",single nucleotide variant,GRCh37
na,na,2,38071251,38071251,CYP1B1,Conflicting classifications of pathogenicity,"Glaucoma, early-onset, digenic|Glaucoma 3A|Congenital ocular coloboma|Glaucoma 3A;Irido-corneo-trabecular dysgenesis|not provided|not specified|CYP1B1-related disorder|Congenital glaucoma|Myopathy, centronuclear, 5|Anterior segment dysgenesis 6|Primary congenital glaucoma|Anterior segment dysgenesis 6;Glaucoma 3A;Glaucoma 3, primary infantile, B",single nucleotide variant,GRCh38
na,na,2,38301838,38301838,CYP1B1,Likely pathogenic,Glaucoma 3A|Primary congenital glaucoma,single nucleotide variant,GRCh37
na,na,2,38074695,38074695,CYP1B1,Likely pathogenic,Glaucoma 3A|Primary congenital glaucoma,single nucleotide variant,GRCh38
na,na,2,38302358,38302358,CYP1B1,Pathogenic,"Glaucoma, primary open angle, juvenile-onset|Glaucoma 3A",Deletion,GRCh37
na,na,2,38075215,38075215,CYP1B1,Pathogenic,"Glaucoma, primary open angle, juvenile-onset|Glaucoma 3A",Deletion,GRCh38
na,na,2,38298230,38298230,CYP1B1,Likely pathogenic,"Glaucoma, primary open angle, juvenile-onset|Glaucoma 3A|Primary congenital glaucoma|Congenital glaucoma",single nucleotide variant,GRCh37
na,na,2,38071087,38071087,CYP1B1,Likely pathogenic,"Glaucoma, primary open angle, juvenile-onset|Glaucoma 3A|Primary congenital glaucoma|Congenital glaucoma",single nucleotide variant,GRCh38
na,na,2,38302291,38302291,CYP1B1,Conflicting classifications of pathogenicity,Primary open angle glaucoma|Congenital ocular coloboma|not specified|not provided|Irido-corneo-trabecular dysgenesis|Congenital glaucoma|Glaucoma 3A|Anterior segment dysgenesis,single nucleotide variant,GRCh37
na,na,2,38075148,38075148,CYP1B1,Conflicting classifications of pathogenicity,Primary open angle glaucoma|Congenital ocular coloboma|not specified|not provided|Irido-corneo-trabecular dysgenesis|Congenital glaucoma|Glaucoma 3A|Anterior segment dysgenesis,single nucleotide variant,GRCh38
na,na,12,48272799,48272799,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47879016,47879016,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48258889,48258889,VDR,Pathogenic/Likely pathogenic,not provided|Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47865106,47865106,VDR,Pathogenic/Likely pathogenic,not provided|Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48240462,48240462,VDR,Pathogenic,not provided|Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47846679,47846679,VDR,Pathogenic,not provided|Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48240157,48240157,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47846374,47846374,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48258868,48258868,VDR,Conflicting classifications of pathogenicity,Vitamin D-dependent rickets type II with alopecia|not provided,single nucleotide variant,GRCh37
na,na,12,47865085,47865085,VDR,Conflicting classifications of pathogenicity,Vitamin D-dependent rickets type II with alopecia|not provided,single nucleotide variant,GRCh38
na,na,12,48258958,48258958,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47865175,47865175,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48251295,48251295,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47857512,47857512,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48240526,48240526,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47846743,47846743,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48272760,48272760,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47878977,47878977,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48240227,48240227,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47846444,47846444,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48240201,48240201,VDR,Uncertain significance,Vitamin D-dependent rickets type II with alopecia|not provided,single nucleotide variant,GRCh37
na,na,12,47846418,47846418,VDR,Uncertain significance,Vitamin D-dependent rickets type II with alopecia|not provided,single nucleotide variant,GRCh38
na,na,12,48238642,48238642,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh37
na,na,12,47844859,47844859,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,single nucleotide variant,GRCh38
na,na,12,48272809,48272809,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia|not provided,single nucleotide variant,GRCh37
na,na,12,47879026,47879026,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia|not provided,single nucleotide variant,GRCh38
na,na,12,48251383,48251383,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,Deletion,GRCh37
na,na,12,47857600,47857600,VDR,Pathogenic,Vitamin D-dependent rickets type II with alopecia,Deletion,GRCh38
na,na,12,48238777,48238777,VDR,Likely pathogenic,Vitamin D-dependent rickets type II with alopecia|not provided,single nucleotide variant,GRCh37
na,na,12,47844994,47844994,VDR,Likely pathogenic,Vitamin D-dependent rickets type II with alopecia|not provided,single nucleotide variant,GRCh38
na,na,2,202141631,202141631,CASP8,Likely pathogenic,Autoimmune lymphoproliferative syndrome type 2B,single nucleotide variant,GRCh37
na,na,2,201276908,201276908,CASP8,Likely pathogenic,Autoimmune lymphoproliferative syndrome type 2B,single nucleotide variant,GRCh38
na,na,2,202149961,202149962,CASP8,Pathogenic,Hepatocellular carcinoma,Microsatellite,GRCh37
na,na,2,201285238,201285239,CASP8,Pathogenic,Hepatocellular carcinoma,Microsatellite,GRCh38
na,na,2,202149589,202149589,CASP8,Benign,"BREAST CANCER, PROTECTION AGAINST|not specified|not provided|Autoimmune lymphoproliferative syndrome type 2B",single nucleotide variant,GRCh37
na,na,2,201284866,201284866,CASP8,Benign,"BREAST CANCER, PROTECTION AGAINST|not specified|not provided|Autoimmune lymphoproliferative syndrome type 2B",single nucleotide variant,GRCh38
na,na,2,202097532,202097537,CASP8,protective,"Lung cancer, protection against",Deletion,GRCh37
na,na,2,201232809,201232814,CASP8,protective,"Lung cancer, protection against",Deletion,GRCh38
na,na,2,202072837,202072837,CASP10,Uncertain significance,Autoimmune lymphoproliferative syndrome type 2A,single nucleotide variant,GRCh37
na,na,2,201208114,201208114,CASP10,Uncertain significance,Autoimmune lymphoproliferative syndrome type 2A,single nucleotide variant,GRCh38
na,na,2,202074111,202074111,CASP10,Pathogenic,Non-Hodgkin lymphoma,single nucleotide variant,GRCh37
na,na,2,201209388,201209388,CASP10,Pathogenic,Non-Hodgkin lymphoma,single nucleotide variant,GRCh38
na,na,2,202070652,202070652,CASP10,Pathogenic,Non-Hodgkin lymphoma|Gastric cancer,single nucleotide variant,GRCh37
na,na,2,201205929,201205929,CASP10,Pathogenic,Non-Hodgkin lymphoma|Gastric cancer,single nucleotide variant,GRCh38
na,na,2,202073912,202073913,CASP10,Pathogenic,Non-Hodgkin lymphoma,Insertion,GRCh37
na,na,2,201209189,201209190,CASP10,Pathogenic,Non-Hodgkin lymphoma,Insertion,GRCh38
na,na,2,202052521,202052521,CASP10,Uncertain significance,Gastric cancer|Autoimmune lymphoproliferative syndrome type 1|Autoimmune lymphoproliferative syndrome type 2A,single nucleotide variant,GRCh37
na,na,2,201187798,201187798,CASP10,Uncertain significance,Gastric cancer|Autoimmune lymphoproliferative syndrome type 1|Autoimmune lymphoproliferative syndrome type 2A,single nucleotide variant,GRCh38
na,na,2,202074086,202074086,CASP10,Uncertain significance,Autoimmune lymphoproliferative syndrome type 2A,single nucleotide variant,GRCh37
na,na,2,201209363,201209363,CASP10,Uncertain significance,Autoimmune lymphoproliferative syndrome type 2A,single nucleotide variant,GRCh38
na,na,17,33903190,33903190,PEX12,Pathogenic,Peroxisome biogenesis disorder 3A (Zellweger),single nucleotide variant,GRCh37
na,na,17,35576171,35576171,PEX12,Pathogenic,Peroxisome biogenesis disorder 3A (Zellweger),single nucleotide variant,GRCh38
na,na,17,33904199,33904199,PEX12,Pathogenic,Peroxisome biogenesis disorder 3A (Zellweger)|Peroxisome biogenesis disorder 3A (Zellweger);Peroxisome biogenesis disorder type 3B|Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder,single nucleotide variant,GRCh37
na,na,17,35577180,35577180,PEX12,Pathogenic,Peroxisome biogenesis disorder 3A (Zellweger)|Peroxisome biogenesis disorder 3A (Zellweger);Peroxisome biogenesis disorder type 3B|Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder,single nucleotide variant,GRCh38
na,na,17,33902922,33902922,PEX12,Pathogenic/Likely pathogenic,Peroxisomal biogenesis disorder 3b|not provided|Peroxisome biogenesis disorder 3A (Zellweger)|Peroxisome biogenesis disorder|Peroxisome biogenesis disorder type 3B;Peroxisome biogenesis disorder 3A (Zellweger),single nucleotide variant,GRCh37
na,na,17,35575903,35575903,PEX12,Pathogenic/Likely pathogenic,Peroxisomal biogenesis disorder 3b|not provided|Peroxisome biogenesis disorder 3A (Zellweger)|Peroxisome biogenesis disorder|Peroxisome biogenesis disorder type 3B;Peroxisome biogenesis disorder 3A (Zellweger),single nucleotide variant,GRCh38
na,na,17,33905014,33905015,PEX12,Pathogenic,Peroxisomal biogenesis disorder 3b,Microsatellite,GRCh37
na,na,17,35577995,35577996,PEX12,Pathogenic,Peroxisomal biogenesis disorder 3b,Microsatellite,GRCh38
na,na,12,48525177,48525177,PFKM,Pathogenic,Peroxisomal biogenesis disorder 3b,single nucleotide variant,GRCh37
na,na,12,48131394,48131394,PFKM,Pathogenic,Peroxisomal biogenesis disorder 3b,single nucleotide variant,GRCh38
na,na,17,33904464,33904464,PEX12,Pathogenic,Peroxisomal biogenesis disorder 3b,single nucleotide variant,GRCh37
na,na,17,35577445,35577445,PEX12,Pathogenic,Peroxisomal biogenesis disorder 3b,single nucleotide variant,GRCh38
na,na,17,33902932,33902932,PEX12,Conflicting classifications of pathogenicity,Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder 3A (Zellweger);Peroxisome biogenesis disorder type 3B,single nucleotide variant,GRCh37
na,na,17,35575913,35575913,PEX12,Conflicting classifications of pathogenicity,Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder 3A (Zellweger);Peroxisome biogenesis disorder type 3B,single nucleotide variant,GRCh38
na,na,6,137219351,137219351,PEX7,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|not provided|PEX7-related disorder|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1;Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1;Phytanic acid storage disease;Peroxisome biogenesis disorder 9B,single nucleotide variant,GRCh37
na,na,6,136898213,136898213,PEX7,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|not provided|PEX7-related disorder|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1;Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1;Phytanic acid storage disease;Peroxisome biogenesis disorder 9B,single nucleotide variant,GRCh38
na,na,6,137191047,137191047,PEX7,Pathogenic/Likely pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|not provided|Rhizomelic chondrodysplasia punctata|Rhizomelic chondrodysplasia punctata type 1;Phytanic acid storage disease;Peroxisome biogenesis disorder 9B|PEX7-related disorder,single nucleotide variant,GRCh37
na,na,6,136869909,136869909,PEX7,Pathogenic/Likely pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|not provided|Rhizomelic chondrodysplasia punctata|Rhizomelic chondrodysplasia punctata type 1;Phytanic acid storage disease;Peroxisome biogenesis disorder 9B|PEX7-related disorder,single nucleotide variant,GRCh38
na,na,6,137191043,137191043,PEX7,Pathogenic/Likely pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|not provided|Rhizomelic chondrodysplasia punctata|Inborn genetic diseases|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1,single nucleotide variant,GRCh37
na,na,6,136869905,136869905,PEX7,Pathogenic/Likely pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|not provided|Rhizomelic chondrodysplasia punctata|Inborn genetic diseases|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1,single nucleotide variant,GRCh38
na,na,6,137191088,137191088,PEX7,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|not provided|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata,single nucleotide variant,GRCh37
na,na,6,136869950,136869950,PEX7,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|not provided|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata,single nucleotide variant,GRCh38
na,na,6,137143840,137143841,PEX7,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B,Duplication,GRCh37
na,na,6,136822702,136822703,PEX7,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B,Duplication,GRCh38
na,na,6,137219380,137219380,PEX7,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata|PEX7-related disorder|not provided|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1,single nucleotide variant,GRCh37
na,na,6,136898242,136898242,PEX7,Pathogenic,Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata|PEX7-related disorder|not provided|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1,single nucleotide variant,GRCh38
na,na,6,137166758,137166758,PEX7,Pathogenic,Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata|Rhizomelic chondrodysplasia punctata type 1,single nucleotide variant,GRCh37
na,na,6,136845620,136845620,PEX7,Pathogenic,Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata|Rhizomelic chondrodysplasia punctata type 1,single nucleotide variant,GRCh38
na,na,6,137166743,137166743,PEX7,Conflicting classifications of pathogenicity,Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|Retinal dystrophy|Inborn genetic diseases|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1|not provided|Phytanic acid storage disease|Peroxisome biogenesis disorder,single nucleotide variant,GRCh37
na,na,6,136845605,136845605,PEX7,Conflicting classifications of pathogenicity,Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|Retinal dystrophy|Inborn genetic diseases|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1|not provided|Phytanic acid storage disease|Peroxisome biogenesis disorder,single nucleotide variant,GRCh38
na,na,6,137143923,137143923,PEX7,Pathogenic,Peroxisome biogenesis disorder 9B|PEX7-related disorder|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Phytanic acid storage disease;Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1|Rhizomelic chondrodysplasia punctata|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,6,136822785,136822785,PEX7,Pathogenic,Peroxisome biogenesis disorder 9B|PEX7-related disorder|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Phytanic acid storage disease;Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1|Rhizomelic chondrodysplasia punctata|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,6,137143843,137143843,PEX7,Pathogenic/Likely pathogenic,Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1,single nucleotide variant,GRCh37
na,na,6,136822705,136822705,PEX7,Pathogenic/Likely pathogenic,Peroxisome biogenesis disorder 9B|Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B;Rhizomelic chondrodysplasia punctata type 1,single nucleotide variant,GRCh38
na,na,2,166611441,166611441,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh37
na,na,2,165754931,165754931,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh38
na,na,2,166626727,166626727,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh37
na,na,2,165770217,165770217,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh38
na,na,2,166611437,166611437,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh37
na,na,2,165754927,165754927,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh38
na,na,2,166621568,166621568,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh37
na,na,2,165765058,165765058,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh38
na,na,2,166606257,166606257,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh37
na,na,2,165749747,165749747,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh38
na,na,2,166615372,166615372,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh37
na,na,2,165758862,165758862,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh38
na,na,2,166615953,166615953,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh37
na,na,2,165759443,165759443,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh38
na,na,2,166611525,166611525,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh37
na,na,2,165755015,165755015,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh38
na,na,2,166618438,166618438,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh37
na,na,2,165761928,165761928,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh38
na,na,2,166618449,166618450,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",Duplication,GRCh37
na,na,2,165761939,165761940,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",Duplication,GRCh38
na,na,2,166611136,166611136,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh37
na,na,2,165754626,165754626,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1|not provided",single nucleotide variant,GRCh38
na,na,2,166621405,166621405,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",Deletion,GRCh37
na,na,2,165764895,165764895,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",Deletion,GRCh38
na,na,2,166606311,166606311,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh37
na,na,2,165749801,165749801,GALNT3,Pathogenic,"Tumoral calcinosis, hyperphosphatemic, familial, 1",single nucleotide variant,GRCh38
na,na,1,92731722,92740095,GLMN,Pathogenic,Glomuvenous malformation,Indel,GRCh37
na,na,1,92266165,92274538,GLMN,Pathogenic,Glomuvenous malformation,Indel,GRCh38
na,na,1,92733686,92733690,GLMN,Pathogenic,Glomuvenous malformation,Microsatellite,GRCh37
na,na,1,92268129,92268133,GLMN,Pathogenic,Glomuvenous malformation,Microsatellite,GRCh38
na,na,1,92762965,92762969,GLMN,Pathogenic,Glomuvenous malformation|not provided|Inborn genetic diseases|GLMN-related disorder,Deletion,GRCh37
na,na,1,92297408,92297412,GLMN,Pathogenic,Glomuvenous malformation|not provided|Inborn genetic diseases|GLMN-related disorder,Deletion,GRCh38
na,na,1,92732009,92732011,GLMN,Pathogenic/Likely pathogenic,Glomuvenous malformation|not specified|not provided|GLMN-related disorder,Deletion,GRCh37
na,na,1,92266452,92266454,GLMN,Pathogenic/Likely pathogenic,Glomuvenous malformation|not specified|not provided|GLMN-related disorder,Deletion,GRCh38
na,na,5,38925333,38925333,OSMR,Pathogenic,"Amyloidosis, primary localized cutaneous, 1",single nucleotide variant,GRCh37
na,na,5,38925231,38925231,OSMR,Pathogenic,"Amyloidosis, primary localized cutaneous, 1",single nucleotide variant,GRCh38
na,na,5,38923339,38923339,OSMR,Pathogenic,"Amyloidosis, primary localized cutaneous, 1",single nucleotide variant,GRCh37
na,na,5,38923237,38923237,OSMR,Pathogenic,"Amyloidosis, primary localized cutaneous, 1",single nucleotide variant,GRCh38
na,na,2,216209551,216209551,ATIC,Conflicting classifications of pathogenicity,AICA-ribosiduria|not provided|See cases,single nucleotide variant,GRCh37
na,na,2,215344828,215344828,ATIC,Conflicting classifications of pathogenicity,AICA-ribosiduria|not provided|See cases,single nucleotide variant,GRCh38
na,na,2,216177332,216177332,ATIC,Pathogenic,AICA-ribosiduria,Indel,GRCh37
na,na,2,215312609,215312609,ATIC,Pathogenic,AICA-ribosiduria,Indel,GRCh38
na,na,10,89692902,89692902,PTEN,Pathogenic/Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome|Neoplasm|Malignant tumor of urinary bladder,single nucleotide variant,GRCh37
na,na,10,87933145,87933145,PTEN,Pathogenic/Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome|Neoplasm|Malignant tumor of urinary bladder,single nucleotide variant,GRCh38
na,na,10,89717672,89717672,PTEN,Pathogenic/Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Macrocephaly-autism syndrome|Cowden syndrome|Ovarian neoplasm|Abnormal cardiovascular system morphology|Gastric cancer|Glioma susceptibility 2|PTEN-related disorder,single nucleotide variant,GRCh37
na,na,10,87957915,87957915,PTEN,Pathogenic/Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Macrocephaly-autism syndrome|Cowden syndrome|Ovarian neoplasm|Abnormal cardiovascular system morphology|Gastric cancer|Glioma susceptibility 2|PTEN-related disorder,single nucleotide variant,GRCh38
na,na,10,89692985,89692985,PTEN,Pathogenic,Lhermitte-Duclos disease|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Cowden syndrome 1,single nucleotide variant,GRCh37
na,na,10,87933228,87933228,PTEN,Pathogenic,Lhermitte-Duclos disease|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Cowden syndrome 1,single nucleotide variant,GRCh38
na,na,10,89711892,89711892,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh37
na,na,10,87952135,87952135,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh38
na,na,10,89692884,89692884,PTEN,Pathogenic,Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome|PTEN-related disorder|Neoplasm,single nucleotide variant,GRCh37
na,na,10,87933127,87933127,PTEN,Pathogenic,Cowden syndrome 1|not provided|PTEN hamartoma tumor syndrome|PTEN-related disorder|Neoplasm,single nucleotide variant,GRCh38
na,na,10,89692886,89692886,PTEN,Pathogenic,Cowden syndrome 1|not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Gastric cancer,single nucleotide variant,GRCh37
na,na,10,87933129,87933129,PTEN,Pathogenic,Cowden syndrome 1|not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Gastric cancer,single nucleotide variant,GRCh38
na,na,10,89692863,89692867,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Deletion,GRCh37
na,na,10,87933106,87933110,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Deletion,GRCh38
na,na,10,89692904,89692904,PTEN,Pathogenic,Cowden syndrome 1|Macrocephaly-autism syndrome|not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Ovarian neoplasm|Rhabdomyosarcoma|Abnormal cardiovascular system morphology|Glioma susceptibility 2|Cowden syndrome 1;Glioma susceptibility 2;Prostate cancer;Macrocephaly-autism syndrome;Familial meningioma|Gastric cancer|Neoplasm|Cowden syndrome 1;Macrocephaly-autism syndrome|Cowden syndrome 1;Glioma susceptibility 2;Macrocephaly-autism syndrome;Familial prostate cancer;Familial meningioma|PTEN-related disorder|Cowden syndrome,single nucleotide variant,GRCh37
na,na,10,87933147,87933147,PTEN,Pathogenic,Cowden syndrome 1|Macrocephaly-autism syndrome|not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Ovarian neoplasm|Rhabdomyosarcoma|Abnormal cardiovascular system morphology|Glioma susceptibility 2|Cowden syndrome 1;Glioma susceptibility 2;Prostate cancer;Macrocephaly-autism syndrome;Familial meningioma|Gastric cancer|Neoplasm|Cowden syndrome 1;Macrocephaly-autism syndrome|Cowden syndrome 1;Glioma susceptibility 2;Macrocephaly-autism syndrome;Familial prostate cancer;Familial meningioma|PTEN-related disorder|Cowden syndrome,single nucleotide variant,GRCh38
na,na,10,89690847,89690847,PTEN,Pathogenic,Endometrial carcinoma|not provided|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|Glioma susceptibility 2|Neoplasm,single nucleotide variant,GRCh37
na,na,10,87931090,87931090,PTEN,Pathogenic,Endometrial carcinoma|not provided|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|Glioma susceptibility 2|Neoplasm,single nucleotide variant,GRCh38
na,na,10,89693010,89693010,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,87933253,87933253,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,89717671,89717671,PTEN,Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Deletion,GRCh37
na,na,10,87957914,87957914,PTEN,Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Deletion,GRCh38
na,na,10,89711968,89711968,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Deletion,GRCh37
na,na,10,87952211,87952211,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Deletion,GRCh38
na,na,10,89711916,89711917,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Indel,GRCh37
na,na,10,87952159,87952160,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Indel,GRCh38
na,na,10,89653806,89653806,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh37
na,na,10,87894049,87894049,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh38
na,na,10,89685314,89685314,PTEN,Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|Cowden syndrome 1;Prostate cancer;Familial meningioma;Macrocephaly-autism syndrome;Glioma susceptibility 2|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,10,87925557,87925557,PTEN,Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|Cowden syndrome 1;Prostate cancer;Familial meningioma;Macrocephaly-autism syndrome;Glioma susceptibility 2|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,10,89717615,89717615,PTEN,Pathogenic,Cowden syndrome 1|Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,87957858,87957858,PTEN,Pathogenic,Cowden syndrome 1|Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,89717741,89717741,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh37
na,na,10,87957984,87957984,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh38
na,na,10,89692905,89692905,PTEN,Pathogenic,Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided|Ovarian neoplasm|Cowden syndrome|PTEN-related disorder,single nucleotide variant,GRCh37
na,na,10,87933148,87933148,PTEN,Pathogenic,Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided|Ovarian neoplasm|Cowden syndrome|PTEN-related disorder,single nucleotide variant,GRCh38
na,na,10,89717735,89717739,PTEN,Likely pathogenic,"Prostate cancer, somatic|PTEN hamartoma tumor syndrome|Neoplasm",Deletion,GRCh37
na,na,10,87957978,87957982,PTEN,Likely pathogenic,"Prostate cancer, somatic|PTEN hamartoma tumor syndrome|Neoplasm",Deletion,GRCh38
na,na,10,89711946,89711946,PTEN,Likely pathogenic,"Prostate cancer, somatic|PTEN hamartoma tumor syndrome",single nucleotide variant,GRCh37
na,na,10,87952189,87952189,PTEN,Likely pathogenic,"Prostate cancer, somatic|PTEN hamartoma tumor syndrome",single nucleotide variant,GRCh38
na,na,10,89692851,89692851,PTEN,Pathogenic,Lhermitte-Duclos disease|not provided,single nucleotide variant,GRCh37
na,na,10,87933094,87933094,PTEN,Pathogenic,Lhermitte-Duclos disease|not provided,single nucleotide variant,GRCh38
na,na,10,89720852,89720852,PTEN,Pathogenic,Proteus-like syndrome|not provided|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Macrocephaly-autism syndrome|PTEN-related disorder|Macrocephaly-autism syndrome;Cowden syndrome 1|Ovarian neoplasm|Cowden syndrome|Cowden syndrome;Macrocephaly-autism syndrome|Familial meningioma;Macrocephaly-autism syndrome;Cowden syndrome 1;Glioma susceptibility 2;Prostate cancer|Abnormality of the nervous system|Familial cancer of breast|Neoplasm,single nucleotide variant,GRCh37
na,na,10,87961095,87961095,PTEN,Pathogenic,Proteus-like syndrome|not provided|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Macrocephaly-autism syndrome|PTEN-related disorder|Macrocephaly-autism syndrome;Cowden syndrome 1|Ovarian neoplasm|Cowden syndrome|Cowden syndrome;Macrocephaly-autism syndrome|Familial meningioma;Macrocephaly-autism syndrome;Cowden syndrome 1;Glioma susceptibility 2;Prostate cancer|Abnormality of the nervous system|Familial cancer of breast|Neoplasm,single nucleotide variant,GRCh38
na,na,10,89624262,89624263,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|not provided,Duplication,GRCh37
na,na,10,87864505,87864506,PTEN,Pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|not provided,Duplication,GRCh38
na,na,na,-1,-1,PTEN,Pathogenic,Cowden syndrome 1,Variation,na
na,na,10,89712015,89712015,PTEN,Pathogenic,Melanoma|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|not provided|PTEN-related disorder|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh37
na,na,10,87952258,87952258,PTEN,Pathogenic,Melanoma|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|not provided|PTEN-related disorder|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh38
na,na,10,89624281,89624281,PTEN,Uncertain significance,Melanoma|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh37
na,na,10,87864524,87864524,PTEN,Uncertain significance,Melanoma|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh38
na,na,10,89717624,89717624,PTEN,Uncertain significance,Melanoma|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,10,87957867,87957867,PTEN,Uncertain significance,Melanoma|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,10,89720650,89720650,PTEN,Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Deletion,GRCh37
na,na,10,87960893,87960893,PTEN,Likely pathogenic,Cowden syndrome 1|PTEN hamartoma tumor syndrome,Deletion,GRCh38
na,na,10,89717676,89717676,PTEN,Uncertain significance,Glioma susceptibility 2|Meningioma|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not specified|not provided|Macrocephaly-autism syndrome,single nucleotide variant,GRCh37
na,na,10,87957919,87957919,PTEN,Uncertain significance,Glioma susceptibility 2|Meningioma|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not specified|not provided|Macrocephaly-autism syndrome,single nucleotide variant,GRCh38
na,na,10,89685286,89685286,PTEN,Likely pathogenic,Vater association with macrocephaly and ventriculomegaly|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh37
na,na,10,87925529,87925529,PTEN,Likely pathogenic,Vater association with macrocephaly and ventriculomegaly|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh38
na,na,10,89692878,89692878,PTEN,Pathogenic,Squamous cell carcinoma of the head and neck,single nucleotide variant,GRCh37
na,na,10,87933121,87933121,PTEN,Pathogenic,Squamous cell carcinoma of the head and neck,single nucleotide variant,GRCh38
na,na,10,89711887,89711887,PTEN,Pathogenic,Proteus-like syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided,Deletion,GRCh37
na,na,10,87952130,87952130,PTEN,Pathogenic,Proteus-like syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided,Deletion,GRCh38
na,na,10,89623462,89623462,PTEN,Uncertain significance,not provided|PTEN hamartoma tumor syndrome|Cowden syndrome 1|7 conditions|Hereditary cancer-predisposing syndrome|not specified|Glioma susceptibility 2,single nucleotide variant,GRCh37
na,na,10,87863705,87863705,PTEN,Uncertain significance,not provided|PTEN hamartoma tumor syndrome|Cowden syndrome 1|7 conditions|Hereditary cancer-predisposing syndrome|not specified|Glioma susceptibility 2,single nucleotide variant,GRCh38
na,na,10,89623365,89623365,PTEN,Uncertain significance,Cowden syndrome 1|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh37
na,na,10,87863608,87863608,PTEN,Uncertain significance,Cowden syndrome 1|PTEN hamartoma tumor syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,PTEN,Pathogenic,Cowden syndrome 1,Deletion,na
na,na,10,89685285,89685285,PTEN,Pathogenic,Cowden syndrome 1,Deletion,GRCh37
na,na,10,87925528,87925528,PTEN,Pathogenic,Cowden syndrome 1,Deletion,GRCh38
na,na,10,89692794,89692794,PTEN,Pathogenic,Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Cowden syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,10,87933037,87933037,PTEN,Pathogenic,Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Cowden syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,10,89717730,89717730,PTEN,Pathogenic,Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|not provided|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|Glioma susceptibility 2,single nucleotide variant,GRCh37
na,na,10,87957973,87957973,PTEN,Pathogenic,Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|not provided|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|Glioma susceptibility 2,single nucleotide variant,GRCh38
na,na,10,89717697,89717697,PTEN,Likely pathogenic,Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,87957940,87957940,PTEN,Likely pathogenic,Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,PTEN,Pathogenic,Macrocephaly-autism syndrome,Insertion,na
na,na,10,89692911,89692911,PTEN,Pathogenic/Likely pathogenic,PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Cowden syndrome 1|PTEN-related disorder|Glioma susceptibility 2,single nucleotide variant,GRCh37
na,na,10,87933154,87933154,PTEN,Pathogenic/Likely pathogenic,PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Cowden syndrome 1|PTEN-related disorder|Glioma susceptibility 2,single nucleotide variant,GRCh38
na,na,2,182543256,182543256,NEUROD1,Pathogenic,Type 2 diabetes mellitus,single nucleotide variant,GRCh37
na,na,2,181678529,181678529,NEUROD1,Pathogenic,Type 2 diabetes mellitus,single nucleotide variant,GRCh38
na,na,2,182542971,182542972,NEUROD1,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 6|NEUROD1-related disorder|not provided|not specified,Duplication,GRCh37
na,na,2,181678244,181678245,NEUROD1,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 6|NEUROD1-related disorder|not provided|not specified,Duplication,GRCh38
na,na,17,59557282,59557282,TBX4,Pathogenic,Coxopodopatellar syndrome,single nucleotide variant,GRCh37
na,na,17,61479921,61479921,TBX4,Pathogenic,Coxopodopatellar syndrome,single nucleotide variant,GRCh38
na,na,17,59534035,59534035,TBX4,Pathogenic,Coxopodopatellar syndrome,single nucleotide variant,GRCh37
na,na,17,61456674,61456674,TBX4,Pathogenic,Coxopodopatellar syndrome,single nucleotide variant,GRCh38
na,na,17,59560831,59560831,TBX4,Pathogenic,Coxopodopatellar syndrome,single nucleotide variant,GRCh37
na,na,17,61483470,61483470,TBX4,Pathogenic,Coxopodopatellar syndrome,single nucleotide variant,GRCh38
na,na,19,7711208,7711208,STXBP2,Pathogenic,Familial hemophagocytic lymphohistiocytosis 5|STXBP2-related disorder|Familial hemophagocytic lymphohistiocytosis,single nucleotide variant,GRCh37
na,na,19,7646322,7646322,STXBP2,Pathogenic,Familial hemophagocytic lymphohistiocytosis 5|STXBP2-related disorder|Familial hemophagocytic lymphohistiocytosis,single nucleotide variant,GRCh38
na,na,19,7707117,7707119,STXBP2,Pathogenic,Familial hemophagocytic lymphohistiocytosis 5,Deletion,GRCh37
na,na,19,7642231,7642233,STXBP2,Pathogenic,Familial hemophagocytic lymphohistiocytosis 5,Deletion,GRCh38
na,na,19,7706967,7706967,STXBP2,Uncertain significance,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITHOUT MICROVILLUS INCLUSION DISEASE|not specified",single nucleotide variant,GRCh37
na,na,19,7642081,7642081,STXBP2,Uncertain significance,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITHOUT MICROVILLUS INCLUSION DISEASE|not specified",single nucleotide variant,GRCh38
na,na,19,7705630,7705630,STXBP2,Pathogenic,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITHOUT MICROVILLUS INCLUSION DISEASE",Deletion,GRCh37
na,na,19,7640744,7640744,STXBP2,Pathogenic,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITHOUT MICROVILLUS INCLUSION DISEASE",Deletion,GRCh38
na,na,19,7707129,7707129,STXBP2,Pathogenic,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITHOUT MICROVILLUS INCLUSION DISEASE",Deletion,GRCh37
na,na,19,7642243,7642243,STXBP2,Pathogenic,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITHOUT MICROVILLUS INCLUSION DISEASE",Deletion,GRCh38
na,na,20,48127563,48127563,PTGIS,Pathogenic,Essential hypertension,single nucleotide variant,GRCh37
na,na,20,49511026,49511026,PTGIS,Pathogenic,Essential hypertension,single nucleotide variant,GRCh38
na,na,11,73694754,73694754,UCP2,risk factor,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4,single nucleotide variant,GRCh37
na,na,11,73983709,73983709,UCP2,risk factor,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4,single nucleotide variant,GRCh38
na,na,5,135392469,135392469,TGFBI,Pathogenic,Groenouw corneal dystrophy type I|7 conditions|Lattice corneal dystrophy Type I|not provided,single nucleotide variant,GRCh37
na,na,5,136056780,136056780,TGFBI,Pathogenic,Groenouw corneal dystrophy type I|7 conditions|Lattice corneal dystrophy Type I|not provided,single nucleotide variant,GRCh38
na,na,5,135392470,135392470,TGFBI,Pathogenic,Thiel-Behnke corneal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,5,136056781,136056781,TGFBI,Pathogenic,Thiel-Behnke corneal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,5,135382095,135382095,TGFBI,Pathogenic,Lattice corneal dystrophy Type I|Epithelial-stromal TGFBI dystrophy|not provided,single nucleotide variant,GRCh37
na,na,5,136046406,136046406,TGFBI,Pathogenic,Lattice corneal dystrophy Type I|Epithelial-stromal TGFBI dystrophy|not provided,single nucleotide variant,GRCh38
na,na,5,135382096,135382096,TGFBI,Pathogenic,Avellino corneal dystrophy|not provided|Lattice corneal dystrophy Type I,single nucleotide variant,GRCh37
na,na,5,136046407,136046407,TGFBI,Pathogenic,Avellino corneal dystrophy|not provided|Lattice corneal dystrophy Type I,single nucleotide variant,GRCh38
na,na,5,135392424,135392426,TGFBI,Pathogenic,Reis-Bucklers' corneal dystrophy,Deletion,GRCh37
na,na,5,136056735,136056737,TGFBI,Pathogenic,Reis-Bucklers' corneal dystrophy,Deletion,GRCh38
na,na,5,135391459,135391459,TGFBI,Pathogenic/Likely pathogenic,"Corneal dystrophy, lattice type 3A|Corneal dystrophy|not specified|not provided|7 conditions",single nucleotide variant,GRCh37
na,na,5,136055770,136055770,TGFBI,Pathogenic/Likely pathogenic,"Corneal dystrophy, lattice type 3A|Corneal dystrophy|not specified|not provided|7 conditions",single nucleotide variant,GRCh38
na,na,5,135382096,135382096,TGFBI,Pathogenic,Reis-Bucklers' corneal dystrophy|Avellino corneal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,5,136046407,136046407,TGFBI,Pathogenic,Reis-Bucklers' corneal dystrophy|Avellino corneal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,5,135382095,135382095,TGFBI,Pathogenic,Groenouw corneal dystrophy type I|Epithelial-stromal TGFBI dystrophy,single nucleotide variant,GRCh37
na,na,5,136046406,136046406,TGFBI,Pathogenic,Groenouw corneal dystrophy type I|Epithelial-stromal TGFBI dystrophy,single nucleotide variant,GRCh38
na,na,5,135392443,135392443,TGFBI,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,5,136056754,136056754,TGFBI,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,5,135392425,135392425,TGFBI,Pathogenic,"Corneal dystrophy, lattice type 3A",single nucleotide variant,GRCh37
na,na,5,136056736,136056736,TGFBI,Pathogenic,"Corneal dystrophy, lattice type 3A",single nucleotide variant,GRCh38
na,na,5,135396587,135396587,TGFBI,Pathogenic,Reis-Bucklers' corneal dystrophy,single nucleotide variant,GRCh37
na,na,5,136060898,136060898,TGFBI,Pathogenic,Reis-Bucklers' corneal dystrophy,single nucleotide variant,GRCh38
na,na,5,135391484,135391484,TGFBI,Pathogenic,Epithelial basement membrane dystrophy,single nucleotide variant,GRCh37
na,na,5,136055795,136055795,TGFBI,Pathogenic,Epithelial basement membrane dystrophy,single nucleotide variant,GRCh38
na,na,5,135398363,135398363,TGFBI,Conflicting classifications of pathogenicity,Epithelial basement membrane dystrophy|Corneal dystrophy|not specified|not provided|7 conditions,single nucleotide variant,GRCh37
na,na,5,136062674,136062674,TGFBI,Conflicting classifications of pathogenicity,Epithelial basement membrane dystrophy|Corneal dystrophy|not specified|not provided|7 conditions,single nucleotide variant,GRCh38
na,na,1,94517254,94517254,ABCA4,Conflicting classifications of pathogenicity,Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy|not provided|Inborn genetic diseases|Peripheral neuropathy;Abnormal macular morphology|Retinal dystrophy|Stargardt disease|Retinitis pigmentosa|Cone-rod dystrophy|Age related macular degeneration 2|Cone-rod dystrophy 3;Age-related macular degeneration;Retinitis pigmentosa 19|Retinitis pigmentosa 19|Stargardt disease 3|ABCA4-related disorder|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19,single nucleotide variant,GRCh37
na,na,1,94051698,94051698,ABCA4,Conflicting classifications of pathogenicity,Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy|not provided|Inborn genetic diseases|Peripheral neuropathy;Abnormal macular morphology|Retinal dystrophy|Stargardt disease|Retinitis pigmentosa|Cone-rod dystrophy|Age related macular degeneration 2|Cone-rod dystrophy 3;Age-related macular degeneration;Retinitis pigmentosa 19|Retinitis pigmentosa 19|Stargardt disease 3|ABCA4-related disorder|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19,single nucleotide variant,GRCh38
na,na,1,94512602,94512602,ABCA4,Conflicting classifications of pathogenicity,not provided|Severe early-childhood-onset retinal dystrophy|Stargardt disease|Retinitis pigmentosa 19|Retinal dystrophy|not specified|Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy;Retinitis pigmentosa 19;Age related macular degeneration 2|ABCA4-related disorder,single nucleotide variant,GRCh37
na,na,1,94047046,94047046,ABCA4,Conflicting classifications of pathogenicity,not provided|Severe early-childhood-onset retinal dystrophy|Stargardt disease|Retinitis pigmentosa 19|Retinal dystrophy|not specified|Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy;Retinitis pigmentosa 19;Age related macular degeneration 2|ABCA4-related disorder,single nucleotide variant,GRCh38
na,na,1,94508999,94508999,ABCA4,Uncertain significance,Severe early-childhood-onset retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,1,94043443,94043443,ABCA4,Uncertain significance,Severe early-childhood-onset retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,1,94471065,94471065,ABCA4,Pathogenic/Likely pathogenic,Severe early-childhood-onset retinal dystrophy|Cone-rod dystrophy 3|not provided|Stargardt disease|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3|Retinal dystrophy|Age related macular degeneration 2,single nucleotide variant,GRCh37
na,na,1,94005509,94005509,ABCA4,Pathogenic/Likely pathogenic,Severe early-childhood-onset retinal dystrophy|Cone-rod dystrophy 3|not provided|Stargardt disease|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3|Retinal dystrophy|Age related macular degeneration 2,single nucleotide variant,GRCh38
na,na,1,94520689,94520689,ABCA4,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,1,94055133,94055133,ABCA4,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,1,94467548,94467548,ABCA4,Conflicting classifications of pathogenicity,"Severe early-childhood-onset retinal dystrophy|not provided|Stargardt Disease, Recessive|Cone-Rod Dystrophy, Recessive|not specified|Retinitis Pigmentosa, Recessive|Macular degeneration|Cone dystrophy|ABCA4-related disorder|Retinitis pigmentosa|Retinal dystrophy|Stargardt disease|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2",single nucleotide variant,GRCh37
na,na,1,94001992,94001992,ABCA4,Conflicting classifications of pathogenicity,"Severe early-childhood-onset retinal dystrophy|not provided|Stargardt Disease, Recessive|Cone-Rod Dystrophy, Recessive|not specified|Retinitis Pigmentosa, Recessive|Macular degeneration|Cone dystrophy|ABCA4-related disorder|Retinitis pigmentosa|Retinal dystrophy|Stargardt disease|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2",single nucleotide variant,GRCh38
na,na,1,94463617,94463617,ABCA4,Benign/Likely benign,"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|not provided|Cone-Rod Dystrophy, Recessive|Macular degeneration|Retinitis Pigmentosa, Recessive|not specified|Stargardt Disease, Recessive|ABCA4-related disorder",single nucleotide variant,GRCh37
na,na,1,93998061,93998061,ABCA4,Benign/Likely benign,"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|not provided|Cone-Rod Dystrophy, Recessive|Macular degeneration|Retinitis Pigmentosa, Recessive|not specified|Stargardt Disease, Recessive|ABCA4-related disorder",single nucleotide variant,GRCh38
na,na,1,94508976,94508976,ABCA4,Pathogenic/Likely pathogenic,Severe early-childhood-onset retinal dystrophy|not provided|Stargardt disease|Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy;Retinitis pigmentosa 19;Age related macular degeneration 2,single nucleotide variant,GRCh37
na,na,1,94043420,94043420,ABCA4,Pathogenic/Likely pathogenic,Severe early-childhood-onset retinal dystrophy|not provided|Stargardt disease|Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy;Retinitis pigmentosa 19;Age related macular degeneration 2,single nucleotide variant,GRCh38
na,na,1,94508434,94508435,ABCA4,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided,Insertion,GRCh37
na,na,1,94042878,94042879,ABCA4,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided,Insertion,GRCh38
na,na,1,94473807,94473807,ABCA4,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance","MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|Severe early-childhood-onset retinal dystrophy|Cone-rod dystrophy 3|not provided|ABCA4-related disorder|Inborn genetic diseases|Macular dystrophy|Retinal dystrophy|Age related macular degeneration 2|Stargardt disease|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19|Retinitis pigmentosa 19|not specified|Retinitis pigmentosa|ABCA4-related retinopathy|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2|Syndromic retinitis pigmentosa|See cases|Cone dystrophy",single nucleotide variant,GRCh37
na,na,1,94008251,94008251,ABCA4,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance","MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|Severe early-childhood-onset retinal dystrophy|Cone-rod dystrophy 3|not provided|ABCA4-related disorder|Inborn genetic diseases|Macular dystrophy|Retinal dystrophy|Age related macular degeneration 2|Stargardt disease|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19|Retinitis pigmentosa 19|not specified|Retinitis pigmentosa|ABCA4-related retinopathy|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2|Syndromic retinitis pigmentosa|See cases|Cone dystrophy",single nucleotide variant,GRCh38
na,na,1,94528222,94528222,ABCA4,Pathogenic,Retinitis pigmentosa 19|not provided,Deletion,GRCh37
na,na,1,94062666,94062666,ABCA4,Pathogenic,Retinitis pigmentosa 19|not provided,Deletion,GRCh38
na,na,1,94473287,94473287,ABCA4,Conflicting classifications of pathogenicity,Stargardt disease|not provided|not specified|Severe early-childhood-onset retinal dystrophy|ABCA4-related disorder|Vitreoretinopathy|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,1,94007731,94007731,ABCA4,Conflicting classifications of pathogenicity,Stargardt disease|not provided|not specified|Severe early-childhood-onset retinal dystrophy|ABCA4-related disorder|Vitreoretinopathy|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,1,94473283,94473283,ABCA4,Pathogenic,Stargardt disease|not provided,single nucleotide variant,GRCh37
na,na,1,94007727,94007727,ABCA4,Pathogenic,Stargardt disease|not provided,single nucleotide variant,GRCh38
na,na,1,94508969,94508969,ABCA4,Pathogenic/Likely pathogenic,Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|ABCA4-related disorder|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3|Macular dystrophy|Stargardt disease|Retinitis pigmentosa|not specified|Age related macular degeneration 2|Optic atrophy|Retinitis pigmentosa 19;Cone-rod dystrophy 3,single nucleotide variant,GRCh37
na,na,1,94043413,94043413,ABCA4,Pathogenic/Likely pathogenic,Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|ABCA4-related disorder|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3|Macular dystrophy|Stargardt disease|Retinitis pigmentosa|not specified|Age related macular degeneration 2|Optic atrophy|Retinitis pigmentosa 19;Cone-rod dystrophy 3,single nucleotide variant,GRCh38
na,na,1,94546115,94546115,ABCA4,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,1,94080559,94080559,ABCA4,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,1,94564484,94564484,ABCA4,Pathogenic/Likely pathogenic,Severe early-childhood-onset retinal dystrophy|not provided|Cone-rod dystrophy 3|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3|Stargardt disease|Retinal dystrophy|Stargardt disease 3,single nucleotide variant,GRCh37
na,na,1,94098928,94098928,ABCA4,Pathogenic/Likely pathogenic,Severe early-childhood-onset retinal dystrophy|not provided|Cone-rod dystrophy 3|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3|Stargardt disease|Retinal dystrophy|Stargardt disease 3,single nucleotide variant,GRCh38
na,na,1,94586550,94586550,ABCA4,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|Stargardt disease 3,single nucleotide variant,GRCh37
na,na,1,94120994,94120994,ABCA4,Pathogenic,Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|Stargardt disease 3,single nucleotide variant,GRCh38
na,na,1,94528713,94528713,ABCA4,Conflicting classifications of pathogenicity,Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3,single nucleotide variant,GRCh37
na,na,1,94063157,94063157,ABCA4,Conflicting classifications of pathogenicity,Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3,single nucleotide variant,GRCh38
na,na,1,94528806,94528806,ABCA4,Conflicting classifications of pathogenicity,not provided|Retinitis pigmentosa|not specified|Severe early-childhood-onset retinal dystrophy|Age related macular degeneration 2|Retinal dystrophy|Macular dystrophy|Stargardt disease|ABCA4-related disorder,single nucleotide variant,GRCh37
na,na,1,94063250,94063250,ABCA4,Conflicting classifications of pathogenicity,not provided|Retinitis pigmentosa|not specified|Severe early-childhood-onset retinal dystrophy|Age related macular degeneration 2|Retinal dystrophy|Macular dystrophy|Stargardt disease|ABCA4-related disorder,single nucleotide variant,GRCh38
na,na,1,94517225,94517226,ABCA4,Pathogenic,Cone-rod dystrophy 3|not provided,Deletion,GRCh37
na,na,1,94051669,94051670,ABCA4,Pathogenic,Cone-rod dystrophy 3|not provided,Deletion,GRCh38
na,na,1,94505604,94505604,ABCA4,Benign/Likely benign,"Cone-rod dystrophy 3|not provided|not specified|Cone-Rod Dystrophy, Recessive|Macular degeneration|Stargardt Disease, Recessive|Retinitis Pigmentosa, Recessive|Severe early-childhood-onset retinal dystrophy|ABCA4-related disorder|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,1,94040048,94040048,ABCA4,Benign/Likely benign,"Cone-rod dystrophy 3|not provided|not specified|Cone-Rod Dystrophy, Recessive|Macular degeneration|Stargardt Disease, Recessive|Retinitis Pigmentosa, Recessive|Severe early-childhood-onset retinal dystrophy|ABCA4-related disorder|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,1,94496666,94496666,ABCA4,Pathogenic/Likely pathogenic,"Severe early-childhood-onset retinal dystrophy|MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|not provided|Mandibulofacial dysostosis with mental deficiency|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2|Stargardt disease|ABCA4-related disorder|Retinal dystrophy|Cone-rod dystrophy 3",single nucleotide variant,GRCh37
na,na,1,94031110,94031110,ABCA4,Pathogenic/Likely pathogenic,"Severe early-childhood-onset retinal dystrophy|MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|not provided|Mandibulofacial dysostosis with mental deficiency|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2|Stargardt disease|ABCA4-related disorder|Retinal dystrophy|Cone-rod dystrophy 3",single nucleotide variant,GRCh38
na,na,1,94512505,94512505,ABCA4,Pathogenic,Cone-rod dystrophy 3|not provided|Severe early-childhood-onset retinal dystrophy|Stargardt disease 3,Deletion,GRCh37
na,na,1,94046949,94046949,ABCA4,Pathogenic,Cone-rod dystrophy 3|not provided|Severe early-childhood-onset retinal dystrophy|Stargardt disease 3,Deletion,GRCh38
na,na,1,94544892,94544892,ABCA4,Pathogenic,"Retinal dystrophy, early-onset severe|not provided",Deletion,GRCh37
na,na,1,94079336,94079336,ABCA4,Pathogenic,"Retinal dystrophy, early-onset severe|not provided",Deletion,GRCh38
na,na,1,94471056,94471056,ABCA4,Pathogenic/Likely pathogenic,"Retinal dystrophy, early-onset severe|Retinal dystrophy|Severe early-childhood-onset retinal dystrophy|not provided|Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy;Retinitis pigmentosa 19;Age related macular degeneration 2|Stargardt disease|Retinitis pigmentosa 19|ABCA4-related retinopathy|Leber congenital amaurosis 14|ABCA4-related disorder",single nucleotide variant,GRCh37
na,na,1,94005500,94005500,ABCA4,Pathogenic/Likely pathogenic,"Retinal dystrophy, early-onset severe|Retinal dystrophy|Severe early-childhood-onset retinal dystrophy|not provided|Cone-rod dystrophy 3;Severe early-childhood-onset retinal dystrophy;Retinitis pigmentosa 19;Age related macular degeneration 2|Stargardt disease|Retinitis pigmentosa 19|ABCA4-related retinopathy|Leber congenital amaurosis 14|ABCA4-related disorder",single nucleotide variant,GRCh38
na,na,1,94481322,94481322,ABCA4,Pathogenic,Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy,single nucleotide variant,GRCh37
na,na,1,94015766,94015766,ABCA4,Pathogenic,Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy,single nucleotide variant,GRCh38
na,na,1,94505651,94505666,ABCA4,Pathogenic,Cone-rod dystrophy 3,Deletion,GRCh37
na,na,1,94040095,94040110,ABCA4,Pathogenic,Cone-rod dystrophy 3,Deletion,GRCh38
na,na,1,94474323,94474323,ABCA4,Pathogenic/Likely pathogenic,Stargardt disease|Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,1,94008767,94008767,ABCA4,Pathogenic/Likely pathogenic,Stargardt disease|Cone-rod dystrophy 3|Severe early-childhood-onset retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,1,94480221,94480221,ABCA4,Conflicting classifications of pathogenicity,Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|not specified|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2|Optic atrophy,single nucleotide variant,GRCh37
na,na,1,94014665,94014665,ABCA4,Conflicting classifications of pathogenicity,Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|not specified|Severe early-childhood-onset retinal dystrophy;Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2|Optic atrophy,single nucleotide variant,GRCh38
na,na,1,94512565,94512565,ABCA4,Conflicting classifications of pathogenicity,"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|Severe early-childhood-onset retinal dystrophy|not specified|not provided|Macular degeneration|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|Stargardt Disease, Recessive|Stargardt disease|ABCA4-related disorder|Stargardt disease 3|Retinal dystrophy|ABCA4-related retinopathy",single nucleotide variant,GRCh37
na,na,1,94047009,94047009,ABCA4,Conflicting classifications of pathogenicity,"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|Severe early-childhood-onset retinal dystrophy|not specified|not provided|Macular degeneration|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|Stargardt Disease, Recessive|Stargardt disease|ABCA4-related disorder|Stargardt disease 3|Retinal dystrophy|ABCA4-related retinopathy",single nucleotide variant,GRCh38
na,na,6,46677098,46677098,PLA2G7,Benign,Platelet-activating factor acetylhydrolase deficiency|PLA2G7-related disorder|not provided,single nucleotide variant,GRCh37
na,na,6,46709361,46709361,PLA2G7,Benign,Platelet-activating factor acetylhydrolase deficiency|PLA2G7-related disorder|not provided,single nucleotide variant,GRCh38
na,na,6,46679303,46679303,PLA2G7,Benign,RECLASSIFIED - MYOC POLYMORPHISM|PLA2G7-related disorder,single nucleotide variant,GRCh37
na,na,6,46711566,46711566,PLA2G7,Benign,RECLASSIFIED - MYOC POLYMORPHISM|PLA2G7-related disorder,single nucleotide variant,GRCh38
na,na,6,46672943,46672943,PLA2G7,Benign,RECLASSIFIED - MYOC POLYMORPHISM|not provided|PLA2G7-related disorder,single nucleotide variant,GRCh37
na,na,6,46705206,46705206,PLA2G7,Benign,RECLASSIFIED - MYOC POLYMORPHISM|not provided|PLA2G7-related disorder,single nucleotide variant,GRCh38
na,na,4,175429850,175429850,HPGD,Pathogenic,"Cranioosteoarthropathy|Hypertrophic osteoarthropathy, primary, autosomal recessive, 1|not provided",single nucleotide variant,GRCh37
na,na,4,174508699,174508699,HPGD,Pathogenic,"Cranioosteoarthropathy|Hypertrophic osteoarthropathy, primary, autosomal recessive, 1|not provided",single nucleotide variant,GRCh38
na,na,4,175439205,175439214,HPGD,Pathogenic,"Hypertrophic osteoarthropathy, primary, autosomal recessive, 1",Indel,GRCh37
na,na,4,174518054,174518063,HPGD,Pathogenic,"Hypertrophic osteoarthropathy, primary, autosomal recessive, 1",Indel,GRCh38
na,na,4,175443136,175443137,HPGD,Pathogenic,"Hypertrophic osteoarthropathy, primary, autosomal recessive, 1|Isolated congenital digital clubbing|not provided",Microsatellite,GRCh37
na,na,4,174521985,174521986,HPGD,Pathogenic,"Hypertrophic osteoarthropathy, primary, autosomal recessive, 1|Isolated congenital digital clubbing|not provided",Microsatellite,GRCh38
na,na,4,175414387,175414387,HPGD,Likely pathogenic,Isolated congenital digital clubbing|not provided,single nucleotide variant,GRCh37
na,na,4,174493236,174493236,HPGD,Likely pathogenic,Isolated congenital digital clubbing|not provided,single nucleotide variant,GRCh38
na,na,17,39023035,39023035,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh37
na,na,17,40866783,40866783,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh38
na,na,17,39023012,39023012,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh37
na,na,17,40866760,40866760,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh38
na,na,17,39023036,39023036,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh37
na,na,17,40866784,40866784,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh38
na,na,17,39023035,39023035,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh37
na,na,17,40866783,40866783,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh38
na,na,17,39019406,39019406,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh37
na,na,17,40863154,40863154,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh38
na,na,17,39023020,39023020,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh37
na,na,17,40866768,40866768,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh38
na,na,17,39023053,39023053,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh37
na,na,17,40866801,40866801,KRT12,Pathogenic,"Corneal dystrophy, Meesmann, 1|not provided",single nucleotide variant,GRCh38
na,na,2,96953706,96953706,SNRNP200,Pathogenic,Retinitis pigmentosa 33|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,96287968,96287968,SNRNP200,Pathogenic,Retinitis pigmentosa 33|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,8,72184037,72184037,EYA1,Pathogenic,Branchiootorenal syndrome 1|Rare genetic deafness|not provided|Melnick-Fraser syndrome|EYA1-related disorder|Otofaciocervical syndrome 1;Branchiootic syndrome 1;Branchiootorenal syndrome 1,single nucleotide variant,GRCh37
na,na,8,71271802,71271802,EYA1,Pathogenic,Branchiootorenal syndrome 1|Rare genetic deafness|not provided|Melnick-Fraser syndrome|EYA1-related disorder|Otofaciocervical syndrome 1;Branchiootic syndrome 1;Branchiootorenal syndrome 1,single nucleotide variant,GRCh38
na,na,8,72128937,72128937,EYA1,Pathogenic,Branchiootorenal syndrome 1,Indel,GRCh37
na,na,8,71216702,71216702,EYA1,Pathogenic,Branchiootorenal syndrome 1,Indel,GRCh38
na,na,8,72182051,72182052,EYA1,Pathogenic,Branchiootic syndrome 1,Microsatellite,GRCh37
na,na,8,71269816,71269817,EYA1,Pathogenic,Branchiootic syndrome 1,Microsatellite,GRCh38
na,na,8,72233982,72233989,EYA1,Pathogenic,Branchiootic syndrome 1,Deletion,GRCh37
na,na,8,71321747,71321754,EYA1,Pathogenic,Branchiootic syndrome 1,Deletion,GRCh38
na,na,na,-1,-1,EYA1,Pathogenic,Branchiootorenal syndrome 1,Insertion,na
na,na,8,72123391,72123394,EYA1,Pathogenic,Branchiootorenal syndrome 1,Deletion,GRCh37
na,na,8,71211156,71211159,EYA1,Pathogenic,Branchiootorenal syndrome 1,Deletion,GRCh38
na,na,8,72128968,72128968,EYA1,Pathogenic/Likely pathogenic,Branchiootorenal syndrome 1|Rare genetic deafness|Melnick-Fraser syndrome|Branchiooculofacial syndrome|Branchiootic syndrome 1|EYA1-related disorder|Otofaciocervical syndrome 1;Branchiootorenal syndrome 1;Branchiootic syndrome 1,single nucleotide variant,GRCh37
na,na,8,71216733,71216733,EYA1,Pathogenic/Likely pathogenic,Branchiootorenal syndrome 1|Rare genetic deafness|Melnick-Fraser syndrome|Branchiooculofacial syndrome|Branchiootic syndrome 1|EYA1-related disorder|Otofaciocervical syndrome 1;Branchiootorenal syndrome 1;Branchiootic syndrome 1,single nucleotide variant,GRCh38
na,na,8,72123450,72123450,EYA1,Pathogenic,Anterior segment anomalies and cataract,single nucleotide variant,GRCh37
na,na,8,71211215,71211215,EYA1,Pathogenic,Anterior segment anomalies and cataract,single nucleotide variant,GRCh38
na,na,8,72156891,72156891,EYA1,Pathogenic,Abnormal anterior chamber morphology,single nucleotide variant,GRCh37
na,na,8,71244656,71244656,EYA1,Pathogenic,Abnormal anterior chamber morphology,single nucleotide variant,GRCh38
na,na,8,72129011,72129011,EYA1,Conflicting classifications of pathogenicity,not provided|Branchiootorenal syndrome with cataract|Otofaciocervical syndrome 1|Branchiootic syndrome 1|Branchiootorenal syndrome 1|not specified|Inborn genetic diseases|Melnick-Fraser syndrome,single nucleotide variant,GRCh37
na,na,8,71216776,71216776,EYA1,Conflicting classifications of pathogenicity,not provided|Branchiootorenal syndrome with cataract|Otofaciocervical syndrome 1|Branchiootic syndrome 1|Branchiootorenal syndrome 1|not specified|Inborn genetic diseases|Melnick-Fraser syndrome,single nucleotide variant,GRCh38
na,na,8,72229853,72229854,EYA1,Pathogenic,Branchiootorenal syndrome 1,Duplication,GRCh37
na,na,8,71317618,71317619,EYA1,Pathogenic,Branchiootorenal syndrome 1,Duplication,GRCh38
na,na,8,72127865,72127865,EYA1,Pathogenic,Branchiootorenal syndrome 1|Melnick-Fraser syndrome|EYA1-related disorder,single nucleotide variant,GRCh37
na,na,8,71215630,71215630,EYA1,Pathogenic,Branchiootorenal syndrome 1|Melnick-Fraser syndrome|EYA1-related disorder,single nucleotide variant,GRCh38
na,na,8,72127705,72127705,EYA1,Pathogenic,Branchiootorenal syndrome 1,single nucleotide variant,GRCh37
na,na,8,71215470,71215470,EYA1,Pathogenic,Branchiootorenal syndrome 1,single nucleotide variant,GRCh38
na,na,8,72211872,72211872,EYA1,Pathogenic,Otofaciocervical syndrome 1|Melnick-Fraser syndrome,single nucleotide variant,GRCh37
na,na,8,71299637,71299637,EYA1,Pathogenic,Otofaciocervical syndrome 1|Melnick-Fraser syndrome,single nucleotide variant,GRCh38
na,na,8,72156897,72156897,EYA1,Pathogenic,Branchiootic syndrome 1|Branchiootorenal syndrome 1|Inborn genetic diseases|not provided|Melnick-Fraser syndrome|Branchiootic syndrome 1;Otofaciocervical syndrome 1;Branchiootorenal syndrome 1|EYA1-related disorder,single nucleotide variant,GRCh37
na,na,8,71244662,71244662,EYA1,Pathogenic,Branchiootic syndrome 1|Branchiootorenal syndrome 1|Inborn genetic diseases|not provided|Melnick-Fraser syndrome|Branchiootic syndrome 1;Otofaciocervical syndrome 1;Branchiootorenal syndrome 1|EYA1-related disorder,single nucleotide variant,GRCh38
na,na,8,72127712,72127718,EYA1,Pathogenic,Branchiootic syndrome 1,Deletion,GRCh37
na,na,8,71215477,71215483,EYA1,Pathogenic,Branchiootic syndrome 1,Deletion,GRCh38
na,na,8,72183988,72183988,EYA1,Pathogenic,Branchiootorenal syndrome 1|Melnick-Fraser syndrome|not provided,single nucleotide variant,GRCh37
na,na,8,71271753,71271753,EYA1,Pathogenic,Branchiootorenal syndrome 1|Melnick-Fraser syndrome|not provided,single nucleotide variant,GRCh38
na,na,1,171605271,171605271,MYOC,Pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636131,171636131,MYOC,Pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605489,171605489,MYOC,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636349,171636349,MYOC,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605471,171605471,MYOC,Pathogenic,"Glaucoma 1, open angle, A|not provided|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636331,171636331,MYOC,Pathogenic,"Glaucoma 1, open angle, A|not provided|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605478,171605478,MYOC,Pathogenic,"Glaucoma 1, open angle, A|Primary open angle glaucoma|not provided|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636338,171636338,MYOC,Pathogenic,"Glaucoma 1, open angle, A|Primary open angle glaucoma|not provided|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605150,171605150,MYOC,Uncertain significance,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636010,171636010,MYOC,Uncertain significance,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605140,171605140,MYOC,Pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood|not provided",single nucleotide variant,GRCh37
na,na,1,171636000,171636000,MYOC,Pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood|not provided",single nucleotide variant,GRCh38
na,na,1,171605481,171605481,MYOC,Pathogenic,"Glaucoma 1, open angle, A|not provided|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636341,171636341,MYOC,Pathogenic,"Glaucoma 1, open angle, A|not provided|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605570,171605570,MYOC,Uncertain significance,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636430,171636430,MYOC,Uncertain significance,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605313,171605313,MYOC,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636173,171636173,MYOC,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171621616,171621616,MYOC,Likely benign,"Glaucoma 1, open angle, A|Glaucoma of childhood|not provided|Glaucoma|RECLASSIFIED - MYOC POLYMORPHISM",single nucleotide variant,GRCh37
na,na,1,171652476,171652476,MYOC,Likely benign,"Glaucoma 1, open angle, A|Glaucoma of childhood|not provided|Glaucoma|RECLASSIFIED - MYOC POLYMORPHISM",single nucleotide variant,GRCh38
na,na,1,171605283,171605283,MYOC,Pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636143,171636143,MYOC,Pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605384,171605384,MYOC,Uncertain significance,"GLAUCOMA 1, OPEN ANGLE, A, DIGENIC|Glaucoma of childhood|not provided",single nucleotide variant,GRCh37
na,na,1,171636244,171636244,MYOC,Uncertain significance,"GLAUCOMA 1, OPEN ANGLE, A, DIGENIC|Glaucoma of childhood|not provided",single nucleotide variant,GRCh38
na,na,1,171621608,171621608,MYOC,Likely benign,"Glaucoma 1, open angle, A|GLAUCOMA 3, PRIMARY CONGENITAL, A, DIGENIC|MYOC-related disorder|Glaucoma of childhood|not provided",single nucleotide variant,GRCh37
na,na,1,171652468,171652468,MYOC,Likely benign,"Glaucoma 1, open angle, A|GLAUCOMA 3, PRIMARY CONGENITAL, A, DIGENIC|MYOC-related disorder|Glaucoma of childhood|not provided",single nucleotide variant,GRCh38
na,na,1,171605846,171605846,MYOC,Uncertain significance,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636706,171636706,MYOC,Uncertain significance,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605826,171605826,MYOC,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636686,171636686,MYOC,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,1,171605442,171605442,MYOC,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh37
na,na,1,171636302,171636302,MYOC,Likely pathogenic,"Glaucoma 1, open angle, A|Glaucoma of childhood",single nucleotide variant,GRCh38
na,na,5,69372372,69372372,SMN2,Conflicting classifications of pathogenicity,"Spinal muscular atrophy, modifier of|Kugelberg-Welander disease|Spinal muscular atrophy|not specified",single nucleotide variant,GRCh37
na,na,5,70076545,70076545,SMN2,Conflicting classifications of pathogenicity,"Spinal muscular atrophy, modifier of|Kugelberg-Welander disease|Spinal muscular atrophy|not specified",single nucleotide variant,GRCh38
na,na,15,25616012,25616012,UBE3A,Pathogenic,Angelman syndrome,single nucleotide variant,GRCh37
na,na,15,25370865,25370865,UBE3A,Pathogenic,Angelman syndrome,single nucleotide variant,GRCh38
na,na,15,25585366,25585366,UBE3A,Pathogenic,Angelman syndrome,single nucleotide variant,GRCh37
na,na,15,25340219,25340219,UBE3A,Pathogenic,Angelman syndrome,single nucleotide variant,GRCh38
na,na,15,25616945,25616945,UBE3A,Pathogenic,Angelman syndrome,single nucleotide variant,GRCh37
na,na,15,25371798,25371798,UBE3A,Pathogenic,Angelman syndrome,single nucleotide variant,GRCh38
na,na,15,25616872,25616872,UBE3A,Likely pathogenic,Angelman syndrome,single nucleotide variant,GRCh37
na,na,15,25371725,25371725,UBE3A,Likely pathogenic,Angelman syndrome,single nucleotide variant,GRCh38
na,na,15,25584200,25584201,UBE3A,Pathogenic,Angelman syndrome,Duplication,GRCh37
na,na,15,25339053,25339054,UBE3A,Pathogenic,Angelman syndrome,Duplication,GRCh38
na,na,7,19156636,19156637,TWIST1,Pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|Inborn genetic diseases,Duplication,GRCh37
na,na,7,19117013,19117014,TWIST1,Pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|Inborn genetic diseases,Duplication,GRCh38
na,na,7,19156589,19156589,TWIST1,Pathogenic,Saethre-Chotzen syndrome,single nucleotide variant,GRCh37
na,na,7,19116966,19116966,TWIST1,Pathogenic,Saethre-Chotzen syndrome,single nucleotide variant,GRCh38
na,na,7,19156636,19156636,TWIST1,Pathogenic,Saethre-Chotzen syndrome,single nucleotide variant,GRCh37
na,na,7,19117013,19117013,TWIST1,Pathogenic,Saethre-Chotzen syndrome,single nucleotide variant,GRCh38
na,na,7,19156577,19156577,TWIST1,Pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|not provided,single nucleotide variant,GRCh37
na,na,7,19116954,19116954,TWIST1,Pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|not provided,single nucleotide variant,GRCh38
na,na,7,19156569,19156569,TWIST1,Pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|not provided,single nucleotide variant,GRCh37
na,na,7,19116946,19116946,TWIST1,Pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|not provided,single nucleotide variant,GRCh38
na,na,7,19156553,19156553,TWIST1,Pathogenic,Saethre-Chotzen syndrome,single nucleotide variant,GRCh37
na,na,7,19116930,19116930,TWIST1,Pathogenic,Saethre-Chotzen syndrome,single nucleotide variant,GRCh38
na,na,7,19156404,19156404,TWIST1,Pathogenic,Saethre-Chotzen syndrome,single nucleotide variant,GRCh37
na,na,7,19116781,19116781,TWIST1,Pathogenic,Saethre-Chotzen syndrome,single nucleotide variant,GRCh38
na,na,7,19156484,19156485,TWIST1,Pathogenic,Robinow-Sorauf syndrome,Duplication,GRCh37
na,na,7,19116861,19116862,TWIST1,Pathogenic,Robinow-Sorauf syndrome,Duplication,GRCh38
na,na,7,19156479,19156479,TWIST1,Pathogenic/Likely pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis,single nucleotide variant,GRCh37
na,na,7,19116856,19116856,TWIST1,Pathogenic/Likely pathogenic,Saethre-Chotzen syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis,single nucleotide variant,GRCh38
na,na,7,19156863,19156863,TWIST1,Pathogenic,Saethre-Chotzen syndrome with eyelid anomalies|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis,single nucleotide variant,GRCh37
na,na,7,19117240,19117240,TWIST1,Pathogenic,Saethre-Chotzen syndrome with eyelid anomalies|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis,single nucleotide variant,GRCh38
na,na,7,19156734,19156734,TWIST1,Pathogenic,Robinow-Sorauf syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|TWIST1-related craniosynostosis,single nucleotide variant,GRCh37
na,na,7,19117111,19117111,TWIST1,Pathogenic,Robinow-Sorauf syndrome|Saethre-Chotzen syndrome;TWIST1-related craniosynostosis|TWIST1-related craniosynostosis,single nucleotide variant,GRCh38
na,na,7,19156389,19156389,TWIST1,Pathogenic,TWIST1-related craniosynostosis,single nucleotide variant,GRCh37
na,na,7,19116766,19116766,TWIST1,Pathogenic,TWIST1-related craniosynostosis,single nucleotide variant,GRCh38
na,na,7,19156382,19156382,TWIST1,Uncertain significance,TWIST1-related craniosynostosis,single nucleotide variant,GRCh37
na,na,7,19116759,19116759,TWIST1,Uncertain significance,TWIST1-related craniosynostosis,single nucleotide variant,GRCh38
na,na,12,115120779,115120779,TBX3,Pathogenic,Ulnar-mammary syndrome,Deletion,GRCh37
na,na,12,114682974,114682974,TBX3,Pathogenic,Ulnar-mammary syndrome,Deletion,GRCh38
na,na,12,115118683,115118683,TBX3,Pathogenic,Ulnar-mammary syndrome,single nucleotide variant,GRCh37
na,na,12,114680878,114680878,TBX3,Pathogenic,Ulnar-mammary syndrome,single nucleotide variant,GRCh38
na,na,12,115115449,115115449,TBX3,Pathogenic,Ulnar-mammary syndrome,single nucleotide variant,GRCh37
na,na,12,114677644,114677644,TBX3,Pathogenic,Ulnar-mammary syndrome,single nucleotide variant,GRCh38
na,na,12,115120917,115120918,TBX3,Pathogenic,Ulnar-mammary syndrome,Duplication,GRCh37
na,na,12,114683112,114683113,TBX3,Pathogenic,Ulnar-mammary syndrome,Duplication,GRCh38
na,na,12,114839668,114839668,TBX5,Pathogenic,Holt-Oram syndrome|not provided,single nucleotide variant,GRCh37
na,na,12,114401863,114401863,TBX5,Pathogenic,Holt-Oram syndrome|not provided,single nucleotide variant,GRCh38
na,na,12,114823326,114823326,TBX5,Pathogenic/Likely pathogenic,Holt-Oram syndrome|not provided|Aortic valve disease 2|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,12,114385521,114385521,TBX5,Pathogenic/Likely pathogenic,Holt-Oram syndrome|not provided|Aortic valve disease 2|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,12,114839635,114839635,TBX5,Pathogenic,Holt-Oram syndrome,single nucleotide variant,GRCh37
na,na,12,114401830,114401830,TBX5,Pathogenic,Holt-Oram syndrome,single nucleotide variant,GRCh38
na,na,12,114823327,114823327,TBX5,Pathogenic,"Holt-Oram syndrome|Heart, malformation of|Aortic valve disease 2|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,12,114385522,114385522,TBX5,Pathogenic,"Holt-Oram syndrome|Heart, malformation of|Aortic valve disease 2|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,12,114836472,114836472,TBX5,Pathogenic,Holt-Oram syndrome,Deletion,GRCh37
na,na,12,114398667,114398667,TBX5,Pathogenic,Holt-Oram syndrome,Deletion,GRCh38
na,na,12,114841559,114841559,TBX5,Pathogenic,Holt-Oram syndrome,single nucleotide variant,GRCh37
na,na,12,114403754,114403754,TBX5,Pathogenic,Holt-Oram syndrome,single nucleotide variant,GRCh38
na,na,12,114839712,114839712,TBX5,Pathogenic,Holt-Oram syndrome,single nucleotide variant,GRCh37
na,na,12,114401907,114401907,TBX5,Pathogenic,Holt-Oram syndrome,single nucleotide variant,GRCh38
na,na,12,114836480,114836480,TBX5,Pathogenic/Likely pathogenic,Holt-Oram syndrome|TBX5-related disorder,single nucleotide variant,GRCh37
na,na,12,114398675,114398675,TBX5,Pathogenic/Likely pathogenic,Holt-Oram syndrome|TBX5-related disorder,single nucleotide variant,GRCh38
na,na,20,62680560,62680560,SOX18,Pathogenic,Hypotrichosis-lymphedema-telangiectasia syndrome,single nucleotide variant,GRCh37
na,na,20,64049207,64049207,SOX18,Pathogenic,Hypotrichosis-lymphedema-telangiectasia syndrome,single nucleotide variant,GRCh38
na,na,20,62680587,62680587,SOX18,Pathogenic,Hypotrichosis-lymphedema-telangiectasia syndrome,single nucleotide variant,GRCh37
na,na,20,64049234,64049234,SOX18,Pathogenic,Hypotrichosis-lymphedema-telangiectasia syndrome,single nucleotide variant,GRCh38
na,na,20,62679954,62679954,SOX18,Likely pathogenic,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,64048601,64048601,SOX18,Likely pathogenic,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome|not provided,single nucleotide variant,GRCh38
na,na,12,56117812,56117812,RDH5,Pathogenic/Likely pathogenic,"Fundus albipunctatus, autosomal recessive|not provided|Pigmentary retinal dystrophy|Congenital stationary night blindness|See cases|RDH5-related disorder|Retinal dystrophy|Retinitis punctata albescens",single nucleotide variant,GRCh37
na,na,12,55724028,55724028,RDH5,Pathogenic/Likely pathogenic,"Fundus albipunctatus, autosomal recessive|not provided|Pigmentary retinal dystrophy|Congenital stationary night blindness|See cases|RDH5-related disorder|Retinal dystrophy|Retinitis punctata albescens",single nucleotide variant,GRCh38
na,na,12,56115186,56115186,RDH5,Uncertain significance,"Fundus albipunctatus, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,12,55721402,55721402,RDH5,Uncertain significance,"Fundus albipunctatus, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,12,56118211,56118211,RDH5,Pathogenic/Likely pathogenic,"Fundus albipunctatus, autosomal recessive|Congenital stationary night blindness|not provided|Pigmentary retinal dystrophy",single nucleotide variant,GRCh37
na,na,12,55724427,55724427,RDH5,Pathogenic/Likely pathogenic,"Fundus albipunctatus, autosomal recessive|Congenital stationary night blindness|not provided|Pigmentary retinal dystrophy",single nucleotide variant,GRCh38
na,na,12,56118252,56118252,RDH5,Pathogenic,"Pigmentary retinal dystrophy|Fundus albipunctatus, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,12,55724468,55724468,RDH5,Pathogenic,"Pigmentary retinal dystrophy|Fundus albipunctatus, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,12,56115692,56115692,RDH5,Pathogenic,"Fundus albipunctatus, autosomal recessive",single nucleotide variant,GRCh37
na,na,12,55721908,55721908,RDH5,Pathogenic,"Fundus albipunctatus, autosomal recessive",single nucleotide variant,GRCh38
na,na,12,56118213,56118213,RDH5,Pathogenic,"Fundus albipunctatus, autosomal recessive",single nucleotide variant,GRCh37
na,na,12,55724429,55724429,RDH5,Pathogenic,"Fundus albipunctatus, autosomal recessive",single nucleotide variant,GRCh38
na,na,12,56118300,56118300,RDH5,Pathogenic,"Fundus albipunctatus, autosomal recessive|not provided|Pigmentary retinal dystrophy",Indel,GRCh37
na,na,12,55724516,55724516,RDH5,Pathogenic,"Fundus albipunctatus, autosomal recessive|not provided|Pigmentary retinal dystrophy",Indel,GRCh38
na,na,12,56115631,56115631,RDH5,Pathogenic,"Fundus albipunctatus, autosomal recessive|not provided|Pigmentary retinal dystrophy",single nucleotide variant,GRCh37
na,na,12,55721847,55721847,RDH5,Pathogenic,"Fundus albipunctatus, autosomal recessive|not provided|Pigmentary retinal dystrophy",single nucleotide variant,GRCh38
na,na,16,2335500,2335500,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency|not provided,single nucleotide variant,GRCh37
na,na,16,2285499,2285499,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency|not provided,single nucleotide variant,GRCh38
na,na,16,2376028,2376028,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh37
na,na,16,2326027,2326027,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh38
na,na,16,2328349,2328349,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh37
na,na,16,2278348,2278348,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh38
na,na,16,2328017,2328017,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh37
na,na,16,2278016,2278016,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh38
na,na,16,2349443,2349443,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh37
na,na,16,2299442,2299442,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh38
na,na,16,2327879,2327879,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh37
na,na,16,2277878,2277878,ABCA3,Pathogenic,Interstitial lung disease due to ABCA3 deficiency,single nucleotide variant,GRCh38
na,na,16,2367662,2367662,ABCA3,Uncertain significance,Interstitial lung disease due to ABCA3 deficiency|not specified,single nucleotide variant,GRCh37
na,na,16,2317661,2317661,ABCA3,Uncertain significance,Interstitial lung disease due to ABCA3 deficiency|not specified,single nucleotide variant,GRCh38
na,na,4,108911206,108911206,HADH,Likely risk allele,Deficiency of 3-hydroxyacyl-CoA dehydrogenase|Hyperinsulinemic hypoglycemia,single nucleotide variant,GRCh37
na,na,4,107990050,107990050,HADH,Likely risk allele,Deficiency of 3-hydroxyacyl-CoA dehydrogenase|Hyperinsulinemic hypoglycemia,single nucleotide variant,GRCh38
na,na,4,108930953,108930953,HADH,Uncertain significance/Uncertain risk allele,"Deficiency of 3-hydroxyacyl-CoA dehydrogenase|Hyperinsulinemic hypoglycemia, familial, 4|Hyperinsulinemic hypoglycemia",single nucleotide variant,GRCh37
na,na,4,108009797,108009797,HADH,Uncertain significance/Uncertain risk allele,"Deficiency of 3-hydroxyacyl-CoA dehydrogenase|Hyperinsulinemic hypoglycemia, familial, 4|Hyperinsulinemic hypoglycemia",single nucleotide variant,GRCh38
na,na,4,108954395,108954395,HADH,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 4",single nucleotide variant,GRCh37
na,na,4,108033239,108033239,HADH,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 4",single nucleotide variant,GRCh38
na,na,4,108944625,108944630,HADH,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 4",Deletion,GRCh37
na,na,4,108023469,108023474,HADH,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 4",Deletion,GRCh38
na,na,22,24167567,24167567,SMARCB1,Pathogenic,"Malignant rhabdoid tumor, somatic",Deletion,GRCh37
na,na,22,23825380,23825380,SMARCB1,Pathogenic,"Malignant rhabdoid tumor, somatic",Deletion,GRCh38
na,na,na,-1,-1,SMARCB1,Pathogenic,"Malignant rhabdoid tumor, somatic",Deletion,na
na,na,22,24145570,24145570,SMARCB1,Pathogenic,Rhabdoid tumor predisposition syndrome 1,Deletion,GRCh37
na,na,22,23803383,23803383,SMARCB1,Pathogenic,Rhabdoid tumor predisposition syndrome 1,Deletion,GRCh38
na,na,22,24167603,24167603,SMARCB1,Likely pathogenic,Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,22,23825416,23825416,SMARCB1,Likely pathogenic,Rhabdoid tumor predisposition syndrome 1|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,22,24129390,24129390,SMARCB1,Pathogenic,SMARCB1-related schwannomatosis|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,22,23787203,23787203,SMARCB1,Pathogenic,SMARCB1-related schwannomatosis|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,22,24145525,24145525,SMARCB1,Pathogenic,"Schwannomatosis 1, somatic",single nucleotide variant,GRCh37
na,na,22,23803338,23803338,SMARCB1,Pathogenic,"Schwannomatosis 1, somatic",single nucleotide variant,GRCh38
na,na,22,24134052,24134065,SMARCB1,Pathogenic,SMARCB1-related schwannomatosis,Indel,GRCh37
na,na,22,23791865,23791878,SMARCB1,Pathogenic,SMARCB1-related schwannomatosis,Indel,GRCh38
na,na,22,24135742,24135748,SMARCB1,Pathogenic,SMARCB1-related schwannomatosis,Deletion,GRCh37
na,na,22,23793555,23793561,SMARCB1,Pathogenic,SMARCB1-related schwannomatosis,Deletion,GRCh38
na,na,22,24158592,24158593,SMARCB1,Pathogenic,SMARCB1-related schwannomatosis|Rhabdoid tumor predisposition syndrome 1,Duplication,GRCh37
na,na,22,23816405,23816406,SMARCB1,Pathogenic,SMARCB1-related schwannomatosis|Rhabdoid tumor predisposition syndrome 1,Duplication,GRCh38
na,na,22,24129448,24129448,SMARCB1,Conflicting classifications of pathogenicity,SMARCB1-related schwannomatosis|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,22,23787261,23787261,SMARCB1,Conflicting classifications of pathogenicity,SMARCB1-related schwannomatosis|not provided|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,19,18194272,18194272,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency|not provided|IL12RB1-related disorder,single nucleotide variant,GRCh37
na,na,19,18083462,18083462,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency|not provided|IL12RB1-related disorder,single nucleotide variant,GRCh38
na,na,19,18180419,18180419,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,single nucleotide variant,GRCh37
na,na,19,18069609,18069609,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,Deletion,na
na,na,19,18186622,18186622,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,single nucleotide variant,GRCh37
na,na,19,18075812,18075812,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,single nucleotide variant,GRCh38
na,na,19,18174031,18186197,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,Deletion,GRCh37
na,na,19,18063221,18075387,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,Deletion,GRCh38
na,na,19,18182921,18182921,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,single nucleotide variant,GRCh37
na,na,19,18072111,18072111,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,single nucleotide variant,GRCh38
na,na,19,18186667,18186667,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,single nucleotide variant,GRCh37
na,na,19,18075857,18075857,IL12RB1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,single nucleotide variant,GRCh38
na,na,6,50805690,50805690,TFAP2B,Pathogenic,Char syndrome,single nucleotide variant,GRCh37
na,na,6,50837977,50837977,TFAP2B,Pathogenic,Char syndrome,single nucleotide variant,GRCh38
na,na,6,50805764,50805764,TFAP2B,Likely pathogenic,Char syndrome|not provided,single nucleotide variant,GRCh37
na,na,6,50838051,50838051,TFAP2B,Likely pathogenic,Char syndrome|not provided,single nucleotide variant,GRCh38
na,na,6,50803878,50803878,TFAP2B,Pathogenic,Char syndrome,single nucleotide variant,GRCh37
na,na,6,50836165,50836165,TFAP2B,Pathogenic,Char syndrome,single nucleotide variant,GRCh38
na,na,6,50803878,50803878,TFAP2B,Pathogenic,Char syndrome,single nucleotide variant,GRCh37
na,na,6,50836165,50836165,TFAP2B,Pathogenic,Char syndrome,single nucleotide variant,GRCh38
na,na,6,50805720,50805720,TFAP2B,Pathogenic/Likely pathogenic,Char syndrome|not provided,single nucleotide variant,GRCh37
na,na,6,50838007,50838007,TFAP2B,Pathogenic/Likely pathogenic,Char syndrome|not provided,single nucleotide variant,GRCh38
na,na,6,50791256,50791256,TFAP2B,Pathogenic,Char syndrome,single nucleotide variant,GRCh37
na,na,6,50823543,50823543,TFAP2B,Pathogenic,Char syndrome,single nucleotide variant,GRCh38
na,na,2,215617178,215617178,BARD1,Benign/Likely benign,"Breast cancer, susceptibility to|Hereditary cancer-predisposing syndrome|not specified|Malignant tumor of breast|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|not provided",single nucleotide variant,GRCh37
na,na,2,214752454,214752454,BARD1,Benign/Likely benign,"Breast cancer, susceptibility to|Hereditary cancer-predisposing syndrome|not specified|Malignant tumor of breast|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|not provided",single nucleotide variant,GRCh38
na,na,11,47469631,47469631,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 4C|Congenital myasthenic syndrome|Congenital myasthenic syndrome 11|not provided|Fetal akinesia deformation sequence 1|Myopathy|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|Inborn genetic diseases|RAPSN-related disorder|Fetal akinesia deformation sequence 2;Congenital myasthenic syndrome 11,single nucleotide variant,GRCh37
na,na,11,47448079,47448079,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 4C|Congenital myasthenic syndrome|Congenital myasthenic syndrome 11|not provided|Fetal akinesia deformation sequence 1|Myopathy|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|Inborn genetic diseases|RAPSN-related disorder|Fetal akinesia deformation sequence 2;Congenital myasthenic syndrome 11,single nucleotide variant,GRCh38
na,na,11,47470476,47470476,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|not provided,single nucleotide variant,GRCh37
na,na,11,47448924,47448924,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|not provided,single nucleotide variant,GRCh38
na,na,11,47464344,47464345,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|RAPSN-related disorder|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2,Duplication,GRCh37
na,na,11,47442792,47442793,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|RAPSN-related disorder|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2,Duplication,GRCh38
na,na,11,47463268,47463268,RAPSN,Pathogenic,Congenital myasthenic syndrome 11,single nucleotide variant,GRCh37
na,na,11,47441716,47441716,RAPSN,Pathogenic,Congenital myasthenic syndrome 11,single nucleotide variant,GRCh38
na,na,11,47470726,47470726,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2;Congenital myasthenic syndrome 11|Abnormality of the musculature|Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh37
na,na,11,47449174,47449174,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2;Congenital myasthenic syndrome 11|Abnormality of the musculature|Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh38
na,na,11,47463227,47463227,RAPSN,Conflicting classifications of pathogenicity,Congenital myasthenic syndrome 11|not provided|Global developmental delay|Fetal akinesia deformation sequence 2|RAPSN-related disorder|Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1,single nucleotide variant,GRCh37
na,na,11,47441675,47441675,RAPSN,Conflicting classifications of pathogenicity,Congenital myasthenic syndrome 11|not provided|Global developmental delay|Fetal akinesia deformation sequence 2|RAPSN-related disorder|Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1,single nucleotide variant,GRCh38
na,na,11,47469717,47469717,RAPSN,Conflicting classifications of pathogenicity,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome,single nucleotide variant,GRCh37
na,na,11,47448165,47448165,RAPSN,Conflicting classifications of pathogenicity,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome,single nucleotide variant,GRCh38
na,na,11,47469405,47469405,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Myopathy|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 2|Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh37
na,na,11,47447853,47447853,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Myopathy|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 2|Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh38
na,na,11,47470384,47470384,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|not provided|Congenital myasthenic syndrome|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh37
na,na,11,47448832,47448832,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|not provided|Congenital myasthenic syndrome|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh38
na,na,11,47469411,47469411,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh37
na,na,11,47447859,47447859,RAPSN,Pathogenic/Likely pathogenic,Congenital myasthenic syndrome 11|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 2|Congenital myasthenic syndrome 11;Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh38
na,na,11,47469479,47469479,RAPSN,Pathogenic,Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh37
na,na,11,47447927,47447927,RAPSN,Pathogenic,Fetal akinesia deformation sequence 2,single nucleotide variant,GRCh38
na,na,11,47464332,47464332,RAPSN,Uncertain significance,Fetal akinesia deformation sequence 2|not specified,single nucleotide variant,GRCh37
na,na,11,47442780,47442780,RAPSN,Uncertain significance,Fetal akinesia deformation sequence 2|not specified,single nucleotide variant,GRCh38
na,na,3,13860617,13860617,WNT7A,Likely pathogenic,Schinzel phocomelia syndrome,single nucleotide variant,GRCh37
na,na,3,13819120,13819120,WNT7A,Likely pathogenic,Schinzel phocomelia syndrome,single nucleotide variant,GRCh38
na,na,3,13896274,13896274,WNT7A,Pathogenic,Fuhrmann syndrome,single nucleotide variant,GRCh37
na,na,3,13854777,13854777,WNT7A,Pathogenic,Fuhrmann syndrome,single nucleotide variant,GRCh38
na,na,18,57026387,57026388,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",Duplication,GRCh37
na,na,18,59359155,59359156,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",Duplication,GRCh38
na,na,18,57005990,57005990,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",single nucleotide variant,GRCh37
na,na,18,59338758,59338758,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",single nucleotide variant,GRCh38
na,na,18,57014771,57014771,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",Deletion,GRCh37
na,na,18,59347539,59347539,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",Deletion,GRCh38
na,na,18,57000341,57000341,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1|LMAN1-related disorder",Deletion,GRCh37
na,na,18,59333109,59333109,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1|LMAN1-related disorder",Deletion,GRCh38
na,na,18,57026475,57026475,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",single nucleotide variant,GRCh37
na,na,18,59359243,59359243,LMAN1,Pathogenic,"Factor V and factor VIII, combined deficiency of, type 1",single nucleotide variant,GRCh38
na,na,13,111372083,111372083,ING1,Pathogenic,Squamous cell carcinoma of the head and neck,single nucleotide variant,GRCh37
na,na,13,110719736,110719736,ING1,Pathogenic,Squamous cell carcinoma of the head and neck,single nucleotide variant,GRCh38
na,na,13,111372086,111372086,ING1,Pathogenic,Squamous cell carcinoma of the head and neck,single nucleotide variant,GRCh37
na,na,13,110719739,110719739,ING1,Pathogenic,Squamous cell carcinoma of the head and neck,single nucleotide variant,GRCh38
na,na,13,111372014,111372014,ING1,Pathogenic,Squamous cell carcinoma of the head and neck,single nucleotide variant,GRCh37
na,na,13,110719667,110719667,ING1,Pathogenic,Squamous cell carcinoma of the head and neck,single nucleotide variant,GRCh38
na,na,7,142481892,142481892,PRSS2,protective,"Pancreatitis, chronic, protection against",single nucleotide variant,GRCh37
na,na,7,142774035,142774035,PRSS2,protective,"Pancreatitis, chronic, protection against",single nucleotide variant,GRCh38
na,na,6,16327918,16327953,ATXN1,Pathogenic,Spinocerebellar ataxia type 1,Microsatellite,GRCh37
na,na,6,16327687,16327722,ATXN1,Pathogenic,Spinocerebellar ataxia type 1,Microsatellite,GRCh38
na,na,2,56098226,56098226,EFEMP1,Pathogenic/Likely pathogenic,not provided|Doyne honeycomb retinal dystrophy|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,55871091,55871091,EFEMP1,Pathogenic/Likely pathogenic,not provided|Doyne honeycomb retinal dystrophy|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,17,2573503,2573503,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation|not provided,single nucleotide variant,GRCh37
na,na,17,2670209,2670209,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation|not provided,single nucleotide variant,GRCh38
na,na,17,2577499,2577499,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation|not provided,single nucleotide variant,GRCh37
na,na,17,2674205,2674205,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation|not provided,single nucleotide variant,GRCh38
na,na,17,2579886,2579907,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation,Deletion,GRCh37
na,na,17,2676592,2676613,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation,Deletion,GRCh38
na,na,17,2573562,2573562,PAFAH1B1,Pathogenic,Subcortical band heterotopia,single nucleotide variant,GRCh37
na,na,17,2670268,2670268,PAFAH1B1,Pathogenic,Subcortical band heterotopia,single nucleotide variant,GRCh38
na,na,17,2579847,2579847,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation,single nucleotide variant,GRCh37
na,na,17,2676553,2676553,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation,single nucleotide variant,GRCh38
na,na,17,2568725,2568725,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation,single nucleotide variant,GRCh37
na,na,17,2665431,2665431,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation,single nucleotide variant,GRCh38
na,na,17,2573541,2573541,PAFAH1B1,Pathogenic/Likely pathogenic,Lissencephaly due to LIS1 mutation|not provided,single nucleotide variant,GRCh37
na,na,17,2670247,2670247,PAFAH1B1,Pathogenic/Likely pathogenic,Lissencephaly due to LIS1 mutation|not provided,single nucleotide variant,GRCh38
na,na,17,2577404,2577404,PAFAH1B1,Likely pathogenic,Subcortical band heterotopia|not provided,single nucleotide variant,GRCh37
na,na,17,2674110,2674110,PAFAH1B1,Likely pathogenic,Subcortical band heterotopia|not provided,single nucleotide variant,GRCh38
na,na,17,2541604,2541604,PAFAH1B1,Pathogenic/Likely pathogenic,Subcortical band heterotopia|Lissencephaly due to LIS1 mutation|Lissencephaly|Intellectual disability|not provided,single nucleotide variant,GRCh37
na,na,17,2638310,2638310,PAFAH1B1,Pathogenic/Likely pathogenic,Subcortical band heterotopia|Lissencephaly due to LIS1 mutation|Lissencephaly|Intellectual disability|not provided,single nucleotide variant,GRCh38
na,na,17,2577512,2577512,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation,single nucleotide variant,GRCh37
na,na,17,2674218,2674218,PAFAH1B1,Pathogenic,Lissencephaly due to LIS1 mutation,single nucleotide variant,GRCh38
na,na,4,111542411,111542411,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh37
na,na,4,110621255,110621255,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh38
na,na,4,111542315,111542315,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh37
na,na,4,110621159,110621159,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh38
na,na,4,111542370,111542370,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh37
na,na,4,110621214,110621214,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh38
na,na,4,111539855,111539855,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1|Anterior segment dysgenesis 4;Axenfeld-Rieger syndrome type 1|not provided,single nucleotide variant,GRCh37
na,na,4,110618699,110618699,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1|Anterior segment dysgenesis 4;Axenfeld-Rieger syndrome type 1|not provided,single nucleotide variant,GRCh38
na,na,4,111539825,111539825,PITX2,Pathogenic/Likely pathogenic,Axenfeld-Rieger syndrome type 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,4,110618669,110618669,PITX2,Pathogenic/Likely pathogenic,Axenfeld-Rieger syndrome type 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,4,111539698,111539698,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh37
na,na,4,110618542,110618542,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh38
na,na,4,111542322,111542322,PITX2,Pathogenic,Anterior segment dysgenesis 4|Anterior segment dysgenesis,single nucleotide variant,GRCh37
na,na,4,110621166,110621166,PITX2,Pathogenic,Anterior segment dysgenesis 4|Anterior segment dysgenesis,single nucleotide variant,GRCh38
na,na,4,111542366,111542366,PITX2,Pathogenic,Anterior segment dysgenesis 4|not provided,single nucleotide variant,GRCh37
na,na,4,110621210,110621210,PITX2,Pathogenic,Anterior segment dysgenesis 4|not provided,single nucleotide variant,GRCh38
na,na,4,111539846,111539846,PITX2,Pathogenic,"ANTERIOR SEGMENT DYSGENESIS 4, PETERS ANOMALY SUBTYPE",single nucleotide variant,GRCh37
na,na,4,110618690,110618690,PITX2,Pathogenic,"ANTERIOR SEGMENT DYSGENESIS 4, PETERS ANOMALY SUBTYPE",single nucleotide variant,GRCh38
na,na,4,111542325,111542325,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh37
na,na,4,110621169,110621169,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,single nucleotide variant,GRCh38
na,na,4,111542421,111542422,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,Duplication,GRCh37
na,na,4,110621265,110621266,PITX2,Pathogenic,Axenfeld-Rieger syndrome type 1,Duplication,GRCh38
na,na,4,111542387,111542387,PITX2,Pathogenic/Likely pathogenic,Ring dermoid of cornea|Anterior segment dysgenesis|Axenfeld-Rieger syndrome type 1|Anterior segment dysgenesis 4;Axenfeld-Rieger syndrome type 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,4,110621231,110621231,PITX2,Pathogenic/Likely pathogenic,Ring dermoid of cornea|Anterior segment dysgenesis|Axenfeld-Rieger syndrome type 1|Anterior segment dysgenesis 4;Axenfeld-Rieger syndrome type 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,5,177420033,177420033,PROP1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh37
na,na,5,177993032,177993032,PROP1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh38
na,na,5,177420042,177420042,PROP1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh37
na,na,5,177993041,177993041,PROP1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh38
na,na,5,177421298,177421299,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2",Deletion,GRCh37
na,na,5,177994297,177994298,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2",Deletion,GRCh38
na,na,5,177421147,177421148,PROP1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|Combined pituitary hormone deficiencies, genetic form|not provided|46,XY partial gonadal dysgenesis|PROP1-related disorder",Microsatellite,GRCh37
na,na,5,177994146,177994147,PROP1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|Combined pituitary hormone deficiencies, genetic form|not provided|46,XY partial gonadal dysgenesis|PROP1-related disorder",Microsatellite,GRCh38
na,na,5,177421186,177421186,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2",single nucleotide variant,GRCh37
na,na,5,177994185,177994185,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2",single nucleotide variant,GRCh38
na,na,5,177421325,177421337,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",Deletion,GRCh37
na,na,5,177994324,177994336,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",Deletion,GRCh38
na,na,5,177421299,177421299,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided|Combined pituitary hormone deficiencies, genetic form|See cases",Deletion,GRCh37
na,na,5,177994298,177994298,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided|Combined pituitary hormone deficiencies, genetic form|See cases",Deletion,GRCh38
na,na,5,177421231,177421231,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh37
na,na,5,177994230,177994230,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh38
na,na,5,177421232,177421232,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh37
na,na,5,177994231,177994231,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh38
na,na,5,177421154,177421154,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh37
na,na,5,177994153,177994153,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2|not provided",single nucleotide variant,GRCh38
na,na,5,177421153,177421153,PROP1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|Inborn genetic diseases|not provided|Combined pituitary hormone deficiencies, genetic form",single nucleotide variant,GRCh37
na,na,5,177994152,177994152,PROP1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 2|Inborn genetic diseases|not provided|Combined pituitary hormone deficiencies, genetic form",single nucleotide variant,GRCh38
na,na,5,177419809,177419809,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2",single nucleotide variant,GRCh37
na,na,5,177992808,177992808,PROP1,Pathogenic,"Pituitary hormone deficiency, combined, 2",single nucleotide variant,GRCh38
na,na,5,179263445,179263445,SQSTM1,Conflicting classifications of pathogenicity,"Paget disease of bone 3|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|not provided|Paget disease of bone 3;Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|Spastic paraplegia-Paget disease of bone syndrome|Amyotrophic lateral sclerosis|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset|Bone Paget disease",single nucleotide variant,GRCh37
na,na,5,179836445,179836445,SQSTM1,Conflicting classifications of pathogenicity,"Paget disease of bone 3|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|not provided|Paget disease of bone 3;Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|Spastic paraplegia-Paget disease of bone syndrome|Amyotrophic lateral sclerosis|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset|Bone Paget disease",single nucleotide variant,GRCh38
na,na,5,179263493,179263494,SQSTM1,Pathogenic,Paget disease of bone 3,Duplication,GRCh37
na,na,5,179836493,179836494,SQSTM1,Pathogenic,Paget disease of bone 3,Duplication,GRCh38
na,na,5,179260783,179260783,SQSTM1,Pathogenic,"Paget disease of bone 3|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset|Myopathy, distal, with rimmed vacuoles",single nucleotide variant,GRCh37
na,na,5,179833783,179833783,SQSTM1,Pathogenic,"Paget disease of bone 3|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset|Myopathy, distal, with rimmed vacuoles",single nucleotide variant,GRCh38
na,na,12,85677655,85677655,ALX1,Pathogenic,Frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome,single nucleotide variant,GRCh37
na,na,12,85283877,85283877,ALX1,Pathogenic,Frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome,single nucleotide variant,GRCh38
na,na,1,203155882,203155882,CHI3L1,risk factor,"Asthma-related traits, susceptibility to, 7",single nucleotide variant,GRCh37
na,na,1,203186754,203186754,CHI3L1,risk factor,"Asthma-related traits, susceptibility to, 7",single nucleotide variant,GRCh38
na,na,na,-1,-1,ATXN2,risk factor,"Amyotrophic lateral sclerosis, susceptibility to, 13",Microsatellite,na
na,na,13,102379135,102379135,FGF14,Pathogenic,Spinocerebellar ataxia 27A,single nucleotide variant,GRCh37
na,na,13,101726785,101726785,FGF14,Pathogenic,Spinocerebellar ataxia 27A,single nucleotide variant,GRCh38
na,na,13,102379082,102379082,FGF14,Pathogenic,Spinocerebellar ataxia 27A,Deletion,GRCh37
na,na,13,101726732,101726732,FGF14,Pathogenic,Spinocerebellar ataxia 27A,Deletion,GRCh38
na,na,7,128850341,128850341,SMO,Pathogenic,"Basal cell carcinoma, somatic",single nucleotide variant,GRCh37
na,na,7,129210500,129210500,SMO,Pathogenic,"Basal cell carcinoma, somatic",single nucleotide variant,GRCh38
na,na,7,128850838,128850838,SMO,Pathogenic,"Basal cell carcinoma, somatic",single nucleotide variant,GRCh37
na,na,7,129210997,129210997,SMO,Pathogenic,"Basal cell carcinoma, somatic",single nucleotide variant,GRCh38
na,na,6,42941740,42941740,PEX6,Likely pathogenic,Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder|Zellweger spectrum disorders,single nucleotide variant,GRCh37
na,na,6,42974002,42974002,PEX6,Likely pathogenic,Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder|Zellweger spectrum disorders,single nucleotide variant,GRCh38
na,na,6,42936027,42936027,PEX6,Pathogenic,Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder|Heimler syndrome 2,single nucleotide variant,GRCh37
na,na,6,42968289,42968289,PEX6,Pathogenic,Peroxisome biogenesis disorder 4A (Zellweger)|Peroxisome biogenesis disorder|Heimler syndrome 2,single nucleotide variant,GRCh38
na,na,6,42937472,42937472,PEX6,Pathogenic,Peroxisome biogenesis disorder 4A (Zellweger),Deletion,GRCh37
na,na,6,42969734,42969734,PEX6,Pathogenic,Peroxisome biogenesis disorder 4A (Zellweger),Deletion,GRCh38
na,na,6,42946005,42946268,PEX6,Pathogenic,Peroxisome biogenesis disorder 4B,Deletion,GRCh37
na,na,6,42978267,42978530,PEX6,Pathogenic,Peroxisome biogenesis disorder 4B,Deletion,GRCh38
na,na,6,42934263,42934263,PEX6,Uncertain significance,Peroxisome biogenesis disorder 4B,single nucleotide variant,GRCh37
na,na,6,42966525,42966525,PEX6,Uncertain significance,Peroxisome biogenesis disorder 4B,single nucleotide variant,GRCh38
na,na,16,1842316,1842316,IGFALS,Pathogenic,Short stature due to primary acid-labile subunit deficiency,Deletion,GRCh37
na,na,16,1792315,1792315,IGFALS,Pathogenic,Short stature due to primary acid-labile subunit deficiency,Deletion,GRCh38
na,na,16,1840801,1840801,IGFALS,Pathogenic,Short stature due to primary acid-labile subunit deficiency,single nucleotide variant,GRCh37
na,na,16,1790800,1790800,IGFALS,Pathogenic,Short stature due to primary acid-labile subunit deficiency,single nucleotide variant,GRCh38
na,na,16,1841827,1841828,IGFALS,Pathogenic,Short stature due to primary acid-labile subunit deficiency,Duplication,GRCh37
na,na,16,1791826,1791827,IGFALS,Pathogenic,Short stature due to primary acid-labile subunit deficiency,Duplication,GRCh38
na,na,3,12422848,12422848,PPARG,Uncertain significance,Morbid obesity|not provided|CAROTID INTIMAL MEDIAL THICKNESS 1;Type 2 diabetes mellitus;Inherited obesity;PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh37
na,na,3,12381349,12381349,PPARG,Uncertain significance,Morbid obesity|not provided|CAROTID INTIMAL MEDIAL THICKNESS 1;Type 2 diabetes mellitus;Inherited obesity;PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh38
na,na,3,12421238,12421238,PPARG,Benign,-,single nucleotide variant,GRCh37
na,na,3,12379739,12379739,PPARG,Benign,-,single nucleotide variant,GRCh38
na,na,3,12434182,12434182,PPARG,Pathogenic,Carcinoma of colon,Deletion,GRCh37
na,na,3,12392683,12392683,PPARG,Pathogenic,Carcinoma of colon,Deletion,GRCh38
na,na,3,12458324,12458324,PPARG,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh37
na,na,3,12416825,12416825,PPARG,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh38
na,na,3,12458422,12458422,PPARG,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh37
na,na,3,12416923,12416923,PPARG,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh38
na,na,3,12458330,12458330,PPARG,Uncertain significance,Carcinoma of colon|PPARG-related disorder,single nucleotide variant,GRCh37
na,na,3,12416831,12416831,PPARG,Uncertain significance,Carcinoma of colon|PPARG-related disorder,single nucleotide variant,GRCh38
na,na,3,12475610,12475610,PPARG,Pathogenic/Likely pathogenic,PPARG-related familial partial lipodystrophy|Lipodystrophy|not provided,single nucleotide variant,GRCh37
na,na,3,12434111,12434111,PPARG,Pathogenic/Likely pathogenic,PPARG-related familial partial lipodystrophy|Lipodystrophy|not provided,single nucleotide variant,GRCh38
na,na,3,12458335,12458335,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh37
na,na,3,12416836,12416836,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh38
na,na,3,12475557,12475557,PPARG,Benign/Likely benign,"Glioma susceptibility 1|not specified|INSULIN RESISTANCE, DIGENIC|PPARG-related familial partial lipodystrophy|Obesity|PPARG POLYMORPHISM|not provided",single nucleotide variant,GRCh37
na,na,3,12434058,12434058,PPARG,Benign/Likely benign,"Glioma susceptibility 1|not specified|INSULIN RESISTANCE, DIGENIC|PPARG-related familial partial lipodystrophy|Obesity|PPARG POLYMORPHISM|not provided",single nucleotide variant,GRCh38
na,na,3,12434186,12434188,PPARG,Pathogenic,"DIABETES MELLITUS, TYPE II, DIGENIC|INSULIN RESISTANCE, DIGENIC",Indel,GRCh37
na,na,3,12392687,12392689,PPARG,Pathogenic,"DIABETES MELLITUS, TYPE II, DIGENIC|INSULIN RESISTANCE, DIGENIC",Indel,GRCh38
na,na,3,12458547,12458547,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh37
na,na,3,12417048,12417048,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh38
na,na,3,12475399,12475399,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy|not provided,single nucleotide variant,GRCh37
na,na,3,12433900,12433900,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy|not provided,single nucleotide variant,GRCh38
na,na,3,12434200,12434200,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh37
na,na,3,12392701,12392701,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh38
na,na,3,12434212,12434212,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh37
na,na,3,12392713,12392713,PPARG,Pathogenic,PPARG-related familial partial lipodystrophy,single nucleotide variant,GRCh38
na,na,3,16639676,16639676,DAZL,Uncertain significance,Reclassified - variant of unknown significance,single nucleotide variant,GRCh37
na,na,3,16598169,16598169,DAZL,Uncertain significance,Reclassified - variant of unknown significance,single nucleotide variant,GRCh38
na,na,12,57441459,57441459,MYO1A,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 48|not specified|not provided|MYO1A-related disorder,single nucleotide variant,GRCh37
na,na,12,57047675,57047675,MYO1A,Conflicting classifications of pathogenicity,Autosomal dominant nonsyndromic hearing loss 48|not specified|not provided|MYO1A-related disorder,single nucleotide variant,GRCh38
na,na,12,57441167,57441168,MYO1A,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 48,Duplication,GRCh37
na,na,12,57047383,57047384,MYO1A,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 48,Duplication,GRCh38
na,na,12,57437119,57437119,MYO1A,Benign/Likely benign,Autosomal dominant nonsyndromic hearing loss 48|not specified|not provided,single nucleotide variant,GRCh37
na,na,12,57043335,57043335,MYO1A,Benign/Likely benign,Autosomal dominant nonsyndromic hearing loss 48|not specified|not provided,single nucleotide variant,GRCh38
na,na,12,57435225,57435225,MYO1A,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 48,single nucleotide variant,GRCh37
na,na,12,57041441,57041441,MYO1A,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 48,single nucleotide variant,GRCh38
na,na,12,57431402,57431402,MYO1A,Benign,Autosomal dominant nonsyndromic hearing loss 48|not specified|not provided,single nucleotide variant,GRCh37
na,na,12,57037618,57037618,MYO1A,Benign,Autosomal dominant nonsyndromic hearing loss 48|not specified|not provided,single nucleotide variant,GRCh38
na,na,12,57423368,57423368,MYO1A,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 48,single nucleotide variant,GRCh37
na,na,12,57029584,57029584,MYO1A,Uncertain significance,Autosomal dominant nonsyndromic hearing loss 48,single nucleotide variant,GRCh38
na,na,3,39307256,39307256,CX3CR1,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,3,39265765,39265765,CX3CR1,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,2,74166145,74166145,DGUOK,Pathogenic,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided,Deletion,GRCh37
na,na,2,73939018,73939018,DGUOK,Pathogenic,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided,Deletion,GRCh38
na,na,2,74173903,74173903,DGUOK,Pathogenic,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided,single nucleotide variant,GRCh37
na,na,2,73946776,73946776,DGUOK,Pathogenic,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided,single nucleotide variant,GRCh38
na,na,2,74185326,74185327,DGUOK,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided|DGUOK-related disorder|Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",Duplication,GRCh37
na,na,2,73958199,73958200,DGUOK,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided|DGUOK-related disorder|Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",Duplication,GRCh38
na,na,2,74184268,74184269,DGUOK,Pathogenic,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided,Deletion,GRCh37
na,na,2,73957141,73957142,DGUOK,Pathogenic,Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided,Deletion,GRCh38
na,na,2,74174015,74174015,DGUOK,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",single nucleotide variant,GRCh37
na,na,2,73946888,73946888,DGUOK,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",single nucleotide variant,GRCh38
na,na,2,74184339,74184339,DGUOK,Pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|Inborn genetic diseases|not provided|DGUOK-related disorder|Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",single nucleotide variant,GRCh37
na,na,2,73957212,73957212,DGUOK,Pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|Inborn genetic diseases|not provided|DGUOK-related disorder|Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",single nucleotide variant,GRCh38
na,na,2,74185328,74185328,DGUOK,Likely pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",single nucleotide variant,GRCh37
na,na,2,73958201,73958201,DGUOK,Likely pathogenic,"Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)|Portal hypertension, noncirrhotic, 1;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type);Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4",single nucleotide variant,GRCh38
na,na,14,35182668,35182668,CFL2,Pathogenic,Nemaline myopathy 7,single nucleotide variant,GRCh37
na,na,14,34713462,34713462,CFL2,Pathogenic,Nemaline myopathy 7,single nucleotide variant,GRCh38
na,na,12,21954091,21954091,ABCC9,Pathogenic,Dilated cardiomyopathy 1O,single nucleotide variant,GRCh37
na,na,12,21801157,21801157,ABCC9,Pathogenic,Dilated cardiomyopathy 1O,single nucleotide variant,GRCh38
na,na,5,41805776,41805776,OXCT1,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency,single nucleotide variant,GRCh37
na,na,5,41805674,41805674,OXCT1,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency,single nucleotide variant,GRCh38
na,na,5,41749681,41749681,OXCT1,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency,single nucleotide variant,GRCh37
na,na,5,41749579,41749579,OXCT1,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency,single nucleotide variant,GRCh38
na,na,5,41862758,41862758,OXCT1,Benign,Succinyl-CoA acetoacetate transferase deficiency|not provided|OXCT1-related disorder,single nucleotide variant,GRCh37
na,na,5,41862656,41862656,OXCT1,Benign,Succinyl-CoA acetoacetate transferase deficiency|not provided|OXCT1-related disorder,single nucleotide variant,GRCh38
na,na,5,41803250,41803250,OXCT1,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,5,41803148,41803148,OXCT1,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,5,41842792,41842792,OXCT1,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency,single nucleotide variant,GRCh37
na,na,5,41842690,41842690,OXCT1,Pathogenic,Succinyl-CoA acetoacetate transferase deficiency,single nucleotide variant,GRCh38
na,na,5,41842787,41842787,OXCT1,Uncertain significance,Succinyl-CoA acetoacetate transferase deficiency,single nucleotide variant,GRCh37
na,na,5,41842685,41842685,OXCT1,Uncertain significance,Succinyl-CoA acetoacetate transferase deficiency,single nucleotide variant,GRCh38
na,na,16,75674156,75674156,KARS1,Pathogenic,Charcot-Marie-Tooth disease recessive intermediate B,single nucleotide variant,GRCh37
na,na,16,75640258,75640258,KARS1,Pathogenic,Charcot-Marie-Tooth disease recessive intermediate B,single nucleotide variant,GRCh38
na,na,16,75670402,75670403,KARS1,Pathogenic,Charcot-Marie-Tooth disease recessive intermediate B,Duplication,GRCh37
na,na,16,75636504,75636505,KARS1,Pathogenic,Charcot-Marie-Tooth disease recessive intermediate B,Duplication,GRCh38
na,na,5,156184672,156184672,SGCD,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F|Dilated cardiomyopathy 1L,Deletion,GRCh37
na,na,5,156757661,156757661,SGCD,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F|Dilated cardiomyopathy 1L,Deletion,GRCh38
na,na,5,156022052,156022052,SGCD,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F|Dilated cardiomyopathy 1L|Autosomal recessive limb-girdle muscular dystrophy type 2F;Dilated cardiomyopathy 1L|not provided|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,5,156595042,156595042,SGCD,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F|Dilated cardiomyopathy 1L|Autosomal recessive limb-girdle muscular dystrophy type 2F;Dilated cardiomyopathy 1L|not provided|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,5,155771584,155771584,SGCD,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F,single nucleotide variant,GRCh37
na,na,5,156344574,156344574,SGCD,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F,single nucleotide variant,GRCh38
na,na,5,156186312,156186312,SGCD,Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F|Dilated cardiomyopathy 1L,single nucleotide variant,GRCh37
na,na,5,156759301,156759301,SGCD,Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F|Dilated cardiomyopathy 1L,single nucleotide variant,GRCh38
na,na,5,156022010,156022010,SGCD,Uncertain significance,"Dilated cardiomyopathy 1L|not specified|Autosomal recessive limb-girdle muscular dystrophy type 2F|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6, DIGENIC|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2F;Dilated cardiomyopathy 1L",single nucleotide variant,GRCh37
na,na,5,156595000,156595000,SGCD,Uncertain significance,"Dilated cardiomyopathy 1L|not specified|Autosomal recessive limb-girdle muscular dystrophy type 2F|MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6, DIGENIC|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2F;Dilated cardiomyopathy 1L",single nucleotide variant,GRCh38
na,na,5,156021950,156021950,SGCD,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F,single nucleotide variant,GRCh37
na,na,5,156594940,156594940,SGCD,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2F,single nucleotide variant,GRCh38
na,na,1,15772212,15772212,CTRC,Conflicting classifications of pathogenicity; association,"Pancreatitis, chronic, susceptibility to|Hereditary pancreatitis|not specified|not provided",single nucleotide variant,GRCh37
na,na,1,15445717,15445717,CTRC,Conflicting classifications of pathogenicity; association,"Pancreatitis, chronic, susceptibility to|Hereditary pancreatitis|not specified|not provided",single nucleotide variant,GRCh38
na,na,1,15767020,15767020,CTRC,Pathogenic,"Pancreatitis, chronic, susceptibility to|Hereditary pancreatitis",single nucleotide variant,GRCh37
na,na,1,15440524,15440524,CTRC,Pathogenic,"Pancreatitis, chronic, susceptibility to|Hereditary pancreatitis",single nucleotide variant,GRCh38
na,na,6,166574246,166574246,TBXT,risk factor,"Neural tube defects, susceptibility to",single nucleotide variant,GRCh37
na,na,6,166160758,166160758,TBXT,risk factor,"Neural tube defects, susceptibility to",single nucleotide variant,GRCh38
na,na,na,-1,-1,TSG101,Uncertain significance,Familial cancer of breast,single nucleotide variant,na
na,na,8,15531332,15531333,TUSC3,Pathogenic,"Intellectual disability, autosomal recessive 7",Duplication,GRCh37
na,na,8,15673823,15673824,TUSC3,Pathogenic,"Intellectual disability, autosomal recessive 7",Duplication,GRCh38
na,na,3,46414944,46414975,CCR5,Benign,"Susceptibility to HIV infection|Resistance to hepatitis C virus|Multiple sclerosis modifier of disease progression|West Nile virus, susceptibility to|not provided|CCR5-related disorder",Deletion,GRCh37
na,na,3,46373453,46373484,CCR5,Benign,"Susceptibility to HIV infection|Resistance to hepatitis C virus|Multiple sclerosis modifier of disease progression|West Nile virus, susceptibility to|not provided|CCR5-related disorder",Deletion,GRCh38
na,na,3,46415286,46415286,CCR5,Benign,"CCR5 POLYMORPHISM, ORIENTAL 1",Deletion,GRCh37
na,na,3,46373795,46373795,CCR5,Benign,"CCR5 POLYMORPHISM, ORIENTAL 1",Deletion,GRCh38
na,na,3,46415061,46415061,CCR5,Benign,"CCR5 POLYMORPHISM, ORIENTAL 2|not provided",single nucleotide variant,GRCh37
na,na,3,46373570,46373570,CCR5,Benign,"CCR5 POLYMORPHISM, ORIENTAL 2|not provided",single nucleotide variant,GRCh38
na,na,3,46415397,46415397,CCR5,Benign,"CCR5 POLYMORPHISM, AFRICAN-AMERICAN|not provided",single nucleotide variant,GRCh37
na,na,3,46373906,46373906,CCR5,Benign,"CCR5 POLYMORPHISM, AFRICAN-AMERICAN|not provided",single nucleotide variant,GRCh38
na,na,3,46414696,46414696,CCR5,protective,Susceptibility to HIV infection,single nucleotide variant,GRCh37
na,na,3,46373205,46373205,CCR5,protective,Susceptibility to HIV infection,single nucleotide variant,GRCh38
na,na,3,46411935,46411935,CCR5,Conflicting classifications of pathogenicity; protective,"CCR5 PROMOTER POLYMORPHISM|Susceptibility to HIV infection|Acquired immunodeficiency syndrome, delayed progression to|CCR5-related disorder",single nucleotide variant,GRCh37
na,na,3,46370444,46370444,CCR5,Conflicting classifications of pathogenicity; protective,"CCR5 PROMOTER POLYMORPHISM|Susceptibility to HIV infection|Acquired immunodeficiency syndrome, delayed progression to|CCR5-related disorder",single nucleotide variant,GRCh38
na,na,3,46412262,46412262,CCR5,Benign,"Human immunodeficiency virus type 1, increased perinatal transmission of|not specified",single nucleotide variant,GRCh37
na,na,3,46370771,46370771,CCR5,Benign,"Human immunodeficiency virus type 1, increased perinatal transmission of|not specified",single nucleotide variant,GRCh38
na,na,3,46414573,46414573,CCR5,protective,Susceptibility to HIV infection,single nucleotide variant,GRCh37
na,na,3,46373082,46373082,CCR5,protective,Susceptibility to HIV infection,single nucleotide variant,GRCh38
na,na,2,74689459,74689459,MOGS,Pathogenic,MOGS-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,2,74462332,74462332,MOGS,Pathogenic,MOGS-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,2,74688962,74688962,MOGS,Pathogenic,MOGS-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,2,74461835,74461835,MOGS,Pathogenic,MOGS-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,16,2140674,2140674,PKD1,Pathogenic,"Polycystic kidney disease, adult type",single nucleotide variant,GRCh37
na,na,16,2090673,2090673,PKD1,Pathogenic,"Polycystic kidney disease, adult type",single nucleotide variant,GRCh38
na,na,16,2140689,2140689,PKD1,Pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh37
na,na,16,2090688,2090688,PKD1,Pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh38
na,na,16,2142487,2142501,PKD1,Likely pathogenic,"Polycystic kidney disease, adult type",Deletion,GRCh37
na,na,16,2092486,2092500,PKD1,Likely pathogenic,"Polycystic kidney disease, adult type",Deletion,GRCh38
na,na,16,2139958,2139958,PKD1,Pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh37
na,na,16,2089957,2089957,PKD1,Pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh38
na,na,16,2141807,2141807,PKD1,Pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh37
na,na,16,2091806,2091806,PKD1,Pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh38
na,na,16,2140469,2140469,PKD1,Pathogenic,"Polycystic kidney disease, adult type",single nucleotide variant,GRCh37
na,na,16,2090468,2090468,PKD1,Pathogenic,"Polycystic kidney disease, adult type",single nucleotide variant,GRCh38
na,na,16,2141862,2141862,PKD1,Pathogenic,"Polycystic kidney disease, adult type|Autosomal dominant polycystic kidney disease",single nucleotide variant,GRCh37
na,na,16,2091861,2091861,PKD1,Pathogenic,"Polycystic kidney disease, adult type|Autosomal dominant polycystic kidney disease",single nucleotide variant,GRCh38
na,na,16,2140777,2140777,PKD1,Pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh37
na,na,16,2090776,2090776,PKD1,Pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh38
na,na,16,2158701,2158728,PKD1,Pathogenic,"Polycystic kidney disease, adult type",Deletion,GRCh37
na,na,16,2108700,2108727,PKD1,Pathogenic,"Polycystic kidney disease, adult type",Deletion,GRCh38
na,na,16,2161873,2161873,PKD1,Pathogenic,"Polycystic kidney disease, adult type",single nucleotide variant,GRCh37
na,na,16,2111872,2111872,PKD1,Pathogenic,"Polycystic kidney disease, adult type",single nucleotide variant,GRCh38
na,na,16,2168022,2168022,PKD1,Conflicting classifications of pathogenicity,"Polycystic kidney disease, adult type|not provided|Polycystic kidney disease|not specified|PKD1-related disorder",single nucleotide variant,GRCh37
na,na,16,2118021,2118021,PKD1,Conflicting classifications of pathogenicity,"Polycystic kidney disease, adult type|not provided|Polycystic kidney disease|not specified|PKD1-related disorder",single nucleotide variant,GRCh38
na,na,16,2164490,2164490,PKD1,Pathogenic/Likely pathogenic,"Polycystic kidney disease, adult type|Polycystic kidney disease 3 with or without polycystic liver disease|not provided|Polycystic kidney disease|PKD1-related disorder",single nucleotide variant,GRCh37
na,na,16,2114489,2114489,PKD1,Pathogenic/Likely pathogenic,"Polycystic kidney disease, adult type|Polycystic kidney disease 3 with or without polycystic liver disease|not provided|Polycystic kidney disease|PKD1-related disorder",single nucleotide variant,GRCh38
na,na,16,2159404,2159404,PKD1,Pathogenic,"Polycystic kidney disease, adult type",single nucleotide variant,GRCh37
na,na,16,2109403,2109403,PKD1,Pathogenic,"Polycystic kidney disease, adult type",single nucleotide variant,GRCh38
na,na,16,2140310,2140310,PKD1,Likely pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh37
na,na,16,2090309,2090309,PKD1,Likely pathogenic,"Polycystic kidney disease, adult type|not provided",single nucleotide variant,GRCh38
na,na,16,2155360,2155367,PKD1,no classification for the single variant,-,Deletion,GRCh37
na,na,16,2105359,2105366,PKD1,no classification for the single variant,-,Deletion,GRCh38
na,na,9,98229504,98229514,PTCH1,Pathogenic,Basal cell nevus syndrome 1,Deletion,GRCh37
na,na,9,95467222,95467232,PTCH1,Pathogenic,Basal cell nevus syndrome 1,Deletion,GRCh38
na,na,9,98241416,98241416,PTCH1,Pathogenic,Gorlin syndrome,single nucleotide variant,GRCh37
na,na,9,95479134,95479134,PTCH1,Pathogenic,Gorlin syndrome,single nucleotide variant,GRCh38
na,na,9,98242765,98242801,PTCH1,Pathogenic,Basal cell nevus syndrome 1,Deletion,GRCh37
na,na,9,95480483,95480519,PTCH1,Pathogenic,Basal cell nevus syndrome 1,Deletion,GRCh38
na,na,9,98241337,98241337,PTCH1,Pathogenic,Gorlin syndrome|Basal cell nevus syndrome 1,single nucleotide variant,GRCh37
na,na,9,95479055,95479055,PTCH1,Pathogenic,Gorlin syndrome|Basal cell nevus syndrome 1,single nucleotide variant,GRCh38
na,na,9,98231224,98231225,PTCH1,Pathogenic,Basal cell nevus syndrome 1,Microsatellite,GRCh37
na,na,9,95468942,95468943,PTCH1,Pathogenic,Basal cell nevus syndrome 1,Microsatellite,GRCh38
na,na,9,98224246,98224246,PTCH1,Pathogenic,Basal cell nevus syndrome 1,Deletion,GRCh37
na,na,9,95461964,95461964,PTCH1,Pathogenic,Basal cell nevus syndrome 1,Deletion,GRCh38
na,na,na,-1,-1,PTCH1,Pathogenic,"Basal cell carcinoma, somatic",single nucleotide variant,na
na,na,9,98215869,98215869,PTCH1,Pathogenic,"Basal cell carcinoma, somatic",single nucleotide variant,GRCh37
na,na,9,95453587,95453587,PTCH1,Pathogenic,"Basal cell carcinoma, somatic",single nucleotide variant,GRCh38
na,na,9,98241320,98241320,PTCH1,Benign/Likely benign,"Holoprosencephaly 7|Gorlin syndrome|Hereditary cancer-predisposing syndrome|PTCH1-related disorder|Basal cell nevus syndrome 1;Holoprosencephaly 7;Basal cell carcinoma, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,9,95479038,95479038,PTCH1,Benign/Likely benign,"Holoprosencephaly 7|Gorlin syndrome|Hereditary cancer-predisposing syndrome|PTCH1-related disorder|Basal cell nevus syndrome 1;Holoprosencephaly 7;Basal cell carcinoma, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,9,98231100,98231100,PTCH1,Benign/Likely benign,"Holoprosencephaly 7|not provided|not specified|Gorlin syndrome|Hereditary cancer-predisposing syndrome|Holoprosencephaly 7;Basal cell carcinoma, susceptibility to, 1;Gorlin syndrome|Basal cell nevus syndrome 1;Holoprosencephaly 7;Basal cell carcinoma, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,9,95468818,95468818,PTCH1,Benign/Likely benign,"Holoprosencephaly 7|not provided|not specified|Gorlin syndrome|Hereditary cancer-predisposing syndrome|Holoprosencephaly 7;Basal cell carcinoma, susceptibility to, 1;Gorlin syndrome|Basal cell nevus syndrome 1;Holoprosencephaly 7;Basal cell carcinoma, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,9,98229479,98229479,PTCH1,Benign,Holoprosencephaly 7|not specified|not provided|Gorlin syndrome|Hereditary cancer-predisposing syndrome|PTCH1-related disorder,single nucleotide variant,GRCh37
na,na,9,95467197,95467197,PTCH1,Benign,Holoprosencephaly 7|not specified|not provided|Gorlin syndrome|Hereditary cancer-predisposing syndrome|PTCH1-related disorder,single nucleotide variant,GRCh38
na,na,9,98220308,98220308,PTCH1,Conflicting classifications of pathogenicity,Holoprosencephaly 7|not provided|Holoprosencephaly sequence|not specified|Hereditary cancer-predisposing syndrome|Gorlin syndrome|PTCH1-related disorder,single nucleotide variant,GRCh37
na,na,9,95458026,95458026,PTCH1,Conflicting classifications of pathogenicity,Holoprosencephaly 7|not provided|Holoprosencephaly sequence|not specified|Hereditary cancer-predisposing syndrome|Gorlin syndrome|PTCH1-related disorder,single nucleotide variant,GRCh38
na,na,9,98222046,98222046,PTCH1,Pathogenic,Holoprosencephaly 7,single nucleotide variant,GRCh37
na,na,9,95459764,95459764,PTCH1,Pathogenic,Holoprosencephaly 7,single nucleotide variant,GRCh38
na,na,9,98240422,98240423,PTCH1,Pathogenic,Gorlin syndrome|Basal cell nevus syndrome 1,Duplication,GRCh37
na,na,9,95478140,95478141,PTCH1,Pathogenic,Gorlin syndrome|Basal cell nevus syndrome 1,Duplication,GRCh38
na,na,12,52380624,52380628,ACVR1B,Pathogenic,Carcinoma of pancreas,Deletion,GRCh37
na,na,12,51986840,51986844,ACVR1B,Pathogenic,Carcinoma of pancreas,Deletion,GRCh38
na,na,12,52385141,52385797,ACVR1B,Pathogenic,Carcinoma of pancreas,Deletion,GRCh37
na,na,12,51991357,51992013,ACVR1B,Pathogenic,Carcinoma of pancreas,Deletion,GRCh38
na,na,10,88676930,88676930,BMPR1A,Pathogenic,Juvenile polyposis syndrome,single nucleotide variant,GRCh37
na,na,10,86917173,86917173,BMPR1A,Pathogenic,Juvenile polyposis syndrome,single nucleotide variant,GRCh38
na,na,10,88677027,88677027,BMPR1A,Pathogenic,Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,86917270,86917270,BMPR1A,Pathogenic,Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,88679073,88679073,BMPR1A,Likely pathogenic,Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome,single nucleotide variant,GRCh37
na,na,10,86919316,86919316,BMPR1A,Likely pathogenic,Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome,single nucleotide variant,GRCh38
na,na,10,88659587,88659587,BMPR1A,Pathogenic/Likely pathogenic,"Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome|not provided|Polyposis syndrome, hereditary mixed, 2",single nucleotide variant,GRCh37
na,na,10,86899830,86899830,BMPR1A,Pathogenic/Likely pathogenic,"Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome|not provided|Polyposis syndrome, hereditary mixed, 2",single nucleotide variant,GRCh38
na,na,10,88679187,88679187,BMPR1A,Pathogenic,Juvenile polyposis syndrome,single nucleotide variant,GRCh37
na,na,10,86919430,86919430,BMPR1A,Pathogenic,Juvenile polyposis syndrome,single nucleotide variant,GRCh38
na,na,10,88683199,88683199,BMPR1A,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome,single nucleotide variant,GRCh37
na,na,10,86923442,86923442,BMPR1A,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome,single nucleotide variant,GRCh38
na,na,9,113563026,113563026,MUSK,Conflicting classifications of pathogenicity,Congenital myasthenic syndrome 9|Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 9;Fetal akinesia deformation sequence 1|not provided|MUSK-related disorder,single nucleotide variant,GRCh37
na,na,9,110800746,110800746,MUSK,Conflicting classifications of pathogenicity,Congenital myasthenic syndrome 9|Fetal akinesia deformation sequence 1|Congenital myasthenic syndrome 9;Fetal akinesia deformation sequence 1|not provided|MUSK-related disorder,single nucleotide variant,GRCh38
na,na,9,113449407,113449408,MUSK,Pathogenic,Congenital myasthenic syndrome 9,Duplication,GRCh37
na,na,9,110687127,110687128,MUSK,Pathogenic,Congenital myasthenic syndrome 9,Duplication,GRCh38
na,na,13,103703640,103703640,SLC10A2,Uncertain significance,not provided,single nucleotide variant,GRCh37
na,na,13,103051290,103051290,SLC10A2,Uncertain significance,not provided,single nucleotide variant,GRCh38
na,na,13,103704969,103704971,SLC10A2,Pathogenic,"Bile acid malabsorption, primary, 1",Inversion,GRCh37
na,na,13,103052619,103052621,SLC10A2,Pathogenic,"Bile acid malabsorption, primary, 1",Inversion,GRCh38
na,na,12,52310003,52310003,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,12,51916219,51916219,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,12,52309898,52309898,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,12,51916114,51916114,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,12,52306971,52306971,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,12,51913187,51913187,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,12,52306964,52306968,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",Indel,GRCh37
na,na,12,51913180,51913184,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",Indel,GRCh38
na,na,12,52309964,52309964,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",single nucleotide variant,GRCh37
na,na,12,51916180,51916180,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",single nucleotide variant,GRCh38
na,na,12,52309891,52309891,ACVRL1,Pathogenic/Likely pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype|ACVRL1-related disorder",single nucleotide variant,GRCh37
na,na,12,51916107,51916107,ACVRL1,Pathogenic/Likely pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype|ACVRL1-related disorder",single nucleotide variant,GRCh38
na,na,12,52308355,52308357,ACVRL1,Pathogenic/Likely pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype",Deletion,GRCh37
na,na,12,51914571,51914573,ACVRL1,Pathogenic/Likely pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype",Deletion,GRCh38
na,na,12,52310002,52310002,ACVRL1,Pathogenic/Likely pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,12,51916218,51916218,ACVRL1,Pathogenic/Likely pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,12,52314615,52314615,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Pulmonary arterial hypertension|not specified|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,12,51920831,51920831,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Pulmonary arterial hypertension|not specified|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,12,52308229,52308229,ACVRL1,Pathogenic/Likely pathogenic,"Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2",single nucleotide variant,GRCh37
na,na,12,51914445,51914445,ACVRL1,Pathogenic/Likely pathogenic,"Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2",single nucleotide variant,GRCh38
na,na,12,52309267,52309267,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|See cases|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,12,51915483,51915483,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|See cases|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,12,52309967,52309967,ACVRL1,Pathogenic/Likely pathogenic,"Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Cardiovascular phenotype|Telangiectasia, hereditary hemorrhagic, type 2",single nucleotide variant,GRCh37
na,na,12,51916183,51916183,ACVRL1,Pathogenic/Likely pathogenic,"Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Cardiovascular phenotype|Telangiectasia, hereditary hemorrhagic, type 2",single nucleotide variant,GRCh38
na,na,12,52309884,52309885,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",Insertion,GRCh37
na,na,12,51916100,51916101,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",Insertion,GRCh38
na,na,12,52310003,52310003,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",single nucleotide variant,GRCh37
na,na,12,51916219,51916219,ACVRL1,Pathogenic,"Telangiectasia, hereditary hemorrhagic, type 2",single nucleotide variant,GRCh38
na,na,8,144998314,144998315,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5B, with muscular dystrophy",Duplication,GRCh37
na,na,8,143924146,143924147,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5B, with muscular dystrophy",Duplication,GRCh38
na,na,8,145004320,145004328,PLEC,Conflicting classifications of pathogenicity,"Epidermolysis bullosa simplex 5B, with muscular dystrophy|not provided|Epidermolysis bullosa simplex, Ogna type;Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex with nail dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2Q;Epidermolysis bullosa simplex 5B, with muscular dystrophy|Epidermolysis bullosa simplex with nail dystrophy",Microsatellite,GRCh37
na,na,8,143930152,143930160,PLEC,Conflicting classifications of pathogenicity,"Epidermolysis bullosa simplex 5B, with muscular dystrophy|not provided|Epidermolysis bullosa simplex, Ogna type;Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex with nail dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2Q;Epidermolysis bullosa simplex 5B, with muscular dystrophy|Epidermolysis bullosa simplex with nail dystrophy",Microsatellite,GRCh38
na,na,8,144998363,144998363,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5B, with muscular dystrophy",Deletion,GRCh37
na,na,8,143924195,143924195,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5B, with muscular dystrophy",Deletion,GRCh38
na,na,8,144999066,144999073,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5B, with muscular dystrophy",Microsatellite,GRCh37
na,na,8,143924898,143924905,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5B, with muscular dystrophy",Microsatellite,GRCh38
na,na,8,144998180,144998180,PLEC,Pathogenic,"Epidermolysis bullosa simplex, Ogna type|not provided|Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex with nail dystrophy;Epidermolysis bullosa simplex, Ogna type;Epidermolysis bullosa simplex 5B, with muscular dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2Q|Simplex epidermolysis bullosa_Ogna type",single nucleotide variant,GRCh37
na,na,8,143924012,143924012,PLEC,Pathogenic,"Epidermolysis bullosa simplex, Ogna type|not provided|Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex with nail dystrophy;Epidermolysis bullosa simplex, Ogna type;Epidermolysis bullosa simplex 5B, with muscular dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2Q|Simplex epidermolysis bullosa_Ogna type",single nucleotide variant,GRCh38
na,na,8,145004311,145004324,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia",Deletion,GRCh37
na,na,8,143930143,143930156,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia",Deletion,GRCh38
na,na,8,145009091,145009091,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia",single nucleotide variant,GRCh37
na,na,8,143934923,143934923,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia",single nucleotide variant,GRCh38
na,na,8,145008166,145008166,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia",single nucleotide variant,GRCh37
na,na,8,143933998,143933998,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia",single nucleotide variant,GRCh38
na,na,8,144994985,144994985,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia|Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex with nail dystrophy;Epidermolysis bullosa simplex, Ogna type;Epidermolysis bullosa simplex 5B, with muscular dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2Q",single nucleotide variant,GRCh37
na,na,8,143920817,143920817,PLEC,Pathogenic,"Epidermolysis bullosa simplex 5C, with pyloric atresia|Epidermolysis bullosa simplex 5C, with pyloric atresia;Epidermolysis bullosa simplex with nail dystrophy;Epidermolysis bullosa simplex, Ogna type;Epidermolysis bullosa simplex 5B, with muscular dystrophy;Autosomal recessive limb-girdle muscular dystrophy type 2Q",single nucleotide variant,GRCh38
na,na,3,46399208,46399208,CCR2,Benign; protective,Susceptibility to HIV infection|CCR2-related disorder,single nucleotide variant,GRCh37
na,na,3,46357717,46357717,CCR2,Benign; protective,Susceptibility to HIV infection|CCR2-related disorder,single nucleotide variant,GRCh38
na,na,10,72195385,72195385,NODAL,Conflicting classifications of pathogenicity,"Heterotaxy, visceral, 5, autosomal|not provided",single nucleotide variant,GRCh37
na,na,10,70435629,70435629,NODAL,Conflicting classifications of pathogenicity,"Heterotaxy, visceral, 5, autosomal|not provided",single nucleotide variant,GRCh38
na,na,10,72195155,72195155,NODAL,Conflicting classifications of pathogenicity,"Inborn genetic diseases|Heterotaxy, visceral, 5, autosomal|Wolff-Parkinson-White pattern|Visceral heterotaxy|NODAL-related disorder|not provided",single nucleotide variant,GRCh37
na,na,10,70435399,70435399,NODAL,Conflicting classifications of pathogenicity,"Inborn genetic diseases|Heterotaxy, visceral, 5, autosomal|Wolff-Parkinson-White pattern|Visceral heterotaxy|NODAL-related disorder|not provided",single nucleotide variant,GRCh38
na,na,19,4117550,4117550,MAP2K2,Pathogenic,Cardiofaciocutaneous syndrome 4|not provided|Cardio-facio-cutaneous syndrome|RASopathy,single nucleotide variant,GRCh37
na,na,19,4117552,4117552,MAP2K2,Pathogenic,Cardiofaciocutaneous syndrome 4|not provided|Cardio-facio-cutaneous syndrome|RASopathy,single nucleotide variant,GRCh38
na,na,19,4117551,4117551,MAP2K2,Pathogenic,Cardiofaciocutaneous syndrome 4|Cardio-facio-cutaneous syndrome,single nucleotide variant,GRCh37
na,na,19,4117553,4117553,MAP2K2,Pathogenic,Cardiofaciocutaneous syndrome 4|Cardio-facio-cutaneous syndrome,single nucleotide variant,GRCh38
na,na,19,4110557,4110557,MAP2K2,Pathogenic,Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 4|not provided|RASopathy|Noonan syndrome and Noonan-related syndrome|MAP2K2-related disorder|Noonan syndrome 1,single nucleotide variant,GRCh37
na,na,19,4110559,4110559,MAP2K2,Pathogenic,Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 4|not provided|RASopathy|Noonan syndrome and Noonan-related syndrome|MAP2K2-related disorder|Noonan syndrome 1,single nucleotide variant,GRCh38
na,na,19,4110574,4110574,MAP2K2,Pathogenic,Cardiofaciocutaneous syndrome 4|not provided|Cardio-facio-cutaneous syndrome|RASopathy,single nucleotide variant,GRCh37
na,na,19,4110576,4110576,MAP2K2,Pathogenic,Cardiofaciocutaneous syndrome 4|not provided|Cardio-facio-cutaneous syndrome|RASopathy,single nucleotide variant,GRCh38
na,na,3,8787411,8787411,CAV3,Pathogenic,Rippling muscle disease 2|not provided|Long QT syndrome,single nucleotide variant,GRCh37
na,na,3,8745725,8745725,CAV3,Pathogenic,Rippling muscle disease 2|not provided|Long QT syndrome,single nucleotide variant,GRCh38
na,na,3,8787286,8787294,CAV3,Pathogenic,Rippling muscle disease 2|not provided,Deletion,GRCh37
na,na,3,8745597,8745605,CAV3,Pathogenic,Rippling muscle disease 2|not provided,Deletion,GRCh38
na,na,3,8787263,8787263,CAV3,Benign/Likely benign,"Rippling muscle disease 2|not provided|not specified|Limb-Girdle Muscular Dystrophy, Dominant|Limb-girdle muscular dystrophy|Cardiovascular phenotype|Long QT syndrome 1|Cardiomyopathy|Long QT syndrome|Caveolinopathy|Long QT syndrome 9;Rippling muscle disease 2;Distal myopathy, Tateyama type;Elevated circulating creatine kinase concentration;Hypertrophic cardiomyopathy 1",single nucleotide variant,GRCh37
na,na,3,8745577,8745577,CAV3,Benign/Likely benign,"Rippling muscle disease 2|not provided|not specified|Limb-Girdle Muscular Dystrophy, Dominant|Limb-girdle muscular dystrophy|Cardiovascular phenotype|Long QT syndrome 1|Cardiomyopathy|Long QT syndrome|Caveolinopathy|Long QT syndrome 9;Rippling muscle disease 2;Distal myopathy, Tateyama type;Elevated circulating creatine kinase concentration;Hypertrophic cardiomyopathy 1",single nucleotide variant,GRCh38
na,na,3,8787313,8787313,CAV3,Conflicting classifications of pathogenicity,"Rippling muscle disease 2|not provided|not specified|Limb-girdle muscular dystrophy|Hypertrophic cardiomyopathy 1;Distal myopathy, Tateyama type;Elevated circulating creatine kinase concentration;Rippling muscle disease 2;Long QT syndrome 9|Cardiovascular phenotype|Long QT syndrome|Caveolinopathy|Cardiomyopathy|Long QT syndrome 1|CAV3-related disorder",single nucleotide variant,GRCh37
na,na,3,8745627,8745627,CAV3,Conflicting classifications of pathogenicity,"Rippling muscle disease 2|not provided|not specified|Limb-girdle muscular dystrophy|Hypertrophic cardiomyopathy 1;Distal myopathy, Tateyama type;Elevated circulating creatine kinase concentration;Rippling muscle disease 2;Long QT syndrome 9|Cardiovascular phenotype|Long QT syndrome|Caveolinopathy|Cardiomyopathy|Long QT syndrome 1|CAV3-related disorder",single nucleotide variant,GRCh38
na,na,3,8775646,8775646,CAV3,Pathogenic,Rippling muscle disease 2|not provided,single nucleotide variant,GRCh37
na,na,3,8733960,8733960,CAV3,Pathogenic,Rippling muscle disease 2|not provided,single nucleotide variant,GRCh38
na,na,3,8787233,8787233,CAV3,Pathogenic/Likely pathogenic,Rippling muscle disease 2|Elevated circulating creatine kinase concentration|not provided|Long QT syndrome|Cardiovascular phenotype|Myopathy with tubular aggregates,single nucleotide variant,GRCh37
na,na,3,8745547,8745547,CAV3,Pathogenic/Likely pathogenic,Rippling muscle disease 2|Elevated circulating creatine kinase concentration|not provided|Long QT syndrome|Cardiovascular phenotype|Myopathy with tubular aggregates,single nucleotide variant,GRCh38
na,na,3,8787234,8787234,CAV3,Likely pathogenic,Rippling muscle disease 2|not provided,single nucleotide variant,GRCh37
na,na,3,8745548,8745548,CAV3,Likely pathogenic,Rippling muscle disease 2|not provided,single nucleotide variant,GRCh38
na,na,3,8775642,8775642,CAV3;SSUH2,Pathogenic,"Elevated circulating creatine kinase concentration|Rippling muscle disease 2|Distal myopathy, Tateyama type|not provided|Long QT syndrome|Hypertrophic cardiomyopathy 1;Rippling muscle disease 2;Distal myopathy, Tateyama type;Elevated circulating creatine kinase concentration;Long QT syndrome 9",single nucleotide variant,GRCh37
na,na,3,8733956,8733956,CAV3;SSUH2,Pathogenic,"Elevated circulating creatine kinase concentration|Rippling muscle disease 2|Distal myopathy, Tateyama type|not provided|Long QT syndrome|Hypertrophic cardiomyopathy 1;Rippling muscle disease 2;Distal myopathy, Tateyama type;Elevated circulating creatine kinase concentration;Long QT syndrome 9",single nucleotide variant,GRCh38
na,na,3,8787357,8787357,CAV3,Uncertain significance,Rippling muscle disease 2|not provided|Long QT syndrome|SUDDEN INFANT DEATH SYNDROME|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,3,8745671,8745671,CAV3,Uncertain significance,Rippling muscle disease 2|not provided|Long QT syndrome|SUDDEN INFANT DEATH SYNDROME|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,3,8787374,8787374,CAV3,Conflicting classifications of pathogenicity,"Rippling muscle disease 2, autosomal recessive|not provided|Long QT syndrome|Rippling muscle disease 2|Cardiovascular phenotype|Rippling muscle disease 2;Long QT syndrome 9;Distal myopathy, Tateyama type;Hypertrophic cardiomyopathy 1;Elevated circulating creatine kinase concentration|Caveolinopathy|Hypertrophic cardiomyopathy 1",single nucleotide variant,GRCh37
na,na,3,8745688,8745688,CAV3,Conflicting classifications of pathogenicity,"Rippling muscle disease 2, autosomal recessive|not provided|Long QT syndrome|Rippling muscle disease 2|Cardiovascular phenotype|Rippling muscle disease 2;Long QT syndrome 9;Distal myopathy, Tateyama type;Hypertrophic cardiomyopathy 1;Elevated circulating creatine kinase concentration|Caveolinopathy|Hypertrophic cardiomyopathy 1",single nucleotide variant,GRCh38
na,na,3,8787385,8787387,CAV3,Uncertain significance,Elevated circulating creatine kinase concentration|Rippling muscle disease 2|not provided|Caveolinopathy,Deletion,GRCh37
na,na,3,8745699,8745701,CAV3,Uncertain significance,Elevated circulating creatine kinase concentration|Rippling muscle disease 2|not provided|Caveolinopathy,Deletion,GRCh38
na,na,3,8775648,8775648,CAV3,Uncertain significance,Elevated circulating creatine kinase concentration|Long QT syndrome|not provided,single nucleotide variant,GRCh37
na,na,3,8733962,8733962,CAV3,Uncertain significance,Elevated circulating creatine kinase concentration|Long QT syndrome|not provided,single nucleotide variant,GRCh38
na,na,3,8787288,8787288,CAV3,Uncertain significance,Primary familial hypertrophic cardiomyopathy|not provided|Caveolinopathy,single nucleotide variant,GRCh37
na,na,3,8745602,8745602,CAV3,Uncertain significance,Primary familial hypertrophic cardiomyopathy|not provided|Caveolinopathy,single nucleotide variant,GRCh38
na,na,3,8775661,8775661,CAV3,Pathogenic,"Distal myopathy, Tateyama type|Long QT syndrome",single nucleotide variant,GRCh37
na,na,3,8733975,8733975,CAV3,Pathogenic,"Distal myopathy, Tateyama type|Long QT syndrome",single nucleotide variant,GRCh38
na,na,3,8787236,8787236,CAV3,Uncertain significance,Rippling muscle disease 2|not provided,single nucleotide variant,GRCh37
na,na,3,8745550,8745550,CAV3,Uncertain significance,Rippling muscle disease 2|not provided,single nucleotide variant,GRCh38
na,na,3,8787520,8787520,CAV3,Pathogenic,Long QT syndrome 9|not provided,single nucleotide variant,GRCh37
na,na,3,8745834,8745834,CAV3,Pathogenic,Long QT syndrome 9|not provided,single nucleotide variant,GRCh38
na,na,3,8787387,8787387,CAV3,risk factor,"Long QT syndrome 9, acquired, susceptibility to|not provided",single nucleotide variant,GRCh37
na,na,3,8745701,8745701,CAV3,risk factor,"Long QT syndrome 9, acquired, susceptibility to|not provided",single nucleotide variant,GRCh38
na,na,3,8787330,8787330,CAV3,Conflicting classifications of pathogenicity,"Long QT syndrome 9|Long QT syndrome 2/9, digenic|not specified|not provided|Long QT syndrome|Cardiovascular phenotype|Cardiomyopathy|Long QT syndrome 1|Caveolinopathy|CAV3-related disorder|Hypertrophic cardiomyopathy",single nucleotide variant,GRCh37
na,na,3,8745644,8745644,CAV3,Conflicting classifications of pathogenicity,"Long QT syndrome 9|Long QT syndrome 2/9, digenic|not specified|not provided|Long QT syndrome|Cardiovascular phenotype|Cardiomyopathy|Long QT syndrome 1|Caveolinopathy|CAV3-related disorder|Hypertrophic cardiomyopathy",single nucleotide variant,GRCh38
na,na,3,8787350,8787350,CAV3,Pathogenic,Long QT syndrome 9|not provided,single nucleotide variant,GRCh37
na,na,3,8745664,8745664,CAV3,Pathogenic,Long QT syndrome 9|not provided,single nucleotide variant,GRCh38
na,na,3,8775602,8775602,CAV3,Pathogenic,Long QT syndrome 9|not provided,single nucleotide variant,GRCh37
na,na,3,8733916,8733916,CAV3,Pathogenic,Long QT syndrome 9|not provided,single nucleotide variant,GRCh38
na,na,3,8787333,8787333,CAV3,Uncertain significance,not provided|Long QT syndrome|Long QT syndrome 9,single nucleotide variant,GRCh37
na,na,3,8745647,8745647,CAV3,Uncertain significance,not provided|Long QT syndrome|Long QT syndrome 9,single nucleotide variant,GRCh38
na,na,2,127834262,127834262,BIN1,Pathogenic,"Myopathy, centronuclear, 2",single nucleotide variant,GRCh37
na,na,2,127076686,127076686,BIN1,Pathogenic,"Myopathy, centronuclear, 2",single nucleotide variant,GRCh38
na,na,2,127826568,127826568,BIN1,Pathogenic,"Myopathy, centronuclear, 2",single nucleotide variant,GRCh37
na,na,2,127068992,127068992,BIN1,Pathogenic,"Myopathy, centronuclear, 2",single nucleotide variant,GRCh38
na,na,2,127806161,127806161,BIN1,Likely pathogenic,"Myopathy, centronuclear, 2",single nucleotide variant,GRCh37
na,na,2,127048585,127048585,BIN1,Likely pathogenic,"Myopathy, centronuclear, 2",single nucleotide variant,GRCh38
na,na,2,127826558,127826558,BIN1,Conflicting classifications of pathogenicity,"Myopathy, centronuclear, 2",single nucleotide variant,GRCh37
na,na,2,127068982,127068982,BIN1,Conflicting classifications of pathogenicity,"Myopathy, centronuclear, 2",single nucleotide variant,GRCh38
na,na,19,1399807,1399808,GAMT,Pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome|Inborn genetic diseases|not provided,Duplication,GRCh37
na,na,19,1399808,1399809,GAMT,Pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome|Inborn genetic diseases|not provided,Duplication,GRCh38
na,na,19,1401417,1401417,GAMT,Pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome|See cases|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,1401418,1401418,GAMT,Pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome|See cases|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,1398979,1398979,GAMT,Likely pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome|not provided,single nucleotide variant,GRCh37
na,na,19,1398980,1398980,GAMT,Likely pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome|not provided,single nucleotide variant,GRCh38
na,na,19,1401328,1401328,GAMT,Likely pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome,single nucleotide variant,GRCh37
na,na,19,1401329,1401329,GAMT,Likely pathogenic,Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome,single nucleotide variant,GRCh38
na,na,18,32374214,32374214,DTNA,Uncertain significance,Left ventricular noncompaction 1,single nucleotide variant,GRCh37
na,na,18,34794250,34794250,DTNA,Uncertain significance,Left ventricular noncompaction 1,single nucleotide variant,GRCh38
na,na,3,142275281,142275281,ATR,Likely benign,Seckel syndrome 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,3,142556439,142556439,ATR,Likely benign,Seckel syndrome 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,14,61115522,61115522,SIX1,Pathogenic,Branchiootic syndrome 3|not provided|Autosomal dominant nonsyndromic hearing loss 23|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23;Branchiootorenal syndrome 1|SIX1-related disorder|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23|Branchiootic syndrome,single nucleotide variant,GRCh37
na,na,14,60648804,60648804,SIX1,Pathogenic,Branchiootic syndrome 3|not provided|Autosomal dominant nonsyndromic hearing loss 23|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23;Branchiootorenal syndrome 1|SIX1-related disorder|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23|Branchiootic syndrome,single nucleotide variant,GRCh38
na,na,14,61115580,61115580,SIX1,Pathogenic,Branchiootic syndrome 3|not provided|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23,single nucleotide variant,GRCh37
na,na,14,60648862,60648862,SIX1,Pathogenic,Branchiootic syndrome 3|not provided|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23,single nucleotide variant,GRCh38
na,na,14,61115509,61115511,SIX1,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 23|Branchiootic syndrome 3|not provided|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23,Deletion,GRCh37
na,na,14,60648791,60648793,SIX1,Pathogenic/Likely pathogenic,Autosomal dominant nonsyndromic hearing loss 23|Branchiootic syndrome 3|not provided|Branchiootic syndrome 3;Autosomal dominant nonsyndromic hearing loss 23,Deletion,GRCh38
na,na,14,61115544,61115544,SIX1,Pathogenic,Branchiootic syndrome 3,single nucleotide variant,GRCh37
na,na,14,60648826,60648826,SIX1,Pathogenic,Branchiootic syndrome 3,single nucleotide variant,GRCh38
na,na,3,122003184,122003184,CASR,Pathogenic/Likely pathogenic,Familial hypocalciuric hypercalcemia 1|Autosomal dominant hypocalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Primary hyperparathyroidism,single nucleotide variant,GRCh37
na,na,3,122284337,122284337,CASR,Pathogenic/Likely pathogenic,Familial hypocalciuric hypercalcemia 1|Autosomal dominant hypocalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Primary hyperparathyroidism,single nucleotide variant,GRCh38
na,na,3,121980771,121980771,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1|Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122261924,122261924,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1|Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,121980436,121980436,CASR,Pathogenic,"Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia 1|not provided|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia|CASR-related disorder",single nucleotide variant,GRCh37
na,na,3,122261589,122261589,CASR,Pathogenic,"Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia 1|not provided|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia|CASR-related disorder",single nucleotide variant,GRCh38
na,na,3,121976122,121976122,CASR,Pathogenic,"Autosomal dominant hypocalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh37
na,na,3,122257275,122257275,CASR,Pathogenic,"Autosomal dominant hypocalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh38
na,na,na,-1,-1,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1|Neonatal severe primary hyperparathyroidism,Insertion,na
na,na,3,121980562,121980562,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|CASR-related disorder|not provided,single nucleotide variant,GRCh37
na,na,3,122261715,122261715,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|CASR-related disorder|not provided,single nucleotide variant,GRCh38
na,na,3,122002546,122002546,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122283699,122283699,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,122003042,122003043,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism,Indel,GRCh37
na,na,3,122284195,122284196,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism,Indel,GRCh38
na,na,3,122002844,122002844,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122283997,122283997,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,121976088,121976088,CASR,Conflicting classifications of pathogenicity,Autosomal dominant hypocalcemia 1|not provided|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh37
na,na,3,122257241,122257241,CASR,Conflicting classifications of pathogenicity,Autosomal dominant hypocalcemia 1|not provided|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh38
na,na,3,122003218,122003218,CASR,Uncertain significance,Autosomal dominant hypocalcemia 1|Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia,single nucleotide variant,GRCh37
na,na,3,122284371,122284371,CASR,Uncertain significance,Autosomal dominant hypocalcemia 1|Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia,single nucleotide variant,GRCh38
na,na,3,121976194,121976194,CASR,Pathogenic,Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|not provided,single nucleotide variant,GRCh37
na,na,3,122257347,122257347,CASR,Pathogenic,Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|not provided,single nucleotide variant,GRCh38
na,na,3,121976096,121976096,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122257249,122257249,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,121976124,121976124,CASR,Pathogenic,Autosomal dominant hypocalcemia 1|CASR-related disorder,single nucleotide variant,GRCh37
na,na,3,122257277,122257277,CASR,Pathogenic,Autosomal dominant hypocalcemia 1|CASR-related disorder,single nucleotide variant,GRCh38
na,na,3,121980453,121980453,CASR,Likely pathogenic,"Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh37
na,na,3,122261606,122261606,CASR,Likely pathogenic,"Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh38
na,na,3,122002636,122002636,CASR,Likely pathogenic,Autosomal dominant hypocalcemia 1|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh37
na,na,3,122283789,122283789,CASR,Likely pathogenic,Autosomal dominant hypocalcemia 1|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh38
na,na,3,122003119,122003119,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122284272,122284272,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,122002810,122002810,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism,single nucleotide variant,GRCh37
na,na,3,122283963,122283963,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism,single nucleotide variant,GRCh38
na,na,3,121973151,121973151,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1,single nucleotide variant,GRCh37
na,na,3,122254304,122254304,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1,single nucleotide variant,GRCh38
na,na,3,121980562,121980562,CASR,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia|CASR-related disorder|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Nephrolithiasis/nephrocalcinosis",single nucleotide variant,GRCh37
na,na,3,122261715,122261715,CASR,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia|CASR-related disorder|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Nephrolithiasis/nephrocalcinosis",single nucleotide variant,GRCh38
na,na,3,121976155,121976155,CASR,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|CASR-related disorder|not provided|Familial hypocalciuric hypercalcemia|Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia 1;Neonatal severe primary hyperparathyroidism;Epilepsy, idiopathic generalized, susceptibility to, 8|Nephrolithiasis/nephrocalcinosis|Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia",single nucleotide variant,GRCh37
na,na,3,122257308,122257308,CASR,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|CASR-related disorder|not provided|Familial hypocalciuric hypercalcemia|Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia 1;Neonatal severe primary hyperparathyroidism;Epilepsy, idiopathic generalized, susceptibility to, 8|Nephrolithiasis/nephrocalcinosis|Autosomal dominant hypocalcemia 1;Familial hypocalciuric hypercalcemia",single nucleotide variant,GRCh38
na,na,3,121976170,121976170,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia,single nucleotide variant,GRCh37
na,na,3,122257323,122257323,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia,single nucleotide variant,GRCh38
na,na,3,121973221,121973221,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1,single nucleotide variant,GRCh37
na,na,3,122254374,122254374,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1,single nucleotide variant,GRCh38
na,na,3,121975938,121975938,CASR,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh37
na,na,3,122257091,122257091,CASR,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh38
na,na,3,122003164,122003164,CASR,Pathogenic,Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh37
na,na,3,122284317,122284317,CASR,Pathogenic,Autosomal dominant hypocalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh38
na,na,3,121973177,121973177,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122254330,122254330,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,122002647,122002647,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122283800,122283800,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,122003478,122004020,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,Deletion,GRCh37
na,na,3,122284636,122285178,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,Deletion,GRCh38
na,na,3,122003442,122003442,CASR,Likely pathogenic,Familial hypocalciuric hypercalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122284595,122284595,CASR,Likely pathogenic,Familial hypocalciuric hypercalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,122002743,122002743,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1|Neonatal severe primary hyperparathyroidism|Nephrolithiasis/nephrocalcinosis|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122283896,122283896,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1|Neonatal severe primary hyperparathyroidism|Nephrolithiasis/nephrocalcinosis|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,121975927,121975927,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh37
na,na,3,122257080,122257080,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh38
na,na,3,122003329,122003329,CASR,Likely pathogenic,Bartter syndrome with hypocalcemia|Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122284482,122284482,CASR,Likely pathogenic,Bartter syndrome with hypocalcemia|Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,121976135,121976135,CASR,Uncertain significance,Bartter syndrome with hypocalcemia|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh37
na,na,3,122257288,122257288,CASR,Uncertain significance,Bartter syndrome with hypocalcemia|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh38
na,na,3,121980435,121980435,CASR,Pathogenic,"Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh37
na,na,3,122261588,122261588,CASR,Pathogenic,"Neonatal severe primary hyperparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh38
na,na,3,121976116,121976116,CASR,Conflicting classifications of pathogenicity,"Autosomal dominant hypocalcemia 1|Bartter syndrome with hypocalcemia|not provided|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1",single nucleotide variant,GRCh37
na,na,3,122257269,122257269,CASR,Conflicting classifications of pathogenicity,"Autosomal dominant hypocalcemia 1|Bartter syndrome with hypocalcemia|not provided|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1",single nucleotide variant,GRCh38
na,na,3,122003260,122003260,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122284413,122284413,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,122003163,122003163,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122284316,122284316,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,122003757,122003757,CASR,Benign,Serum calcium level|Familial hypocalciuric hypercalcemia 1|Familial hypoparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|not specified|Neonatal severe primary hyperparathyroidism|Autosomal dominant hypocalcemia 1|Malignant tumor of breast|not provided|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh37
na,na,3,122284910,122284910,CASR,Benign,Serum calcium level|Familial hypocalciuric hypercalcemia 1|Familial hypoparathyroidism|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|not specified|Neonatal severe primary hyperparathyroidism|Autosomal dominant hypocalcemia 1|Malignant tumor of breast|not provided|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh38
na,na,3,122002611,122002611,CASR,Pathogenic,"Autosomal dominant hypocalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|CASR-related disorder|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Autosomal dominant hypocalcemia|Nephrolithiasis/nephrocalcinosis",single nucleotide variant,GRCh37
na,na,3,122283764,122283764,CASR,Pathogenic,"Autosomal dominant hypocalcemia 1|not provided|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|CASR-related disorder|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Autosomal dominant hypocalcemia|Nephrolithiasis/nephrocalcinosis",single nucleotide variant,GRCh38
na,na,3,121976022,121976022,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism,single nucleotide variant,GRCh37
na,na,3,122257175,122257175,CASR,Pathogenic,Neonatal severe primary hyperparathyroidism,single nucleotide variant,GRCh38
na,na,3,121994675,121994675,CASR,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|not provided|Nephrolithiasis/nephrocalcinosis|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh37
na,na,3,122275828,122275828,CASR,Pathogenic/Likely pathogenic,"Familial hypocalciuric hypercalcemia 1|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|not provided|Nephrolithiasis/nephrocalcinosis|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8",single nucleotide variant,GRCh38
na,na,3,121973074,121973074,CASR,Uncertain significance,Familial hypocalciuric hypercalcemia 1|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh37
na,na,3,122254227,122254227,CASR,Uncertain significance,Familial hypocalciuric hypercalcemia 1|Nephrolithiasis/nephrocalcinosis,single nucleotide variant,GRCh38
na,na,3,122002981,122002981,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh37
na,na,3,122284134,122284134,CASR,Pathogenic,Autosomal dominant hypocalcemia 1,single nucleotide variant,GRCh38
na,na,3,121980421,121980421,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1,single nucleotide variant,GRCh37
na,na,3,122261574,122261574,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1,single nucleotide variant,GRCh38
na,na,3,122002546,122002546,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1,single nucleotide variant,GRCh37
na,na,3,122283699,122283699,CASR,Pathogenic,Familial hypocalciuric hypercalcemia 1,single nucleotide variant,GRCh38
na,na,3,122001008,122001008,CASR,Likely pathogenic,Familial hypocalciuric hypercalcemia 1|not provided,single nucleotide variant,GRCh37
na,na,3,122282161,122282161,CASR,Likely pathogenic,Familial hypocalciuric hypercalcemia 1|not provided,single nucleotide variant,GRCh38
na,na,3,122003494,122003494,CASR,Uncertain significance,"Epilepsy, idiopathic generalized, susceptibility to, 8|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Nephrolithiasis/nephrocalcinosis",single nucleotide variant,GRCh37
na,na,3,122284647,122284647,CASR,Uncertain significance,"Epilepsy, idiopathic generalized, susceptibility to, 8|Familial hypocalciuric hypercalcemia;Autosomal dominant hypocalcemia 1|Neonatal severe primary hyperparathyroidism;Familial hypocalciuric hypercalcemia 1;Autosomal dominant hypocalcemia 1;Epilepsy, idiopathic generalized, susceptibility to, 8|Nephrolithiasis/nephrocalcinosis",single nucleotide variant,GRCh38
na,na,4,38798648,38798648,TLR1,Conflicting classifications of pathogenicity; protective,"Leprosy, protection against|TLR1-related disorder|Leprosy, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,4,38797027,38797027,TLR1,Conflicting classifications of pathogenicity; protective,"Leprosy, protection against|TLR1-related disorder|Leprosy, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,4,38799710,38799710,TLR1,Benign; risk factor,"Leprosy, susceptibility to, 5|TLR1-related disorder",single nucleotide variant,GRCh37
na,na,4,38798089,38798089,TLR1,Benign; risk factor,"Leprosy, susceptibility to, 5|TLR1-related disorder",single nucleotide variant,GRCh38
na,na,2,109368449,109368449,RANBP2,Pathogenic/Likely pathogenic,Familial acute necrotizing encephalopathy|not provided|See cases,single nucleotide variant,GRCh37
na,na,2,108751993,108751993,RANBP2,Pathogenic/Likely pathogenic,Familial acute necrotizing encephalopathy|not provided|See cases,single nucleotide variant,GRCh38
na,na,2,109369922,109369922,RANBP2,risk factor,Familial acute necrotizing encephalopathy,single nucleotide variant,GRCh37
na,na,2,108753466,108753466,RANBP2,risk factor,Familial acute necrotizing encephalopathy,single nucleotide variant,GRCh38
na,na,2,109369930,109369930,RANBP2,Conflicting classifications of pathogenicity,Familial acute necrotizing encephalopathy|not provided,single nucleotide variant,GRCh37
na,na,2,108753474,108753474,RANBP2,Conflicting classifications of pathogenicity,Familial acute necrotizing encephalopathy|not provided,single nucleotide variant,GRCh38
na,na,1,94375309,94375309,GCLM,risk factor,"Myocardial infarction, susceptibility to",single nucleotide variant,GRCh37
na,na,1,93909753,93909753,GCLM,risk factor,"Myocardial infarction, susceptibility to",single nucleotide variant,GRCh38
na,na,17,32611446,32611446,CCL11,protective,Susceptibility to HIV infection,single nucleotide variant,GRCh37
na,na,17,34284427,34284427,CCL11,protective,Susceptibility to HIV infection,single nucleotide variant,GRCh38
na,na,17,32601834,32601835,CCL11,risk factor,Inherited susceptibility to asthma,Microsatellite,GRCh37
na,na,17,34274815,34274816,CCL11,risk factor,Inherited susceptibility to asthma,Microsatellite,GRCh38
na,na,12,31255247,31255247,DDX11,Pathogenic,Warsaw breakage syndrome,single nucleotide variant,GRCh37
na,na,12,31102313,31102313,DDX11,Pathogenic,Warsaw breakage syndrome,single nucleotide variant,GRCh38
na,na,12,31256661,31256663,DDX11,Pathogenic,Warsaw breakage syndrome,Deletion,GRCh37
na,na,12,31103727,31103729,DDX11,Pathogenic,Warsaw breakage syndrome,Deletion,GRCh38
na,na,8,97157413,97157413,GDF6,Conflicting classifications of pathogenicity,"Klippel-Feil syndrome 1, autosomal dominant|Isolated microphthalmia 4|Leber congenital amaurosis 17|Klippel-Feil syndrome|not specified|not provided|Klippel-Feil syndrome 1, autosomal dominant;Congenital anomaly of kidney and urinary tract|Isolated microphthalmia 4;Leber congenital amaurosis 17;Klippel-Feil syndrome 1, autosomal dominant;Microphthalmia, isolated, with coloboma 6|Congenital anomaly of kidney and urinary tract|GDF6-related disorder|Isolated microphthalmia 4;Multiple synostoses syndrome 4;Leber congenital amaurosis 17;Klippel-Feil syndrome 1, autosomal dominant;Microphthalmia, isolated, with coloboma 6|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,8,96145185,96145185,GDF6,Conflicting classifications of pathogenicity,"Klippel-Feil syndrome 1, autosomal dominant|Isolated microphthalmia 4|Leber congenital amaurosis 17|Klippel-Feil syndrome|not specified|not provided|Klippel-Feil syndrome 1, autosomal dominant;Congenital anomaly of kidney and urinary tract|Isolated microphthalmia 4;Leber congenital amaurosis 17;Klippel-Feil syndrome 1, autosomal dominant;Microphthalmia, isolated, with coloboma 6|Congenital anomaly of kidney and urinary tract|GDF6-related disorder|Isolated microphthalmia 4;Multiple synostoses syndrome 4;Leber congenital amaurosis 17;Klippel-Feil syndrome 1, autosomal dominant;Microphthalmia, isolated, with coloboma 6|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,8,97157293,97157293,GDF6,Conflicting classifications of pathogenicity,"Klippel-Feil syndrome 1, autosomal dominant|not provided|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17|GDF6-related disorder|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Multiple synostoses syndrome 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh37
na,na,8,96145065,96145065,GDF6,Conflicting classifications of pathogenicity,"Klippel-Feil syndrome 1, autosomal dominant|not provided|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17|GDF6-related disorder|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Multiple synostoses syndrome 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh38
na,na,8,97156888,97156888,GDF6,Conflicting classifications of pathogenicity,"Klippel-Feil syndrome 1, autosomal dominant|Klippel-Feil syndrome|Klippel-Feil syndrome 1, autosomal dominant;Autosomal dominant Parkinson disease 8|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17|Leber congenital amaurosis 17|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Multiple synostoses syndrome 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh37
na,na,8,96144660,96144660,GDF6,Conflicting classifications of pathogenicity,"Klippel-Feil syndrome 1, autosomal dominant|Klippel-Feil syndrome|Klippel-Feil syndrome 1, autosomal dominant;Autosomal dominant Parkinson disease 8|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17|Leber congenital amaurosis 17|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Multiple synostoses syndrome 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh38
na,na,8,97172796,97172796,GDF6,Likely benign,"Klippel-Feil syndrome 1, autosomal dominant|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh37
na,na,8,96160568,96160568,GDF6,Likely benign,"Klippel-Feil syndrome 1, autosomal dominant|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh38
na,na,8,97157401,97157401,GDF6,Uncertain significance,"Isolated microphthalmia 4|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh37
na,na,8,96145173,96145173,GDF6,Uncertain significance,"Isolated microphthalmia 4|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh38
na,na,8,97157179,97157179,GDF6,Benign,"Isolated microphthalmia 4|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh37
na,na,8,96144951,96144951,GDF6,Benign,"Isolated microphthalmia 4|Klippel-Feil syndrome 1, autosomal dominant;Isolated microphthalmia 4;Microphthalmia, isolated, with coloboma 6;Leber congenital amaurosis 17",single nucleotide variant,GRCh38
na,na,na,-1,-1,GDF5,Pathogenic,"Acromesomelic dysplasia 2C, Hunter-Thompson type",Duplication,na
na,na,20,34022312,34022312,GDF5,Pathogenic/Likely pathogenic,Brachydactyly type C|not provided|Multiple synostoses syndrome 2,single nucleotide variant,GRCh37
na,na,20,35434514,35434514,GDF5,Pathogenic/Likely pathogenic,Brachydactyly type C|not provided|Multiple synostoses syndrome 2,single nucleotide variant,GRCh38
na,na,20,34022014,34022014,GDF5,Likely pathogenic,Grebe syndrome|Brachydactyly type A1C,single nucleotide variant,GRCh37
na,na,20,35434216,35434216,GDF5,Likely pathogenic,Grebe syndrome|Brachydactyly type A1C,single nucleotide variant,GRCh38
na,na,20,34025411,34025412,GDF5,Pathogenic,Grebe syndrome,Duplication,GRCh37
na,na,20,35437631,35437632,GDF5,Pathogenic,Grebe syndrome,Duplication,GRCh38
na,na,20,34021891,34021891,GDF5,Pathogenic,"Acromesomelic dysplasia 2B|Type A2 brachydactyly|not provided|Symphalangism, proximal, 1B",single nucleotide variant,GRCh37
na,na,20,35434093,35434093,GDF5,Pathogenic,"Acromesomelic dysplasia 2B|Type A2 brachydactyly|not provided|Symphalangism, proximal, 1B",single nucleotide variant,GRCh38
na,na,na,-1,-1,GDF5,Pathogenic,Brachydactyly type C,Insertion,na
na,na,20,34025192,34025192,GDF5,Pathogenic,Brachydactyly type C,single nucleotide variant,GRCh37
na,na,20,35437412,35437412,GDF5,Pathogenic,Brachydactyly type C,single nucleotide variant,GRCh38
na,na,20,34025503,34025504,GDF5,Pathogenic,Brachydactyly type C|not provided,Duplication,GRCh37
na,na,20,35437723,35437724,GDF5,Pathogenic,Brachydactyly type C|not provided,Duplication,GRCh38
na,na,20,34021900,34021900,GDF5,Pathogenic,"Symphalangism, proximal, 1B|Multiple synostoses syndrome 2|not provided",single nucleotide variant,GRCh37
na,na,20,35434102,35434102,GDF5,Pathogenic,"Symphalangism, proximal, 1B|Multiple synostoses syndrome 2|not provided",single nucleotide variant,GRCh38
na,na,20,34021898,34021898,GDF5,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,20,35434100,35434100,GDF5,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,20,34021789,34021789,GDF5,Pathogenic,Multiple synostoses syndrome 2,single nucleotide variant,GRCh37
na,na,20,35433991,35433991,GDF5,Pathogenic,Multiple synostoses syndrome 2,single nucleotide variant,GRCh38
na,na,20,34021742,34021742,GDF5,Pathogenic,"Symphalangism, proximal, 1B|not provided",single nucleotide variant,GRCh37
na,na,20,35433944,35433944,GDF5,Pathogenic,"Symphalangism, proximal, 1B|not provided",single nucleotide variant,GRCh38
na,na,20,34025983,34025983,GDF5,Benign,"Acromesomelic dysplasia 2C, Hunter-Thompson type|Acromesomelic dysplasia 2B|Brachydactyly|Grebe syndrome|Multiple synostoses syndrome 2|not provided|Osteoarthritis susceptibility 5",single nucleotide variant,GRCh37
na,na,20,35438203,35438203,GDF5,Benign,"Acromesomelic dysplasia 2C, Hunter-Thompson type|Acromesomelic dysplasia 2B|Brachydactyly|Grebe syndrome|Multiple synostoses syndrome 2|not provided|Osteoarthritis susceptibility 5",single nucleotide variant,GRCh38
na,na,20,34021752,34021752,GDF5,Pathogenic,Brachydactyly type C,single nucleotide variant,GRCh37
na,na,20,35433954,35433954,GDF5,Pathogenic,Brachydactyly type C,single nucleotide variant,GRCh38
na,na,20,34022095,34022095,GDF5,Pathogenic,"Symphalangism, proximal, 1B",single nucleotide variant,GRCh37
na,na,20,35434297,35434297,GDF5,Pathogenic,"Symphalangism, proximal, 1B",single nucleotide variant,GRCh38
na,na,20,34022080,34022080,GDF5,Pathogenic,Acromesomelic dysplasia 2B,single nucleotide variant,GRCh37
na,na,20,35434282,35434282,GDF5,Pathogenic,Acromesomelic dysplasia 2B,single nucleotide variant,GRCh38
na,na,20,34021907,34021907,GDF5,Pathogenic,Acromesomelic dysplasia 2B,single nucleotide variant,GRCh37
na,na,20,35434109,35434109,GDF5,Pathogenic,Acromesomelic dysplasia 2B,single nucleotide variant,GRCh38
na,na,21,45194641,45194641,CSTB,Pathogenic,Unverricht-Lundborg syndrome|not provided|Inborn genetic diseases|Progressive myoclonic epilepsy|Chorea;Dyskinesia|Cerebral dysmyelination;Encephalopathy;Microcephaly,single nucleotide variant,GRCh37
na,na,21,43774760,43774760,CSTB,Pathogenic,Unverricht-Lundborg syndrome|not provided|Inborn genetic diseases|Progressive myoclonic epilepsy|Chorea;Dyskinesia|Cerebral dysmyelination;Encephalopathy;Microcephaly,single nucleotide variant,GRCh38
na,na,21,45194178,45194178,CSTB,Pathogenic,Unverricht-Lundborg syndrome|8 conditions|Self-limited epilepsy with centrotemporal spikes|Progressive myoclonic epilepsy|not provided,single nucleotide variant,GRCh37
na,na,21,43774297,43774297,CSTB,Pathogenic,Unverricht-Lundborg syndrome|8 conditions|Self-limited epilepsy with centrotemporal spikes|Progressive myoclonic epilepsy|not provided,single nucleotide variant,GRCh38
na,na,21,45196141,45196141,CSTB,Pathogenic,Unverricht-Lundborg syndrome,single nucleotide variant,GRCh37
na,na,21,43776260,43776260,CSTB,Pathogenic,Unverricht-Lundborg syndrome,single nucleotide variant,GRCh38
CGCGGGGCGGGG,na,21,45196360,45196371,CSTB,Pathogenic,Unverricht-Lundborg syndrome,Microsatellite,GRCh37
CGCGGGGCGGGG,na,21,43776479,43776490,CSTB,Pathogenic,Unverricht-Lundborg syndrome,Microsatellite,GRCh38
na,na,21,45194168,45194168,CSTB,Pathogenic,Unverricht-Lundborg syndrome,single nucleotide variant,GRCh37
na,na,21,43774287,43774287,CSTB,Pathogenic,Unverricht-Lundborg syndrome,single nucleotide variant,GRCh38
na,na,2,74605231,74605231,DCTN1,Pathogenic,"Neuronopathy, distal hereditary motor, type 7B|Hereditary motor neuron disease|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|Perry syndrome",single nucleotide variant,GRCh37
na,na,2,74378104,74378104,DCTN1,Pathogenic,"Neuronopathy, distal hereditary motor, type 7B|Hereditary motor neuron disease|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|Perry syndrome",single nucleotide variant,GRCh38
na,na,2,74588717,74588717,DCTN1,Benign/Likely benign,"Amyotrophic lateral sclerosis, susceptibility to|not provided|Perry syndrome|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|Amyotrophic lateral sclerosis type 1|Neuronopathy, distal hereditary motor, type 7B|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,2,74361590,74361590,DCTN1,Benign/Likely benign,"Amyotrophic lateral sclerosis, susceptibility to|not provided|Perry syndrome|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|Amyotrophic lateral sclerosis type 1|Neuronopathy, distal hereditary motor, type 7B|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,2,74595997,74595997,DCTN1,Uncertain significance; risk factor,"Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome",single nucleotide variant,GRCh37
na,na,2,74368870,74368870,DCTN1,Uncertain significance; risk factor,"Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome",single nucleotide variant,GRCh38
na,na,2,74594023,74594023,DCTN1,Conflicting classifications of pathogenicity,"Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|not provided|Charcot-Marie-Tooth disease|Amyotrophic lateral sclerosis type 1|Neuronopathy, distal hereditary motor, type 7B|Perry syndrome|Inborn genetic diseases|DCTN1-related disorder",single nucleotide variant,GRCh37
na,na,2,74366896,74366896,DCTN1,Conflicting classifications of pathogenicity,"Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|not provided|Charcot-Marie-Tooth disease|Amyotrophic lateral sclerosis type 1|Neuronopathy, distal hereditary motor, type 7B|Perry syndrome|Inborn genetic diseases|DCTN1-related disorder",single nucleotide variant,GRCh38
na,na,2,74590464,74590464,DCTN1,Uncertain significance,"Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|Inborn genetic diseases|Perry syndrome|not specified",single nucleotide variant,GRCh37
na,na,2,74363337,74363337,DCTN1,Uncertain significance,"Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome;Neuronopathy, distal hereditary motor, type 7B;Amyotrophic lateral sclerosis type 1|Inborn genetic diseases|Perry syndrome|not specified",single nucleotide variant,GRCh38
na,na,2,74605195,74605195,DCTN1,Conflicting classifications of pathogenicity,"Perry syndrome|Neuronopathy, distal hereditary motor, type 7B",single nucleotide variant,GRCh37
na,na,2,74378068,74378068,DCTN1,Conflicting classifications of pathogenicity,"Perry syndrome|Neuronopathy, distal hereditary motor, type 7B",single nucleotide variant,GRCh38
na,na,2,74605185,74605185,DCTN1,Pathogenic,Perry syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,74378058,74378058,DCTN1,Pathogenic,Perry syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,96741053,96741053,CYP2C9,drug response; other,not provided|Tolbutamide response|Warfarin response|Phenytoin response|Glipizide response|Lesinurad response|Flurbiprofen response|Piroxicam response,single nucleotide variant,GRCh37
na,na,10,94981296,94981296,CYP2C9,drug response; other,not provided|Tolbutamide response|Warfarin response|Phenytoin response|Glipizide response|Lesinurad response|Flurbiprofen response|Piroxicam response,single nucleotide variant,GRCh38
na,na,10,96702047,96702047,CYP2C9,Likely benign; drug response; other,Warfarin response|not provided|Piroxicam response|not specified|Flurbiprofen response|Lesinurad response|Phenytoin response,single nucleotide variant,GRCh37
na,na,10,94942290,94942290,CYP2C9,Likely benign; drug response; other,Warfarin response|not provided|Piroxicam response|not specified|Flurbiprofen response|Lesinurad response|Phenytoin response,single nucleotide variant,GRCh38
na,na,10,96707676,96707676,CYP2C9,Pathogenic,Warfarin response,single nucleotide variant,GRCh37
na,na,10,94947919,94947919,CYP2C9,Pathogenic,Warfarin response,single nucleotide variant,GRCh38
na,na,10,96826971,96826971,CYP2C8,Pathogenic,"DRUG METABOLISM, ALTERED, CYP2C8-RELATED",Deletion,GRCh37
na,na,10,95067214,95067214,CYP2C8,Pathogenic,"DRUG METABOLISM, ALTERED, CYP2C8-RELATED",Deletion,GRCh38
na,na,10,101578577,101578577,ABCC2,Pathogenic/Likely pathogenic,Dubin-Johnson syndrome|not provided|ABCC2-related disorder,single nucleotide variant,GRCh37
na,na,10,99818820,99818820,ABCC2,Pathogenic/Likely pathogenic,Dubin-Johnson syndrome|not provided|ABCC2-related disorder,single nucleotide variant,GRCh38
na,na,10,101567988,101567988,ABCC2,Pathogenic,Dubin-Johnson syndrome,single nucleotide variant,GRCh37
na,na,10,99808231,99808231,ABCC2,Pathogenic,Dubin-Johnson syndrome,single nucleotide variant,GRCh38
na,na,10,101578716,101578716,ABCC2,Pathogenic,Dubin-Johnson syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,99818959,99818959,ABCC2,Pathogenic,Dubin-Johnson syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,101605538,101605538,ABCC2,Likely pathogenic,Dubin-Johnson syndrome|ABCC2-related disorder,single nucleotide variant,GRCh37
na,na,10,99845781,99845781,ABCC2,Likely pathogenic,Dubin-Johnson syndrome|ABCC2-related disorder,single nucleotide variant,GRCh38
na,na,10,101571361,101571361,ABCC2,Pathogenic,Dubin-Johnson syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,99811604,99811604,ABCC2,Pathogenic,Dubin-Johnson syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,101595950,101595950,ABCC2,Pathogenic,Dubin-Johnson syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,99836193,99836193,ABCC2,Pathogenic,Dubin-Johnson syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,101595882,101595882,ABCC2,Pathogenic/Likely pathogenic,Dubin-Johnson syndrome|ABCC2-related disorder|not provided,single nucleotide variant,GRCh37
na,na,10,99836125,99836125,ABCC2,Pathogenic/Likely pathogenic,Dubin-Johnson syndrome|ABCC2-related disorder|not provided,single nucleotide variant,GRCh38
na,na,1,150769275,150769275,CTSK,Pathogenic,Pyknodysostosis,single nucleotide variant,GRCh37
na,na,1,150796799,150796799,CTSK,Pathogenic,Pyknodysostosis,single nucleotide variant,GRCh38
na,na,1,150776679,150776679,CTSK,Pathogenic,not provided|Pyknodysostosis|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,1,150804203,150804203,CTSK,Pathogenic,not provided|Pyknodysostosis|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,150772083,150772083,CTSK,Pathogenic/Likely pathogenic,Pyknodysostosis|not provided,single nucleotide variant,GRCh37
na,na,1,150799607,150799607,CTSK,Pathogenic/Likely pathogenic,Pyknodysostosis|not provided,single nucleotide variant,GRCh38
na,na,1,150771704,150771704,CTSK,Pathogenic,Pyknodysostosis,single nucleotide variant,GRCh37
na,na,1,150799228,150799228,CTSK,Pathogenic,Pyknodysostosis,single nucleotide variant,GRCh38
na,na,1,150778585,150778585,CTSK,Pathogenic,Pyknodysostosis,single nucleotide variant,GRCh37
na,na,1,150806109,150806109,CTSK,Pathogenic,Pyknodysostosis,single nucleotide variant,GRCh38
na,na,1,150778667,150778667,CTSK,Pathogenic,Pyknodysostosis,single nucleotide variant,GRCh37
na,na,1,150806191,150806191,CTSK,Pathogenic,Pyknodysostosis,single nucleotide variant,GRCh38
na,na,1,150769339,150769339,CTSK,Pathogenic/Likely pathogenic,Pyknodysostosis|not provided,single nucleotide variant,GRCh37
na,na,1,150796863,150796863,CTSK,Pathogenic/Likely pathogenic,Pyknodysostosis|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,PMP22,Pathogenic,"Charcot-Marie-Tooth disease, type IA|Roussy-Lévy syndrome",Duplication,na
na,na,17,15163998,15163998,PMP22,Pathogenic,"Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh37
na,na,17,15260681,15260681,PMP22,Pathogenic,"Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh38
na,na,17,15142871,15142871,PMP22,Pathogenic,"Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh37
na,na,17,15239554,15239554,PMP22,Pathogenic,"Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh38
na,na,17,14170534,15591587,PMP22,Pathogenic,"Hereditary liability to pressure palsies|Polyneuropathy, inflammatory demyelinating|Autosomal recessive Dejerine-Sottas syndrome",Deletion,GRCh38
na,na,17,15134364,15134364,PMP22,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease, type 1a, autosomal recessive|Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type IA|not specified|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease|Tip-toe gait|6 conditions",single nucleotide variant,GRCh37
na,na,17,15231047,15231047,PMP22,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease, type 1a, autosomal recessive|Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type IA|not specified|Charcot-Marie-Tooth disease, type I|not provided|Charcot-Marie-Tooth disease|Tip-toe gait|6 conditions",single nucleotide variant,GRCh38
na,na,17,15142901,15142901,PMP22,Pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, type IA",single nucleotide variant,GRCh37
na,na,17,15239584,15239584,PMP22,Pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|not provided|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease, type IA",single nucleotide variant,GRCh38
na,na,17,15142892,15142892,PMP22,Pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|Charcot-Marie-Tooth disease, type I|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease, type IA",single nucleotide variant,GRCh37
na,na,17,15239575,15239575,PMP22,Pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|Charcot-Marie-Tooth disease, type I|not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease, type IA",single nucleotide variant,GRCh38
na,na,17,15164009,15164009,PMP22,Pathogenic/Likely pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|Charcot-Marie-Tooth disease, type I|Inborn genetic diseases|Dejerine-Sottas disease|Roussy-Lévy syndrome",single nucleotide variant,GRCh37
na,na,17,15260692,15260692,PMP22,Pathogenic/Likely pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|Charcot-Marie-Tooth disease, type I|Inborn genetic diseases|Dejerine-Sottas disease|Roussy-Lévy syndrome",single nucleotide variant,GRCh38
na,na,17,15164025,15164026,PMP22,Conflicting classifications of pathogenicity,Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease,Deletion,GRCh37
na,na,17,15260708,15260709,PMP22,Conflicting classifications of pathogenicity,Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease,Deletion,GRCh38
na,na,17,15142908,15142908,PMP22,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 1E|not provided|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh37
na,na,17,15239591,15239591,PMP22,Pathogenic/Likely pathogenic,"Charcot-Marie-Tooth disease type 1E|not provided|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh38
na,na,17,15142825,15142826,PMP22,Pathogenic/Likely pathogenic,"Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|not provided",Duplication,GRCh37
na,na,17,15239508,15239509,PMP22,Pathogenic/Likely pathogenic,"Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I|Charcot-Marie-Tooth disease|not provided",Duplication,GRCh38
na,na,17,15142868,15142869,PMP22,Pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT",Microsatellite,GRCh37
na,na,17,15239551,15239552,PMP22,Pathogenic,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT",Microsatellite,GRCh38
na,na,17,15134269,15134269,PMP22,Conflicting classifications of pathogenicity,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|not provided|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh37
na,na,17,15230952,15230952,PMP22,Conflicting classifications of pathogenicity,"DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT|not provided|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh38
na,na,17,15162507,15162507,PMP22,Likely pathogenic,"Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease, type I|not provided",single nucleotide variant,GRCh37
na,na,17,15259190,15259190,PMP22,Likely pathogenic,"Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease, type I|not provided",single nucleotide variant,GRCh38
na,na,17,15134362,15134373,PMP22,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease,Deletion,GRCh37
na,na,17,15231045,15231056,PMP22,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease,Deletion,GRCh38
na,na,17,15162479,15162479,PMP22,Pathogenic,"Charcot-Marie-Tooth disease, type 1a, with focally folded myelin sheaths",single nucleotide variant,GRCh37
na,na,17,15259162,15259162,PMP22,Pathogenic,"Charcot-Marie-Tooth disease, type 1a, with focally folded myelin sheaths",single nucleotide variant,GRCh38
na,na,17,15142908,15142908,PMP22,Conflicting classifications of pathogenicity,"Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh37
na,na,17,15239591,15239591,PMP22,Conflicting classifications of pathogenicity,"Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I",single nucleotide variant,GRCh38
na,na,17,15134248,15134248,PMP22,Pathogenic/Likely pathogenic,"Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Hereditary liability to pressure palsies",single nucleotide variant,GRCh37
na,na,17,15230931,15230931,PMP22,Pathogenic/Likely pathogenic,"Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type I|Hereditary liability to pressure palsies",single nucleotide variant,GRCh38
na,na,17,15163980,15163980,PMP22,Pathogenic,"Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type IA",single nucleotide variant,GRCh37
na,na,17,15260663,15260663,PMP22,Pathogenic,"Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type IA",single nucleotide variant,GRCh38
na,na,17,15239612,15260727,PMP22,Pathogenic,Autosomal recessive Dejerine-Sottas syndrome|Hereditary liability to pressure palsies,Deletion,GRCh38
na,na,1,47882925,47882926,FOXE3,Pathogenic,Congenital primary aphakia,Duplication,GRCh37
na,na,1,47417253,47417254,FOXE3,Pathogenic,Congenital primary aphakia,Duplication,GRCh38
na,na,1,47882707,47882707,FOXE3,Pathogenic,Congenital primary aphakia|not provided|Anterior segment dysgenesis,single nucleotide variant,GRCh37
na,na,1,47417035,47417035,FOXE3,Pathogenic,Congenital primary aphakia|not provided|Anterior segment dysgenesis,single nucleotide variant,GRCh38
na,na,5,169535251,169535251,FOXI1,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 4|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome,single nucleotide variant,GRCh37
na,na,5,170108247,170108247,FOXI1,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 4|not provided|Autosomal recessive nonsyndromic hearing loss 4;Pendred syndrome,single nucleotide variant,GRCh38
na,na,5,169535278,169535278,FOXI1,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome,single nucleotide variant,GRCh37
na,na,5,170108274,170108274,FOXI1,Uncertain significance,Autosomal recessive nonsyndromic hearing loss 4|Pendred syndrome,single nucleotide variant,GRCh38
na,na,6,1610831,1610841,FOXC1,Pathogenic,Anterior segment dysgenesis 3,Deletion,GRCh37
na,na,6,1610596,1610606,FOXC1,Pathogenic,Anterior segment dysgenesis 3,Deletion,GRCh38
na,na,6,1611072,1611072,FOXC1,Pathogenic,Anterior segment dysgenesis 3|Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh37
na,na,6,1610837,1610837,FOXC1,Pathogenic,Anterior segment dysgenesis 3|Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh38
na,na,6,1611058,1611058,FOXC1,Pathogenic,Anterior segment dysgenesis 3,single nucleotide variant,GRCh37
na,na,6,1610823,1610823,FOXC1,Pathogenic,Anterior segment dysgenesis 3,single nucleotide variant,GRCh38
na,na,6,1611015,1611015,FOXC1,Pathogenic,Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh37
na,na,6,1610780,1610780,FOXC1,Pathogenic,Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh38
na,na,6,1610747,1610747,FOXC1,Pathogenic,Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh37
na,na,6,1610512,1610512,FOXC1,Pathogenic,Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh38
na,na,na,-1,-1,FOXC1,Pathogenic,Anterior segment dysgenesis 3,Duplication,na
na,na,na,-1,-1,FOXC1,Pathogenic,Anterior segment dysgenesis 3,Insertion,na
na,na,6,1610925,1610925,FOXC1,Pathogenic,Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh37
na,na,6,1610690,1610690,FOXC1,Pathogenic,Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh38
na,na,6,1610941,1610941,FOXC1,Pathogenic,Anterior segment dysgenesis 3,single nucleotide variant,GRCh37
na,na,6,1610706,1610706,FOXC1,Pathogenic,Anterior segment dysgenesis 3,single nucleotide variant,GRCh38
na,na,6,1611068,1611068,FOXC1,Conflicting classifications of pathogenicity,Axenfeld-Rieger syndrome type 3|not provided,single nucleotide variant,GRCh37
na,na,6,1610833,1610833,FOXC1,Conflicting classifications of pathogenicity,Axenfeld-Rieger syndrome type 3|not provided,single nucleotide variant,GRCh38
na,na,6,1611038,1611038,FOXC1,Pathogenic,Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh37
na,na,6,1610803,1610803,FOXC1,Pathogenic,Axenfeld-Rieger syndrome type 3,single nucleotide variant,GRCh38
na,na,16,86544400,86544400,FOXF1,Pathogenic,Alveolar capillary dysplasia with pulmonary venous misalignment,single nucleotide variant,GRCh37
na,na,16,86510794,86510794,FOXF1,Pathogenic,Alveolar capillary dysplasia with pulmonary venous misalignment,single nucleotide variant,GRCh38
na,na,16,86546689,86546689,FOXF1,Pathogenic,Alveolar capillary dysplasia with pulmonary venous misalignment,single nucleotide variant,GRCh37
na,na,16,86513083,86513083,FOXF1,Pathogenic,Alveolar capillary dysplasia with pulmonary venous misalignment,single nucleotide variant,GRCh38
na,na,16,86545023,86545024,FOXF1,Pathogenic,Alveolar capillary dysplasia with pulmonary venous misalignment,Duplication,GRCh37
na,na,16,86511417,86511418,FOXF1,Pathogenic,Alveolar capillary dysplasia with pulmonary venous misalignment,Duplication,GRCh38
na,na,16,70302259,70302259,AARS1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease axonal type 2N|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|not provided|AARS1-related disorder,single nucleotide variant,GRCh37
na,na,16,70268356,70268356,AARS1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease axonal type 2N|Charcot-Marie-Tooth disease type 2|Charcot-Marie-Tooth disease|not provided|AARS1-related disorder,single nucleotide variant,GRCh38
na,na,7,116166660,116166660,CAV1,Pathogenic,"Congenital generalized lipodystrophy type 3|Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome",single nucleotide variant,GRCh37
na,na,7,116526606,116526606,CAV1,Pathogenic,"Congenital generalized lipodystrophy type 3|Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome",single nucleotide variant,GRCh38
na,na,9,35065360,35065360,VCP,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,35065363,35065363,VCP,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,35065361,35065361,VCP,Pathogenic/Likely pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,GRCh37
na,na,9,35065364,35065364,VCP,Pathogenic/Likely pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6,single nucleotide variant,GRCh38
na,na,9,35064164,35064164,VCP,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided,single nucleotide variant,GRCh37
na,na,9,35064167,35064167,VCP,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided,single nucleotide variant,GRCh38
na,na,9,35067907,35067907,VCP,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,single nucleotide variant,GRCh37
na,na,9,35067910,35067910,VCP,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,single nucleotide variant,GRCh38
na,na,9,35065360,35065360,VCP,Conflicting classifications of pathogenicity,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|not provided,single nucleotide variant,GRCh37
na,na,9,35065363,35065363,VCP,Conflicting classifications of pathogenicity,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia|not provided,single nucleotide variant,GRCh38
na,na,9,35065252,35065252,VCP,Pathogenic/Likely pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Charcot-Marie-Tooth disease type 2Y;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1,single nucleotide variant,GRCh37
na,na,9,35065255,35065255,VCP,Pathogenic/Likely pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Charcot-Marie-Tooth disease type 2Y;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1,single nucleotide variant,GRCh38
na,na,9,35065348,35065348,VCP,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|VCP-related disorder,single nucleotide variant,GRCh37
na,na,9,35065351,35065351,VCP,Pathogenic,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1|not provided|Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|Frontotemporal dementia and/or amyotrophic lateral sclerosis 6|VCP-related disorder,single nucleotide variant,GRCh38
na,na,6,31515340,31515340,NFKBIL1,risk factor,Rheumatoid arthritis,single nucleotide variant,GRCh37
na,na,6,31547563,31547563,NFKBIL1,risk factor,Rheumatoid arthritis,single nucleotide variant,GRCh38
na,na,20,31998009,31998009,SNTA1,Conflicting classifications of pathogenicity,Long QT syndrome 12|not provided|Atrial fibrillation;Long QT syndrome|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,20,33410203,33410203,SNTA1,Conflicting classifications of pathogenicity,Long QT syndrome 12|not provided|Atrial fibrillation;Long QT syndrome|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,14,74959920,74959920,NPC2,Pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,14,74493217,74493217,NPC2,Pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,14,74953027,74953027,NPC2,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C2",single nucleotide variant,GRCh37
na,na,14,74486324,74486324,NPC2,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C2",single nucleotide variant,GRCh38
na,na,14,74951129,74951129,NPC2,Pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,14,74484426,74484426,NPC2,Pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,14,74951282,74951282,NPC2,Pathogenic,"Niemann-Pick disease, type C2",single nucleotide variant,GRCh37
na,na,14,74484579,74484579,NPC2,Pathogenic,"Niemann-Pick disease, type C2",single nucleotide variant,GRCh38
na,na,14,74953107,74953107,NPC2,Uncertain significance,"Niemann-Pick disease, type C2|NPC2-related disorder",single nucleotide variant,GRCh37
na,na,14,74486404,74486404,NPC2,Uncertain significance,"Niemann-Pick disease, type C2|NPC2-related disorder",single nucleotide variant,GRCh38
na,na,14,74947410,74947410,NPC2,Pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,14,74480707,74480707,NPC2,Pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,14,74951123,74951123,NPC2,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C1|Niemann-Pick disease, type C",single nucleotide variant,GRCh37
na,na,14,74484420,74484420,NPC2,Pathogenic/Likely pathogenic,"Niemann-Pick disease, type C2|Niemann-Pick disease, type C1|Niemann-Pick disease, type C",single nucleotide variant,GRCh38
na,na,19,13482558,13482558,CACNA1A,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|not provided",single nucleotide variant,GRCh37
na,na,19,13371744,13371744,CACNA1A,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|not provided",single nucleotide variant,GRCh38
na,na,19,13414691,13414691,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Migraine, sporadic hemiplegic, with progressive cerebellar ataxia|not provided|Episodic ataxia type 2|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2|Inborn genetic diseases|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh37
na,na,19,13303877,13303877,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Migraine, sporadic hemiplegic, with progressive cerebellar ataxia|not provided|Episodic ataxia type 2|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2|Inborn genetic diseases|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh38
na,na,19,13414394,13414394,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Familial hemiplegic migraine",single nucleotide variant,GRCh37
na,na,19,13303580,13303580,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Familial hemiplegic migraine",single nucleotide variant,GRCh38
na,na,19,13340999,13340999,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|not provided",single nucleotide variant,GRCh37
na,na,19,13230185,13230185,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|not provided",single nucleotide variant,GRCh38
na,na,19,13394109,13394109,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh37
na,na,19,13283295,13283295,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh38
na,na,19,13386663,13386663,CACNA1A,Pathogenic,Episodic ataxia type 2|not provided,single nucleotide variant,GRCh37
na,na,19,13275849,13275849,CACNA1A,Pathogenic,Episodic ataxia type 2|not provided,single nucleotide variant,GRCh38
na,na,19,13346516,13346516,CACNA1A,Pathogenic/Likely pathogenic,"Episodic ataxia type 2|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Spinocerebellar ataxia type 6",single nucleotide variant,GRCh37
na,na,19,13235702,13235702,CACNA1A,Pathogenic/Likely pathogenic,"Episodic ataxia type 2|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Spinocerebellar ataxia type 6",single nucleotide variant,GRCh38
na,na,19,13470521,13470521,CACNA1A,Pathogenic/Likely pathogenic,"Spinocerebellar ataxia type 6|Episodic ataxia type 2|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|not provided",single nucleotide variant,GRCh37
na,na,19,13359707,13359707,CACNA1A,Pathogenic/Likely pathogenic,"Spinocerebellar ataxia type 6|Episodic ataxia type 2|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|not provided",single nucleotide variant,GRCh38
na,na,19,13414390,13414390,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1",single nucleotide variant,GRCh37
na,na,19,13303576,13303576,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1",single nucleotide variant,GRCh38
na,na,19,13368288,13368288,CACNA1A,Likely pathogenic,Episodic ataxia type 2,single nucleotide variant,GRCh37
na,na,19,13257474,13257474,CACNA1A,Likely pathogenic,Episodic ataxia type 2,single nucleotide variant,GRCh38
na,na,19,13372366,13372366,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|not provided",single nucleotide variant,GRCh37
na,na,19,13261552,13261552,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|not provided",single nucleotide variant,GRCh38
na,na,19,13342661,13342661,CACNA1A,Pathogenic,Episodic ataxia type 2,single nucleotide variant,GRCh37
na,na,19,13231847,13231847,CACNA1A,Pathogenic,Episodic ataxia type 2,single nucleotide variant,GRCh38
na,na,19,13409633,13409634,CACNA1A,Pathogenic,Episodic ataxia type 2,Duplication,GRCh37
na,na,19,13298819,13298820,CACNA1A,Pathogenic,Episodic ataxia type 2,Duplication,GRCh38
na,na,19,13363829,13363829,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh37
na,na,19,13253015,13253015,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh38
na,na,19,13370403,13370403,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Familial hemiplegic migraine",single nucleotide variant,GRCh37
na,na,19,13259589,13259589,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Familial hemiplegic migraine",single nucleotide variant,GRCh38
na,na,19,13476262,13476262,CACNA1A,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|Episodic ataxia type 2|not provided|Familial hemiplegic migraine|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh37
na,na,19,13365448,13365448,CACNA1A,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|Episodic ataxia type 2|not provided|Familial hemiplegic migraine|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh38
na,na,19,13419266,13419266,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Sporadic hemiplegic migraine|Spinocerebellar ataxia type 6|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 52|Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh37
na,na,19,13308452,13308452,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1|Sporadic hemiplegic migraine|Spinocerebellar ataxia type 6|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Familial hemiplegic migraine|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 52|Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh38
na,na,19,13387936,13387936,CACNA1A,Pathogenic,"Episodic ataxia type 2|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|not provided|CACNA1A-related complex neurodevelopmental disorder",single nucleotide variant,GRCh37
na,na,19,13277122,13277122,CACNA1A,Pathogenic,"Episodic ataxia type 2|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|not provided|CACNA1A-related complex neurodevelopmental disorder",single nucleotide variant,GRCh38
na,na,19,13366031,13366031,CACNA1A,Pathogenic/Likely pathogenic,"Episodic ataxia type 2|Migraine, familial hemiplegic, 1;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42;Spinocerebellar ataxia type 6|Inborn genetic diseases|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh37
na,na,19,13255217,13255217,CACNA1A,Pathogenic/Likely pathogenic,"Episodic ataxia type 2|Migraine, familial hemiplegic, 1;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42;Spinocerebellar ataxia type 6|Inborn genetic diseases|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh38
na,na,19,13372309,13372309,CACNA1A,Pathogenic,Episodic ataxia type 2,single nucleotide variant,GRCh37
na,na,19,13261495,13261495,CACNA1A,Pathogenic,Episodic ataxia type 2,single nucleotide variant,GRCh38
na,na,19,13340972,13340972,CACNA1A,Pathogenic,"Episodic ataxia, type 2, and epilepsy|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh37
na,na,19,13230158,13230158,CACNA1A,Pathogenic,"Episodic ataxia, type 2, and epilepsy|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh38
na,na,19,13346033,13346033,CACNA1A,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|Spinocerebellar ataxia type 6|Episodic ataxia type 2|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Inborn genetic diseases|Neurodevelopmental delay",single nucleotide variant,GRCh37
na,na,19,13235219,13235219,CACNA1A,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|Spinocerebellar ataxia type 6|Episodic ataxia type 2|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Inborn genetic diseases|Neurodevelopmental delay",single nucleotide variant,GRCh38
na,na,19,13470538,13470538,CACNA1A,Pathogenic,Episodic ataxia type 2,single nucleotide variant,GRCh37
na,na,19,13359724,13359724,CACNA1A,Pathogenic,Episodic ataxia type 2,single nucleotide variant,GRCh38
na,na,19,13315086,13354652,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh37
na,na,19,13204242,13243808,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh38
na,na,19,13373603,13373603,CACNA1A,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh37
na,na,19,13262789,13262789,CACNA1A,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 1|not provided|Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Migraine, familial hemiplegic, 1;Spinocerebellar ataxia type 6;Episodic ataxia type 2;Developmental and epileptic encephalopathy, 42|Developmental and epileptic encephalopathy, 42",single nucleotide variant,GRCh38
na,na,19,13359800,13505931,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh38
na,na,19,13446724,13482501,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh37
na,na,19,13335910,13371687,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh38
na,na,19,13446724,13482501,CACNA1A,Pathogenic,Episodic ataxia type 2,Duplication,GRCh37
na,na,19,13335910,13371687,CACNA1A,Pathogenic,Episodic ataxia type 2,Duplication,GRCh38
na,na,19,13255260,13259701,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh38
na,na,19,13214609,13300549,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh38
na,na,19,13317256,13335480,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh37
na,na,19,13206442,13224666,CACNA1A,Pathogenic,Episodic ataxia type 2,Deletion,GRCh38
na,na,19,13317256,13335480,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1",Deletion,GRCh37
na,na,19,13206442,13224666,CACNA1A,Pathogenic,"Migraine, familial hemiplegic, 1",Deletion,GRCh38
na,na,1,66058513,66058513,LEPR,Benign,LEPTIN RECEPTOR POLYMORPHISM|Obesity due to leptin receptor gene deficiency|not specified|Monogenic Non-Syndromic Obesity|not provided,single nucleotide variant,GRCh37
na,na,1,65592830,65592830,LEPR,Benign,LEPTIN RECEPTOR POLYMORPHISM|Obesity due to leptin receptor gene deficiency|not specified|Monogenic Non-Syndromic Obesity|not provided,single nucleotide variant,GRCh38
na,na,1,66087142,66087142,LEPR,Pathogenic,Obesity due to leptin receptor gene deficiency,single nucleotide variant,GRCh37
na,na,1,65621459,65621459,LEPR,Pathogenic,Obesity due to leptin receptor gene deficiency,single nucleotide variant,GRCh38
na,na,1,66036441,66036441,LEPR,Benign,LEPTIN RECEPTOR POLYMORPHISM|Obesity due to leptin receptor gene deficiency|Monogenic Non-Syndromic Obesity|not specified|not provided,single nucleotide variant,GRCh37
na,na,1,65570758,65570758,LEPR,Benign,LEPTIN RECEPTOR POLYMORPHISM|Obesity due to leptin receptor gene deficiency|Monogenic Non-Syndromic Obesity|not specified|not provided,single nucleotide variant,GRCh38
na,na,1,66075952,66075952,LEPR,Benign/Likely benign,LEPTIN RECEPTOR POLYMORPHISM|Obesity due to leptin receptor gene deficiency|not provided|Monogenic Non-Syndromic Obesity|not specified,single nucleotide variant,GRCh37
na,na,1,65610269,65610269,LEPR,Benign/Likely benign,LEPTIN RECEPTOR POLYMORPHISM|Obesity due to leptin receptor gene deficiency|not provided|Monogenic Non-Syndromic Obesity|not specified,single nucleotide variant,GRCh38
na,na,20,33530291,33530291,GSS,Pathogenic,Inherited glutathione synthetase deficiency|not provided|Inborn genetic diseases|Glutathione synthetase deficiency with 5-oxoprolinuria,single nucleotide variant,GRCh37
na,na,20,34942488,34942488,GSS,Pathogenic,Inherited glutathione synthetase deficiency|not provided|Inborn genetic diseases|Glutathione synthetase deficiency with 5-oxoprolinuria,single nucleotide variant,GRCh38
na,na,20,33523414,33523414,GSS,Pathogenic/Likely pathogenic,Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria,single nucleotide variant,GRCh37
na,na,20,34935611,34935611,GSS,Pathogenic/Likely pathogenic,Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria,single nucleotide variant,GRCh38
na,na,20,33519924,33519924,GSS,Pathogenic/Likely pathogenic,Inherited glutathione synthetase deficiency|Glutathione synthetase deficiency with 5-oxoprolinuria|not provided,single nucleotide variant,GRCh37
na,na,20,34932121,34932121,GSS,Pathogenic/Likely pathogenic,Inherited glutathione synthetase deficiency|Glutathione synthetase deficiency with 5-oxoprolinuria|not provided,single nucleotide variant,GRCh38
na,na,20,33530409,33530409,GSS,Pathogenic/Likely pathogenic,not provided|Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency without 5-oxoprolinuria;Glutathione synthetase deficiency with 5-oxoprolinuria,single nucleotide variant,GRCh37
na,na,20,34942606,34942606,GSS,Pathogenic/Likely pathogenic,not provided|Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency without 5-oxoprolinuria;Glutathione synthetase deficiency with 5-oxoprolinuria,single nucleotide variant,GRCh38
na,na,20,33519830,33519830,GSS,Conflicting classifications of pathogenicity,Inherited glutathione synthetase deficiency|not specified|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria,single nucleotide variant,GRCh37
na,na,20,34932027,34932027,GSS,Conflicting classifications of pathogenicity,Inherited glutathione synthetase deficiency|not specified|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria,single nucleotide variant,GRCh38
na,na,20,33524779,33524779,GSS,Pathogenic/Likely pathogenic,Glutathione synthetase deficiency without 5-oxoprolinuria|Inherited glutathione synthetase deficiency|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria,single nucleotide variant,GRCh37
na,na,20,34936976,34936976,GSS,Pathogenic/Likely pathogenic,Glutathione synthetase deficiency without 5-oxoprolinuria|Inherited glutathione synthetase deficiency|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria,single nucleotide variant,GRCh38
na,na,1,23234473,23234473,EPHB2,Pathogenic,Prostate cancer/brain cancer susceptibility,single nucleotide variant,GRCh37
na,na,1,22907980,22907980,EPHB2,Pathogenic,Prostate cancer/brain cancer susceptibility,single nucleotide variant,GRCh38
na,na,1,23189553,23189553,EPHB2,Benign,Prostate cancer/brain cancer susceptibility|not provided,single nucleotide variant,GRCh37
na,na,1,22863060,22863060,EPHB2,Benign,Prostate cancer/brain cancer susceptibility|not provided,single nucleotide variant,GRCh38
na,na,1,23233346,23233346,EPHB2,Likely benign,Prostate cancer/brain cancer susceptibility|not provided|EPHB2-related disorder,single nucleotide variant,GRCh37
na,na,1,22906853,22906853,EPHB2,Likely benign,Prostate cancer/brain cancer susceptibility|not provided|EPHB2-related disorder,single nucleotide variant,GRCh38
na,na,1,23240250,23240250,EPHB2,risk factor,Prostate cancer/brain cancer susceptibility,single nucleotide variant,GRCh37
na,na,1,22913757,22913757,EPHB2,risk factor,Prostate cancer/brain cancer susceptibility,single nucleotide variant,GRCh38
na,na,18,48591909,48591909,SMAD4,Pathogenic,Carcinoma of pancreas,single nucleotide variant,GRCh37
na,na,18,51065539,51065539,SMAD4,Pathogenic,Carcinoma of pancreas,single nucleotide variant,GRCh38
na,na,18,48604655,48604655,SMAD4,Pathogenic,Carcinoma of pancreas,single nucleotide variant,GRCh37
na,na,18,51078285,51078285,SMAD4,Pathogenic,Carcinoma of pancreas,single nucleotide variant,GRCh38
na,na,18,48604721,48604721,SMAD4,Pathogenic,Carcinoma of pancreas,single nucleotide variant,GRCh37
na,na,18,51078351,51078351,SMAD4,Pathogenic,Carcinoma of pancreas,single nucleotide variant,GRCh38
na,na,18,48591918,48591918,SMAD4,Pathogenic/Likely pathogenic,Generalized juvenile polyposis/juvenile polyposis coli|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|not provided|Juvenile polyposis syndrome|Familial thoracic aortic aneurysm and aortic dissection;Hereditary cancer-predisposing syndrome|SMAD4-related disorder|Neoplasm,single nucleotide variant,GRCh37
na,na,18,51065548,51065548,SMAD4,Pathogenic/Likely pathogenic,Generalized juvenile polyposis/juvenile polyposis coli|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|not provided|Juvenile polyposis syndrome|Familial thoracic aortic aneurysm and aortic dissection;Hereditary cancer-predisposing syndrome|SMAD4-related disorder|Neoplasm,single nucleotide variant,GRCh38
na,na,18,48593406,48593406,SMAD4,Pathogenic,Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,single nucleotide variant,GRCh37
na,na,18,51067036,51067036,SMAD4,Pathogenic,Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,TNXB,Pathogenic,Ehlers-Danlos syndrome due to tenascin-X deficiency,Complex,na
na,na,6,32052344,32052345,TNXB,Pathogenic/Likely pathogenic,not provided|TNXB-related disorder|Ehlers-Danlos syndrome due to tenascin-X deficiency;Vesicoureteral reflux 8|Ehlers-Danlos syndrome due to tenascin-X deficiency|Cardiovascular phenotype,Deletion,GRCh37
na,na,6,32084567,32084568,TNXB,Pathogenic/Likely pathogenic,not provided|TNXB-related disorder|Ehlers-Danlos syndrome due to tenascin-X deficiency;Vesicoureteral reflux 8|Ehlers-Danlos syndrome due to tenascin-X deficiency|Cardiovascular phenotype,Deletion,GRCh38
na,na,6,32063512,32063513,TNXB,Pathogenic,not provided|Ehlers-Danlos syndrome due to tenascin-X deficiency,Microsatellite,GRCh37
na,na,6,32095735,32095736,TNXB,Pathogenic,not provided|Ehlers-Danlos syndrome due to tenascin-X deficiency,Microsatellite,GRCh38
na,na,6,32052313,32052313,TNXB,Conflicting classifications of pathogenicity,not provided|Cardiovascular phenotype|TNXB-related disorder|Ehlers-Danlos syndrome|Ehlers-Danlos syndrome due to tenascin-X deficiency|See cases|not specified,single nucleotide variant,GRCh37
na,na,6,32084536,32084536,TNXB,Conflicting classifications of pathogenicity,not provided|Cardiovascular phenotype|TNXB-related disorder|Ehlers-Danlos syndrome|Ehlers-Danlos syndrome due to tenascin-X deficiency|See cases|not specified,single nucleotide variant,GRCh38
na,na,4,149357009,149357009,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Deletion,GRCh37
na,na,4,148435857,148435857,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Deletion,GRCh38
na,na,4,149356638,149356638,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Deletion,GRCh37
na,na,4,148435486,148435486,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Deletion,GRCh38
na,na,4,149356404,149356404,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|Autism spectrum disorder,single nucleotide variant,GRCh37
na,na,4,148435252,148435252,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|Autism spectrum disorder,single nucleotide variant,GRCh38
na,na,4,149075699,149075699,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Deletion,GRCh37
na,na,4,148154548,148154548,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Deletion,GRCh38
na,na,4,149073701,149073701,NR3C2,Uncertain significance,"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy|NR3C2-related disorder|Pseudohyperaldosteronism type 2;Autosomal dominant pseudohypoaldosteronism type 1",single nucleotide variant,GRCh37
na,na,4,148152550,148152550,NR3C2,Uncertain significance,"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy|NR3C2-related disorder|Pseudohyperaldosteronism type 2;Autosomal dominant pseudohypoaldosteronism type 1",single nucleotide variant,GRCh38
na,na,4,149002578,149002579,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Duplication,GRCh37
na,na,4,148081427,148081428,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Duplication,GRCh38
na,na,4,149035283,149035283,NR3C2,Likely pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|not provided,single nucleotide variant,GRCh37
na,na,4,148114132,148114132,NR3C2,Likely pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|not provided,single nucleotide variant,GRCh38
na,na,4,149356881,149356882,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Duplication,GRCh37
na,na,4,148435729,148435730,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Duplication,GRCh38
na,na,4,149357691,149357698,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Deletion,GRCh37
na,na,4,148436539,148436546,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,Deletion,GRCh38
na,na,4,149115976,149115976,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148194825,148194825,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,149075740,149075740,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148154589,148154589,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,149181130,149181130,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148259978,148259978,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,149002514,149002514,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148081363,148081363,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,149357525,149357525,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148436373,148436373,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,149002611,149002611,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|Pseudohyperaldosteronism type 2;Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148081460,148081460,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|Pseudohyperaldosteronism type 2;Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,149356705,149356705,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148435553,148435553,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,149076050,149076050,NR3C2,Likely pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148154899,148154899,NR3C2,Likely pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,149076043,149076043,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148154892,148154892,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,149073677,149073677,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|not provided,single nucleotide variant,GRCh37
na,na,4,148152526,148152526,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1|not provided,single nucleotide variant,GRCh38
na,na,4,149002535,149002535,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh37
na,na,4,148081384,148081384,NR3C2,Pathogenic,Autosomal dominant pseudohypoaldosteronism type 1,single nucleotide variant,GRCh38
na,na,4,88583290,88583290,DMP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 1",Deletion,GRCh37
na,na,4,87662138,87662138,DMP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 1",Deletion,GRCh38
na,na,4,88578183,88578183,DMP1,Pathogenic/Likely pathogenic,"Hypophosphatemic rickets, autosomal recessive, 1|not provided",single nucleotide variant,GRCh37
na,na,4,87657031,87657031,DMP1,Pathogenic/Likely pathogenic,"Hypophosphatemic rickets, autosomal recessive, 1|not provided",single nucleotide variant,GRCh38
na,na,4,88577645,88577645,DMP1,Conflicting classifications of pathogenicity,"Hypophosphatemic rickets, autosomal recessive, 1|not provided|not specified",single nucleotide variant,GRCh37
na,na,4,87656493,87656493,DMP1,Conflicting classifications of pathogenicity,"Hypophosphatemic rickets, autosomal recessive, 1|not provided|not specified",single nucleotide variant,GRCh38
na,na,4,88584414,88584420,DMP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 1",Deletion,GRCh37
na,na,4,87663262,87663268,DMP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 1",Deletion,GRCh38
na,na,6,76566915,76566915,MYO6,Pathogenic,Autosomal dominant nonsyndromic hearing loss 22,single nucleotide variant,GRCh37
na,na,6,75857198,75857198,MYO6,Pathogenic,Autosomal dominant nonsyndromic hearing loss 22,single nucleotide variant,GRCh38
na,na,6,76527299,76527300,MYO6,Pathogenic,Autosomal recessive nonsyndromic hearing loss 37,Duplication,GRCh37
na,na,6,75817582,75817583,MYO6,Pathogenic,Autosomal recessive nonsyndromic hearing loss 37,Duplication,GRCh38
na,na,6,76623836,76623836,MYO6,Pathogenic,Autosomal recessive nonsyndromic hearing loss 37|not provided,single nucleotide variant,GRCh37
na,na,6,75914119,75914119,MYO6,Pathogenic,Autosomal recessive nonsyndromic hearing loss 37|not provided,single nucleotide variant,GRCh38
na,na,6,76550395,76550395,MYO6,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 37|Autosomal dominant nonsyndromic hearing loss 22|not provided,single nucleotide variant,GRCh37
na,na,6,75840678,75840678,MYO6,Conflicting classifications of pathogenicity,Autosomal recessive nonsyndromic hearing loss 37|Autosomal dominant nonsyndromic hearing loss 22|not provided,single nucleotide variant,GRCh38
na,na,6,76551016,76551016,MYO6,Pathogenic/Likely pathogenic,Rare genetic deafness|not provided|Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome,single nucleotide variant,GRCh37
na,na,6,75841299,75841299,MYO6,Pathogenic/Likely pathogenic,Rare genetic deafness|not provided|Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome,single nucleotide variant,GRCh38
na,na,6,76596598,76596598,MYO6,Pathogenic,Autosomal dominant nonsyndromic hearing loss 22|Rare genetic deafness|not provided,single nucleotide variant,GRCh37
na,na,6,75886881,75886881,MYO6,Pathogenic,Autosomal dominant nonsyndromic hearing loss 22|Rare genetic deafness|not provided,single nucleotide variant,GRCh38
na,na,6,76593963,76593963,MYO6,Pathogenic,Autosomal dominant nonsyndromic hearing loss 22,single nucleotide variant,GRCh37
na,na,6,75884246,75884246,MYO6,Pathogenic,Autosomal dominant nonsyndromic hearing loss 22,single nucleotide variant,GRCh38
na,na,16,56928470,56928470,SLC12A3,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided|SLC12A3-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,56894558,56894558,SLC12A3,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided|SLC12A3-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,16,56913065,56913065,SLC12A3,Pathogenic,not provided|Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh37
na,na,16,56879153,56879153,SLC12A3,Pathogenic,not provided|Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh38
na,na,16,56904031,56904031,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,16,56870119,56870119,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,16,56920275,56920275,SLC12A3,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,16,56886363,56886363,SLC12A3,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,16,56920314,56920314,SLC12A3,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided|Familial hypokalemia-hypomagnesemia;Bartter syndrome,single nucleotide variant,GRCh37
na,na,16,56886402,56886402,SLC12A3,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided|Familial hypokalemia-hypomagnesemia;Bartter syndrome,single nucleotide variant,GRCh38
na,na,16,56920314,56920314,SLC12A3,Likely pathogenic,Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh37
na,na,16,56886402,56886402,SLC12A3,Likely pathogenic,Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh38
na,na,16,56933529,56933529,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh37
na,na,16,56899617,56899617,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh38
na,na,16,56918054,56918054,SLC12A3,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,16,56884142,56884142,SLC12A3,Pathogenic/Likely pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,16,56906649,56906649,SLC12A3,Pathogenic,not provided|Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh37
na,na,16,56872737,56872737,SLC12A3,Pathogenic,not provided|Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh38
na,na,16,56917970,56917972,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia,Deletion,GRCh37
na,na,16,56884058,56884060,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia,Deletion,GRCh38
na,na,16,56919240,56919240,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh37
na,na,16,56885328,56885328,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia,single nucleotide variant,GRCh38
na,na,16,56919219,56919219,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,16,56885307,56885307,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,16,56902267,56902267,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh37
na,na,16,56868355,56868355,SLC12A3,Pathogenic,Familial hypokalemia-hypomagnesemia|not provided,single nucleotide variant,GRCh38
na,na,19,46271631,46271631,SIX5,Uncertain significance,Branchiootorenal syndrome 2|not provided,single nucleotide variant,GRCh37
na,na,19,45768373,45768373,SIX5,Uncertain significance,Branchiootorenal syndrome 2|not provided,single nucleotide variant,GRCh38
na,na,19,46270331,46270331,SIX5,Conflicting classifications of pathogenicity,not provided|Branchiootorenal syndrome 2|SIX5-related disorder,single nucleotide variant,GRCh37
na,na,19,45767073,45767073,SIX5,Conflicting classifications of pathogenicity,not provided|Branchiootorenal syndrome 2|SIX5-related disorder,single nucleotide variant,GRCh38
na,na,19,46270124,46270124,SIX5,Pathogenic,Branchiootorenal syndrome 2,single nucleotide variant,GRCh37
na,na,19,45766866,45766866,SIX5,Pathogenic,Branchiootorenal syndrome 2,single nucleotide variant,GRCh38
na,na,19,46269324,46269324,SIX5,Uncertain significance,Branchiootorenal syndrome 2|not provided,single nucleotide variant,GRCh37
na,na,19,45766066,45766066,SIX5,Uncertain significance,Branchiootorenal syndrome 2|not provided,single nucleotide variant,GRCh38
na,na,11,47354740,47354740,MYBPC3,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,11,47333189,47333189,MYBPC3,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,11,47353677,47353678,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Left ventricular noncompaction 1;Hypertrophic cardiomyopathy 4;Primary dilated cardiomyopathy,Duplication,GRCh37
na,na,11,47332126,47332127,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Left ventricular noncompaction 1;Hypertrophic cardiomyopathy 4;Primary dilated cardiomyopathy,Duplication,GRCh38
na,na,11,47354482,47354482,MYBPC3,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 4|Cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,11,47332931,47332931,MYBPC3,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 4|Cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,11,47364129,47364129,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 1|Cardiovascular phenotype|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Cardiomyopathy|Left ventricular noncompaction 10|MYBPC3-related disorder,single nucleotide variant,GRCh37
na,na,11,47342578,47342578,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 1|Cardiovascular phenotype|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Cardiomyopathy|Left ventricular noncompaction 10|MYBPC3-related disorder,single nucleotide variant,GRCh38
na,na,11,47359371,47359371,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4,single nucleotide variant,GRCh37
na,na,11,47337820,47337820,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4,single nucleotide variant,GRCh38
na,na,11,47353775,47353778,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4,Indel,GRCh37
na,na,11,47332224,47332227,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4,Indel,GRCh38
na,na,11,47372907,47372907,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4,single nucleotide variant,GRCh37
na,na,11,47351356,47351356,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4,single nucleotide variant,GRCh38
na,na,11,47356655,47356655,MYBPC3,Uncertain significance,"Cardiomyopathy, dilated, 1MM|Cardiomyopathy",single nucleotide variant,GRCh37
na,na,11,47335104,47335104,MYBPC3,Uncertain significance,"Cardiomyopathy, dilated, 1MM|Cardiomyopathy",single nucleotide variant,GRCh38
na,na,11,47354789,47354789,MYBPC3,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 4|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,11,47333238,47333238,MYBPC3,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 4|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,11,47359085,47359085,MYBPC3,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|MYBPC3-related disorder,single nucleotide variant,GRCh37
na,na,11,47337534,47337534,MYBPC3,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|MYBPC3-related disorder,single nucleotide variant,GRCh38
na,na,11,47368581,47368581,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,11,47347030,47347030,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,11,47353819,47353843,MYBPC3,risk factor,"Cardiomyopathy, familial hypertrophic, 4, susceptibility to",Deletion,GRCh37
na,na,11,47332268,47332292,MYBPC3,risk factor,"Cardiomyopathy, familial hypertrophic, 4, susceptibility to",Deletion,GRCh38
na,na,11,47354743,47354743,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|MYBPC3-related disorder|Cardiovascular phenotype|Left ventricular noncompaction 10|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy,single nucleotide variant,GRCh37
na,na,11,47333192,47333192,MYBPC3,Pathogenic,Hypertrophic cardiomyopathy 4|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|MYBPC3-related disorder|Cardiovascular phenotype|Left ventricular noncompaction 10|Left ventricular noncompaction 10;Hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy,single nucleotide variant,GRCh38
na,na,19,2251417,2251417,AMH,Pathogenic,"Persistent mullerian duct syndrome, type I",single nucleotide variant,GRCh37
na,na,19,2251418,2251418,AMH,Pathogenic,"Persistent mullerian duct syndrome, type I",single nucleotide variant,GRCh38
na,na,19,2250387,2250400,AMH,Pathogenic,"Persistent mullerian duct syndrome, type I|not provided",Deletion,GRCh37
na,na,19,2250388,2250401,AMH,Pathogenic,"Persistent mullerian duct syndrome, type I|not provided",Deletion,GRCh38
na,na,19,2250666,2250666,AMH,Pathogenic,"Persistent mullerian duct syndrome, type I|Persistent Mullerian duct syndrome",single nucleotide variant,GRCh37
na,na,19,2250667,2250667,AMH,Pathogenic,"Persistent mullerian duct syndrome, type I|Persistent Mullerian duct syndrome",single nucleotide variant,GRCh38
na,na,19,2251669,2251670,AMH,Pathogenic,"Persistent mullerian duct syndrome, type I",Duplication,GRCh37
na,na,19,2251670,2251671,AMH,Pathogenic,"Persistent mullerian duct syndrome, type I",Duplication,GRCh38
na,na,12,53818255,53818255,AMHR2,Pathogenic,"Persistent mullerian duct syndrome, type II",single nucleotide variant,GRCh37
na,na,12,53424471,53424471,AMHR2,Pathogenic,"Persistent mullerian duct syndrome, type II",single nucleotide variant,GRCh38
na,na,12,53823971,53823997,AMHR2,Pathogenic,"Persistent mullerian duct syndrome, type II|not provided|Persistent Mullerian duct syndrome",Deletion,GRCh37
na,na,12,53430187,53430213,AMHR2,Pathogenic,"Persistent mullerian duct syndrome, type II|not provided|Persistent Mullerian duct syndrome",Deletion,GRCh38
na,na,12,53819332,53819332,AMHR2,Pathogenic,"Persistent mullerian duct syndrome, type II",Deletion,GRCh37
na,na,12,53425548,53425548,AMHR2,Pathogenic,"Persistent mullerian duct syndrome, type II",Deletion,GRCh38
na,na,12,53823691,53823691,AMHR2,Likely pathogenic,"Persistent mullerian duct syndrome, type II|not provided",single nucleotide variant,GRCh37
na,na,12,53429907,53429907,AMHR2,Likely pathogenic,"Persistent mullerian duct syndrome, type II|not provided",single nucleotide variant,GRCh38
na,na,17,74465813,74465813,AANAT,Uncertain significance,"Delayed sleep phase syndrome, susceptibility to",single nucleotide variant,GRCh37
na,na,17,76469731,76469731,AANAT,Uncertain significance,"Delayed sleep phase syndrome, susceptibility to",single nucleotide variant,GRCh38
na,na,na,-1,-1,GHR,Pathogenic,Laron-type isolated somatotropin defect,Deletion,na
na,na,5,42695093,42695093,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh37
na,na,5,42694991,42694991,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh38
na,na,5,42689036,42689036,GHR,Pathogenic,"Laron-type isolated somatotropin defect|not provided|Laron-type isolated somatotropin defect;Short stature due to partial GHR deficiency;Hypercholesterolemia, familial, 1",single nucleotide variant,GRCh37
na,na,5,42688934,42688934,GHR,Pathogenic,"Laron-type isolated somatotropin defect|not provided|Laron-type isolated somatotropin defect;Short stature due to partial GHR deficiency;Hypercholesterolemia, familial, 1",single nucleotide variant,GRCh38
na,na,5,42689023,42689023,GHR,Pathogenic/Likely pathogenic,Laron-type isolated somatotropin defect|not provided|Growth hormone insensitivity syndrome,single nucleotide variant,GRCh37
na,na,5,42688921,42688921,GHR,Pathogenic/Likely pathogenic,Laron-type isolated somatotropin defect|not provided|Growth hormone insensitivity syndrome,single nucleotide variant,GRCh38
na,na,5,42700080,42700080,GHR,Pathogenic,"Laron-type isolated somatotropin defect|not provided|Hypercholesterolemia, familial, 1;Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect",single nucleotide variant,GRCh37
na,na,5,42699978,42699978,GHR,Pathogenic,"Laron-type isolated somatotropin defect|not provided|Hypercholesterolemia, familial, 1;Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect",single nucleotide variant,GRCh38
na,na,5,42689039,42689039,GHR,Conflicting classifications of pathogenicity,Short stature due to partial GHR deficiency|Growth hormone insensitivity syndrome|not provided,single nucleotide variant,GRCh37
na,na,5,42688937,42688937,GHR,Conflicting classifications of pathogenicity,Short stature due to partial GHR deficiency|Growth hormone insensitivity syndrome|not provided,single nucleotide variant,GRCh38
na,na,5,42700021,42700021,GHR,Conflicting classifications of pathogenicity,"Short stature due to partial GHR deficiency|not provided|Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect|Short stature due to growth hormone secretagogue receptor deficiency;Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect;Hypercholesterolemia, familial, 1|Laron-type isolated somatotropin defect|not specified|GHR-related disorder",single nucleotide variant,GRCh37
na,na,5,42699919,42699919,GHR,Conflicting classifications of pathogenicity,"Short stature due to partial GHR deficiency|not provided|Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect|Short stature due to growth hormone secretagogue receptor deficiency;Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect;Hypercholesterolemia, familial, 1|Laron-type isolated somatotropin defect|not specified|GHR-related disorder",single nucleotide variant,GRCh38
na,na,5,42711416,42711416,GHR,Conflicting classifications of pathogenicity,Short stature due to partial GHR deficiency|not provided,single nucleotide variant,GRCh37
na,na,5,42711314,42711314,GHR,Conflicting classifications of pathogenicity,Short stature due to partial GHR deficiency|not provided,single nucleotide variant,GRCh38
na,na,5,42711393,42711393,GHR,Pathogenic,"not provided|Laron-type isolated somatotropin defect|Hypercholesterolemia, familial, 1;Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect",single nucleotide variant,GRCh37
na,na,5,42711291,42711291,GHR,Pathogenic,"not provided|Laron-type isolated somatotropin defect|Hypercholesterolemia, familial, 1;Short stature due to partial GHR deficiency;Laron-type isolated somatotropin defect",single nucleotide variant,GRCh38
na,na,5,42689122,42689122,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh37
na,na,5,42689020,42689020,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh38
na,na,5,42711308,42711308,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh37
na,na,5,42711206,42711206,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh38
na,na,5,42711432,42711433,GHR,Pathogenic,Laron-type isolated somatotropin defect,Deletion,GRCh37
na,na,5,42711330,42711331,GHR,Pathogenic,Laron-type isolated somatotropin defect,Deletion,GRCh38
na,na,5,42713621,42713621,GHR,Pathogenic,Laron syndrome with elevated serum GH-binding protein,single nucleotide variant,GRCh37
na,na,5,42713519,42713519,GHR,Pathogenic,Laron syndrome with elevated serum GH-binding protein,single nucleotide variant,GRCh38
na,na,5,42700001,42700001,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh37
na,na,5,42699899,42699899,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh38
na,na,5,42718153,42718153,GHR,Pathogenic,Short stature due to partial GHR deficiency|not provided,single nucleotide variant,GRCh37
na,na,5,42718051,42718051,GHR,Pathogenic,Short stature due to partial GHR deficiency|not provided,single nucleotide variant,GRCh38
na,na,5,42711414,42711414,GHR,Pathogenic,Laron syndrome with undetectable serum GH-binding protein,single nucleotide variant,GRCh37
na,na,5,42711312,42711312,GHR,Pathogenic,Laron syndrome with undetectable serum GH-binding protein,single nucleotide variant,GRCh38
na,na,5,42700004,42700004,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh37
na,na,5,42699902,42699902,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh38
na,na,5,42718589,42718589,GHR,Pathogenic,Laron syndrome with undetectable serum GH-binding protein,Deletion,GRCh37
na,na,5,42718487,42718487,GHR,Pathogenic,Laron syndrome with undetectable serum GH-binding protein,Deletion,GRCh38
na,na,5,42718224,42718224,GHR,Pathogenic,Laron syndrome with elevated serum GH-binding protein,single nucleotide variant,GRCh37
na,na,5,42718122,42718122,GHR,Pathogenic,Laron syndrome with elevated serum GH-binding protein,single nucleotide variant,GRCh38
na,na,5,42699932,42699932,GHR,Likely pathogenic,Laron syndrome with undetectable serum GH-binding protein|Growth hormone insensitivity syndrome,single nucleotide variant,GRCh37
na,na,5,42699830,42699830,GHR,Likely pathogenic,Laron syndrome with undetectable serum GH-binding protein|Growth hormone insensitivity syndrome,single nucleotide variant,GRCh38
na,na,5,42699970,42699970,GHR,Conflicting classifications of pathogenicity,Short stature due to partial GHR deficiency|not provided|Laron-type isolated somatotropin defect,single nucleotide variant,GRCh37
na,na,5,42699868,42699868,GHR,Conflicting classifications of pathogenicity,Short stature due to partial GHR deficiency|not provided|Laron-type isolated somatotropin defect,single nucleotide variant,GRCh38
na,na,5,42699994,42699994,GHR,Conflicting classifications of pathogenicity,Laron-type isolated somatotropin defect|not provided,single nucleotide variant,GRCh37
na,na,5,42699892,42699892,GHR,Conflicting classifications of pathogenicity,Laron-type isolated somatotropin defect|not provided,single nucleotide variant,GRCh38
na,na,5,42699998,42699998,GHR,Likely pathogenic,Laron-type isolated somatotropin defect|not provided,single nucleotide variant,GRCh37
na,na,5,42699896,42699896,GHR,Likely pathogenic,Laron-type isolated somatotropin defect|not provided,single nucleotide variant,GRCh38
na,na,5,42700896,42700896,GHR,Pathogenic/Likely pathogenic,Laron-type isolated somatotropin defect|not provided,single nucleotide variant,GRCh37
na,na,5,42700794,42700794,GHR,Pathogenic/Likely pathogenic,Laron-type isolated somatotropin defect|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,GHR,Pathogenic,Laron-type isolated somatotropin defect,Deletion,na
na,na,5,42629171,42629171,GHR,Pathogenic,Laron-type isolated somatotropin defect|Growth hormone insensitivity syndrome,single nucleotide variant,GRCh37
na,na,5,42629069,42629069,GHR,Pathogenic,Laron-type isolated somatotropin defect|Growth hormone insensitivity syndrome,single nucleotide variant,GRCh38
na,na,5,42719239,42719239,GHR,Benign,"Hypercholesterolemia, familial, 1|not specified|Laron-type isolated somatotropin defect|Short stature due to partial GHR deficiency|not provided",single nucleotide variant,GRCh37
na,na,5,42719137,42719137,GHR,Benign,"Hypercholesterolemia, familial, 1|not specified|Laron-type isolated somatotropin defect|Short stature due to partial GHR deficiency|not provided",single nucleotide variant,GRCh38
na,na,5,42695055,42695055,GHR,Pathogenic,Laron-type isolated somatotropin defect|not provided,single nucleotide variant,GRCh37
na,na,5,42694953,42694953,GHR,Pathogenic,Laron-type isolated somatotropin defect|not provided,single nucleotide variant,GRCh38
na,na,5,42719342,42719342,GHR,Likely pathogenic,Laron-type isolated somatotropin defect|not provided,Deletion,GRCh37
na,na,5,42719240,42719240,GHR,Likely pathogenic,Laron-type isolated somatotropin defect|not provided,Deletion,GRCh38
na,na,na,-1,-1,GHR,Pathogenic,Increased responsiveness to growth hormone,Deletion,na
na,na,5,42695087,42695087,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh37
na,na,5,42694985,42694985,GHR,Pathogenic,Laron-type isolated somatotropin defect,single nucleotide variant,GRCh38
na,na,5,42699990,42699990,GHR,Conflicting classifications of pathogenicity,Laron-type isolated somatotropin defect|not provided|not specified,single nucleotide variant,GRCh37
na,na,5,42699888,42699888,GHR,Conflicting classifications of pathogenicity,Laron-type isolated somatotropin defect|not provided|not specified,single nucleotide variant,GRCh38
na,na,11,75272653,75272653,SERPINH1,Pathogenic,Preterm premature rupture of membranes,single nucleotide variant,GRCh37
na,na,11,75561608,75561608,SERPINH1,Pathogenic,Preterm premature rupture of membranes,single nucleotide variant,GRCh38
na,na,11,17409199,17409199,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|not provided|Maturity onset diabetes mellitus in young|Permanent neonatal diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17387652,17387652,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|not provided|Maturity onset diabetes mellitus in young|Permanent neonatal diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17409037,17409037,KCNJ11,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, transient neonatal, 3|Neonatal insulin-dependent diabetes mellitus|Diabetes mellitus, permanent neonatal 2|Neonatal diabetes mellitus|not provided|Hyperinsulinemia",single nucleotide variant,GRCh37
na,na,11,17387490,17387490,KCNJ11,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, transient neonatal, 3|Neonatal insulin-dependent diabetes mellitus|Diabetes mellitus, permanent neonatal 2|Neonatal diabetes mellitus|not provided|Hyperinsulinemia",single nucleotide variant,GRCh38
na,na,11,17409464,17409464,KCNJ11,Pathogenic,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Neonatal insulin-dependent diabetes mellitus|not provided|Neonatal diabetes mellitus|Transitory neonatal diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17387917,17387917,KCNJ11,Pathogenic,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Neonatal insulin-dependent diabetes mellitus|not provided|Neonatal diabetes mellitus|Transitory neonatal diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17409038,17409038,KCNJ11,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus|Diabetes mellitus, transient neonatal, 3|Diabetes mellitus, permanent neonatal 2|Maturity onset diabetes mellitus in young|not provided|Transitory neonatal diabetes mellitus|Neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2;Diabetes mellitus, transient neonatal, 3",single nucleotide variant,GRCh37
na,na,11,17387491,17387491,KCNJ11,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus|Diabetes mellitus, transient neonatal, 3|Diabetes mellitus, permanent neonatal 2|Maturity onset diabetes mellitus in young|not provided|Transitory neonatal diabetes mellitus|Neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2;Diabetes mellitus, transient neonatal, 3",single nucleotide variant,GRCh38
na,na,11,17409463,17409463,KCNJ11,Likely benign,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Transitory neonatal diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17387916,17387916,KCNJ11,Likely benign,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Transitory neonatal diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17409490,17409490,KCNJ11,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2|KCNJ11-related disorder",single nucleotide variant,GRCh37
na,na,11,17387943,17387943,KCNJ11,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2|KCNJ11-related disorder",single nucleotide variant,GRCh38
na,na,11,17409130,17409130,KCNJ11,Likely risk allele,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2|Maturity onset diabetes mellitus in young",single nucleotide variant,GRCh37
na,na,11,17387583,17387583,KCNJ11,Likely risk allele,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2|Maturity onset diabetes mellitus in young",single nucleotide variant,GRCh38
na,na,11,17409129,17409129,KCNJ11,Conflicting classifications of pathogenicity,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2|Neonatal diabetes mellitus|Maturity onset diabetes mellitus in young",single nucleotide variant,GRCh37
na,na,11,17387582,17387582,KCNJ11,Conflicting classifications of pathogenicity,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 2|Neonatal diabetes mellitus|Maturity onset diabetes mellitus in young",single nucleotide variant,GRCh38
na,na,11,17409603,17409603,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided",single nucleotide variant,GRCh37
na,na,11,17388056,17388056,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided",single nucleotide variant,GRCh38
na,na,11,17409772,17409772,KCNJ11,Uncertain significance,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided|not specified",single nucleotide variant,GRCh37
na,na,11,17388225,17388225,KCNJ11,Uncertain significance,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided|not specified",single nucleotide variant,GRCh38
na,na,11,17408878,17408878,KCNJ11,Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided|Type 2 diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17387331,17387331,KCNJ11,Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|not provided|Type 2 diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17409515,17409515,KCNJ11,Conflicting classifications of pathogenicity,"Diabetes mellitus, transient neonatal, 3|Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young type 13|Maturity onset diabetes mellitus in young|not provided",single nucleotide variant,GRCh37
na,na,11,17387968,17387968,KCNJ11,Conflicting classifications of pathogenicity,"Diabetes mellitus, transient neonatal, 3|Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young type 13|Maturity onset diabetes mellitus in young|not provided",single nucleotide variant,GRCh38
na,na,11,17408863,17408863,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|not provided|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus|KCNJ11-related disorder|Diabetes mellitus, permanent neonatal 2;Maturity-onset diabetes of the young type 13;Diabetes mellitus, transient neonatal, 3;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 2",single nucleotide variant,GRCh37
na,na,11,17387316,17387316,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|not provided|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus|KCNJ11-related disorder|Diabetes mellitus, permanent neonatal 2;Maturity-onset diabetes of the young type 13;Diabetes mellitus, transient neonatal, 3;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 2",single nucleotide variant,GRCh38
na,na,11,17409572,17409572,ABCC8;KCNJ11,Benign/Likely benign,"Diabetes mellitus type 2, susceptibility to|Permanent neonatal diabetes mellitus|not specified|Maturity onset diabetes mellitus in young|Transient Neonatal Diabetes, Dominant|Hyperinsulinism, Dominant/Recessive|Hyperinsulinemic hypoglycemia, familial, 2|Diabetes mellitus, transient neonatal, 3|Maturity-onset diabetes of the young type 13|not provided|Type 2 diabetes mellitus|KCNJ11-related disorder",single nucleotide variant,GRCh37
na,na,11,17388025,17388025,ABCC8;KCNJ11,Benign/Likely benign,"Diabetes mellitus type 2, susceptibility to|Permanent neonatal diabetes mellitus|not specified|Maturity onset diabetes mellitus in young|Transient Neonatal Diabetes, Dominant|Hyperinsulinism, Dominant/Recessive|Hyperinsulinemic hypoglycemia, familial, 2|Diabetes mellitus, transient neonatal, 3|Maturity-onset diabetes of the young type 13|not provided|Type 2 diabetes mellitus|KCNJ11-related disorder",single nucleotide variant,GRCh38
na,na,11,17409142,17409142,KCNJ11,drug response,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Glibenclamide response",single nucleotide variant,GRCh37
na,na,11,17387595,17387595,KCNJ11,drug response,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Glibenclamide response",single nucleotide variant,GRCh38
na,na,11,17409140,17409140,KCNJ11,Benign,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Maturity onset diabetes mellitus in young",single nucleotide variant,GRCh37
na,na,11,17387593,17387593,KCNJ11,Benign,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Maturity onset diabetes mellitus in young",single nucleotide variant,GRCh38
na,na,11,17409482,17409482,KCNJ11,Conflicting classifications of pathogenicity,"Diabetes mellitus, transient neonatal, 3|Maturity onset diabetes mellitus in young|Transitory neonatal diabetes mellitus|Type 2 diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17387935,17387935,KCNJ11,Conflicting classifications of pathogenicity,"Diabetes mellitus, transient neonatal, 3|Maturity onset diabetes mellitus in young|Transitory neonatal diabetes mellitus|Type 2 diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17409482,17409482,KCNJ11,Pathogenic,"Diabetes mellitus, transient neonatal, 3",single nucleotide variant,GRCh37
na,na,11,17387935,17387935,KCNJ11,Pathogenic,"Diabetes mellitus, transient neonatal, 3",single nucleotide variant,GRCh38
na,na,11,17408737,17408737,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|not provided|Maturity onset diabetes mellitus in young|Hyperinsulinemic hypoglycemia, familial, 2;Diabetes mellitus, transient neonatal, 3;Permanent neonatal diabetes mellitus 1|Type 2 diabetes mellitus|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 2;Diabetes mellitus, transient neonatal, 3;Maturity-onset diabetes of the young type 13;Diabetes mellitus, permanent neonatal 2",single nucleotide variant,GRCh37
na,na,11,17387190,17387190,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|not provided|Maturity onset diabetes mellitus in young|Hyperinsulinemic hypoglycemia, familial, 2;Diabetes mellitus, transient neonatal, 3;Permanent neonatal diabetes mellitus 1|Type 2 diabetes mellitus|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 2;Diabetes mellitus, transient neonatal, 3;Maturity-onset diabetes of the young type 13;Diabetes mellitus, permanent neonatal 2",single nucleotide variant,GRCh38
na,na,11,17409173,17409173,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|Hypoglycemia|Hyperinsulinemia",single nucleotide variant,GRCh37
na,na,11,17387626,17387626,KCNJ11,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 2|Hypoglycemia|Hyperinsulinemia",single nucleotide variant,GRCh38
na,na,11,17409481,17409481,KCNJ11,Benign,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Neonatal hypoglycemia",single nucleotide variant,GRCh37
na,na,11,17387934,17387934,KCNJ11,Benign,"Diabetes mellitus, permanent neonatal 2|Permanent neonatal diabetes mellitus|Neonatal hypoglycemia",single nucleotide variant,GRCh38
na,na,11,17408795,17408795,KCNJ11,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity-onset diabetes of the young type 13;Diabetes mellitus, transient neonatal, 3;Type 2 diabetes mellitus;Permanent neonatal diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus|not provided|Familial hyperinsulinism|Diabetes mellitus, permanent neonatal 2;Maturity-onset diabetes of the young type 13;Diabetes mellitus, transient neonatal, 3;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 2",single nucleotide variant,GRCh37
na,na,11,17387248,17387248,KCNJ11,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 2|Maturity-onset diabetes of the young type 13;Diabetes mellitus, transient neonatal, 3;Type 2 diabetes mellitus;Permanent neonatal diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 2|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus|not provided|Familial hyperinsulinism|Diabetes mellitus, permanent neonatal 2;Maturity-onset diabetes of the young type 13;Diabetes mellitus, transient neonatal, 3;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 2",single nucleotide variant,GRCh38
na,na,22,26995555,26995555,CRYBB1,Pathogenic,Cataract 17 multiple types,single nucleotide variant,GRCh37
na,na,22,26599591,26599591,CRYBB1,Pathogenic,Cataract 17 multiple types,single nucleotide variant,GRCh38
na,na,11,48145188,48145188,PTPRJ,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh37
na,na,11,48123636,48123636,PTPRJ,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh38
na,na,11,48145375,48145375,PTPRJ,Benign,Carcinoma of colon|not specified|Colorectal cancer|not provided|PTPRJ-related disorder,single nucleotide variant,GRCh37
na,na,11,48123823,48123823,PTPRJ,Benign,Carcinoma of colon|not specified|Colorectal cancer|not provided|PTPRJ-related disorder,single nucleotide variant,GRCh38
na,na,16,2035992,2035992,GFER,Pathogenic,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,1985991,1985991,GFER,Pathogenic,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,161138860,161138860,PPOX,Pathogenic,Variegate porphyria|not provided,single nucleotide variant,GRCh37
na,na,1,161169070,161169070,PPOX,Pathogenic,Variegate porphyria|not provided,single nucleotide variant,GRCh38
na,na,1,161138252,161138252,PPOX,Pathogenic/Likely pathogenic,"Variegate porphyria|Variegate porphyria, childhood-onset",single nucleotide variant,GRCh37
na,na,1,161168462,161168462,PPOX,Pathogenic/Likely pathogenic,"Variegate porphyria|Variegate porphyria, childhood-onset",single nucleotide variant,GRCh38
na,na,1,161136696,161136696,PPOX,Pathogenic,Variegate porphyria,single nucleotide variant,GRCh37
na,na,1,161166906,161166906,PPOX,Pathogenic,Variegate porphyria,single nucleotide variant,GRCh38
na,na,1,161136977,161136977,PPOX,Pathogenic,"Variegate porphyria|not provided|Variegate porphyria, childhood-onset",single nucleotide variant,GRCh37
na,na,1,161167187,161167187,PPOX,Pathogenic,"Variegate porphyria|not provided|Variegate porphyria, childhood-onset",single nucleotide variant,GRCh38
na,na,1,161138253,161138253,PPOX,Pathogenic/Likely pathogenic,Variegate porphyria|not provided|See cases,single nucleotide variant,GRCh37
na,na,1,161168463,161168463,PPOX,Pathogenic/Likely pathogenic,Variegate porphyria|not provided|See cases,single nucleotide variant,GRCh38
na,na,1,161140257,161140257,PPOX,Pathogenic,"Variegate porphyria, childhood-onset",single nucleotide variant,GRCh37
na,na,1,161170467,161170467,PPOX,Pathogenic,"Variegate porphyria, childhood-onset",single nucleotide variant,GRCh38
na,na,1,161138288,161138289,PPOX,Pathogenic,Variegate porphyria,Deletion,GRCh37
na,na,1,161168498,161168499,PPOX,Pathogenic,Variegate porphyria,Deletion,GRCh38
na,na,1,161140551,161140555,PPOX,Pathogenic,Variegate porphyria,Deletion,GRCh37
na,na,1,161170761,161170765,PPOX,Pathogenic,Variegate porphyria,Deletion,GRCh38
na,na,1,161138820,161138821,PPOX,Pathogenic,"Variegate porphyria, childhood-onset",Insertion,GRCh37
na,na,1,161169030,161169031,PPOX,Pathogenic,"Variegate porphyria, childhood-onset",Insertion,GRCh38
na,na,na,-1,-1,PPOX,Pathogenic,"Variegate porphyria, childhood-onset|Variegate porphyria",single nucleotide variant,na
na,na,1,161136672,161136672,PPOX,Pathogenic,"Variegate porphyria|Variegate porphyria, childhood-onset",single nucleotide variant,GRCh37
na,na,1,161166882,161166882,PPOX,Pathogenic,"Variegate porphyria|Variegate porphyria, childhood-onset",single nucleotide variant,GRCh38
na,na,1,161138933,161138933,PPOX,Conflicting classifications of pathogenicity,"not provided|Variegate porphyria|Variegate porphyria, childhood-onset|PPOX-related disorder",single nucleotide variant,GRCh37
na,na,1,161169143,161169143,PPOX,Conflicting classifications of pathogenicity,"not provided|Variegate porphyria|Variegate porphyria, childhood-onset|PPOX-related disorder",single nucleotide variant,GRCh38
na,na,13,22255199,22255199,FGF9,Pathogenic,Multiple synostoses syndrome 3,single nucleotide variant,GRCh37
na,na,13,21681060,21681060,FGF9,Pathogenic,Multiple synostoses syndrome 3,single nucleotide variant,GRCh38
na,na,7,113518434,113518434,PPP1R3A,Conflicting classifications of pathogenicity,"Insulin resistance, susceptibility to|Type 2 diabetes mellitus|not provided|PPP1R3A-related disorder",single nucleotide variant,GRCh37
na,na,7,113878379,113878379,PPP1R3A,Conflicting classifications of pathogenicity,"Insulin resistance, susceptibility to|Type 2 diabetes mellitus|not provided|PPP1R3A-related disorder",single nucleotide variant,GRCh38
na,na,7,113517313,113517318,PPP1R3A,association,GLYCEMIA VARIATION,Indel,GRCh37
na,na,7,113877258,113877263,PPP1R3A,association,GLYCEMIA VARIATION,Indel,GRCh38
na,na,6,35423630,35423630,FANCE,Pathogenic,Fanconi anemia complementation group E,single nucleotide variant,GRCh37
na,na,6,35455853,35455853,FANCE,Pathogenic,Fanconi anemia complementation group E,single nucleotide variant,GRCh38
na,na,6,35423696,35423696,FANCE,Pathogenic/Likely pathogenic,Fanconi anemia complementation group E,single nucleotide variant,GRCh37
na,na,6,35455919,35455919,FANCE,Pathogenic/Likely pathogenic,Fanconi anemia complementation group E,single nucleotide variant,GRCh38
na,na,6,35427100,35427100,FANCE,Pathogenic/Likely pathogenic,Fanconi anemia complementation group E|not provided,single nucleotide variant,GRCh37
na,na,6,35459323,35459323,FANCE,Pathogenic/Likely pathogenic,Fanconi anemia complementation group E|not provided,single nucleotide variant,GRCh38
na,na,4,52895065,52895065,SGCB,Pathogenic,not provided|Autosomal recessive limb-girdle muscular dystrophy type 2E|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,4,52028899,52028899,SGCB,Pathogenic,not provided|Autosomal recessive limb-girdle muscular dystrophy type 2E|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,4,52894965,52894965,SGCB,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,single nucleotide variant,GRCh37
na,na,4,52028799,52028799,SGCB,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,single nucleotide variant,GRCh38
na,na,4,52895888,52895889,SGCB,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E|Autosomal recessive limb-girdle muscular dystrophy,Duplication,GRCh37
na,na,4,52029722,52029723,SGCB,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E|Autosomal recessive limb-girdle muscular dystrophy,Duplication,GRCh38
na,na,4,52895050,52895051,SGCB,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,Deletion,GRCh37
na,na,4,52028884,52028885,SGCB,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,Deletion,GRCh38
na,na,4,52896001,52896001,SGCB,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,single nucleotide variant,GRCh37
na,na,4,52029835,52029835,SGCB,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,single nucleotide variant,GRCh38
na,na,4,52895950,52895950,SGCB,Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,single nucleotide variant,GRCh37
na,na,4,52029784,52029784,SGCB,Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,single nucleotide variant,GRCh38
na,na,4,52895974,52895974,SGCB,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,single nucleotide variant,GRCh37
na,na,4,52029808,52029808,SGCB,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E,single nucleotide variant,GRCh38
na,na,4,52896001,52896001,SGCB,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E|not provided,single nucleotide variant,GRCh37
na,na,4,52029835,52029835,SGCB,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2E|not provided,single nucleotide variant,GRCh38
na,na,1,147380344,147380344,GJA8,Pathogenic/Likely pathogenic,Cataract 1 multiple types,single nucleotide variant,GRCh37
na,na,1,147908217,147908217,GJA8,Pathogenic/Likely pathogenic,Cataract 1 multiple types,single nucleotide variant,GRCh38
na,na,1,147380224,147380224,GJA8,Conflicting classifications of pathogenicity,Cataract 1 multiple types,single nucleotide variant,GRCh37
na,na,1,147908097,147908097,GJA8,Conflicting classifications of pathogenicity,Cataract 1 multiple types,single nucleotide variant,GRCh38
na,na,1,147380823,147380823,GJA8,Benign/Likely benign,Cataract 1 multiple types|not provided|GJA8-related disorder,single nucleotide variant,GRCh37
na,na,1,147908696,147908696,GJA8,Benign/Likely benign,Cataract 1 multiple types|not provided|GJA8-related disorder,single nucleotide variant,GRCh38
na,na,1,147380150,147380150,GJA8,Likely pathogenic,Cataract 1 multiple types,single nucleotide variant,GRCh37
na,na,1,147908023,147908023,GJA8,Likely pathogenic,Cataract 1 multiple types,single nucleotide variant,GRCh38
na,na,1,147380213,147380213,GJA8,Uncertain significance,Cataract 1 multiple types,single nucleotide variant,GRCh37
na,na,1,147908086,147908086,GJA8,Uncertain significance,Cataract 1 multiple types,single nucleotide variant,GRCh38
na,na,1,147380675,147380675,GJA8,Conflicting classifications of pathogenicity,Cataract 1 multiple types|not provided,single nucleotide variant,GRCh37
na,na,1,147908548,147908548,GJA8,Conflicting classifications of pathogenicity,Cataract 1 multiple types|not provided,single nucleotide variant,GRCh38
na,na,1,147380221,147380221,GJA8,Pathogenic,Cataract 1 multiple types,single nucleotide variant,GRCh37
na,na,1,147908094,147908094,GJA8,Pathogenic,Cataract 1 multiple types,single nucleotide variant,GRCh38
na,na,2,26418053,26418053,HADHA,Pathogenic/Likely pathogenic,Mitochondrial trifunctional protein deficiency|LCHAD deficiency with maternal acute fatty liver of pregnancy|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Inborn genetic diseases|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency;Mitochondrial trifunctional protein deficiency|HADHA-related disorder|not specified|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency;Mitochondrial trifunctional protein deficiency 1,single nucleotide variant,GRCh37
na,na,2,26195184,26195184,HADHA,Pathogenic/Likely pathogenic,Mitochondrial trifunctional protein deficiency|LCHAD deficiency with maternal acute fatty liver of pregnancy|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Inborn genetic diseases|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency;Mitochondrial trifunctional protein deficiency|HADHA-related disorder|not specified|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency;Mitochondrial trifunctional protein deficiency 1,single nucleotide variant,GRCh38
na,na,2,26427019,26427019,HADHA,Pathogenic,Mitochondrial trifunctional protein deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,2,26204150,26204150,HADHA,Pathogenic,Mitochondrial trifunctional protein deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,2,26461801,26461801,HADHA,Pathogenic/Likely pathogenic,Mitochondrial trifunctional protein deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1,single nucleotide variant,GRCh37
na,na,2,26238933,26238933,HADHA,Pathogenic/Likely pathogenic,Mitochondrial trifunctional protein deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1,single nucleotide variant,GRCh38
na,na,2,26461799,26461799,HADHA,Pathogenic/Likely pathogenic,not provided|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1,single nucleotide variant,GRCh37
na,na,2,26238931,26238931,HADHA,Pathogenic/Likely pathogenic,not provided|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1,single nucleotide variant,GRCh38
na,na,2,26417450,26417450,HADHA,Pathogenic,Mitochondrial trifunctional protein deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Mitochondrial trifunctional protein deficiency 1|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,2,26194581,26194581,HADHA,Pathogenic,Mitochondrial trifunctional protein deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Mitochondrial trifunctional protein deficiency 1|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,2,26414365,26414366,HADHA,Pathogenic/Likely pathogenic,Mitochondrial trifunctional protein deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency;Mitochondrial trifunctional protein deficiency,Duplication,GRCh37
na,na,2,26191496,26191497,HADHA,Pathogenic/Likely pathogenic,Mitochondrial trifunctional protein deficiency|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency;Mitochondrial trifunctional protein deficiency,Duplication,GRCh38
na,na,2,26432709,26432709,HADHA,Pathogenic,Mitochondrial trifunctional protein deficiency,single nucleotide variant,GRCh37
na,na,2,26209840,26209840,HADHA,Pathogenic,Mitochondrial trifunctional protein deficiency,single nucleotide variant,GRCh38
na,na,2,26437385,26437385,HADHA,Uncertain significance,not specified|Mitochondrial trifunctional protein deficiency 1,single nucleotide variant,GRCh37
na,na,2,26214516,26214516,HADHA,Uncertain significance,not specified|Mitochondrial trifunctional protein deficiency 1,single nucleotide variant,GRCh38
na,na,2,26437316,26437316,HADHA,Pathogenic/Likely pathogenic,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,2,26214447,26214447,HADHA,Pathogenic/Likely pathogenic,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1|Mitochondrial trifunctional protein deficiency 1;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,2,26437359,26437359,HADHA,Pathogenic,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,2,26214490,26214490,HADHA,Pathogenic,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency;Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,5,79970915,79970915,MSH3,Pathogenic/Likely pathogenic,Familial adenomatous polyposis 4|Endometrial carcinoma|not provided|Hereditary cancer-predisposing syndrome|MSH3-related disorder|Neoplasm,Deletion,GRCh37
na,na,5,80675096,80675096,MSH3,Pathogenic/Likely pathogenic,Familial adenomatous polyposis 4|Endometrial carcinoma|not provided|Hereditary cancer-predisposing syndrome|MSH3-related disorder|Neoplasm,Deletion,GRCh38
na,na,1,92941710,92941710,GFI1,Pathogenic,"Neutropenia, severe congenital, 2, autosomal dominant|not provided",single nucleotide variant,GRCh37
na,na,1,92476153,92476153,GFI1,Pathogenic,"Neutropenia, severe congenital, 2, autosomal dominant|not provided",single nucleotide variant,GRCh38
na,na,1,92941647,92941647,GFI1,Conflicting classifications of pathogenicity,"Nonimmune chronic idiopathic neutropenia of adults|Neutropenia, severe congenital, 2, autosomal dominant",single nucleotide variant,GRCh37
na,na,1,92476090,92476090,GFI1,Conflicting classifications of pathogenicity,"Nonimmune chronic idiopathic neutropenia of adults|Neutropenia, severe congenital, 2, autosomal dominant",single nucleotide variant,GRCh38
na,na,17,80223619,80223619,CSNK1D,Pathogenic,Advanced sleep phase syndrome 2,single nucleotide variant,GRCh37
na,na,17,82265743,82265743,CSNK1D,Pathogenic,Advanced sleep phase syndrome 2,single nucleotide variant,GRCh38
na,na,5,251215,251215,SDHA,Likely pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5|Leigh syndrome|not provided|Diffuse midline glioma, H3 K27-altered|Dilated cardiomyopathy 1GG|SDHA-related disorder|Mitochondrial complex II deficiency, nuclear type 1;Neurodegeneration with ataxia and late-onset optic atrophy;Paragangliomas 5;Dilated cardiomyopathy 1GG",single nucleotide variant,GRCh37
na,na,5,251100,251100,SDHA,Likely pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Hereditary cancer-predisposing syndrome|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5|Leigh syndrome|not provided|Diffuse midline glioma, H3 K27-altered|Dilated cardiomyopathy 1GG|SDHA-related disorder|Mitochondrial complex II deficiency, nuclear type 1;Neurodegeneration with ataxia and late-onset optic atrophy;Paragangliomas 5;Dilated cardiomyopathy 1GG",single nucleotide variant,GRCh38
na,na,5,251126,251126,SDHA,Pathogenic/Likely pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5|not provided|Hereditary cancer-predisposing syndrome|Dilated cardiomyopathy 1GG",single nucleotide variant,GRCh37
na,na,5,251011,251011,SDHA,Pathogenic/Likely pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5|not provided|Hereditary cancer-predisposing syndrome|Dilated cardiomyopathy 1GG",single nucleotide variant,GRCh38
na,na,5,218471,218471,SDHA,Pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5|Hereditary cancer-predisposing syndrome|Paragangliomas 5|Neurodegeneration with ataxia and late-onset optic atrophy",single nucleotide variant,GRCh37
na,na,5,218356,218356,SDHA,Pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5|Hereditary cancer-predisposing syndrome|Paragangliomas 5|Neurodegeneration with ataxia and late-onset optic atrophy",single nucleotide variant,GRCh38
na,na,5,251453,251453,SDHA,Pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Dilated cardiomyopathy 1GG|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5",single nucleotide variant,GRCh37
na,na,5,251338,251338,SDHA,Pathogenic,"Mitochondrial complex II deficiency, nuclear type 1|Dilated cardiomyopathy 1GG|Mitochondrial complex II deficiency, nuclear type 1;Paragangliomas 5",single nucleotide variant,GRCh38
na,na,11,2906581,2906581,CDKN1C,Pathogenic,Beckwith-Wiedemann syndrome,single nucleotide variant,GRCh37
na,na,11,2885351,2885351,CDKN1C,Pathogenic,Beckwith-Wiedemann syndrome,single nucleotide variant,GRCh38
na,na,11,2905359,2905359,CDKN1C,Pathogenic,Beckwith-Wiedemann syndrome,Indel,GRCh37
na,na,11,2884129,2884129,CDKN1C,Pathogenic,Beckwith-Wiedemann syndrome,Indel,GRCh38
na,na,11,2906409,2906410,CDKN1C,Pathogenic,Beckwith-Wiedemann syndrome,Indel,GRCh37
na,na,11,2885179,2885180,CDKN1C,Pathogenic,Beckwith-Wiedemann syndrome,Indel,GRCh38
na,na,11,2905980,2905980,CDKN1C,Pathogenic,Beckwith-Wiedemann syndrome,single nucleotide variant,GRCh37
na,na,11,2884750,2884750,CDKN1C,Pathogenic,Beckwith-Wiedemann syndrome,single nucleotide variant,GRCh38
na,na,17,3801376,3801378,P2RX1,Uncertain significance,Platelet-type bleeding disorder 8,Microsatellite,GRCh37
na,na,17,3898082,3898084,P2RX1,Uncertain significance,Platelet-type bleeding disorder 8,Microsatellite,GRCh38
na,na,2,27730940,27730940,GCKR,Benign,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5|not provided,single nucleotide variant,GRCh37
na,na,2,27508073,27508073,GCKR,Benign,FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5|not provided,single nucleotide variant,GRCh38
na,na,15,48543967,48543967,SLC12A1,Uncertain significance,Bartter disease type 1|Familial hypokalemia-hypomagnesemia;Bartter syndrome|not specified,single nucleotide variant,GRCh37
na,na,15,48251770,48251770,SLC12A1,Uncertain significance,Bartter disease type 1|Familial hypokalemia-hypomagnesemia;Bartter syndrome|not specified,single nucleotide variant,GRCh38
na,na,15,48521475,48521475,SLC12A1,Pathogenic,Bartter disease type 1,single nucleotide variant,GRCh37
na,na,15,48229278,48229278,SLC12A1,Pathogenic,Bartter disease type 1,single nucleotide variant,GRCh38
na,na,15,48543900,48543900,SLC12A1,Pathogenic,Bartter disease type 1|not provided|SLC12A1-related disorder,single nucleotide variant,GRCh37
na,na,15,48251703,48251703,SLC12A1,Pathogenic,Bartter disease type 1|not provided|SLC12A1-related disorder,single nucleotide variant,GRCh38
na,na,15,48518772,48518772,SLC12A1,Pathogenic,Bartter disease type 1,single nucleotide variant,GRCh37
na,na,15,48226575,48226575,SLC12A1,Pathogenic,Bartter disease type 1,single nucleotide variant,GRCh38
na,na,15,48551448,48551448,SLC12A1,Pathogenic,Bartter disease type 1,Deletion,GRCh37
na,na,15,48259251,48259251,SLC12A1,Pathogenic,Bartter disease type 1,Deletion,GRCh38
na,na,17,26856175,26856175,FOXN1,Pathogenic,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy|T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant|Severe combined immunodeficiency disease",single nucleotide variant,GRCh37
na,na,17,28529157,28529157,FOXN1,Pathogenic,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy|T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant|Severe combined immunodeficiency disease",single nucleotide variant,GRCh38
na,na,5,37816112,37816112,GDNF,Benign/Likely benign,"Hirschsprung disease, susceptibility to, 3|not specified|not provided|GDNF-related disorder",single nucleotide variant,GRCh37
na,na,5,37816010,37816010,GDNF,Benign/Likely benign,"Hirschsprung disease, susceptibility to, 3|not specified|not provided|GDNF-related disorder",single nucleotide variant,GRCh38
na,na,5,37815941,37815941,GDNF,Benign/Likely benign,"Hirschsprung disease, susceptibility to, 3|not specified|not provided|GDNF-related disorder",single nucleotide variant,GRCh37
na,na,5,37815839,37815839,GDNF,Benign/Likely benign,"Hirschsprung disease, susceptibility to, 3|not specified|not provided|GDNF-related disorder",single nucleotide variant,GRCh38
na,na,5,37815929,37815929,GDNF,risk factor,"Hirschsprung disease, susceptibility to, 3",single nucleotide variant,GRCh37
na,na,5,37815827,37815827,GDNF,risk factor,"Hirschsprung disease, susceptibility to, 3",single nucleotide variant,GRCh38
na,na,5,37815756,37815756,GDNF,Uncertain significance,"Hirschsprung disease, susceptibility to, 3|not specified",single nucleotide variant,GRCh37
na,na,5,37815654,37815654,GDNF,Uncertain significance,"Hirschsprung disease, susceptibility to, 3|not specified",single nucleotide variant,GRCh38
na,na,10,44873550,44873550,CXCL12,protective,Susceptibility to HIV infection,single nucleotide variant,GRCh37
na,na,10,44378102,44378102,CXCL12,protective,Susceptibility to HIV infection,single nucleotide variant,GRCh38
na,na,10,95372567,95372567,PDE6C,Pathogenic/Likely pathogenic,Cone dystrophy 4|Achromatopsia 5|not provided,single nucleotide variant,GRCh37
na,na,10,93612810,93612810,PDE6C,Pathogenic/Likely pathogenic,Cone dystrophy 4|Achromatopsia 5|not provided,single nucleotide variant,GRCh38
na,na,10,95386424,95386424,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh37
na,na,10,93626667,93626667,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh38
na,na,10,95372735,95372736,PDE6C,Pathogenic,Achromatopsia 5|not provided,Microsatellite,GRCh37
na,na,10,93612978,93612979,PDE6C,Pathogenic,Achromatopsia 5|not provided,Microsatellite,GRCh38
na,na,10,95422397,95422401,PDE6C,Pathogenic/Likely pathogenic,Achromatopsia 5|not provided|Cone dystrophy 4|Retinal dystrophy,Deletion,GRCh37
na,na,10,93662640,93662644,PDE6C,Pathogenic/Likely pathogenic,Achromatopsia 5|not provided|Cone dystrophy 4|Retinal dystrophy,Deletion,GRCh38
na,na,10,95395347,95395347,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh37
na,na,10,93635590,93635590,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh38
na,na,10,95380541,95380541,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh37
na,na,10,93620784,93620784,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh38
na,na,10,95422785,95422785,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh37
na,na,10,93663028,93663028,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh38
na,na,10,95380377,95380377,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh37
na,na,10,93620620,93620620,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh38
na,na,10,95399825,95399825,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh37
na,na,10,93640068,93640068,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh38
na,na,10,95400744,95400744,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh37
na,na,10,93640987,93640987,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh38
na,na,10,95381791,95381791,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh37
na,na,10,93622034,93622034,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh38
na,na,10,95422874,95422874,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh37
na,na,10,93663117,93663117,PDE6C,Pathogenic,Achromatopsia 5,single nucleotide variant,GRCh38
na,na,10,95400258,95400259,PDE6C,Pathogenic,Achromatopsia 5,Duplication,GRCh37
na,na,10,93640501,93640502,PDE6C,Pathogenic,Achromatopsia 5,Duplication,GRCh38
na,na,11,19213986,19213986,CSRP3,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1M|not specified|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy 12|Cardiovascular phenotype|not provided|Sudden unexplained death;Hypertrophic cardiomyopathy|Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12|Cardiomyopathy|Hypertrophic cardiomyopathy|CSRP3-related disorder,single nucleotide variant,GRCh37
na,na,11,19192439,19192439,CSRP3,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1M|not specified|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy 12|Cardiovascular phenotype|not provided|Sudden unexplained death;Hypertrophic cardiomyopathy|Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12|Cardiomyopathy|Hypertrophic cardiomyopathy|CSRP3-related disorder,single nucleotide variant,GRCh38
na,na,11,19209792,19209792,CSRP3,Pathogenic,Hypertrophic cardiomyopathy 12|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,11,19188245,19188245,CSRP3,Pathogenic,Hypertrophic cardiomyopathy 12|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,11,19209833,19209833,CSRP3,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 12|not specified|Cardiovascular phenotype|Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12|Hypertrophic cardiomyopathy|not provided|See cases,single nucleotide variant,GRCh37
na,na,11,19188286,19188286,CSRP3,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 12|not specified|Cardiovascular phenotype|Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12|Hypertrophic cardiomyopathy|not provided|See cases,single nucleotide variant,GRCh38
na,na,11,19209758,19209758,CSRP3,Uncertain significance,Dilated cardiomyopathy 1M|Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy,single nucleotide variant,GRCh37
na,na,11,19188211,19188211,CSRP3,Uncertain significance,Dilated cardiomyopathy 1M|Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy,single nucleotide variant,GRCh38
na,na,11,19209828,19209828,CSRP3,Uncertain significance,Hypertrophic cardiomyopathy 12|not specified|Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12|Cardiomyopathy|Cardiovascular phenotype|not provided,single nucleotide variant,GRCh37
na,na,11,19188281,19188281,CSRP3,Uncertain significance,Hypertrophic cardiomyopathy 12|not specified|Dilated cardiomyopathy 1M;Hypertrophic cardiomyopathy 12|Cardiomyopathy|Cardiovascular phenotype|not provided,single nucleotide variant,GRCh38
na,na,11,94170372,94170372,MRE11,Pathogenic,Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome|not provided|Ataxia-telangiectasia-like disorder,single nucleotide variant,GRCh37
na,na,11,94437206,94437206,MRE11,Pathogenic,Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome|not provided|Ataxia-telangiectasia-like disorder,single nucleotide variant,GRCh38
na,na,11,94212892,94212892,MRE11,Conflicting classifications of pathogenicity,Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome|not provided|Ataxia-telangiectasia-like disorder,single nucleotide variant,GRCh37
na,na,11,94479726,94479726,MRE11,Conflicting classifications of pathogenicity,Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome|not provided|Ataxia-telangiectasia-like disorder,single nucleotide variant,GRCh38
na,na,11,94180454,94180454,MRE11,Pathogenic/Likely pathogenic,Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia-like disorder|not provided,single nucleotide variant,GRCh37
na,na,11,94447288,94447288,MRE11,Pathogenic/Likely pathogenic,Ataxia-telangiectasia-like disorder 1|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia-like disorder|not provided,single nucleotide variant,GRCh38
na,na,11,94192632,94192632,MRE11,Likely pathogenic,Ataxia-telangiectasia-like disorder 1|Ataxia-telangiectasia-like disorder,single nucleotide variant,GRCh37
na,na,11,94459466,94459466,MRE11,Likely pathogenic,Ataxia-telangiectasia-like disorder 1|Ataxia-telangiectasia-like disorder,single nucleotide variant,GRCh38
na,na,11,94209484,94209484,MRE11,Pathogenic/Likely pathogenic,Ataxia-telangiectasia-like disorder 1|not provided,single nucleotide variant,GRCh37
na,na,11,94476318,94476318,MRE11,Pathogenic/Likely pathogenic,Ataxia-telangiectasia-like disorder 1|not provided,single nucleotide variant,GRCh38
na,na,11,47256335,47256335,DDB2,Pathogenic,"Xeroderma pigmentosum, group E",single nucleotide variant,GRCh37
na,na,11,47234784,47234784,DDB2,Pathogenic,"Xeroderma pigmentosum, group E",single nucleotide variant,GRCh38
na,na,11,47256423,47256423,DDB2,Pathogenic/Likely pathogenic,"Xeroderma pigmentosum, group E|not provided",single nucleotide variant,GRCh37
na,na,11,47234872,47234872,DDB2,Pathogenic/Likely pathogenic,"Xeroderma pigmentosum, group E|not provided",single nucleotide variant,GRCh38
na,na,11,47256877,47256877,DDB2,Pathogenic,"Xeroderma pigmentosum, group E",single nucleotide variant,GRCh37
na,na,11,47235326,47235326,DDB2,Pathogenic,"Xeroderma pigmentosum, group E",single nucleotide variant,GRCh38
na,na,11,47256859,47256859,DDB2,Pathogenic,"Xeroderma pigmentosum, group E",single nucleotide variant,GRCh37
na,na,11,47235308,47235308,DDB2,Pathogenic,"Xeroderma pigmentosum, group E",single nucleotide variant,GRCh38
na,na,18,21461947,21461947,LAMA3,Pathogenic,"Epidermolysis bullosa, junctional 2B, severe",Deletion,GRCh37
na,na,18,23881983,23881983,LAMA3,Pathogenic,"Epidermolysis bullosa, junctional 2B, severe",Deletion,GRCh38
na,na,18,21487603,21487603,LAMA3,Pathogenic,"Junctional epidermolysis bullosa gravis of Herlitz|not provided|Epidermolysis bullosa, junctional 2B, severe|Epidermolysis bullosa, junctional 2A, intermediate;Epidermolysis bullosa, junctional 2B, severe;Laryngo-onycho-cutaneous syndrome",single nucleotide variant,GRCh37
na,na,18,23907639,23907639,LAMA3,Pathogenic,"Junctional epidermolysis bullosa gravis of Herlitz|not provided|Epidermolysis bullosa, junctional 2B, severe|Epidermolysis bullosa, junctional 2A, intermediate;Epidermolysis bullosa, junctional 2B, severe;Laryngo-onycho-cutaneous syndrome",single nucleotide variant,GRCh38
na,na,18,21519286,21519286,LAMA3,Uncertain significance,"Epidermolysis bullosa, junctional 2B, severe|Epidermolysis bullosa, junctional 2A, intermediate",single nucleotide variant,GRCh37
na,na,18,23939322,23939322,LAMA3,Uncertain significance,"Epidermolysis bullosa, junctional 2B, severe|Epidermolysis bullosa, junctional 2A, intermediate",single nucleotide variant,GRCh38
na,na,2,203421083,203421083,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1|Pulmonary arterial hypertension|Primary pulmonary hypertension|not provided|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension",single nucleotide variant,GRCh37
na,na,2,202556360,202556360,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1|Pulmonary arterial hypertension|Primary pulmonary hypertension|not provided|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension",single nucleotide variant,GRCh38
na,na,2,203329673,203329673,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension",single nucleotide variant,GRCh37
na,na,2,202464950,202464950,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension",single nucleotide variant,GRCh38
na,na,2,203332348,203332348,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Primary pulmonary hypertension|Pulmonary arterial hypertension",single nucleotide variant,GRCh37
na,na,2,202467625,202467625,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Primary pulmonary hypertension|Pulmonary arterial hypertension",single nucleotide variant,GRCh38
na,na,2,203395589,203395589,BMPR2,Likely pathogenic,"Pulmonary hypertension, primary, 1|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Pulmonary arterial hypertension|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1",single nucleotide variant,GRCh37
na,na,2,202530866,202530866,BMPR2,Likely pathogenic,"Pulmonary hypertension, primary, 1|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Pulmonary arterial hypertension|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1",single nucleotide variant,GRCh38
na,na,2,203417479,203417479,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension",single nucleotide variant,GRCh37
na,na,2,202552756,202552756,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension",single nucleotide variant,GRCh38
na,na,2,203417496,203417496,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|not provided|Pulmonary arterial hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Primary pulmonary hypertension|BMPR2-related disorder|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1",single nucleotide variant,GRCh37
na,na,2,202552773,202552773,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|not provided|Pulmonary arterial hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Primary pulmonary hypertension|BMPR2-related disorder|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1",single nucleotide variant,GRCh38
na,na,2,203378530,203378530,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh37
na,na,2,202513807,202513807,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh38
na,na,2,203421005,203421005,BMPR2,Pathogenic/Likely pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Primary pulmonary hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|not provided|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1",single nucleotide variant,GRCh37
na,na,2,202556282,202556282,BMPR2,Pathogenic/Likely pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Primary pulmonary hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|not provided|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1",single nucleotide variant,GRCh38
na,na,2,203417497,203417497,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|not provided|Primary pulmonary hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Pulmonary venoocclusive disease 1",single nucleotide variant,GRCh37
na,na,2,202552774,202552774,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|not provided|Primary pulmonary hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Pulmonary venoocclusive disease 1",single nucleotide variant,GRCh38
na,na,2,203332361,203332361,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension",single nucleotide variant,GRCh37
na,na,2,202467638,202467638,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension",single nucleotide variant,GRCh38
na,na,2,203332361,203332361,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh37
na,na,2,202467638,202467638,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh38
na,na,2,203395543,203395543,BMPR2,Pathogenic,"not provided|Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Primary pulmonary hypertension",single nucleotide variant,GRCh37
na,na,2,202530820,202530820,BMPR2,Pathogenic,"not provided|Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Primary pulmonary hypertension",single nucleotide variant,GRCh38
na,na,2,203421084,203421084,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh37
na,na,2,202556361,202556361,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh38
na,na,2,203383554,203383554,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary hypertension, primary, dexfenfluramine-associated|not provided|Pulmonary arterial hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1|Primary pulmonary hypertension",single nucleotide variant,GRCh37
na,na,2,202518831,202518831,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary hypertension, primary, dexfenfluramine-associated|not provided|Pulmonary arterial hypertension|Idiopathic and/or familial pulmonary arterial hypertension;Pulmonary arterial hypertension|Pulmonary hypertension, primary, 1;Pulmonary venoocclusive disease 1|Primary pulmonary hypertension",single nucleotide variant,GRCh38
na,na,2,203379626,203379626,BMPR2,Likely benign,"Pulmonary hypertension, primary, fenfluramine-associated|not provided|Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Primary pulmonary hypertension",single nucleotide variant,GRCh37
na,na,2,202514903,202514903,BMPR2,Likely benign,"Pulmonary hypertension, primary, fenfluramine-associated|not provided|Pulmonary hypertension, primary, 1|Pulmonary arterial hypertension|Primary pulmonary hypertension",single nucleotide variant,GRCh38
na,na,2,203242240,203242240,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary venoocclusive disease 1",Deletion,GRCh37
na,na,2,202377517,202377517,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary venoocclusive disease 1",Deletion,GRCh38
na,na,2,203329575,203329575,BMPR2,Pathogenic,Pulmonary venoocclusive disease 1,single nucleotide variant,GRCh37
na,na,2,202464852,202464852,BMPR2,Pathogenic,Pulmonary venoocclusive disease 1,single nucleotide variant,GRCh38
na,na,2,203329532,203329702,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary venoocclusive disease 1",Deletion,GRCh37
na,na,2,202464809,202464979,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1|Pulmonary venoocclusive disease 1",Deletion,GRCh38
na,na,na,-1,-1,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1",Deletion,na
na,na,na,-1,-1,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1",Deletion,na
na,na,2,203407054,203407054,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia|Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh37
na,na,2,202542331,202542331,BMPR2,Pathogenic,"Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia|Pulmonary hypertension, primary, 1",single nucleotide variant,GRCh38
na,na,13,110435231,110435231,IRS2,Benign; risk factor,Type 2 diabetes mellitus|IRS2-related disorder,single nucleotide variant,GRCh37
na,na,13,109782884,109782884,IRS2,Benign; risk factor,Type 2 diabetes mellitus|IRS2-related disorder,single nucleotide variant,GRCh38
na,na,13,110436462,110436462,IRS2,risk factor,Type 2 diabetes mellitus,single nucleotide variant,GRCh37
na,na,13,109784115,109784115,IRS2,risk factor,Type 2 diabetes mellitus,single nucleotide variant,GRCh38
na,na,17,42030667,42030667,PYY,Uncertain significance,Obesity,single nucleotide variant,GRCh37
na,na,17,43953299,43953299,PYY,Uncertain significance,Obesity,single nucleotide variant,GRCh38
na,na,12,12871000,12871000,CDKN1B,Pathogenic,Multiple endocrine neoplasia type 4,single nucleotide variant,GRCh37
na,na,12,12718066,12718066,CDKN1B,Pathogenic,Multiple endocrine neoplasia type 4,single nucleotide variant,GRCh38
na,na,16,23226558,23226558,SCNN1G,Pathogenic,Liddle syndrome 2,single nucleotide variant,GRCh37
na,na,16,23215237,23215237,SCNN1G,Pathogenic,Liddle syndrome 2,single nucleotide variant,GRCh38
na,na,16,23226409,23226409,SCNN1G,Pathogenic,"Pseudohypoaldosteronism, type IB3, autosomal recessive",single nucleotide variant,GRCh37
na,na,16,23215088,23215088,SCNN1G,Pathogenic,"Pseudohypoaldosteronism, type IB3, autosomal recessive",single nucleotide variant,GRCh38
na,na,16,23200691,23200691,SCNN1G,Pathogenic,"Pseudohypoaldosteronism, type IB3, autosomal recessive",single nucleotide variant,GRCh37
na,na,16,23189370,23189370,SCNN1G,Pathogenic,"Pseudohypoaldosteronism, type IB3, autosomal recessive",single nucleotide variant,GRCh38
na,na,16,23226467,23226467,SCNN1G,Pathogenic,"Pseudohypoaldosteronism, type IB3, autosomal recessive",Deletion,GRCh37
na,na,16,23215146,23215146,SCNN1G,Pathogenic,"Pseudohypoaldosteronism, type IB3, autosomal recessive",Deletion,GRCh38
na,na,16,23200921,23200921,SCNN1G,Benign/Likely benign,"Bronchiectasis with or without elevated sweat chloride 3|Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided|Liddle syndrome 2|not specified|SCNN1G-related disorder",single nucleotide variant,GRCh37
na,na,16,23189600,23189600,SCNN1G,Benign/Likely benign,"Bronchiectasis with or without elevated sweat chloride 3|Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided|Liddle syndrome 2|not specified|SCNN1G-related disorder",single nucleotide variant,GRCh38
na,na,16,23200963,23200963,SCNN1G,Benign/Likely benign,"Bronchiectasis with or without elevated sweat chloride 3|not specified|Pseudohypoaldosteronism, type IB1, autosomal recessive|Liddle syndrome 2|not provided|Liddle syndrome 2;Bronchiectasis with or without elevated sweat chloride 3;Pseudohypoaldosteronism, type IB1, autosomal recessive",single nucleotide variant,GRCh37
na,na,16,23189642,23189642,SCNN1G,Benign/Likely benign,"Bronchiectasis with or without elevated sweat chloride 3|not specified|Pseudohypoaldosteronism, type IB1, autosomal recessive|Liddle syndrome 2|not provided|Liddle syndrome 2;Bronchiectasis with or without elevated sweat chloride 3;Pseudohypoaldosteronism, type IB1, autosomal recessive",single nucleotide variant,GRCh38
na,na,16,23391895,23391895,SCNN1B,Pathogenic,"Liddle syndrome 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh37
na,na,16,23380574,23380574,SCNN1B,Pathogenic,"Liddle syndrome 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh38
na,na,16,23392046,23392046,SCNN1B,Pathogenic/Likely pathogenic,"Liddle syndrome 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh37
na,na,16,23380725,23380725,SCNN1B,Pathogenic/Likely pathogenic,"Liddle syndrome 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh38
na,na,16,23360029,23360029,SCNN1B,Benign,"Liddle syndrome 1|Bronchiectasis with or without elevated sweat chloride 1|Pseudohypoaldosteronism, type IB2, autosomal recessive",single nucleotide variant,GRCh37
na,na,16,23348708,23348708,SCNN1B,Benign,"Liddle syndrome 1|Bronchiectasis with or without elevated sweat chloride 1|Pseudohypoaldosteronism, type IB2, autosomal recessive",single nucleotide variant,GRCh38
na,na,16,23392057,23392057,SCNN1B,Pathogenic,Liddle syndrome 1,single nucleotide variant,GRCh37
na,na,16,23380736,23380736,SCNN1B,Pathogenic,Liddle syndrome 1,single nucleotide variant,GRCh38
na,na,na,-1,-1,SCNN1B,Pathogenic,Liddle syndrome 1,Insertion,na
na,na,16,23391933,23391964,SCNN1B,Pathogenic,Liddle syndrome 1,Deletion,GRCh37
na,na,16,23380612,23380643,SCNN1B,Pathogenic,Liddle syndrome 1,Deletion,GRCh38
na,na,16,23392048,23392048,SCNN1B,Pathogenic/Likely pathogenic,"Liddle syndrome 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh37
na,na,16,23380727,23380727,SCNN1B,Pathogenic/Likely pathogenic,"Liddle syndrome 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh38
na,na,16,23392046,23392046,SCNN1B,Pathogenic,Liddle syndrome 1,single nucleotide variant,GRCh37
na,na,16,23380725,23380725,SCNN1B,Pathogenic,Liddle syndrome 1,single nucleotide variant,GRCh38
na,na,16,23379200,23379200,SCNN1B,Likely pathogenic,"Bronchiectasis with or without elevated sweat chloride 1|Pseudohypoaldosteronism, type IB1, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh37
na,na,16,23367879,23367879,SCNN1B,Likely pathogenic,"Bronchiectasis with or without elevated sweat chloride 1|Pseudohypoaldosteronism, type IB1, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh38
na,na,16,23391740,23391740,SCNN1B,Pathogenic,Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,16,23380419,23380419,SCNN1B,Pathogenic,Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,16,23379280,23379280,SCNN1B,Uncertain significance,Bronchiectasis with or without elevated sweat chloride 1|not provided,single nucleotide variant,GRCh37
na,na,16,23367959,23367959,SCNN1B,Uncertain significance,Bronchiectasis with or without elevated sweat chloride 1|not provided,single nucleotide variant,GRCh38
na,na,16,23391814,23391814,SCNN1B,Pathogenic,Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh37
na,na,16,23380493,23380493,SCNN1B,Pathogenic,Bronchiectasis with or without elevated sweat chloride 1,single nucleotide variant,GRCh38
na,na,16,23383157,23383157,SCNN1B,Uncertain significance,"Bronchiectasis with or without elevated sweat chloride 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh37
na,na,16,23371836,23371836,SCNN1B,Uncertain significance,"Bronchiectasis with or without elevated sweat chloride 1|not provided|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh38
na,na,16,23379263,23379263,SCNN1B,Uncertain significance,"Bronchiectasis with or without elevated sweat chloride 1|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh37
na,na,16,23367942,23367942,SCNN1B,Uncertain significance,"Bronchiectasis with or without elevated sweat chloride 1|Pseudohypoaldosteronism, type IB2, autosomal recessive;Liddle syndrome 1;Bronchiectasis with or without elevated sweat chloride 1",single nucleotide variant,GRCh38
na,na,16,23360165,23360165,SCNN1B,Conflicting classifications of pathogenicity,"Bronchiectasis with or without elevated sweat chloride 1|not specified|not provided|Liddle syndrome 1|Pseudohypoaldosteronism, type IB1, autosomal recessive|SCNN1B-related disorder",single nucleotide variant,GRCh37
na,na,16,23348844,23348844,SCNN1B,Conflicting classifications of pathogenicity,"Bronchiectasis with or without elevated sweat chloride 1|not specified|not provided|Liddle syndrome 1|Pseudohypoaldosteronism, type IB1, autosomal recessive|SCNN1B-related disorder",single nucleotide variant,GRCh38
na,na,1,227073304,227073304,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh37
na,na,1,226885603,226885603,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh38
na,na,1,227076678,227076678,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh37
na,na,1,226888977,226888977,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh38
na,na,1,227083249,227083249,PSEN2,Uncertain significance,Alzheimer disease 4|not provided|Alzheimer disease,single nucleotide variant,GRCh37
na,na,1,226895548,226895548,PSEN2,Uncertain significance,Alzheimer disease 4|not provided|Alzheimer disease,single nucleotide variant,GRCh38
na,na,1,227083222,227083222,PSEN2,Uncertain significance,Alzheimer disease 4|not provided,single nucleotide variant,GRCh37
na,na,1,226895521,226895521,PSEN2,Uncertain significance,Alzheimer disease 4|not provided,single nucleotide variant,GRCh38
na,na,1,227073246,227073246,PSEN2,Pathogenic/Likely pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh37
na,na,1,226885545,226885545,PSEN2,Pathogenic/Likely pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh38
na,na,1,227076680,227076680,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh37
na,na,1,226888979,226888979,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh38
na,na,1,227073247,227073247,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh37
na,na,1,226885546,226885546,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh38
na,na,1,227073271,227073271,PSEN2,Benign/Likely benign,Dilated cardiomyopathy 1V|Alzheimer disease 4|Alzheimer disease|not provided|PSEN2-related disorder|not specified,single nucleotide variant,GRCh37
na,na,1,226885570,226885570,PSEN2,Benign/Likely benign,Dilated cardiomyopathy 1V|Alzheimer disease 4|Alzheimer disease|not provided|PSEN2-related disorder|not specified,single nucleotide variant,GRCh38
na,na,1,227071518,227071518,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh37
na,na,1,226883817,226883817,PSEN2,Pathogenic,Alzheimer disease 4|not provided,single nucleotide variant,GRCh38
na,na,14,23588048,23588052,CEBPE,Pathogenic,Specific granule deficiency 1,Deletion,GRCh37
na,na,14,23118839,23118843,CEBPE,Pathogenic,Specific granule deficiency 1,Deletion,GRCh38
na,na,14,23587791,23587792,CEBPE,Pathogenic,Specific granule deficiency 1,Duplication,GRCh37
na,na,14,23118582,23118583,CEBPE,Pathogenic,Specific granule deficiency 1,Duplication,GRCh38
na,na,11,128786525,128786525,KCNJ5,Benign/Likely benign,Long QT syndrome 13|Familial hyperaldosteronism type III|Andersen Tawil syndrome|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,11,128916630,128916630,KCNJ5,Benign/Likely benign,Long QT syndrome 13|Familial hyperaldosteronism type III|Andersen Tawil syndrome|Long QT syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,13,28498576,28498576,PDX1,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh37
na,na,13,27924439,27924439,PDX1,risk factor,"Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh38
na,na,13,28494501,28494501,PDX1,Conflicting classifications of pathogenicity,"Type 2 diabetes mellitus|Maturity-onset diabetes of the young type 4|not specified|Monogenic diabetes|Maturity onset diabetes mellitus in young|not provided|Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh37
na,na,13,27920364,27920364,PDX1,Conflicting classifications of pathogenicity,"Type 2 diabetes mellitus|Maturity-onset diabetes of the young type 4|not specified|Monogenic diabetes|Maturity onset diabetes mellitus in young|not provided|Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh38
na,na,13,28494451,28494451,PDX1,Uncertain significance,"Diabetes mellitus type 2, susceptibility to|PDX1-related disorder|not provided",single nucleotide variant,GRCh37
na,na,13,27920314,27920314,PDX1,Uncertain significance,"Diabetes mellitus type 2, susceptibility to|PDX1-related disorder|not provided",single nucleotide variant,GRCh38
na,na,13,28494327,28494327,PDX1,Uncertain significance,"Type 2 diabetes mellitus|not provided|Diabetes mellitus type 2, susceptibility to|Pancreatic agenesis 1;Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 4",single nucleotide variant,GRCh37
na,na,13,27920190,27920190,PDX1,Uncertain significance,"Type 2 diabetes mellitus|not provided|Diabetes mellitus type 2, susceptibility to|Pancreatic agenesis 1;Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 4",single nucleotide variant,GRCh38
na,na,13,28498656,28498656,PDX1,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 4|Monogenic diabetes|not provided|Type 2 diabetes mellitus|Maturity onset diabetes mellitus in young|not specified|Maturity-onset diabetes of the young type 4;Type 2 diabetes mellitus,single nucleotide variant,GRCh37
na,na,13,27924519,27924519,PDX1,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 4|Monogenic diabetes|not provided|Type 2 diabetes mellitus|Maturity onset diabetes mellitus in young|not specified|Maturity-onset diabetes of the young type 4;Type 2 diabetes mellitus,single nucleotide variant,GRCh38
na,na,13,28498478,28498478,PDX1,Pathogenic; risk factor,"Pancreatic agenesis 1|Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh37
na,na,13,27924341,27924341,PDX1,Pathogenic; risk factor,"Pancreatic agenesis 1|Diabetes mellitus type 2, susceptibility to",single nucleotide variant,GRCh38
na,na,13,28498518,28498518,PDX1,Pathogenic,Pancreatic agenesis 1,single nucleotide variant,GRCh37
na,na,13,27924381,27924381,PDX1,Pathogenic,Pancreatic agenesis 1,single nucleotide variant,GRCh38
na,na,2,219924907,219924907,IHH,Pathogenic,Brachydactyly type A1|not provided,single nucleotide variant,GRCh37
na,na,2,219060185,219060185,IHH,Pathogenic,Brachydactyly type A1|not provided,single nucleotide variant,GRCh38
na,na,2,219922341,219922341,IHH,Likely pathogenic,Brachydactyly type A1|not provided,single nucleotide variant,GRCh37
na,na,2,219057619,219057619,IHH,Likely pathogenic,Brachydactyly type A1|not provided,single nucleotide variant,GRCh38
na,na,2,219924890,219924890,IHH,Pathogenic,Brachydactyly type A1,single nucleotide variant,GRCh37
na,na,2,219060168,219060168,IHH,Pathogenic,Brachydactyly type A1,single nucleotide variant,GRCh38
na,na,2,219924892,219924892,IHH,Pathogenic,Brachydactyly type A1|Brachydactyly type A1A|not provided,single nucleotide variant,GRCh37
na,na,2,219060170,219060170,IHH,Pathogenic,Brachydactyly type A1|Brachydactyly type A1A|not provided,single nucleotide variant,GRCh38
na,na,2,219925053,219925053,IHH,Pathogenic,Acrocapitofemoral dysplasia,single nucleotide variant,GRCh37
na,na,2,219060331,219060331,IHH,Pathogenic,Acrocapitofemoral dysplasia,single nucleotide variant,GRCh38
na,na,2,219922163,219922163,IHH,Pathogenic,Acrocapitofemoral dysplasia|not provided,single nucleotide variant,GRCh37
na,na,2,219057441,219057441,IHH,Pathogenic,Acrocapitofemoral dysplasia|not provided,single nucleotide variant,GRCh38
na,na,2,219924906,219924906,IHH,Pathogenic,Brachydactyly type A1,single nucleotide variant,GRCh37
na,na,2,219060184,219060184,IHH,Pathogenic,Brachydactyly type A1,single nucleotide variant,GRCh38
na,na,2,219922271,219922271,IHH,Pathogenic,Brachydactyly type A1,single nucleotide variant,GRCh37
na,na,2,219057549,219057549,IHH,Pathogenic,Brachydactyly type A1,single nucleotide variant,GRCh38
na,na,2,219922349,219922349,IHH,Likely pathogenic,Brachydactyly type A1|not provided,single nucleotide variant,GRCh37
na,na,2,219057627,219057627,IHH,Likely pathogenic,Brachydactyly type A1|not provided,single nucleotide variant,GRCh38
na,na,2,219922343,219922343,IHH,Pathogenic,Brachydactyly type A1,single nucleotide variant,GRCh37
na,na,2,219057621,219057621,IHH,Pathogenic,Brachydactyly type A1,single nucleotide variant,GRCh38
na,na,7,155604726,155604726,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155812032,155812032,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,7,155604519,155604519,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155811825,155811825,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,7,155599239,155599239,SHH,Pathogenic,Holoprosencephaly 3|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,7,155806545,155806545,SHH,Pathogenic,Holoprosencephaly 3|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,7,155599203,155599203,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155806509,155806509,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,7,155599203,155599203,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155806509,155806509,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,7,155596312,155596312,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155803618,155803618,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,7,155596307,155596307,SHH,Conflicting classifications of pathogenicity,Holoprosencephaly 3|not provided|Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies,single nucleotide variant,GRCh37
na,na,7,155803613,155803613,SHH,Conflicting classifications of pathogenicity,Holoprosencephaly 3|not provided|Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies,single nucleotide variant,GRCh38
na,na,7,155596175,155596195,SHH,Pathogenic,Holoprosencephaly 3,Deletion,GRCh37
na,na,7,155803481,155803501,SHH,Pathogenic,Holoprosencephaly 3,Deletion,GRCh38
na,na,7,155596133,155596133,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155803439,155803439,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,7,155595836,155595836,SHH,Uncertain significance,"Holoprosencephaly 3|Schizencephaly|Microphthalmia, isolated, with coloboma 5|Solitary median maxillary central incisor syndrome|not provided",single nucleotide variant,GRCh37
na,na,7,155803142,155803142,SHH,Uncertain significance,"Holoprosencephaly 3|Schizencephaly|Microphthalmia, isolated, with coloboma 5|Solitary median maxillary central incisor syndrome|not provided",single nucleotide variant,GRCh38
na,na,7,155596114,155596114,SHH,Benign/Likely benign,"Holoprosencephaly 3|not specified|not provided|Schizencephaly;Microphthalmia, isolated, with coloboma 5;Holoprosencephaly 3;Solitary median maxillary central incisor syndrome|SHH-related disorder",single nucleotide variant,GRCh37
na,na,7,155803420,155803420,SHH,Benign/Likely benign,"Holoprosencephaly 3|not specified|not provided|Schizencephaly;Microphthalmia, isolated, with coloboma 5;Holoprosencephaly 3;Solitary median maxillary central incisor syndrome|SHH-related disorder",single nucleotide variant,GRCh38
na,na,7,155595713,155595713,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155803019,155803019,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,7,155595843,155595851,SHH,Pathogenic,Holoprosencephaly 3,Deletion,GRCh37
na,na,7,155803149,155803157,SHH,Pathogenic,Holoprosencephaly 3,Deletion,GRCh38
na,na,7,155599221,155599221,SHH,Pathogenic,Solitary median maxillary central incisor syndrome,single nucleotide variant,GRCh37
na,na,7,155806527,155806527,SHH,Pathogenic,Solitary median maxillary central incisor syndrome,single nucleotide variant,GRCh38
na,na,7,155604554,155604554,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155811860,155811860,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,7,155596217,155596217,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155803523,155803523,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,7,155595988,155595988,SHH,Likely pathogenic,Solitary median maxillary central incisor syndrome,single nucleotide variant,GRCh37
na,na,7,155803294,155803294,SHH,Likely pathogenic,Solitary median maxillary central incisor syndrome,single nucleotide variant,GRCh38
na,na,7,155599169,155599169,SHH,Pathogenic,Holoprosencephaly 3|Solitary median maxillary central incisor syndrome|not provided,single nucleotide variant,GRCh37
na,na,7,155806475,155806475,SHH,Pathogenic,Holoprosencephaly 3|Solitary median maxillary central incisor syndrome|not provided,single nucleotide variant,GRCh38
na,na,7,155599207,155599207,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh37
na,na,7,155806513,155806513,SHH,Pathogenic,Holoprosencephaly 3,single nucleotide variant,GRCh38
na,na,16,57931817,57931817,CNGB1,Pathogenic,Retinitis pigmentosa 45,single nucleotide variant,GRCh37
na,na,16,57897913,57897913,CNGB1,Pathogenic,Retinitis pigmentosa 45,single nucleotide variant,GRCh38
na,na,16,57921758,57921758,CNGB1,Pathogenic,Retinitis pigmentosa 45,single nucleotide variant,GRCh37
na,na,16,57887854,57887854,CNGB1,Pathogenic,Retinitis pigmentosa 45,single nucleotide variant,GRCh38
na,na,1,40557070,40557070,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,1,40091398,40091398,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,40558081,40558081,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1|not provided|Retinitis pigmentosa|Inborn genetic diseases|PPT1-related disorder,single nucleotide variant,GRCh37
na,na,1,40092409,40092409,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1|not provided|Retinitis pigmentosa|Inborn genetic diseases|PPT1-related disorder,single nucleotide variant,GRCh38
na,na,1,40557843,40557843,PPT1,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 1|not provided,single nucleotide variant,GRCh37
na,na,1,40092171,40092171,PPT1,Pathogenic/Likely pathogenic,Neuronal ceroid lipofuscinosis 1|not provided,single nucleotide variant,GRCh38
na,na,1,40544302,40544302,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1,single nucleotide variant,GRCh37
na,na,1,40078630,40078630,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1,single nucleotide variant,GRCh38
na,na,1,40562882,40562882,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,1,40097210,40097210,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1|not provided|Neuronal ceroid lipofuscinosis|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,40555167,40555167,PPT1,Pathogenic/Likely pathogenic,"Neuronal ceroid lipofuscinosis 1|Neuronal Ceroid-Lipofuscinosis, Recessive|Neuronal ceroid lipofuscinosis|not provided|Inborn genetic diseases|PPT1-related disorder",single nucleotide variant,GRCh37
na,na,1,40089495,40089495,PPT1,Pathogenic/Likely pathogenic,"Neuronal ceroid lipofuscinosis 1|Neuronal Ceroid-Lipofuscinosis, Recessive|Neuronal ceroid lipofuscinosis|not provided|Inborn genetic diseases|PPT1-related disorder",single nucleotide variant,GRCh38
na,na,1,40557757,40557757,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1,single nucleotide variant,GRCh37
na,na,1,40092085,40092085,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1,single nucleotide variant,GRCh38
na,na,1,40558170,40558170,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1,single nucleotide variant,GRCh37
na,na,1,40092498,40092498,PPT1,Pathogenic,Neuronal ceroid lipofuscinosis 1,single nucleotide variant,GRCh38
na,na,1,114377568,114377568,PTPN22,Benign,"Diabetes mellitus, insulin-dependent, susceptibility to|not provided|chronic fatigue syndrome with infection-triggered onset",single nucleotide variant,GRCh37
na,na,1,113834946,113834946,PTPN22,Benign,"Diabetes mellitus, insulin-dependent, susceptibility to|not provided|chronic fatigue syndrome with infection-triggered onset",single nucleotide variant,GRCh38
na,na,1,114415368,114415368,PTPN22,Benign,"Diabetes mellitus, insulin-dependent, susceptibility to",single nucleotide variant,GRCh37
na,na,1,113872746,113872746,PTPN22,Benign,"Diabetes mellitus, insulin-dependent, susceptibility to",single nucleotide variant,GRCh38
na,na,1,209880216,209880217,HSD11B1,Benign,Cortisone reductase deficiency 2,Duplication,GRCh37
na,na,1,209706871,209706872,HSD11B1,Benign,Cortisone reductase deficiency 2,Duplication,GRCh38
na,na,12,52200426,52200427,SCN8A,Uncertain significance,Cognitive impairment with or without cerebellar ataxia|not provided,Deletion,GRCh37
na,na,12,51806642,51806643,SCN8A,Uncertain significance,Cognitive impairment with or without cerebellar ataxia|not provided,Deletion,GRCh38
na,na,11,1954967,1954967,TNNT3,Pathogenic/Likely pathogenic,"Arthrogryposis, distal, type 2B2|not provided|Arthyrgryposis, distal, type 2B",single nucleotide variant,GRCh37
na,na,11,1933737,1933737,TNNT3,Pathogenic/Likely pathogenic,"Arthrogryposis, distal, type 2B2|not provided|Arthyrgryposis, distal, type 2B",single nucleotide variant,GRCh38
na,na,1,113460418,113460418,SLC16A1,Uncertain significance,Metabolic myopathy due to lactate transporter defect|not provided,single nucleotide variant,GRCh37
na,na,1,112917796,112917796,SLC16A1,Uncertain significance,Metabolic myopathy due to lactate transporter defect|not provided,single nucleotide variant,GRCh38
na,na,1,113456602,113456602,SLC16A1,Conflicting classifications of pathogenicity,Metabolic myopathy due to lactate transporter defect|not specified|not provided,single nucleotide variant,GRCh37
na,na,1,112913980,112913980,SLC16A1,Conflicting classifications of pathogenicity,Metabolic myopathy due to lactate transporter defect|not specified|not provided,single nucleotide variant,GRCh38
na,na,1,113498814,113498814,SLC16A1,Pathogenic,Exercise-induced hyperinsulinism,single nucleotide variant,GRCh37
na,na,1,112956192,112956192,SLC16A1,Pathogenic,Exercise-induced hyperinsulinism,single nucleotide variant,GRCh38
na,na,1,113499002,113499003,SLC16A1,Pathogenic,Exercise-induced hyperinsulinism,Insertion,GRCh37
na,na,1,112956380,112956381,SLC16A1,Pathogenic,Exercise-induced hyperinsulinism,Insertion,GRCh38
na,na,17,68171392,68171392,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome|Short QT syndrome type 3;Andersen Tawil syndrome,single nucleotide variant,GRCh37
na,na,17,70175251,70175251,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome|Short QT syndrome type 3;Andersen Tawil syndrome,single nucleotide variant,GRCh38
na,na,17,68171832,68171832,KCNJ2,Pathogenic/Likely pathogenic,"Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Short QT syndrome type 3;Andersen Tawil syndrome|Cardiovascular phenotype|Short QT syndrome type 3;Andersen Tawil syndrome;Atrial fibrillation, familial, 9",single nucleotide variant,GRCh37
na,na,17,70175691,70175691,KCNJ2,Pathogenic/Likely pathogenic,"Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Short QT syndrome type 3;Andersen Tawil syndrome|Cardiovascular phenotype|Short QT syndrome type 3;Andersen Tawil syndrome;Atrial fibrillation, familial, 9",single nucleotide variant,GRCh38
na,na,17,68172079,68172079,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Short QT syndrome type 3;Andersen Tawil syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,17,70175938,70175938,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Short QT syndrome type 3;Andersen Tawil syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,17,68171465,68171476,KCNJ2,Pathogenic,Andersen Tawil syndrome,Deletion,GRCh37
na,na,17,70175324,70175335,KCNJ2,Pathogenic,Andersen Tawil syndrome,Deletion,GRCh38
na,na,17,68171379,68171379,KCNJ2,Pathogenic,"Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Short QT syndrome type 3;Andersen Tawil syndrome;Atrial fibrillation, familial, 9|Short QT syndrome type 3;Andersen Tawil syndrome|not specified|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,17,70175238,70175238,KCNJ2,Pathogenic,"Andersen Tawil syndrome|Congenital long QT syndrome|not provided|Short QT syndrome type 3;Andersen Tawil syndrome;Atrial fibrillation, familial, 9|Short QT syndrome type 3;Andersen Tawil syndrome|not specified|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,17,68171737,68171737,KCNJ2,Pathogenic,Congenital long QT syndrome|Andersen Tawil syndrome,single nucleotide variant,GRCh37
na,na,17,70175596,70175596,KCNJ2,Pathogenic,Congenital long QT syndrome|Andersen Tawil syndrome,single nucleotide variant,GRCh38
na,na,17,68172084,68172084,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome,single nucleotide variant,GRCh37
na,na,17,70175943,70175943,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome,single nucleotide variant,GRCh38
na,na,17,68171826,68171826,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome,single nucleotide variant,GRCh37
na,na,17,70175685,70175685,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome,single nucleotide variant,GRCh38
na,na,17,68171694,68171694,KCNJ2,Pathogenic,Short QT syndrome type 3|Short QT syndrome|Short QT syndrome type 3;Andersen Tawil syndrome,single nucleotide variant,GRCh37
na,na,17,70175553,70175553,KCNJ2,Pathogenic,Short QT syndrome type 3|Short QT syndrome|Short QT syndrome type 3;Andersen Tawil syndrome,single nucleotide variant,GRCh38
na,na,17,68171404,68171404,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome|Short QT syndrome type 3;Andersen Tawil syndrome,single nucleotide variant,GRCh37
na,na,17,70175263,70175263,KCNJ2,Pathogenic,Andersen Tawil syndrome|Congenital long QT syndrome|Short QT syndrome type 3;Andersen Tawil syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,MSH6,Pathogenic,Lynch syndrome 5,Deletion,na
na,na,na,-1,-1,MSH6,Pathogenic,Lynch syndrome 5,Deletion,na
na,na,2,48027755,48027755,MSH6,Benign,Lynch syndrome 5|not specified|Lynch syndrome|Colorectal / endometrial cancer|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Malignant tumor of breast|Carcinoma of colon|Breast and/or ovarian cancer|Mismatch repair cancer syndrome 3;Endometrial carcinoma;Lynch syndrome 5,single nucleotide variant,GRCh37
na,na,2,47800616,47800616,MSH6,Benign,Lynch syndrome 5|not specified|Lynch syndrome|Colorectal / endometrial cancer|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Malignant tumor of breast|Carcinoma of colon|Breast and/or ovarian cancer|Mismatch repair cancer syndrome 3;Endometrial carcinoma;Lynch syndrome 5,single nucleotide variant,GRCh38
na,na,2,48025772,48025773,MSH6,Pathogenic,Lynch syndrome 5|not provided|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome 1|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome 5;Endometrial carcinoma;Mismatch repair cancer syndrome 3|Endometrial carcinoma|MSH6-related disorder,Duplication,GRCh37
na,na,2,47798633,47798634,MSH6,Pathogenic,Lynch syndrome 5|not provided|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome 1|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome 5;Endometrial carcinoma;Mismatch repair cancer syndrome 3|Endometrial carcinoma|MSH6-related disorder,Duplication,GRCh38
na,na,2,48026724,48026724,MSH6,Pathogenic,Lynch syndrome 5,Deletion,GRCh37
na,na,2,47799585,47799585,MSH6,Pathogenic,Lynch syndrome 5,Deletion,GRCh38
na,na,na,-1,-1,MSH6,Pathogenic,Lynch syndrome 5,Deletion,na
na,na,2,48026694,48026695,MSH6,Pathogenic,Lynch syndrome 5,Duplication,GRCh37
na,na,2,47799555,47799556,MSH6,Pathogenic,Lynch syndrome 5,Duplication,GRCh38
na,na,2,48032831,48032832,MSH6,Pathogenic,Mismatch repair cancer syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Endometrial carcinoma|Lynch syndrome 5|Lynch syndrome,Duplication,GRCh37
na,na,2,47805692,47805693,MSH6,Pathogenic,Mismatch repair cancer syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Endometrial carcinoma|Lynch syndrome 5|Lynch syndrome,Duplication,GRCh38
na,na,14,104165753,104165753,XRCC3,Benign,"Melanoma, cutaneous malignant, susceptibility to, 6|XRCC3-related disorder|not provided",single nucleotide variant,GRCh37
na,na,14,103699416,103699416,XRCC3,Benign,"Melanoma, cutaneous malignant, susceptibility to, 6|XRCC3-related disorder|not provided",single nucleotide variant,GRCh38
na,na,14,104165927,104165927,XRCC3,risk factor,"Breast cancer, susceptibility to",single nucleotide variant,GRCh37
na,na,14,103699590,103699590,XRCC3,risk factor,"Breast cancer, susceptibility to",single nucleotide variant,GRCh38
na,na,10,101964924,101964924,CHUK,Pathogenic,Cocoon syndrome,single nucleotide variant,GRCh37
na,na,10,100205167,100205167,CHUK,Pathogenic,Cocoon syndrome,single nucleotide variant,GRCh38
na,na,5,88027673,88027673,MEF2C,Pathogenic,"Intellectual disability, autosomal dominant 20",single nucleotide variant,GRCh37
na,na,5,88731856,88731856,MEF2C,Pathogenic,"Intellectual disability, autosomal dominant 20",single nucleotide variant,GRCh38
na,na,15,100252770,100252790,MEF2A,Pathogenic,"Coronary artery disease, autosomal dominant, 1",Deletion,GRCh37
na,na,15,99712565,99712585,MEF2A,Pathogenic,"Coronary artery disease, autosomal dominant, 1",Deletion,GRCh38
na,na,15,100230605,100230605,MEF2A,Pathogenic,Coronary artery disease/myocardial infarction,single nucleotide variant,GRCh37
na,na,15,99690400,99690400,MEF2A,Pathogenic,Coronary artery disease/myocardial infarction,single nucleotide variant,GRCh38
na,na,15,100230557,100230557,MEF2A,Benign/Likely benign,Coronary artery disease/myocardial infarction|not specified|not provided,single nucleotide variant,GRCh37
na,na,15,99690352,99690352,MEF2A,Benign/Likely benign,Coronary artery disease/myocardial infarction|not specified|not provided,single nucleotide variant,GRCh38
na,na,15,100230617,100230617,MEF2A,Pathogenic,Coronary artery disease/myocardial infarction,single nucleotide variant,GRCh37
na,na,15,99690412,99690412,MEF2A,Pathogenic,Coronary artery disease/myocardial infarction,single nucleotide variant,GRCh38
na,na,1,53679181,53679181,CPT2,Pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh37
na,na,1,53213509,53213509,CPT2,Pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh38
na,na,1,53668099,53668099,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency|not provided|Carnitine palmitoyl transferase II deficiency, neonatal form|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyl transferase II deficiency, severe infantile form|Inborn genetic diseases|Rhabdomyolysis|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Abnormality of the musculature|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh37
na,na,1,53202427,53202427,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency|not provided|Carnitine palmitoyl transferase II deficiency, neonatal form|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyl transferase II deficiency, severe infantile form|Inborn genetic diseases|Rhabdomyolysis|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Abnormality of the musculature|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh38
na,na,1,53662764,53662764,CPT2,Pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh37
na,na,1,53197092,53197092,CPT2,Pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh38
na,na,1,53678947,53678947,CPT2,Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency",single nucleotide variant,GRCh37
na,na,1,53213275,53213275,CPT2,Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency",single nucleotide variant,GRCh38
na,na,1,53679173,53679173,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form",single nucleotide variant,GRCh37
na,na,1,53213501,53213501,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form",single nucleotide variant,GRCh38
na,na,1,53675866,53675866,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh37
na,na,1,53210194,53210194,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh38
na,na,1,53676494,53676494,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Carnitine palmitoyl transferase II deficiency, myopathic form|Seizure;Abnormality of the nervous system|Carnitine palmitoyl transferase II deficiency, neonatal form|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4|not provided",single nucleotide variant,GRCh37
na,na,1,53210822,53210822,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form;Carnitine palmitoyl transferase II deficiency, myopathic form|Seizure;Abnormality of the nervous system|Carnitine palmitoyl transferase II deficiency, neonatal form|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4|not provided",single nucleotide variant,GRCh38
na,na,1,53676853,53676853,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4|Carnitine palmitoyl transferase II deficiency, severe infantile form|CPT2-related disorder",single nucleotide variant,GRCh37
na,na,1,53211181,53211181,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, severe infantile form|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4|Carnitine palmitoyl transferase II deficiency, severe infantile form|CPT2-related disorder",single nucleotide variant,GRCh38
na,na,1,53676688,53676688,CPT2,Conflicting classifications of pathogenicity; other,"not provided|Carnitine palmitoyltransferase II deficiency|not specified|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form",single nucleotide variant,GRCh37
na,na,1,53211016,53211016,CPT2,Conflicting classifications of pathogenicity; other,"not provided|Carnitine palmitoyltransferase II deficiency|not specified|Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form",single nucleotide variant,GRCh38
na,na,1,53667994,53667994,CPT2,Pathogenic,"Carnitine palmitoyl transferase II deficiency, neonatal form",single nucleotide variant,GRCh37
na,na,1,53202322,53202322,CPT2,Pathogenic,"Carnitine palmitoyl transferase II deficiency, neonatal form",single nucleotide variant,GRCh38
na,na,na,-1,-1,CPT2,Pathogenic,"Carnitine palmitoyl transferase II deficiency, neonatal form",Duplication,na
na,na,1,53676026,53676026,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, neonatal form|not provided|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4|CPT2-related disorder",single nucleotide variant,GRCh37
na,na,1,53210354,53210354,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, neonatal form|not provided|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|Encephalopathy, acute, infection-induced, susceptibility to, 4|CPT2-related disorder",single nucleotide variant,GRCh38
na,na,1,53676706,53676706,CPT2,Pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency",single nucleotide variant,GRCh37
na,na,1,53211034,53211034,CPT2,Pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency",single nucleotide variant,GRCh38
na,na,1,53675984,53675984,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency",single nucleotide variant,GRCh37
na,na,1,53210312,53210312,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyltransferase II deficiency",single nucleotide variant,GRCh38
na,na,1,53675705,53675705,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyl transferase II deficiency, neonatal form|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh37
na,na,1,53210033,53210033,CPT2,Pathogenic/Likely pathogenic,"Carnitine palmitoyl transferase II deficiency, severe infantile form|Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyl transferase II deficiency, myopathic form|Carnitine palmitoyl transferase II deficiency, neonatal form|Encephalopathy, acute, infection-induced, susceptibility to, 4;Carnitine palmitoyl transferase II deficiency, neonatal form;Carnitine palmitoyl transferase II deficiency, myopathic form;Carnitine palmitoyl transferase II deficiency, severe infantile form|not provided|Encephalopathy, acute, infection-induced, susceptibility to, 4",single nucleotide variant,GRCh38
na,na,11,119548444,119548444,NECTIN1,Pathogenic,Cleft lip/palate-ectodermal dysplasia syndrome|Orofacial cleft 7,single nucleotide variant,GRCh37
na,na,11,119677734,119677734,NECTIN1,Pathogenic,Cleft lip/palate-ectodermal dysplasia syndrome|Orofacial cleft 7,single nucleotide variant,GRCh38
na,na,11,119548442,119548442,NECTIN1,Pathogenic,Cleft lip/palate-ectodermal dysplasia syndrome,Deletion,GRCh37
na,na,11,119677732,119677732,NECTIN1,Pathogenic,Cleft lip/palate-ectodermal dysplasia syndrome,Deletion,GRCh38
na,na,11,119545902,119545903,NECTIN1,Pathogenic,Cleft lip/palate-ectodermal dysplasia syndrome,Duplication,GRCh37
na,na,11,119675192,119675193,NECTIN1,Pathogenic,Cleft lip/palate-ectodermal dysplasia syndrome,Duplication,GRCh38
na,na,14,36407609,37670256,NKX2-1,Pathogenic,Benign hereditary chorea,Deletion,GRCh37
na,na,14,36986962,36986962,NKX2-1,Pathogenic,Benign hereditary chorea,single nucleotide variant,GRCh37
na,na,14,36517757,36517757,NKX2-1,Pathogenic,Benign hereditary chorea,single nucleotide variant,GRCh38
na,na,14,36986976,36986976,NKX2-1,Pathogenic/Likely pathogenic,Benign hereditary chorea|not provided|Brain-lung-thyroid syndrome,single nucleotide variant,GRCh37
na,na,14,36517771,36517771,NKX2-1,Pathogenic/Likely pathogenic,Benign hereditary chorea|not provided|Brain-lung-thyroid syndrome,single nucleotide variant,GRCh38
na,na,14,36986781,36986781,NKX2-1,Pathogenic,Benign hereditary chorea,Deletion,GRCh37
na,na,14,36517576,36517576,NKX2-1,Pathogenic,Benign hereditary chorea,Deletion,GRCh38
na,na,14,36986986,36986986,NKX2-1,Pathogenic,Brain-lung-thyroid syndrome,single nucleotide variant,GRCh37
na,na,14,36517781,36517781,NKX2-1,Pathogenic,Brain-lung-thyroid syndrome,single nucleotide variant,GRCh38
na,na,14,36987015,36987016,NKX2-1,Pathogenic,Brain-lung-thyroid syndrome,Duplication,GRCh37
na,na,14,36517810,36517811,NKX2-1,Pathogenic,Brain-lung-thyroid syndrome,Duplication,GRCh38
na,na,14,36987227,36987227,NKX2-1,Conflicting classifications of pathogenicity,Benign hereditary chorea|Brain-lung-thyroid syndrome|not provided,single nucleotide variant,GRCh37
na,na,14,36518022,36518022,NKX2-1,Conflicting classifications of pathogenicity,Benign hereditary chorea|Brain-lung-thyroid syndrome|not provided,single nucleotide variant,GRCh38
na,na,14,36987076,36987076,NKX2-1,Pathogenic/Likely pathogenic,Brain-lung-thyroid syndrome|Benign hereditary chorea|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,14,36517871,36517871,NKX2-1,Pathogenic/Likely pathogenic,Brain-lung-thyroid syndrome|Benign hereditary chorea|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,14,36986944,36986944,NKX2-1,Pathogenic,Benign hereditary chorea|not provided,single nucleotide variant,GRCh37
na,na,14,36517739,36517739,NKX2-1,Pathogenic,Benign hereditary chorea|not provided,single nucleotide variant,GRCh38
na,na,14,36988308,36988309,NKX2-1,Pathogenic,Brain-lung-thyroid syndrome,Duplication,GRCh37
na,na,14,36519103,36519104,NKX2-1,Pathogenic,Brain-lung-thyroid syndrome,Duplication,GRCh38
na,na,14,36987227,36987227,NKX2-1,Pathogenic,Brain-lung-thyroid syndrome,single nucleotide variant,GRCh37
na,na,14,36518022,36518022,NKX2-1,Pathogenic,Brain-lung-thyroid syndrome,single nucleotide variant,GRCh38
na,na,11,132527098,132527098,OPCML,Pathogenic,Ovarian neoplasm,single nucleotide variant,GRCh37
na,na,11,132657203,132657203,OPCML,Pathogenic,Ovarian neoplasm,single nucleotide variant,GRCh38
na,na,12,11992136,11992136,ETV6,Pathogenic,Acute myeloid leukemia,single nucleotide variant,GRCh37
na,na,12,11839202,11839202,ETV6,Pathogenic,Acute myeloid leukemia,single nucleotide variant,GRCh38
na,na,12,12043928,12043929,ETV6,Pathogenic,Acute myeloid leukemia,Insertion,GRCh37
na,na,12,11890994,11890995,ETV6,Pathogenic,Acute myeloid leukemia,Insertion,GRCh38
na,na,8,38001877,38001877,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh37
na,na,8,38144359,38144359,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh38
na,na,8,38003586,38003586,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh37
na,na,8,38146068,38146068,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh38
na,na,8,38006156,38006157,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency,Duplication,GRCh37
na,na,8,38148638,38148639,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency,Duplication,GRCh38
na,na,8,38001900,38001900,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh37
na,na,8,38144382,38144382,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh38
na,na,8,38003481,38003481,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency,single nucleotide variant,GRCh37
na,na,8,38145963,38145963,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency,single nucleotide variant,GRCh38
na,na,8,38002831,38002831,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh37
na,na,8,38145313,38145313,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh38
na,na,8,38003586,38003586,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh37
na,na,8,38146068,38146068,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh38
na,na,8,38003572,38003572,STAR,Pathogenic/Likely pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided|Syndactyly-telecanthus-anogenital and renal malformations syndrome,single nucleotide variant,GRCh37
na,na,8,38146054,38146054,STAR,Pathogenic/Likely pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided|Syndactyly-telecanthus-anogenital and renal malformations syndrome,single nucleotide variant,GRCh38
na,na,8,38003569,38003569,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh37
na,na,8,38146051,38146051,STAR,Pathogenic,Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided,single nucleotide variant,GRCh38
na,na,19,12995833,12995834,KLF1,Pathogenic,"BLOOD GROUP--LUTHERAN INHIBITOR|FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6|Anemia, congenital dyserythropoietic, type IVb|KLF1-related disorder",Duplication,GRCh37
na,na,19,12885019,12885020,KLF1,Pathogenic,"BLOOD GROUP--LUTHERAN INHIBITOR|FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6|Anemia, congenital dyserythropoietic, type IVb|KLF1-related disorder",Duplication,GRCh38
na,na,19,12996475,12996475,KLF1,Pathogenic,BLOOD GROUP--LUTHERAN INHIBITOR,Deletion,GRCh37
na,na,19,12885661,12885661,KLF1,Pathogenic,BLOOD GROUP--LUTHERAN INHIBITOR,Deletion,GRCh38
na,na,19,12996170,12996170,KLF1,Pathogenic,BLOOD GROUP--LUTHERAN INHIBITOR,single nucleotide variant,GRCh37
na,na,19,12885356,12885356,KLF1,Pathogenic,BLOOD GROUP--LUTHERAN INHIBITOR,single nucleotide variant,GRCh38
na,na,19,12996149,12996149,KLF1,Pathogenic,BLOOD GROUP--LUTHERAN INHIBITOR,single nucleotide variant,GRCh37
na,na,19,12885335,12885335,KLF1,Pathogenic,BLOOD GROUP--LUTHERAN INHIBITOR,single nucleotide variant,GRCh38
na,na,19,12996182,12996182,KLF1,Affects,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6,single nucleotide variant,GRCh37
na,na,19,12885368,12885368,KLF1,Affects,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6,single nucleotide variant,GRCh38
na,na,5,172660014,172660014,NKX2-5,Pathogenic,Atrial septal defect 7,single nucleotide variant,GRCh37
na,na,5,173233011,173233011,NKX2-5,Pathogenic,Atrial septal defect 7,single nucleotide variant,GRCh38
na,na,5,172660039,172660039,NKX2-5,Pathogenic,Atrial septal defect 7,single nucleotide variant,GRCh37
na,na,5,173233036,173233036,NKX2-5,Pathogenic,Atrial septal defect 7,single nucleotide variant,GRCh38
na,na,5,172659955,172659955,NKX2-5,Pathogenic,Atrial septal defect 7,single nucleotide variant,GRCh37
na,na,5,173232952,173232952,NKX2-5,Pathogenic,Atrial septal defect 7,single nucleotide variant,GRCh38
na,na,5,172662014,172662014,NKX2-5,Conflicting classifications of pathogenicity,"Tetralogy of Fallot|Hypothyroidism, congenital, nongoitrous, 5|Aortic arch interruption|Hypoplastic left heart syndrome 2|not specified|Congenital heart disease|Cardiovascular phenotype|Atrial septal defect 7|not provided|Persistent truncus arteriosus",single nucleotide variant,GRCh37
na,na,5,173235011,173235011,NKX2-5,Conflicting classifications of pathogenicity,"Tetralogy of Fallot|Hypothyroidism, congenital, nongoitrous, 5|Aortic arch interruption|Hypoplastic left heart syndrome 2|not specified|Congenital heart disease|Cardiovascular phenotype|Atrial septal defect 7|not provided|Persistent truncus arteriosus",single nucleotide variant,GRCh38
na,na,5,172662026,172662026,NKX2-5,Conflicting classifications of pathogenicity,Tetralogy of Fallot|Congenital heart disease|not specified|not provided|Cardiovascular phenotype|Atrial septal defect 7,single nucleotide variant,GRCh37
na,na,5,173235023,173235023,NKX2-5,Conflicting classifications of pathogenicity,Tetralogy of Fallot|Congenital heart disease|not specified|not provided|Cardiovascular phenotype|Atrial septal defect 7,single nucleotide variant,GRCh38
na,na,5,172659901,172659901,NKX2-5,Uncertain significance,Tetralogy of Fallot|not provided|6 conditions|Atrial septal defect 7,single nucleotide variant,GRCh37
na,na,5,173232898,173232898,NKX2-5,Uncertain significance,Tetralogy of Fallot|not provided|6 conditions|Atrial septal defect 7,single nucleotide variant,GRCh38
na,na,5,172659891,172659891,NKX2-5,Uncertain significance,Tetralogy of Fallot|Atrial septal defect 7|Cardiovascular phenotype|6 conditions,single nucleotide variant,GRCh37
na,na,5,173232888,173232888,NKX2-5,Uncertain significance,Tetralogy of Fallot|Atrial septal defect 7|Cardiovascular phenotype|6 conditions,single nucleotide variant,GRCh38
na,na,5,172661866,172661872,NKX2-5,Pathogenic,Atrial septal defect 7,Deletion,GRCh37
na,na,5,173234863,173234869,NKX2-5,Pathogenic,Atrial septal defect 7,Deletion,GRCh38
na,na,5,172661858,172661859,NKX2-5,Pathogenic,Atrial septal defect 7,Microsatellite,GRCh37
na,na,5,173234855,173234856,NKX2-5,Pathogenic,Atrial septal defect 7,Microsatellite,GRCh38
na,na,5,172659651,172659651,NKX2-5,Pathogenic,"Atrial septal defect 7|Atrioventricular septal defect, somatic",single nucleotide variant,GRCh37
na,na,5,173232648,173232648,NKX2-5,Pathogenic,"Atrial septal defect 7|Atrioventricular septal defect, somatic",single nucleotide variant,GRCh38
na,na,5,172661825,172661825,NKX2-5,Pathogenic,Atrial septal defect 7,Deletion,GRCh37
na,na,5,173234822,173234822,NKX2-5,Pathogenic,Atrial septal defect 7,Deletion,GRCh38
na,na,5,172659979,172659979,NKX2-5,Uncertain significance,Atrial septal defect 7,single nucleotide variant,GRCh37
na,na,5,173232976,173232976,NKX2-5,Uncertain significance,Atrial septal defect 7,single nucleotide variant,GRCh38
na,na,5,172659779,172659779,NKX2-5,Pathogenic,Atrial septal defect 7,single nucleotide variant,GRCh37
na,na,5,173232776,173232776,NKX2-5,Pathogenic,Atrial septal defect 7,single nucleotide variant,GRCh38
na,na,5,172660192,172660192,NKX2-5,Benign/Likely benign,"Hypothyroidism, congenital, nongoitrous, 5|not specified|Atrial septal defect 7|Cardiovascular phenotype|not provided|NKX2-5-related disorder",single nucleotide variant,GRCh37
na,na,5,173233189,173233189,NKX2-5,Benign/Likely benign,"Hypothyroidism, congenital, nongoitrous, 5|not specified|Atrial septal defect 7|Cardiovascular phenotype|not provided|NKX2-5-related disorder",single nucleotide variant,GRCh38
na,na,5,172660065,172660065,NKX2-5,Uncertain significance,"Hypothyroidism, congenital, nongoitrous, 5|not provided|Atrial septal defect 7",single nucleotide variant,GRCh37
na,na,5,173233062,173233062,NKX2-5,Uncertain significance,"Hypothyroidism, congenital, nongoitrous, 5|not provided|Atrial septal defect 7",single nucleotide variant,GRCh38
na,na,5,172660000,172660000,NKX2-5,Pathogenic,"Atrioventricular septal defect, somatic",single nucleotide variant,GRCh37
na,na,5,173232997,173232997,NKX2-5,Pathogenic,"Atrioventricular septal defect, somatic",single nucleotide variant,GRCh38
na,na,9,139091646,139091646,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,single nucleotide variant,GRCh37
na,na,9,136199800,136199800,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,single nucleotide variant,GRCh38
na,na,9,139091504,139091526,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,Deletion,GRCh37
na,na,9,136199658,136199680,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,Deletion,GRCh38
na,na,9,139092583,139092583,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,Deletion,GRCh37
na,na,9,136200737,136200737,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,Deletion,GRCh38
na,na,9,139090644,139090644,LHX3,Likely pathogenic,"Non-acquired combined pituitary hormone deficiency with spine abnormalities|Combined pituitary hormone deficiencies, genetic form",single nucleotide variant,GRCh37
na,na,9,136198798,136198798,LHX3,Likely pathogenic,"Non-acquired combined pituitary hormone deficiency with spine abnormalities|Combined pituitary hormone deficiencies, genetic form",single nucleotide variant,GRCh38
na,na,9,139091690,139091691,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,Indel,GRCh37
na,na,9,136199844,136199845,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,Indel,GRCh38
na,na,9,136197325,136205012,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,Deletion,GRCh38
na,na,9,139090601,139090601,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,single nucleotide variant,GRCh37
na,na,9,136198755,136198755,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,single nucleotide variant,GRCh38
na,na,9,139090043,139093129,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,Deletion,GRCh37
na,na,9,136198197,136201283,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,Deletion,GRCh38
na,na,9,139092546,139092546,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,single nucleotide variant,GRCh37
na,na,9,136200700,136200700,LHX3,Pathogenic,Non-acquired combined pituitary hormone deficiency with spine abnormalities,single nucleotide variant,GRCh38
na,na,8,11607722,11607722,GATA4,Pathogenic,Atrial septal defect 2|Transposition of the great arteries|Atrioventricular septal defect 4,single nucleotide variant,GRCh37
na,na,8,11750213,11750213,GATA4,Pathogenic,Atrial septal defect 2|Transposition of the great arteries|Atrioventricular septal defect 4,single nucleotide variant,GRCh38
na,na,8,11614521,11614521,GATA4,Pathogenic,Atrial septal defect 2,Deletion,GRCh37
na,na,8,11757012,11757012,GATA4,Pathogenic,Atrial septal defect 2,Deletion,GRCh38
na,na,8,11565976,11565976,GATA4,Pathogenic,Atrial septal defect 2,single nucleotide variant,GRCh37
na,na,8,11708467,11708467,GATA4,Pathogenic,Atrial septal defect 2,single nucleotide variant,GRCh38
na,na,8,11612591,11612591,GATA4,Uncertain significance,Atrial septal defect 2|Atrioventricular septal defect 4,single nucleotide variant,GRCh37
na,na,8,11755082,11755082,GATA4,Uncertain significance,Atrial septal defect 2|Atrioventricular septal defect 4,single nucleotide variant,GRCh38
na,na,8,11615928,11615928,GATA4,Conflicting classifications of pathogenicity,Atrial septal defect 2|Tetralogy of Fallot|Pulmonic stenosis;Tricuspid regurgitation;Pulmonary valve atresia|Inborn genetic diseases|not specified|not provided|Atrioventricular septal defect 4|GATA4-related disorder|Congenital heart disease|Ventricular septal defect 1;Atrioventricular septal defect 4;Testicular anomalies with or without congenital heart disease;Tetralogy of Fallot;Atrial septal defect 2,single nucleotide variant,GRCh37
na,na,8,11758419,11758419,GATA4,Conflicting classifications of pathogenicity,Atrial septal defect 2|Tetralogy of Fallot|Pulmonic stenosis;Tricuspid regurgitation;Pulmonary valve atresia|Inborn genetic diseases|not specified|not provided|Atrioventricular septal defect 4|GATA4-related disorder|Congenital heart disease|Ventricular septal defect 1;Atrioventricular septal defect 4;Testicular anomalies with or without congenital heart disease;Tetralogy of Fallot;Atrial septal defect 2,single nucleotide variant,GRCh38
na,na,3,184075767,184075768,CLCN2,Conflicting classifications of pathogenicity,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8|Leukoencephalopathy with mild cerebellar ataxia and white matter edema",Duplication,GRCh37
na,na,3,184357979,184357980,CLCN2,Conflicting classifications of pathogenicity,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8|Leukoencephalopathy with mild cerebellar ataxia and white matter edema",Duplication,GRCh38
na,na,3,184076605,184076615,CLCN2,Likely benign,"Epilepsy, idiopathic generalized, susceptibility to, 11|Leukoencephalopathy with mild cerebellar ataxia and white matter edema|not provided",Deletion,GRCh37
na,na,3,184358817,184358827,CLCN2,Likely benign,"Epilepsy, idiopathic generalized, susceptibility to, 11|Leukoencephalopathy with mild cerebellar ataxia and white matter edema|not provided",Deletion,GRCh38
na,na,3,184070598,184070598,CLCN2,Uncertain significance,"EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 2|Leukoencephalopathy with mild cerebellar ataxia and white matter edema",single nucleotide variant,GRCh37
na,na,3,184352810,184352810,CLCN2,Uncertain significance,"EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 2|Leukoencephalopathy with mild cerebellar ataxia and white matter edema",single nucleotide variant,GRCh38
na,na,3,184075476,184075476,CLCN2,Conflicting classifications of pathogenicity,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8|Leukoencephalopathy with mild cerebellar ataxia and white matter edema|not provided|Epilepsy, idiopathic generalized, susceptibility to, 11|Familial hyperaldosteronism type II;Leukoencephalopathy with mild cerebellar ataxia and white matter edema;Epilepsy, idiopathic generalized, susceptibility to, 11|not specified",single nucleotide variant,GRCh37
na,na,3,184357688,184357688,CLCN2,Conflicting classifications of pathogenicity,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8|Leukoencephalopathy with mild cerebellar ataxia and white matter edema|not provided|Epilepsy, idiopathic generalized, susceptibility to, 11|Familial hyperaldosteronism type II;Leukoencephalopathy with mild cerebellar ataxia and white matter edema;Epilepsy, idiopathic generalized, susceptibility to, 11|not specified",single nucleotide variant,GRCh38
na,na,3,184071575,184071575,CLCN2,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 11|Leukoencephalopathy with mild cerebellar ataxia and white matter edema|not provided|Cerebral palsy|not specified|CLCN2-related disorder|Leukoencephalopathy with mild cerebellar ataxia and white matter edema;Epilepsy, idiopathic generalized, susceptibility to, 11",single nucleotide variant,GRCh37
na,na,3,184353787,184353787,CLCN2,Conflicting classifications of pathogenicity,"Epilepsy, idiopathic generalized, susceptibility to, 11|Leukoencephalopathy with mild cerebellar ataxia and white matter edema|not provided|Cerebral palsy|not specified|CLCN2-related disorder|Leukoencephalopathy with mild cerebellar ataxia and white matter edema;Epilepsy, idiopathic generalized, susceptibility to, 11",single nucleotide variant,GRCh38
na,na,na,-1,-1,NRXN1,Pathogenic,Pitt-Hopkins-like syndrome 2,Deletion,na
na,na,2,50723177,50723177,NRXN1,Pathogenic,Pitt-Hopkins-like syndrome 2,single nucleotide variant,GRCh37
na,na,2,50496039,50496039,NRXN1,Pathogenic,Pitt-Hopkins-like syndrome 2,single nucleotide variant,GRCh38
na,na,3,52853401,52853401,ITIH4,Benign,"Hypercholesterolemia, susceptibility to",single nucleotide variant,GRCh37
na,na,3,52819385,52819385,ITIH4,Benign,"Hypercholesterolemia, susceptibility to",single nucleotide variant,GRCh38
na,na,2,191840556,191840556,STAT1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,single nucleotide variant,GRCh37
na,na,2,190975830,190975830,STAT1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,single nucleotide variant,GRCh38
na,na,2,191843694,191843695,STAT1,Likely pathogenic,Immunodeficiency 31B,Microsatellite,GRCh37
na,na,2,190978968,190978969,STAT1,Likely pathogenic,Immunodeficiency 31B,Microsatellite,GRCh38
na,na,2,191843656,191843656,STAT1,Pathogenic,Immunodeficiency 31B,single nucleotide variant,GRCh37
na,na,2,190978930,190978930,STAT1,Pathogenic,Immunodeficiency 31B,single nucleotide variant,GRCh38
na,na,2,191848425,191848425,STAT1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency|not provided,single nucleotide variant,GRCh37
na,na,2,190983699,190983699,STAT1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency|not provided,single nucleotide variant,GRCh38
na,na,2,191856033,191856033,STAT1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,single nucleotide variant,GRCh37
na,na,2,190991307,190991307,STAT1,Pathogenic,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,single nucleotide variant,GRCh38
na,na,2,191841697,191841698,STAT1,Pathogenic,Immunodeficiency 31B,Duplication,GRCh37
na,na,2,190976971,190976972,STAT1,Pathogenic,Immunodeficiency 31B,Duplication,GRCh38
na,na,12,56091063,56091063,ITGA7,Pathogenic,Congenital muscular dystrophy due to integrin alpha-7 deficiency,single nucleotide variant,GRCh37
na,na,12,55697279,55697279,ITGA7,Pathogenic,Congenital muscular dystrophy due to integrin alpha-7 deficiency,single nucleotide variant,GRCh38
na,na,12,56086923,56086923,ITGA7,Pathogenic,Congenital muscular dystrophy due to integrin alpha-7 deficiency,single nucleotide variant,GRCh37
na,na,12,55693139,55693139,ITGA7,Pathogenic,Congenital muscular dystrophy due to integrin alpha-7 deficiency,single nucleotide variant,GRCh38
na,na,12,56091798,56091798,ITGA7,Pathogenic,Congenital muscular dystrophy due to integrin alpha-7 deficiency,Deletion,GRCh37
na,na,12,55698014,55698014,ITGA7,Pathogenic,Congenital muscular dystrophy due to integrin alpha-7 deficiency,Deletion,GRCh38
na,na,1,160390961,160390961,VANGL2,risk factor,"Neural tube defects, susceptibility to",single nucleotide variant,GRCh37
na,na,1,160421171,160421171,VANGL2,risk factor,"Neural tube defects, susceptibility to",single nucleotide variant,GRCh38
na,na,1,160394912,160394912,VANGL2,risk factor,"Neural tube defects, susceptibility to",single nucleotide variant,GRCh37
na,na,1,160425122,160425122,VANGL2,risk factor,"Neural tube defects, susceptibility to",single nucleotide variant,GRCh38
na,na,18,9117867,9117867,NDUFV2,Benign,"not specified|not provided|Mitochondrial complex I deficiency, nuclear type 1|Parkinson disease, mitochondrial|Mitochondrial complex 1 deficiency, nuclear type 7",single nucleotide variant,GRCh37
na,na,18,9117869,9117869,NDUFV2,Benign,"not specified|not provided|Mitochondrial complex I deficiency, nuclear type 1|Parkinson disease, mitochondrial|Mitochondrial complex 1 deficiency, nuclear type 7",single nucleotide variant,GRCh38
na,na,9,94060275,94060275,AUH,Pathogenic,3-methylglutaconic aciduria type 1|not provided,single nucleotide variant,GRCh37
na,na,9,91297993,91297993,AUH,Pathogenic,3-methylglutaconic aciduria type 1|not provided,single nucleotide variant,GRCh38
na,na,9,93978389,93978389,AUH,Pathogenic,3-methylglutaconic aciduria type 1,single nucleotide variant,GRCh37
na,na,9,91216107,91216107,AUH,Pathogenic,3-methylglutaconic aciduria type 1,single nucleotide variant,GRCh38
na,na,9,94124092,94124092,AUH,Pathogenic,3-methylglutaconic aciduria type 1,Deletion,GRCh37
na,na,9,91361810,91361810,AUH,Pathogenic,3-methylglutaconic aciduria type 1,Deletion,GRCh38
na,na,9,94118439,94118439,AUH,Pathogenic,3-methylglutaconic aciduria type 1,single nucleotide variant,GRCh37
na,na,9,91356157,91356157,AUH,Pathogenic,3-methylglutaconic aciduria type 1,single nucleotide variant,GRCh38
na,na,9,93976709,93976709,AUH,Pathogenic/Likely pathogenic,3-methylglutaconic aciduria type 1|AUH-related disorder,single nucleotide variant,GRCh37
na,na,9,91214427,91214427,AUH,Pathogenic/Likely pathogenic,3-methylglutaconic aciduria type 1|AUH-related disorder,single nucleotide variant,GRCh38
na,na,11,68548205,68548205,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh37
na,na,11,68780737,68780737,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh38
na,na,11,68552367,68552367,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh37
na,na,11,68784899,68784899,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh38
na,na,11,68575090,68575090,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency|not provided,single nucleotide variant,GRCh37
na,na,11,68807622,68807622,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency|not provided,single nucleotide variant,GRCh38
na,na,11,68542250,68542251,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,Deletion,GRCh37
na,na,11,68774782,68774783,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,Deletion,GRCh38
na,na,11,68549350,68549350,CPT1A,Likely pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh37
na,na,11,68781882,68781882,CPT1A,Likely pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh38
na,na,11,68542866,68542866,CPT1A,Likely pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh37
na,na,11,68775398,68775398,CPT1A,Likely pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh38
na,na,11,68529156,68529156,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh37
na,na,11,68761688,68761688,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh38
na,na,11,68527728,68536100,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,Deletion,GRCh37
na,na,11,68760260,68768632,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,Deletion,GRCh38
na,na,11,68527709,68527709,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh37
na,na,11,68760241,68760241,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,single nucleotide variant,GRCh38
na,na,11,68560802,68560802,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,Deletion,GRCh37
na,na,11,68793334,68793334,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency,Deletion,GRCh38
na,na,11,68527706,68527706,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency|not provided,single nucleotide variant,GRCh37
na,na,11,68760238,68760238,CPT1A,Pathogenic,Carnitine palmitoyl transferase 1A deficiency|not provided,single nucleotide variant,GRCh38
na,na,17,48069171,48069174,DLX3,Pathogenic,Tricho-dento-osseous syndrome|not provided|DLX3-related disorder|Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism;Tricho-dento-osseous syndrome,Deletion,GRCh37
na,na,17,49991807,49991810,DLX3,Pathogenic,Tricho-dento-osseous syndrome|not provided|DLX3-related disorder|Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism;Tricho-dento-osseous syndrome,Deletion,GRCh38
na,na,17,48069183,48069184,DLX3,Pathogenic,Tricho-dento-osseous syndrome|Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism|not provided,Microsatellite,GRCh37
na,na,17,49991819,49991820,DLX3,Pathogenic,Tricho-dento-osseous syndrome|Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism|not provided,Microsatellite,GRCh38
na,na,12,51386593,51386593,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,single nucleotide variant,GRCh37
na,na,12,50992810,50992810,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,single nucleotide variant,GRCh38
na,na,12,51398693,51398695,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,Microsatellite,GRCh37
na,na,12,51004910,51004912,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,Microsatellite,GRCh38
na,na,12,51386074,51386074,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,single nucleotide variant,GRCh37
na,na,12,50992291,50992291,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,single nucleotide variant,GRCh38
na,na,12,51398657,51398659,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,Deletion,GRCh37
na,na,12,51004874,51004876,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,Deletion,GRCh38
na,na,12,51392997,51392997,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,single nucleotide variant,GRCh37
na,na,12,50999214,50999214,SLC11A2,Pathogenic,Microcytic anemia with liver iron overload,single nucleotide variant,GRCh38
na,na,1,186863296,186863296,PLA2G4A,Pathogenic,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,single nucleotide variant,GRCh37
na,na,1,186894164,186894164,PLA2G4A,Pathogenic,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,single nucleotide variant,GRCh38
na,na,1,186925351,186925351,PLA2G4A,Pathogenic,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,single nucleotide variant,GRCh37
na,na,1,186956219,186956219,PLA2G4A,Pathogenic,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,single nucleotide variant,GRCh38
na,na,3,151055916,151055917,P2RY12,Pathogenic,Platelet-type bleeding disorder 8,Deletion,GRCh37
na,na,3,151338128,151338129,P2RY12,Pathogenic,Platelet-type bleeding disorder 8,Deletion,GRCh38
na,na,3,151055867,151055867,P2RY12,Uncertain significance,Platelet-type bleeding disorder 8|not provided|not specified,single nucleotide variant,GRCh37
na,na,3,151338079,151338079,P2RY12,Uncertain significance,Platelet-type bleeding disorder 8|not provided|not specified,single nucleotide variant,GRCh38
na,na,3,151055841,151055841,P2RY12,Uncertain significance,Platelet-type bleeding disorder 8|not specified|not provided,single nucleotide variant,GRCh37
na,na,3,151338053,151338053,P2RY12,Uncertain significance,Platelet-type bleeding disorder 8|not specified|not provided,single nucleotide variant,GRCh38
na,na,7,103198497,103198497,RELN,Pathogenic,Norman-Roberts syndrome,single nucleotide variant,GRCh37
na,na,7,103558050,103558050,RELN,Pathogenic,Norman-Roberts syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,RELN,Pathogenic,Norman-Roberts syndrome,Deletion,na
na,na,11,17417157,17417157,ABCC8,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Familial hyperinsulinism|Hereditary hyperinsulinism|Type 2 diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17395610,17395610,ABCC8,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Familial hyperinsulinism|Hereditary hyperinsulinism|Type 2 diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17418602,17418602,ABCC8,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Familial hyperinsulinism|Inborn genetic diseases|Hereditary hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1;Diabetes mellitus, permanent neonatal 3|ABCC8-related disorder|Type 2 diabetes mellitus|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3|Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia",single nucleotide variant,GRCh37
na,na,11,17397055,17397055,ABCC8,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Familial hyperinsulinism|Inborn genetic diseases|Hereditary hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1;Diabetes mellitus, permanent neonatal 3|ABCC8-related disorder|Type 2 diabetes mellitus|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3|Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia",single nucleotide variant,GRCh38
na,na,11,17436158,17436158,ABCC8,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 1|Familial hyperinsulinism|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young",single nucleotide variant,GRCh37
na,na,11,17414611,17414611,ABCC8,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 1|Familial hyperinsulinism|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young",single nucleotide variant,GRCh38
na,na,11,17452526,17452526,ABCC8,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus|Familial hyperinsulinism",single nucleotide variant,GRCh37
na,na,11,17430979,17430979,ABCC8,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young|Type 2 diabetes mellitus|Familial hyperinsulinism",single nucleotide variant,GRCh38
na,na,11,17418527,17418527,ABCC8,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh37
na,na,11,17396980,17396980,ABCC8,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh38
na,na,11,17417206,17417206,ABCC8,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Diabetes mellitus, permanent neonatal 3;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1|Hereditary hyperinsulinism|Type 2 diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17395659,17395659,ABCC8,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Diabetes mellitus, permanent neonatal 3;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1|Hereditary hyperinsulinism|Type 2 diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17415881,17415881,ABCC8,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Hereditary hyperinsulinism|Diabetes mellitus, permanent neonatal 3;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2|Diabetes mellitus, transient neonatal, 2|Type 2 diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17394334,17394334,ABCC8,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Hereditary hyperinsulinism|Diabetes mellitus, permanent neonatal 3;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2|Diabetes mellitus, transient neonatal, 2|Type 2 diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17415842,17415842,ABCC8,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided",single nucleotide variant,GRCh37
na,na,11,17394295,17394295,ABCC8,Pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided",single nucleotide variant,GRCh38
na,na,11,17418527,17418527,ABCC8,Conflicting classifications of pathogenicity,"Leucine-induced hypoglycemia|not provided|Type 2 diabetes mellitus|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh37
na,na,11,17396980,17396980,ABCC8,Conflicting classifications of pathogenicity,"Leucine-induced hypoglycemia|not provided|Type 2 diabetes mellitus|Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia;Diabetes mellitus, transient neonatal, 2;Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh38
na,na,11,17485004,17485004,ABCC8,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Diabetes mellitus, permanent neonatal 3;Diabetes mellitus, transient neonatal, 2;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia|Type 2 diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17463457,17463457,ABCC8,Pathogenic/Likely pathogenic,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Diabetes mellitus, permanent neonatal 3;Diabetes mellitus, transient neonatal, 2;Type 2 diabetes mellitus;Hyperinsulinemic hypoglycemia, familial, 1;Leucine-induced hypoglycemia|Type 2 diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17417438,17417440,ABCC8,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young",Microsatellite,GRCh37
na,na,11,17395891,17395893,ABCC8,Conflicting classifications of pathogenicity,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young",Microsatellite,GRCh38
na,na,11,17498513,17498513,ABCC8,Uncertain significance,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young|ABCC8-related disorder|Diabetes mellitus, permanent neonatal 3;Hyperinsulinemic hypoglycemia, familial, 1;Type 2 diabetes mellitus;Diabetes mellitus, transient neonatal, 2;Leucine-induced hypoglycemia",single nucleotide variant,GRCh37
na,na,11,17476966,17476966,ABCC8,Uncertain significance,"Hyperinsulinemic hypoglycemia, familial, 1|not provided|Transitory neonatal diabetes mellitus|Maturity onset diabetes mellitus in young|ABCC8-related disorder|Diabetes mellitus, permanent neonatal 3;Hyperinsulinemic hypoglycemia, familial, 1;Type 2 diabetes mellitus;Diabetes mellitus, transient neonatal, 2;Leucine-induced hypoglycemia",single nucleotide variant,GRCh38
na,na,11,17491666,17491666,ABCC8,Pathogenic/Likely pathogenic,"Diabetes mellitus, permanent neonatal 3|Permanent neonatal diabetes mellitus|not provided|Neonatal diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17470119,17470119,ABCC8,Pathogenic/Likely pathogenic,"Diabetes mellitus, permanent neonatal 3|Permanent neonatal diabetes mellitus|not provided|Neonatal diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17483314,17483314,ABCC8,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh37
na,na,11,17461767,17461767,ABCC8,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh38
na,na,11,17417194,17417194,ABCC8,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh37
na,na,11,17395647,17395647,ABCC8,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh38
na,na,11,17417462,17417462,ABCC8,Pathogenic/Likely pathogenic,"Diabetes mellitus, transient neonatal, 2|Type 2 diabetes mellitus|Permanent neonatal diabetes mellitus|Monogenic diabetes|not provided|ABCC8-related disorder",single nucleotide variant,GRCh37
na,na,11,17395915,17395915,ABCC8,Pathogenic/Likely pathogenic,"Diabetes mellitus, transient neonatal, 2|Type 2 diabetes mellitus|Permanent neonatal diabetes mellitus|Monogenic diabetes|not provided|ABCC8-related disorder",single nucleotide variant,GRCh38
na,na,11,17452434,17452434,ABCC8,Pathogenic,"Diabetes mellitus, transient neonatal, 2|Type 2 diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17430887,17430887,ABCC8,Pathogenic,"Diabetes mellitus, transient neonatal, 2|Type 2 diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17496508,17496508,ABCC8,Conflicting classifications of pathogenicity,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3|Type 2 diabetes mellitus|not specified",single nucleotide variant,GRCh37
na,na,11,17474961,17474961,ABCC8,Conflicting classifications of pathogenicity,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3|Type 2 diabetes mellitus|not specified",single nucleotide variant,GRCh38
na,na,11,17474698,17474698,ABCC8,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh37
na,na,11,17453151,17453151,ABCC8,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh38
na,na,11,17426062,17426062,ABCC8,Uncertain significance,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3|Maturity onset diabetes mellitus in young|Transitory neonatal diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,17404515,17404515,ABCC8,Uncertain significance,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3|Maturity onset diabetes mellitus in young|Transitory neonatal diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,17498190,17498190,ABCC8,Uncertain significance,"Diabetes mellitus, permanent neonatal 3|not provided",single nucleotide variant,GRCh37
na,na,11,17476643,17476643,ABCC8,Uncertain significance,"Diabetes mellitus, permanent neonatal 3|not provided",single nucleotide variant,GRCh38
na,na,11,17496466,17496466,ABCC8,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh37
na,na,11,17474919,17474919,ABCC8,Pathogenic,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 3",single nucleotide variant,GRCh38
na,na,11,68701934,68701934,IGHMBP2,Pathogenic,not provided|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|Autosomal recessive distal spinal muscular atrophy 1|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2S,single nucleotide variant,GRCh37
na,na,11,68934466,68934466,IGHMBP2,Pathogenic,not provided|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|Autosomal recessive distal spinal muscular atrophy 1|Inborn genetic diseases|Charcot-Marie-Tooth disease axonal type 2S,single nucleotide variant,GRCh38
na,na,11,68678998,68678998,IGHMBP2,Pathogenic/Likely pathogenic,Autosomal recessive distal spinal muscular atrophy 1|Charcot-Marie-Tooth disease axonal type 2S|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|not provided,single nucleotide variant,GRCh37
na,na,11,68911530,68911530,IGHMBP2,Pathogenic/Likely pathogenic,Autosomal recessive distal spinal muscular atrophy 1|Charcot-Marie-Tooth disease axonal type 2S|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|not provided,single nucleotide variant,GRCh38
na,na,11,68702872,68702872,IGHMBP2,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|Autosomal recessive distal spinal muscular atrophy 1|Peripheral neuropathy|not provided,single nucleotide variant,GRCh37
na,na,11,68935404,68935404,IGHMBP2,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|Autosomal recessive distal spinal muscular atrophy 1|Peripheral neuropathy|not provided,single nucleotide variant,GRCh38
na,na,11,68673571,68673571,IGHMBP2,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1,single nucleotide variant,GRCh37
na,na,11,68906103,68906103,IGHMBP2,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1,single nucleotide variant,GRCh38
na,na,11,68679034,68679034,IGHMBP2,Pathogenic/Likely pathogenic,Autosomal recessive distal spinal muscular atrophy 1|not provided|Charcot-Marie-Tooth disease axonal type 2S,Deletion,GRCh37
na,na,11,68911566,68911566,IGHMBP2,Pathogenic/Likely pathogenic,Autosomal recessive distal spinal muscular atrophy 1|not provided|Charcot-Marie-Tooth disease axonal type 2S,Deletion,GRCh38
na,na,11,68679067,68679067,IGHMBP2,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1|Charcot-Marie-Tooth disease axonal type 2S,single nucleotide variant,GRCh37
na,na,11,68911599,68911599,IGHMBP2,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1|Charcot-Marie-Tooth disease axonal type 2S,single nucleotide variant,GRCh38
na,na,11,68704560,68704560,IGHMBP2,Pathogenic/Likely pathogenic,"Autosomal recessive distal spinal muscular atrophy 1|not provided|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|Neuronopathy, distal hereditary motor, autosomal dominant",single nucleotide variant,GRCh37
na,na,11,68937092,68937092,IGHMBP2,Pathogenic/Likely pathogenic,"Autosomal recessive distal spinal muscular atrophy 1|not provided|Charcot-Marie-Tooth disease axonal type 2S;Autosomal recessive distal spinal muscular atrophy 1|Neuronopathy, distal hereditary motor, autosomal dominant",single nucleotide variant,GRCh38
na,na,11,68696697,68696697,IGHMBP2,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1,single nucleotide variant,GRCh37
na,na,11,68929229,68929229,IGHMBP2,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1,single nucleotide variant,GRCh38
na,na,11,68674222,68692757,IGHMBP2,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1,Deletion,GRCh37
na,na,11,68906754,68925289,IGHMBP2,Pathogenic,Autosomal recessive distal spinal muscular atrophy 1,Deletion,GRCh38
na,na,10,103535526,103535526,FGF8,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,single nucleotide variant,GRCh37
na,na,10,101775769,101775769,FGF8,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,single nucleotide variant,GRCh38
na,na,10,103534966,103534966,FGF8,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 6 with or without anosmia|not specified|not provided,single nucleotide variant,GRCh37
na,na,10,101775209,101775209,FGF8,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 6 with or without anosmia|not specified|not provided,single nucleotide variant,GRCh38
na,na,10,103534925,103534925,FGF8,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,single nucleotide variant,GRCh37
na,na,10,101775168,101775168,FGF8,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,single nucleotide variant,GRCh38
na,na,10,103534528,103534528,FGF8,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,single nucleotide variant,GRCh37
na,na,10,101774771,101774771,FGF8,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,single nucleotide variant,GRCh38
na,na,10,103531285,103531285,FGF8,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,single nucleotide variant,GRCh37
na,na,10,101771528,101771528,FGF8,Pathogenic,Hypogonadotropic hypogonadism 6 with or without anosmia,single nucleotide variant,GRCh38
na,na,10,103530135,103530135,FGF8,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 6 with or without anosmia|Holoprosencephaly 1|not provided,single nucleotide variant,GRCh37
na,na,10,101770378,101770378,FGF8,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 6 with or without anosmia|Holoprosencephaly 1|not provided,single nucleotide variant,GRCh38
na,na,9,87570425,87570425,NTRK2,Pathogenic,"Obesity, hyperphagia, and developmental delay",single nucleotide variant,GRCh37
na,na,9,84955510,84955510,NTRK2,Pathogenic,"Obesity, hyperphagia, and developmental delay",single nucleotide variant,GRCh38
na,na,6,10626680,10626680,GCNT2,Pathogenic,Cataract 13 with adult I phenotype,single nucleotide variant,GRCh37
na,na,6,10626447,10626447,GCNT2,Pathogenic,Cataract 13 with adult I phenotype,single nucleotide variant,GRCh38
na,na,6,10626785,10626785,GCNT2,Conflicting classifications of pathogenicity,Cataract 13 with adult I phenotype,single nucleotide variant,GRCh37
na,na,6,10626552,10626552,GCNT2,Conflicting classifications of pathogenicity,Cataract 13 with adult I phenotype,single nucleotide variant,GRCh38
na,na,na,-1,-1,GCNT2,Pathogenic,Cataract 13 with adult I phenotype,Deletion,na
na,na,6,10529649,10529649,GCNT2,Pathogenic,ADULT i BLOOD GROUP PHENOTYPE,single nucleotide variant,GRCh37
na,na,6,10529416,10529416,GCNT2,Pathogenic,ADULT i BLOOD GROUP PHENOTYPE,single nucleotide variant,GRCh38
na,na,6,10529827,10529827,GCNT2,Pathogenic,ADULT i BLOOD GROUP PHENOTYPE,single nucleotide variant,GRCh37
na,na,6,10529594,10529594,GCNT2,Pathogenic,ADULT i BLOOD GROUP PHENOTYPE,single nucleotide variant,GRCh38
na,na,1,21546501,21546501,ECE1,Pathogenic,"Hirschsprung disease, cardiac defects, and autonomic dysfunction",single nucleotide variant,GRCh37
na,na,1,21220008,21220008,ECE1,Pathogenic,"Hirschsprung disease, cardiac defects, and autonomic dysfunction",single nucleotide variant,GRCh38
na,na,1,21617245,21617245,ECE1,risk factor,"Hypertension, essential, susceptibility to",single nucleotide variant,GRCh37
na,na,1,21290752,21290752,ECE1,risk factor,"Hypertension, essential, susceptibility to",single nucleotide variant,GRCh38
na,na,1,21617746,21617746,ECE1,risk factor,"Hypertension, essential, susceptibility to",single nucleotide variant,GRCh37
na,na,1,21291253,21291253,ECE1,risk factor,"Hypertension, essential, susceptibility to",single nucleotide variant,GRCh38
na,na,8,63973904,63973904,TTPA,Pathogenic,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided",Deletion,GRCh37
na,na,8,63061345,63061345,TTPA,Pathogenic,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided",Deletion,GRCh38
na,na,8,63985549,63985549,TTPA,Pathogenic/Likely pathogenic,Ataxia and retinitis pigmentosa with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E,single nucleotide variant,GRCh37
na,na,8,63072990,63072990,TTPA,Pathogenic/Likely pathogenic,Ataxia and retinitis pigmentosa with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E,single nucleotide variant,GRCh38
na,na,8,63978501,63978502,TTPA,Pathogenic,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided|Retinal dystrophy",Insertion,GRCh37
na,na,8,63065942,63065943,TTPA,Pathogenic,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided|Retinal dystrophy",Insertion,GRCh38
na,na,8,63976853,63976853,TTPA,Conflicting classifications of pathogenicity,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided|not specified|TTPA-related disorder",single nucleotide variant,GRCh37
na,na,8,63064294,63064294,TTPA,Conflicting classifications of pathogenicity,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided|not specified|TTPA-related disorder",single nucleotide variant,GRCh38
na,na,8,63978615,63978615,TTPA,Pathogenic,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided|TTPA-related disorder|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,8,63066056,63066056,TTPA,Pathogenic,"Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided|TTPA-related disorder|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,12,7362296,7362296,PEX5,Pathogenic/Likely pathogenic,not provided|Peroxisome biogenesis disorder 2B|Peroxisome biogenesis disorder 2A (Zellweger)|Rhizomelic chondrodysplasia punctata type 5,single nucleotide variant,GRCh37
na,na,12,7209700,7209700,PEX5,Pathogenic/Likely pathogenic,not provided|Peroxisome biogenesis disorder 2B|Peroxisome biogenesis disorder 2A (Zellweger)|Rhizomelic chondrodysplasia punctata type 5,single nucleotide variant,GRCh38
na,na,12,7361150,7361150,PEX5,Pathogenic,Peroxisome biogenesis disorder 2A (Zellweger)|not provided|Peroxisome biogenesis disorder 2B|Peroxisome biogenesis disorder 2A (Zellweger);Peroxisome biogenesis disorder 2B;Rhizomelic chondrodysplasia punctata type 5,single nucleotide variant,GRCh37
na,na,12,7208554,7208554,PEX5,Pathogenic,Peroxisome biogenesis disorder 2A (Zellweger)|not provided|Peroxisome biogenesis disorder 2B|Peroxisome biogenesis disorder 2A (Zellweger);Peroxisome biogenesis disorder 2B;Rhizomelic chondrodysplasia punctata type 5,single nucleotide variant,GRCh38
na,na,15,73023915,73023915,BBS4,Pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,single nucleotide variant,GRCh37
na,na,15,72731574,72731574,BBS4,Pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,single nucleotide variant,GRCh38
na,na,15,73001821,73001821,BBS4,Pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,Deletion,GRCh37
na,na,15,72709480,72709480,BBS4,Pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,Deletion,GRCh38
na,na,15,73004583,73004583,BBS4,Pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,single nucleotide variant,GRCh37
na,na,15,72712242,72712242,BBS4,Pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome,single nucleotide variant,GRCh38
na,na,15,73027508,73027508,BBS4,Likely pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 1,single nucleotide variant,GRCh37
na,na,15,72735167,72735167,BBS4,Likely pathogenic,Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 1,single nucleotide variant,GRCh38
na,na,12,98989268,98989268,SLC25A3,Pathogenic,Cardiomyopathy-hypotonia-lactic acidosis syndrome,single nucleotide variant,GRCh37
na,na,12,98595490,98595490,SLC25A3,Pathogenic,Cardiomyopathy-hypotonia-lactic acidosis syndrome,single nucleotide variant,GRCh38
na,na,6,42146112,42146112,GUCA1A;GUCA1ANB-GUCA1A,Pathogenic,Cone dystrophy 3|not provided|Retinitis pigmentosa|Macular dystrophy|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,6,42178374,42178374,GUCA1A;GUCA1ANB-GUCA1A,Pathogenic,Cone dystrophy 3|not provided|Retinitis pigmentosa|Macular dystrophy|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,6,42141500,42141500,GUCA1A;GUCA1ANB-GUCA1A,Conflicting classifications of pathogenicity,Cone dystrophy 3|not provided|Macular dystrophy|Usher syndrome,single nucleotide variant,GRCh37
na,na,6,42173762,42173762,GUCA1A;GUCA1ANB-GUCA1A,Conflicting classifications of pathogenicity,Cone dystrophy 3|not provided|Macular dystrophy|Usher syndrome,single nucleotide variant,GRCh38
na,na,6,42146986,42146986,GUCA1A;GUCA1ANB-GUCA1A,Pathogenic,Retinal dystrophy|not provided|Cone-rod dystrophy 14,single nucleotide variant,GRCh37
na,na,6,42179248,42179248,GUCA1A;GUCA1ANB-GUCA1A,Pathogenic,Retinal dystrophy|not provided|Cone-rod dystrophy 14,single nucleotide variant,GRCh38
na,na,11,128709959,128709959,KCNJ1,Pathogenic,Bartter disease type 2,single nucleotide variant,GRCh37
na,na,11,128840064,128840064,KCNJ1,Pathogenic,Bartter disease type 2,single nucleotide variant,GRCh38
na,na,11,128710096,128710097,KCNJ1,Pathogenic,Bartter disease type 2,Duplication,GRCh37
na,na,11,128840201,128840202,KCNJ1,Pathogenic,Bartter disease type 2,Duplication,GRCh38
na,na,11,128709539,128709539,KCNJ1,Pathogenic,Bartter disease type 2|not provided,single nucleotide variant,GRCh37
na,na,11,128839644,128839644,KCNJ1,Pathogenic,Bartter disease type 2|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,KCNJ1,Pathogenic,Bartter disease type 2,Variation,na
na,na,11,128709555,128709555,KCNJ1,Conflicting classifications of pathogenicity,Bartter disease type 2|not provided|Bartter syndrome,single nucleotide variant,GRCh37
na,na,11,128839660,128839660,KCNJ1,Conflicting classifications of pathogenicity,Bartter disease type 2|not provided|Bartter syndrome,single nucleotide variant,GRCh38
na,na,11,128709126,128709126,KCNJ1,Benign/Likely benign,Bartter disease type 2|not specified|not provided|KCNJ1-related disorder,single nucleotide variant,GRCh37
na,na,11,128839231,128839231,KCNJ1,Benign/Likely benign,Bartter disease type 2|not specified|not provided|KCNJ1-related disorder,single nucleotide variant,GRCh38
na,na,11,128709604,128709604,KCNJ1,Likely pathogenic,Bartter disease type 2|not provided|Bartter syndrome,single nucleotide variant,GRCh37
na,na,11,128839709,128839709,KCNJ1,Likely pathogenic,Bartter disease type 2|not provided|Bartter syndrome,single nucleotide variant,GRCh38
na,na,11,128709696,128709696,KCNJ1,Likely pathogenic,Bartter disease type 2|Bartter syndrome,single nucleotide variant,GRCh37
na,na,11,128839801,128839801,KCNJ1,Likely pathogenic,Bartter disease type 2|Bartter syndrome,single nucleotide variant,GRCh38
na,na,11,128709874,128709874,KCNJ1,Pathogenic,Bartter disease type 2,single nucleotide variant,GRCh37
na,na,11,128839979,128839979,KCNJ1,Pathogenic,Bartter disease type 2,single nucleotide variant,GRCh38
na,na,11,128709824,128709824,KCNJ1,Pathogenic,Bartter disease type 2,single nucleotide variant,GRCh37
na,na,11,128839929,128839929,KCNJ1,Pathogenic,Bartter disease type 2,single nucleotide variant,GRCh38
na,na,5,70241990,70241990,SMN1,Conflicting classifications of pathogenicity,"Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided",single nucleotide variant,GRCh37
na,na,5,70946163,70946163,SMN1,Conflicting classifications of pathogenicity,"Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided",single nucleotide variant,GRCh38
na,na,5,70241954,70241954,SMN1,Pathogenic/Likely pathogenic,Kugelberg-Welander disease|not provided,single nucleotide variant,GRCh37
na,na,5,70946127,70946127,SMN1,Pathogenic/Likely pathogenic,Kugelberg-Welander disease|not provided,single nucleotide variant,GRCh38
na,na,5,70241984,70241984,SMN1,Pathogenic/Likely pathogenic,Werdnig-Hoffmann disease|not provided|Spinal muscular atrophy,single nucleotide variant,GRCh37
na,na,5,70946157,70946157,SMN1,Pathogenic/Likely pathogenic,Werdnig-Hoffmann disease|not provided|Spinal muscular atrophy,single nucleotide variant,GRCh38
na,na,5,70247769,70247769,SMN1,Pathogenic,Werdnig-Hoffmann disease,single nucleotide variant,GRCh37
na,na,5,70951942,70951942,SMN1,Pathogenic,Werdnig-Hoffmann disease,single nucleotide variant,GRCh38
na,na,5,70220935,70220935,SMN1,Pathogenic,"Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided|Spinal muscular atrophy",single nucleotide variant,GRCh37
na,na,5,70925108,70925108,SMN1,Pathogenic,"Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided|Spinal muscular atrophy",single nucleotide variant,GRCh38
na,na,na,-1,-1,SMN1,Pathogenic,"Spinal muscular atrophy, type II|Kugelberg-Welander disease",Deletion,na
na,na,5,70242009,70242009,SMN1,Pathogenic,Kugelberg-Welander disease,single nucleotide variant,GRCh37
na,na,5,70946182,70946182,SMN1,Pathogenic,Kugelberg-Welander disease,single nucleotide variant,GRCh38
na,na,5,70238348,70238352,SMN1,Pathogenic,Werdnig-Hoffmann disease,Deletion,GRCh37
na,na,5,70942521,70942525,SMN1,Pathogenic,Werdnig-Hoffmann disease,Deletion,GRCh38
na,na,5,70234715,70234715,SMN1,Pathogenic,Kugelberg-Welander disease,single nucleotide variant,GRCh37
na,na,5,70938888,70938888,SMN1,Pathogenic,Kugelberg-Welander disease,single nucleotide variant,GRCh38
na,na,5,70238216,70238216,SMN1,Pathogenic,"Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided",single nucleotide variant,GRCh37
na,na,5,70942389,70942389,SMN1,Pathogenic,"Spinal muscular atrophy, type II|Kugelberg-Welander disease|not provided",single nucleotide variant,GRCh38
na,na,5,70234672,70234672,SMN1,Pathogenic,"Spinal muscular atrophy, type II",single nucleotide variant,GRCh37
na,na,5,70938845,70938845,SMN1,Pathogenic,"Spinal muscular atrophy, type II",single nucleotide variant,GRCh38
na,na,5,70238194,70238194,SMN1,Pathogenic,Kugelberg-Welander disease|not provided|Spinal muscular atrophy,single nucleotide variant,GRCh37
na,na,5,70942367,70942367,SMN1,Pathogenic,Kugelberg-Welander disease|not provided|Spinal muscular atrophy,single nucleotide variant,GRCh38
na,na,5,70238243,70238243,SMN1,Pathogenic,"Werdnig-Hoffmann disease|Spinal muscular atrophy, type II|not provided",single nucleotide variant,GRCh37
na,na,5,70942416,70942416,SMN1,Pathogenic,"Werdnig-Hoffmann disease|Spinal muscular atrophy, type II|not provided",single nucleotide variant,GRCh38
na,na,5,70241953,70241953,SMN1,Pathogenic,Kugelberg-Welander disease,single nucleotide variant,GRCh37
na,na,5,70946126,70946126,SMN1,Pathogenic,Kugelberg-Welander disease,single nucleotide variant,GRCh38
na,na,5,70238257,70238257,SMN1,Pathogenic,Werdnig-Hoffmann disease|not provided,single nucleotide variant,GRCh37
na,na,5,70942430,70942430,SMN1,Pathogenic,Werdnig-Hoffmann disease|not provided,single nucleotide variant,GRCh38
na,na,5,70238317,70238317,SMN1,Pathogenic,Werdnig-Hoffmann disease,single nucleotide variant,GRCh37
na,na,5,70942490,70942490,SMN1,Pathogenic,Werdnig-Hoffmann disease,single nucleotide variant,GRCh38
na,na,10,86007463,86007463,RGR,Conflicting classifications of pathogenicity,Retinitis pigmentosa 44|Cone dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,10,84247707,84247707,RGR,Conflicting classifications of pathogenicity,Retinitis pigmentosa 44|Cone dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,19,18896850,18896850,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,single nucleotide variant,GRCh37
na,na,19,18786040,18786040,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,single nucleotide variant,GRCh38
na,na,19,18896861,18896861,COMP,Uncertain significance,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|not specified,single nucleotide variant,GRCh37
na,na,19,18786051,18786051,COMP,Uncertain significance,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|not specified,single nucleotide variant,GRCh38
na,na,19,18896887,18896889,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,Deletion,GRCh37
na,na,19,18786077,18786079,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,Deletion,GRCh38
na,na,19,18898411,18898411,COMP,Pathogenic,"Epiphyseal dysplasia, multiple, 1, severe",single nucleotide variant,GRCh37
na,na,19,18787602,18787602,COMP,Pathogenic,"Epiphyseal dysplasia, multiple, 1, severe",single nucleotide variant,GRCh38
na,na,19,18898453,18898453,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,single nucleotide variant,GRCh37
na,na,19,18787644,18787644,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,single nucleotide variant,GRCh38
na,na,19,18896582,18896582,COMP,Pathogenic/Likely pathogenic,Multiple epiphyseal dysplasia type 1|Multiple epiphyseal dysplasia|not provided,single nucleotide variant,GRCh37
na,na,19,18785772,18785772,COMP,Pathogenic/Likely pathogenic,Multiple epiphyseal dysplasia type 1|Multiple epiphyseal dysplasia|not provided,single nucleotide variant,GRCh38
na,na,19,18896906,18896906,COMP,Pathogenic,"Epiphyseal dysplasia, multiple, 1, severe",single nucleotide variant,GRCh37
na,na,19,18786096,18786096,COMP,Pathogenic,"Epiphyseal dysplasia, multiple, 1, severe",single nucleotide variant,GRCh38
na,na,19,18896846,18896846,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,single nucleotide variant,GRCh37
na,na,19,18786036,18786036,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,single nucleotide variant,GRCh38
na,na,19,18896844,18896845,COMP,Pathogenic/Likely pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|COMP-related disorder,Microsatellite,GRCh37
na,na,19,18786034,18786035,COMP,Pathogenic/Likely pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|COMP-related disorder,Microsatellite,GRCh38
na,na,19,18896844,18896845,COMP,Pathogenic/Likely pathogenic,Multiple epiphyseal dysplasia type 1|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|Multiple epiphyseal dysplasia,Microsatellite,GRCh37
na,na,19,18786034,18786035,COMP,Pathogenic/Likely pathogenic,Multiple epiphyseal dysplasia type 1|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|Multiple epiphyseal dysplasia,Microsatellite,GRCh38
na,na,19,18893935,18893935,COMP,Pathogenic/Likely pathogenic,"Pseudoachondroplasia, severe|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|Multiple epiphyseal dysplasia type 1|not provided",single nucleotide variant,GRCh37
na,na,19,18783125,18783125,COMP,Pathogenic/Likely pathogenic,"Pseudoachondroplasia, severe|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|Multiple epiphyseal dysplasia type 1|not provided",single nucleotide variant,GRCh38
na,na,19,18898393,18898393,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided,single nucleotide variant,GRCh37
na,na,19,18787584,18787584,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided,single nucleotide variant,GRCh38
na,na,19,18898527,18899079,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,Deletion,GRCh37
na,na,19,18787718,18788270,COMP,Pathogenic,Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome,Deletion,GRCh38
na,na,19,18893867,18893868,COMP,Pathogenic,Multiple epiphyseal dysplasia type 1,Duplication,GRCh37
na,na,19,18783057,18783058,COMP,Pathogenic,Multiple epiphyseal dysplasia type 1,Duplication,GRCh38
na,na,19,18893939,18893939,COMP,Pathogenic/Likely pathogenic,Multiple epiphyseal dysplasia type 1|not provided|Multiple epiphyseal dysplasia|Carpal tunnel syndrome 2,single nucleotide variant,GRCh37
na,na,19,18783129,18783129,COMP,Pathogenic/Likely pathogenic,Multiple epiphyseal dysplasia type 1|not provided|Multiple epiphyseal dysplasia|Carpal tunnel syndrome 2,single nucleotide variant,GRCh38
na,na,10,124812676,124812676,ACADSB,Pathogenic,Deficiency of 2-methylbutyryl-CoA dehydrogenase,single nucleotide variant,GRCh37
na,na,10,123053160,123053160,ACADSB,Pathogenic,Deficiency of 2-methylbutyryl-CoA dehydrogenase,single nucleotide variant,GRCh38
na,na,10,124802643,124802643,ACADSB,Pathogenic,Deficiency of 2-methylbutyryl-CoA dehydrogenase,single nucleotide variant,GRCh37
na,na,10,123043127,123043127,ACADSB,Pathogenic,Deficiency of 2-methylbutyryl-CoA dehydrogenase,single nucleotide variant,GRCh38
na,na,10,124800121,124800121,ACADSB,Conflicting classifications of pathogenicity,Deficiency of 2-methylbutyryl-CoA dehydrogenase|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,10,123040605,123040605,ACADSB,Conflicting classifications of pathogenicity,Deficiency of 2-methylbutyryl-CoA dehydrogenase|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,10,124812607,124812607,ACADSB,Pathogenic/Likely pathogenic,Deficiency of 2-methylbutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh37
na,na,10,123053091,123053091,ACADSB,Pathogenic/Likely pathogenic,Deficiency of 2-methylbutyryl-CoA dehydrogenase|not provided,single nucleotide variant,GRCh38
na,na,7,30649345,30649345,GARS1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease|not provided|not specified|Charcot-Marie-Tooth disease type 2,single nucleotide variant,GRCh37
na,na,7,30609729,30609729,GARS1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease|not provided|not specified|Charcot-Marie-Tooth disease type 2,single nucleotide variant,GRCh38
na,na,7,30640795,30640795,GARS1,Pathogenic,"Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 2D",single nucleotide variant,GRCh37
na,na,7,30601179,30601179,GARS1,Pathogenic,"Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 2D",single nucleotide variant,GRCh38
na,na,7,30639612,30639612,GARS1,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease|Neuronopathy, distal hereditary motor, type 5A",single nucleotide variant,GRCh37
na,na,7,30599996,30599996,GARS1,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease|Neuronopathy, distal hereditary motor, type 5A",single nucleotide variant,GRCh38
na,na,7,30668214,30668214,GARS1,Pathogenic,"Neuronopathy, distal hereditary motor, type 5A|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease type 2",single nucleotide variant,GRCh37
na,na,7,30628598,30628598,GARS1,Pathogenic,"Neuronopathy, distal hereditary motor, type 5A|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease type 2",single nucleotide variant,GRCh38
na,na,7,30665896,30665896,GARS1,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease type 2D|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2",single nucleotide variant,GRCh37
na,na,7,30626280,30626280,GARS1,Conflicting classifications of pathogenicity,"Charcot-Marie-Tooth disease type 2D|Neuronopathy, distal hereditary motor, type 5A|Charcot-Marie-Tooth disease|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2",single nucleotide variant,GRCh38
na,na,7,30651723,30651723,GARS1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2D,single nucleotide variant,GRCh37
na,na,7,30612107,30612107,GARS1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease type 2D,single nucleotide variant,GRCh38
na,na,20,43048453,43048453,HNF4A,Pathogenic,Maturity-onset diabetes of the young type 1|not provided|Monogenic diabetes,single nucleotide variant,GRCh37
na,na,20,44419813,44419813,HNF4A,Pathogenic,Maturity-onset diabetes of the young type 1|not provided|Monogenic diabetes,single nucleotide variant,GRCh38
na,na,20,43042435,43042435,HNF4A,Pathogenic,Maturity-onset diabetes of the young type 1|Monogenic diabetes|not provided,single nucleotide variant,GRCh37
na,na,20,44413795,44413795,HNF4A,Pathogenic,Maturity-onset diabetes of the young type 1|Monogenic diabetes|not provided,single nucleotide variant,GRCh38
na,na,20,43042354,43042354,HNF4A,Likely pathogenic,Maturity-onset diabetes of the young type 1|not provided|Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young;Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 1|Maturity onset diabetes mellitus in young|Monogenic diabetes,single nucleotide variant,GRCh37
na,na,20,44413714,44413714,HNF4A,Likely pathogenic,Maturity-onset diabetes of the young type 1|not provided|Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young;Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 1|Maturity onset diabetes mellitus in young|Monogenic diabetes,single nucleotide variant,GRCh38
na,na,20,43057049,43057049,HNF4A,Uncertain significance,Type 2 diabetes mellitus|not provided|Monogenic diabetes|Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 1;Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young,single nucleotide variant,GRCh37
na,na,20,44428409,44428409,HNF4A,Uncertain significance,Type 2 diabetes mellitus|not provided|Monogenic diabetes|Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 1;Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young,single nucleotide variant,GRCh38
na,na,na,-1,-1,HNF4A,Pathogenic,Maturity-onset diabetes of the young type 1,Deletion,na
na,na,20,43047063,43047063,HNF4A,Pathogenic,Maturity-onset diabetes of the young type 1|Monogenic diabetes,Deletion,GRCh37
na,na,20,44418423,44418423,HNF4A,Pathogenic,Maturity-onset diabetes of the young type 1|Monogenic diabetes,Deletion,GRCh38
na,na,20,43052883,43052883,HNF4A,Likely pathogenic,Maturity-onset diabetes of the young type 1|Monogenic diabetes,single nucleotide variant,GRCh37
na,na,20,44424243,44424243,HNF4A,Likely pathogenic,Maturity-onset diabetes of the young type 1|Monogenic diabetes,single nucleotide variant,GRCh38
na,na,1,160249867,160249868,PEX19,Uncertain significance,Peroxisome biogenesis disorder 12A (Zellweger),Duplication,GRCh37
na,na,1,160280077,160280078,PEX19,Uncertain significance,Peroxisome biogenesis disorder 12A (Zellweger),Duplication,GRCh38
na,na,19,15303315,15303315,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided",single nucleotide variant,GRCh37
na,na,19,15192504,15192504,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided",single nucleotide variant,GRCh38
na,na,19,15302945,15302945,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|Migraine without aura;Stroke disorder|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1;Lateral meningocele syndrome;Myofibromatosis, infantile, 2|NOTCH3-related disorder",single nucleotide variant,GRCh37
na,na,19,15192134,15192134,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|Migraine without aura;Stroke disorder|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1;Lateral meningocele syndrome;Myofibromatosis, infantile, 2|NOTCH3-related disorder",single nucleotide variant,GRCh38
na,na,19,15302906,15302906,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|NOTCH3-related disorder",single nucleotide variant,GRCh37
na,na,19,15192095,15192095,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|NOTCH3-related disorder",single nucleotide variant,GRCh38
na,na,19,15308321,15308321,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",single nucleotide variant,GRCh37
na,na,19,15197510,15197510,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",single nucleotide variant,GRCh38
na,na,19,15302600,15302644,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",Deletion,GRCh37
na,na,19,15191789,15191833,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",Deletion,GRCh38
na,na,19,15299815,15299815,NOTCH3,Pathogenic/Likely pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided",single nucleotide variant,GRCh37
na,na,19,15189004,15189004,NOTCH3,Pathogenic/Likely pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided",single nucleotide variant,GRCh38
na,na,19,15302277,15302277,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|NOTCH3-related disorder",single nucleotide variant,GRCh37
na,na,19,15191466,15191466,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|NOTCH3-related disorder",single nucleotide variant,GRCh38
na,na,19,15303053,15303053,NOTCH3,Pathogenic/Likely pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|Recurrent subcortical infarcts|not provided|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1;Lateral meningocele syndrome;Myofibromatosis, infantile, 2|NOTCH3-related disorder",single nucleotide variant,GRCh37
na,na,19,15192242,15192242,NOTCH3,Pathogenic/Likely pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|Recurrent subcortical infarcts|not provided|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1;Lateral meningocele syndrome;Myofibromatosis, infantile, 2|NOTCH3-related disorder",single nucleotide variant,GRCh38
na,na,19,15295262,15295262,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",single nucleotide variant,GRCh37
na,na,19,15184451,15184451,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",single nucleotide variant,GRCh38
na,na,19,15291576,15291576,NOTCH3,Benign,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|not specified|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1;Myofibromatosis, infantile, 2;Lateral meningocele syndrome",single nucleotide variant,GRCh37
na,na,19,15180765,15180765,NOTCH3,Benign,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1|not provided|not specified|Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1;Myofibromatosis, infantile, 2;Lateral meningocele syndrome",single nucleotide variant,GRCh38
na,na,19,15299896,15299896,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",single nucleotide variant,GRCh37
na,na,19,15189085,15189085,NOTCH3,Pathogenic,"Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1",single nucleotide variant,GRCh38
na,na,1,120460386,120460386,NOTCH2,Pathogenic,Alagille syndrome due to a NOTCH2 point mutation,single nucleotide variant,GRCh37
na,na,1,119917763,119917763,NOTCH2,Pathogenic,Alagille syndrome due to a NOTCH2 point mutation,single nucleotide variant,GRCh38
na,na,1,120510178,120510178,NOTCH2,Pathogenic,Alagille syndrome due to a NOTCH2 point mutation,single nucleotide variant,GRCh37
na,na,1,119967555,119967555,NOTCH2,Pathogenic,Alagille syndrome due to a NOTCH2 point mutation,single nucleotide variant,GRCh38
na,na,18,28581690,28581690,DSC3,Pathogenic,Hereditary hypotrichosis with recurrent skin vesicles,single nucleotide variant,GRCh37
na,na,18,31001724,31001724,DSC3,Pathogenic,Hereditary hypotrichosis with recurrent skin vesicles,single nucleotide variant,GRCh38
na,na,2,219249013,219249013,SLC11A1,risk factor,"Mycobacterium tuberculosis, susceptibility to infection by",single nucleotide variant,GRCh37
na,na,2,218384290,218384290,SLC11A1,risk factor,"Mycobacterium tuberculosis, susceptibility to infection by",single nucleotide variant,GRCh38
na,na,2,219259732,219259732,SLC11A1,Uncertain significance,"Buruli ulcer, susceptibility to|Cystic fibrosis",single nucleotide variant,GRCh37
na,na,2,218395009,218395009,SLC11A1,Uncertain significance,"Buruli ulcer, susceptibility to|Cystic fibrosis",single nucleotide variant,GRCh38
na,na,7,6042221,6042221,PMS2,Pathogenic,Lynch syndrome|Hereditary cancer-predisposing syndrome|Mismatch repair cancer syndrome 4|not provided|Hereditary nonpolyposis colorectal neoplasms|Mismatch repair cancer syndrome 1|Lynch syndrome 4|Lynch syndrome 1|Gastric cancer|Lynch syndrome 4;Mismatch repair cancer syndrome 4,single nucleotide variant,GRCh37
na,na,7,6002590,6002590,PMS2,Pathogenic,Lynch syndrome|Hereditary cancer-predisposing syndrome|Mismatch repair cancer syndrome 4|not provided|Hereditary nonpolyposis colorectal neoplasms|Mismatch repair cancer syndrome 1|Lynch syndrome 4|Lynch syndrome 1|Gastric cancer|Lynch syndrome 4;Mismatch repair cancer syndrome 4,single nucleotide variant,GRCh38
na,na,7,6027175,6027175,PMS2,Pathogenic,Mismatch repair cancer syndrome 4|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,7,5987544,5987544,PMS2,Pathogenic,Mismatch repair cancer syndrome 4|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,7,6017260,6017260,PMS2,Pathogenic,Hereditary cancer-predisposing syndrome|Lynch syndrome 4|Mismatch repair cancer syndrome 1|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome|not provided|Mismatch repair cancer syndrome 4|Rhabdomyosarcoma|Hereditary nonpolyposis colon cancer|Lynch syndrome 4;Mismatch repair cancer syndrome 4|PMS2-related disorder|Inherited MMR deficiency (Lynch syndrome),single nucleotide variant,GRCh37
na,na,7,5977629,5977629,PMS2,Pathogenic,Hereditary cancer-predisposing syndrome|Lynch syndrome 4|Mismatch repair cancer syndrome 1|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome|not provided|Mismatch repair cancer syndrome 4|Rhabdomyosarcoma|Hereditary nonpolyposis colon cancer|Lynch syndrome 4;Mismatch repair cancer syndrome 4|PMS2-related disorder|Inherited MMR deficiency (Lynch syndrome),single nucleotide variant,GRCh38
na,na,7,6029554,6029554,PMS2,Pathogenic,Lynch syndrome 4|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms|Hereditary nonpolyposis colon cancer,Deletion,GRCh37
na,na,7,5989923,5989923,PMS2,Pathogenic,Lynch syndrome 4|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms|Hereditary nonpolyposis colon cancer,Deletion,GRCh38
na,na,7,6026514,6026514,PMS2,Pathogenic,Lynch syndrome 4|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer,single nucleotide variant,GRCh37
na,na,7,5986883,5986883,PMS2,Pathogenic,Lynch syndrome 4|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer,single nucleotide variant,GRCh38
na,na,7,6035222,6035222,PMS2,Pathogenic,Lynch syndrome 4,Deletion,GRCh37
na,na,7,5995591,5995591,PMS2,Pathogenic,Lynch syndrome 4,Deletion,GRCh38
na,na,7,6026664,6026665,PMS2,Pathogenic/Likely pathogenic,Mismatch repair cancer syndrome 4|Lynch syndrome 4|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided|Carcinoma of colon,Indel,GRCh37
na,na,7,5987033,5987034,PMS2,Pathogenic/Likely pathogenic,Mismatch repair cancer syndrome 4|Lynch syndrome 4|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided|Carcinoma of colon,Indel,GRCh38
na,na,7,6045549,6045549,PMS2,Likely pathogenic,Mismatch repair cancer syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome 4|Pituitary carcinoma|Mismatch repair cancer syndrome 4|Hereditary nonpolyposis colorectal neoplasms|Breast and/or ovarian cancer|Mismatch repair cancer syndrome 4;Lynch syndrome 4|PMS2-related cancer disorders|Inherited MMR deficiency (Lynch syndrome)|Endometrial carcinoma|Lynch syndrome 1|PMS2-related disorder|Dilated cardiomyopathy 1G;Hypertrophic cardiomyopathy 9,single nucleotide variant,GRCh37
na,na,7,6005918,6005918,PMS2,Likely pathogenic,Mismatch repair cancer syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome 4|Pituitary carcinoma|Mismatch repair cancer syndrome 4|Hereditary nonpolyposis colorectal neoplasms|Breast and/or ovarian cancer|Mismatch repair cancer syndrome 4;Lynch syndrome 4|PMS2-related cancer disorders|Inherited MMR deficiency (Lynch syndrome)|Endometrial carcinoma|Lynch syndrome 1|PMS2-related disorder|Dilated cardiomyopathy 1G;Hypertrophic cardiomyopathy 9,single nucleotide variant,GRCh38
na,na,7,6043634,6043634,PMS2,Pathogenic,Mismatch repair cancer syndrome 4,single nucleotide variant,GRCh37
na,na,7,6004003,6004003,PMS2,Pathogenic,Mismatch repair cancer syndrome 4,single nucleotide variant,GRCh38
na,na,2,242793912,242793912,PDCD1,Benign,RECLASSIFIED - PDCD1 POLYMORPHISM,single nucleotide variant,GRCh37
na,na,2,241851760,241851760,PDCD1,Benign,RECLASSIFIED - PDCD1 POLYMORPHISM,single nucleotide variant,GRCh38
na,na,19,35524558,35524558,SCN1B,Pathogenic/Likely pathogenic,"Generalized epilepsy with febrile seizures plus, type 1|Generalized epilepsy with febrile seizures plus|Atrial fibrillation, familial, 13|not provided|Brugada syndrome 5|Atrial fibrillation, familial, 13;Developmental and epileptic encephalopathy, 52;Brugada syndrome 5;Generalized epilepsy with febrile seizures plus, type 1|Cardiovascular phenotype|SCN1B-related disorder",single nucleotide variant,GRCh37
na,na,19,35033654,35033654,SCN1B,Pathogenic/Likely pathogenic,"Generalized epilepsy with febrile seizures plus, type 1|Generalized epilepsy with febrile seizures plus|Atrial fibrillation, familial, 13|not provided|Brugada syndrome 5|Atrial fibrillation, familial, 13;Developmental and epileptic encephalopathy, 52;Brugada syndrome 5;Generalized epilepsy with febrile seizures plus, type 1|Cardiovascular phenotype|SCN1B-related disorder",single nucleotide variant,GRCh38
na,na,19,35524401,35524401,SCN1B,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 1",single nucleotide variant,GRCh37
na,na,19,35033497,35033497,SCN1B,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 1",single nucleotide variant,GRCh38
na,na,19,35524731,35524731,SCN1B,Conflicting classifications of pathogenicity,"Brugada syndrome 5|not provided|Atrial fibrillation, familial, 13",single nucleotide variant,GRCh37
na,na,19,35033827,35033827,SCN1B,Conflicting classifications of pathogenicity,"Brugada syndrome 5|not provided|Atrial fibrillation, familial, 13",single nucleotide variant,GRCh38
na,na,19,35524454,35524454,SCN1B,Uncertain significance,"Conduction system disorder|not provided|Developmental and epileptic encephalopathy, 52",single nucleotide variant,GRCh37
na,na,19,35033550,35033550,SCN1B,Uncertain significance,"Conduction system disorder|not provided|Developmental and epileptic encephalopathy, 52",single nucleotide variant,GRCh38
na,na,19,35524732,35524732,SCN1B,Pathogenic,Conduction system disorder,single nucleotide variant,GRCh37
na,na,19,35033828,35033828,SCN1B,Pathogenic,Conduction system disorder,single nucleotide variant,GRCh38
na,na,1,120306834,120306834,HMGCS2,Pathogenic/Likely pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,single nucleotide variant,GRCh37
na,na,1,119764211,119764211,HMGCS2,Pathogenic/Likely pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,single nucleotide variant,GRCh38
na,na,1,120295927,120295927,HMGCS2,Pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency|HMGCS2-related disorder,single nucleotide variant,GRCh37
na,na,1,119753304,119753304,HMGCS2,Pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency|HMGCS2-related disorder,single nucleotide variant,GRCh38
na,na,1,120302538,120302538,HMGCS2,Pathogenic/Likely pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,119759915,119759915,HMGCS2,Pathogenic/Likely pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,120293453,120293453,HMGCS2,Pathogenic/Likely pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,single nucleotide variant,GRCh37
na,na,1,119750830,119750830,HMGCS2,Pathogenic/Likely pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,single nucleotide variant,GRCh38
na,na,1,120307194,120307194,HMGCS2,Conflicting classifications of pathogenicity,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,single nucleotide variant,GRCh37
na,na,1,119764571,119764571,HMGCS2,Conflicting classifications of pathogenicity,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,single nucleotide variant,GRCh38
na,na,1,120306854,120306854,HMGCS2,Pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,single nucleotide variant,GRCh37
na,na,1,119764231,119764231,HMGCS2,Pathogenic,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,single nucleotide variant,GRCh38
na,na,12,6483746,6483747,SCNN1A,Pathogenic,"Pseudohypoaldosteronism, type IB1, autosomal recessive",Deletion,GRCh37
na,na,12,6374580,6374581,SCNN1A,Pathogenic,"Pseudohypoaldosteronism, type IB1, autosomal recessive",Deletion,GRCh38
na,na,12,6458147,6458147,SCNN1A,Conflicting classifications of pathogenicity,"Pseudohypoaldosteronism, type IB1, autosomal recessive|Bronchiectasis with or without elevated sweat chloride 2|Bronchiectasis with or without elevated sweat chloride 2;Pseudohypoaldosteronism, type IB1, autosomal recessive;Liddle syndrome 3",single nucleotide variant,GRCh37
na,na,12,6348981,6348981,SCNN1A,Conflicting classifications of pathogenicity,"Pseudohypoaldosteronism, type IB1, autosomal recessive|Bronchiectasis with or without elevated sweat chloride 2|Bronchiectasis with or without elevated sweat chloride 2;Pseudohypoaldosteronism, type IB1, autosomal recessive;Liddle syndrome 3",single nucleotide variant,GRCh38
na,na,12,6458378,6458378,SCNN1A,Pathogenic,"Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided|Incidental Discovery|Liddle syndrome 3;Pseudohypoaldosteronism, type IB1, autosomal recessive;Bronchiectasis with or without elevated sweat chloride 2",Deletion,GRCh37
na,na,12,6349212,6349212,SCNN1A,Pathogenic,"Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided|Incidental Discovery|Liddle syndrome 3;Pseudohypoaldosteronism, type IB1, autosomal recessive;Bronchiectasis with or without elevated sweat chloride 2",Deletion,GRCh38
na,na,12,6471363,6471363,SCNN1A,Pathogenic,"Pseudohypoaldosteronism, type IB1, autosomal recessive",Deletion,GRCh37
na,na,12,6362197,6362197,SCNN1A,Pathogenic,"Pseudohypoaldosteronism, type IB1, autosomal recessive",Deletion,GRCh38
na,na,12,6457364,6457364,SCNN1A,Likely pathogenic,"Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,12,6348198,6348198,SCNN1A,Likely pathogenic,"Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,12,6483610,6483610,SCNN1A,Uncertain significance,Bronchiectasis with or without elevated sweat chloride 2|not provided,single nucleotide variant,GRCh37
na,na,12,6374444,6374444,SCNN1A,Uncertain significance,Bronchiectasis with or without elevated sweat chloride 2|not provided,single nucleotide variant,GRCh38
na,na,12,6458350,6458350,SCNN1A,Benign/Likely benign,"Bronchiectasis with or without elevated sweat chloride 2|not specified|Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,12,6349184,6349184,SCNN1A,Benign/Likely benign,"Bronchiectasis with or without elevated sweat chloride 2|not specified|Pseudohypoaldosteronism, type IB1, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,12,6483709,6483709,SCNN1A,Pathogenic,Bronchiectasis with or without elevated sweat chloride 2,single nucleotide variant,GRCh37
na,na,12,6374543,6374543,SCNN1A,Pathogenic,Bronchiectasis with or without elevated sweat chloride 2,single nucleotide variant,GRCh38
na,na,14,55369120,55369120,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh37
na,na,14,54902402,54902402,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh38
na,na,14,55332097,55332097,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh37
na,na,14,54865379,54865379,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh38
na,na,14,55369377,55369378,GCH1,Pathogenic,Dystonia 5,Duplication,GRCh37
na,na,14,54902659,54902660,GCH1,Pathogenic,Dystonia 5,Duplication,GRCh38
na,na,14,55312510,55312510,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh37
na,na,14,54845792,54845792,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh38
na,na,14,55332156,55332156,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh37
na,na,14,54865438,54865438,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh38
na,na,14,55369379,55369379,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh37
na,na,14,54902661,54902661,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh38
na,na,14,55332067,55332067,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh37
na,na,14,54865349,54865349,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh38
na,na,14,55332044,55332044,GCH1,Pathogenic,Dystonia 5|Dystonia 5;GTP cyclohydrolase I deficiency,single nucleotide variant,GRCh37
na,na,14,54865326,54865326,GCH1,Pathogenic,Dystonia 5|Dystonia 5;GTP cyclohydrolase I deficiency,single nucleotide variant,GRCh38
na,na,14,55332145,55332145,GCH1,Pathogenic,"Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",Deletion,GRCh37
na,na,14,54865427,54865427,GCH1,Pathogenic,"Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",Deletion,GRCh38
na,na,14,55310826,55310826,GCH1,Conflicting classifications of pathogenicity,"GTP cyclohydrolase I deficiency;Dystonia 5|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive|Dystonia 5|Intellectual disability|Dystonia 5;GTP cyclohydrolase I deficiency with hyperphenylalaninemia|not provided|not specified",single nucleotide variant,GRCh37
na,na,14,54844108,54844108,GCH1,Conflicting classifications of pathogenicity,"GTP cyclohydrolase I deficiency;Dystonia 5|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive|Dystonia 5|Intellectual disability|Dystonia 5;GTP cyclohydrolase I deficiency with hyperphenylalaninemia|not provided|not specified",single nucleotide variant,GRCh38
na,na,14,55369059,55369059,GCH1,Conflicting classifications of pathogenicity,"GTP cyclohydrolase I deficiency;Dystonia 5|not provided|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",single nucleotide variant,GRCh37
na,na,14,54902341,54902341,GCH1,Conflicting classifications of pathogenicity,"GTP cyclohydrolase I deficiency;Dystonia 5|not provided|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",single nucleotide variant,GRCh38
na,na,14,55310817,55310817,GCH1,Conflicting classifications of pathogenicity,"Dystonia 5|not provided|GTP cyclohydrolase I deficiency;Dystonia 5|GTP cyclohydrolase I deficiency|Dopa-responsive dystonia|Inborn genetic diseases|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive|Dystonia 5;GTP cyclohydrolase I deficiency with hyperphenylalaninemia|GTP cyclohydrolase I deficiency with hyperphenylalaninemia",single nucleotide variant,GRCh37
na,na,14,54844099,54844099,GCH1,Conflicting classifications of pathogenicity,"Dystonia 5|not provided|GTP cyclohydrolase I deficiency;Dystonia 5|GTP cyclohydrolase I deficiency|Dopa-responsive dystonia|Inborn genetic diseases|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive|Dystonia 5;GTP cyclohydrolase I deficiency with hyperphenylalaninemia|GTP cyclohydrolase I deficiency with hyperphenylalaninemia",single nucleotide variant,GRCh38
na,na,14,55312526,55312526,GCH1,Uncertain significance,Dystonia 5,single nucleotide variant,GRCh37
na,na,14,54845808,54845808,GCH1,Uncertain significance,Dystonia 5,single nucleotide variant,GRCh38
na,na,14,55332094,55332094,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh37
na,na,14,54865376,54865376,GCH1,Pathogenic,Dystonia 5,single nucleotide variant,GRCh38
na,na,14,55310741,55310741,GCH1,Uncertain significance,"not specified|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",single nucleotide variant,GRCh37
na,na,14,54844023,54844023,GCH1,Uncertain significance,"not specified|Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",single nucleotide variant,GRCh38
na,na,14,55310855,55310855,GCH1,Pathogenic,GTP cyclohydrolase I deficiency with hyperphenylalaninemia,single nucleotide variant,GRCh37
na,na,14,54844137,54844137,GCH1,Pathogenic,GTP cyclohydrolase I deficiency with hyperphenylalaninemia,single nucleotide variant,GRCh38
na,na,14,55369240,55369240,GCH1,Pathogenic,Dystonia 5;GTP cyclohydrolase I deficiency|Dystonia 5,single nucleotide variant,GRCh37
na,na,14,54902522,54902522,GCH1,Pathogenic,Dystonia 5;GTP cyclohydrolase I deficiency|Dystonia 5,single nucleotide variant,GRCh38
na,na,14,55312561,55312561,GCH1,Pathogenic,GTP cyclohydrolase I deficiency|GTP cyclohydrolase I deficiency;Dystonia 5|GTP cyclohydrolase I deficiency with hyperphenylalaninemia|not provided,single nucleotide variant,GRCh37
na,na,14,54845843,54845843,GCH1,Pathogenic,GTP cyclohydrolase I deficiency|GTP cyclohydrolase I deficiency;Dystonia 5|GTP cyclohydrolase I deficiency with hyperphenylalaninemia|not provided,single nucleotide variant,GRCh38
na,na,14,54842017,54902826,GCH1,Pathogenic,Dystonia 5,Deletion,GRCh38
na,na,14,55312517,55312517,GCH1,Pathogenic,"Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",single nucleotide variant,GRCh37
na,na,14,54845799,54845799,GCH1,Pathogenic,"Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive",single nucleotide variant,GRCh38
na,na,9,27206760,27206760,TEK,Pathogenic,Multiple cutaneous and mucosal venous malformations|Segmental undergrowth associated with venous malformation without capillary component|Abnormal cardiovascular system morphology|not provided|TEK-related disorder,single nucleotide variant,GRCh37
na,na,9,27206762,27206762,TEK,Pathogenic,Multiple cutaneous and mucosal venous malformations|Segmental undergrowth associated with venous malformation without capillary component|Abnormal cardiovascular system morphology|not provided|TEK-related disorder,single nucleotide variant,GRCh38
na,na,9,27212708,27212708,TEK,Likely pathogenic,Multiple cutaneous and mucosal venous malformations|Blue rubber bleb nevus,single nucleotide variant,GRCh37
na,na,9,27212710,27212710,TEK,Likely pathogenic,Multiple cutaneous and mucosal venous malformations|Blue rubber bleb nevus,single nucleotide variant,GRCh38
na,na,6,45390460,45390474,RUNX2,Pathogenic,Cleidocranial dysostosis,Indel,GRCh37
na,na,6,45422723,45422737,RUNX2,Pathogenic,Cleidocranial dysostosis,Indel,GRCh38
na,na,6,45480014,45480014,RUNX2,Pathogenic,Cleidocranial dysostosis,single nucleotide variant,GRCh37
na,na,6,45512277,45512277,RUNX2,Pathogenic,Cleidocranial dysostosis,single nucleotide variant,GRCh38
na,na,6,45390490,45390491,RUNX2,Pathogenic,"Cleidocranial dysplasia 1, forme fruste, with brachydactyly",Duplication,GRCh37
na,na,6,45422753,45422754,RUNX2,Pathogenic,"Cleidocranial dysplasia 1, forme fruste, with brachydactyly",Duplication,GRCh38
na,na,6,45399700,45399700,RUNX2,Likely pathogenic,Cleidocranial dysostosis,single nucleotide variant,GRCh37
na,na,6,45431963,45431963,RUNX2,Likely pathogenic,Cleidocranial dysostosis,single nucleotide variant,GRCh38
na,na,6,45399748,45399748,RUNX2,Likely pathogenic,Cleidocranial dysostosis|not provided,single nucleotide variant,GRCh37
na,na,6,45432011,45432011,RUNX2,Likely pathogenic,Cleidocranial dysostosis|not provided,single nucleotide variant,GRCh38
na,na,6,45514853,45514854,RUNX2,Pathogenic/Likely pathogenic,not provided|Cleidocranial dysostosis|Inborn genetic diseases,Duplication,GRCh37
na,na,6,45547116,45547117,RUNX2,Pathogenic/Likely pathogenic,not provided|Cleidocranial dysostosis|Inborn genetic diseases,Duplication,GRCh38
na,na,6,45514677,45514678,RUNX2,Pathogenic,Cleidocranial dysostosis,Duplication,GRCh37
na,na,6,45546940,45546941,RUNX2,Pathogenic,Cleidocranial dysostosis,Duplication,GRCh38
na,na,6,45405777,45405777,RUNX2,Pathogenic,Cleidocranial dysostosis|not provided|Cleidocranial dysostosis;Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome|RUNX2-related disorder,single nucleotide variant,GRCh37
na,na,6,45438040,45438040,RUNX2,Pathogenic,Cleidocranial dysostosis|not provided|Cleidocranial dysostosis;Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome|RUNX2-related disorder,single nucleotide variant,GRCh38
na,na,6,45405776,45405776,RUNX2,Pathogenic,Cleidocranial dysostosis|not provided,single nucleotide variant,GRCh37
na,na,6,45438039,45438039,RUNX2,Pathogenic,Cleidocranial dysostosis|not provided,single nucleotide variant,GRCh38
na,na,6,45405701,45405701,RUNX2,Pathogenic,"Cleidocranial dysostosis|Cleidocranial dysplasia 1, forme fruste, dental anomalies only|not provided",single nucleotide variant,GRCh37
na,na,6,45437964,45437964,RUNX2,Pathogenic,"Cleidocranial dysostosis|Cleidocranial dysplasia 1, forme fruste, dental anomalies only|not provided",single nucleotide variant,GRCh38
na,na,6,45515041,45515041,RUNX2,Pathogenic,Cleidocranial dysostosis,single nucleotide variant,GRCh37
na,na,6,45547304,45547304,RUNX2,Pathogenic,Cleidocranial dysostosis,single nucleotide variant,GRCh38
na,na,6,45399682,45399682,RUNX2,Pathogenic,Cleidocranial dysostosis,single nucleotide variant,GRCh37
na,na,6,45431945,45431945,RUNX2,Pathogenic,Cleidocranial dysostosis,single nucleotide variant,GRCh38
na,na,6,45514701,45514702,RUNX2,Pathogenic,Cleidocranial dysostosis,Duplication,GRCh37
na,na,6,45546964,45546965,RUNX2,Pathogenic,Cleidocranial dysostosis,Duplication,GRCh38
na,na,20,32856998,32856998,ASIP,association,"SKIN/HAIR/EYE PIGMENTATION 9, DARK/LIGHT HAIR",single nucleotide variant,GRCh37
na,na,20,34269192,34269192,ASIP,association,"SKIN/HAIR/EYE PIGMENTATION 9, DARK/LIGHT HAIR",single nucleotide variant,GRCh38
na,na,12,53040532,53040532,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh37
na,na,12,52646748,52646748,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh38
na,na,12,53040534,53040534,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|Exfoliative ichthyosis|not provided,single nucleotide variant,GRCh37
na,na,12,52646750,52646750,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|Exfoliative ichthyosis|not provided,single nucleotide variant,GRCh38
na,na,12,53045385,53045385,KRT2,Likely pathogenic,Ichthyosis bullosa of Siemens,single nucleotide variant,GRCh37
na,na,12,52651601,52651601,KRT2,Likely pathogenic,Ichthyosis bullosa of Siemens,single nucleotide variant,GRCh38
na,na,12,53040558,53040558,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh37
na,na,12,52646774,52646774,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh38
na,na,12,53045371,53045371,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh37
na,na,12,52651587,52651587,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh38
na,na,12,53040567,53040567,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh37
na,na,12,52646783,52646783,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh38
na,na,12,53045371,53045371,KRT2,Pathogenic,Ichthyosis bullosa of Siemens,single nucleotide variant,GRCh37
na,na,12,52651587,52651587,KRT2,Pathogenic,Ichthyosis bullosa of Siemens,single nucleotide variant,GRCh38
na,na,12,53045369,53045369,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh37
na,na,12,52651585,52651585,KRT2,Pathogenic,Ichthyosis bullosa of Siemens|not provided,single nucleotide variant,GRCh38
na,na,13,32921029,32921034,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome",Deletion,GRCh37
na,na,13,32346892,32346897,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome",Deletion,GRCh38
na,na,13,32914767,32914768,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Endometrial carcinoma|Familial cancer of breast|8 conditions|BRCA2-related cancer predisposition|BRCA2-related disorder",Deletion,GRCh37
na,na,13,32340630,32340631,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Endometrial carcinoma|Familial cancer of breast|8 conditions|BRCA2-related cancer predisposition|BRCA2-related disorder",Deletion,GRCh38
na,na,13,32915083,32915084,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Endometrial carcinoma|Prostate cancer|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1",Deletion,GRCh37
na,na,13,32340946,32340947,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Endometrial carcinoma|Prostate cancer|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1",Deletion,GRCh38
na,na,13,32914210,32914211,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Gastric cancer|8 conditions|BRCA2-related cancer predisposition",Microsatellite,GRCh37
na,na,13,32340073,32340074,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1|Gastric cancer|8 conditions|BRCA2-related cancer predisposition",Microsatellite,GRCh38
na,na,13,32911298,32911301,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Breast neoplasm|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast|BRCA2-related disorder|Uterine corpus cancer|Gastric cancer|Fanconi anemia complementation group D1;Hereditary breast ovarian cancer syndrome|BRCA2-related cancer predisposition|8 conditions",Deletion,GRCh37
na,na,13,32337161,32337164,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Breast neoplasm|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast|BRCA2-related disorder|Uterine corpus cancer|Gastric cancer|Fanconi anemia complementation group D1;Hereditary breast ovarian cancer syndrome|BRCA2-related cancer predisposition|8 conditions",Deletion,GRCh38
na,na,13,32912393,32912395,BRCA2,Conflicting classifications of pathogenicity,"Breast-ovarian cancer, familial, susceptibility to, 2",Microsatellite,GRCh37
na,na,13,32338256,32338258,BRCA2,Conflicting classifications of pathogenicity,"Breast-ovarian cancer, familial, susceptibility to, 2",Microsatellite,GRCh38
na,na,13,32914438,32914438,BRCA2,Pathogenic,"Pancreatic cancer, susceptibility to, 2|Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|BRCA2-related disorder|Hereditary cancer-predisposing syndrome|not provided|Breast neoplasm|Breast and/or ovarian cancer|Ovarian neoplasm|Hereditary breast ovarian cancer syndrome;Fanconi anemia complementation group D1|BRCA2-related cancer predisposition|Endometrial carcinoma|8 conditions",Deletion,GRCh37
na,na,13,32340301,32340301,BRCA2,Pathogenic,"Pancreatic cancer, susceptibility to, 2|Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|BRCA2-related disorder|Hereditary cancer-predisposing syndrome|not provided|Breast neoplasm|Breast and/or ovarian cancer|Ovarian neoplasm|Hereditary breast ovarian cancer syndrome;Fanconi anemia complementation group D1|BRCA2-related cancer predisposition|Endometrial carcinoma|8 conditions",Deletion,GRCh38
na,na,13,32905141,32905145,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Breast carcinoma|not provided|BRCA2-related disorder|BRCA2-related cancer predisposition",Deletion,GRCh37
na,na,13,32331004,32331008,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Breast carcinoma|not provided|BRCA2-related disorder|BRCA2-related cancer predisposition",Deletion,GRCh38
na,na,13,32945138,32945139,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast|Breast and/or ovarian cancer|BRCA2-related cancer predisposition|Familial cancer of breast;Breast-ovarian cancer, familial, susceptibility to, 2",Microsatellite,GRCh37
na,na,13,32371001,32371002,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast|Breast and/or ovarian cancer|BRCA2-related cancer predisposition|Familial cancer of breast;Breast-ovarian cancer, familial, susceptibility to, 2",Microsatellite,GRCh38
na,na,13,32906729,32906729,BRCA2,Benign,"not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|8 conditions|Breast ductal adenocarcinoma|Fanconi anemia complementation group D1|Familial cancer of breast|Breast carcinoma|BRCA2-related cancer predisposition",single nucleotide variant,GRCh37
na,na,13,32332592,32332592,BRCA2,Benign,"not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|8 conditions|Breast ductal adenocarcinoma|Fanconi anemia complementation group D1|Familial cancer of breast|Breast carcinoma|BRCA2-related cancer predisposition",single nucleotide variant,GRCh38
na,na,13,32950906,32950906,BRCA2,Uncertain significance,Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome,single nucleotide variant,GRCh37
na,na,13,32376769,32376769,BRCA2,Uncertain significance,Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome,single nucleotide variant,GRCh38
na,na,13,32937504,32937504,BRCA2,Pathogenic,"BRCA2-related disorder|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Familial cancer of breast",single nucleotide variant,GRCh37
na,na,13,32363367,32363367,BRCA2,Pathogenic,"BRCA2-related disorder|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Familial cancer of breast",single nucleotide variant,GRCh38
na,na,13,32903605,32903606,BRCA2,Pathogenic,"Medulloblastoma|Fanconi anemia complementation group D1|Wilms tumor 1|Glioma susceptibility 3|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast|Prostate cancer|Gastric cancer|8 conditions|Uterine corpus cancer|BRCA2-related cancer predisposition|BRCA2-related disorder",Deletion,GRCh37
na,na,13,32329468,32329469,BRCA2,Pathogenic,"Medulloblastoma|Fanconi anemia complementation group D1|Wilms tumor 1|Glioma susceptibility 3|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast|Prostate cancer|Gastric cancer|8 conditions|Uterine corpus cancer|BRCA2-related cancer predisposition|BRCA2-related disorder",Deletion,GRCh38
na,na,13,32937558,32937558,BRCA2,Pathogenic,"Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Hereditary breast ovarian cancer syndrome",single nucleotide variant,GRCh37
na,na,13,32363421,32363421,BRCA2,Pathogenic,"Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Hereditary breast ovarian cancer syndrome",single nucleotide variant,GRCh38
na,na,13,32913140,32913140,BRCA2,Pathogenic,"Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Fanconi anemia|Familial cancer of breast",single nucleotide variant,GRCh37
na,na,13,32339003,32339003,BRCA2,Pathogenic,"Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Fanconi anemia|Familial cancer of breast",single nucleotide variant,GRCh38
na,na,13,32930658,32930658,BRCA2,Pathogenic/Likely pathogenic,"Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,13,32356521,32356521,BRCA2,Pathogenic/Likely pathogenic,"Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,13,32914137,32914137,BRCA2,Pathogenic,"Wilms tumor 1|Glioma susceptibility 3|Medulloblastoma|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,13,32340000,32340000,BRCA2,Pathogenic,"Wilms tumor 1|Glioma susceptibility 3|Medulloblastoma|Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,13,32954222,32954222,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast|BRCA2-related cancer predisposition",single nucleotide variant,GRCh37
na,na,13,32380085,32380085,BRCA2,Pathogenic,"Breast-ovarian cancer, familial, susceptibility to, 2|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Familial cancer of breast|BRCA2-related cancer predisposition",single nucleotide variant,GRCh38
na,na,13,32900751,32900751,BRCA2,Pathogenic,"Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Breast-ovarian cancer, familial, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,13,32326614,32326614,BRCA2,Pathogenic,"Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Breast-ovarian cancer, familial, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,13,32900752,32900752,BRCA2,Pathogenic,"Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Fanconi anemia|Malignant tumor of breast|Familial cancer of breast|BRCA2-related cancer predisposition",single nucleotide variant,GRCh37
na,na,13,32326615,32326615,BRCA2,Pathogenic,"Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Fanconi anemia|Malignant tumor of breast|Familial cancer of breast|BRCA2-related cancer predisposition",single nucleotide variant,GRCh38
na,na,17,7912849,7912849,GUCY2D,Pathogenic,Leber congenital amaurosis 1|not provided|GUCY2D-related recessive retinopathy,single nucleotide variant,GRCh37
na,na,17,8009531,8009531,GUCY2D,Pathogenic,Leber congenital amaurosis 1|not provided|GUCY2D-related recessive retinopathy,single nucleotide variant,GRCh38
na,na,17,7906519,7906519,GUCY2D,Benign,"Leber congenital amaurosis 1|not specified|not provided|Cone-rod dystrophy 6;Leber congenital amaurosis 1|Cone-rod dystrophy 6|Night blindness, congenital stationary, type1i;Cone-rod dystrophy 6;Choroidal dystrophy, central areolar, 1;Leber congenital amaurosis 1|GUCY2D-related recessive retinopathy",single nucleotide variant,GRCh37
na,na,17,8003201,8003201,GUCY2D,Benign,"Leber congenital amaurosis 1|not specified|not provided|Cone-rod dystrophy 6;Leber congenital amaurosis 1|Cone-rod dystrophy 6|Night blindness, congenital stationary, type1i;Cone-rod dystrophy 6;Choroidal dystrophy, central areolar, 1;Leber congenital amaurosis 1|GUCY2D-related recessive retinopathy",single nucleotide variant,GRCh38
na,na,17,7918017,7918017,GUCY2D,not provided,not provided,single nucleotide variant,GRCh37
na,na,17,8014699,8014699,GUCY2D,not provided,not provided,single nucleotide variant,GRCh38
na,na,17,7918018,7918018,GUCY2D,Pathogenic/Likely pathogenic,"Cone-rod dystrophy 6|not provided|Cone-rod dystrophy 6;Leber congenital amaurosis 1|Retinal dystrophy|Choroidal dystrophy, central areolar, 1|Cone dystrophy|Leber congenital amaurosis 1",single nucleotide variant,GRCh37
na,na,17,8014700,8014700,GUCY2D,Pathogenic/Likely pathogenic,"Cone-rod dystrophy 6|not provided|Cone-rod dystrophy 6;Leber congenital amaurosis 1|Retinal dystrophy|Choroidal dystrophy, central areolar, 1|Cone dystrophy|Leber congenital amaurosis 1",single nucleotide variant,GRCh38
na,na,17,7918019,7918019,GUCY2D,Pathogenic/Likely pathogenic,Cone-rod dystrophy 6|not provided|Retinal dystrophy|Progressive cone dystrophy (without rod involvement)|Cone dystrophy|Visual impairment;Macular dystrophy|Retinitis pigmentosa|Leber congenital amaurosis 1;Cone-rod dystrophy 6|Cone-rod dystrophy,single nucleotide variant,GRCh37
na,na,17,8014701,8014701,GUCY2D,Pathogenic/Likely pathogenic,Cone-rod dystrophy 6|not provided|Retinal dystrophy|Progressive cone dystrophy (without rod involvement)|Cone dystrophy|Visual impairment;Macular dystrophy|Retinitis pigmentosa|Leber congenital amaurosis 1;Cone-rod dystrophy 6|Cone-rod dystrophy,single nucleotide variant,GRCh38
na,na,17,7918722,7918722,GUCY2D,Pathogenic,Cone-rod dystrophy 6,single nucleotide variant,GRCh37
na,na,17,8015404,8015404,GUCY2D,Pathogenic,Cone-rod dystrophy 6,single nucleotide variant,GRCh38
na,na,19,17954595,17954595,JAK3,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,single nucleotide variant,GRCh37
na,na,19,17843786,17843786,JAK3,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,JAK3,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,Deletion,na
na,na,19,17948747,17948747,JAK3,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,single nucleotide variant,GRCh37
na,na,19,17837938,17837938,JAK3,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,single nucleotide variant,GRCh38
na,na,19,17950394,17950394,JAK3,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,single nucleotide variant,GRCh37
na,na,19,17839585,17839585,JAK3,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,single nucleotide variant,GRCh38
na,na,19,17953895,17953895,JAK3,Uncertain significance,T-B+ severe combined immunodeficiency due to JAK3 deficiency,single nucleotide variant,GRCh37
na,na,19,17843086,17843086,JAK3,Uncertain significance,T-B+ severe combined immunodeficiency due to JAK3 deficiency,single nucleotide variant,GRCh38
na,na,19,17955053,17955055,JAK3,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,Deletion,GRCh37
na,na,19,17844244,17844246,JAK3,Pathogenic,T-B+ severe combined immunodeficiency due to JAK3 deficiency,Deletion,GRCh38
na,na,9,33442298,33442298,AQP3,Affects,GIL BLOOD GROUP,single nucleotide variant,GRCh37
na,na,9,33442300,33442300,AQP3,Affects,GIL BLOOD GROUP,single nucleotide variant,GRCh38
na,na,3,38592932,38592932,SCN5A,Pathogenic,Long QT syndrome 3|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Cardiac arrhythmia|Long QT syndrome|SCN5A-related disorder,single nucleotide variant,GRCh37
na,na,3,38551441,38551441,SCN5A,Pathogenic,Long QT syndrome 3|Congenital long QT syndrome|not provided|Cardiovascular phenotype|Cardiac arrhythmia|Long QT syndrome|SCN5A-related disorder,single nucleotide variant,GRCh38
na,na,3,38601909,38601909,SCN5A,Pathogenic/Likely pathogenic,Long QT syndrome 3|Congenital long QT syndrome|Cardiovascular phenotype|not provided|Long QT syndrome,single nucleotide variant,GRCh37
na,na,3,38560418,38560418,SCN5A,Pathogenic/Likely pathogenic,Long QT syndrome 3|Congenital long QT syndrome|Cardiovascular phenotype|not provided|Long QT syndrome,single nucleotide variant,GRCh38
na,na,3,38608046,38608046,SCN5A,Uncertain significance,Brugada syndrome|not provided|Brugada syndrome 1|Cardiac arrhythmia|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,3,38566555,38566555,SCN5A,Uncertain significance,Brugada syndrome|not provided|Brugada syndrome 1|Cardiac arrhythmia|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,3,38662329,38662330,SCN5A,Pathogenic,Brugada syndrome 1,Duplication,GRCh37
na,na,3,38620838,38620839,SCN5A,Pathogenic,Brugada syndrome 1,Duplication,GRCh38
na,na,3,38601693,38601693,SCN5A,Pathogenic,Brugada syndrome 1|Cardiovascular phenotype|not provided,Deletion,GRCh37
na,na,3,38560202,38560202,SCN5A,Pathogenic,Brugada syndrome 1|Cardiovascular phenotype|not provided,Deletion,GRCh38
na,na,3,38592996,38592996,SCN5A,Pathogenic,Sick sinus syndrome 1|Familial isolated arrhythmogenic right ventricular dysplasia|not provided|Long QT syndrome 3|Cardiovascular phenotype|8 conditions|Cardiac arrhythmia|Brugada syndrome|SCN5A-related disorder,single nucleotide variant,GRCh37
na,na,3,38551505,38551505,SCN5A,Pathogenic,Sick sinus syndrome 1|Familial isolated arrhythmogenic right ventricular dysplasia|not provided|Long QT syndrome 3|Cardiovascular phenotype|8 conditions|Cardiac arrhythmia|Brugada syndrome|SCN5A-related disorder,single nucleotide variant,GRCh38
na,na,3,38592479,38592479,SCN5A,Pathogenic,Long QT syndrome 3|Congenital long QT syndrome|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,3,38550988,38550988,SCN5A,Pathogenic,Long QT syndrome 3|Congenital long QT syndrome|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,3,38592995,38592995,SCN5A,Pathogenic,"Long QT syndrome 3|Long QT syndrome 3/6, digenic|Congenital long QT syndrome|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,3,38551504,38551504,SCN5A,Pathogenic,"Long QT syndrome 3|Long QT syndrome 3/6, digenic|Congenital long QT syndrome|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,3,38592513,38592513,SCN5A,Pathogenic/Likely pathogenic,Long QT syndrome 3|Brugada syndrome 1|Sinoatrial node disorder|Congenital long QT syndrome|not provided|Brugada syndrome|Cardiovascular phenotype|Long QT syndrome 1|Congenital long QT syndrome;Brugada syndrome|Cardiac arrhythmia|8 conditions|SCN5A-related disorder,single nucleotide variant,GRCh37
na,na,3,38551022,38551022,SCN5A,Pathogenic/Likely pathogenic,Long QT syndrome 3|Brugada syndrome 1|Sinoatrial node disorder|Congenital long QT syndrome|not provided|Brugada syndrome|Cardiovascular phenotype|Long QT syndrome 1|Congenital long QT syndrome;Brugada syndrome|Cardiac arrhythmia|8 conditions|SCN5A-related disorder,single nucleotide variant,GRCh38
na,na,3,38603904,38603904,SCN5A,Pathogenic,"Progressive familial heart block, type 1A|not provided",single nucleotide variant,GRCh37
na,na,3,38562413,38562413,SCN5A,Pathogenic,"Progressive familial heart block, type 1A|not provided",single nucleotide variant,GRCh38
na,na,3,38592732,38592732,SCN5A,Pathogenic,"Heart block, nonprogressive",Deletion,GRCh37
na,na,3,38551241,38551241,SCN5A,Pathogenic,"Heart block, nonprogressive",Deletion,GRCh38
na,na,3,38597155,38597155,SCN5A,Conflicting classifications of pathogenicity,Brugada syndrome 1|not provided|Primary familial hypertrophic cardiomyopathy|Cardiac arrhythmia|not specified|Cardiovascular phenotype|Brugada syndrome (shorter-than-normal QT interval),single nucleotide variant,GRCh37
na,na,3,38555664,38555664,SCN5A,Conflicting classifications of pathogenicity,Brugada syndrome 1|not provided|Primary familial hypertrophic cardiomyopathy|Cardiac arrhythmia|not specified|Cardiovascular phenotype|Brugada syndrome (shorter-than-normal QT interval),single nucleotide variant,GRCh38
na,na,3,38592093,38592093,SCN5A,Conflicting classifications of pathogenicity,Brugada syndrome 1|Brugada syndrome|not provided|Brugada syndrome;Long QT syndrome|Cardiac arrhythmia|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,3,38550602,38550602,SCN5A,Conflicting classifications of pathogenicity,Brugada syndrome 1|Brugada syndrome|not provided|Brugada syndrome;Long QT syndrome|Cardiac arrhythmia|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,3,38592475,38592476,SCN5A,Pathogenic,Long QT syndrome 3|Brugada syndrome 1|not provided,Duplication,GRCh37
na,na,3,38550984,38550985,SCN5A,Pathogenic,Long QT syndrome 3|Brugada syndrome 1|not provided,Duplication,GRCh38
na,na,3,38592734,38592734,SCN5A,Pathogenic/Likely pathogenic,"not provided|Ventricular fibrillation, paroxysmal familial, type 1|Ventricular fibrillation|Cardiovascular phenotype|Brugada syndrome 1|8 conditions|Brugada syndrome|Cardiac arrhythmia|Brugada syndrome 1;Long QT syndrome 3",single nucleotide variant,GRCh37
na,na,3,38551243,38551243,SCN5A,Pathogenic/Likely pathogenic,"not provided|Ventricular fibrillation, paroxysmal familial, type 1|Ventricular fibrillation|Cardiovascular phenotype|Brugada syndrome 1|8 conditions|Brugada syndrome|Cardiac arrhythmia|Brugada syndrome 1;Long QT syndrome 3",single nucleotide variant,GRCh38
na,na,3,38622828,38622829,SCN5A,Conflicting classifications of pathogenicity,Long QT syndrome 3|not provided|Cardiovascular phenotype,Indel,GRCh37
na,na,3,38581337,38581338,SCN5A,Conflicting classifications of pathogenicity,Long QT syndrome 3|not provided|Cardiovascular phenotype,Indel,GRCh38
na,na,3,38595800,38595800,SCN5A,Pathogenic/Likely pathogenic,"Progressive familial heart block, type 1A|Atrioventricular block|not provided|Atrial fibrillation, familial, 10|SCN5A-related disorder",single nucleotide variant,GRCh37
na,na,3,38554309,38554309,SCN5A,Pathogenic/Likely pathogenic,"Progressive familial heart block, type 1A|Atrioventricular block|not provided|Atrial fibrillation, familial, 10|SCN5A-related disorder",single nucleotide variant,GRCh38
na,na,3,38645553,38645553,SCN5A,Pathogenic,"Cardiac conduction defect, nonprogressive|Conduction system disorder",single nucleotide variant,GRCh37
na,na,3,38604062,38604062,SCN5A,Pathogenic,"Cardiac conduction defect, nonprogressive|Conduction system disorder",single nucleotide variant,GRCh38
na,na,3,38651267,38651267,SCN5A,Uncertain significance,"Progressive familial heart block, type 1A|Atrioventricular block|not specified|Migraine;Primary dilated cardiomyopathy;Hemiplegia|Long QT syndrome 3|Ventricular fibrillation, paroxysmal familial, type 1|Dilated cardiomyopathy 1E|Sick sinus syndrome 1|Brugada syndrome 1|Cardiac arrhythmia|not provided|8 conditions|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,3,38609776,38609776,SCN5A,Uncertain significance,"Progressive familial heart block, type 1A|Atrioventricular block|not specified|Migraine;Primary dilated cardiomyopathy;Hemiplegia|Long QT syndrome 3|Ventricular fibrillation, paroxysmal familial, type 1|Dilated cardiomyopathy 1E|Sick sinus syndrome 1|Brugada syndrome 1|Cardiac arrhythmia|not provided|8 conditions|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,3,38622661,38622661,SCN5A,Conflicting classifications of pathogenicity,"Congenital long QT syndrome|Long QT syndrome 3|not provided|8 conditions|Cardiac arrhythmia|SCN5A-related disorder|Dilated cardiomyopathy 1E;Atrial fibrillation, familial, 10;Brugada syndrome 1;Long QT syndrome 3",single nucleotide variant,GRCh37
na,na,3,38581170,38581170,SCN5A,Conflicting classifications of pathogenicity,"Congenital long QT syndrome|Long QT syndrome 3|not provided|8 conditions|Cardiac arrhythmia|SCN5A-related disorder|Dilated cardiomyopathy 1E;Atrial fibrillation, familial, 10;Brugada syndrome 1;Long QT syndrome 3",single nucleotide variant,GRCh38
na,na,3,38592386,38592386,SCN5A,Uncertain significance,Long QT syndrome 3|Congenital long QT syndrome|not specified|SUDDEN INFANT DEATH SYNDROME|not provided|Cardiovascular phenotype|Cardiac arrhythmia|8 conditions,single nucleotide variant,GRCh37
na,na,3,38550895,38550895,SCN5A,Uncertain significance,Long QT syndrome 3|Congenital long QT syndrome|not specified|SUDDEN INFANT DEATH SYNDROME|not provided|Cardiovascular phenotype|Cardiac arrhythmia|8 conditions,single nucleotide variant,GRCh38
na,na,3,38648200,38648200,SCN5A,Pathogenic,Brugada syndrome 1|Brugada syndrome|Cardiovascular phenotype|SCN5A-related disorder|Cardiac arrhythmia|not provided,single nucleotide variant,GRCh37
na,na,3,38606709,38606709,SCN5A,Pathogenic,Brugada syndrome 1|Brugada syndrome|Cardiovascular phenotype|SCN5A-related disorder|Cardiac arrhythmia|not provided,single nucleotide variant,GRCh38
na,na,3,38639278,38639278,SCN5A,Pathogenic/Likely pathogenic,Brugada syndrome 1|Brugada syndrome|Cardiac arrhythmia|not provided|Congenital long QT syndrome,single nucleotide variant,GRCh37
na,na,3,38597787,38597787,SCN5A,Pathogenic/Likely pathogenic,Brugada syndrome 1|Brugada syndrome|Cardiac arrhythmia|not provided|Congenital long QT syndrome,single nucleotide variant,GRCh38
na,na,3,38616876,38616876,SCN5A,Benign/Likely benign,"Brugada syndrome 1|Long QT syndrome 3, acquired, susceptibility to|not provided|Primary familial hypertrophic cardiomyopathy|Brugada syndrome|not specified|Cardiovascular phenotype|Long QT syndrome 3|Ventricular fibrillation, paroxysmal familial, type 1|Dilated cardiomyopathy 1E|Sick sinus syndrome 1|Progressive familial heart block, type 1A|8 conditions|Cardiac arrhythmia|Cardiomyopathy",single nucleotide variant,GRCh37
na,na,3,38575385,38575385,SCN5A,Benign/Likely benign,"Brugada syndrome 1|Long QT syndrome 3, acquired, susceptibility to|not provided|Primary familial hypertrophic cardiomyopathy|Brugada syndrome|not specified|Cardiovascular phenotype|Long QT syndrome 3|Ventricular fibrillation, paroxysmal familial, type 1|Dilated cardiomyopathy 1E|Sick sinus syndrome 1|Progressive familial heart block, type 1A|8 conditions|Cardiac arrhythmia|Cardiomyopathy",single nucleotide variant,GRCh38
na,na,3,38620907,38620907,SCN5A,Conflicting classifications of pathogenicity,"Long QT syndrome 3, acquired, susceptibility to|SUDDEN INFANT DEATH SYNDROME|not provided|not specified|Brugada syndrome|Progressive familial heart block, type 1A|Ventricular fibrillation, paroxysmal familial, type 1|Sick sinus syndrome 1|Dilated cardiomyopathy 1E|Congenital long QT syndrome|Cardiovascular phenotype|Long QT syndrome 3|Brugada syndrome 1|Primary dilated cardiomyopathy|Cardiomyopathy|Cardiac arrhythmia|8 conditions",single nucleotide variant,GRCh37
na,na,3,38579416,38579416,SCN5A,Conflicting classifications of pathogenicity,"Long QT syndrome 3, acquired, susceptibility to|SUDDEN INFANT DEATH SYNDROME|not provided|not specified|Brugada syndrome|Progressive familial heart block, type 1A|Ventricular fibrillation, paroxysmal familial, type 1|Sick sinus syndrome 1|Dilated cardiomyopathy 1E|Congenital long QT syndrome|Cardiovascular phenotype|Long QT syndrome 3|Brugada syndrome 1|Primary dilated cardiomyopathy|Cardiomyopathy|Cardiac arrhythmia|8 conditions",single nucleotide variant,GRCh38
na,na,3,38603976,38603976,SCN5A,Conflicting classifications of pathogenicity,Sick sinus syndrome 1|Sick sinus syndrome|Cardiac arrhythmia|Brugada syndrome 1;Long QT syndrome 3;Dilated cardiomyopathy 1E,single nucleotide variant,GRCh37
na,na,3,38562485,38562485,SCN5A,Conflicting classifications of pathogenicity,Sick sinus syndrome 1|Sick sinus syndrome|Cardiac arrhythmia|Brugada syndrome 1;Long QT syndrome 3;Dilated cardiomyopathy 1E,single nucleotide variant,GRCh38
na,na,3,38601661,38601661,SCN5A,Pathogenic,Sick sinus syndrome 1|Brugada syndrome 1|Conduction system disorder|Brugada syndrome|not provided|Cardiovascular phenotype|8 conditions|Congenital long QT syndrome|Cardiac arrhythmia,single nucleotide variant,GRCh37
na,na,3,38560170,38560170,SCN5A,Pathogenic,Sick sinus syndrome 1|Brugada syndrome 1|Conduction system disorder|Brugada syndrome|not provided|Cardiovascular phenotype|8 conditions|Congenital long QT syndrome|Cardiac arrhythmia,single nucleotide variant,GRCh38
na,na,3,38655278,38655278,SCN5A,Conflicting classifications of pathogenicity,Brugada syndrome|AV junctional rhythm|Cardiovascular phenotype|Sick sinus syndrome 1|not specified|SCN5A-related disorder|Primary familial dilated cardiomyopathy|Long QT syndrome 3|Dilated cardiomyopathy 1E|Cardiac arrhythmia|not provided|Long QT syndrome 3;Brugada syndrome 1,single nucleotide variant,GRCh37
na,na,3,38613787,38613787,SCN5A,Conflicting classifications of pathogenicity,Brugada syndrome|AV junctional rhythm|Cardiovascular phenotype|Sick sinus syndrome 1|not specified|SCN5A-related disorder|Primary familial dilated cardiomyopathy|Long QT syndrome 3|Dilated cardiomyopathy 1E|Cardiac arrhythmia|not provided|Long QT syndrome 3;Brugada syndrome 1,single nucleotide variant,GRCh38
na,na,3,38592480,38592480,SCN5A,Pathogenic,Brugada syndrome 1|Brugada syndrome,single nucleotide variant,GRCh37
na,na,3,38550989,38550989,SCN5A,Pathogenic,Brugada syndrome 1|Brugada syndrome,single nucleotide variant,GRCh38
na,na,3,38645558,38645558,SCN5A,Uncertain significance,Conduction system disorder|Brugada syndrome 1|not provided|8 conditions|Cardiac arrhythmia,single nucleotide variant,GRCh37
na,na,3,38604067,38604067,SCN5A,Uncertain significance,Conduction system disorder|Brugada syndrome 1|not provided|8 conditions|Cardiac arrhythmia,single nucleotide variant,GRCh38
na,na,3,38607956,38607956,SCN5A,Conflicting classifications of pathogenicity,"Brugada syndrome 1|Brugada syndrome|Long QT syndrome 3|not provided|Progressive familial heart block, type 1A|Ventricular fibrillation, paroxysmal familial, type 1|Sick sinus syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia",single nucleotide variant,GRCh37
na,na,3,38566465,38566465,SCN5A,Conflicting classifications of pathogenicity,"Brugada syndrome 1|Brugada syndrome|Long QT syndrome 3|not provided|Progressive familial heart block, type 1A|Ventricular fibrillation, paroxysmal familial, type 1|Sick sinus syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia",single nucleotide variant,GRCh38
na,na,3,38622493,38622493,SCN5A,Conflicting classifications of pathogenicity,"Brugada syndrome 1|Congenital long QT syndrome|Long QT syndrome 3|Atrial fibrillation, familial, 10|not specified|Cardiovascular phenotype|not provided|Cardiac arrhythmia|Dilated cardiomyopathy 1E",single nucleotide variant,GRCh37
na,na,3,38581002,38581002,SCN5A,Conflicting classifications of pathogenicity,"Brugada syndrome 1|Congenital long QT syndrome|Long QT syndrome 3|Atrial fibrillation, familial, 10|not specified|Cardiovascular phenotype|not provided|Cardiac arrhythmia|Dilated cardiomyopathy 1E",single nucleotide variant,GRCh38
na,na,3,38607917,38607917,SCN5A,Pathogenic,"Atrial fibrillation, familial, 10|Dilated cardiomyopathy 1E|not provided|Brugada syndrome|Atrial standstill 1, digenic|Cardiovascular phenotype|Long QT syndrome 3|Cardiac arrhythmia|SCN5A-related disorder",single nucleotide variant,GRCh37
na,na,3,38566426,38566426,SCN5A,Pathogenic,"Atrial fibrillation, familial, 10|Dilated cardiomyopathy 1E|not provided|Brugada syndrome|Atrial standstill 1, digenic|Cardiovascular phenotype|Long QT syndrome 3|Cardiac arrhythmia|SCN5A-related disorder",single nucleotide variant,GRCh38
na,na,3,38592408,38592408,SCN5A,Conflicting classifications of pathogenicity,"Long QT syndrome 2/3, digenic|Long QT syndrome|Congenital long QT syndrome|Brugada syndrome 1|Cardiac arrhythmia|Cardiovascular phenotype|Atrial fibrillation|not provided",single nucleotide variant,GRCh37
na,na,3,38550917,38550917,SCN5A,Conflicting classifications of pathogenicity,"Long QT syndrome 2/3, digenic|Long QT syndrome|Congenital long QT syndrome|Brugada syndrome 1|Cardiac arrhythmia|Cardiovascular phenotype|Atrial fibrillation|not provided",single nucleotide variant,GRCh38
na,na,3,38598759,38598759,SCN5A,Pathogenic,Brugada syndrome 1,single nucleotide variant,GRCh37
na,na,3,38557268,38557268,SCN5A,Pathogenic,Brugada syndrome 1,single nucleotide variant,GRCh38
na,na,3,38595800,38595800,SCN5A,Pathogenic/Likely pathogenic,Primary dilated cardiomyopathy|Dilated cardiomyopathy 1E|Brugada syndrome 1;Long QT syndrome 3|8 conditions|not provided,single nucleotide variant,GRCh37
na,na,3,38554309,38554309,SCN5A,Pathogenic/Likely pathogenic,Primary dilated cardiomyopathy|Dilated cardiomyopathy 1E|Brugada syndrome 1;Long QT syndrome 3|8 conditions|not provided,single nucleotide variant,GRCh38
na,na,3,38655243,38655243,SCN5A,Conflicting classifications of pathogenicity,"Brugada syndrome|Brugada syndrome, lidocaine-induced|not provided|Brugada syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia|not specified",single nucleotide variant,GRCh37
na,na,3,38613752,38613752,SCN5A,Conflicting classifications of pathogenicity,"Brugada syndrome|Brugada syndrome, lidocaine-induced|not provided|Brugada syndrome 1|Cardiovascular phenotype|Cardiac arrhythmia|not specified",single nucleotide variant,GRCh38
na,na,9,21971093,21971093,CDKN2A,Uncertain significance,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Familial melanoma|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,9,21971094,21971094,CDKN2A,Uncertain significance,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Familial melanoma|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,9,21971120,21971120,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Hereditary cancer-predisposing syndrome|Lip and oral cavity carcinoma|Neoplasm|Familial melanoma",single nucleotide variant,GRCh37
na,na,9,21971121,21971121,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Hereditary cancer-predisposing syndrome|Lip and oral cavity carcinoma|Neoplasm|Familial melanoma",single nucleotide variant,GRCh38
na,na,9,21971114,21971132,CDKN2A,Pathogenic; risk factor,"Melanoma, cutaneous malignant, susceptibility to, 2|Melanoma-pancreatic cancer syndrome",Deletion,GRCh37
na,na,9,21971115,21971133,CDKN2A,Pathogenic; risk factor,"Melanoma, cutaneous malignant, susceptibility to, 2|Melanoma-pancreatic cancer syndrome",Deletion,GRCh38
na,na,na,-1,-1,CDKN2A,risk factor,"Melanoma, cutaneous malignant, susceptibility to, 2",Deletion,na
na,na,9,21971057,21971057,CDKN2A,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Melanoma-pancreatic cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial melanoma|Melanoma|CDKN2A-related disorder|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome;Melanoma, cutaneous malignant, susceptibility to, 2;Melanoma and neural system tumor syndrome",single nucleotide variant,GRCh37
na,na,9,21971058,21971058,CDKN2A,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Melanoma-pancreatic cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Familial melanoma|Melanoma|CDKN2A-related disorder|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome;Melanoma, cutaneous malignant, susceptibility to, 2;Melanoma and neural system tumor syndrome",single nucleotide variant,GRCh38
na,na,9,21994141,21994142,CDKN2A,risk factor,"Melanoma, cutaneous malignant, susceptibility to, 2",Microsatellite,GRCh37
na,na,9,21994142,21994143,CDKN2A,risk factor,"Melanoma, cutaneous malignant, susceptibility to, 2",Microsatellite,GRCh38
na,na,9,21971199,21971199,CDKN2A,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Familial melanoma|Hereditary cancer-predisposing syndrome|CDKN2A-related disorder|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome",single nucleotide variant,GRCh37
na,na,9,21971200,21971200,CDKN2A,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Familial melanoma|Hereditary cancer-predisposing syndrome|CDKN2A-related disorder|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome",single nucleotide variant,GRCh38
na,na,9,21974756,21974756,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|not provided|Melanoma-pancreatic cancer syndrome|Familial melanoma|Melanoma, cutaneous malignant, susceptibility to, 2;Melanoma and neural system tumor syndrome;Melanoma-pancreatic cancer syndrome|Melanoma and neural system tumor syndrome",single nucleotide variant,GRCh37
na,na,9,21974757,21974757,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|not provided|Melanoma-pancreatic cancer syndrome|Familial melanoma|Melanoma, cutaneous malignant, susceptibility to, 2;Melanoma and neural system tumor syndrome;Melanoma-pancreatic cancer syndrome|Melanoma and neural system tumor syndrome",single nucleotide variant,GRCh38
na,na,9,21971053,21971053,CDKN2A,Conflicting classifications of pathogenicity,Familial melanoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,9,21971054,21971054,CDKN2A,Conflicting classifications of pathogenicity,Familial melanoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,9,21977568,21999392,CDKN2A,Pathogenic,Melanoma and neural system tumor syndrome,Deletion,GRCh38
na,na,9,21970981,21970981,CDKN2A,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome|not provided|Familial melanoma|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome;Melanoma and neural system tumor syndrome;Melanoma, cutaneous malignant, susceptibility to, 2",single nucleotide variant,GRCh37
na,na,9,21970982,21970982,CDKN2A,Pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome|not provided|Familial melanoma|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome;Melanoma and neural system tumor syndrome;Melanoma, cutaneous malignant, susceptibility to, 2",single nucleotide variant,GRCh38
na,na,9,21970994,21970994,CDKN2A,Uncertain significance,"Melanoma, cutaneous malignant, susceptibility to, 2|Familial melanoma",single nucleotide variant,GRCh37
na,na,9,21970995,21970995,CDKN2A,Uncertain significance,"Melanoma, cutaneous malignant, susceptibility to, 2|Familial melanoma",single nucleotide variant,GRCh38
na,na,9,21971182,21971182,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome|Familial melanoma|not provided|Melanoma-pancreatic cancer syndrome;Melanoma, cutaneous malignant, susceptibility to, 2;Melanoma and neural system tumor syndrome|Melanoma and neural system tumor syndrome",single nucleotide variant,GRCh37
na,na,9,21971183,21971183,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome|Familial melanoma|not provided|Melanoma-pancreatic cancer syndrome;Melanoma, cutaneous malignant, susceptibility to, 2;Melanoma and neural system tumor syndrome|Melanoma and neural system tumor syndrome",single nucleotide variant,GRCh38
na,na,9,21971018,21971019,CDKN2A,Conflicting classifications of pathogenicity,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Familial melanoma",Indel,GRCh37
na,na,9,21971019,21971020,CDKN2A,Conflicting classifications of pathogenicity,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Familial melanoma",Indel,GRCh38
na,na,9,21971191,21971191,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Familial melanoma|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome",single nucleotide variant,GRCh37
na,na,9,21971192,21971192,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|not provided|Familial melanoma|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome",single nucleotide variant,GRCh38
na,na,9,21971092,21971092,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|not provided|Familial melanoma|Melanoma-pancreatic cancer syndrome",single nucleotide variant,GRCh37
na,na,9,21971093,21971093,CDKN2A,Pathogenic/Likely pathogenic,"Melanoma, cutaneous malignant, susceptibility to, 2|Hereditary cancer-predisposing syndrome|not provided|Familial melanoma|Melanoma-pancreatic cancer syndrome",single nucleotide variant,GRCh38
na,na,10,78850191,78850191,KCNMA1,Pathogenic,Generalized epilepsy-paroxysmal dyskinesia syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,77090433,77090433,KCNMA1,Pathogenic,Generalized epilepsy-paroxysmal dyskinesia syndrome|not provided,single nucleotide variant,GRCh38
na,na,16,3900690,3900690,CREBBP,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,single nucleotide variant,GRCh37
na,na,16,3850689,3850689,CREBBP,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,single nucleotide variant,GRCh38
na,na,16,3843534,3843534,CREBBP,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,single nucleotide variant,GRCh37
na,na,16,3793533,3793533,CREBBP,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,single nucleotide variant,GRCh38
na,na,16,3790400,3790400,CREBBP,Likely pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations|CREBBP-related disorder,single nucleotide variant,GRCh37
na,na,16,3740399,3740399,CREBBP,Likely pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations|CREBBP-related disorder,single nucleotide variant,GRCh38
na,na,16,3786806,3786807,CREBBP,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,Deletion,GRCh37
na,na,16,3736805,3736806,CREBBP,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,Deletion,GRCh38
na,na,16,3807895,3807895,CREBBP,Pathogenic/Likely pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,16,3757894,3757894,CREBBP,Pathogenic/Likely pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,16,3799632,3799632,CREBBP,Pathogenic/Likely pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations|not provided|Inborn genetic diseases|Abnormality of the nervous system|Intellectual disability|CREBBP-related disorder|Menke-Hennekam syndrome 1;Rubinstein-Taybi syndrome due to CREBBP mutations,single nucleotide variant,GRCh37
na,na,16,3749631,3749631,CREBBP,Pathogenic/Likely pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations|not provided|Inborn genetic diseases|Abnormality of the nervous system|Intellectual disability|CREBBP-related disorder|Menke-Hennekam syndrome 1;Rubinstein-Taybi syndrome due to CREBBP mutations,single nucleotide variant,GRCh38
na,na,16,3795357,3795357,CREBBP,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,single nucleotide variant,GRCh37
na,na,16,3745356,3745356,CREBBP,Pathogenic,Rubinstein-Taybi syndrome due to CREBBP mutations,single nucleotide variant,GRCh38
na,na,17,48245078,48245078,SGCA,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,17,50167717,50167717,SGCA,Pathogenic/Likely pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,17,48245873,48245873,SGCA,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D,single nucleotide variant,GRCh37
na,na,17,50168512,50168512,SGCA,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D,single nucleotide variant,GRCh38
na,na,17,48245014,48245014,SGCA,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided|Sarcoglycanopathy|Abnormality of the musculature|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,17,50167653,50167653,SGCA,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided|Sarcoglycanopathy|Abnormality of the musculature|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,17,48245759,48245759,SGCA,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D,single nucleotide variant,GRCh37
na,na,17,50168398,50168398,SGCA,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D,single nucleotide variant,GRCh38
na,na,17,48247606,48247606,SGCA,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided|Sarcoglycanopathy|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh37
na,na,17,50170245,50170245,SGCA,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided|Sarcoglycanopathy|Autosomal recessive limb-girdle muscular dystrophy,single nucleotide variant,GRCh38
na,na,na,-1,-1,SGCA,Pathogenic,Autosomal recessive limb-girdle muscular dystrophy type 2D,Variation,na
na,na,5,36679737,36679737,SLC1A3,Pathogenic,Episodic ataxia type 6,single nucleotide variant,GRCh37
na,na,5,36679635,36679635,SLC1A3,Pathogenic,Episodic ataxia type 6,single nucleotide variant,GRCh38
na,na,5,36674182,36674182,SLC1A3,Pathogenic,Episodic ataxia type 6,single nucleotide variant,GRCh37
na,na,5,36674080,36674080,SLC1A3,Pathogenic,Episodic ataxia type 6,single nucleotide variant,GRCh38
na,na,11,102826119,102826119,MMP13,Pathogenic,"Spondyloepimetaphyseal dysplasia, Missouri type|not provided",single nucleotide variant,GRCh37
na,na,11,102955390,102955390,MMP13,Pathogenic,"Spondyloepimetaphyseal dysplasia, Missouri type|not provided",single nucleotide variant,GRCh38
na,na,11,102826122,102826122,MMP13,Pathogenic,"Metaphyseal anadysplasia 1, autosomal dominant",single nucleotide variant,GRCh37
na,na,11,102955393,102955393,MMP13,Pathogenic,"Metaphyseal anadysplasia 1, autosomal dominant",single nucleotide variant,GRCh38
na,na,11,102826071,102826071,MMP13,Pathogenic,"Metaphyseal anadysplasia 1, autosomal dominant|not provided|Spondyloepimetaphyseal dysplasia, Missouri type|Spondyloepimetaphyseal dysplasia, Missouri type;Metaphyseal chondrodysplasia, Spahr type",single nucleotide variant,GRCh37
na,na,11,102955342,102955342,MMP13,Pathogenic,"Metaphyseal anadysplasia 1, autosomal dominant|not provided|Spondyloepimetaphyseal dysplasia, Missouri type|Spondyloepimetaphyseal dysplasia, Missouri type;Metaphyseal chondrodysplasia, Spahr type",single nucleotide variant,GRCh38
na,na,11,102822846,102822846,MMP13,Pathogenic,"Metaphyseal chondrodysplasia, Spahr type",single nucleotide variant,GRCh37
na,na,11,102952117,102952117,MMP13,Pathogenic,"Metaphyseal chondrodysplasia, Spahr type",single nucleotide variant,GRCh38
na,na,11,14316390,14316390,RRAS2,Pathogenic,Noonan syndrome 12|Ovarian neoplasm|Noonan syndrome,single nucleotide variant,GRCh37
na,na,11,14294844,14294844,RRAS2,Pathogenic,Noonan syndrome 12|Ovarian neoplasm|Noonan syndrome,single nucleotide variant,GRCh38
na,na,7,77200477,77200477,PTPN12,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh37
na,na,7,77571160,77571160,PTPN12,Pathogenic,Carcinoma of colon,single nucleotide variant,GRCh38
na,na,2,170062140,170062140,LRP2,Pathogenic/Likely pathogenic,Donnai-Barrow syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,169205630,169205630,LRP2,Pathogenic/Likely pathogenic,Donnai-Barrow syndrome|not provided,single nucleotide variant,GRCh38
na,na,2,170042373,170042374,LRP2,Pathogenic,Donnai-Barrow syndrome,Deletion,GRCh37
na,na,2,169185863,169185864,LRP2,Pathogenic,Donnai-Barrow syndrome,Deletion,GRCh38
na,na,2,170112747,170112747,LRP2,Pathogenic,Donnai-Barrow syndrome,single nucleotide variant,GRCh37
na,na,2,169256237,169256237,LRP2,Pathogenic,Donnai-Barrow syndrome,single nucleotide variant,GRCh38
na,na,2,170055352,170055355,LRP2,Pathogenic,Donnai-Barrow syndrome,Deletion,GRCh37
na,na,2,169198842,169198845,LRP2,Pathogenic,Donnai-Barrow syndrome,Deletion,GRCh38
na,na,2,170058137,170058137,LRP2,Pathogenic,Donnai-Barrow syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,169201627,169201627,LRP2,Pathogenic,Donnai-Barrow syndrome|not provided,single nucleotide variant,GRCh38
na,na,2,170034511,170034511,LRP2,Pathogenic,Donnai-Barrow syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,169178001,169178001,LRP2,Pathogenic,Donnai-Barrow syndrome|not provided,single nucleotide variant,GRCh38
na,na,2,170136858,170136858,LRP2,Pathogenic,Donnai-Barrow syndrome,single nucleotide variant,GRCh37
na,na,2,169280348,169280348,LRP2,Pathogenic,Donnai-Barrow syndrome,single nucleotide variant,GRCh38
na,na,2,170139461,170139461,LRP2,Pathogenic,Donnai-Barrow syndrome|not provided,single nucleotide variant,GRCh37
na,na,2,169282951,169282951,LRP2,Pathogenic,Donnai-Barrow syndrome|not provided,single nucleotide variant,GRCh38
na,na,21,46309291,46309291,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1|ITGB2-related disorder|not provided,single nucleotide variant,GRCh37
na,na,21,44889376,44889376,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1|ITGB2-related disorder|not provided,single nucleotide variant,GRCh38
na,na,21,46321561,46321561,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh37
na,na,21,44901646,44901646,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh38
na,na,21,46323333,46323333,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh37
na,na,21,44903418,44903418,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh38
na,na,21,46321643,46321643,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh37
na,na,21,44901728,44901728,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh38
na,na,21,46330696,46330696,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh37
na,na,21,44910781,44910781,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh38
na,na,21,46309312,46309312,ITGB2,Benign/Likely benign,Leukocyte adhesion deficiency 1|not provided|not specified|ITGB2-related disorder,single nucleotide variant,GRCh37
na,na,21,44889397,44889397,ITGB2,Benign/Likely benign,Leukocyte adhesion deficiency 1|not provided|not specified|ITGB2-related disorder,single nucleotide variant,GRCh38
na,na,21,46314917,46314917,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh37
na,na,21,44895002,44895002,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh38
na,na,21,46321615,46321615,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh37
na,na,21,44901700,44901700,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh38
na,na,21,46323397,46323397,ITGB2,Pathogenic/Likely pathogenic,Leukocyte adhesion deficiency 1|not provided,single nucleotide variant,GRCh37
na,na,21,44903482,44903482,ITGB2,Pathogenic/Likely pathogenic,Leukocyte adhesion deficiency 1|not provided,single nucleotide variant,GRCh38
na,na,21,46320282,46320282,ITGB2,Pathogenic/Likely pathogenic,Leukocyte adhesion deficiency 1|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,21,44900367,44900367,ITGB2,Pathogenic/Likely pathogenic,Leukocyte adhesion deficiency 1|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,21,46323367,46323367,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh37
na,na,21,44903452,44903452,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh38
na,na,21,46320315,46320315,ITGB2,Pathogenic/Likely pathogenic,not provided|Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh37
na,na,21,44900400,44900400,ITGB2,Pathogenic/Likely pathogenic,not provided|Leukocyte adhesion deficiency 1,single nucleotide variant,GRCh38
na,na,21,46323327,46323486,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,Deletion,GRCh37
na,na,21,44903412,44903571,ITGB2,Pathogenic,Leukocyte adhesion deficiency 1,Deletion,GRCh38
na,na,2,99006159,99006159,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|Retinal dystrophy|Achromatopsia,single nucleotide variant,GRCh37
na,na,2,98389696,98389696,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|Retinal dystrophy|Achromatopsia,single nucleotide variant,GRCh38
na,na,2,99012480,99012480,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|Monochromacy|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,98396017,98396017,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|Monochromacy|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,2,99012481,99012481,CNGA3,Pathogenic,Achromatopsia 2|not provided|Retinal dystrophy|Achromatopsia,single nucleotide variant,GRCh37
na,na,2,98396018,98396018,CNGA3,Pathogenic,Achromatopsia 2|not provided|Retinal dystrophy|Achromatopsia,single nucleotide variant,GRCh38
na,na,2,99013302,99013302,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|not provided|Achromatopsia|not specified|Retinal dystrophy|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,2,98396839,98396839,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|not provided|Achromatopsia|not specified|Retinal dystrophy|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,2,99012505,99012505,CNGA3,Pathogenic,Achromatopsia 2|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,98396042,98396042,CNGA3,Pathogenic,Achromatopsia 2|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,2,99013274,99013274,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|Monochromacy|not provided|Achromatopsia|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,98396811,98396811,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|Monochromacy|not provided|Achromatopsia|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,2,99012861,99012861,CNGA3,Pathogenic,Achromatopsia 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,98396398,98396398,CNGA3,Pathogenic,Achromatopsia 2|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,2,99013218,99013218,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|not provided|Achromatopsia|CNGA3-related retinopathy|CNGA3-related disorder|Retinal dystrophy|Achromatopsia 3,single nucleotide variant,GRCh37
na,na,2,98396755,98396755,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|not provided|Achromatopsia|CNGA3-related retinopathy|CNGA3-related disorder|Retinal dystrophy|Achromatopsia 3,single nucleotide variant,GRCh38
na,na,2,99012462,99012462,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|Achromatopsia|Photophobia;Color vision defect;Macular degeneration|not provided|Optic atrophy|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,2,98395999,98395999,CNGA3,Pathogenic/Likely pathogenic,Achromatopsia 2|Achromatopsia|Photophobia;Color vision defect;Macular degeneration|not provided|Optic atrophy|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,2,99012939,99012939,CNGA3,Pathogenic,Achromatopsia 2|Retinal dystrophy|Achromatopsia|not provided,single nucleotide variant,GRCh37
na,na,2,98396476,98396476,CNGA3,Pathogenic,Achromatopsia 2|Retinal dystrophy|Achromatopsia|not provided,single nucleotide variant,GRCh38
na,na,9,107568557,107568557,ABCA1,Pathogenic,Tangier disease|ABCA1-related disorder,single nucleotide variant,GRCh37
na,na,9,104806276,104806276,ABCA1,Pathogenic,Tangier disease|ABCA1-related disorder,single nucleotide variant,GRCh38
na,na,9,107578423,107578423,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh37
na,na,9,104816142,104816142,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh38
na,na,9,107593308,107593308,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh37
na,na,9,104831027,104831027,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh38
na,na,9,107591230,107591232,ABCA1,Pathogenic,"Hypoalphalipoproteinemia, primary, 1",Microsatellite,GRCh37
na,na,9,104828949,104828951,ABCA1,Pathogenic,"Hypoalphalipoproteinemia, primary, 1",Microsatellite,GRCh38
na,na,9,107593274,107593274,ABCA1,Pathogenic,Tangier disease,Deletion,GRCh37
na,na,9,104830993,104830993,ABCA1,Pathogenic,Tangier disease,Deletion,GRCh38
na,na,9,107584801,107584801,ABCA1,Pathogenic,Tangier disease|not provided,single nucleotide variant,GRCh37
na,na,9,104822520,104822520,ABCA1,Pathogenic,Tangier disease|not provided,single nucleotide variant,GRCh38
na,na,9,107584795,107584795,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh37
na,na,9,104822514,104822514,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh38
na,na,9,107593329,107593329,ABCA1,Uncertain significance,Tangier disease|not provided,single nucleotide variant,GRCh37
na,na,9,104831048,104831048,ABCA1,Uncertain significance,Tangier disease|not provided,single nucleotide variant,GRCh38
na,na,9,107594021,107594034,ABCA1,Pathogenic,Tangier disease,Indel,GRCh37
na,na,9,104831740,104831753,ABCA1,Pathogenic,Tangier disease,Indel,GRCh38
na,na,9,107581062,107581063,ABCA1,Pathogenic,Tangier disease,Deletion,GRCh37
na,na,9,104818781,104818782,ABCA1,Pathogenic,Tangier disease,Deletion,GRCh38
na,na,9,107549221,107549221,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh37
na,na,9,104786940,104786940,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh38
na,na,9,107584880,107584880,ABCA1,Pathogenic,Tangier disease,Deletion,GRCh37
na,na,9,104822599,104822599,ABCA1,Pathogenic,Tangier disease,Deletion,GRCh38
na,na,9,107566949,107566949,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh37
na,na,9,104804668,104804668,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh38
na,na,9,107584802,107584802,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh37
na,na,9,104822521,104822521,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,ABCA1,Pathogenic,Tangier disease,Indel,na
na,na,9,107560785,107560785,ABCA1,Pathogenic,"Tangier disease, variant",single nucleotide variant,GRCh37
na,na,9,104798504,104798504,ABCA1,Pathogenic,"Tangier disease, variant",single nucleotide variant,GRCh38
na,na,9,107581111,107581111,ABCA1,Uncertain significance,"Hypoalphalipoproteinemia, primary, 1|not provided",single nucleotide variant,GRCh37
na,na,9,104818830,104818830,ABCA1,Uncertain significance,"Hypoalphalipoproteinemia, primary, 1|not provided",single nucleotide variant,GRCh38
na,na,9,107550750,107550750,ABCA1,Pathogenic,"Hypoalphalipoproteinemia, primary, 1",single nucleotide variant,GRCh37
na,na,9,104788469,104788469,ABCA1,Pathogenic,"Hypoalphalipoproteinemia, primary, 1",single nucleotide variant,GRCh38
na,na,9,107576435,107576435,ABCA1,Benign,"Tangier disease|Hypoalphalipoproteinemia, primary, 1",single nucleotide variant,GRCh37
na,na,9,104814154,104814154,ABCA1,Benign,"Tangier disease|Hypoalphalipoproteinemia, primary, 1",single nucleotide variant,GRCh38
na,na,9,107576448,107576451,ABCA1,Pathogenic,"Hypoalphalipoproteinemia, primary, 1",Deletion,GRCh37
na,na,9,104814167,104814170,ABCA1,Pathogenic,"Hypoalphalipoproteinemia, primary, 1",Deletion,GRCh38
na,na,9,107593379,107593379,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh37
na,na,9,104831098,104831098,ABCA1,Pathogenic,Tangier disease,single nucleotide variant,GRCh38
na,na,9,107620867,107620867,ABCA1,Benign,"|Tangier disease|Hypoalphalipoproteinemia, primary, 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,9,104858586,104858586,ABCA1,Benign,"|Tangier disease|Hypoalphalipoproteinemia, primary, 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,9,107647655,107647655,ABCA1,Benign,ABCA1 polymorphism,single nucleotide variant,GRCh37
na,na,9,104885374,104885374,ABCA1,Benign,ABCA1 polymorphism,single nucleotide variant,GRCh38
na,na,3,184094034,184094034,THPO,Pathogenic/Likely pathogenic,Thrombocythemia 1|not provided,single nucleotide variant,GRCh37
na,na,3,184376246,184376246,THPO,Pathogenic/Likely pathogenic,Thrombocythemia 1|not provided,single nucleotide variant,GRCh38
na,na,3,184094078,184094078,THPO,Likely pathogenic,Thrombocythemia 1|not provided,single nucleotide variant,GRCh37
na,na,3,184376290,184376290,THPO,Likely pathogenic,Thrombocythemia 1|not provided,single nucleotide variant,GRCh38
na,na,19,49458970,49458971,BAX,Uncertain significance,Carcinoma of colon|Inborn genetic diseases,Duplication,GRCh37
na,na,19,48955713,48955714,BAX,Uncertain significance,Carcinoma of colon|Inborn genetic diseases,Duplication,GRCh38
na,na,19,49458971,49458971,BAX,Pathogenic,Carcinoma of colon,Deletion,GRCh37
na,na,19,48955714,48955714,BAX,Pathogenic,Carcinoma of colon,Deletion,GRCh38
na,na,19,49459056,49459056,BAX,Pathogenic,T-cell acute lymphoblastic leukemia,single nucleotide variant,GRCh37
na,na,19,48955799,48955799,BAX,Pathogenic,T-cell acute lymphoblastic leukemia,single nucleotide variant,GRCh38
na,na,19,49458971,49458977,BAX,Pathogenic,T-cell acute lymphoblastic leukemia,Deletion,GRCh37
na,na,19,48955714,48955720,BAX,Pathogenic,T-cell acute lymphoblastic leukemia,Deletion,GRCh38
na,na,14,57268858,57268859,OTX2,Pathogenic,Syndromic microphthalmia type 5,Duplication,GRCh37
na,na,14,56802140,56802141,OTX2,Pathogenic,Syndromic microphthalmia type 5,Duplication,GRCh38
na,na,14,57269058,57269058,OTX2,Pathogenic,Syndromic microphthalmia type 5,single nucleotide variant,GRCh37
na,na,14,56802340,56802340,OTX2,Pathogenic,Syndromic microphthalmia type 5,single nucleotide variant,GRCh38
na,na,14,57272094,57272094,OTX2,Pathogenic,Syndromic microphthalmia type 5,Deletion,GRCh37
na,na,14,56805376,56805376,OTX2,Pathogenic,Syndromic microphthalmia type 5,Deletion,GRCh38
na,na,14,57268786,57268786,OTX2,Pathogenic,Syndromic microphthalmia type 5,single nucleotide variant,GRCh37
na,na,14,56802068,56802068,OTX2,Pathogenic,Syndromic microphthalmia type 5,single nucleotide variant,GRCh38
na,na,10,119305311,119305312,EMX2,Pathogenic,Schizencephaly,Insertion,GRCh37
na,na,10,117545800,117545801,EMX2,Pathogenic,Schizencephaly,Insertion,GRCh38
na,na,10,119305142,119305142,EMX2,Pathogenic,Schizencephaly,single nucleotide variant,GRCh37
na,na,10,117545631,117545631,EMX2,Pathogenic,Schizencephaly,single nucleotide variant,GRCh38
na,na,10,119305139,119305139,EMX2,Pathogenic,Schizencephaly,single nucleotide variant,GRCh37
na,na,10,117545628,117545628,EMX2,Pathogenic,Schizencephaly,single nucleotide variant,GRCh38
na,na,10,119305143,119305143,EMX2,Pathogenic,Schizencephaly,single nucleotide variant,GRCh37
na,na,10,117545632,117545632,EMX2,Pathogenic,Schizencephaly,single nucleotide variant,GRCh38
na,na,1,203186858,203186861,CHIT1,no classification for the single variant,-,Microsatellite,GRCh37
na,na,1,203217730,203217733,CHIT1,no classification for the single variant,-,Microsatellite,GRCh38
na,na,1,203194834,203194834,CHIT1,Conflicting classifications of pathogenicity,Chitotriosidase deficiency,single nucleotide variant,GRCh37
na,na,1,203225706,203225706,CHIT1,Conflicting classifications of pathogenicity,Chitotriosidase deficiency,single nucleotide variant,GRCh38
na,na,1,203194186,203194186,CHIT1,Benign,Chitotriosidase deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,203225058,203225058,CHIT1,Benign,Chitotriosidase deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,225592233,225592238,LBR,Pathogenic,Pelger-Huët anomaly|RHIZOMELIC SKELETAL DYSPLASIA WITH PELGER-HUET ANOMALY,Microsatellite,GRCh37
na,na,1,225404531,225404536,LBR,Pathogenic,Pelger-Huët anomaly|RHIZOMELIC SKELETAL DYSPLASIA WITH PELGER-HUET ANOMALY,Microsatellite,GRCh38
na,na,1,225609981,225609981,LBR,Pathogenic,Pelger-Huët anomaly,single nucleotide variant,GRCh37
na,na,1,225422279,225422279,LBR,Pathogenic,Pelger-Huët anomaly,single nucleotide variant,GRCh38
na,na,1,225592188,225592194,LBR,Pathogenic,Greenberg dysplasia|Pelger-Huët anomaly,Indel,GRCh37
na,na,1,225404486,225404492,LBR,Pathogenic,Greenberg dysplasia|Pelger-Huët anomaly,Indel,GRCh38
na,na,1,225609789,225609789,LBR,Conflicting classifications of pathogenicity,Pelger-Huët anomaly|not provided,single nucleotide variant,GRCh37
na,na,1,225422087,225422087,LBR,Conflicting classifications of pathogenicity,Pelger-Huët anomaly|not provided,single nucleotide variant,GRCh38
na,na,1,225592417,225592417,LBR,Pathogenic,Pelger-Huët anomaly,single nucleotide variant,GRCh37
na,na,1,225404715,225404715,LBR,Pathogenic,Pelger-Huët anomaly,single nucleotide variant,GRCh38
na,na,1,225591147,225591147,LBR,Pathogenic,Pelger-Huët anomaly,single nucleotide variant,GRCh37
na,na,1,225403445,225403445,LBR,Pathogenic,Pelger-Huët anomaly,single nucleotide variant,GRCh38
na,na,1,225599113,225599113,LBR,Conflicting classifications of pathogenicity,Reynolds syndrome|Greenberg dysplasia|Greenberg dysplasia;Regressive spondylometaphyseal dysplasia|not provided,single nucleotide variant,GRCh37
na,na,1,225411411,225411411,LBR,Conflicting classifications of pathogenicity,Reynolds syndrome|Greenberg dysplasia|Greenberg dysplasia;Regressive spondylometaphyseal dysplasia|not provided,single nucleotide variant,GRCh38
na,na,10,112039740,112039740,MXI1,Pathogenic,Prostate cancer,Deletion,GRCh37
na,na,10,110279982,110279982,MXI1,Pathogenic,Prostate cancer,Deletion,GRCh38
na,na,10,112039054,112039054,MXI1,Pathogenic,Prostate cancer,single nucleotide variant,GRCh37
na,na,10,110279296,110279296,MXI1,Pathogenic,Prostate cancer,single nucleotide variant,GRCh38
na,na,10,112039775,112039775,MXI1,Pathogenic,Prostate cancer,single nucleotide variant,GRCh37
na,na,10,110280017,110280017,MXI1,Pathogenic,Prostate cancer,single nucleotide variant,GRCh38
na,na,10,111988034,111988034,MXI1,Pathogenic,Neurofibrosarcoma,single nucleotide variant,GRCh37
na,na,10,110228276,110228276,MXI1,Pathogenic,Neurofibrosarcoma,single nucleotide variant,GRCh38
na,na,6,154360797,154360797,OPRM1,Uncertain significance; drug response,"Opioid dependence, susceptibility to, 1|Tramadol response",single nucleotide variant,GRCh37
na,na,6,154039662,154039662,OPRM1,Uncertain significance; drug response,"Opioid dependence, susceptibility to, 1|Tramadol response",single nucleotide variant,GRCh38
na,na,12,41327565,41327566,CNTN1,Pathogenic,Compton-North congenital myopathy,Duplication,GRCh37
na,na,12,40933763,40933764,CNTN1,Pathogenic,Compton-North congenital myopathy,Duplication,GRCh38
na,na,16,11000490,11000490,CIITA,Pathogenic,MHC class II deficiency 1,single nucleotide variant,GRCh37
na,na,16,10906633,10906633,CIITA,Pathogenic,MHC class II deficiency 1,single nucleotide variant,GRCh38
na,na,16,11016348,11016348,CIITA,Pathogenic,MHC class II deficiency 1,single nucleotide variant,GRCh37
na,na,16,10922491,10922491,CIITA,Pathogenic,MHC class II deficiency 1,single nucleotide variant,GRCh38
na,na,16,11001412,11001412,CIITA,Pathogenic,MHC class II deficiency|MHC class II deficiency 1,single nucleotide variant,GRCh37
na,na,16,10907555,10907555,CIITA,Pathogenic,MHC class II deficiency|MHC class II deficiency 1,single nucleotide variant,GRCh38
na,na,16,11009427,11009507,CIITA,Pathogenic,MHC class II deficiency 1,Deletion,GRCh37
na,na,16,10915570,10915650,CIITA,Pathogenic,MHC class II deficiency 1,Deletion,GRCh38
na,na,16,11012312,11012314,CIITA,Pathogenic,MHC class II deficiency 1,Deletion,GRCh37
na,na,16,10918455,10918457,CIITA,Pathogenic,MHC class II deficiency 1,Deletion,GRCh38
na,na,16,10970902,10970902,CIITA,risk factor,Rheumatoid arthritis,single nucleotide variant,GRCh37
na,na,16,10877045,10877045,CIITA,risk factor,Rheumatoid arthritis,single nucleotide variant,GRCh38
na,na,10,18828274,18828274,CACNB2,Conflicting classifications of pathogenicity,Brugada syndrome 4|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,10,18539345,18539345,CACNB2,Conflicting classifications of pathogenicity,Brugada syndrome 4|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,MT,1606,1606,MT-TV,Uncertain significance,"Ataxia, progressive seizures, mental deterioration, and hearing loss|MELAS syndrome|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,1606,1606,MT-TV,Uncertain significance,"Ataxia, progressive seizures, mental deterioration, and hearing loss|MELAS syndrome|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,1624,1624,MT-TV,Likely pathogenic,"Leigh syndrome|MELAS syndrome|Leigh syndrome, mitochondrial|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,1624,1624,MT-TV,Likely pathogenic,"Leigh syndrome|MELAS syndrome|Leigh syndrome, mitochondrial|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,5874,5874,MT-TY,Uncertain significance,"Exercise intolerance and complex III deficiency, somatic|not provided|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,5874,5874,MT-TY,Uncertain significance,"Exercise intolerance and complex III deficiency, somatic|not provided|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,5885,5885,MT-TY,Uncertain significance,Kearns-Sayre syndrome|Mitochondrial disease,Deletion,GRCh37
na,na,MT,5885,5885,MT-TY,Uncertain significance,Kearns-Sayre syndrome|Mitochondrial disease,Deletion,GRCh38
na,na,MT,5877,5877,MT-TY,Uncertain significance,Kearns-Sayre syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,5877,5877,MT-TY,Uncertain significance,Kearns-Sayre syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,5843,5843,MT-TY,Benign,Focal segmental glomerulosclerosis and dilated cardiomyopathy|MELAS syndrome,single nucleotide variant,GRCh37
na,na,MT,5843,5843,MT-TY,Benign,Focal segmental glomerulosclerosis and dilated cardiomyopathy|MELAS syndrome,single nucleotide variant,GRCh38
na,na,MT,5549,5549,MT-TW,Uncertain significance,Mitochondrial encephalopathy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,5549,5549,MT-TW,Uncertain significance,Mitochondrial encephalopathy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,5537,5538,MT-TW,Pathogenic,Mitochondrial encephalopathy|Leigh syndrome|not provided,Insertion,GRCh37
na,na,MT,5537,5538,MT-TW,Pathogenic,Mitochondrial encephalopathy|Leigh syndrome|not provided,Insertion,GRCh38
na,na,MT,5521,5521,MT-TW,Likely pathogenic,Inborn mitochondrial myopathy|MELAS syndrome|not provided|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,5521,5521,MT-TW,Likely pathogenic,Inborn mitochondrial myopathy|MELAS syndrome|not provided|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,5532,5532,MT-TW,Uncertain significance,"Neurogastrointestinal syndrome, mitochondrial|MELAS syndrome|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,5532,5532,MT-TW,Uncertain significance,"Neurogastrointestinal syndrome, mitochondrial|MELAS syndrome|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,5545,5545,MT-TW,Uncertain significance,"Encephalocardiomyopathy, mitochondrial|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,5545,5545,MT-TW,Uncertain significance,"Encephalocardiomyopathy, mitochondrial|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,15950,15950,MT-TT,Uncertain significance,"Parkinson disease, mitochondrial|MELAS syndrome",single nucleotide variant,GRCh37
na,na,MT,15950,15950,MT-TT,Uncertain significance,"Parkinson disease, mitochondrial|MELAS syndrome",single nucleotide variant,GRCh38
na,na,MT,12258,12258,MT-TS2,Likely pathogenic,"Cerebellar ataxia, cataract, and diabetes mellitus|Retinitis pigmentosa-deafness syndrome|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,12258,12258,MT-TS2,Likely pathogenic,"Cerebellar ataxia, cataract, and diabetes mellitus|Retinitis pigmentosa-deafness syndrome|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,12207,12207,MT-TS2,Uncertain significance,MERRF/MELAS overlap syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,12207,12207,MT-TS2,Uncertain significance,MERRF/MELAS overlap syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,7512,7512,MT-TS1,Likely pathogenic,"MERRF/MELAS overlap syndrome|Mitochondrial cytochrome c oxidase deficiency|MELAS syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease|Limb ataxia",single nucleotide variant,GRCh37
na,na,MT,7512,7512,MT-TS1,Likely pathogenic,"MERRF/MELAS overlap syndrome|Mitochondrial cytochrome c oxidase deficiency|MELAS syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease|Limb ataxia",single nucleotide variant,GRCh38
na,na,MT,7445,7445,MT-TS1;MT-CO1,Pathogenic,Mitochondrial non-syndromic sensorineural hearing loss|Palmoplantar keratoderma-deafness syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,7445,7445,MT-TS1;MT-CO1,Pathogenic,Mitochondrial non-syndromic sensorineural hearing loss|Palmoplantar keratoderma-deafness syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,7510,7510,MT-TS1,Likely pathogenic,Mitochondrial non-syndromic sensorineural hearing loss|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,7510,7510,MT-TS1,Likely pathogenic,Mitochondrial non-syndromic sensorineural hearing loss|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,7511,7511,MT-TS1,Likely pathogenic,"Mitochondrial non-syndromic sensorineural hearing loss|MELAS syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,7511,7511,MT-TS1,Likely pathogenic,"Mitochondrial non-syndromic sensorineural hearing loss|MELAS syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,7445,7445,MT-CO1;MT-TS1,Uncertain significance,Mitochondrial non-syndromic sensorineural hearing loss|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,7445,7445,MT-CO1;MT-TS1,Uncertain significance,Mitochondrial non-syndromic sensorineural hearing loss|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,7497,7497,MT-TS1,Likely pathogenic,"Exercise intolerance, muscle pain, and lactic acidemia|MELAS syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,7497,7497,MT-TS1,Likely pathogenic,"Exercise intolerance, muscle pain, and lactic acidemia|MELAS syndrome|Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,15990,15990,MT-TP,Likely pathogenic,Myopathy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,15990,15990,MT-TP,Likely pathogenic,Myopathy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,15965,15965,MT-TP,Benign,"Parkinson disease, mitochondrial|MELAS syndrome",single nucleotide variant,GRCh37
na,na,MT,15965,15965,MT-TP,Benign,"Parkinson disease, mitochondrial|MELAS syndrome",single nucleotide variant,GRCh38
na,na,MT,15967,15967,MT-TP,Uncertain significance,MERFF syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,15967,15967,MT-TP,Uncertain significance,MERFF syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,583,583,MT-TF,Uncertain significance,MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,583,583,MT-TF,Uncertain significance,MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,611,611,MT-TF,Pathogenic,MERRF syndrome,single nucleotide variant,GRCh37
na,na,MT,611,611,MT-TF,Pathogenic,MERRF syndrome,single nucleotide variant,GRCh38
na,na,MT,622,622,MT-TF,Uncertain significance,"Myopathy, mitochondrial, late-onset|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,622,622,MT-TF,Uncertain significance,"Myopathy, mitochondrial, late-onset|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,616,616,MT-TF,Likely pathogenic,"Epilepsy, mitochondrial|MELAS syndrome|Mitochondrial disease|Interstitial nephritis",single nucleotide variant,GRCh37
na,na,MT,616,616,MT-TF,Likely pathogenic,"Epilepsy, mitochondrial|MELAS syndrome|Mitochondrial disease|Interstitial nephritis",single nucleotide variant,GRCh38
na,na,MT,616,616,MT-TF,Pathogenic,"Epilepsy, mitochondrial",single nucleotide variant,GRCh37
na,na,MT,616,616,MT-TF,Pathogenic,"Epilepsy, mitochondrial",single nucleotide variant,GRCh38
na,na,MT,4409,4409,MT-TM,Pathogenic,Inborn mitochondrial myopathy,single nucleotide variant,GRCh37
na,na,MT,4409,4409,MT-TM,Pathogenic,Inborn mitochondrial myopathy,single nucleotide variant,GRCh38
na,na,MT,8344,8344,MT-TK,Pathogenic,"Leigh syndrome|MERRF syndrome|Parkinson disease, mitochondrial|not provided|Mitochondrial disease|MELAS syndrome|MT-TK-related mitochondrial disorder|MT-TK-related disorder|Complex hereditary spastic paraplegia",single nucleotide variant,GRCh37
na,na,MT,8344,8344,MT-TK,Pathogenic,"Leigh syndrome|MERRF syndrome|Parkinson disease, mitochondrial|not provided|Mitochondrial disease|MELAS syndrome|MT-TK-related mitochondrial disorder|MT-TK-related disorder|Complex hereditary spastic paraplegia",single nucleotide variant,GRCh38
na,na,MT,8356,8356,MT-TK,Likely pathogenic,MERRF syndrome|MERRF/MELAS overlap syndrome|Mitochondrial disease|MELAS syndrome,single nucleotide variant,GRCh37
na,na,MT,8356,8356,MT-TK,Likely pathogenic,MERRF syndrome|MERRF/MELAS overlap syndrome|Mitochondrial disease|MELAS syndrome,single nucleotide variant,GRCh38
na,na,MT,8363,8363,MT-TK,Likely pathogenic,Cardiomyopathy and Deafness|Leigh syndrome|MERRF syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,8363,8363,MT-TK,Likely pathogenic,Cardiomyopathy and Deafness|Leigh syndrome|MERRF syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,8342,8342,MT-TK,Uncertain significance,Progressive external ophthalmoplegia with myoclonus|not specified|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,8342,8342,MT-TK,Uncertain significance,Progressive external ophthalmoplegia with myoclonus|not specified|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,8313,8313,MT-TK,Likely pathogenic,Mitochondrial DNA depletion syndrome 1|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,8313,8313,MT-TK,Likely pathogenic,Mitochondrial DNA depletion syndrome 1|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,8296,8296,MT-TK,Uncertain significance,Diabetes-deafness syndrome maternally transmitted|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,8296,8296,MT-TK,Uncertain significance,Diabetes-deafness syndrome maternally transmitted|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,8361,8361,MT-TK,Pathogenic,MERRF syndrome,single nucleotide variant,GRCh37
na,na,MT,8361,8361,MT-TK,Pathogenic,MERRF syndrome,single nucleotide variant,GRCh38
na,na,MT,12315,12315,MT-TL2,Likely pathogenic,Mitochondrial encephalomyopathy|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,12315,12315,MT-TL2,Likely pathogenic,Mitochondrial encephalomyopathy|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,12320,12320,MT-TL2,Uncertain significance,Inborn mitochondrial myopathy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,12320,12320,MT-TL2,Uncertain significance,Inborn mitochondrial myopathy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,12297,12297,MT-TL2,Benign,"Cardiomyopathy, mitochondrial|MELAS syndrome|not provided",single nucleotide variant,GRCh37
na,na,MT,12297,12297,MT-TL2,Benign,"Cardiomyopathy, mitochondrial|MELAS syndrome|not provided",single nucleotide variant,GRCh38
na,na,MT,3243,3243,MT-TL1,Pathogenic/Likely pathogenic,"MELAS syndrome|Cyclical vomiting syndrome|Age related macular degeneration 2|Mitochondrial complex IV deficiency, nuclear type 1|3-methylglutaconic aciduria type 1|MERRF/MELAS overlap syndrome|Diabetes-deafness syndrome maternally transmitted|Leigh syndrome|not provided|Mitochondrial disease|Short stature;Stroke disorder;Sensorineural hearing loss disorder;Glucose intolerance|MELAS syndrome;MERRF syndrome|Cerebral palsy|not specified|See cases|Charcot-Marie-Tooth disease, axonal, mitochondrial form, 1|Maternally-inherited mitochondrial myopathy|MELAS syndrome;Leigh Syndrome (mtDNA mutation);Hypertrophic cardiomyopathy;Diabetes-deafness syndrome maternally transmitted|Auditory neuropathy spectrum disorder|Leigh syndrome, mitochondrial",single nucleotide variant,GRCh37
na,na,MT,3243,3243,MT-TL1,Pathogenic/Likely pathogenic,"MELAS syndrome|Cyclical vomiting syndrome|Age related macular degeneration 2|Mitochondrial complex IV deficiency, nuclear type 1|3-methylglutaconic aciduria type 1|MERRF/MELAS overlap syndrome|Diabetes-deafness syndrome maternally transmitted|Leigh syndrome|not provided|Mitochondrial disease|Short stature;Stroke disorder;Sensorineural hearing loss disorder;Glucose intolerance|MELAS syndrome;MERRF syndrome|Cerebral palsy|not specified|See cases|Charcot-Marie-Tooth disease, axonal, mitochondrial form, 1|Maternally-inherited mitochondrial myopathy|MELAS syndrome;Leigh Syndrome (mtDNA mutation);Hypertrophic cardiomyopathy;Diabetes-deafness syndrome maternally transmitted|Auditory neuropathy spectrum disorder|Leigh syndrome, mitochondrial",single nucleotide variant,GRCh38
na,na,MT,3271,3271,MT-TL1,Pathogenic,MELAS syndrome|MERRF syndrome;MELAS syndrome|not specified|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,3271,3271,MT-TL1,Pathogenic,MELAS syndrome|MERRF syndrome;MELAS syndrome|not specified|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,3256,3256,MT-TL1,Likely pathogenic,"MERRF syndrome|Diabetes mellitus, noninsulin-dependent, maternally transmitted|MELAS syndrome|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,3256,3256,MT-TL1,Likely pathogenic,"MERRF syndrome|Diabetes mellitus, noninsulin-dependent, maternally transmitted|MELAS syndrome|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,3303,3303,MT-TL1,Likely pathogenic,MELAS syndrome|Mitochondrial disease|MITOCHONDRIAL CARDIOMYOPATHY WITH OR WITHOUT SKELETAL MYOPATHY,single nucleotide variant,GRCh37
na,na,MT,3303,3303,MT-TL1,Likely pathogenic,MELAS syndrome|Mitochondrial disease|MITOCHONDRIAL CARDIOMYOPATHY WITH OR WITHOUT SKELETAL MYOPATHY,single nucleotide variant,GRCh38
na,na,MT,3250,3250,MT-TL1,Uncertain significance,"MELAS syndrome|Mitochondrial skeletal myopathy, responsive to riboflavin",single nucleotide variant,GRCh37
na,na,MT,3250,3250,MT-TL1,Uncertain significance,"MELAS syndrome|Mitochondrial skeletal myopathy, responsive to riboflavin",single nucleotide variant,GRCh38
na,na,MT,3252,3252,MT-TL1,Likely pathogenic,Mitochondrial encephalomyopathy|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,3252,3252,MT-TL1,Likely pathogenic,Mitochondrial encephalomyopathy|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,3251,3251,MT-TL1,Likely pathogenic,"Progressive external ophthalmoplegia, proximal myopathy, and sudden death|MELAS syndrome|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,3251,3251,MT-TL1,Likely pathogenic,"Progressive external ophthalmoplegia, proximal myopathy, and sudden death|MELAS syndrome|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,3260,3260,MT-TL1,Likely pathogenic,MELAS syndrome|Mitochondrial disease|MITOCHONDRIAL CARDIOMYOPATHY WITH OR WITHOUT SKELETAL MYOPATHY,single nucleotide variant,GRCh37
na,na,MT,3260,3260,MT-TL1,Likely pathogenic,MELAS syndrome|Mitochondrial disease|MITOCHONDRIAL CARDIOMYOPATHY WITH OR WITHOUT SKELETAL MYOPATHY,single nucleotide variant,GRCh38
na,na,MT,3290,3290,MT-TL1,Benign,SUDDEN INFANT DEATH SYNDROME|MELAS syndrome,single nucleotide variant,GRCh37
na,na,MT,3290,3290,MT-TL1,Benign,SUDDEN INFANT DEATH SYNDROME|MELAS syndrome,single nucleotide variant,GRCh38
na,na,MT,3274,3274,MT-TL1,Uncertain significance,Neuropsychiatric disorder and early-onset cataract|MELAS syndrome|Mitochondrial disease|MERRF syndrome,single nucleotide variant,GRCh37
na,na,MT,3274,3274,MT-TL1,Uncertain significance,Neuropsychiatric disorder and early-onset cataract|MELAS syndrome|Mitochondrial disease|MERRF syndrome,single nucleotide variant,GRCh38
na,na,MT,3249,3249,MT-TL1,Uncertain significance,Kearns-Sayre syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,3249,3249,MT-TL1,Uncertain significance,Kearns-Sayre syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,3242,3242,MT-TL1,Likely pathogenic,Myelodysplastic syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,3242,3242,MT-TL1,Likely pathogenic,Myelodysplastic syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,4317,4317,MT-TI,Benign,"Cardiomyopathy, fatal infantile|MELAS syndrome",single nucleotide variant,GRCh37
na,na,MT,4317,4317,MT-TI,Benign,"Cardiomyopathy, fatal infantile|MELAS syndrome",single nucleotide variant,GRCh38
na,na,MT,4269,4269,MT-TI,Pathogenic,"Cardiomyopathy, fatal|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,4269,4269,MT-TI,Pathogenic,"Cardiomyopathy, fatal|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,4295,4295,MT-TI,Uncertain significance,Primary familial hypertrophic cardiomyopathy|Mitochondrial non-syndromic sensorineural hearing loss|not specified|not provided|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,4295,4295,MT-TI,Uncertain significance,Primary familial hypertrophic cardiomyopathy|Mitochondrial non-syndromic sensorineural hearing loss|not specified|not provided|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,4284,4284,MT-TI,Uncertain significance,Multisystem disorder|MERRF syndrome|MELAS syndrome|Mitochondrial disease|not provided,single nucleotide variant,GRCh37
na,na,MT,4284,4284,MT-TI,Uncertain significance,Multisystem disorder|MERRF syndrome|MELAS syndrome|Mitochondrial disease|not provided,single nucleotide variant,GRCh38
na,na,MT,4290,4290,MT-TI,Uncertain significance,"Encephalopathy, familial progressive necrotizing|MELAS syndrome",single nucleotide variant,GRCh37
na,na,MT,4290,4290,MT-TI,Uncertain significance,"Encephalopathy, familial progressive necrotizing|MELAS syndrome",single nucleotide variant,GRCh38
na,na,MT,4300,4300,MT-TI,Likely pathogenic,"Primary familial hypertrophic cardiomyopathy|MERRF syndrome|Mitochondrial disease|Primary dilated cardiomyopathy;Asymmetric septal hypertrophy|Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial",single nucleotide variant,GRCh37
na,na,MT,4300,4300,MT-TI,Likely pathogenic,"Primary familial hypertrophic cardiomyopathy|MERRF syndrome|Mitochondrial disease|Primary dilated cardiomyopathy;Asymmetric septal hypertrophy|Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial",single nucleotide variant,GRCh38
na,na,MT,4291,4291,MT-TI,Uncertain significance,"Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,4291,4291,MT-TI,Uncertain significance,"Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,12192,12192,MT-TH,Benign,"CARDIOMYOPATHY, IDIOPATHIC DILATED, MITOCHONDRIAL|CARDIOMYOPATHY, HYPERTROPHIC, MITOCHONDRIAL|MELAS syndrome",single nucleotide variant,GRCh37
na,na,MT,12192,12192,MT-TH,Benign,"CARDIOMYOPATHY, IDIOPATHIC DILATED, MITOCHONDRIAL|CARDIOMYOPATHY, HYPERTROPHIC, MITOCHONDRIAL|MELAS syndrome",single nucleotide variant,GRCh38
na,na,MT,12183,12183,MT-TH,Uncertain significance,PIGMENTARY RETINOPATHY AND SENSORINEURAL DEAFNESS|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,12183,12183,MT-TH,Uncertain significance,PIGMENTARY RETINOPATHY AND SENSORINEURAL DEAFNESS|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,12147,12147,MT-TH,Likely pathogenic,MERRF/MELAS overlap syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,12147,12147,MT-TH,Likely pathogenic,MERRF/MELAS overlap syndrome|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,9997,9997,MT-TG,Uncertain significance,Primary familial hypertrophic cardiomyopathy|not specified|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,9997,9997,MT-TG,Uncertain significance,Primary familial hypertrophic cardiomyopathy|not specified|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,10010,10010,MT-TG,Uncertain significance,Exercise intolerance|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,10010,10010,MT-TG,Uncertain significance,Exercise intolerance|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,10044,10044,MT-TG,Benign,Sudden death|MELAS syndrome,single nucleotide variant,GRCh37
na,na,MT,10044,10044,MT-TG,Benign,Sudden death|MELAS syndrome,single nucleotide variant,GRCh38
na,na,MT,4365,4366,MT-TQ,Pathogenic,Myopathy,Duplication,GRCh37
na,na,MT,4365,4366,MT-TQ,Pathogenic,Myopathy,Duplication,GRCh38
na,na,MT,4336,4336,MT-CO1;MT-TQ,Benign,Sensorineural deafness and migraine|not provided|MELAS syndrome|not specified|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,4336,4336,MT-CO1;MT-TQ,Benign,Sensorineural deafness and migraine|not provided|MELAS syndrome|not specified|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,4332,4332,MT-TQ,Uncertain significance,MELAS syndrome|MT-TQ-related myopathy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,4332,4332,MT-TQ,Uncertain significance,MELAS syndrome|MT-TQ-related myopathy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,14709,14709,MT-TE,Likely pathogenic,"Myopathy, mitochondrial, with diabetes mellitus|Diabetes-deafness syndrome maternally transmitted|MELAS syndrome|Inborn mitochondrial myopathy|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,14709,14709,MT-TE,Likely pathogenic,"Myopathy, mitochondrial, with diabetes mellitus|Diabetes-deafness syndrome maternally transmitted|MELAS syndrome|Inborn mitochondrial myopathy|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,14674,14674,MT-TE,Likely pathogenic,Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|not provided|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,14674,14674,MT-TE,Likely pathogenic,Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|not provided|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,7526,7526,MT-TD,Pathogenic,"Mitochondrial myopathy, isolated",single nucleotide variant,GRCh37
na,na,MT,7526,7526,MT-TD,Pathogenic,"Mitochondrial myopathy, isolated",single nucleotide variant,GRCh38
na,na,MT,5703,5703,MT-TN,Pathogenic,"Ophthalmoplegia, isolated|Mitochondrial disease|Mitochondrial complex IV deficiency, nuclear type 1",single nucleotide variant,GRCh37
na,na,MT,5703,5703,MT-TN,Pathogenic,"Ophthalmoplegia, isolated|Mitochondrial disease|Mitochondrial complex IV deficiency, nuclear type 1",single nucleotide variant,GRCh38
na,na,MT,5692,5692,MT-TN,Pathogenic,"Ophthalmoplegia, isolated",single nucleotide variant,GRCh37
na,na,MT,5692,5692,MT-TN,Pathogenic,"Ophthalmoplegia, isolated",single nucleotide variant,GRCh38
na,na,MT,5728,5728,MT-TN,Likely pathogenic,"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 2|Mitochondrial complex IV deficiency, nuclear type 1|MELAS syndrome|Mitochondrial disease|not provided",single nucleotide variant,GRCh37
na,na,MT,5728,5728,MT-TN,Likely pathogenic,"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 2|Mitochondrial complex IV deficiency, nuclear type 1|MELAS syndrome|Mitochondrial disease|not provided",single nucleotide variant,GRCh38
na,na,MT,10438,10438,MT-TR,Pathogenic,Mitochondrial encephalomyopathy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,10438,10438,MT-TR,Pathogenic,Mitochondrial encephalomyopathy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,5650,5650,MT-TA,Likely pathogenic,Myotonic dystrophy-like myopathy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,5650,5650,MT-TA,Likely pathogenic,Myotonic dystrophy-like myopathy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,5591,5591,MT-TA,Uncertain significance,Inborn mitochondrial myopathy|MELAS syndrome|Mitochondrial disease|not provided,single nucleotide variant,GRCh37
na,na,MT,5591,5591,MT-TA,Uncertain significance,Inborn mitochondrial myopathy|MELAS syndrome|Mitochondrial disease|not provided,single nucleotide variant,GRCh38
na,na,MT,2991,2991,MT-RNR2,Pathogenic,Chloramphenicol resistance,single nucleotide variant,GRCh37
na,na,MT,2991,2991,MT-RNR2,Pathogenic,Chloramphenicol resistance,single nucleotide variant,GRCh38
na,na,MT,2939,2939,MT-RNR2,Pathogenic,Chloramphenicol resistance,single nucleotide variant,GRCh37
na,na,MT,2939,2939,MT-RNR2,Pathogenic,Chloramphenicol resistance,single nucleotide variant,GRCh38
na,na,MT,1555,1555,MT-RNR1;MT-ND1,Pathogenic; drug response,"Aminoglycoside-induced deafness|Mitochondrial non-syndromic sensorineural hearing loss|Restrictive cardiomyopathy|not provided|Mitochondrial non-syndromic sensorineural hearing loss;Aminoglycoside-induced deafness|Gentamicin response|Rare genetic deafness|tobramycin response - Toxicity|aminoglycoside antibacterials response - Toxicity|gentamicin response - Toxicity|kanamycin response - Toxicity|amikacin response - Toxicity|streptomycin response - Toxicity|Aminoglycoside induced ototoxicity|Mitochondrial disease|Hearing loss, sensorineural, autosomal-mitochondrial type",single nucleotide variant,GRCh37
na,na,MT,1555,1555,MT-RNR1;MT-ND1,Pathogenic; drug response,"Aminoglycoside-induced deafness|Mitochondrial non-syndromic sensorineural hearing loss|Restrictive cardiomyopathy|not provided|Mitochondrial non-syndromic sensorineural hearing loss;Aminoglycoside-induced deafness|Gentamicin response|Rare genetic deafness|tobramycin response - Toxicity|aminoglycoside antibacterials response - Toxicity|gentamicin response - Toxicity|kanamycin response - Toxicity|amikacin response - Toxicity|streptomycin response - Toxicity|Aminoglycoside induced ototoxicity|Mitochondrial disease|Hearing loss, sensorineural, autosomal-mitochondrial type",single nucleotide variant,GRCh38
T,C(2_7),MT,961,961,MT-RNR1,Pathogenic,Aminoglycoside-induced deafness,Indel,GRCh37
T,C(2_7),MT,961,961,MT-RNR1,Pathogenic,Aminoglycoside-induced deafness,Indel,GRCh38
na,na,MT,1291,1291,MT-RNR1,Likely benign,Mitochondrial non-syndromic sensorineural hearing loss|not provided,single nucleotide variant,GRCh37
na,na,MT,1291,1291,MT-RNR1,Likely benign,Mitochondrial non-syndromic sensorineural hearing loss|not provided,single nucleotide variant,GRCh38
na,na,MT,1095,1095,MT-RNR1,drug response,Aminoglycoside-induced deafness|Auditory neuropathy|Mitochondrial non-syndromic sensorineural hearing loss|not specified|streptomycin response - Toxicity|not provided|gentamicin response - Toxicity|aminoglycoside antibacterials response - Toxicity|kanamycin response - Toxicity,single nucleotide variant,GRCh37
na,na,MT,1095,1095,MT-RNR1,drug response,Aminoglycoside-induced deafness|Auditory neuropathy|Mitochondrial non-syndromic sensorineural hearing loss|not specified|streptomycin response - Toxicity|not provided|gentamicin response - Toxicity|aminoglycoside antibacterials response - Toxicity|kanamycin response - Toxicity,single nucleotide variant,GRCh38
na,na,MT,1494,1494,MT-RNR1;MT-TS1,Likely pathogenic; drug response,Aminoglycoside-induced deafness|Mitochondrial non-syndromic sensorineural hearing loss|Gentamicin response|Rare genetic deafness|gentamicin response - Toxicity|streptomycin response - Toxicity|aminoglycoside antibacterials response - Toxicity|kanamycin response - Toxicity|tobramycin response - Toxicity|Mitochondrial disease|Aminoglycoside Ototoxicity,single nucleotide variant,GRCh37
na,na,MT,1494,1494,MT-RNR1;MT-TS1,Likely pathogenic; drug response,Aminoglycoside-induced deafness|Mitochondrial non-syndromic sensorineural hearing loss|Gentamicin response|Rare genetic deafness|gentamicin response - Toxicity|streptomycin response - Toxicity|aminoglycoside antibacterials response - Toxicity|kanamycin response - Toxicity|tobramycin response - Toxicity|Mitochondrial disease|Aminoglycoside Ototoxicity,single nucleotide variant,GRCh38
na,na,MT,961,961,MT-RNR1,Likely benign,Mitochondrial non-syndromic sensorineural hearing loss|not specified,single nucleotide variant,GRCh37
na,na,MT,961,961,MT-RNR1,Likely benign,Mitochondrial non-syndromic sensorineural hearing loss|not specified,single nucleotide variant,GRCh38
na,na,MT,827,827,MT-RNR1,drug response,Mitochondrial non-syndromic sensorineural hearing loss|Aminoglycoside-induced deafness|Gentamicin response,single nucleotide variant,GRCh37
na,na,MT,827,827,MT-RNR1,drug response,Mitochondrial non-syndromic sensorineural hearing loss|Aminoglycoside-induced deafness|Gentamicin response,single nucleotide variant,GRCh38
na,na,MT,8393,8393,MT-ATP8,Benign,"Brain pseudoatrophy, reversible, valproate-induced, susceptibility to|Leigh syndrome",single nucleotide variant,GRCh37
na,na,MT,8393,8393,MT-ATP8,Benign,"Brain pseudoatrophy, reversible, valproate-induced, susceptibility to|Leigh syndrome",single nucleotide variant,GRCh38
na,na,MT,8529,8529,MT-ATP6;MT-ATP8,Uncertain significance,"Cardiomyopathy, apical hypertrophic, and neuropathy|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,8529,8529,MT-ATP6;MT-ATP8,Uncertain significance,"Cardiomyopathy, apical hypertrophic, and neuropathy|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,8528,8528,MT-ATP8;MT-ATP6,Likely pathogenic,"Cardiomyopathy, infantile hypertrophic|Histiocytoid cardiomyopathy|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,8528,8528,MT-ATP8;MT-ATP6,Likely pathogenic,"Cardiomyopathy, infantile hypertrophic|Histiocytoid cardiomyopathy|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,8993,8993,"covers 26 genes, none of which curated to show dosage sensitivity",Pathogenic,"Leigh syndrome|NARP syndrome|Cerebellar ataxia|not provided|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|8 conditions|Mitochondrial disease|Rod-cone dystrophy|Leber optic atrophy|not specified|Striatonigral degeneration, infantile, mitochondrial",single nucleotide variant,GRCh37
na,na,MT,8993,8993,"covers 26 genes, none of which curated to show dosage sensitivity",Pathogenic,"Leigh syndrome|NARP syndrome|Cerebellar ataxia|not provided|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|8 conditions|Mitochondrial disease|Rod-cone dystrophy|Leber optic atrophy|not specified|Striatonigral degeneration, infantile, mitochondrial",single nucleotide variant,GRCh38
na,na,MT,8993,8993,MT-ATP6,Pathogenic,"Ataxia and polyneuropathy, adult-onset|Leigh syndrome|Mitochondrial disease|NARP syndrome|not provided|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|Leber optic atrophy",single nucleotide variant,GRCh37
na,na,MT,8993,8993,MT-ATP6,Pathogenic,"Ataxia and polyneuropathy, adult-onset|Leigh syndrome|Mitochondrial disease|NARP syndrome|not provided|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|Leber optic atrophy",single nucleotide variant,GRCh38
na,na,MT,9101,9101,MT-ATP6,Benign/Likely benign,Leber optic atrophy|Leigh syndrome|not specified,single nucleotide variant,GRCh37
na,na,MT,9101,9101,MT-ATP6,Benign/Likely benign,Leber optic atrophy|Leigh syndrome|not specified,single nucleotide variant,GRCh38
na,na,MT,9176,9176,MT-ATP6,Pathogenic,"Striatonigral degeneration, infantile, mitochondrial|Leigh syndrome|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leber optic atrophy|Leigh syndrome, mitochondrial|Maternally-inherited spastic paraplegia|Mitochondrial disease|NARP syndrome",single nucleotide variant,GRCh37
na,na,MT,9176,9176,MT-ATP6,Pathogenic,"Striatonigral degeneration, infantile, mitochondrial|Leigh syndrome|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leber optic atrophy|Leigh syndrome, mitochondrial|Maternally-inherited spastic paraplegia|Mitochondrial disease|NARP syndrome",single nucleotide variant,GRCh38
na,na,MT,8851,8851,MT-ATP6,Uncertain significance,"Leigh syndrome|Striatonigral degeneration, infantile, mitochondrial|not provided|Leber optic atrophy|Mitochondrial disease|NARP syndrome",single nucleotide variant,GRCh37
na,na,MT,8851,8851,MT-ATP6,Uncertain significance,"Leigh syndrome|Striatonigral degeneration, infantile, mitochondrial|not provided|Leber optic atrophy|Mitochondrial disease|NARP syndrome",single nucleotide variant,GRCh38
na,na,MT,9204,9205,MT-ATP6;MT-CO3,Likely pathogenic,Seizures and lactic acidosis|Leber optic atrophy|Mitochondrial disease,Deletion,GRCh37
na,na,MT,9204,9205,MT-ATP6;MT-CO3,Likely pathogenic,Seizures and lactic acidosis|Leber optic atrophy|Mitochondrial disease,Deletion,GRCh38
na,na,MT,9185,9185,MT-ATP6,Pathogenic,"Leigh syndrome|Charcot-Marie-Tooth disease|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Mitochondrial disease|Leber optic atrophy|Mitochondrial DNA-Associated Leigh Syndrome and NARP|NARP syndrome|Charcot-Marie-Tooth disease, type IA",single nucleotide variant,GRCh37
na,na,MT,9185,9185,MT-ATP6,Pathogenic,"Leigh syndrome|Charcot-Marie-Tooth disease|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Mitochondrial disease|Leber optic atrophy|Mitochondrial DNA-Associated Leigh Syndrome and NARP|NARP syndrome|Charcot-Marie-Tooth disease, type IA",single nucleotide variant,GRCh38
na,na,MT,8617,8618,MT-ATP6,Likely pathogenic,NARP syndrome|Mitochondrial disease,Duplication,GRCh37
na,na,MT,8617,8618,MT-ATP6,Likely pathogenic,NARP syndrome|Mitochondrial disease,Duplication,GRCh38
na,na,MT,9176,9176,MT-ATP6,Likely pathogenic,"Leigh syndrome|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leber optic atrophy|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,9176,9176,MT-ATP6,Likely pathogenic,"Leigh syndrome|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leber optic atrophy|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,9438,9438,MT-CO3,Benign,Leber optic atrophy|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,9438,9438,MT-CO3,Benign,Leber optic atrophy|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,9804,9804,MT-CO3,Uncertain significance,Leber optic atrophy|not provided|See cases|Leigh syndrome|not specified|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,9804,9804,MT-CO3,Uncertain significance,Leber optic atrophy|not provided|See cases|Leigh syndrome|not specified|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,9480,9494,MT-CO3,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial complex IV deficiency with recurrent myoglobinuria|Mitochondrial disease",Deletion,GRCh37
na,na,MT,9480,9494,MT-CO3,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial complex IV deficiency with recurrent myoglobinuria|Mitochondrial disease",Deletion,GRCh38
na,na,MT,9952,9952,MT-CO3,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,9952,9952,MT-CO3,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,9531,9532,MT-CO3,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome|Mitochondrial disease",Duplication,GRCh37
na,na,MT,9531,9532,MT-CO3,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome|Mitochondrial disease",Duplication,GRCh38
na,na,MT,9379,9379,MT-CO3,Uncertain significance,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,9379,9379,MT-CO3,Uncertain significance,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,7587,7587,MT-CO2,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,7587,7587,MT-CO2,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,8009,8009,MT-CO2,Benign,Familial colorectal cancer|not specified,single nucleotide variant,GRCh37
na,na,MT,8009,8009,MT-CO2,Benign,Familial colorectal cancer|not specified,single nucleotide variant,GRCh38
na,na,MT,7671,7671,MT-CO2,Uncertain significance,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,7671,7671,MT-CO2,Uncertain significance,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,8042,8043,MT-CO2,Uncertain significance,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",Deletion,GRCh37
na,na,MT,8042,8043,MT-CO2,Uncertain significance,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",Deletion,GRCh38
na,na,MT,7896,7896,MT-CO2,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,7896,7896,MT-CO2,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,7444,7444,MT-CO1;MT-TS1,Likely benign,Aminoglycoside-induced deafness|Mitochondrial non-syndromic sensorineural hearing loss|Leber optic atrophy|Leigh syndrome|not provided|Mitochondrial disease|not specified,single nucleotide variant,GRCh37
na,na,MT,7444,7444,MT-CO1;MT-TS1,Likely benign,Aminoglycoside-induced deafness|Mitochondrial non-syndromic sensorineural hearing loss|Leber optic atrophy|Leigh syndrome|not provided|Mitochondrial disease|not specified,single nucleotide variant,GRCh38
na,na,MT,6742,6742,MT-CO1,Uncertain significance,Myelodysplastic syndrome with ring sideroblasts|not specified|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,6742,6742,MT-CO1,Uncertain significance,Myelodysplastic syndrome with ring sideroblasts|not specified|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,6721,6721,MT-CO1,Uncertain significance,Myelodysplastic syndrome with ring sideroblasts|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,6721,6721,MT-CO1,Uncertain significance,Myelodysplastic syndrome with ring sideroblasts|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,6480,6480,MT-CO1,Conflicting classifications of pathogenicity,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,6480,6480,MT-CO1,Conflicting classifications of pathogenicity,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,6264,6264,MT-CO1,Uncertain significance,Familial colorectal cancer|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,6264,6264,MT-CO1,Uncertain significance,Familial colorectal cancer|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,6930,6930,MT-CO1,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,6930,6930,MT-CO1,Likely pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,5920,5920,MT-CO1,Likely pathogenic,"Myoglobinuria, recurrent|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,5920,5920,MT-CO1,Likely pathogenic,"Myoglobinuria, recurrent|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,6489,6489,MT-CO1,Benign/Likely benign,Cytochrome c oxidase I deficiency|Leigh syndrome|not specified,single nucleotide variant,GRCh37
na,na,MT,6489,6489,MT-CO1,Benign/Likely benign,Cytochrome c oxidase I deficiency|Leigh syndrome|not specified,single nucleotide variant,GRCh38
na,na,MT,6328,6328,MT-CO1,Uncertain significance,Cytochrome c oxidase I deficiency|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,6328,6328,MT-CO1,Uncertain significance,Cytochrome c oxidase I deficiency|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,6277,6277,MT-CO1,Pathogenic,Familial colorectal cancer,single nucleotide variant,GRCh37
na,na,MT,6277,6277,MT-CO1,Pathogenic,Familial colorectal cancer,single nucleotide variant,GRCh38
na,na,MT,7275,7275,MT-CO1,Pathogenic,Familial colorectal cancer,single nucleotide variant,GRCh37
na,na,MT,7275,7275,MT-CO1,Pathogenic,Familial colorectal cancer,single nucleotide variant,GRCh38
na,na,MT,15257,15257,MT-CYB,Benign/Likely benign,Leber optic atrophy|Leigh syndrome|not specified,single nucleotide variant,GRCh37
na,na,MT,15257,15257,MT-CYB,Benign/Likely benign,Leber optic atrophy|Leigh syndrome|not specified,single nucleotide variant,GRCh38
na,na,MT,15812,15812,MT-CYB,Benign,Leber optic atrophy|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,15812,15812,MT-CYB,Benign,Leber optic atrophy|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,14985,14985,MT-CYB,Uncertain significance,Familial colorectal cancer|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,14985,14985,MT-CYB,Uncertain significance,Familial colorectal cancer|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,15572,15572,MT-CYB,Benign,Familial colorectal cancer|not specified,single nucleotide variant,GRCh37
na,na,MT,15572,15572,MT-CYB,Benign,Familial colorectal cancer|not specified,single nucleotide variant,GRCh38
na,na,MT,15615,15615,MT-CYB,Likely pathogenic,Exercise intolerance|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency,single nucleotide variant,GRCh37
na,na,MT,15615,15615,MT-CYB,Likely pathogenic,Exercise intolerance|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency,single nucleotide variant,GRCh38
na,na,MT,14846,14846,MT-CYB,Uncertain significance,Exercise intolerance|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|MT-CYB associated Exercise intolerance;MT-CYB associated Mitochondrial myopathy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,14846,14846,MT-CYB,Uncertain significance,Exercise intolerance|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|MT-CYB associated Exercise intolerance;MT-CYB associated Mitochondrial myopathy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,15242,15242,MT-CYB,Likely pathogenic,Mitochondrial encephalomyopathy|Leigh syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,15242,15242,MT-CYB,Likely pathogenic,Mitochondrial encephalomyopathy|Leigh syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,15150,15150,MT-CYB,Likely pathogenic,Exercise intolerance|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,15150,15150,MT-CYB,Likely pathogenic,Exercise intolerance|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,15197,15197,MT-CYB,Uncertain significance,Exercise intolerance|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,15197,15197,MT-CYB,Uncertain significance,Exercise intolerance|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,15579,15579,MT-CYB,Uncertain significance,Multisystem disorder|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,15579,15579,MT-CYB,Uncertain significance,Multisystem disorder|Mitochondrial myopathy with reversible cytochrome C oxidase deficiency|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,15498,15498,MT-CYB,Uncertain significance,Histiocytoid cardiomyopathy|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,15498,15498,MT-CYB,Uncertain significance,Histiocytoid cardiomyopathy|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,14849,14849,MT-CYB,Uncertain significance,"Exercise intolerance, cardiomyopathy, and septooptic dysplasia|Leigh syndrome|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,14849,14849,MT-CYB,Uncertain significance,"Exercise intolerance, cardiomyopathy, and septooptic dysplasia|Leigh syndrome|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,14781,14784,MT-CYB,Likely pathogenic,Parkinsonism/MELAS overlap syndrome|Mitochondrial disease,Microsatellite,GRCh37
na,na,MT,14781,14784,MT-CYB,Likely pathogenic,Parkinsonism/MELAS overlap syndrome|Mitochondrial disease,Microsatellite,GRCh38
na,na,MT,15497,15497,MT-CYB,Benign/Likely benign,Obesity|Leigh syndrome|not provided,single nucleotide variant,GRCh37
na,na,MT,15497,15497,MT-CYB,Benign/Likely benign,Obesity|Leigh syndrome|not provided,single nucleotide variant,GRCh38
na,na,MT,14484,14484,MT-ND6,Pathogenic,Leber optic atrophy|Leigh syndrome|not provided|Mitochondrial disease|Retinal dystrophy|Optic atrophy,single nucleotide variant,GRCh37
na,na,MT,14484,14484,MT-ND6,Pathogenic,Leber optic atrophy|Leigh syndrome|not provided|Mitochondrial disease|Retinal dystrophy|Optic atrophy,single nucleotide variant,GRCh38
na,na,MT,14459,14459,MT-ND5;MT-ND6,Pathogenic,Leber optic atrophy|Leigh syndrome|Leber optic atrophy and dystonia|Leigh syndrome due to mitochondrial complex I deficiency|MELAS syndrome|Mitochondrial disease|not provided,single nucleotide variant,GRCh37
na,na,MT,14459,14459,MT-ND5;MT-ND6,Pathogenic,Leber optic atrophy|Leigh syndrome|Leber optic atrophy and dystonia|Leigh syndrome due to mitochondrial complex I deficiency|MELAS syndrome|Mitochondrial disease|not provided,single nucleotide variant,GRCh38
na,na,MT,14596,14596,MT-ND6,Uncertain significance,Leber optic atrophy|Leber optic atrophy and dystonia|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,14596,14596,MT-ND6,Uncertain significance,Leber optic atrophy|Leber optic atrophy and dystonia|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,14495,14495,MT-ND6,Likely pathogenic,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,14495,14495,MT-ND6,Likely pathogenic,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,14453,14453,MT-ND6,Likely pathogenic,MELAS syndrome|Leigh syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,14453,14453,MT-ND6,Likely pathogenic,MELAS syndrome|Leigh syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,14482,14482,MT-ND6,Likely pathogenic,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,14482,14482,MT-ND6,Likely pathogenic,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,14487,14487,MT-ND6,Pathogenic,"Striatal necrosis, bilateral, with dystonia|Leigh syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial disease|MELAS syndrome|Leber optic atrophy",single nucleotide variant,GRCh37
na,na,MT,14487,14487,MT-ND6,Pathogenic,"Striatal necrosis, bilateral, with dystonia|Leigh syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial disease|MELAS syndrome|Leber optic atrophy",single nucleotide variant,GRCh38
na,na,MT,14319,14319,MT-ND6,Benign,Autosomal recessive early-onset Parkinson disease 6|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,14319,14319,MT-ND6,Benign,Autosomal recessive early-onset Parkinson disease 6|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,13708,13708,MT-ND5,Benign/Likely benign,Leber optic atrophy|Leigh syndrome|not specified,single nucleotide variant,GRCh37
na,na,MT,13708,13708,MT-ND5,Benign/Likely benign,Leber optic atrophy|Leigh syndrome|not specified,single nucleotide variant,GRCh38
na,na,MT,13730,13730,MT-ND5,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,13730,13730,MT-ND5,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,12706,12706,MT-ND5,Likely pathogenic,Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,12706,12706,MT-ND5,Likely pathogenic,Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,12770,12770,MT-ND5,Uncertain significance,MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,12770,12770,MT-ND5,Uncertain significance,MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,13045,13045,MT-ND5,Uncertain significance,MELAS syndrome|Leber optic atrophy|Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,13045,13045,MT-ND5,Uncertain significance,MELAS syndrome|Leber optic atrophy|Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,13084,13084,MT-ND5,Uncertain significance,Leigh syndrome due to mitochondrial complex I deficiency|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,13084,13084,MT-ND5,Uncertain significance,Leigh syndrome due to mitochondrial complex I deficiency|MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,13513,13513,MT-ND5,Pathogenic,MELAS syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome|not provided|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,13513,13513,MT-ND5,Pathogenic,MELAS syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome|not provided|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,13042,13042,MT-ND5,Likely pathogenic,MELAS syndrome|MERRF syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,13042,13042,MT-ND5,Likely pathogenic,MELAS syndrome|MERRF syndrome|Leigh syndrome due to mitochondrial complex I deficiency|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,12848,12848,MT-ND5,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,12848,12848,MT-ND5,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,12397,12397,MT-ND5,Benign,Autosomal recessive early-onset Parkinson disease 6|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,12397,12397,MT-ND5,Benign,Autosomal recessive early-onset Parkinson disease 6|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,10563,10563,MT-ND4L,Uncertain significance,Familial colorectal cancer|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,10563,10563,MT-ND4L,Uncertain significance,Familial colorectal cancer|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,10663,10663,MT-ND4L,Likely pathogenic,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,10663,10663,MT-ND4L,Likely pathogenic,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,11778,11778,MT-ND4,Pathogenic,"Leber optic atrophy|not provided|Mitochondrial disease|not specified|Leber optic atrophy and dystonia|Leber optic atrophy, susceptibility to|Optic atrophy|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,MT,11778,11778,MT-ND4,Pathogenic,"Leber optic atrophy|not provided|Mitochondrial disease|not specified|Leber optic atrophy and dystonia|Leber optic atrophy, susceptibility to|Optic atrophy|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,MT,11084,11084,MT-ND4,Benign,MELAS syndrome|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,11084,11084,MT-ND4,Benign,MELAS syndrome|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,11696,11696,MT-ND4,Benign,Leber optic atrophy and dystonia|Leber optic atrophy|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,11696,11696,MT-ND4,Benign,Leber optic atrophy and dystonia|Leber optic atrophy|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,11777,11777,MT-ND4,Likely pathogenic,Mitochondrial complex I deficiency|Leber optic atrophy|Leigh syndrome|Mitochondrial disease|Leber optic atrophy and dystonia,single nucleotide variant,GRCh37
na,na,MT,11777,11777,MT-ND4,Likely pathogenic,Mitochondrial complex I deficiency|Leber optic atrophy|Leigh syndrome|Mitochondrial disease|Leber optic atrophy and dystonia,single nucleotide variant,GRCh38
na,na,MT,10191,10191,MT-ND3,Pathogenic,"Mitochondrial complex 1 deficiency, mitochondrial type 1|Leigh syndrome|Mitochondrial disease|Mitochondrial complex I deficiency",single nucleotide variant,GRCh37
na,na,MT,10191,10191,MT-ND3,Pathogenic,"Mitochondrial complex 1 deficiency, mitochondrial type 1|Leigh syndrome|Mitochondrial disease|Mitochondrial complex I deficiency",single nucleotide variant,GRCh38
na,na,MT,10398,10398,MT-ND3,Benign,"Parkinson disease, resistance to|Leigh syndrome|not provided|not specified",single nucleotide variant,GRCh37
na,na,MT,10398,10398,MT-ND3,Benign,"Parkinson disease, resistance to|Leigh syndrome|not provided|not specified",single nucleotide variant,GRCh38
na,na,MT,10158,10158,MT-ND3,Pathogenic,"not provided|Leigh syndrome|Mitochondrial complex 1 deficiency, mitochondrial type 1|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,MT,10158,10158,MT-ND3,Pathogenic,"not provided|Leigh syndrome|Mitochondrial complex 1 deficiency, mitochondrial type 1|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,MT,10197,10197,MT-ND3,Pathogenic,"Mitochondrial complex 1 deficiency, mitochondrial type 1|Leber optic atrophy and dystonia|Leigh syndrome|Mitochondrial DNA-Associated Leigh Syndrome and NARP|not provided|not specified|Mitochondrial disease|See cases|Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy",single nucleotide variant,GRCh37
na,na,MT,10197,10197,MT-ND3,Pathogenic,"Mitochondrial complex 1 deficiency, mitochondrial type 1|Leber optic atrophy and dystonia|Leigh syndrome|Mitochondrial DNA-Associated Leigh Syndrome and NARP|not provided|not specified|Mitochondrial disease|See cases|Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy",single nucleotide variant,GRCh38
na,na,MT,4917,4917,MT-ND2,Benign,Leber optic atrophy|Leigh syndrome|not specified,single nucleotide variant,GRCh37
na,na,MT,4917,4917,MT-ND2,Benign,Leber optic atrophy|Leigh syndrome|not specified,single nucleotide variant,GRCh38
na,na,MT,5244,5244,MT-ND2,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,5244,5244,MT-ND2,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,4640,4640,MT-ND2,Benign,Leber optic atrophy|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,4640,4640,MT-ND2,Benign,Leber optic atrophy|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,5132,5133,MT-ND2,Uncertain significance,Mitochondrial complex I deficiency|Mitochondrial disease,Deletion,GRCh37
na,na,MT,5132,5133,MT-ND2,Uncertain significance,Mitochondrial complex I deficiency|Mitochondrial disease,Deletion,GRCh38
na,na,MT,4810,4810,MT-ND2,Likely pathogenic,Mitochondrial complex I deficiency|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,4810,4810,MT-ND2,Likely pathogenic,Mitochondrial complex I deficiency|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,4681,4681,MT-ND2,Uncertain significance,Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,4681,4681,MT-ND2,Uncertain significance,Leigh syndrome due to mitochondrial complex I deficiency|Leigh syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,3460,3460,MT-ND1,Pathogenic,"Leber optic atrophy|Leigh syndrome|not provided|MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 3|Optic atrophy|Mitochondrial disease|MELAS syndrome",single nucleotide variant,GRCh37
na,na,MT,3460,3460,MT-ND1,Pathogenic,"Leber optic atrophy|Leigh syndrome|not provided|MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 3|Optic atrophy|Mitochondrial disease|MELAS syndrome",single nucleotide variant,GRCh38
na,na,MT,4160,4160,MT-ND1,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,4160,4160,MT-ND1,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,4216,4216,MT-ND1,Benign,Leber optic atrophy|not provided|Leigh syndrome|not specified,single nucleotide variant,GRCh37
na,na,MT,4216,4216,MT-ND1,Benign,Leber optic atrophy|not provided|Leigh syndrome|not specified,single nucleotide variant,GRCh38
na,na,MT,3394,3394,MT-ND1,Uncertain significance,Leber optic atrophy|not provided|Leigh syndrome|Optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,3394,3394,MT-ND1,Uncertain significance,Leber optic atrophy|not provided|Leigh syndrome|Optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,3397,3397,MT-ND1,Benign,"Alzheimer disease|Parkinson disease, late-onset|Leigh syndrome",single nucleotide variant,GRCh37
na,na,MT,3397,3397,MT-ND1,Benign,"Alzheimer disease|Parkinson disease, late-onset|Leigh syndrome",single nucleotide variant,GRCh38
na,na,MT,4136,4136,MT-ND1,Benign,Leber optic atrophy|Leigh syndrome|not provided,single nucleotide variant,GRCh37
na,na,MT,4136,4136,MT-ND1,Benign,Leber optic atrophy|Leigh syndrome|not provided,single nucleotide variant,GRCh38
na,na,MT,3308,3308,MT-ND1,Benign/Likely benign,Carcinoma of colon|SUDDEN INFANT DEATH SYNDROME|not specified|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,3308,3308,MT-ND1,Benign/Likely benign,Carcinoma of colon|SUDDEN INFANT DEATH SYNDROME|not specified|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,3308,3308,MT-ND1,Likely benign,SUDDEN INFANT DEATH SYNDROME|Leigh syndrome,single nucleotide variant,GRCh37
na,na,MT,3308,3308,MT-ND1,Likely benign,SUDDEN INFANT DEATH SYNDROME|Leigh syndrome,single nucleotide variant,GRCh38
na,na,MT,3796,3796,MT-ND1,Benign,"Dystonia, adult-onset|not provided|Leigh syndrome|not specified",single nucleotide variant,GRCh37
na,na,MT,3796,3796,MT-ND1,Benign,"Dystonia, adult-onset|not provided|Leigh syndrome|not specified",single nucleotide variant,GRCh38
na,na,MT,3902,3908,MT-ND1,Likely pathogenic,"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 3|Mitochondrial disease",Inversion,GRCh37
na,na,MT,3902,3908,MT-ND1,Likely pathogenic,"MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 3|Mitochondrial disease",Inversion,GRCh38
na,na,MT,4171,4171,MT-ND1,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,4171,4171,MT-ND1,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,3697,3697,MT-ND1,Likely pathogenic,Leber optic atrophy and dystonia|Leber optic atrophy|MELAS syndrome|Mitochondrial disease|7 conditions,single nucleotide variant,GRCh37
na,na,MT,3697,3697,MT-ND1,Likely pathogenic,Leber optic atrophy and dystonia|Leber optic atrophy|MELAS syndrome|Mitochondrial disease|7 conditions,single nucleotide variant,GRCh38
na,na,MT,3946,3946,"covers 22 genes, none of which curated to show dosage sensitivity",Likely pathogenic,MELAS syndrome|Leigh syndrome|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,3946,3946,"covers 22 genes, none of which curated to show dosage sensitivity",Likely pathogenic,MELAS syndrome|Leigh syndrome|Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,3949,3949,MT-ND1,Uncertain significance,MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,3949,3949,MT-ND1,Uncertain significance,MELAS syndrome|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,MT,3733,3733,MT-ND1,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh37
na,na,MT,3733,3733,MT-ND1,Uncertain significance,Leber optic atrophy|Mitochondrial disease,single nucleotide variant,GRCh38
na,na,Y,2655278,2655281,SRY,Pathogenic,"46,XY sex reversal 1",Microsatellite,GRCh37
na,na,Y,2787237,2787240,SRY,Pathogenic,"46,XY sex reversal 1",Microsatellite,GRCh38
na,na,Y,2655319,2655319,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787278,2787278,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655467,2655467,SRY,Pathogenic,"46,XY sex reversal 1|not provided",single nucleotide variant,GRCh37
na,na,Y,2787426,2787426,SRY,Pathogenic,"46,XY sex reversal 1|not provided",single nucleotide variant,GRCh38
na,na,Y,2655368,2655368,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787327,2787327,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655375,2655375,SRY,Pathogenic,"46,XY sex reversal 1|46,XY TRUE HERMAPHRODITISM",single nucleotide variant,GRCh37
na,na,Y,2787334,2787334,SRY,Pathogenic,"46,XY sex reversal 1|46,XY TRUE HERMAPHRODITISM",single nucleotide variant,GRCh38
na,na,Y,2655328,2655328,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787287,2787287,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655321,2655321,SRY,Pathogenic,"46,XY sex reversal 1",Deletion,GRCh37
na,na,Y,2787280,2787280,SRY,Pathogenic,"46,XY sex reversal 1",Deletion,GRCh38
na,na,Y,2655308,2655308,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787267,2787267,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655325,2655325,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787284,2787284,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655442,2655442,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787401,2787401,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655453,2655453,SRY,Likely pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787412,2787412,SRY,Likely pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655436,2655436,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787395,2787395,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655371,2655371,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787330,2787330,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655362,2655362,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787321,2787321,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655633,2655633,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787592,2787592,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655248,2655248,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787207,2787207,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655641,2655641,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787600,2787600,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655592,2655592,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787551,2787551,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655361,2655361,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787320,2787320,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,2655265,2655265,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh37
na,na,Y,2787224,2787224,SRY,Pathogenic,"46,XY sex reversal 1",single nucleotide variant,GRCh38
na,na,Y,14847659,14847662,USP9Y,Pathogenic,"Spermatogenic failure, Y-linked, 2",Microsatellite,GRCh37
na,na,Y,12735725,12735728,USP9Y,Pathogenic,"Spermatogenic failure, Y-linked, 2",Microsatellite,GRCh38
na,na,na,-1,-1,USP9Y,Pathogenic,"Hypospermatogenesis, nonobstructive, Y-linked",Deletion,na
na,na,X,47774581,47774581,ZNF81,Uncertain significance,"Intellectual disability, X-linked 45",single nucleotide variant,GRCh37
na,na,X,47915182,47915182,ZNF81,Uncertain significance,"Intellectual disability, X-linked 45",single nucleotide variant,GRCh38
na,na,X,47308837,47308837,ZNF41,Likely benign,not provided,single nucleotide variant,GRCh37
na,na,X,47449438,47449438,ZNF41,Likely benign,not provided,single nucleotide variant,GRCh38
na,na,X,47315839,47315839,ZNF41,Likely benign,not provided|ZNF41-related disorder,single nucleotide variant,GRCh37
na,na,X,47456440,47456440,ZNF41,Likely benign,not provided|ZNF41-related disorder,single nucleotide variant,GRCh38
na,na,X,84526673,84526674,ZNF711,Pathogenic,"Intellectual disability, X-linked 97|not provided",Microsatellite,GRCh37
na,na,X,85271667,85271668,ZNF711,Pathogenic,"Intellectual disability, X-linked 97|not provided",Microsatellite,GRCh38
na,na,X,84526121,84526121,ZNF711,Pathogenic,"Intellectual disability, X-linked 97",single nucleotide variant,GRCh37
na,na,X,85271115,85271115,ZNF711,Pathogenic,"Intellectual disability, X-linked 97",single nucleotide variant,GRCh38
na,na,X,37553802,37553802,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh37
na,na,X,37694549,37694549,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh38
na,na,X,37586888,37586888,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh37
na,na,X,37727635,37727635,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,Deletion,na
na,na,X,37587390,37587390,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,Deletion,GRCh37
na,na,X,37728137,37728137,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,Deletion,GRCh38
na,na,X,37587260,37587260,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh37
na,na,X,37728007,37728007,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh38
na,na,X,37587316,37587329,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,Deletion,GRCh37
na,na,X,37728063,37728076,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,Deletion,GRCh38
na,na,X,37587321,37587321,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh37
na,na,X,37728068,37728068,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh38
na,na,X,37587275,37587275,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh37
na,na,X,37728022,37728022,XK,Pathogenic,McLeod neuroacanthocytosis syndrome,single nucleotide variant,GRCh38
na,na,X,53228211,53228211,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,single nucleotide variant,GRCh37
na,na,X,53199029,53199029,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,single nucleotide variant,GRCh38
na,na,X,53250046,53250047,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,Duplication,GRCh37
na,na,X,53220864,53220865,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,Duplication,GRCh38
na,na,X,53241049,53241049,KDM5C,Likely pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,53211867,53211867,KDM5C,Likely pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,53228322,53228322,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type|not provided,single nucleotide variant,GRCh37
na,na,X,53199140,53199140,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type|not provided,single nucleotide variant,GRCh38
na,na,X,53240727,53240727,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,single nucleotide variant,GRCh37
na,na,X,53211545,53211545,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,single nucleotide variant,GRCh38
na,na,X,53228018,53228018,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,single nucleotide variant,GRCh37
na,na,X,53198836,53198836,KDM5C,Pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type,single nucleotide variant,GRCh38
na,na,X,53247580,53247580,KDM5C,Likely pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,53218398,53218398,KDM5C,Likely pathogenic,Syndromic X-linked intellectual disability Claes-Jensen type|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,73072592,73072592,XIST,Pathogenic,"X inactivation, familial skewed, 1",single nucleotide variant,GRCh37
na,na,X,73852757,73852757,XIST,Pathogenic,"X inactivation, familial skewed, 1",single nucleotide variant,GRCh38
na,na,X,47065388,47065388,UBA1,Uncertain significance,Infantile-onset X-linked spinal muscular atrophy,single nucleotide variant,GRCh37
na,na,X,47205989,47205989,UBA1,Uncertain significance,Infantile-onset X-linked spinal muscular atrophy,single nucleotide variant,GRCh38
na,na,X,47065410,47065410,UBA1,Uncertain significance,Infantile-onset X-linked spinal muscular atrophy,single nucleotide variant,GRCh37
na,na,X,47206011,47206011,UBA1,Uncertain significance,Infantile-onset X-linked spinal muscular atrophy,single nucleotide variant,GRCh38
na,na,X,47065502,47065502,UBA1,Conflicting classifications of pathogenicity,Infantile-onset X-linked spinal muscular atrophy|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,47206103,47206103,UBA1,Conflicting classifications of pathogenicity,Infantile-onset X-linked spinal muscular atrophy|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,105279259,105279259,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh37
na,na,X,106035268,106035268,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh38
na,na,X,105279368,105279368,SERPINA7,Conflicting classifications of pathogenicity,"Thyroxine-binding globulin, variant A|Thyroxine-binding globulin deficiency|not provided|SERPINA7-related disorder",single nucleotide variant,GRCh37
na,na,X,106035377,106035377,SERPINA7,Conflicting classifications of pathogenicity,"Thyroxine-binding globulin, variant A|Thyroxine-binding globulin deficiency|not provided|SERPINA7-related disorder",single nucleotide variant,GRCh38
na,na,X,105278361,105278361,SERPINA7,Benign,"Thyroxine-binding globulin, variant P|not provided|not specified|Thyroxine-binding globulin quantitative trait locus|SERPINA7-related disorder",single nucleotide variant,GRCh37
na,na,X,106034370,106034370,SERPINA7,Benign,"Thyroxine-binding globulin, variant P|not provided|not specified|Thyroxine-binding globulin quantitative trait locus|SERPINA7-related disorder",single nucleotide variant,GRCh38
na,na,X,105280479,105280479,SERPINA7,Pathogenic,"Thyroxine-binding globulin, slow",single nucleotide variant,GRCh37
na,na,X,106036488,106036488,SERPINA7,Pathogenic,"Thyroxine-binding globulin, slow",single nucleotide variant,GRCh38
na,na,X,105277688,105277688,SERPINA7,association,"Thyroxine-binding globulin deficiency, partial",single nucleotide variant,GRCh37
na,na,X,106033697,106033697,SERPINA7,association,"Thyroxine-binding globulin deficiency, partial",single nucleotide variant,GRCh38
na,na,X,105280653,105280653,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh37
na,na,X,106036662,106036662,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh38
na,na,X,105280495,105280495,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh37
na,na,X,106036504,106036504,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh38
na,na,X,105280703,105280703,SERPINA7,Pathogenic,"Thyroxine-binding globulin deficiency, partial",single nucleotide variant,GRCh37
na,na,X,106036712,106036712,SERPINA7,Pathogenic,"Thyroxine-binding globulin deficiency, partial",single nucleotide variant,GRCh38
na,na,X,105277625,105277625,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh37
na,na,X,106033634,106033634,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh38
na,na,X,105278284,105278284,SERPINA7,Pathogenic,"Thyroxine-binding globulin, Chicago",single nucleotide variant,GRCh37
na,na,X,106034293,106034293,SERPINA7,Pathogenic,"Thyroxine-binding globulin, Chicago",single nucleotide variant,GRCh38
na,na,X,106032435,106038727,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,copy number gain,GRCh38
na,na,X,105277591,105277591,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh37
na,na,X,106033600,106033600,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh38
na,na,X,105278371,105278371,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh37
na,na,X,106034380,106034380,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh38
na,na,X,105279378,105279378,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh37
na,na,X,106035387,106035387,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh38
na,na,X,105280876,105280876,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh37
na,na,X,106036885,106036885,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh38
na,na,X,105277518,105277536,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh37
na,na,X,106033527,106033545,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh38
na,na,X,105278361,105278361,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh37
na,na,X,106034370,106034370,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh38
na,na,X,105277694,105277694,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh37
na,na,X,106033703,106033703,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,Deletion,GRCh38
na,na,X,105278221,105278221,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh37
na,na,X,106034230,106034230,SERPINA7,association,Thyroxine-binding globulin quantitative trait locus,single nucleotide variant,GRCh38
na,na,na,-1,-1,AR,Pathogenic,Androgen resistance syndrome,Deletion,na
na,na,na,-1,-1,AR,Pathogenic,Androgen resistance syndrome,Deletion,na
na,na,X,66941679,66941679,AR,Pathogenic,Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,67721837,67721837,AR,Pathogenic,Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,66931515,66931515,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67711673,67711673,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66942818,66942818,AR,Pathogenic,"Androgen resistance syndrome|Prostate cancer;Hypospadias 1, X-linked;Kennedy disease;Androgen resistance syndrome;Partial androgen insensitivity syndrome|Kennedy disease;Androgen resistance syndrome|AR-related disorder",single nucleotide variant,GRCh37
na,na,X,67722976,67722976,AR,Pathogenic,"Androgen resistance syndrome|Prostate cancer;Hypospadias 1, X-linked;Kennedy disease;Androgen resistance syndrome;Partial androgen insensitivity syndrome|Kennedy disease;Androgen resistance syndrome|AR-related disorder",single nucleotide variant,GRCh38
na,na,X,66941747,66941747,AR,Pathogenic,Kennedy disease;Androgen resistance syndrome|Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67721905,67721905,AR,Pathogenic,Kennedy disease;Androgen resistance syndrome|Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66905854,66905854,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67686012,67686012,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66931301,66931301,AR,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh37
na,na,X,67711459,67711459,AR,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh38
na,na,X,66937437,66937437,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh37
na,na,X,67717595,67717595,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh38
na,na,X,66943570,66943570,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67723728,67723728,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66905872,66905872,AR,Pathogenic,Partial androgen insensitivity syndrome|Kennedy disease;Androgen resistance syndrome|not provided|Disorder of sexual differentiation,single nucleotide variant,GRCh37
na,na,X,67686030,67686030,AR,Pathogenic,Partial androgen insensitivity syndrome|Kennedy disease;Androgen resistance syndrome|not provided|Disorder of sexual differentiation,single nucleotide variant,GRCh38
na,na,X,66941718,66941718,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67721876,67721876,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66765168,66765169,AR,Pathogenic,Androgen resistance syndrome,Deletion,GRCh37
na,na,X,67545326,67545327,AR,Pathogenic,Androgen resistance syndrome,Deletion,GRCh38
na,na,X,66942790,66942790,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67722948,67722948,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66937337,66937337,AR,Conflicting classifications of pathogenicity,"Prostate cancer, somatic|Prostate cancer|Kennedy disease;Androgen resistance syndrome",single nucleotide variant,GRCh37
na,na,X,67717495,67717495,AR,Conflicting classifications of pathogenicity,"Prostate cancer, somatic|Prostate cancer|Kennedy disease;Androgen resistance syndrome",single nucleotide variant,GRCh38
na,na,X,66765160,66765162,AR,Pathogenic,Kennedy disease,Microsatellite,GRCh37
na,na,X,67545318,67545320,AR,Pathogenic,Kennedy disease,Microsatellite,GRCh38
na,na,X,66941680,66941680,AR,Pathogenic,Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,67721838,67721838,AR,Pathogenic,Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,66905906,66905906,AR,Pathogenic/Likely pathogenic,Partial androgen insensitivity syndrome|not provided|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67686064,67686064,AR,Pathogenic/Likely pathogenic,Partial androgen insensitivity syndrome|not provided|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66942818,66942818,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh37
na,na,X,67722976,67722976,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh38
na,na,X,66942786,66942786,AR,Pathogenic/Likely pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome;Kennedy disease|Androgen resistance syndrome|Male infertility,single nucleotide variant,GRCh37
na,na,X,67722944,67722944,AR,Pathogenic/Likely pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome;Kennedy disease|Androgen resistance syndrome|Male infertility,single nucleotide variant,GRCh38
na,na,X,66943530,66943530,AR,Pathogenic,"Hypospadias 1, X-linked",single nucleotide variant,GRCh37
na,na,X,67723688,67723688,AR,Pathogenic,"Hypospadias 1, X-linked",single nucleotide variant,GRCh38
na,na,X,66765166,66765166,AR,Pathogenic,Androgen resistance syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,67545324,67545324,AR,Pathogenic,Androgen resistance syndrome|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,AR,Pathogenic,Androgen resistance syndrome,Deletion,na
na,na,na,-1,-1,AR,Pathogenic,Androgen resistance syndrome,Deletion,na
na,na,X,66905909,66905909,AR,Pathogenic,"Androgen insensitivity, partial, with breast cancer",single nucleotide variant,GRCh37
na,na,X,67686067,67686067,AR,Pathogenic,"Androgen insensitivity, partial, with breast cancer",single nucleotide variant,GRCh38
na,na,X,66942741,66942741,AR,Pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Androgen resistance syndrome;Kennedy disease|not provided,single nucleotide variant,GRCh37
na,na,X,67722899,67722899,AR,Pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Androgen resistance syndrome;Kennedy disease|not provided,single nucleotide variant,GRCh38
na,na,X,66942740,66942740,AR,Pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,67722898,67722898,AR,Pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,66943552,66943552,AR,Pathogenic,"Prostate cancer, somatic|Neoplasm",single nucleotide variant,GRCh37
na,na,X,67723710,67723710,AR,Pathogenic,"Prostate cancer, somatic|Neoplasm",single nucleotide variant,GRCh38
na,na,X,66931391,66931391,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67711549,67711549,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66943553,66943553,AR,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh37
na,na,X,67723711,67723711,AR,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh38
na,na,X,66943543,66943543,AR,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh37
na,na,X,67723701,67723701,AR,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh38
na,na,X,66943628,66943628,AR,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh37
na,na,X,67723786,67723786,AR,Pathogenic,"Prostate cancer, somatic",single nucleotide variant,GRCh38
na,na,X,66931522,66931522,AR,Uncertain significance,"Prostate cancer, somatic|Kennedy disease;Androgen resistance syndrome|not specified",single nucleotide variant,GRCh37
na,na,X,67711680,67711680,AR,Uncertain significance,"Prostate cancer, somatic|Kennedy disease;Androgen resistance syndrome|not specified",single nucleotide variant,GRCh38
na,na,X,66931481,66931481,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67711639,67711639,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66863220,66863220,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67643378,67643378,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66863229,66863229,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67643387,67643387,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66863126,66863126,AR,Uncertain significance,"Hypospadias 1, X-linked|not specified",single nucleotide variant,GRCh37
na,na,X,67643284,67643284,AR,Uncertain significance,"Hypospadias 1, X-linked|not specified",single nucleotide variant,GRCh38
na,na,X,66764992,66764992,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh37
na,na,X,67545150,67545150,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh38
na,na,X,66941699,66941699,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67721857,67721857,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66905841,66905841,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh37
na,na,X,67685999,67685999,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh38
na,na,X,66765509,66765509,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh37
na,na,X,67545667,67545667,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh38
na,na,X,66941751,66941751,AR,Conflicting classifications of pathogenicity,Partial androgen insensitivity syndrome|not provided|Kennedy disease;Androgen resistance syndrome|Prostate cancer|not specified|Male infertility,single nucleotide variant,GRCh37
na,na,X,67721909,67721909,AR,Conflicting classifications of pathogenicity,Partial androgen insensitivity syndrome|not provided|Kennedy disease;Androgen resistance syndrome|Prostate cancer|not specified|Male infertility,single nucleotide variant,GRCh38
na,na,X,66941779,66941779,AR,Likely pathogenic,Partial androgen insensitivity syndrome|Kennedy disease;Androgen resistance syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,67721937,67721937,AR,Likely pathogenic,Partial androgen insensitivity syndrome|Kennedy disease;Androgen resistance syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,66765166,66765167,AR,Pathogenic,Androgen resistance syndrome,Duplication,GRCh37
na,na,X,67545324,67545325,AR,Pathogenic,Androgen resistance syndrome,Duplication,GRCh38
na,na,X,66937326,66937326,AR,Conflicting classifications of pathogenicity,Prostate cancer susceptibility|Prostate cancer|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67717484,67717484,AR,Conflicting classifications of pathogenicity,Prostate cancer susceptibility|Prostate cancer|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66943587,66943587,AR,Pathogenic,Androgen resistance syndrome|not provided|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67723745,67723745,AR,Pathogenic,Androgen resistance syndrome|not provided|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66941810,66941810,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh37
na,na,X,67721968,67721968,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh38
na,na,X,66931495,66931495,AR,Pathogenic,Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67711653,67711653,AR,Pathogenic,Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66863213,66863213,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67643371,67643371,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66942815,66942815,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67722973,67722973,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66931427,66931427,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67711585,67711585,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66937377,66937377,AR,Pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67717535,67717535,AR,Pathogenic,Partial androgen insensitivity syndrome|Androgen resistance syndrome|Kennedy disease;Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66937377,66937377,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh37
na,na,X,67717535,67717535,AR,Pathogenic,Androgen resistance syndrome,single nucleotide variant,GRCh38
na,na,X,66937427,66937433,AR,Pathogenic,Androgen resistance syndrome,Indel,GRCh37
na,na,X,67717585,67717591,AR,Pathogenic,Androgen resistance syndrome,Indel,GRCh38
na,na,X,66937368,66937368,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh37
na,na,X,67717526,67717526,AR,Pathogenic,Partial androgen insensitivity syndrome,single nucleotide variant,GRCh38
na,na,X,66931295,66931295,AR,Conflicting classifications of pathogenicity,Partial androgen insensitivity syndrome|not specified|not provided|Castleman-Kojima disease|Male infertility|Kennedy disease;Androgen resistance syndrome|AR-related disorder,single nucleotide variant,GRCh37
na,na,X,67711453,67711453,AR,Conflicting classifications of pathogenicity,Partial androgen insensitivity syndrome|not specified|not provided|Castleman-Kojima disease|Male infertility|Kennedy disease;Androgen resistance syndrome|AR-related disorder,single nucleotide variant,GRCh38
na,na,na,-1,-1,TAF1,Pathogenic,X-linked dystonia-parkinsonism,Insertion,na
na,na,X,49050771,49050772,SYP,Pathogenic,"Intellectual disability, X-linked 96",Duplication,GRCh37
na,na,X,49194314,49194315,SYP,Pathogenic,"Intellectual disability, X-linked 96",Duplication,GRCh38
na,na,X,49054223,49054224,SYP,Pathogenic,"Intellectual disability, X-linked 96",Indel,GRCh37
na,na,X,49197764,49197765,SYP,Pathogenic,"Intellectual disability, X-linked 96",Indel,GRCh38
na,na,X,49048187,49048187,SYP,Pathogenic,"Intellectual disability, X-linked 96",single nucleotide variant,GRCh37
na,na,X,49191730,49191730,SYP,Pathogenic,"Intellectual disability, X-linked 96",single nucleotide variant,GRCh38
na,na,X,47435621,47435621,SYN1,Pathogenic,"Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders",single nucleotide variant,GRCh37
na,na,X,47576222,47576222,SYN1,Pathogenic,"Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders",single nucleotide variant,GRCh38
na,na,X,139586481,139586482,SOX3,Pathogenic,X-linked intellectual disability with isolated growth hormone deficiency,Duplication,GRCh37
na,na,X,140504316,140504317,SOX3,Pathogenic,X-linked intellectual disability with isolated growth hormone deficiency,Duplication,GRCh38
na,na,na,-1,-1,SOX3,Pathogenic,"Panhypopituitarism, X-linked",Insertion,na
na,na,X,139586494,139586495,SOX3,Pathogenic,"Panhypopituitarism, X-linked",Duplication,GRCh37
na,na,X,140504329,140504330,SOX3,Pathogenic,"Panhypopituitarism, X-linked",Duplication,GRCh38
na,na,X,601772,601772,SHOX,Pathogenic,SHOX-related short stature|not provided|Leri-Weill dyschondrosteosis|SHOX-related disorder,single nucleotide variant,GRCh37
na,na,Y,551772,551772,SHOX,Pathogenic,SHOX-related short stature|not provided|Leri-Weill dyschondrosteosis|SHOX-related disorder,single nucleotide variant,GRCh37
na,na,X,641037,641037,SHOX,Pathogenic,SHOX-related short stature|not provided|Leri-Weill dyschondrosteosis|SHOX-related disorder,single nucleotide variant,GRCh38
na,na,Y,641037,641037,SHOX,Pathogenic,SHOX-related short stature|not provided|Leri-Weill dyschondrosteosis|SHOX-related disorder,single nucleotide variant,GRCh38
na,na,X,601786,601786,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,Y,551786,551786,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,X,641051,641051,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,Y,641051,641051,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,na,-1,-1,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis,Deletion,na
na,na,X,595469,595469,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,Y,545469,545469,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,X,634734,634734,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,Y,634734,634734,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,X,595533,595533,SHOX,Likely pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,Y,545533,545533,SHOX,Likely pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,X,634798,634798,SHOX,Likely pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,Y,634798,634798,SHOX,Likely pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,X,591812,591812,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,Deletion,GRCh37
na,na,Y,541812,541812,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,Deletion,GRCh37
na,na,X,631077,631077,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,Deletion,GRCh38
na,na,Y,631077,631077,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,Deletion,GRCh38
na,na,X,601586,601586,SHOX,Pathogenic,Leri-Weill dyschondrosteosis|not provided|SHOX-related disorder,single nucleotide variant,GRCh37
na,na,Y,551586,551586,SHOX,Pathogenic,Leri-Weill dyschondrosteosis|not provided|SHOX-related disorder,single nucleotide variant,GRCh37
na,na,X,640851,640851,SHOX,Pathogenic,Leri-Weill dyschondrosteosis|not provided|SHOX-related disorder,single nucleotide variant,GRCh38
na,na,Y,640851,640851,SHOX,Pathogenic,Leri-Weill dyschondrosteosis|not provided|SHOX-related disorder,single nucleotide variant,GRCh38
na,na,X,601571,601571,SHOX,Pathogenic/Likely pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis|not provided,single nucleotide variant,GRCh37
na,na,Y,551571,551571,SHOX,Pathogenic/Likely pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis|not provided,single nucleotide variant,GRCh37
na,na,X,640836,640836,SHOX,Pathogenic/Likely pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis|not provided,single nucleotide variant,GRCh38
na,na,Y,640836,640836,SHOX,Pathogenic/Likely pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis|not provided,single nucleotide variant,GRCh38
na,na,X,605214,605215,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis,Duplication,GRCh37
na,na,Y,555214,555215,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis,Duplication,GRCh37
na,na,X,644479,644480,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis,Duplication,GRCh38
na,na,Y,644479,644480,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis,Duplication,GRCh38
na,na,X,595424,595425,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|not provided,Microsatellite,GRCh37
na,na,Y,545424,545425,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|not provided,Microsatellite,GRCh37
na,na,X,634689,634690,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|not provided,Microsatellite,GRCh38
na,na,Y,634689,634690,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|not provided,Microsatellite,GRCh38
na,na,X,595379,595379,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,Y,545379,545379,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,X,634644,634644,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,Y,634644,634644,SHOX,Pathogenic,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,X,605369,605369,SHOX,Uncertain significance,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,Y,555369,555369,SHOX,Uncertain significance,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh37
na,na,X,644634,644634,SHOX,Uncertain significance,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,Y,644634,644634,SHOX,Uncertain significance,Leri-Weill dyschondrosteosis,single nucleotide variant,GRCh38
na,na,na,-1,-1,SHOX,Pathogenic,Langer mesomelic dysplasia syndrome|Leri-Weill dyschondrosteosis,Deletion,na
na,na,X,113965735,113965735,HTR2C,Benign,HTR2C POLYMORPHISM|not provided|HTR2C-related disorder,single nucleotide variant,GRCh37
na,na,X,114731326,114731326,HTR2C,Benign,HTR2C POLYMORPHISM|not provided|HTR2C-related disorder,single nucleotide variant,GRCh38
na,na,X,18665351,18665351,RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,X,18647231,18647231,RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,X,18665333,18665333,RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy|Retinoschisis,single nucleotide variant,GRCh37
na,na,X,18647213,18647213,RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy|Retinoschisis,single nucleotide variant,GRCh38
na,na,X,18665423,18665423,CDKL5;RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,18647303,18647303,CDKL5;RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,18665421,18665421,RS1,Pathogenic,Juvenile retinoschisis|not provided,single nucleotide variant,GRCh37
na,na,X,18647301,18647301,RS1,Pathogenic,Juvenile retinoschisis|not provided,single nucleotide variant,GRCh38
na,na,X,18665416,18665416,RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,X,18647296,18647296,RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,X,18665312,18665312,RS1,Pathogenic,Juvenile retinoschisis|not provided,single nucleotide variant,GRCh37
na,na,X,18647192,18647192,RS1,Pathogenic,Juvenile retinoschisis|not provided,single nucleotide variant,GRCh38
na,na,X,18690151,18690151,RS1,Pathogenic/Likely pathogenic,Juvenile retinoschisis|not provided,single nucleotide variant,GRCh37
na,na,X,18672031,18672031,RS1,Pathogenic/Likely pathogenic,Juvenile retinoschisis|not provided,single nucleotide variant,GRCh38
na,na,X,18660132,18660132,RS1,Pathogenic,Juvenile retinoschisis|not provided,single nucleotide variant,GRCh37
na,na,X,18642012,18642012,RS1,Pathogenic,Juvenile retinoschisis|not provided,single nucleotide variant,GRCh38
na,na,X,18660191,18660191,RS1,Pathogenic/Likely pathogenic,Juvenile retinoschisis|not provided|Retinoschisis|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,X,18642071,18642071,RS1,Pathogenic/Likely pathogenic,Juvenile retinoschisis|not provided|Retinoschisis|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,X,18665332,18665332,RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy|RS1-related disorder,single nucleotide variant,GRCh37
na,na,X,18647212,18647212,RS1,Pathogenic,Juvenile retinoschisis|not provided|Retinal dystrophy|RS1-related disorder,single nucleotide variant,GRCh38
na,na,X,38178162,38178162,RPGR,Uncertain significance,Retinitis pigmentosa 3|not provided|RPGR-related retinopathy,single nucleotide variant,GRCh37
na,na,X,38318909,38318909,RPGR,Uncertain significance,Retinitis pigmentosa 3|not provided|RPGR-related retinopathy,single nucleotide variant,GRCh38
na,na,X,38169943,38169943,RPGR,Pathogenic,not provided|Retinitis pigmentosa 3,single nucleotide variant,GRCh37
na,na,X,38310690,38310690,RPGR,Pathogenic,not provided|Retinitis pigmentosa 3,single nucleotide variant,GRCh38
na,na,X,38163999,38163999,RPGR,Pathogenic,Retinitis pigmentosa 3|not provided|Retinitis pigmentosa|Primary ciliary dyskinesia|RPGR-related retinopathy,single nucleotide variant,GRCh37
na,na,X,38304746,38304746,RPGR,Pathogenic,Retinitis pigmentosa 3|not provided|Retinitis pigmentosa|Primary ciliary dyskinesia|RPGR-related retinopathy,single nucleotide variant,GRCh38
na,na,X,38182174,38182174,RPGR,Likely pathogenic,Retinitis pigmentosa 3|not provided|Primary ciliary dyskinesia|Retinal dystrophy|RPGR-related disorder|RPGR-related retinopathy,single nucleotide variant,GRCh37
na,na,X,38322921,38322921,RPGR,Likely pathogenic,Retinitis pigmentosa 3|not provided|Primary ciliary dyskinesia|Retinal dystrophy|RPGR-related disorder|RPGR-related retinopathy,single nucleotide variant,GRCh38
na,na,na,-1,-1,RPGR,Pathogenic,Retinitis pigmentosa 3,Deletion,na
na,na,X,38180294,38180294,RPGR,Pathogenic,Retinitis pigmentosa 3|not provided,single nucleotide variant,GRCh37
na,na,X,38321041,38321041,RPGR,Pathogenic,Retinitis pigmentosa 3|not provided,single nucleotide variant,GRCh38
na,na,X,38145602,38145602,RPGR,Pathogenic,Retinitis pigmentosa 3|not provided|Primary ciliary dyskinesia,single nucleotide variant,GRCh37
na,na,X,38286349,38286349,RPGR,Pathogenic,Retinitis pigmentosa 3|not provided|Primary ciliary dyskinesia,single nucleotide variant,GRCh38
na,na,X,38145155,38145156,RPGR,Pathogenic,"X-linked cone-rod dystrophy 1|Retinal dystrophy|Cone dystrophy|Retinitis pigmentosa 3|Cone dystrophy 1, X-linked|Primary ciliary dyskinesia|RPGR-related retinopathy|RPGR-related disorder",Deletion,GRCh37
na,na,X,38285902,38285903,RPGR,Pathogenic,"X-linked cone-rod dystrophy 1|Retinal dystrophy|Cone dystrophy|Retinitis pigmentosa 3|Cone dystrophy 1, X-linked|Primary ciliary dyskinesia|RPGR-related retinopathy|RPGR-related disorder",Deletion,GRCh38
na,na,X,38145159,38145160,RPGR,Pathogenic,X-linked cone-rod dystrophy 1|Retinal dystrophy|Retinitis pigmentosa 3|Cone dystrophy|RPGR-related disorder|Primary ciliary dyskinesia,Microsatellite,GRCh37
na,na,X,38285906,38285907,RPGR,Pathogenic,X-linked cone-rod dystrophy 1|Retinal dystrophy|Retinitis pigmentosa 3|Cone dystrophy|RPGR-related disorder|Primary ciliary dyskinesia,Microsatellite,GRCh38
na,na,X,38178081,38178081,RPGR,Pathogenic,"Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness|not provided",single nucleotide variant,GRCh37
na,na,X,38318828,38318828,RPGR,Pathogenic,"Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness|not provided",single nucleotide variant,GRCh38
na,na,X,38164032,38164033,RPGR,Pathogenic,"RETINITIS PIGMENTOSA, SINORESPIRATORY INFECTIONS, AND DEAFNESS",Microsatellite,GRCh37
na,na,X,38304779,38304780,RPGR,Pathogenic,"RETINITIS PIGMENTOSA, SINORESPIRATORY INFECTIONS, AND DEAFNESS",Microsatellite,GRCh38
na,na,X,38176671,38176671,RPGR,Pathogenic,"not provided|RETINITIS PIGMENTOSA, SINORESPIRATORY INFECTIONS, AND DEAFNESS",single nucleotide variant,GRCh37
na,na,X,38317418,38317418,RPGR,Pathogenic,"not provided|RETINITIS PIGMENTOSA, SINORESPIRATORY INFECTIONS, AND DEAFNESS",single nucleotide variant,GRCh38
na,na,X,38145404,38145405,RPGR,Pathogenic,X-linked cone-rod dystrophy 1,Inversion,GRCh37
na,na,X,38286151,38286152,RPGR,Pathogenic,X-linked cone-rod dystrophy 1,Inversion,GRCh38
na,na,X,38145323,38145323,RPGR,Pathogenic,X-linked cone-rod dystrophy 1,single nucleotide variant,GRCh37
na,na,X,38286070,38286070,RPGR,Pathogenic,X-linked cone-rod dystrophy 1,single nucleotide variant,GRCh38
na,na,X,38176560,38176616,RPGR,Pathogenic,"Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness",Deletion,GRCh37
na,na,X,38317307,38317363,RPGR,Pathogenic,"Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness",Deletion,GRCh38
na,na,X,38160137,38160137,RPGR,Uncertain significance,Retinitis pigmentosa 3|Primary ciliary dyskinesia|not specified,single nucleotide variant,GRCh37
na,na,X,38300884,38300884,RPGR,Uncertain significance,Retinitis pigmentosa 3|Primary ciliary dyskinesia|not specified,single nucleotide variant,GRCh38
na,na,X,118717141,118717141,UBE2A,Pathogenic,Syndromic X-linked intellectual disability Nascimento type,single nucleotide variant,GRCh37
na,na,X,119583178,119583178,UBE2A,Pathogenic,Syndromic X-linked intellectual disability Nascimento type,single nucleotide variant,GRCh38
na,na,X,71802412,71802412,PHKA1,Pathogenic,Glycogen storage disease IXd,single nucleotide variant,GRCh37
na,na,X,72582562,72582562,PHKA1,Pathogenic,Glycogen storage disease IXd,single nucleotide variant,GRCh38
na,na,X,71802247,71802247,PHKA1,Pathogenic,Glycogen storage disease IXd,single nucleotide variant,GRCh37
na,na,X,72582397,72582397,PHKA1,Pathogenic,Glycogen storage disease IXd,single nucleotide variant,GRCh38
na,na,X,71877460,71877460,PHKA1,Pathogenic,Glycogen storage disease IXd,single nucleotide variant,GRCh37
na,na,X,72657610,72657610,PHKA1,Pathogenic,Glycogen storage disease IXd,single nucleotide variant,GRCh38
na,na,X,71887247,71887247,PHKA1,Pathogenic,Glycogen storage disease IXd,Deletion,GRCh37
na,na,X,72667397,72667397,PHKA1,Pathogenic,Glycogen storage disease IXd,Deletion,GRCh38
na,na,X,71887275,71887275,PHKA1,Pathogenic,Glycogen storage disease IXd,single nucleotide variant,GRCh37
na,na,X,72667425,72667425,PHKA1,Pathogenic,Glycogen storage disease IXd,single nucleotide variant,GRCh38
na,na,X,106884166,106884166,PRPS1,Likely pathogenic,Phosphoribosylpyrophosphate synthetase superactivity|Arts syndrome|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,107640936,107640936,PRPS1,Likely pathogenic,Phosphoribosylpyrophosphate synthetase superactivity|Arts syndrome|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,106888423,106888423,PRPS1,Likely pathogenic,Phosphoribosylpyrophosphate synthetase superactivity|Arts syndrome,single nucleotide variant,GRCh37
na,na,X,107645193,107645193,PRPS1,Likely pathogenic,Phosphoribosylpyrophosphate synthetase superactivity|Arts syndrome,single nucleotide variant,GRCh38
na,na,X,106882556,106882556,PRPS1,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,single nucleotide variant,GRCh37
na,na,X,107639326,107639326,PRPS1,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,single nucleotide variant,GRCh38
na,na,X,106884210,106884210,PRPS1,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,single nucleotide variant,GRCh37
na,na,X,107640980,107640980,PRPS1,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,single nucleotide variant,GRCh38
na,na,X,106888445,106888445,PRPS1,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,single nucleotide variant,GRCh37
na,na,X,107645215,107645215,PRPS1,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,single nucleotide variant,GRCh38
na,na,X,106888455,106888455,PRPS1,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,single nucleotide variant,GRCh37
na,na,X,107645225,107645225,PRPS1,no classifications from unflagged records,Phosphoribosylpyrophosphate synthetase superactivity,single nucleotide variant,GRCh38
na,na,X,106882531,106882531,PRPS1,Pathogenic,Charcot-Marie-Tooth disease X-linked recessive 5,single nucleotide variant,GRCh37
na,na,X,107639301,107639301,PRPS1,Pathogenic,Charcot-Marie-Tooth disease X-linked recessive 5,single nucleotide variant,GRCh38
na,na,X,106884169,106884169,PRPS1,Likely pathogenic,Charcot-Marie-Tooth disease X-linked recessive 5|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh37
na,na,X,107640939,107640939,PRPS1,Likely pathogenic,Charcot-Marie-Tooth disease X-linked recessive 5|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh38
na,na,X,106885645,106885645,PRPS1,Uncertain significance,not provided|Arts syndrome,single nucleotide variant,GRCh37
na,na,X,107642415,107642415,PRPS1,Uncertain significance,not provided|Arts syndrome,single nucleotide variant,GRCh38
na,na,X,106884223,106884223,PRPS1,Pathogenic,Arts syndrome,single nucleotide variant,GRCh37
na,na,X,107640993,107640993,PRPS1,Pathogenic,Arts syndrome,single nucleotide variant,GRCh38
na,na,X,106882595,106882595,PRPS1,Pathogenic,"Hearing loss, X-linked 1",single nucleotide variant,GRCh37
na,na,X,107639365,107639365,PRPS1,Pathogenic,"Hearing loss, X-linked 1",single nucleotide variant,GRCh38
na,na,X,106882661,106882661,PRPS1,Uncertain significance,"Hearing loss, X-linked 1|Charcot-Marie-Tooth Neuropathy X",single nucleotide variant,GRCh37
na,na,X,107639431,107639431,PRPS1,Uncertain significance,"Hearing loss, X-linked 1|Charcot-Marie-Tooth Neuropathy X",single nucleotide variant,GRCh38
na,na,X,106893221,106893221,PRPS1,Pathogenic/Likely pathogenic,"Hearing loss, X-linked 1|PRPS1-related disorder",single nucleotide variant,GRCh37
na,na,X,107649991,107649991,PRPS1,Pathogenic/Likely pathogenic,"Hearing loss, X-linked 1|PRPS1-related disorder",single nucleotide variant,GRCh38
na,na,X,106893174,106893174,PRPS1,Pathogenic,"Hearing loss, X-linked 1",single nucleotide variant,GRCh37
na,na,X,107649944,107649944,PRPS1,Pathogenic,"Hearing loss, X-linked 1",single nucleotide variant,GRCh38
na,na,X,77378737,77378737,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh37
na,na,X,78123240,78123240,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh38
na,na,X,77373643,77373643,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh37
na,na,X,78118146,78118146,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh38
na,na,X,77378731,77378733,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,Indel,GRCh37
na,na,X,78123234,78123236,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,Indel,GRCh38
na,na,X,77380489,77380489,PGK1,other,Phosphoglycerate kinase electrophoretic variant PGK II,single nucleotide variant,GRCh37
na,na,X,78124992,78124992,PGK1,other,Phosphoglycerate kinase electrophoretic variant PGK II,single nucleotide variant,GRCh38
na,na,X,77369387,77369387,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh37
na,na,X,78113890,78113890,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh38
na,na,X,77372864,77372864,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh37
na,na,X,78117367,78117367,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh38
na,na,X,77380380,77380380,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh37
na,na,X,78124883,78124883,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh38
na,na,X,77373596,77373598,PGK1,Conflicting classifications of pathogenicity,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|PGK1-related disorder,Microsatellite,GRCh37
na,na,X,78118099,78118101,PGK1,Conflicting classifications of pathogenicity,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|PGK1-related disorder,Microsatellite,GRCh38
na,na,X,77378693,77378693,PGK1,Uncertain significance,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,78123196,78123196,PGK1,Uncertain significance,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,77378789,77378789,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh37
na,na,X,78123292,78123292,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh38
na,na,X,77369264,77369264,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh37
na,na,X,78113767,78113767,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh38
na,na,X,77380393,77380393,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh37
na,na,X,78124896,78124896,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh38
na,na,X,77372882,77372882,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,78117385,78117385,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,77378451,77378451,PGK1,Likely pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,78122954,78122954,PGK1,Likely pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,77380841,77380841,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh37
na,na,X,78125344,78125344,PGK1,Pathogenic,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,single nucleotide variant,GRCh38
na,na,X,15342785,15342785,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Deletion,GRCh37
na,na,X,15324663,15324663,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Deletion,GRCh38
na,na,X,15349759,15349759,PIGA,Likely pathogenic,Paroxysmal nocturnal hemoglobinuria|not provided,single nucleotide variant,GRCh37
na,na,X,15331637,15331637,PIGA,Likely pathogenic,Paroxysmal nocturnal hemoglobinuria|not provided,single nucleotide variant,GRCh38
na,na,X,15349593,15349594,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Insertion,GRCh37
na,na,X,15331471,15331472,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Insertion,GRCh38
na,na,X,15342860,15342860,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Deletion,GRCh37
na,na,X,15324738,15324738,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Deletion,GRCh38
na,na,X,15349890,15349890,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,single nucleotide variant,GRCh37
na,na,X,15331768,15331768,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,single nucleotide variant,GRCh38
na,na,X,15349803,15349804,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Insertion,GRCh37
na,na,X,15331681,15331682,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Insertion,GRCh38
na,na,X,15349622,15349622,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Deletion,GRCh37
na,na,X,15331500,15331500,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Deletion,GRCh38
na,na,X,15339759,15339760,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Deletion,GRCh37
na,na,X,15321637,15321638,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Deletion,GRCh38
na,na,X,15342786,15342786,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,single nucleotide variant,GRCh37
na,na,X,15324664,15324664,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,single nucleotide variant,GRCh38
na,na,X,15339727,15339728,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Insertion,GRCh37
na,na,X,15321605,15321606,PIGA,Pathogenic,Paroxysmal nocturnal hemoglobinuria,Insertion,GRCh38
na,na,X,43591031,43591031,MAOA,Pathogenic,Brunner syndrome,single nucleotide variant,GRCh37
na,na,X,43731784,43731784,MAOA,Pathogenic,Brunner syndrome,single nucleotide variant,GRCh38
na,na,X,43514349,43514378,MAOA,Pathogenic; risk factor,"Autism, severe|Antisocial behavior, susceptibility to",Microsatellite,GRCh37
na,na,X,43655101,43655130,MAOA,Pathogenic; risk factor,"Autism, severe|Antisocial behavior, susceptibility to",Microsatellite,GRCh38
na,na,X,147018053,147018053,FMR1,Pathogenic,Fragile X syndrome,single nucleotide variant,GRCh37
na,na,X,147936534,147936534,FMR1,Pathogenic,Fragile X syndrome,single nucleotide variant,GRCh38
na,na,X,147010279,147010279,FMR1,Pathogenic,Fragile X syndrome,Deletion,GRCh37
na,na,X,147928761,147928761,FMR1,Pathogenic,Fragile X syndrome,Deletion,GRCh38
na,na,X,147003450,147003451,FMR1,Pathogenic,Fragile X syndrome,Indel,GRCh37
na,na,X,147921932,147921933,FMR1,Pathogenic,Fragile X syndrome,Indel,GRCh38
na,na,na,-1,-1,FMR1,Pathogenic,Fragile X-associated tremor/ataxia syndrome|Fragile X syndrome|Premature ovarian failure 1,Microsatellite,na
na,na,X,119582941,119582941,LAMP2,Pathogenic,Danon disease,single nucleotide variant,GRCh37
na,na,X,120449086,120449086,LAMP2,Pathogenic,Danon disease,single nucleotide variant,GRCh38
na,na,X,119580155,119580155,LAMP2,Pathogenic,Danon disease,single nucleotide variant,GRCh37
na,na,X,120446300,120446300,LAMP2,Pathogenic,Danon disease,single nucleotide variant,GRCh38
na,na,X,119575704,119575704,LAMP2,Pathogenic,Danon disease,Indel,GRCh37
na,na,X,120441849,120441849,LAMP2,Pathogenic,Danon disease,Indel,GRCh38
na,na,X,119581695,119581695,LAMP2,Pathogenic/Likely pathogenic,Danon disease|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,X,120447840,120447840,LAMP2,Pathogenic/Likely pathogenic,Danon disease|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,X,119603011,119603011,LAMP2,Pathogenic,Danon disease,Deletion,GRCh37
na,na,X,120469156,120469156,LAMP2,Pathogenic,Danon disease,Deletion,GRCh38
na,na,X,119576498,119576499,LAMP2,Pathogenic,Danon disease,Duplication,GRCh37
na,na,X,120442643,120442644,LAMP2,Pathogenic,Danon disease,Duplication,GRCh38
na,na,X,119602983,119602989,LAMP2,Pathogenic,Danon disease,Deletion,GRCh37
na,na,X,120469128,120469134,LAMP2,Pathogenic,Danon disease,Deletion,GRCh38
na,na,X,119582861,119582861,LAMP2,Pathogenic,Danon disease,single nucleotide variant,GRCh37
na,na,X,120449006,120449006,LAMP2,Pathogenic,Danon disease,single nucleotide variant,GRCh38
na,na,X,119576454,119576454,LAMP2,Pathogenic,Danon disease|not provided|Danon disease;Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,X,120442599,120442599,LAMP2,Pathogenic,Danon disease|not provided|Danon disease;Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,X,119575717,119575717,LAMP2,Uncertain significance,Danon disease,single nucleotide variant,GRCh37
na,na,X,120441862,120441862,LAMP2,Uncertain significance,Danon disease,single nucleotide variant,GRCh38
na,na,X,153131293,153131293,L1CAM,Pathogenic,X-linked hydrocephalus syndrome,single nucleotide variant,GRCh37
na,na,X,153865838,153865838,L1CAM,Pathogenic,X-linked hydrocephalus syndrome,single nucleotide variant,GRCh38
na,na,X,153135858,153135858,L1CAM,Pathogenic,X-linked hydrocephalus syndrome,single nucleotide variant,GRCh37
na,na,X,153870403,153870403,L1CAM,Pathogenic,X-linked hydrocephalus syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,L1CAM,Pathogenic,X-linked hydrocephalus syndrome,Duplication,na
na,na,X,153136309,153136309,L1CAM,Pathogenic,MASA syndrome,single nucleotide variant,GRCh37
na,na,X,153870854,153870854,L1CAM,Pathogenic,MASA syndrome,single nucleotide variant,GRCh38
na,na,X,153133489,153133489,L1CAM,Pathogenic,MASA syndrome,single nucleotide variant,GRCh37
na,na,X,153868034,153868034,L1CAM,Pathogenic,MASA syndrome,single nucleotide variant,GRCh38
na,na,X,153134321,153134321,L1CAM,Pathogenic,X-linked hydrocephalus syndrome|not provided|Hydrocephalus due to aqueductal stenosis|Spastic paraplegia|L1 syndrome,single nucleotide variant,GRCh37
na,na,X,153868866,153868866,L1CAM,Pathogenic,X-linked hydrocephalus syndrome|not provided|Hydrocephalus due to aqueductal stenosis|Spastic paraplegia|L1 syndrome,single nucleotide variant,GRCh38
na,na,X,153136388,153136388,L1CAM,Pathogenic,X-linked hydrocephalus syndrome|L1 syndrome|Inborn genetic diseases|Spastic paraplegia,single nucleotide variant,GRCh37
na,na,X,153870933,153870933,L1CAM,Pathogenic,X-linked hydrocephalus syndrome|L1 syndrome|Inborn genetic diseases|Spastic paraplegia,single nucleotide variant,GRCh38
na,na,X,153128972,153128973,L1CAM,Pathogenic,MASA syndrome|not provided,Deletion,GRCh37
na,na,X,153863517,153863518,L1CAM,Pathogenic,MASA syndrome|not provided,Deletion,GRCh38
na,na,X,153128311,153128311,L1CAM,Pathogenic/Likely pathogenic,X-linked hydrocephalus syndrome|MASA syndrome|not provided|Hydrops fetalis;Severe hydrocephalus|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,153862856,153862856,L1CAM,Pathogenic/Likely pathogenic,X-linked hydrocephalus syndrome|MASA syndrome|not provided|Hydrops fetalis;Severe hydrocephalus|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,153136403,153136403,L1CAM,Pathogenic,MASA syndrome,single nucleotide variant,GRCh37
na,na,X,153870948,153870948,L1CAM,Pathogenic,MASA syndrome,single nucleotide variant,GRCh38
na,na,X,153135273,153135273,L1CAM,Pathogenic,MASA syndrome|not provided|X-linked hydrocephalus syndrome|Spastic paraplegia|L1CAM-related disorders,single nucleotide variant,GRCh37
na,na,X,153869818,153869818,L1CAM,Pathogenic,MASA syndrome|not provided|X-linked hydrocephalus syndrome|Spastic paraplegia|L1CAM-related disorders,single nucleotide variant,GRCh38
na,na,X,153132113,153132114,L1CAM,Pathogenic,X-linked hydrocephalus syndrome,Deletion,GRCh37
na,na,X,153866658,153866659,L1CAM,Pathogenic,X-linked hydrocephalus syndrome,Deletion,GRCh38
na,na,X,153132281,153132281,L1CAM,Pathogenic,Spastic paraplegia|not provided|X-linked hydrocephalus syndrome,single nucleotide variant,GRCh37
na,na,X,153866826,153866826,L1CAM,Pathogenic,Spastic paraplegia|not provided|X-linked hydrocephalus syndrome,single nucleotide variant,GRCh38
na,na,X,153133250,153133250,L1CAM,Likely pathogenic,Spastic paraplegia|X-linked hydrocephalus syndrome,single nucleotide variant,GRCh37
na,na,X,153867795,153867795,L1CAM,Likely pathogenic,Spastic paraplegia|X-linked hydrocephalus syndrome,single nucleotide variant,GRCh38
na,na,X,153130348,153130348,L1CAM,Pathogenic,"Hydrocephalus, X-linked, with congenital idiopathic intestinal pseudoobstruction|not provided",single nucleotide variant,GRCh37
na,na,X,153864893,153864893,L1CAM,Pathogenic,"Hydrocephalus, X-linked, with congenital idiopathic intestinal pseudoobstruction|not provided",single nucleotide variant,GRCh38
na,na,X,153135930,153135930,L1CAM,Pathogenic/Likely pathogenic,X-linked complicated corpus callosum dysgenesis|X-linked hydrocephalus syndrome|Congenital cerebellar hypoplasia|not provided|MASA syndrome|L1 syndrome|Spastic paraplegia|X-linked complicated corpus callosum dysgenesis;MASA syndrome;X-linked hydrocephalus syndrome,single nucleotide variant,GRCh37
na,na,X,153870475,153870475,L1CAM,Pathogenic/Likely pathogenic,X-linked complicated corpus callosum dysgenesis|X-linked hydrocephalus syndrome|Congenital cerebellar hypoplasia|not provided|MASA syndrome|L1 syndrome|Spastic paraplegia|X-linked complicated corpus callosum dysgenesis;MASA syndrome;X-linked hydrocephalus syndrome,single nucleotide variant,GRCh38
na,na,X,8499953,8503220,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Deletion,GRCh37
na,na,X,8531912,8535179,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Deletion,GRCh38
na,na,X,8555850,8555850,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh37
na,na,X,8587809,8587809,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh38
na,na,X,8553395,8553395,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh37
na,na,X,8585354,8585354,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh38
na,na,X,8553390,8553390,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh37
na,na,X,8585349,8585349,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh38
na,na,X,8553333,8553333,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Deletion,GRCh37
na,na,X,8585292,8585292,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Deletion,GRCh38
na,na,na,-1,-1,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Deletion,na
na,na,X,8504893,8504893,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh37
na,na,X,8536852,8536852,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh38
na,na,X,8555833,8556017,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Deletion,GRCh37
na,na,X,8587792,8587976,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Deletion,GRCh38
na,na,X,8699972,8699973,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Duplication,GRCh37
na,na,X,8731931,8731932,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Duplication,GRCh38
na,na,X,8553380,8553380,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia|not provided,single nucleotide variant,GRCh37
na,na,X,8585339,8585339,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Deletion,na
na,na,X,8536293,8536293,ANOS1,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 1 with or without anosmia|not specified|not provided,single nucleotide variant,GRCh37
na,na,X,8568252,8568252,ANOS1,Conflicting classifications of pathogenicity,Hypogonadotropic hypogonadism 1 with or without anosmia|not specified|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,Deletion,na
na,na,X,8538539,8538539,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh37
na,na,X,8570498,8570498,ANOS1,Pathogenic,Hypogonadotropic hypogonadism 1 with or without anosmia,single nucleotide variant,GRCh38
na,na,X,70330453,70330453,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh37
na,na,X,71110603,71110603,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh38
na,na,X,70328128,70328128,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh37
na,na,X,71108278,71108278,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh38
na,na,X,70330830,70330830,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh37
na,na,X,71110980,71110980,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh38
na,na,X,70330467,70330467,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh37
na,na,X,71110617,71110617,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh38
na,na,X,70330353,70330353,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh37
na,na,X,71110503,71110503,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh38
na,na,X,70330142,70330142,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh37
na,na,X,71110292,71110292,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh38
na,na,X,70328173,70328173,IL2RG,Pathogenic,"Combined immunodeficiency, X-linked|X-linked severe combined immunodeficiency",single nucleotide variant,GRCh37
na,na,X,71108323,71108323,IL2RG,Pathogenic,"Combined immunodeficiency, X-linked|X-linked severe combined immunodeficiency",single nucleotide variant,GRCh38
na,na,X,70329123,70329124,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,Duplication,GRCh37
na,na,X,71109273,71109274,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,Duplication,GRCh38
na,na,X,70330465,70330465,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh37
na,na,X,71110615,71110615,IL2RG,Pathogenic,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh38
na,na,X,70328449,70328449,IL2RG,Pathogenic,X-linked severe combined immunodeficiency|not provided,single nucleotide variant,GRCh37
na,na,X,71108599,71108599,IL2RG,Pathogenic,X-linked severe combined immunodeficiency|not provided,single nucleotide variant,GRCh38
na,na,X,70329171,70329171,IL2RG,Pathogenic,"Combined immunodeficiency, X-linked|Inborn genetic diseases|X-linked severe combined immunodeficiency",single nucleotide variant,GRCh37
na,na,X,71109321,71109321,IL2RG,Pathogenic,"Combined immunodeficiency, X-linked|Inborn genetic diseases|X-linked severe combined immunodeficiency",single nucleotide variant,GRCh38
na,na,X,70330356,70330356,IL2RG,Uncertain significance,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh37
na,na,X,71110506,71110506,IL2RG,Uncertain significance,X-linked severe combined immunodeficiency,single nucleotide variant,GRCh38
na,na,X,133624229,133624229,HPRT1,Pathogenic; other,HPRT ANN ARBOR|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134490199,134490199,HPRT1,Pathogenic; other,HPRT ANN ARBOR|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133609315,133609315,HPRT1,Likely pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ARLINGTON|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134475285,134475285,HPRT1,Likely pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ARLINGTON|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133632707,133632707,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ASHVILLE,single nucleotide variant,GRCh37
na,na,X,134498677,134498677,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ASHVILLE,single nucleotide variant,GRCh38
na,na,X,133607416,133607417,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT CHICAGO,Duplication,GRCh37
na,na,X,134473386,134473387,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT CHICAGO,Duplication,GRCh38
na,na,na,-1,-1,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT CONNERSVILLE,Deletion,na
na,na,X,133607483,133607483,HPRT1,Pathogenic; other,Lesch-Nyhan syndrome|HPRT DETROIT,single nucleotide variant,GRCh37
na,na,X,134473453,134473453,HPRT1,Pathogenic; other,Lesch-Nyhan syndrome|HPRT DETROIT,single nucleotide variant,GRCh38
na,na,X,133634093,133634113,HPRT1,Pathogenic; other,Lesch-Nyhan syndrome|HPRT EVANSVILLE,Deletion,GRCh37
na,na,X,134500063,134500083,HPRT1,Pathogenic; other,Lesch-Nyhan syndrome|HPRT EVANSVILLE,Deletion,GRCh38
na,na,X,133609298,133609298,HPRT1,Pathogenic; other,HPRT FLINT|Lesch-Nyhan syndrome,single nucleotide variant,GRCh37
na,na,X,134475268,134475268,HPRT1,Pathogenic; other,HPRT FLINT|Lesch-Nyhan syndrome,single nucleotide variant,GRCh38
na,na,X,133632685,133632685,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh37
na,na,X,134498655,134498655,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh38
na,na,X,133620505,133620505,HPRT1,Likely pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT LONDON|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134486475,134486475,HPRT1,Likely pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT LONDON|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133632637,133632639,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT MICHIGAN,Microsatellite,GRCh37
na,na,X,134498607,134498609,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT MICHIGAN,Microsatellite,GRCh38
na,na,X,133624222,133624222,HPRT1,Pathogenic; other,HPRT MIDLAND|Lesch-Nyhan syndrome,single nucleotide variant,GRCh37
na,na,X,134490192,134490192,HPRT1,Pathogenic; other,HPRT MIDLAND|Lesch-Nyhan syndrome,single nucleotide variant,GRCh38
na,na,X,133627616,133627616,HPRT1,Likely pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MILWAUKEE|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134493586,134493586,HPRT1,Likely pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MILWAUKEE|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133609388,133609388,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MUNICH,single nucleotide variant,GRCh37
na,na,X,134475358,134475358,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MUNICH,single nucleotide variant,GRCh38
na,na,X,133632700,133632700,HPRT1,Pathogenic; other,Lesch-Nyhan syndrome|HPRT NEW BRITON,single nucleotide variant,GRCh37
na,na,X,134498670,134498670,HPRT1,Pathogenic; other,Lesch-Nyhan syndrome|HPRT NEW BRITON,single nucleotide variant,GRCh38
na,na,X,133609285,133609285,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT NEW HAVEN|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134475255,134475255,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT NEW HAVEN|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133609287,133609287,HPRT1,Likely pathogenic,HPRT YALE|Lesch-Nyhan syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,134475257,134475257,HPRT1,Likely pathogenic,HPRT YALE|Lesch-Nyhan syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,133620501,133620501,HPRT1,Pathogenic,Lesch-Nyhan syndrome|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,134486471,134486471,HPRT1,Pathogenic,Lesch-Nyhan syndrome|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,133634060,133634060,HPRT1,Likely pathogenic,Lesch-Nyhan syndrome|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134500030,134500030,HPRT1,Likely pathogenic,Lesch-Nyhan syndrome|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133607495,133607495,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh37
na,na,X,134473465,134473465,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh38
na,na,X,133632463,133632463,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh37
na,na,X,134498433,134498433,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh38
na,na,X,133609392,133609393,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Microsatellite,GRCh37
na,na,X,134475362,134475363,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Microsatellite,GRCh38
na,na,X,133607486,133607486,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,GRCh37
na,na,X,134473456,134473456,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,GRCh38
na,na,X,133624224,133624224,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,GRCh37
na,na,X,134490194,134490194,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,GRCh38
na,na,X,133609232,133609271,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,GRCh37
na,na,X,134475202,134475241,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,GRCh38
na,na,X,133632719,133632719,HPRT1,Likely pathogenic,Lesch-Nyhan syndrome|not provided|HPRT1-related disorder,single nucleotide variant,GRCh37
na,na,X,134498689,134498689,HPRT1,Likely pathogenic,Lesch-Nyhan syndrome|not provided|HPRT1-related disorder,single nucleotide variant,GRCh38
na,na,X,133634056,133634058,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Indel,GRCh37
na,na,X,134500026,134500028,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Indel,GRCh38
na,na,X,133632471,133632471,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh37
na,na,X,134498441,134498441,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh38
na,na,X,133607387,133607387,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT1-related disorder,single nucleotide variant,GRCh37
na,na,X,134473357,134473357,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT1-related disorder,single nucleotide variant,GRCh38
na,na,X,133632461,133632461,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh37
na,na,X,134498431,134498431,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh38
na,na,X,133609227,133609227,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT TORONTO,single nucleotide variant,GRCh37
na,na,X,134475197,134475197,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT TORONTO,single nucleotide variant,GRCh38
na,na,X,133609227,133609227,HPRT1,Pathogenic,Lesch-Nyhan syndrome|not provided|HPRT FUJIMI|Microcephaly|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134475197,134475197,HPRT1,Pathogenic,Lesch-Nyhan syndrome|not provided|HPRT FUJIMI|Microcephaly|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133609246,133609246,HPRT1,Pathogenic; other,"HPRT MONTREAL|Lesch-nyhan syndrome, neurologic variant|HPRT1-related disorder",single nucleotide variant,GRCh37
na,na,X,134475216,134475216,HPRT1,Pathogenic; other,"HPRT MONTREAL|Lesch-nyhan syndrome, neurologic variant|HPRT1-related disorder",single nucleotide variant,GRCh38
na,na,X,133627563,133627563,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh37
na,na,X,134493533,134493533,HPRT1,Pathogenic,Lesch-Nyhan syndrome,single nucleotide variant,GRCh38
na,na,X,133632442,133632442,HPRT1,Pathogenic/Likely pathogenic,Lesch-Nyhan syndrome|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134498412,134498412,HPRT1,Pathogenic/Likely pathogenic,Lesch-Nyhan syndrome|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,na
na,na,na,-1,-1,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,na
na,na,X,134493178,134501176,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,GRCh38
na,na,na,-1,-1,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,na
na,na,X,134460165,134500668,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,GRCh38
na,na,na,-1,-1,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,na
na,na,na,-1,-1,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Duplication,na
na,na,X,133632437,133632437,HPRT1,Pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134498407,134498407,HPRT1,Pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133607407,133607407,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT URANGAN,single nucleotide variant,GRCh37
na,na,X,134473377,134473377,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT URANGAN,single nucleotide variant,GRCh38
na,na,X,133609248,133609248,HPRT1,Pathogenic; other,HPRT TOOWONG|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134475218,134475218,HPRT1,Pathogenic; other,HPRT TOOWONG|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133609308,133609308,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT SWAN,single nucleotide variant,GRCh37
na,na,X,134475278,134475278,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT SWAN,single nucleotide variant,GRCh38
na,na,X,133627621,133627621,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT CHERMSIDE|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134493591,134493591,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT CHERMSIDE|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133607431,133607432,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT COORPAROO,Duplication,GRCh37
na,na,X,134473401,134473402,HPRT1,Pathogenic,Lesch-Nyhan syndrome|HPRT COORPAROO,Duplication,GRCh38
na,na,X,133609231,133609231,HPRT1,Uncertain significance,HPRT EDINBURGH|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134475201,134475201,HPRT1,Uncertain significance,HPRT EDINBURGH|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133627554,133627554,HPRT1,Uncertain significance,Lesch-Nyhan syndrome|HPRT TOKYO|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134493524,134493524,HPRT1,Uncertain significance,Lesch-Nyhan syndrome|HPRT TOKYO|Lesch-Nyhan syndrome;Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,133632687,133632687,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MOOSE JAW,single nucleotide variant,GRCh37
na,na,X,134498657,134498657,HPRT1,Pathogenic; other,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MOOSE JAW,single nucleotide variant,GRCh38
na,na,X,133627594,133627594,HPRT1,Pathogenic; other,Lesch-Nyhan syndrome|HPRT PARIS,single nucleotide variant,GRCh37
na,na,X,134493564,134493564,HPRT1,Pathogenic; other,Lesch-Nyhan syndrome|HPRT PARIS,single nucleotide variant,GRCh38
na,na,X,134459605,134462608,HPRT1,Pathogenic,Lesch-Nyhan syndrome,Deletion,GRCh38
na,na,X,133609269,133609269,HPRT1,Pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,134475239,134475239,HPRT1,Pathogenic,Partial hypoxanthine-guanine phosphoribosyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,154065952,154065952,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154837677,154837677,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154090034,154090034,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154861759,154861759,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154124378,154124378,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154896103,154896103,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154974508,154986431,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154930804,154933516,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,155022409,155022724,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154091436,154091436,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154863161,154863161,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154219579,154219579,F8,Uncertain significance,Hereditary factor VIII deficiency disease|F8-related disorder,single nucleotide variant,GRCh37
na,na,X,154991304,154991304,F8,Uncertain significance,Hereditary factor VIII deficiency disease|F8-related disorder,single nucleotide variant,GRCh38
na,na,X,154090033,154090033,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,154861758,154861758,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197743,154197743,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969468,154969468,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Benign,FACTOR VIII POLYMORPHISM,Insertion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Insertion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154065951,154065951,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154837676,154837676,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132300,154132300,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154904025,154904025,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154194800,154194800,F8,Pathogenic,FACTOR VIII (OKAYAMA)|Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154966525,154966525,F8,Pathogenic,FACTOR VIII (OKAYAMA)|Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154156952,154156952,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154928677,154928677,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154156943,154156943,F8,Pathogenic,FACTOR VIII (EAST HARTFORD)|Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154928668,154928668,F8,Pathogenic,FACTOR VIII (EAST HARTFORD)|Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154156969,154156969,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,154928694,154928694,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,154156882,154156882,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154928607,154928607,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154132301,154132301,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904026,154904026,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Benign,FACTOR VIII POLYMORPHISM,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154863228,155022724,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154835791,154837753,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154805077,155030999,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154194801,154194801,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154966526,154966526,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154065951,154065951,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154837676,154837676,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154091378,154091378,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154863103,154863103,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154124377,154124377,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154896102,154896102,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154221246,154221246,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154992971,154992971,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154134848,154175973,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154906573,154947698,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154194909,154194909,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154966634,154966634,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154132358,154132358,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904083,154904083,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197630,154197630,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969355,154969355,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194939,154194939,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966664,154966664,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194892,154194895,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154966617,154966620,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154173409,154173410,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh37
na,na,X,154945134,154945135,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh38
na,na,X,154194352,154194352,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 8 defect",single nucleotide variant,GRCh37
na,na,X,154966077,154966077,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 8 defect",single nucleotide variant,GRCh38
na,na,X,154156898,154156898,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154928623,154928623,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154065973,154065973,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154837698,154837698,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154134696,154134696,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154906421,154906421,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154182316,154182316,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154954041,154954041,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Inversion,na
na,na,X,154250785,154250785,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,155022510,155022510,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154250751,154250751,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,155022476,155022476,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154250739,154250739,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,155022464,155022464,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154250707,154250707,F8,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 8 defect|not specified",single nucleotide variant,GRCh37
na,na,X,155022432,155022432,F8,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 8 defect|not specified",single nucleotide variant,GRCh38
na,na,X,154227839,154227840,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh37
na,na,X,154999564,154999565,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh38
na,na,X,154227819,154227820,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154999544,154999545,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154227807,154227810,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,Deletion,GRCh37
na,na,X,154999532,154999535,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,Deletion,GRCh38
na,na,X,154225271,154225272,F8,Pathogenic,Hereditary factor VIII deficiency disease,Microsatellite,GRCh37
na,na,X,154996996,154996997,F8,Pathogenic,Hereditary factor VIII deficiency disease,Microsatellite,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154215582,154215582,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154987307,154987307,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154225370,154225370,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154997095,154997095,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154225361,154225361,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154997086,154997086,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154225340,154225340,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154997065,154997065,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154225325,154225325,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154997050,154997050,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154225313,154225313,F8,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|not specified|Thrombophilia, X-linked, due to factor 8 defect",single nucleotide variant,GRCh37
na,na,X,154997038,154997038,F8,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|not specified|Thrombophilia, X-linked, due to factor 8 defect",single nucleotide variant,GRCh38
na,na,X,154225308,154225308,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154997033,154997033,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154225286,154225286,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154997011,154997011,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154225248,154225248,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154996973,154996973,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154221416,154221416,F8,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 8 defect|Hemorrhage|F8-related disorder|Thrombophilia, X-linked, due to factor 8 defect;Hereditary factor VIII deficiency disease",single nucleotide variant,GRCh37
na,na,X,154993141,154993141,F8,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 8 defect|Hemorrhage|F8-related disorder|Thrombophilia, X-linked, due to factor 8 defect;Hereditary factor VIII deficiency disease",single nucleotide variant,GRCh38
na,na,X,154221414,154221414,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154993139,154993139,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154221408,154221408,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154993133,154993133,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154221402,154221402,F8,Uncertain significance,Hereditary factor VIII deficiency disease|not specified,single nucleotide variant,GRCh37
na,na,X,154993127,154993127,F8,Uncertain significance,Hereditary factor VIII deficiency disease|not specified,single nucleotide variant,GRCh38
na,na,X,154221321,154221321,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154993046,154993046,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154221319,154221319,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154993044,154993044,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154221271,154221271,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease|F8-related disorder,single nucleotide variant,GRCh37
na,na,X,154992996,154992996,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease|F8-related disorder,single nucleotide variant,GRCh38
na,na,X,154221258,154221258,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154992983,154992983,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154215517,154215517,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154987242,154987242,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154215512,154215512,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154987237,154987237,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154213060,154213061,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154984785,154984786,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154213080,154213080,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154984805,154984805,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154212959,154212959,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder,single nucleotide variant,GRCh37
na,na,X,154984684,154984684,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder,single nucleotide variant,GRCh38
na,na,X,154197818,154197818,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969543,154969543,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197793,154197793,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969518,154969518,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197783,154197783,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969508,154969508,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197766,154197766,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154969491,154969491,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154197761,154197761,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969486,154969486,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197734,154197734,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969459,154969459,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197719,154197719,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969444,154969444,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197713,154197713,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided|F8-related disorder,single nucleotide variant,GRCh37
na,na,X,154969438,154969438,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided|F8-related disorder,single nucleotide variant,GRCh38
na,na,X,154197713,154197713,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969438,154969438,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197708,154197708,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154969433,154969433,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154197692,154197692,F8,Pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder|not provided,single nucleotide variant,GRCh37
na,na,X,154969417,154969417,F8,Pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder|not provided,single nucleotide variant,GRCh38
na,na,X,154197680,154197680,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154969405,154969405,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154197675,154197675,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154969400,154969400,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154197672,154197672,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154969397,154969397,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154197635,154197635,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969360,154969360,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194946,154194946,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966671,154966671,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154197629,154197629,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154969354,154969354,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194929,154194929,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966654,154966654,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194893,154194894,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154966618,154966619,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154194797,154194797,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966522,154966522,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194797,154194797,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154966522,154966522,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154194798,154194798,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966523,154966523,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194774,154194775,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154966499,154966500,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154194758,154194758,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966483,154966483,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194746,154194746,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966471,154966471,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194395,154194395,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966120,154966120,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194395,154194395,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154966120,154966120,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154194357,154194357,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966082,154966082,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194340,154194340,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154966065,154966065,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194271,154194271,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154965996,154965996,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154194270,154194270,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154965995,154965995,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154189406,154189406,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154961131,154961131,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154189395,154189395,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154961120,154961120,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154189371,154189381,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154961096,154961106,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154185447,154185447,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154957172,154957172,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154185387,154185388,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh37
na,na,X,154957112,154957113,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh38
na,na,X,154185354,154185354,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154957079,154957079,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154185348,154185348,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154957073,154957073,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154185336,154185336,F8,Pathogenic,Hereditary factor VIII deficiency disease|Mild hemophilia A|not provided,single nucleotide variant,GRCh37
na,na,X,154957061,154957061,F8,Pathogenic,Hereditary factor VIII deficiency disease|Mild hemophilia A|not provided,single nucleotide variant,GRCh38
na,na,X,154185336,154185336,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154957061,154957061,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154185335,154185335,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect|not provided",single nucleotide variant,GRCh37
na,na,X,154957060,154957060,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect|not provided",single nucleotide variant,GRCh38
na,na,X,154185324,154185324,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided|F8-related disorder,single nucleotide variant,GRCh37
na,na,X,154957049,154957049,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided|F8-related disorder,single nucleotide variant,GRCh38
na,na,X,154185302,154185302,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154957027,154957027,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154185258,154185258,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154956983,154956983,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154185254,154185254,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154956979,154956979,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154185234,154185234,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154956959,154956959,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154185255,154185255,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154956980,154956980,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154182266,154182266,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,154953991,154953991,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,154182262,154182262,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154953987,154953987,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154182258,154182258,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154953983,154953983,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154182256,154182256,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154953981,154953981,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154182236,154182236,F8,Pathogenic,"Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease|Familial aortopathy|Thrombophilia, X-linked, due to factor 8 defect",single nucleotide variant,GRCh37
na,na,X,154953961,154953961,F8,Pathogenic,"Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease|Familial aortopathy|Thrombophilia, X-linked, due to factor 8 defect",single nucleotide variant,GRCh38
na,na,X,154182178,154182178,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154953903,154953903,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154182162,154182162,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154953887,154953887,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154176128,154176128,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154947853,154947853,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154176129,154176129,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154947854,154947854,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154176121,154176121,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154947846,154947846,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154176098,154176098,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154947823,154947823,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154176069,154176071,F8,Uncertain significance,Hereditary factor VIII deficiency disease,Microsatellite,GRCh37
na,na,X,154947794,154947796,F8,Uncertain significance,Hereditary factor VIII deficiency disease,Microsatellite,GRCh38
na,na,X,154176057,154176057,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154947782,154947782,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154159916,154159916,F8,Pathogenic/Likely pathogenic,"Hereditary factor VIII deficiency disease|Abnormality of coagulation|Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect|Thrombophilia, X-linked, due to factor 8 defect|not provided",single nucleotide variant,GRCh37
na,na,X,154931641,154931641,F8,Pathogenic/Likely pathogenic,"Hereditary factor VIII deficiency disease|Abnormality of coagulation|Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect|Thrombophilia, X-linked, due to factor 8 defect|not provided",single nucleotide variant,GRCh38
na,na,X,154159898,154159898,F8,Pathogenic,"Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 8 defect;Hereditary factor VIII deficiency disease",single nucleotide variant,GRCh37
na,na,X,154931623,154931623,F8,Pathogenic,"Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 8 defect;Hereditary factor VIII deficiency disease",single nucleotide variant,GRCh38
na,na,X,154159850,154159850,F8,Pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder,single nucleotide variant,GRCh37
na,na,X,154931575,154931575,F8,Pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder,single nucleotide variant,GRCh38
na,na,X,154159682,154159682,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154931407,154931407,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154159119,154159120,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh37
na,na,X,154930844,154930845,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh38
na,na,X,154159102,154159103,F8,Pathogenic,Hereditary factor VIII deficiency disease,Microsatellite,GRCh37
na,na,X,154930827,154930828,F8,Pathogenic,Hereditary factor VIII deficiency disease,Microsatellite,GRCh38
na,na,X,154158896,154158896,F8,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|not specified|Thrombophilia, X-linked, due to factor 8 defect|not provided",single nucleotide variant,GRCh37
na,na,X,154930621,154930621,F8,Conflicting classifications of pathogenicity,"Hereditary factor VIII deficiency disease|not specified|Thrombophilia, X-linked, due to factor 8 defect|not provided",single nucleotide variant,GRCh38
na,na,X,154158516,154158517,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154930241,154930242,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154158428,154158428,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,Deletion,GRCh37
na,na,X,154930153,154930153,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,Deletion,GRCh38
na,na,X,154158373,154158373,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154930098,154930098,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154158034,154158035,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh37
na,na,X,154929759,154929760,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh38
na,na,X,154157941,154157944,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect",Deletion,GRCh37
na,na,X,154929666,154929669,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect",Deletion,GRCh38
na,na,X,154157822,154157823,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh37
na,na,X,154929547,154929548,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh38
na,na,X,154157765,154157769,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154929490,154929494,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154157734,154157737,F8,Pathogenic,Hereditary factor VIII deficiency disease,Microsatellite,GRCh37
na,na,X,154929459,154929462,F8,Pathogenic,Hereditary factor VIII deficiency disease,Microsatellite,GRCh38
na,na,X,154157686,154157686,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154929411,154929411,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154157402,154157403,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154929127,154929128,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154157239,154157240,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,Duplication,GRCh37
na,na,X,154928964,154928965,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,Duplication,GRCh38
na,na,X,154157207,154157207,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154928932,154928932,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154157165,154157165,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154928890,154928890,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154156942,154156942,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder|not provided|Abnormality of coagulation,single nucleotide variant,GRCh37
na,na,X,154928667,154928667,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder|not provided|Abnormality of coagulation,single nucleotide variant,GRCh38
na,na,X,154156922,154156922,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154928647,154928647,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154156922,154156922,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154928647,154928647,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154134850,154134850,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154906575,154906575,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154134763,154134763,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154906488,154906488,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154134745,154134745,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154906470,154906470,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154134743,154134743,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154906468,154906468,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154134732,154134732,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154906457,154906457,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133273,154133273,F8,Pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder|not provided,single nucleotide variant,GRCh37
na,na,X,154904998,154904998,F8,Pathogenic,Hereditary factor VIII deficiency disease|F8-related disorder|not provided,single nucleotide variant,GRCh38
na,na,X,154133274,154133274,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904999,154904999,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133274,154133274,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904999,154904999,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133264,154133264,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904989,154904989,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133250,154133250,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904975,154904975,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133229,154133229,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904954,154904954,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133146,154133146,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904871,154904871,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133142,154133142,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904867,154904867,F8,Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133139,154133139,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904864,154904864,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133193,154133193,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904918,154904918,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133114,154133114,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904839,154904839,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154133086,154133086,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904811,154904811,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132793,154132793,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904518,154904518,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132793,154132793,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904518,154904518,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132786,154132786,F8,Uncertain significance,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154904511,154904511,F8,Uncertain significance,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154132768,154132768,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904493,154904493,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132763,154132764,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh37
na,na,X,154904488,154904489,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh38
na,na,X,154132709,154132709,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904434,154904434,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132676,154132676,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904401,154904401,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132666,154132667,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh37
na,na,X,154904391,154904392,F8,Pathogenic,Hereditary factor VIII deficiency disease,Duplication,GRCh38
na,na,X,154132357,154132357,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154904082,154904082,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154132300,154132300,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904025,154904025,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132297,154132297,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904022,154904022,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132279,154132279,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154904004,154904004,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132243,154132243,F8,Uncertain significance,Hereditary factor VIII deficiency disease|not specified,single nucleotide variant,GRCh37
na,na,X,154903968,154903968,F8,Uncertain significance,Hereditary factor VIII deficiency disease|not specified,single nucleotide variant,GRCh38
na,na,X,154132241,154132241,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154903966,154903966,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154132226,154132226,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154903951,154903951,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154132218,154132218,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154903943,154903943,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154130392,154130392,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154902117,154902117,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154130425,154130425,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154902150,154902150,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154130395,154130395,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154902120,154902120,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154130328,154130328,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154902053,154902053,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154128221,154128221,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154899946,154899946,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154128151,154128151,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154899876,154899876,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154124503,154124503,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154896228,154896228,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154124421,154124421,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154896146,154896146,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154124410,154124410,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154896135,154896135,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154124368,154124368,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154896093,154896093,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154124368,154124369,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154896093,154896094,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154091467,154091468,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154863192,154863193,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154091399,154091399,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154863124,154863124,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154091426,154091426,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect|not provided",single nucleotide variant,GRCh37
na,na,X,154863151,154863151,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease;Thrombophilia, X-linked, due to factor 8 defect|not provided",single nucleotide variant,GRCh38
na,na,X,154091417,154091417,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154863142,154863142,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154091414,154091414,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154863139,154863139,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154091400,154091400,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154863125,154863125,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154091399,154091399,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154863124,154863124,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154091387,154091387,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154863112,154863112,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154091388,154091388,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 8 defect",single nucleotide variant,GRCh37
na,na,X,154863113,154863113,F8,Pathogenic,"Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 8 defect",single nucleotide variant,GRCh38
na,na,X,154090085,154090085,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154861810,154861810,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154090044,154090046,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154861769,154861771,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154090033,154090033,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154861758,154861758,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154090034,154090034,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154861759,154861759,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154090017,154090017,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154861742,154861742,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154088863,154088863,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154860588,154860588,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154088813,154088813,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154860538,154860538,F8,Pathogenic,Hereditary factor VIII deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154088812,154088813,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154860537,154860538,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154088742,154088742,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154860467,154860467,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154066010,154066014,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154837735,154837739,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154065972,154065972,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,154837697,154837697,F8,Pathogenic,Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,154065961,154065961,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154837686,154837686,F8,Pathogenic/Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154065960,154065960,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154837685,154837685,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154969553,155022724,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154986438,154997956,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154931495,154990580,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154959165,154963500,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154133219,154133522,F8,Pathogenic,Hereditary factor VIII deficiency disease,Indel,GRCh37
na,na,X,154904944,154905247,F8,Pathogenic,Hereditary factor VIII deficiency disease,Indel,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,na
na,na,X,154185234,154185234,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh37
na,na,X,154956959,154956959,F8,Pathogenic,Hereditary factor VIII deficiency disease,Deletion,GRCh38
na,na,X,154221220,154221220,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,154992945,154992945,F8,Likely pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,154250724,154250724,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,155022449,155022449,F8,Pathogenic,Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F8,Pathogenic,Hereditary factor VIII deficiency disease,Insertion,na
na,na,X,1285921,1309479,CSF2RA,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 4",Deletion,GRCh38
na,na,X,1409342,1409342,CSF2RA,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 4",single nucleotide variant,GRCh37
na,na,Y,1359342,1359342,CSF2RA,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 4",single nucleotide variant,GRCh37
na,na,X,1290449,1290449,CSF2RA,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 4",single nucleotide variant,GRCh38
na,na,Y,1290449,1290449,CSF2RA,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 4",single nucleotide variant,GRCh38
na,na,X,122616707,122616707,GRIA3,Pathogenic,Syndromic X-linked intellectual disability 94|not provided,single nucleotide variant,GRCh37
na,na,X,123482856,123482856,GRIA3,Pathogenic,Syndromic X-linked intellectual disability 94|not provided,single nucleotide variant,GRCh38
na,na,X,122561805,122561805,GRIA3,Pathogenic,Syndromic X-linked intellectual disability 94,single nucleotide variant,GRCh37
na,na,X,123427954,123427954,GRIA3,Pathogenic,Syndromic X-linked intellectual disability 94,single nucleotide variant,GRCh38
na,na,X,122598756,122598756,GRIA3,Pathogenic,Syndromic X-linked intellectual disability 94,single nucleotide variant,GRCh37
na,na,X,123464905,123464905,GRIA3,Pathogenic,Syndromic X-linked intellectual disability 94,single nucleotide variant,GRCh38
na,na,X,123184278,123490915,GRIA3,Pathogenic,Syndromic X-linked intellectual disability 94,Deletion,GRCh38
na,na,X,153763492,153763492,G6PD,Conflicting classifications of pathogenicity,"G6PD A+|not provided|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|Inborn genetic diseases|G6PD deficiency;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154535277,154535277,G6PD,Conflicting classifications of pathogenicity,"G6PD A+|not provided|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|Inborn genetic diseases|G6PD deficiency;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153764217,153764217,G6PD,Pathogenic/Likely pathogenic,"G6PD ASAHI|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;G6PD deficiency|not specified|Inborn genetic diseases|Malaria, susceptibility to",single nucleotide variant,GRCh37
na,na,X,154536002,154536002,G6PD,Pathogenic/Likely pathogenic,"G6PD ASAHI|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;G6PD deficiency|not specified|Inborn genetic diseases|Malaria, susceptibility to",single nucleotide variant,GRCh38
na,na,X,153761801,153761801,G6PD,Pathogenic/Likely pathogenic,"G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided",single nucleotide variant,GRCh37
na,na,X,154533586,154533586,G6PD,Pathogenic/Likely pathogenic,"G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided",single nucleotide variant,GRCh38
na,na,X,153761205,153761205,G6PD,Pathogenic,"G6PD CHATHAM|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Inborn genetic diseases|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh37
na,na,X,154532990,154532990,G6PD,Pathogenic,"G6PD CHATHAM|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Inborn genetic diseases|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh38
na,na,X,153763402,153763402,G6PD,Conflicting classifications of pathogenicity,"G6PD ILESHA|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh37
na,na,X,154535187,154535187,G6PD,Conflicting classifications of pathogenicity,"G6PD ILESHA|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh38
na,na,X,153760953,153760953,G6PD,Benign/Likely benign,"G6PD deficiency|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh37
na,na,X,154532738,154532738,G6PD,Benign/Likely benign,"G6PD deficiency|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh38
na,na,X,153760654,153760654,G6PD,Benign/Likely benign,"G6PD deficiency|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh37
na,na,X,154532439,154532439,G6PD,Benign/Likely benign,"G6PD deficiency|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh38
na,na,X,153762710,153762710,G6PD,Pathogenic/Likely pathogenic,"G6PD MAHIDOL|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154534495,154534495,G6PD,Pathogenic/Likely pathogenic,"G6PD MAHIDOL|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153762634,153762634,G6PD,Pathogenic/Likely pathogenic,"not provided|G6PD SASSARI|G6PD MEDITERRANEAN|G6PD CAGLIARI|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Inborn genetic diseases|G6PD deficient hemolytic anemia|Hemolytic anemia, G6PD deficient (favism)|See cases|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh37
na,na,X,154534419,154534419,G6PD,Pathogenic/Likely pathogenic,"not provided|G6PD SASSARI|G6PD MEDITERRANEAN|G6PD CAGLIARI|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Inborn genetic diseases|G6PD deficient hemolytic anemia|Hemolytic anemia, G6PD deficient (favism)|See cases|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh38
na,na,X,153764247,153764247,G6PD,Conflicting classifications of pathogenicity,"G6PD METAPONTO|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",single nucleotide variant,GRCh37
na,na,X,154536032,154536032,G6PD,Conflicting classifications of pathogenicity,"G6PD METAPONTO|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",single nucleotide variant,GRCh38
na,na,X,153760891,153760891,G6PD,Pathogenic,"G6PD PORTICI|G6PD NASHVILLE|G6PD ANAHEIM|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|not provided",single nucleotide variant,GRCh37
na,na,X,154532676,154532676,G6PD,Pathogenic,"G6PD PORTICI|G6PD NASHVILLE|G6PD ANAHEIM|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|not provided",single nucleotide variant,GRCh38
na,na,X,153760626,153760626,G6PD,Pathogenic/Likely pathogenic,"G6PD SANTIAGO DE CUBA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",single nucleotide variant,GRCh37
na,na,X,154532411,154532411,G6PD,Pathogenic/Likely pathogenic,"G6PD SANTIAGO DE CUBA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",single nucleotide variant,GRCh38
na,na,X,153761811,153761811,G6PD,Pathogenic,"G6PD SEATTLE-LIKE|G6PD MODENA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|G6PD deficiency|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh37
na,na,X,154533596,154533596,G6PD,Pathogenic,"G6PD SEATTLE-LIKE|G6PD MODENA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|G6PD deficiency|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh38
na,na,X,153762372,153762372,G6PD,Likely pathogenic,"G6PD HARILAOU|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154534157,154534157,G6PD,Likely pathogenic,"G6PD HARILAOU|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153762771,153762771,G6PD,Benign,"G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154534556,154534556,G6PD,Benign,"G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760913,153760913,G6PD,Pathogenic/Likely pathogenic,"G6PD IOWA CITY|G6PD IOWA|G6PD SPRINGFIELD|G6PD WALTER REED|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD-related disorder",single nucleotide variant,GRCh37
na,na,X,154532698,154532698,G6PD,Pathogenic/Likely pathogenic,"G6PD IOWA CITY|G6PD IOWA|G6PD SPRINGFIELD|G6PD WALTER REED|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD-related disorder",single nucleotide variant,GRCh38
na,na,X,153760909,153760909,G6PD,Pathogenic,"G6PD BEVERLY HILLS|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532694,154532694,G6PD,Pathogenic,"G6PD BEVERLY HILLS|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760916,153760916,G6PD,Pathogenic,"G6PD TOMAH|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532701,154532701,G6PD,Pathogenic,"G6PD TOMAH|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760841,153760841,G6PD,Pathogenic/Likely pathogenic,"G6PD RIVERSIDE|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532626,154532626,G6PD,Pathogenic/Likely pathogenic,"G6PD RIVERSIDE|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760604,153760604,G6PD,Pathogenic/Likely pathogenic,"G6PD ANDALUS|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532389,154532389,G6PD,Pathogenic/Likely pathogenic,"G6PD ANDALUS|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760484,153760484,G6PD,Pathogenic,"G6PD AGRIGENTO|G6PD TAIWAN-HAKKA|G6PD GIFU|G6PD CANTON|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|not provided|Malaria, susceptibility to|G6PD-related disorder|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532269,154532269,G6PD,Pathogenic,"G6PD AGRIGENTO|G6PD TAIWAN-HAKKA|G6PD GIFU|G6PD CANTON|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|not provided|Malaria, susceptibility to|G6PD-related disorder|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760967,153760967,G6PD,Pathogenic/Likely pathogenic,"G6PD PUERTO LIMON|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh37
na,na,X,154532752,154532752,G6PD,Pathogenic/Likely pathogenic,"G6PD PUERTO LIMON|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh38
na,na,X,153762655,153762655,G6PD,Pathogenic/Likely pathogenic,"G6PD MALAGA|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154534440,154534440,G6PD,Pathogenic/Likely pathogenic,"G6PD MALAGA|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153762560,153762560,G6PD,Pathogenic/Likely pathogenic,"G6PD MINNESOTA|G6PD MARION|G6PD GASTONIA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|See cases",single nucleotide variant,GRCh37
na,na,X,154534345,154534345,G6PD,Pathogenic/Likely pathogenic,"G6PD MINNESOTA|G6PD MARION|G6PD GASTONIA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|See cases",single nucleotide variant,GRCh38
na,na,X,153761012,153761012,G6PD,Pathogenic,"G6PD IERAPETRA|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532797,154532797,G6PD,Pathogenic,"G6PD IERAPETRA|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153761337,153761337,G6PD,Pathogenic/Likely pathogenic,"G6PD VIANGCHAN|G6PD JAMMU|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|not provided|G6PD deficient hemolytic anemia|Inborn genetic diseases|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh37
na,na,X,154533122,154533122,G6PD,Pathogenic/Likely pathogenic,"G6PD VIANGCHAN|G6PD JAMMU|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|not provided|G6PD deficient hemolytic anemia|Inborn genetic diseases|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh38
na,na,X,153762340,153762340,G6PD,Pathogenic,G6PD deficiency,single nucleotide variant,GRCh37
na,na,X,154534125,154534125,G6PD,Pathogenic,G6PD deficiency,single nucleotide variant,GRCh38
na,na,X,153761240,153761240,G6PD,Conflicting classifications of pathogenicity,"G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|G6PD-related disorder|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",single nucleotide variant,GRCh37
na,na,X,154533025,154533025,G6PD,Conflicting classifications of pathogenicity,"G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|G6PD-related disorder|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",single nucleotide variant,GRCh38
na,na,X,153760472,153760472,G6PD,Conflicting classifications of pathogenicity,"G6PD PETRICH-LIKE|G6PD ANANT|G6PD SAPPORO-LIKE|G6PD KAIPING|G6PD DHON|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Malaria, susceptibility to|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,X,154532257,154532257,G6PD,Conflicting classifications of pathogenicity,"G6PD PETRICH-LIKE|G6PD ANANT|G6PD SAPPORO-LIKE|G6PD KAIPING|G6PD DHON|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Malaria, susceptibility to|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,X,153760980,153760980,G6PD,Likely pathogenic,"G6PD LOMA LINDA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532765,154532765,G6PD,Likely pathogenic,"G6PD LOMA LINDA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153762605,153762605,G6PD,Pathogenic,"G6PD COIMBRA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",single nucleotide variant,GRCh37
na,na,X,154534390,154534390,G6PD,Pathogenic,"G6PD COIMBRA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",single nucleotide variant,GRCh38
na,na,X,153763551,153763551,G6PD,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,X,154535336,154535336,G6PD,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,X,153762704,153762704,G6PD,Pathogenic/Likely pathogenic,"G6PD TAIWAN-HAKKA 2|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to",single nucleotide variant,GRCh37
na,na,X,154534489,154534489,G6PD,Pathogenic/Likely pathogenic,"G6PD TAIWAN-HAKKA 2|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to",single nucleotide variant,GRCh38
na,na,X,153762604,153762604,G6PD,Likely pathogenic,"G6PD SANTIAGO|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154534389,154534389,G6PD,Likely pathogenic,"G6PD SANTIAGO|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153762340,153762340,G6PD,Conflicting classifications of pathogenicity,"G6PD MEXICO CITY|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",single nucleotide variant,GRCh37
na,na,X,154534125,154534125,G6PD,Conflicting classifications of pathogenicity,"G6PD MEXICO CITY|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",single nucleotide variant,GRCh38
na,na,X,153760910,153760910,G6PD,Pathogenic,"G6PD GUADALAJARA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh37
na,na,X,154532695,154532695,G6PD,Pathogenic,"G6PD GUADALAJARA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh38
na,na,X,153760889,153760889,G6PD,Likely pathogenic,"G6PD ALHAMBRA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532674,154532674,G6PD,Likely pathogenic,"G6PD ALHAMBRA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760840,153760840,G6PD,Pathogenic,"G6PD JAPAN|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532625,154532625,G6PD,Pathogenic,"G6PD JAPAN|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760649,153760649,G6PD,Conflicting classifications of pathogenicity,"G6PD PAWNEE|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh37
na,na,X,154532434,154532434,G6PD,Conflicting classifications of pathogenicity,"G6PD PAWNEE|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh38
na,na,X,153774261,153774263,G6PD,Conflicting classifications of pathogenicity,"G6PD SUNDERLAND|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",Microsatellite,GRCh37
na,na,X,154546046,154546048,G6PD,Conflicting classifications of pathogenicity,"G6PD SUNDERLAND|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",Microsatellite,GRCh38
na,na,X,153761259,153761259,G6PD,Pathogenic/Likely pathogenic,"G6PD KERALA-KALYAN|G6PD KERALA|G6PD KALYAN|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|not provided|Malaria, susceptibility to|Congenital nonspherocytic hemolytic anemia|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154533044,154533044,G6PD,Pathogenic/Likely pathogenic,"G6PD KERALA-KALYAN|G6PD KERALA|G6PD KALYAN|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|not provided|Malaria, susceptibility to|Congenital nonspherocytic hemolytic anemia|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153764371,153764371,G6PD,Pathogenic/Likely pathogenic,"G6PD AURES|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh37
na,na,X,154536156,154536156,G6PD,Pathogenic/Likely pathogenic,"G6PD AURES|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder",single nucleotide variant,GRCh38
na,na,X,153774276,153774276,G6PD,Pathogenic,"G6PD GAOHE|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Inborn genetic diseases|Malaria, susceptibility to|Early-onset coronary artery disease|G6PD deficiency|not provided",single nucleotide variant,GRCh37
na,na,X,154546061,154546061,G6PD,Pathogenic,"G6PD GAOHE|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Inborn genetic diseases|Malaria, susceptibility to|Early-onset coronary artery disease|G6PD deficiency|not provided",single nucleotide variant,GRCh38
na,na,X,153763476,153763476,G6PD,Pathogenic/Likely pathogenic,"G6PD QUING YUAN|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",single nucleotide variant,GRCh37
na,na,X,154535261,154535261,G6PD,Pathogenic/Likely pathogenic,"G6PD QUING YUAN|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",single nucleotide variant,GRCh38
na,na,X,153761184,153761184,G6PD,Conflicting classifications of pathogenicity,"G6PD MAHIDOL-LIKE|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",single nucleotide variant,GRCh37
na,na,X,154532969,154532969,G6PD,Conflicting classifications of pathogenicity,"G6PD MAHIDOL-LIKE|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to",single nucleotide variant,GRCh38
na,na,X,153764383,153764383,G6PD,Pathogenic/Likely pathogenic,"G6PD ORISSA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to|G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154536168,154536168,G6PD,Pathogenic/Likely pathogenic,"G6PD ORISSA|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to|G6PD deficiency|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153762680,153762680,G6PD,Pathogenic,"G6PD NANKANG|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",single nucleotide variant,GRCh37
na,na,X,154534465,154534465,G6PD,Pathogenic,"G6PD NANKANG|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",single nucleotide variant,GRCh38
na,na,X,153760460,153760460,G6PD,Likely pathogenic,"G6PD NEAPOLIS|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532245,154532245,G6PD,Likely pathogenic,"G6PD NEAPOLIS|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760987,153760987,G6PD,Likely pathogenic,"G6PD SERRES|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532772,154532772,G6PD,Likely pathogenic,"G6PD SERRES|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153761228,153761251,G6PD,Pathogenic/Likely pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",Deletion,GRCh37
na,na,X,154533013,154533036,G6PD,Pathogenic/Likely pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to;Anemia, nonspherocytic hemolytic, due to G6PD deficiency",Deletion,GRCh38
na,na,X,153761849,153761849,G6PD,Likely pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD AVEIRO",single nucleotide variant,GRCh37
na,na,X,154533634,154533634,G6PD,Likely pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD AVEIRO",single nucleotide variant,GRCh38
na,na,X,153761244,153761244,G6PD,Likely pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD REHOVOT",single nucleotide variant,GRCh37
na,na,X,154533029,154533029,G6PD,Likely pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD REHOVOT",single nucleotide variant,GRCh38
na,na,X,153760418,153760418,G6PD,Conflicting classifications of pathogenicity,"G6PD SPLIT|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532203,154532203,G6PD,Conflicting classifications of pathogenicity,"G6PD SPLIT|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153764211,153764211,G6PD,Pathogenic/Likely pathogenic,"G6PD NAMORU|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh37
na,na,X,154535996,154535996,G6PD,Pathogenic/Likely pathogenic,"G6PD NAMORU|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",single nucleotide variant,GRCh38
na,na,X,153762604,153762604,G6PD,Pathogenic/Likely pathogenic,"G6PD NILGIRI|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",single nucleotide variant,GRCh37
na,na,X,154534389,154534389,G6PD,Pathogenic/Likely pathogenic,"G6PD NILGIRI|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",single nucleotide variant,GRCh38
na,na,X,153764237,153764239,G6PD,Pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency",Deletion,GRCh37
na,na,X,154536022,154536024,G6PD,Pathogenic,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency",Deletion,GRCh38
na,na,X,153760679,153760679,G6PD,Pathogenic,"G6PD ZURICH|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532464,154532464,G6PD,Pathogenic,"G6PD ZURICH|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,153760677,153760678,G6PD,Pathogenic,"G6PD VARNSDORF|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",Deletion,GRCh37
na,na,X,154532462,154532463,G6PD,Pathogenic,"G6PD VARNSDORF|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",Deletion,GRCh38
na,na,X,153760484,153760484,G6PD,Pathogenic,"G6PD COSENZA|not provided|G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh37
na,na,X,154532269,154532269,G6PD,Pathogenic,"G6PD COSENZA|not provided|G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",single nucleotide variant,GRCh38
na,na,X,48650744,48650744,GATA1,Pathogenic,"Thrombocytopenia, X-linked, with dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",single nucleotide variant,GRCh37
na,na,X,48792337,48792337,GATA1,Pathogenic,"Thrombocytopenia, X-linked, with dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",single nucleotide variant,GRCh38
na,na,X,48650784,48650784,GATA1,Pathogenic/Likely pathogenic,"Thrombocytopenia, X-linked, without dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia|Thrombocytopenia",single nucleotide variant,GRCh37
na,na,X,48792377,48792377,GATA1,Pathogenic/Likely pathogenic,"Thrombocytopenia, X-linked, without dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia|Thrombocytopenia",single nucleotide variant,GRCh38
na,na,X,48650753,48650754,GATA1,Pathogenic,"Thrombocytopenia, X-linked, without dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",Indel,GRCh37
na,na,X,48792346,48792347,GATA1,Pathogenic,"Thrombocytopenia, X-linked, without dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",Indel,GRCh38
na,na,X,48649699,48649700,GATA1,Pathogenic,"LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, SOMATIC",Duplication,GRCh37
na,na,X,48791292,48791293,GATA1,Pathogenic,"LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, SOMATIC",Duplication,GRCh38
na,na,X,48650783,48650783,GATA1,Pathogenic,"Thrombocytopenia, X-linked, with dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",single nucleotide variant,GRCh37
na,na,X,48792376,48792376,GATA1,Pathogenic,"Thrombocytopenia, X-linked, with dyserythropoietic anemia|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",single nucleotide variant,GRCh38
na,na,X,48650778,48650778,GATA1,Pathogenic,"Beta-thalassemia-X-linked thrombocytopenia syndrome|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis;Diamond-Blackfan anemia|not provided|X-linked dyserythropoetic anemia with abnormal platelets and neutropenia",single nucleotide variant,GRCh37
na,na,X,48792371,48792371,GATA1,Pathogenic,"Beta-thalassemia-X-linked thrombocytopenia syndrome|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis;Diamond-Blackfan anemia|not provided|X-linked dyserythropoetic anemia with abnormal platelets and neutropenia",single nucleotide variant,GRCh38
na,na,X,48649667,48649668,GATA1,Pathogenic,Acute megakaryoblastic leukemia|Diamond-Blackfan anemia;GATA binding protein 1 related thrombocytopenia with dyserythropoiesis,Duplication,GRCh37
na,na,X,48791260,48791261,GATA1,Pathogenic,Acute megakaryoblastic leukemia|Diamond-Blackfan anemia;GATA binding protein 1 related thrombocytopenia with dyserythropoiesis,Duplication,GRCh38
na,na,X,70443981,70443981,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh37
na,na,X,71224131,71224131,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh38
na,na,X,70444071,70444071,GJB1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh37
na,na,X,71224221,71224221,GJB1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh38
na,na,X,70443972,70443972,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,71224122,71224122,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,70443954,70443954,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh37
na,na,X,71224104,71224104,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh38
na,na,X,70444215,70444215,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,71224365,71224365,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,70443646,70443646,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh37
na,na,X,71223796,71223796,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh38
na,na,X,70444024,70444024,GJB1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,71224174,71224174,GJB1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,70443751,70443751,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided,single nucleotide variant,GRCh37
na,na,X,71223901,71223901,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided,single nucleotide variant,GRCh38
na,na,X,70443594,70443594,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh37
na,na,X,71223744,71223744,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh38
na,na,X,70443840,70443840,GJB1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,71223990,71223990,GJB1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,70444171,70444171,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided,single nucleotide variant,GRCh37
na,na,X,71224321,71224321,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X|not provided,single nucleotide variant,GRCh38
na,na,X,70443811,70443811,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth disease|not provided,single nucleotide variant,GRCh37
na,na,X,71223961,71223961,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth disease|not provided,single nucleotide variant,GRCh38
na,na,X,70443029,70443029,GJB1,Uncertain significance,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh37
na,na,X,71223179,71223179,GJB1,Uncertain significance,Charcot-Marie-Tooth disease X-linked dominant 1|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh38
na,na,X,70443721,70443721,GJB1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh37
na,na,X,71223871,71223871,GJB1,Pathogenic/Likely pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1|not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X,single nucleotide variant,GRCh38
na,na,X,70443031,70443031,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh37
na,na,X,71223181,71223181,GJB1,Pathogenic,Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh38
na,na,X,70444261,70444261,GJB1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease X-linked dominant 1|not specified|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,71224411,71224411,GJB1,Conflicting classifications of pathogenicity,Charcot-Marie-Tooth disease X-linked dominant 1|not specified|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,70443964,70443964,GJB1,Pathogenic,Dejerine-Sottas disease|Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh37
na,na,X,71224114,71224114,GJB1,Pathogenic,Dejerine-Sottas disease|Charcot-Marie-Tooth disease X-linked dominant 1,single nucleotide variant,GRCh38
na,na,na,-1,-1,COL4A5,Pathogenic,X-linked Alport syndrome,Deletion,na
na,na,na,-1,-1,COL4A5,Pathogenic,X-linked Alport syndrome,Indel,na
na,na,na,-1,-1,COL4A5,Pathogenic,X-linked Alport syndrome,Deletion,na
na,na,na,-1,-1,COL4A5,Pathogenic,X-linked Alport syndrome,Deletion,na
na,na,X,107908791,107908791,COL4A5,Pathogenic,X-linked Alport syndrome,single nucleotide variant,GRCh37
na,na,X,108665561,108665561,COL4A5,Pathogenic,X-linked Alport syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,COL4A5,no classification for the single variant,-,Deletion,na
na,na,X,107840272,107840272,COL4A5,Pathogenic,X-linked Alport syndrome,single nucleotide variant,GRCh37
na,na,X,108597042,108597042,COL4A5,Pathogenic,X-linked Alport syndrome,single nucleotide variant,GRCh38
na,na,X,107826151,107826151,COL4A5,Pathogenic,X-linked Alport syndrome,single nucleotide variant,GRCh37
na,na,X,108582921,108582921,COL4A5,Pathogenic,X-linked Alport syndrome,single nucleotide variant,GRCh38
na,na,X,107802313,107802313,COL4A5,Pathogenic,X-linked Alport syndrome,single nucleotide variant,GRCh37
na,na,X,108559083,108559083,COL4A5,Pathogenic,X-linked Alport syndrome,single nucleotide variant,GRCh38
na,na,X,107938639,107938639,COL4A5,Pathogenic,X-linked Alport syndrome|Alport syndrome|not provided|COL4A5-related disorder,single nucleotide variant,GRCh37
na,na,X,108695409,108695409,COL4A5,Pathogenic,X-linked Alport syndrome|Alport syndrome|not provided|COL4A5-related disorder,single nucleotide variant,GRCh38
na,na,X,107939580,107939580,COL4A5,Pathogenic/Likely pathogenic,X-linked Alport syndrome|Hematuria|not provided|COL4A5-related disorder,single nucleotide variant,GRCh37
na,na,X,108696350,108696350,COL4A5,Pathogenic/Likely pathogenic,X-linked Alport syndrome|Hematuria|not provided|COL4A5-related disorder,single nucleotide variant,GRCh38
na,na,X,55041190,55041190,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55014757,55014757,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55042016,55042016,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55015583,55015583,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55047628,55047628,ALAS2,Pathogenic,X-linked sideroblastic anemia 1|not provided,single nucleotide variant,GRCh37
na,na,X,55021195,55021195,ALAS2,Pathogenic,X-linked sideroblastic anemia 1|not provided,single nucleotide variant,GRCh38
na,na,X,55044051,55044051,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55017618,55017618,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55044027,55044027,ALAS2,Pathogenic,"Sideroblastic anemia 1, late-onset",single nucleotide variant,GRCh37
na,na,X,55017594,55017594,ALAS2,Pathogenic,"Sideroblastic anemia 1, late-onset",single nucleotide variant,GRCh38
na,na,X,55047609,55047609,ALAS2,Likely pathogenic,"Sideroblastic anemia 1, late-onset|X-linked sideroblastic anemia 1",single nucleotide variant,GRCh37
na,na,X,55021176,55021176,ALAS2,Likely pathogenic,"Sideroblastic anemia 1, late-onset|X-linked sideroblastic anemia 1",single nucleotide variant,GRCh38
na,na,X,55047554,55047554,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55021121,55021121,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55041386,55041386,ALAS2,Pathogenic,X-linked sideroblastic anemia 1|not provided,single nucleotide variant,GRCh37
na,na,X,55014953,55014953,ALAS2,Pathogenic,X-linked sideroblastic anemia 1|not provided,single nucleotide variant,GRCh38
na,na,X,55035675,55035675,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55009242,55009242,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55041433,55041433,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55015000,55015000,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55047648,55047648,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55021215,55021215,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55047648,55047648,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55021215,55021215,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55057617,55057617,ALAS2,Benign/Likely benign,X-linked sideroblastic anemia 1|not provided|ALAS2-related disorder,single nucleotide variant,GRCh37
na,na,X,55031184,55031184,ALAS2,Benign/Likely benign,X-linked sideroblastic anemia 1|not provided|ALAS2-related disorder,single nucleotide variant,GRCh38
na,na,X,55039949,55039949,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55013516,55013516,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55035668,55035671,ALAS2,Pathogenic/Likely pathogenic,X-linked erythropoietic protoporphyria|not provided|See cases,Microsatellite,GRCh37
na,na,X,55009235,55009238,ALAS2,Pathogenic/Likely pathogenic,X-linked erythropoietic protoporphyria|not provided|See cases,Microsatellite,GRCh38
na,na,X,55035677,55035678,ALAS2,Pathogenic,X-linked erythropoietic protoporphyria,Deletion,GRCh37
na,na,X,55009244,55009245,ALAS2,Pathogenic,X-linked erythropoietic protoporphyria,Deletion,GRCh38
na,na,X,55047528,55047528,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh37
na,na,X,55021095,55021095,ALAS2,Pathogenic,X-linked sideroblastic anemia 1,single nucleotide variant,GRCh38
na,na,X,55041263,55041263,ALAS2,Pathogenic,X-linked sideroblastic anemia 1|not provided|ALAS2-related disorder,single nucleotide variant,GRCh37
na,na,X,55014830,55014830,ALAS2,Pathogenic,X-linked sideroblastic anemia 1|not provided|ALAS2-related disorder,single nucleotide variant,GRCh38
na,na,X,148564603,148564603,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II|Mucopolysaccharidosis, MPS-III-A|See cases|not provided",single nucleotide variant,GRCh37
na,na,X,149483072,149483072,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II|Mucopolysaccharidosis, MPS-III-A|See cases|not provided",single nucleotide variant,GRCh38
na,na,X,148571853,148571853,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II|not provided",single nucleotide variant,GRCh37
na,na,X,149490322,149490322,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II|not provided",single nucleotide variant,GRCh38
na,na,X,148564425,148564425,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh37
na,na,X,149482894,149482894,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh38
na,na,X,148582508,148582508,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh37
na,na,X,149500977,149500977,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh38
na,na,X,148579832,148579832,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II|not provided|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,X,149498301,149498301,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II|not provided|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,X,148568514,148568514,IDS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-II|not provided",single nucleotide variant,GRCh37
na,na,X,149486983,149486983,IDS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-II|not provided",single nucleotide variant,GRCh38
na,na,X,149478764,149505354,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",Deletion,GRCh38
na,na,X,148564666,148564666,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh37
na,na,X,149483135,149483135,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh38
na,na,X,148584856,148584856,IDS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh37
na,na,X,149503326,149503326,IDS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh38
na,na,X,148564505,148564505,IDS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh37
na,na,X,149482974,149482974,IDS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh38
na,na,X,148579836,148579837,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",Deletion,GRCh37
na,na,X,149498305,149498306,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",Deletion,GRCh38
na,na,X,148564528,148564528,IDS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, type II, mild form|Mucopolysaccharidosis, MPS-II|not provided",single nucleotide variant,GRCh37
na,na,X,149482997,149482997,IDS,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, type II, mild form|Mucopolysaccharidosis, MPS-II|not provided",single nucleotide variant,GRCh38
na,na,X,148564527,148564527,IDS,Pathogenic,"Mucopolysaccharidosis type 2, severe form|Mucopolysaccharidosis, MPS-II|not provided",single nucleotide variant,GRCh37
na,na,X,149482996,149482996,IDS,Pathogenic,"Mucopolysaccharidosis type 2, severe form|Mucopolysaccharidosis, MPS-II|not provided",single nucleotide variant,GRCh38
na,na,X,148568762,148568762,IDS,Likely pathogenic,"Mucopolysaccharidosis, type II, mild form|Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh37
na,na,X,149487231,149487231,IDS,Likely pathogenic,"Mucopolysaccharidosis, type II, mild form|Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh38
na,na,X,148564527,148564527,IDS,Pathogenic,"Mucopolysaccharidosis type 2, severe form|Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh37
na,na,X,149482996,149482996,IDS,Pathogenic,"Mucopolysaccharidosis type 2, severe form|Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh38
na,na,X,148584909,148584911,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",Deletion,GRCh37
na,na,X,149503379,149503381,IDS,Pathogenic,"Mucopolysaccharidosis, MPS-II",Deletion,GRCh38
na,na,X,148564464,148564464,IDS,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh37
na,na,X,149482933,149482933,IDS,Conflicting classifications of pathogenicity,"Mucopolysaccharidosis, MPS-II",single nucleotide variant,GRCh38
na,na,X,153420209,153420209,OPN1LW,Pathogenic,Cone monochromatism,single nucleotide variant,GRCh37
na,na,X,154154734,154154734,OPN1LW,Pathogenic,Cone monochromatism,single nucleotide variant,GRCh38
na,na,X,153418541,153418541,OPN1LW,Benign,RED CONE POLYMORPHISM|not provided|not specified,single nucleotide variant,GRCh37
na,na,X,154153068,154153068,OPN1LW,Benign,RED CONE POLYMORPHISM|not provided|not specified,single nucleotide variant,GRCh38
na,na,X,153420077,153420077,OPN1LW,Pathogenic,Cone monochromatism|not provided|Protan defect,single nucleotide variant,GRCh37
na,na,X,154154602,154154602,OPN1LW,Pathogenic,Cone monochromatism|not provided|Protan defect,single nucleotide variant,GRCh38
na,na,X,153424319,153424319,OPN1LW,Pathogenic,Protan defect,single nucleotide variant,GRCh37
na,na,X,154158844,154158844,OPN1LW,Pathogenic,Protan defect,single nucleotide variant,GRCh38
na,na,X,154153459,154154928,OPN1LW,Pathogenic,Cone monochromatism,Deletion,GRCh38
na,na,X,153457207,153457207,OPN1MW,Pathogenic,Cone monochromatism|Deuteranomaly,single nucleotide variant,GRCh37
na,na,X,154191716,154191716,OPN1MW,Pathogenic,Cone monochromatism|Deuteranomaly,single nucleotide variant,GRCh38
na,na,X,153461425,153461425,OPN1MW,Pathogenic,Deuteranomaly,single nucleotide variant,GRCh37
na,na,X,154195934,154195934,OPN1MW,Pathogenic,Deuteranomaly,single nucleotide variant,GRCh38
na,na,X,153448055,153448055,OPN1MW,Pathogenic,Deuteranomaly,single nucleotide variant,GRCh37
na,na,X,154182566,154182566,OPN1MW,Pathogenic,Deuteranomaly,single nucleotide variant,GRCh38
na,na,X,153453428,153453428,OPN1MW,Pathogenic,Deuteranomaly,single nucleotide variant,GRCh37
na,na,X,154187939,154187939,OPN1MW,Pathogenic,Deuteranomaly,single nucleotide variant,GRCh38
na,na,X,153455662,153455662,OPN1MW,Pathogenic,"Cone dystrophy 5, X-linked",single nucleotide variant,GRCh37
na,na,X,154190173,154190173,OPN1MW,Pathogenic,"Cone dystrophy 5, X-linked",single nucleotide variant,GRCh38
na,na,X,9707710,9707711,GPR143,Pathogenic,"Ocular albinism, type I",Duplication,GRCh37
na,na,X,9739670,9739671,GPR143,Pathogenic,"Ocular albinism, type I",Duplication,GRCh38
na,na,X,9727430,9727430,GPR143,Pathogenic,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh37
na,na,X,9759390,9759390,GPR143,Pathogenic,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh38
na,na,X,9727372,9727372,GPR143,Uncertain significance,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh37
na,na,X,9759332,9759332,GPR143,Uncertain significance,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh38
na,na,X,9711677,9711677,GPR143,Pathogenic,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh37
na,na,X,9743637,9743637,GPR143,Pathogenic,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh38
na,na,X,9727430,9727430,GPR143,Pathogenic,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh37
na,na,X,9759390,9759390,GPR143,Pathogenic,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh38
na,na,X,9733754,9733754,GPR143,Pathogenic,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh37
na,na,X,9765714,9765714,GPR143,Pathogenic,"Ocular albinism, type I|not provided",single nucleotide variant,GRCh38
na,na,X,9728851,9728851,GPR143,Pathogenic,"Nystagmus 6, congenital, X-linked",single nucleotide variant,GRCh37
na,na,X,9760811,9760811,GPR143,Pathogenic,"Nystagmus 6, congenital, X-linked",single nucleotide variant,GRCh38
na,na,X,9733660,9733696,GPR143,Pathogenic,"Nystagmus 6, congenital, X-linked|GPR143-related disorder",Deletion,GRCh37
na,na,X,9765620,9765656,GPR143,Pathogenic,"Nystagmus 6, congenital, X-linked|GPR143-related disorder",Deletion,GRCh38
na,na,X,9733608,9733609,GPR143,Pathogenic,"Nystagmus 6, congenital, X-linked|not provided",Duplication,GRCh37
na,na,X,9765568,9765569,GPR143,Pathogenic,"Nystagmus 6, congenital, X-linked|not provided",Duplication,GRCh38
na,na,X,147582158,147582160,AFF2,Pathogenic,FRAXE,Microsatellite,GRCh37
na,na,X,148500638,148500640,AFF2,Pathogenic,FRAXE,Microsatellite,GRCh38
na,na,X,18919605,18919605,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18901487,18901487,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,18926983,18926983,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18908865,18908865,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,18961827,18961827,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18943709,18943709,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,18915417,18915417,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18897299,18897299,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,18911697,18911697,PHKA2,Pathogenic,Glycogen storage disease IXa1|not provided,single nucleotide variant,GRCh37
na,na,X,18893579,18893579,PHKA2,Pathogenic,Glycogen storage disease IXa1|not provided,single nucleotide variant,GRCh38
na,na,X,18969253,18969255,PHKA2,Pathogenic,Glycogen storage disease IXa1,Deletion,GRCh37
na,na,X,18951135,18951137,PHKA2,Pathogenic,Glycogen storage disease IXa1,Deletion,GRCh38
na,na,X,18912518,18912518,PHKA2,Pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18894400,18894400,PHKA2,Pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,18958135,18958135,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18940017,18940017,PHKA2,Pathogenic,Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,18963257,18963257,PHKA2,Likely pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18945139,18945139,PHKA2,Likely pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,18969281,18969281,PHKA2,Pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18951163,18951163,PHKA2,Pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,18969282,18969282,PHKA2,Pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18951164,18951164,PHKA2,Pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,18963258,18963258,PHKA2,Likely pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1|not provided,single nucleotide variant,GRCh37
na,na,X,18945140,18945140,PHKA2,Likely pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1|not provided,single nucleotide variant,GRCh38
na,na,X,18959759,18959761,PHKA2,Pathogenic,Glycogen storage disease IXa2,Deletion,GRCh37
na,na,X,18941641,18941643,PHKA2,Pathogenic,Glycogen storage disease IXa2,Deletion,GRCh38
na,na,X,18913259,18913260,PHKA2,Pathogenic,Glycogen storage disease IXa2,Duplication,GRCh37
na,na,X,18895141,18895142,PHKA2,Pathogenic,Glycogen storage disease IXa2,Duplication,GRCh38
na,na,X,18963249,18963249,PHKA2,Likely pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh37
na,na,X,18945131,18945131,PHKA2,Likely pathogenic,Glycogen storage disease IXa2|Glycogen storage disease IXa1,single nucleotide variant,GRCh38
na,na,X,154493358,154493358,RAB39B,Pathogenic,"Intellectual disability, X-linked 72",single nucleotide variant,GRCh37
na,na,X,155264073,155264073,RAB39B,Pathogenic,"Intellectual disability, X-linked 72",single nucleotide variant,GRCh38
na,na,X,154493553,154493553,RAB39B,Pathogenic,"Intellectual disability, X-linked 72",single nucleotide variant,GRCh37
na,na,X,155264268,155264268,RAB39B,Pathogenic,"Intellectual disability, X-linked 72",single nucleotide variant,GRCh38
na,na,X,46696550,46696552,RP2,Likely pathogenic,Retinitis pigmentosa 2|Retinitis pigmentosa|not provided,Deletion,GRCh37
na,na,X,46837115,46837117,RP2,Likely pathogenic,Retinitis pigmentosa 2|Retinitis pigmentosa|not provided,Deletion,GRCh38
na,na,X,46696611,46696611,RP2,Pathogenic,Retinitis pigmentosa 2|not provided,single nucleotide variant,GRCh37
na,na,X,46837176,46837176,RP2,Pathogenic,Retinitis pigmentosa 2|not provided,single nucleotide variant,GRCh38
na,na,X,46713161,46713161,RP2,Pathogenic/Likely pathogenic,Retinitis pigmentosa 2|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,46853726,46853726,RP2,Pathogenic/Likely pathogenic,Retinitis pigmentosa 2|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,46713261,46713261,RP2,Pathogenic,Retinitis pigmentosa 2,single nucleotide variant,GRCh37
na,na,X,46853826,46853826,RP2,Pathogenic,Retinitis pigmentosa 2,single nucleotide variant,GRCh38
na,na,X,46713261,46713261,RP2,Pathogenic,Retinitis pigmentosa 2,Deletion,GRCh37
na,na,X,46853826,46853826,RP2,Pathogenic,Retinitis pigmentosa 2,Deletion,GRCh38
na,na,X,46713161,46713161,RP2,Pathogenic,Retinitis pigmentosa 2,single nucleotide variant,GRCh37
na,na,X,46853726,46853726,RP2,Pathogenic,Retinitis pigmentosa 2,single nucleotide variant,GRCh38
na,na,X,46713166,46713166,RP2,Pathogenic,Retinitis pigmentosa 2|Retinal dystrophy|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,X,46853731,46853731,RP2,Pathogenic,Retinitis pigmentosa 2|Retinal dystrophy|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,X,7243397,7243397,STS,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,single nucleotide variant,GRCh37
na,na,X,7325356,7325356,STS,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,single nucleotide variant,GRCh38
na,na,X,7252107,7252107,STS,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,single nucleotide variant,GRCh37
na,na,X,7334066,7334066,STS,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,single nucleotide variant,GRCh38
na,na,X,7223150,7223150,STS,Conflicting classifications of pathogenicity,X-linked ichthyosis with steryl-sulfatase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,7305109,7305109,STS,Conflicting classifications of pathogenicity,X-linked ichthyosis with steryl-sulfatase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,7243398,7243398,STS,Uncertain significance,X-linked ichthyosis with steryl-sulfatase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,7325357,7325357,STS,Uncertain significance,X-linked ichthyosis with steryl-sulfatase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,7252101,7252101,STS,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,single nucleotide variant,GRCh37
na,na,X,7334060,7334060,STS,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,single nucleotide variant,GRCh38
na,na,X,7243540,7243540,STS,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,single nucleotide variant,GRCh37
na,na,X,7325499,7325499,STS,Pathogenic,X-linked ichthyosis with steryl-sulfatase deficiency,single nucleotide variant,GRCh38
na,na,X,138612875,138612875,F9,Pathogenic,Hemophilia B leyden,single nucleotide variant,GRCh37
na,na,X,139530716,139530716,F9,Pathogenic,Hemophilia B leyden,single nucleotide variant,GRCh38
na,na,X,138612906,138612906,F9,Pathogenic,Hemophilia B leyden,Deletion,GRCh37
na,na,X,139530747,139530747,F9,Pathogenic,Hemophilia B leyden,Deletion,GRCh38
na,na,na,-1,-1,F9,Benign,F9 POLYMORPHISM,single nucleotide variant,na
na,na,X,138619218,138619218,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139537059,139537059,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Variation,na
na,na,X,138619249,138619249,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139537090,139537090,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138612975,138612975,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139530816,139530816,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138613002,138613002,F9,Uncertain significance,Hereditary factor IX deficiency disease|not specified,single nucleotide variant,GRCh37
na,na,X,139530843,139530843,F9,Uncertain significance,Hereditary factor IX deficiency disease|not specified,single nucleotide variant,GRCh38
na,na,X,138619298,138619298,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139537139,139537139,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138619303,138619303,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh37
na,na,X,139537144,139537144,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh38
na,na,X,138619304,138619304,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked",single nucleotide variant,GRCh37
na,na,X,139537145,139537145,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked",single nucleotide variant,GRCh38
na,na,X,138619317,138619317,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139537158,139537158,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138623235,138623235,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139541076,139541076,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138623244,138623244,F9,Likely pathogenic,Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,139541085,139541085,F9,Likely pathogenic,Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,138623258,138623258,F9,Pathogenic,"Hereditary factor IX deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139541099,139541099,F9,Pathogenic,"Hereditary factor IX deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138623273,138623273,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder|Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139541114,139541114,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder|Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138623286,138623286,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139541127,139541127,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138630609,138630609,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139548450,139548450,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138630626,138630626,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139548467,139548467,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138633271,138633271,F9,Pathogenic/Likely pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked",single nucleotide variant,GRCh37
na,na,X,139551112,139551112,F9,Pathogenic/Likely pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked",single nucleotide variant,GRCh38
na,na,X,138633272,138633272,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh37
na,na,X,139551113,139551113,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh38
na,na,X,138643724,138643724,F9,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh37
na,na,X,139561565,139561565,F9,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh38
na,na,X,138633280,138633280,F9,Benign,"Deep venous thrombosis, protection against|not specified|not provided|Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139551121,139551121,F9,Benign,"Deep venous thrombosis, protection against|not specified|not provided|Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138633355,138633355,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139551196,139551196,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138633376,138633376,F9,Pathogenic/Likely pathogenic,"Hereditary factor IX deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder",single nucleotide variant,GRCh37
na,na,X,139551217,139551217,F9,Pathogenic/Likely pathogenic,"Hereditary factor IX deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder",single nucleotide variant,GRCh38
na,na,X,138633377,138633377,F9,Pathogenic,Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided,single nucleotide variant,GRCh37
na,na,X,139551218,139551218,F9,Pathogenic,Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided,single nucleotide variant,GRCh38
na,na,X,138633241,138633241,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139551082,139551082,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138633382,138633382,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139551223,139551223,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138633382,138633382,F9,Pathogenic,Hemophilia b(m),single nucleotide variant,GRCh37
na,na,X,139551223,139551223,F9,Pathogenic,Hemophilia b(m),single nucleotide variant,GRCh38
na,na,X,138633409,138633409,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139551250,139551250,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138633410,138633410,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139551251,139551251,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138633424,138633424,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139551265,139551265,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Variation,na
na,na,X,138642980,138642980,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139560821,139560821,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138642995,138642995,F9,Benign/Likely benign,"Hereditary factor IX deficiency disease|FACTOR IX, DNA POLYMORPHISM|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder|not provided",single nucleotide variant,GRCh37
na,na,X,139560836,139560836,F9,Benign/Likely benign,"Hereditary factor IX deficiency disease|FACTOR IX, DNA POLYMORPHISM|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder|not provided",single nucleotide variant,GRCh38
na,na,X,138633397,138633397,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139551238,139551238,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643725,138643725,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor VIII deficiency disease|not provided",single nucleotide variant,GRCh37
na,na,X,139561566,139561566,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor VIII deficiency disease|not provided",single nucleotide variant,GRCh38
na,na,X,138643736,138643736,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139561577,139561577,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138643761,138643761,F9,Likely pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561602,139561602,F9,Likely pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643842,138643842,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561683,139561683,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643853,138643853,F9,Likely pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561694,139561694,F9,Likely pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643869,138643869,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|F9-related disorder|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked",single nucleotide variant,GRCh37
na,na,X,139561710,139561710,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|F9-related disorder|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked",single nucleotide variant,GRCh38
na,na,X,138643902,138643902,F9,Pathogenic,"Hereditary factor IX deficiency disease|F9-related disorder|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139561743,139561743,F9,Pathogenic,"Hereditary factor IX deficiency disease|F9-related disorder|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138643908,138643908,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561749,139561749,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643912,138643912,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561753,139561753,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643913,138643913,F9,Pathogenic/Likely pathogenic,Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561754,139561754,F9,Pathogenic/Likely pathogenic,Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643979,138643979,F9,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh37
na,na,X,139561820,139561820,F9,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh38
na,na,X,138643980,138643980,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh37
na,na,X,139561821,139561821,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh38
na,na,X,138643988,138643988,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139561829,139561829,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138643994,138643994,F9,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder",single nucleotide variant,GRCh37
na,na,X,139561835,139561835,F9,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder",single nucleotide variant,GRCh38
na,na,X,138644024,138644024,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561865,139561865,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138644061,138644061,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561902,139561902,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643932,138643932,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561773,139561773,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Variation,na
na,na,X,138644084,138644084,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561925,139561925,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Variation,na
na,na,X,138644151,138644151,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561992,139561992,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138644151,138644151,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561992,139561992,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138644168,138644168,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139562009,139562009,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,na
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Insertion,na
na,na,X,138644172,138644172,F9,Pathogenic/Likely pathogenic,"Hereditary factor IX deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139562013,139562013,F9,Pathogenic/Likely pathogenic,"Hereditary factor IX deficiency disease|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138644201,138644201,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139562042,139562042,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138644213,138644213,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139562054,139562054,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,139530739,139563459,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,GRCh38
na,na,X,139530738,139537009,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,GRCh38
na,na,X,138612923,138623234,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,GRCh37
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,na
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,na
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,na
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,na
na,na,X,138630522,138630522,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,GRCh37
na,na,X,139548363,139548363,F9,Pathogenic,Hereditary factor IX deficiency disease,Deletion,GRCh38
na,na,X,138643964,138643964,F9,Pathogenic,Hereditary factor IX deficiency disease|not specified,single nucleotide variant,GRCh37
na,na,X,139561805,139561805,F9,Pathogenic,Hereditary factor IX deficiency disease|not specified,single nucleotide variant,GRCh38
na,na,X,138630614,138630614,F9,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139548455,139548455,F9,Pathogenic,"Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138643751,138643751,F9,Benign/Likely benign,"FACTOR IX POLYMORPHISM|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not specified|F9-related disorder",single nucleotide variant,GRCh37
na,na,X,139561592,139561592,F9,Benign/Likely benign,"FACTOR IX POLYMORPHISM|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not specified|F9-related disorder",single nucleotide variant,GRCh38
na,na,X,138644031,138644031,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561872,139561872,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138623285,138623285,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139541126,139541126,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138612902,138612902,F9,Pathogenic,Hemophilia B leyden,single nucleotide variant,GRCh37
na,na,X,139530743,139530743,F9,Pathogenic,Hemophilia B leyden,single nucleotide variant,GRCh38
na,na,X,138612890,138612890,F9,Pathogenic,Hemophilia B leyden,single nucleotide variant,GRCh37
na,na,X,139530731,139530731,F9,Pathogenic,Hemophilia B leyden,single nucleotide variant,GRCh38
na,na,X,138612907,138612907,F9,Likely pathogenic,"Hemophilia B leyden|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh37
na,na,X,139530748,139530748,F9,Likely pathogenic,"Hemophilia B leyden|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided",single nucleotide variant,GRCh38
na,na,X,138643914,138643914,F9,Pathogenic,Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,X,139561755,139561755,F9,Pathogenic,Hereditary factor IX deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,X,138623347,138627796,F9,Pathogenic,Hereditary factor IX deficiency disease,Indel,GRCh37
na,na,X,139541188,139545637,F9,Pathogenic,Hereditary factor IX deficiency disease,Indel,GRCh38
na,na,X,138644076,138644076,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561917,139561917,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138644075,138644075,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139561916,139561916,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138644072,138644072,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561913,139561913,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643716,138643716,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561557,139561557,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138612869,138612869,F9,Pathogenic,HEMOPHILIA B BRANDENBURG,single nucleotide variant,GRCh37
na,na,X,139530710,139530710,F9,Pathogenic,HEMOPHILIA B BRANDENBURG,single nucleotide variant,GRCh38
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,na
na,na,X,138612954,138612954,F9,Conflicting classifications of pathogenicity,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139530795,139530795,F9,Conflicting classifications of pathogenicity,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138613005,138613005,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh37
na,na,X,139530846,139530846,F9,Pathogenic,"Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect",single nucleotide variant,GRCh38
na,na,X,138644100,138644100,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561941,139561941,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643995,138643995,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561836,139561836,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138619190,138619190,F9,Pathogenic,"Warfarin sensitivity, X-linked",single nucleotide variant,GRCh37
na,na,X,139537031,139537031,F9,Pathogenic,"Warfarin sensitivity, X-linked",single nucleotide variant,GRCh38
na,na,X,138644033,138644033,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561874,139561874,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,na,-1,-1,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,na
na,na,X,138619547,138619547,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139537388,139537388,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138643875,138643875,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139561716,139561716,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138642931,138642931,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh37
na,na,X,139560772,139560772,F9,Pathogenic,Hereditary factor IX deficiency disease,single nucleotide variant,GRCh38
na,na,X,138633238,138633239,F9,Pathogenic,Hereditary factor IX deficiency disease,Microsatellite,GRCh37
na,na,X,139551079,139551080,F9,Pathogenic,Hereditary factor IX deficiency disease,Microsatellite,GRCh38
na,na,X,138643995,138643995,F9,Pathogenic,"Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease",single nucleotide variant,GRCh37
na,na,X,139561836,139561836,F9,Pathogenic,"Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease",single nucleotide variant,GRCh38
na,na,X,77096808,77096808,MAGT1,Uncertain significance,not provided,single nucleotide variant,GRCh37
na,na,X,77841311,77841311,MAGT1,Uncertain significance,not provided,single nucleotide variant,GRCh38
na,na,X,153595512,153635582,CCNQ,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,Deletion,GRCh38
na,na,X,152850928,152855176,CCNQ,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,Deletion,GRCh37
na,na,X,153585470,153589718,CCNQ,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,Deletion,GRCh38
na,na,X,152857963,152857963,CCNQ,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,single nucleotide variant,GRCh37
na,na,X,153592505,153592505,CCNQ,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,single nucleotide variant,GRCh38
na,na,X,152860130,152860131,CCNQ,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,Duplication,GRCh37
na,na,X,153594672,153594673,CCNQ,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,Duplication,GRCh38
na,na,X,152853913,152853913,CCNQ,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,single nucleotide variant,GRCh37
na,na,X,153588455,153588455,CCNQ,Pathogenic,Syndactyly-telecanthus-anogenital and renal malformations syndrome,single nucleotide variant,GRCh38
na,na,X,53564617,53564617,HUWE1,Pathogenic/Likely pathogenic,"Intellectual disability, X-linked syndromic, Turner type|not provided",single nucleotide variant,GRCh37
na,na,X,53537656,53537656,HUWE1,Pathogenic/Likely pathogenic,"Intellectual disability, X-linked syndromic, Turner type|not provided",single nucleotide variant,GRCh38
na,na,X,53578381,53578381,HUWE1,Pathogenic/Likely pathogenic,"Intellectual disability, X-linked syndromic, Turner type|not provided",single nucleotide variant,GRCh37
na,na,X,53551420,53551420,HUWE1,Pathogenic/Likely pathogenic,"Intellectual disability, X-linked syndromic, Turner type|not provided",single nucleotide variant,GRCh38
na,na,X,53562435,53562435,HUWE1,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked syndromic, Turner type|not provided|Non-syndromic X-linked intellectual disability",single nucleotide variant,GRCh37
na,na,X,53535474,53535474,HUWE1,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked syndromic, Turner type|not provided|Non-syndromic X-linked intellectual disability",single nucleotide variant,GRCh38
na,na,X,43809178,43809178,NDP,Uncertain significance,Atrophia bulborum hereditaria|not provided,single nucleotide variant,GRCh37
na,na,X,43949932,43949932,NDP,Uncertain significance,Atrophia bulborum hereditaria|not provided,single nucleotide variant,GRCh38
na,na,X,43809223,43809223,NDP,Likely pathogenic,"Atrophia bulborum hereditaria|Exudative vitreoretinopathy 2, X-linked",single nucleotide variant,GRCh37
na,na,X,43949977,43949977,NDP,Likely pathogenic,"Atrophia bulborum hereditaria|Exudative vitreoretinopathy 2, X-linked",single nucleotide variant,GRCh38
na,na,X,43809268,43809268,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh37
na,na,X,43950022,43950022,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh38
na,na,X,43817761,43817761,NDP,Likely pathogenic,Atrophia bulborum hereditaria|not provided,single nucleotide variant,GRCh37
na,na,X,43958515,43958515,NDP,Likely pathogenic,Atrophia bulborum hereditaria|not provided,single nucleotide variant,GRCh38
na,na,X,43809160,43809160,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh37
na,na,X,43949914,43949914,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh38
na,na,X,43809077,43809077,NDP,Pathogenic,"Exudative vitreoretinopathy 2, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,43949831,43949831,NDP,Pathogenic,"Exudative vitreoretinopathy 2, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,43809241,43809241,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh37
na,na,X,43949995,43949995,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh38
na,na,X,43809063,43809063,NDP,Pathogenic,Atrophia bulborum hereditaria|not provided,single nucleotide variant,GRCh37
na,na,X,43949817,43949817,NDP,Pathogenic,Atrophia bulborum hereditaria|not provided,single nucleotide variant,GRCh38
na,na,X,43817891,43817891,NDP,Pathogenic,Atrophia bulborum hereditaria|not provided,single nucleotide variant,GRCh37
na,na,X,43958645,43958645,NDP,Pathogenic,Atrophia bulborum hereditaria|not provided,single nucleotide variant,GRCh38
na,na,X,43809086,43809086,NDP,Pathogenic/Likely pathogenic,"Exudative vitreoretinopathy 2, X-linked|not provided|Atrophia bulborum hereditaria|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,X,43949840,43949840,NDP,Pathogenic/Likely pathogenic,"Exudative vitreoretinopathy 2, X-linked|not provided|Atrophia bulborum hereditaria|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,X,43817854,43817854,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh37
na,na,X,43958608,43958608,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh38
na,na,X,43809266,43809266,NDP,Pathogenic,Atrophia bulborum hereditaria|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,43950020,43950020,NDP,Pathogenic,Atrophia bulborum hereditaria|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,43817767,43817767,NDP,Pathogenic,"Exudative vitreoretinopathy, X-linked|not provided|Atrophia bulborum hereditaria|Atrophia bulborum hereditaria;Exudative vitreoretinopathy 2, X-linked",single nucleotide variant,GRCh37
na,na,X,43958521,43958521,NDP,Pathogenic,"Exudative vitreoretinopathy, X-linked|not provided|Atrophia bulborum hereditaria|Atrophia bulborum hereditaria;Exudative vitreoretinopathy 2, X-linked",single nucleotide variant,GRCh38
na,na,X,43817789,43817789,NDP,Pathogenic,Atrophia bulborum hereditaria,Deletion,GRCh37
na,na,X,43958543,43958543,NDP,Pathogenic,Atrophia bulborum hereditaria,Deletion,GRCh38
na,na,X,43809134,43809134,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh37
na,na,X,43949888,43949888,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh38
na,na,X,43809119,43809119,NDP,Pathogenic,"Exudative vitreoretinopathy 2, X-linked",single nucleotide variant,GRCh37
na,na,X,43949873,43949873,NDP,Pathogenic,"Exudative vitreoretinopathy 2, X-linked",single nucleotide variant,GRCh38
na,na,X,43809085,43809085,NDP,Pathogenic,"Exudative vitreoretinopathy 2, X-linked",single nucleotide variant,GRCh37
na,na,X,43949839,43949839,NDP,Pathogenic,"Exudative vitreoretinopathy 2, X-linked",single nucleotide variant,GRCh38
na,na,X,43809159,43809159,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh37
na,na,X,43949913,43949913,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh38
na,na,X,43817758,43817758,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh37
na,na,X,43958512,43958512,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh38
na,na,X,43809229,43809229,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh37
na,na,X,43949983,43949983,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh38
na,na,X,43809145,43809145,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh37
na,na,X,43949899,43949899,NDP,Pathogenic,Atrophia bulborum hereditaria,single nucleotide variant,GRCh38
na,na,X,48374310,48374311,PORCN,Pathogenic,Focal dermal hypoplasia,Duplication,GRCh37
na,na,X,48515922,48515923,PORCN,Pathogenic,Focal dermal hypoplasia,Duplication,GRCh38
na,na,X,48369724,48369724,PORCN,Pathogenic,Focal dermal hypoplasia|not provided|Focal dermal hypoplasia;Anophthalmia-microphthalmia syndrome,single nucleotide variant,GRCh37
na,na,X,48511336,48511336,PORCN,Pathogenic,Focal dermal hypoplasia|not provided|Focal dermal hypoplasia;Anophthalmia-microphthalmia syndrome,single nucleotide variant,GRCh38
na,na,X,48370320,48370320,PORCN,Pathogenic,Focal dermal hypoplasia|not provided,single nucleotide variant,GRCh37
na,na,X,48511932,48511932,PORCN,Pathogenic,Focal dermal hypoplasia|not provided,single nucleotide variant,GRCh38
na,na,X,48369768,48369768,PORCN,Pathogenic,Focal dermal hypoplasia|not provided,single nucleotide variant,GRCh37
na,na,X,48511380,48511380,PORCN,Pathogenic,Focal dermal hypoplasia|not provided,single nucleotide variant,GRCh38
na,na,X,63412496,63412496,AMER1,Pathogenic,Osteopathia striata with cranial sclerosis,Deletion,GRCh37
na,na,X,64192616,64192616,AMER1,Pathogenic,Osteopathia striata with cranial sclerosis,Deletion,GRCh38
na,na,X,63412386,63412387,AMER1,Pathogenic,Osteopathia striata with cranial sclerosis,Duplication,GRCh37
na,na,X,64192506,64192507,AMER1,Pathogenic,Osteopathia striata with cranial sclerosis,Duplication,GRCh38
na,na,X,57537466,65512709,AMER1,Pathogenic,Osteopathia striata with cranial sclerosis,Deletion,GRCh38
na,na,X,63412110,63412110,AMER1,Pathogenic,Osteopathia striata with cranial sclerosis|not provided|Neoplasm|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,64192230,64192230,AMER1,Pathogenic,Osteopathia striata with cranial sclerosis|not provided|Neoplasm|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,63412095,63412095,AMER1,Pathogenic,Osteopathia striata with cranial sclerosis|Inborn genetic diseases|not provided|AMER1-related disorder,single nucleotide variant,GRCh37
na,na,X,64192215,64192215,AMER1,Pathogenic,Osteopathia striata with cranial sclerosis|Inborn genetic diseases|not provided|AMER1-related disorder,single nucleotide variant,GRCh38
na,na,X,128963110,128963113,ZDHHC9,Pathogenic,Syndromic X-linked intellectual disability Raymond type,Deletion,GRCh37
na,na,X,129829134,129829137,ZDHHC9,Pathogenic,Syndromic X-linked intellectual disability Raymond type,Deletion,GRCh38
na,na,X,128975750,128975750,ZDHHC9,Pathogenic,Syndromic X-linked intellectual disability Raymond type,single nucleotide variant,GRCh37
na,na,X,129841774,129841774,ZDHHC9,Pathogenic,Syndromic X-linked intellectual disability Raymond type,single nucleotide variant,GRCh38
na,na,X,128957700,128957700,ZDHHC9,Pathogenic/Likely pathogenic,Syndromic X-linked intellectual disability Raymond type|not provided|Intellectual disability,single nucleotide variant,GRCh37
na,na,X,129823724,129823724,ZDHHC9,Pathogenic/Likely pathogenic,Syndromic X-linked intellectual disability Raymond type|not provided|Intellectual disability,single nucleotide variant,GRCh38
na,na,X,128957694,128957694,ZDHHC9,Pathogenic,Syndromic X-linked intellectual disability Raymond type,single nucleotide variant,GRCh37
na,na,X,129823718,129823718,ZDHHC9,Pathogenic,Syndromic X-linked intellectual disability Raymond type,single nucleotide variant,GRCh38
na,na,X,100653021,100653021,GLA,Pathogenic,Fabry disease|not provided|GLA-related disorder,single nucleotide variant,GRCh37
na,na,X,101398033,101398033,GLA,Pathogenic,Fabry disease|not provided|GLA-related disorder,single nucleotide variant,GRCh38
na,na,X,100656579,100656980,GLA,no classification for the single variant,-,Deletion,GRCh37
na,na,X,101401591,101401992,GLA,no classification for the single variant,-,Deletion,GRCh38
na,na,X,100653455,100653455,GLA,Pathogenic,"Fabry disease|Fabry disease, cardiac variant|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|not provided",single nucleotide variant,GRCh37
na,na,X,101398467,101398467,GLA,Pathogenic,"Fabry disease|Fabry disease, cardiac variant|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy|not provided",single nucleotide variant,GRCh38
na,na,X,100662761,100662761,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101407773,101407773,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100653471,100653471,GLA,Pathogenic/Likely pathogenic,"not provided|Fabry disease, cardiac variant|Fabry disease",single nucleotide variant,GRCh37
na,na,X,101398483,101398483,GLA,Pathogenic/Likely pathogenic,"not provided|Fabry disease, cardiac variant|Fabry disease",single nucleotide variant,GRCh38
na,na,X,100662774,100662774,GLA,Pathogenic,not provided|Fabry disease,single nucleotide variant,GRCh37
na,na,X,101407786,101407786,GLA,Pathogenic,not provided|Fabry disease,single nucleotide variant,GRCh38
na,na,X,100653357,100653357,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101398369,101398369,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100653522,100653522,GLA,Likely pathogenic,"Fabry disease, cardiac variant|not provided",single nucleotide variant,GRCh37
na,na,X,101398534,101398534,GLA,Likely pathogenic,"Fabry disease, cardiac variant|not provided",single nucleotide variant,GRCh38
na,na,X,100653375,100653375,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398387,101398387,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100658972,100658972,GLA,Conflicting classifications of pathogenicity,not specified|not provided|Fabry disease|Cardiovascular phenotype|GLA-related disorder,single nucleotide variant,GRCh37
na,na,X,101403984,101403984,GLA,Conflicting classifications of pathogenicity,not specified|not provided|Fabry disease|Cardiovascular phenotype|GLA-related disorder,single nucleotide variant,GRCh38
na,na,X,100662791,100662791,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101407803,101407803,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100662726,100662726,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101407738,101407738,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100656731,100656731,GLA,Uncertain significance,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101401743,101401743,GLA,Uncertain significance,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100656701,100656701,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101401713,101401713,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100656683,100656683,GLA,Pathogenic/Likely pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101401695,101401695,GLA,Pathogenic/Likely pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100655687,100655687,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101400699,101400699,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100653930,100653930,GLA,Pathogenic,Fabry disease|not provided|Cardiovascular phenotype|Fabry disease;Hypertrophic cardiomyopathy|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,X,101398942,101398942,GLA,Pathogenic,Fabry disease|not provided|Cardiovascular phenotype|Fabry disease;Hypertrophic cardiomyopathy|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,X,100653551,100653551,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101398563,101398563,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100653894,100653894,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398906,101398906,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100653895,100653895,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398907,101398907,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100653783,100653783,GLA,Pathogenic/Likely pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398795,101398795,GLA,Pathogenic/Likely pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100653777,100653777,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398789,101398789,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100653496,100653496,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101398508,101398508,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100653467,100653467,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101398479,101398479,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100653420,100653420,GLA;RPL36A-HNRNPH2,Conflicting classifications of pathogenicity; other,Fabry disease|not specified|Sudden unexplained death|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy|not provided,single nucleotide variant,GRCh37
na,na,X,101398432,101398432,GLA;RPL36A-HNRNPH2,Conflicting classifications of pathogenicity; other,Fabry disease|not specified|Sudden unexplained death|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy|not provided,single nucleotide variant,GRCh38
na,na,X,100653378,100653378,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101398390,101398390,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100653374,100653374,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398386,101398386,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100653067,100653067,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398079,101398079,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100653062,100653062,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398074,101398074,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100653063,100653063,GLA,Pathogenic,Fabry disease|not provided|GLA-related disorder,single nucleotide variant,GRCh37
na,na,X,101398075,101398075,GLA,Pathogenic,Fabry disease|not provided|GLA-related disorder,single nucleotide variant,GRCh38
na,na,X,100653006,100653006,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101398018,101398018,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100652895,100652895,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101397907,101397907,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100658797,100658797,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101403809,101403809,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100656740,100656740,GLA;RPL36A-HNRNPH2,Conflicting classifications of pathogenicity,Fabry disease|Cardiomyopathy|not specified|not provided|Cardiovascular phenotype|GLA-related disorder,single nucleotide variant,GRCh37
na,na,X,101401752,101401752,GLA;RPL36A-HNRNPH2,Conflicting classifications of pathogenicity,Fabry disease|Cardiomyopathy|not specified|not provided|Cardiovascular phenotype|GLA-related disorder,single nucleotide variant,GRCh38
na,na,X,100662755,100662767,GLA,Pathogenic,Fabry disease,Deletion,GRCh37
na,na,X,101407767,101407779,GLA,Pathogenic,Fabry disease,Deletion,GRCh38
na,na,na,-1,-1,GLA,Pathogenic,Fabry disease,Deletion,na
na,na,X,100653402,100653403,GLA,Pathogenic/Likely pathogenic,Fabry disease|not provided,Duplication,GRCh37
na,na,X,101398414,101398415,GLA,Pathogenic/Likely pathogenic,Fabry disease|not provided,Duplication,GRCh38
na,na,X,100653060,100653070,GLA,Pathogenic,Fabry disease,Deletion,GRCh37
na,na,X,101398072,101398082,GLA,Pathogenic,Fabry disease,Deletion,GRCh38
na,na,X,100653046,100653047,GLA,Pathogenic,Fabry disease,Duplication,GRCh37
na,na,X,101398058,101398059,GLA,Pathogenic,Fabry disease,Duplication,GRCh38
na,na,X,100652911,100652963,GLA,Pathogenic,Fabry disease,Deletion,GRCh37
na,na,X,101397923,101397975,GLA,Pathogenic,Fabry disease,Deletion,GRCh38
na,na,na,-1,-1,GLA,Pathogenic,Fabry disease,Deletion,na
na,na,X,100658217,100662873,GLA,Pathogenic,Fabry disease,Deletion,GRCh37
na,na,X,101403229,101407885,GLA,Pathogenic,Fabry disease,Deletion,GRCh38
na,na,na,-1,-1,GLA,Pathogenic,Fabry disease,Deletion,na
na,na,X,100652808,100657327,GLA,Pathogenic,Fabry disease,Deletion,GRCh37
na,na,X,101397820,101402339,GLA,Pathogenic,Fabry disease,Deletion,GRCh38
na,na,na,-1,-1,GLA,Pathogenic,Fabry disease,Deletion,na
na,na,X,100653358,100653359,GLA,Pathogenic,Fabry disease,Duplication,GRCh37
na,na,X,101398370,101398371,GLA,Pathogenic,Fabry disease,Duplication,GRCh38
na,na,X,100653469,100653469,GLA,Pathogenic,"Fabry disease, cardiac variant",single nucleotide variant,GRCh37
na,na,X,101398481,101398481,GLA,Pathogenic,"Fabry disease, cardiac variant",single nucleotide variant,GRCh38
na,na,X,100662834,100662834,GLA,Pathogenic,"Fabry disease, cardiac variant",single nucleotide variant,GRCh37
na,na,X,101407846,101407846,GLA,Pathogenic,"Fabry disease, cardiac variant",single nucleotide variant,GRCh38
na,na,X,100652938,100652940,GLA,Pathogenic,Fabry disease,Deletion,GRCh37
na,na,X,101397950,101397952,GLA,Pathogenic,Fabry disease,Deletion,GRCh38
na,na,X,100662698,100662698,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101407710,101407710,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100652992,100652992,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398004,101398004,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100654735,100654735,GLA,Pathogenic,"Fabry disease, cardiac variant|Fabry disease|not provided|Cardiomyopathy|Fabry disease;Hypertrophic cardiomyopathy|GLA-related disorder|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,X,101399747,101399747,GLA,Pathogenic,"Fabry disease, cardiac variant|Fabry disease|not provided|Cardiomyopathy|Fabry disease;Hypertrophic cardiomyopathy|GLA-related disorder|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,X,100656740,100656740,GLA,Pathogenic/Likely pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101401752,101401752,GLA,Pathogenic/Likely pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100653908,100653908,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh37
na,na,X,101398920,101398920,GLA,Pathogenic,Fabry disease|not provided,single nucleotide variant,GRCh38
na,na,X,100652859,100652859,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101397871,101397871,GLA,Pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,100653542,100653542,GLA,Pathogenic/Likely pathogenic,Fabry disease,single nucleotide variant,GRCh37
na,na,X,101398554,101398554,GLA,Pathogenic/Likely pathogenic,Fabry disease,single nucleotide variant,GRCh38
na,na,X,99922289,99922289,SRPX2,Conflicting classifications of pathogenicity,"Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked|not specified|not provided",single nucleotide variant,GRCh37
na,na,X,100667292,100667292,SRPX2,Conflicting classifications of pathogenicity,"Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked|not specified|not provided",single nucleotide variant,GRCh38
na,na,X,99917224,99917224,SRPX2,Uncertain significance,"Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked",single nucleotide variant,GRCh37
na,na,X,100662227,100662227,SRPX2,Uncertain significance,"Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked",single nucleotide variant,GRCh38
na,na,X,15870542,15870542,AP1S2,Pathogenic,Pettigrew syndrome,single nucleotide variant,GRCh37
na,na,X,15852419,15852419,AP1S2,Pathogenic,Pettigrew syndrome,single nucleotide variant,GRCh38
na,na,X,15870494,15870494,AP1S2,Pathogenic,Pettigrew syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,15852371,15852371,AP1S2,Pathogenic,Pettigrew syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,15864136,15864139,AP1S2,Pathogenic,Pettigrew syndrome,Deletion,GRCh37
na,na,X,15846013,15846016,AP1S2,Pathogenic,Pettigrew syndrome,Deletion,GRCh38
na,na,X,15864021,15864021,AP1S2,Likely pathogenic,Pettigrew syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,15845898,15845898,AP1S2,Likely pathogenic,Pettigrew syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,15864088,15864088,AP1S2,Pathogenic,Pettigrew syndrome,single nucleotide variant,GRCh37
na,na,X,15845965,15845965,AP1S2,Pathogenic,Pettigrew syndrome,single nucleotide variant,GRCh38
na,na,X,131219653,131219653,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",single nucleotide variant,GRCh37
na,na,X,132085625,132085625,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",single nucleotide variant,GRCh38
na,na,X,131214081,131214081,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,132080053,132080053,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,131233494,131233494,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",single nucleotide variant,GRCh37
na,na,X,132099466,132099466,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",single nucleotide variant,GRCh38
na,na,X,131231326,131231326,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",single nucleotide variant,GRCh37
na,na,X,132097298,132097298,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",single nucleotide variant,GRCh38
na,na,X,131234732,131234732,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,132100704,132100704,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,131261830,131261832,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",Microsatellite,GRCh37
na,na,X,132127802,132127804,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",Microsatellite,GRCh38
na,na,X,131220020,131220020,FRMD7,Pathogenic/Likely pathogenic,"Nystagmus 1, congenital, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,132085992,132085992,FRMD7,Pathogenic/Likely pathogenic,"Nystagmus 1, congenital, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,131218574,131218574,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",single nucleotide variant,GRCh37
na,na,X,132084546,132084546,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",single nucleotide variant,GRCh38
na,na,X,131212769,131212770,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",Deletion,GRCh37
na,na,X,132078741,132078742,FRMD7,Pathogenic,"Nystagmus 1, congenital, X-linked",Deletion,GRCh38
na,na,X,119760820,119760820,C1GALT1C1,Pathogenic,Polyagglutinable erythrocyte syndrome,single nucleotide variant,GRCh37
na,na,X,120626965,120626965,C1GALT1C1,Pathogenic,Polyagglutinable erythrocyte syndrome,single nucleotide variant,GRCh38
na,na,X,119760629,119760629,C1GALT1C1,Benign/Likely benign,"Polyagglutinable erythrocyte syndrome|Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature|C1GALT1C1-related disorder|not provided",single nucleotide variant,GRCh37
na,na,X,120626774,120626774,C1GALT1C1,Benign/Likely benign,"Polyagglutinable erythrocyte syndrome|Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature|C1GALT1C1-related disorder|not provided",single nucleotide variant,GRCh38
na,na,X,119760568,119760568,C1GALT1C1,Pathogenic,Polyagglutinable erythrocyte syndrome,single nucleotide variant,GRCh37
na,na,X,120626713,120626713,C1GALT1C1,Pathogenic,Polyagglutinable erythrocyte syndrome,single nucleotide variant,GRCh38
na,na,X,84563194,84563194,POF1B,Conflicting classifications of pathogenicity,Premature ovarian failure 2B|not provided|Premature ovarian insufficiency,single nucleotide variant,GRCh37
na,na,X,85308188,85308188,POF1B,Conflicting classifications of pathogenicity,Premature ovarian failure 2B|not provided|Premature ovarian insufficiency,single nucleotide variant,GRCh38
na,na,X,50350876,50350876,SHROOM4,Uncertain significance,"X-linked intellectual disability, Stocco dos Santos type",single nucleotide variant,GRCh37
na,na,X,50607876,50607876,SHROOM4,Uncertain significance,"X-linked intellectual disability, Stocco dos Santos type",single nucleotide variant,GRCh38
na,na,X,46360672,46360672,ZNF674,Uncertain significance,not provided,single nucleotide variant,GRCh37
na,na,X,46501237,46501237,ZNF674,Uncertain significance,not provided,single nucleotide variant,GRCh38
na,na,X,54037547,54037558,PHF8,Pathogenic,Syndromic X-linked intellectual disability Siderius type,Deletion,GRCh37
na,na,X,54011114,54011125,PHF8,Pathogenic,Syndromic X-linked intellectual disability Siderius type,Deletion,GRCh38
na,na,X,54040962,54040962,PHF8,Pathogenic,Syndromic X-linked intellectual disability Siderius type,single nucleotide variant,GRCh37
na,na,X,54014529,54014529,PHF8,Pathogenic,Syndromic X-linked intellectual disability Siderius type,single nucleotide variant,GRCh38
na,na,X,54043095,54043095,PHF8,Pathogenic,Syndromic X-linked intellectual disability Siderius type,single nucleotide variant,GRCh37
na,na,X,54016662,54016662,PHF8,Pathogenic,Syndromic X-linked intellectual disability Siderius type,single nucleotide variant,GRCh38
na,na,X,54037665,54037665,PHF8,Pathogenic,Syndromic X-linked intellectual disability Siderius type,single nucleotide variant,GRCh37
na,na,X,54011232,54011232,PHF8,Pathogenic,Syndromic X-linked intellectual disability Siderius type,single nucleotide variant,GRCh38
na,na,X,40456521,40456521,ATP6AP2,Pathogenic,Syndromic X-linked intellectual disability Hedera type,single nucleotide variant,GRCh37
na,na,X,40597269,40597269,ATP6AP2,Pathogenic,Syndromic X-linked intellectual disability Hedera type,single nucleotide variant,GRCh38
na,na,X,79947587,79947587,BRWD3,Pathogenic,"Intellectual disability, X-linked 93",single nucleotide variant,GRCh37
na,na,X,80692088,80692088,BRWD3,Pathogenic,"Intellectual disability, X-linked 93",single nucleotide variant,GRCh38
na,na,X,79990664,79990665,BRWD3,Pathogenic,"Intellectual disability, X-linked 93",Duplication,GRCh37
na,na,X,80735165,80735166,BRWD3,Pathogenic,"Intellectual disability, X-linked 93",Duplication,GRCh38
na,na,X,79932731,79932731,BRWD3,Pathogenic,"Intellectual disability, X-linked 93",single nucleotide variant,GRCh37
na,na,X,80677232,80677232,BRWD3,Pathogenic,"Intellectual disability, X-linked 93",single nucleotide variant,GRCh38
na,na,X,10427817,10427819,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,Microsatellite,GRCh37
na,na,X,10459777,10459779,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,Microsatellite,GRCh38
na,na,X,10422940,10422941,MID1,Uncertain significance,X-linked Opitz G/BBB syndrome|not provided,Duplication,GRCh37
na,na,X,10454900,10454901,MID1,Uncertain significance,X-linked Opitz G/BBB syndrome|not provided,Duplication,GRCh38
na,na,X,10423006,10423007,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,Duplication,GRCh37
na,na,X,10454966,10454967,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,Duplication,GRCh38
na,na,X,10417535,10417535,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,single nucleotide variant,GRCh37
na,na,X,10449495,10449495,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,single nucleotide variant,GRCh38
na,na,X,10535245,10535245,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,single nucleotide variant,GRCh37
na,na,X,10567205,10567205,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,Duplication,na
na,na,X,10450649,10450649,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,single nucleotide variant,GRCh37
na,na,X,10482609,10482609,MID1,Pathogenic,X-linked Opitz G/BBB syndrome,single nucleotide variant,GRCh38
na,na,X,10423018,10423019,MID1,Pathogenic,X-linked Opitz G/BBB syndrome|Inborn genetic diseases,Microsatellite,GRCh37
na,na,X,10454978,10454979,MID1,Pathogenic,X-linked Opitz G/BBB syndrome|Inborn genetic diseases,Microsatellite,GRCh38
na,na,X,22056586,22056586,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets,single nucleotide variant,GRCh37
na,na,X,22038468,22038468,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets,single nucleotide variant,GRCh38
na,na,X,22056586,22056586,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets,single nucleotide variant,GRCh37
na,na,X,22038468,22038468,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets,single nucleotide variant,GRCh38
na,na,X,22112198,22112198,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh37
na,na,X,22094080,22094080,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh38
na,na,X,22065234,22065234,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh37
na,na,X,22047116,22047116,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh38
na,na,X,22112123,22112123,PHEX,Pathogenic,not provided,single nucleotide variant,GRCh37
na,na,X,22094005,22094005,PHEX,Pathogenic,not provided,single nucleotide variant,GRCh38
na,na,X,22231039,22231039,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh37
na,na,X,22212922,22212922,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets,single nucleotide variant,na
na,na,X,22113485,22113485,PHEX,Uncertain significance,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh37
na,na,X,22095367,22095367,PHEX,Uncertain significance,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh38
na,na,X,22231074,22231074,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh37
na,na,X,22212957,22212957,PHEX,Pathogenic,Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided,single nucleotide variant,GRCh38
na,na,X,54492233,54492234,FGD1,Pathogenic,Aarskog syndrome,Duplication,GRCh37
na,na,X,54465800,54465801,FGD1,Pathogenic,Aarskog syndrome,Duplication,GRCh38
na,na,X,54482666,54482666,FGD1,Pathogenic,Aarskog syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,54456233,54456233,FGD1,Pathogenic,Aarskog syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,54491955,54491955,FGD1,Conflicting classifications of pathogenicity,Aarskog syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,54465522,54465522,FGD1,Conflicting classifications of pathogenicity,Aarskog syndrome|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,FGD1,Pathogenic,Aarskog syndrome,Deletion,na
na,na,X,54496615,54496615,FGD1,Conflicting classifications of pathogenicity,not provided|Aarskog syndrome|Intellectual disability|Inborn genetic diseases|FGD1-related disorder,single nucleotide variant,GRCh37
na,na,X,54470182,54470182,FGD1,Conflicting classifications of pathogenicity,not provided|Aarskog syndrome|Intellectual disability|Inborn genetic diseases|FGD1-related disorder,single nucleotide variant,GRCh38
na,na,X,54494334,54494334,FGD1,Uncertain significance,Aarskog syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,54467901,54467901,FGD1,Uncertain significance,Aarskog syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,54475658,54475658,FGD1,Pathogenic,Aarskog syndrome,Deletion,GRCh37
na,na,X,54449225,54449225,FGD1,Pathogenic,Aarskog syndrome,Deletion,GRCh38
na,na,X,54494229,54494229,FGD1,Pathogenic,Aarskog syndrome,single nucleotide variant,GRCh37
na,na,X,54467796,54467796,FGD1,Pathogenic,Aarskog syndrome,single nucleotide variant,GRCh38
na,na,X,54496605,54496606,FGD1,Pathogenic,Aarskog syndrome|not provided,Duplication,GRCh37
na,na,X,54470172,54470173,FGD1,Pathogenic,Aarskog syndrome|not provided,Duplication,GRCh38
na,na,X,54492230,54492230,FGD1,Pathogenic,Aarskog syndrome,single nucleotide variant,GRCh37
na,na,X,54465797,54465797,FGD1,Pathogenic,Aarskog syndrome,single nucleotide variant,GRCh38
na,na,X,153171693,153171693,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",Deletion,GRCh37
na,na,X,153906239,153906239,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",Deletion,GRCh38
na,na,X,153171355,153171355,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh37
na,na,X,153905901,153905901,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh38
na,na,X,153171513,153171513,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh37
na,na,X,153906059,153906059,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh38
na,na,X,153171574,153171574,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|Nephrogenic diabetes insipidus",single nucleotide variant,GRCh37
na,na,X,153906120,153906120,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|Nephrogenic diabetes insipidus",single nucleotide variant,GRCh38
na,na,X,153171567,153171567,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh37
na,na,X,153906113,153906113,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh38
na,na,X,153171297,153171297,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,153905843,153905843,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,153171642,153171643,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",Insertion,GRCh37
na,na,X,153906188,153906189,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",Insertion,GRCh38
na,na,X,153171173,153171173,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh37
na,na,X,153905719,153905719,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh38
na,na,X,153171799,153171799,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,153906345,153906345,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,153172075,153172075,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided|Diabetes insipidus, nephrogenic, X-linked;Nephrogenic syndrome of inappropriate antidiuresis",single nucleotide variant,GRCh37
na,na,X,153906621,153906621,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided|Diabetes insipidus, nephrogenic, X-linked;Nephrogenic syndrome of inappropriate antidiuresis",single nucleotide variant,GRCh38
na,na,X,153171213,153171213,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,153905759,153905759,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,153171562,153171562,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh37
na,na,X,153906108,153906108,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh38
na,na,X,153171692,153171693,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",Duplication,GRCh37
na,na,X,153906238,153906239,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",Duplication,GRCh38
na,na,X,153171062,153171062,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",Deletion,GRCh37
na,na,X,153905608,153905608,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",Deletion,GRCh38
na,na,X,153171370,153171370,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|Nephrogenic diabetes insipidus|Nephrogenic syndrome of inappropriate antidiuresis|not provided",single nucleotide variant,GRCh37
na,na,X,153905916,153905916,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|Nephrogenic diabetes insipidus|Nephrogenic syndrome of inappropriate antidiuresis|not provided",single nucleotide variant,GRCh38
na,na,X,153171501,153171501,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,153906047,153906047,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,153171273,153171273,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh37
na,na,X,153905819,153905819,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh38
na,na,X,153171097,153171097,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh37
na,na,X,153905643,153905643,AVPR2,Pathogenic,"Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh38
na,na,X,153171270,153171270,AVPR2,Likely pathogenic,"Diabetes insipidus, nephrogenic, X-linked|Nephrogenic diabetes insipidus|not provided|Nephrogenic syndrome of inappropriate antidiuresis;Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh37
na,na,X,153905816,153905816,AVPR2,Likely pathogenic,"Diabetes insipidus, nephrogenic, X-linked|Nephrogenic diabetes insipidus|not provided|Nephrogenic syndrome of inappropriate antidiuresis;Diabetes insipidus, nephrogenic, X-linked",single nucleotide variant,GRCh38
na,na,X,153171369,153171369,AVPR2,Pathogenic,Nephrogenic syndrome of inappropriate antidiuresis|not provided,single nucleotide variant,GRCh37
na,na,X,153905915,153905915,AVPR2,Pathogenic,Nephrogenic syndrome of inappropriate antidiuresis|not provided,single nucleotide variant,GRCh38
na,na,X,153171370,153171370,AVPR2,Pathogenic,Nephrogenic syndrome of inappropriate antidiuresis,single nucleotide variant,GRCh37
na,na,X,153905916,153905916,AVPR2,Pathogenic,Nephrogenic syndrome of inappropriate antidiuresis,single nucleotide variant,GRCh38
na,na,na,-1,-1,OCRL,Pathogenic,Lowe syndrome,Deletion,na
na,na,X,128723882,128723882,OCRL,Pathogenic,Lowe syndrome|not provided|Dent disease type 2;Lowe syndrome,single nucleotide variant,GRCh37
na,na,X,129589905,129589905,OCRL,Pathogenic,Lowe syndrome|not provided|Dent disease type 2;Lowe syndrome,single nucleotide variant,GRCh38
na,na,X,128703273,128703273,OCRL,Pathogenic,Lowe syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,129569296,129569296,OCRL,Pathogenic,Lowe syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,128703346,128703346,OCRL,Pathogenic,Lowe syndrome,single nucleotide variant,GRCh37
na,na,X,129569369,129569369,OCRL,Pathogenic,Lowe syndrome,single nucleotide variant,GRCh38
na,na,X,128701310,128701310,OCRL,Pathogenic,Dent disease type 2,single nucleotide variant,GRCh37
na,na,X,129567333,129567333,OCRL,Pathogenic,Dent disease type 2,single nucleotide variant,GRCh38
na,na,X,128696373,128696373,OCRL,Pathogenic/Likely pathogenic,Dent disease type 2|Lowe syndrome|not provided|OCRL-related disorder,single nucleotide variant,GRCh37
na,na,X,129562396,129562396,OCRL,Pathogenic/Likely pathogenic,Dent disease type 2|Lowe syndrome|not provided|OCRL-related disorder,single nucleotide variant,GRCh38
na,na,X,53276313,53276313,IQSEC2,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked 1|not provided|Intellectual disability",single nucleotide variant,GRCh37
na,na,X,53247131,53247131,IQSEC2,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked 1|not provided|Intellectual disability",single nucleotide variant,GRCh38
na,na,X,53277960,53277960,IQSEC2,Pathogenic,"Intellectual disability, X-linked 1",single nucleotide variant,GRCh37
na,na,X,53248778,53248778,IQSEC2,Pathogenic,"Intellectual disability, X-linked 1",single nucleotide variant,GRCh38
na,na,X,53279485,53279485,IQSEC2,Pathogenic,"Intellectual disability, X-linked 1",single nucleotide variant,GRCh37
na,na,X,53250303,53250303,IQSEC2,Pathogenic,"Intellectual disability, X-linked 1",single nucleotide variant,GRCh38
na,na,X,53284038,53284038,IQSEC2,Pathogenic,"Intellectual disability, X-linked 1",single nucleotide variant,GRCh37
na,na,X,53254856,53254856,IQSEC2,Pathogenic,"Intellectual disability, X-linked 1",single nucleotide variant,GRCh38
na,na,na,-1,-1,FANCB,Pathogenic,Fanconi anemia complementation group B,Deletion,na
na,na,X,14868622,14868622,FANCB,Pathogenic,Fanconi anemia complementation group B,single nucleotide variant,GRCh37
na,na,X,14850500,14850500,FANCB,Pathogenic,Fanconi anemia complementation group B,single nucleotide variant,GRCh38
na,na,X,19377758,19377761,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Microsatellite,GRCh37
na,na,X,19359640,19359643,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Microsatellite,GRCh38
na,na,X,19377059,19377065,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided,Microsatellite,GRCh37
na,na,X,19358941,19358947,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided,Microsatellite,GRCh38
na,na,X,19377731,19377731,PDHA1,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided|See cases|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,19359613,19359613,PDHA1,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided|See cases|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,19377071,19377073,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Deletion,GRCh37
na,na,X,19358953,19358955,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Deletion,GRCh38
na,na,X,19377757,19377758,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Deletion,GRCh37
na,na,X,19359639,19359640,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Deletion,GRCh38
na,na,X,19377668,19377687,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Deletion,GRCh37
na,na,X,19359550,19359569,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Deletion,GRCh38
na,na,X,19377029,19377030,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Duplication,GRCh37
na,na,X,19358911,19358912,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Duplication,GRCh38
na,na,X,19373831,19373831,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,19355713,19355713,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,19377038,19377038,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided|Inborn genetic diseases|PDHA1-related disorder,single nucleotide variant,GRCh37
na,na,X,19358920,19358920,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided|Inborn genetic diseases|PDHA1-related disorder,single nucleotide variant,GRCh38
na,na,X,19377737,19377738,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided|Inborn genetic diseases|Pyruvate dehydrogenase complex deficiency,Duplication,GRCh37
na,na,X,19359619,19359620,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided|Inborn genetic diseases|Pyruvate dehydrogenase complex deficiency,Duplication,GRCh38
na,na,X,19373817,19373817,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh37
na,na,X,19355699,19355699,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh38
na,na,X,19373478,19373478,PDHA1,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh37
na,na,X,19355360,19355360,PDHA1,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh38
na,na,X,19373590,19373590,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh37
na,na,X,19355472,19355472,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh38
na,na,X,19377077,19377077,PDHA1,Likely pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,19358959,19358959,PDHA1,Likely pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,19375782,19375782,PDHA1,Benign,not specified|Pyruvate dehydrogenase E1-alpha deficiency|not provided|Pyruvate dehydrogenase complex deficiency|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,19357664,19357664,PDHA1,Benign,not specified|Pyruvate dehydrogenase E1-alpha deficiency|not provided|Pyruvate dehydrogenase complex deficiency|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,19375799,19375800,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Insertion,GRCh37
na,na,X,19357681,19357682,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Insertion,GRCh38
na,na,X,19362184,19362184,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh37
na,na,X,19344066,19344066,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh38
na,na,X,19377123,19377124,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Duplication,GRCh37
na,na,X,19359005,19359006,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Duplication,GRCh38
na,na,X,19377671,19377672,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Duplication,GRCh37
na,na,X,19359553,19359554,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Duplication,GRCh38
na,na,X,19375801,19375801,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|PDHA1-related disorder,single nucleotide variant,GRCh37
na,na,X,19357683,19357683,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency|PDHA1-related disorder,single nucleotide variant,GRCh38
na,na,X,19377849,19377850,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Duplication,GRCh37
na,na,X,19359731,19359732,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,Duplication,GRCh38
na,na,X,19373511,19373511,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh37
na,na,X,19355393,19355393,PDHA1,Pathogenic,Pyruvate dehydrogenase E1-alpha deficiency,single nucleotide variant,GRCh38
na,na,X,48340103,48340103,FTSJ1,Pathogenic,"Intellectual disability, X-linked 9|not provided",single nucleotide variant,GRCh37
na,na,X,48481715,48481715,FTSJ1,Pathogenic,"Intellectual disability, X-linked 9|not provided",single nucleotide variant,GRCh38
na,na,X,48337009,48337009,FTSJ1,Pathogenic,"Intellectual disability, X-linked 9",single nucleotide variant,GRCh37
na,na,X,48478621,48478621,FTSJ1,Pathogenic,"Intellectual disability, X-linked 9",single nucleotide variant,GRCh38
na,na,X,48336556,48336556,FTSJ1,Pathogenic,"Intellectual disability, X-linked 9",Deletion,GRCh37
na,na,X,48478168,48478168,FTSJ1,Pathogenic,"Intellectual disability, X-linked 9",Deletion,GRCh38
na,na,X,48337003,48337003,FTSJ1,Pathogenic,"Intellectual disability, X-linked 9",single nucleotide variant,GRCh37
na,na,X,48478615,48478615,FTSJ1,Pathogenic,"Intellectual disability, X-linked 9",single nucleotide variant,GRCh38
na,na,X,123499636,123499636,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency|not provided|X-linked lymphoproliferative syndrome,single nucleotide variant,GRCh37
na,na,X,124365786,124365786,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency|not provided|X-linked lymphoproliferative syndrome,single nucleotide variant,GRCh38
na,na,X,123499645,123499645,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh37
na,na,X,124365795,124365795,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh38
na,na,X,123499618,123499776,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,Deletion,GRCh37
na,na,X,124365768,124365926,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,Deletion,GRCh38
na,na,X,123480587,123480587,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh37
na,na,X,124346737,124346737,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh38
na,na,X,123499610,123499610,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh37
na,na,X,124365760,124365760,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh38
na,na,X,123505239,123505239,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh37
na,na,X,124371389,124371389,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh38
na,na,X,123504126,123504126,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh37
na,na,X,124370276,124370276,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh38
na,na,X,123504027,123504027,SH2D1A,Uncertain significance,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh37
na,na,X,124370177,124370177,SH2D1A,Uncertain significance,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh38
na,na,X,123480483,123480483,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh37
na,na,X,124346633,124346633,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh38
na,na,X,124346562,124365760,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,Deletion,GRCh38
na,na,X,123480495,123480495,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh37
na,na,X,124346645,124346645,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh38
na,na,X,123499637,123499637,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh37
na,na,X,124365787,124365787,SH2D1A,Pathogenic,X-linked lymphoproliferative disease due to SH2D1A deficiency,single nucleotide variant,GRCh38
na,na,X,39934345,39934345,BCOR,Pathogenic,Oculofaciocardiodental syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,40075092,40075092,BCOR,Pathogenic,Oculofaciocardiodental syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,39921647,39921647,BCOR,Pathogenic,Oculofaciocardiodental syndrome,single nucleotide variant,GRCh37
na,na,X,40062394,40062394,BCOR,Pathogenic,Oculofaciocardiodental syndrome,single nucleotide variant,GRCh38
na,na,X,39931673,39931673,BCOR,Pathogenic,Oculofaciocardiodental syndrome,single nucleotide variant,GRCh37
na,na,X,40072420,40072420,BCOR,Pathogenic,Oculofaciocardiodental syndrome,single nucleotide variant,GRCh38
na,na,X,39922189,39922189,BCOR,Pathogenic,Oculofaciocardiodental syndrome,Deletion,GRCh37
na,na,X,40062936,40062936,BCOR,Pathogenic,Oculofaciocardiodental syndrome,Deletion,GRCh38
na,na,X,40012195,40063607,BCOR,Pathogenic,Oculofaciocardiodental syndrome,Deletion,GRCh38
na,na,X,39923805,39923805,BCOR,Pathogenic,Oculofaciocardiodental syndrome,Deletion,GRCh37
na,na,X,40064552,40064552,BCOR,Pathogenic,Oculofaciocardiodental syndrome,Deletion,GRCh38
na,na,na,-1,-1,BCOR,Pathogenic,Oculofaciocardiodental syndrome,Deletion,na
na,na,X,39931986,39931986,BCOR,Pathogenic,Oculofaciocardiodental syndrome,Deletion,GRCh37
na,na,X,40072733,40072733,BCOR,Pathogenic,Oculofaciocardiodental syndrome,Deletion,GRCh38
na,na,X,37664351,37664351,CYBB,Pathogenic,"not provided|Granulomatous disease, chronic, X-linked, variant|Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh37
na,na,X,37805098,37805098,CYBB,Pathogenic,"not provided|Granulomatous disease, chronic, X-linked, variant|Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh38
na,na,X,37664273,37664273,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided",single nucleotide variant,GRCh37
na,na,X,37805020,37805020,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided",single nucleotide variant,GRCh38
na,na,X,37655345,37655345,CYBB,Uncertain significance,"Granulomatous disease, chronic, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,37796092,37796092,CYBB,Uncertain significance,"Granulomatous disease, chronic, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,37642818,37642818,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided|CYBB-related disorder",single nucleotide variant,GRCh37
na,na,X,37783565,37783565,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided|CYBB-related disorder",single nucleotide variant,GRCh38
na,na,X,37658264,37658264,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided",single nucleotide variant,GRCh37
na,na,X,37799011,37799011,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided",single nucleotide variant,GRCh38
na,na,X,37653046,37653046,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided|Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh37
na,na,X,37793793,37793793,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided|Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh38
na,na,X,37651277,37651277,CYBB,Pathogenic,"not provided|Granulomatous disease, chronic, X-linked, variant|Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh37
na,na,X,37792024,37792024,CYBB,Pathogenic,"not provided|Granulomatous disease, chronic, X-linked, variant|Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh38
na,na,X,37663143,37663143,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,37803890,37803890,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,37668818,37668818,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh37
na,na,X,37809565,37809565,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh38
na,na,X,37658209,37658209,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided|Chronic granulomatous disease",single nucleotide variant,GRCh37
na,na,X,37798956,37798956,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided|Chronic granulomatous disease",single nucleotide variant,GRCh38
na,na,X,37642858,37642858,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh37
na,na,X,37783605,37783605,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh38
na,na,X,37668857,37668857,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,37809604,37809604,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,37651276,37651276,CYBB,Likely pathogenic,"not provided|Granulomatous disease, chronic, X-linked, variant|Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh37
na,na,X,37792023,37792023,CYBB,Likely pathogenic,"not provided|Granulomatous disease, chronic, X-linked, variant|Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh38
na,na,X,37642853,37642853,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided|X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency;Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh37
na,na,X,37783600,37783600,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked|not provided|X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency;Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh38
na,na,na,-1,-1,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",Insertion,na
na,na,X,37663139,37663139,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided",single nucleotide variant,GRCh37
na,na,X,37803886,37803886,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked, variant|not provided",single nucleotide variant,GRCh38
na,na,X,37654042,37654042,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh37
na,na,X,37794789,37794789,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh38
na,na,na,-1,-1,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",Insertion,na
na,na,X,37639381,37639381,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh37
na,na,X,37780128,37780128,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",single nucleotide variant,GRCh38
na,na,X,37641385,37641387,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",Indel,GRCh37
na,na,X,37782132,37782134,CYBB,Pathogenic,"Granulomatous disease, chronic, X-linked",Indel,GRCh38
na,na,X,30714158,30714158,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh37
na,na,X,30696041,30696041,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh38
na,na,X,30738213,30738968,GK,Pathogenic,Inborn glycerol kinase deficiency,Deletion,GRCh37
na,na,X,30720096,30720851,GK,Pathogenic,Inborn glycerol kinase deficiency,Deletion,GRCh38
na,na,X,30738838,30738838,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh37
na,na,X,30720721,30720721,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh38
na,na,X,30700906,30728743,GK,Pathogenic,Inborn glycerol kinase deficiency,Deletion,GRCh38
na,na,X,30738756,30738756,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh37
na,na,X,30720639,30720639,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh38
na,na,X,30742241,30742241,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh37
na,na,X,30724124,30724124,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,GK,Pathogenic,Inborn glycerol kinase deficiency,Insertion,na
na,na,X,30725701,30725701,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh37
na,na,X,30707584,30707584,GK,Pathogenic,Inborn glycerol kinase deficiency,single nucleotide variant,GRCh38
na,na,X,30326634,30326634,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308517,30308517,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30326374,30326374,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308257,30308257,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30326693,30326693,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308576,30308576,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30326681,30326681,NR0B1,Pathogenic/Likely pathogenic,"Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308564,30308564,NR0B1,Pathogenic/Likely pathogenic,"Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30326777,30326777,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308660,30308660,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30326968,30326968,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308851,30308851,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30326642,30326642,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Deletion,GRCh37
na,na,X,30308525,30308525,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Deletion,GRCh38
na,na,X,30327208,30327208,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,30309091,30309091,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,30322790,30322790,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30304673,30304673,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30322926,30322926,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,30304809,30304809,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,30326668,30326668,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308551,30308551,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30322732,30322733,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Indel,GRCh37
na,na,X,30304615,30304616,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Indel,GRCh38
na,na,X,30326716,30326716,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Deletion,GRCh37
na,na,X,30308599,30308599,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Deletion,GRCh38
na,na,na,-1,-1,NR0B1,Pathogenic,"46,XY sex reversal 2",Duplication,na
na,na,X,30326335,30326335,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308218,30308218,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30326608,30326608,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308491,30308491,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,na,-1,-1,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Deletion,na
na,na,X,30322875,30322878,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",Deletion,GRCh37
na,na,X,30304758,30304761,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",Deletion,GRCh38
na,na,X,30326890,30326890,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308773,30308773,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30322793,30322793,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30304676,30304676,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30326980,30326980,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked|NR0B1-related disorder|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",Deletion,GRCh37
na,na,X,30308863,30308863,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked|NR0B1-related disorder|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",Deletion,GRCh38
na,na,X,30326339,30326339,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308222,30308222,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,na,-1,-1,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Insertion,na
na,na,X,30326343,30326343,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308226,30308226,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30322274,30324504,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Indel,GRCh37
na,na,X,30304157,30306387,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",Indel,GRCh38
na,na,X,30322912,30322912,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30304795,30304795,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30326591,30326591,NR0B1,Uncertain significance,"Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30308474,30308474,NR0B1,Uncertain significance,"Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30327372,30327372,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30309255,30309255,NR0B1,Pathogenic,"Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,30327166,30327166,NR0B1,Conflicting classifications of pathogenicity,"Mineralocorticoid deficiency, isolated|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,30309049,30309049,NR0B1,Conflicting classifications of pathogenicity,"Mineralocorticoid deficiency, isolated|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,48759667,48759668,PQBP1,Pathogenic,Renpenning syndrome|not provided|PQBP1-related disorder,Microsatellite,GRCh37
na,na,X,48902390,48902391,PQBP1,Pathogenic,Renpenning syndrome|not provided|PQBP1-related disorder,Microsatellite,GRCh38
na,na,X,48759668,48759671,PQBP1,Pathogenic/Likely pathogenic,Renpenning syndrome|not provided|Microcephaly;Hyperactivity;Delayed speech and language development|Inborn genetic diseases|Intellectual disability|See cases,Microsatellite,GRCh37
na,na,X,48902391,48902394,PQBP1,Pathogenic/Likely pathogenic,Renpenning syndrome|not provided|Microcephaly;Hyperactivity;Delayed speech and language development|Inborn genetic diseases|Intellectual disability|See cases,Microsatellite,GRCh38
na,na,X,48759668,48759669,PQBP1,Pathogenic,Renpenning syndrome,Microsatellite,GRCh37
na,na,X,48902391,48902392,PQBP1,Pathogenic,Renpenning syndrome,Microsatellite,GRCh38
na,na,X,48760065,48760066,PQBP1,Pathogenic,Renpenning syndrome|not provided,Duplication,GRCh37
na,na,X,48902788,48902789,PQBP1,Pathogenic,Renpenning syndrome|not provided,Duplication,GRCh38
na,na,X,48759761,48759783,PQBP1,Pathogenic,Renpenning syndrome,Deletion,GRCh37
na,na,X,48902484,48902506,PQBP1,Pathogenic,Renpenning syndrome,Deletion,GRCh38
na,na,X,48759534,48759554,PQBP1,Benign/Likely benign,Renpenning syndrome|not specified|not provided|PQBP1-related disorder,Deletion,GRCh37
na,na,X,48902257,48902277,PQBP1,Benign/Likely benign,Renpenning syndrome|not specified|not provided|PQBP1-related disorder,Deletion,GRCh38
na,na,X,48759221,48759221,PQBP1,Pathogenic,Renpenning syndrome,single nucleotide variant,GRCh37
na,na,X,48901944,48901944,PQBP1,Pathogenic,Renpenning syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency,Deletion,na
na,na,X,38260563,38260563,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38401310,38401310,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38260562,38260562,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38401309,38401309,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38240628,38240628,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency,single nucleotide variant,GRCh37
na,na,X,38381375,38381375,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency,single nucleotide variant,GRCh38
na,na,X,38262976,38262976,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38403723,38403723,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38260601,38260601,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38401348,38401348,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38226600,38226600,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38367347,38367347,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38212026,38212026,OTC,Pathogenic/Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,38352773,38352773,OTC,Pathogenic/Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,38226603,38226603,OTC,Benign,ORNITHINE TRANSCARBAMYLASE POLYMORPHISM|not specified|Ornithine carbamoyltransferase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,38367350,38367350,OTC,Benign,ORNITHINE TRANSCARBAMYLASE POLYMORPHISM|not specified|Ornithine carbamoyltransferase deficiency|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,38268050,38268050,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38408797,38408797,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38260526,38260526,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38401273,38401273,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38268240,38268240,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38408987,38408987,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38268005,38268005,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38408752,38408752,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38229091,38229091,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38369838,38369838,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38226614,38226614,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38367361,38367361,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38260625,38260625,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38401372,38401372,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38229068,38229068,OTC,Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38369815,38369815,OTC,Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38229113,38229113,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38369860,38369860,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38271159,38271159,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38411906,38411906,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38280303,38280303,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38421050,38421050,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38240682,38240682,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38381429,38381429,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38260585,38260585,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38401332,38401332,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38262947,38262947,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38403694,38403694,OTC,Pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38226584,38226584,OTC,Pathogenic/Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38367331,38367331,OTC,Pathogenic/Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,38226585,38226585,OTC,Pathogenic/Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,38367332,38367332,OTC,Pathogenic/Likely pathogenic,Ornithine carbamoyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,99662274,99662274,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh37
na,na,X,100407276,100407276,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh38
na,na,X,99663343,99663343,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh37
na,na,X,100408345,100408345,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh38
na,na,X,99661584,99661584,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh37
na,na,X,100406586,100406586,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh38
na,na,X,99661565,99661566,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",Duplication,GRCh37
na,na,X,100406567,100406568,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",Duplication,GRCh38
na,na,X,99663454,99663454,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh37
na,na,X,100408456,100408456,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh38
na,na,X,99662555,99662556,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",Duplication,GRCh37
na,na,X,100407557,100407558,PCDH19,Pathogenic,"Developmental and epileptic encephalopathy, 9",Duplication,GRCh38
na,na,X,99661925,99661925,PCDH19,Likely pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh37
na,na,X,100406927,100406927,PCDH19,Likely pathogenic,"Developmental and epileptic encephalopathy, 9",single nucleotide variant,GRCh38
na,na,X,17744675,17744676,NHS,Pathogenic,Nance-Horan syndrome,Duplication,GRCh37
na,na,X,17726555,17726556,NHS,Pathogenic,Nance-Horan syndrome,Duplication,GRCh38
na,na,X,17745747,17745747,NHS,Pathogenic,Nance-Horan syndrome,Deletion,GRCh37
na,na,X,17727627,17727627,NHS,Pathogenic,Nance-Horan syndrome,Deletion,GRCh38
na,na,X,17742490,17742490,NHS,Pathogenic,not provided|Nance-Horan syndrome|Cataract 40,single nucleotide variant,GRCh37
na,na,X,17724370,17724370,NHS,Pathogenic,not provided|Nance-Horan syndrome|Cataract 40,single nucleotide variant,GRCh38
na,na,X,17706013,17706014,NHS,Pathogenic,Nance-Horan syndrome,Duplication,GRCh37
na,na,X,17687893,17687894,NHS,Pathogenic,Nance-Horan syndrome,Duplication,GRCh38
na,na,X,17393995,17393995,NHS,Pathogenic,Nance-Horan syndrome,single nucleotide variant,GRCh37
na,na,X,17375872,17375872,NHS,Pathogenic,Nance-Horan syndrome,single nucleotide variant,GRCh38
na,na,X,17739559,17739559,NHS,Pathogenic,Nance-Horan syndrome,single nucleotide variant,GRCh37
na,na,X,17721439,17721439,NHS,Pathogenic,Nance-Horan syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,NHS,Pathogenic,Cataract 40,copy number gain,na
na,na,X,17551843,17556653,NHS,Pathogenic,Cataract 40,Deletion,GRCh37
na,na,X,17533720,17538531,NHS,Pathogenic,Cataract 40,Deletion,GRCh38
na,na,X,68836333,68836333,EDA,Pathogenic/Likely pathogenic,"Hypohidrotic X-linked ectodermal dysplasia|Tooth agenesis, selective, X-linked, 1;Hypohidrotic X-linked ectodermal dysplasia",single nucleotide variant,GRCh37
na,na,X,69616489,69616489,EDA,Pathogenic/Likely pathogenic,"Hypohidrotic X-linked ectodermal dysplasia|Tooth agenesis, selective, X-linked, 1;Hypohidrotic X-linked ectodermal dysplasia",single nucleotide variant,GRCh38
na,na,X,68836358,68836358,EDA,Conflicting classifications of pathogenicity,Hypohidrotic X-linked ectodermal dysplasia|not specified|not provided|EDA-related disorder,single nucleotide variant,GRCh37
na,na,X,69616514,69616514,EDA,Conflicting classifications of pathogenicity,Hypohidrotic X-linked ectodermal dysplasia|not specified|not provided|EDA-related disorder,single nucleotide variant,GRCh38
na,na,X,68836219,68836219,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia|not provided,single nucleotide variant,GRCh37
na,na,X,69616375,69616375,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia|not provided,single nucleotide variant,GRCh38
na,na,X,68836339,68836339,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,single nucleotide variant,GRCh37
na,na,X,69616495,69616495,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,single nucleotide variant,GRCh38
na,na,X,69176943,69176943,EDA,Pathogenic,"Hypohidrotic X-linked ectodermal dysplasia|not provided|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh37
na,na,X,69957093,69957093,EDA,Pathogenic,"Hypohidrotic X-linked ectodermal dysplasia|not provided|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh38
na,na,X,69176946,69176946,EDA,Pathogenic/Likely pathogenic,Hypohidrotic X-linked ectodermal dysplasia|not provided|EDA-related disorder,single nucleotide variant,GRCh37
na,na,X,69957096,69957096,EDA,Pathogenic/Likely pathogenic,Hypohidrotic X-linked ectodermal dysplasia|not provided|EDA-related disorder,single nucleotide variant,GRCh38
na,na,X,69176947,69176947,EDA,Pathogenic,"Hypohidrotic X-linked ectodermal dysplasia|not provided|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh37
na,na,X,69957097,69957097,EDA,Pathogenic,"Hypohidrotic X-linked ectodermal dysplasia|not provided|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh38
na,na,X,69247806,69247806,EDA,Conflicting classifications of pathogenicity,Hypohidrotic X-linked ectodermal dysplasia|not specified,single nucleotide variant,GRCh37
na,na,X,70027956,70027956,EDA,Conflicting classifications of pathogenicity,Hypohidrotic X-linked ectodermal dysplasia|not specified,single nucleotide variant,GRCh38
na,na,X,69247851,69247851,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,single nucleotide variant,GRCh37
na,na,X,70028001,70028001,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,single nucleotide variant,GRCh38
na,na,X,69255328,69255328,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia|not provided,single nucleotide variant,GRCh37
na,na,X,70035478,70035478,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia|not provided,single nucleotide variant,GRCh38
na,na,X,68836335,68836335,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,single nucleotide variant,GRCh37
na,na,X,69616491,69616491,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,single nucleotide variant,GRCh38
na,na,na,-1,-1,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,Deletion,na
na,na,na,-1,-1,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,Deletion,na
na,na,X,68836345,68836345,EDA,Pathogenic,"Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh37
na,na,X,69616501,69616501,EDA,Pathogenic,"Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh38
na,na,X,69255355,69255355,EDA,Pathogenic,"Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh37
na,na,X,70035505,70035505,EDA,Pathogenic,"Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh38
na,na,X,69247753,69247754,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,Insertion,GRCh37
na,na,X,70027903,70027904,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,Insertion,GRCh38
na,na,X,69253363,69253364,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,Microsatellite,GRCh37
na,na,X,70033513,70033514,EDA,Pathogenic,Hypohidrotic X-linked ectodermal dysplasia,Microsatellite,GRCh38
na,na,X,69255296,69255296,EDA,Pathogenic,"Tooth agenesis, selective, X-linked, 1|Hypohidrotic X-linked ectodermal dysplasia|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh37
na,na,X,70035446,70035446,EDA,Pathogenic,"Tooth agenesis, selective, X-linked, 1|Hypohidrotic X-linked ectodermal dysplasia|Hypohidrotic X-linked ectodermal dysplasia;Tooth agenesis, selective, X-linked, 1",single nucleotide variant,GRCh38
na,na,X,62944437,62944437,ARHGEF9,Pathogenic,"Developmental and epileptic encephalopathy, 8",single nucleotide variant,GRCh37
na,na,X,63724557,63724557,ARHGEF9,Pathogenic,"Developmental and epileptic encephalopathy, 8",single nucleotide variant,GRCh38
na,na,X,5821533,5821534,NLGN4X,risk factor,"Autism, susceptibility to, X-linked 2",Duplication,GRCh37
na,na,X,5903492,5903493,NLGN4X,risk factor,"Autism, susceptibility to, X-linked 2",Duplication,GRCh38
na,na,X,5821464,5821465,NLGN4X,Pathogenic; risk factor,"Autism, susceptibility to, X-linked 2|X-linked intellectual disability",Microsatellite,GRCh37
na,na,X,5903423,5903424,NLGN4X,Pathogenic; risk factor,"Autism, susceptibility to, X-linked 2|X-linked intellectual disability",Microsatellite,GRCh38
na,na,na,-1,-1,NLGN4X,Pathogenic; risk factor,"Autism, susceptibility to, X-linked 2|X-linked intellectual disability",Deletion,na
na,na,X,149809779,149809779,MTM1,Pathogenic/Likely pathogenic,Severe X-linked myotubular myopathy|not provided,single nucleotide variant,GRCh37
na,na,X,150641306,150641306,MTM1,Pathogenic/Likely pathogenic,Severe X-linked myotubular myopathy|not provided,single nucleotide variant,GRCh38
na,na,X,149826430,149826430,MTM1,Pathogenic,Severe X-linked myotubular myopathy,single nucleotide variant,GRCh37
na,na,X,150657957,150657957,MTM1,Pathogenic,Severe X-linked myotubular myopathy,single nucleotide variant,GRCh38
na,na,X,149767124,149767124,MTM1,Pathogenic,Severe X-linked myotubular myopathy|Centronuclear myopathy|not provided,single nucleotide variant,GRCh37
na,na,X,150598660,150598660,MTM1,Pathogenic,Severe X-linked myotubular myopathy|Centronuclear myopathy|not provided,single nucleotide variant,GRCh38
na,na,X,149814155,149814155,MTM1,Likely pathogenic,Severe X-linked myotubular myopathy,single nucleotide variant,GRCh37
na,na,X,150645682,150645682,MTM1,Likely pathogenic,Severe X-linked myotubular myopathy,single nucleotide variant,GRCh38
na,na,X,149767058,149767061,MTM1,Pathogenic,Severe X-linked myotubular myopathy|not provided|MTM1-related disorder|Centronuclear myopathy,Deletion,GRCh37
na,na,X,150598594,150598597,MTM1,Pathogenic,Severe X-linked myotubular myopathy|not provided|MTM1-related disorder|Centronuclear myopathy,Deletion,GRCh38
na,na,X,149828127,149828127,MTM1,Pathogenic/Likely pathogenic,Severe X-linked myotubular myopathy|not provided|Centronuclear myopathy|MTM1-related disorder,single nucleotide variant,GRCh37
na,na,X,150659654,150659654,MTM1,Pathogenic/Likely pathogenic,Severe X-linked myotubular myopathy|not provided|Centronuclear myopathy|MTM1-related disorder,single nucleotide variant,GRCh38
na,na,X,149814198,149814198,MTM1,Pathogenic,Severe X-linked myotubular myopathy|not provided,single nucleotide variant,GRCh37
na,na,X,150645725,150645725,MTM1,Pathogenic,Severe X-linked myotubular myopathy|not provided,single nucleotide variant,GRCh38
na,na,X,149809883,149809883,MTM1,Pathogenic,Severe X-linked myotubular myopathy|not provided|Centronuclear myopathy,single nucleotide variant,GRCh37
na,na,X,150641410,150641410,MTM1,Pathogenic,Severe X-linked myotubular myopathy|not provided|Centronuclear myopathy,single nucleotide variant,GRCh38
na,na,X,149809815,149809815,MTM1,Pathogenic,Severe X-linked myotubular myopathy,Deletion,GRCh37
na,na,X,150641342,150641342,MTM1,Pathogenic,Severe X-linked myotubular myopathy,Deletion,GRCh38
na,na,X,149807440,149807440,MTM1,Likely pathogenic,Severe X-linked myotubular myopathy|not provided,single nucleotide variant,GRCh37
na,na,X,150638967,150638967,MTM1,Likely pathogenic,Severe X-linked myotubular myopathy|not provided,single nucleotide variant,GRCh38
na,na,X,133559286,133559286,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome|not provided|Intellectual disability,single nucleotide variant,GRCh37
na,na,X,134425256,134425256,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome|not provided|Intellectual disability,single nucleotide variant,GRCh38
na,na,X,133527586,133527586,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh37
na,na,X,134393556,134393556,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh38
na,na,X,133547967,133547967,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh37
na,na,X,134413937,134413937,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh38
na,na,X,133511781,133511781,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,134377751,134377751,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,133547953,133547953,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh37
na,na,X,134413923,134413923,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh38
na,na,X,133511649,133511649,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome|Hereditary spastic paraplegia 4|not provided,single nucleotide variant,GRCh37
na,na,X,134377619,134377619,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome|Hereditary spastic paraplegia 4|not provided,single nucleotide variant,GRCh38
na,na,X,133549085,133549085,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,134415055,134415055,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,133511669,133511669,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh37
na,na,X,134377639,134377639,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh38
na,na,X,133512027,133512027,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh37
na,na,X,134377997,134377997,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,single nucleotide variant,GRCh38
na,na,X,133511668,133511669,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,Duplication,GRCh37
na,na,X,134377638,134377639,PHF6,Pathogenic,Borjeson-Forssman-Lehmann syndrome,Duplication,GRCh38
na,na,X,103043389,103043389,PLP1,Pathogenic,Pelizaeus-Merzbacher disease|not provided,single nucleotide variant,GRCh37
na,na,X,103788460,103788460,PLP1,Pathogenic,Pelizaeus-Merzbacher disease|not provided,single nucleotide variant,GRCh38
na,na,X,103042760,103042760,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease|not provided,single nucleotide variant,GRCh37
na,na,X,103787831,103787831,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease|not provided,single nucleotide variant,GRCh38
na,na,X,103040550,103040550,PLP1,Pathogenic/Likely pathogenic,Pelizaeus-Merzbacher disease|Hereditary spastic paraplegia 2|not provided,single nucleotide variant,GRCh37
na,na,X,103785621,103785621,PLP1,Pathogenic/Likely pathogenic,Pelizaeus-Merzbacher disease|Hereditary spastic paraplegia 2|not provided,single nucleotide variant,GRCh38
na,na,X,103042740,103042740,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103787811,103787811,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103043398,103043398,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103788469,103788469,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103776506,104817980,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,Deletion,GRCh38
na,na,X,103042817,103042817,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103787888,103787888,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103043414,103043414,PLP1,Uncertain significance,Pelizaeus-Merzbacher disease|Hereditary spastic paraplegia 2,single nucleotide variant,GRCh37
na,na,X,103788485,103788485,PLP1,Uncertain significance,Pelizaeus-Merzbacher disease|Hereditary spastic paraplegia 2,single nucleotide variant,GRCh38
na,na,X,103042880,103042880,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103787951,103787951,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103041422,103041422,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103786493,103786493,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103043404,103043404,PLP1,Pathogenic,"Pelizaeus-Merzbacher disease, connatal",single nucleotide variant,GRCh37
na,na,X,103788475,103788475,PLP1,Pathogenic,"Pelizaeus-Merzbacher disease, connatal",single nucleotide variant,GRCh38
na,na,X,103041620,103041620,PLP1,Uncertain significance,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease|not provided,single nucleotide variant,GRCh37
na,na,X,103786691,103786691,PLP1,Uncertain significance,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease|not provided,single nucleotide variant,GRCh38
na,na,X,103042833,103042833,PLP1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103787904,103787904,PLP1,Pathogenic/Likely pathogenic,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103040634,103040634,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103785705,103785705,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103031926,103031926,PLP1,Pathogenic,"Pelizaeus-Merzbacher disease, mild|Hereditary spastic paraplegia 2",single nucleotide variant,GRCh37
na,na,X,103776998,103776998,PLP1,Pathogenic,"Pelizaeus-Merzbacher disease, mild|Hereditary spastic paraplegia 2",single nucleotide variant,GRCh38
na,na,X,103044275,103044275,PLP1,Likely pathogenic,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103789346,103789346,PLP1,Likely pathogenic,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103041636,103041636,PLP1,Pathogenic/Likely pathogenic,"Pelizaeus-Merzbacher disease, atypical|Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease",single nucleotide variant,GRCh37
na,na,X,103786707,103786707,PLP1,Pathogenic/Likely pathogenic,"Pelizaeus-Merzbacher disease, atypical|Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease",single nucleotide variant,GRCh38
na,na,X,103044290,103044290,PLP1,Pathogenic,"Pelizaeus-Merzbacher disease, connatal",single nucleotide variant,GRCh37
na,na,X,103789361,103789361,PLP1,Pathogenic,"Pelizaeus-Merzbacher disease, connatal",single nucleotide variant,GRCh38
na,na,X,103042782,103042782,PLP1,Likely pathogenic,Hereditary spastic paraplegia 2|not provided,single nucleotide variant,GRCh37
na,na,X,103787853,103787853,PLP1,Likely pathogenic,Hereditary spastic paraplegia 2|not provided,single nucleotide variant,GRCh38
na,na,X,103477300,104817980,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,Duplication,GRCh38
na,na,X,103044330,103044330,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103789401,103789401,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103041659,103041659,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103786730,103786730,PLP1,Likely pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103041681,103041699,PLP1,Likely pathogenic,"Pelizaeus-Merzbacher disease, atypical|Pelizaeus-Merzbacher disease",Deletion,GRCh37
na,na,X,103786752,103786770,PLP1,Likely pathogenic,"Pelizaeus-Merzbacher disease, atypical|Pelizaeus-Merzbacher disease",Deletion,GRCh38
na,na,X,103041611,103041611,PLP1,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103786682,103786682,PLP1,Conflicting classifications of pathogenicity,Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,103040675,103040675,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh37
na,na,X,103785746,103785746,PLP1,Pathogenic,Pelizaeus-Merzbacher disease,single nucleotide variant,GRCh38
na,na,X,153641543,153641543,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh37
na,na,X,154413206,154413206,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh38
na,na,X,153640466,153640466,TAFAZZIN,Pathogenic/Likely pathogenic,3-Methylglutaconic aciduria type 2|not provided,single nucleotide variant,GRCh37
na,na,X,154412129,154412129,TAFAZZIN,Pathogenic/Likely pathogenic,3-Methylglutaconic aciduria type 2|not provided,single nucleotide variant,GRCh38
na,na,X,153641543,153641543,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh37
na,na,X,154413206,154413206,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh38
na,na,X,153648081,153648082,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,Duplication,GRCh37
na,na,X,154419742,154419743,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,Duplication,GRCh38
na,na,X,153648418,153648418,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,Deletion,GRCh37
na,na,X,154420079,154420079,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,Deletion,GRCh38
na,na,X,153648376,153648376,TAFAZZIN,Pathogenic/Likely pathogenic,3-Methylglutaconic aciduria type 2|TAFAZZIN-related disorder|not provided,single nucleotide variant,GRCh37
na,na,X,154420037,154420037,TAFAZZIN,Pathogenic/Likely pathogenic,3-Methylglutaconic aciduria type 2|TAFAZZIN-related disorder|not provided,single nucleotide variant,GRCh38
na,na,X,153640294,153640294,TAFAZZIN,Likely pathogenic,3-Methylglutaconic aciduria type 2|not provided,single nucleotide variant,GRCh37
na,na,X,154411957,154411957,TAFAZZIN,Likely pathogenic,3-Methylglutaconic aciduria type 2|not provided,single nucleotide variant,GRCh38
na,na,X,153641699,153641699,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh37
na,na,X,154413362,154413362,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh38
na,na,X,153641886,153641886,TAFAZZIN,Uncertain significance,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh37
na,na,X,154413549,154413549,TAFAZZIN,Uncertain significance,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh38
na,na,X,153640421,153640421,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh37
na,na,X,154412084,154412084,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh38
na,na,X,153641585,153641585,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh37
na,na,X,154413248,154413248,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh38
na,na,X,153648390,153648393,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,Deletion,GRCh37
na,na,X,154420051,154420054,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,Deletion,GRCh38
na,na,X,153648550,153648550,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh37
na,na,X,154420211,154420211,TAFAZZIN,Pathogenic,3-Methylglutaconic aciduria type 2,single nucleotide variant,GRCh38
na,na,X,48542716,48542716,WAS,Pathogenic,Wiskott-Aldrich syndrome,Deletion,GRCh37
na,na,X,48684327,48684327,WAS,Pathogenic,Wiskott-Aldrich syndrome,Deletion,GRCh38
na,na,X,48542796,48542796,WAS,Pathogenic,Wiskott-Aldrich syndrome,single nucleotide variant,GRCh37
na,na,X,48684407,48684407,WAS,Pathogenic,Wiskott-Aldrich syndrome,single nucleotide variant,GRCh38
na,na,X,48542796,48542796,WAS,Pathogenic,Wiskott-Aldrich syndrome|not provided|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,single nucleotide variant,GRCh37
na,na,X,48684407,48684407,WAS,Pathogenic,Wiskott-Aldrich syndrome|not provided|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,single nucleotide variant,GRCh38
na,na,X,48542706,48542706,WAS,Pathogenic,Thrombocytopenia 1|not provided|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1|Wiskott-Aldrich syndrome,single nucleotide variant,GRCh37
na,na,X,48684317,48684317,WAS,Pathogenic,Thrombocytopenia 1|not provided|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1|Wiskott-Aldrich syndrome,single nucleotide variant,GRCh38
na,na,X,48545317,48545317,WAS,Pathogenic,Thrombocytopenia 1,single nucleotide variant,GRCh37
na,na,X,48686928,48686928,WAS,Pathogenic,Thrombocytopenia 1,single nucleotide variant,GRCh38
na,na,X,48544348,48544349,WAS,Pathogenic,Thrombocytopenia 1,Duplication,GRCh37
na,na,X,48685959,48685960,WAS,Pathogenic,Thrombocytopenia 1,Duplication,GRCh38
na,na,X,48542342,48542342,WAS,Pathogenic,Wiskott-Aldrich syndrome|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,single nucleotide variant,GRCh37
na,na,X,48683953,48683953,WAS,Pathogenic,Wiskott-Aldrich syndrome|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,single nucleotide variant,GRCh38
na,na,X,48542243,48542243,WAS,Pathogenic,Wiskott-Aldrich syndrome,single nucleotide variant,GRCh37
na,na,X,48683854,48683854,WAS,Pathogenic,Wiskott-Aldrich syndrome,single nucleotide variant,GRCh38
na,na,X,48544149,48544150,WAS,Pathogenic,Wiskott-Aldrich syndrome,Microsatellite,GRCh37
na,na,X,48685760,48685761,WAS,Pathogenic,Wiskott-Aldrich syndrome,Microsatellite,GRCh38
na,na,X,48542783,48542783,WAS,Likely pathogenic,"WISKOTT-ALDRICH SYNDROME, ATTENUATED|not provided",single nucleotide variant,GRCh37
na,na,X,48684394,48684394,WAS,Likely pathogenic,"WISKOTT-ALDRICH SYNDROME, ATTENUATED|not provided",single nucleotide variant,GRCh38
na,na,X,48542673,48542673,WAS,Pathogenic,Thrombocytopenia 1|Thrombocytopenia|Thrombocytopenia 1;Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia|not provided|Wiskott-Aldrich syndrome|WAS-related disorder,single nucleotide variant,GRCh37
na,na,X,48684284,48684284,WAS,Pathogenic,Thrombocytopenia 1|Thrombocytopenia|Thrombocytopenia 1;Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia|not provided|Wiskott-Aldrich syndrome|WAS-related disorder,single nucleotide variant,GRCh38
na,na,X,48547210,48547210,WAS,Pathogenic,Wiskott-Aldrich syndrome,Deletion,GRCh37
na,na,X,48688821,48688821,WAS,Pathogenic,Wiskott-Aldrich syndrome,Deletion,GRCh38
na,na,X,48546720,48546720,WAS,Pathogenic/Likely pathogenic,X-linked severe congenital neutropenia|not provided|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,single nucleotide variant,GRCh37
na,na,X,48688331,48688331,WAS,Pathogenic/Likely pathogenic,X-linked severe congenital neutropenia|not provided|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,single nucleotide variant,GRCh38
na,na,X,48542712,48542712,WAS,Pathogenic,"THROMBOCYTOPENIA, X-LINKED, INTERMITTENT",single nucleotide variant,GRCh37
na,na,X,48684323,48684323,WAS,Pathogenic,"THROMBOCYTOPENIA, X-LINKED, INTERMITTENT",single nucleotide variant,GRCh38
na,na,X,48547812,48547812,WAS,Pathogenic,"THROMBOCYTOPENIA, X-LINKED, INTERMITTENT",single nucleotide variant,GRCh37
na,na,X,48689423,48689423,WAS,Pathogenic,"THROMBOCYTOPENIA, X-LINKED, INTERMITTENT",single nucleotide variant,GRCh38
na,na,na,-1,-1,WAS,Pathogenic,Wiskott-Aldrich syndrome,Deletion,na
na,na,X,48545169,48545169,WAS,Pathogenic,Wiskott-Aldrich syndrome,single nucleotide variant,GRCh37
na,na,X,48686780,48686780,WAS,Pathogenic,Wiskott-Aldrich syndrome,single nucleotide variant,GRCh38
na,na,X,48544525,48544525,WAS,Pathogenic,Wiskott-Aldrich syndrome,single nucleotide variant,GRCh37
na,na,X,48686136,48686136,WAS,Pathogenic,Wiskott-Aldrich syndrome,single nucleotide variant,GRCh38
na,na,X,48542249,48542249,WAS,Pathogenic,Wiskott-Aldrich syndrome|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,Deletion,GRCh37
na,na,X,48683860,48683860,WAS,Pathogenic,Wiskott-Aldrich syndrome|Wiskott-Aldrich syndrome;X-linked severe congenital neutropenia;Thrombocytopenia 1,Deletion,GRCh38
na,na,X,48542314,48542315,WAS,Pathogenic,Wiskott-Aldrich syndrome,Deletion,GRCh37
na,na,X,48683925,48683926,WAS,Pathogenic,Wiskott-Aldrich syndrome,Deletion,GRCh38
na,na,X,11314055,11318781,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh37
na,na,X,11295935,11300661,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh38
na,na,X,11316363,11316363,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh37
na,na,X,11298243,11298243,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh38
na,na,X,11312922,11312930,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh37
na,na,X,11294802,11294810,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh38
na,na,X,11316953,11316953,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh37
na,na,X,11298833,11298833,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh38
na,na,X,11316363,11316363,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,single nucleotide variant,GRCh37
na,na,X,11298243,11298243,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,single nucleotide variant,GRCh38
na,na,X,11317052,11317052,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,single nucleotide variant,GRCh37
na,na,X,11298932,11298932,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,single nucleotide variant,GRCh38
na,na,X,11316689,11316689,AMELX,Pathogenic,Amelogenesis imperfecta type 1E|not provided|AMELX-related disorder,single nucleotide variant,GRCh37
na,na,X,11298569,11298569,AMELX,Pathogenic,Amelogenesis imperfecta type 1E|not provided|AMELX-related disorder,single nucleotide variant,GRCh38
na,na,X,11317019,11317019,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh37
na,na,X,11298899,11298899,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh38
na,na,X,11316899,11316899,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh37
na,na,X,11298779,11298779,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,Deletion,GRCh38
na,na,X,11312910,11312910,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,single nucleotide variant,GRCh37
na,na,X,11294790,11294790,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,single nucleotide variant,GRCh38
na,na,X,11312919,11312919,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,single nucleotide variant,GRCh37
na,na,X,11294799,11294799,AMELX,Pathogenic,Amelogenesis imperfecta type 1E,single nucleotide variant,GRCh38
na,na,X,85155705,85155706,CHM,Pathogenic,Choroideremia,Indel,GRCh37
na,na,X,85900700,85900701,CHM,Pathogenic,Choroideremia,Indel,GRCh38
na,na,X,85149219,85149219,CHM,Pathogenic,Choroideremia|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,X,85894214,85894214,CHM,Pathogenic,Choroideremia|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,X,85149232,85149232,CHM,Pathogenic,Choroideremia,single nucleotide variant,GRCh37
na,na,X,85894227,85894227,CHM,Pathogenic,Choroideremia,single nucleotide variant,GRCh38
na,na,X,85133992,85133995,CHM,Pathogenic,Choroideremia|Retinal dystrophy|not provided,Microsatellite,GRCh37
na,na,X,85878987,85878990,CHM,Pathogenic,Choroideremia|Retinal dystrophy|not provided,Microsatellite,GRCh38
na,na,X,85149206,85149206,CHM,Pathogenic,Choroideremia|not provided,single nucleotide variant,GRCh37
na,na,X,85894201,85894201,CHM,Pathogenic,Choroideremia|not provided,single nucleotide variant,GRCh38
na,na,X,85212923,85212923,CHM,Pathogenic,Choroideremia|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,X,85957918,85957918,CHM,Pathogenic,Choroideremia|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,na,-1,-1,CHM,Pathogenic,Choroideremia,Insertion,na
na,na,X,135741491,135741491,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh37
na,na,X,136659332,136659332,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh38
na,na,X,135738552,135738552,CD40LG,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,X,136656393,136656393,CD40LG,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,X,135741468,135741468,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh37
na,na,X,136659309,136659309,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh38
na,na,X,135741252,135741252,CD40LG,Pathogenic,Hyper-IgM syndrome type 1|not provided,single nucleotide variant,GRCh37
na,na,X,136659093,136659093,CD40LG,Pathogenic,Hyper-IgM syndrome type 1|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,Variation,na
na,na,X,135730514,135730514,CD40LG,Pathogenic/Likely pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh37
na,na,X,136648355,136648355,CD40LG,Pathogenic/Likely pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh38
na,na,X,135741207,135741207,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh37
na,na,X,136659048,136659048,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh38
na,na,X,135741206,135741206,CD40LG,Likely pathogenic,Hyper-IgM syndrome type 1|not provided,single nucleotide variant,GRCh37
na,na,X,136659047,136659047,CD40LG,Likely pathogenic,Hyper-IgM syndrome type 1|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,Deletion,na
na,na,X,135741194,135741201,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,Deletion,GRCh37
na,na,X,136659035,136659042,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,Deletion,GRCh38
na,na,na,-1,-1,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,Deletion,na
na,na,X,135738536,135738536,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh37
na,na,X,136656377,136656377,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,single nucleotide variant,GRCh38
na,na,X,135732453,135732454,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,Duplication,GRCh37
na,na,X,136650294,136650295,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,Duplication,GRCh38
na,na,na,-1,-1,CD40LG,Pathogenic,Hyper-IgM syndrome type 1,Insertion,na
na,na,X,153609298,153609299,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,Deletion,GRCh37
na,na,X,154380938,154380939,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,Deletion,GRCh38
na,na,X,153607845,153607845,EMD,Pathogenic,not provided|X-linked Emery-Dreifuss muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,154379485,154379485,EMD,Pathogenic,not provided|X-linked Emery-Dreifuss muscular dystrophy,single nucleotide variant,GRCh38
na,na,na,-1,-1,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,Deletion,na
na,na,X,153608104,153608105,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,Duplication,GRCh37
na,na,X,154379744,154379745,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,Duplication,GRCh38
na,na,X,153608097,153608097,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,X,154379737,154379737,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,X,153609406,153609406,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,Deletion,GRCh37
na,na,X,154381046,154381046,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,Deletion,GRCh38
na,na,X,153609340,153609340,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,154380980,154380980,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,153609339,153609339,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,154380979,154380979,EMD,Pathogenic,X-linked Emery-Dreifuss muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,47486963,47486963,CFP,Pathogenic,"Properdin deficiency, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,47627564,47627564,CFP,Pathogenic,"Properdin deficiency, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,47487606,47487606,CFP,Uncertain significance,"Properdin deficiency, type II|not provided",single nucleotide variant,GRCh37
na,na,X,47628207,47628207,CFP,Uncertain significance,"Properdin deficiency, type II|not provided",single nucleotide variant,GRCh38
na,na,X,47486219,47486219,CFP,Pathogenic,"Properdin deficiency, X-linked",single nucleotide variant,GRCh37
na,na,X,47626820,47626820,CFP,Pathogenic,"Properdin deficiency, X-linked",single nucleotide variant,GRCh38
na,na,X,47486689,47486689,CFP,Pathogenic,"Properdin deficiency, X-linked",single nucleotide variant,GRCh37
na,na,X,47627290,47627290,CFP,Pathogenic,"Properdin deficiency, X-linked",single nucleotide variant,GRCh38
na,na,X,47485461,47485461,CFP,Pathogenic,"Properdin deficiency, type III",single nucleotide variant,GRCh37
na,na,X,47626062,47626062,CFP,Pathogenic,"Properdin deficiency, type III",single nucleotide variant,GRCh38
na,na,X,25031776,25031777,ARX,Pathogenic/Likely pathogenic,"Developmental and epileptic encephalopathy, 1|X-linked lissencephaly with abnormal genitalia|not provided|Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related|Inborn genetic diseases|X-linked lissencephaly with abnormal genitalia;Corpus callosum agenesis-abnormal genitalia syndrome;Partington syndrome;Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related|Intellectual disability, X-linked, with or without seizures, ARX-related|West syndrome",Microsatellite,GRCh37
na,na,X,25013659,25013660,ARX,Pathogenic/Likely pathogenic,"Developmental and epileptic encephalopathy, 1|X-linked lissencephaly with abnormal genitalia|not provided|Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related|Inborn genetic diseases|X-linked lissencephaly with abnormal genitalia;Corpus callosum agenesis-abnormal genitalia syndrome;Partington syndrome;Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related|Intellectual disability, X-linked, with or without seizures, ARX-related|West syndrome",Microsatellite,GRCh38
na,na,X,25031660,25031661,ARX,Conflicting classifications of pathogenicity,"Partington syndrome|not provided|Developmental and epileptic encephalopathy, 1|Intellectual disability, X-linked, with or without seizures, ARX-related|Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related",Duplication,GRCh37
na,na,X,25013543,25013544,ARX,Conflicting classifications of pathogenicity,"Partington syndrome|not provided|Developmental and epileptic encephalopathy, 1|Intellectual disability, X-linked, with or without seizures, ARX-related|Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related",Duplication,GRCh38
na,na,X,25031054,25031054,ARX,Pathogenic,"Developmental and epileptic encephalopathy, 1|Corpus callosum agenesis-abnormal genitalia syndrome;X-linked lissencephaly with abnormal genitalia;Developmental and epileptic encephalopathy, 1;Partington syndrome;Intellectual disability, X-linked, with or without seizures, ARX-related|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,X,25012937,25012937,ARX,Pathogenic,"Developmental and epileptic encephalopathy, 1|Corpus callosum agenesis-abnormal genitalia syndrome;X-linked lissencephaly with abnormal genitalia;Developmental and epileptic encephalopathy, 1;Partington syndrome;Intellectual disability, X-linked, with or without seizures, ARX-related|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,X,25022327,25023843,ARX,Pathogenic,"Developmental and epileptic encephalopathy, 1",Deletion,GRCh37
na,na,X,25004210,25005726,ARX,Pathogenic,"Developmental and epileptic encephalopathy, 1",Deletion,GRCh38
na,na,X,25031657,25031688,ARX,Pathogenic,X-linked lissencephaly with abnormal genitalia,Deletion,GRCh37
na,na,X,25013540,25013571,ARX,Pathogenic,X-linked lissencephaly with abnormal genitalia,Deletion,GRCh38
na,na,X,25031117,25031117,ARX,Pathogenic,"X-linked lissencephaly with abnormal genitalia|not provided|Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related",single nucleotide variant,GRCh37
na,na,X,25013000,25013000,ARX,Pathogenic,"X-linked lissencephaly with abnormal genitalia|not provided|Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related",single nucleotide variant,GRCh38
na,na,X,25028379,25028379,ARX,Pathogenic,X-linked lissencephaly with abnormal genitalia,single nucleotide variant,GRCh37
na,na,X,25010262,25010262,ARX,Pathogenic,X-linked lissencephaly with abnormal genitalia,single nucleotide variant,GRCh38
na,na,X,25025488,25025489,ARX,Pathogenic/Likely pathogenic,"X-linked lissencephaly with abnormal genitalia|Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related|Intellectual disability, X-linked, with or without seizures, ARX-related",Duplication,GRCh37
na,na,X,25007371,25007372,ARX,Pathogenic/Likely pathogenic,"X-linked lissencephaly with abnormal genitalia|Developmental and epileptic encephalopathy, 1;Intellectual disability, X-linked, with or without seizures, ARX-related|Intellectual disability, X-linked, with or without seizures, ARX-related",Duplication,GRCh38
na,na,na,-1,-1,ARX,Pathogenic,X-linked lissencephaly with abnormal genitalia,Deletion,na
na,na,X,25031084,25031084,ARX,Pathogenic,X-linked lissencephaly with abnormal genitalia,single nucleotide variant,GRCh37
na,na,X,25012967,25012967,ARX,Pathogenic,X-linked lissencephaly with abnormal genitalia,single nucleotide variant,GRCh38
na,na,X,25033757,25033757,ARX,Pathogenic,"Intellectual disability, X-linked, with or without seizures, ARX-related",single nucleotide variant,GRCh37
na,na,X,25015640,25015640,ARX,Pathogenic,"Intellectual disability, X-linked, with or without seizures, ARX-related",single nucleotide variant,GRCh38
na,na,X,25031256,25031256,ARX,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked, with or without seizures, ARX-related|not provided|Intellectual disability, X-linked, with or without seizures, ARX-related;Developmental and epileptic encephalopathy, 1|Inborn genetic diseases|not specified",single nucleotide variant,GRCh37
na,na,X,25013139,25013139,ARX,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked, with or without seizures, ARX-related|not provided|Intellectual disability, X-linked, with or without seizures, ARX-related;Developmental and epileptic encephalopathy, 1|Inborn genetic diseases|not specified",single nucleotide variant,GRCh38
na,na,X,25031114,25031114,ARX,Pathogenic,Corpus callosum agenesis-abnormal genitalia syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,25012997,25012997,ARX,Pathogenic,Corpus callosum agenesis-abnormal genitalia syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,25028391,25028391,ARX,Pathogenic,Hydranencephaly with abnormal genitalia,single nucleotide variant,GRCh37
na,na,X,25010274,25010274,ARX,Pathogenic,Hydranencephaly with abnormal genitalia,single nucleotide variant,GRCh38
na,na,X,25031770,25031771,ARX,Pathogenic,"Developmental and epileptic encephalopathy, 1|Intellectual disability, X-linked, with or without seizures, ARX-related;Developmental and epileptic encephalopathy, 1",Duplication,GRCh37
na,na,X,25013653,25013654,ARX,Pathogenic,"Developmental and epileptic encephalopathy, 1|Intellectual disability, X-linked, with or without seizures, ARX-related;Developmental and epileptic encephalopathy, 1",Duplication,GRCh38
na,na,X,25031880,25031880,ARX,Pathogenic,X-linked lissencephaly with abnormal genitalia,single nucleotide variant,GRCh37
na,na,X,25013763,25013763,ARX,Pathogenic,X-linked lissencephaly with abnormal genitalia,single nucleotide variant,GRCh38
na,na,X,32472913,32472913,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32454796,32454796,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,na,-1,-1,DMD,Pathogenic,"Becker muscular dystrophy, atypical",Deletion,na
na,na,X,32503048,32503048,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,32484931,32484931,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,32364095,32364095,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32345978,32345978,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31462738,31462738,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31444621,31444621,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31200853,31200853,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31182736,31182736,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31196901,31196901,DMD,Pathogenic,Duchenne muscular dystrophy|Becker muscular dystrophy|not provided|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy|Becker muscular dystrophy;Dilated cardiomyopathy 3B;Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31178784,31178784,DMD,Pathogenic,Duchenne muscular dystrophy|Becker muscular dystrophy|not provided|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy|Becker muscular dystrophy;Dilated cardiomyopathy 3B;Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31134195,31173538,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,32632555,32632556,DMD,Pathogenic,Duchenne muscular dystrophy,Duplication,GRCh37
na,na,X,32614438,32614439,DMD,Pathogenic,Duchenne muscular dystrophy,Duplication,GRCh38
na,na,X,31893325,31893326,DMD,Pathogenic,Duchenne muscular dystrophy,Indel,GRCh37
na,na,X,31875208,31875209,DMD,Pathogenic,Duchenne muscular dystrophy,Indel,GRCh38
na,na,X,32472310,32491276,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,32501843,32545158,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,31893448,31893448,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31875331,31875331,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32862911,32862911,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32844794,32844794,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32519950,32519950,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,32501833,32501833,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,32519893,32519893,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh37
na,na,X,32501776,32501776,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,32519938,32519938,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32501821,32501821,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32834682,32834682,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Duchenne muscular dystrophy;Becker muscular dystrophy;Dilated cardiomyopathy 3B,single nucleotide variant,GRCh37
na,na,X,32816565,32816565,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Duchenne muscular dystrophy;Becker muscular dystrophy;Dilated cardiomyopathy 3B,single nucleotide variant,GRCh38
na,na,X,32519869,32519869,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32501752,32501752,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31497221,31497221,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31479104,31479104,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32867870,32867870,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32849753,32849753,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32472777,32472777,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32454660,32454660,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32834612,32834612,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32816495,32816495,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,33020201,33211556,DMD,Pathogenic,Dilated cardiomyopathy 3B,Deletion,GRCh38
na,na,X,32834599,32834599,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh37
na,na,X,32816482,32816482,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,32563427,32563427,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32545310,32545310,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31198554,31198554,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31180437,31180437,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32867938,32867938,DMD,Conflicting classifications of pathogenicity,Becker muscular dystrophy|Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,32849821,32849821,DMD,Conflicting classifications of pathogenicity,Becker muscular dystrophy|Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,32867856,32867857,DMD,Pathogenic,Intermediate muscular dystrophy,Deletion,GRCh37
na,na,X,32849739,32849740,DMD,Pathogenic,Intermediate muscular dystrophy,Deletion,GRCh38
na,na,X,32867853,32867853,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32849736,32849736,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32862965,32862966,DMD,Pathogenic,Duchenne muscular dystrophy,Duplication,GRCh37
na,na,X,32844848,32844849,DMD,Pathogenic,Duchenne muscular dystrophy,Duplication,GRCh38
na,na,X,32717369,32717369,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32699252,32699252,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32717336,32717336,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32699219,32699219,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32717312,32717312,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32699195,32699195,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32717267,32717277,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh37
na,na,X,32699150,32699160,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,32632464,32632464,DMD,Pathogenic,Intermediate muscular dystrophy|Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32614347,32614347,DMD,Pathogenic,Intermediate muscular dystrophy|Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32613987,32613987,DMD,Pathogenic,"Duchenne muscular dystrophy|Becker muscular dystrophy, Cardiomyopathy, Duchenne muscular dystrophy, Dystrophin deficiency|not provided",single nucleotide variant,GRCh37
na,na,X,32595870,32595870,DMD,Pathogenic,"Duchenne muscular dystrophy|Becker muscular dystrophy, Cardiomyopathy, Duchenne muscular dystrophy, Dystrophin deficiency|not provided",single nucleotide variant,GRCh38
na,na,X,32613874,32613874,DMD,Pathogenic,Becker muscular dystrophy|Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32595757,32595757,DMD,Pathogenic,Becker muscular dystrophy|Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32583859,32583859,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32565742,32565742,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32519944,32519944,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32501827,32501827,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32519935,32519935,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32501818,32501818,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32519874,32519925,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh37
na,na,X,32501757,32501808,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,32503119,32503120,DMD,Pathogenic,Duchenne muscular dystrophy,Insertion,GRCh37
na,na,X,32485002,32485003,DMD,Pathogenic,Duchenne muscular dystrophy,Insertion,GRCh38
na,na,X,32486656,32486656,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,32468539,32468539,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,32482791,32482791,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32464674,32464674,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32429889,32429889,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32411772,32411772,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,32407722,32407722,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,32389605,32389605,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,32360240,32360240,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,X,32342123,32342123,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,X,32305736,32305736,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh37
na,na,X,32287619,32287619,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,32235179,32235179,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,32217062,32217062,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,32235098,32235098,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,32216981,32216981,DMD,Pathogenic,Duchenne muscular dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,31947833,31947849,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh37
na,na,X,31929716,31929732,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,31947835,31947835,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31929718,31929718,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31792217,31792217,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31774100,31774100,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31496431,31496431,DMD,Benign/Likely benign,Duchenne muscular dystrophy|not specified|Cardiovascular phenotype|Dilated cardiomyopathy 3B|not provided|Dystrophin deficiency;Cardiomyopathy;Becker muscular dystrophy;Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31478314,31478314,DMD,Benign/Likely benign,Duchenne muscular dystrophy|not specified|Cardiovascular phenotype|Dilated cardiomyopathy 3B|not provided|Dystrophin deficiency;Cardiomyopathy;Becker muscular dystrophy;Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31496426,31496426,DMD,Benign/Likely benign,Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype|not provided|Dystrophin deficiency;Cardiomyopathy;Becker muscular dystrophy;Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31478309,31478309,DMD,Benign/Likely benign,Duchenne muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype|not provided|Dystrophin deficiency;Cardiomyopathy;Becker muscular dystrophy;Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31496398,31496398,DMD,Benign/Likely benign,Becker muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype|Duchenne muscular dystrophy|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy|DMD-related disorder|not provided,single nucleotide variant,GRCh37
na,na,X,31478281,31478281,DMD,Benign/Likely benign,Becker muscular dystrophy|not specified|Dilated cardiomyopathy 3B|Cardiovascular phenotype|Duchenne muscular dystrophy|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy|DMD-related disorder|not provided,single nucleotide variant,GRCh38
na,na,X,31341742,31341742,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31323625,31323625,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31196868,31196868,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|X-linked DMD-related dystrophinopathy|Abnormality of the musculature|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy|See cases,single nucleotide variant,GRCh37
na,na,X,31178751,31178751,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|X-linked DMD-related dystrophinopathy|Abnormality of the musculature|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy|See cases,single nucleotide variant,GRCh38
na,na,X,31196781,31196781,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31178664,31178664,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31196049,31196049,DMD,Uncertain significance,Becker muscular dystrophy|not provided|not specified|Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31177932,31177932,DMD,Uncertain significance,Becker muscular dystrophy|not provided|not specified|Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31187636,31187636,DMD,Pathogenic,Becker muscular dystrophy,Deletion,GRCh37
na,na,X,31169519,31169519,DMD,Pathogenic,Becker muscular dystrophy,Deletion,GRCh38
na,na,X,31187622,31187629,DMD,Pathogenic,Duchenne muscular dystrophy,Indel,GRCh37
na,na,X,31169505,31169512,DMD,Pathogenic,Duchenne muscular dystrophy,Indel,GRCh38
na,na,X,32716112,32716112,DMD,Uncertain significance,Dilated cardiomyopathy 3B|not provided,single nucleotide variant,GRCh37
na,na,X,32697995,32697995,DMD,Uncertain significance,Dilated cardiomyopathy 3B|not provided,single nucleotide variant,GRCh38
na,na,X,32466728,32466728,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32448611,32448611,DMD,Pathogenic,Becker muscular dystrophy,single nucleotide variant,GRCh38
na,na,na,-1,-1,DMD,Pathogenic,Dilated cardiomyopathy 3B,Insertion,na
na,na,X,31224780,31224780,DMD,Pathogenic,Duchenne muscular dystrophy|Dilated cardiomyopathy 3B|not provided|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy|Qualitative or quantitative defects of dystrophin,single nucleotide variant,GRCh37
na,na,X,31206663,31206663,DMD,Pathogenic,Duchenne muscular dystrophy|Dilated cardiomyopathy 3B|not provided|Dystrophin deficiency;Becker muscular dystrophy;Cardiomyopathy;Duchenne muscular dystrophy|Qualitative or quantitative defects of dystrophin,single nucleotide variant,GRCh38
na,na,X,32456489,32456489,DMD,Pathogenic,Becker muscular dystrophy|Duchenne muscular dystrophy|not provided|Qualitative or quantitative defects of dystrophin|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,X,32438372,32438372,DMD,Pathogenic,Becker muscular dystrophy|Duchenne muscular dystrophy|not provided|Qualitative or quantitative defects of dystrophin|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,X,32834738,32834738,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh37
na,na,X,32816621,32816621,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,32235105,32235120,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh37
na,na,X,32216988,32217003,DMD,Pathogenic,Duchenne muscular dystrophy,Deletion,GRCh38
na,na,X,31279418,31279418,DMD,Pathogenic/Likely pathogenic,Becker muscular dystrophy|not provided|Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,31261301,31261301,DMD,Pathogenic/Likely pathogenic,Becker muscular dystrophy|not provided|Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,X,31496447,31496447,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Becker muscular dystrophy;Duchenne muscular dystrophy;Dilated cardiomyopathy 3B,single nucleotide variant,GRCh37
na,na,X,31478330,31478330,DMD,Pathogenic,Duchenne muscular dystrophy|not provided|Becker muscular dystrophy;Duchenne muscular dystrophy;Dilated cardiomyopathy 3B,single nucleotide variant,GRCh38
na,na,X,32328331,32328331,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh37
na,na,X,32310214,32310214,DMD,Pathogenic,Duchenne muscular dystrophy,single nucleotide variant,GRCh38
na,na,na,-1,-1,DMD,Pathogenic,"Becker muscular dystrophy, atypical",single nucleotide variant,na
na,na,X,152991592,152991592,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh37
na,na,X,153726137,153726137,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh38
na,na,X,153002668,153002668,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh37
na,na,X,153737214,153737214,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh38
na,na,X,153006026,153006026,ABCD1,Pathogenic,Adrenoleukodystrophy|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,X,153740572,153740572,ABCD1,Pathogenic,Adrenoleukodystrophy|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,X,153001649,153001649,ABCD1,Pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,153736195,153736195,ABCD1,Pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,152991164,152991164,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,153725709,153725709,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,152991241,152991241,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh37
na,na,X,153725786,153725786,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh38
na,na,X,152991517,152991517,ABCD1,Pathogenic,Adrenoleukodystrophy|X-linked spondyloepimetaphyseal dysplasia|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,153726062,153726062,ABCD1,Pathogenic,Adrenoleukodystrophy|X-linked spondyloepimetaphyseal dysplasia|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,153001686,153001686,ABCD1,Pathogenic,Adrenoleukodystrophy|not specified|not provided,single nucleotide variant,GRCh37
na,na,X,153736232,153736232,ABCD1,Pathogenic,Adrenoleukodystrophy|not specified|not provided,single nucleotide variant,GRCh38
na,na,X,153001826,153001826,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,153736372,153736372,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,153001964,153001964,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided|ABCD1-related disorder,single nucleotide variant,GRCh37
na,na,X,153736510,153736510,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided|ABCD1-related disorder,single nucleotide variant,GRCh38
na,na,X,153002632,153002633,ABCD1,Pathogenic,Adrenoleukodystrophy|not provided|ABCD1-related disorder,Deletion,GRCh37
na,na,X,153737178,153737179,ABCD1,Pathogenic,Adrenoleukodystrophy|not provided|ABCD1-related disorder,Deletion,GRCh38
na,na,X,153002646,153002646,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh37
na,na,X,153737192,153737192,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh38
na,na,X,153005601,153005601,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh37
na,na,X,153740147,153740147,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh38
na,na,X,153005608,153005608,ABCD1,Pathogenic,Adrenoleukodystrophy,Deletion,GRCh37
na,na,X,153740154,153740154,ABCD1,Pathogenic,Adrenoleukodystrophy,Deletion,GRCh38
na,na,X,153005609,153005609,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided|X-linked spondyloepimetaphyseal dysplasia,single nucleotide variant,GRCh37
na,na,X,153740155,153740155,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided|X-linked spondyloepimetaphyseal dysplasia,single nucleotide variant,GRCh38
na,na,X,153005692,153005692,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh37
na,na,X,153740238,153740238,ABCD1,Pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh38
na,na,X,153008451,153008452,ABCD1,Pathogenic,Adrenoleukodystrophy,Deletion,GRCh37
na,na,X,153742997,153742998,ABCD1,Pathogenic,Adrenoleukodystrophy,Deletion,GRCh38
na,na,X,153008477,153008477,ABCD1,Pathogenic,Primary adrenocortical insufficiency|not provided|Adrenoleukodystrophy,single nucleotide variant,GRCh37
na,na,X,153743023,153743023,ABCD1,Pathogenic,Primary adrenocortical insufficiency|not provided|Adrenoleukodystrophy,single nucleotide variant,GRCh38
na,na,X,153008478,153008478,ABCD1,Pathogenic,Primary adrenocortical insufficiency,Deletion,GRCh37
na,na,X,153743024,153743024,ABCD1,Pathogenic,Primary adrenocortical insufficiency,Deletion,GRCh38
na,na,X,153008510,153008510,ABCD1,Pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,153743056,153743056,ABCD1,Pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,153008509,153008509,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,153743055,153743055,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,152991591,152991593,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,Microsatellite,GRCh37
na,na,X,153726136,153726138,ABCD1,Pathogenic/Likely pathogenic,Adrenoleukodystrophy|not provided,Microsatellite,GRCh38
na,na,X,153008526,153008526,ABCD1,Likely pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh37
na,na,X,153743072,153743072,ABCD1,Likely pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh38
na,na,X,152991621,152991621,ABCD1,Likely pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh37
na,na,X,153726166,153726166,ABCD1,Likely pathogenic,Adrenoleukodystrophy,single nucleotide variant,GRCh38
na,na,X,152990704,152990729,ABCD1,Pathogenic,Adrenoleukodystrophy,Deletion,GRCh37
na,na,X,153725249,153725274,ABCD1,Pathogenic,Adrenoleukodystrophy,Deletion,GRCh38
na,na,X,100603537,100603537,TIMM8A,Pathogenic,Deafness dystonia syndrome,Deletion,GRCh37
na,na,X,101348549,101348549,TIMM8A,Pathogenic,Deafness dystonia syndrome,Deletion,GRCh38
na,na,X,100601624,100601633,TIMM8A,Pathogenic,Deafness dystonia syndrome,Deletion,GRCh37
na,na,X,101346636,101346645,TIMM8A,Pathogenic,Deafness dystonia syndrome,Deletion,GRCh38
na,na,X,100603583,100603583,TIMM8A,Pathogenic,Deafness dystonia syndrome,single nucleotide variant,GRCh37
na,na,X,101348595,101348595,TIMM8A,Pathogenic,Deafness dystonia syndrome,single nucleotide variant,GRCh38
na,na,X,100601583,100601583,TIMM8A,Likely pathogenic,Deafness dystonia syndrome,single nucleotide variant,GRCh37
na,na,X,101346595,101346595,TIMM8A,Likely pathogenic,Deafness dystonia syndrome,single nucleotide variant,GRCh38
na,na,X,100603580,100603580,TIMM8A,Pathogenic,Deafness dystonia syndrome|not provided,Deletion,GRCh37
na,na,X,101348592,101348592,TIMM8A,Pathogenic,Deafness dystonia syndrome|not provided,Deletion,GRCh38
na,na,X,101345661,101348742,TIMM8A,Pathogenic,Deafness dystonia syndrome,Deletion,GRCh38
na,na,X,100601543,100601543,TIMM8A,Pathogenic,Deafness dystonia syndrome,single nucleotide variant,GRCh37
na,na,X,101346555,101346555,TIMM8A,Pathogenic,Deafness dystonia syndrome,single nucleotide variant,GRCh38
na,na,X,100601671,100601671,TIMM8A,Pathogenic,Deafness dystonia syndrome,single nucleotide variant,GRCh37
na,na,X,101346683,101346683,TIMM8A,Pathogenic,Deafness dystonia syndrome,single nucleotide variant,GRCh38
na,na,X,100603526,100603526,TIMM8A,Pathogenic,Deafness dystonia syndrome,Deletion,GRCh37
na,na,X,101348538,101348538,TIMM8A,Pathogenic,Deafness dystonia syndrome,Deletion,GRCh38
na,na,X,70387358,70387358,NLGN3,risk factor,"Autism, susceptibility to, X-linked 1",single nucleotide variant,GRCh37
na,na,X,71167508,71167508,NLGN3,risk factor,"Autism, susceptibility to, X-linked 1",single nucleotide variant,GRCh38
na,na,X,79282820,79282820,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh37
na,na,X,80027321,80027321,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh38
na,na,X,79282348,79282348,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh37
na,na,X,80026849,80026849,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh38
na,na,X,79278735,79278735,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh37
na,na,X,80023236,80023236,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh38
na,na,X,79281277,79281277,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh37
na,na,X,80025778,80025778,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh38
na,na,X,79282233,79282233,TBX22,Pathogenic,Cleft palate with ankyloglossia,Deletion,GRCh37
na,na,X,80026734,80026734,TBX22,Pathogenic,Cleft palate with ankyloglossia,Deletion,GRCh38
na,na,X,79277934,79277934,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh37
na,na,X,80022435,80022435,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh38
na,na,X,79282210,79282210,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh37
na,na,X,80026711,80026711,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh38
na,na,X,79281226,79281227,TBX22,Pathogenic,Cleft palate with ankyloglossia,Duplication,GRCh37
na,na,X,80025727,80025728,TBX22,Pathogenic,Cleft palate with ankyloglossia,Duplication,GRCh38
na,na,X,79282359,79282359,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh37
na,na,X,80026860,80026860,TBX22,Pathogenic,Cleft palate with ankyloglossia,single nucleotide variant,GRCh38
na,na,X,79286295,79286295,TBX22,Pathogenic,"Cleft palate with or without ankyloglossia, X-linked",Deletion,GRCh37
na,na,X,80030796,80030796,TBX22,Pathogenic,"Cleft palate with or without ankyloglossia, X-linked",Deletion,GRCh38
na,na,X,119673204,119673204,CUL4B,Pathogenic,X-linked intellectual disability Cabezas type|not provided,single nucleotide variant,GRCh37
na,na,X,120539349,120539349,CUL4B,Pathogenic,X-linked intellectual disability Cabezas type|not provided,single nucleotide variant,GRCh38
na,na,X,119678034,119678034,CUL4B,Pathogenic,X-linked intellectual disability Cabezas type|Global developmental delay;Abnormal facial shape;Seizure;Short stature;Intellectual disability|not provided,single nucleotide variant,GRCh37
na,na,X,120544179,120544179,CUL4B,Pathogenic,X-linked intellectual disability Cabezas type|Global developmental delay;Abnormal facial shape;Seizure;Short stature;Intellectual disability|not provided,single nucleotide variant,GRCh38
na,na,X,119679374,119679374,CUL4B,Pathogenic,X-linked intellectual disability Cabezas type,single nucleotide variant,GRCh37
na,na,X,120545519,120545519,CUL4B,Pathogenic,X-linked intellectual disability Cabezas type,single nucleotide variant,GRCh38
na,na,X,100609675,100609675,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|X-linked agammaglobulinemia with growth hormone deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,101354687,101354687,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|X-linked agammaglobulinemia with growth hormone deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,100611833,100611833,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101356845,101356845,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100630236,100630236,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101375248,101375248,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100630230,100630230,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|Inherited Immunodeficiency Diseases|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101375242,101375242,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|Inherited Immunodeficiency Diseases|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100613318,100613318,BTK,Uncertain significance,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101358330,101358330,BTK,Uncertain significance,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100608853,100608853,BTK,Pathogenic,X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101353865,101353865,BTK,Pathogenic,X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100630190,100630190,BTK,Pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|not provided|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101375202,101375202,BTK,Pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|not provided|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100630271,100630271,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101375283,101375283,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,BTK,Pathogenic,"Hypogammaglobulinemia, X-linked",single nucleotide variant,na
na,na,X,100630176,100630176,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101375188,101375188,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100629533,100629536,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,Deletion,GRCh37
na,na,X,101374545,101374548,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,Deletion,GRCh38
na,na,X,100630128,100630129,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh37
na,na,X,101375140,101375141,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh38
na,na,X,100625068,100625068,BTK,Pathogenic,X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101370080,101370080,BTK,Pathogenic,X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100625069,100625069,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101370081,101370081,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100625039,100625039,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101370051,101370051,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100624988,100624988,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,Deletion,GRCh37
na,na,X,101370000,101370000,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,Deletion,GRCh38
na,na,X,100617191,100617192,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,Duplication,GRCh37
na,na,X,101362203,101362204,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,Duplication,GRCh38
na,na,X,100617160,100617161,BTK,Pathogenic,X-linked agammaglobulinemia,Insertion,GRCh37
na,na,X,101362172,101362173,BTK,Pathogenic,X-linked agammaglobulinemia,Insertion,GRCh38
na,na,X,100615679,100615679,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh37
na,na,X,101360691,101360691,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh38
na,na,X,100615614,100615614,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101360626,101360626,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100615577,100615577,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101360589,101360589,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100615569,100615569,BTK,Pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|not provided|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101360581,101360581,BTK,Pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|not provided|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100615075,100615075,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101360087,101360087,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,na,-1,-1,BTK,Pathogenic,X-linked agammaglobulinemia,Indel,na
na,na,X,100614313,100614313,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia;X-linked agammaglobulinemia with growth hormone deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,101359325,101359325,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia;X-linked agammaglobulinemia with growth hormone deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,100613660,100613660,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101358672,101358672,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100613399,100613399,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101358411,101358411,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100613604,100613604,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh37
na,na,X,101358616,101358616,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh38
na,na,X,100612549,100612549,BTK,Pathogenic,X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101357561,101357561,BTK,Pathogenic,X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100612542,100612543,BTK,Pathogenic,X-linked agammaglobulinemia,Duplication,GRCh37
na,na,X,101357554,101357555,BTK,Pathogenic,X-linked agammaglobulinemia,Duplication,GRCh38
na,na,X,100611898,100611898,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101356910,101356910,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100611846,100611846,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101356858,101356858,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100611100,100611100,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101356112,101356112,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100611090,100611090,BTK,Uncertain significance,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101356102,101356102,BTK,Uncertain significance,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100611048,100611048,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|not provided|Autosomal recessive agammaglobulinemia 1,single nucleotide variant,GRCh37
na,na,X,101356060,101356060,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|not provided|Autosomal recessive agammaglobulinemia 1,single nucleotide variant,GRCh38
na,na,X,100611047,100611047,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia with growth hormone deficiency;X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101356059,101356059,BTK,Pathogenic,X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia with growth hormone deficiency;X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100609660,100609660,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh37
na,na,X,101354672,101354672,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh38
na,na,X,100609624,100609624,BTK,Conflicting classifications of pathogenicity,X-linked agammaglobulinemia with growth hormone deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,101354636,101354636,BTK,Conflicting classifications of pathogenicity,X-linked agammaglobulinemia with growth hormone deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,100609617,100609617,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101354629,101354629,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100608924,100608924,BTK,Pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101353936,101353936,BTK,Pathogenic,X-linked agammaglobulinemia|Autosomal recessive agammaglobulinemia 1|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100608867,100608867,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101353879,101353879,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100608324,100608324,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101353336,101353336,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100608317,100608317,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101353329,101353329,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100608270,100608270,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101353282,101353282,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100608252,100608252,BTK,Likely pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101353264,101353264,BTK,Likely pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100608201,100608201,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101353213,101353213,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100608184,100608184,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101353196,101353196,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,na,-1,-1,BTK,Pathogenic,X-linked agammaglobulinemia,Insertion,na
na,na,X,100604898,100604898,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101349910,101349910,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,na,-1,-1,BTK,Pathogenic,X-linked agammaglobulinemia,Insertion,na
na,na,X,100608923,100608923,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|not provided|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh37
na,na,X,101353935,101353935,BTK,Pathogenic/Likely pathogenic,X-linked agammaglobulinemia|not provided|X-linked agammaglobulinemia with growth hormone deficiency,single nucleotide variant,GRCh38
na,na,X,100615689,100615690,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh37
na,na,X,101360701,101360702,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh38
na,na,X,100641045,100641045,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh37
na,na,X,101386057,101386057,BTK,Pathogenic,X-linked agammaglobulinemia,single nucleotide variant,GRCh38
na,na,X,100608019,100614090,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh37
na,na,X,101353031,101359102,BTK,Pathogenic,X-linked agammaglobulinemia,Deletion,GRCh38
na,na,X,118972469,118972470,UPF3B,Pathogenic,Syndromic X-linked intellectual disability 14,Deletion,GRCh37
na,na,X,119838506,119838507,UPF3B,Pathogenic,Syndromic X-linked intellectual disability 14,Deletion,GRCh38
na,na,X,118971734,118971734,UPF3B,Pathogenic,Syndromic X-linked intellectual disability 14|not provided,single nucleotide variant,GRCh37
na,na,X,119837771,119837771,UPF3B,Pathogenic,Syndromic X-linked intellectual disability 14|not provided,single nucleotide variant,GRCh38
na,na,X,118977256,118977256,UPF3B,Pathogenic,Syndromic X-linked intellectual disability 14,single nucleotide variant,GRCh37
na,na,X,119843293,119843293,UPF3B,Pathogenic,Syndromic X-linked intellectual disability 14,single nucleotide variant,GRCh38
na,na,X,21886594,21886594,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",single nucleotide variant,GRCh37
na,na,X,21868476,21868476,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",single nucleotide variant,GRCh38
na,na,X,21863325,21863325,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",single nucleotide variant,GRCh37
na,na,X,21845207,21845207,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",single nucleotide variant,GRCh38
na,na,X,21899039,21899039,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome|not provided",single nucleotide variant,GRCh37
na,na,X,21880921,21880921,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome|not provided",single nucleotide variant,GRCh38
na,na,X,21900637,21900637,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",single nucleotide variant,GRCh37
na,na,X,21882519,21882519,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",single nucleotide variant,GRCh38
na,na,X,21886591,21886591,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",single nucleotide variant,GRCh37
na,na,X,21868473,21868473,MBTPS2,Pathogenic,"IFAP syndrome 1, with or without BRESHECK syndrome",single nucleotide variant,GRCh38
na,na,X,49107902,49107902,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome|Hydrops fetalis,single nucleotide variant,GRCh37
na,na,X,49251441,49251441,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome|Hydrops fetalis,single nucleotide variant,GRCh38
na,na,X,49107783,49107801,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,Indel,GRCh37
na,na,X,49251322,49251340,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,Indel,GRCh38
na,na,X,49108159,49108159,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh37
na,na,X,49251698,49251698,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh38
na,na,X,49107941,49107941,FOXP3,Pathogenic/Likely pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh37
na,na,X,49251480,49251480,FOXP3,Pathogenic/Likely pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh38
na,na,X,49107797,49107798,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,Deletion,GRCh37
na,na,X,49251336,49251337,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,Deletion,GRCh38
na,na,X,49110374,49110374,FOXP3,Uncertain significance,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh37
na,na,X,49253913,49253913,FOXP3,Uncertain significance,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh38
na,na,X,49111953,49111955,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome|not provided,Deletion,GRCh37
na,na,X,49255492,49255494,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome|not provided,Deletion,GRCh38
na,na,X,49114209,49114209,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,Deletion,GRCh37
na,na,X,49257752,49257752,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,Deletion,GRCh38
na,na,X,49108153,49108154,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,Indel,GRCh37
na,na,X,49251692,49251693,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,Indel,GRCh38
na,na,X,49109661,49109661,FOXP3,Conflicting classifications of pathogenicity,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh37
na,na,X,49253200,49253200,FOXP3,Conflicting classifications of pathogenicity,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,na
na,na,X,49114960,49114960,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh37
na,na,X,49258503,49258503,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh38
na,na,X,49108172,49108172,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh37
na,na,X,49251711,49251711,FOXP3,Pathogenic,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,single nucleotide variant,GRCh38
na,na,X,41333755,41333755,NYX,Conflicting classifications of pathogenicity,Congenital stationary night blindness 1A|not provided|not specified,single nucleotide variant,GRCh37
na,na,X,41474502,41474502,NYX,Conflicting classifications of pathogenicity,Congenital stationary night blindness 1A|not provided|not specified,single nucleotide variant,GRCh38
na,na,X,41332811,41332811,NYX,Pathogenic,not provided|Congenital stationary night blindness 1A,single nucleotide variant,GRCh37
na,na,X,41473558,41473558,NYX,Pathogenic,not provided|Congenital stationary night blindness 1A,single nucleotide variant,GRCh38
na,na,X,41333265,41333266,NYX,Pathogenic,Congenital stationary night blindness 1A|not provided,Indel,GRCh37
na,na,X,41474012,41474013,NYX,Pathogenic,Congenital stationary night blindness 1A|not provided,Indel,GRCh38
na,na,X,41332987,41332987,NYX,Pathogenic,Congenital stationary night blindness 1A,single nucleotide variant,GRCh37
na,na,X,41473734,41473734,NYX,Pathogenic,Congenital stationary night blindness 1A,single nucleotide variant,GRCh38
na,na,X,41333008,41333008,NYX,Pathogenic,Congenital stationary night blindness 1A,single nucleotide variant,GRCh37
na,na,X,41473755,41473755,NYX,Pathogenic,Congenital stationary night blindness 1A,single nucleotide variant,GRCh38
na,na,X,152027360,152027360,NSDHL,Likely pathogenic,Child syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,152858816,152858816,NSDHL,Likely pathogenic,Child syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,152034432,152034432,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh37
na,na,X,152865888,152865888,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh38
na,na,X,152034447,152034447,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh37
na,na,X,152865903,152865903,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh38
na,na,X,152018962,152018962,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh37
na,na,X,152850418,152850418,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh38
na,na,X,152034363,152034363,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh37
na,na,X,152865819,152865819,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh38
na,na,X,152031176,152031176,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh37
na,na,X,152862632,152862632,NSDHL,Pathogenic,Child syndrome,single nucleotide variant,GRCh38
na,na,X,136649818,136649818,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh37
na,na,X,137567659,137567659,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh38
na,na,X,136649654,136649654,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh37
na,na,X,137567495,137567495,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh38
na,na,X,136651222,136651222,ZIC3,Pathogenic,"Congenital heart defects, multiple types, 1, X-linked",single nucleotide variant,GRCh37
na,na,X,137569063,137569063,ZIC3,Pathogenic,"Congenital heart defects, multiple types, 1, X-linked",single nucleotide variant,GRCh38
na,na,X,136649595,136649595,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh37
na,na,X,137567436,137567436,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh38
na,na,X,136649608,136649608,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh37
na,na,X,137567449,137567449,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh38
na,na,X,136651213,136651213,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh37
na,na,X,137569054,137569054,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh38
na,na,X,136649499,136649499,ZIC3,Benign/Likely benign,"not specified|Congenital heart defects, multiple types, 1, X-linked|VACTERL association, X-linked, with or without hydrocephalus|Congenital heart defects 1, nonsyndromic, 1|not provided|Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh37
na,na,X,137567340,137567340,ZIC3,Benign/Likely benign,"not specified|Congenital heart defects, multiple types, 1, X-linked|VACTERL association, X-linked, with or without hydrocephalus|Congenital heart defects 1, nonsyndromic, 1|not provided|Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh38
na,na,X,136649822,136649823,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",Insertion,GRCh37
na,na,X,137567663,137567664,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",Insertion,GRCh38
na,na,X,136649613,136649613,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh37
na,na,X,137567454,137567454,ZIC3,Pathogenic,"Heterotaxy, visceral, 1, X-linked",single nucleotide variant,GRCh38
na,na,X,53459034,53459034,HSD17B10,Pathogenic,HSD10 mitochondrial disease|not provided,single nucleotide variant,GRCh37
na,na,X,53432086,53432086,HSD17B10,Pathogenic,HSD10 mitochondrial disease|not provided,single nucleotide variant,GRCh38
na,na,X,53459058,53459058,HSD17B10,Uncertain significance,HSD10 mitochondrial disease|not specified,single nucleotide variant,GRCh37
na,na,X,53432110,53432110,HSD17B10,Uncertain significance,HSD10 mitochondrial disease|not specified,single nucleotide variant,GRCh38
na,na,X,53458398,53458398,HSD17B10,Pathogenic,HSD10 mitochondrial disease,single nucleotide variant,GRCh37
na,na,X,53431450,53431450,HSD17B10,Pathogenic,HSD10 mitochondrial disease,single nucleotide variant,GRCh38
na,na,X,53458767,53458767,HSD17B10,Pathogenic,HSD10 mitochondrial disease,single nucleotide variant,GRCh37
na,na,X,53431819,53431819,HSD17B10,Pathogenic,HSD10 mitochondrial disease,single nucleotide variant,GRCh38
na,na,X,53458393,53458393,HSD17B10,Uncertain significance,HSD10 mitochondrial disease,single nucleotide variant,GRCh37
na,na,X,53431445,53431445,HSD17B10,Uncertain significance,HSD10 mitochondrial disease,single nucleotide variant,GRCh38
na,na,X,154556377,154565046,IKBKG,Pathogenic,Incontinentia pigmenti syndrome,Deletion,GRCh38
na,na,X,153792222,153792223,IKBKG,Pathogenic,Incontinentia pigmenti syndrome|not provided,Duplication,GRCh37
na,na,X,154564007,154564008,IKBKG,Pathogenic,Incontinentia pigmenti syndrome|not provided,Duplication,GRCh38
na,na,X,153792635,153792635,IKBKG,Conflicting classifications of pathogenicity,Incontinentia pigmenti syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,154564420,154564420,IKBKG,Conflicting classifications of pathogenicity,Incontinentia pigmenti syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,153792675,153792675,IKBKG,Pathogenic,"Incontinentia pigmenti syndrome|ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED",single nucleotide variant,GRCh37
na,na,X,154564460,154564460,IKBKG,Pathogenic,"Incontinentia pigmenti syndrome|ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED",single nucleotide variant,GRCh38
na,na,X,153780334,153780335,IKBKG,Pathogenic,Incontinentia pigmenti syndrome,Duplication,GRCh37
na,na,X,154552119,154552120,IKBKG,Pathogenic,Incontinentia pigmenti syndrome,Duplication,GRCh38
na,na,X,153780401,153780401,IKBKG,Pathogenic,Incontinentia pigmenti syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,154552186,154552186,IKBKG,Pathogenic,Incontinentia pigmenti syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,153792587,153792587,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1|not provided,single nucleotide variant,GRCh37
na,na,X,154564372,154564372,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1|not provided,single nucleotide variant,GRCh38
na,na,X,153792665,153792665,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh37
na,na,X,154564450,154564450,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh38
na,na,X,153792666,153792666,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1|not provided,single nucleotide variant,GRCh37
na,na,X,154564451,154564451,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1|not provided,single nucleotide variant,GRCh38
na,na,X,153792633,153792633,IKBKG,Likely pathogenic,"ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED|Incontinentia pigmenti syndrome|Ectodermal dysplasia and immunodeficiency 1",single nucleotide variant,GRCh37
na,na,X,154564418,154564418,IKBKG,Likely pathogenic,"ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED|Incontinentia pigmenti syndrome|Ectodermal dysplasia and immunodeficiency 1",single nucleotide variant,GRCh38
na,na,X,153792579,153792580,IKBKG,Pathogenic,Incontinentia pigmenti syndrome,Duplication,GRCh37
na,na,X,154564364,154564365,IKBKG,Pathogenic,Incontinentia pigmenti syndrome,Duplication,GRCh38
na,na,X,153785441,153785442,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,Duplication,GRCh37
na,na,X,154558768,154560134,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,Duplication,GRCh38
na,na,X,153786805,153786805,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh37
na,na,X,154558590,154558590,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh38
na,na,X,153792623,153792623,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh37
na,na,X,154564408,154564408,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh38
na,na,X,153790004,153790004,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh37
na,na,X,154561789,154561789,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh38
na,na,X,153791909,153791910,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,Duplication,GRCh37
na,na,X,154563694,154563695,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,Duplication,GRCh38
na,na,X,153792173,153792173,IKBKG,Pathogenic,Immunodeficiency 33,single nucleotide variant,GRCh37
na,na,X,154563958,154563958,IKBKG,Pathogenic,Immunodeficiency 33,single nucleotide variant,GRCh38
na,na,X,153780326,153780327,IKBKG,Pathogenic,Immunodeficiency 33,Duplication,GRCh37
na,na,X,154552111,154552112,IKBKG,Pathogenic,Immunodeficiency 33,Duplication,GRCh38
na,na,X,153791119,153791119,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh37
na,na,X,154562904,154562904,IKBKG,Pathogenic,Ectodermal dysplasia and immunodeficiency 1,single nucleotide variant,GRCh38
na,na,X,153791805,153791805,IKBKG,Likely pathogenic,Immunodeficiency 33|not provided,single nucleotide variant,GRCh37
na,na,X,154563590,154563590,IKBKG,Likely pathogenic,Immunodeficiency 33|not provided,single nucleotide variant,GRCh38
na,na,X,153791817,153791817,IKBKG,Pathogenic,Immunodeficiency 33,single nucleotide variant,GRCh37
na,na,X,154563602,154563602,IKBKG,Pathogenic,Immunodeficiency 33,single nucleotide variant,GRCh38
na,na,X,153786864,153786864,IKBKG,Pathogenic,not provided|Immunodeficiency 33,single nucleotide variant,GRCh37
na,na,X,154558649,154558649,IKBKG,Pathogenic,not provided|Immunodeficiency 33,single nucleotide variant,GRCh38
na,na,X,50659132,50659132,BMP15,Pathogenic,Ovarian dysgenesis 2,single nucleotide variant,GRCh37
na,na,X,50916132,50916132,BMP15,Pathogenic,Ovarian dysgenesis 2,single nucleotide variant,GRCh38
na,na,X,50654009,50654009,BMP15,Conflicting classifications of pathogenicity,Premature ovarian failure 4|Ovarian dysgenesis 2,single nucleotide variant,GRCh37
na,na,X,50911009,50911009,BMP15,Conflicting classifications of pathogenicity,Premature ovarian failure 4|Ovarian dysgenesis 2,single nucleotide variant,GRCh38
na,na,X,50658966,50658966,BMP15,Conflicting classifications of pathogenicity,Premature ovarian failure 4|Ovarian dysgenesis 2,single nucleotide variant,GRCh37
na,na,X,50915966,50915966,BMP15,Conflicting classifications of pathogenicity,Premature ovarian failure 4|Ovarian dysgenesis 2,single nucleotide variant,GRCh38
na,na,X,50659059,50659059,BMP15,Pathogenic,Premature ovarian failure 4,single nucleotide variant,GRCh37
na,na,X,50916059,50916059,BMP15,Pathogenic,Premature ovarian failure 4,single nucleotide variant,GRCh38
na,na,X,50653985,50653985,BMP15,Conflicting classifications of pathogenicity,Premature ovarian failure 4|Ovarian dysgenesis 2|not provided|BMP15-related disorder,single nucleotide variant,GRCh37
na,na,X,50910985,50910985,BMP15,Conflicting classifications of pathogenicity,Premature ovarian failure 4|Ovarian dysgenesis 2|not provided|BMP15-related disorder,single nucleotide variant,GRCh38
na,na,X,135084330,135084335,SLC9A6,Pathogenic,Christianson syndrome,Deletion,GRCh37
na,na,X,136002171,136002176,SLC9A6,Pathogenic,Christianson syndrome,Deletion,GRCh38
na,na,X,135106524,135106524,SLC9A6,Pathogenic,Christianson syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,136024365,136024365,SLC9A6,Pathogenic,Christianson syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,135080347,135080348,SLC9A6,Pathogenic,Christianson syndrome,Indel,GRCh37
na,na,X,135998188,135998189,SLC9A6,Pathogenic,Christianson syndrome,Indel,GRCh38
na,na,X,135080645,135080646,SLC9A6,Pathogenic,Christianson syndrome,Deletion,GRCh37
na,na,X,135998486,135998487,SLC9A6,Pathogenic,Christianson syndrome,Deletion,GRCh38
na,na,X,29973223,29973223,IL1RAPL1,Pathogenic,"Intellectual disability, X-linked 21",single nucleotide variant,GRCh37
na,na,X,29955106,29955106,IL1RAPL1,Pathogenic,"Intellectual disability, X-linked 21",single nucleotide variant,GRCh38
na,na,X,29973306,29973306,IL1RAPL1,Likely pathogenic,"Intellectual disability, X-linked 21",single nucleotide variant,GRCh37
na,na,X,29955189,29955189,IL1RAPL1,Likely pathogenic,"Intellectual disability, X-linked 21",single nucleotide variant,GRCh38
na,na,na,-1,-1,IL1RAPL1,Pathogenic,"Intellectual disability, X-linked 21",Deletion,na
na,na,X,48382246,48382246,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh37
na,na,X,48523858,48523858,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh38
na,na,X,48382346,48382346,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant|not provided,single nucleotide variant,GRCh37
na,na,X,48523958,48523958,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant|not provided,single nucleotide variant,GRCh38
na,na,X,48382397,48382397,EBP,Pathogenic/Likely pathogenic,Chondrodysplasia punctata 2 X-linked dominant|Connective tissue disorder|not provided,single nucleotide variant,GRCh37
na,na,X,48524009,48524009,EBP,Pathogenic/Likely pathogenic,Chondrodysplasia punctata 2 X-linked dominant|Connective tissue disorder|not provided,single nucleotide variant,GRCh38
na,na,X,48385414,48385414,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh37
na,na,X,48527026,48527026,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh38
na,na,X,48385594,48385594,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,Deletion,GRCh37
na,na,X,48527206,48527206,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,Deletion,GRCh38
na,na,X,48386738,48386739,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,Insertion,GRCh37
na,na,X,48528350,48528351,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,Insertion,GRCh38
na,na,X,48385590,48385590,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh37
na,na,X,48527202,48527202,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh38
na,na,X,48386675,48386675,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh37
na,na,X,48528287,48528287,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh38
na,na,X,48386739,48386739,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh37
na,na,X,48528351,48528351,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant,single nucleotide variant,GRCh38
na,na,X,48385644,48385644,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant|not provided|Chondrodysplasia punctata 2 X-linked dominant;MEND syndrome,single nucleotide variant,GRCh37
na,na,X,48527256,48527256,EBP,Pathogenic,Chondrodysplasia punctata 2 X-linked dominant|not provided|Chondrodysplasia punctata 2 X-linked dominant;MEND syndrome,single nucleotide variant,GRCh38
na,na,X,48382212,48382212,EBP,Pathogenic,MEND syndrome,single nucleotide variant,GRCh37
na,na,X,48523824,48523824,EBP,Pathogenic,MEND syndrome,single nucleotide variant,GRCh38
na,na,X,18600062,18600062,CDKL5,Likely pathogenic,"Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2|CDKL5 disorder",single nucleotide variant,GRCh37
na,na,X,18581942,18581942,CDKL5,Likely pathogenic,"Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2|CDKL5 disorder",single nucleotide variant,GRCh38
na,na,X,18602444,18602444,CDKL5,Likely pathogenic,"Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2|CDKL5 disorder",single nucleotide variant,GRCh37
na,na,X,18584324,18584324,CDKL5,Likely pathogenic,"Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2|CDKL5 disorder",single nucleotide variant,GRCh38
na,na,X,18646494,18646494,CDKL5,Pathogenic,"Developmental and epileptic encephalopathy, 2|Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like|CDKL5 disorder",single nucleotide variant,GRCh37
na,na,X,18628374,18628374,CDKL5,Pathogenic,"Developmental and epileptic encephalopathy, 2|Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like|CDKL5 disorder",single nucleotide variant,GRCh38
na,na,X,18582616,18582616,CDKL5,Pathogenic,"Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like|CDKL5 disorder|not provided",single nucleotide variant,GRCh37
na,na,X,18564496,18564496,CDKL5,Pathogenic,"Atypical Rett syndrome|Developmental and epileptic encephalopathy, 2|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like|CDKL5 disorder|not provided",single nucleotide variant,GRCh38
na,na,X,18593543,18593543,CDKL5,Pathogenic,"Developmental and epileptic encephalopathy, 2|not provided|Rett syndrome|CDKL5 disorder|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like",single nucleotide variant,GRCh37
na,na,X,18575423,18575423,CDKL5,Pathogenic,"Developmental and epileptic encephalopathy, 2|not provided|Rett syndrome|CDKL5 disorder|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like",single nucleotide variant,GRCh38
na,na,X,18616619,18616619,CDKL5,Conflicting classifications of pathogenicity,"Developmental and epileptic encephalopathy, 2|CDKL5 disorder|not provided",single nucleotide variant,GRCh37
na,na,X,18598499,18598499,CDKL5,Conflicting classifications of pathogenicity,"Developmental and epileptic encephalopathy, 2|CDKL5 disorder|not provided",single nucleotide variant,GRCh38
na,na,X,18616628,18616628,CDKL5,Uncertain significance,"Developmental and epileptic encephalopathy, 2|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like|CDKL5 disorder",single nucleotide variant,GRCh37
na,na,X,18598508,18598508,CDKL5,Uncertain significance,"Developmental and epileptic encephalopathy, 2|Developmental and epileptic encephalopathy, 2;Angelman syndrome-like|CDKL5 disorder",single nucleotide variant,GRCh38
na,na,X,13738029,13738030,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,Deletion,GRCh37
na,na,X,13719910,13719911,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,Deletion,GRCh38
na,na,X,13734699,13734700,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda|not provided,Microsatellite,GRCh37
na,na,X,13716580,13716581,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda|not provided,Microsatellite,GRCh38
na,na,X,13734733,13734734,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,Deletion,GRCh37
na,na,X,13716614,13716615,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,Deletion,GRCh38
na,na,X,13734172,13734176,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda|Hereditary spastic paraplegia 4|not provided,Deletion,GRCh37
na,na,X,13716053,13716057,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda|Hereditary spastic paraplegia 4|not provided,Deletion,GRCh38
na,na,X,13737985,13737985,TRAPPC2,Pathogenic,"Spondyloepiphyseal dysplasia tarda|not provided|Spondyloepiphyseal dysplasia tarda, X-linked|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,X,13719866,13719866,TRAPPC2,Pathogenic,"Spondyloepiphyseal dysplasia tarda|not provided|Spondyloepiphyseal dysplasia tarda, X-linked|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,X,13734199,13734199,TRAPPC2,Likely pathogenic,Spondyloepiphyseal dysplasia tarda|Connective tissue disorder,single nucleotide variant,GRCh37
na,na,X,13716080,13716080,TRAPPC2,Likely pathogenic,Spondyloepiphyseal dysplasia tarda|Connective tissue disorder,single nucleotide variant,GRCh38
na,na,X,13732558,13732558,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,single nucleotide variant,GRCh37
na,na,X,13714439,13714439,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,single nucleotide variant,GRCh38
na,na,X,13732620,13732620,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,single nucleotide variant,GRCh37
na,na,X,13714501,13714501,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,single nucleotide variant,GRCh38
na,na,X,13734649,13734649,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,single nucleotide variant,GRCh37
na,na,X,13716530,13716530,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,single nucleotide variant,GRCh38
na,na,X,13732562,13732562,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,Deletion,GRCh37
na,na,X,13714443,13714443,TRAPPC2,Pathogenic,Spondyloepiphyseal dysplasia tarda,Deletion,GRCh38
na,na,X,69670638,69670638,DLG3,Likely pathogenic,"Intellectual disability, X-linked 90|not provided",single nucleotide variant,GRCh37
na,na,X,70450788,70450788,DLG3,Likely pathogenic,"Intellectual disability, X-linked 90|not provided",single nucleotide variant,GRCh38
na,na,X,69673644,69673644,DLG3,Pathogenic,"Intellectual disability, X-linked 90",single nucleotide variant,GRCh37
na,na,X,70453794,70453794,DLG3,Pathogenic,"Intellectual disability, X-linked 90",single nucleotide variant,GRCh38
na,na,X,70347217,70347217,MED12,Pathogenic/Likely pathogenic,"FG syndrome 1|6 conditions|FG syndrome 1;Blepharophimosis - intellectual disability syndrome, MKB type;X-linked intellectual disability with marfanoid habitus|Intellectual disability|not provided|Blepharophimosis - intellectual disability syndrome, MKB type|FG syndrome|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh37
na,na,X,71127367,71127367,MED12,Pathogenic/Likely pathogenic,"FG syndrome 1|6 conditions|FG syndrome 1;Blepharophimosis - intellectual disability syndrome, MKB type;X-linked intellectual disability with marfanoid habitus|Intellectual disability|not provided|Blepharophimosis - intellectual disability syndrome, MKB type|FG syndrome|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh38
na,na,X,70347781,70347781,MED12,Pathogenic/Likely pathogenic,X-linked intellectual disability with marfanoid habitus|not provided|FG syndrome 1|FG syndrome,single nucleotide variant,GRCh37
na,na,X,71127931,71127931,MED12,Pathogenic/Likely pathogenic,X-linked intellectual disability with marfanoid habitus|not provided|FG syndrome 1|FG syndrome,single nucleotide variant,GRCh38
na,na,X,2876464,2876464,ARSL,Uncertain significance,"X-linked chondrodysplasia punctata 1|Chondrodysplasia punctata, brachytelephalangic, autosomal",single nucleotide variant,GRCh37
na,na,X,2958423,2958423,ARSL,Uncertain significance,"X-linked chondrodysplasia punctata 1|Chondrodysplasia punctata, brachytelephalangic, autosomal",single nucleotide variant,GRCh38
na,na,X,2871265,2871265,ARSL,Pathogenic/Likely pathogenic,X-linked chondrodysplasia punctata 1|not provided,single nucleotide variant,GRCh37
na,na,X,2953224,2953224,ARSL,Pathogenic/Likely pathogenic,X-linked chondrodysplasia punctata 1|not provided,single nucleotide variant,GRCh38
na,na,X,2871282,2871282,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh37
na,na,X,2953241,2953241,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh38
na,na,X,2871204,2871204,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh37
na,na,X,2953163,2953163,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh38
na,na,X,2867466,2867466,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh37
na,na,X,2949425,2949425,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh38
na,na,X,2853168,2853168,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh37
na,na,X,2935127,2935127,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh38
na,na,X,2852911,2852911,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh37
na,na,X,2934870,2934870,ARSL,Pathogenic,X-linked chondrodysplasia punctata 1,single nucleotide variant,GRCh38
na,na,X,2852900,2852900,ARSL,Pathogenic/Likely pathogenic,"X-linked chondrodysplasia punctata 1|not provided|See cases|Chondrodysplasia punctata, brachytelephalangic, autosomal|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,X,2934859,2934859,ARSL,Pathogenic/Likely pathogenic,"X-linked chondrodysplasia punctata 1|not provided|See cases|Chondrodysplasia punctata, brachytelephalangic, autosomal|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,X,41413096,41413096,CASK,Pathogenic,Syndromic X-linked intellectual disability Najm type|not provided|Intellectual disability,single nucleotide variant,GRCh37
na,na,X,41553843,41553843,CASK,Pathogenic,Syndromic X-linked intellectual disability Najm type|not provided|Intellectual disability,single nucleotide variant,GRCh38
na,na,X,41495831,41495831,CASK,Pathogenic,Syndromic X-linked intellectual disability Najm type,single nucleotide variant,GRCh37
na,na,X,41636578,41636578,CASK,Pathogenic,Syndromic X-linked intellectual disability Najm type,single nucleotide variant,GRCh38
na,na,X,41712457,41712457,CASK,Pathogenic,FG syndrome 4,single nucleotide variant,GRCh37
na,na,X,41853204,41853204,CASK,Pathogenic,FG syndrome 4,single nucleotide variant,GRCh38
na,na,X,41519721,41519721,CASK,Conflicting classifications of pathogenicity,"FG syndrome 4|Intellectual disability, CASK-related, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,41660468,41660468,CASK,Conflicting classifications of pathogenicity,"FG syndrome 4|Intellectual disability, CASK-related, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,41401970,41401970,CASK,Likely pathogenic,FG syndrome 4|FG syndrome 4;Syndromic X-linked intellectual disability Najm type,single nucleotide variant,GRCh37
na,na,X,41542717,41542717,CASK,Likely pathogenic,FG syndrome 4|FG syndrome 4;Syndromic X-linked intellectual disability Najm type,single nucleotide variant,GRCh38
na,na,X,41379699,41379699,CASK,Pathogenic,FG syndrome 4,single nucleotide variant,GRCh37
na,na,X,41520446,41520446,CASK,Pathogenic,FG syndrome 4,single nucleotide variant,GRCh38
na,na,X,41448815,41448815,CASK,Conflicting classifications of pathogenicity,"FG syndrome 4|Syndromic X-linked intellectual disability Najm type|not provided|Intellectual disability, CASK-related, X-linked|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,X,41589562,41589562,CASK,Conflicting classifications of pathogenicity,"FG syndrome 4|Syndromic X-linked intellectual disability Najm type|not provided|Intellectual disability, CASK-related, X-linked|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,X,13774778,13774778,OFD1,Pathogenic,Orofaciodigital syndrome I,single nucleotide variant,GRCh37
na,na,X,13756659,13756659,OFD1,Pathogenic,Orofaciodigital syndrome I,single nucleotide variant,GRCh38
na,na,X,13754798,13754798,OFD1,Pathogenic,Orofaciodigital syndrome I,Deletion,GRCh37
na,na,X,13736678,13736678,OFD1,Pathogenic,Orofaciodigital syndrome I,Deletion,GRCh38
na,na,X,13762524,13762524,OFD1,Pathogenic,Orofaciodigital syndrome I,single nucleotide variant,GRCh37
na,na,X,13744405,13744405,OFD1,Pathogenic,Orofaciodigital syndrome I,single nucleotide variant,GRCh38
na,na,X,13778466,13778467,OFD1,Pathogenic,Orofaciodigital syndrome I,Insertion,GRCh37
na,na,X,13760347,13760348,OFD1,Pathogenic,Orofaciodigital syndrome I,Insertion,GRCh38
na,na,X,13764568,13768647,OFD1,no classification for the single variant,-,Deletion,GRCh37
na,na,X,13746449,13750528,OFD1,no classification for the single variant,-,Deletion,GRCh38
na,na,X,13778701,13778702,OFD1,Pathogenic,Simpson-Golabi-Behmel syndrome type 2|Orofaciodigital syndrome I,Duplication,GRCh37
na,na,X,13760582,13760583,OFD1,Pathogenic,Simpson-Golabi-Behmel syndrome type 2|Orofaciodigital syndrome I,Duplication,GRCh38
na,na,X,13786256,13786262,OFD1,Pathogenic,Joubert syndrome 10,Deletion,GRCh37
na,na,X,13768137,13768143,OFD1,Pathogenic,Joubert syndrome 10,Deletion,GRCh38
na,na,X,13786182,13786182,OFD1,Pathogenic,Joubert syndrome 10,Deletion,GRCh37
na,na,X,13768063,13768063,OFD1,Pathogenic,Joubert syndrome 10,Deletion,GRCh38
na,na,X,129281468,129281470,AIFM1,Pathogenic,Severe X-linked mitochondrial encephalomyopathy,Deletion,GRCh37
na,na,X,130147493,130147495,AIFM1,Pathogenic,Severe X-linked mitochondrial encephalomyopathy,Deletion,GRCh38
na,na,X,135289984,135289984,FHL1,Pathogenic,X-linked scapuloperoneal muscular dystrophy|not provided,single nucleotide variant,GRCh37
na,na,X,136207825,136207825,FHL1,Pathogenic,X-linked scapuloperoneal muscular dystrophy|not provided,single nucleotide variant,GRCh38
na,na,X,135290784,135290784,FHL1,Pathogenic/Likely pathogenic,not provided|X-linked myopathy with postural muscle atrophy,single nucleotide variant,GRCh37
na,na,X,136208625,136208625,FHL1,Pathogenic/Likely pathogenic,not provided|X-linked myopathy with postural muscle atrophy,single nucleotide variant,GRCh38
na,na,X,135289998,135289999,FHL1,Pathogenic,X-linked myopathy with postural muscle atrophy|X-linked scapuloperoneal muscular dystrophy,Duplication,GRCh37
na,na,X,136207839,136207840,FHL1,Pathogenic,X-linked myopathy with postural muscle atrophy|X-linked scapuloperoneal muscular dystrophy,Duplication,GRCh38
na,na,X,135289986,135289986,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe",single nucleotide variant,GRCh37
na,na,X,136207827,136207827,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe",single nucleotide variant,GRCh38
na,na,X,135290014,135290014,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe|Centronuclear myopathy",single nucleotide variant,GRCh37
na,na,X,136207855,136207855,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe|Centronuclear myopathy",single nucleotide variant,GRCh38
na,na,X,135290076,135290076,FHL1,Pathogenic/Likely pathogenic,"Myopathy, reducing body, X-linked, childhood-onset|X-linked myopathy with postural muscle atrophy|Abnormality of the musculature",single nucleotide variant,GRCh37
na,na,X,136207917,136207917,FHL1,Pathogenic/Likely pathogenic,"Myopathy, reducing body, X-linked, childhood-onset|X-linked myopathy with postural muscle atrophy|Abnormality of the musculature",single nucleotide variant,GRCh38
na,na,X,135290077,135290077,FHL1,Likely pathogenic,"Myopathy, reducing body, X-linked, childhood-onset|X-linked myopathy with postural muscle atrophy",single nucleotide variant,GRCh37
na,na,X,136207918,136207918,FHL1,Likely pathogenic,"Myopathy, reducing body, X-linked, childhood-onset|X-linked myopathy with postural muscle atrophy",single nucleotide variant,GRCh38
na,na,X,135290068,135290068,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe|X-linked myopathy with postural muscle atrophy",single nucleotide variant,GRCh37
na,na,X,136207909,136207909,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe|X-linked myopathy with postural muscle atrophy",single nucleotide variant,GRCh38
na,na,X,135289328,135289328,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, childhood-onset",single nucleotide variant,GRCh37
na,na,X,136207169,136207169,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, childhood-onset",single nucleotide variant,GRCh38
na,na,X,135292182,135292182,FHL1,Pathogenic,Emery-Dreifuss muscular dystrophy 6,single nucleotide variant,GRCh37
na,na,X,136210023,136210023,FHL1,Pathogenic,Emery-Dreifuss muscular dystrophy 6,single nucleotide variant,GRCh38
na,na,X,135290737,135290737,FHL1,Pathogenic,Emery-Dreifuss muscular dystrophy 6|X-linked myopathy with postural muscle atrophy,single nucleotide variant,GRCh37
na,na,X,136208578,136208578,FHL1,Pathogenic,Emery-Dreifuss muscular dystrophy 6|X-linked myopathy with postural muscle atrophy,single nucleotide variant,GRCh38
na,na,X,135292156,135292157,FHL1,Pathogenic,Emery-Dreifuss muscular dystrophy 6,Duplication,GRCh37
na,na,X,136209997,136209998,FHL1,Pathogenic,Emery-Dreifuss muscular dystrophy 6,Duplication,GRCh38
na,na,X,135291551,135291551,FHL1,Pathogenic,X-linked myopathy with postural muscle atrophy,single nucleotide variant,GRCh37
na,na,X,136209392,136209392,FHL1,Pathogenic,X-linked myopathy with postural muscle atrophy,single nucleotide variant,GRCh38
na,na,X,135290801,135290801,FHL1,Pathogenic,X-linked myopathy with postural muscle atrophy,single nucleotide variant,GRCh37
na,na,X,136208642,136208642,FHL1,Pathogenic,X-linked myopathy with postural muscle atrophy,single nucleotide variant,GRCh38
na,na,X,135289987,135289987,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe",single nucleotide variant,GRCh37
na,na,X,136207828,136207828,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe",single nucleotide variant,GRCh38
na,na,X,135289988,135289988,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe|X-linked myopathy with postural muscle atrophy",single nucleotide variant,GRCh37
na,na,X,136207829,136207829,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, early-onset, severe|X-linked myopathy with postural muscle atrophy",single nucleotide variant,GRCh38
na,na,X,135290067,135290075,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, childhood-onset",Deletion,GRCh37
na,na,X,136207908,136207916,FHL1,Pathogenic,"Myopathy, reducing body, X-linked, childhood-onset",Deletion,GRCh38
na,na,X,108904872,108904872,ACSL4,Pathogenic,"Intellectual disability, X-linked 63",single nucleotide variant,GRCh37
na,na,X,109661643,109661643,ACSL4,Pathogenic,"Intellectual disability, X-linked 63",single nucleotide variant,GRCh38
na,na,X,108912404,108912404,ACSL4,Pathogenic,"Intellectual disability, X-linked 63",single nucleotide variant,GRCh37
na,na,X,109669175,109669175,ACSL4,Pathogenic,"Intellectual disability, X-linked 63",single nucleotide variant,GRCh38
na,na,X,108917632,108917632,ACSL4,Likely pathogenic,"Intellectual disability, X-linked 63|not provided",single nucleotide variant,GRCh37
na,na,X,109674403,109674403,ACSL4,Likely pathogenic,"Intellectual disability, X-linked 63|not provided",single nucleotide variant,GRCh38
na,na,X,128870791,128870791,XPNPEP2,risk factor,Susceptibility to angioedema induced by ACE inhibitors,single nucleotide variant,GRCh37
na,na,X,129736814,129736814,XPNPEP2,risk factor,Susceptibility to angioedema induced by ACE inhibitors,single nucleotide variant,GRCh38
na,na,X,110439716,110439716,PAK3,Pathogenic,"Intellectual disability, X-linked 30|not provided",single nucleotide variant,GRCh37
na,na,X,111196488,111196488,PAK3,Pathogenic,"Intellectual disability, X-linked 30|not provided",single nucleotide variant,GRCh38
na,na,X,110385347,110385347,PAK3,Pathogenic,"Intellectual disability, X-linked 30",single nucleotide variant,GRCh37
na,na,X,111142119,111142119,PAK3,Pathogenic,"Intellectual disability, X-linked 30",single nucleotide variant,GRCh38
na,na,X,110437630,110437630,PAK3,Pathogenic,"Intellectual disability, X-linked 30|not provided",single nucleotide variant,GRCh37
na,na,X,111194402,111194402,PAK3,Pathogenic,"Intellectual disability, X-linked 30|not provided",single nucleotide variant,GRCh38
na,na,X,110439798,110439798,PAK3,Pathogenic,"Intellectual disability, X-linked 30",single nucleotide variant,GRCh37
na,na,X,111196570,111196570,PAK3,Pathogenic,"Intellectual disability, X-linked 30",single nucleotide variant,GRCh38
na,na,X,110385428,110385428,PAK3,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked 30|not provided|Intellectual disability",single nucleotide variant,GRCh37
na,na,X,111142200,111142200,PAK3,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked 30|not provided|Intellectual disability",single nucleotide variant,GRCh38
na,na,X,69353741,69353743,IGBP1,Pathogenic,Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,Indel,GRCh37
na,na,X,70133891,70133893,IGBP1,Pathogenic,Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,Indel,GRCh38
na,na,X,74291351,74291351,ABCB7,Pathogenic,X-linked sideroblastic anemia with ataxia|not provided,single nucleotide variant,GRCh37
na,na,X,75071516,75071516,ABCB7,Pathogenic,X-linked sideroblastic anemia with ataxia|not provided,single nucleotide variant,GRCh38
na,na,X,74290268,74290268,ABCB7,Pathogenic,X-linked sideroblastic anemia with ataxia,single nucleotide variant,GRCh37
na,na,X,75070433,75070433,ABCB7,Pathogenic,X-linked sideroblastic anemia with ataxia,single nucleotide variant,GRCh38
na,na,X,74290334,74290334,ABCB7,Pathogenic,X-linked sideroblastic anemia with ataxia,single nucleotide variant,GRCh37
na,na,X,75070499,75070499,ABCB7,Pathogenic,X-linked sideroblastic anemia with ataxia,single nucleotide variant,GRCh38
na,na,X,67316819,67316819,OPHN1,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,Deletion,GRCh37
na,na,X,68096977,68096977,OPHN1,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,Deletion,GRCh38
na,na,X,67430074,67430075,OPHN1,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,Duplication,GRCh37
na,na,X,68210232,68210233,OPHN1,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,Duplication,GRCh38
na,na,X,67518909,67518909,OPHN1,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,single nucleotide variant,GRCh37
na,na,X,68299067,68299067,OPHN1,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,OPHN1,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,Deletion,na
na,na,X,67432007,67432008,OPHN1,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,Microsatellite,GRCh37
na,na,X,68212165,68212166,OPHN1,Pathogenic,X-linked intellectual disability-cerebellar hypoplasia syndrome,Microsatellite,GRCh38
na,na,X,153993740,153993740,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh37
na,na,X,154765465,154765465,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh38
na,na,X,153993741,153993743,DKC1,Likely pathogenic,"Dyskeratosis congenita, X-linked|Dyskeratosis congenita",Deletion,GRCh37
na,na,X,154765466,154765468,DKC1,Likely pathogenic,"Dyskeratosis congenita, X-linked|Dyskeratosis congenita",Deletion,GRCh38
na,na,X,153993753,153993753,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh37
na,na,X,154765478,154765478,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh38
na,na,X,153994224,153994225,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",Indel,GRCh37
na,na,X,154765949,154765950,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",Indel,GRCh38
na,na,X,154002926,154002926,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh37
na,na,X,154774651,154774651,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh38
na,na,X,154001427,154001427,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked|Dyskeratosis congenita",single nucleotide variant,GRCh37
na,na,X,154773152,154773152,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked|Dyskeratosis congenita",single nucleotide variant,GRCh38
na,na,X,154776372,154778319,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",Deletion,GRCh38
na,na,X,153991848,153991848,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked|DKC1-related disorder",single nucleotide variant,GRCh37
na,na,X,154763573,154763573,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked|DKC1-related disorder",single nucleotide variant,GRCh38
na,na,X,153993780,153993780,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked|not provided|Dyskeratosis congenita",single nucleotide variant,GRCh37
na,na,X,154765505,154765505,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked|not provided|Dyskeratosis congenita",single nucleotide variant,GRCh38
na,na,X,153994588,153994588,DKC1,Conflicting classifications of pathogenicity,"Hoyeraal-Hreidarsson syndrome|Dyskeratosis congenita, X-linked|not provided|Dyskeratosis congenita",single nucleotide variant,GRCh37
na,na,X,154766313,154766313,DKC1,Conflicting classifications of pathogenicity,"Hoyeraal-Hreidarsson syndrome|Dyskeratosis congenita, X-linked|not provided|Dyskeratosis congenita",single nucleotide variant,GRCh38
na,na,X,153993747,153993747,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked|Hoyeraal-Hreidarsson syndrome",single nucleotide variant,GRCh37
na,na,X,154765472,154765472,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked|Hoyeraal-Hreidarsson syndrome",single nucleotide variant,GRCh38
na,na,X,153993725,153993725,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh37
na,na,X,154765450,154765450,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh38
na,na,X,154001438,154001438,DKC1,Uncertain significance,"Dyskeratosis congenita, X-linked|Dyskeratosis congenita",single nucleotide variant,GRCh37
na,na,X,154773163,154773163,DKC1,Uncertain significance,"Dyskeratosis congenita, X-linked|Dyskeratosis congenita",single nucleotide variant,GRCh38
na,na,X,154002981,154002981,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh37
na,na,X,154774706,154774706,DKC1,Pathogenic,"Dyskeratosis congenita, X-linked",single nucleotide variant,GRCh38
na,na,X,110653443,110653443,DCX,Pathogenic/Likely pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation",single nucleotide variant,GRCh37
na,na,X,111410215,111410215,DCX,Pathogenic/Likely pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation",single nucleotide variant,GRCh38
na,na,X,110644349,110644349,DCX,Pathogenic,"Ectopic tissue|Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|not provided",single nucleotide variant,GRCh37
na,na,X,111401121,111401121,DCX,Pathogenic,"Ectopic tissue|Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|not provided",single nucleotide variant,GRCh38
na,na,X,110644550,110644550,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation",single nucleotide variant,GRCh37
na,na,X,111401322,111401322,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation",single nucleotide variant,GRCh38
na,na,X,110653451,110653451,DCX,Pathogenic,"Lissencephaly type 1 due to doublecortin gene mutation|Subcortical laminar heterotopia, X-linked",single nucleotide variant,GRCh37
na,na,X,111410223,111410223,DCX,Pathogenic,"Lissencephaly type 1 due to doublecortin gene mutation|Subcortical laminar heterotopia, X-linked",single nucleotide variant,GRCh38
na,na,X,110644315,110644315,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|Neurodevelopmental disorder",single nucleotide variant,GRCh37
na,na,X,111401087,111401087,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|Neurodevelopmental disorder",single nucleotide variant,GRCh38
na,na,X,110653488,110653488,DCX,Uncertain significance,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|not provided",single nucleotide variant,GRCh37
na,na,X,111410260,111410260,DCX,Uncertain significance,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|not provided",single nucleotide variant,GRCh38
na,na,X,110653591,110653592,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked",Microsatellite,GRCh37
na,na,X,111410363,111410364,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked",Microsatellite,GRCh38
na,na,X,110644231,110644232,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked",Microsatellite,GRCh37
na,na,X,111401003,111401004,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked",Microsatellite,GRCh38
na,na,X,110653394,110653394,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|not provided",single nucleotide variant,GRCh37
na,na,X,111410166,111410166,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|not provided",single nucleotide variant,GRCh38
na,na,X,110653362,110653362,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked",single nucleotide variant,GRCh37
na,na,X,111410134,111410134,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked",single nucleotide variant,GRCh38
na,na,X,110644336,110644336,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|not provided|Ectopic tissue|Abnormal cerebral morphology|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,X,111401108,111401108,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|not provided|Ectopic tissue|Abnormal cerebral morphology|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,X,110653416,110653416,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation",single nucleotide variant,GRCh37
na,na,X,111410188,111410188,DCX,Pathogenic,"Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation",single nucleotide variant,GRCh38
na,na,X,149638434,149638434,MAMLD1,Pathogenic,"Hypospadias 2, X-linked",single nucleotide variant,GRCh37
na,na,X,150470162,150470162,MAMLD1,Pathogenic,"Hypospadias 2, X-linked",single nucleotide variant,GRCh38
na,na,X,149638653,149638653,MAMLD1,Pathogenic,"Hypospadias 2, X-linked",single nucleotide variant,GRCh37
na,na,X,150470381,150470381,MAMLD1,Pathogenic,"Hypospadias 2, X-linked",single nucleotide variant,GRCh38
na,na,X,149671679,149671679,MAMLD1,Pathogenic,"Hypospadias 2, X-linked|46,XY ovotesticular disorder of sex development",single nucleotide variant,GRCh37
na,na,X,150503409,150503409,MAMLD1,Pathogenic,"Hypospadias 2, X-linked|46,XY ovotesticular disorder of sex development",single nucleotide variant,GRCh38
na,na,X,49084510,49084510,CACNA1F,Pathogenic,Congenital stationary night blindness 2A,single nucleotide variant,GRCh37
na,na,X,49228048,49228048,CACNA1F,Pathogenic,Congenital stationary night blindness 2A,single nucleotide variant,GRCh38
na,na,X,49074970,49074970,CACNA1F,Pathogenic,Congenital stationary night blindness 2A|Congenital stationary night blindness|Retinal dystrophy|not provided|CACNA1F-related disorder,single nucleotide variant,GRCh37
na,na,X,49218511,49218511,CACNA1F,Pathogenic,Congenital stationary night blindness 2A|Congenital stationary night blindness|Retinal dystrophy|not provided|CACNA1F-related disorder,single nucleotide variant,GRCh38
na,na,X,49075803,49075803,CACNA1F,Pathogenic,Congenital stationary night blindness 2A|Congenital stationary night blindness|not provided,single nucleotide variant,GRCh37
na,na,X,49219344,49219344,CACNA1F,Pathogenic,Congenital stationary night blindness 2A|Congenital stationary night blindness|not provided,single nucleotide variant,GRCh38
na,na,X,49066801,49066801,CACNA1F,Pathogenic,Congenital stationary night blindness 2A,Deletion,GRCh37
na,na,X,49210341,49210341,CACNA1F,Pathogenic,Congenital stationary night blindness 2A,Deletion,GRCh38
na,na,X,49079035,49079035,CACNA1F,Pathogenic,"Congenital stationary night blindness, type 2A, severe|not provided",single nucleotide variant,GRCh37
na,na,X,49222576,49222576,CACNA1F,Pathogenic,"Congenital stationary night blindness, type 2A, severe|not provided",single nucleotide variant,GRCh38
na,na,X,49071701,49071705,CACNA1F,Pathogenic,X-linked cone-rod dystrophy 3,Indel,GRCh37
na,na,X,49215241,49215245,CACNA1F,Pathogenic,X-linked cone-rod dystrophy 3,Indel,GRCh38
na,na,X,49070438,49070862,CACNA1F,Pathogenic,Aland island eye disease,Deletion,GRCh37
na,na,X,49213978,49214402,CACNA1F,Pathogenic,Aland island eye disease,Deletion,GRCh38
na,na,na,-1,-1,DIAPH2,Pathogenic,Premature ovarian failure 2A,Translocation,na
na,na,X,21990694,21990694,SMS,Pathogenic,Syndromic X-linked intellectual disability Snyder type,single nucleotide variant,GRCh37
na,na,X,21972576,21972576,SMS,Pathogenic,Syndromic X-linked intellectual disability Snyder type,single nucleotide variant,GRCh38
na,na,X,21985430,21985430,SMS,Pathogenic,Syndromic X-linked intellectual disability Snyder type|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,X,21967312,21967312,SMS,Pathogenic,Syndromic X-linked intellectual disability Snyder type|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,X,21995244,21995244,SMS,Pathogenic,Syndromic X-linked intellectual disability Snyder type,single nucleotide variant,GRCh37
na,na,X,21977126,21977126,SMS,Pathogenic,Syndromic X-linked intellectual disability Snyder type,single nucleotide variant,GRCh38
na,na,X,153667373,153667373,GDI1,Uncertain significance,"Intellectual disability, X-linked 41|not specified",single nucleotide variant,GRCh37
na,na,X,154439027,154439027,GDI1,Uncertain significance,"Intellectual disability, X-linked 41|not specified",single nucleotide variant,GRCh38
na,na,X,153667165,153667165,GDI1,Pathogenic,"Intellectual disability, X-linked 41",single nucleotide variant,GRCh37
na,na,X,154438819,154438819,GDI1,Pathogenic,"Intellectual disability, X-linked 41",single nucleotide variant,GRCh38
na,na,X,153670943,153670943,GDI1,Pathogenic,"Intellectual disability, X-linked 41",single nucleotide variant,GRCh37
na,na,X,154442596,154442596,GDI1,Pathogenic,"Intellectual disability, X-linked 41",single nucleotide variant,GRCh38
na,na,X,38540512,38540512,TSPAN7,Pathogenic,"Intellectual disability, X-linked 58",single nucleotide variant,GRCh37
na,na,X,38681258,38681258,TSPAN7,Pathogenic,"Intellectual disability, X-linked 58",single nucleotide variant,GRCh38
na,na,X,38535032,38535032,TSPAN7,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked 58|not provided|History of neurodevelopmental disorder",single nucleotide variant,GRCh37
na,na,X,38675778,38675778,TSPAN7,Conflicting classifications of pathogenicity,"Intellectual disability, X-linked 58|not provided|History of neurodevelopmental disorder",single nucleotide variant,GRCh38
na,na,X,38535087,38535088,TSPAN7,Pathogenic,"Intellectual disability, X-linked 58",Microsatellite,GRCh37
na,na,X,38675833,38675834,TSPAN7,Pathogenic,"Intellectual disability, X-linked 58",Microsatellite,GRCh38
na,na,X,73749190,73749190,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,single nucleotide variant,GRCh37
na,na,X,74529355,74529355,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,single nucleotide variant,GRCh38
na,na,X,73744611,73744611,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,Deletion,GRCh37
na,na,X,74524776,74524776,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,Deletion,GRCh38
na,na,X,73740843,73740843,SLC16A2,Pathogenic/Likely pathogenic,Allan-Herndon-Dudley syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,74521008,74521008,SLC16A2,Pathogenic/Likely pathogenic,Allan-Herndon-Dudley syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,74305035,74520989,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,Deletion,GRCh38
na,na,X,73749067,73749067,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome|Intellectual disability,single nucleotide variant,GRCh37
na,na,X,74529232,74529232,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome|Intellectual disability,single nucleotide variant,GRCh38
na,na,na,-1,-1,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,Deletion,na
na,na,X,73751249,73751249,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,single nucleotide variant,GRCh37
na,na,X,74531414,74531414,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,single nucleotide variant,GRCh38
na,na,X,73745637,73745637,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,single nucleotide variant,GRCh37
na,na,X,74525802,74525802,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,single nucleotide variant,GRCh38
na,na,X,73745679,73745679,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,single nucleotide variant,GRCh37
na,na,X,74525844,74525844,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,single nucleotide variant,GRCh38
na,na,X,73740855,73740857,SLC16A2,Pathogenic/Likely pathogenic,Allan-Herndon-Dudley syndrome|not provided,Microsatellite,GRCh37
na,na,X,74521020,74521022,SLC16A2,Pathogenic/Likely pathogenic,Allan-Herndon-Dudley syndrome|not provided,Microsatellite,GRCh38
na,na,X,73751380,73751380,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,Deletion,GRCh37
na,na,X,74531545,74531545,SLC16A2,Pathogenic,Allan-Herndon-Dudley syndrome,Deletion,GRCh38
na,na,X,47041667,47041668,RBM10,Pathogenic,TARP syndrome,Duplication,GRCh37
na,na,X,47182268,47182269,RBM10,Pathogenic,TARP syndrome,Duplication,GRCh38
na,na,X,47039892,47039892,RBM10,Pathogenic,TARP syndrome,single nucleotide variant,GRCh37
na,na,X,47180493,47180493,RBM10,Pathogenic,TARP syndrome,single nucleotide variant,GRCh38
na,na,X,123019804,123019804,XIAP,Pathogenic,X-linked lymphoproliferative disease due to XIAP deficiency,Deletion,GRCh37
na,na,X,123885954,123885954,XIAP,Pathogenic,X-linked lymphoproliferative disease due to XIAP deficiency,Deletion,GRCh38
na,na,X,123019864,123019864,XIAP,Pathogenic,X-linked lymphoproliferative disease due to XIAP deficiency,single nucleotide variant,GRCh37
na,na,X,123886014,123886014,XIAP,Pathogenic,X-linked lymphoproliferative disease due to XIAP deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,XIAP,Pathogenic,X-linked lymphoproliferative disease due to XIAP deficiency,Deletion,na
na,na,X,119005896,119005896,NDUFA1,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 12",single nucleotide variant,GRCh37
na,na,X,119871933,119871933,NDUFA1,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 12",single nucleotide variant,GRCh38
na,na,X,119007275,119007275,NDUFA1,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 12",single nucleotide variant,GRCh37
na,na,X,119873312,119873312,NDUFA1,Pathogenic,"Mitochondrial complex 1 deficiency, nuclear type 12",single nucleotide variant,GRCh38
na,na,na,-1,-1,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,Deletion,na
na,na,X,20227425,20227425,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20209307,20209307,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,X,20206041,20206041,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20187923,20187923,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,X,20222221,20222221,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20204103,20204103,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,X,20213264,20213264,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20195146,20195146,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,X,20213249,20213249,RPS6KA3,Likely pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20195131,20195131,RPS6KA3,Likely pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,X,20212341,20212342,RPS6KA3,Pathogenic,Coffin-Lowry syndrome|not provided,Deletion,GRCh37
na,na,X,20194223,20194224,RPS6KA3,Pathogenic,Coffin-Lowry syndrome|not provided,Deletion,GRCh38
na,na,X,20174262,20174262,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20156144,20156144,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,X,20173553,20173553,RPS6KA3,Pathogenic/Likely pathogenic,Coffin-Lowry syndrome|not provided|Intellectual disability|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,X,20155435,20155435,RPS6KA3,Pathogenic/Likely pathogenic,Coffin-Lowry syndrome|not provided|Intellectual disability|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,X,20193362,20193362,RPS6KA3,Pathogenic,"Intellectual disability, X-linked 19",single nucleotide variant,GRCh37
na,na,X,20175244,20175244,RPS6KA3,Pathogenic,"Intellectual disability, X-linked 19",single nucleotide variant,GRCh38
na,na,X,20211632,20211632,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20193514,20193514,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,X,20212304,20212304,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20194186,20194186,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,X,20173595,20173595,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,Deletion,GRCh37
na,na,X,20155477,20155477,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,Deletion,GRCh38
na,na,X,20194472,20194472,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20176354,20176354,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,Insertion,na
na,na,X,20204456,20204456,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh37
na,na,X,20186338,20186338,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,single nucleotide variant,GRCh38
na,na,X,20187533,20187535,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,Deletion,GRCh37
na,na,X,20169415,20169417,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,Deletion,GRCh38
na,na,na,-1,-1,RPS6KA3,Pathogenic,Coffin-Lowry syndrome,Duplication,na
na,na,X,11124365,11133035,HCCS,Pathogenic,Linear skin defects with multiple congenital anomalies 1,Deletion,GRCh37
na,na,X,11106245,11114915,HCCS,Pathogenic,Linear skin defects with multiple congenital anomalies 1,Deletion,GRCh38
na,na,X,11139094,11139094,HCCS,Pathogenic,Linear skin defects with multiple congenital anomalies 1,single nucleotide variant,GRCh37
na,na,X,11120974,11120974,HCCS,Pathogenic,Linear skin defects with multiple congenital anomalies 1,single nucleotide variant,GRCh38
na,na,X,11139772,11139772,HCCS,Likely pathogenic,Linear skin defects with multiple congenital anomalies 1|HCCS-related disorder,single nucleotide variant,GRCh37
na,na,X,11121652,11121652,HCCS,Likely pathogenic,Linear skin defects with multiple congenital anomalies 1|HCCS-related disorder,single nucleotide variant,GRCh38
na,na,X,53426578,53426580,SMC1A,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome,Deletion,GRCh37
na,na,X,53399656,53399658,SMC1A,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome,Deletion,GRCh38
na,na,X,53436060,53436060,SMC1A,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome,single nucleotide variant,GRCh37
na,na,X,53409129,53409129,SMC1A,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome,single nucleotide variant,GRCh38
na,na,X,53442041,53442055,SMC1A,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome,Deletion,GRCh37
na,na,X,53415092,53415106,SMC1A,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome,Deletion,GRCh38
na,na,X,53436051,53436051,SMC1A,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,53409120,53409120,SMC1A,Pathogenic,Congenital muscular hypertrophy-cerebral syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,82763977,82763977,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,Deletion,GRCh37
na,na,X,83508969,83508969,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,Deletion,GRCh38
na,na,X,82763936,82763936,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh37
na,na,X,83508928,83508928,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh38
na,na,X,82764282,82764282,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh37
na,na,X,83509274,83509274,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh38
na,na,X,82764332,82764332,POU3F4,Likely pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh37
na,na,X,83509324,83509324,POU3F4,Likely pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh38
na,na,X,82764191,82764194,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,Deletion,GRCh37
na,na,X,83509183,83509186,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,Deletion,GRCh38
na,na,X,82764267,82764267,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh37
na,na,X,83509259,83509259,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh38
na,na,X,82764322,82764322,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh37
na,na,X,83509314,83509314,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh38
na,na,X,82764299,82764299,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh37
na,na,X,83509291,83509291,POU3F4,Pathogenic,X-linked mixed hearing loss with perilymphatic gusher,single nucleotide variant,GRCh38
na,na,X,133087208,133087220,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,Deletion,GRCh37
na,na,X,133953181,133953193,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,Deletion,GRCh38
na,na,na,-1,-1,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,Deletion,na
na,na,X,132887655,132887655,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,single nucleotide variant,GRCh37
na,na,X,133753628,133753628,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,single nucleotide variant,GRCh38
na,na,X,132826396,132826396,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,single nucleotide variant,GRCh37
na,na,X,133692368,133692368,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,single nucleotide variant,GRCh38
na,na,X,132887946,132887946,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1|not provided|Wilms tumor 1,single nucleotide variant,GRCh37
na,na,X,133753919,133753919,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1|not provided|Wilms tumor 1,single nucleotide variant,GRCh38
na,na,X,132888180,132888180,GPC3,Pathogenic,Wilms tumor 1,single nucleotide variant,GRCh37
na,na,X,133754153,133754153,GPC3,Pathogenic,Wilms tumor 1,single nucleotide variant,GRCh38
na,na,X,132670190,132670190,GPC3,Uncertain significance,Wilms tumor 1,single nucleotide variant,GRCh37
na,na,X,133536162,133536162,GPC3,Uncertain significance,Wilms tumor 1,single nucleotide variant,GRCh38
na,na,X,132795703,132795954,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,Deletion,GRCh37
na,na,X,133661675,133661926,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,Deletion,GRCh38
na,na,X,133087076,133087076,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,single nucleotide variant,GRCh37
na,na,X,133953049,133953049,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1,single nucleotide variant,GRCh38
na,na,X,132833930,132833930,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1|Wilms tumor 1|not provided,single nucleotide variant,GRCh37
na,na,X,133699902,133699902,GPC3,Pathogenic,Simpson-Golabi-Behmel syndrome type 1|Wilms tumor 1|not provided,single nucleotide variant,GRCh38
na,na,X,132670229,132670229,GPC3,Pathogenic/Likely pathogenic,Simpson-Golabi-Behmel syndrome type 1|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,X,133536201,133536201,GPC3,Pathogenic/Likely pathogenic,Simpson-Golabi-Behmel syndrome type 1|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,X,152960032,152960032,SLC6A8,Pathogenic,Creatine transporter deficiency|Inborn genetic diseases|not provided|Intellectual disability,single nucleotide variant,GRCh37
na,na,X,153694577,153694577,SLC6A8,Pathogenic,Creatine transporter deficiency|Inborn genetic diseases|not provided|Intellectual disability,single nucleotide variant,GRCh38
na,na,X,152959041,152959041,SLC6A8,Pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh37
na,na,X,153693586,153693586,SLC6A8,Pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh38
na,na,X,152959434,152959436,SLC6A8,Pathogenic,Creatine transporter deficiency|not provided,Microsatellite,GRCh37
na,na,X,153693979,153693981,SLC6A8,Pathogenic,Creatine transporter deficiency|not provided,Microsatellite,GRCh38
na,na,X,152958754,152958755,SLC6A8,Pathogenic,Creatine transporter deficiency,Duplication,GRCh37
na,na,X,153693299,153693300,SLC6A8,Pathogenic,Creatine transporter deficiency,Duplication,GRCh38
na,na,X,152954288,152954288,SLC6A8,Uncertain significance,Creatine transporter deficiency|not provided,single nucleotide variant,GRCh37
na,na,X,153688833,153688833,SLC6A8,Uncertain significance,Creatine transporter deficiency|not provided,single nucleotide variant,GRCh38
na,na,X,152955828,152955828,SLC6A8,Pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh37
na,na,X,153690373,153690373,SLC6A8,Pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh38
na,na,X,152958816,152958816,SLC6A8,Pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh37
na,na,X,153693361,153693361,SLC6A8,Pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh38
na,na,X,152956759,152956759,SLC6A8,Likely pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh37
na,na,X,153691304,153691304,SLC6A8,Likely pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh38
na,na,X,152959879,152959879,SLC6A8,Likely pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh37
na,na,X,153694424,153694424,SLC6A8,Likely pathogenic,Creatine transporter deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,EFNB1,Pathogenic,Craniofrontonasal syndrome,Deletion,na
na,na,X,68058663,68058663,EFNB1,Pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,68838820,68838820,EFNB1,Pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,68058492,68058492,EFNB1,Pathogenic/Likely pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,68838649,68838649,EFNB1,Pathogenic/Likely pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,68059551,68059551,EFNB1,Pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,68839708,68839708,EFNB1,Pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,68059552,68059552,EFNB1,Pathogenic,Craniofrontonasal syndrome,single nucleotide variant,GRCh37
na,na,X,68839709,68839709,EFNB1,Pathogenic,Craniofrontonasal syndrome,single nucleotide variant,GRCh38
na,na,X,68059572,68059572,EFNB1,Pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,68839729,68839729,EFNB1,Pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,68059574,68059574,EFNB1,Pathogenic,Craniofrontonasal syndrome,single nucleotide variant,GRCh37
na,na,X,68839731,68839731,EFNB1,Pathogenic,Craniofrontonasal syndrome,single nucleotide variant,GRCh38
na,na,X,68049728,68049728,EFNB1,Pathogenic,Craniofrontonasal syndrome,single nucleotide variant,GRCh37
na,na,X,68829885,68829885,EFNB1,Pathogenic,Craniofrontonasal syndrome,single nucleotide variant,GRCh38
na,na,X,68049729,68049729,EFNB1,Pathogenic,Craniofrontonasal syndrome,single nucleotide variant,GRCh37
na,na,X,68829886,68829886,EFNB1,Pathogenic,Craniofrontonasal syndrome,single nucleotide variant,GRCh38
na,na,X,68058527,68058527,EFNB1,Pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,68838684,68838684,EFNB1,Pathogenic,Craniofrontonasal syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,115303595,115303595,AGTR2,Benign/Likely benign,"not provided|not specified|Intellectual disability, X-linked 88",single nucleotide variant,GRCh37
na,na,X,116172342,116172342,AGTR2,Benign/Likely benign,"not provided|not specified|Intellectual disability, X-linked 88",single nucleotide variant,GRCh38
na,na,X,115303928,115303928,AGTR2,Likely benign,not provided|not specified|AGTR2-related disorder,Deletion,GRCh37
na,na,X,116172675,116172675,AGTR2,Likely benign,not provided|not specified|AGTR2-related disorder,Deletion,GRCh38
na,na,X,115304504,115304504,AGTR2,Conflicting classifications of pathogenicity,not provided|AGTR2-related disorder,single nucleotide variant,GRCh37
na,na,X,116173251,116173251,AGTR2,Conflicting classifications of pathogenicity,not provided|AGTR2-related disorder,single nucleotide variant,GRCh38
na,na,X,115304542,115304542,AGTR2,Uncertain significance,not provided,single nucleotide variant,GRCh37
na,na,X,116173289,116173289,AGTR2,Uncertain significance,not provided,single nucleotide variant,GRCh38
na,na,X,115303690,115303690,AGTR2,Uncertain significance,not provided,single nucleotide variant,GRCh37
na,na,X,116172437,116172437,AGTR2,Uncertain significance,not provided,single nucleotide variant,GRCh38
na,na,X,76889184,76889184,ATRX,Likely pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,77633696,77633696,ATRX,Likely pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,76889170,76889170,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh37
na,na,X,77633682,77633682,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh38
na,na,X,76889060,76889060,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh37
na,na,X,77633572,77633572,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh38
na,na,X,76856021,76856021,ATRX,Benign/Likely benign,"Alpha thalassemia-X-linked intellectual disability syndrome|not specified|not provided|Atypical teratoid rhabdoid tumor|Astrocytoma, anaplastic|Inborn genetic diseases|Intellectual disability-hypotonic facies syndrome, X-linked, 1",single nucleotide variant,GRCh37
na,na,X,77600552,77600552,ATRX,Benign/Likely benign,"Alpha thalassemia-X-linked intellectual disability syndrome|not specified|not provided|Atypical teratoid rhabdoid tumor|Astrocytoma, anaplastic|Inborn genetic diseases|Intellectual disability-hypotonic facies syndrome, X-linked, 1",single nucleotide variant,GRCh38
na,na,X,76849172,76849172,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh37
na,na,X,77593702,77593702,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh38
na,na,X,76829791,76829791,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh37
na,na,X,77574326,77574326,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh38
na,na,X,76814156,76814156,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh37
na,na,X,77558685,77558685,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh38
na,na,X,76776310,76776310,ATRX,Pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|not provided|Intellectual disability-hypotonic facies syndrome, X-linked, 1|ATRX-related disorder",single nucleotide variant,GRCh37
na,na,X,77520832,77520832,ATRX,Pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|not provided|Intellectual disability-hypotonic facies syndrome, X-linked, 1|ATRX-related disorder",single nucleotide variant,GRCh38
na,na,X,76776304,76776304,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh37
na,na,X,77520826,77520826,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh38
na,na,X,76874459,76874459,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh37
na,na,X,77618991,77618991,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh38
na,na,X,76814252,76814252,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked|Alpha thalassemia-X-linked intellectual disability syndrome;Intellectual disability-hypotonic facies syndrome, X-linked, 1|Alpha thalassemia-X-linked intellectual disability syndrome|not provided|ATRX-related disorder",single nucleotide variant,GRCh37
na,na,X,77558781,77558781,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked|Alpha thalassemia-X-linked intellectual disability syndrome;Intellectual disability-hypotonic facies syndrome, X-linked, 1|Alpha thalassemia-X-linked intellectual disability syndrome|not provided|ATRX-related disorder",single nucleotide variant,GRCh38
na,na,X,76888698,76888698,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",single nucleotide variant,GRCh37
na,na,X,77633210,77633210,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",single nucleotide variant,GRCh38
na,na,X,76939997,76939997,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh37
na,na,X,77684505,77684505,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh38
na,na,X,76944337,76944337,ATRX,Likely pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|Alpha thalassemia-X-linked intellectual disability syndrome;Intellectual disability-hypotonic facies syndrome, X-linked, 1",single nucleotide variant,GRCh37
na,na,X,77688844,77688844,ATRX,Likely pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|Alpha thalassemia-X-linked intellectual disability syndrome;Intellectual disability-hypotonic facies syndrome, X-linked, 1",single nucleotide variant,GRCh38
na,na,X,76940012,76940012,ATRX,Pathogenic/Likely pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|not provided|Inborn genetic diseases|Intellectual disability-hypotonic facies syndrome, X-linked, 1;Alpha thalassemia-X-linked intellectual disability syndrome;Acquired hemoglobin H disease|Intellectual disability-hypotonic facies syndrome, X-linked, 1|Renier-Gabreels-Jasper syndrome",single nucleotide variant,GRCh37
na,na,X,77684520,77684520,ATRX,Pathogenic/Likely pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|not provided|Inborn genetic diseases|Intellectual disability-hypotonic facies syndrome, X-linked, 1;Alpha thalassemia-X-linked intellectual disability syndrome;Acquired hemoglobin H disease|Intellectual disability-hypotonic facies syndrome, X-linked, 1|Renier-Gabreels-Jasper syndrome",single nucleotide variant,GRCh38
na,na,X,76875910,76875910,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh37
na,na,X,77620442,77620442,ATRX,Pathogenic,Alpha thalassemia-X-linked intellectual disability syndrome,single nucleotide variant,GRCh38
na,na,X,76764109,76764109,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",single nucleotide variant,GRCh37
na,na,X,77508631,77508631,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",single nucleotide variant,GRCh38
na,na,X,76889148,76889148,ATRX,Likely pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|Intellectual disability-hypotonic facies syndrome, X-linked, 1|ATRX-related disorder|not provided",single nucleotide variant,GRCh37
na,na,X,77633660,77633660,ATRX,Likely pathogenic,"Alpha thalassemia-X-linked intellectual disability syndrome|Intellectual disability-hypotonic facies syndrome, X-linked, 1|ATRX-related disorder|not provided",single nucleotide variant,GRCh38
na,na,X,77041467,77041467,ATRX,Pathogenic,Acquired hemoglobin H disease,single nucleotide variant,GRCh37
na,na,X,77785981,77785981,ATRX,Pathogenic,Acquired hemoglobin H disease,single nucleotide variant,GRCh38
na,na,X,76953077,76953077,ATRX,Pathogenic,Acquired hemoglobin H disease,single nucleotide variant,GRCh37
na,na,X,77697589,77697589,ATRX,Pathogenic,Acquired hemoglobin H disease,single nucleotide variant,GRCh38
na,na,X,76972632,76972632,ATRX,Pathogenic/Likely pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked|Alpha thalassemia-X-linked intellectual disability syndrome|Intellectual disability|Intellectual disability-hypotonic facies syndrome, X-linked, 1|Inborn genetic diseases|not provided|Alpha thalassemia-X-linked intellectual disability syndrome;Acquired hemoglobin H disease;Intellectual disability-hypotonic facies syndrome, X-linked, 1",single nucleotide variant,GRCh37
na,na,X,77717155,77717155,ATRX,Pathogenic/Likely pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked|Alpha thalassemia-X-linked intellectual disability syndrome|Intellectual disability|Intellectual disability-hypotonic facies syndrome, X-linked, 1|Inborn genetic diseases|not provided|Alpha thalassemia-X-linked intellectual disability syndrome;Acquired hemoglobin H disease;Intellectual disability-hypotonic facies syndrome, X-linked, 1",single nucleotide variant,GRCh38
na,na,X,76939522,76939522,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",single nucleotide variant,GRCh37
na,na,X,77684030,77684030,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",single nucleotide variant,GRCh38
na,na,X,76845372,76845372,ATRX,Conflicting classifications of pathogenicity,"Intellectual disability-hypotonic facies syndrome, X-linked|Inborn genetic diseases|History of neurodevelopmental disorder|not provided",single nucleotide variant,GRCh37
na,na,X,77589902,77589902,ATRX,Conflicting classifications of pathogenicity,"Intellectual disability-hypotonic facies syndrome, X-linked|Inborn genetic diseases|History of neurodevelopmental disorder|not provided",single nucleotide variant,GRCh38
na,na,X,76940434,76940434,ATRX,Pathogenic/Likely pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked|Inborn genetic diseases|Alpha thalassemia-X-linked intellectual disability syndrome",single nucleotide variant,GRCh37
na,na,X,77684942,77684942,ATRX,Pathogenic/Likely pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked|Inborn genetic diseases|Alpha thalassemia-X-linked intellectual disability syndrome",single nucleotide variant,GRCh38
na,na,X,76778768,76778768,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",single nucleotide variant,GRCh37
na,na,X,77523290,77523290,ATRX,Pathogenic,"Intellectual disability-hypotonic facies syndrome, X-linked",single nucleotide variant,GRCh38
na,na,X,153596288,153596288,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154367920,154367920,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153596007,153596007,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154367639,154367639,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153596109,153596109,FLNA,Uncertain significance,"Heterotopia, periventricular, X-linked dominant|not provided",single nucleotide variant,GRCh37
na,na,X,154367741,154367741,FLNA,Uncertain significance,"Heterotopia, periventricular, X-linked dominant|not provided",single nucleotide variant,GRCh38
na,na,X,153599240,153599240,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154370872,154370872,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153599323,153599327,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",Deletion,GRCh37
na,na,X,154370955,154370959,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",Deletion,GRCh38
na,na,X,153592950,153592950,FLNA,Conflicting classifications of pathogenicity,"Heterotopia, periventricular, X-linked dominant|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|not provided|Neurodevelopmental delay",single nucleotide variant,GRCh37
na,na,X,154364582,154364582,FLNA,Conflicting classifications of pathogenicity,"Heterotopia, periventricular, X-linked dominant|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|not provided|Neurodevelopmental delay",single nucleotide variant,GRCh38
na,na,X,153580057,153580057,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154351689,154351689,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153599369,153599369,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154371001,154371001,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153596212,153596212,FLNA,Pathogenic/Likely pathogenic,"Oto-palato-digital syndrome, type I|Familial thoracic aortic aneurysm and aortic dissection|Conductive hearing impairment;Short stature;Cleft palate|not provided|not specified|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|FLNA-related disorder",single nucleotide variant,GRCh37
na,na,X,154367844,154367844,FLNA,Pathogenic/Likely pathogenic,"Oto-palato-digital syndrome, type I|Familial thoracic aortic aneurysm and aortic dissection|Conductive hearing impairment;Short stature;Cleft palate|not provided|not specified|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|FLNA-related disorder",single nucleotide variant,GRCh38
na,na,X,153595873,153595873,FLNA,Pathogenic,"Oto-palato-digital syndrome, type II|not provided|Frontometaphyseal dysplasia;Heterotopia, periventricular, X-linked dominant;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome",single nucleotide variant,GRCh37
na,na,X,154367505,154367505,FLNA,Pathogenic,"Oto-palato-digital syndrome, type II|not provided|Frontometaphyseal dysplasia;Heterotopia, periventricular, X-linked dominant;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome",single nucleotide variant,GRCh38
na,na,X,153588687,153588687,FLNA,Pathogenic,Frontometaphyseal dysplasia 1,single nucleotide variant,GRCh37
na,na,X,154360319,154360319,FLNA,Pathogenic,Frontometaphyseal dysplasia 1,single nucleotide variant,GRCh38
na,na,X,153588601,153588601,FLNA,Pathogenic/Likely pathogenic,Melnick-Needles syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,154360233,154360233,FLNA,Pathogenic/Likely pathogenic,Melnick-Needles syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,153588567,153588567,FLNA,Pathogenic/Likely pathogenic,"Melnick-Needles syndrome|Melnick-Needles syndrome;Oto-palato-digital syndrome, type I;Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154360199,154360199,FLNA,Pathogenic/Likely pathogenic,"Melnick-Needles syndrome|Melnick-Needles syndrome;Oto-palato-digital syndrome, type I;Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153578417,153578417,FLNA,Pathogenic,"Heterotopia, periventricular, with frontometaphyseal dysplasia",single nucleotide variant,GRCh37
na,na,X,154350049,154350049,FLNA,Pathogenic,"Heterotopia, periventricular, with frontometaphyseal dysplasia",single nucleotide variant,GRCh38
na,na,X,153588606,153588606,FLNA,Pathogenic/Likely pathogenic,"Frontometaphyseal dysplasia 1|not provided|Oto-palato-digital syndrome, type II|9 conditions|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154360238,154360238,FLNA,Pathogenic/Likely pathogenic,"Frontometaphyseal dysplasia 1|not provided|Oto-palato-digital syndrome, type II|9 conditions|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153585835,153585843,FLNA,Pathogenic,Otopalatodigital syndrome spectrum disorder,Deletion,GRCh37
na,na,X,154357467,154357475,FLNA,Pathogenic,Otopalatodigital syndrome spectrum disorder,Deletion,GRCh38
na,na,X,153590411,153590411,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",Deletion,GRCh37
na,na,X,154362043,154362043,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",Deletion,GRCh38
na,na,X,153587770,153587770,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",Deletion,GRCh37
na,na,X,154359402,154359402,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",Deletion,GRCh38
na,na,X,153599498,153599498,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154371130,154371130,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153596225,153596225,FLNA,Pathogenic,"Oto-palato-digital syndrome, type I",single nucleotide variant,GRCh37
na,na,X,154367857,154367857,FLNA,Pathogenic,"Oto-palato-digital syndrome, type I",single nucleotide variant,GRCh38
na,na,X,153596449,153596449,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154368081,154368081,FLNA,Pathogenic,"Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153583228,153583228,FLNA,Pathogenic,Otopalatodigital syndrome spectrum disorder,single nucleotide variant,GRCh37
na,na,X,154354860,154354860,FLNA,Pathogenic,Otopalatodigital syndrome spectrum disorder,single nucleotide variant,GRCh38
na,na,X,153592993,153592993,FLNA,Conflicting classifications of pathogenicity,"Heterotopia, periventricular, X-linked dominant|Cardiac valvular dysplasia, X-linked|not provided|Heterotopia, periventricular, X-linked dominant;Frontometaphyseal dysplasia;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome|FLNA-related periventricular nodular heterotopia|FLNA-related disorder",single nucleotide variant,GRCh37
na,na,X,154364625,154364625,FLNA,Conflicting classifications of pathogenicity,"Heterotopia, periventricular, X-linked dominant|Cardiac valvular dysplasia, X-linked|not provided|Heterotopia, periventricular, X-linked dominant;Frontometaphyseal dysplasia;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome|FLNA-related periventricular nodular heterotopia|FLNA-related disorder",single nucleotide variant,GRCh38
na,na,X,153599546,153599547,FLNA,Pathogenic,"Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked",Microsatellite,GRCh37
na,na,X,154371178,154371179,FLNA,Pathogenic,"Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked",Microsatellite,GRCh38
na,na,X,153596246,153596246,FLNA,Conflicting classifications of pathogenicity,"Oto-palato-digital syndrome, type II|Oto-palato-digital syndrome, type I|not provided|Frontometaphyseal dysplasia;Heterotopia, periventricular, X-linked dominant;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome",single nucleotide variant,GRCh37
na,na,X,154367878,154367878,FLNA,Conflicting classifications of pathogenicity,"Oto-palato-digital syndrome, type II|Oto-palato-digital syndrome, type I|not provided|Frontometaphyseal dysplasia;Heterotopia, periventricular, X-linked dominant;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome",single nucleotide variant,GRCh38
na,na,X,153596100,153596100,FLNA,Pathogenic,"Oto-palato-digital syndrome, type II",single nucleotide variant,GRCh37
na,na,X,154367732,154367732,FLNA,Pathogenic,"Oto-palato-digital syndrome, type II",single nucleotide variant,GRCh38
na,na,X,153588207,153588207,FLNA,Benign/Likely benign,"FG syndrome 2|Heterotopia, periventricular, X-linked dominant;Frontometaphyseal dysplasia;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection|FLNA-related disorder",single nucleotide variant,GRCh37
na,na,X,154359839,154359839,FLNA,Benign/Likely benign,"FG syndrome 2|Heterotopia, periventricular, X-linked dominant;Frontometaphyseal dysplasia;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection|FLNA-related disorder",single nucleotide variant,GRCh38
na,na,X,153583193,153583193,FLNA,Pathogenic,"Terminal osseous dysplasia-pigmentary defects syndrome|not provided|Heterotopia, periventricular, X-linked dominant|Heterotopia, periventricular, X-linked dominant;Frontometaphyseal dysplasia;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome",single nucleotide variant,GRCh37
na,na,X,154354825,154354825,FLNA,Pathogenic,"Terminal osseous dysplasia-pigmentary defects syndrome|not provided|Heterotopia, periventricular, X-linked dominant|Heterotopia, periventricular, X-linked dominant;Frontometaphyseal dysplasia;Oto-palato-digital syndrome, type II;Melnick-Needles syndrome",single nucleotide variant,GRCh38
na,na,X,153593006,153593006,FLNA,Pathogenic,"Cardiac valvular dysplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,154364638,154364638,FLNA,Pathogenic,"Cardiac valvular dysplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,153595771,153595771,FLNA,Pathogenic/Likely pathogenic,"Cardiac valvular dysplasia, X-linked|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh37
na,na,X,154367403,154367403,FLNA,Pathogenic/Likely pathogenic,"Cardiac valvular dysplasia, X-linked|Frontometaphyseal dysplasia;Melnick-Needles syndrome;Oto-palato-digital syndrome, type II;Heterotopia, periventricular, X-linked dominant|Heterotopia, periventricular, X-linked dominant",single nucleotide variant,GRCh38
na,na,X,153592631,153592631,FLNA,Pathogenic,"Cardiac valvular dysplasia, X-linked",single nucleotide variant,GRCh37
na,na,X,154364263,154364263,FLNA,Pathogenic,"Cardiac valvular dysplasia, X-linked",single nucleotide variant,GRCh38
na,na,X,153590180,153592124,FLNA,Pathogenic,"Cardiac valvular dysplasia, X-linked",Indel,GRCh37
na,na,X,154361812,154363756,FLNA,Pathogenic,"Cardiac valvular dysplasia, X-linked",Indel,GRCh38
na,na,X,77298935,77298935,ATP7A,Conflicting classifications of pathogenicity,"Menkes disease, mild|Menkes kinky-hair syndrome",single nucleotide variant,GRCh37
na,na,X,78043437,78043437,ATP7A,Conflicting classifications of pathogenicity,"Menkes disease, mild|Menkes kinky-hair syndrome",single nucleotide variant,GRCh38
na,na,X,77270249,77270249,ATP7A,Conflicting classifications of pathogenicity,"Cutis laxa, X-linked",single nucleotide variant,GRCh37
na,na,X,78014752,78014752,ATP7A,Conflicting classifications of pathogenicity,"Cutis laxa, X-linked",single nucleotide variant,GRCh38
na,na,X,77266713,77266713,ATP7A,Pathogenic,"Cutis laxa, X-linked|Menkes kinky-hair syndrome",single nucleotide variant,GRCh37
na,na,X,78011216,78011216,ATP7A,Pathogenic,"Cutis laxa, X-linked|Menkes kinky-hair syndrome",single nucleotide variant,GRCh38
na,na,na,-1,-1,ATP7A,Pathogenic,"Cutis laxa, X-linked",Deletion,na
na,na,X,77284768,77284768,ATP7A,Pathogenic,"Menkes kinky-hair syndrome|Menkes kinky-hair syndrome;Cutis laxa, X-linked;X-linked distal spinal muscular atrophy type 3",single nucleotide variant,GRCh37
na,na,X,78029271,78029271,ATP7A,Pathogenic,"Menkes kinky-hair syndrome|Menkes kinky-hair syndrome;Cutis laxa, X-linked;X-linked distal spinal muscular atrophy type 3",single nucleotide variant,GRCh38
na,na,X,77258734,77258734,ATP7A,Conflicting classifications of pathogenicity,Menkes kinky-hair syndrome,single nucleotide variant,GRCh37
na,na,X,78003237,78003237,ATP7A,Conflicting classifications of pathogenicity,Menkes kinky-hair syndrome,single nucleotide variant,GRCh38
na,na,X,77301914,77301914,ATP7A,Conflicting classifications of pathogenicity,"Cutis laxa, X-linked",Deletion,GRCh37
na,na,X,78046417,78046417,ATP7A,Conflicting classifications of pathogenicity,"Cutis laxa, X-linked",Deletion,GRCh38
na,na,X,77284886,77284886,ATP7A,Pathogenic,Menkes kinky-hair syndrome,single nucleotide variant,GRCh37
na,na,X,78029389,78029389,ATP7A,Pathogenic,Menkes kinky-hair syndrome,single nucleotide variant,GRCh38
na,na,X,77266940,77266941,ATP7A,Conflicting classifications of pathogenicity,"Menkes disease, copper-replacement responsive|Menkes kinky-hair syndrome",Duplication,GRCh37
na,na,X,78011443,78011444,ATP7A,Conflicting classifications of pathogenicity,"Menkes disease, copper-replacement responsive|Menkes kinky-hair syndrome",Duplication,GRCh38
na,na,X,77244025,77244032,ATP7A,Conflicting classifications of pathogenicity,Menkes kinky-hair syndrome,Deletion,GRCh37
na,na,X,77988529,77988536,ATP7A,Conflicting classifications of pathogenicity,Menkes kinky-hair syndrome,Deletion,GRCh38
na,na,na,-1,-1,ATP7A,Pathogenic,Menkes kinky-hair syndrome,Deletion,na
na,na,X,77298192,77298192,ATP7A,Pathogenic,"Cutis laxa, X-linked|Menkes kinky-hair syndrome|not provided",single nucleotide variant,GRCh37
na,na,X,78042694,78042694,ATP7A,Pathogenic,"Cutis laxa, X-linked|Menkes kinky-hair syndrome|not provided",single nucleotide variant,GRCh38
na,na,X,77244218,77244218,ATP7A,Pathogenic,"Menkes kinky-hair syndrome|not provided|Menkes kinky-hair syndrome;Cutis laxa, X-linked;X-linked distal spinal muscular atrophy type 3",single nucleotide variant,GRCh37
na,na,X,77988722,77988722,ATP7A,Pathogenic,"Menkes kinky-hair syndrome|not provided|Menkes kinky-hair syndrome;Cutis laxa, X-linked;X-linked distal spinal muscular atrophy type 3",single nucleotide variant,GRCh38
na,na,X,77284811,77284811,ATP7A,Conflicting classifications of pathogenicity,X-linked distal spinal muscular atrophy type 3|Charcot-Marie-Tooth disease|Menkes kinky-hair syndrome,single nucleotide variant,GRCh37
na,na,X,78029314,78029314,ATP7A,Conflicting classifications of pathogenicity,X-linked distal spinal muscular atrophy type 3|Charcot-Marie-Tooth disease|Menkes kinky-hair syndrome,single nucleotide variant,GRCh38
na,na,X,77300999,77300999,ATP7A,Pathogenic,"X-linked distal spinal muscular atrophy type 3|Charcot-Marie-Tooth disease|Menkes kinky-hair syndrome;Cutis laxa, X-linked;X-linked distal spinal muscular atrophy type 3|Menkes kinky-hair syndrome",single nucleotide variant,GRCh37
na,na,X,78045502,78045502,ATP7A,Pathogenic,"X-linked distal spinal muscular atrophy type 3|Charcot-Marie-Tooth disease|Menkes kinky-hair syndrome;Cutis laxa, X-linked;X-linked distal spinal muscular atrophy type 3|Menkes kinky-hair syndrome",single nucleotide variant,GRCh38
na,na,X,49851017,49851017,CLCN5,Pathogenic,"Dent disease type 1|Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",single nucleotide variant,GRCh37
na,na,X,50086360,50086360,CLCN5,Pathogenic,"Dent disease type 1|Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",single nucleotide variant,GRCh38
na,na,X,49855335,49855335,CLCN5,Pathogenic,Dent disease type 1|not provided,single nucleotide variant,GRCh37
na,na,X,50090678,50090678,CLCN5,Pathogenic,Dent disease type 1|not provided,single nucleotide variant,GRCh38
na,na,X,49846380,49846380,CLCN5,Pathogenic,Dent disease type 1,single nucleotide variant,GRCh37
na,na,X,50081723,50081723,CLCN5,Pathogenic,Dent disease type 1,single nucleotide variant,GRCh38
na,na,X,49854796,49854796,CLCN5,Pathogenic,Dent disease type 1,single nucleotide variant,GRCh37
na,na,X,50090139,50090139,CLCN5,Pathogenic,Dent disease type 1,single nucleotide variant,GRCh38
na,na,X,49855503,49855503,CLCN5,Conflicting classifications of pathogenicity,"X-linked recessive nephrolithiasis with renal failure|CLCN5-related disorder|Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis;Dent disease type 1",single nucleotide variant,GRCh37
na,na,X,50090846,50090846,CLCN5,Conflicting classifications of pathogenicity,"X-linked recessive nephrolithiasis with renal failure|CLCN5-related disorder|Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis;Dent disease type 1",single nucleotide variant,GRCh38
na,na,X,49853524,49853524,CLCN5,Pathogenic,Dent disease type 1|X-linked recessive nephrolithiasis with renal failure,single nucleotide variant,GRCh37
na,na,X,50088867,50088867,CLCN5,Pathogenic,Dent disease type 1|X-linked recessive nephrolithiasis with renal failure,single nucleotide variant,GRCh38
na,na,X,49850644,49850644,CLCN5,Pathogenic,"Hypophosphatemic rickets, X-linked recessive|Dent disease type 1|not provided|X-linked recessive nephrolithiasis with renal failure;Dent disease type 1;Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis;Hypophosphatemic rickets, X-linked recessive|CLCN5-related disorder",single nucleotide variant,GRCh37
na,na,X,50085987,50085987,CLCN5,Pathogenic,"Hypophosphatemic rickets, X-linked recessive|Dent disease type 1|not provided|X-linked recessive nephrolithiasis with renal failure;Dent disease type 1;Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis;Hypophosphatemic rickets, X-linked recessive|CLCN5-related disorder",single nucleotide variant,GRCh38
na,na,X,49851208,49851208,CLCN5,Pathogenic,"Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",single nucleotide variant,GRCh37
na,na,X,50086551,50086551,CLCN5,Pathogenic,"Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",single nucleotide variant,GRCh38
na,na,X,49855476,49855476,CLCN5,Pathogenic,"Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",Deletion,GRCh37
na,na,X,50090819,50090819,CLCN5,Pathogenic,"Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",Deletion,GRCh38
na,na,X,49851019,49851019,CLCN5,Pathogenic,"Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",single nucleotide variant,GRCh37
na,na,X,50086362,50086362,CLCN5,Pathogenic,"Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis",single nucleotide variant,GRCh38
na,na,X,49837208,49837208,CLCN5,Pathogenic,X-linked recessive nephrolithiasis with renal failure,single nucleotide variant,GRCh37
na,na,X,50072553,50072553,CLCN5,Pathogenic,X-linked recessive nephrolithiasis with renal failure,single nucleotide variant,GRCh38
na,na,na,-1,-1,CLCN5,Pathogenic,Dent disease type 1,Insertion,na
na,na,X,49850692,49850692,CLCN5,Pathogenic,Dent disease type 1,single nucleotide variant,GRCh37
na,na,X,50086035,50086035,CLCN5,Pathogenic,Dent disease type 1,single nucleotide variant,GRCh38
na,na,X,153296882,153296882,MECP2,Pathogenic,"Rett syndrome, zappella variant|Rett syndrome|not provided|X-linked intellectual disability-psychosis-macroorchidism syndrome|Angelman syndrome|not specified|Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases|Intellectual disability|Neurodevelopmental delay|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder",single nucleotide variant,GRCh37
na,na,X,154031431,154031431,MECP2,Pathogenic,"Rett syndrome, zappella variant|Rett syndrome|not provided|X-linked intellectual disability-psychosis-macroorchidism syndrome|Angelman syndrome|not specified|Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases|Intellectual disability|Neurodevelopmental delay|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder",single nucleotide variant,GRCh38
na,na,X,153296815,153296815,MECP2,Likely pathogenic,Rett syndrome,single nucleotide variant,GRCh37
na,na,X,154031364,154031364,MECP2,Likely pathogenic,Rett syndrome,single nucleotide variant,GRCh38
na,na,X,153296806,153296806,MECP2,Pathogenic/Likely pathogenic,"Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Angelman syndrome|Autism, susceptibility to, X-linked 3|Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|X-linked intellectual disability-psychosis-macroorchidism syndrome|Abnormality of the nervous system|Neurodevelopmental delay|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder",single nucleotide variant,GRCh37
na,na,X,154031355,154031355,MECP2,Pathogenic/Likely pathogenic,"Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Angelman syndrome|Autism, susceptibility to, X-linked 3|Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|X-linked intellectual disability-psychosis-macroorchidism syndrome|Abnormality of the nervous system|Neurodevelopmental delay|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder",single nucleotide variant,GRCh38
na,na,X,153297719,153297719,MECP2,Pathogenic/Likely pathogenic,"Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|not specified|Autism, susceptibility to, X-linked 3|Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome|X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|MECP2-related disorder",single nucleotide variant,GRCh37
na,na,X,154032268,154032268,MECP2,Pathogenic/Likely pathogenic,"Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|not specified|Autism, susceptibility to, X-linked 3|Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome|X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|MECP2-related disorder",single nucleotide variant,GRCh38
na,na,X,153296471,153296471,MECP2,Pathogenic,"Rett syndrome|not provided|Encephalopathy, neonatal severeMental retardation, X-linked, syndromic 13Rett syndrome|Rett syndrome;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome;Severe neonatal-onset encephalopathy with microcephaly|Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|MECP2-related disorder",single nucleotide variant,GRCh37
na,na,X,154031020,154031020,MECP2,Pathogenic,"Rett syndrome|not provided|Encephalopathy, neonatal severeMental retardation, X-linked, syndromic 13Rett syndrome|Rett syndrome;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome;Severe neonatal-onset encephalopathy with microcephaly|Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|MECP2-related disorder",single nucleotide variant,GRCh38
na,na,X,153296099,153296099,MECP2,Pathogenic,X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome,single nucleotide variant,GRCh37
na,na,X,154030648,154030648,MECP2,Pathogenic,X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome,single nucleotide variant,GRCh38
na,na,X,153297867,153297868,MECP2,Pathogenic,Rett syndrome|Angelman syndrome,Deletion,GRCh37
na,na,X,154032416,154032417,MECP2,Pathogenic,Rett syndrome|Angelman syndrome,Deletion,GRCh38
na,na,X,153296399,153296399,MECP2,Pathogenic,"Rett syndrome|Autism, susceptibility to, X-linked 3|not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|See cases|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder",single nucleotide variant,GRCh37
na,na,X,154030948,154030948,MECP2,Pathogenic,"Rett syndrome|Autism, susceptibility to, X-linked 3|not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|See cases|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder",single nucleotide variant,GRCh38
na,na,X,153296860,153296860,MECP2,Pathogenic/Likely pathogenic,"X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|8 conditions|Severe neonatal-onset encephalopathy with microcephaly|not provided|Autism, susceptibility to, X-linked 3|Atypical behavior|Intellectual disability|Autism, susceptibility to, X-linked 3;Rett syndrome;Syndromic X-linked intellectual disability Lubs type;X-linked intellectual disability-psychosis-macroorchidism syndrome;Severe neonatal-onset encephalopathy with microcephaly|Neurodevelopmental disorder|Syndromic X-linked intellectual disability Lubs type|Inborn genetic diseases|MECP2-related disorder|Rett syndrome;X-linked intellectual disability-psychosis-macroorchidism syndrome",single nucleotide variant,GRCh37
na,na,X,154031409,154031409,MECP2,Pathogenic/Likely pathogenic,"X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|8 conditions|Severe neonatal-onset encephalopathy with microcephaly|not provided|Autism, susceptibility to, X-linked 3|Atypical behavior|Intellectual disability|Autism, susceptibility to, X-linked 3;Rett syndrome;Syndromic X-linked intellectual disability Lubs type;X-linked intellectual disability-psychosis-macroorchidism syndrome;Severe neonatal-onset encephalopathy with microcephaly|Neurodevelopmental disorder|Syndromic X-linked intellectual disability Lubs type|Inborn genetic diseases|MECP2-related disorder|Rett syndrome;X-linked intellectual disability-psychosis-macroorchidism syndrome",single nucleotide variant,GRCh38
na,na,X,153296363,153296363,MECP2,Pathogenic,"Rett syndrome|not provided|Angelman syndrome|Intellectual disability|Severe neonatal-onset encephalopathy with microcephaly|Autism, susceptibility to, X-linked 3|Inborn genetic diseases|Neurodevelopmental delay|Autism, susceptibility to, X-linked 3;Rett syndrome;Syndromic X-linked intellectual disability Lubs type;X-linked intellectual disability-psychosis-macroorchidism syndrome;Severe neonatal-onset encephalopathy with microcephaly|See cases|MECP2-related disorder",single nucleotide variant,GRCh37
na,na,X,154030912,154030912,MECP2,Pathogenic,"Rett syndrome|not provided|Angelman syndrome|Intellectual disability|Severe neonatal-onset encephalopathy with microcephaly|Autism, susceptibility to, X-linked 3|Inborn genetic diseases|Neurodevelopmental delay|Autism, susceptibility to, X-linked 3;Rett syndrome;Syndromic X-linked intellectual disability Lubs type;X-linked intellectual disability-psychosis-macroorchidism syndrome;Severe neonatal-onset encephalopathy with microcephaly|See cases|MECP2-related disorder",single nucleotide variant,GRCh38
na,na,X,153296869,153296869,MECP2,Pathogenic/Likely pathogenic,X-linked intellectual disability-psychosis-macroorchidism syndrome|Severe neonatal-onset encephalopathy with microcephaly|not provided,single nucleotide variant,GRCh37
na,na,X,154031418,154031418,MECP2,Pathogenic/Likely pathogenic,X-linked intellectual disability-psychosis-macroorchidism syndrome|Severe neonatal-onset encephalopathy with microcephaly|not provided,single nucleotide variant,GRCh38
na,na,X,153296777,153296777,MECP2,Pathogenic,Rett syndrome|not provided|Intellectual disability|Severe neonatal-onset encephalopathy with microcephaly|Global developmental delay;Developmental regression|Inborn genetic diseases|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder,single nucleotide variant,GRCh37
na,na,X,154031326,154031326,MECP2,Pathogenic,Rett syndrome|not provided|Intellectual disability|Severe neonatal-onset encephalopathy with microcephaly|Global developmental delay;Developmental regression|Inborn genetic diseases|Syndromic X-linked intellectual disability Lubs type|MECP2-related disorder,single nucleotide variant,GRCh38
na,na,X,153296516,153296516,MECP2,Pathogenic/Likely pathogenic,"Rett syndrome|not provided|X-linked intellectual disability-psychosis-macroorchidism syndrome|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|Abnormality of the nervous system|Neurodevelopmental delay|Syndromic X-linked intellectual disability Lubs type|Autism|MECP2-related disorder",single nucleotide variant,GRCh37
na,na,X,154031065,154031065,MECP2,Pathogenic/Likely pathogenic,"Rett syndrome|not provided|X-linked intellectual disability-psychosis-macroorchidism syndrome|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly;Syndromic X-linked intellectual disability Lubs type;Autism, susceptibility to, X-linked 3;X-linked intellectual disability-psychosis-macroorchidism syndrome|Inborn genetic diseases|Abnormality of the nervous system|Neurodevelopmental delay|Syndromic X-linked intellectual disability Lubs type|Autism|MECP2-related disorder",single nucleotide variant,GRCh38
na,na,X,153295997,153295997,MECP2,Benign,Severe neonatal-onset encephalopathy with microcephaly|not specified|not provided|MECP2-related disorder|Inborn genetic diseases|Rett syndrome,single nucleotide variant,GRCh37
na,na,X,154030546,154030546,MECP2,Benign,Severe neonatal-onset encephalopathy with microcephaly|not specified|not provided|MECP2-related disorder|Inborn genetic diseases|Rett syndrome,single nucleotide variant,GRCh38
na,na,X,153296856,153296856,MECP2,Pathogenic,Atypical Rett syndrome|Angelman syndrome|Rett syndrome|Inborn genetic diseases|Severe neonatal-onset encephalopathy with microcephaly|not provided,single nucleotide variant,GRCh37
na,na,X,154031405,154031405,MECP2,Pathogenic,Atypical Rett syndrome|Angelman syndrome|Rett syndrome|Inborn genetic diseases|Severe neonatal-onset encephalopathy with microcephaly|not provided,single nucleotide variant,GRCh38
na,na,X,153295916,153295916,MECP2,Pathogenic,Rett syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,154030465,154030465,MECP2,Pathogenic,Rett syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,153297737,153297737,MECP2,Pathogenic,Rett syndrome|not provided,single nucleotide variant,GRCh37
na,na,X,154032286,154032286,MECP2,Pathogenic,Rett syndrome|not provided,single nucleotide variant,GRCh38
na,na,X,153884414,154363935,MECP2,Pathogenic,Syndromic X-linked intellectual disability Lubs type,copy number gain,GRCh38
na,na,X,153296605,153296605,MECP2,Likely pathogenic,X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly,single nucleotide variant,GRCh37
na,na,X,154031154,154031154,MECP2,Likely pathogenic,X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly,single nucleotide variant,GRCh38
na,na,X,153296091,153296123,MECP2,Pathogenic,Severe neonatal-onset encephalopathy with microcephaly,Deletion,GRCh37
na,na,X,154030640,154030672,MECP2,Pathogenic,Severe neonatal-onset encephalopathy with microcephaly,Deletion,GRCh38
na,na,X,153296315,153296315,MECP2,Conflicting classifications of pathogenicity,X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly,single nucleotide variant,GRCh37
na,na,X,154030864,154030864,MECP2,Conflicting classifications of pathogenicity,X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly,single nucleotide variant,GRCh38
na,na,X,153296825,153296825,MECP2,Likely pathogenic,"Rett syndrome, zappella variant|X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|not provided|X-linked intellectual disability-psychosis-macroorchidism syndrome;Autism, susceptibility to, X-linked 3;Syndromic X-linked intellectual disability Lubs type;Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly|Severe neonatal-onset encephalopathy with microcephaly|MECP2-related disorder",single nucleotide variant,GRCh37
na,na,X,154031374,154031374,MECP2,Likely pathogenic,"Rett syndrome, zappella variant|X-linked intellectual disability-psychosis-macroorchidism syndrome|Rett syndrome|not provided|X-linked intellectual disability-psychosis-macroorchidism syndrome;Autism, susceptibility to, X-linked 3;Syndromic X-linked intellectual disability Lubs type;Rett syndrome;Severe neonatal-onset encephalopathy with microcephaly|Severe neonatal-onset encephalopathy with microcephaly|MECP2-related disorder",single nucleotide variant,GRCh38
na,na,X,153363118,153363118,MECP2,Pathogenic/Likely pathogenic,Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly,single nucleotide variant,GRCh37
na,na,X,154097661,154097661,MECP2,Pathogenic/Likely pathogenic,Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly,single nucleotide variant,GRCh38
na,na,X,153296569,153296569,MECP2,Pathogenic,Rett syndrome|not specified|Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases,Deletion,GRCh37
na,na,X,154031118,154031118,MECP2,Pathogenic,Rett syndrome|not specified|Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases,Deletion,GRCh38
na,na,11,76867115,76867115,MYO7A,Pathogenic,Usher syndrome type 1B|Usher syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 2,single nucleotide variant,GRCh37
na,na,11,77156069,77156069,MYO7A,Pathogenic,Usher syndrome type 1B|Usher syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 2,single nucleotide variant,GRCh38
na,na,11,76868015,76868015,MYO7A,Pathogenic,Usher syndrome type 1B|Rare genetic deafness|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome type 1|not provided|Autosomal recessive nonsyndromic hearing loss 2,single nucleotide variant,GRCh37
na,na,11,77156969,77156969,MYO7A,Pathogenic,Usher syndrome type 1B|Rare genetic deafness|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome type 1|not provided|Autosomal recessive nonsyndromic hearing loss 2,single nucleotide variant,GRCh38
na,na,11,76867962,76867967,MYO7A,Pathogenic,Usher syndrome type 1B,Deletion,GRCh37
na,na,11,77156916,77156921,MYO7A,Pathogenic,Usher syndrome type 1B,Deletion,GRCh38
na,na,11,76867950,76867950,MYO7A,Pathogenic/Likely pathogenic,Rare genetic deafness|Usher syndrome type 1B|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|not provided|Usher syndrome|Retinal dystrophy|Autosomal recessive nonsyndromic hearing loss 2,single nucleotide variant,GRCh37
na,na,11,77156904,77156904,MYO7A,Pathogenic/Likely pathogenic,Rare genetic deafness|Usher syndrome type 1B|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|not provided|Usher syndrome|Retinal dystrophy|Autosomal recessive nonsyndromic hearing loss 2,single nucleotide variant,GRCh38
na,na,11,76867949,76867949,MYO7A,Pathogenic/Likely pathogenic,Usher syndrome type 1B|not provided|Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1;Autosomal dominant nonsyndromic hearing loss 11,single nucleotide variant,GRCh37
na,na,11,77156903,77156903,MYO7A,Pathogenic/Likely pathogenic,Usher syndrome type 1B|not provided|Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1;Autosomal dominant nonsyndromic hearing loss 11,single nucleotide variant,GRCh38
na,na,11,76869378,76869378,MYO7A,Likely benign,Usher syndrome type 1B|not specified|Autosomal dominant nonsyndromic hearing loss 11|Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome type 1|Usher syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 2;Autosomal dominant nonsyndromic hearing loss 11;Usher syndrome type 1|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,11,77158332,77158332,MYO7A,Likely benign,Usher syndrome type 1B|not specified|Autosomal dominant nonsyndromic hearing loss 11|Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome type 1|Usher syndrome|not provided|Autosomal recessive nonsyndromic hearing loss 2;Autosomal dominant nonsyndromic hearing loss 11;Usher syndrome type 1|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,11,76868046,76868046,MYO7A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome,single nucleotide variant,GRCh37
na,na,11,77157000,77157000,MYO7A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome,single nucleotide variant,GRCh38
na,na,11,76900480,76900481,MYO7A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 2,Duplication,GRCh37
na,na,11,77189435,77189436,MYO7A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 2,Duplication,GRCh38
na,na,11,76877208,76877208,MYO7A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome type 1B,single nucleotide variant,GRCh37
na,na,11,77166162,77166162,MYO7A,Pathogenic,Autosomal recessive nonsyndromic hearing loss 2|Usher syndrome type 1B,single nucleotide variant,GRCh38
na,na,11,76891489,76891497,MYO7A,Pathogenic,Autosomal dominant nonsyndromic hearing loss 11,Deletion,GRCh37
na,na,11,77180443,77180451,MYO7A,Pathogenic,Autosomal dominant nonsyndromic hearing loss 11,Deletion,GRCh38
na,na,11,76883880,76883880,MYO7A,Pathogenic,Usher syndrome type 1B|not provided,single nucleotide variant,GRCh37
na,na,11,77172834,77172834,MYO7A,Pathogenic,Usher syndrome type 1B|not provided,single nucleotide variant,GRCh38
na,na,11,76853829,76853829,MYO7A,Pathogenic,"Usher syndrome type 1B|Rare genetic deafness|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|Retinitis pigmentosa|Hearing loss, autosomal recessive|not provided",single nucleotide variant,GRCh37
na,na,11,77142783,77142783,MYO7A,Pathogenic,"Usher syndrome type 1B|Rare genetic deafness|Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2|Retinitis pigmentosa|Hearing loss, autosomal recessive|not provided",single nucleotide variant,GRCh38
na,na,11,76885862,76885862,MYO7A,Pathogenic,Usher syndrome type 1B|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1|not provided|Autosomal recessive nonsyndromic hearing loss 2;Autosomal dominant nonsyndromic hearing loss 11;Usher syndrome type 1,single nucleotide variant,GRCh37
na,na,11,77174816,77174816,MYO7A,Pathogenic,Usher syndrome type 1B|Rare genetic deafness|Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1|not provided|Autosomal recessive nonsyndromic hearing loss 2;Autosomal dominant nonsyndromic hearing loss 11;Usher syndrome type 1,single nucleotide variant,GRCh38
na,na,na,-1,-1,MYO7A,Pathogenic,Usher syndrome type 1B,single nucleotide variant,na
na,na,11,76893620,76893620,MYO7A,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,11,77182575,77182575,MYO7A,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,11,76873195,76873195,MYO7A,Pathogenic,Autosomal dominant nonsyndromic hearing loss 11|not provided,single nucleotide variant,GRCh37
na,na,11,77162149,77162149,MYO7A,Pathogenic,Autosomal dominant nonsyndromic hearing loss 11|not provided,single nucleotide variant,GRCh38
na,na,11,76913443,76913445,MYO7A,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 2|Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1;Autosomal dominant nonsyndromic hearing loss 11|Usher syndrome,Microsatellite,GRCh37
na,na,11,77202398,77202400,MYO7A,Pathogenic/Likely pathogenic,Autosomal recessive nonsyndromic hearing loss 2|Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1;Autosomal dominant nonsyndromic hearing loss 11|Usher syndrome,Microsatellite,GRCh38
na,na,15,80445443,80445443,FAH,Pathogenic/Likely pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh37
na,na,15,80153101,80153101,FAH,Pathogenic/Likely pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh38
na,na,15,80454624,80454624,FAH,Pathogenic/Likely pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh37
na,na,15,80162282,80162282,FAH,Pathogenic/Likely pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh38
na,na,15,80473411,80473411,FAH,Pathogenic,Tyrosinemia type I|not provided,single nucleotide variant,GRCh37
na,na,15,80181069,80181069,FAH,Pathogenic,Tyrosinemia type I|not provided,single nucleotide variant,GRCh38
na,na,15,80472526,80472526,FAH,Benign/Likely benign; other,Fumarylacetoacetase pseudodeficiency|Tyrosinemia type I|not provided|not specified,single nucleotide variant,GRCh37
na,na,15,80180184,80180184,FAH,Benign/Likely benign; other,Fumarylacetoacetase pseudodeficiency|Tyrosinemia type I|not provided|not specified,single nucleotide variant,GRCh38
na,na,15,80472514,80472514,FAH,Pathogenic,Tyrosinemia type I|not provided,single nucleotide variant,GRCh37
na,na,15,80180172,80180172,FAH,Pathogenic,Tyrosinemia type I|not provided,single nucleotide variant,GRCh38
na,na,15,80472572,80472572,FAH,Pathogenic,Tyrosinemia type I|not provided|Tyrosinemia|FAH-related disorder,single nucleotide variant,GRCh37
na,na,15,80180230,80180230,FAH,Pathogenic,Tyrosinemia type I|not provided|Tyrosinemia|FAH-related disorder,single nucleotide variant,GRCh38
na,na,15,80473390,80473390,FAH,Pathogenic,Tyrosinemia type I|FAH-related disorder|not provided,single nucleotide variant,GRCh37
na,na,15,80181048,80181048,FAH,Pathogenic,Tyrosinemia type I|FAH-related disorder|not provided,single nucleotide variant,GRCh38
na,na,15,80473462,80473462,FAH,Pathogenic/Likely pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh37
na,na,15,80181120,80181120,FAH,Pathogenic/Likely pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh38
na,na,15,80465435,80465435,FAH,Pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh37
na,na,15,80173093,80173093,FAH,Pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh38
na,na,15,80460605,80460605,FAH,Pathogenic,Tyrosinemia type I|not provided|FAH-related disorder,single nucleotide variant,GRCh37
na,na,15,80168263,80168263,FAH,Pathogenic,Tyrosinemia type I|not provided|FAH-related disorder,single nucleotide variant,GRCh38
na,na,15,80465485,80465485,FAH,Pathogenic/Likely pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh37
na,na,15,80173143,80173143,FAH,Pathogenic/Likely pathogenic,Tyrosinemia type I,single nucleotide variant,GRCh38
na,na,7,142459789,142459789,PRSS1,Pathogenic,Hereditary pancreatitis|not provided|PRSS1-related disorder,single nucleotide variant,GRCh37
na,na,7,142751938,142751938,PRSS1,Pathogenic,Hereditary pancreatitis|not provided|PRSS1-related disorder,single nucleotide variant,GRCh38
na,na,7,142458451,142458451,PRSS1,Pathogenic,Hereditary pancreatitis|Trypsinogen deficiency;Hereditary pancreatitis|Vitamin D-dependent rickets type II with alopecia|Myoepithelial tumor|not provided|PRSS1-related disorder,single nucleotide variant,GRCh37
na,na,7,142750600,142750600,PRSS1,Pathogenic,Hereditary pancreatitis|Trypsinogen deficiency;Hereditary pancreatitis|Vitamin D-dependent rickets type II with alopecia|Myoepithelial tumor|not provided|PRSS1-related disorder,single nucleotide variant,GRCh38
na,na,7,142458433,142458433,PRSS1,Likely pathogenic,Hereditary pancreatitis,single nucleotide variant,GRCh37
na,na,7,142750582,142750582,PRSS1,Likely pathogenic,Hereditary pancreatitis,single nucleotide variant,GRCh38
na,na,7,142459659,142459659,PRSS1,Uncertain significance,not provided|Hereditary pancreatitis|not specified,single nucleotide variant,GRCh37
na,na,7,142751808,142751808,PRSS1,Uncertain significance,not provided|Hereditary pancreatitis|not specified,single nucleotide variant,GRCh38
na,na,7,142458526,142458526,PRSS1,Conflicting classifications of pathogenicity,Hereditary pancreatitis|not specified,single nucleotide variant,GRCh37
na,na,7,142750675,142750675,PRSS1,Conflicting classifications of pathogenicity,Hereditary pancreatitis|not specified,single nucleotide variant,GRCh38
na,na,7,142459789,142459790,PRSS1,Pathogenic,Hereditary pancreatitis,Indel,GRCh37
na,na,7,142751938,142751939,PRSS1,Pathogenic,Hereditary pancreatitis,Indel,GRCh38
na,na,7,142459788,142459788,PRSS1,Pathogenic,Hereditary pancreatitis|not provided|PRSS1-related disorder,single nucleotide variant,GRCh37
na,na,7,142751937,142751937,PRSS1,Pathogenic,Hereditary pancreatitis|not provided|PRSS1-related disorder,single nucleotide variant,GRCh38
na,na,na,-1,-1,PRSS1,Pathogenic,Hereditary pancreatitis,copy number gain,na
na,na,7,142459785,142459785,PRSS1,Uncertain significance,Hereditary pancreatitis|not provided|not specified,single nucleotide variant,GRCh37
na,na,7,142751934,142751934,PRSS1,Uncertain significance,Hereditary pancreatitis|not provided|not specified,single nucleotide variant,GRCh38
na,na,7,139717566,139717566,TBXAS1,Pathogenic,Ghosal hematodiaphyseal dysplasia,single nucleotide variant,GRCh37
na,na,7,140017766,140017766,TBXAS1,Pathogenic,Ghosal hematodiaphyseal dysplasia,single nucleotide variant,GRCh38
na,na,7,139611032,139611032,TBXAS1,Conflicting classifications of pathogenicity,not provided|Ghosal hematodiaphyseal dysplasia,single nucleotide variant,GRCh37
na,na,7,139911233,139911233,TBXAS1,Conflicting classifications of pathogenicity,not provided|Ghosal hematodiaphyseal dysplasia,single nucleotide variant,GRCh38
na,na,7,139717547,139717547,TBXAS1,Pathogenic,Ghosal hematodiaphyseal dysplasia,single nucleotide variant,GRCh37
na,na,7,140017747,140017747,TBXAS1,Pathogenic,Ghosal hematodiaphyseal dysplasia,single nucleotide variant,GRCh38
na,na,7,139715531,139715531,TBXAS1,Conflicting classifications of pathogenicity,Ghosal hematodiaphyseal dysplasia|not provided,single nucleotide variant,GRCh37
na,na,7,140015731,140015731,TBXAS1,Conflicting classifications of pathogenicity,Ghosal hematodiaphyseal dysplasia|not provided,single nucleotide variant,GRCh38
na,na,4,187208978,187208978,F11,Pathogenic,Hereditary factor XI deficiency disease|not provided|Plasma factor XI deficiency,single nucleotide variant,GRCh37
na,na,4,186287824,186287824,F11,Pathogenic,Hereditary factor XI deficiency disease|not provided|Plasma factor XI deficiency,single nucleotide variant,GRCh38
na,na,4,187195347,187195347,F11,Pathogenic,Hereditary factor XI deficiency disease|not provided|Abnormal bleeding;Thrombocytopenia|Inborn genetic diseases|Plasma factor XI deficiency|F11-related disorder,single nucleotide variant,GRCh37
na,na,4,186274193,186274193,F11,Pathogenic,Hereditary factor XI deficiency disease|not provided|Abnormal bleeding;Thrombocytopenia|Inborn genetic diseases|Plasma factor XI deficiency|F11-related disorder,single nucleotide variant,GRCh38
na,na,4,187201412,187201412,F11,Pathogenic,Hereditary factor XI deficiency disease|not provided|Factor XI|Plasma factor XI deficiency|F11-related disorder,single nucleotide variant,GRCh37
na,na,4,186280258,186280258,F11,Pathogenic,Hereditary factor XI deficiency disease|not provided|Factor XI|Plasma factor XI deficiency|F11-related disorder,single nucleotide variant,GRCh38
na,na,4,187201626,187201626,F11,Pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh37
na,na,4,186280472,186280472,F11,Pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh38
na,na,4,187195434,187195434,F11,Pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh37
na,na,4,186274280,186274280,F11,Pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh38
na,na,4,187206865,187206865,F11,Pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh37
na,na,4,186285711,186285711,F11,Pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh38
na,na,4,187195382,187195382,F11,Pathogenic/Likely pathogenic,not provided|Hereditary factor XI deficiency disease|Plasma factor XI deficiency,single nucleotide variant,GRCh37
na,na,4,186274228,186274228,F11,Pathogenic/Likely pathogenic,not provided|Hereditary factor XI deficiency disease|Plasma factor XI deficiency,single nucleotide variant,GRCh38
na,na,4,187205321,187205321,F11,Uncertain significance,Hereditary factor XI deficiency disease|not specified,single nucleotide variant,GRCh37
na,na,4,186284167,186284167,F11,Uncertain significance,Hereditary factor XI deficiency disease|not specified,single nucleotide variant,GRCh38
na,na,4,187201487,187201487,F11,Likely pathogenic,Hereditary factor XI deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,4,186280333,186280333,F11,Likely pathogenic,Hereditary factor XI deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,4,187205399,187205399,F11,Uncertain significance,Hereditary factor XI deficiency disease|not specified,single nucleotide variant,GRCh37
na,na,4,186284245,186284245,F11,Uncertain significance,Hereditary factor XI deficiency disease|not specified,single nucleotide variant,GRCh38
na,na,4,187209672,187209672,F11,Pathogenic/Likely pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh37
na,na,4,186288518,186288518,F11,Pathogenic/Likely pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh38
na,na,4,187192873,187192873,F11,Pathogenic/Likely pathogenic,Hereditary factor XI deficiency disease|not provided|Factor XI deficiency|Plasma factor XI deficiency,single nucleotide variant,GRCh37
na,na,4,186271719,186271719,F11,Pathogenic/Likely pathogenic,Hereditary factor XI deficiency disease|not provided|Factor XI deficiency|Plasma factor XI deficiency,single nucleotide variant,GRCh38
na,na,4,187201219,187201219,F11,Conflicting classifications of pathogenicity,Hereditary factor XI deficiency disease|not provided,single nucleotide variant,GRCh37
na,na,4,186280065,186280065,F11,Conflicting classifications of pathogenicity,Hereditary factor XI deficiency disease|not provided,single nucleotide variant,GRCh38
na,na,4,187205363,187205363,F11,Likely pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh37
na,na,4,186284209,186284209,F11,Likely pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh38
na,na,4,187209650,187209650,F11,Pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh37
na,na,4,186288496,186288496,F11,Pathogenic,Hereditary factor XI deficiency disease,single nucleotide variant,GRCh38
na,na,4,186261554,186293752,F11,Pathogenic,Hereditary factor XI deficiency disease,Deletion,GRCh38
na,na,3,124454069,124454069,UMPS,Likely benign,not provided,single nucleotide variant,GRCh37
na,na,3,124735222,124735222,UMPS,Likely benign,not provided,single nucleotide variant,GRCh38
na,na,3,124456430,124456430,UMPS,Pathogenic,Oroticaciduria,single nucleotide variant,GRCh37
na,na,3,124737583,124737583,UMPS,Pathogenic,Oroticaciduria,single nucleotide variant,GRCh38
na,na,4,996535,996535,IDUA,Pathogenic,"Hurler syndrome|not provided|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S|Mucopolysaccharidosis, MPS-I-H/S|See cases|Inborn genetic diseases|IDUA-related disorder|Hurler syndrome;Mucopolysaccharidosis type 1",single nucleotide variant,GRCh37
na,na,4,1002747,1002747,IDUA,Pathogenic,"Hurler syndrome|not provided|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S|Mucopolysaccharidosis, MPS-I-H/S|See cases|Inborn genetic diseases|IDUA-related disorder|Hurler syndrome;Mucopolysaccharidosis type 1",single nucleotide variant,GRCh38
na,na,4,981646,981646,IDUA;SLC26A1,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis, MPS-I-S|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S|not provided|Interstitial pneumonitis|IDUA-related disorder|Mucopolysaccharidosis",single nucleotide variant,GRCh37
na,na,4,987858,987858,IDUA;SLC26A1,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis, MPS-I-S|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S|not provided|Interstitial pneumonitis|IDUA-related disorder|Mucopolysaccharidosis",single nucleotide variant,GRCh38
na,na,4,997206,997206,IDUA,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis type 1|not provided|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S|Inborn genetic diseases|Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh37
na,na,4,1003418,1003418,IDUA,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis type 1|not provided|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S|Inborn genetic diseases|Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh38
na,na,4,996555,996555,IDUA,Conflicting classifications of pathogenicity,not specified|Mucopolysaccharidosis type 1|not provided|Hurler syndrome,single nucleotide variant,GRCh37
na,na,4,1002767,1002767,IDUA,Conflicting classifications of pathogenicity,not specified|Mucopolysaccharidosis type 1|not provided|Hurler syndrome,single nucleotide variant,GRCh38
na,na,4,981630,981630,IDUA,Pathogenic,Hurler syndrome|not provided|Mucopolysaccharidosis type 1,single nucleotide variant,GRCh37
na,na,4,987842,987842,IDUA,Pathogenic,Hurler syndrome|not provided|Mucopolysaccharidosis type 1,single nucleotide variant,GRCh38
na,na,4,995905,995905,IDUA,Likely pathogenic,Hurler syndrome|Mucopolysaccharidosis type 1,single nucleotide variant,GRCh37
na,na,4,1002117,1002117,IDUA,Likely pathogenic,Hurler syndrome|Mucopolysaccharidosis type 1,single nucleotide variant,GRCh38
na,na,4,996180,996180,IDUA,Pathogenic,Hurler syndrome,single nucleotide variant,GRCh37
na,na,4,1002392,1002392,IDUA,Pathogenic,Hurler syndrome,single nucleotide variant,GRCh38
na,na,4,998080,998080,IDUA,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis type 1|not provided|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh37
na,na,4,1004292,1004292,IDUA,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis type 1|not provided|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh38
na,na,4,996896,996896,IDUA,Likely pathogenic,"Mucopolysaccharidosis, MPS-I-S|Mucopolysaccharidosis type 1|not provided|Mucopolysaccharidosis, MPS-I-S;Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S",single nucleotide variant,GRCh37
na,na,4,1003108,1003108,IDUA,Likely pathogenic,"Mucopolysaccharidosis, MPS-I-S|Mucopolysaccharidosis type 1|not provided|Mucopolysaccharidosis, MPS-I-S;Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S",single nucleotide variant,GRCh38
na,na,4,996890,996890,IDUA,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|not provided|Mucopolysaccharidosis type 1",single nucleotide variant,GRCh37
na,na,4,1003102,1003102,IDUA,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|not provided|Mucopolysaccharidosis type 1",single nucleotide variant,GRCh38
na,na,4,998179,998179,IDUA,Likely pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1",single nucleotide variant,GRCh37
na,na,4,1004391,1004391,IDUA,Likely pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1",single nucleotide variant,GRCh38
na,na,4,995488,995489,IDUA,Pathogenic,Hurler syndrome|Mucopolysaccharidosis type 1,Duplication,GRCh37
na,na,4,1001700,1001701,IDUA,Pathogenic,Hurler syndrome|Mucopolysaccharidosis type 1,Duplication,GRCh38
na,na,4,981704,981704,IDUA,Pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh37
na,na,4,987916,987916,IDUA,Pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh38
na,na,4,995875,995875,IDUA,Conflicting classifications of pathogenicity,IDUA PSEUDODEFICIENCY|Hurler syndrome|Mucopolysaccharidosis type 1|not provided,single nucleotide variant,GRCh37
na,na,4,1002087,1002087,IDUA,Conflicting classifications of pathogenicity,IDUA PSEUDODEFICIENCY|Hurler syndrome|Mucopolysaccharidosis type 1|not provided,single nucleotide variant,GRCh38
na,na,4,998074,998074,IDUA,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1|Hurler syndrome",single nucleotide variant,GRCh37
na,na,4,1004286,1004286,IDUA,Pathogenic/Likely pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1|Hurler syndrome",single nucleotide variant,GRCh38
na,na,4,996175,996175,IDUA,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1|not provided|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh37
na,na,4,1002387,1002387,IDUA,Pathogenic,"Hurler syndrome|Mucopolysaccharidosis, MPS-I-H/S|Mucopolysaccharidosis type 1|not provided|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh38
na,na,4,996121,996121,IDUA,Pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh37
na,na,4,1002333,1002333,IDUA,Pathogenic,"Mucopolysaccharidosis, MPS-I-H/S|Hurler syndrome|Mucopolysaccharidosis type 1|Hurler syndrome;Mucopolysaccharidosis, MPS-I-H/S;Mucopolysaccharidosis, MPS-I-S",single nucleotide variant,GRCh38
na,na,12,110032849,110032849,MVK,Pathogenic,Mevalonic aciduria,single nucleotide variant,GRCh37
na,na,12,109595044,109595044,MVK,Pathogenic,Mevalonic aciduria,single nucleotide variant,GRCh38
na,na,12,110034320,110034320,MVK,Pathogenic/Likely pathogenic,"Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria|not provided|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria|MVK-related disorder|not specified|Porokeratosis 3, disseminated superficial actinic type|Autoinflammatory syndrome|Inborn genetic diseases|Mevalonic aciduria|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,12,109596515,109596515,MVK,Pathogenic/Likely pathogenic,"Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria|not provided|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria|MVK-related disorder|not specified|Porokeratosis 3, disseminated superficial actinic type|Autoinflammatory syndrome|Inborn genetic diseases|Mevalonic aciduria|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,12,110032947,110032947,MVK,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever|not provided|Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,12,109595142,109595142,MVK,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever|not provided|Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,12,110012686,110012686,MVK,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not provided|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria",single nucleotide variant,GRCh37
na,na,12,109574881,109574881,MVK,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not provided|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria",single nucleotide variant,GRCh38
na,na,12,110029080,110029080,MVK,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria|not provided|not specified|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria|Autoinflammatory syndrome|MVK-related disorder|Inborn genetic diseases|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,12,109591275,109591275,MVK,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria|not provided|not specified|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria|Autoinflammatory syndrome|MVK-related disorder|Inborn genetic diseases|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,12,110019322,110019322,MVK,Likely pathogenic,"Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever",single nucleotide variant,GRCh37
na,na,12,109581517,109581517,MVK,Likely pathogenic,"Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever",single nucleotide variant,GRCh38
na,na,12,110032875,110032875,MVK,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not provided|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever|Autoinflammatory syndrome",single nucleotide variant,GRCh37
na,na,12,109595070,109595070,MVK,Pathogenic,"Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|not provided|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever|Autoinflammatory syndrome",single nucleotide variant,GRCh38
na,na,12,110012643,110012661,MVK,Pathogenic,Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever,Deletion,GRCh37
na,na,12,109574838,109574856,MVK,Pathogenic,Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever,Deletion,GRCh38
na,na,6,80878662,80878662,BCKDHB,Pathogenic/Likely pathogenic,Maple syrup urine disease|not provided|Maple syrup urine disease type 1B|Inborn genetic diseases|Maple syrup urine disease type 1A,single nucleotide variant,GRCh37
na,na,6,80168945,80168945,BCKDHB,Pathogenic/Likely pathogenic,Maple syrup urine disease|not provided|Maple syrup urine disease type 1B|Inborn genetic diseases|Maple syrup urine disease type 1A,single nucleotide variant,GRCh38
na,na,6,80878730,80878730,BCKDHB,Likely pathogenic,Maple syrup urine disease type 1B|Maple syrup urine disease,single nucleotide variant,GRCh37
na,na,6,80169013,80169013,BCKDHB,Likely pathogenic,Maple syrup urine disease type 1B|Maple syrup urine disease,single nucleotide variant,GRCh38
na,na,6,80877407,80877407,BCKDHB,Pathogenic,Maple syrup urine disease type 1B,single nucleotide variant,GRCh37
na,na,6,80167690,80167690,BCKDHB,Pathogenic,Maple syrup urine disease type 1B,single nucleotide variant,GRCh38
na,na,6,81053370,81053373,BCKDHB,Likely pathogenic,Maple syrup urine disease|Maple syrup urine disease type 1B,Microsatellite,GRCh37
na,na,6,80343653,80343656,BCKDHB,Likely pathogenic,Maple syrup urine disease|Maple syrup urine disease type 1B,Microsatellite,GRCh38
na,na,na,-1,-1,BCKDHB,Pathogenic,Maple syrup urine disease type 1B,Insertion,na
na,na,na,-1,-1,DBT,Pathogenic,Maple syrup urine disease type 2,Deletion,na
na,na,1,100680485,100680485,DBT,Pathogenic/Likely pathogenic,not provided|Maple syrup urine disease|See cases|Maple syrup urine disease type 2|Maple syrup urine disease type 1A,single nucleotide variant,GRCh37
na,na,1,100214929,100214929,DBT,Pathogenic/Likely pathogenic,not provided|Maple syrup urine disease|See cases|Maple syrup urine disease type 2|Maple syrup urine disease type 1A,single nucleotide variant,GRCh38
na,na,na,-1,-1,DBT,Pathogenic,Maple syrup urine disease type 2,Insertion,na
na,na,1,100676249,100676249,DBT,Pathogenic,Maple syrup urine disease type 2,Deletion,GRCh37
na,na,1,100210693,100210693,DBT,Pathogenic,Maple syrup urine disease type 2,Deletion,GRCh38
na,na,1,100672742,100672742,DBT,Pathogenic/Likely pathogenic,Maple syrup urine disease|DBT-related disorder|Maple syrup urine disease type 2|Maple syrup urine disease type 1A,single nucleotide variant,GRCh37
na,na,1,100207186,100207186,DBT,Pathogenic/Likely pathogenic,Maple syrup urine disease|DBT-related disorder|Maple syrup urine disease type 2|Maple syrup urine disease type 1A,single nucleotide variant,GRCh38
na,na,1,100661812,100661812,DBT,Pathogenic,Maple syrup urine disease type 2,single nucleotide variant,GRCh37
na,na,1,100196256,100196256,DBT,Pathogenic,Maple syrup urine disease type 2,single nucleotide variant,GRCh38
na,na,1,100696428,100696428,DBT,Pathogenic,Maple syrup urine disease type 2,single nucleotide variant,GRCh37
na,na,1,100230872,100230872,DBT,Pathogenic,Maple syrup urine disease type 2,single nucleotide variant,GRCh38
na,na,1,100672060,100672060,DBT,Benign,Maple syrup urine disease|Maple syrup urine disease type 2,single nucleotide variant,GRCh37
na,na,1,100206504,100206504,DBT,Benign,Maple syrup urine disease|Maple syrup urine disease type 2,single nucleotide variant,GRCh38
na,na,1,100706416,100706417,DBT,Pathogenic,Maple syrup urine disease type 2|Maple syrup urine disease|Maple syrup urine disease type 1A|not provided,Deletion,GRCh37
na,na,1,100240860,100240861,DBT,Pathogenic,Maple syrup urine disease type 2|Maple syrup urine disease|Maple syrup urine disease type 1A|not provided,Deletion,GRCh38
na,na,1,100661376,100666120,DBT,Pathogenic,Maple syrup urine disease type 2,Deletion,GRCh37
na,na,1,100195820,100200564,DBT,Pathogenic,Maple syrup urine disease type 2,Deletion,GRCh38
na,na,1,100661905,100661905,DBT,Pathogenic,Maple syrup urine disease type 2,single nucleotide variant,GRCh37
na,na,1,100196349,100196349,DBT,Pathogenic,Maple syrup urine disease type 2,single nucleotide variant,GRCh38
na,na,1,100681730,100681730,DBT,Pathogenic,Maple syrup urine disease type 2,single nucleotide variant,GRCh37
na,na,1,100216174,100216174,DBT,Pathogenic,Maple syrup urine disease type 2,single nucleotide variant,GRCh38
na,na,1,24144011,24144012,HMGCL,Pathogenic,Deficiency of hydroxymethylglutaryl-CoA lyase|not provided,Microsatellite,GRCh37
na,na,1,23817521,23817522,HMGCL,Pathogenic,Deficiency of hydroxymethylglutaryl-CoA lyase|not provided,Microsatellite,GRCh38
na,na,1,24144010,24144010,HMGCL,Uncertain significance,Deficiency of hydroxymethylglutaryl-CoA lyase|not provided,single nucleotide variant,GRCh37
na,na,1,23817520,23817520,HMGCL,Uncertain significance,Deficiency of hydroxymethylglutaryl-CoA lyase|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,HMGCL,Pathogenic,Deficiency of hydroxymethylglutaryl-CoA lyase,Deletion,na
na,na,1,24147022,24147022,HMGCL,Pathogenic,Deficiency of hydroxymethylglutaryl-CoA lyase|not provided|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,1,23820532,23820532,HMGCL,Pathogenic,Deficiency of hydroxymethylglutaryl-CoA lyase|not provided|Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,1,24130931,24130931,HMGCL,Pathogenic,Deficiency of hydroxymethylglutaryl-CoA lyase,single nucleotide variant,GRCh37
na,na,1,23804441,23804441,HMGCL,Pathogenic,Deficiency of hydroxymethylglutaryl-CoA lyase,single nucleotide variant,GRCh38
na,na,9,103046624,103046624,INVS,Pathogenic/Likely pathogenic,Infantile nephronophthisis|not provided|Nephronophthisis,single nucleotide variant,GRCh37
na,na,9,100284342,100284342,INVS,Pathogenic/Likely pathogenic,Infantile nephronophthisis|not provided|Nephronophthisis,single nucleotide variant,GRCh38
na,na,9,103027117,103027117,INVS,Uncertain significance,Infantile nephronophthisis|Nephronophthisis|not specified,single nucleotide variant,GRCh37
na,na,9,100264835,100264835,INVS,Uncertain significance,Infantile nephronophthisis|Nephronophthisis|not specified,single nucleotide variant,GRCh38
na,na,9,103055258,103055258,INVS,Pathogenic,Infantile nephronophthisis|Nephronophthisis|INVS-related disorder,single nucleotide variant,GRCh37
na,na,9,100292976,100292976,INVS,Pathogenic,Infantile nephronophthisis|Nephronophthisis|INVS-related disorder,single nucleotide variant,GRCh38
na,na,9,103055234,103055234,INVS,Pathogenic/Likely pathogenic,Infantile nephronophthisis|Nephronophthisis|not provided|INVS-related disorder,single nucleotide variant,GRCh37
na,na,9,100292952,100292952,INVS,Pathogenic/Likely pathogenic,Infantile nephronophthisis|Nephronophthisis|not provided|INVS-related disorder,single nucleotide variant,GRCh38
na,na,9,103015407,103015407,INVS,Pathogenic,Infantile nephronophthisis|Nephronophthisis|not provided|INVS-related disorder,Deletion,GRCh37
na,na,9,100253125,100253125,INVS,Pathogenic,Infantile nephronophthisis|Nephronophthisis|not provided|INVS-related disorder,Deletion,GRCh38
na,na,7,107542785,107542785,DLD,Pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh37
na,na,7,107902340,107902340,DLD,Pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh38
na,na,7,107559543,107559543,DLD,Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh37
na,na,7,107919098,107919098,DLD,Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh38
na,na,7,107555951,107555951,DLD,Pathogenic,Pyruvate dehydrogenase E3 deficiency|not provided|Inborn genetic diseases|DLD-related disorder,single nucleotide variant,GRCh37
na,na,7,107915506,107915506,DLD,Pathogenic,Pyruvate dehydrogenase E3 deficiency|not provided|Inborn genetic diseases|DLD-related disorder,single nucleotide variant,GRCh38
na,na,7,107559657,107559657,DLD,Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh37
na,na,7,107919212,107919212,DLD,Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh38
na,na,7,107557849,107557849,DLD,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh37
na,na,7,107917404,107917404,DLD,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh38
na,na,7,107556142,107556142,DLD,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh37
na,na,7,107915697,107915697,DLD,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh38
na,na,7,107557794,107557794,DLD,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E3 deficiency|not provided|Inborn genetic diseases|See cases|DLD-related disorder,single nucleotide variant,GRCh37
na,na,7,107917349,107917349,DLD,Pathogenic/Likely pathogenic,Pyruvate dehydrogenase E3 deficiency|not provided|Inborn genetic diseases|See cases|DLD-related disorder,single nucleotide variant,GRCh38
na,na,7,107557752,107557752,DLD,Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh37
na,na,7,107917307,107917307,DLD,Likely pathogenic,Pyruvate dehydrogenase E3 deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,GCSH,Uncertain significance,Glycine encephalopathy,Complex,na
na,na,3,49456475,49456475,AMT,Conflicting classifications of pathogenicity,Glycine encephalopathy|Glycine encephalopathy 2,single nucleotide variant,GRCh37
na,na,3,49419042,49419042,AMT,Conflicting classifications of pathogenicity,Glycine encephalopathy|Glycine encephalopathy 2,single nucleotide variant,GRCh38
na,na,3,49459656,49459656,AMT,Conflicting classifications of pathogenicity,Glycine encephalopathy|Inborn genetic diseases|Glycine encephalopathy 2|Glycine encephalopathy 1,single nucleotide variant,GRCh37
na,na,3,49422223,49422223,AMT,Conflicting classifications of pathogenicity,Glycine encephalopathy|Inborn genetic diseases|Glycine encephalopathy 2|Glycine encephalopathy 1,single nucleotide variant,GRCh38
na,na,3,49459670,49459670,AMT,Pathogenic/Likely pathogenic,Glycine encephalopathy|Glycine encephalopathy 1|Glycine encephalopathy 2,single nucleotide variant,GRCh37
na,na,3,49422237,49422237,AMT,Pathogenic/Likely pathogenic,Glycine encephalopathy|Glycine encephalopathy 1|Glycine encephalopathy 2,single nucleotide variant,GRCh38
na,na,3,49456455,49456455,AMT,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|Glycine encephalopathy 1,single nucleotide variant,GRCh37
na,na,3,49419022,49419022,AMT,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|Glycine encephalopathy 1,single nucleotide variant,GRCh38
na,na,3,49455325,49455325,AMT,Pathogenic,Glycine encephalopathy|not provided|Glycine encephalopathy 2|Glycine encephalopathy 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,3,49417892,49417892,AMT,Pathogenic,Glycine encephalopathy|not provided|Glycine encephalopathy 2|Glycine encephalopathy 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,3,49456815,49456815,AMT,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|Glycine encephalopathy 1,single nucleotide variant,GRCh37
na,na,3,49419382,49419382,AMT,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|Glycine encephalopathy 1,single nucleotide variant,GRCh38
na,na,3,49455407,49455407,AMT,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|not provided|Glycine encephalopathy 1,single nucleotide variant,GRCh37
na,na,3,49417974,49417974,AMT,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 2|not provided|Glycine encephalopathy 1,single nucleotide variant,GRCh38
na,na,9,6588417,6588417,GLDC,Pathogenic/Likely pathogenic,Glycine encephalopathy|Glycine encephalopathy 1,single nucleotide variant,GRCh37
na,na,9,6588417,6588417,GLDC,Pathogenic/Likely pathogenic,Glycine encephalopathy|Glycine encephalopathy 1,single nucleotide variant,GRCh38
na,na,9,6620184,6645307,GLDC,Pathogenic,Glycine encephalopathy 1,Deletion,GRCh37
na,na,9,6589230,6589230,GLDC,Pathogenic,Glycine encephalopathy|Generalized epilepsy;Obesity;Global developmental delay|Glycine encephalopathy 1|GLDC-related disorder|not provided,single nucleotide variant,GRCh37
na,na,9,6589230,6589230,GLDC,Pathogenic,Glycine encephalopathy|Generalized epilepsy;Obesity;Global developmental delay|Glycine encephalopathy 1|GLDC-related disorder|not provided,single nucleotide variant,GRCh38
na,na,9,6554703,6554703,GLDC,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 1,single nucleotide variant,GRCh37
na,na,9,6554703,6554703,GLDC,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 1,single nucleotide variant,GRCh38
na,na,9,6553420,6553420,GLDC,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 1|not provided,single nucleotide variant,GRCh37
na,na,9,6553420,6553420,GLDC,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 1|not provided,single nucleotide variant,GRCh38
na,na,9,6645498,6645498,GLDC,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 1,single nucleotide variant,GRCh37
na,na,9,6645498,6645498,GLDC,Pathogenic,Glycine encephalopathy|Glycine encephalopathy 1,single nucleotide variant,GRCh38
na,na,9,6595109,6595109,GLDC,Pathogenic,Glycine encephalopathy|not provided|Glycine encephalopathy 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,9,6595109,6595109,GLDC,Pathogenic,Glycine encephalopathy|not provided|Glycine encephalopathy 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,9,6554768,6554768,GLDC,Pathogenic/Likely pathogenic,Glycine encephalopathy|not provided|Glycine encephalopathy 1,single nucleotide variant,GRCh37
na,na,9,6554768,6554768,GLDC,Pathogenic/Likely pathogenic,Glycine encephalopathy|not provided|Glycine encephalopathy 1,single nucleotide variant,GRCh38
na,na,14,51378873,51378873,PYGL,Pathogenic,"Glycogen storage disease, type VI",single nucleotide variant,GRCh37
na,na,14,50912155,50912155,PYGL,Pathogenic,"Glycogen storage disease, type VI",single nucleotide variant,GRCh38
na,na,14,51390819,51390819,PYGL,Pathogenic,"Glycogen storage disease, type VI",single nucleotide variant,GRCh37
na,na,14,50924101,50924101,PYGL,Pathogenic,"Glycogen storage disease, type VI",single nucleotide variant,GRCh38
na,na,14,51387782,51387782,PYGL,Benign,"not specified|Glycogen storage disease, type VI|not provided",single nucleotide variant,GRCh37
na,na,14,50921064,50921064,PYGL,Benign,"not specified|Glycogen storage disease, type VI|not provided",single nucleotide variant,GRCh38
na,na,14,51382651,51382651,PYGL,Pathogenic,"Glycogen storage disease, type VI",single nucleotide variant,GRCh37
na,na,14,50915933,50915933,PYGL,Pathogenic,"Glycogen storage disease, type VI",single nucleotide variant,GRCh38
na,na,14,51379746,51379746,PYGL,Pathogenic/Likely pathogenic,"Glycogen storage disease, type VI",single nucleotide variant,GRCh37
na,na,14,50913028,50913028,PYGL,Pathogenic/Likely pathogenic,"Glycogen storage disease, type VI",single nucleotide variant,GRCh38
na,na,17,41059575,41059576,G6PC1,Pathogenic,"Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease, type I",Microsatellite,GRCh37
na,na,17,42907558,42907559,G6PC1,Pathogenic,"Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease, type I",Microsatellite,GRCh38
na,na,17,41055964,41055964,G6PC1,Pathogenic,"Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease|Hypoglycemia;Short stature|not specified|Glycogen storage disease, type I",single nucleotide variant,GRCh37
na,na,17,42903947,42903947,G6PC1,Pathogenic,"Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease|Hypoglycemia;Short stature|not specified|Glycogen storage disease, type I",single nucleotide variant,GRCh38
na,na,17,41063252,41063252,G6PC1,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,single nucleotide variant,GRCh37
na,na,17,42911235,42911235,G6PC1,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,single nucleotide variant,GRCh38
na,na,17,41063408,41063408,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease|G6PC1-related disorder|not specified,single nucleotide variant,GRCh37
na,na,17,42911391,42911391,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease|G6PC1-related disorder|not specified,single nucleotide variant,GRCh38
na,na,17,41053122,41053122,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh37
na,na,17,42901105,42901105,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh38
na,na,17,41053127,41053127,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh37
na,na,17,42901110,42901110,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh38
na,na,17,41063017,41063017,G6PC1,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,single nucleotide variant,GRCh37
na,na,17,42911000,42911000,G6PC1,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,single nucleotide variant,GRCh38
na,na,17,41053006,41053006,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not specified|not provided,single nucleotide variant,GRCh37
na,na,17,42900989,42900989,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not specified|not provided,single nucleotide variant,GRCh38
na,na,17,41056045,41056045,G6PC1,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,single nucleotide variant,GRCh37
na,na,17,42904028,42904028,G6PC1,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,single nucleotide variant,GRCh38
na,na,17,41059569,41059569,G6PC1,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh37
na,na,17,42907552,42907552,G6PC1,Pathogenic/Likely pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh38
na,na,17,41061424,41061424,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh37
na,na,17,42909407,42909407,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh38
na,na,17,41061435,41061435,G6PC1,Pathogenic,"Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease, type I",single nucleotide variant,GRCh37
na,na,17,42909418,42909418,G6PC1,Pathogenic,"Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided|Glycogen storage disease, type I",single nucleotide variant,GRCh38
na,na,17,41055965,41055965,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,single nucleotide variant,GRCh37
na,na,17,42903948,42903948,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|not provided,single nucleotide variant,GRCh38
na,na,17,41061370,41061370,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh37
na,na,17,42909353,42909353,G6PC1,Pathogenic,Glycogen storage disease due to glucose-6-phosphatase deficiency type IA,single nucleotide variant,GRCh38
na,na,3,136046026,136046026,PCCB,Pathogenic/Likely pathogenic,Propionic acidemia|not provided,single nucleotide variant,GRCh37
na,na,3,136327184,136327184,PCCB,Pathogenic/Likely pathogenic,Propionic acidemia|not provided,single nucleotide variant,GRCh38
na,na,3,136046099,136046106,PCCB,Pathogenic,Propionic acidemia,Deletion,GRCh37
na,na,3,136327257,136327264,PCCB,Pathogenic,Propionic acidemia,Deletion,GRCh38
na,na,3,136045723,136045724,PCCB,Pathogenic,Propionic acidemia|not provided,Duplication,GRCh37
na,na,3,136326881,136326882,PCCB,Pathogenic,Propionic acidemia|not provided,Duplication,GRCh38
na,na,3,135980866,135980866,PCCB,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh37
na,na,3,136262024,136262024,PCCB,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh38
na,na,3,136046081,136046081,PCCB,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh37
na,na,3,136327239,136327239,PCCB,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh38
na,na,3,136048785,136048786,PCCB,Pathogenic,Propionic acidemia,Duplication,GRCh37
na,na,3,136329943,136329944,PCCB,Pathogenic,Propionic acidemia,Duplication,GRCh38
na,na,3,136046480,136046480,PCCB,Pathogenic/Likely pathogenic,Propionic acidemia,single nucleotide variant,GRCh37
na,na,3,136327638,136327638,PCCB,Pathogenic/Likely pathogenic,Propionic acidemia,single nucleotide variant,GRCh38
na,na,3,136003251,136003251,PCCB,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh37
na,na,3,136284409,136284409,PCCB,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh38
na,na,13,101101501,101101509,PCCA,Pathogenic,Propionic acidemia,Deletion,GRCh37
na,na,13,100449247,100449255,PCCA,Pathogenic,Propionic acidemia,Deletion,GRCh38
na,na,13,100920985,100920985,PCCA,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh37
na,na,13,100268731,100268731,PCCA,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh38
na,na,13,100953766,100953766,PCCA,Pathogenic/Likely pathogenic,Propionic acidemia,single nucleotide variant,GRCh37
na,na,13,100301512,100301512,PCCA,Pathogenic/Likely pathogenic,Propionic acidemia,single nucleotide variant,GRCh38
na,na,13,100958030,100958030,PCCA,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh37
na,na,13,100305776,100305776,PCCA,Pathogenic,Propionic acidemia,single nucleotide variant,GRCh38
na,na,4,159593610,159593610,ETFDH,Pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,4,158672458,158672458,ETFDH,Pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,4,159601620,159601620,ETFDH,Pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,Deletion,GRCh37
na,na,4,158680468,158680468,ETFDH,Pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,Deletion,GRCh38
na,na,4,159603421,159603421,ETFDH,Pathogenic,Multiple acyl-CoA dehydrogenase deficiency|Glutaric acidemia IIc|not provided|See cases,single nucleotide variant,GRCh37
na,na,4,158682269,158682269,ETFDH,Pathogenic,Multiple acyl-CoA dehydrogenase deficiency|Glutaric acidemia IIc|not provided|See cases,single nucleotide variant,GRCh38
na,na,4,159606289,159606289,ETFDH,Pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,4,158685137,158685137,ETFDH,Pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,4,159603551,159603551,ETFDH,Pathogenic/Likely pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,4,158682399,158682399,ETFDH,Pathogenic/Likely pathogenic,Glutaric acidemia IIc|Multiple acyl-CoA dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,2,27315225,27315225,KHK,Uncertain significance,Essential fructosuria,single nucleotide variant,GRCh37
na,na,2,27092357,27092357,KHK,Uncertain significance,Essential fructosuria,single nucleotide variant,GRCh38
na,na,2,27315234,27315234,KHK,Pathogenic,Essential fructosuria,single nucleotide variant,GRCh37
na,na,2,27092366,27092366,KHK,Pathogenic,Essential fructosuria,single nucleotide variant,GRCh38
na,na,4,187157943,187157943,KLKB1,Pathogenic,Prekallikrein deficiency,single nucleotide variant,GRCh37
na,na,4,186236789,186236789,KLKB1,Pathogenic,Prekallikrein deficiency,single nucleotide variant,GRCh38
na,na,4,187173231,187173231,KLKB1,Pathogenic,Prekallikrein deficiency,single nucleotide variant,GRCh37
na,na,4,186252077,186252077,KLKB1,Pathogenic,Prekallikrein deficiency,single nucleotide variant,GRCh38
na,na,4,187178437,187178437,KLKB1,Conflicting classifications of pathogenicity,Prekallikrein deficiency|not provided|Inherited prekallikrein deficiency,single nucleotide variant,GRCh37
na,na,4,186257283,186257283,KLKB1,Conflicting classifications of pathogenicity,Prekallikrein deficiency|not provided|Inherited prekallikrein deficiency,single nucleotide variant,GRCh38
na,na,4,187157973,187157973,KLKB1,Pathogenic,Prekallikrein deficiency,single nucleotide variant,GRCh37
na,na,4,186236819,186236819,KLKB1,Pathogenic,Prekallikrein deficiency,single nucleotide variant,GRCh38
na,na,4,187158034,187158034,KLKB1,Benign,Prekallikrein deficiency|not specified|not provided|Inherited prekallikrein deficiency,single nucleotide variant,GRCh37
na,na,4,186236880,186236880,KLKB1,Benign,Prekallikrein deficiency|not specified|not provided|Inherited prekallikrein deficiency,single nucleotide variant,GRCh38
na,na,3,10131999,10131999,FANCD2,Pathogenic/Likely pathogenic,Fanconi anemia complementation group D2|Inborn genetic diseases|Fanconi anemia,single nucleotide variant,GRCh37
na,na,3,10090315,10090315,FANCD2,Pathogenic/Likely pathogenic,Fanconi anemia complementation group D2|Inborn genetic diseases|Fanconi anemia,single nucleotide variant,GRCh38
na,na,3,10084749,10084749,FANCD2,Pathogenic/Likely pathogenic,Fanconi anemia|Fanconi anemia complementation group D2,single nucleotide variant,GRCh37
na,na,3,10043065,10043065,FANCD2,Pathogenic/Likely pathogenic,Fanconi anemia|Fanconi anemia complementation group D2,single nucleotide variant,GRCh38
na,na,3,10084803,10084803,FANCD2,Pathogenic,Fanconi anemia complementation group D2|Fanconi anemia,single nucleotide variant,GRCh37
na,na,3,10043119,10043119,FANCD2,Pathogenic,Fanconi anemia complementation group D2|Fanconi anemia,single nucleotide variant,GRCh38
na,na,na,-1,-1,FANCD2,Pathogenic,Fanconi anemia complementation group D2,Deletion,na
na,na,9,97864005,97864005,FANCC,Pathogenic/Likely pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|FANCC-related disorder,single nucleotide variant,GRCh37
na,na,9,95101723,95101723,FANCC,Pathogenic/Likely pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|FANCC-related disorder,single nucleotide variant,GRCh38
na,na,9,97912338,97912338,FANCC,Pathogenic,Fanconi anemia complementation group C|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia|Malignant tumor of breast|FANCC-related disorder,single nucleotide variant,GRCh37
na,na,9,95150056,95150056,FANCC,Pathogenic,Fanconi anemia complementation group C|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia|Malignant tumor of breast|FANCC-related disorder,single nucleotide variant,GRCh38
na,na,9,97934315,97934315,FANCC,Pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|FANCC-related disorder,single nucleotide variant,GRCh37
na,na,9,95172033,95172033,FANCC,Pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|FANCC-related disorder,single nucleotide variant,GRCh38
na,na,9,98011537,98011537,FANCC,Pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|FANCC-related disorder,single nucleotide variant,GRCh37
na,na,9,95249255,95249255,FANCC,Pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|FANCC-related disorder,single nucleotide variant,GRCh38
na,na,9,97864024,97864024,FANCC,Pathogenic/Likely pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,9,95101742,95101742,FANCC,Pathogenic/Likely pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,9,97864110,97864111,FANCC,Pathogenic/Likely pathogenic,Fanconi anemia complementation group C|Fanconi anemia|not provided|Hereditary cancer-predisposing syndrome,Duplication,GRCh37
na,na,9,95101828,95101829,FANCC,Pathogenic/Likely pathogenic,Fanconi anemia complementation group C|Fanconi anemia|not provided|Hereditary cancer-predisposing syndrome,Duplication,GRCh38
na,na,9,98011507,98011507,FANCC,Pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|FANCC-related disorder,Deletion,GRCh37
na,na,9,95249225,95249225,FANCC,Pathogenic,Fanconi anemia complementation group C|not provided|Fanconi anemia|Hereditary cancer-predisposing syndrome|FANCC-related disorder,Deletion,GRCh38
na,na,9,97869394,97869394,FANCC,Pathogenic,Fanconi anemia complementation group C,single nucleotide variant,GRCh37
na,na,9,95107112,95107112,FANCC,Pathogenic,Fanconi anemia complementation group C,single nucleotide variant,GRCh38
na,na,9,98011408,98011408,FANCC,Pathogenic,Fanconi anemia complementation group C|Fanconi anemia|not provided,single nucleotide variant,GRCh37
na,na,9,95249126,95249126,FANCC,Pathogenic,Fanconi anemia complementation group C|Fanconi anemia|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,FANCC,Pathogenic,Fanconi anemia complementation group C,Deletion,na
na,na,13,113803460,113803460,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh37
na,na,13,113149146,113149146,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh38
na,na,13,113801758,113801758,F10,Pathogenic,Factor X deficiency,Deletion,GRCh37
na,na,13,113147444,113147444,F10,Pathogenic,Factor X deficiency,Deletion,GRCh38
na,na,13,113803376,113803376,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh37
na,na,13,113149062,113149062,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh38
na,na,13,113803511,113803511,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh37
na,na,13,113149197,113149197,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh38
na,na,13,113777230,113777230,F10,Pathogenic,Factor X deficiency|not provided,single nucleotide variant,GRCh37
na,na,13,113122916,113122916,F10,Pathogenic,Factor X deficiency|not provided,single nucleotide variant,GRCh38
na,na,13,113801804,113801804,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh37
na,na,13,113147490,113147490,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh38
na,na,13,113803484,113803484,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh37
na,na,13,113149170,113149170,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh38
na,na,13,113795286,113795286,F10,Conflicting classifications of pathogenicity,Factor X deficiency|not specified|not provided|Abnormal bleeding|Hereditary factor X deficiency disease|F10-related disorder,single nucleotide variant,GRCh37
na,na,13,113140972,113140972,F10,Conflicting classifications of pathogenicity,Factor X deficiency|not specified|not provided|Abnormal bleeding|Hereditary factor X deficiency disease|F10-related disorder,single nucleotide variant,GRCh38
na,na,13,113803328,113803328,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh37
na,na,13,113149014,113149014,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh38
na,na,13,113783835,113783835,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh37
na,na,13,113129521,113129521,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh38
na,na,13,113783909,113783909,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh37
na,na,13,113129595,113129595,F10,Pathogenic,Factor X deficiency,single nucleotide variant,GRCh38
na,na,13,113801810,113801810,F10,Pathogenic,"Factor x deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,13,113147496,113147496,F10,Pathogenic,"Factor x deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,13,113771818,113771818,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113117504,113117504,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113773177,113773177,F7,Pathogenic,Factor VII deficiency|not provided,single nucleotide variant,GRCh37
na,na,13,113118863,113118863,F7,Pathogenic,Factor VII deficiency|not provided,single nucleotide variant,GRCh38
na,na,13,113768193,113768193,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113113879,113113879,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113768275,113768275,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113113961,113113961,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113760193,113760193,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113105879,113105879,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113772982,113772982,F7,Pathogenic/Likely pathogenic,"Factor VII deficiency|not provided|Abnormal bleeding|Congenital factor VII deficiency|Congenital factor VII deficiency;Myocardial infarction, susceptibility to|F7-related disorder",single nucleotide variant,GRCh37
na,na,13,113118668,113118668,F7,Pathogenic/Likely pathogenic,"Factor VII deficiency|not provided|Abnormal bleeding|Congenital factor VII deficiency|Congenital factor VII deficiency;Myocardial infarction, susceptibility to|F7-related disorder",single nucleotide variant,GRCh38
na,na,13,113772770,113772786,F7,Pathogenic,Factor VII deficiency|Congenital factor VII deficiency,Deletion,GRCh37
na,na,13,113118456,113118472,F7,Pathogenic,Factor VII deficiency|Congenital factor VII deficiency,Deletion,GRCh38
na,na,13,113759830,113759831,F7,Benign,"Myocardial infarction, decreased susceptibility to|not provided",Insertion,GRCh37
na,na,13,113105516,113105517,F7,Benign,"Myocardial infarction, decreased susceptibility to|not provided",Insertion,GRCh38
na,na,13,113773159,113773159,F10;F7,Conflicting classifications of pathogenicity,"Myocardial infarction, decreased susceptibility to|not specified|Factor X deficiency|Factor VII deficiency|not provided",single nucleotide variant,GRCh37
na,na,13,113118845,113118845,F10;F7,Conflicting classifications of pathogenicity,"Myocardial infarction, decreased susceptibility to|not specified|Factor X deficiency|Factor VII deficiency|not provided",single nucleotide variant,GRCh38
na,na,13,113760062,113760062,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113105748,113105748,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113768207,113768207,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113113893,113113893,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113773086,113773086,F7,Pathogenic/Likely pathogenic,"Factor VII deficiency|Congenital factor VII deficiency|Congenital factor VII deficiency;Myocardial infarction, susceptibility to",single nucleotide variant,GRCh37
na,na,13,113118772,113118772,F7,Pathogenic/Likely pathogenic,"Factor VII deficiency|Congenital factor VII deficiency|Congenital factor VII deficiency;Myocardial infarction, susceptibility to",single nucleotide variant,GRCh38
na,na,13,113771136,113771136,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113116822,113116822,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113765126,113765126,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113110812,113110812,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113773145,113773145,F7,Likely pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113118831,113118831,F7,Likely pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113773161,113773161,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113118847,113118847,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,13,113772904,113772904,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh37
na,na,13,113118590,113118590,F7,Pathogenic,Factor VII deficiency,single nucleotide variant,GRCh38
na,na,7,134346527,134346527,BPGM,Pathogenic,Deficiency of bisphosphoglycerate mutase|not provided,single nucleotide variant,GRCh37
na,na,7,134661775,134661775,BPGM,Pathogenic,Deficiency of bisphosphoglycerate mutase|not provided,single nucleotide variant,GRCh38
na,na,7,134346319,134346319,BPGM,Pathogenic,Deficiency of bisphosphoglycerate mutase,Deletion,GRCh37
na,na,7,134661567,134661567,BPGM,Pathogenic,Deficiency of bisphosphoglycerate mutase,Deletion,GRCh38
na,na,16,67470003,67470003,HSD11B2,Likely pathogenic,Apparent mineralocorticoid excess,single nucleotide variant,GRCh37
na,na,16,67436100,67436100,HSD11B2,Likely pathogenic,Apparent mineralocorticoid excess,single nucleotide variant,GRCh38
na,na,16,67470018,67470018,HSD11B2,Pathogenic,Apparent mineralocorticoid excess,single nucleotide variant,GRCh37
na,na,16,67436115,67436115,HSD11B2,Pathogenic,Apparent mineralocorticoid excess,single nucleotide variant,GRCh38
na,na,16,67470697,67470697,HSD11B2,Pathogenic,Apparent mineralocorticoid excess,single nucleotide variant,GRCh37
na,na,16,67436794,67436794,HSD11B2,Pathogenic,Apparent mineralocorticoid excess,single nucleotide variant,GRCh38
na,na,16,67470004,67470004,HSD11B2,Pathogenic/Likely pathogenic,Apparent mineralocorticoid excess|not provided,single nucleotide variant,GRCh37
na,na,16,67436101,67436101,HSD11B2,Pathogenic/Likely pathogenic,Apparent mineralocorticoid excess|not provided,single nucleotide variant,GRCh38
na,na,16,67470698,67470700,HSD11B2,Pathogenic/Likely pathogenic,Apparent mineralocorticoid excess|not provided,Deletion,GRCh37
na,na,16,67436795,67436797,HSD11B2,Pathogenic/Likely pathogenic,Apparent mineralocorticoid excess|not provided,Deletion,GRCh38
na,na,16,67470523,67470523,HSD11B2,Pathogenic,Apparent mineralocorticoid excess,single nucleotide variant,GRCh37
na,na,16,67436620,67436620,HSD11B2,Pathogenic,Apparent mineralocorticoid excess,single nucleotide variant,GRCh38
na,na,16,67470167,67470167,HSD11B2,Pathogenic,"Apparent mineralocorticoid excess, mild",single nucleotide variant,GRCh37
na,na,16,67436264,67436264,HSD11B2,Pathogenic,"Apparent mineralocorticoid excess, mild",single nucleotide variant,GRCh38
na,na,16,67469605,67469610,HSD11B2,Conflicting classifications of pathogenicity,"Apparent mineralocorticoid excess, mild|Apparent mineralocorticoid excess",Deletion,GRCh37
na,na,16,67435702,67435707,HSD11B2,Conflicting classifications of pathogenicity,"Apparent mineralocorticoid excess, mild|Apparent mineralocorticoid excess",Deletion,GRCh38
na,na,16,67470154,67470154,HSD11B2,Uncertain significance,Apparent mineralocorticoid excess|not provided,single nucleotide variant,GRCh37
na,na,16,67436251,67436251,HSD11B2,Uncertain significance,Apparent mineralocorticoid excess|not provided,single nucleotide variant,GRCh38
na,na,16,67470581,67470583,HSD11B2,Uncertain significance,Apparent mineralocorticoid excess|not provided,Deletion,GRCh37
na,na,16,67436678,67436680,HSD11B2,Uncertain significance,Apparent mineralocorticoid excess|not provided,Deletion,GRCh38
na,na,5,40979845,40979845,C7,Pathogenic,Complement component 7 deficiency,single nucleotide variant,GRCh37
na,na,5,40979743,40979743,C7,Pathogenic,Complement component 7 deficiency,single nucleotide variant,GRCh38
na,na,5,40976914,40976915,C7,Pathogenic,Complement component 7 deficiency,Microsatellite,GRCh37
na,na,5,40976812,40976813,C7,Pathogenic,Complement component 7 deficiency,Microsatellite,GRCh38
na,na,5,40959622,40959622,C7,Conflicting classifications of pathogenicity,"Complement component 7 deficiency|C7 and C6 deficiency, combined subtotal|not provided|C7-related disorder|not specified",single nucleotide variant,GRCh37
na,na,5,40959520,40959520,C7,Conflicting classifications of pathogenicity,"Complement component 7 deficiency|C7 and C6 deficiency, combined subtotal|not provided|C7-related disorder|not specified",single nucleotide variant,GRCh38
na,na,5,40931165,40931165,C7,Pathogenic,Complement component 7 deficiency|not provided,single nucleotide variant,GRCh37
na,na,5,40931063,40931063,C7,Pathogenic,Complement component 7 deficiency|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,C7,Pathogenic,Complement component 7 deficiency,Deletion,na
na,na,5,40955530,40955530,C7,Conflicting classifications of pathogenicity,Complement component 7 deficiency|not provided|C7-related disorder,single nucleotide variant,GRCh37
na,na,5,40955428,40955428,C7,Conflicting classifications of pathogenicity,Complement component 7 deficiency|not provided|C7-related disorder,single nucleotide variant,GRCh38
na,na,5,40958183,40958183,C7,Pathogenic,Complement component 7 deficiency|not provided,Deletion,GRCh37
na,na,5,40958081,40958081,C7,Pathogenic,Complement component 7 deficiency|not provided,Deletion,GRCh38
na,na,5,40958332,40958332,C7,Pathogenic,Complement component 7 deficiency,single nucleotide variant,GRCh37
na,na,5,40958230,40958230,C7,Pathogenic,Complement component 7 deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,C7,Pathogenic,Complement component 7 deficiency,Deletion,na
na,na,5,41181560,41181560,C6,Pathogenic,Complement component 6 deficiency|not provided,Deletion,GRCh37
na,na,5,41181458,41181458,C6,Pathogenic,Complement component 6 deficiency|not provided,Deletion,GRCh38
na,na,4,110667554,110667554,CFI,Conflicting classifications of pathogenicity,Factor I deficiency|not provided,single nucleotide variant,GRCh37
na,na,4,109746398,109746398,CFI,Conflicting classifications of pathogenicity,Factor I deficiency|not provided,single nucleotide variant,GRCh38
na,na,4,110667387,110667387,CFI,Pathogenic/Likely pathogenic,Atypical hemolytic-uremic syndrome with I factor anomaly|CFI-related disorder|not provided,single nucleotide variant,GRCh37
na,na,4,109746231,109746231,CFI,Pathogenic/Likely pathogenic,Atypical hemolytic-uremic syndrome with I factor anomaly|CFI-related disorder|not provided,single nucleotide variant,GRCh38
na,na,4,110662230,110662230,CFI,risk factor,Atypical hemolytic-uremic syndrome with I factor anomaly,single nucleotide variant,GRCh37
na,na,4,109741074,109741074,CFI,risk factor,Atypical hemolytic-uremic syndrome with I factor anomaly,single nucleotide variant,GRCh38
na,na,4,110662164,110662164,CFI,risk factor,Atypical hemolytic-uremic syndrome with I factor anomaly,single nucleotide variant,GRCh37
na,na,4,109741008,109741008,CFI,risk factor,Atypical hemolytic-uremic syndrome with I factor anomaly,single nucleotide variant,GRCh38
na,na,4,110681723,110681723,CFI,Pathogenic,Factor I deficiency,single nucleotide variant,GRCh37
na,na,4,109760567,109760567,CFI,Pathogenic,Factor I deficiency,single nucleotide variant,GRCh38
na,na,4,110670750,110670750,CFI,Uncertain significance,Atypical hemolytic-uremic syndrome with I factor anomaly|not provided|Factor I deficiency;Atypical hemolytic-uremic syndrome with I factor anomaly;Age related macular degeneration 13,single nucleotide variant,GRCh37
na,na,4,109749594,109749594,CFI,Uncertain significance,Atypical hemolytic-uremic syndrome with I factor anomaly|not provided|Factor I deficiency;Atypical hemolytic-uremic syndrome with I factor anomaly;Age related macular degeneration 13,single nucleotide variant,GRCh38
na,na,4,110662246,110662246,CFI,Uncertain significance,Atypical hemolytic-uremic syndrome with I factor anomaly|not provided,single nucleotide variant,GRCh37
na,na,4,109741090,109741090,CFI,Uncertain significance,Atypical hemolytic-uremic syndrome with I factor anomaly|not provided,single nucleotide variant,GRCh38
na,na,6,31901653,31901653,C2,Pathogenic,"C2 deficiency, type II",single nucleotide variant,GRCh37
na,na,6,31933876,31933876,C2,Pathogenic,"C2 deficiency, type II",single nucleotide variant,GRCh38
na,na,6,31911031,31911031,C2,Uncertain significance,"C2 deficiency, type II|not provided",single nucleotide variant,GRCh37
na,na,6,31943254,31943254,C2,Uncertain significance,"C2 deficiency, type II|not provided",single nucleotide variant,GRCh38
na,na,6,31903804,31903804,C2,Benign/Likely benign,Age related macular degeneration 14|Complement component 2 deficiency|not specified|not provided|Complement component 2 deficiency;Age related macular degeneration 14,single nucleotide variant,GRCh37
na,na,6,31936027,31936027,C2,Benign/Likely benign,Age related macular degeneration 14|Complement component 2 deficiency|not specified|not provided|Complement component 2 deficiency;Age related macular degeneration 14,single nucleotide variant,GRCh38
na,na,6,31910938,31910938,C2,protective,Age related macular degeneration 14,single nucleotide variant,GRCh37
na,na,6,31943161,31943161,C2,protective,Age related macular degeneration 14,single nucleotide variant,GRCh38
na,na,3,48895151,48895152,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency,Duplication,GRCh37
na,na,3,48857718,48857719,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency,Duplication,GRCh38
na,na,3,48921429,48921556,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency,Deletion,GRCh37
na,na,3,48883996,48884123,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency,Deletion,GRCh38
na,na,na,-1,-1,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency,Deletion,na
na,na,3,48900014,48900014,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,48862581,48862581,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency|not provided,single nucleotide variant,GRCh38
na,na,3,48936144,48936144,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency|not provided,Deletion,GRCh37
na,na,3,48898711,48898711,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency|not provided,Deletion,GRCh38
na,na,3,48921567,48921567,SLC25A20,Pathogenic,not provided|Carnitine acylcarnitine translocase deficiency|SLC25A20-related disorder,single nucleotide variant,GRCh37
na,na,3,48884134,48884134,SLC25A20,Pathogenic,not provided|Carnitine acylcarnitine translocase deficiency|SLC25A20-related disorder,single nucleotide variant,GRCh38
na,na,3,48896530,48896530,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency|not provided,single nucleotide variant,GRCh37
na,na,3,48859097,48859097,SLC25A20,Pathogenic,Carnitine acylcarnitine translocase deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,49253591,49253591,FUT1,Affects,Bombay phenotype,single nucleotide variant,GRCh37
na,na,19,48750334,48750334,FUT1,Affects,Bombay phenotype,single nucleotide variant,GRCh38
na,na,19,49254048,49254048,FUT1,Pathogenic,Para-Bombay phenotype,single nucleotide variant,GRCh37
na,na,19,48750791,48750791,FUT1,Pathogenic,Para-Bombay phenotype,single nucleotide variant,GRCh38
na,na,19,49253713,49253713,FUT1,Pathogenic,Para-Bombay phenotype,single nucleotide variant,GRCh37
na,na,19,48750456,48750456,FUT1,Pathogenic,Para-Bombay phenotype,single nucleotide variant,GRCh38
na,na,19,49253814,49253814,FUT1,Pathogenic; Affects,"BOMBAY PHENOTYPE, DIGENIC|Bombay phenotype",single nucleotide variant,GRCh37
na,na,19,48750557,48750557,FUT1,Pathogenic; Affects,"BOMBAY PHENOTYPE, DIGENIC|Bombay phenotype",single nucleotide variant,GRCh38
na,na,11,66293652,66293652,BBS1,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 1|not provided|Retinal dystrophy|Bardet-Biedl syndrome|Retinitis pigmentosa|Usher syndrome|See cases|Inborn genetic diseases|BBS1-related disorder,single nucleotide variant,GRCh37
na,na,11,66526181,66526181,BBS1,Pathogenic/Likely pathogenic,Bardet-Biedl syndrome 1|not provided|Retinal dystrophy|Bardet-Biedl syndrome|Retinitis pigmentosa|Usher syndrome|See cases|Inborn genetic diseases|BBS1-related disorder,single nucleotide variant,GRCh38
na,na,11,66299163,66299163,BBS1,Pathogenic,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|not provided|Retinitis pigmentosa|Inborn genetic diseases|BBS1-related disorder,single nucleotide variant,GRCh37
na,na,11,66531692,66531692,BBS1,Pathogenic,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|not provided|Retinitis pigmentosa|Inborn genetic diseases|BBS1-related disorder,single nucleotide variant,GRCh38
na,na,11,66282150,66282150,BBS1,Pathogenic,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|not provided|BBS1-related disorder,single nucleotide variant,GRCh37
na,na,11,66514679,66514679,BBS1,Pathogenic,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|not provided|BBS1-related disorder,single nucleotide variant,GRCh38
na,na,11,66290947,66290947,BBS1,Pathogenic,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|BBS1-related disorder,Deletion,GRCh37
na,na,11,66523476,66523476,BBS1,Pathogenic,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|BBS1-related disorder,Deletion,GRCh38
na,na,11,66298444,66298444,BBS1,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,11,66530973,66530973,BBS1,Conflicting classifications of pathogenicity,Bardet-Biedl syndrome 1|Bardet-Biedl syndrome|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,11,66287196,66287196,BBS1,Benign/Likely benign,"Bardet-Biedl syndrome|not provided|not specified|BBS1-related ciliopathy|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 1/7, digenic",single nucleotide variant,GRCh37
na,na,11,66519725,66519725,BBS1,Benign/Likely benign,"Bardet-Biedl syndrome|not provided|not specified|BBS1-related ciliopathy|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 1/7, digenic",single nucleotide variant,GRCh38
na,na,6,32007203,32007203,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Inborn genetic diseases|not provided|Congenital adrenal hyperplasia,single nucleotide variant,GRCh37
na,na,6,32039426,32039426,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Inborn genetic diseases|not provided|Congenital adrenal hyperplasia,single nucleotide variant,GRCh38
na,na,6,32007887,32007887,CYP21A2,Pathogenic/Likely pathogenic,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Carcinoma, adrenocortical, androgen-secreting|Adenoma, cortisol-producing|Inborn genetic diseases|not provided|Congenital adrenal hyperplasia|CYP21A2-related disorder",single nucleotide variant,GRCh37
na,na,6,32040110,32040110,CYP21A2,Pathogenic/Likely pathogenic,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Carcinoma, adrenocortical, androgen-secreting|Adenoma, cortisol-producing|Inborn genetic diseases|not provided|Congenital adrenal hyperplasia|CYP21A2-related disorder",single nucleotide variant,GRCh38
na,na,6,32008312,32008312,CYP21A2;LOC106780800;TNXB,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder,single nucleotide variant,GRCh37
na,na,6,32040535,32040535,CYP21A2;LOC106780800;TNXB,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder,single nucleotide variant,GRCh38
na,na,6,32006291,32006291,CYP21A2,Pathogenic/Likely pathogenic,not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,single nucleotide variant,GRCh37
na,na,6,32038514,32038514,CYP21A2,Pathogenic/Likely pathogenic,not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,single nucleotide variant,GRCh38
na,na,6,32007849,32007849,CYP21A2;LOC106780800;TNXB,Benign,Congenital adrenal hyperplasia|21-HYDROXYLASE POLYMORPHISM|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not specified|not provided,single nucleotide variant,GRCh37
na,na,6,32040072,32040072,CYP21A2;LOC106780800;TNXB,Benign,Congenital adrenal hyperplasia|21-HYDROXYLASE POLYMORPHISM|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not specified|not provided,single nucleotide variant,GRCh38
na,na,6,32006858,32006858,CYP21A2,Conflicting classifications of pathogenicity,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Inborn genetic diseases|See cases|Congenital adrenal hyperplasia,single nucleotide variant,GRCh37
na,na,6,32039081,32039081,CYP21A2,Conflicting classifications of pathogenicity,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Inborn genetic diseases|See cases|Congenital adrenal hyperplasia,single nucleotide variant,GRCh38
na,na,6,32007917,32007917,CYP21A2,Pathogenic/Likely pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,single nucleotide variant,GRCh37
na,na,6,32040140,32040140,CYP21A2,Pathogenic/Likely pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,single nucleotide variant,GRCh38
na,na,6,32008874,32008875,CYP21A2,Pathogenic/Likely pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder,Indel,GRCh37
na,na,6,32041097,32041098,CYP21A2,Pathogenic/Likely pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder,Indel,GRCh38
na,na,6,32006895,32006895,CYP21A2,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,6,32039118,32039118,CYP21A2,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,6,32008783,32008783,CYP21A2,Pathogenic/Likely pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder|Congenital lipoid adrenal hyperplasia due to STAR deficency|See cases,single nucleotide variant,GRCh37
na,na,6,32041006,32041006,CYP21A2,Pathogenic/Likely pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|CYP21A2-related disorder|Congenital lipoid adrenal hyperplasia due to STAR deficency|See cases,single nucleotide variant,GRCh38
na,na,na,-1,-1,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Deletion,na
na,na,na,-1,-1,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Variation,na
na,na,6,32006214,32006215,CYP21A2,Benign,21-HYDROXYLASE POLYMORPHISM|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Microsatellite,GRCh37
na,na,6,32038437,32038438,CYP21A2,Benign,21-HYDROXYLASE POLYMORPHISM|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Microsatellite,GRCh38
na,na,na,-1,-1,CYP21A2,Benign,21-HYDROXYLASE POLYMORPHISM,single nucleotide variant,na
na,na,6,32006910,32006917,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,Deletion,GRCh37
na,na,6,32039133,32039140,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,Deletion,GRCh38
na,na,6,32007983,32007983,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,single nucleotide variant,GRCh37
na,na,6,32040206,32040206,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,single nucleotide variant,GRCh38
na,na,6,32008198,32008198,CYP21A2;LOC106780800;TNXB,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Congenital adrenal hyperplasia|CYP21A2-related disorder,single nucleotide variant,GRCh37
na,na,6,32040421,32040421,CYP21A2;LOC106780800;TNXB,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Congenital adrenal hyperplasia|CYP21A2-related disorder,single nucleotide variant,GRCh38
na,na,6,32008262,32008262,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,single nucleotide variant,GRCh37
na,na,6,32040485,32040485,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,single nucleotide variant,GRCh38
na,na,6,32008543,32008543,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,single nucleotide variant,GRCh37
na,na,6,32040766,32040766,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,single nucleotide variant,GRCh38
na,na,6,32008469,32008469,CYP21A2,Uncertain significance,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not specified,single nucleotide variant,GRCh37
na,na,6,32040692,32040692,CYP21A2,Uncertain significance,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not specified,single nucleotide variant,GRCh38
na,na,6,32007587,32007587,CYP21A2,Conflicting classifications of pathogenicity,not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Congenital adrenal hyperplasia,single nucleotide variant,GRCh37
na,na,6,32039810,32039810,CYP21A2,Conflicting classifications of pathogenicity,not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Congenital adrenal hyperplasia,single nucleotide variant,GRCh38
na,na,6,32008703,32008703,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|CYP21A2-related disorder|not provided,single nucleotide variant,GRCh37
na,na,6,32040926,32040926,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|CYP21A2-related disorder|not provided,single nucleotide variant,GRCh38
na,na,6,32006282,32006283,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Duplication,GRCh37
na,na,6,32038505,32038506,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Duplication,GRCh38
na,na,6,32006869,32006869,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,single nucleotide variant,GRCh37
na,na,6,32039092,32039092,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,single nucleotide variant,GRCh38
na,na,6,32007195,32007196,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Duplication,GRCh37
na,na,6,32039418,32039419,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Duplication,GRCh38
na,na,6,32008648,32008648,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,single nucleotide variant,GRCh37
na,na,6,32040871,32040871,CYP21A2,Pathogenic,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided,single nucleotide variant,GRCh38
na,na,6,32008452,32008452,CYP21A2,Pathogenic,"Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency",single nucleotide variant,GRCh37
na,na,6,32040675,32040675,CYP21A2,Pathogenic,"Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency",single nucleotide variant,GRCh38
na,na,6,32006387,32006387,CYP21A2,Conflicting classifications of pathogenicity,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not specified|Congenital adrenal hyperplasia|not provided,single nucleotide variant,GRCh37
na,na,6,32038610,32038610,CYP21A2,Conflicting classifications of pathogenicity,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not specified|Congenital adrenal hyperplasia|not provided,single nucleotide variant,GRCh38
na,na,1,119964636,119964636,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,119422013,119422013,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,119964679,119964680,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,Duplication,GRCh37
na,na,1,119422056,119422057,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,Duplication,GRCh38
na,na,1,119964866,119964867,HSD3B2,no classification for the single variant,-,Indel,GRCh37
na,na,1,119422243,119422244,HSD3B2,no classification for the single variant,-,Indel,GRCh38
na,na,1,119964869,119964869,HSD3B2,Pathogenic,not provided|3 beta-Hydroxysteroid dehydrogenase deficiency|Congenital adrenal hyperplasia,single nucleotide variant,GRCh37
na,na,1,119422246,119422246,HSD3B2,Pathogenic,not provided|3 beta-Hydroxysteroid dehydrogenase deficiency|Congenital adrenal hyperplasia,single nucleotide variant,GRCh38
na,na,1,119958071,119958071,HSD3B2,Likely pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,1,119415448,119415448,HSD3B2,Likely pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,1,119965243,119965243,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,1,119422620,119422620,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,1,119964548,119964548,HSD3B2,Pathogenic/Likely pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,119421925,119421925,HSD3B2,Pathogenic/Likely pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,single nucleotide variant,GRCh38
na,na,1,119964788,119964788,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|Congenital adrenal hyperplasia,single nucleotide variant,GRCh37
na,na,1,119422165,119422165,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|Congenital adrenal hyperplasia,single nucleotide variant,GRCh38
na,na,1,119964900,119964900,HSD3B2,Pathogenic/Likely pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided|Congenital adrenal hyperplasia,single nucleotide variant,GRCh37
na,na,1,119422277,119422277,HSD3B2,Pathogenic/Likely pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided|Congenital adrenal hyperplasia,single nucleotide variant,GRCh38
na,na,1,119964991,119964991,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,Deletion,GRCh37
na,na,1,119422368,119422368,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency|not provided,Deletion,GRCh38
na,na,1,119965146,119965146,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency,single nucleotide variant,GRCh37
na,na,1,119422523,119422523,HSD3B2,Pathogenic,3 beta-Hydroxysteroid dehydrogenase deficiency,single nucleotide variant,GRCh38
na,na,22,29196757,29196757,XBP1,risk factor,-,single nucleotide variant,GRCh37
na,na,22,28800769,28800769,XBP1,risk factor,-,single nucleotide variant,GRCh38
na,na,10,75871844,75871844,VCL,Uncertain significance,Dilated cardiomyopathy 1W|Hypertrophic cardiomyopathy 15|Cardiovascular phenotype|Dilated cardiomyopathy 1W;Hypertrophic cardiomyopathy 15|Primary familial hypertrophic cardiomyopathy,single nucleotide variant,GRCh37
na,na,10,74112086,74112086,VCL,Uncertain significance,Dilated cardiomyopathy 1W|Hypertrophic cardiomyopathy 15|Cardiovascular phenotype|Dilated cardiomyopathy 1W;Hypertrophic cardiomyopathy 15|Primary familial hypertrophic cardiomyopathy,single nucleotide variant,GRCh38
na,na,10,75842257,75842257,VCL,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 15|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Dilated cardiomyopathy 1W|not provided|Hypertrophic cardiomyopathy 15;Dilated cardiomyopathy 1W|not specified|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,10,74082499,74082499,VCL,Conflicting classifications of pathogenicity,Hypertrophic cardiomyopathy 15|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Dilated cardiomyopathy 1W|not provided|Hypertrophic cardiomyopathy 15;Dilated cardiomyopathy 1W|not specified|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,10,17271872,17271872,VIM,Pathogenic,Cataract 30|not provided,single nucleotide variant,GRCh37
na,na,10,17229873,17229873,VIM,Pathogenic,Cataract 30|not provided,single nucleotide variant,GRCh38
na,na,9,2621793,2654485,VLDLR,Pathogenic,"Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1",Deletion,GRCh37
na,na,9,2621793,2654485,VLDLR,Pathogenic,"Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1",Deletion,GRCh38
na,na,9,2643480,2643480,VLDLR,Pathogenic,"Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1",single nucleotide variant,GRCh37
na,na,9,2643480,2643480,VLDLR,Pathogenic,"Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1",single nucleotide variant,GRCh38
na,na,9,2651877,2651877,VLDLR,Pathogenic,"Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1",Deletion,GRCh37
na,na,9,2651877,2651877,VLDLR,Pathogenic,"Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1",Deletion,GRCh38
na,na,20,3063683,3063683,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh37
na,na,20,3083037,3083037,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh38
na,na,20,3063802,3063802,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh37
na,na,20,3083156,3083156,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh38
na,na,20,3065266,3065266,AVP,Pathogenic,Neurohypophyseal diabetes insipidus|not provided|AVP-related disorder,single nucleotide variant,GRCh37
na,na,20,3084620,3084620,AVP,Pathogenic,Neurohypophyseal diabetes insipidus|not provided|AVP-related disorder,single nucleotide variant,GRCh38
na,na,20,3063651,3063651,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh37
na,na,20,3083005,3083005,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh38
na,na,20,3063668,3063668,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh37
na,na,20,3083022,3083022,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh38
na,na,20,3065318,3065318,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,Deletion,GRCh37
na,na,20,3084672,3084672,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,Deletion,GRCh38
na,na,20,3063658,3063658,AVP,Conflicting classifications of pathogenicity,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh37
na,na,20,3083012,3083012,AVP,Conflicting classifications of pathogenicity,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh38
na,na,20,3065265,3065265,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh37
na,na,20,3084619,3084619,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh38
na,na,20,3063784,3063784,AVP,Likely pathogenic,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh37
na,na,20,3083138,3083138,AVP,Likely pathogenic,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh38
na,na,20,3063785,3063785,AVP,Pathogenic,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh37
na,na,20,3083139,3083139,AVP,Pathogenic,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh38
na,na,20,3063434,3063434,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh37
na,na,20,3082788,3082788,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh38
na,na,20,3063685,3063685,AVP,Pathogenic,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh37
na,na,20,3083039,3083039,AVP,Pathogenic,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh38
na,na,20,3063670,3063670,AVP,Likely pathogenic,Neurohypophyseal diabetes insipidus|AVP-related disorder,single nucleotide variant,GRCh37
na,na,20,3083024,3083024,AVP,Likely pathogenic,Neurohypophyseal diabetes insipidus|AVP-related disorder,single nucleotide variant,GRCh38
na,na,20,3063745,3063745,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh37
na,na,20,3083099,3083099,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh38
na,na,20,3065301,3065301,AVP,Pathogenic,"Diabetes insipidus, neurohypophyseal, autosomal recessive",single nucleotide variant,GRCh37
na,na,20,3084655,3084655,AVP,Pathogenic,"Diabetes insipidus, neurohypophyseal, autosomal recessive",single nucleotide variant,GRCh38
na,na,20,3063425,3063425,AVP,Pathogenic,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh37
na,na,20,3082779,3082779,AVP,Pathogenic,Neurohypophyseal diabetes insipidus|not provided,single nucleotide variant,GRCh38
na,na,20,3065260,3065260,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh37
na,na,20,3084614,3084614,AVP,Pathogenic,Neurohypophyseal diabetes insipidus,single nucleotide variant,GRCh38
na,na,20,3065255,3065257,AVP,Uncertain significance,Neurohypophyseal diabetes insipidus|not provided,Deletion,GRCh37
na,na,20,3084609,3084611,AVP,Uncertain significance,Neurohypophyseal diabetes insipidus|not provided,Deletion,GRCh38
na,na,6,43738350,43738350,VEGFA,Benign,"Microvascular complications of diabetes, susceptibility to, 1|not provided",single nucleotide variant,GRCh37
na,na,6,43770613,43770613,VEGFA,Benign,"Microvascular complications of diabetes, susceptibility to, 1|not provided",single nucleotide variant,GRCh38
na,na,6,43736389,43736389,VEGFA,Benign,"Atherosclerosis, susceptibility to",single nucleotide variant,GRCh37
na,na,6,43768652,43768652,VEGFA,Benign,"Atherosclerosis, susceptibility to",single nucleotide variant,GRCh38
na,na,2,71163175,71163175,ATP6V1B1,Pathogenic,Renal tubular acidosis with progressive nerve deafness|not provided,single nucleotide variant,GRCh37
na,na,2,70936045,70936045,ATP6V1B1,Pathogenic,Renal tubular acidosis with progressive nerve deafness|not provided,single nucleotide variant,GRCh38
na,na,2,71187209,71187209,ATP6V1B1,Pathogenic/Likely pathogenic,Renal tubular acidosis with progressive nerve deafness|not provided,single nucleotide variant,GRCh37
na,na,2,70960079,70960079,ATP6V1B1,Pathogenic/Likely pathogenic,Renal tubular acidosis with progressive nerve deafness|not provided,single nucleotide variant,GRCh38
na,na,2,71185243,71185243,ATP6V1B1,Pathogenic,Renal tubular acidosis with progressive nerve deafness|Nephrolithiasis;Nephrocalcinosis|Distal renal tubular acidosis|not provided,single nucleotide variant,GRCh37
na,na,2,70958113,70958113,ATP6V1B1,Pathogenic,Renal tubular acidosis with progressive nerve deafness|Nephrolithiasis;Nephrocalcinosis|Distal renal tubular acidosis|not provided,single nucleotide variant,GRCh38
na,na,2,71185233,71185233,ATP6V1B1,Pathogenic/Likely pathogenic,Renal tubular acidosis with progressive nerve deafness|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,2,70958103,70958103,ATP6V1B1,Pathogenic/Likely pathogenic,Renal tubular acidosis with progressive nerve deafness|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,16,68857496,68857496,CDH1,Likely benign,Hereditary diffuse gastric adenocarcinoma|Endometrial carcinoma|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|CDH1-related diffuse gastric and lobular breast cancer syndrome|not specified|not provided,single nucleotide variant,GRCh37
na,na,16,68823593,68823593,CDH1,Likely benign,Hereditary diffuse gastric adenocarcinoma|Endometrial carcinoma|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|CDH1-related diffuse gastric and lobular breast cancer syndrome|not specified|not provided,single nucleotide variant,GRCh38
na,na,16,68856041,68856041,CDH1,Benign,Hereditary diffuse gastric adenocarcinoma|Endometrial carcinoma|not provided|not specified|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Breast and/or ovarian cancer|6 conditions|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh37
na,na,16,68822138,68822138,CDH1,Benign,Hereditary diffuse gastric adenocarcinoma|Endometrial carcinoma|not provided|not specified|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Breast and/or ovarian cancer|6 conditions|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh38
na,na,16,68867265,68867265,CDH1,Likely benign,Ovarian neoplasm|Hereditary cancer-predisposing syndrome|Hereditary diffuse gastric adenocarcinoma|not specified|Familial cancer of breast|not provided|CDH1-related diffuse gastric and lobular breast cancer syndrome|6 conditions|CDH1-related disorder|Ovarian cancer;Familial cancer of breast,single nucleotide variant,GRCh37
na,na,16,68833362,68833362,CDH1,Likely benign,Ovarian neoplasm|Hereditary cancer-predisposing syndrome|Hereditary diffuse gastric adenocarcinoma|not specified|Familial cancer of breast|not provided|CDH1-related diffuse gastric and lobular breast cancer syndrome|6 conditions|CDH1-related disorder|Ovarian cancer;Familial cancer of breast,single nucleotide variant,GRCh38
na,na,16,68844193,68844193,CDH1,Pathogenic,Breast lobular carcinoma|Hereditary diffuse gastric adenocarcinoma|Gastric cancer|CDH1-related diffuse gastric and lobular breast cancer syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,16,68810290,68810290,CDH1,Pathogenic,Breast lobular carcinoma|Hereditary diffuse gastric adenocarcinoma|Gastric cancer|CDH1-related diffuse gastric and lobular breast cancer syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,16,68863642,68863643,CDH1,Likely pathogenic,Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast,Duplication,GRCh37
na,na,16,68829739,68829740,CDH1,Likely pathogenic,Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome|Hereditary cancer-predisposing syndrome|Familial cancer of breast,Duplication,GRCh38
na,na,16,68857460,68857460,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome|Familial cancer of breast;Ovarian cancer|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,16,68823557,68823557,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome|Familial cancer of breast;Ovarian cancer|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,16,68772210,68772210,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh37
na,na,16,68738307,68738307,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh38
na,na,16,68772221,68772221,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh37
na,na,16,68738318,68738318,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh38
na,na,16,68855984,68855984,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh37
na,na,16,68822081,68822081,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh38
na,na,16,68856093,68856093,CDH1,Pathogenic/Likely pathogenic,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|not provided,single nucleotide variant,GRCh37
na,na,16,68822190,68822190,CDH1,Pathogenic/Likely pathogenic,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|not provided,single nucleotide variant,GRCh38
na,na,16,68846047,68846047,CDH1,Benign,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|not specified|Gastric adenocarcinoma|not provided|CDH1-related disorder|Breast and/or ovarian cancer|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh37
na,na,16,68812144,68812144,CDH1,Benign,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|not specified|Gastric adenocarcinoma|not provided|CDH1-related disorder|Breast and/or ovarian cancer|CDH1-related diffuse gastric and lobular breast cancer syndrome,single nucleotide variant,GRCh38
na,na,16,68867247,68867247,CDH1,Benign,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of stomach|not specified|not provided|Hereditary breast ovarian cancer syndrome|CDH1-related diffuse gastric and lobular breast cancer syndrome|CDH1-related disorder|Familial cancer of breast;Ovarian cancer,single nucleotide variant,GRCh37
na,na,16,68833344,68833344,CDH1,Benign,Hereditary diffuse gastric adenocarcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of stomach|not specified|not provided|Hereditary breast ovarian cancer syndrome|CDH1-related diffuse gastric and lobular breast cancer syndrome|CDH1-related disorder|Familial cancer of breast;Ovarian cancer,single nucleotide variant,GRCh38
na,na,16,68771034,68771034,CDH1,Benign,not provided|Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome|Prostate cancer susceptibility,single nucleotide variant,GRCh37
na,na,16,68737131,68737131,CDH1,Benign,not provided|Hereditary diffuse gastric adenocarcinoma|CDH1-related diffuse gastric and lobular breast cancer syndrome|Prostate cancer susceptibility,single nucleotide variant,GRCh38
na,na,16,68842472,68842472,CDH1,Pathogenic,Diffuse gastric and lobular breast cancer syndrome with cleft lip and with or without cleft palate,single nucleotide variant,GRCh37
na,na,16,68808569,68808569,CDH1,Pathogenic,Diffuse gastric and lobular breast cancer syndrome with cleft lip and with or without cleft palate,single nucleotide variant,GRCh38
na,na,na,-1,-1,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma,Deletion,na
na,na,16,68866797,68867626,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma,Indel,GRCh37
na,na,16,68832894,68833723,CDH1,Pathogenic,Hereditary diffuse gastric adenocarcinoma,Indel,GRCh38
na,na,11,62186530,62186530,SCGB1A1,Uncertain significance,Inherited susceptibility to asthma,single nucleotide variant,GRCh37
na,na,11,62419058,62419058,SCGB1A1,Uncertain significance,Inherited susceptibility to asthma,single nucleotide variant,GRCh38
na,na,16,20360068,20360094,UMOD,Pathogenic,not provided|Familial juvenile hyperuricemic nephropathy type 1|UMOD-related disorder,Deletion,GRCh37
na,na,16,20348746,20348772,UMOD,Pathogenic,not provided|Familial juvenile hyperuricemic nephropathy type 1|UMOD-related disorder,Deletion,GRCh38
na,na,16,20360180,20360180,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1|not provided,single nucleotide variant,GRCh37
na,na,16,20348858,20348858,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1|not provided,single nucleotide variant,GRCh38
na,na,16,20359974,20359974,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh37
na,na,16,20348652,20348652,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh38
na,na,16,20360316,20360316,UMOD,Likely pathogenic,Familial juvenile hyperuricemic nephropathy type 1|UMOD-related disorder,single nucleotide variant,GRCh37
na,na,16,20348994,20348994,UMOD,Likely pathogenic,Familial juvenile hyperuricemic nephropathy type 1|UMOD-related disorder,single nucleotide variant,GRCh38
na,na,16,20360393,20360393,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh37
na,na,16,20349071,20349071,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh38
na,na,16,20360247,20360247,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh37
na,na,16,20348925,20348925,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh38
na,na,16,20360240,20360240,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh37
na,na,16,20348918,20348918,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh38
na,na,16,20359859,20359859,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh37
na,na,16,20348537,20348537,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh38
na,na,16,20359620,20359620,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh37
na,na,16,20348298,20348298,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh38
na,na,16,20359575,20359575,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh37
na,na,16,20348253,20348253,UMOD,Pathogenic,Familial juvenile hyperuricemic nephropathy type 1,single nucleotide variant,GRCh38
na,na,16,20359806,20359806,UMOD,Likely pathogenic,Familial juvenile hyperuricemic nephropathy type 1|not provided,single nucleotide variant,GRCh37
na,na,16,20348484,20348484,UMOD,Likely pathogenic,Familial juvenile hyperuricemic nephropathy type 1|not provided,single nucleotide variant,GRCh38
na,na,10,75673101,75673101,PLAU,Benign,"Alzheimer disease, late-onset, susceptibility to|not provided",single nucleotide variant,GRCh37
na,na,10,73913343,73913343,PLAU,Benign,"Alzheimer disease, late-onset, susceptibility to|not provided",single nucleotide variant,GRCh38
na,na,2,234675692,234675705,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1|not provided,Indel,GRCh37
na,na,2,233767046,233767059,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1|not provided,Indel,GRCh38
na,na,2,234676905,234676905,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome,single nucleotide variant,GRCh37
na,na,2,233768259,233768259,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome,single nucleotide variant,GRCh38
na,na,2,234675806,234675806,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1,single nucleotide variant,GRCh37
na,na,2,233767160,233767160,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1,single nucleotide variant,GRCh38
na,na,2,234676519,234676519,UGT1A1,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome type 1|Gilbert syndrome|not provided|UGT1A1-related disorder|Gilbert syndrome;Crigler-Najjar syndrome type 1;Lucey-Driscoll syndrome;Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh37
na,na,2,233767873,233767873,UGT1A1,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome type 1|Gilbert syndrome|not provided|UGT1A1-related disorder|Gilbert syndrome;Crigler-Najjar syndrome type 1;Lucey-Driscoll syndrome;Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh38
na,na,2,234675807,234675807,"covers 10 genes, none of which curated to show dosage sensitivity",Likely pathogenic,"Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh37
na,na,2,233767161,233767161,"covers 10 genes, none of which curated to show dosage sensitivity",Likely pathogenic,"Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh38
na,na,2,234669441,234669443,UGT1A1,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",Microsatellite,GRCh37
na,na,2,233760795,233760797,UGT1A1,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",Microsatellite,GRCh38
na,na,2,234675738,234675738,UGT1A1,Pathogenic/Likely pathogenic,Crigler-Najjar syndrome type 1|Gilbert syndrome|not provided|UGT1A1-related disorder,single nucleotide variant,GRCh37
na,na,2,233767092,233767092,UGT1A1,Pathogenic/Likely pathogenic,Crigler-Najjar syndrome type 1|Gilbert syndrome|not provided|UGT1A1-related disorder,single nucleotide variant,GRCh38
na,na,2,234669773,234669773,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1,single nucleotide variant,GRCh37
na,na,2,233761127,233761127,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1,single nucleotide variant,GRCh38
na,na,2,234669619,234669619,UGT1A1,Conflicting classifications of pathogenicity; other,"Gilbert syndrome|Crigler-Najjar syndrome, type II|not specified|not provided|UGT1A1-related disorder|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome",single nucleotide variant,GRCh37
na,na,2,233760973,233760973,UGT1A1,Conflicting classifications of pathogenicity; other,"Gilbert syndrome|Crigler-Najjar syndrome, type II|not specified|not provided|UGT1A1-related disorder|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome",single nucleotide variant,GRCh38
na,na,2,234668881,234668881,"covers 10 genes, none of which curated to show dosage sensitivity",Conflicting classifications of pathogenicity; drug response; other,"Gilbert syndrome|Crigler-Najjar syndrome, type II|Lucey-Driscoll syndrome|BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Irinotecan response|not specified|not provided|Gilbert syndrome;Crigler-Najjar syndrome type 1;Lucey-Driscoll syndrome;Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome|UGT1A1-related disorder",Microsatellite,GRCh37
na,na,2,233760233,233760234,"covers 10 genes, none of which curated to show dosage sensitivity",Conflicting classifications of pathogenicity; drug response; other,"Gilbert syndrome|Crigler-Najjar syndrome, type II|Lucey-Driscoll syndrome|BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Irinotecan response|not specified|not provided|Gilbert syndrome;Crigler-Najjar syndrome type 1;Lucey-Driscoll syndrome;Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome|UGT1A1-related disorder",Microsatellite,GRCh38
na,na,2,234669407,234669408,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1,Insertion,GRCh37
na,na,2,233760761,233760762,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1,Insertion,GRCh38
na,na,2,234669798,234669798,UGT1A1,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh37
na,na,2,233761152,233761152,UGT1A1,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh38
na,na,2,234669078,234669078,UGT1A1,Likely pathogenic,"Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh37
na,na,2,233760432,233760432,UGT1A1,Likely pathogenic,"Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh38
na,na,2,234676864,234676864,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1,single nucleotide variant,GRCh37
na,na,2,233768218,233768218,UGT1A1,Pathogenic,Crigler-Najjar syndrome type 1,single nucleotide variant,GRCh38
na,na,2,234669144,234669144,"covers 10 genes, none of which curated to show dosage sensitivity",Conflicting classifications of pathogenicity; drug response,"Gilbert syndrome|BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Lucey-Driscoll syndrome|not specified|Irinotecan response|Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1;Lucey-Driscoll syndrome;Gilbert syndrome;Crigler-Najjar syndrome type 1|UGT1A1-related disorder|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Gilbert syndrome;Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome type 1",single nucleotide variant,GRCh37
na,na,2,233760498,233760498,"covers 10 genes, none of which curated to show dosage sensitivity",Conflicting classifications of pathogenicity; drug response,"Gilbert syndrome|BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Lucey-Driscoll syndrome|not specified|Irinotecan response|Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1;Lucey-Driscoll syndrome;Gilbert syndrome;Crigler-Najjar syndrome type 1|UGT1A1-related disorder|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Gilbert syndrome;Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome type 1",single nucleotide variant,GRCh38
na,na,2,234681059,234681059,UGT1A1,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome, type II|Lucey-Driscoll syndrome|Hyperbilirubinemia|not provided|Gilbert syndrome;Crigler-Najjar syndrome type 1;Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1;Lucey-Driscoll syndrome|Gilbert syndrome|Crigler-Najjar syndrome type 1|UGT1A1-related disorder",single nucleotide variant,GRCh37
na,na,2,233772413,233772413,UGT1A1,Pathogenic/Likely pathogenic,"Crigler-Najjar syndrome, type II|Lucey-Driscoll syndrome|Hyperbilirubinemia|not provided|Gilbert syndrome;Crigler-Najjar syndrome type 1;Crigler-Najjar syndrome, type II;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1;Lucey-Driscoll syndrome|Gilbert syndrome|Crigler-Najjar syndrome type 1|UGT1A1-related disorder",single nucleotide variant,GRCh38
na,na,2,234667582,234667582,UGT1A1,Pathogenic,Lucey-Driscoll syndrome,single nucleotide variant,GRCh37
na,na,2,233758936,233758936,UGT1A1,Pathogenic,Lucey-Driscoll syndrome,single nucleotide variant,GRCh38
na,na,2,234676568,234676568,"covers 10 genes, none of which curated to show dosage sensitivity",Likely pathogenic,"Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Gilbert syndrome",single nucleotide variant,GRCh37
na,na,2,233767922,233767922,"covers 10 genes, none of which curated to show dosage sensitivity",Likely pathogenic,"Crigler-Najjar syndrome type 1|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Gilbert syndrome",single nucleotide variant,GRCh38
na,na,na,-1,-1,UGT1A1,Pathogenic,"Crigler-Najjar syndrome, type II",Deletion,na
na,na,2,234669457,234669457,UGT1A1,Likely pathogenic; other,"Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|UGT1A1-related disorder",single nucleotide variant,GRCh37
na,na,2,233760811,233760811,UGT1A1,Likely pathogenic; other,"Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|UGT1A1-related disorder",single nucleotide variant,GRCh38
na,na,2,234676979,234676979,UGT1A1,Uncertain significance,"Crigler-Najjar syndrome, type II|Gilbert syndrome|not specified",single nucleotide variant,GRCh37
na,na,2,233768333,233768333,UGT1A1,Uncertain significance,"Crigler-Najjar syndrome, type II|Gilbert syndrome|not specified",single nucleotide variant,GRCh38
na,na,2,234668977,234668977,UGT1A1,Likely pathogenic,"Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh37
na,na,2,233760331,233760331,UGT1A1,Likely pathogenic,"Crigler-Najjar syndrome, type II|not provided|Crigler-Najjar syndrome, type II;Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Gilbert syndrome;BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",single nucleotide variant,GRCh38
na,na,2,234665659,234665659,"covers 10 genes, none of which curated to show dosage sensitivity",Conflicting classifications of pathogenicity,"Gilbert syndrome, susceptibility to|Gilbert syndrome|not provided|UGT1A9-related disorder|Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Crigler-Najjar syndrome, type II|UGT1A8-related condition",single nucleotide variant,GRCh37
na,na,2,233757013,233757013,"covers 10 genes, none of which curated to show dosage sensitivity",Conflicting classifications of pathogenicity,"Gilbert syndrome, susceptibility to|Gilbert syndrome|not provided|UGT1A9-related disorder|Lucey-Driscoll syndrome;Crigler-Najjar syndrome type 1;Crigler-Najjar syndrome, type II|UGT1A8-related condition",single nucleotide variant,GRCh38
na,na,2,234672639,234672639,UGT1A1,Benign; association,"BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Gilbert syndrome",single nucleotide variant,GRCh37
na,na,2,233763993,233763993,UGT1A1,Benign; association,"BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Gilbert syndrome",single nucleotide variant,GRCh38
na,na,12,109537042,109537042,UNG,Pathogenic,Hyper-IgM syndrome type 5,Deletion,GRCh37
na,na,12,109099237,109099237,UNG,Pathogenic,Hyper-IgM syndrome type 5,Deletion,GRCh38
na,na,12,109540680,109540681,UNG,Pathogenic,Hyper-IgM syndrome type 5,Microsatellite,GRCh37
na,na,12,109102875,109102876,UNG,Pathogenic,Hyper-IgM syndrome type 5,Microsatellite,GRCh38
na,na,12,109541367,109541367,UNG,Pathogenic,Hyper-IgM syndrome type 5,single nucleotide variant,GRCh37
na,na,12,109103562,109103562,UNG,Pathogenic,Hyper-IgM syndrome type 5,single nucleotide variant,GRCh38
na,na,12,109537081,109537082,UNG,Pathogenic,Hyper-IgM syndrome type 5,Deletion,GRCh37
na,na,12,109099276,109099277,UNG,Pathogenic,Hyper-IgM syndrome type 5,Deletion,GRCh38
na,na,1,161009523,161009523,USF1,risk factor,"Hyperlipidemia, familial combined, susceptibility to",single nucleotide variant,GRCh37
na,na,1,161039733,161039733,USF1,risk factor,"Hyperlipidemia, familial combined, susceptibility to",single nucleotide variant,GRCh38
na,na,1,161010762,161010762,USF1,risk factor,"Hyperlipidemia, familial combined, susceptibility to",single nucleotide variant,GRCh37
na,na,1,161040972,161040972,USF1,risk factor,"Hyperlipidemia, familial combined, susceptibility to",single nucleotide variant,GRCh38
na,na,11,118971106,118971106,DPAGT1,Conflicting classifications of pathogenicity,DPAGT1-congenital disorder of glycosylation|DPAGT1-congenital disorder of glycosylation;Congenital myasthenic syndrome 13|not provided|Congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,11,119100396,119100396,DPAGT1,Conflicting classifications of pathogenicity,DPAGT1-congenital disorder of glycosylation|DPAGT1-congenital disorder of glycosylation;Congenital myasthenic syndrome 13|not provided|Congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,4,41262768,41262768,UCHL1,risk factor,"Parkinson disease 5, autosomal dominant, susceptibility to",single nucleotide variant,GRCh37
na,na,4,41260751,41260751,UCHL1,risk factor,"Parkinson disease 5, autosomal dominant, susceptibility to",single nucleotide variant,GRCh38
na,na,4,41259633,41259633,UCHL1,Benign,"Parkinson disease 5, autosomal dominant, susceptibility to|not provided|Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome",single nucleotide variant,GRCh37
na,na,4,41257616,41257616,UCHL1,Benign,"Parkinson disease 5, autosomal dominant, susceptibility to|not provided|Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome",single nucleotide variant,GRCh38
na,na,1,156849157,156849157,NTRK1,Pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh37
na,na,1,156879365,156879365,NTRK1,Pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh38
na,na,1,156846288,156846288,NTRK1,Likely pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh37
na,na,1,156876496,156876496,NTRK1,Likely pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh38
na,na,1,156851382,156851382,NTRK1,Pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh37
na,na,1,156881590,156881590,NTRK1,Pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh38
na,na,1,156830751,156830751,NTRK1,not provided,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh37
na,na,1,156860959,156860959,NTRK1,not provided,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh38
na,na,1,156848946,156848946,NTRK1,Benign/Likely benign,Familial medullary thyroid carcinoma|Hereditary insensitivity to pain with anhidrosis|not specified|not provided,single nucleotide variant,GRCh37
na,na,1,156879154,156879154,NTRK1,Benign/Likely benign,Familial medullary thyroid carcinoma|Hereditary insensitivity to pain with anhidrosis|not specified|not provided,single nucleotide variant,GRCh38
na,na,1,156849828,156849828,NTRK1,Pathogenic/Likely pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh37
na,na,1,156880036,156880036,NTRK1,Pathogenic/Likely pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh38
na,na,1,156843650,156843650,NTRK1,Conflicting classifications of pathogenicity,Hereditary insensitivity to pain with anhidrosis|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh37
na,na,1,156873858,156873858,NTRK1,Conflicting classifications of pathogenicity,Hereditary insensitivity to pain with anhidrosis|Charcot-Marie-Tooth disease,single nucleotide variant,GRCh38
na,na,1,156846318,156846318,NTRK1,Pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh37
na,na,1,156876526,156876526,NTRK1,Pathogenic,Hereditary insensitivity to pain with anhidrosis,single nucleotide variant,GRCh38
na,na,1,162746131,162746131,DDR2,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,single nucleotide variant,GRCh37
na,na,1,162776341,162776341,DDR2,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,single nucleotide variant,GRCh38
na,na,1,162746054,162746054,DDR2,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,single nucleotide variant,GRCh37
na,na,1,162776264,162776264,DDR2,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,single nucleotide variant,GRCh38
na,na,1,162746015,162746015,DDR2,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,single nucleotide variant,GRCh37
na,na,1,162776225,162776225,DDR2,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,single nucleotide variant,GRCh38
na,na,1,162746161,162746161,DDR2,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,single nucleotide variant,GRCh37
na,na,1,162776371,162776371,DDR2,Pathogenic,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,single nucleotide variant,GRCh38
na,na,4,55955106,55955106,KDR,Pathogenic,not specified|Capillary infantile hemangioma,single nucleotide variant,GRCh37
na,na,4,55088939,55088939,KDR,Pathogenic,not specified|Capillary infantile hemangioma,single nucleotide variant,GRCh38
na,na,4,55972946,55972946,KDR,Likely benign,Capillary infantile hemangioma|not specified|not provided,single nucleotide variant,GRCh37
na,na,4,55106779,55106779,KDR,Likely benign,Capillary infantile hemangioma|not specified|not provided,single nucleotide variant,GRCh38
na,na,8,11405576,11405576,BLK,Benign/Likely benign,Maturity-onset diabetes of the young type 11|not specified|Monogenic diabetes|not provided,single nucleotide variant,GRCh37
na,na,8,11548067,11548067,BLK,Benign/Likely benign,Maturity-onset diabetes of the young type 11|not specified|Monogenic diabetes|not provided,single nucleotide variant,GRCh38
na,na,8,11421955,11421955,BLK,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 11|not specified,single nucleotide variant,GRCh37
na,na,8,11564446,11564446,BLK,Conflicting classifications of pathogenicity,Maturity-onset diabetes of the young type 11|not specified,single nucleotide variant,GRCh38
na,na,8,11430641,11430641,BLK,Benign,Maturity-onset diabetes of the young type 11|not specified|BLK-related disorder,single nucleotide variant,GRCh37
na,na,8,11573132,11573132,BLK,Benign,Maturity-onset diabetes of the young type 11|not specified|BLK-related disorder,single nucleotide variant,GRCh38
na,na,8,11331747,11331747,BLK,Pathogenic,Maturity-onset diabetes of the young type 11,single nucleotide variant,GRCh37
na,na,8,11474238,11474238,BLK,Pathogenic,Maturity-onset diabetes of the young type 11,single nucleotide variant,GRCh38
na,na,8,11422122,11422122,BLK,Pathogenic,Maturity-onset diabetes of the young type 11,single nucleotide variant,GRCh37
na,na,8,11564613,11564613,BLK,Pathogenic,Maturity-onset diabetes of the young type 11,single nucleotide variant,GRCh38
na,na,11,2186957,2186957,TH,Pathogenic/Likely pathogenic,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh37
na,na,11,2165727,2165727,TH,Pathogenic/Likely pathogenic,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh38
na,na,11,2189126,2189126,TH,Pathogenic/Likely pathogenic,Autosomal recessive DOPA responsive dystonia|not provided,single nucleotide variant,GRCh37
na,na,11,2167896,2167896,TH,Pathogenic/Likely pathogenic,Autosomal recessive DOPA responsive dystonia|not provided,single nucleotide variant,GRCh38
na,na,11,2185569,2185569,TH,Conflicting classifications of pathogenicity,Autosomal recessive DOPA responsive dystonia|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,11,2164339,2164339,TH,Conflicting classifications of pathogenicity,Autosomal recessive DOPA responsive dystonia|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,11,2189135,2189135,TH,Pathogenic,Autosomal recessive DOPA responsive dystonia|not provided,single nucleotide variant,GRCh37
na,na,11,2167905,2167905,TH,Pathogenic,Autosomal recessive DOPA responsive dystonia|not provided,single nucleotide variant,GRCh38
na,na,11,2187923,2187923,TH,Pathogenic/Likely pathogenic,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh37
na,na,11,2166693,2166693,TH,Pathogenic/Likely pathogenic,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh38
na,na,11,2188225,2188225,TH,Uncertain significance,Autosomal recessive DOPA responsive dystonia|not specified,single nucleotide variant,GRCh37
na,na,11,2166995,2166995,TH,Uncertain significance,Autosomal recessive DOPA responsive dystonia|not specified,single nucleotide variant,GRCh38
na,na,11,2187992,2187992,TH,Conflicting classifications of pathogenicity,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh37
na,na,11,2166762,2166762,TH,Conflicting classifications of pathogenicity,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh38
na,na,11,2187017,2187017,TH,Pathogenic,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh37
na,na,11,2165787,2165787,TH,Pathogenic,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh38
na,na,11,2190990,2190990,TH,Pathogenic,Autosomal recessive DOPA responsive dystonia,Deletion,GRCh37
na,na,11,2169760,2169760,TH,Pathogenic,Autosomal recessive DOPA responsive dystonia,Deletion,GRCh38
na,na,11,2187774,2187774,TH,Likely pathogenic,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh37
na,na,11,2166544,2166544,TH,Likely pathogenic,Autosomal recessive DOPA responsive dystonia,single nucleotide variant,GRCh38
na,na,12,6443265,6443265,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh37
na,na,12,6334099,6334099,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh38
na,na,12,6442989,6442989,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided|Multiple sclerosis,single nucleotide variant,GRCh37
na,na,12,6333823,6333823,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided|Multiple sclerosis,single nucleotide variant,GRCh38
na,na,12,6443275,6443275,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,single nucleotide variant,GRCh37
na,na,12,6334109,6334109,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,single nucleotide variant,GRCh38
na,na,12,6442983,6442983,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,single nucleotide variant,GRCh37
na,na,12,6333817,6333817,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,single nucleotide variant,GRCh38
na,na,12,6442656,6442656,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh37
na,na,12,6333490,6333490,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh38
na,na,12,6442655,6442655,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh37
na,na,12,6333489,6333489,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh38
na,na,12,6442643,6442643,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh37
na,na,12,6333477,6333477,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh38
na,na,12,6443274,6443274,TNFRSF1A,Pathogenic/Likely pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,single nucleotide variant,GRCh37
na,na,12,6334108,6334108,TNFRSF1A,Pathogenic/Likely pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|not provided,single nucleotide variant,GRCh38
na,na,12,6443266,6443266,TNFRSF1A,Likely pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,6334100,6334100,TNFRSF1A,Likely pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS)|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,na,-1,-1,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),Deletion,na
na,na,12,6442930,6442930,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh37
na,na,12,6333764,6333764,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),single nucleotide variant,GRCh38
na,na,na,-1,-1,TNFRSF1A,Pathogenic,TNF receptor-associated periodic fever syndrome (TRAPS),Variation,na
na,na,17,7577539,7577539,TP53,Pathogenic,"Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm|Ovarian neoplasm|Lip and oral cavity carcinoma|Choroid plexus carcinoma|Gallbladder cancer|Malignant lymphoma, large B-cell, diffuse|Adrenocortical carcinoma, hereditary|Breast and/or ovarian cancer|Congenital fibrosarcoma|Gastric cancer|TP53-related disorder|Familial pancreatic carcinoma",single nucleotide variant,GRCh37
na,na,17,7674221,7674221,TP53,Pathogenic,"Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm|Ovarian neoplasm|Lip and oral cavity carcinoma|Choroid plexus carcinoma|Gallbladder cancer|Malignant lymphoma, large B-cell, diffuse|Adrenocortical carcinoma, hereditary|Breast and/or ovarian cancer|Congenital fibrosarcoma|Gastric cancer|TP53-related disorder|Familial pancreatic carcinoma",single nucleotide variant,GRCh38
na,na,17,7577509,7577509,TP53,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1|not provided|not specified|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Li-Fraumeni syndrome,single nucleotide variant,GRCh37
na,na,17,7674191,7674191,TP53,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1|not provided|not specified|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Li-Fraumeni syndrome,single nucleotide variant,GRCh38
na,na,17,7577548,7577548,TP53,Pathogenic,Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Neoplasm,single nucleotide variant,GRCh37
na,na,17,7674230,7674230,TP53,Pathogenic,Li-Fraumeni syndrome 1|not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Neoplasm,single nucleotide variant,GRCh38
na,na,17,7577526,7577526,TP53,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,7674208,7674208,TP53,Conflicting classifications of pathogenicity,Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,7579472,7579472,TP53,Benign,TP53 POLYMORPHISM|not provided|Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Lip and oral cavity carcinoma|Hereditary breast ovarian cancer syndrome|Acute myeloid leukemia|12 conditions|Neoplasm,single nucleotide variant,GRCh37
na,na,17,7676154,7676154,TP53,Benign,TP53 POLYMORPHISM|not provided|Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Lip and oral cavity carcinoma|Hereditary breast ovarian cancer syndrome|Acute myeloid leukemia|12 conditions|Neoplasm,single nucleotide variant,GRCh38
na,na,17,7577534,7577534,TP53,Pathogenic/Likely pathogenic,Hepatocellular carcinoma|Cervical cancer|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Squamous cell carcinoma of the head and neck|not provided|Li-Fraumeni syndrome 1|Adrenal cortex carcinoma|Neoplasm,single nucleotide variant,GRCh37
na,na,17,7674216,7674216,TP53,Pathogenic/Likely pathogenic,Hepatocellular carcinoma|Cervical cancer|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Squamous cell carcinoma of the head and neck|not provided|Li-Fraumeni syndrome 1|Adrenal cortex carcinoma|Neoplasm,single nucleotide variant,GRCh38
na,na,17,7578461,7578461,TP53,Pathogenic/Likely pathogenic,Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Neoplasm|Li-Fraumeni syndrome 1|Squamous cell carcinoma|not provided,single nucleotide variant,GRCh37
na,na,17,7675143,7675143,TP53,Pathogenic/Likely pathogenic,Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Neoplasm|Li-Fraumeni syndrome 1|Squamous cell carcinoma|not provided,single nucleotide variant,GRCh38
na,na,17,7577556,7577556,TP53,Pathogenic/Likely pathogenic,Li-fraumeni-like syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Li-Fraumeni syndrome 1|not provided|Familial cancer of breast,single nucleotide variant,GRCh37
na,na,17,7674238,7674238,TP53,Pathogenic/Likely pathogenic,Li-fraumeni-like syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Li-Fraumeni syndrome 1|not provided|Familial cancer of breast,single nucleotide variant,GRCh38
na,na,17,7577547,7577547,TP53,Pathogenic/Likely pathogenic,"Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|not provided|Adrenocortical carcinoma, hereditary",single nucleotide variant,GRCh37
na,na,17,7674229,7674229,TP53,Pathogenic/Likely pathogenic,"Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|not provided|Adrenocortical carcinoma, hereditary",single nucleotide variant,GRCh38
na,na,17,7577538,7577538,TP53,Pathogenic,"Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Sarcoma|not provided|Li-Fraumeni syndrome|Multiple myeloma|Neoplasm|11 conditions|Lymphoma|Ovarian neoplasm|Lip and oral cavity carcinoma|Rhabdomyosarcoma|Familial cancer of breast|Breast carcinoma|Ductal carcinoma in situ|Gastric cancer|Malignant tumor of urinary bladder|Adrenocortical carcinoma, hereditary|TP53-related disorder|Adrenal cortex carcinoma|Hereditary breast ovarian cancer syndrome|Colorectal cancer|12 conditions",single nucleotide variant,GRCh37
na,na,17,7674220,7674220,TP53,Pathogenic,"Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Sarcoma|not provided|Li-Fraumeni syndrome|Multiple myeloma|Neoplasm|11 conditions|Lymphoma|Ovarian neoplasm|Lip and oral cavity carcinoma|Rhabdomyosarcoma|Familial cancer of breast|Breast carcinoma|Ductal carcinoma in situ|Gastric cancer|Malignant tumor of urinary bladder|Adrenocortical carcinoma, hereditary|TP53-related disorder|Adrenal cortex carcinoma|Hereditary breast ovarian cancer syndrome|Colorectal cancer|12 conditions",single nucleotide variant,GRCh38
na,na,17,7578532,7578532,TP53,Pathogenic,Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,7675214,7675214,TP53,Pathogenic,Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,7577124,7577124,TP53,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome,single nucleotide variant,GRCh37
na,na,17,7673806,7673806,TP53,Pathogenic/Likely pathogenic,Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome,single nucleotide variant,GRCh38
na,na,17,7577559,7577559,TP53,Pathogenic/Likely pathogenic,Bone osteosarcoma|Hepatoblastoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Lip and oral cavity carcinoma|Li-Fraumeni syndrome 1|not provided|12 conditions|Neoplasm,single nucleotide variant,GRCh37
na,na,17,7674241,7674241,TP53,Pathogenic/Likely pathogenic,Bone osteosarcoma|Hepatoblastoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Lip and oral cavity carcinoma|Li-Fraumeni syndrome 1|not provided|12 conditions|Neoplasm,single nucleotide variant,GRCh38
na,na,17,7578220,7578221,TP53,Pathogenic,Li-Fraumeni syndrome 1,Deletion,GRCh37
na,na,17,7674902,7674903,TP53,Pathogenic,Li-Fraumeni syndrome 1,Deletion,GRCh38
na,na,17,7579329,7579329,TP53,Pathogenic,Li-fraumeni-like syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,17,7676011,7676011,TP53,Pathogenic,Li-fraumeni-like syndrome|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,17,7577094,7577094,TP53,Pathogenic/Likely pathogenic,"Li-fraumeni-like syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck|Ovarian neoplasm|Pleomorphic xanthoastrocytoma;Astrocytoma, anaplastic|Colorectal cancer|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Neoplasm|TP53-related disorder|Adrenocortical carcinoma, hereditary",single nucleotide variant,GRCh37
na,na,17,7673776,7673776,TP53,Pathogenic/Likely pathogenic,"Li-fraumeni-like syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck|Ovarian neoplasm|Pleomorphic xanthoastrocytoma;Astrocytoma, anaplastic|Colorectal cancer|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Neoplasm|TP53-related disorder|Adrenocortical carcinoma, hereditary",single nucleotide variant,GRCh38
na,na,17,7577548,7577548,TP53,Pathogenic,"Li-fraumeni-like syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Adenocarcinoma|not provided|Astrocytoma, anaplastic|Li-Fraumeni syndrome|Atypical teratoid rhabdoid tumor|Ovarian neoplasm|Colorectal cancer|Familial ovarian cancer|Breast carcinoma|12 conditions|Gastric cancer|Malignant tumor of urinary bladder|Adrenocortical carcinoma, hereditary|TP53-related disorder|See cases",single nucleotide variant,GRCh37
na,na,17,7674230,7674230,TP53,Pathogenic,"Li-fraumeni-like syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Adenocarcinoma|not provided|Astrocytoma, anaplastic|Li-Fraumeni syndrome|Atypical teratoid rhabdoid tumor|Ovarian neoplasm|Colorectal cancer|Familial ovarian cancer|Breast carcinoma|12 conditions|Gastric cancer|Malignant tumor of urinary bladder|Adrenocortical carcinoma, hereditary|TP53-related disorder|See cases",single nucleotide variant,GRCh38
na,na,17,7577120,7577120,TP53,Pathogenic,"Li-Fraumeni syndrome 1|Thyroid gland undifferentiated (anaplastic) carcinoma|not provided|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Malignant tumor of breast|Familial cancer of breast|Colorectal cancer;Multiple myeloma|Rhabdomyosarcoma|Gastric cancer|Adrenocortical carcinoma, hereditary|Breast and/or ovarian cancer|12 conditions|TP53-related disorder",single nucleotide variant,GRCh37
na,na,17,7673802,7673802,TP53,Pathogenic,"Li-Fraumeni syndrome 1|Thyroid gland undifferentiated (anaplastic) carcinoma|not provided|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Malignant tumor of breast|Familial cancer of breast|Colorectal cancer;Multiple myeloma|Rhabdomyosarcoma|Gastric cancer|Adrenocortical carcinoma, hereditary|Breast and/or ovarian cancer|12 conditions|TP53-related disorder",single nucleotide variant,GRCh38
na,na,17,7576872,7576872,TP53,Conflicting classifications of pathogenicity,Familial colorectal cancer|Non-Hodgkin lymphoma|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,7673554,7673554,TP53,Conflicting classifications of pathogenicity,Familial colorectal cancer|Non-Hodgkin lymphoma|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,7577099,7577099,TP53,Pathogenic/Likely pathogenic,Nasopharyngeal carcinoma|Li-Fraumeni syndrome|Acute myeloid leukemia|Malignant tumor of urinary bladder|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,17,7673781,7673781,TP53,Pathogenic/Likely pathogenic,Nasopharyngeal carcinoma|Li-Fraumeni syndrome|Acute myeloid leukemia|Malignant tumor of urinary bladder|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,17,7578479,7578479,TP53,Pathogenic/Likely pathogenic,"Breast adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Rhabdomyosarcoma",single nucleotide variant,GRCh37
na,na,17,7675161,7675161,TP53,Pathogenic/Likely pathogenic,"Breast adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Rhabdomyosarcoma",single nucleotide variant,GRCh38
na,na,17,7578479,7578479,TP53,Pathogenic/Likely pathogenic,Breast adenocarcinoma|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Rhabdomyosarcoma|Ovarian neoplasm|Li-Fraumeni syndrome 1,single nucleotide variant,GRCh37
na,na,17,7675161,7675161,TP53,Pathogenic/Likely pathogenic,Breast adenocarcinoma|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Rhabdomyosarcoma|Ovarian neoplasm|Li-Fraumeni syndrome 1,single nucleotide variant,GRCh38
na,na,17,7579582,7579582,TP53,Uncertain significance,Carcinoma of pancreas|Li-Fraumeni syndrome,single nucleotide variant,GRCh37
na,na,17,7676264,7676264,TP53,Uncertain significance,Carcinoma of pancreas|Li-Fraumeni syndrome,single nucleotide variant,GRCh38
na,na,17,7577511,7577511,TP53,Conflicting classifications of pathogenicity,Li-fraumeni-like syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,17,7674193,7674193,TP53,Conflicting classifications of pathogenicity,Li-fraumeni-like syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,na,-1,-1,TP53,Pathogenic,Li-Fraumeni syndrome 1,Deletion,na
na,na,17,7578406,7578406,TP53,Pathogenic,"Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm|not provided|Malignant tumor of esophagus|Gastric cancer|Ovarian neoplasm|Lip and oral cavity carcinoma|Squamous cell carcinoma of the head and neck|Familial cancer of breast|Colorectal cancer|TP53-related disorder|12 conditions|Adrenocortical carcinoma, hereditary",single nucleotide variant,GRCh37
na,na,17,7675088,7675088,TP53,Pathogenic,"Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm|not provided|Malignant tumor of esophagus|Gastric cancer|Ovarian neoplasm|Lip and oral cavity carcinoma|Squamous cell carcinoma of the head and neck|Familial cancer of breast|Colorectal cancer|TP53-related disorder|12 conditions|Adrenocortical carcinoma, hereditary",single nucleotide variant,GRCh38
na,na,17,7573996,7573996,TP53,Likely pathogenic,"Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenal cortex carcinoma|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary",single nucleotide variant,GRCh37
na,na,17,7670678,7670678,TP53,Likely pathogenic,"Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenal cortex carcinoma|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary",single nucleotide variant,GRCh38
na,na,17,7578518,7578518,TP53,Likely pathogenic,Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,7675200,7675200,TP53,Likely pathogenic,Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,7578398,7578398,TP53,Pathogenic,"Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|not provided",Deletion,GRCh37
na,na,17,7675080,7675080,TP53,Pathogenic,"Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|not provided",Deletion,GRCh38
na,na,17,7577063,7577063,TP53,Uncertain significance,Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,17,7673745,7673745,TP53,Uncertain significance,Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,17,7574017,7574017,TP53,Pathogenic/Likely pathogenic,"ADRENOCORTICAL CARCINOMA, PEDIATRIC|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Breast neoplasm|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Squamous cell carcinoma of the head and neck|Hereditary breast ovarian cancer syndrome|12 conditions|Gastric cancer|TP53-related disorder",single nucleotide variant,GRCh37
na,na,17,7670699,7670699,TP53,Pathogenic/Likely pathogenic,"ADRENOCORTICAL CARCINOMA, PEDIATRIC|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Breast neoplasm|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Squamous cell carcinoma of the head and neck|Hereditary breast ovarian cancer syndrome|12 conditions|Gastric cancer|TP53-related disorder",single nucleotide variant,GRCh38
na,na,17,7578448,7578449,TP53,Pathogenic,Choroid plexus papilloma|Bone osteosarcoma,Duplication,GRCh37
na,na,17,7675130,7675131,TP53,Pathogenic,Choroid plexus papilloma|Bone osteosarcoma,Duplication,GRCh38
na,na,na,-1,-1,TP53,Pathogenic,Li-Fraumeni syndrome 1,Indel,na
na,na,17,7578283,7578283,TP53,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|Familial colorectal cancer|not specified|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1;Familial cancer of breast,single nucleotide variant,GRCh37
na,na,17,7674965,7674965,TP53,Conflicting classifications of pathogenicity,Hereditary cancer-predisposing syndrome|Familial colorectal cancer|not specified|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1;Familial cancer of breast,single nucleotide variant,GRCh38
na,na,17,7578190,7578190,TP53,Pathogenic,Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Ovarian neoplasm|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,7674872,7674872,TP53,Pathogenic,Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Ovarian neoplasm|Hereditary cancer-predisposing syndrome|not provided,single nucleotide variant,GRCh38
na,na,17,7577084,7577084,TP53,Pathogenic,"ADRENOCORTICAL CARCINOMA, PEDIATRIC|Choroid plexus carcinoma|Li-Fraumeni syndrome|Neoplasm",single nucleotide variant,GRCh37
na,na,17,7673766,7673766,TP53,Pathogenic,"ADRENOCORTICAL CARCINOMA, PEDIATRIC|Choroid plexus carcinoma|Li-Fraumeni syndrome|Neoplasm",single nucleotide variant,GRCh38
na,na,na,-1,-1,TNF,Pathogenic,"TNF receptor binding, altered",Variation,na
na,na,6,31544934,31544934,TNF,Pathogenic,"TNF receptor binding, altered",single nucleotide variant,GRCh37
na,na,6,31577157,31577157,TNF,Pathogenic,"TNF receptor binding, altered",single nucleotide variant,GRCh38
na,na,6,31542963,31542963,TNF,risk factor,"Malaria, cerebral, susceptibility to",single nucleotide variant,GRCh37
na,na,6,31575186,31575186,TNF,risk factor,"Malaria, cerebral, susceptibility to",single nucleotide variant,GRCh38
na,na,6,31542482,31542482,TNF,risk factor,|,single nucleotide variant,GRCh37
na,na,6,31574705,31574705,TNF,risk factor,|,single nucleotide variant,GRCh38
na,na,6,31542476,31542476,TNF,protective,"Alzheimer disease, protection against",single nucleotide variant,GRCh37
na,na,6,31574699,31574699,TNF,protective,"Alzheimer disease, protection against",single nucleotide variant,GRCh38
na,na,16,2135302,2135302,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,Deletion,GRCh37
na,na,16,2085301,2085301,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,Deletion,GRCh38
na,na,16,2137898,2137898,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|not provided|Tuberous sclerosis 2;Lymphangiomyomatosis;Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|TSC2-related disorder,single nucleotide variant,GRCh37
na,na,16,2087897,2087897,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|not provided|Tuberous sclerosis 2;Lymphangiomyomatosis;Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|TSC2-related disorder,single nucleotide variant,GRCh38
na,na,16,2098650,2098650,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,single nucleotide variant,GRCh37
na,na,16,2048649,2048649,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,single nucleotide variant,GRCh38
na,na,16,2121893,2121894,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,Duplication,GRCh37
na,na,16,2071892,2071893,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,Duplication,GRCh38
na,na,16,2114342,2114342,TSC2,Pathogenic,Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2;Lymphangiomyomatosis;Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,16,2064341,2064341,TSC2,Pathogenic,Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2;Lymphangiomyomatosis;Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,16,2120572,2120572,TSC2,Pathogenic/Likely pathogenic,Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2;Lymphangiomyomatosis;Isolated focal cortical dysplasia type II,single nucleotide variant,GRCh37
na,na,16,2070571,2070571,TSC2,Pathogenic/Likely pathogenic,Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2;Lymphangiomyomatosis;Isolated focal cortical dysplasia type II,single nucleotide variant,GRCh38
na,na,16,2122294,2122294,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,single nucleotide variant,GRCh37
na,na,16,2072293,2072293,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,single nucleotide variant,GRCh38
na,na,16,2113043,2113043,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided,single nucleotide variant,GRCh37
na,na,16,2063042,2063042,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided,single nucleotide variant,GRCh38
na,na,16,2110791,2110791,TSC2,Pathogenic,Tuberous sclerosis syndrome|Lymphangiomyomatosis|not provided|Tuberous sclerosis 2,single nucleotide variant,GRCh37
na,na,16,2060790,2060790,TSC2,Pathogenic,Tuberous sclerosis syndrome|Lymphangiomyomatosis|not provided|Tuberous sclerosis 2,single nucleotide variant,GRCh38
na,na,16,2134966,2134966,TSC2,Pathogenic/Likely pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II,single nucleotide variant,GRCh37
na,na,16,2084965,2084965,TSC2,Pathogenic/Likely pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II,single nucleotide variant,GRCh38
na,na,16,2138294,2138311,TSC2,Pathogenic/Likely pathogenic,Tuberous sclerosis 2|Lymphangiomyomatosis;Tuberous sclerosis syndrome|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided,Deletion,GRCh37
na,na,16,2088293,2088310,TSC2,Pathogenic/Likely pathogenic,Tuberous sclerosis 2|Lymphangiomyomatosis;Tuberous sclerosis syndrome|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided,Deletion,GRCh38
na,na,16,2126143,2126143,TSC2,Pathogenic/Likely pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II;Lymphangiomyomatosis;Tuberous sclerosis 2|TSC2-related disorder,single nucleotide variant,GRCh37
na,na,16,2076142,2076142,TSC2,Pathogenic/Likely pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II;Lymphangiomyomatosis;Tuberous sclerosis 2|TSC2-related disorder,single nucleotide variant,GRCh38
na,na,16,2126142,2126142,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Isolated focal cortical dysplasia type II;Lymphangiomyomatosis;Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,16,2076141,2076141,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Isolated focal cortical dysplasia type II;Lymphangiomyomatosis;Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,16,2126142,2126142,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided,single nucleotide variant,GRCh37
na,na,16,2076141,2076141,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided,single nucleotide variant,GRCh38
na,na,16,2122983,2122986,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided,Deletion,GRCh37
na,na,16,2072982,2072985,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided,Deletion,GRCh38
na,na,16,2112562,2112562,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,single nucleotide variant,GRCh37
na,na,16,2062561,2062561,TSC2,Pathogenic,Tuberous sclerosis 2|Tuberous sclerosis syndrome,single nucleotide variant,GRCh38
na,na,1,201334766,201334766,TNNT2,Pathogenic,"Dilated cardiomyopathy 1D|Hypertrophic cardiomyopathy 2|Cardiomyopathy, familial restrictive, 3|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Cardiomyopathy",single nucleotide variant,GRCh37
na,na,1,201365638,201365638,TNNT2,Pathogenic,"Dilated cardiomyopathy 1D|Hypertrophic cardiomyopathy 2|Cardiomyopathy, familial restrictive, 3|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Cardiomyopathy",single nucleotide variant,GRCh38
na,na,1,201334425,201334425,TNNT2,Pathogenic/Likely pathogenic,"Hypertrophic cardiomyopathy 2|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Cardiovascular phenotype|Cardiomyopathy, familial restrictive, 3|Dilated cardiomyopathy 1D",single nucleotide variant,GRCh37
na,na,1,201365297,201365297,TNNT2,Pathogenic/Likely pathogenic,"Hypertrophic cardiomyopathy 2|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Cardiovascular phenotype|Cardiomyopathy, familial restrictive, 3|Dilated cardiomyopathy 1D",single nucleotide variant,GRCh38
na,na,1,201328373,201328373,TNNT2,Conflicting classifications of pathogenicity,"Hypertrophic cardiomyopathy 2|not specified|not provided|Hypertrophic cardiomyopathy 1|Costello syndrome|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Cardiovascular phenotype|Cardiomyopathy|Dilated cardiomyopathy 1D|Hypertrophic cardiomyopathy",single nucleotide variant,GRCh37
na,na,1,201359245,201359245,TNNT2,Conflicting classifications of pathogenicity,"Hypertrophic cardiomyopathy 2|not specified|not provided|Hypertrophic cardiomyopathy 1|Costello syndrome|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Cardiovascular phenotype|Cardiomyopathy|Dilated cardiomyopathy 1D|Hypertrophic cardiomyopathy",single nucleotide variant,GRCh38
na,na,1,201334372,201334372,TNNT2,Pathogenic,"Hypertrophic cardiomyopathy 2|not provided|Dilated cardiomyopathy 1D|Cardiomyopathy|Cardiomyopathy, familial restrictive, 3|Hypertrophic cardiomyopathy",single nucleotide variant,GRCh37
na,na,1,201365244,201365244,TNNT2,Pathogenic,"Hypertrophic cardiomyopathy 2|not provided|Dilated cardiomyopathy 1D|Cardiomyopathy|Cardiomyopathy, familial restrictive, 3|Hypertrophic cardiomyopathy",single nucleotide variant,GRCh38
na,na,1,201333464,201333464,TNNT2,Pathogenic/Likely pathogenic,"Dilated cardiomyopathy 1D|Primary dilated cardiomyopathy|not provided|Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Familial isolated dilated cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy 2|Cardiomyopathy, familial restrictive, 3|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,1,201364336,201364336,TNNT2,Pathogenic/Likely pathogenic,"Dilated cardiomyopathy 1D|Primary dilated cardiomyopathy|not provided|Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Familial isolated dilated cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy 2|Cardiomyopathy, familial restrictive, 3|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,1,201333494,201333494,TNNT2,Pathogenic/Likely pathogenic,"Dilated cardiomyopathy 1D|Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2;Cardiomyopathy, familial restrictive, 3|Cardiomyopathy, familial restrictive, 3|Hypertrophic cardiomyopathy 2",single nucleotide variant,GRCh37
na,na,1,201364366,201364366,TNNT2,Pathogenic/Likely pathogenic,"Dilated cardiomyopathy 1D|Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2;Cardiomyopathy, familial restrictive, 3|Cardiomyopathy, familial restrictive, 3|Hypertrophic cardiomyopathy 2",single nucleotide variant,GRCh38
na,na,1,201331116,201331116,TNNT2,Pathogenic,Dilated cardiomyopathy 1D,single nucleotide variant,GRCh37
na,na,1,201361988,201361988,TNNT2,Pathogenic,Dilated cardiomyopathy 1D,single nucleotide variant,GRCh38
na,na,1,201328764,201328764,TNNT2,Uncertain significance,"Dilated cardiomyopathy 1D|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Cardiomyopathy|Cardiovascular phenotype|Hypertrophic cardiomyopathy 2|Cardiomyopathy, familial restrictive, 3",single nucleotide variant,GRCh37
na,na,1,201359636,201359636,TNNT2,Uncertain significance,"Dilated cardiomyopathy 1D|Cardiomyopathy, familial restrictive, 3;Dilated cardiomyopathy 1D;Hypertrophic cardiomyopathy 2|Cardiomyopathy|Cardiovascular phenotype|Hypertrophic cardiomyopathy 2|Cardiomyopathy, familial restrictive, 3",single nucleotide variant,GRCh38
na,na,19,55665514,55665514,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,19,55154146,55154146,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7|Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,19,55663219,55663219,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7,single nucleotide variant,GRCh37
na,na,19,55151851,55151851,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7,single nucleotide variant,GRCh38
na,na,19,55667607,55667607,TNNI3,Benign/Likely benign,"Hypertrophic cardiomyopathy 7|not specified|Hypertrophic cardiomyopathy|not provided|Dilated Cardiomyopathy, Recessive|Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiovascular phenotype|Familial restrictive cardiomyopathy|Cardiomyopathy;Amyloidosis, hereditary systemic 1|Dilated cardiomyopathy 2A|Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy 7;Dilated cardiomyopathy 2A;Cardiomyopathy, familial restrictive, 1;Dilated cardiomyopathy 1FF",single nucleotide variant,GRCh37
na,na,19,55156239,55156239,TNNI3,Benign/Likely benign,"Hypertrophic cardiomyopathy 7|not specified|Hypertrophic cardiomyopathy|not provided|Dilated Cardiomyopathy, Recessive|Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiovascular phenotype|Familial restrictive cardiomyopathy|Cardiomyopathy;Amyloidosis, hereditary systemic 1|Dilated cardiomyopathy 2A|Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy 7;Dilated cardiomyopathy 2A;Cardiomyopathy, familial restrictive, 1;Dilated cardiomyopathy 1FF",single nucleotide variant,GRCh38
na,na,19,55663249,55663249,TNNI3,Pathogenic/Likely pathogenic,"Hypertrophic cardiomyopathy 7|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy 7;Dilated cardiomyopathy 2A;Cardiomyopathy, familial restrictive, 1;Dilated cardiomyopathy 1FF|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,55151881,55151881,TNNI3,Pathogenic/Likely pathogenic,"Hypertrophic cardiomyopathy 7|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy 7;Dilated cardiomyopathy 2A;Cardiomyopathy, familial restrictive, 1;Dilated cardiomyopathy 1FF|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,55663266,55663266,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy 7",single nucleotide variant,GRCh37
na,na,19,55151898,55151898,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy 7",single nucleotide variant,GRCh38
na,na,19,55663260,55663260,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1|Restrictive cardiomyopathy;Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Restrictive cardiomyopathy|Cardiovascular phenotype|SUDDEN INFANT DEATH SYNDROME|Dilated cardiomyopathy 2A",single nucleotide variant,GRCh37
na,na,19,55151892,55151892,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1|Restrictive cardiomyopathy;Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Restrictive cardiomyopathy|Cardiovascular phenotype|SUDDEN INFANT DEATH SYNDROME|Dilated cardiomyopathy 2A",single nucleotide variant,GRCh38
na,na,19,55665415,55665415,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy 7",single nucleotide variant,GRCh37
na,na,19,55154047,55154047,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy 7",single nucleotide variant,GRCh38
na,na,19,55665514,55665514,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy|Restrictive cardiomyopathy;Hypertrophic cardiomyopathy|SUDDEN INFANT DEATH SYNDROME|Hypertrophic cardiomyopathy 7;Dilated cardiomyopathy 2A;Cardiomyopathy, familial restrictive, 1;Dilated cardiomyopathy 1FF|TNNI3-related disorder",single nucleotide variant,GRCh37
na,na,19,55154146,55154146,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy|Restrictive cardiomyopathy;Hypertrophic cardiomyopathy|SUDDEN INFANT DEATH SYNDROME|Hypertrophic cardiomyopathy 7;Dilated cardiomyopathy 2A;Cardiomyopathy, familial restrictive, 1;Dilated cardiomyopathy 1FF|TNNI3-related disorder",single nucleotide variant,GRCh38
na,na,19,55665516,55665516,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1",single nucleotide variant,GRCh37
na,na,19,55154148,55154148,TNNI3,Pathogenic,"Cardiomyopathy, familial restrictive, 1",single nucleotide variant,GRCh38
na,na,19,55665436,55665436,TNNI3,Conflicting classifications of pathogenicity,"Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,19,55154068,55154068,TNNI3,Conflicting classifications of pathogenicity,"Cardiomyopathy, familial restrictive, 1|Hypertrophic cardiomyopathy|not specified|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,19,55668420,55668420,TNNI3,Pathogenic,Dilated cardiomyopathy 1FF,single nucleotide variant,GRCh37
na,na,19,55157052,55157052,TNNI3,Pathogenic,Dilated cardiomyopathy 1FF,single nucleotide variant,GRCh38
na,na,19,55663280,55663280,TNNI3,Pathogenic,Dilated cardiomyopathy 1FF,single nucleotide variant,GRCh37
na,na,19,55151912,55151912,TNNI3,Pathogenic,Dilated cardiomyopathy 1FF,single nucleotide variant,GRCh38
na,na,19,55663228,55663228,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7,single nucleotide variant,GRCh37
na,na,19,55151860,55151860,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7,single nucleotide variant,GRCh38
na,na,19,55665398,55665400,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7,Deletion,GRCh37
na,na,19,55154030,55154032,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7,Deletion,GRCh38
na,na,19,55668465,55668465,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,19,55157097,55157097,TNNI3,Pathogenic,Hypertrophic cardiomyopathy 7|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,11,1862753,1862753,TNNI2,Pathogenic,Distal arthrogryposis type 2B1|not provided,single nucleotide variant,GRCh37
na,na,11,1841523,1841523,TNNI2,Pathogenic,Distal arthrogryposis type 2B1|not provided,single nucleotide variant,GRCh38
na,na,11,1862698,1862698,TNNI2,Pathogenic,Distal arthrogryposis type 2B1|not provided|Ulnar deviation of the wrist;Congenital finger flexion contractures;Calcaneovalgus deformity;Distal arthrogryposis,single nucleotide variant,GRCh37
na,na,11,1841468,1841468,TNNI2,Pathogenic,Distal arthrogryposis type 2B1|not provided|Ulnar deviation of the wrist;Congenital finger flexion contractures;Calcaneovalgus deformity;Distal arthrogryposis,single nucleotide variant,GRCh38
na,na,11,1862754,1862756,TNNI2,Pathogenic/Likely pathogenic,Distal arthrogryposis type 2B1|not provided|TNNI2-related disorder,Microsatellite,GRCh37
na,na,11,1841524,1841526,TNNI2,Pathogenic/Likely pathogenic,Distal arthrogryposis type 2B1|not provided|TNNI2-related disorder,Microsatellite,GRCh38
na,na,11,1862728,1862730,TNNI2,Pathogenic,Distal arthrogryposis type 2B1|not provided,Microsatellite,GRCh37
na,na,11,1841498,1841500,TNNI2,Pathogenic,Distal arthrogryposis type 2B1|not provided,Microsatellite,GRCh38
na,na,19,55648544,55648544,TNNT1,Pathogenic,Nemaline myopathy 5|not provided,single nucleotide variant,GRCh37
na,na,19,55137176,55137176,TNNT1,Pathogenic,Nemaline myopathy 5|not provided,single nucleotide variant,GRCh38
na,na,3,52485301,52485301,TNNC1,Likely pathogenic,Dilated cardiomyopathy 1Z|not provided,single nucleotide variant,GRCh37
na,na,3,52451285,52451285,TNNC1,Likely pathogenic,Dilated cardiomyopathy 1Z|not provided,single nucleotide variant,GRCh38
na,na,3,52486238,52486238,TNNC1,Uncertain significance,Hypertrophic cardiomyopathy 13|not specified|Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,3,52452222,52452222,TNNC1,Uncertain significance,Hypertrophic cardiomyopathy 13|not specified|Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,3,52488009,52488009,TNNC1,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 13|not specified|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z|Cardiomyopathy|Dilated cardiomyopathy 1Z,single nucleotide variant,GRCh37
na,na,3,52453993,52453993,TNNC1,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 13|not specified|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z|Cardiomyopathy|Dilated cardiomyopathy 1Z,single nucleotide variant,GRCh38
na,na,3,52485826,52485826,TNNC1,Uncertain significance,Hypertrophic cardiomyopathy 13|Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z,single nucleotide variant,GRCh37
na,na,3,52451810,52451810,TNNC1,Uncertain significance,Hypertrophic cardiomyopathy 13|Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z,single nucleotide variant,GRCh38
na,na,3,52485426,52485426,TNNC1,Uncertain significance,Hypertrophic cardiomyopathy 13|Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z|Dilated cardiomyopathy 1S|not specified|Cardiovascular phenotype|not provided|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,3,52451410,52451410,TNNC1,Uncertain significance,Hypertrophic cardiomyopathy 13|Hypertrophic cardiomyopathy 13;Dilated cardiomyopathy 1Z|Dilated cardiomyopathy 1S|not specified|Cardiovascular phenotype|not provided|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,1,154164469,154164469,TPM3,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy 4A, autosomal dominant",single nucleotide variant,GRCh37
na,na,1,154191993,154191993,TPM3,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy 4A, autosomal dominant",single nucleotide variant,GRCh38
na,na,1,154140414,154140414,TPM3,Likely pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,154167938,154167938,TPM3,Likely pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive",single nucleotide variant,GRCh38
na,na,1,154140417,154140417,TPM3,Uncertain significance,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,154167941,154167941,TPM3,Uncertain significance,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive",single nucleotide variant,GRCh38
na,na,1,154164401,154164401,TPM3,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy 4A, autosomal dominant|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,154191925,154191925,TPM3,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy 4A, autosomal dominant|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive",single nucleotide variant,GRCh38
na,na,1,154145447,154145447,TPM3,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy 4A, autosomal dominant|Congenital myopathy 4B, autosomal recessive;Congenital myopathy with fiber type disproportion|See cases",single nucleotide variant,GRCh37
na,na,1,154172971,154172971,TPM3,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided|Congenital myopathy 4A, autosomal dominant|Congenital myopathy 4B, autosomal recessive;Congenital myopathy with fiber type disproportion|See cases",single nucleotide variant,GRCh38
na,na,1,154140416,154140416,TPM3,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided",Deletion,GRCh37
na,na,1,154167940,154167940,TPM3,Pathogenic,"Congenital myopathy 4B, autosomal recessive|not provided",Deletion,GRCh38
na,na,1,154148670,154148670,TPM3,Pathogenic,"Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy 4A, autosomal dominant",single nucleotide variant,GRCh37
na,na,1,154176194,154176194,TPM3,Pathogenic,"Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy 4A, autosomal dominant",single nucleotide variant,GRCh38
na,na,1,154145448,154145448,TPM3,Pathogenic/Likely pathogenic,"Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy 4B, autosomal recessive|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive|Congenital myopathy 4A, autosomal dominant|TPM3-related core myopathy",single nucleotide variant,GRCh37
na,na,1,154172972,154172972,TPM3,Pathogenic/Likely pathogenic,"Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy 4B, autosomal recessive|Congenital myopathy with fiber type disproportion;Congenital myopathy 4B, autosomal recessive|Congenital myopathy 4A, autosomal dominant|TPM3-related core myopathy",single nucleotide variant,GRCh38
na,na,1,154145448,154145448,TPM3,Pathogenic,"Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy 4A, autosomal dominant|Congenital myopathy 4B, autosomal recessive;Congenital myopathy with fiber type disproportion|Inborn genetic diseases|Nemaline myopathy",single nucleotide variant,GRCh37
na,na,1,154172972,154172972,TPM3,Pathogenic,"Congenital myopathy with fiber type disproportion|not provided|Congenital myopathy 4A, autosomal dominant|Congenital myopathy 4B, autosomal recessive;Congenital myopathy with fiber type disproportion|Inborn genetic diseases|Nemaline myopathy",single nucleotide variant,GRCh38
na,na,15,63353114,63353114,TPM1,Pathogenic,Hypertrophic cardiomyopathy 3|not provided|Hypertrophic cardiomyopathy,single nucleotide variant,GRCh37
na,na,15,63060915,63060915,TPM1,Pathogenic,Hypertrophic cardiomyopathy 3|not provided|Hypertrophic cardiomyopathy,single nucleotide variant,GRCh38
na,na,15,63353098,63353098,TPM1,Pathogenic,Hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy 1Y|Cardiomyopathy|Primary dilated cardiomyopathy,single nucleotide variant,GRCh37
na,na,15,63060899,63060899,TPM1,Pathogenic,Hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy 1Y|Cardiomyopathy|Primary dilated cardiomyopathy,single nucleotide variant,GRCh38
na,na,15,63349227,63349227,TPM1,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 3|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,15,63057028,63057028,TPM1,Pathogenic/Likely pathogenic,Hypertrophic cardiomyopathy 3|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,15,63336271,63336271,TPM1,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1Y|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,15,63044072,63044072,TPM1,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1Y|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,15,63336229,63336229,TPM1,Uncertain significance,Dilated cardiomyopathy 1Y|Hypertrophic cardiomyopathy,single nucleotide variant,GRCh37
na,na,15,63044030,63044030,TPM1,Uncertain significance,Dilated cardiomyopathy 1Y|Hypertrophic cardiomyopathy,single nucleotide variant,GRCh38
na,na,9,35685747,35685747,TPM2,Pathogenic,"Arthrogryposis, distal, type 1A|not provided",single nucleotide variant,GRCh37
na,na,9,35685750,35685750,TPM2,Pathogenic,"Arthrogryposis, distal, type 1A|not provided",single nucleotide variant,GRCh38
na,na,9,35685483,35685483,TPM2,Uncertain significance,"Congenital myopathy 23|not provided|Arthrogryposis, distal, type 1A",single nucleotide variant,GRCh37
na,na,9,35685486,35685486,TPM2,Uncertain significance,"Congenital myopathy 23|not provided|Arthrogryposis, distal, type 1A",single nucleotide variant,GRCh38
na,na,9,35685669,35685669,TPM2,Pathogenic/Likely pathogenic,"Congenital myopathy 23|not provided|Arthrogryposis, distal, type 1A|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,9,35685672,35685672,TPM2,Pathogenic/Likely pathogenic,"Congenital myopathy 23|not provided|Arthrogryposis, distal, type 1A|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,9,35685526,35685526,TPM2,Pathogenic,"Arthrogryposis, distal, type 2B4|not provided|Arthrogryposis, distal, type 1A|TPM2-related disorder|Arthrogryposis",single nucleotide variant,GRCh37
na,na,9,35685529,35685529,TPM2,Pathogenic,"Arthrogryposis, distal, type 2B4|not provided|Arthrogryposis, distal, type 1A|TPM2-related disorder|Arthrogryposis",single nucleotide variant,GRCh38
na,na,9,35689262,35689262,TPM2,Pathogenic,"not provided|Congenital myopathy 23|Arthrogryposis, distal, type 1A",single nucleotide variant,GRCh37
na,na,9,35689265,35689265,TPM2,Pathogenic,"not provided|Congenital myopathy 23|Arthrogryposis, distal, type 1A",single nucleotide variant,GRCh38
na,na,9,35685506,35685508,TPM2,Pathogenic,"not provided|Congenital myopathy 23|Arthrogryposis, distal, type 1A|TPM2-related disorder",Microsatellite,GRCh37
na,na,9,35685509,35685511,TPM2,Pathogenic,"not provided|Congenital myopathy 23|Arthrogryposis, distal, type 1A|TPM2-related disorder",Microsatellite,GRCh38
na,na,9,35689236,35689238,TPM2,Likely pathogenic,"not provided|Arthrogryposis, distal, type 1A|Congenital myopathy 23",Microsatellite,GRCh37
na,na,9,35689239,35689241,TPM2,Likely pathogenic,"not provided|Arthrogryposis, distal, type 1A|Congenital myopathy 23",Microsatellite,GRCh38
na,na,9,35684762,35684762,TPM2,Pathogenic,not provided|Congenital myopathy 23,single nucleotide variant,GRCh37
na,na,9,35684765,35684765,TPM2,Pathogenic,not provided|Congenital myopathy 23,single nucleotide variant,GRCh38
na,na,12,6978338,6978338,TPI1,Pathogenic/Likely pathogenic,Triosephosphate isomerase deficiency|not provided,single nucleotide variant,GRCh37
na,na,12,6869174,6869174,TPI1,Pathogenic/Likely pathogenic,Triosephosphate isomerase deficiency|not provided,single nucleotide variant,GRCh38
na,na,12,6978464,6978464,TPI1,Uncertain significance,Triosephosphate isomerase manchester|not provided,single nucleotide variant,GRCh37
na,na,12,6869300,6869300,TPI1,Uncertain significance,Triosephosphate isomerase manchester|not provided,single nucleotide variant,GRCh38
na,na,12,6979518,6979518,TPI1,Pathogenic,Triosephosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,12,6870354,6870354,TPI1,Pathogenic,Triosephosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,12,6978037,6978037,TPI1,Pathogenic,Triosephosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,12,6868873,6868873,TPI1,Pathogenic,Triosephosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,12,6978905,6978905,TPI1,Pathogenic,Triosephosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,12,6869741,6869741,TPI1,Pathogenic,Triosephosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,12,6978533,6978533,TPI1,Pathogenic,Triosephosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,12,6869369,6869369,TPI1,Pathogenic,Triosephosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,14,76447266,76447266,TGFB3,Uncertain significance,Arrhythmogenic right ventricular dysplasia 1|not provided|TGFB3-related disorder|Rienhoff syndrome|Arrhythmogenic right ventricular dysplasia 1;Rienhoff syndrome,single nucleotide variant,GRCh37
na,na,14,75980923,75980923,TGFB3,Uncertain significance,Arrhythmogenic right ventricular dysplasia 1|not provided|TGFB3-related disorder|Rienhoff syndrome|Arrhythmogenic right ventricular dysplasia 1;Rienhoff syndrome,single nucleotide variant,GRCh38
na,na,14,76425035,76425035,TGFB3,Uncertain significance,Arrhythmogenic right ventricular dysplasia 1|Rienhoff syndrome|TGFB3-related disorder,single nucleotide variant,GRCh37
na,na,14,75958692,75958692,TGFB3,Uncertain significance,Arrhythmogenic right ventricular dysplasia 1|Rienhoff syndrome|TGFB3-related disorder,single nucleotide variant,GRCh38
na,na,9,139402690,139402690,NOTCH1,Pathogenic,Aortic valve disease 1|Adams-Oliver syndrome 5|not provided,single nucleotide variant,GRCh37
na,na,9,136508238,136508238,NOTCH1,Pathogenic,Aortic valve disease 1|Adams-Oliver syndrome 5|not provided,single nucleotide variant,GRCh38
na,na,9,139399836,139399836,NOTCH1,Pathogenic,Aortic valve disease 1,Deletion,GRCh37
na,na,9,136505384,136505384,NOTCH1,Pathogenic,Aortic valve disease 1,Deletion,GRCh38
na,na,14,24727742,24727742,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,Deletion,GRCh37
na,na,14,24258536,24258536,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,Deletion,GRCh38
na,na,14,24731434,24731434,TGM1,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 1|not specified|not provided,single nucleotide variant,GRCh37
na,na,14,24262228,24262228,TGM1,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 1|not specified|not provided,single nucleotide variant,GRCh38
na,na,14,24730981,24730981,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Abnormality of the skin,single nucleotide variant,GRCh37
na,na,14,24261775,24261775,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Abnormality of the skin,single nucleotide variant,GRCh38
na,na,14,24730930,24730930,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,single nucleotide variant,GRCh37
na,na,14,24261724,24261724,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,single nucleotide variant,GRCh38
na,na,14,24730985,24730985,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,14,24261779,24261779,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,14,24728926,24728926,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,14,24259720,24259720,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,14,24730984,24730984,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Abnormality of the skin|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,14,24261778,24261778,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Abnormality of the skin|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,14,24728305,24728305,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,14,24259099,24259099,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,14,24727852,24727852,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided,single nucleotide variant,GRCh37
na,na,14,24258646,24258646,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided,single nucleotide variant,GRCh38
na,na,14,24728293,24728293,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis|TGM1-related disorder|Abnormality of the skin,single nucleotide variant,GRCh37
na,na,14,24259087,24259087,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis|TGM1-related disorder|Abnormality of the skin,single nucleotide variant,GRCh38
na,na,14,24727873,24727873,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Abnormality of the skin|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,14,24258667,24258667,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Abnormality of the skin|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,14,24723469,24723469,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,Deletion,GRCh37
na,na,14,24254263,24254263,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,Deletion,GRCh38
na,na,14,24725217,24725217,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|Lamellar ichthyosis|not provided,single nucleotide variant,GRCh37
na,na,14,24256011,24256011,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|Lamellar ichthyosis|not provided,single nucleotide variant,GRCh38
na,na,14,24729190,24729190,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,14,24259984,24259984,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,14,24727864,24727864,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,single nucleotide variant,GRCh37
na,na,14,24258658,24258658,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,single nucleotide variant,GRCh38
na,na,14,24730984,24730984,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,single nucleotide variant,GRCh37
na,na,14,24261778,24261778,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,single nucleotide variant,GRCh38
na,na,14,24729165,24729165,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|TGM1-related disorder,single nucleotide variant,GRCh37
na,na,14,24259959,24259959,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|TGM1-related disorder,single nucleotide variant,GRCh38
na,na,14,24724663,24724663,TGM1,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 1|not specified|not provided,single nucleotide variant,GRCh37
na,na,14,24255457,24255457,TGM1,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 1|not specified|not provided,single nucleotide variant,GRCh38
na,na,14,24731278,24731278,TGM1,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 1|not provided,single nucleotide variant,GRCh37
na,na,14,24262072,24262072,TGM1,Conflicting classifications of pathogenicity,Autosomal recessive congenital ichthyosis 1|not provided,single nucleotide variant,GRCh38
na,na,14,24729156,24729156,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,single nucleotide variant,GRCh37
na,na,14,24259950,24259950,TGM1,Pathogenic,Autosomal recessive congenital ichthyosis 1,single nucleotide variant,GRCh38
na,na,14,24728975,24728975,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,14,24259769,24259769,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,14,24729761,24729761,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Congenital ichthyosiform erythroderma|Lamellar ichthyosis,single nucleotide variant,GRCh37
na,na,14,24260555,24260555,TGM1,Pathogenic/Likely pathogenic,Autosomal recessive congenital ichthyosis 1|not provided|Congenital ichthyosiform erythroderma|Lamellar ichthyosis,single nucleotide variant,GRCh38
na,na,3,30732982,30732983,TGFBR2,Pathogenic,"Colorectal cancer, hereditary nonpolyposis, type 6",Microsatellite,GRCh37
na,na,3,30691490,30691491,TGFBR2,Pathogenic,"Colorectal cancer, hereditary nonpolyposis, type 6",Microsatellite,GRCh38
na,na,3,30713619,30713619,TGFBR2,Benign/Likely benign,"Colorectal cancer, hereditary nonpolyposis, type 6|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Familial colorectal cancer|Loeys-Dietz syndrome 2|not provided|Ehlers-Danlos syndrome|not specified",single nucleotide variant,GRCh37
na,na,3,30672127,30672127,TGFBR2,Benign/Likely benign,"Colorectal cancer, hereditary nonpolyposis, type 6|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Familial colorectal cancer|Loeys-Dietz syndrome 2|not provided|Ehlers-Danlos syndrome|not specified",single nucleotide variant,GRCh38
na,na,3,30732963,30732963,TGFBR2,Pathogenic,Malignant tumor of esophagus|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh37
na,na,3,30691471,30691471,TGFBR2,Pathogenic,Malignant tumor of esophagus|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh38
na,na,3,30730003,30730003,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh37
na,na,3,30688511,30688511,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh38
na,na,3,30713598,30713598,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh37
na,na,3,30672106,30672106,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh38
na,na,3,30715688,30715688,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh37
na,na,3,30674196,30674196,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh38
na,na,3,30732996,30732996,TGFBR2,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh37
na,na,3,30691504,30691504,TGFBR2,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh38
na,na,3,30713681,30713681,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh37
na,na,3,30672189,30672189,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh38
na,na,3,30713738,30713738,TGFBR2,Conflicting classifications of pathogenicity,"Loeys-Dietz syndrome 2|Loeys-Dietz syndrome|Colorectal cancer, hereditary nonpolyposis, type 6|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh37
na,na,3,30672246,30672246,TGFBR2,Conflicting classifications of pathogenicity,"Loeys-Dietz syndrome 2|Loeys-Dietz syndrome|Colorectal cancer, hereditary nonpolyposis, type 6|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh38
na,na,3,30713744,30713744,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh37
na,na,3,30672252,30672252,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh38
na,na,3,30732970,30732970,TGFBR2,Pathogenic,"Loeys-Dietz syndrome 2|Colorectal cancer, hereditary nonpolyposis, type 6|Loeys-Dietz syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh37
na,na,3,30691478,30691478,TGFBR2,Pathogenic,"Loeys-Dietz syndrome 2|Colorectal cancer, hereditary nonpolyposis, type 6|Loeys-Dietz syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection",single nucleotide variant,GRCh38
na,na,3,30732969,30732969,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome|Neoplasm|TGFBR2-related disorder,single nucleotide variant,GRCh37
na,na,3,30691477,30691477,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome|Neoplasm|TGFBR2-related disorder,single nucleotide variant,GRCh38
na,na,3,30686237,30686237,TGFBR2,Conflicting classifications of pathogenicity,Loeys-Dietz syndrome 2|Familial thoracic aortic aneurysm and aortic dissection|Isolated thoracic aortic aneurysm|not provided,single nucleotide variant,GRCh37
na,na,3,30644745,30644745,TGFBR2,Conflicting classifications of pathogenicity,Loeys-Dietz syndrome 2|Familial thoracic aortic aneurysm and aortic dissection|Isolated thoracic aortic aneurysm|not provided,single nucleotide variant,GRCh38
na,na,3,30715720,30715720,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2|not provided|Cardiovascular phenotype|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh37
na,na,3,30674228,30674228,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2|not provided|Cardiovascular phenotype|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh38
na,na,3,30715721,30715721,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh37
na,na,3,30674229,30674229,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2|not provided|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh38
na,na,3,30729874,30729874,TGFBR2,Likely pathogenic,Loeys-Dietz syndrome 2|not provided,single nucleotide variant,GRCh37
na,na,3,30688382,30688382,TGFBR2,Likely pathogenic,Loeys-Dietz syndrome 2|not provided,single nucleotide variant,GRCh38
na,na,3,30715615,30715615,TGFBR2,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 2|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh37
na,na,3,30674123,30674123,TGFBR2,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 2|Familial thoracic aortic aneurysm and aortic dissection,single nucleotide variant,GRCh38
na,na,3,30715622,30715622,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh37
na,na,3,30674130,30674130,TGFBR2,Pathogenic,Loeys-Dietz syndrome 2,single nucleotide variant,GRCh38
na,na,3,30729962,30729962,TGFBR2,Pathogenic,"Loeys-Dietz syndrome 2|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided|Loeys-Dietz syndrome 2;Malignant tumor of esophagus;Colorectal cancer, hereditary nonpolyposis, type 6|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,3,30688470,30688470,TGFBR2,Pathogenic,"Loeys-Dietz syndrome 2|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided|Loeys-Dietz syndrome 2;Malignant tumor of esophagus;Colorectal cancer, hereditary nonpolyposis, type 6|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,9,101904965,101904965,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1,single nucleotide variant,GRCh37
na,na,9,99142683,99142683,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1,single nucleotide variant,GRCh38
na,na,9,101908835,101908835,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1,single nucleotide variant,GRCh37
na,na,9,99146553,99146553,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1,single nucleotide variant,GRCh38
na,na,9,101900165,101900165,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1,single nucleotide variant,GRCh37
na,na,9,99137883,99137883,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1,single nucleotide variant,GRCh38
na,na,9,101911535,101911535,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,9,99149253,99149253,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,9,101900288,101900288,TGFBR1,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype|Marfan syndrome;Loeys-Dietz syndrome 1|Multiple self-healing squamous epithelioma;Loeys-Dietz syndrome 1,single nucleotide variant,GRCh37
na,na,9,99138006,99138006,TGFBR1,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 1|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype|Marfan syndrome;Loeys-Dietz syndrome 1|Multiple self-healing squamous epithelioma;Loeys-Dietz syndrome 1,single nucleotide variant,GRCh38
na,na,9,101911535,101911535,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1|Familial thoracic aortic aneurysm and aortic dissection;Loeys-Dietz syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome|TGFBR1-related disorder,single nucleotide variant,GRCh37
na,na,9,99149253,99149253,TGFBR1,Pathogenic,Loeys-Dietz syndrome 1|Familial thoracic aortic aneurysm and aortic dissection;Loeys-Dietz syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome|TGFBR1-related disorder,single nucleotide variant,GRCh38
na,na,9,101911534,101911534,TGFBR1,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 1|Loeys-Dietz syndrome;Familial thoracic aortic aneurysm and aortic dissection|not provided|Familial thoracic aortic aneurysm and aortic dissection|Multiple self-healing squamous epithelioma;Loeys-Dietz syndrome 1|Loeys-Dietz syndrome,single nucleotide variant,GRCh37
na,na,9,99149252,99149252,TGFBR1,Pathogenic/Likely pathogenic,Loeys-Dietz syndrome 1|Loeys-Dietz syndrome;Familial thoracic aortic aneurysm and aortic dissection|not provided|Familial thoracic aortic aneurysm and aortic dissection|Multiple self-healing squamous epithelioma;Loeys-Dietz syndrome 1|Loeys-Dietz syndrome,single nucleotide variant,GRCh38
na,na,9,101894968,101894968,TGFBR1,Uncertain significance,Loeys-Dietz syndrome 1|not provided,single nucleotide variant,GRCh37
na,na,9,99132686,99132686,TGFBR1,Uncertain significance,Loeys-Dietz syndrome 1|not provided,single nucleotide variant,GRCh38
na,na,19,41848114,41848114,TGFB1,Pathogenic,Diaphyseal dysplasia,single nucleotide variant,GRCh37
na,na,19,41342209,41342209,TGFB1,Pathogenic,Diaphyseal dysplasia,single nucleotide variant,GRCh38
na,na,19,41848134,41848134,TGFB1,Pathogenic,Diaphyseal dysplasia|not provided|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,41342229,41342229,TGFB1,Pathogenic,Diaphyseal dysplasia|not provided|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,41848120,41848120,TGFB1,Uncertain significance,Diaphyseal dysplasia|not provided,single nucleotide variant,GRCh37
na,na,19,41342215,41342215,TGFB1,Uncertain significance,Diaphyseal dysplasia|not provided,single nucleotide variant,GRCh38
na,na,19,41848135,41848135,TGFB1,Pathogenic,Diaphyseal dysplasia|not provided|See cases,single nucleotide variant,GRCh37
na,na,19,41342230,41342230,TGFB1,Pathogenic,Diaphyseal dysplasia|not provided|See cases,single nucleotide variant,GRCh38
na,na,19,41858709,41858709,TGFB1,Pathogenic,Diaphyseal dysplasia,single nucleotide variant,GRCh37
na,na,19,41352804,41352804,TGFB1,Pathogenic,Diaphyseal dysplasia,single nucleotide variant,GRCh38
na,na,19,41848120,41848120,TGFB1,Pathogenic,Diaphyseal dysplasia,single nucleotide variant,GRCh37
na,na,19,41342215,41342215,TGFB1,Pathogenic,Diaphyseal dysplasia,single nucleotide variant,GRCh38
na,na,19,41858921,41858921,TGFB1,Benign,"Breast cancer, invasive, susceptibility to|Cystic fibrosis|not specified|not provided|Inflammatory bowel disease, immunodeficiency, and encephalopathy|Diaphyseal dysplasia|Meckel syndrome, type 10",single nucleotide variant,GRCh37
na,na,19,41353016,41353016,TGFB1,Benign,"Breast cancer, invasive, susceptibility to|Cystic fibrosis|not specified|not provided|Inflammatory bowel disease, immunodeficiency, and encephalopathy|Diaphyseal dysplasia|Meckel syndrome, type 10",single nucleotide variant,GRCh38
na,na,3,24169101,24169101,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,24127610,24127610,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,24169114,24169114,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,24127623,24127623,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,24164403,24164403,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,24122912,24122912,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh38
na,na,na,-1,-1,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal recessive",Deletion,na
na,na,3,24169122,24169124,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|Thyroid hormone resistance, generalized, autosomal recessive",Deletion,GRCh37
na,na,3,24127631,24127633,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|Thyroid hormone resistance, generalized, autosomal recessive",Deletion,GRCh38
na,na,3,24169205,24169205,THRB,Uncertain significance,Generalized resistance to thyroid hormone|not specified,single nucleotide variant,GRCh37
na,na,3,24127714,24127714,THRB,Uncertain significance,Generalized resistance to thyroid hormone|not specified,single nucleotide variant,GRCh38
na,na,3,24169170,24169170,THRB,Pathogenic,Generalized resistance to thyroid hormone,single nucleotide variant,GRCh37
na,na,3,24127679,24127679,THRB,Pathogenic,Generalized resistance to thyroid hormone,single nucleotide variant,GRCh38
na,na,3,24169185,24169185,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|Thyroid hormone resistance syndrome",single nucleotide variant,GRCh37
na,na,3,24127694,24127694,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|Thyroid hormone resistance syndrome",single nucleotide variant,GRCh38
na,na,3,24169140,24169140,THRB,Conflicting classifications of pathogenicity,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|not specified",single nucleotide variant,GRCh37
na,na,3,24127649,24127649,THRB,Conflicting classifications of pathogenicity,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|not specified",single nucleotide variant,GRCh38
na,na,3,24169100,24169100,THRB,Pathogenic,Generalized resistance to thyroid hormone,single nucleotide variant,GRCh37
na,na,3,24127609,24127609,THRB,Pathogenic,Generalized resistance to thyroid hormone,single nucleotide variant,GRCh38
na,na,3,24169100,24169100,THRB,Conflicting classifications of pathogenicity,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|not specified",single nucleotide variant,GRCh37
na,na,3,24127609,24127609,THRB,Conflicting classifications of pathogenicity,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|not specified",single nucleotide variant,GRCh38
na,na,3,24169094,24169094,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,24127603,24127603,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,24164437,24164437,THRB,Likely pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder",single nucleotide variant,GRCh37
na,na,3,24122946,24122946,THRB,Likely pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder",single nucleotide variant,GRCh38
na,na,3,24164412,24164412,THRB,Pathogenic,Generalized resistance to thyroid hormone,single nucleotide variant,GRCh37
na,na,3,24122921,24122921,THRB,Pathogenic,Generalized resistance to thyroid hormone,single nucleotide variant,GRCh38
na,na,3,24164419,24164420,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",Duplication,GRCh37
na,na,3,24122928,24122929,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",Duplication,GRCh38
na,na,3,24164404,24164404,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder",single nucleotide variant,GRCh37
na,na,3,24122913,24122913,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder",single nucleotide variant,GRCh38
na,na,3,24164434,24164434,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,24122943,24122943,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,24169101,24169101,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh37
na,na,3,24127610,24127610,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh38
na,na,3,24169175,24169175,THRB,Pathogenic/Likely pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|Inborn genetic diseases|not provided|THRB-related disorder",single nucleotide variant,GRCh37
na,na,3,24127684,24127684,THRB,Pathogenic/Likely pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|Inborn genetic diseases|not provided|THRB-related disorder",single nucleotide variant,GRCh38
na,na,3,24185030,24185030,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|Thyroid hormone resistance syndrome|not provided",single nucleotide variant,GRCh37
na,na,3,24143539,24143539,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|Thyroid hormone resistance syndrome|not provided",single nucleotide variant,GRCh38
na,na,3,24169187,24169187,THRB,Pathogenic,"Selective pituitary resistance to thyroid hormone|Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh37
na,na,3,24127696,24127696,THRB,Pathogenic,"Selective pituitary resistance to thyroid hormone|Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh38
na,na,na,-1,-1,THRB,Pathogenic,Selective pituitary resistance to thyroid hormone,Variation,na
na,na,3,24169176,24169176,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|Selective pituitary resistance to thyroid hormone;Thyroid hormone resistance, generalized, autosomal recessive;Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder",single nucleotide variant,GRCh37
na,na,3,24127685,24127685,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|Selective pituitary resistance to thyroid hormone;Thyroid hormone resistance, generalized, autosomal recessive;Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder",single nucleotide variant,GRCh38
na,na,3,24169122,24169122,THRB,Pathogenic,"Selective pituitary resistance to thyroid hormone|Thyroid hormone resistance, generalized, autosomal dominant|not provided|Selective pituitary resistance to thyroid hormone;Thyroid hormone resistance, generalized, autosomal recessive;Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,24127631,24127631,THRB,Pathogenic,"Selective pituitary resistance to thyroid hormone|Thyroid hormone resistance, generalized, autosomal dominant|not provided|Selective pituitary resistance to thyroid hormone;Thyroid hormone resistance, generalized, autosomal recessive;Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,24164448,24164448,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not specified|not provided",single nucleotide variant,GRCh37
na,na,3,24122957,24122957,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not specified|not provided",single nucleotide variant,GRCh38
na,na,3,24164399,24164400,THRB,Pathogenic,Generalized resistance to thyroid hormone,Insertion,GRCh37
na,na,3,24122908,24122909,THRB,Pathogenic,Generalized resistance to thyroid hormone,Insertion,GRCh38
na,na,3,24164385,24164385,THRB,Pathogenic,Generalized resistance to thyroid hormone,single nucleotide variant,GRCh37
na,na,3,24122894,24122894,THRB,Pathogenic,Generalized resistance to thyroid hormone,single nucleotide variant,GRCh38
na,na,3,24169175,24169175,THRB,Pathogenic,Selective pituitary resistance to thyroid hormone,single nucleotide variant,GRCh37
na,na,3,24127684,24127684,THRB,Pathogenic,Selective pituitary resistance to thyroid hormone,single nucleotide variant,GRCh38
na,na,3,24164425,24164425,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh37
na,na,3,24122934,24122934,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh38
na,na,3,24164388,24164388,THRB,Likely pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh37
na,na,3,24122897,24122897,THRB,Likely pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh38
na,na,3,24164459,24164459,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh37
na,na,3,24122968,24122968,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided",single nucleotide variant,GRCh38
na,na,3,24185002,24185002,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder|Selective pituitary resistance to thyroid hormone;Thyroid hormone resistance, generalized, autosomal recessive;Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,24143511,24143511,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|not provided|THRB-related disorder|Selective pituitary resistance to thyroid hormone;Thyroid hormone resistance, generalized, autosomal recessive;Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,24185003,24185003,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|THRB-related disorder|not provided",single nucleotide variant,GRCh37
na,na,3,24143512,24143512,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant|THRB-related disorder|not provided",single nucleotide variant,GRCh38
na,na,3,24164613,24164613,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,24123122,24123122,THRB,Pathogenic,"Thyroid hormone resistance, generalized, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,24169125,24169125,THRB,Pathogenic,Selective pituitary resistance to thyroid hormone,single nucleotide variant,GRCh37
na,na,3,24127634,24127634,THRB,Pathogenic,Selective pituitary resistance to thyroid hormone,single nucleotide variant,GRCh38
na,na,3,24164455,24164456,THRB,Pathogenic,Selective pituitary resistance to thyroid hormone,Duplication,GRCh37
na,na,3,24122964,24122965,THRB,Pathogenic,Selective pituitary resistance to thyroid hormone,Duplication,GRCh38
na,na,12,56486761,56486761,ERBB3,Pathogenic,Lethal congenital contracture syndrome 2,single nucleotide variant,GRCh37
na,na,12,56092977,56092977,ERBB3,Pathogenic,Lethal congenital contracture syndrome 2,single nucleotide variant,GRCh38
na,na,20,36031762,36031762,SRC,Pathogenic,"Colon cancer, advanced",single nucleotide variant,GRCh37
na,na,20,37403359,37403359,SRC,Pathogenic,"Colon cancer, advanced",single nucleotide variant,GRCh38
na,na,8,128750677,128750677,MYC,Pathogenic,Burkitt lymphoma,single nucleotide variant,GRCh37
na,na,8,127738431,127738431,MYC,Pathogenic,Burkitt lymphoma,single nucleotide variant,GRCh38
na,na,8,128750765,128750765,MYC,Pathogenic,Burkitt lymphoma,single nucleotide variant,GRCh37
na,na,8,127738519,127738519,MYC,Pathogenic,Burkitt lymphoma,single nucleotide variant,GRCh38
na,na,8,128750625,128750625,MYC,Pathogenic,Burkitt lymphoma,single nucleotide variant,GRCh37
na,na,8,127738379,127738379,MYC,Pathogenic,Burkitt lymphoma,single nucleotide variant,GRCh38
na,na,8,128750683,128750683,MYC,other,Burkitt lymphoma|Cholesteatoma of middle ear|Neoplasm,single nucleotide variant,GRCh37
na,na,8,127738437,127738437,MYC,other,Burkitt lymphoma|Cholesteatoma of middle ear|Neoplasm,single nucleotide variant,GRCh38
na,na,12,25398285,25398285,KRAS,Likely pathogenic,Lung carcinoma|Non-small cell lung carcinoma|Endometrial carcinoma|Lung adenocarcinoma|Gallbladder cancer|not provided|RASopathy|Lung cancer|Neoplasm,single nucleotide variant,GRCh37
na,na,12,25245351,25245351,KRAS,Likely pathogenic,Lung carcinoma|Non-small cell lung carcinoma|Endometrial carcinoma|Lung adenocarcinoma|Gallbladder cancer|not provided|RASopathy|Lung cancer|Neoplasm,single nucleotide variant,GRCh38
na,na,12,25398285,25398285,KRAS,Pathogenic/Likely pathogenic,Malignant tumor of urinary bladder|Squamous cell lung carcinoma|Non-small cell lung carcinoma|not provided|RASopathy|Adenoid cystic carcinoma|Neoplasm,single nucleotide variant,GRCh37
na,na,12,25245351,25245351,KRAS,Pathogenic/Likely pathogenic,Malignant tumor of urinary bladder|Squamous cell lung carcinoma|Non-small cell lung carcinoma|not provided|RASopathy|Adenoid cystic carcinoma|Neoplasm,single nucleotide variant,GRCh38
na,na,12,25398281,25398281,KRAS,Pathogenic,"Breast adenocarcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|OCULOECTODERMAL SYNDROME, SOMATIC|not provided|Nevus sebaceous|RASopathy|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis|KRAS-related disorder|Familial pancreatic carcinoma|Neoplasm",single nucleotide variant,GRCh37
na,na,12,25245347,25245347,KRAS,Pathogenic,"Breast adenocarcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|OCULOECTODERMAL SYNDROME, SOMATIC|not provided|Nevus sebaceous|RASopathy|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis|KRAS-related disorder|Familial pancreatic carcinoma|Neoplasm",single nucleotide variant,GRCh38
na,na,12,25380283,25380283,KRAS,Pathogenic,"Bladder cancer, transitional cell, somatic",single nucleotide variant,GRCh37
na,na,12,25227349,25227349,KRAS,Pathogenic,"Bladder cancer, transitional cell, somatic",single nucleotide variant,GRCh38
na,na,12,25398284,25398284,KRAS,Pathogenic/Likely pathogenic,Carcinoma of pancreas|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|RASopathy|Cerebral arteriovenous malformation|not provided|Vascular Tumors Including Pyogenic Granuloma|Acute myeloid leukemia|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|Gastric cancer|Encephalocraniocutaneous lipomatosis|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Cardiovascular phenotype|12 conditions|KRAS-related overgrowth|Congenital Pulmonary Airway Malformations|Neoplasm,single nucleotide variant,GRCh37
na,na,12,25245350,25245350,KRAS,Pathogenic/Likely pathogenic,Carcinoma of pancreas|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|RASopathy|Cerebral arteriovenous malformation|not provided|Vascular Tumors Including Pyogenic Granuloma|Acute myeloid leukemia|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|Gastric cancer|Encephalocraniocutaneous lipomatosis|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Cardiovascular phenotype|12 conditions|KRAS-related overgrowth|Congenital Pulmonary Airway Malformations|Neoplasm,single nucleotide variant,GRCh38
na,na,12,25398284,25398284,KRAS,Pathogenic,"Carcinoma of pancreas|Nevus sebaceous|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|not provided|Cerebral arteriovenous malformation|Lung sarcomatoid carcinoma|Linear nevus sebaceous syndrome|Chronic myelogenous leukemia, BCR-ABL1 positive|RASopathy|Neoplasm",single nucleotide variant,GRCh37
na,na,12,25245350,25245350,KRAS,Pathogenic,"Carcinoma of pancreas|Nevus sebaceous|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|not provided|Cerebral arteriovenous malformation|Lung sarcomatoid carcinoma|Linear nevus sebaceous syndrome|Chronic myelogenous leukemia, BCR-ABL1 positive|RASopathy|Neoplasm",single nucleotide variant,GRCh38
na,na,12,25398285,25398285,KRAS,Pathogenic,Gastric cancer|Ovarian neoplasm|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|not provided|RASopathy|Vascular malformation|Neoplasm|Cardiofaciocutaneous syndrome 2,single nucleotide variant,GRCh37
na,na,12,25245351,25245351,KRAS,Pathogenic,Gastric cancer|Ovarian neoplasm|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|not provided|RASopathy|Vascular malformation|Neoplasm|Cardiofaciocutaneous syndrome 2,single nucleotide variant,GRCh38
na,na,12,25398289,25398290,KRAS,Pathogenic,Acute myeloid leukemia,Duplication,GRCh37
na,na,12,25245355,25245356,KRAS,Pathogenic,Acute myeloid leukemia,Duplication,GRCh38
na,na,12,25380280,25380280,KRAS,Pathogenic,Cardiofaciocutaneous syndrome 2|RASopathy|not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome 3|Noonan syndrome;Cardio-facio-cutaneous syndrome|Inborn genetic diseases|Toriello-Lacassie-Droste syndrome;Noonan syndrome 3,single nucleotide variant,GRCh37
na,na,12,25227346,25227346,KRAS,Pathogenic,Cardiofaciocutaneous syndrome 2|RASopathy|not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome 3|Noonan syndrome;Cardio-facio-cutaneous syndrome|Inborn genetic diseases|Toriello-Lacassie-Droste syndrome;Noonan syndrome 3,single nucleotide variant,GRCh38
na,na,12,25362838,25362838,KRAS,Pathogenic,Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|not specified|11 conditions|Noonan syndrome 1|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,12,25209904,25209904,KRAS,Pathogenic,Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|not specified|11 conditions|Noonan syndrome 1|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,12,25380285,25380285,KRAS,Pathogenic,Noonan syndrome 3|not provided|Noonan syndrome|RASopathy,single nucleotide variant,GRCh37
na,na,12,25227351,25227351,KRAS,Pathogenic,Noonan syndrome 3|not provided|Noonan syndrome|RASopathy,single nucleotide variant,GRCh38
na,na,12,25398279,25398279,KRAS,Pathogenic,Noonan syndrome 3|not provided|Endometrial carcinoma|RASopathy|Cardio-facio-cutaneous syndrome;Noonan syndrome|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome,single nucleotide variant,GRCh37
na,na,12,25245345,25245345,KRAS,Pathogenic,Noonan syndrome 3|not provided|Endometrial carcinoma|RASopathy|Cardio-facio-cutaneous syndrome;Noonan syndrome|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome,single nucleotide variant,GRCh38
na,na,12,25398218,25398218,KRAS,Pathogenic/Likely pathogenic,Cardiofaciocutaneous syndrome 2|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Autoimmune lymphoproliferative syndrome type 4;Acute myeloid leukemia;Noonan syndrome 3;Cardiofaciocutaneous syndrome 2|RASopathy|Noonan syndrome 3,single nucleotide variant,GRCh37
na,na,12,25245284,25245284,KRAS,Pathogenic/Likely pathogenic,Cardiofaciocutaneous syndrome 2|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Autoimmune lymphoproliferative syndrome type 4;Acute myeloid leukemia;Noonan syndrome 3;Cardiofaciocutaneous syndrome 2|RASopathy|Noonan syndrome 3,single nucleotide variant,GRCh38
na,na,12,25362841,25362841,KRAS,Pathogenic,Noonan syndrome 3,single nucleotide variant,GRCh37
na,na,12,25209907,25209907,KRAS,Pathogenic,Noonan syndrome 3,single nucleotide variant,GRCh38
na,na,12,25398282,25398282,KRAS,Pathogenic,Non-small cell lung carcinoma|Pilocytic astrocytoma|not provided,single nucleotide variant,GRCh37
na,na,12,25245348,25245348,KRAS,Pathogenic,Non-small cell lung carcinoma|Pilocytic astrocytoma|not provided,single nucleotide variant,GRCh38
na,na,12,25398304,25398304,KRAS,Pathogenic,Cardiofaciocutaneous syndrome 2|not provided|Inborn genetic diseases|RASopathy,single nucleotide variant,GRCh37
na,na,12,25245370,25245370,KRAS,Pathogenic,Cardiofaciocutaneous syndrome 2|not provided|Inborn genetic diseases|RASopathy,single nucleotide variant,GRCh38
na,na,12,25362828,25362828,KRAS,Pathogenic,Cardiofaciocutaneous syndrome 2|not provided|RASopathy|KRAS-related disorder,single nucleotide variant,GRCh37
na,na,12,25209894,25209894,KRAS,Pathogenic,Cardiofaciocutaneous syndrome 2|not provided|RASopathy|KRAS-related disorder,single nucleotide variant,GRCh38
na,na,12,25398306,25398306,KRAS,Pathogenic/Likely pathogenic,"Noonan syndrome 3|RASopathy|not provided|Noonan syndrome|Prostate cancer, hereditary, 1|KRAS-related disorder",single nucleotide variant,GRCh37
na,na,12,25245372,25245372,KRAS,Pathogenic/Likely pathogenic,"Noonan syndrome 3|RASopathy|not provided|Noonan syndrome|Prostate cancer, hereditary, 1|KRAS-related disorder",single nucleotide variant,GRCh38
na,na,12,25380280,25380280,KRAS,Pathogenic,Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2,single nucleotide variant,GRCh37
na,na,12,25227346,25227346,KRAS,Pathogenic,Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2,single nucleotide variant,GRCh38
na,na,22,39623114,39623248,PDGFB,Pathogenic,Meningioma,Deletion,GRCh37
na,na,22,39227109,39227243,PDGFB,Pathogenic,Meningioma,Deletion,GRCh38
na,na,na,-1,-1,PDGFB,Pathogenic,Dermatofibrosarcoma protuberans,Translocation,na
na,na,11,534288,534288,HRAS,Pathogenic,"Malignant tumor of urinary bladder|Costello syndrome|Myopathy, congenital, with excess of muscle spindles|Epidermal nevus|not provided|HRAS-related disorder|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,11,534288,534288,HRAS,Pathogenic,"Malignant tumor of urinary bladder|Costello syndrome|Myopathy, congenital, with excess of muscle spindles|Epidermal nevus|not provided|HRAS-related disorder|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,11,533875,533875,HRAS,Pathogenic/Likely pathogenic,"Thyroid cancer, nonmedullary, 2|Spermatocytic seminoma|Noonan syndrome 3|not provided|Lip and oral cavity carcinoma|Epidermal nevus",single nucleotide variant,GRCh37
na,na,11,533875,533875,HRAS,Pathogenic/Likely pathogenic,"Thyroid cancer, nonmedullary, 2|Spermatocytic seminoma|Noonan syndrome 3|not provided|Lip and oral cavity carcinoma|Epidermal nevus",single nucleotide variant,GRCh38
na,na,11,534289,534289,HRAS,Pathogenic,"Myopathy, congenital, with excess of muscle spindles|Costello syndrome|Epidermal nevus with urothelial cancer, somatic|Nevus sebaceous|not provided|RASopathy|Wooly hair nevus|Rhabdomyosarcoma|Lip and oral cavity carcinoma|Noonan syndrome and Noonan-related syndrome|See cases|Cardiovascular phenotype|HRAS-related disorder|Noonan syndrome 1|Epidermal nevus|6 conditions",single nucleotide variant,GRCh37
na,na,11,534289,534289,HRAS,Pathogenic,"Myopathy, congenital, with excess of muscle spindles|Costello syndrome|Epidermal nevus with urothelial cancer, somatic|Nevus sebaceous|not provided|RASopathy|Wooly hair nevus|Rhabdomyosarcoma|Lip and oral cavity carcinoma|Noonan syndrome and Noonan-related syndrome|See cases|Cardiovascular phenotype|HRAS-related disorder|Noonan syndrome 1|Epidermal nevus|6 conditions",single nucleotide variant,GRCh38
na,na,11,534288,534288,HRAS,Pathogenic,Costello syndrome|not provided|Inborn genetic diseases|6 conditions|Rhabdomyosarcoma|Noonan syndrome and Noonan-related syndrome,single nucleotide variant,GRCh37
na,na,11,534288,534288,HRAS,Pathogenic,Costello syndrome|not provided|Inborn genetic diseases|6 conditions|Rhabdomyosarcoma|Noonan syndrome and Noonan-related syndrome,single nucleotide variant,GRCh38
na,na,11,534285,534285,HRAS,Pathogenic/Likely pathogenic,Costello syndrome|not provided|RASopathy|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|HRAS-related disorder|6 conditions,single nucleotide variant,GRCh37
na,na,11,534285,534285,HRAS,Pathogenic/Likely pathogenic,Costello syndrome|not provided|RASopathy|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|HRAS-related disorder|6 conditions,single nucleotide variant,GRCh38
na,na,11,533553,533553,HRAS,Pathogenic,Costello syndrome|not provided|RASopathy,single nucleotide variant,GRCh37
na,na,11,533553,533553,HRAS,Pathogenic,Costello syndrome|not provided|RASopathy,single nucleotide variant,GRCh38
na,na,11,534286,534286,HRAS,Pathogenic,Costello syndrome|RASopathy|not provided|Noonan syndrome|6 conditions|Noonan syndrome and Noonan-related syndrome|HRAS-related disorder|Linear nevus sebaceous syndrome,single nucleotide variant,GRCh37
na,na,11,534286,534286,HRAS,Pathogenic,Costello syndrome|RASopathy|not provided|Noonan syndrome|6 conditions|Noonan syndrome and Noonan-related syndrome|HRAS-related disorder|Linear nevus sebaceous syndrome,single nucleotide variant,GRCh38
na,na,11,533467,533467,HRAS,Pathogenic,Costello syndrome,single nucleotide variant,GRCh37
na,na,11,533467,533467,HRAS,Pathogenic,Costello syndrome,single nucleotide variant,GRCh38
na,na,11,533869,533869,HRAS,Pathogenic,"Myopathy, congenital, with excess of muscle spindles|not provided|Costello syndrome",single nucleotide variant,GRCh37
na,na,11,533869,533869,HRAS,Pathogenic,"Myopathy, congenital, with excess of muscle spindles|not provided|Costello syndrome",single nucleotide variant,GRCh38
na,na,11,534259,534259,HRAS,Likely pathogenic,"Myopathy, congenital, with excess of muscle spindles|not provided|Costello syndrome",single nucleotide variant,GRCh37
na,na,11,534259,534259,HRAS,Likely pathogenic,"Myopathy, congenital, with excess of muscle spindles|not provided|Costello syndrome",single nucleotide variant,GRCh38
na,na,11,533883,533883,HRAS,Pathogenic,Costello syndrome|not provided|HRAS-related disorder|RASopathy,single nucleotide variant,GRCh37
na,na,11,533883,533883,HRAS,Pathogenic,Costello syndrome|not provided|HRAS-related disorder|RASopathy,single nucleotide variant,GRCh38
na,na,11,533466,533466,HRAS,Likely pathogenic,Costello syndrome,single nucleotide variant,GRCh37
na,na,11,533466,533466,HRAS,Likely pathogenic,Costello syndrome,single nucleotide variant,GRCh38
na,na,11,534288,534288,HRAS;LRRC56,Pathogenic/Likely pathogenic,"Costello syndrome, severe|Costello syndrome|Nevus sebaceous|RASopathy|not provided|Lip and oral cavity carcinoma|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|HRAS-related disorder",single nucleotide variant,GRCh37
na,na,11,534288,534288,HRAS;LRRC56,Pathogenic/Likely pathogenic,"Costello syndrome, severe|Costello syndrome|Nevus sebaceous|RASopathy|not provided|Lip and oral cavity carcinoma|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|HRAS-related disorder",single nucleotide variant,GRCh38
na,na,11,534289,534289,HRAS,Pathogenic,Costello syndrome|Nevus sebaceous|Epidermal nevus|RASopathy|not provided|6 conditions,single nucleotide variant,GRCh37
na,na,11,534289,534289,HRAS,Pathogenic,Costello syndrome|Nevus sebaceous|Epidermal nevus|RASopathy|not provided|6 conditions,single nucleotide variant,GRCh38
na,na,3,133475813,133475813,TF,Pathogenic,Transferrin variant D1,single nucleotide variant,GRCh37
na,na,3,133756969,133756969,TF,Pathogenic,Transferrin variant D1,single nucleotide variant,GRCh38
na,na,3,133476698,133476698,TF,Benign,Transferrin variant D(Chi)|Atransferrinemia|not provided,single nucleotide variant,GRCh37
na,na,3,133757854,133757854,TF,Benign,Transferrin variant D(Chi)|Atransferrinemia|not provided,single nucleotide variant,GRCh38
na,na,3,133496032,133496032,TF,Likely benign,Transferrin variant B2|Atransferrinemia|not provided|not specified|TF-related disorder,single nucleotide variant,GRCh37
na,na,3,133777188,133777188,TF,Likely benign,Transferrin variant B2|Atransferrinemia|not provided|not specified|TF-related disorder,single nucleotide variant,GRCh38
na,na,3,133494354,133494354,TF,Benign,TF*C2|Atransferrinemia|not provided,single nucleotide variant,GRCh37
na,na,3,133775510,133775510,TF,Benign,TF*C2|Atransferrinemia|not provided,single nucleotide variant,GRCh38
na,na,3,133495956,133495956,TF,Pathogenic,Transferrin variant Bv,single nucleotide variant,GRCh37
na,na,3,133777112,133777112,TF,Pathogenic,Transferrin variant Bv,single nucleotide variant,GRCh38
na,na,3,133474266,133474268,TF,Pathogenic,Atransferrinemia,Indel,GRCh37
na,na,3,133755422,133755424,TF,Pathogenic,Atransferrinemia,Indel,GRCh38
na,na,3,133485220,133485220,TF,Pathogenic,Atransferrinemia,single nucleotide variant,GRCh37
na,na,3,133766376,133766376,TF,Pathogenic,Atransferrinemia,single nucleotide variant,GRCh38
na,na,3,133472451,133472451,TF,Pathogenic,Atransferrinemia,single nucleotide variant,GRCh37
na,na,3,133753607,133753607,TF,Pathogenic,Atransferrinemia,single nucleotide variant,GRCh38
na,na,3,133475812,133475812,TF,Benign,Iron deficiency anemia|Atransferrinemia|not provided|TF-related disorder,single nucleotide variant,GRCh37
na,na,3,133756968,133756968,TF,Benign,Iron deficiency anemia|Atransferrinemia|not provided|TF-related disorder,single nucleotide variant,GRCh38
na,na,3,133478150,133478150,TF,Uncertain significance,Atransferrinemia|not specified,single nucleotide variant,GRCh37
na,na,3,133759306,133759306,TF,Uncertain significance,Atransferrinemia|not specified,single nucleotide variant,GRCh38
na,na,9,133748283,133748283,ABL1,Likely pathogenic; association,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib|Chronic myelogenous leukemia, BCR-ABL1 positive",single nucleotide variant,GRCh37
na,na,9,130872896,130872896,ABL1,Likely pathogenic; association,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib|Chronic myelogenous leukemia, BCR-ABL1 positive",single nucleotide variant,GRCh38
na,na,9,133738307,133738307,ABL1,Pathogenic,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",single nucleotide variant,GRCh37
na,na,9,130862920,130862920,ABL1,Pathogenic,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",single nucleotide variant,GRCh38
na,na,9,133738306,133738306,ABL1,Pathogenic,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",single nucleotide variant,GRCh37
na,na,9,130862919,130862919,ABL1,Pathogenic,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",single nucleotide variant,GRCh38
na,na,9,133738357,133738357,ABL1,Pathogenic,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",single nucleotide variant,GRCh37
na,na,9,130862970,130862970,ABL1,Pathogenic,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib",single nucleotide variant,GRCh38
na,na,9,133748270,133748270,ABL1,Pathogenic,"Chronic myelogenous leukemia, BCR-ABL1 positive",single nucleotide variant,GRCh37
na,na,9,130872883,130872883,ABL1,Pathogenic,"Chronic myelogenous leukemia, BCR-ABL1 positive",single nucleotide variant,GRCh38
na,na,9,133748391,133748391,ABL1,Pathogenic,"Chronic myelogenous leukemia, BCR-ABL1 positive",single nucleotide variant,GRCh37
na,na,9,130873004,130873004,ABL1,Pathogenic,"Chronic myelogenous leukemia, BCR-ABL1 positive",single nucleotide variant,GRCh38
na,na,11,12958749,12958749,TEAD1,Pathogenic,Helicoid peripapillary chorioretinal degeneration,single nucleotide variant,GRCh37
na,na,11,12937202,12937202,TEAD1,Pathogenic,Helicoid peripapillary chorioretinal degeneration,single nucleotide variant,GRCh38
na,na,10,31815733,31815734,ZEB1,Pathogenic,Posterior polymorphous corneal dystrophy 3,Deletion,GRCh37
na,na,10,31526805,31526806,ZEB1,Pathogenic,Posterior polymorphous corneal dystrophy 3,Deletion,GRCh38
na,na,10,31809611,31809611,ZEB1,Pathogenic,Posterior polymorphous corneal dystrophy 3,single nucleotide variant,GRCh37
na,na,10,31520683,31520683,ZEB1,Pathogenic,Posterior polymorphous corneal dystrophy 3,single nucleotide variant,GRCh38
na,na,10,31750140,31750140,ZEB1,Benign,"Corneal dystrophy, Fuchs endothelial, 6|not provided|not specified|ZEB1-related disorder",single nucleotide variant,GRCh37
na,na,10,31461211,31461211,ZEB1,Benign,"Corneal dystrophy, Fuchs endothelial, 6|not provided|not specified|ZEB1-related disorder",single nucleotide variant,GRCh38
na,na,10,31810782,31810782,ZEB1,Conflicting classifications of pathogenicity,"Corneal dystrophy, Fuchs endothelial, 6|not provided|not specified",single nucleotide variant,GRCh37
na,na,10,31521854,31521854,ZEB1,Conflicting classifications of pathogenicity,"Corneal dystrophy, Fuchs endothelial, 6|not provided|not specified",single nucleotide variant,GRCh38
na,na,17,36099446,36099446,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|not provided|Nonpapillary renal cell carcinoma;Renal cysts and diabetes syndrome;Type 2 diabetes mellitus,single nucleotide variant,GRCh37
na,na,17,37739455,37739455,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|not provided|Nonpapillary renal cell carcinoma;Renal cysts and diabetes syndrome;Type 2 diabetes mellitus,single nucleotide variant,GRCh38
na,na,17,36104575,36104575,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,37744584,37744584,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,HNF1B,Pathogenic,Renal cysts and diabetes syndrome,Deletion,na
na,na,17,36091805,36091805,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|Autosomal dominant medullary cystic kidney disease with or without hyperuricemia|not provided|Nonpapillary renal cell carcinoma;Type 2 diabetes mellitus;Renal cysts and diabetes syndrome|Maturity onset diabetes mellitus in young,single nucleotide variant,GRCh37
na,na,17,37731814,37731814,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|Autosomal dominant medullary cystic kidney disease with or without hyperuricemia|not provided|Nonpapillary renal cell carcinoma;Type 2 diabetes mellitus;Renal cysts and diabetes syndrome|Maturity onset diabetes mellitus in young,single nucleotide variant,GRCh38
na,na,17,36061127,36061127,HNF1B,Conflicting classifications of pathogenicity,Type 2 diabetes mellitus|Renal cysts and diabetes syndrome|Ovarian cancer,single nucleotide variant,GRCh37
na,na,17,37701122,37701122,HNF1B,Conflicting classifications of pathogenicity,Type 2 diabetes mellitus|Renal cysts and diabetes syndrome|Ovarian cancer,single nucleotide variant,GRCh38
na,na,17,36070661,36070662,HNF1B,Pathogenic,Renal cysts and diabetes syndrome,Duplication,GRCh37
na,na,17,37710653,37710654,HNF1B,Pathogenic,Renal cysts and diabetes syndrome,Duplication,GRCh38
na,na,17,36099430,36099430,HNF1B,Pathogenic/Likely pathogenic,Renal cysts and diabetes syndrome|Nonpapillary renal cell carcinoma;Renal cysts and diabetes syndrome;Type 2 diabetes mellitus|not provided,single nucleotide variant,GRCh37
na,na,17,37739439,37739439,HNF1B,Pathogenic/Likely pathogenic,Renal cysts and diabetes syndrome|Nonpapillary renal cell carcinoma;Renal cysts and diabetes syndrome;Type 2 diabetes mellitus|not provided,single nucleotide variant,GRCh38
na,na,17,36099430,36099430,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|not provided|HNF1B-related disorder,single nucleotide variant,GRCh37
na,na,17,37739439,37739439,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|not provided|HNF1B-related disorder,single nucleotide variant,GRCh38
na,na,17,36099532,36099532,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|not provided,single nucleotide variant,GRCh37
na,na,17,37739541,37739541,HNF1B,Pathogenic,Renal cysts and diabetes syndrome|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,HNF1B,Pathogenic,Renal cysts and diabetes syndrome,Duplication,na
na,na,17,36099481,36099481,HNF1B,Pathogenic/Likely pathogenic,Renal cysts and diabetes syndrome|not provided|Maturity onset diabetes mellitus in young|Renal cysts and diabetes syndrome;Nonpapillary renal cell carcinoma;Type 2 diabetes mellitus|Type 2 diabetes mellitus,single nucleotide variant,GRCh37
na,na,17,37739490,37739490,HNF1B,Pathogenic/Likely pathogenic,Renal cysts and diabetes syndrome|not provided|Maturity onset diabetes mellitus in young|Renal cysts and diabetes syndrome;Nonpapillary renal cell carcinoma;Type 2 diabetes mellitus|Type 2 diabetes mellitus,single nucleotide variant,GRCh38
na,na,17,36104830,36104830,HNF1B,Pathogenic,Chromophobe renal cell carcinoma|Renal cysts and diabetes syndrome,Deletion,GRCh37
na,na,17,37744839,37744839,HNF1B,Pathogenic,Chromophobe renal cell carcinoma|Renal cysts and diabetes syndrome,Deletion,GRCh38
na,na,2,179650726,179650726,TTN,Pathogenic,Hypertrophic cardiomyopathy 9,single nucleotide variant,GRCh37
na,na,2,178785999,178785999,TTN,Pathogenic,Hypertrophic cardiomyopathy 9,single nucleotide variant,GRCh38
na,na,2,179440167,179440168,TTN,Pathogenic,Dilated cardiomyopathy 1G,Duplication,GRCh37
na,na,2,178575440,178575441,TTN,Pathogenic,Dilated cardiomyopathy 1G,Duplication,GRCh38
na,na,2,179647707,179647707,TTN,Likely pathogenic,Dilated cardiomyopathy 1G|Primary dilated cardiomyopathy,single nucleotide variant,GRCh37
na,na,2,178782980,178782980,TTN,Likely pathogenic,Dilated cardiomyopathy 1G|Primary dilated cardiomyopathy,single nucleotide variant,GRCh38
na,na,2,179391925,179391935,TTN,Pathogenic,Tibial muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2J|Dilated cardiomyopathy 1G;Autosomal recessive limb-girdle muscular dystrophy type 2J|not provided|6 conditions|Cardiovascular phenotype,Indel,GRCh37
na,na,2,178527198,178527208,TTN,Pathogenic,Tibial muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2J|Dilated cardiomyopathy 1G;Autosomal recessive limb-girdle muscular dystrophy type 2J|not provided|6 conditions|Cardiovascular phenotype,Indel,GRCh38
na,na,2,179391848,179391848,TTN,Likely pathogenic,Tibial muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|not provided|Primary familial dilated cardiomyopathy,single nucleotide variant,GRCh37
na,na,2,178527121,178527121,TTN,Likely pathogenic,Tibial muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|not provided|Primary familial dilated cardiomyopathy,single nucleotide variant,GRCh38
na,na,2,179391875,179391875,TTN,Pathogenic/Likely pathogenic,Tibial muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|Autosomal recessive limb-girdle muscular dystrophy type 2J,single nucleotide variant,GRCh37
na,na,2,178527148,178527148,TTN,Pathogenic/Likely pathogenic,Tibial muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|Autosomal recessive limb-girdle muscular dystrophy type 2J,single nucleotide variant,GRCh38
na,na,2,179650717,179650717,TTN,Uncertain significance,Dilated cardiomyopathy 1G|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G,single nucleotide variant,GRCh37
na,na,2,178785990,178785990,TTN,Uncertain significance,Dilated cardiomyopathy 1G|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G,single nucleotide variant,GRCh38
na,na,2,179667000,179667000,TTN,Uncertain significance,Dilated cardiomyopathy 1G|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G,single nucleotide variant,GRCh37
na,na,2,178802273,178802273,TTN,Uncertain significance,Dilated cardiomyopathy 1G|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G,single nucleotide variant,GRCh38
na,na,2,179604852,179604852,TTN,Pathogenic,Dilated cardiomyopathy 1G,single nucleotide variant,GRCh37
na,na,2,178740125,178740125,TTN,Pathogenic,Dilated cardiomyopathy 1G,single nucleotide variant,GRCh38
na,na,2,179602841,179602841,TTN,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1G|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|TTN-related disorder,single nucleotide variant,GRCh37
na,na,2,178738114,178738114,TTN,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1G|not provided|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|TTN-related disorder,single nucleotide variant,GRCh38
na,na,2,179664293,179664293,TTN,Conflicting classifications of pathogenicity,"Myopathy, myofibrillar, 9, with early respiratory failure|not provided|not specified|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|Cardiomyopathy|Early-onset myopathy with fatal cardiomyopathy|Tibial muscular dystrophy|Dilated cardiomyopathy 1G|Autosomal recessive limb-girdle muscular dystrophy type 2J|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,2,178799566,178799566,TTN,Conflicting classifications of pathogenicity,"Myopathy, myofibrillar, 9, with early respiratory failure|not provided|not specified|Autosomal recessive limb-girdle muscular dystrophy type 2J;Dilated cardiomyopathy 1G|Cardiomyopathy|Early-onset myopathy with fatal cardiomyopathy|Tibial muscular dystrophy|Dilated cardiomyopathy 1G|Autosomal recessive limb-girdle muscular dystrophy type 2J|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,2,179393810,179393810,TTN,Pathogenic,Early-onset myopathy with fatal cardiomyopathy,Deletion,GRCh37
na,na,2,178529083,178529083,TTN,Pathogenic,Early-onset myopathy with fatal cardiomyopathy,Deletion,GRCh38
na,na,2,179395807,179395814,TTN,Pathogenic,Early-onset myopathy with fatal cardiomyopathy,Deletion,GRCh37
na,na,2,178531080,178531087,TTN,Pathogenic,Early-onset myopathy with fatal cardiomyopathy,Deletion,GRCh38
na,na,17,66520205,66520206,PRKAR1A,Pathogenic,"Carney complex, type 1|not provided|Hereditary cancer-predisposing syndrome",Microsatellite,GRCh37
na,na,17,68524064,68524065,PRKAR1A,Pathogenic,"Carney complex, type 1|not provided|Hereditary cancer-predisposing syndrome",Microsatellite,GRCh38
na,na,17,66525027,66525028,PRKAR1A,Pathogenic,"Carney complex, type 1",Indel,GRCh37
na,na,17,68528886,68528887,PRKAR1A,Pathogenic,"Carney complex, type 1",Indel,GRCh38
na,na,17,66525135,66525135,PRKAR1A,Likely pathogenic,"Carney complex, type 1|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,17,68528994,68528994,PRKAR1A,Likely pathogenic,"Carney complex, type 1|not provided|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,17,66521961,66521964,PRKAR1A,Pathogenic,Familial atrial myxoma,Deletion,GRCh37
na,na,17,68525820,68525823,PRKAR1A,Pathogenic,Familial atrial myxoma,Deletion,GRCh38
na,na,17,66524030,66524031,PRKAR1A,Pathogenic,"Carney complex, type 1|Hereditary cancer-predisposing syndrome",Microsatellite,GRCh37
na,na,17,68527889,68527890,PRKAR1A,Pathogenic,"Carney complex, type 1|Hereditary cancer-predisposing syndrome",Microsatellite,GRCh38
na,na,17,66511541,66511541,PRKAR1A,Pathogenic,"Carney complex, type 1|not provided",single nucleotide variant,GRCh37
na,na,17,68515400,68515400,PRKAR1A,Pathogenic,"Carney complex, type 1|not provided",single nucleotide variant,GRCh38
na,na,17,66508690,66508690,PRKAR1A,Conflicting classifications of pathogenicity,"Pigmented nodular adrenocortical disease, primary, 1|Carney complex, type 1",single nucleotide variant,GRCh37
na,na,17,68512549,68512549,PRKAR1A,Conflicting classifications of pathogenicity,"Pigmented nodular adrenocortical disease, primary, 1|Carney complex, type 1",single nucleotide variant,GRCh38
na,na,na,-1,-1,PRKAR1A,Pathogenic,"Pigmented nodular adrenocortical disease, primary, 1",Deletion,na
na,na,17,66522054,66522054,PRKAR1A,Pathogenic,"Carney complex, type 1",single nucleotide variant,GRCh37
na,na,17,68525913,68525913,PRKAR1A,Pathogenic,"Carney complex, type 1",single nucleotide variant,GRCh38
na,na,17,66526060,66526060,PRKAR1A,Pathogenic,"Adrenocortical tumor, somatic",single nucleotide variant,GRCh37
na,na,17,68529919,68529919,PRKAR1A,Pathogenic,"Adrenocortical tumor, somatic",single nucleotide variant,GRCh38
na,na,17,66518939,66518939,PRKAR1A,Uncertain significance,"Carney complex, type 1|Carney complex|Hereditary cancer-predisposing syndrome|PRKAR1A-related disorder|not provided|Acrodysostosis 1 with or without hormone resistance",single nucleotide variant,GRCh37
na,na,17,68522798,68522798,PRKAR1A,Uncertain significance,"Carney complex, type 1|Carney complex|Hereditary cancer-predisposing syndrome|PRKAR1A-related disorder|not provided|Acrodysostosis 1 with or without hormone resistance",single nucleotide variant,GRCh38
na,na,17,66523965,66523970,PRKAR1A,Pathogenic/Likely pathogenic,"Pigmented nodular adrenocortical disease, primary, 1|Carney complex, type 1|CARNEY COMPLEX, TYPE I|Familial atrial myxoma;Pigmented nodular adrenocortical disease, primary, 1;Acrodysostosis 1 with or without hormone resistance;Carney complex, type 1",Microsatellite,GRCh37
na,na,17,68527824,68527829,PRKAR1A,Pathogenic/Likely pathogenic,"Pigmented nodular adrenocortical disease, primary, 1|Carney complex, type 1|CARNEY COMPLEX, TYPE I|Familial atrial myxoma;Pigmented nodular adrenocortical disease, primary, 1;Acrodysostosis 1 with or without hormone resistance;Carney complex, type 1",Microsatellite,GRCh38
na,na,22,33255338,33255338,TIMP3,Pathogenic,Sorsby fundus dystrophy|not provided,single nucleotide variant,GRCh37
na,na,22,32859351,32859351,TIMP3,Pathogenic,Sorsby fundus dystrophy|not provided,single nucleotide variant,GRCh38
na,na,22,33255300,33255300,TIMP3,Pathogenic,Sorsby fundus dystrophy|not provided,single nucleotide variant,GRCh37
na,na,22,32859313,32859313,TIMP3,Pathogenic,Sorsby fundus dystrophy|not provided,single nucleotide variant,GRCh38
na,na,22,33255264,33255264,TIMP3,Pathogenic,Sorsby fundus dystrophy|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,22,32859277,32859277,TIMP3,Pathogenic,Sorsby fundus dystrophy|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,22,33255293,33255293,TIMP3,Pathogenic,Sorsby fundus dystrophy,single nucleotide variant,GRCh37
na,na,22,32859306,32859306,TIMP3,Pathogenic,Sorsby fundus dystrophy,single nucleotide variant,GRCh38
na,na,22,33255212,33255212,TIMP3,Uncertain significance,Sorsby fundus dystrophy|not provided,single nucleotide variant,GRCh37
na,na,22,32859225,32859225,TIMP3,Uncertain significance,Sorsby fundus dystrophy|not provided,single nucleotide variant,GRCh38
na,na,8,110100084,110100093,TRHR,Likely pathogenic,"Hypothyroidism, congenital, nongoitrous, 7",Indel,GRCh37
na,na,8,109087855,109087864,TRHR,Likely pathogenic,"Hypothyroidism, congenital, nongoitrous, 7",Indel,GRCh38
na,na,8,110099790,110099790,TRHR,Pathogenic,"Hypothyroidism, congenital, nongoitrous, 7",single nucleotide variant,GRCh37
na,na,8,109087561,109087561,TRHR,Pathogenic,"Hypothyroidism, congenital, nongoitrous, 7",single nucleotide variant,GRCh38
na,na,1,115576128,115576128,TSHB,Pathogenic/Likely pathogenic,Isolated thyroid-stimulating hormone deficiency,single nucleotide variant,GRCh37
na,na,1,115033507,115033507,TSHB,Pathogenic/Likely pathogenic,Isolated thyroid-stimulating hormone deficiency,single nucleotide variant,GRCh38
na,na,1,115576077,115576077,TSHB,Pathogenic,Isolated thyroid-stimulating hormone deficiency,single nucleotide variant,GRCh37
na,na,1,115033456,115033456,TSHB,Pathogenic,Isolated thyroid-stimulating hormone deficiency,single nucleotide variant,GRCh38
na,na,1,115576636,115576636,TSHB,Pathogenic/Likely pathogenic,Isolated thyroid-stimulating hormone deficiency|not provided|TSHB-related disorder,single nucleotide variant,GRCh37
na,na,1,115034015,115034015,TSHB,Pathogenic/Likely pathogenic,Isolated thyroid-stimulating hormone deficiency|not provided|TSHB-related disorder,single nucleotide variant,GRCh38
na,na,1,115576150,115576150,TSHB,Pathogenic,Isolated thyroid-stimulating hormone deficiency|not provided,single nucleotide variant,GRCh37
na,na,1,115033529,115033529,TSHB,Pathogenic,Isolated thyroid-stimulating hormone deficiency|not provided,single nucleotide variant,GRCh38
na,na,8,133883590,133883590,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh37
na,na,8,132871345,132871345,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh38
na,na,8,133900662,133900662,TG,Conflicting classifications of pathogenicity,Iodotyrosyl coupling defect|not provided|Premature ovarian failure,single nucleotide variant,GRCh37
na,na,8,132888417,132888417,TG,Conflicting classifications of pathogenicity,Iodotyrosyl coupling defect|not provided|Premature ovarian failure,single nucleotide variant,GRCh38
na,na,8,133935642,133935642,TG,Pathogenic,"Iodotyrosyl coupling defect|not provided|Congenital hypothyroidism|TG-related disorder|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect",single nucleotide variant,GRCh37
na,na,8,132923397,132923397,TG,Pathogenic,"Iodotyrosyl coupling defect|not provided|Congenital hypothyroidism|TG-related disorder|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect",single nucleotide variant,GRCh38
na,na,8,133919031,133919031,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh37
na,na,8,132906786,132906786,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh38
na,na,8,133984049,133984049,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh37
na,na,8,132971804,132971804,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh38
na,na,8,133894854,133894854,TG,Pathogenic,"Iodotyrosyl coupling defect|not provided|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect|TG-related disorder|Congenital hypothyroidism",single nucleotide variant,GRCh37
na,na,8,132882609,132882609,TG,Pathogenic,"Iodotyrosyl coupling defect|not provided|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect|TG-related disorder|Congenital hypothyroidism",single nucleotide variant,GRCh38
na,na,8,133984058,133984058,TG,Benign,"Autoimmune thyroid disease, susceptibility to, 3|not specified|Iodotyrosyl coupling defect|not provided",single nucleotide variant,GRCh37
na,na,8,132971813,132971813,TG,Benign,"Autoimmune thyroid disease, susceptibility to, 3|not specified|Iodotyrosyl coupling defect|not provided",single nucleotide variant,GRCh38
na,na,8,133900252,133900252,TG,Benign,"Autoimmune thyroid disease, susceptibility to, 3|not specified|Iodotyrosyl coupling defect|not provided",single nucleotide variant,GRCh37
na,na,8,132888007,132888007,TG,Benign,"Autoimmune thyroid disease, susceptibility to, 3|not specified|Iodotyrosyl coupling defect|not provided",single nucleotide variant,GRCh38
na,na,8,133909974,133909974,TG,Benign,"Autoimmune thyroid disease, susceptibility to, 3|not specified|Iodotyrosyl coupling defect|not provided",single nucleotide variant,GRCh37
na,na,8,132897729,132897729,TG,Benign,"Autoimmune thyroid disease, susceptibility to, 3|not specified|Iodotyrosyl coupling defect|not provided",single nucleotide variant,GRCh38
na,na,8,133898760,133898760,TG,Pathogenic,Iodotyrosyl coupling defect|not provided|TG-related disorder,Deletion,GRCh37
na,na,8,132886515,132886515,TG,Pathogenic,Iodotyrosyl coupling defect|not provided|TG-related disorder,Deletion,GRCh38
na,na,8,134030185,134030185,TG,Pathogenic,"Iodotyrosyl coupling defect|Autoimmune thyroid disease, susceptibility to, 3|not provided",single nucleotide variant,GRCh37
na,na,8,133017940,133017940,TG,Pathogenic,"Iodotyrosyl coupling defect|Autoimmune thyroid disease, susceptibility to, 3|not provided",single nucleotide variant,GRCh38
na,na,8,133995594,133995594,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh37
na,na,8,132983349,132983349,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh38
na,na,8,133911054,133911054,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh37
na,na,8,132898809,132898809,TG,Pathogenic,Iodotyrosyl coupling defect,single nucleotide variant,GRCh38
na,na,8,134042152,134042152,TG,Pathogenic/Likely pathogenic,"Iodotyrosyl coupling defect|TG-related disorder|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect",single nucleotide variant,GRCh37
na,na,8,133029907,133029907,TG,Pathogenic/Likely pathogenic,"Iodotyrosyl coupling defect|TG-related disorder|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect",single nucleotide variant,GRCh38
na,na,8,133980042,133980042,TG,Uncertain significance,Iodotyrosyl coupling defect|not provided,single nucleotide variant,GRCh37
na,na,8,132967797,132967797,TG,Uncertain significance,Iodotyrosyl coupling defect|not provided,single nucleotide variant,GRCh38
na,na,8,134034366,134034366,TG,Likely pathogenic,"Iodotyrosyl coupling defect|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect|not provided",single nucleotide variant,GRCh37
na,na,8,133022121,133022121,TG,Likely pathogenic,"Iodotyrosyl coupling defect|Autoimmune thyroid disease, susceptibility to, 3;Iodotyrosyl coupling defect|not provided",single nucleotide variant,GRCh38
na,na,8,133885467,133885467,TG,Pathogenic,Iodotyrosyl coupling defect|Congenital hypothyroidism,single nucleotide variant,GRCh37
na,na,8,132873222,132873222,TG,Pathogenic,Iodotyrosyl coupling defect|Congenital hypothyroidism,single nucleotide variant,GRCh38
na,na,12,98928103,98928103,TMPO,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1T|not specified|Loeys-Dietz syndrome 2|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy 25|not provided|TMPO-related disorder,single nucleotide variant,GRCh37
na,na,12,98534325,98534325,TMPO,Conflicting classifications of pathogenicity,Dilated cardiomyopathy 1T|not specified|Loeys-Dietz syndrome 2|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy 25|not provided|TMPO-related disorder,single nucleotide variant,GRCh38
na,na,16,66565297,66565297,TK2,Pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|Mitochondrial DNA depletion syndrome|not provided|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,16,66531394,66531394,TK2,Pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|Mitochondrial DNA depletion syndrome|not provided|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,16,66547698,66547698,TK2,Pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|not provided|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,16,66513795,66513795,TK2,Pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|not provided|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,16,66565335,66565335,TK2,Pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3|TK2-related disorder|Mitochondrial DNA depletion syndrome|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,16,66531432,66531432,TK2,Pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3|TK2-related disorder|Mitochondrial DNA depletion syndrome|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,16,66575854,66575854,TK2,Likely pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|Mitochondrial disease",single nucleotide variant,GRCh37
na,na,16,66541951,66541951,TK2,Likely pathogenic,"Mitochondrial DNA depletion syndrome, myopathic form|Mitochondrial disease",single nucleotide variant,GRCh38
na,na,19,3600454,3600454,TBXA2R,Benign,"Bleeding disorder, platelet-type, 13, susceptibility to|Asthma",single nucleotide variant,GRCh37
na,na,19,3600456,3600456,TBXA2R,Benign,"Bleeding disorder, platelet-type, 13, susceptibility to|Asthma",single nucleotide variant,GRCh38
na,na,6,169635010,169635010,THBS2,Benign; risk factor,"Lumbar disk herniation, susceptibility to|THBS2-related disorder",single nucleotide variant,GRCh37
na,na,6,169234915,169234915,THBS2,Benign; risk factor,"Lumbar disk herniation, susceptibility to|THBS2-related disorder",single nucleotide variant,GRCh38
na,na,20,23028686,23028686,THBD,Benign,Thrombomodulin-related bleeding disorder|Atypical hemolytic-uremic syndrome with thrombomodulin anomaly|not provided|Kidney disorder|not specified|THBD-related disorder,single nucleotide variant,GRCh37
na,na,20,23048049,23048049,THBD,Benign,Thrombomodulin-related bleeding disorder|Atypical hemolytic-uremic syndrome with thrombomodulin anomaly|not provided|Kidney disorder|not specified|THBD-related disorder,single nucleotide variant,GRCh38
na,na,20,23030000,23030000,THBD,Pathogenic,Thrombomodulin-related bleeding disorder,single nucleotide variant,GRCh37
na,na,20,23049363,23049363,THBD,Pathogenic,Thrombomodulin-related bleeding disorder,single nucleotide variant,GRCh38
na,na,20,23028453,23028454,THBD,Pathogenic,Thrombomodulin-related bleeding disorder,Duplication,GRCh37
na,na,20,23047816,23047817,THBD,Pathogenic,Thrombomodulin-related bleeding disorder,Duplication,GRCh38
na,na,20,23030015,23030015,THBD,Conflicting classifications of pathogenicity,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly|not provided|Atypical hemolytic-uremic syndrome|not specified|THBD-related disorder,single nucleotide variant,GRCh37
na,na,20,23049378,23049378,THBD,Conflicting classifications of pathogenicity,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly|not provided|Atypical hemolytic-uremic syndrome|not specified|THBD-related disorder,single nucleotide variant,GRCh38
na,na,20,23029984,23029984,THBD,risk factor,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly,single nucleotide variant,GRCh37
na,na,20,23049347,23049347,THBD,risk factor,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly,single nucleotide variant,GRCh38
na,na,20,23028659,23028659,THBD,Conflicting classifications of pathogenicity,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly|not provided|Atypical hemolytic-uremic syndrome|THBD-related disorder|Thrombomodulin-related bleeding disorder,single nucleotide variant,GRCh37
na,na,20,23048022,23048022,THBD,Conflicting classifications of pathogenicity,Atypical hemolytic-uremic syndrome with thrombomodulin anomaly|not provided|Atypical hemolytic-uremic syndrome|THBD-related disorder|Thrombomodulin-related bleeding disorder,single nucleotide variant,GRCh38
na,na,6,18143955,18143955,TPMT,drug response,Thiopurine S-methyltransferase deficiency,single nucleotide variant,GRCh37
na,na,6,18143724,18143724,TPMT,drug response,Thiopurine S-methyltransferase deficiency,single nucleotide variant,GRCh38
na,na,6,18139228,18139228,TPMT,Benign/Likely benign; other,Thiopurine S-methyltransferase deficiency|not provided|TPMT-related disorder,single nucleotide variant,GRCh37
na,na,6,18138997,18138997,TPMT,Benign/Likely benign; other,Thiopurine S-methyltransferase deficiency|not provided|TPMT-related disorder,single nucleotide variant,GRCh38
na,na,6,18131012,18131012,TPMT,drug response,Thiopurine S-methyltransferase deficiency,single nucleotide variant,GRCh37
na,na,6,18130781,18130781,TPMT,drug response,Thiopurine S-methyltransferase deficiency,single nucleotide variant,GRCh38
na,na,6,18130918,18130918,TPMT,Likely benign; other,Thiopurine S-methyltransferase deficiency|not provided,single nucleotide variant,GRCh37
na,na,6,18130687,18130687,TPMT,Likely benign; other,Thiopurine S-methyltransferase deficiency|not provided,single nucleotide variant,GRCh38
na,na,6,18130993,18130993,TPMT,drug response,Thiopurine S-methyltransferase deficiency,single nucleotide variant,GRCh37
na,na,6,18130762,18130762,TPMT,drug response,Thiopurine S-methyltransferase deficiency,single nucleotide variant,GRCh38
na,na,6,18134115,18134115,TPMT,drug response,Thiopurine S-methyltransferase deficiency,single nucleotide variant,GRCh37
na,na,6,18133884,18133884,TPMT,drug response,Thiopurine S-methyltransferase deficiency,single nucleotide variant,GRCh38
na,na,3,46621476,46621476,CRIPTO,Uncertain significance,Forebrain defects,single nucleotide variant,GRCh37
na,na,3,46579986,46579986,CRIPTO,Uncertain significance,Forebrain defects,single nucleotide variant,GRCh38
na,na,5,1294397,1294397,TERT,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|not provided|Dyskeratosis congenita, autosomal dominant 2|not specified|Dyskeratosis congenita|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|TERT-related disorder",single nucleotide variant,GRCh37
na,na,5,1294282,1294282,TERT,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|not provided|Dyskeratosis congenita, autosomal dominant 2|not specified|Dyskeratosis congenita|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|TERT-related disorder",single nucleotide variant,GRCh38
na,na,5,1293767,1293767,TERT,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Autosomal recessive dyskeratosis congenita 4|not specified|not provided|Dyskeratosis congenita, autosomal dominant 2|Idiopathic Pulmonary Fibrosis;Dyskeratosis congenita, autosomal dominant 2|Dyskeratosis congenita|Acute myeloid leukemia;Melanoma, cutaneous malignant, susceptibility to, 9;Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1;Dyskeratosis congenita, autosomal dominant 2",single nucleotide variant,GRCh37
na,na,5,1293652,1293652,TERT,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Autosomal recessive dyskeratosis congenita 4|not specified|not provided|Dyskeratosis congenita, autosomal dominant 2|Idiopathic Pulmonary Fibrosis;Dyskeratosis congenita, autosomal dominant 2|Dyskeratosis congenita|Acute myeloid leukemia;Melanoma, cutaneous malignant, susceptibility to, 9;Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1;Dyskeratosis congenita, autosomal dominant 2",single nucleotide variant,GRCh38
na,na,5,1279456,1279456,TERT,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|TERT-related disorder|Dyskeratosis congenita|Pulmonary fibrosis|not provided",single nucleotide variant,GRCh37
na,na,5,1279341,1279341,TERT,Conflicting classifications of pathogenicity,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|TERT-related disorder|Dyskeratosis congenita|Pulmonary fibrosis|not provided",single nucleotide variant,GRCh38
na,na,5,1272367,1272367,TERT,Uncertain significance,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis",single nucleotide variant,GRCh37
na,na,5,1272252,1272252,TERT,Uncertain significance,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis",single nucleotide variant,GRCh38
na,na,5,1254510,1254510,TERT,Uncertain significance,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 2;Interstitial lung disease 2|Interstitial lung disease 2|Dyskeratosis congenita, autosomal dominant 2|7 conditions|not provided|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|TERT-related disorder|Dyskeratosis congenita",single nucleotide variant,GRCh37
na,na,5,1254395,1254395,TERT,Uncertain significance,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Aplastic anemia|Dyskeratosis congenita, autosomal dominant 2;Interstitial lung disease 2|Interstitial lung disease 2|Dyskeratosis congenita, autosomal dominant 2|7 conditions|not provided|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|TERT-related disorder|Dyskeratosis congenita",single nucleotide variant,GRCh38
na,na,5,1264656,1264656,TERT,Pathogenic,"Dyskeratosis congenita, autosomal dominant 2|Dyskeratosis congenita, autosomal dominant 1",single nucleotide variant,GRCh37
na,na,5,1264541,1264541,TERT,Pathogenic,"Dyskeratosis congenita, autosomal dominant 2|Dyskeratosis congenita, autosomal dominant 1",single nucleotide variant,GRCh38
na,na,5,1266639,1266639,TERT,Pathogenic/Likely pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Interstitial lung disease 2|not provided|Dyskeratosis congenita, autosomal dominant 2|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|Pulmonary fibrosis",single nucleotide variant,GRCh37
na,na,5,1266524,1266524,TERT,Pathogenic/Likely pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Interstitial lung disease 2|not provided|Dyskeratosis congenita, autosomal dominant 2|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|Pulmonary fibrosis",single nucleotide variant,GRCh38
na,na,5,1278802,1278802,TERT,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Interstitial lung disease 2|not provided|Pulmonary fibrosis",Deletion,GRCh37
na,na,5,1278687,1278687,TERT,Pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Interstitial lung disease 2|not provided|Pulmonary fibrosis",Deletion,GRCh38
na,na,5,1294885,1294885,TERT,Pathogenic/Likely pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Interstitial lung disease 2|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|not provided",single nucleotide variant,GRCh37
na,na,5,1294770,1294770,TERT,Pathogenic/Likely pathogenic,"Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1|Interstitial lung disease 2|Dyskeratosis congenita, autosomal dominant 2;Idiopathic Pulmonary Fibrosis|not provided",single nucleotide variant,GRCh38
na,na,17,34207405,34207405,CCL5,Likely benign,"Human immunodeficiency virus type 1, delayed disease progression with infection by|CCL5-related condition",single nucleotide variant,GRCh37
na,na,17,35880401,35880401,CCL5,Likely benign,"Human immunodeficiency virus type 1, delayed disease progression with infection by|CCL5-related condition",single nucleotide variant,GRCh38
na,na,17,34207003,34207003,CCL5,Pathogenic,"Human immunodeficiency virus type 1, rapid disease progression with infection by",single nucleotide variant,GRCh37
na,na,17,35879999,35879999,CCL5,Pathogenic,"Human immunodeficiency virus type 1, rapid disease progression with infection by",single nucleotide variant,GRCh38
na,na,5,156668673,156668673,ITK,Likely pathogenic,Lymphoproliferative syndrome 1,single nucleotide variant,GRCh37
na,na,5,157241663,157241663,ITK,Likely pathogenic,Lymphoproliferative syndrome 1,single nucleotide variant,GRCh38
na,na,2,87017523,87017523,CD8A,Pathogenic,Susceptibility to respiratory infections associated with CD8alpha chain mutation,single nucleotide variant,GRCh37
na,na,2,86790400,86790400,CD8A,Pathogenic,Susceptibility to respiratory infections associated with CD8alpha chain mutation,single nucleotide variant,GRCh38
na,na,11,2417201,2417201,CD81,Pathogenic,"Immunodeficiency, common variable, 6",single nucleotide variant,GRCh37
na,na,11,2395971,2395971,CD81,Pathogenic,"Immunodeficiency, common variable, 6",single nucleotide variant,GRCh38
na,na,11,118184591,118184591,CD3E,Likely pathogenic,Immunodeficiency 18,single nucleotide variant,GRCh37
na,na,11,118313876,118313876,CD3E,Likely pathogenic,Immunodeficiency 18,single nucleotide variant,GRCh38
na,na,11,118183405,118183405,CD3E,Pathogenic,Immunodeficiency 18,single nucleotide variant,GRCh37
na,na,11,118312690,118312690,CD3E,Pathogenic,Immunodeficiency 18,single nucleotide variant,GRCh38
na,na,11,118183357,118183358,CD3E,Pathogenic,"Immunodeficiency 18, severe combined immunodeficiency variant",Deletion,GRCh37
na,na,11,118312642,118312643,CD3E,Pathogenic,"Immunodeficiency 18, severe combined immunodeficiency variant",Deletion,GRCh38
na,na,11,118211162,118211162,CD3D,Pathogenic,Immunodeficiency 19|not provided,single nucleotide variant,GRCh37
na,na,11,118340447,118340447,CD3D,Pathogenic,Immunodeficiency 19|not provided,single nucleotide variant,GRCh38
na,na,11,118210617,118210617,CD3D,Pathogenic,Immunodeficiency 19,single nucleotide variant,GRCh37
na,na,11,118339902,118339902,CD3D,Pathogenic,Immunodeficiency 19,single nucleotide variant,GRCh38
na,na,1,167408592,167408592,CD247,Pathogenic,Immunodeficiency 25,single nucleotide variant,GRCh37
na,na,1,167439355,167439355,CD247,Pathogenic,Immunodeficiency 25,single nucleotide variant,GRCh38
na,na,1,167408591,167408592,CD247,Pathogenic,Immunodeficiency 25,Inversion,GRCh37
na,na,1,167439354,167439355,CD247,Pathogenic,Immunodeficiency 25,Inversion,GRCh38
na,na,1,167408591,167408591,CD247,Pathogenic,Immunodeficiency 25,single nucleotide variant,GRCh37
na,na,1,167439354,167439354,CD247,Pathogenic,Immunodeficiency 25,single nucleotide variant,GRCh38
na,na,1,167408590,167408592,CD247,Pathogenic,Immunodeficiency 25,Indel,GRCh37
na,na,1,167439353,167439355,CD247,Pathogenic,Immunodeficiency 25,Indel,GRCh38
na,na,11,118215139,118215139,CD3G,Pathogenic/Likely pathogenic,Combined immunodeficiency due to CD3gamma deficiency,single nucleotide variant,GRCh37
na,na,11,118344424,118344424,CD3G,Pathogenic/Likely pathogenic,Combined immunodeficiency due to CD3gamma deficiency,single nucleotide variant,GRCh38
na,na,11,118220456,118220472,CD3G,Pathogenic,Combined immunodeficiency due to CD3gamma deficiency,Deletion,GRCh37
na,na,11,118349741,118349757,CD3G,Pathogenic,Combined immunodeficiency due to CD3gamma deficiency,Deletion,GRCh38
na,na,1,31347320,31347320,SDC3,association,"Obesity, association with",single nucleotide variant,GRCh37
na,na,1,30874473,30874473,SDC3,association,"Obesity, association with",single nucleotide variant,GRCh38
na,na,1,31349647,31349647,SDC3,association,"Obesity, association with",single nucleotide variant,GRCh37
na,na,1,30876800,30876800,SDC3,association,"Obesity, association with",single nucleotide variant,GRCh38
na,na,9,136221512,136221512,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",single nucleotide variant,GRCh37
na,na,9,133354657,133354657,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",single nucleotide variant,GRCh38
na,na,9,136219301,136219301,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome|not provided|Mitochondrial disease|Charcot-Marie-Tooth disease type 4K;Mitochondrial complex IV deficiency, nuclear type 1",single nucleotide variant,GRCh37
na,na,9,133352446,133352446,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome|not provided|Mitochondrial disease|Charcot-Marie-Tooth disease type 4K;Mitochondrial complex IV deficiency, nuclear type 1",single nucleotide variant,GRCh38
na,na,9,136220602,136220602,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",single nucleotide variant,GRCh37
na,na,9,133353747,133353747,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",single nucleotide variant,GRCh38
na,na,9,136219586,136219587,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",Deletion,GRCh37
na,na,9,133352731,133352732,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",Deletion,GRCh38
na,na,9,136218929,136218929,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|not provided",single nucleotide variant,GRCh37
na,na,9,133352074,133352074,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|not provided",single nucleotide variant,GRCh38
na,na,9,136220748,136220748,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome",single nucleotide variant,GRCh37
na,na,9,133353893,133353893,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|Leigh syndrome",single nucleotide variant,GRCh38
na,na,9,136219562,136219563,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",Insertion,GRCh37
na,na,9,133352707,133352708,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1",Insertion,GRCh38
na,na,9,136218825,136218826,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|not provided|Leigh syndrome|Inborn genetic diseases|Cerebellar ataxia;Muscle weakness;Dysarthria;Abnormal pyramidal sign|Charcot-Marie-Tooth disease type 4K;Leigh syndrome due to mitochondrial complex IV deficiency|See cases|Mitochondrial complex IV deficiency, nuclear type 1;Charcot-Marie-Tooth disease type 4K|SURF1-related disorder",Microsatellite,GRCh37
na,na,9,133351970,133351971,SURF1,Pathogenic,"Mitochondrial complex IV deficiency, nuclear type 1|not provided|Leigh syndrome|Inborn genetic diseases|Cerebellar ataxia;Muscle weakness;Dysarthria;Abnormal pyramidal sign|Charcot-Marie-Tooth disease type 4K;Leigh syndrome due to mitochondrial complex IV deficiency|See cases|Mitochondrial complex IV deficiency, nuclear type 1;Charcot-Marie-Tooth disease type 4K|SURF1-related disorder",Microsatellite,GRCh38
na,na,2,47602439,47602439,EPCAM,Pathogenic,Congenital diarrhea 5 with tufting enteropathy|Hereditary cancer-predisposing syndrome|not provided|Gastric cancer,single nucleotide variant,GRCh37
na,na,2,47375300,47375300,EPCAM,Pathogenic,Congenital diarrhea 5 with tufting enteropathy|Hereditary cancer-predisposing syndrome|not provided|Gastric cancer,single nucleotide variant,GRCh38
na,na,2,47602372,47602372,EPCAM,Uncertain significance,Congenital diarrhea 5 with tufting enteropathy|not provided,single nucleotide variant,GRCh37
na,na,2,47375233,47375233,EPCAM,Uncertain significance,Congenital diarrhea 5 with tufting enteropathy|not provided,single nucleotide variant,GRCh38
na,na,2,47600959,47600959,EPCAM,Pathogenic,Congenital diarrhea 5 with tufting enteropathy,single nucleotide variant,GRCh37
na,na,2,47373820,47373820,EPCAM,Pathogenic,Congenital diarrhea 5 with tufting enteropathy,single nucleotide variant,GRCh38
na,na,2,47604159,47604160,EPCAM,Pathogenic,Congenital diarrhea 5 with tufting enteropathy|not provided|EPCAM-related disorder,Duplication,GRCh37
na,na,2,47377020,47377021,EPCAM,Pathogenic,Congenital diarrhea 5 with tufting enteropathy|not provided|EPCAM-related disorder,Duplication,GRCh38
na,na,2,47610837,47615745,EPCAM,Pathogenic,Lynch syndrome 8,Deletion,GRCh37
na,na,2,47383698,47388606,EPCAM,Pathogenic,Lynch syndrome 8,Deletion,GRCh38
na,na,2,47377952,47400851,EPCAM,Pathogenic,Lynch syndrome 8,Deletion,GRCh38
na,na,4,24801834,24801834,SOD3,Benign,"Superoxide dismutase, elevated extracellular|SOD3-related disorder",single nucleotide variant,GRCh37
na,na,4,24800212,24800212,SOD3,Benign,"Superoxide dismutase, elevated extracellular|SOD3-related disorder",single nucleotide variant,GRCh38
na,na,1,17359573,17359573,SDHB,Pathogenic,Paragangliomas 4|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|not provided|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|Carney-Stratakis syndrome;Paragangliomas 4;Pheochromocytoma|Von Hippel-Lindau syndrome,single nucleotide variant,GRCh37
na,na,1,17033078,17033078,SDHB,Pathogenic,Paragangliomas 4|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|not provided|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|Carney-Stratakis syndrome;Paragangliomas 4;Pheochromocytoma|Von Hippel-Lindau syndrome,single nucleotide variant,GRCh38
na,na,1,17350520,17350520,SDHB,Pathogenic/Likely pathogenic,Paragangliomas 4|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas 4;Gastrointestinal stromal tumor;Pheochromocytoma|not provided,single nucleotide variant,GRCh37
na,na,1,17024025,17024025,SDHB,Pathogenic/Likely pathogenic,Paragangliomas 4|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas 4;Gastrointestinal stromal tumor;Pheochromocytoma|not provided,single nucleotide variant,GRCh38
na,na,1,17349143,17349143,SDHB,Pathogenic/Likely pathogenic,"Paragangliomas 4|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome|not provided|Hereditary pheochromocytoma-paraganglioma|Paragangliomas 4;Gastrointestinal stromal tumor;Pheochromocytoma|SDHB-related disorder|Mitochondrial complex 2 deficiency, nuclear type 4",single nucleotide variant,GRCh37
na,na,1,17022648,17022648,SDHB,Pathogenic/Likely pathogenic,"Paragangliomas 4|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome|not provided|Hereditary pheochromocytoma-paraganglioma|Paragangliomas 4;Gastrointestinal stromal tumor;Pheochromocytoma|SDHB-related disorder|Mitochondrial complex 2 deficiency, nuclear type 4",single nucleotide variant,GRCh38
na,na,1,17349149,17349152,SDHB,Pathogenic,Paragangliomas 4|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma,Microsatellite,GRCh37
na,na,1,17022654,17022657,SDHB,Pathogenic,Paragangliomas 4|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma,Microsatellite,GRCh38
na,na,1,17371377,17371377,SDHB,Pathogenic,Paragangliomas 4|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|not provided|Hereditary pheochromocytoma-paraganglioma|Gastrointestinal stromal tumor,single nucleotide variant,GRCh37
na,na,1,17044882,17044882,SDHB,Pathogenic,Paragangliomas 4|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|not provided|Hereditary pheochromocytoma-paraganglioma|Gastrointestinal stromal tumor,single nucleotide variant,GRCh38
na,na,na,-1,-1,SDHB,Pathogenic,Paragangliomas 4,Deletion,na
na,na,1,17371320,17371320,SDHB,Pathogenic,Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|SDHB-related disorder|Paragangliomas 4,single nucleotide variant,GRCh37
na,na,1,17044825,17044825,SDHB,Pathogenic,Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|SDHB-related disorder|Paragangliomas 4,single nucleotide variant,GRCh38
na,na,1,17355216,17355216,SDHB,Pathogenic,Paragangliomas 4,single nucleotide variant,GRCh37
na,na,1,17028721,17028721,SDHB,Pathogenic,Paragangliomas 4,single nucleotide variant,GRCh38
na,na,1,17355123,17355123,SDHB,Pathogenic/Likely pathogenic,Paragangliomas 4|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma,single nucleotide variant,GRCh37
na,na,1,17028628,17028628,SDHB,Pathogenic/Likely pathogenic,Paragangliomas 4|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma,single nucleotide variant,GRCh38
na,na,1,17355219,17355219,SDHB,Conflicting classifications of pathogenicity,Pheochromocytoma|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,1,17028724,17028724,SDHB,Conflicting classifications of pathogenicity,Pheochromocytoma|Gastrointestinal stromal tumor;Paragangliomas 4;Pheochromocytoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,1,17355094,17355094,SDHB,Pathogenic,Carney-Stratakis syndrome,single nucleotide variant,GRCh37
na,na,1,17028599,17028599,SDHB,Pathogenic,Carney-Stratakis syndrome,single nucleotide variant,GRCh38
na,na,1,17380507,17380507,SDHB,Benign/Likely benign,"Cowden syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma|Paragangliomas 4|Gastrointestinal stromal tumor|Paragangliomas 4;Gastrointestinal stromal tumor;Pheochromocytoma|Carney-Stratakis syndrome;Paragangliomas 4;Gastrointestinal stromal tumor;Mitochondrial complex 2 deficiency, nuclear type 4;Pheochromocytoma|SDHB-related disorder",single nucleotide variant,GRCh37
na,na,1,17054012,17054012,SDHB,Benign/Likely benign,"Cowden syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma|Paragangliomas 4|Gastrointestinal stromal tumor|Paragangliomas 4;Gastrointestinal stromal tumor;Pheochromocytoma|Carney-Stratakis syndrome;Paragangliomas 4;Gastrointestinal stromal tumor;Mitochondrial complex 2 deficiency, nuclear type 4;Pheochromocytoma|SDHB-related disorder",single nucleotide variant,GRCh38
na,na,1,17354297,17354297,SDHB,Conflicting classifications of pathogenicity,Cowden syndrome|not provided|Paragangliomas 4|Hereditary cancer-predisposing syndrome|not specified|Paragangliomas 4;Gastrointestinal stromal tumor;Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|Gastrointestinal stromal tumor|Carney-Stratakis syndrome|Malignant tumor of breast,single nucleotide variant,GRCh37
na,na,1,17027802,17027802,SDHB,Conflicting classifications of pathogenicity,Cowden syndrome|not provided|Paragangliomas 4|Hereditary cancer-predisposing syndrome|not specified|Paragangliomas 4;Gastrointestinal stromal tumor;Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|Gastrointestinal stromal tumor|Carney-Stratakis syndrome|Malignant tumor of breast,single nucleotide variant,GRCh38
na,na,11,102715947,102715948,MMP3,risk factor,"Coronary heart disease, susceptibility to, 6",Duplication,GRCh37
na,na,11,102845216,102845217,MMP3,risk factor,"Coronary heart disease, susceptibility to, 6",Duplication,GRCh38
na,na,9,127265497,127265498,NR5A1,Pathogenic,"46,XY sex reversal 3",Indel,GRCh37
na,na,9,124503218,124503219,NR5A1,Pathogenic,"46,XY sex reversal 3",Indel,GRCh38
na,na,9,127262475,127262475,NR5A1,Pathogenic,"ADRENAL INSUFFICIENCY, NR5A1-RELATED",single nucleotide variant,GRCh37
na,na,9,124500196,124500196,NR5A1,Pathogenic,"ADRENAL INSUFFICIENCY, NR5A1-RELATED",single nucleotide variant,GRCh38
na,na,9,127262964,127262964,NR5A1,Pathogenic,"46,XY sex reversal 3|ADRENAL INSUFFICIENCY, NR5A1-RELATED|46,XX sex reversal 4",single nucleotide variant,GRCh37
na,na,9,124500685,124500685,NR5A1,Pathogenic,"46,XY sex reversal 3|ADRENAL INSUFFICIENCY, NR5A1-RELATED|46,XX sex reversal 4",single nucleotide variant,GRCh38
na,na,9,127253433,127253440,NR5A1,Pathogenic,"46,XY sex reversal 3",Deletion,GRCh37
na,na,9,124491154,124491161,NR5A1,Pathogenic,"46,XY sex reversal 3",Deletion,GRCh38
na,na,9,127265627,127265627,NR5A1,Pathogenic,"46,XY sex reversal 3",single nucleotide variant,GRCh37
na,na,9,124503348,124503348,NR5A1,Pathogenic,"46,XY sex reversal 3",single nucleotide variant,GRCh38
na,na,9,127265657,127265657,NR5A1,Pathogenic,"46,XY sex reversal 3",Deletion,GRCh37
na,na,9,124503378,124503378,NR5A1,Pathogenic,"46,XY sex reversal 3",Deletion,GRCh38
na,na,9,127265632,127265632,NR5A1,Pathogenic,"46,XY sex reversal 3",single nucleotide variant,GRCh37
na,na,9,124503353,124503353,NR5A1,Pathogenic,"46,XY sex reversal 3",single nucleotide variant,GRCh38
na,na,9,127265368,127265368,NR5A1,Pathogenic,"46,XY sex reversal 3",single nucleotide variant,GRCh37
na,na,9,124503089,124503089,NR5A1,Pathogenic,"46,XY sex reversal 3",single nucleotide variant,GRCh38
na,na,9,127262968,127262968,NR5A1,Likely pathogenic,"46,XY sex reversal 3|not provided",single nucleotide variant,GRCh37
na,na,9,124500689,124500689,NR5A1,Likely pathogenic,"46,XY sex reversal 3|not provided",single nucleotide variant,GRCh38
na,na,9,127245113,127245113,NR5A1,Pathogenic,"46,XY sex reversal 3",single nucleotide variant,GRCh37
na,na,9,124482834,124482834,NR5A1,Pathogenic,"46,XY sex reversal 3",single nucleotide variant,GRCh38
na,na,9,127262573,127262573,NR5A1,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",Deletion,GRCh37
na,na,9,124500294,124500294,NR5A1,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",Deletion,GRCh38
na,na,9,127255422,127255422,NR5A1,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",single nucleotide variant,GRCh37
na,na,9,124493143,124493143,NR5A1,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",single nucleotide variant,GRCh38
na,na,9,127265672,127265672,NR5A1,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",single nucleotide variant,GRCh37
na,na,9,124503393,124503393,NR5A1,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",single nucleotide variant,GRCh38
na,na,9,127262849,127262849,NR5A1,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",Deletion,GRCh37
na,na,9,124500570,124500570,NR5A1,Pathogenic,"46,XY sex reversal 3|Premature ovarian failure 7",Deletion,GRCh38
na,na,9,127262540,127262548,NR5A1,Pathogenic,Premature ovarian failure 7,Microsatellite,GRCh37
na,na,9,124500261,124500269,NR5A1,Pathogenic,Premature ovarian failure 7,Microsatellite,GRCh38
na,na,9,127262871,127262871,NR5A1,Conflicting classifications of pathogenicity,"not provided|not specified|Oligosynaptic infertility;46,XY disorder of sex development|Spermatogenic failure 8|NR5A1-related disorder",single nucleotide variant,GRCh37
na,na,9,124500592,124500592,NR5A1,Conflicting classifications of pathogenicity,"not provided|not specified|Oligosynaptic infertility;46,XY disorder of sex development|Spermatogenic failure 8|NR5A1-related disorder",single nucleotide variant,GRCh38
na,na,1,53440462,53440463,SCP2,Pathogenic,Sterol carrier protein 2 deficiency|not provided,Duplication,GRCh37
na,na,1,52974790,52974791,SCP2,Pathogenic,Sterol carrier protein 2 deficiency|not provided,Duplication,GRCh38
na,na,12,89328335,89328335,KITLG,Affects,"SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN",single nucleotide variant,GRCh37
na,na,12,88934558,88934558,KITLG,Affects,"SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN",single nucleotide variant,GRCh38
na,na,12,89299746,89299746,KITLG,Affects,"SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN",single nucleotide variant,GRCh37
na,na,12,88905969,88905969,KITLG,Affects,"SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN",single nucleotide variant,GRCh38
na,na,12,88939551,88939551,KITLG,Pathogenic,"Hyperpigmentation with or without hypopigmentation, familial progressive",single nucleotide variant,GRCh37
na,na,12,88545774,88545774,KITLG,Pathogenic,"Hyperpigmentation with or without hypopigmentation, familial progressive",single nucleotide variant,GRCh38
na,na,3,181430677,181430677,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome|not provided,single nucleotide variant,GRCh37
na,na,3,181712889,181712889,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome|not provided,single nucleotide variant,GRCh38
na,na,3,181430425,181430425,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh37
na,na,3,181712637,181712637,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh38
na,na,3,181430396,181430396,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh37
na,na,3,181712608,181712608,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh38
na,na,3,181430438,181430438,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh37
na,na,3,181712650,181712650,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh38
na,na,3,181430611,181430611,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh37
na,na,3,181712823,181712823,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh38
na,na,3,179547548,182152788,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,Deletion,GRCh38
na,na,3,181430311,181430311,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh37
na,na,3,181712523,181712523,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh38
na,na,3,181430369,181430369,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh37
na,na,3,181712581,181712581,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh38
na,na,3,181430286,181430286,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh37
na,na,3,181712498,181712498,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh38
na,na,3,181430537,181430537,SOX2,Conflicting classifications of pathogenicity,Optic nerve hypoplasia and abnormalities of the central nervous system|Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh37
na,na,3,181712749,181712749,SOX2,Conflicting classifications of pathogenicity,Optic nerve hypoplasia and abnormalities of the central nervous system|Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh38
na,na,3,181430719,181430719,SOX2,Uncertain significance,Optic nerve hypoplasia and abnormalities of the central nervous system|Inborn genetic diseases|Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh37
na,na,3,181712931,181712931,SOX2,Uncertain significance,Optic nerve hypoplasia and abnormalities of the central nervous system|Inborn genetic diseases|Anophthalmia/microphthalmia-esophageal atresia syndrome,single nucleotide variant,GRCh38
na,na,3,181430697,181430697,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,Deletion,GRCh37
na,na,3,181712909,181712909,SOX2,Pathogenic,Anophthalmia/microphthalmia-esophageal atresia syndrome,Deletion,GRCh38
na,na,na,-1,-1,SPTB,Benign,not specified,Variation,na
na,na,na,-1,-1,SPTB,Benign,not specified,Variation,na
na,na,14,65234443,65234443,SPTB,Likely pathogenic,Elliptocytosis 3|not provided,single nucleotide variant,GRCh37
na,na,14,64767725,64767725,SPTB,Likely pathogenic,Elliptocytosis 3|not provided,single nucleotide variant,GRCh38
na,na,14,65234018,65234018,SPTB,Pathogenic,Elliptocytosis 3,single nucleotide variant,GRCh37
na,na,14,64767300,64767300,SPTB,Pathogenic,Elliptocytosis 3,single nucleotide variant,GRCh38
na,na,14,65234463,65234464,SPTB,Pathogenic,Elliptocytosis 3,Microsatellite,GRCh37
na,na,14,64767745,64767746,SPTB,Pathogenic,Elliptocytosis 3,Microsatellite,GRCh38
na,na,14,65234423,65234423,SPTB,Pathogenic,Elliptocytosis 3,Deletion,GRCh37
na,na,14,64767705,64767705,SPTB,Pathogenic,Elliptocytosis 3,Deletion,GRCh38
na,na,14,65268515,65268515,SPTB,Pathogenic,Hereditary spherocytosis type 2,single nucleotide variant,GRCh37
na,na,14,64801797,64801797,SPTB,Pathogenic,Hereditary spherocytosis type 2,single nucleotide variant,GRCh38
na,na,14,65234547,65234547,SPTB,Pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 3",single nucleotide variant,GRCh37
na,na,14,64767829,64767829,SPTB,Pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 3",single nucleotide variant,GRCh38
na,na,14,65234545,65234545,SPTB,Pathogenic/Likely pathogenic,Elliptocytosis 3|Hereditary spherocytosis type 2|not provided|SPTB-related disorder,single nucleotide variant,GRCh37
na,na,14,64767827,64767827,SPTB,Pathogenic/Likely pathogenic,Elliptocytosis 3|Hereditary spherocytosis type 2|not provided|SPTB-related disorder,single nucleotide variant,GRCh38
na,na,na,-1,-1,SPTB,Pathogenic,Hereditary spherocytosis type 2,Deletion,na
na,na,14,65234526,65234526,SPTB,Conflicting classifications of pathogenicity,"ANEMIA, PERINATAL HEMOLYTIC, FATAL OR NEAR-FATAL|Hereditary spherocytosis type 2|not provided|SPTB-related disorder",single nucleotide variant,GRCh37
na,na,14,64767808,64767808,SPTB,Conflicting classifications of pathogenicity,"ANEMIA, PERINATAL HEMOLYTIC, FATAL OR NEAR-FATAL|Hereditary spherocytosis type 2|not provided|SPTB-related disorder",single nucleotide variant,GRCh38
na,na,14,65234409,65234409,SPTB,Pathogenic,Elliptocytosis 3,single nucleotide variant,GRCh37
na,na,14,64767691,64767691,SPTB,Pathogenic,Elliptocytosis 3,single nucleotide variant,GRCh38
na,na,14,65289812,65289812,SPTB,Pathogenic/Likely pathogenic,Hereditary spherocytosis type 2|not specified|not provided,single nucleotide variant,GRCh37
na,na,14,64823094,64823094,SPTB,Pathogenic/Likely pathogenic,Hereditary spherocytosis type 2|not specified|not provided,single nucleotide variant,GRCh38
na,na,14,65260469,65260469,SPTB,Pathogenic,Hereditary spherocytosis type 2,Deletion,GRCh37
na,na,14,64793751,64793751,SPTB,Pathogenic,Hereditary spherocytosis type 2,Deletion,GRCh38
na,na,14,65239585,65239585,SPTB,Pathogenic,Hereditary spherocytosis type 2|not provided|Elliptocytosis 3;Hereditary spherocytosis type 2,single nucleotide variant,GRCh37
na,na,14,64772867,64772867,SPTB,Pathogenic,Hereditary spherocytosis type 2|not provided|Elliptocytosis 3;Hereditary spherocytosis type 2,single nucleotide variant,GRCh38
na,na,1,158648224,158648224,SPTA1,Pathogenic/Likely pathogenic,Elliptocytosis 2|not provided|Spherocytosis,single nucleotide variant,GRCh37
na,na,1,158678434,158678434,SPTA1,Pathogenic/Likely pathogenic,Elliptocytosis 2|not provided|Spherocytosis,single nucleotide variant,GRCh38
na,na,1,158641925,158641925,SPTA1,Uncertain significance,Elliptocytosis 2|not provided,single nucleotide variant,GRCh37
na,na,1,158672135,158672135,SPTA1,Uncertain significance,Elliptocytosis 2|not provided,single nucleotide variant,GRCh38
na,na,1,158624528,158624528,SPTA1,Benign/Likely benign,"SPHEROCYTOSIS, TYPE 3, AUTOSOMAL RECESSIVE|not specified|Hereditary spherocytosis type 3|Pyropoikilocytosis, hereditary|Pyropoikilocytosis, hereditary;Hereditary spherocytosis type 3;Elliptocytosis 2|not provided",single nucleotide variant,GRCh37
na,na,1,158654738,158654738,SPTA1,Benign/Likely benign,"SPHEROCYTOSIS, TYPE 3, AUTOSOMAL RECESSIVE|not specified|Hereditary spherocytosis type 3|Pyropoikilocytosis, hereditary|Pyropoikilocytosis, hereditary;Hereditary spherocytosis type 3;Elliptocytosis 2|not provided",single nucleotide variant,GRCh38
na,na,1,158651385,158651386,SPTA1,Pathogenic/Likely pathogenic,"Elliptocytosis 2|not provided|Pyropoikilocytosis, hereditary|SPTA1-related disorder",Duplication,GRCh37
na,na,1,158681595,158681596,SPTA1,Pathogenic/Likely pathogenic,"Elliptocytosis 2|not provided|Pyropoikilocytosis, hereditary|SPTA1-related disorder",Duplication,GRCh38
na,na,1,158648222,158648222,SPTA1,Conflicting classifications of pathogenicity,Elliptocytosis 2|not provided,single nucleotide variant,GRCh37
na,na,1,158678432,158678432,SPTA1,Conflicting classifications of pathogenicity,Elliptocytosis 2|not provided,single nucleotide variant,GRCh38
na,na,1,158655027,158655027,SPTA1,Pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 2",single nucleotide variant,GRCh37
na,na,1,158685237,158685237,SPTA1,Pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 2",single nucleotide variant,GRCh38
na,na,1,158655025,158655025,SPTA1,Likely pathogenic,Elliptocytosis 2,single nucleotide variant,GRCh37
na,na,1,158685235,158685235,SPTA1,Likely pathogenic,Elliptocytosis 2,single nucleotide variant,GRCh38
na,na,1,158655017,158655017,SPTA1,Uncertain significance,Elliptocytosis 2|Hereditary spherocytosis type 2;Elliptocytosis 2,single nucleotide variant,GRCh37
na,na,1,158685227,158685227,SPTA1,Uncertain significance,Elliptocytosis 2|Hereditary spherocytosis type 2;Elliptocytosis 2,single nucleotide variant,GRCh38
na,na,1,158655041,158655041,SPTA1,Pathogenic,Elliptocytosis 2,single nucleotide variant,GRCh37
na,na,1,158685251,158685251,SPTA1,Pathogenic,Elliptocytosis 2,single nucleotide variant,GRCh38
na,na,1,158655079,158655079,SPTA1,Pathogenic/Likely pathogenic,Elliptocytosis 2|not provided,single nucleotide variant,GRCh37
na,na,1,158685289,158685289,SPTA1,Pathogenic/Likely pathogenic,Elliptocytosis 2|not provided,single nucleotide variant,GRCh38
na,na,1,158655080,158655080,SPTA1,Pathogenic,"Elliptocytosis 2|Pyropoikilocytosis, hereditary|not provided",single nucleotide variant,GRCh37
na,na,1,158685290,158685290,SPTA1,Pathogenic,"Elliptocytosis 2|Pyropoikilocytosis, hereditary|not provided",single nucleotide variant,GRCh38
na,na,1,158655080,158655080,SPTA1,Pathogenic,"Elliptocytosis 2|Pyropoikilocytosis, hereditary|not provided|SPTA1-related disorder",single nucleotide variant,GRCh37
na,na,1,158685290,158685290,SPTA1,Pathogenic,"Elliptocytosis 2|Pyropoikilocytosis, hereditary|not provided|SPTA1-related disorder",single nucleotide variant,GRCh38
na,na,1,158655079,158655079,SPTA1,Pathogenic/Likely pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 2|Prenatal anemia|not provided|SPTA1-related disorder",single nucleotide variant,GRCh37
na,na,1,158685289,158685289,SPTA1,Pathogenic/Likely pathogenic,"Pyropoikilocytosis, hereditary|Elliptocytosis 2|Prenatal anemia|not provided|SPTA1-related disorder",single nucleotide variant,GRCh38
na,na,1,158650431,158650431,SPTA1,Conflicting classifications of pathogenicity,"Pyropoikilocytosis, hereditary|Elliptocytosis 2|not provided",single nucleotide variant,GRCh37
na,na,1,158680641,158680641,SPTA1,Conflicting classifications of pathogenicity,"Pyropoikilocytosis, hereditary|Elliptocytosis 2|not provided",single nucleotide variant,GRCh38
na,na,1,158655019,158655019,SPTA1,Uncertain significance,"Pyropoikilocytosis, hereditary|not provided",single nucleotide variant,GRCh37
na,na,1,158685229,158685229,SPTA1,Uncertain significance,"Pyropoikilocytosis, hereditary|not provided",single nucleotide variant,GRCh38
na,na,1,158632583,158632583,SPTA1,Conflicting classifications of pathogenicity,"Elliptocytosis 2|Pyropoikilocytosis, hereditary|Hereditary spherocytosis type 3|not provided|Pyropoikilocytosis, hereditary;Hereditary spherocytosis type 3;Elliptocytosis 2|not specified",single nucleotide variant,GRCh37
na,na,1,158662793,158662793,SPTA1,Conflicting classifications of pathogenicity,"Elliptocytosis 2|Pyropoikilocytosis, hereditary|Hereditary spherocytosis type 3|not provided|Pyropoikilocytosis, hereditary;Hereditary spherocytosis type 3;Elliptocytosis 2|not specified",single nucleotide variant,GRCh38
na,na,1,158631200,158631200,SPTA1,Pathogenic,Elliptocytosis 2,single nucleotide variant,GRCh37
na,na,1,158661410,158661410,SPTA1,Pathogenic,Elliptocytosis 2,single nucleotide variant,GRCh38
na,na,na,-1,-1,SPTA1,Pathogenic,"Elliptocytosis 2|Pyropoikilocytosis, hereditary",Insertion,na
na,na,1,158626459,158626459,SPTA1,Pathogenic/Likely pathogenic,"Pyropoikilocytosis, hereditary|not provided",single nucleotide variant,GRCh37
na,na,1,158656669,158656669,SPTA1,Pathogenic/Likely pathogenic,"Pyropoikilocytosis, hereditary|not provided",single nucleotide variant,GRCh38
na,na,1,158606553,158606553,SPTA1,Pathogenic,Hereditary spherocytosis type 3,single nucleotide variant,GRCh37
na,na,1,158636763,158636763,SPTA1,Pathogenic,Hereditary spherocytosis type 3,single nucleotide variant,GRCh38
na,na,1,158623059,158623059,SPTA1,Pathogenic,"Pyropoikilocytosis, hereditary",single nucleotide variant,GRCh37
na,na,1,158653269,158653269,SPTA1,Pathogenic,"Pyropoikilocytosis, hereditary",single nucleotide variant,GRCh38
na,na,2,39222361,39222362,SOS1,Conflicting classifications of pathogenicity,"Fibromatosis, gingival, 1|not provided|Fibromatosis, gingival, 1;Noonan syndrome 4|Noonan syndrome 4",Duplication,GRCh37
na,na,2,38995220,38995221,SOS1,Conflicting classifications of pathogenicity,"Fibromatosis, gingival, 1|not provided|Fibromatosis, gingival, 1;Noonan syndrome 4|Noonan syndrome 4",Duplication,GRCh38
na,na,2,39278352,39278352,SOS1,Pathogenic,"Noonan syndrome 4|Noonan syndrome|RASopathy|not provided|Noonan syndrome 4;Fibromatosis, gingival, 1|Noonan syndrome 1",single nucleotide variant,GRCh37
na,na,2,39051211,39051211,SOS1,Pathogenic,"Noonan syndrome 4|Noonan syndrome|RASopathy|not provided|Noonan syndrome 4;Fibromatosis, gingival, 1|Noonan syndrome 1",single nucleotide variant,GRCh38
na,na,2,39278343,39278343,SOS1,Pathogenic,Noonan syndrome 4|not provided|Noonan syndrome|RASopathy|Noonan syndrome 1|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,2,39051202,39051202,SOS1,Pathogenic,Noonan syndrome 4|not provided|Noonan syndrome|RASopathy|Noonan syndrome 1|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,2,39249915,39249915,SOS1,Pathogenic,"Noonan syndrome 4|Noonan syndrome|not provided|RASopathy|Fibromatosis, gingival, 1;Noonan syndrome 4|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,2,39022774,39022774,SOS1,Pathogenic,"Noonan syndrome 4|Noonan syndrome|not provided|RASopathy|Fibromatosis, gingival, 1;Noonan syndrome 4|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,2,39249913,39249913,SOS1,Pathogenic,"RASopathy|Noonan syndrome 4|Noonan syndrome 1|not provided|Noonan syndrome|Noonan syndrome 4;Fibromatosis, gingival, 1|Noonan syndrome and Noonan-related syndrome",single nucleotide variant,GRCh37
na,na,2,39022772,39022772,SOS1,Pathogenic,"RASopathy|Noonan syndrome 4|Noonan syndrome 1|not provided|Noonan syndrome|Noonan syndrome 4;Fibromatosis, gingival, 1|Noonan syndrome and Noonan-related syndrome",single nucleotide variant,GRCh38
na,na,2,39250275,39250275,SOS1,Pathogenic,Noonan syndrome 4|not provided|Noonan syndrome|RASopathy,single nucleotide variant,GRCh37
na,na,2,39023134,39023134,SOS1,Pathogenic,Noonan syndrome 4|not provided|Noonan syndrome|RASopathy,single nucleotide variant,GRCh38
na,na,16,1129586,1129586,SSTR5,Benign/Likely benign,not provided,single nucleotide variant,GRCh37
na,na,16,1079586,1079586,SSTR5,Benign/Likely benign,not provided,single nucleotide variant,GRCh38
na,na,2,166165261,166165261,SCN2A,Uncertain significance,"Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|not provided|Inborn genetic diseases|Complex neurodevelopmental disorder",single nucleotide variant,GRCh37
na,na,2,165308751,165308751,SCN2A,Uncertain significance,"Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|not provided|Inborn genetic diseases|Complex neurodevelopmental disorder",single nucleotide variant,GRCh38
na,na,2,166231210,166231210,SCN2A,Pathogenic,"Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder",single nucleotide variant,GRCh37
na,na,2,165374700,165374700,SCN2A,Pathogenic,"Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder",single nucleotide variant,GRCh38
na,na,2,166243391,166243391,SCN2A,Pathogenic,"Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|not provided",single nucleotide variant,GRCh37
na,na,2,165386881,165386881,SCN2A,Pathogenic,"Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|not provided",single nucleotide variant,GRCh38
na,na,2,166201176,166201176,SCN2A,Pathogenic/Likely pathogenic,"Seizures, benign familial infantile, 3|not provided|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3;Episodic ataxia, type 9|Developmental and epileptic encephalopathy, 11",single nucleotide variant,GRCh37
na,na,2,165344666,165344666,SCN2A,Pathogenic/Likely pathogenic,"Seizures, benign familial infantile, 3|not provided|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3;Episodic ataxia, type 9|Developmental and epileptic encephalopathy, 11",single nucleotide variant,GRCh38
na,na,2,166165924,166165924,SCN2A,Pathogenic/Likely pathogenic,"Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 11|Benign familial infantile epilepsy|Seizure",single nucleotide variant,GRCh37
na,na,2,165309414,165309414,SCN2A,Pathogenic/Likely pathogenic,"Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy, 11|Benign familial infantile epilepsy|Seizure",single nucleotide variant,GRCh38
na,na,2,166229841,166229841,SCN2A,Pathogenic,"Seizures, benign familial infantile, 3|not provided|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy|Benign familial infantile epilepsy|benign sporadic infantile epilepsy",single nucleotide variant,GRCh37
na,na,2,165373331,165373331,SCN2A,Pathogenic,"Seizures, benign familial infantile, 3|not provided|Developmental and epileptic encephalopathy, 11;Seizures, benign familial infantile, 3|Developmental and epileptic encephalopathy, 11|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy|Benign familial infantile epilepsy|benign sporadic infantile epilepsy",single nucleotide variant,GRCh38
na,na,2,166210789,166210789,SCN2A,Uncertain significance,"Seizures, benign familial infantile, 3|Seizures, benign familial infantile, 3;Developmental and epileptic encephalopathy, 11|Complex neurodevelopmental disorder",single nucleotide variant,GRCh37
na,na,2,165354279,165354279,SCN2A,Uncertain significance,"Seizures, benign familial infantile, 3|Seizures, benign familial infantile, 3;Developmental and epileptic encephalopathy, 11|Complex neurodevelopmental disorder",single nucleotide variant,GRCh38
na,na,2,166848842,166848842,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy|not provided|Developmental and epileptic encephalopathy|Autosomal dominant epilepsy",single nucleotide variant,GRCh37
na,na,2,165992332,165992332,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Severe myoclonic epilepsy in infancy|not provided|Developmental and epileptic encephalopathy|Autosomal dominant epilepsy",single nucleotide variant,GRCh38
na,na,2,166894608,166894608,SCN1A,Pathogenic/Likely pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Developmental and epileptic encephalopathy|Severe myoclonic epilepsy in infancy|not provided|Inborn genetic diseases|Seizure|SCN1A-related disorder",single nucleotide variant,GRCh37
na,na,2,166038098,166038098,SCN1A,Pathogenic/Likely pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Developmental and epileptic encephalopathy|Severe myoclonic epilepsy in infancy|not provided|Inborn genetic diseases|Seizure|SCN1A-related disorder",single nucleotide variant,GRCh38
na,na,2,166911187,166911187,SCN1A,Likely pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Developmental and epileptic encephalopathy",single nucleotide variant,GRCh37
na,na,2,166054677,166054677,SCN1A,Likely pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Developmental and epileptic encephalopathy",single nucleotide variant,GRCh38
na,na,2,166859209,166859209,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh37
na,na,2,166002699,166002699,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh38
na,na,2,166848817,166848817,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Developmental and epileptic encephalopathy|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh37
na,na,2,165992307,165992307,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Developmental and epileptic encephalopathy|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh38
na,na,2,166870349,166870349,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|not provided",single nucleotide variant,GRCh37
na,na,2,166013839,166013839,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|not provided",single nucleotide variant,GRCh38
na,na,2,166909398,166909399,SCN1A,Pathogenic,Severe myoclonic epilepsy in infancy,Microsatellite,GRCh37
na,na,2,166052888,166052889,SCN1A,Pathogenic,Severe myoclonic epilepsy in infancy,Microsatellite,GRCh38
na,na,2,166909392,166909392,SCN1A,Pathogenic/Likely pathogenic,"Severe myoclonic epilepsy in infancy|not provided|Severe myoclonic epilepsy in infancy;Generalized epilepsy with febrile seizures plus, type 2;Migraine, familial hemiplegic, 3|Developmental and epileptic encephalopathy|Intellectual disability|Generalized epilepsy with febrile seizures plus, type 2|Inborn genetic diseases|Severe myoclonic epilepsy in infancy;Generalized epilepsy with febrile seizures plus, type 2;Developmental and epileptic encephalopathy 6B;Febrile seizures, familial, 3a",single nucleotide variant,GRCh37
na,na,2,166052882,166052882,SCN1A,Pathogenic/Likely pathogenic,"Severe myoclonic epilepsy in infancy|not provided|Severe myoclonic epilepsy in infancy;Generalized epilepsy with febrile seizures plus, type 2;Migraine, familial hemiplegic, 3|Developmental and epileptic encephalopathy|Intellectual disability|Generalized epilepsy with febrile seizures plus, type 2|Inborn genetic diseases|Severe myoclonic epilepsy in infancy;Generalized epilepsy with febrile seizures plus, type 2;Developmental and epileptic encephalopathy 6B;Febrile seizures, familial, 3a",single nucleotide variant,GRCh38
na,na,2,166893031,166893031,SCN1A,Pathogenic,Severe myoclonic epilepsy in infancy|Developmental and epileptic encephalopathy,single nucleotide variant,GRCh37
na,na,2,166036521,166036521,SCN1A,Pathogenic,Severe myoclonic epilepsy in infancy|Developmental and epileptic encephalopathy,single nucleotide variant,GRCh38
na,na,2,166868689,166868689,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Developmental and epileptic encephalopathy|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,2,166012179,166012179,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1|Developmental and epileptic encephalopathy|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,2,166858983,166858983,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1",single nucleotide variant,GRCh37
na,na,2,166002473,166002473,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|Generalized epilepsy with febrile seizures plus, type 1",single nucleotide variant,GRCh38
na,na,2,166854559,166854559,SCN1A,Pathogenic,"Migraine, familial hemiplegic, 3|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh37
na,na,2,165998049,165998049,SCN1A,Pathogenic,"Migraine, familial hemiplegic, 3|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh38
na,na,2,166848659,166848659,SCN1A,Pathogenic,"Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Developmental and epileptic encephalopathy",single nucleotide variant,GRCh37
na,na,2,165992149,165992149,SCN1A,Pathogenic,"Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|Developmental and epileptic encephalopathy",single nucleotide variant,GRCh38
na,na,2,166850677,166850677,SCN1A,Pathogenic,"Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2",single nucleotide variant,GRCh37
na,na,2,165994167,165994167,SCN1A,Pathogenic,"Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2",single nucleotide variant,GRCh38
na,na,2,166912960,166912960,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|not provided|Febrile seizures, familial, 3a|Migraine, familial hemiplegic, 3;Generalized epilepsy with febrile seizures plus, type 2;Developmental and epileptic encephalopathy 6B;Severe myoclonic epilepsy in infancy|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh37
na,na,2,166056450,166056450,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2|not provided|Febrile seizures, familial, 3a|Migraine, familial hemiplegic, 3;Generalized epilepsy with febrile seizures plus, type 2;Developmental and epileptic encephalopathy 6B;Severe myoclonic epilepsy in infancy|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh38
na,na,2,166909544,166909544,SCN1A,drug response,"Febrile seizures, familial, 3a|carbamazepine response - Dosage|Developmental and epileptic encephalopathy",single nucleotide variant,GRCh37
na,na,2,166053034,166053034,SCN1A,drug response,"Febrile seizures, familial, 3a|carbamazepine response - Dosage|Developmental and epileptic encephalopathy",single nucleotide variant,GRCh38
na,na,2,166895994,166895994,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2",Deletion,GRCh37
na,na,2,166039484,166039484,SCN1A,Pathogenic,"Generalized epilepsy with febrile seizures plus, type 2",Deletion,GRCh38
na,na,2,165985812,166009718,SCN1A,Pathogenic,Severe myoclonic epilepsy in infancy,Deletion,GRCh38
na,na,2,166858636,166865034,SCN1A,Pathogenic,Severe myoclonic epilepsy in infancy,Indel,GRCh37
na,na,2,166002126,166008524,SCN1A,Pathogenic,Severe myoclonic epilepsy in infancy,Indel,GRCh38
na,na,2,166870350,166870350,SCN1A,Pathogenic,Severe myoclonic epilepsy in infancy,Deletion,GRCh37
na,na,2,166013840,166013840,SCN1A,Pathogenic,Severe myoclonic epilepsy in infancy,Deletion,GRCh38
na,na,2,166852609,166852609,SCN1A,Pathogenic,"Migraine, familial hemiplegic, 3|not provided|Developmental and epileptic encephalopathy|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh37
na,na,2,165996099,165996099,SCN1A,Pathogenic,"Migraine, familial hemiplegic, 3|not provided|Developmental and epileptic encephalopathy|Severe myoclonic epilepsy in infancy",single nucleotide variant,GRCh38
na,na,2,166854557,166854557,SCN1A,Pathogenic,"Migraine, familial hemiplegic, 3",single nucleotide variant,GRCh37
na,na,2,165998047,165998047,SCN1A,Pathogenic,"Migraine, familial hemiplegic, 3",single nucleotide variant,GRCh38
na,na,16,31500240,31500240,SLC5A2,Pathogenic,Familial renal glucosuria,single nucleotide variant,GRCh37
na,na,16,31488919,31488919,SLC5A2,Pathogenic,Familial renal glucosuria,single nucleotide variant,GRCh38
na,na,16,31501798,31501798,SLC5A2,Conflicting classifications of pathogenicity,Familial renal glucosuria|not provided|not specified|SLC5A2-related disorder,single nucleotide variant,GRCh37
na,na,16,31490477,31490477,SLC5A2,Conflicting classifications of pathogenicity,Familial renal glucosuria|not provided|not specified|SLC5A2-related disorder,single nucleotide variant,GRCh38
na,na,16,31497522,31497522,SLC5A2,Conflicting classifications of pathogenicity,Familial renal glucosuria|SLC5A2-related disorder|not provided,Deletion,GRCh37
na,na,16,31486201,31486201,SLC5A2,Conflicting classifications of pathogenicity,Familial renal glucosuria|SLC5A2-related disorder|not provided,Deletion,GRCh38
na,na,22,32439350,32439350,SLC5A1,Likely pathogenic,Congenital glucose-galactose malabsorption,single nucleotide variant,GRCh37
na,na,22,32043363,32043363,SLC5A1,Likely pathogenic,Congenital glucose-galactose malabsorption,single nucleotide variant,GRCh38
na,na,22,32439351,32439351,SLC5A1,Uncertain significance,Congenital glucose-galactose malabsorption,single nucleotide variant,GRCh37
na,na,22,32043364,32043364,SLC5A1,Uncertain significance,Congenital glucose-galactose malabsorption,single nucleotide variant,GRCh38
na,na,19,42482193,42482193,ATP1A3,Pathogenic,Dystonia 12|Alternating hemiplegia of childhood 2|not provided,single nucleotide variant,GRCh37
na,na,19,41978041,41978041,ATP1A3,Pathogenic,Dystonia 12|Alternating hemiplegia of childhood 2|not provided,single nucleotide variant,GRCh38
na,na,19,42489242,42489242,ATP1A3,Pathogenic,Dystonia 12,single nucleotide variant,GRCh37
na,na,19,41985090,41985090,ATP1A3,Pathogenic,Dystonia 12,single nucleotide variant,GRCh38
na,na,19,42489234,42489234,ATP1A3,Pathogenic/Likely pathogenic,Dystonia 12|not provided,single nucleotide variant,GRCh37
na,na,19,41985082,41985082,ATP1A3,Pathogenic/Likely pathogenic,Dystonia 12|not provided,single nucleotide variant,GRCh38
na,na,19,42474685,42474685,ATP1A3,Likely pathogenic,Dystonia 12|not provided,single nucleotide variant,GRCh37
na,na,19,41970533,41970533,ATP1A3,Likely pathogenic,Dystonia 12|not provided,single nucleotide variant,GRCh38
na,na,19,42474620,42474620,ATP1A3,Pathogenic,Dystonia 12,single nucleotide variant,GRCh37
na,na,19,41970468,41970468,ATP1A3,Pathogenic,Dystonia 12,single nucleotide variant,GRCh38
na,na,19,42474557,42474557,ATP1A3,Pathogenic,Dystonia 12,single nucleotide variant,GRCh37
na,na,19,41970405,41970405,ATP1A3,Pathogenic,Dystonia 12,single nucleotide variant,GRCh38
na,na,19,42472989,42472989,ATP1A3,Pathogenic,Dystonia 12|Alternating hemiplegia of childhood 2|Dystonia 12;Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome;Alternating hemiplegia of childhood 2|not provided|Seizure|ATP1A3-associated neurological disorder,single nucleotide variant,GRCh37
na,na,19,41968837,41968837,ATP1A3,Pathogenic,Dystonia 12|Alternating hemiplegia of childhood 2|Dystonia 12;Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome;Alternating hemiplegia of childhood 2|not provided|Seizure|ATP1A3-associated neurological disorder,single nucleotide variant,GRCh38
na,na,1,160105635,160105635,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",single nucleotide variant,GRCh37
na,na,1,160135845,160135845,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",single nucleotide variant,GRCh38
na,na,1,160106455,160106455,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",single nucleotide variant,GRCh37
na,na,1,160136665,160136665,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",single nucleotide variant,GRCh38
na,na,1,160105300,160105300,ATP1A2,Likely pathogenic,"Migraine, familial hemiplegic, 2",single nucleotide variant,GRCh37
na,na,1,160135510,160135510,ATP1A2,Likely pathogenic,"Migraine, familial hemiplegic, 2",single nucleotide variant,GRCh38
na,na,1,160105036,160105036,ATP1A2,Likely pathogenic,"Migraine, familial hemiplegic, 2|not provided",single nucleotide variant,GRCh37
na,na,1,160135246,160135246,ATP1A2,Likely pathogenic,"Migraine, familial hemiplegic, 2|not provided",single nucleotide variant,GRCh38
na,na,1,160098557,160098557,ATP1A2,Pathogenic/Likely pathogenic,Alternating hemiplegia of childhood 1|Familial hemiplegic migraine|ATP1A2-related disorder,single nucleotide variant,GRCh37
na,na,1,160128767,160128767,ATP1A2,Pathogenic/Likely pathogenic,Alternating hemiplegia of childhood 1|Familial hemiplegic migraine|ATP1A2-related disorder,single nucleotide variant,GRCh38
na,na,1,160097494,160097494,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",single nucleotide variant,GRCh37
na,na,1,160127704,160127704,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",single nucleotide variant,GRCh38
na,na,1,160098457,160098457,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2",single nucleotide variant,GRCh37
na,na,1,160128667,160128667,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2",single nucleotide variant,GRCh38
na,na,1,160105260,160105260,ATP1A2,Conflicting classifications of pathogenicity,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|not provided",single nucleotide variant,GRCh37
na,na,1,160135470,160135470,ATP1A2,Conflicting classifications of pathogenicity,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|not provided",single nucleotide variant,GRCh38
na,na,1,160109525,160109525,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|Migraine, familial hemiplegic, 2;Alternating hemiplegia of childhood 1|not provided",single nucleotide variant,GRCh37
na,na,1,160139735,160139735,ATP1A2,Pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|Migraine, familial hemiplegic, 2;Alternating hemiplegia of childhood 1|not provided",single nucleotide variant,GRCh38
na,na,1,160100073,160100073,ATP1A2,Pathogenic,"Migraine, familial basilar|not provided|Familial hemiplegic migraine|Developmental and epileptic encephalopathy 98|Migraine, familial hemiplegic, 2|ATP1A2-related disorder",single nucleotide variant,GRCh37
na,na,1,160130283,160130283,ATP1A2,Pathogenic,"Migraine, familial basilar|not provided|Familial hemiplegic migraine|Developmental and epileptic encephalopathy 98|Migraine, familial hemiplegic, 2|ATP1A2-related disorder",single nucleotide variant,GRCh38
na,na,1,160097450,160097450,ATP1A2,Likely pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",single nucleotide variant,GRCh37
na,na,1,160127660,160127660,ATP1A2,Likely pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine",single nucleotide variant,GRCh38
na,na,1,160098797,160098797,ATP1A2,Uncertain significance,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|Alternating hemiplegia of childhood 1|ATP1A2-related disorder",single nucleotide variant,GRCh37
na,na,1,160129007,160129007,ATP1A2,Uncertain significance,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|Alternating hemiplegia of childhood 1|ATP1A2-related disorder",single nucleotide variant,GRCh38
na,na,1,160093018,160093018,ATP1A2,Uncertain significance,"Migraine, familial hemiplegic, 2|not provided|Familial hemiplegic migraine",single nucleotide variant,GRCh37
na,na,1,160123228,160123228,ATP1A2,Uncertain significance,"Migraine, familial hemiplegic, 2|not provided|Familial hemiplegic migraine",single nucleotide variant,GRCh38
na,na,1,160098551,160098551,ATP1A2,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|Inborn genetic diseases|not provided",single nucleotide variant,GRCh37
na,na,1,160128761,160128761,ATP1A2,Pathogenic/Likely pathogenic,"Migraine, familial hemiplegic, 2|Familial hemiplegic migraine|Inborn genetic diseases|not provided",single nucleotide variant,GRCh38
na,na,5,176813020,176813021,SLC34A1,Pathogenic,Hypophosphatemic nephrolithiasis/osteoporosis 1,Indel,GRCh37
na,na,5,177386019,177386020,SLC34A1,Pathogenic,Hypophosphatemic nephrolithiasis/osteoporosis 1,Indel,GRCh38
na,na,5,176813474,176813474,SLC34A1,Uncertain significance,Hypophosphatemic nephrolithiasis/osteoporosis 1|not provided,single nucleotide variant,GRCh37
na,na,5,177386473,177386473,SLC34A1,Uncertain significance,Hypophosphatemic nephrolithiasis/osteoporosis 1|not provided,single nucleotide variant,GRCh38
na,na,5,176813493,176813494,SLC34A1,Uncertain significance,Fanconi renotubular syndrome 2|not provided,Duplication,GRCh37
na,na,5,177386492,177386493,SLC34A1,Uncertain significance,Fanconi renotubular syndrome 2|not provided,Duplication,GRCh38
na,na,17,28564285,28564327,SLC6A4,Likely benign,"Serotonin transporter activity, increased/decreased|Autism spectrum disorder",Deletion,GRCh37
na,na,17,30237267,30237309,SLC6A4,Likely benign,"Serotonin transporter activity, increased/decreased|Autism spectrum disorder",Deletion,GRCh38
na,na,17,28538374,28538374,SLC6A4,Uncertain significance,"Obsessive-compulsive disorder, susceptibility to|Behavior disorder",single nucleotide variant,GRCh37
na,na,17,30211356,30211356,SLC6A4,Uncertain significance,"Obsessive-compulsive disorder, susceptibility to|Behavior disorder",single nucleotide variant,GRCh38
na,na,2,73115493,73115493,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency,single nucleotide variant,GRCh37
na,na,2,72888364,72888364,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency,single nucleotide variant,GRCh38
na,na,2,73115583,73115587,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency,Deletion,GRCh37
na,na,2,72888454,72888458,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency,Deletion,GRCh38
na,na,2,73115586,73115586,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided|Dystonic disorder|SPR-related disorder,single nucleotide variant,GRCh37
na,na,2,72888457,72888457,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided|Dystonic disorder|SPR-related disorder,single nucleotide variant,GRCh38
na,na,2,73114549,73114549,SPR,Uncertain significance,Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided,single nucleotide variant,GRCh37
na,na,2,72887420,72887420,SPR,Uncertain significance,Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided,single nucleotide variant,GRCh38
na,na,2,73115626,73115626,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency,single nucleotide variant,GRCh37
na,na,2,72888497,72888497,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency,single nucleotide variant,GRCh38
na,na,2,73118631,73118631,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided|Dystonic disorder,single nucleotide variant,GRCh37
na,na,2,72891502,72891502,SPR,Pathogenic,Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided|Dystonic disorder,single nucleotide variant,GRCh38
na,na,19,49206674,49206674,FUT2,Benign,VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1|SECRETOR/NONSECRETOR POLYMORPHISM|Familial Otitis Media|VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1;Bombay phenotype|not provided,single nucleotide variant,GRCh37
na,na,19,48703417,48703417,FUT2,Benign,VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1|SECRETOR/NONSECRETOR POLYMORPHISM|Familial Otitis Media|VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1;Bombay phenotype|not provided,single nucleotide variant,GRCh38
na,na,19,49206631,49206631,FUT2,Benign,"SECRETOR/NONSECRETOR POLYMORPHISM, JAPANESE TYPE|Familial Otitis Media|not provided",single nucleotide variant,GRCh37
na,na,19,48703374,48703374,FUT2,Benign,"SECRETOR/NONSECRETOR POLYMORPHISM, JAPANESE TYPE|Familial Otitis Media|not provided",single nucleotide variant,GRCh38
na,na,na,-1,-1,FUT2,Pathogenic,"BOMBAY PHENOTYPE, DIGENIC",Deletion,na
na,na,1,47716957,47716957,STIL,Pathogenic,"Microcephaly 7, primary, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,47251285,47251285,STIL,Pathogenic,"Microcephaly 7, primary, autosomal recessive",single nucleotide variant,GRCh38
na,na,1,47717017,47717017,STIL,Pathogenic,"Microcephaly 7, primary, autosomal recessive",Deletion,GRCh37
na,na,1,47251345,47251345,STIL,Pathogenic,"Microcephaly 7, primary, autosomal recessive",Deletion,GRCh38
na,na,1,47728574,47728574,STIL,Pathogenic,"Microcephaly 7, primary, autosomal recessive",single nucleotide variant,GRCh37
na,na,1,47262902,47262902,STIL,Pathogenic,"Microcephaly 7, primary, autosomal recessive",single nucleotide variant,GRCh38
na,na,2,234243725,234243725,SAG,Pathogenic,Oguchi disease|Retinitis pigmentosa 47|SAG-related disorder|Retinal dystrophy|not provided,Deletion,GRCh37
na,na,2,233335079,233335079,SAG,Pathogenic,Oguchi disease|Retinitis pigmentosa 47|SAG-related disorder|Retinal dystrophy|not provided,Deletion,GRCh38
na,na,20,32880273,32880273,AHCY,Pathogenic,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase,single nucleotide variant,GRCh37
na,na,20,34292467,34292467,AHCY,Pathogenic,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase,single nucleotide variant,GRCh38
na,na,20,32880181,32880181,AHCY,Pathogenic/Likely pathogenic,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase|not provided|Inborn genetic diseases|Rhabdomyolysis,single nucleotide variant,GRCh37
na,na,20,34292375,34292375,AHCY,Pathogenic/Likely pathogenic,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase|not provided|Inborn genetic diseases|Rhabdomyolysis,single nucleotide variant,GRCh38
na,na,1,237798237,237798237,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1|not provided|Cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,1,237634937,237634937,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1|not provided|Cardiomyopathy|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,1,237811823,237811823,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh37
na,na,1,237648523,237648523,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh38
na,na,1,237947324,237947324,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh37
na,na,1,237784024,237784024,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh38
na,na,1,237954741,237954741,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1|not provided|Cardiovascular phenotype|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,1,237791441,237791441,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1|not provided|Cardiovascular phenotype|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,1,237804238,237804238,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh37
na,na,1,237640938,237640938,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh38
na,na,1,237617696,237617696,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia|Long QT syndrome|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh37
na,na,1,237454396,237454396,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia|Long QT syndrome|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh38
na,na,1,237802368,237802368,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh37
na,na,1,237639068,237639068,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh38
na,na,1,237961337,237961337,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh37
na,na,1,237798037,237798037,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh38
na,na,1,237947614,237947614,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh37
na,na,1,237784314,237784314,RYR2,Pathogenic,Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh38
na,na,1,237982481,237982481,RYR2,Uncertain significance,Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome|Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh37
na,na,1,237819181,237819181,RYR2,Uncertain significance,Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome|Catecholaminergic polymorphic ventricular tachycardia 1,single nucleotide variant,GRCh38
na,na,19,38948185,38948185,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|Malignant hyperthermia of anesthesia|RYR1-related disorder|Inborn genetic diseases|desflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|enflurane response - Toxicity|succinylcholine response - Toxicity|King Denborough syndrome;Congenital myopathy with fiber type disproportion;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy",single nucleotide variant,GRCh37
na,na,19,38457545,38457545,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|Malignant hyperthermia of anesthesia|RYR1-related disorder|Inborn genetic diseases|desflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|enflurane response - Toxicity|succinylcholine response - Toxicity|King Denborough syndrome;Congenital myopathy with fiber type disproportion;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy",single nucleotide variant,GRCh38
na,na,19,38937350,38937350,RYR1,Likely pathogenic,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia",single nucleotide variant,GRCh37
na,na,19,38446710,38446710,RYR1,Likely pathogenic,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia",single nucleotide variant,GRCh38
na,na,19,38990637,38990637,RYR1,Pathogenic; drug response,"Central core myopathy|not provided|RYR1-related disorder|enflurane response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|Malignant hyperthermia of anesthesia|Malignant hyperthermia, susceptibility to, 1;Central core myopathy|Malignant hyperthermia, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,19,38499997,38499997,RYR1,Pathogenic; drug response,"Central core myopathy|not provided|RYR1-related disorder|enflurane response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|Malignant hyperthermia of anesthesia|Malignant hyperthermia, susceptibility to, 1;Central core myopathy|Malignant hyperthermia, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,19,38934851,38934851,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|not provided|RYR1-related disorder|desflurane response - Toxicity|halothane response - Toxicity|methoxyflurane response - Toxicity|enflurane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|Malignant hyperthermia of anesthesia",single nucleotide variant,GRCh37
na,na,19,38444211,38444211,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|not provided|RYR1-related disorder|desflurane response - Toxicity|halothane response - Toxicity|methoxyflurane response - Toxicity|enflurane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|Malignant hyperthermia of anesthesia",single nucleotide variant,GRCh38
na,na,19,38942490,38942490,RYR1,Uncertain significance; drug response,"Central core myopathy|not provided|succinylcholine response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|enflurane response - Toxicity|RYR1-related disorder|halothane response - Toxicity|methoxyflurane response - Toxicity|not specified",single nucleotide variant,GRCh37
na,na,19,38451850,38451850,RYR1,Uncertain significance; drug response,"Central core myopathy|not provided|succinylcholine response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|enflurane response - Toxicity|RYR1-related disorder|halothane response - Toxicity|methoxyflurane response - Toxicity|not specified",single nucleotide variant,GRCh38
na,na,19,38939352,38939352,RYR1,Pathogenic,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder",single nucleotide variant,GRCh37
na,na,19,38448712,38448712,RYR1,Pathogenic,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder",single nucleotide variant,GRCh38
na,na,19,38990633,38990633,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|Central core myopathy|Inborn genetic diseases|King Denborough syndrome;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy",single nucleotide variant,GRCh37
na,na,19,38499993,38499993,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|Central core myopathy|Inborn genetic diseases|King Denborough syndrome;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy",single nucleotide variant,GRCh38
na,na,19,38991294,38991294,RYR1,Likely pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|Malignant hyperthermia of anesthesia|RYR1-related disorder|sevoflurane response - Toxicity|King Denborough syndrome;Malignant hyperthermia, susceptibility to, 1;Congenital myopathy with fiber type disproportion;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity",single nucleotide variant,GRCh37
na,na,19,38500654,38500654,RYR1,Likely pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|Malignant hyperthermia of anesthesia|RYR1-related disorder|sevoflurane response - Toxicity|King Denborough syndrome;Malignant hyperthermia, susceptibility to, 1;Congenital myopathy with fiber type disproportion;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity",single nucleotide variant,GRCh38
na,na,19,38991295,38991295,RYR1,drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|desflurane response - Toxicity|enflurane response - Toxicity|succinylcholine response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|Malignant hyperthermia of anesthesia",single nucleotide variant,GRCh37
na,na,19,38500655,38500655,RYR1,drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|desflurane response - Toxicity|enflurane response - Toxicity|succinylcholine response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|Malignant hyperthermia of anesthesia",single nucleotide variant,GRCh38
na,na,19,38985204,38985204,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|not provided|RYR1-related disorder|enflurane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity",single nucleotide variant,GRCh37
na,na,19,38494564,38494564,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|not provided|RYR1-related disorder|enflurane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity",single nucleotide variant,GRCh38
na,na,19,38985205,38985205,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|not provided|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity|RYR1-related disorder|enflurane response - Toxicity|isoflurane response - Toxicity",single nucleotide variant,GRCh37
na,na,19,38494565,38494565,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|not provided|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity|RYR1-related disorder|enflurane response - Toxicity|isoflurane response - Toxicity",single nucleotide variant,GRCh38
na,na,19,39075629,39075629,RYR1,Uncertain significance; drug response,"Central core myopathy|Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1;Congenital myopathy with fiber type disproportion;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|halothane response - Toxicity|methoxyflurane response - Toxicity|enflurane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|Congenital myopathy|RYR1-related myopathy",single nucleotide variant,GRCh37
na,na,19,38584989,38584989,RYR1,Uncertain significance; drug response,"Central core myopathy|Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1;Congenital myopathy with fiber type disproportion;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|halothane response - Toxicity|methoxyflurane response - Toxicity|enflurane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|Congenital myopathy|RYR1-related myopathy",single nucleotide variant,GRCh38
na,na,19,38985219,38985219,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Congenital multicore myopathy with external ophthalmoplegia|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|Central core myopathy|isoflurane response - Toxicity|sevoflurane response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|Malignant hyperthermia of anesthesia",single nucleotide variant,GRCh37
na,na,19,38494579,38494579,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|Congenital multicore myopathy with external ophthalmoplegia|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|Central core myopathy|isoflurane response - Toxicity|sevoflurane response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|Malignant hyperthermia of anesthesia",single nucleotide variant,GRCh38
na,na,19,38986923,38986923,RYR1,Pathogenic,"Malignant hyperthermia, susceptibility to, 1|not provided|Ptosis;Absence of the sacrum;History of neonatal hypotonia|Malignant hyperthermia of anesthesia|RYR1-related disorder|King Denborough syndrome|Malignant hyperthermia, susceptibility to|King Denborough syndrome;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,19,38496283,38496283,RYR1,Pathogenic,"Malignant hyperthermia, susceptibility to, 1|not provided|Ptosis;Absence of the sacrum;History of neonatal hypotonia|Malignant hyperthermia of anesthesia|RYR1-related disorder|King Denborough syndrome|Malignant hyperthermia, susceptibility to|King Denborough syndrome;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,19,39070734,39070734,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|sevoflurane response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|RYR1-related disorder",single nucleotide variant,GRCh37
na,na,19,38580094,38580094,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|sevoflurane response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|succinylcholine response - Toxicity|RYR1-related disorder",single nucleotide variant,GRCh38
na,na,19,39070644,39070644,RYR1,Uncertain significance; drug response,"Central core myopathy|Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|succinylcholine response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|desflurane response - Toxicity",single nucleotide variant,GRCh37
na,na,19,38580004,38580004,RYR1,Uncertain significance; drug response,"Central core myopathy|Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-related disorder|succinylcholine response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|desflurane response - Toxicity",single nucleotide variant,GRCh38
na,na,19,39055614,39055622,RYR1,Pathogenic,Central core myopathy|not provided,Deletion,GRCh37
na,na,19,38564974,38564982,RYR1,Pathogenic,Central core myopathy|not provided,Deletion,GRCh38
na,na,19,39071080,39071080,RYR1,Conflicting classifications of pathogenicity; drug response,"Central core myopathy|not provided|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|Malignant hyperthermia of anesthesia|RYR1-related myopathy",single nucleotide variant,GRCh37
na,na,19,38580440,38580440,RYR1,Conflicting classifications of pathogenicity; drug response,"Central core myopathy|not provided|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|desflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|Malignant hyperthermia of anesthesia|RYR1-related myopathy",single nucleotide variant,GRCh38
na,na,19,39016095,39016095,RYR1,Pathogenic,not provided|Congenital multicore myopathy with external ophthalmoplegia,single nucleotide variant,GRCh37
na,na,19,38525455,38525455,RYR1,Pathogenic,not provided|Congenital multicore myopathy with external ophthalmoplegia,single nucleotide variant,GRCh38
na,na,19,39071043,39071043,RYR1,drug response,"Congenital multicore myopathy with external ophthalmoplegia|not provided|Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder|succinylcholine response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|desflurane response - Toxicity|sevoflurane response - Toxicity|Malignant hyperthermia of anesthesia|RYR1-related myopathy|Centronuclear myopathy|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,19,38580403,38580403,RYR1,drug response,"Congenital multicore myopathy with external ophthalmoplegia|not provided|Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder|succinylcholine response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|desflurane response - Toxicity|sevoflurane response - Toxicity|Malignant hyperthermia of anesthesia|RYR1-related myopathy|Centronuclear myopathy|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,19,38994959,38994959,RYR1,Likely pathogenic,"not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia|Malignant hyperthermia, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,19,38504319,38504319,RYR1,Likely pathogenic,"not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia|Malignant hyperthermia, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,19,39071085,39071105,RYR1,Pathogenic,Central core myopathy,Deletion,GRCh37
na,na,19,38580445,38580465,RYR1,Pathogenic,Central core myopathy,Deletion,GRCh38
na,na,19,39074134,39074134,RYR1,Pathogenic,Congenital multicore myopathy with external ophthalmoplegia|not provided,single nucleotide variant,GRCh37
na,na,19,38583494,38583494,RYR1,Pathogenic,Congenital multicore myopathy with external ophthalmoplegia|not provided,single nucleotide variant,GRCh38
na,na,19,38934252,38934252,RYR1,Conflicting classifications of pathogenicity,"Congenital multicore myopathy with external ophthalmoplegia|not provided|RYR1-related disorder|Congenital myopathy with fiber type disproportion|Malignant hyperthermia, susceptibility to, 1|Central core myopathy|Centronuclear myopathy|King Denborough syndrome;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy",single nucleotide variant,GRCh37
na,na,19,38443612,38443612,RYR1,Conflicting classifications of pathogenicity,"Congenital multicore myopathy with external ophthalmoplegia|not provided|RYR1-related disorder|Congenital myopathy with fiber type disproportion|Malignant hyperthermia, susceptibility to, 1|Central core myopathy|Centronuclear myopathy|King Denborough syndrome;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy",single nucleotide variant,GRCh38
na,na,19,38990601,38990601,RYR1,Conflicting classifications of pathogenicity,"Congenital multicore myopathy with external ophthalmoplegia|not provided|Clubfoot;EMG abnormality;Lower limb amyotrophy|Congenital myopathy with fiber type disproportion|RYR1-related disorder|King Denborough syndrome;Congenital myopathy with fiber type disproportion;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease|Central core myopathy",single nucleotide variant,GRCh37
na,na,19,38499961,38499961,RYR1,Conflicting classifications of pathogenicity,"Congenital multicore myopathy with external ophthalmoplegia|not provided|Clubfoot;EMG abnormality;Lower limb amyotrophy|Congenital myopathy with fiber type disproportion|RYR1-related disorder|King Denborough syndrome;Congenital myopathy with fiber type disproportion;Malignant hyperthermia, susceptibility to, 1;Congenital multicore myopathy with external ophthalmoplegia;Central core myopathy|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease|Central core myopathy",single nucleotide variant,GRCh38
na,na,19,39070620,39070620,RYR1,Pathogenic,Congenital multicore myopathy with external ophthalmoplegia|not provided,single nucleotide variant,GRCh37
na,na,19,38579980,38579980,RYR1,Pathogenic,Congenital multicore myopathy with external ophthalmoplegia|not provided,single nucleotide variant,GRCh38
na,na,19,39013751,39013751,RYR1,Uncertain significance,"Congenital multicore myopathy with external ophthalmoplegia|not provided|Malignant hyperthermia, susceptibility to, 1",single nucleotide variant,GRCh37
na,na,19,38523111,38523111,RYR1,Uncertain significance,"Congenital multicore myopathy with external ophthalmoplegia|not provided|Malignant hyperthermia, susceptibility to, 1",single nucleotide variant,GRCh38
na,na,19,39062821,39062821,RYR1,Pathogenic/Likely pathogenic,Central core myopathy|not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia,single nucleotide variant,GRCh37
na,na,19,38572181,38572181,RYR1,Pathogenic/Likely pathogenic,Central core myopathy|not provided|RYR1-related disorder|Malignant hyperthermia of anesthesia,single nucleotide variant,GRCh38
na,na,19,38945999,38945999,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|desflurane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|methoxyflurane response - Toxicity|succinylcholine response - Toxicity",single nucleotide variant,GRCh37
na,na,19,38455359,38455359,RYR1,Pathogenic; drug response,"Malignant hyperthermia, susceptibility to, 1|not provided|desflurane response - Toxicity|isoflurane response - Toxicity|sevoflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|methoxyflurane response - Toxicity|succinylcholine response - Toxicity",single nucleotide variant,GRCh38
na,na,19,38946337,38946338,RYR1,Pathogenic,Congenital multicore myopathy with external ophthalmoplegia|not provided|RYR1-related disorder,Duplication,GRCh37
na,na,19,38455697,38455698,RYR1,Pathogenic,Congenital multicore myopathy with external ophthalmoplegia|not provided|RYR1-related disorder,Duplication,GRCh38
na,na,19,39075697,39075698,RYR1,Likely pathogenic,"Neuromuscular disease, congenital, with uniform type 1 fiber|not provided|RYR1-related disorder",Indel,GRCh37
na,na,19,38585057,38585058,RYR1,Likely pathogenic,"Neuromuscular disease, congenital, with uniform type 1 fiber|not provided|RYR1-related disorder",Indel,GRCh38
na,na,19,39055982,39056001,RYR1,Pathogenic,"Neuromuscular disease, congenital, with uniform type 1 fiber|not provided|RYR1-related disorder|Central core myopathy|RYR1-related myopathy",Deletion,GRCh37
na,na,19,38565342,38565361,RYR1,Pathogenic,"Neuromuscular disease, congenital, with uniform type 1 fiber|not provided|RYR1-related disorder|Central core myopathy|RYR1-related myopathy",Deletion,GRCh38
na,na,11,62380989,62380990,ROM1,Uncertain significance,"Retinitis pigmentosa 7, digenic|not provided",Duplication,GRCh37
na,na,11,62613517,62613518,ROM1,Uncertain significance,"Retinitis pigmentosa 7, digenic|not provided",Duplication,GRCh38
na,na,11,62381083,62381084,ROM1,Conflicting classifications of pathogenicity,"Retinitis pigmentosa 7, digenic|Retinitis pigmentosa|not provided|Retinitis pigmentosa 7|Retinal dystrophy|ROM1-related disorder|not specified",Duplication,GRCh37
na,na,11,62613611,62613612,ROM1,Conflicting classifications of pathogenicity,"Retinitis pigmentosa 7, digenic|Retinitis pigmentosa|not provided|Retinitis pigmentosa 7|Retinal dystrophy|ROM1-related disorder|not specified",Duplication,GRCh38
na,na,15,82824835,82824835,RPS17,Pathogenic,Diamond-Blackfan anemia 4|Diamond-Blackfan anemia,single nucleotide variant,GRCh37
na,na,15,82540427,82540427,RPS17,Pathogenic,Diamond-Blackfan anemia 4|Diamond-Blackfan anemia,single nucleotide variant,GRCh38
na,na,15,82823347,82823348,RPS17,Pathogenic,Diamond-Blackfan anemia 4,Microsatellite,GRCh37
na,na,15,82538939,82538940,RPS17,Pathogenic,Diamond-Blackfan anemia 4,Microsatellite,GRCh38
na,na,3,197678115,197678115,RPL35A,Pathogenic,Diamond-Blackfan anemia 5,single nucleotide variant,GRCh37
na,na,3,197951244,197951244,RPL35A,Pathogenic,Diamond-Blackfan anemia 5,single nucleotide variant,GRCh38
na,na,3,197678096,197678098,RPL35A,Conflicting classifications of pathogenicity,Diamond-Blackfan anemia 5|not provided,Microsatellite,GRCh37
na,na,3,197951225,197951227,RPL35A,Conflicting classifications of pathogenicity,Diamond-Blackfan anemia 5|not provided,Microsatellite,GRCh38
na,na,3,197681013,197681013,RPL35A,Pathogenic,Diamond-Blackfan anemia 5,single nucleotide variant,GRCh37
na,na,3,197954142,197954142,RPL35A,Pathogenic,Diamond-Blackfan anemia 5,single nucleotide variant,GRCh38
na,na,1,182555149,182555149,RNASEL,Conflicting classifications of pathogenicity,"Prostate cancer, hereditary, 1|not provided|Prostate cancer|RNASEL-related disorder",single nucleotide variant,GRCh37
na,na,1,182586014,182586014,RNASEL,Conflicting classifications of pathogenicity,"Prostate cancer, hereditary, 1|not provided|Prostate cancer|RNASEL-related disorder",single nucleotide variant,GRCh38
na,na,1,182555939,182555939,RNASEL,Pathogenic,"Prostate cancer, hereditary, 1",single nucleotide variant,GRCh37
na,na,1,182586804,182586804,RNASEL,Pathogenic,"Prostate cancer, hereditary, 1",single nucleotide variant,GRCh38
na,na,1,182554557,182554557,RNASEL,Likely benign,"Prostate cancer, hereditary, 1|Prostate cancer susceptibility|Hereditary cancer",single nucleotide variant,GRCh37
na,na,1,182585422,182585422,RNASEL,Likely benign,"Prostate cancer, hereditary, 1|Prostate cancer susceptibility|Hereditary cancer",single nucleotide variant,GRCh38
na,na,2,89037515,89037515,RPIA,Pathogenic,Deficiency of ribose-5-phosphate isomerase,Deletion,GRCh37
na,na,2,88737998,88737998,RPIA,Pathogenic,Deficiency of ribose-5-phosphate isomerase,Deletion,GRCh38
na,na,2,89028797,89028797,RPIA,Pathogenic,Deficiency of ribose-5-phosphate isomerase,single nucleotide variant,GRCh37
na,na,2,88729279,88729279,RPIA,Pathogenic,Deficiency of ribose-5-phosphate isomerase,single nucleotide variant,GRCh38
na,na,13,114429445,114435102,GRK1,Pathogenic,Oguchi disease-2,Deletion,GRCh37
na,na,13,113726472,113732129,GRK1,Pathogenic,Oguchi disease-2,Deletion,GRCh38
na,na,13,114434261,114434261,GRK1,Pathogenic/Likely pathogenic,Oguchi disease-2|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,13,113731288,113731288,GRK1,Pathogenic/Likely pathogenic,Oguchi disease-2|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,13,114434294,114434294,GRK1,Pathogenic/Likely pathogenic,Oguchi disease-2,single nucleotide variant,GRCh37
na,na,13,113731321,113731321,GRK1,Pathogenic/Likely pathogenic,Oguchi disease-2,single nucleotide variant,GRCh38
na,na,3,129247644,129247644,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy|Pigmentary retinal dystrophy;Retinitis pigmentosa 4;Congenital stationary night blindness autosomal dominant 1|RHO-related disorder,single nucleotide variant,GRCh37
na,na,3,129528801,129528801,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy|Pigmentary retinal dystrophy;Retinitis pigmentosa 4;Congenital stationary night blindness autosomal dominant 1|RHO-related disorder,single nucleotide variant,GRCh38
na,na,3,129252554,129252554,RHO,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 4|not provided|Retinitis pigmentosa|Blurred vision;Peripheral visual field loss;Night blindness|Retinal dystrophy|RHO-related disorder|Microcephaly 17, primary, autosomal recessive",single nucleotide variant,GRCh37
na,na,3,129533711,129533711,RHO,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 4|not provided|Retinitis pigmentosa|Blurred vision;Peripheral visual field loss;Night blindness|Retinal dystrophy|RHO-related disorder|Microcephaly 17, primary, autosomal recessive",single nucleotide variant,GRCh38
na,na,3,129252553,129252553,RHO,Pathogenic,Retinitis pigmentosa 4|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129533710,129533710,RHO,Pathogenic,Retinitis pigmentosa 4|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129247749,129247749,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided|RHO-related disorder,single nucleotide variant,GRCh37
na,na,3,129528906,129528906,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided|RHO-related disorder,single nucleotide variant,GRCh38
na,na,3,129247626,129247626,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not specified|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,3,129528783,129528783,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not specified|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,3,129247709,129247709,RHO,Uncertain significance,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh37
na,na,3,129528866,129528866,RHO,Uncertain significance,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh38
na,na,3,129247836,129247836,RHO,Likely pathogenic,Retinitis pigmentosa 4|Pigmentary retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129528993,129528993,RHO,Likely pathogenic,Retinitis pigmentosa 4|Pigmentary retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129247842,129247842,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided|Pigmentary retinal dystrophy|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129528999,129528999,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided|Pigmentary retinal dystrophy|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129247892,129247892,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,3,129529049,129529049,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,3,129251131,129251131,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129532288,129532288,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129249761,129249761,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh37
na,na,3,129530918,129530918,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh38
na,na,3,129251096,129251096,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129532253,129532253,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129251132,129251132,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129532289,129532289,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129251195,129251195,RHO,Likely pathogenic,Retinitis pigmentosa 4|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129532352,129532352,RHO,Likely pathogenic,Retinitis pigmentosa 4|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129249760,129249760,RHO,Pathogenic,Retinitis pigmentosa|Retinitis pigmentosa 4|Retinitis punctata albescens|not provided|Retinal dystrophy|RHO-related disorder,single nucleotide variant,GRCh37
na,na,3,129530917,129530917,RHO,Pathogenic,Retinitis pigmentosa|Retinitis pigmentosa 4|Retinitis punctata albescens|not provided|Retinal dystrophy|RHO-related disorder,single nucleotide variant,GRCh38
na,na,3,129252544,129252544,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129533701,129533701,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129251565,129251565,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh37
na,na,3,129532722,129532722,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh38
na,na,3,129252554,129252554,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,3,129533711,129533711,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,3,129251107,129251107,RHO,Pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,3,129532264,129532264,RHO,Pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,3,129251479,129251479,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh37
na,na,3,129532636,129532636,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh38
na,na,3,129247905,129247905,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129529062,129529062,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129251424,129251424,RHO,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 4, autosomal recessive|not provided|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,3,129532581,129532581,RHO,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 4, autosomal recessive|not provided|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,3,129247734,129247734,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh37
na,na,3,129528891,129528891,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh38
na,na,3,129247892,129247892,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,3,129529049,129529049,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,3,129251131,129251131,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh37
na,na,3,129532288,129532288,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh38
na,na,3,129247620,129247620,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129528777,129528777,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129251183,129251183,RHO,Pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,3,129532340,129532340,RHO,Pathogenic,Retinitis pigmentosa 4|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,3,129251554,129251554,RHO,Pathogenic,Congenital stationary night blindness autosomal dominant 1,single nucleotide variant,GRCh37
na,na,3,129532711,129532711,RHO,Pathogenic,Congenital stationary night blindness autosomal dominant 1,single nucleotide variant,GRCh38
na,na,3,129247845,129247845,RHO,Pathogenic,Congenital stationary night blindness autosomal dominant 1|Pigmentary retinal dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129529002,129529002,RHO,Pathogenic,Congenital stationary night blindness autosomal dominant 1|Pigmentary retinal dystrophy|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129249805,129249805,RHO,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 4, autosomal recessive|not provided|Retinitis pigmentosa 4|Autosomal recessive retinitis pigmentosa|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,3,129530962,129530962,RHO,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 4, autosomal recessive|not provided|Retinitis pigmentosa 4|Autosomal recessive retinitis pigmentosa|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,3,129247727,129247727,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|RHO-related disorder,single nucleotide variant,GRCh37
na,na,3,129528884,129528884,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|RHO-related disorder,single nucleotide variant,GRCh38
na,na,3,129247917,129247917,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh37
na,na,3,129529074,129529074,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh38
na,na,3,129249848,129249848,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129531005,129531005,RHO,Pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,3,129249868,129249868,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|Retinal dystrophy|not provided,single nucleotide variant,GRCh37
na,na,3,129531025,129531025,RHO,Pathogenic,Retinitis pigmentosa 4|Retinitis pigmentosa|Retinal dystrophy|not provided,single nucleotide variant,GRCh38
na,na,3,129251468,129251470,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided,Microsatellite,GRCh37
na,na,3,129532625,129532627,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided,Microsatellite,GRCh38
na,na,3,129252547,129252547,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh37
na,na,3,129533704,129533704,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh38
na,na,3,129252554,129252554,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh37
na,na,3,129533711,129533711,RHO,Pathogenic,Retinitis pigmentosa 4|not provided,single nucleotide variant,GRCh38
na,na,3,129247857,129247857,RHO,Likely pathogenic,Congenital stationary night blindness autosomal dominant 1,single nucleotide variant,GRCh37
na,na,3,129529014,129529014,RHO,Likely pathogenic,Congenital stationary night blindness autosomal dominant 1,single nucleotide variant,GRCh38
na,na,3,129247643,129247643,RHO,Pathogenic,Retinitis pigmentosa 4,single nucleotide variant,GRCh37
na,na,3,129528800,129528800,RHO,Pathogenic,Retinitis pigmentosa 4,single nucleotide variant,GRCh38
na,na,3,129252547,129252547,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,3,129533704,129533704,RHO,Pathogenic/Likely pathogenic,Retinitis pigmentosa 4|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,6,49604369,49604372,RHAG,Pathogenic,"Rh-null, regulator type",Indel,GRCh37
na,na,6,49636656,49636659,RHAG,Pathogenic,"Rh-null, regulator type",Indel,GRCh38
na,na,6,49574915,49574915,RHAG,Pathogenic,"Rh-null, regulator type",Deletion,GRCh37
na,na,6,49607202,49607202,RHAG,Pathogenic,"Rh-null, regulator type",Deletion,GRCh38
na,na,6,49586997,49586997,RHAG,Pathogenic,Rh mod blood group phenotype,single nucleotide variant,GRCh37
na,na,6,49619284,49619284,RHAG,Pathogenic,Rh mod blood group phenotype,single nucleotide variant,GRCh38
na,na,6,49580219,49580219,RHAG,Likely pathogenic,"Rh-null, regulator type|Overhydrated hereditary stomatocytosis",single nucleotide variant,GRCh37
na,na,6,49612506,49612506,RHAG,Likely pathogenic,"Rh-null, regulator type|Overhydrated hereditary stomatocytosis",single nucleotide variant,GRCh38
na,na,6,49604368,49604368,RHAG,Pathogenic,"Rh-null, regulator type|Rh-null, regulator type;Overhydrated hereditary stomatocytosis|RHAG-related disorder",single nucleotide variant,GRCh37
na,na,6,49636655,49636655,RHAG,Pathogenic,"Rh-null, regulator type|Rh-null, regulator type;Overhydrated hereditary stomatocytosis|RHAG-related disorder",single nucleotide variant,GRCh38
na,na,6,49578859,49578859,RHAG,Pathogenic,"Rh-null, regulator type",single nucleotide variant,GRCh37
na,na,6,49611146,49611146,RHAG,Pathogenic,"Rh-null, regulator type",single nucleotide variant,GRCh38
na,na,6,49604523,49604523,RHAG,Pathogenic,Rh mod blood group phenotype,single nucleotide variant,GRCh37
na,na,6,49636810,49636810,RHAG,Pathogenic,Rh mod blood group phenotype,single nucleotide variant,GRCh38
na,na,6,49578736,49578736,RHAG,Pathogenic,"Rh-null, regulator type|Rh deficiency syndrome",single nucleotide variant,GRCh37
na,na,6,49611023,49611023,RHAG,Pathogenic,"Rh-null, regulator type|Rh deficiency syndrome",single nucleotide variant,GRCh38
na,na,6,49580247,49580247,RHAG,Benign/Likely benign,"not provided|Rh-null, regulator type|Rh-null, regulator type;Overhydrated hereditary stomatocytosis",single nucleotide variant,GRCh37
na,na,6,49612534,49612534,RHAG,Benign/Likely benign,"not provided|Rh-null, regulator type|Rh-null, regulator type;Overhydrated hereditary stomatocytosis",single nucleotide variant,GRCh38
na,na,6,49574634,49574634,RHAG,Pathogenic,"Rh-null, regulator type",single nucleotide variant,GRCh37
na,na,6,49606921,49606921,RHAG,Pathogenic,"Rh-null, regulator type",single nucleotide variant,GRCh38
na,na,10,95360496,95360496,FFAR4;RBP4,Conflicting classifications of pathogenicity,Progressive retinal dystrophy due to retinol transport defect|not provided,single nucleotide variant,GRCh37
na,na,10,93600739,93600739,FFAR4;RBP4,Conflicting classifications of pathogenicity,Progressive retinal dystrophy due to retinol transport defect|not provided,single nucleotide variant,GRCh38
na,na,10,95360227,95360227,RBP4;FFAR4,Likely pathogenic,Progressive retinal dystrophy due to retinol transport defect,single nucleotide variant,GRCh37
na,na,10,93600470,93600470,RBP4;FFAR4,Likely pathogenic,Progressive retinal dystrophy due to retinol transport defect,single nucleotide variant,GRCh38
na,na,13,49047524,49047524,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,Deletion,GRCh37
na,na,13,48473388,48473388,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,Deletion,GRCh38
na,na,13,49030487,49030487,RB1,Pathogenic,Retinoblastoma,single nucleotide variant,GRCh37
na,na,13,48456351,48456351,RB1,Pathogenic,Retinoblastoma,single nucleotide variant,GRCh38
na,na,13,48953730,48953730,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma;Bone osteosarcoma|not provided,single nucleotide variant,GRCh37
na,na,13,48379594,48379594,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma;Bone osteosarcoma|not provided,single nucleotide variant,GRCh38
na,na,13,49027133,49027133,RB1,Likely pathogenic,Retinoblastoma|not provided,single nucleotide variant,GRCh37
na,na,13,48452997,48452997,RB1,Likely pathogenic,Retinoblastoma|not provided,single nucleotide variant,GRCh38
na,na,13,49039374,49039374,RB1,Pathogenic,Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma;Bone osteosarcoma,single nucleotide variant,GRCh37
na,na,13,48465238,48465238,RB1,Pathogenic,Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma;Bone osteosarcoma,single nucleotide variant,GRCh38
na,na,13,49039166,49039166,RB1,Pathogenic,Retinoblastoma,Deletion,GRCh37
na,na,13,48465030,48465030,RB1,Pathogenic,Retinoblastoma,Deletion,GRCh38
na,na,13,48941740,48941740,RB1,Pathogenic/Likely pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,13,48367604,48367604,RB1,Pathogenic/Likely pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,13,48942685,48942685,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|not provided|Neoplasm,single nucleotide variant,GRCh37
na,na,13,48368549,48368549,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|not provided|Neoplasm,single nucleotide variant,GRCh38
na,na,13,49037865,49037865,RB1,Pathogenic/Likely pathogenic,Malignant tumor of urinary bladder|Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,13,48463729,48463729,RB1,Pathogenic/Likely pathogenic,Malignant tumor of urinary bladder|Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,13,49039164,49039164,RB1,Pathogenic,Small cell lung carcinoma|Retinoblastoma,single nucleotide variant,GRCh37
na,na,13,48465028,48465028,RB1,Pathogenic,Small cell lung carcinoma|Retinoblastoma,single nucleotide variant,GRCh38
na,na,na,-1,-1,RB1,Pathogenic,Retinoblastoma,Deletion,na
na,na,13,48941668,48941669,RB1,Pathogenic,Retinoblastoma,Duplication,GRCh37
na,na,13,48367532,48367533,RB1,Pathogenic,Retinoblastoma,Duplication,GRCh38
na,na,13,49027189,49027198,RB1,Pathogenic,Retinoblastoma,Deletion,GRCh37
na,na,13,48453053,48453062,RB1,Pathogenic,Retinoblastoma,Deletion,GRCh38
na,na,13,49030474,49030482,RB1,Pathogenic,Retinoblastoma,Deletion,GRCh37
na,na,13,48456338,48456346,RB1,Pathogenic,Retinoblastoma,Deletion,GRCh38
na,na,13,49039133,49039133,RB1,Pathogenic,Retinoblastoma,single nucleotide variant,GRCh37
na,na,13,48464997,48464997,RB1,Pathogenic,Retinoblastoma,single nucleotide variant,GRCh38
na,na,13,48877860,48877860,RB1,Likely pathogenic,Retinoblastoma,single nucleotide variant,GRCh37
na,na,13,48303724,48303724,RB1,Likely pathogenic,Retinoblastoma,single nucleotide variant,GRCh38
na,na,13,48877851,48877851,RB1,Pathogenic/Likely pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,13,48303715,48303715,RB1,Pathogenic/Likely pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,13,49033844,49033844,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Retinoblastoma;Bone osteosarcoma;Small cell lung carcinoma|not provided|Vulvar adenocarcinoma of mammary gland type,single nucleotide variant,GRCh37
na,na,13,48459708,48459708,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Retinoblastoma;Bone osteosarcoma;Small cell lung carcinoma|not provided|Vulvar adenocarcinoma of mammary gland type,single nucleotide variant,GRCh38
na,na,13,49033886,49033886,RB1,Pathogenic,Retinoblastoma,single nucleotide variant,GRCh37
na,na,13,48459750,48459750,RB1,Pathogenic,Retinoblastoma,single nucleotide variant,GRCh38
na,na,13,49037971,49037971,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,13,48463835,48463835,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,13,48955550,48955550,RB1,Pathogenic,Trilateral retinoblastoma|Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,13,48381414,48381414,RB1,Pathogenic,Trilateral retinoblastoma|Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,13,48954315,48954317,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,Microsatellite,GRCh37
na,na,13,48380179,48380181,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,Microsatellite,GRCh38
na,na,13,49037894,49037894,RB1,Pathogenic/Likely pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|Hereditary retinoblastoma,single nucleotide variant,GRCh37
na,na,13,48463758,48463758,RB1,Pathogenic/Likely pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome|Hereditary retinoblastoma,single nucleotide variant,GRCh38
na,na,13,48923160,48923160,RB1,Pathogenic,Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma;Bone osteosarcoma,single nucleotide variant,GRCh37
na,na,13,48349024,48349024,RB1,Pathogenic,Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of urinary bladder;Small cell lung carcinoma;Retinoblastoma;Bone osteosarcoma,single nucleotide variant,GRCh38
na,na,13,49030343,49030343,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh37
na,na,13,48456207,48456207,RB1,Pathogenic,Retinoblastoma|Hereditary cancer-predisposing syndrome,single nucleotide variant,GRCh38
na,na,13,48878089,48878090,RB1,Pathogenic,Retinoblastoma,Duplication,GRCh37
na,na,13,48303953,48303954,RB1,Pathogenic,Retinoblastoma,Duplication,GRCh38
na,na,13,49046098,49046098,RB1,Pathogenic/Likely pathogenic,Retinoblastoma|not provided,single nucleotide variant,GRCh37
na,na,13,48471962,48471962,RB1,Pathogenic/Likely pathogenic,Retinoblastoma|not provided,single nucleotide variant,GRCh38
na,na,15,89758364,89758364,RLBP1,Pathogenic/Likely pathogenic,Pigmentary retinal dystrophy|Retinitis punctata albescens|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|not provided|Bothnia retinal dystrophy;Newfoundland cone-rod dystrophy;Pigmentary retinal dystrophy|Bothnia retinal dystrophy,single nucleotide variant,GRCh37
na,na,15,89215133,89215133,RLBP1,Pathogenic/Likely pathogenic,Pigmentary retinal dystrophy|Retinitis punctata albescens|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|not provided|Bothnia retinal dystrophy;Newfoundland cone-rod dystrophy;Pigmentary retinal dystrophy|Bothnia retinal dystrophy,single nucleotide variant,GRCh38
na,na,15,89761796,89761796,RLBP1,Pathogenic,Retinitis punctata albescens|Newfoundland cone-rod dystrophy|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,15,89218565,89218565,RLBP1,Pathogenic,Retinitis punctata albescens|Newfoundland cone-rod dystrophy|not provided|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,15,89754025,89754025,RLBP1,Pathogenic/Likely pathogenic,Bothnia retinal dystrophy|Retinitis punctata albescens|RLBP1-related disorder|not provided|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,15,89210794,89210794,RLBP1,Pathogenic/Likely pathogenic,Bothnia retinal dystrophy|Retinitis punctata albescens|RLBP1-related disorder|not provided|Retinitis pigmentosa|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,15,89754981,89754981,RLBP1,Pathogenic/Likely pathogenic,Retinitis punctata albescens|Retinitis pigmentosa|RLBP1-related disorder|not provided|Retinal dystrophy|Bothnia retinal dystrophy;Retinitis punctata albescens|Bothnia retinal dystrophy;Newfoundland cone-rod dystrophy;Pigmentary retinal dystrophy,single nucleotide variant,GRCh37
na,na,15,89211750,89211750,RLBP1,Pathogenic/Likely pathogenic,Retinitis punctata albescens|Retinitis pigmentosa|RLBP1-related disorder|not provided|Retinal dystrophy|Bothnia retinal dystrophy;Retinitis punctata albescens|Bothnia retinal dystrophy;Newfoundland cone-rod dystrophy;Pigmentary retinal dystrophy,single nucleotide variant,GRCh38
na,na,17,79618674,79618674,PDE6G,Pathogenic,Retinitis pigmentosa 57|Retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,17,81651644,81651644,PDE6G,Pathogenic,Retinitis pigmentosa 57|Retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,4,647908,647908,PDE6B,Pathogenic,Retinitis pigmentosa 40|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,4,654119,654119,PDE6B,Pathogenic,Retinitis pigmentosa 40|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,4,654379,654379,PDE6B,Pathogenic,Retinitis pigmentosa 40|not provided,single nucleotide variant,GRCh37
na,na,4,660590,660590,PDE6B,Pathogenic,Retinitis pigmentosa 40|not provided,single nucleotide variant,GRCh38
na,na,4,654274,654274,PDE6B,Pathogenic,Retinitis pigmentosa 40|Retinal dystrophy,Deletion,GRCh37
na,na,4,660485,660485,PDE6B,Pathogenic,Retinitis pigmentosa 40|Retinal dystrophy,Deletion,GRCh38
na,na,4,655977,655977,PDE6B,Pathogenic,Retinitis pigmentosa 40|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,4,662188,662188,PDE6B,Pathogenic,Retinitis pigmentosa 40|Retinitis pigmentosa|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,4,647701,647701,PDE6B,Pathogenic,Congenital stationary night blindness autosomal dominant 2|not provided,single nucleotide variant,GRCh37
na,na,4,653912,653912,PDE6B,Pathogenic,Congenital stationary night blindness autosomal dominant 2|not provided,single nucleotide variant,GRCh38
na,na,4,619583,619584,PDE6B,Pathogenic,Retinitis pigmentosa 40|not provided,Duplication,GRCh37
na,na,4,625794,625795,PDE6B,Pathogenic,Retinitis pigmentosa 40|not provided,Duplication,GRCh38
na,na,4,661711,661711,PDE6B,Pathogenic,Retinitis pigmentosa 40|Autosomal recessive retinitis pigmentosa,single nucleotide variant,GRCh37
na,na,4,667922,667922,PDE6B,Pathogenic,Retinitis pigmentosa 40|Autosomal recessive retinitis pigmentosa,single nucleotide variant,GRCh38
na,na,5,149265917,149265917,PDE6A,Pathogenic,Retinitis pigmentosa 43|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh37
na,na,5,149886354,149886354,PDE6A,Pathogenic,Retinitis pigmentosa 43|Retinitis pigmentosa|not provided,single nucleotide variant,GRCh38
na,na,5,149286908,149286908,PDE6A,Pathogenic,Retinitis pigmentosa 43,single nucleotide variant,GRCh37
na,na,5,149907345,149907345,PDE6A,Pathogenic,Retinitis pigmentosa 43,single nucleotide variant,GRCh38
na,na,5,149274791,149274791,PDE6A,Pathogenic,Retinitis pigmentosa 43,single nucleotide variant,GRCh37
na,na,5,149895228,149895228,PDE6A,Pathogenic,Retinitis pigmentosa 43,single nucleotide variant,GRCh38
na,na,1,68905269,68905269,RPE65,Pathogenic,Leber congenital amaurosis 2|not provided|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Leber congenital amaurosis|Retinitis pigmentosa 20|RPE65-related recessive retinopathy|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,1,68439586,68439586,RPE65,Pathogenic,Leber congenital amaurosis 2|not provided|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Leber congenital amaurosis|Retinitis pigmentosa 20|RPE65-related recessive retinopathy|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,1,68910541,68910541,RPE65,Pathogenic,Retinitis pigmentosa 20|not provided|Leber congenital amaurosis 2;Retinitis pigmentosa 20|Retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis 2|RPE65-related disorder;Leber congenital amaurosis;Retinitis pigmentosa 20|Autosomal recessive retinitis pigmentosa|Leber congenital amaurosis|Abnormality of the eye|RPE65-related recessive retinopathy|Retinitis pigmentosa 87 with choroidal involvement;Leber congenital amaurosis 2;Retinitis pigmentosa 20,single nucleotide variant,GRCh37
na,na,1,68444858,68444858,RPE65,Pathogenic,Retinitis pigmentosa 20|not provided|Leber congenital amaurosis 2;Retinitis pigmentosa 20|Retinitis pigmentosa|Retinal dystrophy|Leber congenital amaurosis 2|RPE65-related disorder;Leber congenital amaurosis;Retinitis pigmentosa 20|Autosomal recessive retinitis pigmentosa|Leber congenital amaurosis|Abnormality of the eye|RPE65-related recessive retinopathy|Retinitis pigmentosa 87 with choroidal involvement;Leber congenital amaurosis 2;Retinitis pigmentosa 20,single nucleotide variant,GRCh38
na,na,1,68896843,68896843,RPE65,Likely pathogenic,Retinitis pigmentosa 20|not provided|Retinitis pigmentosa 20;Leber congenital amaurosis 2|not specified|Retinitis pigmentosa 20;Retinitis pigmentosa 87 with choroidal involvement;Leber congenital amaurosis 2|RPE65-related recessive retinopathy,single nucleotide variant,GRCh37
na,na,1,68431160,68431160,RPE65,Likely pathogenic,Retinitis pigmentosa 20|not provided|Retinitis pigmentosa 20;Leber congenital amaurosis 2|not specified|Retinitis pigmentosa 20;Retinitis pigmentosa 87 with choroidal involvement;Leber congenital amaurosis 2|RPE65-related recessive retinopathy,single nucleotide variant,GRCh38
na,na,1,68903911,68903911,RPE65,Pathogenic,Retinitis pigmentosa 20|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Leber congenital amaurosis 2|RPE65-related recessive retinopathy|Leber congenital amaurosis|Retinitis pigmentosa 20;Retinitis pigmentosa 87 with choroidal involvement;Leber congenital amaurosis 2,single nucleotide variant,GRCh37
na,na,1,68438228,68438228,RPE65,Pathogenic,Retinitis pigmentosa 20|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Leber congenital amaurosis 2|RPE65-related recessive retinopathy|Leber congenital amaurosis|Retinitis pigmentosa 20;Retinitis pigmentosa 87 with choroidal involvement;Leber congenital amaurosis 2,single nucleotide variant,GRCh38
na,na,1,68903976,68903976,RPE65,Pathogenic,Retinitis pigmentosa 20|not provided|Leber congenital amaurosis 2|RPE65-related recessive retinopathy|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Leber congenital amaurosis|Retinal dystrophy|Retinitis pigmentosa 87 with choroidal involvement;Retinitis pigmentosa 20;Leber congenital amaurosis 2,single nucleotide variant,GRCh37
na,na,1,68438293,68438293,RPE65,Pathogenic,Retinitis pigmentosa 20|not provided|Leber congenital amaurosis 2|RPE65-related recessive retinopathy|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Leber congenital amaurosis|Retinal dystrophy|Retinitis pigmentosa 87 with choroidal involvement;Retinitis pigmentosa 20;Leber congenital amaurosis 2,single nucleotide variant,GRCh38
na,na,1,68910315,68910315,RPE65,Benign,Retinitis pigmentosa 20|not provided|Leber congenital amaurosis 2;Retinitis pigmentosa 20|Leber congenital amaurosis 2|Leber congenital amaurosis|not specified|RPE65-related recessive retinopathy|RPE65-related disorder|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,1,68444632,68444632,RPE65,Benign,Retinitis pigmentosa 20|not provided|Leber congenital amaurosis 2;Retinitis pigmentosa 20|Leber congenital amaurosis 2|Leber congenital amaurosis|not specified|RPE65-related recessive retinopathy|RPE65-related disorder|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,1,68895518,68895518,RPE65,Pathogenic,Retinitis pigmentosa 20|Leber congenital amaurosis 2|not provided|Retinitis pigmentosa|Leber congenital amaurosis|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Retinal dystrophy|RPE65-related recessive retinopathy,single nucleotide variant,GRCh37
na,na,1,68429835,68429835,RPE65,Pathogenic,Retinitis pigmentosa 20|Leber congenital amaurosis 2|not provided|Retinitis pigmentosa|Leber congenital amaurosis|Retinitis pigmentosa 20;Leber congenital amaurosis 2|Retinal dystrophy|RPE65-related recessive retinopathy,single nucleotide variant,GRCh38
na,na,1,211654461,211654461,RD3,Pathogenic,Leber congenital amaurosis 12,single nucleotide variant,GRCh37
na,na,1,211481119,211481119,RD3,Pathogenic,Leber congenital amaurosis 12,single nucleotide variant,GRCh38
na,na,1,204124206,204124206,REN,Pathogenic,"HYPERPRORENINEMIA, FAMILIAL",single nucleotide variant,GRCh37
na,na,1,204155078,204155078,REN,Pathogenic,"HYPERPRORENINEMIA, FAMILIAL",single nucleotide variant,GRCh38
na,na,1,204131245,204131245,REN,Pathogenic/Likely pathogenic,Renal tubular dysgenesis|Familial juvenile hyperuricemic nephropathy type 2|Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2|not provided,single nucleotide variant,GRCh37
na,na,1,204162117,204162117,REN,Pathogenic/Likely pathogenic,Renal tubular dysgenesis|Familial juvenile hyperuricemic nephropathy type 2|Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2|not provided,single nucleotide variant,GRCh38
na,na,1,204128527,204128527,REN,Pathogenic,Renal tubular dysgenesis,single nucleotide variant,GRCh37
na,na,1,204159399,204159399,REN,Pathogenic,Renal tubular dysgenesis,single nucleotide variant,GRCh38
na,na,1,204135375,204135377,REN,Pathogenic/Likely pathogenic,Familial juvenile hyperuricemic nephropathy type 2|Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2|not provided,Microsatellite,GRCh37
na,na,1,204166247,204166249,REN,Pathogenic/Likely pathogenic,Familial juvenile hyperuricemic nephropathy type 2|Renal tubular dysgenesis of genetic origin;Familial juvenile hyperuricemic nephropathy type 2|not provided,Microsatellite,GRCh38
na,na,1,204135375,204135375,REN,Pathogenic,Familial juvenile hyperuricemic nephropathy type 2,single nucleotide variant,GRCh37
na,na,1,204166247,204166247,REN,Pathogenic,Familial juvenile hyperuricemic nephropathy type 2,single nucleotide variant,GRCh38
na,na,15,41011016,41011016,RAD51,Conflicting classifications of pathogenicity,Familial cancer of breast|RAD51-related disorder|not specified|not provided|Hereditary cancer,single nucleotide variant,GRCh37
na,na,15,40718818,40718818,RAD51,Conflicting classifications of pathogenicity,Familial cancer of breast|RAD51-related disorder|not specified|not provided|Hereditary cancer,single nucleotide variant,GRCh38
na,na,15,40987528,40987528,RAD51,Benign,"Breast cancer, susceptibility to, in BRCA1 and BRCA2 carriers|not provided",single nucleotide variant,GRCh37
na,na,15,40695330,40695330,RAD51,Benign,"Breast cancer, susceptibility to, in BRCA1 and BRCA2 carriers|not provided",single nucleotide variant,GRCh38
na,na,11,36614286,36614286,RAG2,Conflicting classifications of pathogenicity,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Recombinase activating gene 2 deficiency;Inborn error of immunity|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh37
na,na,11,36592736,36592736,RAG2,Conflicting classifications of pathogenicity,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Recombinase activating gene 2 deficiency;Inborn error of immunity|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh38
na,na,11,36615033,36615033,RAG2,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn error of immunity|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Recombinase activating gene 2 deficiency|not provided|Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh37
na,na,11,36593483,36593483,RAG2,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn error of immunity|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Recombinase activating gene 2 deficiency|not provided|Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh38
na,na,11,36615596,36615596,RAG2,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn error of immunity|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh37
na,na,11,36594046,36594046,RAG2,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn error of immunity|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh38
na,na,11,36614865,36614865,RAG2,Likely pathogenic,Histiocytic medullary reticulosis|Severe combined immunodeficiency disease|Inborn error of immunity;Recombinase activating gene 2 deficiency;Histiocytic medullary reticulosis,single nucleotide variant,GRCh37
na,na,11,36593315,36593315,RAG2,Likely pathogenic,Histiocytic medullary reticulosis|Severe combined immunodeficiency disease|Inborn error of immunity;Recombinase activating gene 2 deficiency;Histiocytic medullary reticulosis,single nucleotide variant,GRCh38
na,na,11,36615436,36615436,RAG2,Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas|Recombinase activating gene 2 deficiency|not provided",single nucleotide variant,GRCh37
na,na,11,36593886,36593886,RAG2,Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas|Recombinase activating gene 2 deficiency|not provided",single nucleotide variant,GRCh38
na,na,11,36614900,36614902,RAG2,Pathogenic,"Severe combined immunodeficiency, B cell-negative",Deletion,GRCh37
na,na,11,36593350,36593352,RAG2,Pathogenic,"Severe combined immunodeficiency, B cell-negative",Deletion,GRCh38
na,na,11,36615075,36615075,RAG2,Benign,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn error of immunity|not provided|not specified|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Histiocytic medullary reticulosis|Recombinase activating gene 2 deficiency",single nucleotide variant,GRCh37
na,na,11,36593525,36593525,RAG2,Benign,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Recombinase activating gene 2 deficiency;Inborn error of immunity|not provided|not specified|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Histiocytic medullary reticulosis|Recombinase activating gene 2 deficiency",single nucleotide variant,GRCh38
na,na,11,36615604,36615604,RAG2,Pathogenic,"Severe combined immunodeficiency, B cell-negative|Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Recombinase activating gene 2 deficiency;Inborn error of immunity|Recombinase activating gene 2 deficiency",single nucleotide variant,GRCh37
na,na,11,36594054,36594054,RAG2,Pathogenic,"Severe combined immunodeficiency, B cell-negative|Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Recombinase activating gene 2 deficiency;Inborn error of immunity|Recombinase activating gene 2 deficiency",single nucleotide variant,GRCh38
na,na,11,36615489,36615489,RAG2,Likely pathogenic,Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas;Recombinase activating gene 2 deficiency;Inborn error of immunity,single nucleotide variant,GRCh37
na,na,11,36593939,36593939,RAG2,Likely pathogenic,Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas;Recombinase activating gene 2 deficiency;Inborn error of immunity,single nucleotide variant,GRCh38
na,na,11,36614367,36614367,RAG2,Pathogenic,"Combined immunodeficiency with skin granulomas|not provided|Recombinase activating gene 2 deficiency;Inborn error of immunity;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Common variable immunodeficiency|Severe combined immunodeficiency disease|Recombinase activating gene 2 deficiency|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis",single nucleotide variant,GRCh37
na,na,11,36592817,36592817,RAG2,Pathogenic,"Combined immunodeficiency with skin granulomas|not provided|Recombinase activating gene 2 deficiency;Inborn error of immunity;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Common variable immunodeficiency|Severe combined immunodeficiency disease|Recombinase activating gene 2 deficiency|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis",single nucleotide variant,GRCh38
na,na,11,36597018,36597018,RAG1,Pathogenic,"Severe combined immunodeficiency, B cell-negative|not provided|Severe combined immunodeficiency disease|Combined immunodeficiency due to partial RAG1 deficiency|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",single nucleotide variant,GRCh37
na,na,11,36575468,36575468,RAG1,Pathogenic,"Severe combined immunodeficiency, B cell-negative|not provided|Severe combined immunodeficiency disease|Combined immunodeficiency due to partial RAG1 deficiency|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",single nucleotide variant,GRCh38
na,na,11,36597174,36597174,RAG1,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh37
na,na,11,36575624,36575624,RAG1,Pathogenic/Likely pathogenic,"Severe combined immunodeficiency, B cell-negative|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh38
na,na,11,36597668,36597668,RAG1,Likely pathogenic,"Severe combined immunodeficiency, B cell-negative|Recombinase activating gene 1 deficiency",single nucleotide variant,GRCh37
na,na,11,36576118,36576118,RAG1,Likely pathogenic,"Severe combined immunodeficiency, B cell-negative|Recombinase activating gene 1 deficiency",single nucleotide variant,GRCh38
na,na,11,36595321,36595321,RAG1,Uncertain significance,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh37
na,na,11,36573771,36573771,RAG1,Uncertain significance,"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh38
na,na,11,36596536,36596536,RAG1,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",single nucleotide variant,GRCh37
na,na,11,36574986,36574986,RAG1,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",single nucleotide variant,GRCh38
na,na,11,36596040,36596040,RAG1,Pathogenic,"Histiocytic medullary reticulosis|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh37
na,na,11,36574490,36574490,RAG1,Pathogenic,"Histiocytic medullary reticulosis|not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh38
na,na,11,36597589,36597589,RAG1,Pathogenic,Histiocytic medullary reticulosis,single nucleotide variant,GRCh37
na,na,11,36576039,36576039,RAG1,Pathogenic,Histiocytic medullary reticulosis,single nucleotide variant,GRCh38
na,na,11,36596041,36596041,RAG1,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh37
na,na,11,36574491,36574491,RAG1,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas",single nucleotide variant,GRCh38
na,na,11,36596140,36596140,RAG1,Pathogenic,Histiocytic medullary reticulosis,single nucleotide variant,GRCh37
na,na,11,36574590,36574590,RAG1,Pathogenic,Histiocytic medullary reticulosis,single nucleotide variant,GRCh38
na,na,11,36596535,36596535,RAG1,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, B cell-negative|not provided|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency disease|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",single nucleotide variant,GRCh37
na,na,11,36574985,36574985,RAG1,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, B cell-negative|not provided|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency disease|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",single nucleotide variant,GRCh38
na,na,11,36597064,36597064,RAG1,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Inherited Immunodeficiency Diseases|not provided|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Combined immunodeficiency with skin granulomas;Combined immunodeficiency due to partial RAG1 deficiency;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis",single nucleotide variant,GRCh37
na,na,11,36575514,36575514,RAG1,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Inherited Immunodeficiency Diseases|not provided|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Combined immunodeficiency with skin granulomas;Combined immunodeficiency due to partial RAG1 deficiency;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis",single nucleotide variant,GRCh38
na,na,11,36596465,36596477,RAG1,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency",Deletion,GRCh37
na,na,11,36574915,36574927,RAG1,Pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency",Deletion,GRCh38
na,na,11,36597375,36597375,RAG1,Pathogenic,"Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas|not provided",single nucleotide variant,GRCh37
na,na,11,36575825,36575825,RAG1,Pathogenic,"Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with skin granulomas|not provided",single nucleotide variant,GRCh38
na,na,11,36597796,36597796,RAG1,Pathogenic,Combined immunodeficiency due to partial RAG1 deficiency,single nucleotide variant,GRCh37
na,na,11,36576246,36576246,RAG1,Pathogenic,Combined immunodeficiency due to partial RAG1 deficiency,single nucleotide variant,GRCh38
na,na,11,36595794,36595794,RAG1,Pathogenic/Likely pathogenic,"Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh37
na,na,11,36574244,36574244,RAG1,Pathogenic/Likely pathogenic,"Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh38
na,na,11,36596373,36596373,RAG1,Conflicting classifications of pathogenicity,"Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|not specified|Combined immunodeficiency with skin granulomas;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",single nucleotide variant,GRCh37
na,na,11,36574823,36574823,RAG1,Conflicting classifications of pathogenicity,"Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|not specified|Combined immunodeficiency with skin granulomas;Histiocytic medullary reticulosis;Combined immunodeficiency due to partial RAG1 deficiency;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive",single nucleotide variant,GRCh38
na,na,11,36597187,36597187,RAG1,Pathogenic,"Combined immunodeficiency with skin granulomas|not provided|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency disease|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh37
na,na,11,36575637,36575637,RAG1,Pathogenic,"Combined immunodeficiency with skin granulomas|not provided|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency disease|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh38
na,na,11,36597777,36597777,RAG1,Pathogenic,"Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency disease|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh37
na,na,11,36576227,36576227,RAG1,Pathogenic,"Combined immunodeficiency with skin granulomas|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency disease|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh38
na,na,11,36595837,36595837,RAG1,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas;Combined immunodeficiency due to partial RAG1 deficiency|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency disease",single nucleotide variant,GRCh37
na,na,11,36574287,36574287,RAG1,Pathogenic/Likely pathogenic,"Histiocytic medullary reticulosis|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Combined immunodeficiency with skin granulomas|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;Histiocytic medullary reticulosis;Combined immunodeficiency with skin granulomas;Combined immunodeficiency due to partial RAG1 deficiency|Combined immunodeficiency due to partial RAG1 deficiency|Severe combined immunodeficiency disease",single nucleotide variant,GRCh38
na,na,11,36597180,36597180,RAG1,Pathogenic,"Severe combined immunodeficiency, B cell-negative|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency disease|Combined immunodeficiency with skin granulomas;Combined immunodeficiency due to partial RAG1 deficiency;Histiocytic medullary reticulosis;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh37
na,na,11,36575630,36575630,RAG1,Pathogenic,"Severe combined immunodeficiency, B cell-negative|Combined immunodeficiency with skin granulomas;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Severe combined immunodeficiency disease|Combined immunodeficiency with skin granulomas;Combined immunodeficiency due to partial RAG1 deficiency;Histiocytic medullary reticulosis;Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|Combined immunodeficiency due to partial RAG1 deficiency",single nucleotide variant,GRCh38
na,na,6,42689715,42689717,PRPH2,Pathogenic/Likely pathogenic,Retinitis pigmentosa 7|not provided,Microsatellite,GRCh37
na,na,6,42721977,42721979,PRPH2,Pathogenic/Likely pathogenic,Retinitis pigmentosa 7|not provided,Microsatellite,GRCh38
na,na,6,42672284,42672284,PRPH2,Pathogenic,Retinitis pigmentosa 7|not provided|PRPH2-related disorder|Retinal dystrophy|Retinitis pigmentosa|Patterned dystrophy of the retinal pigment epithelium,single nucleotide variant,GRCh37
na,na,6,42704546,42704546,PRPH2,Pathogenic,Retinitis pigmentosa 7|not provided|PRPH2-related disorder|Retinal dystrophy|Retinitis pigmentosa|Patterned dystrophy of the retinal pigment epithelium,single nucleotide variant,GRCh38
na,na,6,42689519,42689519,PRPH2,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 7, digenic|not provided|Leber congenital amaurosis 18|Patterned macular dystrophy 1|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|PRPH2-related disorder|Retinitis pigmentosa",single nucleotide variant,GRCh37
na,na,6,42721781,42721781,PRPH2,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 7, digenic|not provided|Leber congenital amaurosis 18|Patterned macular dystrophy 1|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|PRPH2-related disorder|Retinitis pigmentosa",single nucleotide variant,GRCh38
na,na,6,42689558,42689558,PRPH2,Pathogenic/Likely pathogenic,"Choroidal dystrophy, central areolar 2|not provided|Macular dystrophy|Retinitis pigmentosa|Retinal dystrophy|PRPH2-related disorder|Patterned dystrophy of the retinal pigment epithelium|Stargardt disease|Vitelliform macular dystrophy 3|Retinitis pigmentosa 7",single nucleotide variant,GRCh37
na,na,6,42721820,42721820,PRPH2,Pathogenic/Likely pathogenic,"Choroidal dystrophy, central areolar 2|not provided|Macular dystrophy|Retinitis pigmentosa|Retinal dystrophy|PRPH2-related disorder|Patterned dystrophy of the retinal pigment epithelium|Stargardt disease|Vitelliform macular dystrophy 3|Retinitis pigmentosa 7",single nucleotide variant,GRCh38
na,na,6,42672157,42672157,PRPH2,Pathogenic,not provided|Vitelliform macular dystrophy 3,single nucleotide variant,GRCh37
na,na,6,42704419,42704419,PRPH2,Pathogenic,not provided|Vitelliform macular dystrophy 3,single nucleotide variant,GRCh38
na,na,6,42689573,42689573,PRPH2,Pathogenic,Patterned macular dystrophy 1|not provided|PRPH2-related disorder,single nucleotide variant,GRCh37
na,na,6,42721835,42721835,PRPH2,Pathogenic,Patterned macular dystrophy 1|not provided|PRPH2-related disorder,single nucleotide variant,GRCh38
na,na,6,42689559,42689559,PRPH2,Pathogenic/Likely pathogenic,"Choroidal dystrophy, central areolar 2|not provided|PRPH2-related disorder|maculopathy|Retinitis pigmentosa|Patterned dystrophy of the retinal pigment epithelium|Vitelliform macular dystrophy 2|Cone-rod dystrophy|Stargardt disease|Patterned macular dystrophy 1|Retinitis pigmentosa 7|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,6,42721821,42721821,PRPH2,Pathogenic/Likely pathogenic,"Choroidal dystrophy, central areolar 2|not provided|PRPH2-related disorder|maculopathy|Retinitis pigmentosa|Patterned dystrophy of the retinal pigment epithelium|Vitelliform macular dystrophy 2|Cone-rod dystrophy|Stargardt disease|Patterned macular dystrophy 1|Retinitis pigmentosa 7|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,6,42666176,42666177,PRPH2,Pathogenic,Patterned macular dystrophy 1|not provided|PRPH2-related disorder|Retinal dystrophy,Deletion,GRCh37
na,na,6,42698438,42698439,PRPH2,Pathogenic,Patterned macular dystrophy 1|not provided|PRPH2-related disorder|Retinal dystrophy,Deletion,GRCh38
na,na,6,42672199,42672199,PRPH2,Pathogenic,Retinitis pigmentosa 7|not provided|Retinal dystrophy,single nucleotide variant,GRCh37
na,na,6,42704461,42704461,PRPH2,Pathogenic,Retinitis pigmentosa 7|not provided|Retinal dystrophy,single nucleotide variant,GRCh38
na,na,6,42672302,42672302,PRPH2,Pathogenic/Likely pathogenic,not provided|PRPH2-related disorder|Retinal dystrophy|Stargardt disease|Patterned dystrophy of the retinal pigment epithelium|Vitelliform macular dystrophy 2|Vitelliform macular dystrophy 3,single nucleotide variant,GRCh37
na,na,6,42704564,42704564,PRPH2,Pathogenic/Likely pathogenic,not provided|PRPH2-related disorder|Retinal dystrophy|Stargardt disease|Patterned dystrophy of the retinal pigment epithelium|Vitelliform macular dystrophy 2|Vitelliform macular dystrophy 3,single nucleotide variant,GRCh38
na,na,6,42689651,42689652,PRPH2,Pathogenic,Patterned macular dystrophy 1|not provided,Duplication,GRCh37
na,na,6,42721913,42721914,PRPH2,Pathogenic,Patterned macular dystrophy 1|not provided,Duplication,GRCh38
na,na,6,42690071,42690071,PRPH2,Pathogenic/Likely pathogenic,not provided|Retinal dystrophy|Vitelliform macular dystrophy 3|PRPH2-related disorder,single nucleotide variant,GRCh37
na,na,6,42722333,42722333,PRPH2,Pathogenic/Likely pathogenic,not provided|Retinal dystrophy|Vitelliform macular dystrophy 3|PRPH2-related disorder,single nucleotide variant,GRCh38
na,na,6,42666127,42666127,PRPH2,Pathogenic,not provided|Vitelliform macular dystrophy 3,single nucleotide variant,GRCh37
na,na,6,42698389,42698389,PRPH2,Pathogenic,not provided|Vitelliform macular dystrophy 3,single nucleotide variant,GRCh38
na,na,6,42689960,42689960,PRPH2,Pathogenic,not provided|Retinal dystrophy|Stargardt disease|PRPH2-related disorder|Vitelliform macular dystrophy 3,Deletion,GRCh37
na,na,6,42722222,42722222,PRPH2,Pathogenic,not provided|Retinal dystrophy|Stargardt disease|PRPH2-related disorder|Vitelliform macular dystrophy 3,Deletion,GRCh38
na,na,6,42689610,42689612,PRPH2,Pathogenic,Retinitis pigmentosa 7|not provided|Patterned macular dystrophy 1|Cone-rod dystrophy|Stargardt disease|PRPH2-related disorder|Retinal dystrophy,Microsatellite,GRCh37
na,na,6,42721872,42721874,PRPH2,Pathogenic,Retinitis pigmentosa 7|not provided|Patterned macular dystrophy 1|Cone-rod dystrophy|Stargardt disease|PRPH2-related disorder|Retinal dystrophy,Microsatellite,GRCh38
na,na,6,42689937,42689937,PRPH2,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 7|not provided|Patterned dystrophy of the retinal pigment epithelium|Patterned macular dystrophy 1|PRPH2-related disorder|Retinal dystrophy|Stargardt disease|Choroidal dystrophy, central areolar 2",single nucleotide variant,GRCh37
na,na,6,42722199,42722199,PRPH2,Pathogenic/Likely pathogenic,"Retinitis pigmentosa 7|not provided|Patterned dystrophy of the retinal pigment epithelium|Patterned macular dystrophy 1|PRPH2-related disorder|Retinal dystrophy|Stargardt disease|Choroidal dystrophy, central areolar 2",single nucleotide variant,GRCh38
na,na,6,42689555,42689555,PRPH2,Pathogenic,Retinitis pigmentosa 7|not provided|PRPH2-related disorder,single nucleotide variant,GRCh37
na,na,6,42721817,42721817,PRPH2,Pathogenic,Retinitis pigmentosa 7|not provided|PRPH2-related disorder,single nucleotide variant,GRCh38
na,na,6,42672347,42672347,PRPH2,Pathogenic,"Choroidal dystrophy, central areolar 2|not provided|PRPH2-related disorder|Retinal dystrophy",single nucleotide variant,GRCh37
na,na,6,42704609,42704609,PRPH2,Pathogenic,"Choroidal dystrophy, central areolar 2|not provided|PRPH2-related disorder|Retinal dystrophy",single nucleotide variant,GRCh38
na,na,6,42689649,42689649,PRPH2,Pathogenic/Likely pathogenic,"Choroidal dystrophy, central areolar 2|not provided|Cone dystrophy|Stargardt disease|Retinitis pigmentosa|maculopathy|Progressive cone dystrophy (without rod involvement)|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|PRPH2-related disorder|Patterned macular dystrophy 1",single nucleotide variant,GRCh37
na,na,6,42721911,42721911,PRPH2,Pathogenic/Likely pathogenic,"Choroidal dystrophy, central areolar 2|not provided|Cone dystrophy|Stargardt disease|Retinitis pigmentosa|maculopathy|Progressive cone dystrophy (without rod involvement)|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|PRPH2-related disorder|Patterned macular dystrophy 1",single nucleotide variant,GRCh38
na,na,11,110102614,110102614,RDX,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,single nucleotide variant,GRCh37
na,na,11,110231889,110231889,RDX,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,single nucleotide variant,GRCh38
na,na,11,110104143,110104144,RDX,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,Duplication,GRCh37
na,na,11,110233418,110233419,RDX,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,Duplication,GRCh38
na,na,11,110134689,110134689,RDX,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,single nucleotide variant,GRCh37
na,na,11,110263964,110263964,RDX,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,single nucleotide variant,GRCh38
na,na,11,110128491,110128491,RDX,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,single nucleotide variant,GRCh37
na,na,11,110257766,110257766,RDX,Pathogenic,Autosomal recessive nonsyndromic hearing loss 24,single nucleotide variant,GRCh38
na,na,3,58416578,58416578,PDHB,Likely pathogenic,Pyruvate dehydrogenase E1-beta deficiency,single nucleotide variant,GRCh37
na,na,3,58430851,58430851,PDHB,Likely pathogenic,Pyruvate dehydrogenase E1-beta deficiency,single nucleotide variant,GRCh38
na,na,3,58413811,58413811,PDHB,Pathogenic,Pyruvate dehydrogenase E1-beta deficiency,single nucleotide variant,GRCh37
na,na,3,58428084,58428084,PDHB,Pathogenic,Pyruvate dehydrogenase E1-beta deficiency,single nucleotide variant,GRCh38
na,na,17,79892202,79892202,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B|not provided|Inborn genetic diseases|Cutis laxa,single nucleotide variant,GRCh37
na,na,17,81934326,81934326,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B|not provided|Inborn genetic diseases|Cutis laxa,single nucleotide variant,GRCh38
na,na,17,79892546,79892546,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B,single nucleotide variant,GRCh37
na,na,17,81934670,81934670,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B,single nucleotide variant,GRCh38
na,na,17,79892522,79892544,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B,Deletion,GRCh37
na,na,17,81934646,81934668,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B,Deletion,GRCh38
na,na,17,79892197,79892200,PYCR1,Likely pathogenic,Autosomal recessive cutis laxa type 2B|PYCR1-related de Barsy syndrome;Autosomal recessive cutis laxa type 2B,Deletion,GRCh37
na,na,17,81934321,81934324,PYCR1,Likely pathogenic,Autosomal recessive cutis laxa type 2B|PYCR1-related de Barsy syndrome;Autosomal recessive cutis laxa type 2B,Deletion,GRCh38
na,na,17,79894680,79894680,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B,Deletion,GRCh37
na,na,17,81936804,81936804,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B,Deletion,GRCh38
na,na,17,79892987,79892987,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B,single nucleotide variant,GRCh37
na,na,17,81935111,81935111,PYCR1,Pathogenic,Autosomal recessive cutis laxa type 2B,single nucleotide variant,GRCh38
na,na,17,79892986,79892986,PYCR1,Pathogenic/Likely pathogenic,Autosomal recessive cutis laxa type 2B|PYCR1-related de Barsy syndrome|Wiedemann-Rautenstrauch-like progeroid syndrome|not provided|Cutis laxa,single nucleotide variant,GRCh37
na,na,17,81935110,81935110,PYCR1,Pathogenic/Likely pathogenic,Autosomal recessive cutis laxa type 2B|PYCR1-related de Barsy syndrome|Wiedemann-Rautenstrauch-like progeroid syndrome|not provided|Cutis laxa,single nucleotide variant,GRCh38
na,na,17,79892247,79892247,PYCR1,Pathogenic/Likely pathogenic,PYCR1-related de Barsy syndrome|not provided|Inborn genetic diseases|Cutis laxa,single nucleotide variant,GRCh37
na,na,17,81934371,81934371,PYCR1,Pathogenic/Likely pathogenic,PYCR1-related de Barsy syndrome|not provided|Inborn genetic diseases|Cutis laxa,single nucleotide variant,GRCh38
na,na,10,81317020,81317020,SFTPA2,Pathogenic/Likely risk allele,Interstitial lung disease 2|Pulmonary fibrosis,single nucleotide variant,GRCh37
na,na,10,79557264,79557264,SFTPA2,Pathogenic/Likely risk allele,Interstitial lung disease 2|Pulmonary fibrosis,single nucleotide variant,GRCh38
na,na,10,81317119,81317119,SFTPA2,Pathogenic,Interstitial lung disease 2,single nucleotide variant,GRCh37
na,na,10,79557363,79557363,SFTPA2,Pathogenic,Interstitial lung disease 2,single nucleotide variant,GRCh38
na,na,2,85893772,85893772,SFTPB,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 1|Hereditary pulmonary alveolar proteinosis|not provided|SFTPB-related disorder",Indel,GRCh37
na,na,2,85666649,85666649,SFTPB,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 1|Hereditary pulmonary alveolar proteinosis|not provided|SFTPB-related disorder",Indel,GRCh38
na,na,2,85893768,85893768,SFTPB,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 1|not provided",Deletion,GRCh37
na,na,2,85666645,85666645,SFTPB,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 1|not provided",Deletion,GRCh38
na,na,na,-1,-1,SFTPB,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 1",Deletion,na
na,na,2,85890937,85890937,SFTPB,Conflicting classifications of pathogenicity,"Surfactant metabolism dysfunction, pulmonary, 1|not provided|Hereditary pulmonary alveolar proteinosis",single nucleotide variant,GRCh37
na,na,2,85663814,85663814,SFTPB,Conflicting classifications of pathogenicity,"Surfactant metabolism dysfunction, pulmonary, 1|not provided|Hereditary pulmonary alveolar proteinosis",single nucleotide variant,GRCh38
na,na,2,85892846,85892846,SFTPB,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 1",single nucleotide variant,GRCh37
na,na,2,85665723,85665723,SFTPB,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 1",single nucleotide variant,GRCh38
na,na,10,81373777,81373777,SFTPA1,Benign,"Pulmonary fibrosis, idiopathic, susceptibility to|not specified|not provided|SFTPA1-related disorder",single nucleotide variant,GRCh37
na,na,10,79614021,79614021,SFTPA1,Benign,"Pulmonary fibrosis, idiopathic, susceptibility to|not specified|not provided|SFTPA1-related disorder",single nucleotide variant,GRCh38
na,na,8,22021060,22021060,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2|not provided",single nucleotide variant,GRCh37
na,na,8,22163547,22163547,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2|not provided",single nucleotide variant,GRCh38
na,na,8,22020609,22020609,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2|not provided|Pulmonary fibrosis|Hereditary pulmonary alveolar proteinosis",single nucleotide variant,GRCh37
na,na,8,22163096,22163096,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2|not provided|Pulmonary fibrosis|Hereditary pulmonary alveolar proteinosis",single nucleotide variant,GRCh38
na,na,8,22021460,22021460,SFTPC,Conflicting classifications of pathogenicity,"Surfactant metabolism dysfunction, pulmonary, 2|Interstitial lung disease 2|not provided|Hereditary pulmonary alveolar proteinosis|SFTPC-related disorder|not specified",single nucleotide variant,GRCh37
na,na,8,22163947,22163947,SFTPC,Conflicting classifications of pathogenicity,"Surfactant metabolism dysfunction, pulmonary, 2|Interstitial lung disease 2|not provided|Hereditary pulmonary alveolar proteinosis|SFTPC-related disorder|not specified",single nucleotide variant,GRCh38
na,na,8,22021523,22021523,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh37
na,na,8,22164010,22164010,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh38
na,na,8,22021060,22021060,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh37
na,na,8,22163547,22163547,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh38
na,na,8,22020971,22020971,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh37
na,na,8,22163458,22163458,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh38
na,na,8,22020240,22020240,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh37
na,na,8,22162727,22162727,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh38
na,na,8,22021541,22021541,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh37
na,na,8,22164028,22164028,SFTPC,Pathogenic,"Surfactant metabolism dysfunction, pulmonary, 2",single nucleotide variant,GRCh38
na,na,3,165548529,165548529,BCHE,Conflicting classifications of pathogenicity,Postanesthetic apnea|Deficiency of butyrylcholinesterase|not provided|BCHE-related disorder,single nucleotide variant,GRCh37
na,na,3,165830741,165830741,BCHE,Conflicting classifications of pathogenicity,Postanesthetic apnea|Deficiency of butyrylcholinesterase|not provided|BCHE-related disorder,single nucleotide variant,GRCh38
na,na,3,165548387,165548387,BCHE,Pathogenic,Deficiency of butyrylcholinesterase|not provided,Indel,GRCh37
na,na,3,165830599,165830599,BCHE,Pathogenic,Deficiency of butyrylcholinesterase|not provided,Indel,GRCh38
na,na,3,165548314,165548314,BCHE,Likely pathogenic,"BCHE, H variant|not provided",single nucleotide variant,GRCh37
na,na,3,165830526,165830526,BCHE,Likely pathogenic,"BCHE, H variant|not provided",single nucleotide variant,GRCh38
na,na,3,165548010,165548010,BCHE,Conflicting classifications of pathogenicity,"BCHE, flouride 1|not provided|Deficiency of butyrylcholinesterase",single nucleotide variant,GRCh37
na,na,3,165830222,165830222,BCHE,Conflicting classifications of pathogenicity,"BCHE, flouride 1|not provided|Deficiency of butyrylcholinesterase",single nucleotide variant,GRCh38
na,na,3,165547569,165547569,BCHE,Conflicting classifications of pathogenicity,"BCHE, fluoride 2|Deficiency of butyrylcholinesterase|BCHE-related disorder",single nucleotide variant,GRCh37
na,na,3,165829781,165829781,BCHE,Conflicting classifications of pathogenicity,"BCHE, fluoride 2|Deficiency of butyrylcholinesterase|BCHE-related disorder",single nucleotide variant,GRCh38
na,na,3,165491280,165491280,BCHE,Conflicting classifications of pathogenicity,Butyrylcholinesterase activity|Deficiency of butyrylcholinesterase|not specified|not provided,single nucleotide variant,GRCh37
na,na,3,165773492,165773492,BCHE,Conflicting classifications of pathogenicity,Butyrylcholinesterase activity|Deficiency of butyrylcholinesterase|not specified|not provided,single nucleotide variant,GRCh38
na,na,3,165504043,165504043,BCHE,Uncertain significance,"BCHE, J variant|not specified",single nucleotide variant,GRCh37
na,na,3,165786255,165786255,BCHE,Uncertain significance,"BCHE, J variant|not specified",single nucleotide variant,GRCh38
na,na,na,-1,-1,BCHE,Pathogenic,BCHE Newfoundland,Variation,na
na,na,na,-1,-1,BCHE,Pathogenic,BCHE Cynthiana,Variation,na
na,na,na,-1,-1,BCHE,Pathogenic,BCHE Johannesburg,Variation,na
na,na,na,-1,-1,BCHE,Pathogenic,Deficiency of butyrylcholinesterase,Duplication,na
na,na,3,165547750,165547750,BCHE,Pathogenic/Likely pathogenic,"Butyrylcholinesterase deficiency, fluoride-resistant, Japanese type|Deficiency of butyrylcholinesterase",single nucleotide variant,GRCh37
na,na,3,165829962,165829962,BCHE,Pathogenic/Likely pathogenic,"Butyrylcholinesterase deficiency, fluoride-resistant, Japanese type|Deficiency of butyrylcholinesterase",single nucleotide variant,GRCh38
na,na,3,165548355,165548355,BCHE,Pathogenic,Deficiency of butyrylcholinesterase,single nucleotide variant,GRCh37
na,na,3,165830567,165830567,BCHE,Pathogenic,Deficiency of butyrylcholinesterase,single nucleotide variant,GRCh38
na,na,3,165547818,165547818,BCHE,Pathogenic/Likely pathogenic,Deficiency of butyrylcholinesterase,single nucleotide variant,GRCh37
na,na,3,165830030,165830030,BCHE,Pathogenic/Likely pathogenic,Deficiency of butyrylcholinesterase,single nucleotide variant,GRCh38
na,na,na,-1,-1,BCHE,Pathogenic,Postanesthetic apnea,Deletion,na
na,na,3,165491308,165491308,BCHE,no classification for the single variant,-,single nucleotide variant,GRCh37
na,na,3,165773520,165773520,BCHE,no classification for the single variant,-,single nucleotide variant,GRCh38
na,na,16,79632937,79632937,MAF,Pathogenic,Cataract 21 multiple types,single nucleotide variant,GRCh37
na,na,16,79599040,79599040,MAF,Pathogenic,Cataract 21 multiple types,single nucleotide variant,GRCh38
na,na,16,79632910,79632910,MAF,Pathogenic,Cataract 21 multiple types,single nucleotide variant,GRCh37
na,na,16,79599013,79599013,MAF,Pathogenic,Cataract 21 multiple types,single nucleotide variant,GRCh38
na,na,15,43507389,43507389,EPB42,Conflicting classifications of pathogenicity,Hereditary spherocytosis type 5|EPB42-related disorder,single nucleotide variant,GRCh37
na,na,15,43215191,43215191,EPB42,Conflicting classifications of pathogenicity,Hereditary spherocytosis type 5|EPB42-related disorder,single nucleotide variant,GRCh38
na,na,15,43508487,43508487,EPB42,Pathogenic,Hereditary spherocytosis type 5,Deletion,GRCh37
na,na,15,43216289,43216289,EPB42,Pathogenic,Hereditary spherocytosis type 5,Deletion,GRCh38
na,na,15,43500967,43500967,EPB42,Likely pathogenic,Hereditary spherocytosis type 5,single nucleotide variant,GRCh37
na,na,15,43208769,43208769,EPB42,Likely pathogenic,Hereditary spherocytosis type 5,single nucleotide variant,GRCh38
na,na,15,43501471,43501471,EPB42,Pathogenic,Hereditary spherocytosis type 5,single nucleotide variant,GRCh37
na,na,15,43209273,43209273,EPB42,Pathogenic,Hereditary spherocytosis type 5,single nucleotide variant,GRCh38
na,na,15,43495435,43495435,EPB42,Pathogenic,Hereditary spherocytosis type 5,single nucleotide variant,GRCh37
na,na,15,43203237,43203237,EPB42,Pathogenic,Hereditary spherocytosis type 5,single nucleotide variant,GRCh38
na,na,19,11559889,11559889,PRKCSH,Pathogenic,Polycystic liver disease 1,single nucleotide variant,GRCh37
na,na,19,11449074,11449074,PRKCSH,Pathogenic,Polycystic liver disease 1,single nucleotide variant,GRCh38
na,na,19,11548793,11548793,PRKCSH,Pathogenic,Polycystic liver disease 1,single nucleotide variant,GRCh37
na,na,19,11437972,11437972,PRKCSH,Pathogenic,Polycystic liver disease 1,single nucleotide variant,GRCh38
na,na,19,11559991,11559992,PRKCSH,Pathogenic,Polycystic liver disease 1,Deletion,GRCh37
na,na,19,11449176,11449177,PRKCSH,Pathogenic,Polycystic liver disease 1,Deletion,GRCh38
na,na,19,11559419,11559419,PRKCSH,Pathogenic,Polycystic liver disease 1,single nucleotide variant,GRCh37
na,na,19,11448604,11448604,PRKCSH,Pathogenic,Polycystic liver disease 1,single nucleotide variant,GRCh38
na,na,19,11559732,11559732,PRKCSH,Pathogenic/Likely pathogenic,Polycystic liver disease 1|not provided,single nucleotide variant,GRCh37
na,na,19,11448917,11448917,PRKCSH,Pathogenic/Likely pathogenic,Polycystic liver disease 1|not provided,single nucleotide variant,GRCh38
na,na,19,11548713,11548714,PRKCSH,Pathogenic,Polycystic liver disease 1,Duplication,GRCh37
na,na,19,11437892,11437893,PRKCSH,Pathogenic,Polycystic liver disease 1,Duplication,GRCh38
na,na,19,54392907,54392907,PRKCG,Pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh37
na,na,19,53889653,53889653,PRKCG,Pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh38
na,na,19,54392961,54392961,PRKCG,Pathogenic,Spinocerebellar ataxia type 14,single nucleotide variant,GRCh37
na,na,19,53889707,53889707,PRKCG,Pathogenic,Spinocerebellar ataxia type 14,single nucleotide variant,GRCh38
na,na,19,54392989,54392989,PRKCG,Pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh37
na,na,19,53889735,53889735,PRKCG,Pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh38
na,na,19,54392959,54392959,PRKCG,Pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh37
na,na,19,53889705,53889705,PRKCG,Pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh38
na,na,19,54392986,54392986,PRKCG,Pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh37
na,na,19,53889732,53889732,PRKCG,Pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh38
na,na,19,54409982,54409982,PRKCG,Pathogenic,Spinocerebellar ataxia type 14,single nucleotide variant,GRCh37
na,na,19,53906728,53906728,PRKCG,Pathogenic,Spinocerebellar ataxia type 14,single nucleotide variant,GRCh38
na,na,19,54401354,54401354,PRKCG,Likely pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh37
na,na,19,53898100,53898100,PRKCG,Likely pathogenic,Spinocerebellar ataxia type 14|not provided,single nucleotide variant,GRCh38
na,na,19,54392909,54392909,PRKCG,Pathogenic,Spinocerebellar ataxia type 14,single nucleotide variant,GRCh37
na,na,19,53889655,53889655,PRKCG,Pathogenic,Spinocerebellar ataxia type 14,single nucleotide variant,GRCh38
na,na,19,54410146,54410247,PRKCG,Pathogenic,Spinocerebellar ataxia type 14,Deletion,GRCh37
na,na,19,53906892,53906993,PRKCG,Pathogenic,Spinocerebellar ataxia type 14,Deletion,GRCh38
na,na,2,98354447,98354447,ZAP70,Pathogenic,Combined immunodeficiency due to ZAP70 deficiency|not provided|ZAP70-Related Severe Combined Immunodeficiency|ZAP70-related disorder|Severe combined immunodeficiency disease,single nucleotide variant,GRCh37
na,na,2,97737984,97737984,ZAP70,Pathogenic,Combined immunodeficiency due to ZAP70 deficiency|not provided|ZAP70-Related Severe Combined Immunodeficiency|ZAP70-related disorder|Severe combined immunodeficiency disease,single nucleotide variant,GRCh38
na,na,2,98354291,98354291,ZAP70,Pathogenic,Combined immunodeficiency due to ZAP70 deficiency,single nucleotide variant,GRCh37
na,na,2,97737828,97737828,ZAP70,Pathogenic,Combined immunodeficiency due to ZAP70 deficiency,single nucleotide variant,GRCh38
na,na,2,98354246,98354258,ZAP70,Pathogenic,Combined immunodeficiency due to ZAP70 deficiency|ZAP70-Related Severe Combined Immunodeficiency,Deletion,GRCh37
na,na,2,97737783,97737795,ZAP70,Pathogenic,Combined immunodeficiency due to ZAP70 deficiency|ZAP70-Related Severe Combined Immunodeficiency,Deletion,GRCh38
na,na,2,98354040,98354040,ZAP70,Uncertain significance,Combined immunodeficiency due to ZAP70 deficiency|ZAP70-Related Severe Combined Immunodeficiency,single nucleotide variant,GRCh37
na,na,2,97737577,97737577,ZAP70,Uncertain significance,Combined immunodeficiency due to ZAP70 deficiency|ZAP70-Related Severe Combined Immunodeficiency,single nucleotide variant,GRCh38
na,na,1,16451799,16451799,EPHA2,Pathogenic,Cataract 6 multiple types,single nucleotide variant,GRCh37
na,na,1,16125304,16125304,EPHA2,Pathogenic,Cataract 6 multiple types,single nucleotide variant,GRCh38
na,na,1,16455935,16455935,EPHA2,Pathogenic,Cataract 6 multiple types,single nucleotide variant,GRCh37
na,na,1,16129440,16129440,EPHA2,Pathogenic,Cataract 6 multiple types,single nucleotide variant,GRCh38
na,na,1,16458722,16458722,EPHA2,Conflicting classifications of pathogenicity,"Cataract 6, age-related cortical|Cataract 6 multiple types|not specified|EPHA2-related disorder|Meniere disease",single nucleotide variant,GRCh37
na,na,1,16132227,16132227,EPHA2,Conflicting classifications of pathogenicity,"Cataract 6, age-related cortical|Cataract 6 multiple types|not specified|EPHA2-related disorder|Meniere disease",single nucleotide variant,GRCh38
na,na,10,123276892,123276892,FGFR2,Pathogenic/Likely pathogenic,Crouzon syndrome|Pfeiffer syndrome|FGFR2-related craniosynostosis|11 conditions|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Craniosynostosis syndrome|11 conditions,single nucleotide variant,GRCh37
na,na,10,121517378,121517378,FGFR2,Pathogenic/Likely pathogenic,Crouzon syndrome|Pfeiffer syndrome|FGFR2-related craniosynostosis|11 conditions|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Craniosynostosis syndrome|11 conditions,single nucleotide variant,GRCh38
na,na,10,123276899,123276899,FGFR2,Pathogenic,Crouzon syndrome|not provided|FGFR2-related craniosynostosis,single nucleotide variant,GRCh37
na,na,10,121517385,121517385,FGFR2,Pathogenic,Crouzon syndrome|not provided|FGFR2-related craniosynostosis,single nucleotide variant,GRCh38
na,na,10,123276856,123276856,FGFR2,Pathogenic,Crouzon syndrome|Inborn genetic diseases|FGFR2-related craniosynostosis|See cases|not provided,single nucleotide variant,GRCh37
na,na,10,121517342,121517342,FGFR2,Pathogenic,Crouzon syndrome|Inborn genetic diseases|FGFR2-related craniosynostosis|See cases|not provided,single nucleotide variant,GRCh38
na,na,10,123276893,123276893,FGFR2,Pathogenic,Crouzon syndrome|Jackson-Weiss syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh37
na,na,10,121517379,121517379,FGFR2,Pathogenic,Crouzon syndrome|Jackson-Weiss syndrome|Pfeiffer syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh38
na,na,10,123276893,123276893,FGFR2,Pathogenic,Crouzon syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis,single nucleotide variant,GRCh37
na,na,10,121517379,121517379,FGFR2,Pathogenic,Crouzon syndrome|Jackson-Weiss syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis,single nucleotide variant,GRCh38
na,na,10,123276885,123276885,FGFR2,Pathogenic,"Scaphocephaly and axenfeld-rieger anomaly|Crouzon syndrome|Craniosynostosis, nonclassifiable autosomal dominant|Craniosynostosis syndrome|FGFR2-related craniosynostosis|11 conditions|not provided|FGFR2-related disorder|Acrocephalosyndactyly type I|11 conditions",single nucleotide variant,GRCh37
na,na,10,121517371,121517371,FGFR2,Pathogenic,"Scaphocephaly and axenfeld-rieger anomaly|Crouzon syndrome|Craniosynostosis, nonclassifiable autosomal dominant|Craniosynostosis syndrome|FGFR2-related craniosynostosis|11 conditions|not provided|FGFR2-related disorder|Acrocephalosyndactyly type I|11 conditions",single nucleotide variant,GRCh38
na,na,10,123276886,123276886,FGFR2,Pathogenic,Crouzon syndrome|Jackson-Weiss syndrome|FGFR2-related craniosynostosis|Pfeiffer syndrome|FGFR2-related disorder,single nucleotide variant,GRCh37
na,na,10,121517372,121517372,FGFR2,Pathogenic,Crouzon syndrome|Jackson-Weiss syndrome|FGFR2-related craniosynostosis|Pfeiffer syndrome|FGFR2-related disorder,single nucleotide variant,GRCh38
na,na,10,123276934,123276934,FGFR2,Pathogenic/Likely pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh37
na,na,10,121517420,121517420,FGFR2,Pathogenic/Likely pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh38
na,na,10,123276877,123276877,FGFR2,Pathogenic/Likely pathogenic,Crouzon syndrome|22 conditions|FGFR2-related craniosynostosis|not provided|Pfeiffer syndrome|Meier-Gorlin syndrome 1,single nucleotide variant,GRCh37
na,na,10,121517363,121517363,FGFR2,Pathogenic/Likely pathogenic,Crouzon syndrome|22 conditions|FGFR2-related craniosynostosis|not provided|Pfeiffer syndrome|Meier-Gorlin syndrome 1,single nucleotide variant,GRCh38
na,na,10,123279677,123279677,FGFR2,Pathogenic,Acrocephalosyndactyly type I|Endometrial carcinoma|not provided|FGFR2-related craniosynostosis|11 conditions|Pfeiffer syndrome|11 conditions|FGFR2-related disorder|Neoplasm,single nucleotide variant,GRCh37
na,na,10,121520163,121520163,FGFR2,Pathogenic,Acrocephalosyndactyly type I|Endometrial carcinoma|not provided|FGFR2-related craniosynostosis|11 conditions|Pfeiffer syndrome|11 conditions|FGFR2-related disorder|Neoplasm,single nucleotide variant,GRCh38
na,na,10,123279674,123279674,FGFR2,Pathogenic/Likely pathogenic,Acrocephalosyndactyly type I|FGFR2-related craniosynostosis|11 conditions|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2-related disorder,single nucleotide variant,GRCh37
na,na,10,121520160,121520160,FGFR2,Pathogenic/Likely pathogenic,Acrocephalosyndactyly type I|FGFR2-related craniosynostosis|11 conditions|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2-related disorder,single nucleotide variant,GRCh38
na,na,10,123276896,123276896,FGFR2,Pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh37
na,na,10,121517382,121517382,FGFR2,Pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh38
na,na,10,123276891,123276891,FGFR2,Pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh37
na,na,10,121517377,121517377,FGFR2,Pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh38
na,na,10,123279566,123279566,FGFR2,Pathogenic,Jackson-Weiss syndrome|Crouzon syndrome|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis,single nucleotide variant,GRCh37
na,na,10,121520052,121520052,FGFR2,Pathogenic,Jackson-Weiss syndrome|Crouzon syndrome|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis,single nucleotide variant,GRCh38
na,na,10,123274794,123274794,FGFR2,Pathogenic/Likely pathogenic,Beare-Stevenson cutis gyrata syndrome|Endometrial carcinoma|not provided|FGFR2-related craniosynostosis|11 conditions|FGFR2-related disorder,single nucleotide variant,GRCh37
na,na,10,121515280,121515280,FGFR2,Pathogenic/Likely pathogenic,Beare-Stevenson cutis gyrata syndrome|Endometrial carcinoma|not provided|FGFR2-related craniosynostosis|11 conditions|FGFR2-related disorder,single nucleotide variant,GRCh38
na,na,10,123274803,123274803,FGFR2,Pathogenic,Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis,single nucleotide variant,GRCh37
na,na,10,121515289,121515289,FGFR2,Pathogenic,Beare-Stevenson cutis gyrata syndrome|FGFR2-related craniosynostosis,single nucleotide variant,GRCh38
na,na,10,123279676,123279677,FGFR2,Likely pathogenic,Acrocephalosyndactyly type I,Indel,GRCh37
na,na,10,121520162,121520163,FGFR2,Likely pathogenic,Acrocephalosyndactyly type I,Indel,GRCh38
na,na,10,123279675,123279677,FGFR2,Pathogenic,Pfeiffer syndrome variant,Indel,GRCh37
na,na,10,121520161,121520163,FGFR2,Pathogenic,Pfeiffer syndrome variant,Indel,GRCh38
na,na,10,123279562,123279562,FGFR2,Pathogenic,"Pfeiffer syndrome|Aural atresia, congenital|FGFR2-related disorder|not provided",single nucleotide variant,GRCh37
na,na,10,121520048,121520048,FGFR2,Pathogenic,"Pfeiffer syndrome|Aural atresia, congenital|FGFR2-related disorder|not provided",single nucleotide variant,GRCh38
na,na,10,123279558,123279558,FGFR2,Likely pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis,single nucleotide variant,GRCh37
na,na,10,121520044,121520044,FGFR2,Likely pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis,single nucleotide variant,GRCh38
na,na,10,123279564,123279564,FGFR2,Pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh37
na,na,10,121520050,121520050,FGFR2,Pathogenic,Crouzon syndrome|FGFR2-related craniosynostosis|not provided,single nucleotide variant,GRCh38
na,na,10,123279564,123279564,FGFR2,Pathogenic,Crouzon syndrome|FGFR2-related disorder,single nucleotide variant,GRCh37
na,na,10,121520050,121520050,FGFR2,Pathogenic,Crouzon syndrome|FGFR2-related disorder,single nucleotide variant,GRCh38
na,na,10,123279623,123279628,FGFR2,Pathogenic,Saethre-Chotzen syndrome,Deletion,GRCh37
na,na,10,121520109,121520114,FGFR2,Pathogenic,Saethre-Chotzen syndrome,Deletion,GRCh38
na,na,10,123276865,123276865,FGFR2,Pathogenic,Pfeiffer syndrome type 3|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis|Crouzon syndrome|FGFR2-related disorder,single nucleotide variant,GRCh37
na,na,10,121517351,121517351,FGFR2,Pathogenic,Pfeiffer syndrome type 3|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis|Crouzon syndrome|FGFR2-related disorder,single nucleotide variant,GRCh38
na,na,na,-1,-1,FGFR2,Pathogenic,Acrocephalosyndactyly type I,Insertion,na
na,na,10,123279612,123279614,FGFR2,Pathogenic,Pfeiffer syndrome,Deletion,GRCh37
na,na,10,121520098,121520100,FGFR2,Pathogenic,Pfeiffer syndrome,Deletion,GRCh38
na,na,10,123276974,123276974,FGFR2,Pathogenic,"Craniosynostosis, nonsyndromic unicoronal|Crouzon syndrome|not provided|FGFR2-related craniosynostosis|11 conditions",single nucleotide variant,GRCh37
na,na,10,121517460,121517460,FGFR2,Pathogenic,"Craniosynostosis, nonsyndromic unicoronal|Crouzon syndrome|not provided|FGFR2-related craniosynostosis|11 conditions",single nucleotide variant,GRCh38
na,na,10,123279633,123279633,FGFR2,Pathogenic,Pfeiffer syndrome|Crouzon syndrome|not provided|FGFR2-related craniosynostosis|Gastric cancer,single nucleotide variant,GRCh37
na,na,10,121520119,121520119,FGFR2,Pathogenic,Pfeiffer syndrome|Crouzon syndrome|not provided|FGFR2-related craniosynostosis|Gastric cancer,single nucleotide variant,GRCh38
na,na,10,123276978,123276978,FGFR2,Pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis,single nucleotide variant,GRCh37
na,na,10,121517464,121517464,FGFR2,Pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis,single nucleotide variant,GRCh38
na,na,10,123276971,123276980,FGFR2,Pathogenic,Pfeiffer syndrome,Indel,GRCh37
na,na,10,121517457,121517466,FGFR2,Pathogenic,Pfeiffer syndrome,Indel,GRCh38
na,na,10,123279562,123279562,FGFR2,Pathogenic,Pfeiffer syndrome|Craniofacial-skeletal-dermatologic dysplasia|FGFR2-related craniosynostosis|not provided|11 conditions,single nucleotide variant,GRCh37
na,na,10,121520048,121520048,FGFR2,Pathogenic,Pfeiffer syndrome|Craniofacial-skeletal-dermatologic dysplasia|FGFR2-related craniosynostosis|not provided|11 conditions,single nucleotide variant,GRCh38
na,na,10,123256215,123256215,FGFR2,Pathogenic/Likely pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis|not provided|FGFR2-related disorder,single nucleotide variant,GRCh37
na,na,10,121496701,121496701,FGFR2,Pathogenic/Likely pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis|not provided|FGFR2-related disorder,single nucleotide variant,GRCh38
na,na,10,123258105,123258105,FGFR2,Pathogenic/Likely pathogenic,"Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis",single nucleotide variant,GRCh37
na,na,10,121498591,121498591,FGFR2,Pathogenic/Likely pathogenic,"Crouzon syndrome|Familial scaphocephaly syndrome, McGillivray type|Pfeiffer syndrome|not provided|FGFR2-related craniosynostosis",single nucleotide variant,GRCh38
na,na,10,123247549,123247549,FGFR2,Pathogenic,"Levy-Hollister syndrome|not provided|FGFR2-related craniosynostosis|Familial scaphocephaly syndrome, McGillivray type",single nucleotide variant,GRCh37
na,na,10,121488035,121488035,FGFR2,Pathogenic,"Levy-Hollister syndrome|not provided|FGFR2-related craniosynostosis|Familial scaphocephaly syndrome, McGillivray type",single nucleotide variant,GRCh38
na,na,10,123247542,123247544,FGFR2,Pathogenic,Levy-Hollister syndrome,Deletion,GRCh37
na,na,10,121488028,121488030,FGFR2,Pathogenic,Levy-Hollister syndrome,Deletion,GRCh38
na,na,10,123247609,123247609,FGFR2,Pathogenic,Levy-Hollister syndrome|not provided,single nucleotide variant,GRCh37
na,na,10,121488095,121488095,FGFR2,Pathogenic,Levy-Hollister syndrome|not provided,single nucleotide variant,GRCh38
na,na,10,123276830,123276830,FGFR2,Pathogenic,Pfeiffer syndrome|Crouzon syndrome|FGFR2-related craniosynostosis|not provided|Pfeiffer syndrome;Crouzon syndrome;Acrocephalosyndactyly type I,single nucleotide variant,GRCh37
na,na,10,121517316,121517316,FGFR2,Pathogenic,Pfeiffer syndrome|Crouzon syndrome|FGFR2-related craniosynostosis|not provided|Pfeiffer syndrome;Crouzon syndrome;Acrocephalosyndactyly type I,single nucleotide variant,GRCh38
na,na,10,123276955,123276955,FGFR2,Pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis,single nucleotide variant,GRCh37
na,na,10,121517441,121517441,FGFR2,Pathogenic,Pfeiffer syndrome|FGFR2-related craniosynostosis,single nucleotide variant,GRCh38
na,na,11,46747447,46747447,F2,Conflicting classifications of pathogenicity; risk factor,"PROTHROMBIN TYPE 3|not provided|Congenital prothrombin deficiency|Cerebral palsy|Congenital prothrombin deficiency;Pregnancy loss, recurrent, susceptibility to, 2;Ischemic stroke;Thrombophilia due to thrombin defect|not specified|Thrombophilia due to thrombin defect",single nucleotide variant,GRCh37
na,na,11,46725897,46725897,F2,Conflicting classifications of pathogenicity; risk factor,"PROTHROMBIN TYPE 3|not provided|Congenital prothrombin deficiency|Cerebral palsy|Congenital prothrombin deficiency;Pregnancy loss, recurrent, susceptibility to, 2;Ischemic stroke;Thrombophilia due to thrombin defect|not specified|Thrombophilia due to thrombin defect",single nucleotide variant,GRCh38
na,na,11,46748113,46748113,F2,Pathogenic,Congenital prothrombin deficiency|Thrombophilia due to thrombin defect,single nucleotide variant,GRCh37
na,na,11,46726563,46726563,F2,Pathogenic,Congenital prothrombin deficiency|Thrombophilia due to thrombin defect,single nucleotide variant,GRCh38
na,na,11,46750296,46750296,F2,Pathogenic/Likely pathogenic,not provided|Congenital prothrombin deficiency,single nucleotide variant,GRCh37
na,na,11,46728746,46728746,F2,Pathogenic/Likely pathogenic,not provided|Congenital prothrombin deficiency,single nucleotide variant,GRCh38
na,na,11,46749688,46749688,F2,Likely pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh37
na,na,11,46728138,46728138,F2,Likely pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh38
na,na,11,46760891,46760891,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh37
na,na,11,46739341,46739341,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh38
na,na,11,46749554,46749554,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh37
na,na,11,46728004,46728004,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh38
na,na,11,46749707,46749707,F2,Pathogenic,DYSPROTHROMBINEMIA PROTHROMBIN HIMI-II,single nucleotide variant,GRCh37
na,na,11,46728157,46728157,F2,Pathogenic,DYSPROTHROMBINEMIA PROTHROMBIN HIMI-II,single nucleotide variant,GRCh38
na,na,11,46744971,46744972,F2,Pathogenic,Congenital prothrombin deficiency,Insertion,GRCh37
na,na,11,46723421,46723422,F2,Pathogenic,Congenital prothrombin deficiency,Insertion,GRCh38
na,na,11,46761055,46761055,F2,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance; risk factor","Ischemic stroke|Pregnancy loss, recurrent, susceptibility to, 2|Congenital prothrombin deficiency|Venous thromboembolism|not provided|Cerebral palsy|Thrombophilia caused by F2 prothrombin deficiency|Congenital prothrombin deficiency;Pregnancy loss, recurrent, susceptibility to, 2;Ischemic stroke;Thrombophilia due to thrombin defect|Thrombophilia due to thrombin defect",single nucleotide variant,GRCh37
na,na,11,46739505,46739505,F2,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance; risk factor","Ischemic stroke|Pregnancy loss, recurrent, susceptibility to, 2|Congenital prothrombin deficiency|Venous thromboembolism|not provided|Cerebral palsy|Thrombophilia caused by F2 prothrombin deficiency|Congenital prothrombin deficiency;Pregnancy loss, recurrent, susceptibility to, 2;Ischemic stroke;Thrombophilia due to thrombin defect|Thrombophilia due to thrombin defect",single nucleotide variant,GRCh38
na,na,11,46748284,46748284,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh37
na,na,11,46726734,46726734,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh38
na,na,11,46748311,46748311,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh37
na,na,11,46726761,46726761,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh38
na,na,11,46749689,46749689,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh37
na,na,11,46728139,46728139,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh38
na,na,11,46760874,46760874,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh37
na,na,11,46739324,46739324,F2,Pathogenic,Congenital prothrombin deficiency,single nucleotide variant,GRCh38
na,na,20,49199355,49199356,PTPN1,risk factor,"Insulin resistance, susceptibility to",Duplication,GRCh37
na,na,20,50582818,50582819,PTPN1,risk factor,"Insulin resistance, susceptibility to",Duplication,GRCh38
na,na,3,93598150,93598150,PROS1,Conflicting classifications of pathogenicity,"Protein S Heerlen|Thrombophilia due to protein S deficiency, autosomal recessive|not specified|not provided|Thrombophilia due to protein S deficiency, autosomal dominant|Hereditary thrombophilia due to congenital protein S deficiency|Retinal dystrophy|Optic atrophy",single nucleotide variant,GRCh37
na,na,3,93879306,93879306,PROS1,Conflicting classifications of pathogenicity,"Protein S Heerlen|Thrombophilia due to protein S deficiency, autosomal recessive|not specified|not provided|Thrombophilia due to protein S deficiency, autosomal dominant|Hereditary thrombophilia due to congenital protein S deficiency|Retinal dystrophy|Optic atrophy",single nucleotide variant,GRCh38
na,na,3,93617368,93617368,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,93898524,93898524,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,93624643,93624643,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant|Thrombophilia due to protein S deficiency, autosomal recessive|PROS1-related disorder",single nucleotide variant,GRCh37
na,na,3,93905799,93905799,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant|Thrombophilia due to protein S deficiency, autosomal recessive|PROS1-related disorder",single nucleotide variant,GRCh38
na,na,na,-1,-1,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",single nucleotide variant,na
na,na,3,93593089,93593089,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,93874245,93874245,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,93603749,93603749,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",single nucleotide variant,GRCh37
na,na,3,93884905,93884905,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant",single nucleotide variant,GRCh38
na,na,3,93617306,93617306,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant|Thrombophilia due to protein S deficiency, autosomal recessive",single nucleotide variant,GRCh37
na,na,3,93898462,93898462,PROS1,Pathogenic,"Thrombophilia due to protein S deficiency, autosomal dominant|Thrombophilia due to protein S deficiency, autosomal recessive",single nucleotide variant,GRCh38
na,na,3,93595999,93595999,PROS1,Uncertain significance,"Thrombophilia due to protein S deficiency, autosomal dominant|Protein S deficiency disease",single nucleotide variant,GRCh37
na,na,3,93877155,93877155,PROS1,Uncertain significance,"Thrombophilia due to protein S deficiency, autosomal dominant|Protein S deficiency disease",single nucleotide variant,GRCh38
na,na,12,112888198,112888198,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|Noonan syndrome|not provided|LEOPARD syndrome 1;Noonan syndrome 1|Noonan syndrome and Noonan-related syndrome|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,12,112450394,112450394,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|Noonan syndrome|not provided|LEOPARD syndrome 1;Noonan syndrome 1|Noonan syndrome and Noonan-related syndrome|LEOPARD syndrome 1;Metachondromatosis;Noonan syndrome 1;Juvenile myelomonocytic leukemia|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,12,112888199,112888199,PTPN11,Pathogenic/Likely pathogenic,Noonan syndrome 1|Noonan syndrome|not provided|LEOPARD syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;Noonan syndrome 1|RASopathy|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,12,112450395,112450395,PTPN11,Pathogenic/Likely pathogenic,Noonan syndrome 1|Noonan syndrome|not provided|LEOPARD syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;Noonan syndrome 1|RASopathy|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,12,112915523,112915523,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|not provided|Noonan syndrome|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome 1;LEOPARD syndrome 1|Cardiovascular phenotype|Thrombocytopenia;Abnormal bleeding|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1|LEOPARD syndrome 1|Hereditary cancer-predisposing syndrome|Noonan syndrome and Noonan-related syndrome|Metachondromatosis|PTPN11-related disorder|Male infertility with azoospermia or oligozoospermia due to single gene mutation,single nucleotide variant,GRCh37
na,na,12,112477719,112477719,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|not provided|Noonan syndrome|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome 1;LEOPARD syndrome 1|Cardiovascular phenotype|Thrombocytopenia;Abnormal bleeding|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1|LEOPARD syndrome 1|Hereditary cancer-predisposing syndrome|Noonan syndrome and Noonan-related syndrome|Metachondromatosis|PTPN11-related disorder|Male infertility with azoospermia or oligozoospermia due to single gene mutation,single nucleotide variant,GRCh38
na,na,12,112915524,112915524,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|Noonan syndrome|not provided|Noonan syndrome 3|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1;LEOPARD syndrome 1|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder|Cardiovascular phenotype|Neoplasm,single nucleotide variant,GRCh37
na,na,12,112477720,112477720,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|Noonan syndrome|not provided|Noonan syndrome 3|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1;LEOPARD syndrome 1|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder|Cardiovascular phenotype|Neoplasm,single nucleotide variant,GRCh38
na,na,12,112910827,112910827,PTPN11,Pathogenic/Likely pathogenic,RASopathy|LEOPARD syndrome 1|Noonan syndrome with multiple lentigines|not provided|Noonan syndrome 1|CBL-related disorder|not specified|Cardiovascular phenotype|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome;Noonan syndrome with multiple lentigines|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder,single nucleotide variant,GRCh37
na,na,12,112473023,112473023,PTPN11,Pathogenic/Likely pathogenic,RASopathy|LEOPARD syndrome 1|Noonan syndrome with multiple lentigines|not provided|Noonan syndrome 1|CBL-related disorder|not specified|Cardiovascular phenotype|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome;Noonan syndrome with multiple lentigines|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder,single nucleotide variant,GRCh38
na,na,12,112888168,112888168,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|not provided|Noonan syndrome|6 conditions|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome;Juvenile myelomonocytic leukemia|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|PTPN11-related disorder,single nucleotide variant,GRCh37
na,na,12,112450364,112450364,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|not provided|Noonan syndrome|6 conditions|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome;Juvenile myelomonocytic leukemia|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|PTPN11-related disorder,single nucleotide variant,GRCh38
na,na,12,112888166,112888166,PTPN11,Pathogenic,Noonan syndrome 1|not provided|RASopathy|Abnormal cardiovascular system morphology;Short stature|Noonan syndrome;Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|Metachondromatosis|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|PTPN11-related disorder,single nucleotide variant,GRCh37
na,na,12,112450362,112450362,PTPN11,Pathogenic,Noonan syndrome 1|not provided|RASopathy|Abnormal cardiovascular system morphology;Short stature|Noonan syndrome;Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|Metachondromatosis|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|PTPN11-related disorder,single nucleotide variant,GRCh38
na,na,12,112926270,112926270,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|LEOPARD syndrome 1|Noonan syndrome|not provided|Noonan syndrome with multiple lentigines|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|PTPN11-related disorder|Hypertrophic cardiomyopathy|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,12,112488466,112488466,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|LEOPARD syndrome 1|Noonan syndrome|not provided|Noonan syndrome with multiple lentigines|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|PTPN11-related disorder|Hypertrophic cardiomyopathy|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,12,112926884,112926884,PTPN11,Pathogenic,Noonan syndrome 1|Juvenile myelomonocytic leukemia;Noonan syndrome|Noonan syndrome|not provided|RASopathy|Noonan syndrome 1;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1;Metachondromatosis|PTPN11-related disorder|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,12,112489080,112489080,PTPN11,Pathogenic,Noonan syndrome 1|Juvenile myelomonocytic leukemia;Noonan syndrome|Noonan syndrome|not provided|RASopathy|Noonan syndrome 1;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1;Metachondromatosis|PTPN11-related disorder|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,12,112888172,112888172,PTPN11,Pathogenic,"Noonan syndrome 1|RASopathy|not provided|Noonan syndrome|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome 3|B lymphoblastic leukemia lymphoma, no ICD-O subtype;Lymphoma|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1|Noonan syndrome and Noonan-related syndrome|Metachondromatosis|LEOPARD syndrome 1|PTPN11-related disorder|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,12,112450368,112450368,PTPN11,Pathogenic,"Noonan syndrome 1|RASopathy|not provided|Noonan syndrome|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1;Juvenile myelomonocytic leukemia|Noonan syndrome 3|B lymphoblastic leukemia lymphoma, no ICD-O subtype;Lymphoma|Noonan syndrome 1;Metachondromatosis;LEOPARD syndrome 1|Noonan syndrome and Noonan-related syndrome|Metachondromatosis|LEOPARD syndrome 1|PTPN11-related disorder|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,12,112888202,112888202,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|Noonan syndrome|not provided|LEOPARD syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;Noonan syndrome 1|Noonan syndrome and Noonan-related syndrome|Metachondromatosis|Cardiovascular phenotype|LEOPARD syndrome 1,single nucleotide variant,GRCh37
na,na,12,112450398,112450398,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy|Noonan syndrome|not provided|LEOPARD syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;Noonan syndrome 1|Noonan syndrome and Noonan-related syndrome|Metachondromatosis|Cardiovascular phenotype|LEOPARD syndrome 1,single nucleotide variant,GRCh38
na,na,12,112915455,112915455,PTPN11,Pathogenic,Noonan syndrome 1|not provided|Noonan syndrome|Early T cell progenitor acute lymphoblastic leukemia|RASopathy|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder|LEOPARD syndrome 1|Metachondromatosis,single nucleotide variant,GRCh37
na,na,12,112477651,112477651,PTPN11,Pathogenic,Noonan syndrome 1|not provided|Noonan syndrome|Early T cell progenitor acute lymphoblastic leukemia|RASopathy|Non-immune hydrops fetalis|Noonan syndrome and Noonan-related syndrome|PTPN11-related disorder|LEOPARD syndrome 1|Metachondromatosis,single nucleotide variant,GRCh38
na,na,12,112888210,112888210,PTPN11,Conflicting classifications of pathogenicity,Juvenile myelomonocytic leukemia|RASopathy|Noonan syndrome|not provided|Malignant neoplastic disease|Neoplasm|Noonan syndrome 1|PTPN11-related disorder,single nucleotide variant,GRCh37
na,na,12,112450406,112450406,PTPN11,Conflicting classifications of pathogenicity,Juvenile myelomonocytic leukemia|RASopathy|Noonan syndrome|not provided|Malignant neoplastic disease|Neoplasm|Noonan syndrome 1|PTPN11-related disorder,single nucleotide variant,GRCh38
na,na,12,112888211,112888211,PTPN11,Pathogenic,Juvenile myelomonocytic leukemia|RASopathy|not provided|Noonan syndrome and Noonan-related syndrome,single nucleotide variant,GRCh37
na,na,12,112450407,112450407,PTPN11,Pathogenic,Juvenile myelomonocytic leukemia|RASopathy|not provided|Noonan syndrome and Noonan-related syndrome,single nucleotide variant,GRCh38
na,na,12,112888211,112888211,PTPN11,Conflicting classifications of pathogenicity,Juvenile myelomonocytic leukemia|not provided|RASopathy,single nucleotide variant,GRCh37
na,na,12,112450407,112450407,PTPN11,Conflicting classifications of pathogenicity,Juvenile myelomonocytic leukemia|not provided|RASopathy,single nucleotide variant,GRCh38
na,na,12,112888211,112888211,PTPN11,Pathogenic,Juvenile myelomonocytic leukemia|not provided,single nucleotide variant,GRCh37
na,na,12,112450407,112450407,PTPN11,Pathogenic,Juvenile myelomonocytic leukemia|not provided,single nucleotide variant,GRCh38
na,na,12,112888220,112888220,PTPN11,Pathogenic,Noonan syndrome 1|Noonan syndrome|RASopathy|Noonan syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1|not provided|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 3|PTPN11-related disorder|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,12,112450416,112450416,PTPN11,Pathogenic,Noonan syndrome 1|Noonan syndrome|RASopathy|Noonan syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1|not provided|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 3|PTPN11-related disorder|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,12,112924286,112924286,PTPN11,Uncertain significance,Noonan syndrome 1|RASopathy|not provided|Acute megakaryoblastic leukemia in down syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,12,112486482,112486482,PTPN11,Uncertain significance,Noonan syndrome 1|RASopathy|not provided|Acute megakaryoblastic leukemia in down syndrome|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,12,112926248,112926248,PTPN11,Pathogenic,Noonan syndrome with multiple lentigines|not provided|LEOPARD syndrome 1|RASopathy|Noonan syndrome 1|not specified|PTPN11-related disorder,single nucleotide variant,GRCh37
na,na,12,112488444,112488444,PTPN11,Pathogenic,Noonan syndrome with multiple lentigines|not provided|LEOPARD syndrome 1|RASopathy|Noonan syndrome 1|not specified|PTPN11-related disorder,single nucleotide variant,GRCh38
na,na,12,112926258,112926258,PTPN11,Pathogenic,RASopathy|LEOPARD syndrome 1|not provided|Noonan syndrome;Noonan syndrome with multiple lentigines|Noonan syndrome 1|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|PTPN11-related disorder,single nucleotide variant,GRCh37
na,na,12,112488454,112488454,PTPN11,Pathogenic,RASopathy|LEOPARD syndrome 1|not provided|Noonan syndrome;Noonan syndrome with multiple lentigines|Noonan syndrome 1|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|PTPN11-related disorder,single nucleotide variant,GRCh38
na,na,12,112926909,112926909,PTPN11,Pathogenic,LEOPARD syndrome 1|RASopathy|not provided|Noonan syndrome;Noonan syndrome with multiple lentigines|Noonan syndrome with multiple lentigines|Noonan syndrome 3|Noonan syndrome 1|Noonan syndrome 1;LEOPARD syndrome 1|PTPN11-related disorder,single nucleotide variant,GRCh37
na,na,12,112489105,112489105,PTPN11,Pathogenic,LEOPARD syndrome 1|RASopathy|not provided|Noonan syndrome;Noonan syndrome with multiple lentigines|Noonan syndrome with multiple lentigines|Noonan syndrome 3|Noonan syndrome 1|Noonan syndrome 1;LEOPARD syndrome 1|PTPN11-related disorder,single nucleotide variant,GRCh38
na,na,12,112926909,112926909,PTPN11,Pathogenic/Likely pathogenic,Noonan syndrome 1|not provided|RASopathy|LEOPARD syndrome 1|Cardiovascular phenotype|PTPN11-related disorder,single nucleotide variant,GRCh37
na,na,12,112489105,112489105,PTPN11,Pathogenic/Likely pathogenic,Noonan syndrome 1|not provided|RASopathy|LEOPARD syndrome 1|Cardiovascular phenotype|PTPN11-related disorder,single nucleotide variant,GRCh38
na,na,12,112888161,112888163,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy,Deletion,GRCh37
na,na,12,112450357,112450359,PTPN11,Pathogenic,Noonan syndrome 1|RASopathy,Deletion,GRCh38
na,na,12,112891180,112891190,PTPN11,Pathogenic,Metachondromatosis,Deletion,GRCh37
na,na,12,112453376,112453386,PTPN11,Pathogenic,Metachondromatosis,Deletion,GRCh38
na,na,12,112891078,112891078,PTPN11,Pathogenic,Metachondromatosis|RASopathy,single nucleotide variant,GRCh37
na,na,12,112453274,112453274,PTPN11,Pathogenic,Metachondromatosis|RASopathy,single nucleotide variant,GRCh38
na,na,12,112856920,112856920,PTPN11,Pathogenic/Likely pathogenic,Noonan syndrome 1|Noonan syndrome|not provided|Metachondromatosis|Noonan syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1|RASopathy|LEOPARD syndrome 1|See cases,single nucleotide variant,GRCh37
na,na,12,112419116,112419116,PTPN11,Pathogenic/Likely pathogenic,Noonan syndrome 1|Noonan syndrome|not provided|Metachondromatosis|Noonan syndrome 1;Metachondromatosis;Juvenile myelomonocytic leukemia;LEOPARD syndrome 1|RASopathy|LEOPARD syndrome 1|See cases,single nucleotide variant,GRCh38
na,na,15,66727442,66727442,MAP2K1,Likely pathogenic,Cardiofaciocutaneous syndrome 3|not provided|Cardio-facio-cutaneous syndrome|RASopathy,single nucleotide variant,GRCh37
na,na,15,66435104,66435104,MAP2K1,Likely pathogenic,Cardiofaciocutaneous syndrome 3|not provided|Cardio-facio-cutaneous syndrome|RASopathy,single nucleotide variant,GRCh38
na,na,15,66729181,66729181,MAP2K1,Pathogenic,Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome|not provided|Cardiofaciocutaneous syndrome 3;Noonan syndrome 1|RASopathy|Melorheostosis|MAP2K1-related disorder|Noonan syndrome 1|Cardiovascular phenotype|Neoplasm,single nucleotide variant,GRCh37
na,na,15,66436843,66436843,MAP2K1,Pathogenic,Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome|not provided|Cardiofaciocutaneous syndrome 3;Noonan syndrome 1|RASopathy|Melorheostosis|MAP2K1-related disorder|Noonan syndrome 1|Cardiovascular phenotype|Neoplasm,single nucleotide variant,GRCh38
na,na,15,66729175,66729175,MAP2K1,Pathogenic/Likely pathogenic,Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome|not provided|RASopathy,single nucleotide variant,GRCh37
na,na,15,66436837,66436837,MAP2K1,Pathogenic/Likely pathogenic,Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome|not provided|RASopathy,single nucleotide variant,GRCh38
na,na,2,25384441,25384441,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,single nucleotide variant,GRCh37
na,na,2,25161572,25161572,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,single nucleotide variant,GRCh38
na,na,2,25384321,25384321,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,Deletion,GRCh37
na,na,2,25161452,25161452,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,Deletion,GRCh38
na,na,2,25387652,25387652,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency|Obesity;Obesity due to pro-opiomelanocortin deficiency|not provided,single nucleotide variant,GRCh37
na,na,2,25164783,25164783,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency|Obesity;Obesity due to pro-opiomelanocortin deficiency|not provided,single nucleotide variant,GRCh38
na,na,2,25384048,25384048,POMC,Conflicting classifications of pathogenicity,"Obesity, early-onset, susceptibility to|not provided|Obesity due to pro-opiomelanocortin deficiency|Obesity due to pro-opiomelanocortin deficiency;Inherited obesity|POMC-related disorder",single nucleotide variant,GRCh37
na,na,2,25161179,25161179,POMC,Conflicting classifications of pathogenicity,"Obesity, early-onset, susceptibility to|not provided|Obesity due to pro-opiomelanocortin deficiency|Obesity due to pro-opiomelanocortin deficiency;Inherited obesity|POMC-related disorder",single nucleotide variant,GRCh38
na,na,2,25384349,25384350,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,Duplication,GRCh37
na,na,2,25161480,25161481,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,Duplication,GRCh38
na,na,2,25384603,25384603,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,single nucleotide variant,GRCh37
na,na,2,25161734,25161734,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,single nucleotide variant,GRCh38
na,na,na,-1,-1,POMC,Pathogenic,Obesity due to pro-opiomelanocortin deficiency,Deletion,na
na,na,14,52767341,52767341,PTGER2,risk factor,"Asthma, aspirin-induced, susceptibility to",single nucleotide variant,GRCh37
na,na,14,52300623,52300623,PTGER2,risk factor,"Asthma, aspirin-induced, susceptibility to",single nucleotide variant,GRCh38
na,na,10,73587841,73587841,PSAP,Pathogenic/Likely pathogenic,"Sphingolipid activator protein 1 deficiency|Inborn genetic diseases|not provided|Combined PSAP deficiency;Gaucher disease due to saposin C deficiency;Krabbe disease due to saposin A deficiency;Sphingolipid activator protein 1 deficiency;Parkinson disease 24, autosomal dominant, susceptibility to",single nucleotide variant,GRCh37
na,na,10,71828084,71828084,PSAP,Pathogenic/Likely pathogenic,"Sphingolipid activator protein 1 deficiency|Inborn genetic diseases|not provided|Combined PSAP deficiency;Gaucher disease due to saposin C deficiency;Krabbe disease due to saposin A deficiency;Sphingolipid activator protein 1 deficiency;Parkinson disease 24, autosomal dominant, susceptibility to",single nucleotide variant,GRCh38
na,na,10,73583679,73583679,PSAP,Likely pathogenic,Sphingolipid activator protein 1 deficiency|Metachromatic leukodystrophy,single nucleotide variant,GRCh37
na,na,10,71823922,71823922,PSAP,Likely pathogenic,Sphingolipid activator protein 1 deficiency|Metachromatic leukodystrophy,single nucleotide variant,GRCh38
na,na,10,73585649,73585649,PSAP,Pathogenic/Likely pathogenic,"Sphingolipid activator protein 1 deficiency|Combined PSAP deficiency|Parkinson disease 24, autosomal dominant, susceptibility to",single nucleotide variant,GRCh37
na,na,10,71825892,71825892,PSAP,Pathogenic/Likely pathogenic,"Sphingolipid activator protein 1 deficiency|Combined PSAP deficiency|Parkinson disease 24, autosomal dominant, susceptibility to",single nucleotide variant,GRCh38
na,na,10,73579518,73579518,PSAP,Pathogenic,Gaucher disease due to saposin C deficiency,single nucleotide variant,GRCh37
na,na,10,71819761,71819761,PSAP,Pathogenic,Gaucher disease due to saposin C deficiency,single nucleotide variant,GRCh38
na,na,10,73610978,73610978,PSAP,Pathogenic,Combined PSAP deficiency|Gaucher disease due to saposin C deficiency|Sphingolipid activator protein 1 deficiency,single nucleotide variant,GRCh37
na,na,10,71851221,71851221,PSAP,Pathogenic,Combined PSAP deficiency|Gaucher disease due to saposin C deficiency|Sphingolipid activator protein 1 deficiency,single nucleotide variant,GRCh38
na,na,10,73587915,73587915,PSAP,Pathogenic,"Sphingolipid activator protein 1 deficiency|Parkinson disease 24, autosomal dominant, susceptibility to",single nucleotide variant,GRCh37
na,na,10,71828158,71828158,PSAP,Pathogenic,"Sphingolipid activator protein 1 deficiency|Parkinson disease 24, autosomal dominant, susceptibility to",single nucleotide variant,GRCh38
na,na,10,73587848,73587848,PSAP,Pathogenic/Likely pathogenic,Sphingolipid activator protein 1 deficiency|Metachromatic leukodystrophy|PSAP-related disorder,single nucleotide variant,GRCh37
na,na,10,71828091,71828091,PSAP,Pathogenic/Likely pathogenic,Sphingolipid activator protein 1 deficiency|Metachromatic leukodystrophy|PSAP-related disorder,single nucleotide variant,GRCh38
na,na,10,73581748,73581748,PSAP,Pathogenic,Combined PSAP deficiency,Deletion,GRCh37
na,na,10,71821991,71821991,PSAP,Pathogenic,Combined PSAP deficiency,Deletion,GRCh38
na,na,10,73591643,73591645,PSAP,Uncertain significance,Krabbe disease due to saposin A deficiency|Sphingolipid activator protein 1 deficiency,Deletion,GRCh37
na,na,10,71831886,71831888,PSAP,Uncertain significance,Krabbe disease due to saposin A deficiency|Sphingolipid activator protein 1 deficiency,Deletion,GRCh38
na,na,10,73579519,73579519,PSAP,Pathogenic,Gaucher disease due to saposin C deficiency,single nucleotide variant,GRCh37
na,na,10,71819762,71819762,PSAP,Pathogenic,Gaucher disease due to saposin C deficiency,single nucleotide variant,GRCh38
na,na,10,73579284,73579284,PSAP,Pathogenic,Gaucher disease due to saposin C deficiency,single nucleotide variant,GRCh37
na,na,10,71819527,71819527,PSAP,Pathogenic,Gaucher disease due to saposin C deficiency,single nucleotide variant,GRCh38
na,na,10,73579617,73579617,PSAP,Likely pathogenic,Gaucher disease due to saposin C deficiency|Metachromatic leukodystrophy,single nucleotide variant,GRCh37
na,na,10,71819860,71819860,PSAP,Likely pathogenic,Gaucher disease due to saposin C deficiency|Metachromatic leukodystrophy,single nucleotide variant,GRCh38
na,na,10,73579659,73579659,PSAP,Likely pathogenic,Combined PSAP deficiency|Sphingolipid activator protein 1 deficiency,single nucleotide variant,GRCh37
na,na,10,71819902,71819902,PSAP,Likely pathogenic,Combined PSAP deficiency|Sphingolipid activator protein 1 deficiency,single nucleotide variant,GRCh38
na,na,10,73587916,73587916,PSAP,Pathogenic,Sphingolipid activator protein 1 deficiency,single nucleotide variant,GRCh37
na,na,10,71828159,71828159,PSAP,Pathogenic,Sphingolipid activator protein 1 deficiency,single nucleotide variant,GRCh38
na,na,10,73581713,73581714,PSAP,Pathogenic/Likely pathogenic,"Sphingolipid activator protein 1 deficiency|not provided|Sphingolipid activator protein 1 deficiency;Krabbe disease due to saposin A deficiency;Gaucher disease due to saposin C deficiency;Combined PSAP deficiency;Parkinson disease 24, autosomal dominant, susceptibility to",Microsatellite,GRCh37
na,na,10,71821956,71821957,PSAP,Pathogenic/Likely pathogenic,"Sphingolipid activator protein 1 deficiency|not provided|Sphingolipid activator protein 1 deficiency;Krabbe disease due to saposin A deficiency;Gaucher disease due to saposin C deficiency;Combined PSAP deficiency;Parkinson disease 24, autosomal dominant, susceptibility to",Microsatellite,GRCh38
na,na,11,114121104,114121104,ZBTB16,Uncertain significance,"Skeletal defects, genital hypoplasia, and intellectual disability",single nucleotide variant,GRCh37
na,na,11,114250382,114250382,ZBTB16,Uncertain significance,"Skeletal defects, genital hypoplasia, and intellectual disability",single nucleotide variant,GRCh38
na,na,11,2182055,2182055,INS,Pathogenic,Hyperproinsulinemia,single nucleotide variant,GRCh37
na,na,11,2160825,2160825,INS,Pathogenic,Hyperproinsulinemia,single nucleotide variant,GRCh38
na,na,11,2182059,2182059,INS,Pathogenic,Hyperproinsulinemia,single nucleotide variant,GRCh37
na,na,11,2160829,2160829,INS,Pathogenic,Hyperproinsulinemia,single nucleotide variant,GRCh38
na,na,11,2182102,2182102,INS,Uncertain significance,Hyperproinsulinemia,single nucleotide variant,GRCh37
na,na,11,2160872,2160872,INS,Uncertain significance,Hyperproinsulinemia,single nucleotide variant,GRCh38
na,na,11,2181149,2181149,INS,Pathogenic/Likely pathogenic,"Hyperproinsulinemia|not provided|INS-related disorder|Maturity-onset diabetes of the young type 10;Hyperproinsulinemia;Diabetes mellitus, permanent neonatal 4;Type 1 diabetes mellitus 2",single nucleotide variant,GRCh37
na,na,11,2159919,2159919,INS,Pathogenic/Likely pathogenic,"Hyperproinsulinemia|not provided|INS-related disorder|Maturity-onset diabetes of the young type 10;Hyperproinsulinemia;Diabetes mellitus, permanent neonatal 4;Type 1 diabetes mellitus 2",single nucleotide variant,GRCh38
na,na,11,2181141,2181141,INS,Uncertain significance,"Hyperproinsulinemia|Diabetes mellitus, permanent neonatal 4",single nucleotide variant,GRCh37
na,na,11,2159911,2159911,INS,Uncertain significance,"Hyperproinsulinemia|Diabetes mellitus, permanent neonatal 4",single nucleotide variant,GRCh38
na,na,11,2181149,2181149,INS,Pathogenic,Hyperproinsulinemia,single nucleotide variant,GRCh37
na,na,11,2159919,2159919,INS,Pathogenic,Hyperproinsulinemia,single nucleotide variant,GRCh38
na,na,11,2181149,2181149,INS,Pathogenic,Hyperproinsulinemia,single nucleotide variant,GRCh37
na,na,11,2159919,2159919,INS,Pathogenic,Hyperproinsulinemia,single nucleotide variant,GRCh38
na,na,11,2181128,2181128,INS,Conflicting classifications of pathogenicity,"Permanent neonatal diabetes mellitus|not provided|Diabetes mellitus, permanent neonatal 4|Neonatal diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,2159898,2159898,INS,Conflicting classifications of pathogenicity,"Permanent neonatal diabetes mellitus|not provided|Diabetes mellitus, permanent neonatal 4|Neonatal diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,2182131,2182131,INS,Pathogenic/Likely risk allele,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 4|not provided",single nucleotide variant,GRCh37
na,na,11,2160901,2160901,INS,Pathogenic/Likely risk allele,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 4|not provided",single nucleotide variant,GRCh38
na,na,11,2182059,2182059,INS,Likely pathogenic/Likely risk allele,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 4|Neonatal diabetes mellitus",single nucleotide variant,GRCh37
na,na,11,2160829,2160829,INS,Likely pathogenic/Likely risk allele,"Permanent neonatal diabetes mellitus|Diabetes mellitus, permanent neonatal 4|Neonatal diabetes mellitus",single nucleotide variant,GRCh38
na,na,11,2182186,2182186,INS,Likely risk allele,Maturity-onset diabetes of the young type 10,single nucleotide variant,GRCh37
na,na,11,2160956,2160956,INS,Likely risk allele,Maturity-onset diabetes of the young type 10,single nucleotide variant,GRCh38
na,na,11,2182065,2182065,INS,Conflicting classifications of pathogenicity,"Maturity-onset diabetes of the young type 10|not provided|Diabetes mellitus, permanent neonatal 4",single nucleotide variant,GRCh37
na,na,11,2160835,2160835,INS,Conflicting classifications of pathogenicity,"Maturity-onset diabetes of the young type 10|not provided|Diabetes mellitus, permanent neonatal 4",single nucleotide variant,GRCh38
na,na,11,2182039,2182039,INS,Pathogenic/Likely pathogenic/Likely risk allele,Type 1 diabetes mellitus 2|not provided|Diabetes mellitus type 1|Monogenic diabetes|INS-related disorder,single nucleotide variant,GRCh37
na,na,11,2160809,2160809,INS,Pathogenic/Likely pathogenic/Likely risk allele,Type 1 diabetes mellitus 2|not provided|Diabetes mellitus type 1|Monogenic diabetes|INS-related disorder,single nucleotide variant,GRCh38
na,na,17,47481625,47481625,PHB1,risk factor,"Breast cancer, susceptibility to",single nucleotide variant,GRCh37
na,na,17,49404263,49404263,PHB1,risk factor,"Breast cancer, susceptibility to",single nucleotide variant,GRCh38
na,na,20,4680026,4680049,PRNP,Pathogenic,Huntington disease-like 1|Inherited Creutzfeldt-Jakob disease|Gerstmann-Straussler-Scheinker syndrome|Inherited prion disease,Microsatellite,GRCh37
na,na,20,4699379,4699380,PRNP,Pathogenic,Huntington disease-like 1|Inherited Creutzfeldt-Jakob disease|Gerstmann-Straussler-Scheinker syndrome|Inherited prion disease,Microsatellite,GRCh38
na,na,20,4680171,4680171,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|not provided|Huntington disease-like 1|Inherited Creutzfeldt-Jakob disease|Spongiform encephalopathy with neuropsychiatric features,single nucleotide variant,GRCh37
na,na,20,4699525,4699525,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|not provided|Huntington disease-like 1|Inherited Creutzfeldt-Jakob disease|Spongiform encephalopathy with neuropsychiatric features,single nucleotide variant,GRCh38
na,na,20,4680216,4680216,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Inborn genetic diseases|not provided,single nucleotide variant,GRCh37
na,na,20,4699570,4699570,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Inborn genetic diseases|not provided,single nucleotide variant,GRCh38
na,na,20,4680251,4680251,PRNP,Benign/Likely benign,|||Inherited prion disease|not specified|Huntington disease-like 1|Inherited Creutzfeldt-Jakob disease|not provided|Autism spectrum disorder|6 conditions|Fatal familial insomnia,single nucleotide variant,GRCh37
na,na,20,4699605,4699605,PRNP,Benign/Likely benign,|||Inherited prion disease|not specified|Huntington disease-like 1|Inherited Creutzfeldt-Jakob disease|not provided|Autism spectrum disorder|6 conditions|Fatal familial insomnia,single nucleotide variant,GRCh38
na,na,20,4680464,4680464,PRNP,Pathogenic,Inherited Creutzfeldt-Jakob disease|Fatal familial insomnia|Huntington disease-like 1|not provided|6 conditions,single nucleotide variant,GRCh37
na,na,20,4699818,4699818,PRNP,Pathogenic,Inherited Creutzfeldt-Jakob disease|Fatal familial insomnia|Huntington disease-like 1|not provided|6 conditions,single nucleotide variant,GRCh38
na,na,20,4680398,4680398,PRNP,Pathogenic/Likely pathogenic,Fatal familial insomnia|not provided|Huntington disease-like 1|Gerstmann-Straussler-Scheinker syndrome;Huntington disease-like 1;Spongiform encephalopathy with neuropsychiatric features,single nucleotide variant,GRCh37
na,na,20,4699752,4699752,PRNP,Pathogenic/Likely pathogenic,Fatal familial insomnia|not provided|Huntington disease-like 1|Gerstmann-Straussler-Scheinker syndrome;Huntington disease-like 1;Spongiform encephalopathy with neuropsychiatric features,single nucleotide variant,GRCh38
na,na,20,4680459,4680459,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1|not provided,single nucleotide variant,GRCh37
na,na,20,4699813,4699813,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1|not provided,single nucleotide variant,GRCh38
na,na,20,4680516,4680516,PRNP,Likely pathogenic,Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1|PRNP-related disorder,single nucleotide variant,GRCh37
na,na,20,4699870,4699870,PRNP,Likely pathogenic,Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1|PRNP-related disorder,single nucleotide variant,GRCh38
na,na,20,4680494,4680494,PRNP,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance",Inherited Creutzfeldt-Jakob disease|Huntington disease-like 1|6 conditions|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,20,4699848,4699848,PRNP,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance",Inherited Creutzfeldt-Jakob disease|Huntington disease-like 1|6 conditions|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,20,4680180,4680180,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,20,4699534,4699534,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,20,4680404,4680404,PRNP,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance",Inherited Creutzfeldt-Jakob disease|Inherited prion disease|Huntington disease-like 1|Gerstmann-Straussler-Scheinker syndrome|6 conditions,single nucleotide variant,GRCh37
na,na,20,4699758,4699758,PRNP,"Pathogenic/Likely pathogenic/Pathogenic, low penetrance",Inherited Creutzfeldt-Jakob disease|Inherited prion disease|Huntington disease-like 1|Gerstmann-Straussler-Scheinker syndrome|6 conditions,single nucleotide variant,GRCh38
na,na,20,4680561,4680561,PRNP,Uncertain significance,Inherited Creutzfeldt-Jakob disease|Huntington disease-like 1|6 conditions,single nucleotide variant,GRCh37
na,na,20,4699915,4699915,PRNP,Uncertain significance,Inherited Creutzfeldt-Jakob disease|Huntington disease-like 1|6 conditions,single nucleotide variant,GRCh38
na,na,20,4680413,4680413,PRNP,Pathogenic,Spongiform encephalopathy with neuropsychiatric features|Huntington disease-like 1,single nucleotide variant,GRCh37
na,na,20,4699767,4699767,PRNP,Pathogenic,Spongiform encephalopathy with neuropsychiatric features|Huntington disease-like 1,single nucleotide variant,GRCh38
na,na,20,4680378,4680378,PRNP,Benign,Spongiform encephalopathy with neuropsychiatric features|Inherited prion disease|Huntington disease-like 1|not provided|not specified,single nucleotide variant,GRCh37
na,na,20,4699732,4699732,PRNP,Benign,Spongiform encephalopathy with neuropsychiatric features|Inherited prion disease|Huntington disease-like 1|not provided|not specified,single nucleotide variant,GRCh38
na,na,20,4680521,4680521,PRNP,Benign,Inherited prion disease|Huntington disease-like 1|not provided|Reclassified - variant of unknown significance,single nucleotide variant,GRCh37
na,na,20,4699875,4699875,PRNP,Benign,Inherited prion disease|Huntington disease-like 1|not provided|Reclassified - variant of unknown significance,single nucleotide variant,GRCh38
na,na,20,4680258,4680258,PRNP,Pathogenic/Likely pathogenic,Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1,single nucleotide variant,GRCh37
na,na,20,4699612,4699612,PRNP,Pathogenic/Likely pathogenic,Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1,single nucleotide variant,GRCh38
na,na,20,4680489,4680489,PRNP,Pathogenic/Likely pathogenic,Inherited Creutzfeldt-Jakob disease|not provided|PRNP-related disorder|Huntington disease-like 1,single nucleotide variant,GRCh37
na,na,20,4699843,4699843,PRNP,Pathogenic/Likely pathogenic,Inherited Creutzfeldt-Jakob disease|not provided|PRNP-related disorder|Huntington disease-like 1,single nucleotide variant,GRCh38
na,na,20,4680426,4680426,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Spongiform encephalopathy with neuropsychiatric features,single nucleotide variant,GRCh37
na,na,20,4699780,4699780,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome|Spongiform encephalopathy with neuropsychiatric features,single nucleotide variant,GRCh38
na,na,20,4680179,4680179,PRNP,Pathogenic,Spongiform encephalopathy with neuropsychiatric features,single nucleotide variant,GRCh37
na,na,20,4699533,4699533,PRNP,Pathogenic,Spongiform encephalopathy with neuropsychiatric features,single nucleotide variant,GRCh38
na,na,20,4680264,4680264,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome,single nucleotide variant,GRCh37
na,na,20,4699618,4699618,PRNP,Pathogenic,Gerstmann-Straussler-Scheinker syndrome,single nucleotide variant,GRCh38
na,na,20,4680179,4680179,PRNP,Uncertain significance,Gerstmann-Straussler-Scheinker syndrome|not provided,single nucleotide variant,GRCh37
na,na,20,4699533,4699533,PRNP,Uncertain significance,Gerstmann-Straussler-Scheinker syndrome|not provided,single nucleotide variant,GRCh38
na,na,20,4680246,4680246,PRNP,protective,"Kuru, protection against",single nucleotide variant,GRCh37
na,na,20,4699600,4699600,PRNP,protective,"Kuru, protection against",single nucleotide variant,GRCh38
na,na,18,29172937,29172937,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiomyopathy|Charcot-Marie-Tooth disease|Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic;Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|TTR-related disorder",single nucleotide variant,GRCh37
na,na,18,31592974,31592974,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiomyopathy|Charcot-Marie-Tooth disease|Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic;Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|TTR-related disorder",single nucleotide variant,GRCh38
na,na,18,29172946,29172946,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31592983,31592983,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29178595,29178595,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31598632,31598632,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29175115,29175115,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31595152,31595152,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29175120,29175120,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Charcot-Marie-Tooth disease|Cardiomyopathy|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31595157,31595157,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Charcot-Marie-Tooth disease|Cardiomyopathy|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29175172,29175172,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not specified|not provided|Cardiovascular phenotype|Charcot-Marie-Tooth disease|Amyloidosis, hereditary systemic 1;Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic",single nucleotide variant,GRCh37
na,na,18,31595209,31595209,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not specified|not provided|Cardiovascular phenotype|Charcot-Marie-Tooth disease|Amyloidosis, hereditary systemic 1;Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic",single nucleotide variant,GRCh38
na,na,18,29175193,29175193,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh37
na,na,18,31595230,31595230,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh38
na,na,18,29178585,29178585,TTR,Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31598622,31598622,TTR,Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,na,-1,-1,TTR,Benign,TRANSTHYRETIN POLYMORPHISM,Variation,na
na,na,18,29178618,29178618,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiomyopathy|Cardiovascular phenotype|ATTRV122I amyloidosis|Charcot-Marie-Tooth disease|Carpal tunnel syndrome 1;Amyloidosis, hereditary systemic 1;Hyperthyroxinemia, dystransthyretinemic|Tip-toe gait|TTR-related disorder|Amyloidosis",single nucleotide variant,GRCh37
na,na,18,31598655,31598655,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiomyopathy|Cardiovascular phenotype|ATTRV122I amyloidosis|Charcot-Marie-Tooth disease|Carpal tunnel syndrome 1;Amyloidosis, hereditary systemic 1;Hyperthyroxinemia, dystransthyretinemic|Tip-toe gait|TTR-related disorder|Amyloidosis",single nucleotide variant,GRCh38
na,na,18,29175210,29175210,TTR,Conflicting classifications of pathogenicity,"Amyloidosis, hereditary systemic 1|not specified|Cardiovascular phenotype|Cardiomyopathy|Heart failure|not provided|Charcot-Marie-Tooth disease",single nucleotide variant,GRCh37
na,na,18,31595247,31595247,TTR,Conflicting classifications of pathogenicity,"Amyloidosis, hereditary systemic 1|not specified|Cardiovascular phenotype|Cardiomyopathy|Heart failure|not provided|Charcot-Marie-Tooth disease",single nucleotide variant,GRCh38
na,na,18,29172974,29172974,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31593011,31593011,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29175092,29175092,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh37
na,na,18,31595129,31595129,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh38
na,na,18,29172938,29172938,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31592975,31592975,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29172955,29172955,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31592992,31592992,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29178610,29178610,TTR,Benign/Likely benign,"AMYLOIDOSIS, HEREDITARY SYSTEMIC 1, MODIFIER OF|not specified|not provided|Charcot-Marie-Tooth disease|Cardiovascular phenotype|Amyloidosis, hereditary systemic 1|Cardiomyopathy|Hyperthyroxinemia, dystransthyretinemic",single nucleotide variant,GRCh37
na,na,18,31598647,31598647,TTR,Benign/Likely benign,"AMYLOIDOSIS, HEREDITARY SYSTEMIC 1, MODIFIER OF|not specified|not provided|Charcot-Marie-Tooth disease|Cardiovascular phenotype|Amyloidosis, hereditary systemic 1|Cardiomyopathy|Hyperthyroxinemia, dystransthyretinemic",single nucleotide variant,GRCh38
na,na,18,29175115,29175115,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31595152,31595152,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29172988,29172988,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31593025,31593025,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29172922,29172922,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31592959,31592959,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29175106,29175106,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31595143,31595143,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29175091,29175091,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31595128,31595128,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29172937,29172937,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|Charcot-Marie-Tooth disease|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31592974,31592974,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|Charcot-Marie-Tooth disease|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29175087,29175087,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31595124,31595124,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29175207,29175207,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31595244,31595244,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29175152,29175152,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31595189,31595189,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29172877,29172877,TTR,Conflicting classifications of pathogenicity,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31592914,31592914,TTR,Conflicting classifications of pathogenicity,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29175154,29175154,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31595191,31595191,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29175144,29175144,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|Hyperthyroxinemia, dystransthyretinemic;Carpal tunnel syndrome 1;Amyloidosis, hereditary systemic 1|not provided",single nucleotide variant,GRCh37
na,na,18,31595181,31595181,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|Hyperthyroxinemia, dystransthyretinemic;Carpal tunnel syndrome 1;Amyloidosis, hereditary systemic 1|not provided",single nucleotide variant,GRCh38
na,na,18,29175123,29175123,TTR,Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31595160,31595160,TTR,Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29178544,29178544,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31598581,31598581,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29178594,29178594,TTR,Pathogenic,Carpal tunnel syndrome 1,single nucleotide variant,GRCh37
na,na,18,31598631,31598631,TTR,Pathogenic,Carpal tunnel syndrome 1,single nucleotide variant,GRCh38
na,na,18,29178573,29178573,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Hereditary amyloidosis|Cardiovascular phenotype|Amyloidosis, hereditary systemic 1;Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic",single nucleotide variant,GRCh37
na,na,18,31598610,31598610,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Hereditary amyloidosis|Cardiovascular phenotype|Amyloidosis, hereditary systemic 1;Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic",single nucleotide variant,GRCh38
na,na,18,29172989,29172989,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31593026,31593026,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29172865,29172865,TTR,Benign/Likely benign,"TRANSTHYRETIN POLYMORPHISM|not specified|Cardiovascular phenotype|Charcot-Marie-Tooth disease|Amyloidosis, hereditary systemic 1|not provided|Hypertrophic cardiomyopathy|Carpal tunnel syndrome 1;Amyloidosis, hereditary systemic 1;Hyperthyroxinemia, dystransthyretinemic",single nucleotide variant,GRCh37
na,na,18,31592902,31592902,TTR,Benign/Likely benign,"TRANSTHYRETIN POLYMORPHISM|not specified|Cardiovascular phenotype|Charcot-Marie-Tooth disease|Amyloidosis, hereditary systemic 1|not provided|Hypertrophic cardiomyopathy|Carpal tunnel syndrome 1;Amyloidosis, hereditary systemic 1;Hyperthyroxinemia, dystransthyretinemic",single nucleotide variant,GRCh38
na,na,18,29175132,29175132,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Amyloidosis, hereditary systemic 1;Carpal tunnel syndrome;Hyperthyroxinemia, dystransthyretinemic|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31595169,31595169,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Amyloidosis, hereditary systemic 1;Carpal tunnel syndrome;Hyperthyroxinemia, dystransthyretinemic|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29178580,29178580,TTR,Uncertain significance,"Hyperthyroxinemia, dystransthyretinemic|not provided|Amyloidosis, hereditary systemic 1|Charcot-Marie-Tooth disease|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31598617,31598617,TTR,Uncertain significance,"Hyperthyroxinemia, dystransthyretinemic|not provided|Amyloidosis, hereditary systemic 1|Charcot-Marie-Tooth disease|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29172907,29172907,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31592944,31592944,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29172946,29172946,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh37
na,na,18,31592983,31592983,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype|not provided",single nucleotide variant,GRCh38
na,na,18,29172884,29172884,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not specified",single nucleotide variant,GRCh37
na,na,18,31592921,31592921,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not specified",single nucleotide variant,GRCh38
na,na,18,29178565,29178565,TTR,Conflicting classifications of pathogenicity,"Amyloidosis, hereditary systemic 1|not specified|not provided|Cardiomyopathy|Cardiovascular phenotype|Charcot-Marie-Tooth disease",single nucleotide variant,GRCh37
na,na,18,31598602,31598602,TTR,Conflicting classifications of pathogenicity,"Amyloidosis, hereditary systemic 1|not specified|not provided|Cardiomyopathy|Cardiovascular phenotype|Charcot-Marie-Tooth disease",single nucleotide variant,GRCh38
na,na,18,29172988,29172988,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31593025,31593025,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29178615,29178617,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided",Microsatellite,GRCh37
na,na,18,31598652,31598654,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1|not provided",Microsatellite,GRCh38
na,na,18,29172980,29172980,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31593017,31593017,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29175100,29175100,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31595137,31595137,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29172902,29172902,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31592939,31592939,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29172938,29172938,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh37
na,na,18,31592975,31592975,TTR,Pathogenic,"Amyloidosis, hereditary systemic 1",single nucleotide variant,GRCh38
na,na,18,29175147,29175147,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31595184,31595184,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,18,29178543,29178543,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic;Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",single nucleotide variant,GRCh37
na,na,18,31598580,31598580,TTR,Pathogenic/Likely pathogenic,"Amyloidosis, hereditary systemic 1|not provided|Carpal tunnel syndrome 1;Hyperthyroxinemia, dystransthyretinemic;Amyloidosis, hereditary systemic 1|Cardiovascular phenotype",single nucleotide variant,GRCh38
na,na,12,5154436,5154436,KCNA5,Pathogenic,"Atrial fibrillation, familial, 7",single nucleotide variant,GRCh37
na,na,12,5045270,5045270,KCNA5,Pathogenic,"Atrial fibrillation, familial, 7",single nucleotide variant,GRCh38
na,na,12,5154893,5154893,KCNA5,Uncertain significance,"Atrial fibrillation, familial, 7|not provided",single nucleotide variant,GRCh37
na,na,12,5045727,5045727,KCNA5,Uncertain significance,"Atrial fibrillation, familial, 7|not provided",single nucleotide variant,GRCh38
na,na,12,5155040,5155040,KCNA5,Conflicting classifications of pathogenicity,"Atrial fibrillation, familial, 7",single nucleotide variant,GRCh37
na,na,12,5045874,5045874,KCNA5,Conflicting classifications of pathogenicity,"Atrial fibrillation, familial, 7",single nucleotide variant,GRCh38
na,na,12,5155141,5155141,KCNA5,Pathogenic,"Atrial fibrillation, familial, 7",single nucleotide variant,GRCh37
na,na,12,5045975,5045975,KCNA5,Pathogenic,"Atrial fibrillation, familial, 7",single nucleotide variant,GRCh38
na,na,19,50826951,50826951,KCNC3,Pathogenic,Spinocerebellar ataxia type 13|not provided,single nucleotide variant,GRCh37
na,na,19,50323694,50323694,KCNC3,Pathogenic,Spinocerebellar ataxia type 13|not provided,single nucleotide variant,GRCh38
na,na,19,50826866,50826866,KCNC3,Pathogenic,Spinocerebellar ataxia type 13,single nucleotide variant,GRCh37
na,na,19,50323609,50323609,KCNC3,Pathogenic,Spinocerebellar ataxia type 13,single nucleotide variant,GRCh38
na,na,21,35821756,35821761,KCNE1,Likely pathogenic,Jervell and Lange-Nielsen syndrome 2|not provided|Long QT syndrome|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2,Indel,GRCh37
na,na,21,34449458,34449463,KCNE1,Likely pathogenic,Jervell and Lange-Nielsen syndrome 2|not provided|Long QT syndrome|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2,Indel,GRCh38
na,na,21,35821913,35821913,KCNE1,Pathogenic,Jervell and Lange-Nielsen syndrome 2|Congenital long QT syndrome|Long QT syndrome 5,single nucleotide variant,GRCh37
na,na,21,34449615,34449615,KCNE1,Pathogenic,Jervell and Lange-Nielsen syndrome 2|Congenital long QT syndrome|Long QT syndrome 5,single nucleotide variant,GRCh38
na,na,21,35821707,35821707,KCNE1,Conflicting classifications of pathogenicity,Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 1|not provided|Cardiovascular phenotype|Long QT syndrome|Jervell and Lange-Nielsen syndrome|not specified|Arrhythmogenic right ventricular cardiomyopathy,single nucleotide variant,GRCh37
na,na,21,34449409,34449409,KCNE1,Conflicting classifications of pathogenicity,Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 1|not provided|Cardiovascular phenotype|Long QT syndrome|Jervell and Lange-Nielsen syndrome|not specified|Arrhythmogenic right ventricular cardiomyopathy,single nucleotide variant,GRCh38
na,na,21,35821712,35821712,KCNE1,Conflicting classifications of pathogenicity,Long QT syndrome 5|Congenital long QT syndrome|Long QT syndrome|not specified|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh37
na,na,21,34449414,34449414,KCNE1,Conflicting classifications of pathogenicity,Long QT syndrome 5|Congenital long QT syndrome|Long QT syndrome|not specified|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2|not provided|Cardiovascular phenotype,single nucleotide variant,GRCh38
na,na,21,35821680,35821680,KCNE1,Conflicting classifications of pathogenicity; other; risk factor,"Long QT syndrome 5, acquired, susceptibility to|Long QT syndrome 2/5, digenic|not specified|not provided|Long QT syndrome|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 2|Congenital long QT syndrome|Long QT syndrome 5|Cardiomyopathy|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2",single nucleotide variant,GRCh37
na,na,21,34449382,34449382,KCNE1,Conflicting classifications of pathogenicity; other; risk factor,"Long QT syndrome 5, acquired, susceptibility to|Long QT syndrome 2/5, digenic|not specified|not provided|Long QT syndrome|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 2|Congenital long QT syndrome|Long QT syndrome 5|Cardiomyopathy|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2",single nucleotide variant,GRCh38
na,na,12,5021767,5021767,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh37
na,na,12,4912601,4912601,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh38
na,na,12,5021259,5021259,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh37
na,na,12,4912093,4912093,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh38
na,na,12,5021064,5021064,KCNA1,Pathogenic,Episodic ataxia type 1|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,12,4911898,4911898,KCNA1,Pathogenic,Episodic ataxia type 1|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,12,5021289,5021289,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh37
na,na,12,4912123,4912123,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh38
na,na,12,5021095,5021095,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh37
na,na,12,4911929,4911929,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh38
na,na,12,5021519,5021519,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh37
na,na,12,4912353,4912353,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh38
na,na,12,5021220,5021220,KCNA1,Pathogenic,Episodic ataxia type 1|not provided,single nucleotide variant,GRCh37
na,na,12,4912054,4912054,KCNA1,Pathogenic,Episodic ataxia type 1|not provided,single nucleotide variant,GRCh38
na,na,12,5021754,5021754,KCNA1,Pathogenic,Episodic ataxia type 1|not provided,single nucleotide variant,GRCh37
na,na,12,4912588,4912588,KCNA1,Pathogenic,Episodic ataxia type 1|not provided,single nucleotide variant,GRCh38
na,na,12,5021074,5021074,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh37
na,na,12,4911908,4911908,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh38
na,na,12,5021268,5021268,KCNA1,Pathogenic,Myokymia 1|not provided,single nucleotide variant,GRCh37
na,na,12,4912102,4912102,KCNA1,Pathogenic,Myokymia 1|not provided,single nucleotide variant,GRCh38
na,na,12,5021275,5021275,KCNA1,Pathogenic,Myokymia 1,single nucleotide variant,GRCh37
na,na,12,4912109,4912109,KCNA1,Pathogenic,Myokymia 1,single nucleotide variant,GRCh38
na,na,12,5021793,5021793,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh37
na,na,12,4912627,4912627,KCNA1,Pathogenic,Episodic ataxia type 1,single nucleotide variant,GRCh38
na,na,12,5021221,5021221,KCNA1,Pathogenic,Episodic ataxia type 1|not provided,single nucleotide variant,GRCh37
na,na,12,4912055,4912055,KCNA1,Pathogenic,Episodic ataxia type 1|not provided,single nucleotide variant,GRCh38
na,na,12,5021221,5021221,KCNA1,Pathogenic,Myokymia 1,single nucleotide variant,GRCh37
na,na,12,4912055,4912055,KCNA1,Pathogenic,Myokymia 1,single nucleotide variant,GRCh38
na,na,12,5021307,5021307,KCNA1,Pathogenic,Myokymia 1 with hypomagnesemia,single nucleotide variant,GRCh37
na,na,12,4912141,4912141,KCNA1,Pathogenic,Myokymia 1 with hypomagnesemia,single nucleotide variant,GRCh38
na,na,15,89864114,89864114,POLG,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Mitochondrial disease|not provided|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome",single nucleotide variant,GRCh37
na,na,15,89320883,89320883,POLG,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Mitochondrial disease|not provided|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome",single nucleotide variant,GRCh38
na,na,15,89870432,89870432,POLG,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Spinocerebellar ataxia with epilepsy|Progressive sclerosing poliodystrophy|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|POLG-Related Spectrum Disorders|Mitochondrial disease|Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|POLG-related disorder|Mitochondrial DNA depletion syndrome 4b|Tip-toe gait|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Neurodevelopmental delay|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,15,89327201,89327201,POLG,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Spinocerebellar ataxia with epilepsy|Progressive sclerosing poliodystrophy|not provided|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|POLG-Related Spectrum Disorders|Mitochondrial disease|Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|POLG-related disorder|Mitochondrial DNA depletion syndrome 4b|Tip-toe gait|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Neurodevelopmental delay|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,15,89872286,89872286,POLG,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|not provided|Progressive sclerosing poliodystrophy|Inborn genetic diseases|6 conditions|POLG-related disorder|Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",single nucleotide variant,GRCh37
na,na,15,89329055,89329055,POLG,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|not provided|Progressive sclerosing poliodystrophy|Inborn genetic diseases|6 conditions|POLG-related disorder|Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",single nucleotide variant,GRCh38
na,na,15,89876978,89876978,POLG,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1",single nucleotide variant,GRCh37
na,na,15,89333747,89333747,POLG,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1",single nucleotide variant,GRCh38
na,na,15,89868751,89868751,POLG,Pathogenic,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive sclerosing poliodystrophy|not provided|Mitochondrial DNA depletion syndrome|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",single nucleotide variant,GRCh37
na,na,15,89325520,89325520,POLG,Pathogenic,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive sclerosing poliodystrophy|not provided|Mitochondrial DNA depletion syndrome|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",single nucleotide variant,GRCh38
na,na,15,89864184,89864184,POLG,Pathogenic,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive sclerosing poliodystrophy|not provided|Mitochondrial DNA depletion syndrome|Mitochondrial disease|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",single nucleotide variant,GRCh37
na,na,15,89320953,89320953,POLG,Pathogenic,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive sclerosing poliodystrophy|not provided|Mitochondrial DNA depletion syndrome|Mitochondrial disease|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",single nucleotide variant,GRCh38
na,na,15,89862284,89862284,POLG,Pathogenic/Likely pathogenic,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|not provided|POLG-Related Spectrum Disorders|Progressive sclerosing poliodystrophy|See cases|Autosomal dominant non-syndromic intellectual disability|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",single nucleotide variant,GRCh37
na,na,15,89319053,89319053,POLG,Pathogenic/Likely pathogenic,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|not provided|POLG-Related Spectrum Disorders|Progressive sclerosing poliodystrophy|See cases|Autosomal dominant non-syndromic intellectual disability|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b",single nucleotide variant,GRCh38
na,na,15,89865023,89865023,POLG,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|not provided|POLG-Related Spectrum Disorders|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome|Mitochondrial disease|Inborn genetic diseases|POLG-related disorder|6 conditions",single nucleotide variant,GRCh37
na,na,15,89321792,89321792,POLG,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|not provided|POLG-Related Spectrum Disorders|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome|Mitochondrial disease|Inborn genetic diseases|POLG-related disorder|6 conditions",single nucleotide variant,GRCh38
na,na,15,89873415,89873415,POLG,Conflicting classifications of pathogenicity,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome 1|Progressive sclerosing poliodystrophy|not provided|not specified|POLG-Related Spectrum Disorders|Global developmental delay|Tip-toe gait|POLG-related disorder|Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b|Inborn genetic diseases|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Abnormality of the nervous system|Mitochondrial disease|Hypertrophic cardiomyopathy|See cases|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Mitochondrial DNA depletion syndrome|6 conditions",single nucleotide variant,GRCh37
na,na,15,89330184,89330184,POLG,Conflicting classifications of pathogenicity,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome 1|Progressive sclerosing poliodystrophy|not provided|not specified|POLG-Related Spectrum Disorders|Global developmental delay|Tip-toe gait|POLG-related disorder|Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b|Inborn genetic diseases|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Abnormality of the nervous system|Mitochondrial disease|Hypertrophic cardiomyopathy|See cases|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Mitochondrial DNA depletion syndrome|6 conditions",single nucleotide variant,GRCh38
na,na,15,89864473,89864473,POLG,Pathogenic,Progressive sclerosing poliodystrophy,single nucleotide variant,GRCh37
na,na,15,89321242,89321242,POLG,Pathogenic,Progressive sclerosing poliodystrophy,single nucleotide variant,GRCh38
na,na,15,89868870,89868870,POLG,Conflicting classifications of pathogenicity,"Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|not specified|Progressive sclerosing poliodystrophy|not provided|Global developmental delay|Mitochondrial disease|Tip-toe gait|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Abnormality of the nervous system|Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b|Inborn genetic diseases|POLG-related disorder|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Hypertrophic cardiomyopathy|See cases|6 conditions",single nucleotide variant,GRCh37
na,na,15,89325639,89325639,POLG,Conflicting classifications of pathogenicity,"Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|not specified|Progressive sclerosing poliodystrophy|not provided|Global developmental delay|Mitochondrial disease|Tip-toe gait|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Abnormality of the nervous system|Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b|Inborn genetic diseases|POLG-related disorder|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Hereditary spastic paraplegia|Hypertrophic cardiomyopathy|See cases|6 conditions",single nucleotide variant,GRCh38
na,na,15,89864974,89864974,POLG,Pathogenic,"Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b|Progressive sclerosing poliodystrophy",single nucleotide variant,GRCh37
na,na,15,89321743,89321743,POLG,Pathogenic,"Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b|Progressive sclerosing poliodystrophy",single nucleotide variant,GRCh38
na,na,15,89866657,89866657,POLG,Pathogenic/Likely pathogenic,"Progressive sclerosing poliodystrophy|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Spinocerebellar ataxia with epilepsy|not provided|POLG-Related Spectrum Disorders|Mitochondrial disease|not specified|Mitochondrial DNA depletion syndrome 4b|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Inborn genetic diseases|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|6 conditions|POLG-related disorder",single nucleotide variant,GRCh37
na,na,15,89323426,89323426,POLG,Pathogenic/Likely pathogenic,"Progressive sclerosing poliodystrophy|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Spinocerebellar ataxia with epilepsy|not provided|POLG-Related Spectrum Disorders|Mitochondrial disease|not specified|Mitochondrial DNA depletion syndrome 4b|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Inborn genetic diseases|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive sclerosing poliodystrophy;Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|6 conditions|POLG-related disorder",single nucleotide variant,GRCh38
na,na,15,89864109,89864109,POLG,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive sclerosing poliodystrophy",single nucleotide variant,GRCh37
na,na,15,89320878,89320878,POLG,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|Progressive sclerosing poliodystrophy",single nucleotide variant,GRCh38
na,na,15,89865073,89865073,POLG,Benign/Likely benign,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|not specified|not provided|Progressive sclerosing poliodystrophy|POLG-Related Spectrum Disorders|Hereditary spastic paraplegia|Inborn genetic diseases|POLG-related disorder",single nucleotide variant,GRCh37
na,na,15,89321842,89321842,POLG,Benign/Likely benign,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1|not specified|not provided|Progressive sclerosing poliodystrophy|POLG-Related Spectrum Disorders|Hereditary spastic paraplegia|Inborn genetic diseases|POLG-related disorder",single nucleotide variant,GRCh38
na,na,15,89870237,89870237,POLG,Uncertain significance,Spinocerebellar ataxia with epilepsy|Progressive sclerosing poliodystrophy|not provided|not specified|6 conditions,single nucleotide variant,GRCh37
na,na,15,89327006,89327006,POLG,Uncertain significance,Spinocerebellar ataxia with epilepsy|Progressive sclerosing poliodystrophy|not provided|not specified|6 conditions,single nucleotide variant,GRCh38
na,na,15,89862506,89862506,POLG,Pathogenic,Progressive sclerosing poliodystrophy,single nucleotide variant,GRCh37
na,na,15,89319275,89319275,POLG,Pathogenic,Progressive sclerosing poliodystrophy,single nucleotide variant,GRCh38
na,na,15,89865008,89865008,POLG,Conflicting classifications of pathogenicity,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive sclerosing poliodystrophy|not specified|not provided|Mitochondrial DNA depletion syndrome|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",single nucleotide variant,GRCh37
na,na,15,89321777,89321777,POLG,Conflicting classifications of pathogenicity,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive sclerosing poliodystrophy|not specified|not provided|Mitochondrial DNA depletion syndrome|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",single nucleotide variant,GRCh38
na,na,15,89866691,89866691,POLG,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive sclerosing poliodystrophy|not provided|Mitochondrial disease|POLG-Related Spectrum Disorders|Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Inborn genetic diseases|POLG-related disorder|Hereditary spastic paraplegia|Tip-toe gait",single nucleotide variant,GRCh37
na,na,15,89323460,89323460,POLG,Pathogenic/Likely pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Progressive sclerosing poliodystrophy|not provided|Mitochondrial disease|POLG-Related Spectrum Disorders|Mitochondrial DNA depletion syndrome 4b;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Mitochondrial DNA depletion syndrome 4b;Progressive sclerosing poliodystrophy|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Inborn genetic diseases|POLG-related disorder|Hereditary spastic paraplegia|Tip-toe gait",single nucleotide variant,GRCh38
na,na,15,89870196,89870196,POLG,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1",single nucleotide variant,GRCh37
na,na,15,89326965,89326965,POLG,Pathogenic,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1",single nucleotide variant,GRCh38
na,na,15,89873488,89873488,POLG,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome 4b|not provided|Progressive sclerosing poliodystrophy|Abnormality of corpus callosum|Inborn genetic diseases|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome",single nucleotide variant,GRCh37
na,na,15,89330257,89330257,POLG,Pathogenic/Likely pathogenic,"Mitochondrial DNA depletion syndrome 4b|not provided|Progressive sclerosing poliodystrophy|Abnormality of corpus callosum|Inborn genetic diseases|Progressive sclerosing poliodystrophy;Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1;Mitochondrial DNA depletion syndrome 4b|Mitochondrial DNA depletion syndrome",single nucleotide variant,GRCh38
na,na,15,89862217,89862217,POLG,Pathogenic,Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|not provided,single nucleotide variant,GRCh37
na,na,15,89318986,89318986,POLG,Pathogenic,Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4b|not provided,single nucleotide variant,GRCh38
na,na,4,88964429,88964429,PKD2,Pathogenic,Polycystic kidney disease 2,single nucleotide variant,GRCh37
na,na,4,88043277,88043277,PKD2,Pathogenic,Polycystic kidney disease 2,single nucleotide variant,GRCh38
na,na,4,88986631,88986631,PKD2,Pathogenic,Polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|not provided,single nucleotide variant,GRCh37
na,na,4,88065479,88065479,PKD2,Pathogenic,Polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|not provided,single nucleotide variant,GRCh38
na,na,4,88964503,88964503,PKD2,Pathogenic,Polycystic kidney disease 2,single nucleotide variant,GRCh37
na,na,4,88043351,88043351,PKD2,Pathogenic,Polycystic kidney disease 2,single nucleotide variant,GRCh38
na,na,4,88940706,88940707,PKD2,Pathogenic,Polycystic kidney disease 2,Duplication,GRCh37
na,na,4,88019554,88019555,PKD2,Pathogenic,Polycystic kidney disease 2,Duplication,GRCh38
na,na,4,88967864,88967864,PKD2,Pathogenic,Polycystic kidney disease 2|Polycystic kidney disease|not provided|Autosomal dominant polycystic kidney disease,single nucleotide variant,GRCh37
na,na,4,88046712,88046712,PKD2,Pathogenic,Polycystic kidney disease 2|Polycystic kidney disease|not provided|Autosomal dominant polycystic kidney disease,single nucleotide variant,GRCh38
na,na,4,88986558,88986559,PKD2,Pathogenic,Polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|Polycystic kidney disease|not provided|Inborn genetic diseases|PKD2-related disorder,Duplication,GRCh37
na,na,4,88065406,88065407,PKD2,Pathogenic,Polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|Polycystic kidney disease|not provided|Inborn genetic diseases|PKD2-related disorder,Duplication,GRCh38
na,na,4,88968006,88968006,PKD2,Pathogenic,Polycystic kidney disease 2,single nucleotide variant,GRCh37
na,na,4,88046854,88046854,PKD2,Pathogenic,Polycystic kidney disease 2,single nucleotide variant,GRCh38
na,na,4,88979170,88979171,PKD2,Pathogenic,Polycystic kidney disease 2,Indel,GRCh37
na,na,4,88058018,88058019,PKD2,Pathogenic,Polycystic kidney disease 2,Indel,GRCh38
na,na,1,207106478,207106478,PIGR,Uncertain significance,IgA glomerulonephritis,single nucleotide variant,GRCh37
na,na,1,206933133,206933133,PIGR,Uncertain significance,IgA glomerulonephritis,single nucleotide variant,GRCh38
na,na,1,169563951,169563951,SELP,Benign,SELECTIN P POLYMORPHISM|not provided|SELP-related disorder,single nucleotide variant,GRCh37
na,na,1,169594713,169594713,SELP,Benign,SELECTIN P POLYMORPHISM|not provided|SELP-related disorder,single nucleotide variant,GRCh38
na,na,1,169565346,169565346,SELP,Benign,SELECTIN P POLYMORPHISM,single nucleotide variant,GRCh37
na,na,1,169596108,169596108,SELP,Benign,SELECTIN P POLYMORPHISM,single nucleotide variant,GRCh38
na,na,3,128780764,128780764,GP9,Pathogenic,Bernard-Soulier syndrome type C|Bernard Soulier syndrome|Macrothrombocytopenia|Thrombocytopenia|not provided|GP9-related disorder,single nucleotide variant,GRCh37
na,na,3,129061921,129061921,GP9,Pathogenic,Bernard-Soulier syndrome type C|Bernard Soulier syndrome|Macrothrombocytopenia|Thrombocytopenia|not provided|GP9-related disorder,single nucleotide variant,GRCh38
na,na,3,128780692,128780692,GP9,Pathogenic,Bernard-Soulier syndrome type C,single nucleotide variant,GRCh37
na,na,3,129061849,129061849,GP9,Pathogenic,Bernard-Soulier syndrome type C,single nucleotide variant,GRCh38
na,na,3,128780794,128780794,GP9,Pathogenic,Bernard-Soulier syndrome type C|not provided|Bernard Soulier syndrome|Macrothrombocytopenia,single nucleotide variant,GRCh37
na,na,3,129061951,129061951,GP9,Pathogenic,Bernard-Soulier syndrome type C|not provided|Bernard Soulier syndrome|Macrothrombocytopenia,single nucleotide variant,GRCh38
na,na,3,128780749,128780749,GP9,Pathogenic,Bernard-Soulier syndrome type C,single nucleotide variant,GRCh37
na,na,3,129061906,129061906,GP9,Pathogenic,Bernard-Soulier syndrome type C,single nucleotide variant,GRCh38
na,na,3,128780652,128780652,GP9,Likely pathogenic,Bernard-Soulier syndrome type C|not provided|Bernard Soulier syndrome,single nucleotide variant,GRCh37
na,na,3,129061809,129061809,GP9,Likely pathogenic,Bernard-Soulier syndrome type C|not provided|Bernard Soulier syndrome,single nucleotide variant,GRCh38
na,na,3,128780602,128780602,GP9,Uncertain significance,Bernard-Soulier syndrome type C|not provided,single nucleotide variant,GRCh37
na,na,3,129061759,129061759,GP9,Uncertain significance,Bernard-Soulier syndrome type C|not provided,single nucleotide variant,GRCh38
na,na,7,80286003,80286003,CD36,Conflicting classifications of pathogenicity,"Platelet-type bleeding disorder 10|Inherited bleeding disorder, platelet-type|not specified",single nucleotide variant,GRCh37
na,na,7,80656687,80656687,CD36,Conflicting classifications of pathogenicity,"Platelet-type bleeding disorder 10|Inherited bleeding disorder, platelet-type|not specified",single nucleotide variant,GRCh38
na,na,7,80300449,80300449,CD36,Conflicting classifications of pathogenicity,"Platelet-type bleeding disorder 10|Malaria, cerebral, susceptibility to|not specified",single nucleotide variant,GRCh37
na,na,7,80671133,80671133,CD36,Conflicting classifications of pathogenicity,"Platelet-type bleeding disorder 10|Malaria, cerebral, susceptibility to|not specified",single nucleotide variant,GRCh38
na,na,na,-1,-1,CD36,Pathogenic; risk factor,"Platelet-type bleeding disorder 10|Malaria, cerebral, susceptibility to",Deletion,na
na,na,7,80276575,80276598,CD36,Pathogenic; protective,"Platelet-type bleeding disorder 10|Malaria, cerebral, resistance to",Microsatellite,GRCh37
na,na,7,80647259,80647282,CD36,Pathogenic; protective,"Platelet-type bleeding disorder 10|Malaria, cerebral, resistance to",Microsatellite,GRCh38
na,na,7,80300417,80300418,CD36,Likely pathogenic,Platelet-type bleeding disorder 10,Duplication,GRCh37
na,na,7,80671101,80671102,CD36,Likely pathogenic,Platelet-type bleeding disorder 10,Duplication,GRCh38
na,na,7,80299280,80299280,CD36,Pathogenic,Platelet-type bleeding disorder 10,single nucleotide variant,GRCh37
na,na,7,80669964,80669964,CD36,Pathogenic,Platelet-type bleeding disorder 10,single nucleotide variant,GRCh38
na,na,7,80302708,80302708,CD36,Pathogenic,Platelet-type bleeding disorder 10,single nucleotide variant,GRCh37
na,na,7,80673392,80673392,CD36,Pathogenic,Platelet-type bleeding disorder 10,single nucleotide variant,GRCh38
na,na,4,55152093,55152093,PDGFRA,Conflicting classifications of pathogenicity,Gastrointestinal stromal tumor|not provided,single nucleotide variant,GRCh37
na,na,4,54285926,54285926,PDGFRA,Conflicting classifications of pathogenicity,Gastrointestinal stromal tumor|not provided,single nucleotide variant,GRCh38
na,na,4,55152092,55152103,PDGFRA,Conflicting classifications of pathogenicity,Gastrointestinal stromal tumor|not provided,Deletion,GRCh37
na,na,4,54285925,54285936,PDGFRA,Conflicting classifications of pathogenicity,Gastrointestinal stromal tumor|not provided,Deletion,GRCh38
na,na,4,55152101,55152112,PDGFRA,Pathogenic,Gastrointestinal stromal tumor,Deletion,GRCh37
na,na,4,54285934,54285945,PDGFRA,Pathogenic,Gastrointestinal stromal tumor,Deletion,GRCh38
na,na,4,55141036,55141036,PDGFRA,Conflicting classifications of pathogenicity,"Gastrointestinal stromal tumor|Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|not provided",single nucleotide variant,GRCh37
na,na,4,54274869,54274869,PDGFRA,Conflicting classifications of pathogenicity,"Gastrointestinal stromal tumor|Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|not provided",single nucleotide variant,GRCh38
na,na,4,55141030,55141031,PDGFRA,Pathogenic,Gastrointestinal stromal tumor,Insertion,GRCh37
na,na,4,54274863,54274864,PDGFRA,Pathogenic,Gastrointestinal stromal tumor,Insertion,GRCh38
na,na,4,55141032,55141046,PDGFRA,Pathogenic,Gastrointestinal stromal tumor,Deletion,GRCh37
na,na,4,54274865,54274879,PDGFRA,Pathogenic,Gastrointestinal stromal tumor,Deletion,GRCh38
na,na,4,55141050,55141067,PDGFRA,Pathogenic,Gastrointestinal stromal tumor,Deletion,GRCh37
na,na,4,54274883,54274900,PDGFRA,Pathogenic,Gastrointestinal stromal tumor,Deletion,GRCh38
na,na,4,55144547,55144547,PDGFRA,Uncertain significance,"Hypereosinophilic syndrome, idiopathic, resistant to imatinib|Gastrointestinal stromal tumor",single nucleotide variant,GRCh37
na,na,4,54278380,54278380,PDGFRA,Uncertain significance,"Hypereosinophilic syndrome, idiopathic, resistant to imatinib|Gastrointestinal stromal tumor",single nucleotide variant,GRCh38
na,na,4,55152104,55152104,PDGFRA,Conflicting classifications of pathogenicity,"Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh37
na,na,4,54285937,54285937,PDGFRA,Conflicting classifications of pathogenicity,"Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|Gastrointestinal stromal tumor|Hereditary cancer-predisposing syndrome",single nucleotide variant,GRCh38
na,na,4,55141018,55141018,PDGFRA,Likely pathogenic,"Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|Gastrointestinal stromal tumor",single nucleotide variant,GRCh37
na,na,4,54274851,54274851,PDGFRA,Likely pathogenic,"Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal|Gastrointestinal stromal tumor",single nucleotide variant,GRCh38
na,na,17,45363730,45363730,ITGB3,Pathogenic,"Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|Myocardial infarction, susceptibility to;Glanzmann thrombasthenia 2;Bleeding disorder, platelet-type, 24|not provided|Platelet-type bleeding disorder 16|Bleeding disorder, platelet-type, 24",single nucleotide variant,GRCh37
na,na,17,47286364,47286364,ITGB3,Pathogenic,"Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|Myocardial infarction, susceptibility to;Glanzmann thrombasthenia 2;Bleeding disorder, platelet-type, 24|not provided|Platelet-type bleeding disorder 16|Bleeding disorder, platelet-type, 24",single nucleotide variant,GRCh38
na,na,17,45361880,45361880,ITGB3,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 2,single nucleotide variant,GRCh37
na,na,17,47284514,47284514,ITGB3,Pathogenic,Glanzmann thrombasthenia|Glanzmann thrombasthenia 2,single nucleotide variant,GRCh38
na,na,17,45363729,45363729,ITGB3,Likely pathogenic,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia 1|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh37
na,na,17,47286363,47286363,ITGB3,Likely pathogenic,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia 1|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh38
na,na,17,45387535,45387535,ITGB3,Uncertain significance,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia,single nucleotide variant,GRCh37
na,na,17,47310169,47310169,ITGB3,Uncertain significance,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia,single nucleotide variant,GRCh38
na,na,17,45361953,45361953,ITGB3,Benign,PEN(a)/PEN(b) ALLOANTIGEN POLYMORPHISM|not provided|Glanzmann thrombasthenia|not specified,single nucleotide variant,GRCh37
na,na,17,47284587,47284587,ITGB3,Benign,PEN(a)/PEN(b) ALLOANTIGEN POLYMORPHISM|not provided|Glanzmann thrombasthenia|not specified,single nucleotide variant,GRCh38
na,na,17,45360730,45360730,ITGB3,Benign,"PL(A1)/(A2) ALLOANTIGEN POLYMORPHISM|Glanzmann thrombasthenia|not specified|Myocardial infarction, susceptibility to|not provided",single nucleotide variant,GRCh37
na,na,17,47283364,47283364,ITGB3,Benign,"PL(A1)/(A2) ALLOANTIGEN POLYMORPHISM|Glanzmann thrombasthenia|not specified|Myocardial infarction, susceptibility to|not provided",single nucleotide variant,GRCh38
na,na,17,45369541,45369541,ITGB3,Uncertain significance,Mo ALLOANTIGEN POLYMORPHISM|not specified|not provided,single nucleotide variant,GRCh37
na,na,17,47292175,47292175,ITGB3,Uncertain significance,Mo ALLOANTIGEN POLYMORPHISM|not specified|not provided,single nucleotide variant,GRCh38
na,na,17,45351871,45351871,ITGB3,Pathogenic,Glanzmann thrombasthenia 2,single nucleotide variant,GRCh37
na,na,17,47274505,47274505,ITGB3,Pathogenic,Glanzmann thrombasthenia 2,single nucleotide variant,GRCh38
na,na,17,45369788,45369788,ITGB3,Benign,Ca/Tu ALLOANTIGEN POLYMORPHISM|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh37
na,na,17,47292422,47292422,ITGB3,Benign,Ca/Tu ALLOANTIGEN POLYMORPHISM|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh38
na,na,17,45368393,45368393,ITGB3,Pathogenic,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh37
na,na,17,47291027,47291027,ITGB3,Pathogenic,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh38
na,na,na,-1,-1,ITGB3,Pathogenic,Glanzmann thrombasthenia 2,Deletion,na
na,na,17,45384950,45384950,ITGB3,Pathogenic,"Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|Platelet-type bleeding disorder 16|Glanzmann thrombasthenia 2|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|not provided|Myocardial infarction, susceptibility to;Glanzmann thrombasthenia 2;Bleeding disorder, platelet-type, 24",single nucleotide variant,GRCh37
na,na,17,47307584,47307584,ITGB3,Pathogenic,"Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|Platelet-type bleeding disorder 16|Glanzmann thrombasthenia 2|Hyper-IgE recurrent infection syndrome 1, autosomal dominant|not provided|Myocardial infarction, susceptibility to;Glanzmann thrombasthenia 2;Bleeding disorder, platelet-type, 24",single nucleotide variant,GRCh38
na,na,17,45377854,45377854,ITGB3,Pathogenic,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh37
na,na,17,47300488,47300488,ITGB3,Pathogenic,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh38
na,na,17,45361875,45361875,ITGB3,Pathogenic,"Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not provided|Myocardial infarction, susceptibility to;Glanzmann thrombasthenia 2;Bleeding disorder, platelet-type, 24",single nucleotide variant,GRCh37
na,na,17,47284509,47284509,ITGB3,Pathogenic,"Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|Glanzmann thrombasthenia 1|not provided|Myocardial infarction, susceptibility to;Glanzmann thrombasthenia 2;Bleeding disorder, platelet-type, 24",single nucleotide variant,GRCh38
na,na,17,45364494,45364494,ITGB3,Uncertain significance,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh37
na,na,17,47287128,47287128,ITGB3,Uncertain significance,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia|not provided,single nucleotide variant,GRCh38
na,na,17,45363751,45363751,ITGB3,Uncertain significance,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia,single nucleotide variant,GRCh37
na,na,17,47286385,47286385,ITGB3,Uncertain significance,Glanzmann thrombasthenia 2|Glanzmann thrombasthenia,single nucleotide variant,GRCh38
na,na,7,100775347,100775348,SERPINE1,Pathogenic,Congenital plasminogen activator inhibitor type 1 deficiency,Microsatellite,GRCh37
na,na,7,101132066,101132067,SERPINE1,Pathogenic,Congenital plasminogen activator inhibitor type 1 deficiency,Microsatellite,GRCh38
na,na,7,100769707,100769707,SERPINE1,Pathogenic; other,Transcription level of plasminogen activator inhibitor 1,Duplication,GRCh37
na,na,7,101126426,101126426,SERPINE1,Pathogenic; other,Transcription level of plasminogen activator inhibitor 1,Duplication,GRCh38
na,na,7,100771717,100771717,SERPINE1,Benign/Likely benign,Congenital plasminogen activator inhibitor type 1 deficiency|not specified|Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process|not provided|SERPINE1-related disorder,single nucleotide variant,GRCh37
na,na,7,101128436,101128436,SERPINE1,Benign/Likely benign,Congenital plasminogen activator inhibitor type 1 deficiency|not specified|Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process|not provided|SERPINE1-related disorder,single nucleotide variant,GRCh38
na,na,6,161159625,161159625,PLG,Conflicting classifications of pathogenicity,"Dysplasminogenemia|Plasminogen deficiency, type I|not specified|not provided",single nucleotide variant,GRCh37
na,na,6,160738593,160738593,PLG,Conflicting classifications of pathogenicity,"Dysplasminogenemia|Plasminogen deficiency, type I|not specified|not provided",single nucleotide variant,GRCh38
na,na,6,161143463,161143463,PLG,Pathogenic,Dysplasminogenemia,single nucleotide variant,GRCh37
na,na,6,160722431,160722431,PLG,Pathogenic,Dysplasminogenemia,single nucleotide variant,GRCh38
na,na,6,161158008,161158008,PLG,Pathogenic,Dysplasminogenemia,single nucleotide variant,GRCh37
na,na,6,160736976,160736976,PLG,Pathogenic,Dysplasminogenemia,single nucleotide variant,GRCh38
na,na,6,161137712,161137712,PLG,Pathogenic,"Plasminogen deficiency, type I",single nucleotide variant,GRCh37
na,na,6,160716680,160716680,PLG,Pathogenic,"Plasminogen deficiency, type I",single nucleotide variant,GRCh38
na,na,6,161159615,161159615,PLG,Pathogenic,"Plasminogen deficiency, type I",single nucleotide variant,GRCh37
na,na,6,160738583,160738583,PLG,Pathogenic,"Plasminogen deficiency, type I",single nucleotide variant,GRCh38
na,na,6,161152261,161152261,PLG,Pathogenic,"Plasminogen deficiency, type I",single nucleotide variant,GRCh37
na,na,6,160731229,160731229,PLG,Pathogenic,"Plasminogen deficiency, type I",single nucleotide variant,GRCh38
na,na,6,161173272,161173272,PLG,Uncertain significance,Dysplasminogenemia|PLG-related disorder|not provided,single nucleotide variant,GRCh37
na,na,6,160752240,160752240,PLG,Uncertain significance,Dysplasminogenemia|PLG-related disorder|not provided,single nucleotide variant,GRCh38
na,na,6,161137695,161137697,PLG,Uncertain significance,"Plasminogen deficiency, type I|not provided",Microsatellite,GRCh37
na,na,6,160716663,160716665,PLG,Uncertain significance,"Plasminogen deficiency, type I|not provided",Microsatellite,GRCh38
na,na,6,161162449,161162449,PLG,Pathogenic,"Plasminogen deficiency, type I",Deletion,GRCh37
na,na,6,160741417,160741417,PLG,Pathogenic,"Plasminogen deficiency, type I",Deletion,GRCh38
na,na,6,161127501,161127501,PLG,Pathogenic/Likely pathogenic,"Plasminogen deficiency, type I|not provided|Otitis media, susceptibility to|Deep venous thrombosis|Angioedema, hereditary, 4;Plasminogen deficiency, type I",single nucleotide variant,GRCh37
na,na,6,160706469,160706469,PLG,Pathogenic/Likely pathogenic,"Plasminogen deficiency, type I|not provided|Otitis media, susceptibility to|Deep venous thrombosis|Angioedema, hereditary, 4;Plasminogen deficiency, type I",single nucleotide variant,GRCh38
na,na,6,132211550,132211550,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1|not provided",single nucleotide variant,GRCh37
na,na,6,131890410,131890410,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1|not provided",single nucleotide variant,GRCh38
na,na,6,132206079,132206079,ENPP1,Conflicting classifications of pathogenicity,"Arterial calcification, generalized, of infancy, 1|not specified|Hypophosphatemic rickets, autosomal recessive, 2|Type 2 diabetes mellitus|not provided",single nucleotide variant,GRCh37
na,na,6,131884939,131884939,ENPP1,Conflicting classifications of pathogenicity,"Arterial calcification, generalized, of infancy, 1|not specified|Hypophosphatemic rickets, autosomal recessive, 2|Type 2 diabetes mellitus|not provided",single nucleotide variant,GRCh38
na,na,6,132185691,132185701,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1",Deletion,GRCh37
na,na,6,131864551,131864561,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1",Deletion,GRCh38
na,na,6,132198145,132198145,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1",single nucleotide variant,GRCh37
na,na,6,131877005,131877005,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1",single nucleotide variant,GRCh38
na,na,6,132172368,132172368,ENPP1,Conflicting classifications of pathogenicity,"Insulin resistance, susceptibility to|Obesity|not specified|Hypophosphatemic rickets, autosomal recessive, 2|Arterial calcification, generalized, of infancy, 1|Hypopigmentation-punctate palmoplantar keratoderma syndrome|Diabetes mellitus type 2, susceptibility to|not provided|Hypophosphatemic rickets|Type 2 diabetes mellitus|ENPP1-related disorder|Hypopigmentation-punctate palmoplantar keratoderma syndrome;Type 2 diabetes mellitus;Arterial calcification, generalized, of infancy, 1;Inherited obesity;Hypophosphatemic rickets, autosomal recessive, 2",single nucleotide variant,GRCh37
na,na,6,131851228,131851228,ENPP1,Conflicting classifications of pathogenicity,"Insulin resistance, susceptibility to|Obesity|not specified|Hypophosphatemic rickets, autosomal recessive, 2|Arterial calcification, generalized, of infancy, 1|Hypopigmentation-punctate palmoplantar keratoderma syndrome|Diabetes mellitus type 2, susceptibility to|not provided|Hypophosphatemic rickets|Type 2 diabetes mellitus|ENPP1-related disorder|Hypopigmentation-punctate palmoplantar keratoderma syndrome;Type 2 diabetes mellitus;Arterial calcification, generalized, of infancy, 1;Inherited obesity;Hypophosphatemic rickets, autosomal recessive, 2",single nucleotide variant,GRCh38
na,na,6,132212694,132212694,ENPP1,Benign,"Obesity|Hypophosphatemic rickets, autosomal recessive, 2|Arterial calcification, generalized, of infancy, 1",single nucleotide variant,GRCh37
na,na,6,131891554,131891554,ENPP1,Benign,"Obesity|Hypophosphatemic rickets, autosomal recessive, 2|Arterial calcification, generalized, of infancy, 1",single nucleotide variant,GRCh38
na,na,6,132182844,132182844,ENPP1,Pathogenic/Likely pathogenic,"Arterial calcification, generalized, of infancy, 1|Coronary sclerosis, medial, of infancy|not provided",single nucleotide variant,GRCh37
na,na,6,131861704,131861704,ENPP1,Pathogenic/Likely pathogenic,"Arterial calcification, generalized, of infancy, 1|Coronary sclerosis, medial, of infancy|not provided",single nucleotide variant,GRCh38
na,na,6,132186026,132186026,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1",single nucleotide variant,GRCh37
na,na,6,131864886,131864886,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1",single nucleotide variant,GRCh38
na,na,6,132206903,132212517,ENPP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2",Deletion,GRCh37
na,na,6,131885763,131891377,ENPP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2",Deletion,GRCh38
na,na,6,132181528,132181528,ENPP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2|Arterial calcification, generalized, of infancy, 1",single nucleotide variant,GRCh37
na,na,6,131860388,131860388,ENPP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2|Arterial calcification, generalized, of infancy, 1",single nucleotide variant,GRCh38
na,na,6,132204849,132204850,ENPP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2",Duplication,GRCh37
na,na,6,131883709,131883710,ENPP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2",Duplication,GRCh38
na,na,6,132211575,132211575,ENPP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2",single nucleotide variant,GRCh37
na,na,6,131890435,131890435,ENPP1,Pathogenic,"Hypophosphatemic rickets, autosomal recessive, 2",single nucleotide variant,GRCh38
na,na,6,132179875,132179875,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1|not provided|ENPP1-related disorder",single nucleotide variant,GRCh37
na,na,6,131858735,131858735,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1|not provided|ENPP1-related disorder",single nucleotide variant,GRCh38
na,na,6,132181608,132181609,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1",Deletion,GRCh37
na,na,6,131860468,131860469,ENPP1,Pathogenic,"Arterial calcification, generalized, of infancy, 1",Deletion,GRCh38
na,na,17,39913674,39913675,JUP,Pathogenic,Naxos disease|not provided|Arrhythmogenic right ventricular dysplasia 12;Naxos disease|Arrhythmogenic right ventricular dysplasia 12,Deletion,GRCh37
na,na,17,41757422,41757423,JUP,Pathogenic,Naxos disease|not provided|Arrhythmogenic right ventricular dysplasia 12;Naxos disease|Arrhythmogenic right ventricular dysplasia 12,Deletion,GRCh38
na,na,17,39927988,39927989,JUP,Uncertain significance,Arrhythmogenic right ventricular dysplasia 12|Arrhythmogenic right ventricular dysplasia 12;Naxos disease,Microsatellite,GRCh37
na,na,17,41771736,41771737,JUP,Uncertain significance,Arrhythmogenic right ventricular dysplasia 12|Arrhythmogenic right ventricular dysplasia 12;Naxos disease,Microsatellite,GRCh38
na,na,6,2948930,2948930,SERPINB6,Pathogenic,Autosomal recessive nonsyndromic hearing loss 91,single nucleotide variant,GRCh37
na,na,6,2948696,2948696,SERPINB6,Pathogenic,Autosomal recessive nonsyndromic hearing loss 91,single nucleotide variant,GRCh38
na,na,3,87311311,87311311,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",single nucleotide variant,GRCh37
na,na,3,87262161,87262161,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",single nucleotide variant,GRCh38
na,na,3,87309109,87309109,POU1F1,Conflicting classifications of pathogenicity,"Pituitary hormone deficiency, combined, 1|not provided",single nucleotide variant,GRCh37
na,na,3,87259959,87259959,POU1F1,Conflicting classifications of pathogenicity,"Pituitary hormone deficiency, combined, 1|not provided",single nucleotide variant,GRCh38
na,na,3,87311353,87311353,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",single nucleotide variant,GRCh37
na,na,3,87262203,87262203,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",single nucleotide variant,GRCh38
na,na,3,87325542,87325542,POU1F1,Likely pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",single nucleotide variant,GRCh37
na,na,3,87276392,87276392,POU1F1,Likely pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",single nucleotide variant,GRCh38
na,na,3,87313449,87313449,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1|Combined pituitary hormone deficiencies, genetic form",single nucleotide variant,GRCh37
na,na,3,87264299,87264299,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1|Combined pituitary hormone deficiencies, genetic form",single nucleotide variant,GRCh38
na,na,3,87309172,87309172,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh37
na,na,3,87260022,87260022,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh38
na,na,3,87313473,87313473,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh37
na,na,3,87264323,87264323,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh38
na,na,3,87309205,87309205,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh37
na,na,3,87260055,87260055,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh38
na,na,3,87309173,87309173,POU1F1,Likely pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",Deletion,GRCh37
na,na,3,87260023,87260023,POU1F1,Likely pathogenic,"Pituitary hormone deficiency, combined, 1|not provided",Deletion,GRCh38
na,na,3,87311248,87311248,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh37
na,na,3,87262098,87262098,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh38
na,na,3,87313444,87313444,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh37
na,na,3,87264294,87264294,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh38
na,na,3,87309232,87309232,POU1F1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 1|POU1F1-related disorder|not provided|Combined pituitary hormone deficiencies, genetic form",single nucleotide variant,GRCh37
na,na,3,87260082,87260082,POU1F1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 1|POU1F1-related disorder|not provided|Combined pituitary hormone deficiencies, genetic form",single nucleotide variant,GRCh38
na,na,3,87311310,87311310,POU1F1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 1|not provided|Combined pituitary hormone deficiencies, genetic form|POU1F1-related disorder",single nucleotide variant,GRCh37
na,na,3,87262160,87262160,POU1F1,Pathogenic/Likely pathogenic,"Pituitary hormone deficiency, combined, 1|not provided|Combined pituitary hormone deficiencies, genetic form|POU1F1-related disorder",single nucleotide variant,GRCh38
na,na,3,87309144,87309145,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",Duplication,GRCh37
na,na,3,87259994,87259995,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",Duplication,GRCh38
na,na,3,87311288,87311288,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh37
na,na,3,87262138,87262138,POU1F1,Pathogenic,"Pituitary hormone deficiency, combined, 1",single nucleotide variant,GRCh38
na,na,16,47630337,47630338,PHKB,Pathogenic,Glycogen storage disease IXb,Duplication,GRCh37
na,na,16,47596426,47596427,PHKB,Pathogenic,Glycogen storage disease IXb,Duplication,GRCh38
na,na,16,47684830,47684830,PHKB,Pathogenic/Likely pathogenic,Glycogen storage disease IXb|not provided,single nucleotide variant,GRCh37
na,na,16,47650919,47650919,PHKB,Pathogenic/Likely pathogenic,Glycogen storage disease IXb|not provided,single nucleotide variant,GRCh38
na,na,16,47536900,47536900,PHKB,Pathogenic/Likely pathogenic,Glycogen storage disease IXb|Glycogen phosphorylase kinase deficiency,single nucleotide variant,GRCh37
na,na,16,47502989,47502989,PHKB,Pathogenic/Likely pathogenic,Glycogen storage disease IXb|Glycogen phosphorylase kinase deficiency,single nucleotide variant,GRCh38
na,na,16,47630336,47630336,PHKB,Pathogenic,Glycogen storage disease IXb|Glycogen phosphorylase kinase deficiency|PHKB-related disorder,single nucleotide variant,GRCh37
na,na,16,47596425,47596425,PHKB,Pathogenic,Glycogen storage disease IXb|Glycogen phosphorylase kinase deficiency|PHKB-related disorder,single nucleotide variant,GRCh38
na,na,16,47730319,47730319,PHKB,Uncertain significance,Glycogen storage disease IXb,single nucleotide variant,GRCh37
na,na,16,47696408,47696408,PHKB,Uncertain significance,Glycogen storage disease IXb,single nucleotide variant,GRCh38
na,na,16,47536948,47536948,PHKB,Conflicting classifications of pathogenicity,Glycogen storage disease IXb|not specified|not provided,single nucleotide variant,GRCh37
na,na,16,47503037,47503037,PHKB,Conflicting classifications of pathogenicity,Glycogen storage disease IXb|not specified|not provided,single nucleotide variant,GRCh38
na,na,7,56088812,56088812,PSPH,Uncertain significance,Deficiency of phosphoserine phosphatase|not provided,single nucleotide variant,GRCh37
na,na,7,56021119,56021119,PSPH,Uncertain significance,Deficiency of phosphoserine phosphatase|not provided,single nucleotide variant,GRCh38
na,na,7,56087413,56087413,PSPH,Pathogenic,Deficiency of phosphoserine phosphatase,single nucleotide variant,GRCh37
na,na,7,56019720,56019720,PSPH,Pathogenic,Deficiency of phosphoserine phosphatase,single nucleotide variant,GRCh38
na,na,16,30762591,30762592,PHKG2,Pathogenic,Glycogen storage disease IXc,Duplication,GRCh37
na,na,16,30751270,30751271,PHKG2,Pathogenic,Glycogen storage disease IXc,Duplication,GRCh38
na,na,16,30767512,30767512,PHKG2,Pathogenic,Glycogen storage disease IXc,single nucleotide variant,GRCh37
na,na,16,30756191,30756191,PHKG2,Pathogenic,Glycogen storage disease IXc,single nucleotide variant,GRCh38
na,na,16,30762915,30762915,PHKG2,Pathogenic,Glycogen storage disease IXc,single nucleotide variant,GRCh37
na,na,16,30751594,30751594,PHKG2,Pathogenic,Glycogen storage disease IXc,single nucleotide variant,GRCh38
na,na,16,30762461,30762461,PHKG2,Pathogenic,Glycogen storage disease IXc|not provided,single nucleotide variant,GRCh37
na,na,16,30751140,30751140,PHKG2,Pathogenic,Glycogen storage disease IXc|not provided,single nucleotide variant,GRCh38
na,na,16,30762873,30762873,PHKG2,Pathogenic,Glycogen storage disease IXc,Deletion,GRCh37
na,na,16,30751552,30751552,PHKG2,Pathogenic,Glycogen storage disease IXc,Deletion,GRCh38
na,na,16,30764755,30764755,PHKG2,Pathogenic,Glycogen storage disease IXc,single nucleotide variant,GRCh37
na,na,16,30753434,30753434,PHKG2,Pathogenic,Glycogen storage disease IXc,single nucleotide variant,GRCh38
na,na,16,30767717,30767717,PHKG2,Pathogenic,Glycogen storage disease IXc,single nucleotide variant,GRCh37
na,na,16,30756396,30756396,PHKG2,Pathogenic,Glycogen storage disease IXc,single nucleotide variant,GRCh38
na,na,14,64892470,64892470,MTHFD1,Conflicting classifications of pathogenicity,"Spina bifida, folate-sensitive, susceptibility to|not provided|Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia|not specified",single nucleotide variant,GRCh37
na,na,14,64425752,64425752,MTHFD1,Conflicting classifications of pathogenicity,"Spina bifida, folate-sensitive, susceptibility to|not provided|Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia|not specified",single nucleotide variant,GRCh38
na,na,14,64908845,64908845,MTHFD1,Benign/Likely benign,"Neural tube defects, folate-sensitive, susceptibility to|not specified|Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia|not provided",single nucleotide variant,GRCh37
na,na,14,64442127,64442127,MTHFD1,Benign/Likely benign,"Neural tube defects, folate-sensitive, susceptibility to|not specified|Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia|not provided",single nucleotide variant,GRCh38
na,na,20,44548193,44548193,PLTP,Benign,RECLASSIFIED - PLTP POLYMORPHISM,single nucleotide variant,GRCh37
na,na,20,45919554,45919554,PLTP,Benign,RECLASSIFIED - PLTP POLYMORPHISM,single nucleotide variant,GRCh38
na,na,1,20304913,20304914,PLA2G2A,Pathogenic,Familial colorectal cancer,Microsatellite,GRCh37
na,na,1,19978420,19978421,PLA2G2A,Pathogenic,Familial colorectal cancer,Microsatellite,GRCh38
na,na,6,118880109,118880109,PLN,Pathogenic,Dilated cardiomyopathy 1P|not provided|Primary dilated cardiomyopathy|Cardiomyopathy,single nucleotide variant,GRCh37
na,na,6,118558946,118558946,PLN,Pathogenic,Dilated cardiomyopathy 1P|not provided|Primary dilated cardiomyopathy|Cardiomyopathy,single nucleotide variant,GRCh38
na,na,6,118880200,118880200,PLN,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1P|Hypertrophic cardiomyopathy 18|Sudden cardiac death|Cardiac arrest|Hypertrophic cardiomyopathy|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy 18;Dilated cardiomyopathy 1P|Intrinsic cardiomyopathy,single nucleotide variant,GRCh37
na,na,6,118559037,118559037,PLN,Pathogenic/Likely pathogenic,Dilated cardiomyopathy 1P|Hypertrophic cardiomyopathy 18|Sudden cardiac death|Cardiac arrest|Hypertrophic cardiomyopathy|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy 18;Dilated cardiomyopathy 1P|Intrinsic cardiomyopathy,single nucleotide variant,GRCh38
na,na,19,34868480,34868480,GPI,Uncertain significance,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,19,34377575,34377575,GPI,Uncertain significance,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,19,34884949,34884949,GPI,Pathogenic/Likely pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,19,34394044,34394044,GPI,Pathogenic/Likely pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,19,34890838,34890838,GPI,Conflicting classifications of pathogenicity,Hemolytic anemia due to glucophosphate isomerase deficiency|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,19,34399933,34399933,GPI,Conflicting classifications of pathogenicity,Hemolytic anemia due to glucophosphate isomerase deficiency|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,19,34890879,34890879,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency|not provided,single nucleotide variant,GRCh37
na,na,19,34399974,34399974,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,34869876,34869876,GPI,Conflicting classifications of pathogenicity,Hemolytic anemia due to glucophosphate isomerase deficiency|not provided,single nucleotide variant,GRCh37
na,na,19,34378971,34378971,GPI,Conflicting classifications of pathogenicity,Hemolytic anemia due to glucophosphate isomerase deficiency|not provided,single nucleotide variant,GRCh38
na,na,19,34856230,34856230,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,19,34365325,34365325,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,19,34884925,34884925,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,19,34394020,34394020,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,19,34884937,34884937,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,19,34394032,34394032,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,19,34856185,34856185,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,19,34365280,34365280,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,19,34887267,34887267,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh37
na,na,19,34396362,34396362,GPI,Pathogenic,Hemolytic anemia due to glucophosphate isomerase deficiency,single nucleotide variant,GRCh38
na,na,1,64095192,64095192,PGM1,Pathogenic,PGM1-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,1,63629521,63629521,PGM1,Pathogenic,PGM1-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,1,64114187,64114187,PGM1,Pathogenic,PGM1-congenital disorder of glycosylation,single nucleotide variant,GRCh37
na,na,1,63648516,63648516,PGM1,Pathogenic,PGM1-congenital disorder of glycosylation,single nucleotide variant,GRCh38
na,na,3,178952085,178952085,PIK3CA,Pathogenic,"Breast adenocarcinoma|Carcinoma of colon|Hepatocellular carcinoma|Non-small cell lung carcinoma|Seborrheic keratosis|OVARIAN CANCER, EPITHELIAL, SOMATIC|CLOVES syndrome|Ovarian neoplasm|PIK3CA related overgrowth syndrome|Neoplasm|Rosette-forming glioneuronal tumor|not provided|Lip and oral cavity carcinoma|CEREBRAL CAVERNOUS MALFORMATIONS 4, SOMATIC|CLAPO syndrome|Cerebrofacial Vascular Metameric Syndrome (CVMS)|MACRODACTYLY, SOMATIC|Abnormal cardiovascular system morphology|Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes|Megalencephaly-capillary malformation-polymicrogyria syndrome|Segmental undergrowth associated with mainly venous malformation with capillary component|Segmental undergrowth associated with lymphatic malformation|Gastric cancer|Congenital macrodactylia|Breast carcinoma|PIK3CA-related disorder|Klippel-Trenaunay-like-Syndrome|Rare venous malformation|PIK3CA-Related Overgrowth Spectrum Disorders|Rare combined vascular malformation",single nucleotide variant,GRCh37
na,na,3,179234297,179234297,PIK3CA,Pathogenic,"Breast adenocarcinoma|Carcinoma of colon|Hepatocellular carcinoma|Non-small cell lung carcinoma|Seborrheic keratosis|OVARIAN CANCER, EPITHELIAL, SOMATIC|CLOVES syndrome|Ovarian neoplasm|PIK3CA related overgrowth syndrome|Neoplasm|Rosette-forming glioneuronal tumor|not provided|Lip and oral cavity carcinoma|CEREBRAL CAVERNOUS MALFORMATIONS 4, SOMATIC|CLAPO syndrome|Cerebrofacial Vascular Metameric Syndrome (CVMS)|MACRODACTYLY, SOMATIC|Abnormal cardiovascular system morphology|Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes|Megalencephaly-capillary malformation-polymicrogyria syndrome|Segmental undergrowth associated with mainly venous malformation with capillary component|Segmental undergrowth associated with lymphatic malformation|Gastric cancer|Congenital macrodactylia|Breast carcinoma|PIK3CA-related disorder|Klippel-Trenaunay-like-Syndrome|Rare venous malformation|PIK3CA-Related Overgrowth Spectrum Disorders|Rare combined vascular malformation",single nucleotide variant,GRCh38
na,na,3,178952085,178952085,PIK3CA,Pathogenic,"Breast adenocarcinoma|PIK3CA related overgrowth syndrome|CLOVES syndrome|Stroke disorder;Macrodactyly of toe|Ovarian neoplasm|CLAPO syndrome|Cowden syndrome 1|Megalencephaly-capillary malformation-polymicrogyria syndrome|CEREBRAL CAVERNOUS MALFORMATIONS 4, SOMATIC|Hemihypertrophy|not provided|Colorectal cancer|Cavernous lymphangioma|Neoplasm|Inborn genetic diseases",single nucleotide variant,GRCh37
na,na,3,179234297,179234297,PIK3CA,Pathogenic,"Breast adenocarcinoma|PIK3CA related overgrowth syndrome|CLOVES syndrome|Stroke disorder;Macrodactyly of toe|Ovarian neoplasm|CLAPO syndrome|Cowden syndrome 1|Megalencephaly-capillary malformation-polymicrogyria syndrome|CEREBRAL CAVERNOUS MALFORMATIONS 4, SOMATIC|Hemihypertrophy|not provided|Colorectal cancer|Cavernous lymphangioma|Neoplasm|Inborn genetic diseases",single nucleotide variant,GRCh38
na,na,3,178936094,178936094,PIK3CA,Likely pathogenic,Breast adenocarcinoma|PIK3CA related overgrowth syndrome,single nucleotide variant,GRCh37
na,na,3,179218306,179218306,PIK3CA,Likely pathogenic,Breast adenocarcinoma|PIK3CA related overgrowth syndrome,single nucleotide variant,GRCh38
na,na,3,178936091,178936091,PIK3CA,Pathogenic/Likely pathogenic,"Carcinoma of colon|OVARIAN CANCER, EPITHELIAL, SOMATIC|Seborrheic keratosis|Breast adenocarcinoma|Non-small cell lung carcinoma|Megalencephaly-capillary malformation-polymicrogyria syndrome|Sarcoma|Ovarian neoplasm|not provided|Abnormal cardiovascular system morphology|CLOVES syndrome|PIK3CA related overgrowth syndrome|Gallbladder cancer|Cerebrofacial Vascular Metameric Syndrome (CVMS)|Eccrine angiomatous hamartoma|Segmental undergrowth associated with lymphatic malformation|Gastric cancer|Angioosteohypertrophic syndrome|Rare venous malformation|Rare combined vascular malformation|PIK3CA overgrowth syndrome|HEMIFACIAL MYOHYPERPLASIA, SOMATIC|Neoplasm",single nucleotide variant,GRCh37
na,na,3,179218303,179218303,PIK3CA,Pathogenic/Likely pathogenic,"Carcinoma of colon|OVARIAN CANCER, EPITHELIAL, SOMATIC|Seborrheic keratosis|Breast adenocarcinoma|Non-small cell lung carcinoma|Megalencephaly-capillary malformation-polymicrogyria syndrome|Sarcoma|Ovarian neoplasm|not provided|Abnormal cardiovascular system morphology|CLOVES syndrome|PIK3CA related overgrowth syndrome|Gallbladder cancer|Cerebrofacial Vascular Metameric Syndrome (CVMS)|Eccrine angiomatous hamartoma|Segmental undergrowth associated with lymphatic malformation|Gastric cancer|Angioosteohypertrophic syndrome|Rare venous malformation|Rare combined vascular malformation|PIK3CA overgrowth syndrome|HEMIFACIAL MYOHYPERPLASIA, SOMATIC|Neoplasm",single nucleotide variant,GRCh38
na,na,3,178936092,178936092,PIK3CA,Pathogenic,Epidermal nevus|Carcinoma of colon|PIK3CA related overgrowth syndrome,single nucleotide variant,GRCh37
na,na,3,179218304,179218304,PIK3CA,Pathogenic,Epidermal nevus|Carcinoma of colon|PIK3CA related overgrowth syndrome,single nucleotide variant,GRCh38
na,na,3,178936094,178936094,PIK3CA,Conflicting classifications of pathogenicity,"Carcinoma of colon|OVARIAN CANCER, EPITHELIAL, SOMATIC|Prostate cancer|PIK3CA related overgrowth syndrome|Ovarian neoplasm|Segmental undergrowth associated with mainly venous malformation with capillary component|not provided|Megalencephaly-capillary malformation-polymicrogyria syndrome",single nucleotide variant,GRCh37
na,na,3,179218306,179218306,PIK3CA,Conflicting classifications of pathogenicity,"Carcinoma of colon|OVARIAN CANCER, EPITHELIAL, SOMATIC|Prostate cancer|PIK3CA related overgrowth syndrome|Ovarian neoplasm|Segmental undergrowth associated with mainly venous malformation with capillary component|not provided|Megalencephaly-capillary malformation-polymicrogyria syndrome",single nucleotide variant,GRCh38
na,na,3,178952146,178952147,PIK3CA,Likely pathogenic,Hepatocellular carcinoma|PIK3CA related overgrowth syndrome|Gastric cancer,Duplication,GRCh37
na,na,3,179234358,179234359,PIK3CA,Likely pathogenic,Hepatocellular carcinoma|PIK3CA related overgrowth syndrome|Gastric cancer,Duplication,GRCh38
na,na,3,178936092,178936092,PIK3CA,Pathogenic,Hepatocellular carcinoma|Ovarian neoplasm|Abnormal cardiovascular system morphology,single nucleotide variant,GRCh37
na,na,3,179218304,179218304,PIK3CA,Pathogenic,Hepatocellular carcinoma|Ovarian neoplasm|Abnormal cardiovascular system morphology,single nucleotide variant,GRCh38
na,na,2,233243586,233243586,ALPP,Benign,"ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-1 POLYMORPHISM",single nucleotide variant,GRCh37
na,na,2,232378876,232378876,ALPP,Benign,"ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-1 POLYMORPHISM",single nucleotide variant,GRCh38
na,na,2,233243586,233243586,ALPP,Benign,"ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-3 POLYMORPHISM|not provided",single nucleotide variant,GRCh37
na,na,2,232378876,232378876,ALPP,Benign,"ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-3 POLYMORPHISM|not provided",single nucleotide variant,GRCh38
na,na,1,21890596,21890596,ALPL,Pathogenic,Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia,single nucleotide variant,GRCh37
na,na,1,21564103,21564103,ALPL,Pathogenic,Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia,single nucleotide variant,GRCh38
na,na,1,21887619,21887619,ALPL,Pathogenic,Infantile hypophosphatasia|Adult hypophosphatasia|not provided|Hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh37
na,na,1,21561126,21561126,ALPL,Pathogenic,Infantile hypophosphatasia|Adult hypophosphatasia|not provided|Hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh38
na,na,1,21900176,21900176,ALPL,Pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|Adult hypophosphatasia|not provided|Hypophosphatasia|Osteogenesis imperfecta|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh37
na,na,1,21573683,21573683,ALPL,Pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|Adult hypophosphatasia|not provided|Hypophosphatasia|Osteogenesis imperfecta|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh38
na,na,1,21887620,21887620,ALPL,Likely pathogenic,Infantile hypophosphatasia|not provided|Adult hypophosphatasia|Hypophosphatasia,single nucleotide variant,GRCh37
na,na,1,21561127,21561127,ALPL,Likely pathogenic,Infantile hypophosphatasia|not provided|Adult hypophosphatasia|Hypophosphatasia,single nucleotide variant,GRCh38
na,na,1,21890681,21890681,ALPL,Conflicting classifications of pathogenicity,Infantile hypophosphatasia|not provided|not specified,single nucleotide variant,GRCh37
na,na,1,21564188,21564188,ALPL,Conflicting classifications of pathogenicity,Infantile hypophosphatasia|not provided|not specified,single nucleotide variant,GRCh38
na,na,1,21887155,21887155,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Hypophosphatasia|not provided|Adult hypophosphatasia|Childhood hypophosphatasia|Childhood hypophosphatasia;Adult hypophosphatasia;Infantile hypophosphatasia,single nucleotide variant,GRCh37
na,na,1,21560662,21560662,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Hypophosphatasia|not provided|Adult hypophosphatasia|Childhood hypophosphatasia|Childhood hypophosphatasia;Adult hypophosphatasia;Infantile hypophosphatasia,single nucleotide variant,GRCh38
na,na,1,21903131,21903131,ALPL,Pathogenic,Infantile hypophosphatasia,single nucleotide variant,GRCh37
na,na,1,21576638,21576638,ALPL,Pathogenic,Infantile hypophosphatasia,single nucleotide variant,GRCh38
na,na,1,21900187,21900187,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Hypophosphatasia|not provided|Adult hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh37
na,na,1,21573694,21573694,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Hypophosphatasia|not provided|Adult hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh38
na,na,1,21890632,21890632,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|Adult hypophosphatasia|not provided|Hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Odontohypophosphatasia|Osteogenesis imperfecta|Inborn genetic diseases|ALPL-related disorder|See cases,single nucleotide variant,GRCh37
na,na,1,21564139,21564139,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|Adult hypophosphatasia|not provided|Hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Odontohypophosphatasia|Osteogenesis imperfecta|Inborn genetic diseases|ALPL-related disorder|See cases,single nucleotide variant,GRCh38
na,na,1,21902361,21902361,ALPL,Pathogenic,Adult hypophosphatasia|Infantile hypophosphatasia|not provided|Hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Childhood hypophosphatasia|ALPL-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,1,21575868,21575868,ALPL,Pathogenic,Adult hypophosphatasia|Infantile hypophosphatasia|not provided|Hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Childhood hypophosphatasia|ALPL-related disorder|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,21902229,21902229,ALPL,Pathogenic,Infantile hypophosphatasia|not provided|Hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Adult hypophosphatasia|Osteogenesis imperfecta|ALPL-related disorder,single nucleotide variant,GRCh37
na,na,1,21575736,21575736,ALPL,Pathogenic,Infantile hypophosphatasia|not provided|Hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Adult hypophosphatasia|Osteogenesis imperfecta|ALPL-related disorder,single nucleotide variant,GRCh38
na,na,1,21900274,21900274,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Hypophosphatasia|Adult hypophosphatasia|not provided|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh37
na,na,1,21573781,21573781,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Hypophosphatasia|Adult hypophosphatasia|not provided|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh38
na,na,1,21904125,21904125,ALPL,Pathogenic,Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia,Deletion,GRCh37
na,na,1,21577632,21577632,ALPL,Pathogenic,Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia,Deletion,GRCh38
na,na,1,21889712,21889712,ALPL,Pathogenic/Likely pathogenic,Childhood hypophosphatasia|Infantile hypophosphatasia|Hypophosphatasia|not provided|Adult hypophosphatasia|Osteogenesis imperfecta|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Odontohypophosphatasia,single nucleotide variant,GRCh37
na,na,1,21563219,21563219,ALPL,Pathogenic/Likely pathogenic,Childhood hypophosphatasia|Infantile hypophosphatasia|Hypophosphatasia|not provided|Adult hypophosphatasia|Osteogenesis imperfecta|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|Odontohypophosphatasia,single nucleotide variant,GRCh38
na,na,1,21890546,21890546,ALPL,Pathogenic,Childhood hypophosphatasia|Infantile hypophosphatasia|not provided,single nucleotide variant,GRCh37
na,na,1,21564053,21564053,ALPL,Pathogenic,Childhood hypophosphatasia|Infantile hypophosphatasia|not provided,single nucleotide variant,GRCh38
na,na,1,21889651,21889651,ALPL,Pathogenic,Childhood hypophosphatasia|Adult hypophosphatasia|Odontohypophosphatasia|Infantile hypophosphatasia|not provided|Hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh37
na,na,1,21563158,21563158,ALPL,Pathogenic,Childhood hypophosphatasia|Adult hypophosphatasia|Odontohypophosphatasia|Infantile hypophosphatasia|not provided|Hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh38
na,na,1,21890710,21890710,ALPL,Pathogenic,Perinatal lethal hypophosphatasia|Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|ALPL-related disorder|Adult hypophosphatasia;Childhood hypophosphatasia;Infantile hypophosphatasia|Inborn genetic diseases,single nucleotide variant,GRCh37
na,na,1,21564217,21564217,ALPL,Pathogenic,Perinatal lethal hypophosphatasia|Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|ALPL-related disorder|Adult hypophosphatasia;Childhood hypophosphatasia;Infantile hypophosphatasia|Inborn genetic diseases,single nucleotide variant,GRCh38
na,na,1,21903075,21903075,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Perinatal lethal hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|Childhood hypophosphatasia|ALPL-related disorder|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia,single nucleotide variant,GRCh37
na,na,1,21576582,21576582,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Perinatal lethal hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|Childhood hypophosphatasia|ALPL-related disorder|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia,single nucleotide variant,GRCh38
na,na,1,21889628,21889628,ALPL,Pathogenic,Odontohypophosphatasia,single nucleotide variant,GRCh37
na,na,1,21563135,21563135,ALPL,Pathogenic,Odontohypophosphatasia,single nucleotide variant,GRCh38
na,na,1,21903932,21903932,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia,single nucleotide variant,GRCh37
na,na,1,21577439,21577439,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia,single nucleotide variant,GRCh38
na,na,1,21894694,21894694,ALPL,Pathogenic,Childhood hypophosphatasia|Odontohypophosphatasia|not provided|Hypophosphatasia|Infantile hypophosphatasia|Adult hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh37
na,na,1,21568201,21568201,ALPL,Pathogenic,Childhood hypophosphatasia|Odontohypophosphatasia|not provided|Hypophosphatasia|Infantile hypophosphatasia|Adult hypophosphatasia|ALPL-related disorder,single nucleotide variant,GRCh38
na,na,1,21890587,21890587,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|Osteogenesis imperfecta|ALPL-related disorder,single nucleotide variant,GRCh37
na,na,1,21564094,21564094,ALPL,Pathogenic/Likely pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|Childhood hypophosphatasia;Infantile hypophosphatasia;Adult hypophosphatasia|not provided|Hypophosphatasia|Adult hypophosphatasia|Osteogenesis imperfecta|ALPL-related disorder,single nucleotide variant,GRCh38
na,na,1,21896819,21896819,ALPL,Pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|not provided|ALPL-related disorder|Hypophosphatasia|Childhood hypophosphatasia;Adult hypophosphatasia;Infantile hypophosphatasia|Adult hypophosphatasia,single nucleotide variant,GRCh37
na,na,1,21570326,21570326,ALPL,Pathogenic,Infantile hypophosphatasia|Childhood hypophosphatasia|not provided|ALPL-related disorder|Hypophosphatasia|Childhood hypophosphatasia;Adult hypophosphatasia;Infantile hypophosphatasia|Adult hypophosphatasia,single nucleotide variant,GRCh38
na,na,2,277003,277003,ACP1,Benign,ACP1 A/B POLYMORPHISM|not provided,single nucleotide variant,GRCh37
na,na,2,277003,277003,ACP1,Benign,ACP1 A/B POLYMORPHISM|not provided,single nucleotide variant,GRCh38
na,na,7,87082396,87082402,ABCB4,Pathogenic,Progressive familial intrahepatic cholestasis type 3,Deletion,GRCh37
na,na,7,87453080,87453086,ABCB4,Pathogenic,Progressive familial intrahepatic cholestasis type 3,Deletion,GRCh38
na,na,7,87041264,87041264,ABCB4,Pathogenic/Likely pathogenic,"Progressive familial intrahepatic cholestasis type 3|Cholestasis, intrahepatic, of pregnancy, 3|Low phospholipid associated cholelithiasis|not provided",single nucleotide variant,GRCh37
na,na,7,87411948,87411948,ABCB4,Pathogenic/Likely pathogenic,"Progressive familial intrahepatic cholestasis type 3|Cholestasis, intrahepatic, of pregnancy, 3|Low phospholipid associated cholelithiasis|not provided",single nucleotide variant,GRCh38
na,na,7,87069002,87069002,ABCB4,Pathogenic,"Progressive familial intrahepatic cholestasis type 3|Cholestasis, intrahepatic, of pregnancy, 3",Deletion,GRCh37
na,na,7,87439686,87439686,ABCB4,Pathogenic,"Progressive familial intrahepatic cholestasis type 3|Cholestasis, intrahepatic, of pregnancy, 3",Deletion,GRCh38
na,na,7,87069077,87069077,ABCB4,Uncertain significance,"Cholestasis, intrahepatic, of pregnancy, 3|not provided|not specified|ABCB4-related disorder",single nucleotide variant,GRCh37
na,na,7,87439761,87439761,ABCB4,Uncertain significance,"Cholestasis, intrahepatic, of pregnancy, 3|not provided|not specified|ABCB4-related disorder",single nucleotide variant,GRCh38
na,na,7,87076396,87076396,ABCB4,Pathogenic/Likely pathogenic,"Low phospholipid associated cholelithiasis|Cholestasis, intrahepatic, of pregnancy, 3|Progressive familial intrahepatic cholestasis type 3|not provided|Progressive familial intrahepatic cholestasis|Low phospholipid associated cholelithiasis;Cholestasis, intrahepatic, of pregnancy, 3;Progressive familial intrahepatic cholestasis type 3|ABCB4-related disorder",single nucleotide variant,GRCh37
na,na,7,87447080,87447080,ABCB4,Pathogenic/Likely pathogenic,"Low phospholipid associated cholelithiasis|Cholestasis, intrahepatic, of pregnancy, 3|Progressive familial intrahepatic cholestasis type 3|not provided|Progressive familial intrahepatic cholestasis|Low phospholipid associated cholelithiasis;Cholestasis, intrahepatic, of pregnancy, 3;Progressive familial intrahepatic cholestasis type 3|ABCB4-related disorder",single nucleotide variant,GRCh38
na,na,7,87082273,87082273,ABCB4,Benign/Likely benign,"Low phospholipid associated cholelithiasis|not provided|not specified|Progressive familial intrahepatic cholestasis type 3|Cholestasis, intrahepatic, of pregnancy, 3",single nucleotide variant,GRCh37
na,na,7,87452957,87452957,ABCB4,Benign/Likely benign,"Low phospholipid associated cholelithiasis|not provided|not specified|Progressive familial intrahepatic cholestasis type 3|Cholestasis, intrahepatic, of pregnancy, 3",single nucleotide variant,GRCh38
na,na,7,87035609,87035609,ABCB4,Conflicting classifications of pathogenicity,Low phospholipid associated cholelithiasis|not provided|not specified,single nucleotide variant,GRCh37
na,na,7,87406293,87406293,ABCB4,Conflicting classifications of pathogenicity,Low phospholipid associated cholelithiasis|not provided|not specified,single nucleotide variant,GRCh38
na,na,7,87072662,87072663,ABCB4,Pathogenic,"Low phospholipid associated cholelithiasis|Cholestasis, intrahepatic, of pregnancy, 3",Indel,GRCh37
na,na,7,87443346,87443347,ABCB4,Pathogenic,"Low phospholipid associated cholelithiasis|Cholestasis, intrahepatic, of pregnancy, 3",Indel,GRCh38
na,na,7,87053263,87053264,ABCB4,Pathogenic,Progressive familial intrahepatic cholestasis type 3,Duplication,GRCh37
na,na,7,87423947,87423948,ABCB4,Pathogenic,Progressive familial intrahepatic cholestasis type 3,Duplication,GRCh38
na,na,7,87073002,87073002,ABCB4,Pathogenic,Progressive familial intrahepatic cholestasis type 3,single nucleotide variant,GRCh37
na,na,7,87443686,87443686,ABCB4,Pathogenic,Progressive familial intrahepatic cholestasis type 3,single nucleotide variant,GRCh38
na,na,7,87082366,87082366,ABCB4,Pathogenic,"Cholestasis, intrahepatic, of pregnancy, 3|not provided|ABCB4-related disorder|Progressive familial intrahepatic cholestasis type 3",single nucleotide variant,GRCh37
na,na,7,87453050,87453050,ABCB4,Pathogenic,"Cholestasis, intrahepatic, of pregnancy, 3|not provided|ABCB4-related disorder|Progressive familial intrahepatic cholestasis type 3",single nucleotide variant,GRCh38
na,na,7,87060844,87060844,ABCB4,Conflicting classifications of pathogenicity,"Cholestasis, intrahepatic, of pregnancy, 3|Low phospholipid associated cholelithiasis|Progressive familial intrahepatic cholestasis type 3|not specified|not provided|Progressive familial intrahepatic cholestasis type 1|ABCB4-related disorder|Cholestasis, intrahepatic, of pregnancy, 3;Progressive familial intrahepatic cholestasis type 3;Low phospholipid associated cholelithiasis",single nucleotide variant,GRCh37
na,na,7,87431528,87431528,ABCB4,Conflicting classifications of pathogenicity,"Cholestasis, intrahepatic, of pregnancy, 3|Low phospholipid associated cholelithiasis|Progressive familial intrahepatic cholestasis type 3|not specified|not provided|Progressive familial intrahepatic cholestasis type 1|ABCB4-related disorder|Cholestasis, intrahepatic, of pregnancy, 3;Progressive familial intrahepatic cholestasis type 3;Low phospholipid associated cholelithiasis",single nucleotide variant,GRCh38
na,na,7,87195534,87195534,ABCB1,Pathogenic,COLCHICINE RESISTANCE,single nucleotide variant,GRCh37
na,na,7,87566218,87566218,ABCB1,Pathogenic,COLCHICINE RESISTANCE,single nucleotide variant,GRCh38
na,na,22,46614274,46614274,PPARA,Benign,"Hyperapobetalipoproteinemia, susceptibility to",single nucleotide variant,GRCh37
na,na,22,46218377,46218377,PPARA,Benign,"Hyperapobetalipoproteinemia, susceptibility to",single nucleotide variant,GRCh38
na,na,1,94980759,94980759,ABCD3,Uncertain significance,not specified,single nucleotide variant,GRCh37
na,na,1,94515203,94515203,ABCD3,Uncertain significance,not specified,single nucleotide variant,GRCh38
na,na,1,94884084,94884084,ABCD3,Uncertain significance,not specified,single nucleotide variant,GRCh37
na,na,1,94418528,94418528,ABCD3,Uncertain significance,not specified,single nucleotide variant,GRCh38
na,na,8,77896060,77896060,PEX2,Pathogenic,Peroxisome biogenesis disorder 5A (Zellweger)|Peroxisome biogenesis disorder 5B|Zellweger spectrum disorders|Peroxisome biogenesis disorder 5A (Zellweger);Peroxisome biogenesis disorder 5B|Peroxisome biogenesis disorder|PEX2-related disorder|not provided,single nucleotide variant,GRCh37
na,na,8,76983824,76983824,PEX2,Pathogenic,Peroxisome biogenesis disorder 5A (Zellweger)|Peroxisome biogenesis disorder 5B|Zellweger spectrum disorders|Peroxisome biogenesis disorder 5A (Zellweger);Peroxisome biogenesis disorder 5B|Peroxisome biogenesis disorder|PEX2-related disorder|not provided,single nucleotide variant,GRCh38
na,na,8,77896252,77896252,PEX2,Likely pathogenic,Peroxisome biogenesis disorder 5B|Peroxisome biogenesis disorder,single nucleotide variant,GRCh37
na,na,8,76984016,76984016,PEX2,Likely pathogenic,Peroxisome biogenesis disorder 5B|Peroxisome biogenesis disorder,single nucleotide variant,GRCh38
na,na,12,49689404,49689404,PRPH,Conflicting classifications of pathogenicity,"Amyotrophic lateral sclerosis, susceptibility to|not provided|not specified|PRPH-related disorder",single nucleotide variant,GRCh37
na,na,12,49295621,49295621,PRPH,Conflicting classifications of pathogenicity,"Amyotrophic lateral sclerosis, susceptibility to|not provided|not specified|PRPH-related disorder",single nucleotide variant,GRCh38
na,na,10,72358355,72358355,PRF1,Pathogenic,"Familial hemophagocytic lymphohistiocytosis 2|not provided|Autoinflammatory syndrome|Aplastic anemia|Inborn genetic diseases|Aplastic anemia;Familial hemophagocytic lymphohistiocytosis 2;Lymphoma, non-Hodgkin, familial",single nucleotide variant,GRCh37
na,na,10,70598599,70598599,PRF1,Pathogenic,"Familial hemophagocytic lymphohistiocytosis 2|not provided|Autoinflammatory syndrome|Aplastic anemia|Inborn genetic diseases|Aplastic anemia;Familial hemophagocytic lymphohistiocytosis 2;Lymphoma, non-Hodgkin, familial",single nucleotide variant,GRCh38
na,na,10,72360469,72360469,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia,single nucleotide variant,GRCh37
na,na,10,70600713,70600713,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia,single nucleotide variant,GRCh38
na,na,10,72358804,72358804,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Inborn genetic diseases|Familial hemophagocytic lymphohistiocytosis type 1|Autoinflammatory syndrome|Familial hemophagocytic lymphohistiocytosis|Aplastic anemia,single nucleotide variant,GRCh37
na,na,10,70599048,70599048,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Inborn genetic diseases|Familial hemophagocytic lymphohistiocytosis type 1|Autoinflammatory syndrome|Familial hemophagocytic lymphohistiocytosis|Aplastic anemia,single nucleotide variant,GRCh38
na,na,10,72358191,72358191,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2,single nucleotide variant,GRCh37
na,na,10,70598435,70598435,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2,single nucleotide variant,GRCh38
na,na,10,72358443,72358443,PRF1,Uncertain significance,Familial hemophagocytic lymphohistiocytosis 2|not specified,single nucleotide variant,GRCh37
na,na,10,70598687,70598687,PRF1,Uncertain significance,Familial hemophagocytic lymphohistiocytosis 2|not specified,single nucleotide variant,GRCh38
na,na,10,72358641,72358641,PRF1,Pathogenic/Likely pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Familial hemophagocytic lymphohistiocytosis|Aplastic anemia,single nucleotide variant,GRCh37
na,na,10,70598885,70598885,PRF1,Pathogenic/Likely pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Familial hemophagocytic lymphohistiocytosis|Aplastic anemia,single nucleotide variant,GRCh38
na,na,10,72358929,72358929,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2,single nucleotide variant,GRCh37
na,na,10,70599173,70599173,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2,single nucleotide variant,GRCh38
na,na,10,72358722,72358722,PRF1,Conflicting classifications of pathogenicity,Familial hemophagocytic lymphohistiocytosis 2|not specified|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh37
na,na,10,70598966,70598966,PRF1,Conflicting classifications of pathogenicity,Familial hemophagocytic lymphohistiocytosis 2|not specified|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh38
na,na,10,72358173,72358173,PRF1,Pathogenic/Likely pathogenic,"Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia|Autoinflammatory syndrome|Aplastic anemia;Lymphoma, non-Hodgkin, familial;Familial hemophagocytic lymphohistiocytosis 2",single nucleotide variant,GRCh37
na,na,10,70598417,70598417,PRF1,Pathogenic/Likely pathogenic,"Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia|Autoinflammatory syndrome|Aplastic anemia;Lymphoma, non-Hodgkin, familial;Familial hemophagocytic lymphohistiocytosis 2",single nucleotide variant,GRCh38
na,na,10,72360387,72360387,PRF1,Conflicting classifications of pathogenicity; risk factor,"Hemophagocytic lymphohistiocytosis, familial, 2, susceptibility to|not provided|not specified|Familial hemophagocytic lymphohistiocytosis 2|Autoinflammatory syndrome|PRF1-related disorder",single nucleotide variant,GRCh37
na,na,10,70600631,70600631,PRF1,Conflicting classifications of pathogenicity; risk factor,"Hemophagocytic lymphohistiocytosis, familial, 2, susceptibility to|not provided|not specified|Familial hemophagocytic lymphohistiocytosis 2|Autoinflammatory syndrome|PRF1-related disorder",single nucleotide variant,GRCh38
na,na,10,72358314,72358314,PRF1,Uncertain significance,Aplastic anemia|not specified,single nucleotide variant,GRCh37
na,na,10,70598558,70598558,PRF1,Uncertain significance,Aplastic anemia|not specified,single nucleotide variant,GRCh38
na,na,10,72360648,72360648,PRF1,Benign/Likely benign,Aplastic anemia|not specified|Familial hemophagocytic lymphohistiocytosis 2|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh37
na,na,10,70600892,70600892,PRF1,Benign/Likely benign,Aplastic anemia|not specified|Familial hemophagocytic lymphohistiocytosis 2|not provided|Autoinflammatory syndrome,single nucleotide variant,GRCh38
na,na,10,72358386,72358387,PRF1,Pathogenic,"Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia|Aplastic anemia;Lymphoma, non-Hodgkin, familial;Familial hemophagocytic lymphohistiocytosis 2|Familial hemophagocytic lymphohistiocytosis",Deletion,GRCh37
na,na,10,70598630,70598631,PRF1,Pathogenic,"Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia|Aplastic anemia;Lymphoma, non-Hodgkin, familial;Familial hemophagocytic lymphohistiocytosis 2|Familial hemophagocytic lymphohistiocytosis",Deletion,GRCh38
na,na,10,72360452,72360452,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia,Deletion,GRCh37
na,na,10,70600696,70600696,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia,Deletion,GRCh38
na,na,10,72358231,72358231,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia,single nucleotide variant,GRCh37
na,na,10,70598475,70598475,PRF1,Pathogenic,Familial hemophagocytic lymphohistiocytosis 2|Aplastic anemia,single nucleotide variant,GRCh38
na,na,6,32800412,32800412,TAP2,Benign,not specified|MHC class I deficiency|not provided|TAP2 POLYMORPHISM,single nucleotide variant,GRCh37
na,na,6,32832635,32832635,TAP2,Benign,not specified|MHC class I deficiency|not provided|TAP2 POLYMORPHISM,single nucleotide variant,GRCh38
na,na,6,32796751,32796751,TAP2,Benign,MHC class I deficiency|TAP2 POLYMORPHISM,single nucleotide variant,GRCh37
na,na,6,32828974,32828974,TAP2,Benign,MHC class I deficiency|TAP2 POLYMORPHISM,single nucleotide variant,GRCh38
na,na,6,32796685,32796685,TAP2,Benign,MHC class I deficiency|TAP2 POLYMORPHISM,single nucleotide variant,GRCh37
na,na,6,32828908,32828908,TAP2,Benign,MHC class I deficiency|TAP2 POLYMORPHISM,single nucleotide variant,GRCh38
na,na,6,32803059,32803059,TAP2,Pathogenic,MHC class I deficiency 2,single nucleotide variant,GRCh37
na,na,6,32835282,32835282,TAP2,Pathogenic,MHC class I deficiency 2,single nucleotide variant,GRCh38
na,na,6,32800568,32800568,TAP2,Pathogenic,MHC class I deficiency,Deletion,GRCh37
na,na,6,32832791,32832791,TAP2,Pathogenic,MHC class I deficiency,Deletion,GRCh38
